"doi","is_coi_pred","coi_text","is_funded_pred","funding_text","support_1","support_3","support_4","support_5","support_6","support_7","support_8","support_9","support_10","developed_1","received_1","received_2","recipient_1","authors_1","authors_2","thank_1","thank_2","fund_1","fund_2","fund_3","supported_1","financial_1","financial_2","financial_3","grant_1","french_1","common_1","common_2","common_3","common_4","common_5","acknow_1","disclosure_1","disclosure_2","is_register_pred","register_text","is_relevant","is_method","is_NCT","is_explicit","prospero_1","registered_1","registered_2","registered_3","registered_4","registered_5","not_registered_1","registration_1","registration_2","registration_3","registration_4","registry_1","reg_title_1","reg_title_2","reg_title_3","reg_title_4","funded_ct_1","ct_2","protocol_1","fund","project"
"10.1001/jama.2023.17002",TRUE,"Conflict of Interest Disclosures: Dr Grams Dr Stengel reported receiving grants from GSK reported receiving nonfinancial support from Fresenius Medical Care Boehringer Ingelheim and <section> KDIGO (Kidney Disease: Improving Global Vifor Fresenius. Dr Wheeler reported receiving Outcomes) and the Korean Society of Nephrology personal fees from Astellas AstraZeneca Bayer and receiving personal fees from the Nephrology Boehringer Ingelheim Eledon Galderma GSK Self-Assessment Program. Dr Coresh reported Gilead Janssen Merck Sharp and Dohme receiving personal fees from Healthy.io. ProKidney Tricida Vifor and Zydus. Dr Levey Dr Matsushita reported receiving personal fees reported receiving personal fees from AstraZeneca. <section> from Kowa Kyowa Kirin Akebia and AMGA. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Grams Dr Stengel reported receiving grants from GSK reported receiving nonfinancial support from Fresenius Medical Care Boehringer Ingelheim and <section> Funding/Support: The CKD Prognosis Consortium GlaxoSmithKline) Vifor France Boehringer data coordinating center is funded in part by Ingelheim and AstraZeneca.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jama.2023.9106",TRUE,"Conflict of Interest Disclosures: Dr Limaye reported enrolling patients as a site investigator during the conduct of the study and receiving grants and personal fees from Merck and Moderna; serving as chair on a data and safety monitoring board for NobelPharma; receiving grants from Takeda; receiving fees paid to University of Washington from AiCuris and Vera for consulting activities; and personal fees from AlloVir and GSK outside the submitted work. Dr Budde reported receiving grants from MSD to the institution and personal fees from MSD during the conduct of the study and personal fees from Takeda Chiesi Natera Aicuris Astellas Astra CareDx Carealytics Neovii Paladin Pirche Stada Veloxis Kirche and Vifor outside the submitted work. Dr Humar reported receiving grants from Merck during the conduct of the study and personal fees from Takeda and Merck for serving on an advisory boards and grants from Qiagen for research support outside the submitted work. Dr Vincenti reported receiving grants from Merck during the conduct of the study and being a member of the scientific advisory board. Dr Kuypers reported receiving consulting fees to the institution from Merck during the conduct of the study and fees to the institution from Hansa and Astellas outside the submitted work. Dr Carroll reported receiving grants from Merck during the conduct of the study. Dr Stauffer reported being a current Merck employee. <section> Dr Murata reported being a current employee of Gilead Sciences being a former employee of ViiV Healthcare and Janssen and receiving support for meeting attendance while working at ViiV and Janssen. Drs Strizki Teal Gilbert and Haber reported being employed by Merck during the conduct of the study. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Limaye reported enrolling patients as a site investigator during the conduct of the study and receiving grants and personal fees from Merck and Moderna; serving as chair on a data and safety monitoring board for NobelPharma; receiving grants from Takeda; receiving fees paid to University of Washington from AiCuris and Vera for consulting activities; and personal fees from AlloVir and GSK outside the submitted work. <section> Funding/Support: This study was funded by Merck Sharp & Dohme LLC a subsidiary of Merck & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamacardio.2023.1090",TRUE,"Conflict of Interest Disclosures: Dr Butler reports consulting fees from Abbott Adrenomed American Regent Amgen Applied Therapeutics AstraZeneca Bayer Boehringer Ingelheim Cardior CVRx Eli Lilly Foundry G3 Pharma Imbria Impulse Dynamics Innolife Janssen LivaNova Luitpold Medtronic Merck Novartis NovoNordisk Occlutech Pfizer Relypsa Roche Sanofi Sequana Medical V-Wave Ltd and Vifor. No other disclosures were",TRUE,"Dr Filippatos reports lectures and/or committee member contributions in trials sponsored by Medtronic Vifor Servier Novartis Bayer Amgen and Boehringer Ingelheim as well as grants from the European Union outside the submitted work. Dr Anker has received grants from Vifor; has received personal fees from Vifor Bayer Boehringer Ingelheim Brahms Novartis Occlutech Servier Impulse Dynamics Cardiac Dimensions SAB Biotherapeutics Thermo Fisher Scientific and V-Wave and has received grants and personal fees from Abbott Vascular outside the submitted work. <section> Funding/Support: The EMPEROR-Preserved trial was funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamacardio.2023.1505",TRUE,"Conflict of Interest Disclosures: Dr Agarwal reported receiving personal fees and nonfinancial support from Bayer Healthcare Pharmaceuticals Akebia Therapeutics AstraZeneca Boehringer Ingelheim Eli Lilly Vifor Pharma and Lexicon; data safety monitoring board fees from Chinook and Vertex; being associate editor of the American Journal of Nephrology and Nephrology Dialysis Transplantation; being an author for UpToDate; and receiving research grants from the US Veterans Administration and the National Institutes of Health. No other disclosures were reported. <section> Role of the Funder/Sponsor: The funders had no role in the design of the study; Bayer AG employees included as authors (please refer to disclosures section for details) were either physicians or statisticians and as such participated in the collection management analysis and interpretation of the data as well as the preparation review and approval of the manuscript and decision to submit the manuscript for publication.",TRUE,"<section> Conflict of Interest Disclosures: Dr Agarwal reported receiving personal fees and nonfinancial support from Bayer Healthcare Pharmaceuticals Akebia Therapeutics AstraZeneca Boehringer Ingelheim Eli Lilly Vifor Pharma and Lexicon; data safety monitoring board fees from Chinook and Vertex; being associate editor of the American Journal of Nephrology and Nephrology Dialysis Transplantation; being an author for UpToDate; and receiving research grants from the US Veterans Administration and the National Institutes of Health. <section> Funding/Support: This work was supported by Bayer AG who funded the FIDELIO-DKD and FIGARO-DKD studies and the combined analysis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamacardio.2023.3003",TRUE,"Conflict of Interest Disclosures: Dr Balligand reported receiving grants from the European Commission during the conduct of the study grants from Novartis and Daiichi-Sankyo outside the submitted work and consulting fees from Amgen Novartis and Daiichi-Sankyo outside the submitted work. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Balligand reported receiving grants from the European Commission during the conduct of the study grants from Novartis and Daiichi-Sankyo outside the submitted work and consulting fees from Amgen Novartis and Daiichi-Sankyo outside the submitted work. <section> Funding/Support: This study was funded by 2020;324(15):1512-1521. doi:10.1001/jama.2020.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamadermatol.2023.1729",TRUE,"Conflict of Interest Disclosures: Dr Carreira reported grants from Spanish Ministry of Health during the conduct of the study. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Carreira reported grants from Spanish Ministry of Health during the conduct of the study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2022.55599",TRUE,"Conflict of Interest Disclosures: Dr de Kraker reported receiving grants from Innovative Medicines Initiative Joint Undertaking outside the submitted work. Dr Thiabaud reported receiving grants from the Federal Office of Public Health during the conduct of the study. Dr Schreiber reported receiving grants from the Federal Office of Public Health during the conduct of the study and receiving grants from Pfizer and Gilead to attend PWS; receiving grants from the Medical Faculty of the University of Zürich; receiving personal fees from Pfizer; and serving on the advisory boards of Pfizer and Gilead outside of submitted work. Dr Iten reported receiving support for data collection form the Federal Office of Public Health during the conduct of the study. Dr Harbarth reported receiving grants from the Federal Office of Public Health during the conduct of the study and receiving grants from European Commission outside the submitted work. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr de Kraker reported receiving grants from Innovative Medicines Initiative Joint Undertaking outside the submitted work. <section> Funding/Support: The COVID-19 Hospitalbased Surveillance (CH-SUR) system was supported by the Swiss Federal Office of Public Health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2022.56208",TRUE,"Conflict of Interest Disclosures: Dr Zepp reported receiving grants from Gemeinsamer Bundesausschuss Government Project support during the conduct of the study; personal fees from Member Data Safety Monitoring Board (DSMB) CureVac Development of COVID-19-Vaccine from DSMB IcosaVax from DSMB Coalition for Epidemic Preparedness Innovations (CEPI) and from DSMB-OBSERVER for CEPI/Safety Platform for Emergency Vaccines outside the submitted work; and being a member of the German vaccination program advisory board Ständige Impfkommisson at the Robert Koch Institute in Berlin Germany. Dr Lühmann reported receiving grants from Gemeinsamer Bundesausschuss (Innovationsausschuss) during the conduct of the study. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Zepp reported receiving grants from Gemeinsamer Bundesausschuss Government Project support during the conduct of the study; personal fees from Member Data Safety Monitoring Board (DSMB) CureVac Development of COVID-19-Vaccine from DSMB IcosaVax from DSMB Coalition for Epidemic Preparedness Innovations (CEPI) and from DSMB-OBSERVER for CEPI/Safety Platform for Emergency Vaccines outside the submitted work; and being a member of the German vaccination program advisory board Ständige Impfkommisson at the Robert Koch Institute in Berlin Germany. <section> Funding/Support: The study was funded by the Innovation Fund of the German Joint Federal Committee (G-BA Berlin Germany Grant No.: VSF1_2021-194).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.0090",TRUE,"Conflict of Interest Disclosures: Dr Rühle reported receiving personal fees from Novocure grants from Novocure and personal fees from Merck Healthcare Germany Darmstadt outside the submitted work. Dr Gkika reported receiving personal fees from Novocure IntraOp and AstraZeneca outside the submitted work. Dr Belka reported receiving grants from Helmholtz Zentrum Munich nonfinancial support from LMU Munich and grants from the German Cancer Consortium during the conduct of the study; personal fees from Merck Darmstadt personal fees from Bristol-Myers Squibb and grants from Elekta outside the submitted work. Dr Mayer reported receiving grants from Varian Inc during the conduct of the study and personal fees from Merck Serono GmbH outside the submitted work. Dr Nicolay reported receiving speaker honoraria from Merck Healthcare Germany Darmstadt and a research grant from Novocure. No other disclosures were reported.",TRUE,"<section> Funding/Support: Dr Rühle was supported by the IMM-PACT-Programme for Clinician Scientists Department of Medicine II Medical Center–University of Freiburg and Faculty of Medicine University of Freiburg funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)–413517907.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.12810",TRUE,"Conflict of Interest Disclosures: Dr Desrivières reported receiving grants from the Medical Research Council the Medical Research Foundation the European Commission and Innovate UK outside the submitted work. No other disclosures were reported.",TRUE,"<section> Funding/Support: The Indian Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA) was supported by grant ICMR/MRC/3/M/2015-NCD-I from the the Indian Council of Medical Research and Newton Grant MR/N000390/1 from the Medical Research Council United Kingdom. This study was also supported by grant 101057429 from the European Union–funded Horizon Europe project EnvironMENTAL; Horizon 2020– funded advanced grant ‘STRATIFY’ 695313 from the European Research Council; grant SGA3 945539 from the Human Brain Project; grant 529 R01DA049238 from the National Institutes of Health; grant 675346 from the German Research Foundation; grant 82202093 from the National Natural Science Foundation of China; and the Chinese National Highend Foreign Expert Recruitment Plan and the Alexander von Humboldt Foundation (Dr Schumann).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.13734",TRUE,"Conflict of Interest Disclosures: Dr Schneider reported receiving personal fees from Biogen and Eisai outside the submitted work. No other disclosures were reported.",TRUE,"<section> Funding/Support: Dr Frikke-Schmidt was funded by grants from the Lundbeck Foundation (grant No.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.1870",TRUE,"Conflict of Interest Disclosures: Dr Eckardt reported receiving grants from AstraZeneca Bayer CSL Vifor and Evotec during the conduct of the study and personal fees from Akebia Therapeutics AstraZeneca Bayer Otsuka Pharmaceutical Company Retrophin (now Travere Therapeutics) and Sanofi Aventis outside the submitted work. <section> Dr Heerspink reported receiving grants from AstraZeneca Janssen Pharmaceuticals and Novo Nordisk and personal fees from AstraZeneca Bayer Boehringer Ingelheim Chinook Therapeutics CSL Behring Dimerix Limited Eli Lilly and Company Gilead Sciences Janssen Pharmaceuticals Novo Nordisk and Travere Therapeutics outside the submitted work. Dr Schmid reported receiving grants from Travere Therapeutics outside the submitted work. Dr Oberbauer reported receiving personal fees from AstraZeneca CSL Vifor and Hansa Biopharma outside the submitted work. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Eckardt reported receiving grants from AstraZeneca Bayer CSL Vifor and Evotec during the conduct of the study and personal fees from Akebia Therapeutics AstraZeneca Bayer Otsuka Pharmaceutical Company Retrophin (now Travere Therapeutics) and Sanofi Aventis outside the submitted work. <section> Funding/Support: This study was supported by grant 115974 from the IMI2 JU (Drs Böger Eckardt and Oberbauer) and grant 01ZX1912B from the German Federal Ministry of Education and Research (Dr Schultheiss). The DIACORE study was supported by a grant from the KFH Foundation for Preventive Medicine (Dr Böger). The GCKD study was supported by grant 01ER0804 from the German Federal Ministry of Education and Research and funding from the KFH Foundation for Preventive Medicine and corporate sponsors.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.22750",TRUE,"Conflict of Interest Disclosures: Mr Mascheroni reported receiving nonfinancial support from KU Leuven and being an employee of Medtronic during the conduct of the study.",TRUE,"<section> Conflict of Interest Disclosures: Mr Mascheroni reported receiving nonfinancial support from KU Leuven and being an employee of Medtronic during the conduct of the study. <section> Funding/Support: This study was supported by Medtronic which provided the training infrastructure and organization.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.24511",TRUE,"Conflict of Interest Disclosures: Dr Stangier reported receiving grants from University of Frankfurt during the conduct of the study. Dr Starck reported receiving grants from University of Frankfurt during the conduct of the study. Dr Gutermann reported receiving grants from Goethe University Frankfurt during the conduct of the study. <section> No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Stangier reported receiving grants from University of Frankfurt during the conduct of the study. <section> Funding/Support: This study was funded by the Federal Commissioner for Migration Integration and Refugees (grant",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.25197",TRUE,"Conflict of Interest Disclosures: None reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.31168",TRUE,"Conflict of Interest Disclosures: Dr Donovan reported receiving grants from the Medical Faculty at Lund University during the conduct of the study. Dr Reinhart reported holding shares from InflaRx who have received an Emergency Use Authorization by the US Food and Drug Administration for for the treatment of viral sepsis related to COVID-19. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Donovan reported receiving grants from the Medical Faculty at Lund University during the conduct of the study. <section> Funding/Support: This study was funded by Swedish government funds for clinical research (to Drs Linder and Mellhammar) and the Marta Larsson Foundation (to Dr Linder).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.31410",TRUE,"Conflict of Interest Disclosures: Dr Neves reported being a board member at ASAPbio a nonprofit organization promoting the productive use of preprints in the life sciences. Dr Malički reported being an Editor in Chief of Research Integrity and Peer Review. Dr Amaral reported receiving grants from Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) covering part of the current work personal fees from a CNPq Research Productivity scholarship during the conduct of the study and grants from eLife outside the submitted work and has consistently advocated for the use of preprints over the past 5 years having acted as a pro bono ambassador for ASAPbio in the past. No other disclosures were reported.",TRUE,"<section> Funding/Support: Dr Carneiro and Mr da Costa reported receiving a scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico during the conduct of the study. Mr Lubiana and Ms Andrejew received grants from São Paulo Research Foundation (019/26284-1 and 2019/24553-5 respectively).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.34078",TRUE,"Conflict of Interest Disclosures: Dr Ratheesh reported receiving grants from The University of Melbourne and the Australian National Health and Medical Research Council (NHMRC) during the conduct of the study. Dr McGorry reported receiving grant funding from Janssen-Cilag AstraZeneca Eli Lilly Novartis Pfizer the Colonial Foundation the NHMRC the Australian Research Council the National Alliance for Research on Schizophrenia & Depression the Stanley Foundation the National Institutes of Health Wellcome Trust and the Australian and Victorian governments and receiving honoraria for consultancy and teaching from Janssen-Cilag Eli Lilly Pfizer AstraZeneca Roche Bristol Myers Squibb and Lundbeck. Dr Berk reported receiving grants from the NHMRC; the Medical Research Future Fund; Wellcome Trust; A2 Milk Company; Victorian government Department of Jobs Precincts and Regions; the Meat and Livestock Board; Woolworths; and the Harry Windsor Foundation; receiving personal fees from Allergan AstraZeneca Bioadvantex Bionomics Collaborative Medicinal Development Janssen Lundbeck Merck Otsuka Servier the Milken Foundation Allori for Eisai the Association for Controversies in Psychiatry the American Society for Clinical Pathology Medplan Canada the European Psychiatric Association and Abbott India during the conduct of the study; and having patents issued for modulation of physiological processes and agents useful for same and for modulation of diseases of the central nervous system and related disorders. Dr Nelson reported receiving grants from the NHMRC. No other disclosures were",TRUE,"<section> Conflict of Interest Disclosures: Dr Ratheesh reported receiving grants from The University of Melbourne and the Australian National Health and Medical Research Council (NHMRC) during the conduct of the study. <section> Funding/Support: This work was supported by research grant 1859082 from The University of Melbourne (Dr Ratheesh).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.42107",TRUE,"Conflict of Interest Disclosures: Dr Takahashi reported receiving nonfinancial support from Merck & Co Inc during the conduct of the study and personal fees from AstraZeneca Eli Lilly Pfizer and Eisai and grants from Eisai Kyowa-Hakko Kirin Nippon Kayaku and Taiho outside the submitted work. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Takahashi reported receiving nonfinancial support from Merck & Co Inc during the conduct of the study and personal fees from AstraZeneca Eli Lilly Pfizer and Eisai and grants from Eisai Kyowa-Hakko Kirin Nippon Kayaku and Taiho outside the submitted work. <section> Funding/Support: This study was supported by MSD.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamanetworkopen.2023.43689",TRUE,"Conflict of Interest Disclosures: Dr Schmidt reported receiving advisor fees from Fosanis GmbH outside the submitted work. Dr Hilfenhaus reported receiving speaker fees from AstraZeneca outside the submitted work. Dr Keller reported service on advisory boards for Roche Janssen-Cilag Bristol-Myers Squibb/Celgene Takeda Gilead Pfizer AstraZeneca Lilly and Pentixapharm; he reported receiving clinical research support from Janssen-Cilag Bristol-Myers Squibb and Roche; and he reported receiving travel support from Roche Bristol-Myers Squibb/ Celgene Gilead Lilly Takeda and Janssen-Cilag outside the submitted work. Dr Rieke reported receiving consulting advisory board or speaking fees from Lilly Bayer Roche and Bristol-Myers Squibb outside the submitted work. No other disclosures were reported.",TRUE,"<section> Funding/Support: This project was supported by the Deutsche Forschungsgemeinschaft (No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2022.4782",TRUE,"Conflict of Interest Disclosures: Dr Meinel reported grants from Bangerter-Rhyner Foundation during the conduct of the study. No other administration in emergency situations: the Munich disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Meinel reported grants from Bangerter-Rhyner Foundation during the conduct of the study. <section> Funding/Support: The study was supported by (MR REPAIR).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2022.5128",TRUE,"Conflict of Interest Disclosures: Dr Logroscino <section> No other disclosures were reported. doi:10.1212/WNL.0b013e31821103e6",TRUE,"Dr Rowe was partially supported by grant SUAG/ Dr Seelaar Hardiman Ludolph Moreno Otto Remes Rowe was partially supported by grant 733050513 from Seelaar Solje Stefanova Traykov Jelic Rydell the Netherlands Organisation for Health Research Pender Anderl-Straub Gabilondo Krüger Murley and Development Alzheimer Nederland and the Rittman van der Ende Hartikainen Mehrabian Bluefield Project to Cure Frontotemporal Dementia. <section> Administrative technical or material support: Graff partially supported by N175090 from the Ministry Ludolph Otto Remes Rowe Seelaar Pender of Education and Science Republic of Serbia. <section> Funding/Support: Dr Logroscino was partially 6. Höglinger GU Respondek G Stamelou M et al; supported by grant B84I18000540002 from Movement Disorder Societyendorsed PSP Study the Regione Puglia and CNR for Tecnopolo per Group.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2022.5332",TRUE,"Conflict of Interest Disclosures: Dr Torke reported receiving travel support from EMD Serono and research support from the Universitätsmedizin Göttingen. Dr Weber reported receiving research support from the Deutsche Forschungsgemeinschaft (WE 3547/5-1 WE3547/ 7-1 in association with SFB TRR 274) Novartis TEVA Biogen-Idec Roche Merck and the ProFutura Program of the Universitätsmedizin Göttingen; serving as an editor for PLOS One; receiving travel funding and/or speaker honoraria from Biogen-Idec Merck Serono Novartis Roche TEVA Bayer and Genzyme; and being an employee of the Universitätsmedizin Göttingen and Fraunhofer Gesellschaft Germany. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Torke reported receiving travel support from EMD Serono and research support from the Universitätsmedizin Göttingen.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2023.1792",TRUE,"Conflict of Interest Disclosures: Dr Czorlich has received personal fees from Acasti Pharma outside the submitted work. Dr Lemcke has received grants from the German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung e.V.) and B.Braun Aesculap as well as personal fees from Aesculap Academy outside the submitted work. <section> Dr Meyer has received grants from the Technical University of Munich during the conduct of the study; grants from Zeiss; personal fees from Brainlab and Icotec; royalties from Spineart and Medacta; and owns stock in Sonovum outside the submitted work. Dr Rohde has received nonfinancial support from Zeiss and personal fees from Storz outside the submitted work. No other disclosures were reported.",TRUE,"Dr Lemcke has received grants from the German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung e.V.) and B.Braun Aesculap as well as personal fees from Aesculap Academy outside the submitted work. <section> Dr Meyer has received grants from the Technical University of Munich during the conduct of the study; grants from Zeiss; personal fees from Brainlab and Icotec; royalties from Spineart and Medacta; and owns stock in Sonovum outside the submitted work. <section> Funding/Support: The EARLYDRAIN trial was partially funded by the Center for Stroke Research.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2023.2523",TRUE,"Conflict of Interest Disclosures: Dr Ayroza Galvão the Swiss MS Society Swiss National Science Ribeiro Gomes reported grants from Roche during Foundation Novartis Biogen Merck Bristol Myers the conduct of the study. Dr de Moura Brasil Matos Squibb and Roche outside the submitted work. <section> reported grants from Hoffmann La Roche outside Dr Papadopoulou reported grants from University the submitted work. Dr Pereira reported grants of Basel grants from University Hospital of Basel from CNPq–Conselho Nacional de and grants from Swiss Multiple Sclerosis Society Desenvolvimento Científico e Tecnológico (308172/ during the conduct of the study; advisory board <section> 2018-3) during the conduct of the study. Dr Ribeiro and/or speaking fees to their institution from Monteiro reported grants from CNPq–Conselho AbbVie Eli Lilly Lundbeck and TEVA and Nacional de Desenvolvimento Científico e conference travel support from TEVA outside the Tecnológico during the conduct of the study. Dr submitted work. <section> Schindler reported nonfinancial support from UCB Dr Pröbstel reported advisory board and/or Pharma outside the submitted work. Dr Chien consultant fees from Roche Biogen and Novartis reported grants from Novartis and Alexion during outside the submitted work. No other disclosures the conduct of the study and nonfinancial support were reported.",TRUE,"<section> Funding/Support: The study was funded by an Research Standing Committee on Science outside ECTRIMS Clinical Fellowship and a Swiss the submitted work.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2023.2536",TRUE,"Conflict of Interest Disclosures: Dr Lilja reported grants from The Swedish Research Council (2016-00428) The Swedish Heart-Lung Foundation The Gorthon Foundation The Knutsson Foundation the Hans-Gabriel and Alice Trolle-Wachtmeisters Foundation for Medical Research the Skane County Council’s Research and Development Foundation the Skane University Hospital Foundations; the Swedish National Health System and the Laerdal Foundation during the conduct of the study. Dr Belohlavek reported consultant fees lecture honoraria and personal fees from Abiomed Xenios Resuscitec AstraZeneca Boehringer Ingelheim and Getinge outside the submitted work. Dr Cariou reported personal fees from Bard for lectures outside the submitted work. Dr Eastwood reported being a chief principal investigator of the TAME cardiac arrest trial (NCT03114033) that permitted coenrollment with the TTM2 trial. Dr Grejs reported nonfinancial support from BD to travel to the TTM2 hypothermia symposium outside the submitted work. Dr Hammond reported grants from the National Health and Medical Research Council of Australia Emerging Leader Grant (APP1196320) outside the submitted work. Dr Lascarrou reported personal fees from Zoll and BD and grants from the French Ministry Health Nantes University Hospital and Agence BioMedecine outside the submitted <section> work. Dr Rylander reported nonfinancial support from The Swedish Research Council (2016-00428) during the conduct of the study. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Lilja reported grants from The Swedish Research Council (2016-00428) The Swedish Heart-Lung Foundation The Gorthon Foundation The Knutsson Foundation the Hans-Gabriel and Alice Trolle-Wachtmeisters Foundation for Medical Research the Skane County Council’s Research and Development Foundation the Skane University Hospital Foundations; the Swedish National Health System and the Laerdal Foundation during the conduct of the study. <section> Funding/Support: This work was supported by: The Swedish Research Council (2016-00428) The Swedish Heart-Lung Foundation The Gorthon Foundation The Knutsson Foundation Hans-Gabriel and Alice Trolle-Wachtmeisters Foundation for Medical Research Skane County Council’s Research and Development Foundation The Skane University Hospital Foundations the Swedish National Health System (ALF) the Laerdal Foundation and Dr Hammond was supported by a National Health and Medical Research Council Emerging Leader grant (APP1196320).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaneurol.2023.3284",TRUE,"Conflict of Interest Disclosures: Drs Salvalaggio and Pini and Prof Corbetta reported a patent pending (102022000015360) for the method to compute the tract density index. Dr Lombardi reported receiving personal fees from Bayer and Health4U outside the submitted work. No other disclosures were reported.",TRUE,"<section> Funding/Support: This study was supported by Germany Excellence Strategy EXC 2025-390648296 to the Cluster of Excellence “Matters of Activity. Image Space Material” from the German Research Foundation (Dr Fekonja and Prof Picht); European Union Horizon 2020 research and innovation program grant 818521 from the European Research Council and Investments for the Future Program RRI IMPACT from the University of Bordeaux funded by the French government (Dr Thiebaut De Schotten); and Ricerca Scientifica di Eccellenza 2018 grant 55403 from Fondazione Cassa di Risparmio di Padova e Rovigo grants RF-2008-12366899 and RF-2019-12369300 from Italian Ministero della Salute grant CUP C94I20000420007 from Celeghin Foundation Padova grant 361/18 from BIAL Foundation and European Union Horizon 2020 research and innovation program grants 860563 and 869505 from the European Research Council (Prof Corbetta).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaoto.2023.0841",TRUE,"YT Lam M Alexandru A Anagiotos M Armengot A Burgess N Caversaccio S Crowley S Dheyauldeen N Emiralioglu E Erdem C van Gogh O Gunaydın E Haarman A Harris Isolde Hayn H Ismail-Koch B Karadag C Kempeneers S Kim N Lorent U Ozcelik C Pioch A-L Poirrier A Reula P Yiallouros and A Yumusakhuylu have no conflicts of interest to declare.",TRUE,"<section> The study was supported by a Swiss National Science Foundation Ambizione fellowship (PZ00P3_185923) granted to M Goutaki. The authors participate in the BEAT-PCD clinical research collaboration supported by the European Respiratory Society and most centers participate in the ERN-LUNG (PCD core).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamaoto.2023.3111",TRUE,"Conflict of Interest Disclosures: Dr Hofmann reported being a participant in the BIH-Charité Clinician Scientist Program funded by the Charité– Universitätsmedizin Berlin and the Berlin Institute of Health. No other disclosures were reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamapsychiatry.2023.2949",TRUE,"Conflict of Interest Disclosures: Dr Banaschewski reported personal fees from Eye Level (advisory board) Infectopharm (advisory board) Lundbeck 8. No other disclosures were reported. reward system.",TRUE,"<section> Funding/Support: The study was funded by National Institute on Alcohol Abuse and Alcoholism 14.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamapsychiatry.2023.2983",TRUE,"Conflict of Interest Disclosures: Dr Köhler-Forsberg reported personal fees from WCG Clinical and Lundbeck Pharma A/S outside the submitted work. Dr Gamradt reported personal <section> fees from Abcam for giving a webinar presentation outside the submitted work. Dr Chae reported receiving research funding from the Deutsche Forschungsgemeinschaft outside the submitted work. Prof Correll reported receiving personal fees from AbbVie Inc outside the submitted work and consulting advising or receiving honoraria from Acadia Pharmaceuticals Alkermes PLC Allergan PLC Angelini Pharma Aristo Pharma GmbH Biogen Inc Boehringer Ingelheim Cardio Diagnostics Cerevel Therapeutics LLC CNX Therapeutics Ltd COMPASS Pathways PLC Darnitsa Denovo Gedeon Richter PLC Hikma Pharmaceuticals PLC Holmusk Intra-Cellular Therapies Janssen/Johnson & Johnson Karuna Therapeutics LB Pharmaceuticals Lundbeck MedAvante-ProPhase Inc Medincell Merck & Co MindPax Mitsubishi Tanabe Pharma Corporation Mylan NV Neurocrine Biosciences Inc Neurelis Inc Newron Pharmaceuticals SpA Noven Novo Nordisk A/S Otsuka Pharmaceutical Co Ltd Pharmabrain GmbH PPD Biotech Recordati Relmada Therapeutics Inc Reviva Labs Laboratorios Farmaceuticos ROVI Seqirus Limited SK Life Science Inc Sunovion Pharmaceutical Inc Sun Pharmaceutical Industries Ltd Supernus Pharmaceuticals Takeda Pharmaceuticals International Teva Pharmaceutical Industries Ltd and Viatris Inc; providing expert testimony for Janssen Pharmaceuticals and Otsuka Pharmaceutical Co Ltd; serving on a data safety monitoring board for COMPASS Pathways PCL Denovo Lundbeck Relmada Therapeutics Inc Reviva Labs Laboratorios Farmaceuticos ROVI Sage Therapeutics Supernus Pharmaceuticals and Teva Pharmaceutical Industries Ltd; receiving grant support from Janssen Pharmaceuticals and Takeda Pharmaceuticals International; receiving royalties from UpToDate; and holding a stock option in Cardio Diagnostics MindPax LB Pharmaceuticals and The Quantic Group. Prof Gold reported receiving personal fees from Hexal AG and Streamed Up and grants from the National Multiple Sclerosis Society Deutsche Forschungsgemeinschaft DFG Bundesministerium für Gesundheit Bundesministerium für Bildung und Forschung and the European Commission outside the submitted work. Dr Otte reported receiving personal fees from Fortbildungskolleg Janssen Pharmaceuticals Lundbeck Neuraxpharm PeakProfiling GmbH and LIMES Klinikgruppe and grants from the German Research Foundation German Federal Ministry of Education and Research European Union and Berlin Institute of Health outside the submitted work. No other disclosures were reported.",TRUE,"<section> Funding/Support: This research was supported in part by Mentor-Based Postdoctoral Fellowship Program in Rehabilitation Research MB-1707-28359 from the National Multiple Sclerosis Society (Prof Gold) and the BIH Charité Clinician Scientist Program funded by the Charité– Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (Dr Chae).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamapsychiatry.2023.2996",TRUE,"Conflict of Interest Disclosures: Dr Schumann reported grants from the German Research Foundation the National Institutes of Health and the National Science Foundation of China. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Schumann reported grants from the German Research Foundation the National Institutes of Health and the National Science Foundation of China. Dr Desrivieres reported grants from UK Research and Innovation Innovate UK Funded under the UK government’s Horizon Europe funding guarantee as part of the Horizon Europe HORIZON-HLTH-2021-STAYHLTH-01 during the conduct of the study; grants from Medical Research Council Medical Research Foundation and the National Institutes of Health outside the submitted work. <section> Funding/Support: The environMENTAL project is funded by the European Commission (Horizon",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1001/jamapsychiatry.2023.3582",TRUE,"Conflict of Interest Disclosures: Dr Myran reported receiving grants from the Canadian Institutes of Health Research during the conduct of the study. Dr Solmi reported receiving honoraria for participation on advisory boards or presentations from AbbVie Angelini Lundbeck and Otsuka outside the submitted work. No other disclosures were reported.",TRUE,"Conflict of Interest Disclosures: Dr Myran reported receiving grants from the Canadian Institutes of Health Research during the conduct of the study. Funding/Support: Dr Myran was supported with a Dr data and Tanuseputro was supported by a Physician Services Incorporated Graham Farquharson Knowledge Translation Fellowship. This study was supported by the University of Ottawa site of ICES (formerly known as the Institute for Clinical Evaluative data: All Sciences) which is funded by an annual grant from the Ontario Ministry of Health and Ministry of Solmi Long-Term Care. This study also received funding by grant 452360 from the Canadian Institutes of Health <section> Disclaimer: The analyses conclusions opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamasurg.2022.6855",TRUE,"Conflict of Interest Disclosures: Dr Stoppe reported grants and nonfinancial support from Biosyn Arzneimittel Gmbh and grants from Hecht Foundation during the conduct of the study and consultant fees from B. No other disclosures were reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Stoppe reported grants and nonfinancial support from Biosyn Arzneimittel Gmbh and grants from Hecht Foundation during the conduct of the study and consultant fees from B. <section> Dr Fremes was a site investigator of the SUSTAIN study and received fees for perpatient enrollment to their institution during the conduct of the study; received grants from Medtronic and Boston Scientific as a site coinvestigator for SURTAVI and Low Risk trials and received fees for perpatient enrollment to their institution; received grants from Boston Scientific as a site co–principal investigator for the NeoAccurate IDE trial and received fees for perpatient enrollment to their institution; and received grants from the Canadian Institutes of Health Research as the nominated principal investigator of the ROMA trial outside the submitted work. <section> Funding/Support: The study has been funded by the Lotte and John Hecht Memorial Foundation. The analytical work in the laboratory of Dr Schomburg is funded by the Deutsche Forschungsgemeinschaft Dr Stoppe received support by the DFG (grants STO 1099/ 10-11 and STO 1099/8-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamasurg.2023.1772",TRUE,"Conflict of Interest Disclosures: Dr Kuemmel has received personal fees from Roche/Genentech Genomic Health Novartis AstraZeneca Amgen Celgene SOMATEX Daiichi Sankyo pfm medical Pfizer MSD Oncology Lilly Sonoscape Gilead Sciences Seagen and Agendia outside the submitted work and is codirector of the WSG Study Group. No other disclosures were and the Arbeitsgemeinschaft Gynäkologische reported.",TRUE,"<section> Funding/Support: Tumark Vision (SOMATEX) clips HER2-blockade with pertuzumab and trastuzumab (n = 186) and O-Twist (BIP) clips (n = 10) were in HER2-positive early breast cancer: a subanalysis provided free of charge. of data from the randomized phase III GeparSepto trial. <section> Additional Contributions: We thank the patients 115-126. doi:10.1016/S1470-2045(17)30716-7 study sites and the investigators including Sabine 6.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1001/jamasurg.2023.2840",TRUE,"Conflict of Interest Disclosures: Dr Weber reported receiving grants from the Swiss State Secretary for Education Research and Innovation No other disclosures were multicentre open-label phase 3 noninferiority trial. reported.",TRUE,"<section> Conflict of Interest Disclosures: Dr Weber reported receiving grants from the Swiss State Secretary for Education Research and Innovation <section> Funding/Support: The trial was supported by research agreements with the following 6.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/14651858.cd008634.pub3",TRUE,"Conflicts of interest mentioned",TRUE,"SOURCES OF SUPPORT............................................................................................................................................................................... The trial was funded by a national grant agency. <section> • New Source of support Other <section> • Ministry of Education and Research Germany The first version of this Cochrane Review was funded by a grant the update was not externally funded.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/14651858.cd011535.pub6",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest <section> Quote (p 1327): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest: not stated <section> Declarations of interest: (quote p 1013) ""None identified"" <section> Declarations of interest <section> Declarations of interest: Quote (appendix): boards for Novartis Eli Lilly LEO Pharma as an investigator for AbbVie Merck Vie Biogen Eli Lilly Janssen-Cilag re and Sanofi-Aventis. P.V. has no conflicts of interest to declare. <section> Declarations of interest: AK J-HL and VY declare no competing interests."" <section> Declarations of interest <section> Funding source: financial support for this study was provided by Schering-Plough Research Institute now Merck Sharp & Dohme Corporation Whitehouse Station NJ USA Declarations of interest: (Quote Appendix 1): ""J.B. has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott Celgene Centocor Janssen-Cilag Johnson and Johnson Merck Novartis Pfizer Schering-Plough and Wyeth. G.W. has no conflicts of interest to disclose. <section> Declarations of interest <section> Declarations of interest: Quote (disclosure forms): ""Dr. <section> Declarations of interest: Quote (p 485): gen Boehringer Ingelheim BMS Celgene UCB Pharma; and research support Pharma. <section> Declarations of interest: Quote (disclosure forms at NEJM.org) ""Dr. No other potential conflict of interest relevant to this article was report- <section> Declarations of interest: Quote (p 496-497): Amgen BiogenIdec Boehringer Ingelheim GSK Janssen-Cilag Kyowa Kirin LEO Bioepis Sanofi Sun Pharma Takeda Vie Almirall Biogen-Idec Celgene and Valeant; and has participated in Boehringer Ingelheim Celgene Covagen gos Galderma Janssen-Cilag Kyowa ma Pfizer Sanofi Sun Pharma Takeda KAP has been a consultant for AbbVie ta Boehringer Ingelheim Bristol Myers Dice PharmaceuticalsDow Pharma Hakko Kirin LEO Pharma Meiji Seika er PRCL Research Regeneron Roche on speakers’ bureau for AbbVie Amgen Kyowa Hakko KirinLEO Pharma MSD ical research grants from AbbVie Akros alta Boehringer Ingelheim BMS Can-Fite ly Evelo Galapagos Galderma Genentech Medimmune MSD Merck-Serono Moberg Sanofi-Aventis/Genzyme Sun Pharma side of the submitted work. <section> Declarations of interest: (quote p 89): ""Dr Bissonnette and Dr Bolduc have been investigators advisors and/ or consultants and received grants and/or honoraria from Abbott Amgen Astellas Novartis Janssen Ortho Pfizer Celgene and Tribute. Drs Tardif Harel Pressacco and Guertin have no conflicts of interest to declare."" <section> Declarations of interest: Quote (p. 8): study investigator for AbbVie Aligos Bristol-Myers Squibb Dermavant Eli Patricia Lee does not have any conflicts of interest but her spouse is a speaker for AbbVie. <section> Declarations of interest (p 1): ""U.M. has been an advisor and/or received speaker honoraria and/or received grants and/or participated in clinical trials for the following companies: Abbott/AbbVie Almirall Hermal Amgen Biogen Boehringer Ingelheim Celgene Centocor Foamix Forward Pharma Galderma Janssen LEO Pharma Lilly Medac Miltenyi Biotec MSD Novartis Pfizer Teva UCB VBL and XenoPort. <section> Declarations of interest: <section> Quote (p 2): ""L Cai J Gu J Zheng M Zheng G Wang L-Y Xi F Hao X-M Liu Q-N Sun Y Wang W Lai H Fang Y-T Tu Q Sun J Chen and X-H Gao were investigators for this study and J-Z Zhang was the principal investigator for this study; all declare no financial professional or personal relationships that might be perceived as a conflict of interest. <section> Declarations of interest: Quote (p 2672): ''Lin Cai has participated in advisory boards and/or as an investigator and/or speaker and received grants and/or honoraria from Novartis AbbVie Pfizer Inc. <section> Declarations of interest: Quote (P lius Biotech Inc. <section> Declarations of interest: not stated The filling in of the characteristics and ROB tool for this study was made from the article translated from Russian into English. <section> Declarations of interest: not stated <section> Declarations of interest <section> Declarations of interest <section> Declarations of interest <section> Declarations of interest: Quote (p 1-2): ""A. <section> Declarations of interest: not stated <section> Declarations of interest: not stated <section> Declarations of interest: <section> Declarations of interest <section> Quote (p 578): ""Disclosures. <section> Declarations of interest (p 400): ""Dr Thaçi has served as a consultant served as an advisory board member and/or received honoraria for lecturing for AbbVie Amgen Biogen-Idec Celgene Eli Lilly Janssen-Cilag Leo Pharma MSD Novartis Pfizer Regeneron and Sanofi. <section> Declarations of interest: not stated <section> Declarations of interest (quote e305): not stated <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p. <section> Declarations of interest <section> Declarations of interest <section> Declarations of interest: not stated (p 277): ""Drs Ellis and Voorhees are consultants to Sandoz Pharmaceuticals corporation (the manufacturer of cyclosporine)."" <section> Declarations of interest: not stated <section> Declarations of interest (p 337): ""Disclosure text of this article at NEJM.org."" <section> Declarations of interest: quote (p 48): gen Biogen Idec Boehringer Ingelheim ka Janssen LEO Pharma Lilly MedImmune Stiefel and Wyeth; a consultant for Celgene Centocor Forward Pharma &Johnson Kyowa Kirin LEO Pharma tis Pfizer Takeda Pharmaceuticals gene Centocor Isotechnika Janssen <section> Declarations of interest (Appendix): gen Celgene Eli Lilly Janssen LEO for Amgen Celgene Galderma Merck bVie Janssen OrthoBiotech and Medac. <section> Declarations of interest (p 386): ""Consultancies: Dr Reich (Abbott Biogen Idec Centocor SchringPlough Essex Serano Wyeth) Dr Nestle (Biogen Idec Centocor Schring-Plough Genentech Galder- <section> Funding source (p 31. e1) by Centocor Inc Malvern Penn and Schering-Plough Kenilworth NJ Declarations of interest (appendix): ""Dr Menter has received consulting research and/or speaking support from Abbott Laboratories Allergan Inc Allermed Amgen Inc Astralis Inc Berlex Inc Biogen Idec Inc Centocor Inc Cephalon Collagenex Pharmaceuticals CombinatoRx Connetics Corp Corixa Corporation Dermik Laboratories Doak Dermatologics Dow Ferndale Laboratories Inc Fujisawa Healthcare Inc Galderma Genentech Inc Genzyme GlaxoSmithKline Ligand Pharmaceuticals Medicis MedImmune Inc Novartis Pharmaceuticals Otsuka Pharmaceutical Inc Protein Design Labs QLT USA Regeneration Pharma AG Roche Laboratories Serono Sinclair Synta Pharma Thermosurgery 3M Pharmaceuticals Vertex XOMA and Zars Inc. <section> Declarations of interest (p 855): ""none declared"" <section> Declarations of interest (quote p 484): ""A.B. has served as a scientific consultant and clinical study investigator for AbbVie Amgen Boehringer Ingelheim Celgene Janssen Lilly Merck Novartis Pfizer and Sandoz. <section> Declarations of interest <section> Declarations of interest (p 337): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest (p 116): ""none declared"" <section> Declarations of interest (p 1345): ""PG has received lecture fees from Merck-Serono Schering-Plough Wyeth. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 598): ""Dr Gordon has received research support and honoraria and is a consultant for Abbott. <section> Declarations of interest (p 144): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest: not stated except ""Dr Zitnik is an employee of Amgen"" (p 1627). <section> Declarations of interest: (p 534): ""Drs Gottlieb and Menter have received research support from and served as consultants for Centocor Inc. <section> Declarations of interest: Quote (Appendix 1): ""A.B.G. has been a consultant or served on an advisory board for Amgen Centocor Celgene Bristol Myers Squibb Beiersdorf Abbott TEVA Actelion UCB Novo Nordisk Immune Control DermiPsor Incyte PureTech Magen Biosciences Cytokine Pharmasciences Alnylam Ono Pfizer Schering Canfite Schering UCB BIND Biosciences and Merck and has received research/educational grants (paid to Tufts Medical Center) from Centocor Amgen Immune Control Abbott Novo Nordisk UCB and Novartis. <section> Declarations of interest: (Appendix): ""A.B.G. is a consultant and/or advisory board member for Abbott Actelion Amgen Astellas Beiersdorf Bristol-Myers Squibb Can-Fite Celgene Centocor (Janssen) Dermipsor Incyte Lilly Merck Novartis Novo Nordisk Pfizer TEVA and UCB and is a recipient of research/educational grants paid to Tufts Medical Center by Abbott Amgen Celgene Centocor (Janssen) Immune Control Novartis Novo Nordisk Pfizer and UCB. <section> Declarations of interest: none <section> Declarations of interest: not stated <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p Pharmaceutical K.K. <section> Declarations of interest: Quote (p 12): ""none"" <section> Declarations of interest: Quote (p 12): ""The authors declare no conflict of interest."" <section> Declarations of interest <section> Declarations of interest: Quote (p cal study investigator for AbbVie Aclaris ers Squibb Dermavant Dermira Eli vartis Ortho Pfizer Regeneron Sandoz paid speaker for AbbVie. <section> Declarations of interest: Quote (p 2073-2074): ""Liudmila Odnopozova has no conflict of interest to disclose. <section> Declarations of interest: Quote (p 10): ""KR has served as adviser paid speaker or participated in clinical trials sponsored by AbbVie Affibody Almirall Amgen Biogen Boehringer Ingelheim Celgene Centocor Covagen Forward Pharma Fresenius Medical Care GlaxoSmithKline Janssen-Cilag Kyowa Kirin Leo Lilly Medac Merck Sharp & Dohme Novartis Miltenyi Biotec Ocean Pharma Pfizer Regeneron Samsung Bioepis Sanofi Takeda UCB Valeant and Xenoport. <section> Declarations of interest <section> Declarations of interest: Quote (Appendix 1): ""A.B. has served as a scientific adviser and/or clinical study investigator for AbbVie Aclaris Almirall Arena Athenex Boehringer Ingelheim Bristol-Myers Squibb Dermavant Dermira Eli Lilly and Company FLX Bio Forte Galderma Janssen LEO Novartis Ortho Pfizer Regeneron Sandoz Sanofi Genzyme Sun Pharma and UCB Pharma and as a paid speaker for AbbVie. <section> Declarations of interest <section> Declarations of interest (p 29): ""Dr gen Celgene Corporation Eli Lilly and Pharmaceuticals Corporation Pfizer sponsored by Novartis and has received vartis. Dr Kreutzer has received honoraria conducts clinical trials for AbbVie Pharmaceuticals has served as investigator for and received for and received grants from Amgen silis are full-time employees of and Tedremets has no conflicts of interest <section> Declarations of interest: Min have no conflicts of interest relevant to the content of this article."" <section> Declaration of interest (p 590-1): ""Dr. No other potential conflict of interest relevant to this article was reported."" <section> Funding source and declarations of interest: not stated but the first author was employed by Sandoz Pharma Ltd. <section> Declarations of interest All other authors report no competing interests."" <section> Declarations of interest: Quote (p 2021): ""Drs. <section> Declarations of interest: Quote (p 1198): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest: Quote (p 1): ""K. <section> Declarations of interest: Quote: ""The <section> authors declare that they have no conflict of interest."" <section> Declarations of interest: Quote (p 173): ""Drs Zhu Zang and Wand served as investigators for this Janssen RD-sponsored study..."" <section> Declarations of interest: not stated <section> Declarations of interest (p 595): ""not <section> Declaration of interests: Quote (p 9):""Bardur Sigurgeirsson has consulted for Novartis and several other pharmaceutical companies; served on an advisory board for Novartis and several other pharmaceutical companies; and been a speaker for Novartis and several other pharmaceutical companies. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 536): ""RBW has received personal fees from AbbVie Almirall Amgen Boehringer Ingelheim Pharma Celgene Janssen-Cilag Leo Lilly Novartis Pfizer and Xenoport outside the submitted work. IZ TMF and NB-S declare no competing interests."" <section> Declarations of interest: Quote (p 9): ""This research was funded by Amgen K.K. <section> Declarations of interest: Quote (p 51): ""H. Niiro has no conflict of interest to declare. <section> Declarations of interest: not stated <section> Declarations of interest: not stated <section> Declarations of interest: not stated RoB completed according to protocol posted on ClinicalTrials.gov <section> Declarations of interest: not stated RoB completed according protocol posted on ClinicalTrials.gov <section> Declarations of interest: not stated RoB completed according to ClinicalTrials.gov protocol. <section> Declarations of interest: not stated RoB completed according to ClinicalTrials.gov protocol <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 883): ""Mamitaro Ohtsuki reports consultancy and speaker fees. Osamu Nemoto has no relevant financial or personal relationships and no potential conflicts of interest to declare."" <section> Declarations of interest: Quote (p 1062): ""M. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 2382): ""GvdK was involved in clinical trials for Janssen AbbVie Novartis Pfizer UCB Leo Pharma and Eli Lilly as a subinvestigator. The remaining authors state no conflict of interest."" <section> Declarations of interest: Quote (p EliLilly Janssen and Pfizer; a consultant Leo Pharma and Regeneron. <section> Declarations of interest: Quote (p 1080): ""J.P.O. has been an investigator or consultant for Schering-Plough Abbott Merck-Serono Centocor Pfizer Janssen-Cilag Meda-Pharma Pierre-Fabre Galderma and Leo-Pharma. E.B. has no conflicts of interest. <section> Declarations of interest: Quote (p 1304): ""S.T. has received research support from Amgen; C.E.M.G. has been a paid consultant for Wyeth and Amgen; A.M.N and R.Z. are both full-time employees of Amgen."" <section> Declarations of interest: Quote (pp Amgen Astellas Celgene Centocor son & Johnson Merck Norvartis Pfizer No other potential conflict of interest was relevant to this article was reported."" <section> Declarations of interest: Quote (p 745): ""KP has served as an investigator for Abbott Amgen Celgene Centocor Galderma Incyte Isotechnika Janssen Lilly Medimmune Merck Novartis and Pfizer; an adviser for Abbott Amgen Astellas BMS Celgene Centocor Galderma Incyte Isotechnika Janssen Johnson & Johnson Lilly Medimmune Merck Novartis Pfizer and UCB; and a speaker for Abbott Amgen Astellas Celgene Centocor Isotechnika Janssen Novartis and Pfizer. <section> Declarations of interest: Quote (Appendix): ""K.A.P. has received honoraria for lecturing at industry-sponsored meetings and has received industry funding for presentations and consultation at national and international meetings; he has also received research grants from and been a paid consultant to Novartis and other pharmaceutical companies; has served as a scientific officer for pharmaceutical and biotechnology corporations; and is a participant on clinical scientific and corporate advisory boards. M.A. D.R.B. and P.K. declare no conflicts of interest."" <section> Declarations of interest: Quote (p 27): ""Dr Papp is a consultant and investigator for Celgene Corporation Abbott Amgen Centocor Janssen-Ortho Merck Novartis and Pfizer and an investigator for Astellas Leo Pharma and Galderma receiving honoraria and grants. <section> Declarations of interest: Quote (Appendix 1): ""E.P.B. A.M. Q.L. Y.Z. and R.S. are current or former employees of Merck & Co. Inc. <section> Declarations of interest: Quote (p 1093): ""Dr Papp has served as a consultant speaker scientific officer steering committee member investigatoror advisory board member for3M Abbott Akesis Akros Alza Amgen Astellas Baxter BMS Boehringer Ingelheim CanFite Celgene Cipher Dermira Eli Lilly Forward Pharma Funxional Therapeutics Galderma GSK Isotechnika Janssen Johnson & Johnson Kirin Kyowa Lypanosys MedImmune Merck-Serono Mitsubishi Pharma MSD Novartis Pfizer Roche Takeda UCB Valeant and Vertex. <section> Declarations of interest: Quote (p 1560): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" No other potential conflict of interest relevant to this article was reported."" <section> Declarations of interest: Quote (p 1574): ""MAW is an employee of Avillion (Northbrook IL USA). <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 1673): ""CLL has served as a consultant for Abbott Amgen Centocor and Genentech as an investigator for Abbott Allergan Altana Alza Amgen Astellas Celgene Centocor Genentech Bristol Myers Eli Lilly Fujisawa Galderma CombinatoRx 3M Pharmaceuticals Perrigo Isreal Pharamceutical ScheringPlough Serono RTL Novartis Vitae and Wyeth and as a speaker for Abbott Amgen Centocor Genentech and Warner Chilcott. <section> Declaration of interest: Quote (p 1684): ""KP has served as a consultant and advisory board member for Abbott Alza Amgen Celgene Centocor Isotechnika Janssen Ortho Biotech Johnson & Johnson Medimmune MerckSerono and Wyeth. <section> Declaration of interest: Quote: ""A.C.Q. de Vries: none reported; H.B. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p1331): ""Luis Puig has received consultancy/speaker’s honoraria from and/or participated in clinical trials sponsored by Abbvie Almirall Amgen Baxalta Biogen Boehringer Ingelheim Celgene Gebro Janssen JSC BIOCAD Leo-Pharma Lilly Merck-Serono MSD Mylan Novartis Pfizer Regeneron Roche Sandoz Samsung-Bioepis Sanofi and UCB. <section> Declarations of interest: Quote (p 2): ""Dr Armstrong has received research grants and personal fees from Bristol Myers Squibb Eli Lilly Janssen Leo Pharma and Novartis; has received personal fees from Boehringer Ingelheim/Parexel Celgene Dermavant Genentech GlaxoSmithKline Menlo Therapeutics Merck Modernizing Medicine Ortho Dermatologics Pfizer Regeneron Sanofi Genzyme Science Sun Pharma and Valeant; and has received grants from Dermira Kyowa Hakko Kirin and UCB outside the submitted work. <section> Declarations of interest: Quote (p for AbbVie Almirall Amgen Arcutis Connect Biopharma Dermavant Eli Leo Pharma Maruho Meiji Seika Pharma Sanofi Genzyme Sun Pharma UCB bVie Eli Lilly Janssen and Sanofi Genzyme; CorEvitas’ (Corrona) Psoriasis Registry; tas' (Corrona) Psoriasis Registry Dermavant search support from and served on rall Amgen Biogen Idec Boehringer Pharma Novartis Pfizer Regeneron has served as a linical investigator Eli Lilly Janssen Leo Pharma Novartis AbbVie Allergan Almirall Amgen Arcutis Squibb Celgene Cellceutix Centocor ma Dr. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 275): ""D.T. has received honoraria as an investigator or consultant for and/or received speakers’ honoraria and/or research grants from AbbVie Almirall Amgen Boehringer Ingelheim Celgene Dignity Dr Reddy Galapagos GSK Janssen LEO Lilly Morphosis MSD Novartis Pfizer Regeneron/Sanofi Sandoz-Hexal and UCB. <section> Declarations of interest: Quote (p 8): ""WS has received fees for speaking/consulting from Abbott Schering-Plough Wyeth and Janssen-Cilag. <section> Declarations of interest: Quote (Appendix): ""M.S. is an advisor and/or paid speaker for and/or has participated in clinical trials sponsored by AbbVie Actelion Almirall Biogen Boehringer Ingelheim Celgene GlaxoSmithKline Janssen Cilag LEO Pharma Eli Lilly Merck Sharp & Dohme Mibe Mundipharma Novartis Pfizer Regeneron and Sanofi. <section> Declarations of interest: Quote (pp 177-8): ""Robert Strohal has been a paid consultant of and has received research grants from Pfizer Inc which provided funding for the PRISTINE study. <section> Declarations of interest: not stated On ClinicalTrials.gov (NCT02489227) waiting for the publication to contact the main author RoB completed according study protocol posted on ClinicalTrials.gov <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 180): ""K.R. has served as consultant and or paid speaker for and or has participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott Biogen Idec Celgene Centocor Janssen-Cilag Leo Medac Merck MSD (formerly Essex Schering-Plough) Novartis and Pfizer (formerly Wyeth). <section> Declarations of interest: Quote (p ipated in clinical trials sponsored by LAR WMB TMF and NAB-S declare no conflict of interests. <section> Declarations of interest: Quote (p878-879): and/or participated in clinical trials ma Celgene Centocor Covagen Lilly and Company Medac Merck Sharp Takeda UCB Pharma and Xenoport. <section> Declarations of interest: Quote (p 287): ""Declaration of interests: KR has served as a consultant or paid speaker for or participated in clinical trials sponsored by Abbvie Amgen Biogen-Idec Celgene Centocor Covagen Forward Pharma GlaxoSmithKline Janssen-Cilag Leo Lilly Medac Merck & Co Novartis Pfizer Vertex and Takeda. <section> Declarations of interest: Quote (p paid speaker for or participated in Centocor Covagen Forward Pharma Novartis Pfizer Vertex and Takeda. <section> 287): ""Declaration of interests: KR has served as a consultant or clinical trials sponsored by Abbvie Amgen Biogen-Idec Celgene GlaxoSmithKline Janssen-Cilag Leo Lilly Medac Merck & Co KAP has served as a consultant or paid speaker for or participated Anacor AbbVie Active Biotech Allergan Astellas AstraZeneca CanFite Celgene Dermira Eli-Lilly Forward Janssen Kyowa Hako Kirin Kythera Leo Pharma Merck & <section> Declarations of interest: Quote (p 106): ""Dr Menter has received research support and/or lecture honoraria from Abbott Amgen Astellas Biogen Centocor Genentech and Wyeth. <section> Declarations of interest: Quote (appendix): ""P.R. has received honoraria for lecturing in industry-sponsored meetings and has received research grants from pharmaceutical companies as an investigator. J.-P.O. A.M. and R.E.S. declare no conflicts of interest."" <section> Declarations of interest: not stated <section> Declarations of interest: not stated <section> Declarations of interest: not stated <section> Declarations of interest (p 27): ""The man and Jinling Wu in the preparation NY supported by Novartis. <section> Declarations of interest: Quote (p 816): ""Haeyoun Jeong is a full-time employee of Kyowa Kirin Korea Co. Ltd. The other authors have no conflicts of interest to declare."" <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 60-1): ""R.B.W. has received honoraria and/or research grants from AbbVie Almirall Bristol-Myers Squibb Celgene Janssen Leo Lilly MSD Novartis Sun Xenoport and UCB Pharma. <section> Declarations of interest: Quote (p 221): ""There are no conflicts of interest."" <section> Declarations of interest: not stated <section> Declarations of interest: Quote (abstract Kristensen et al): ""L. <section> Declarations of interest: Quote (Appendix 1): ""B.E.S. has been an investigator consultant speaker and served on an advisory board for Amgen Abbott and Centocor; and has also been a speaker for Astellas. <section> Declarations of interests: Quote (p 3-4): ""ASVV: AbbVie Allergan Celgene Corporation Derm Tech Dermira Novartis and Valeant – honoraria for advisory board and/or consulting; Merck – pension (exspouse). ST: No conflicts or potential conflicts of interest to disclose. <section> Declarations of interest: Quote (p 693): ""The authors and AbbVie scientists designed the study and analyzed and interpreted the data. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (article): ""DT: received grant/research support from AbbVie Inc. Celgene Novartis; has participated in a speakers bureau for AbbVie Inc. Amgen Almirall Biogen-Idec Boehringer Ingelheim Bristol Myers Squibb Celgene Eli Lilly Galapagos Janssen-Cilag LEO Pharma Morphosis Novartis Pfizer Regeneron Pharmaceuticals Sandoz/Hexal Sanofi and UCB Pharma; and has served as a consultant/member of scientific board for AbbVie Inc. Almirall Celgene Eli Lilly Janssen-Cilag LEO Pharma Novartis Pfizer Regeneron Pharmaceuticals Sandoz/Hexal Sanofi and UCB Pharma. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (Appendix): ""Conflicts of interest. <section> Declarations of interest: Quote (pp 367-8): ""S Tyring has received research support from Amgen. <section> Declarations of interest: Quote (p 660): ""KBG has received honoraria for serving as a consultant and/or grants as an investigator from AbbVie Almirall Amgen Boehringer Ingelheim Bristol-Myers Squibb Celgene Dermira Eli Lilly GlaxoSmithKline Janssen Leo Pharma Novartis Pfizer Regeneron Sanofi-Aventis Sun and UCB. <section> Declarations of interest: Quote (p 660): ""KBG has received honoraria for serving as a consultant and/or grants as an investigator from AbbVie Almirall Amgen Boehringer Ingelheim Bristol-Myers Squibb Celgene Dermira Eli Lilly GlaxoSmithKline Janssen Leo Pharma Novartis Pfizer Regeneron Sanofi-Aventis Sun and UCB. <section> Declarations of interest: Quote (p 525-6): ""Yoshinori Umezawa hasreceived consulting agreements and/or speaker fees from Maruho Co. <section> Declarations of interest: Quote (p 355): ""Disclosure forms provided by the authors are available with the full text of this article at NEJM.org."" <section> Declarations of interest: Quote (pp. <section> Declarations of interest: Quote (pp 550-1): ""CEMG has received grants and personal fees from Eli Lilly Abbvie Janssen Novartis Sandoz Pfizer and GlaxoSmithKline; personal fees from Actelion Amgen and UCB Pharma; grants from LEO Pharma and Merck Sharp & Dohme; and is president of the International Psoriasis Council. <section> Declarations of interest: Quote (p 413): ""Investigator-initiated project grant from Pfizer. <section> Declarations of interest: Quote: (p 1177): ""C.Z. M.P.B. L.P. and J.W. are employed by Wyeth Pharmaceuticals which supported this study financially."" <section> Declarations of interest: Quote (p 10): ""Dr Mehta is a full-time US Government Employee and receives research grants to the National Heart Lung and Blood Institute (NHLBI) from AbbVie Janssen Celgene and Novartis. Dr Chiesa Fuxench has no conflicts of interest. <section> Declarations of interest: Quote: ""Dr Gelfand served as a consultant for BMS Boehringer Ingelheim Janssen Biologics Novartis Corp UCB (DSMB) Sanofi and Pfizer receiving honoraria; and receives research grants (to the Trustees of the University of Pennsylvania) from AbbVie Boehringer Ingelheim Janssen Novartis Celgene Ortho Dermatologics and Pfizer; and received payment for continuing medical education work related to psoriasis that was supported indirectly by Lilly Ortho Dermatolog- <section> Declarations of interest: Quote (p. All the other authors state no conflict of interest."" <section> Declarations of interest: Quote (p 95): ""A Menter has held advisory board consultant investigator and speaker roles with and grants/research funding and honoraria from Abbott Labs Amgen Janssen Biotech Inc. LEO Pharma and Sienna; advisory board and investigator roles with and grants/research funding and honoraria from Boehringer Ingelheim; investigator roles with and grants/research funding from Celgene and Merck; consultant and investigator roles with and honoraria from Eli Lilly and Novartis; and consultant investigator and speaker roles with and honoraria from UCB Pharma. P Arenberger reports no disclosures. <section> Declarations of interest: Quote (p 405): ""Dr Blauvelt has served as a scientific adviser and clinical study investigator for AbbVie Amgen Boehringer Ingelheim Celgene Dermira Genentech GSK Janssen Eli Lilly Merck Novartis Pfizer Regeneron Sandoz Sanofi-Genzyme Sun UCB and Valeant and as a paid speaker for Eli Lilly. <section> Declarations of interest: Quote (p 1): ""Dr Reich has served as advisor and/or paid speaker for and/ or participated in clinical trials sponsored by AbbVie Amgen Biogen Boehringer Ingelheim Pharma Celgene Covagen Eli Lilly Forward Pharma GlaxoSmithKline Janssen Leo Medac Merck Sharp & Dohme Novartis Ocean Pharma Pfizer Regeneron Takeda UCB Pharma and Xenoport. <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 5074): ""None"" <section> Declarations of interest: not stated <section> Declarations of interest: Quote (p 449): ""There is no conflicting interest."" <section> Declarations of interest: Quote (p 7): ""The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this <section> Declarations of interest: ""WS reports grants and personal fees from Novartis Sanofi Genzyme outside the submitted ing interests."" <section> D E C L A R A T I O N S O F I N T E R E S T Emilie Sbidian: has declared no conflict of interest. <section> Anna Chaimani: has declared no conflict of interest. <section> Robin Guelimi: has declared no conflict of interest. <section> Camille Hua: has declared no conflict of interest. <section> Carolyn Hughes: has declared no conflict of interest. <section> Maria Kinberger: has declared no conflict of interest. <section> Sivem Afach: has declared no conflict of interest. <section> Laurence Le Cleach: has declared no conflict of interest.",TRUE,"<section> SOURCES OF SUPPORT............................................................................................................................................................................... Most studies (138/179) declared funding by a pharmaceutical company and 24 studies did not report a funding source. <section> Funding We consider that the probability that we have missed an eligible trial is low considering our wide search and this view is supported by the absence of smallstudy effects (testing by the comparisonadjusted funnel plots). In total 11/21 were funded by the pharmaceutical industry and 3/21 were funded by academical grants; the funding was unknown for seven reviews. <section> Funding source: Quote (p. <section> Funding source <section> Quote (p 623): ""The study was funded by Hexal AG a Sandoz company. <section> Funding <section> Quote (p 53): ""Funding for this study was provided by Dr. <section> Funding source <section> Funding source: not stated <section> Funding source: Quote (p 8): ""The study was sponsored by Novartis Pharma AG Basel Switzerland."" <section> Funding source: Quote: ""This paper is not funded"". <section> Funding source: <section> Quote (p 1): ""This study was funded by Amgen Inc. <section> Funding source: Quote (p 1319): “Amgen funded both studies. ... and Amgen conducted the data analyses. <section> Funding source <section> Funding source: support by Abbott <section> Funding source: (quote p 1013) no funding source <section> Funding source <section> Quote (p 942): ""This study was funded by Novartis Pharma AG."" <section> Funding source: Quote (p 316): ""This from Merck KGaA"". <section> study was sponsored by Merck. <section> Funding source: <section> Quote (p 555): ""This study was designed and funded by Pfizer Inc. <section> Funding source: Amgen Inc. <section> Funding source: financial support for this study was provided by Schering-Plough Research Institute now Merck Sharp & Dohme Corporation Whitehouse Station NJ USA Declarations of interest: (Quote Appendix 1): ""J.B. has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott Celgene Centocor Janssen-Cilag Johnson and Johnson Merck Novartis Pfizer Schering-Plough and Wyeth. <section> Funding source <section> Quote (p 277): ""Supported by UCB Pharma."" <section> Funding source: Quote (p 2): ""The sponsor UCB Pharma funded and designed the trial with the participation of authors employed by the sponsor"". <section> Funding source: Quote (p 475): ""Funding <section> Notes Funding source: Quote (p 2) ""The trial was funded by UCB Pharma and designed by the ninth through <section> Funding source: Quote (p 487): ""Funding <section> • Change in the most diseased segment T Funding source: Abbott Laboratories <section> Funding source: Quote (p. <section> work was supported by AbbVie. <section> Funding source: Quote (p 1): “This research was funded by Almirall S.A.”. <section> Funding source: <section> Notes Funding source: Quote (p 2672) :''This study was sponsored by Novartis Pharma AG Basel Switzer- <section> Funding source: Quote (p 594): ""This China. <section> study was funded by Shanghai Henlius Biotech Inc. Shanghai fees were also sponsored by Shanghai Henlius Biotech Inc."" <section> Funding source: Quote (clinicaltrials.gov): ""Biocad"" <section> • PASI 75 PASI Funding source: not stated <section> Funding source 1061): ""The CARIMA study was funded by Novartis Pharma GmbH Germany. 1061): ""EVS received grants from the Deutsche Forschungsgemeinschaft. <section> Funding source <section> Funding source: <section> In addition they have participated in continuing medical education events supported by unrestricted educational grants from Abbott. R.G.L. reports receiving fees as a consultant or advisory board member for Abbott Amgen Astellas BoehringerIngelheim Barrier Therapeutics and Genentech; he has received lecture fees from Abbott Amgen/ Wyeth and Biogen-Idec and has been the principal investigator and received grants from Abbott Amgen Astellas Centocor Galderma and Genentech. <section> Funding source: Quote (p 2): ""The trial was funded in full by LEO Pharma A/S Ballerup Denmark."" <section> Funding source: Y Johnson and Johnson Centocor Inc. <section> • PASI weeks 1 5 9 Funding source: Czech Ministry of Education <section> Funding source : <section> Quote (p 226): ""Funding sources: Supported of certolizumab pegol in psoriasis."" Dr Piguet has received honoraria or fees for consulting and/or speaking for AbbVie Almirall Celgene Janssen Novartis and Pfizer; and has received departmental support for Cardiff University from AbbVie Almirall Alliance Beiersdorf UK Ltd Biotest Celgene Dermal Eli Lilly Galderma Genus Pharma GlobeMicro Janssen-Celag LaRoche-Posay L'Oreal LEO Pharma Meda MSD Novartis Pfizer Sinclair Pharma Spirit Stiefel Samumed Thornton Ross TyPham and UCB. <section> Funding <section> Quote (p 302): ""Supported by Dermira Inc and UCB Inc."" <section> Funding source <section> Quote (p 302): ""Supported by Dermira Inc and UCB Inc."" <section> Funding <section> Quote (p 572): ""Funding: Novartis Pharma AG Basel Switzerland."" <section> Funding source: <section> Funding source: not stated <section> Funding source (quote e305): not stated <section> Funding source: not stated but 1 out of 4 authors was a staff member of Sandoz pharmaceutical com- <section> Notes Funding source: Quote (p. 831): ""This study was funded by Janssen Research & Development."" <section> Funding source: <section> Quote (p 928): ""The study was funded by Hexal AG a Sandoz company. Professor Arenberger has received grants from Novartis. <section> Funding source: All authors had acthe development review and approval of this article and in the deresearch funding (paid to her institution) from AbbVie Amgen Lilly Merck Novan Novartis Pfizer Valeant and Viament and to Anacor Celgene Lilly Novartis Pfizer and Valeant. <section> Funding source (p 277): Sandoz Research Institute the Babcock Dermatologic Endowment (Ann Arbor) and a clinical research centre grant (M01-RR-00042) from the National Institutes of Health <section> Funding source: not stated <section> Funding source quote (p 326): ""funded <section> Funding source: quote (p 37): ""This <section> study was sponsored by Celgene Corporation"". <section> Funding source: U.M. has been an advisor for and/or received speaker honoraria from and/or received grants from and/or participated in clinical trials for Abbott/AbbVie Almirall-Hermal Amgen BASF Biogen Idec Celgene Centocor Eli Lilly Forward Pharma Galderma Janssen LEO Pharma Medac MSD Miltenyi Biotech Novartis Pfizer Teva VBL and XenoPort. <section> Funding source (p 386): ""This study was funded by Centocor and Schering-Plough Kenilworth NJ USA"". <section> Funding source (p 31. e1) by Centocor Inc Malvern Penn and Schering-Plough Kenilworth NJ Declarations of interest (appendix): ""Dr Menter has received consulting research and/or speaking support from Abbott Laboratories Allergan Inc Allermed Amgen Inc Astralis Inc Berlex Inc Biogen Idec Inc Centocor Inc Cephalon Collagenex Pharmaceuticals CombinatoRx Connetics Corp Corixa Corporation Dermik Laboratories Doak Dermatologics Dow Ferndale Laboratories Inc Fujisawa Healthcare Inc Galderma Genentech Inc Genzyme GlaxoSmithKline Ligand Pharmaceuticals Medicis MedImmune Inc Novartis Pharmaceuticals Otsuka Pharmaceutical Inc Protein Design Labs QLT USA Regeneration Pharma AG Roche Laboratories Serono Sinclair Synta Pharma Thermosurgery 3M Pharmaceuticals Vertex XOMA and Zars Inc. <section> Funding source (p 855): none <section> Funding source: Novartis Pharmaceuticals Basel Switzerland <section> Funding source <section> Quote (p 747): ""The study was sponsored by Alvotech Swiss AG. <section> Funding source quote (p 326): ""funded by Novartis Pharmaceuticals"" <section> Funding source (p 121): ""Financial support from the Swedish Psoriasis Association and the Welander <section> Funding source: not stated <section> Funding source quote (p 655): ""Supported in part by Hoffman-La Roche Inc. Nutley NJ and the Babcock Dermatologic Endowment"" <section> Funding source: Quote (p 598): ""Supported by Abbott Laboratories"" <section> Funding source: Quote (p 137): “This study was sponsored by Janssen Research and Development. <section> Funding source: Quote (p 1631): ""This study was sponsored by Immunex Corp a subsidiary of Amgem <section> Funding source: Quote (p 534): ""Supported by Centocor Inc"" <section> Funding source: Quote (Appendix 1): ""Abbott Laboratories funded this study and participated in the study design data collection data management data analysis and preparation of the manuscript. <section> Funding source: Quote (p 649): ""This study was funded by Immunex Corporation a wholly owned subsidiary of Amgen Inc and by Wyeth which was acquired by Pfizer..."" <section> Declarations of interest: (Appendix): ""A.B.G. is a consultant and/or advisory board member for Abbott Actelion Amgen Astellas Beiersdorf Bristol-Myers Squibb Can-Fite Celgene Centocor (Janssen) Dermipsor Incyte Lilly Merck Novartis Novo Nordisk Pfizer TEVA and UCB and is a recipient of research/educational grants paid to Tufts Medical Center by Abbott Amgen Celgene Centocor (Janssen) Immune Control Novartis Novo Nordisk Pfizer and UCB. <section> Funding source: none <section> Funding source: Quote (p 664): ""Supported <section> Funding source: not stated <section> Funding source: Quote (p 242): ""This Johnson & Johnson family of companies."" <section> 12 through 64 in NAPSI and joint pain as measured by the change study was supported by Janssen pharmaceutical KK a part of the <section> Funding source: Quote (p 12): ""This study was supported by a grant from the Hellenic Cardiology Society and Hellenic Society of Lipidiology and Atherosclerosis. This study was not funded by any pharmaceutical company and that none of the coauthors received support from the manufacturers of the agents used for treatment"". <section> Funding source: Quote (p 12): ""This research received no external funding."" <section> Funding source C.P. has received grants from and has been a consultant for AbbVie Almirall Amgen Boehringer Ingelheim Celgene Eli Lilly Janssen LEO Pharma Merck Novartis Pfizer Sandoz and UCB Pharma. <section> Funding source: Quote (p 658): ""Funding heim."" <section> Funding source: Quote (p 2073): ""AbbVie funded this study and participated in the study design research analysis data collection and interpretation of data and in the writing reviewing and approval of the publication. <section> Funding source: Quote (p 1): ""Abbvie and Boehringer Ingelheim"" <section> Funding source <section> Quote (p 1315): ""This study was funded in full by Eli Lilly and Company Indianapolis IN U.S.A"". <section> Funding source (Quote p 1348): ""Funding for this study was provided by Eli Lilly and Company Indianapolis IN U.S.A. K.B.G. has consulting relationships with AbbVie Amgen Celgene Eli Lilly and Company Janssen Novartis Pfizer Dermira and Boehringer Ingelheim and has received grants from AbbVie Amgen Celgene and Janssen. <section> Funding source <section> Quote (p 1014): ""This study was funded in full by Eli Lilly and Company Indianapolis IN U.S.A."" <section> Funding source: Quote (supplemental signed by the scientific steering committee sis and all authors had access to the Dr Kreutzer has received honoraria conducts clinical trials for AbbVie Pharmaceuticals has served as investigator for and received for and received grants from Amgen silis are fulltime employees of and Tedremets has no conflicts of interest <section> file): “The study was sponsored by Novartis Pharma and deand Novartis personnel. Dr Lacour has participated in clinical trials honoraria as a coordinator of clinical trials sponsored by Nofor giving speeches for has received travel grants from and Biogen Novartis and Janssen-Cilag. <section> Funding source <section> Quote (p 33): ""Funding provided by <section> Funding source (p 590): ""Supported Langley grant support from Centocor Abbott and Amgen/Wyeth; Dr. <section> Funding source and declarations of interest: not stated but the first author was employed by Sandoz Pharma Ltd. <section> Funding source <section> Quote (p 8): ""This study was funded by Pfizer Pharmaceuticals Korea Limited; etanercept is a product <section> Funding source: Quote (p 2021): ""Supported by Immunex Seattle a whollyowned subsidiary of Agen Thousand Oaks Calif"" <section> Funding source: Quote (p 1190): ""Funded by Eli Lilly"" <section> Funding source: <section> Quote (p 2): ""This study was sponsored by Celgene Corporation."" <section> Funding source: Quote: ""This research search Project (Grant number: LGF20H110002). <section> and static Physician’s Global Assessment (sPGA) at weeks 12 and was supported by Zhejiang Public Walfare Technology ReMedical Health Science and Technology Project of (Grant Number: 2018KY088) and 3SBIO INC."" <section> Funding source: Quote (p 173): ""This study was supported by Janssen Research & Development"". <section> Funding source: Quote (p 591): ""Supported by Roche Dermatologics Nutley New Jersey and the Skin Research Foundation of California Santa Monica California"" <section> Funding source: not stated <section> Funding: Quote (p 1): ""This investigation was sponsored by Novartis Pharma AG Basel Switzerland."" <section> Funding source: not stated but 3 out of 4 authors from Sandoz Pharmaceuticals <section> Funding source: Quote (p 528): ""Funding design data collection data analysis JN has received grants from Amgen Novartis Janssen-Cilag LEO Lilly Medac Regeneron and Dermapharm outside the submitted work. <section> Funding source: Quote (p 1): ""Amgen"" <section> Declarations of interest: Quote (p 9): ""This research was funded by Amgen K.K. <section> Funding source: Quote (p 51): “The study was supported by Kyowa Hakko Kirin Co. Ltd.” <section> Funding source: Quote (ClinicalTrials.gov): ""Coherus Biosciences Inc."" <section> Funding source: <section> Funding source: Quote (ClinicalTrials.gov): ""Biocad"" <section> Funding source: Quote (ClinicalTrials.gov): ""Novartis Pharmaceuticals"" <section> Funding source: Quote (clinicaltrials.gov)""Eli Lilly and Company"" <section> Funding source: Quote (ClinicalTrials.gov): ""Eli Lilly and Company"" <section> Funding source: not stated <section> Funding source: Quote (p 883): ""The authors received editorial support in the preparation of the manuscript from Kathy Covino Ph.D. of Peloton Advantage LLC funded by Celgene Corporation. This study was funded by Celgene Corporation."" <section> Funding source: Quote (p 883): ""Funding: This study was funded by Janssen PharmaceuticalTokyo <section> Funding source: Hoffman-La Roche Inc. <section> Funding source: Quote (p 2382):""There was no funding source for this study."" <section> Funding source: Quote (p 7): ""Janssen ployed by Janssen participated in designing and in preparing reviewing and approving Janssen provided editorial and submission <section> Funding source: Quote (p 1080): ""Wyeth Research which was acquired by Pfizer in October 2009 sponsored this clinical trial and was responsible for the collection and analysis of data. <section> Funding source: Quote (p 1304): ""This study was supported by Immunex Corporation (Seattle WA U.S.A)"". <section> Funding source: Quote (p 1182): ""The <section> study was funded by Amgen"". <section> Funding source: Quote (p 738): ""Funding <section> Funding source: Quote (p412): ""Novartis Pharm AG Basel Switzerland"" <section> Funding source: Quote (p 27): ""This study was sponsored by Celgene Corporation"". <section> Funding source: Quote (p 930): “This study was funded by Merck & Co nc. Kenilworth NJ USA”. <section> Funding source: Quote (p 1093): ""Amgen Inc funded this study and participated in the design and conduct of the study; collection management analysis and interpretation of data; and preparation review and approval of the manuscript. Dr Bachelez has served as a consultant speaker steering committee member investigator or advisory board member for AbbVie Amgen Baxalta BoehringerIngelheim Celgene Janssen LEO Pharma Lilly MSD Novartis Pfizer and Takeda and received grant support from Pfizer. <section> Funding source: Quote (p 1553): ""The trial was funded by Boehringer Ingelheim"". <section> Funding <section> Quote (p 1320): ""Supported by Bristol-Myers Squibb"" <section> Funding source: Quote (p 1574): ""This study was funded by Avillion."" <section> Funding source: Quote (p 162): ""This study was supported by Centocore Inc"". <section> Funding source: Quote (p 1665): ""Centocor Inc."" KBG has served as a consultant for Abbott Amgen Astellas Centocor and Genentech and has received grant support from Abbott Astellas and Centocor. <section> Funding source: Centocor Inc (p 1675) <section> Funding source: Quote (p 1): ""study was funded by a program grant from the Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW; project 152001006)."" <section> Funding source: not stated <section> Funding source: Quote (p1330): ""Sponsorship for this study and the Rapid Service Fee were funded by JSC BIOCAD Ul. <section> Funding source: Quote (p 2): ""This clinical trial was sponsored by Bristol Myers Squibb."" <section> Declarations of interest: Quote (p 2): ""Dr Armstrong has received research grants and personal fees from Bristol Myers Squibb Eli Lilly Janssen Leo Pharma and Novartis; has received personal fees from Boehringer Ingelheim/Parexel Celgene Dermavant Genentech GlaxoSmithKline Menlo Therapeutics Merck Modernizing Medicine Ortho Dermatologics Pfizer Regeneron Sanofi Genzyme Science Sun Pharma and Valeant; and has received grants from Dermira Kyowa Hakko Kirin and UCB outside the submitted work. Dr Morita has received honoraria as a meeting chair or lecturer from AbbVie AYUMI Boehringer Ingelheim Japan Celgene K.K. Eisai Eli Lilly Japan K.K. Inforward Janssen Pharmaceutical K.K. Kyowa Kirin Maruho Co. Mitsubishi Tanabe Pharma Nippon Kayaku Novartis Pharma K.K. Taiho Pharmaceutical Torii Pharmaceutical. and Ushio; has received funding from AbbVie GK Eisai Eli Lilly Japan K.K. Kyowa Hakko Kirin Leo Pharma KK Maruho Mitsubishi Tanabe Pharma Novartis Pharma K.K. Taiho Pharmaceutical and Torii Pharmaceutical; has received consulting fees <section> Funding source: Quote (p 2 preproof): <section> ""This clinical trial was sponsored by Bristol Myers Squibb"". Dr Foley has received grant support from Amgen Bristol Myers Squibb Celgene Eli Lilly Galderma Janssen Leo Pharma Merck Novartis Pfizer Sanofi and Sun Pharma; has served as an investigator for AbbVie Amgen Arcutis Argenx Aslan AstraZeneca Boehringer Ingelheim Botanix Bristol Myers Squibb Celgene Celtaxsys CSL Cutanea Dermira Eli Lilly Evelo Galderma Genentech Geneseq GlaxoSmithKline Hexima Janssen Kymab Leo Pharma Merck Novartis Pfizer Regeneron Reistone Roche Sanofi Sun Pharma Teva UCB and Valeant; has served on advisory boards for AbbVie Amgen Aslan Boehringer Ingelheim Bristol Myers Squibb Celgene Eli Lilly Galderma GlaxoSmithKline Janssen Leo Pharma Mayne Pharma MedImmune Novartis Pfizer Sanofi Sun Pharma UCB and Valeant; has served as a consultant for Aslan Bristol Myers Squibb Eli Lilly Galderma GenesisCare Hexima Janssen Leo Pharma Mayne Pharma Novartis Pfizer Roche and UCB; has received travel grants from AbbVie EliLilly Galderma Janssen Leo Pharma Merck Novartis Pfizer Roche Sanofi and Sun Pharma; and has served as a speaker for or received honoraria from AbbVie Amgen Celgene Eli Lilly Galderma GlaxoSmithKline Janssen Leo Pharma Merck Novartis Pfizer Roche Sanofi Sun Pharma and Valeant. Dr Paul has received grants from and has been a consultant for AbbVie Almirall Amgen Boehringer Ingelheim Bristol Myers Squibb Celgene Eli Lilly Janssen Leo Pharma Merck Mylan Novartis Pfizer Sandoz and UCB. <section> Funding source: Quote (ClinicalTrials.gov): ""Bristol-Myers Squibb"" <section> Funding source: Quote (p 265): ""Funding for the trial and its publication was provided by JanssenCilag GmbH"". A.P. has received honoraria as an investigator for and/or received speakers’ honoraria from and/or received grants from and/or been an advisor for AbbVie Almirall-Hermal Amgen Biogen Idec Boehringer Ingelheim Celgene GSK Eli Lilly Galderma Hexal Janssen LEO Pharma Medac Merck Serono Mitsubishi MSD Novartis Pfizer Tigercat Pharma Regeneron Roche Sandoz Biopharmaceuticals Schering-Plough and UCB Pharma. M. <section> Sebastian has received honoraria as an investigator for received grants from and been an advisor or consultant for AbbVie Boehringer Ingelheim Celgene Dr Reddy GSK MSD Mundipharma Novartis UCB Pharma Janssen Almirall LEO Pharma Galderma Lilly and Regeneron. M. Sticherling has received honoraria as an investigator and/or speaker for has received grants from and/or has participated in clinical studies for AbbVie Actelion Almirall Amgen Celgene Galderma GSK Janssen LEO Lilly MSD Mundipharma Novartis Pfizer Sandoz Sanofi and UCB Pharma. S.G. has been an advisor for and/or received speakers’ honoraria from and/or received grants from and/or participated in clinical trials for Abbott/AbbVie Almirall-Hermal Amgen Baxalta Bayer Health Care Biogen Idec Bioskin Boehringer Ingelheim Celgene Centocor Dermira Eli Lilly Foamix Forward Pharma Galderma Hexal AG Isotechnika Janssen LEO Pharma Medac Merck Serono Mitsubishi Tanabe MSD Novartis Pfizer Polichem SA Regeneron Pharmaceuticals Sandoz Biopharmaceuticals Sanofi-Aventis Schering-Plough Sienna Biopharmaceuticals Takeda Teva UCB Pharma VBL Therapeutics and Wyeth Pharma. K.E. has received honoraria as an investigator for and/or received speakers’ honoraria from and/or received grants from and/ or been an advisor for Janssen AbbVie Celgene Hexal LEO Lilly Novartis and Sanofi."" <section> Funding source: Quote (p 8): ""Wyeth Research which was acquired by Pfizer in October 2009 sponsored this clinical trial and was responsible for the collection and analysis of data..."" <section> Funding source: Quote (p 1024): ""Novartis Pharma GmbH"" <section> Funding source: Quote (p 177): ""The PRISTINE trial was sponsored by Pfizer Inc..."" <section> Funding source: Quote (ClinicalTrials.gov): ""Coherus Biosciences Inc."" <section> Funding source: not stated <section> Funding source: Quote (p 180): ""This <section> study was funded by UCB Pharma Brussels Belgium"". <section> Funding source: Quote (p 534): ""This Switzerland."" RB received grants from Novartis during the conduct of this study and has received grants personal fees and nonfinancial support from AbbVie Amgen Astellas Celgene Eli Lilly Janssen Pfizer and Tribute. YP has received grants from AbbVie Amgen Celgene Eli Lilly Janssen Merck Pfizer and Novartis (outside the submitted work). <section> Funding source: Quote (p. <section> as 2 SC injections followed by 80 mg ixekizumab given SC every ixekizumab given SC every 4 weeks until week 24) n = by 215 mg FAE given orally 1 to 3 times/day until week 24) n = up to 30 mg methotrexate given orally once a week until week study was supported by Eli Lilly (Indianapolis IN U.S.A.). <section> Funding source: Quote (p 276): ""Funding Merck & Co"" SKT has participated in trials supported by grants from Merck & Co. <section> Funding source: Quote (p 276): ""Funding SKT has participated in trials supported by grants from Merck & Co. <section> Funding source: Quote (p 106): ""Supported by Abbott Laboratories"" <section> Funding source: Quote (p 402): ""Novartis Pharma AG Basel Switzerland"" <section> Funding source: not stated <section> Funding source: not stated <section> Funding source: not stated <section> Funding source: Quote (p 27): “Study and all authors had access to data”. <section> Funding source: Quote (p 816): ""funded by Kyowa Kirin Korea Co. Ltd."" <section> Funding source: Immunex Corporation <section> Funding source: Quote (p 60): ""This study was funded by Novartis Pharmaceuticals U.K. <section> Funding source: Quote (p 221): ""Nil"" <section> Funding source: not stated <section> Funding source: Quote (ClinicalTrials.gov): ""Eli Lilly and Company"" <section> Funding source: Quote (Appendix 1): ""Abbott Laboratories funded this study and participated in the study design data collection data management data analysis and preparation of the manuscript. <section> Funding source: Quote (p 2): ""The authors acknowledge financial support for this study from Celgene Corporation. <section> Funding source: Quote (p 693): ""AbbVie and Boehringer Ingelheim funded the SustaIMM <section> Funding source: supported by a grant from Hoffmann La Roche & Co Ltd <section> Funding source: Quote (article): ""AbbVie Inc. funded the research for this study and participated in the study design"". <section> Funding source: not stated <section> Funding source: Quote (p 1): ""Funding sources: This study was funded by Novartis Pharma AG Basel P.A. has received grants from Novartis. M.A. has received grants from and/or participated in clinical trials for AbbVie Almirall Amgen Biogen Idec Boehringer Ingelheim Celgene Centocor Eli Lilly Janssen-Cilag LEO Medac MSD (formerly Essex Schering-Plough) Mundipharma Novartis Pfizer (formerly Wyeth) Pohl Boskamp Sandoz and Xenoport; and has served as an advisor for and/or received speaker honoraria from AbbVie Almirall Amgen Biogen Idec Boehringer Ingelheim Celgene Centocor Eli Lilly Janssen-Cilag LEO Medac MSD (formerly Essex Schering-Plough) Mundipharma Novartis Pfizer (formerly Wyeth) Pohl Boskamp Sandoz and Xenoport. <section> Funding source: Quote (p 361): ""The study was designed by Immunex S Tyring and other members of the Etanercept Psoriasis study group (The complete data set was held at the central dataprocessing fa- <section> Funding source: Quote (p 650): ""AbbVie and Boehringer Ingelheim"" <section> Funding source: Quote (p 650): ""AbbVie and Boehringer Ingelheim"" <section> Funding source: Quote (p 525): ""This study was sponsored by UCB Pharma."" <section> Funding source: Quote (p 346): “The trials were sponsored by Eli Lilly and were designed by the scientific steering committee and Eli Lilly personnel. <section> Funding source: Quote (p. PvdK has received grants from Celgene Centocor Allmiral Pfizer Philips AbbVie Eli Lilly Galderma Novartis Janssen Cilag and Leo Pharma; and has served as a speaker for Amgen a consultant for Sandoz and Mitisibishu and a speaker and consultant for Celgene AbbVie Eli Lilly Galderma Novartis Janssen Cilag and Leo Pharma. <section> Funding source: Quote (p 541): ""Funding Eli Lilly and Co."" PvdK has received grants from Celgene Centocor Allmiral Pfizer Philips AbbVie Eli Lilly Galderma Novartis Janssen Cilag and Leo Pharma; and has served as a speaker for Amgen a consultant for Sandoz and Mitisibishu and a speaker and consultant for Celgene AbbVie Eli Lilly Galderma Novartis Janssen Cilag and Leo Pharma. <section> Funding source: Quote (supplemental appendix): ""This investigatorinitiated study was supported by a grant of Pfizer Pharmaceuticals. <section> Funding source: Quote (p 1184): ""This study was supported financially by Wyeth Pharmaceuticals Collegeville PA USA)"". <section> Funding source: Quote (p 10): ""This study was supported by grants (National Heart Lung and Blood Institute R01-HL111293 K24-AR-064310) and by an unrestricted grant from AbbVie (to the Trustees of the University of Pennsylvania). Dr Mehta is supported by National Institutes of Health Intramural Research Program (Z01 HL-06193). However she was being funded at the time by a research grant from the National Psoriasis Foundation and a training grant from the National Institutes of Health. <section> Funding source: Quote: ""This study is funded by Novartis Pharmaceuticals Corporation East Hanover <section> Funding source: Quote (p. 92): ""This study was funded by a grant to the Trustees of the University of Pennsylvania from Janssen Pharmaceuticals (JMG). NNM received additional funding from NHLBI Intramural Research Program (HL006193-05). MHN receives a research grant via the Trustees of the University of Pennsylvania from Boehringer Ingelheim and she is supported by a K23-AR073932 career development award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. <section> Funding source: Quote (p 95): ""Boehringer Ingelheim provided funding and were responsible for the <section> Funding source: Quote (p 405): ""Supported by Janssen Research & Development LLC Spring House <section> Funding source: Quote (p 1): ""Supported by Janssen Research & Development LLC."" <section> Funding source: not stated <section> Funding source: not stated <section> Funding source: not stated <section> Funding source: Quote (p 449): ""This work was supported by grants from National Natural Science Foundation of China (No. 81673050 81872522) the Program of Science and Technology Commission of Shanghai Municipality (No. <section> Funding source: Quote (p 7): ""The study was funded by Sinocelltech Ltd. and supported by the National Major Scientific and Technological Special Project for “Significant New Drugs Innovation and Development” (grant number 2018ZX09736002)"". <section> Funding: Hisun Pharmaceutical <section> Funding: Janssen Research & Development <section> Funding: AbbVie <section> Funding: <section> Funding Quote (ClinicalTrials.gov): <section> Funding quote (abstract) by Biogen Abstract: “Results of a phase III ment of moderateto-severe plaque in 2005 in the JEADV Suppl. <section> Funding Quote (ClinicalTrials.gov Recruitment status: unknown; Estimated study completion date: Last update posted: January 2012 We sent an email to Prof. <section> Notes Funding: Janssen Research & Development NCT05272150 Last checked in October 2022 <section> Funding: Dermatology Hospital <section> Funding: Shanghai Skin Disease Last checked in October 2022 <section> Notes Funding: Peking University People's <section> Notes Funding: Peking University People's <section> Notes Funding: GMERS Medical College Last check in October 2022 <section> Funding: Chinese Society of Academic Degree and Master Education' <section> Funding: Affibody <section> Notes Funding: Hospital Physiotherapy Last check in October 2022 <section> Funding: Jansssen-Cilag Germany <section> Funding: Quote (clinicaltrials.gov): NCT05190419 <section> Notes Funding: ""Gefördert durch die Deutsche 422744262—TRR 289—Funded Foundation)—Project-ID 422744262—TRR <section> Notes Funding: Shahroud University of Last check in October 2022 <section> Notes Funding: Tabriz University of Medical Last checked in October 2022 <section> Funding: Chengdu PLA General Last checked in October 2022 <section> Funding: Aarhus University Hospital-LEO <section> Funding: Sun Pharma Global FZE <section> Funding: Sun Pharma Global FZE <section> Funding: Sinocelltech Ltd. <section> Notes Funding: Tianjin Hemay Pharmaceutical Last check in October 2022 <section> Notes Funding: Novartis Pharmaceuticals <section> Notes Funding: LEO Pharma <section> clintrials@chdr.nl <section> Notes Funding: Janssen Pharmaceuticals <section> Funding: Alvotech Swiss AG Last checked in October 2022 <section> Funding: LEO Pharma <section> Funding: Bioeq GmbH <section> Funding: Amgen Last checked in October 2022 <section> Funding: Celltrion <section> Funding: AbbVie <section> Funding: Bio-Thera Solutions Last checked in October 2022 <section> Notes Funding: Dong-A ST Co. Ltd. <section> Notes Funding: Tianjin Hemay Pharmaceutical Last check in October 2022 <section> Funding: AbbVie <section> Funding: Janssen Research & Development <section> Notes Funding: Alvotech Swiss AG <section> Funding: Samsung Bioepis Co. <section> Notes Funding: NYU Langone Health <section> Notes Funding: UCB Biopharma Last checked in October 2022 <section> Notes Funding: Quote (clinicaltrials.gov): <section> Notes Funding: Biocon Biologics UK Ltd. <section> Notes Funding: Shanghai Junshi Bioscience <section> Funding: Sunshine Guojian Pharmaceutical <section> • No sources of support provided <section> • French Ministry of Health France Grant support was from the Programme Hospitalier de Recherche Clinique (DGOS n°APHP-180680).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/14651858.cd014808",TRUE,"DECLARATIONS OF INTEREST..................................................................................................................................................................... <section> 5. <section> Notes: funding for trial and notable conflicts of interest of trial <section> JH declares having no conflicts of interest. <section> CS declares having no conflicts of interest. <section> HE declares having no conflicts of interest. <section> PJ declares having no conflicts of interest. <section> LGH declares having no conflicts of interest.",TRUE,"SOURCES OF SUPPORT............................................................................................................................................................................... <section> This project was supported by the National Institute for Health and Care Research (NIHR) via Cochrane Infrastructure funding to the Heart Group until 31 March 2023.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/14651858.cd014962.pub2",TRUE,"<section> DECLARATIONS OF INTEREST..................................................................................................................................................................... <section> AM: has no relevant conflicts of interest to declare. <section> MS: has no known conflicts of interest to declare.",TRUE,"<section> SOURCES OF SUPPORT............................................................................................................................................................................... <section> The research was part of a project supported by the German Federal Ministry of Education and Research (NaFoUniMedCovid19 funding number: 01KX2021; part of the project CEOsys). <section> ◦ In part funded by the governments of Denmark Japan Mexico and Singapore <section> • Sponsor/funding: this study was sponsored by Gilead Sciences <section> ◦ This study was funded by ID-19 National Key Research nology project The latter was funded in 2021 by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> KA: is member of the CEOsys project which was funded in 2021 by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> KD: is member of the CEOsys project which was funded in 2021 by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> MIM: is member of the CEOsys project which was funded in 2021 by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> MG: works as an Intensive Care Medicine Consultant and is member of the CEOsys project which was funded in 2021 by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> This review is part of the CEOsys project funded by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol for this review was registered with PROSPERO on 26 February 2021 (CRD42021238065). <section> Trial registration number: NCT04280705 <section> Trial registration number: EudraCT number 2020-003510-12 NCT04501952 (ClinicalTrials.gov) <section> Trial registration number: NCT04292730 <section> Trial registration number: NCT04257656 <section> Trial registration number: NCT04330690 <section> • Trial registration number: EudraCT2020-000936-23 NCT04315948 (ClinicalTrials.gov) <section> Trial registration number: NCT04321616 <section> Trial registration number: NCT04315948 (ClinicalTrials.gov); ISRCTN83971151 (ISRCTN registry)",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/14651858.cd015078",TRUE,"DECLARATIONS OF INTEREST..................................................................................................................................................................... <section> • No other authors reported disclosures. <section> ASA: acetylsalicylic acid; COI: conflicts of interest; CNS: central nervous vein thrombosis; ECMO: extracorporeal membrane oxygenation; eGFR: interquartile range; IV: intravenous; n.i.: no information; NR: not reported; <section> there is no conflict of interest <section> COI: conflict of interest; ECMO: extracorporeal membrane oxygenation; NR: not reported; RCT: randomised controlled trial",TRUE,"SOURCES OF SUPPORT............................................................................................................................................................................... <section> The research was part of a project supported by the German Federal Ministry of Education and Research (NaFoUniMedCovid19 funding number: 01KX2021; part of the project ""CEOsys""). <section> components of the primary study end point as well as mortality funded by National Institutes of Health (NIH) Agreement 1OT2Htrial was supported by Other Transition Authorities from Institute (NHLBI). <section> personal fees from Bristol Myers Squibb Pfizer Abbott Alnyand that his institution has received research funding from CSL personal fees for data and safety monitoring board membership grants from Sergey Brin Family Foundation Research in COVID. Dr Shankar-Hari is funded by an (grant CS-2016-16-011) and Dr Gordon is funded by an NIHR re- <section> Funding: National Key R&D Program Taikang Insurance Group Co. Ltd from individuals. <section> D E C L A R A T I O N S O F I N T E R E S T AF: works as an Intensive Care Medicine Physician and is member of the CEOsys project funded by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021 paid to the institution. <section> • Federal Ministry of Education and Research of Germany Germany This review is part of the CEOsys project funded by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2021.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Two studies are listed as having completed according to the trial registries but no results have been published yet (NCT04391179; NCT04659109). <section> • Trial registration number: NCT04505774 <section> • Trial registration number: NCT04409834 <section> • Trial registration number: NCT04498273 <section> Trial registration number: NCT04324463 <section> • Trial registration number: NCT04381936 <section> Trial registration number: NCT02735707 <section> • Trial registration number: NCT04391179 <section> • Trial registration number: NCT04659109 <section> • Trial registration number: CTRI/2020/07/026791 <section> Trial registration number: ChiTR2000030055 <section> Trial registration number: CTRI/2020/08/027503 <section> Trial registration number: CTRI/2021/03/032059 <section> Trial registration number: CTRI/2021/06/034254 <section> Trial registration number: IRCT20180205038626N7 <section> • Trial registration number: NCT04363840 <section> Trial registration number: NCT04365309 <section> • Trial registration number: NCT04445623 <section> Trial registration number: NCT04703608 <section> Trial registration number: NCT04768179 <section> Trial registration number: NCT04808895 <section> • Trial registration number: NCT04937088 <section> Trial registration number: NCT05073718",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/1873-3468.14675",TRUE,"Conflict of interest <section> PD is a co-founder and shareholder of LambdaGen Pte. Ltd. All other authors declare no conflict of interest.",TRUE,"<section> This work was funded by the Ministry of Education Academic Research Fund Tier 3 (MOE2012-T3-1-001 to PD) and by the National Research Foundation (NRF) Singapore Competitive Research Programme (CRP) Grant Award Number NRF-CRP18-2017-01 (GG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/1878-0261.13418",TRUE,"Conflict of interest The other authors declare no conflict of interest.",TRUE,"Dr Dragomir was supported by Berlin Institute of Health Junior Clinician Scientist Program. <section> Work in Dr Sandra Dias lab was supported by FAPESP grant # 21/05726-6. Dr Slaby was supported by the project National Institute for Cancer Research",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/1878-0261.13435",TRUE,"Conflict of interest <section> MR reports honoraria (self) and advisory/consultancy fees from Roche Novartis MSD AstraZeneca Seagen Somatex and Lilly; and travel expenses from Novartis Celgene and Pfizer. SB DG AT has declared no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/acn3.51875",TRUE,"Conflict of Interest Statement <section> None of the authors reports conflicts of interest regarding this manuscript.",TRUE,"<section> This study was funded within the framework of the ERANet for Research Programmes on Rare Diseases (RISCA) and EU FP6 (EUROSCA).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This study is registered with ClinicalTrials.gov numbers NCT02440763 and NCT01037777.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/acn3.51911",TRUE,"Conflict of Interest <section> Ho Jin Kim has received a grant from the National Research Foundation of Korea; consultancy/speaker fees or research support from Alexion AprilBio Altos Biologics Biogen Celltrion Daewoong Pharmaceutical Eisai GC Pharma HanAll Biopharma Handok Horizon Therapeutics (formerly Viela Bio) Kolon Life Science MDimune Merck Serono Mitsubishi Tanabe Pharma Novartis Roche Sanofi Genzyme Teva-Handok and UCB; and is a coeditor for the Multiple Sclerosis Journal and an associate editor for the Journal of Clinical Neurology.",TRUE,"<section> Funding Information <section> The N-Momentum trial was funded by MedImmune/ AstraZeneca and Viela Bio (now part of Horizon Therapeutics).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/acn3.51931",TRUE,"Conflict of Interest <section> T.-Y. Lin has received compensation from ADA Health unrelated to the presented work. C. Chien has received research support from Novartis and Alexion and speaking and writing honoraria from Bayer Healthcare and the British Society for Immunology as well as serves as a member of the Standing Committee on Science for the Canadian Institutes of Health Research (CIHR). J. Kuchling has received congress registration fees from Biogen and speaker honoraria from Sanofi Genzyme and Bayer Schering. JK is participant in the BIH-Charité Junior Clinician Scientist Program funded by the Charité— Universitätsmedizin Berlin and Berlin Institute of Health. S. Asseyer has received speaking honoraria from Alexion Bayer and Roche. S. Motamedi reports no relevant disclosures. J. Bellmann-Strobl has received travel grants and speaking honoraria from Bayer Healthcare Biogen Idec Merck Serono Sanofi Genzyme Teva Pharmaceuticals Roche and Novartis none of them related to this work. T. <section> Schmitz-Hübsch reports no relevant disclosures.",TRUE,"<section> Funding Information <section> The study was supported by a limited research grant from Bayer Vital GmbH (to FP). C. Chien has received research support from Novartis and Alexion and speaking and writing honoraria from Bayer Healthcare and the British Society for Immunology as well as serves as a member of the Standing Committee on Science for the Canadian Institutes of Health Research (CIHR). K. <section> Ruprecht received research support from Novartis Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité GuthyJackson Charitable Foundation and Arthur Arnstein Foundation; received travel grants from Guthy-Jackson Charitable Foundation; received speaker’s honoraria from Novartis. <section> Genzyme Biogen MedImmune Shire and Alexion; received research support from Bayer Novartis Biogen Teva Sanofi-Aventis/Geynzme Alexion and Merck Serono; and received research support from the German Research Council Werth Stiftung of the City of Cologne German Ministry of Education and Research Arthur Arnstein Stiftung Berlin EU FP7 Framework Program Arthur Arnstein Foundation Berlin Guthy-Jackson Charitable Foundation and NMSS.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/acr.25219",TRUE,"<section> Author disclosures are available at https://onlinelibrary.wiley.com/doi/10. 1002/acr.25219.",TRUE,"<section> This work was supported by the National Center for Advancing Translational Sciences NIH University of California San Francisco (UCSF) Clinical & Translational Science Institute (grant TL1-TR-001871); Precision Medicine in Rheumatology (PREMIER) an NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P30 Center for the Advancement of Precision Medicine in Rheumatology at UCSF (grant P30-AR-070155); the NIH/NIAMS (grant K24-AR-074534); and the Rheumatology Research Foundation Scientist Development Award (to Dr. Data collection was supported by the American College of Rheumatology’s Rheumatology Informatics System for Effectiveness (RISE) registry. Palmowski’s work was supported by a research grant from the Deutsche Autoimmun-Stiftung (“German Autoimmune Foundation”).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/acr.25220",TRUE,"<section> Author disclosures are available at https://onlinelibrary.wiley.com/doi/10. 1002/acr.25220.",TRUE,"<section> Supported by the American College of Rheumatology and European Alliance of Associations for Rheumatology. Duarte-García’s work was supported by the Rheumatology Research Foundation Scientist Development Award and the Centers for Disease Control and Prevention.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/acr2.11642",TRUE,"<section> Author disclosures are available at https://onlinelibrary.wiley.com/doi/10. 1002/acr2.11642. <section> ADDITIONAL DISCLOSURES",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/adfm.202301986",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"X.F. F.Y. and L.W. acknowledge the support from China Scholarship Council (CSC).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/adtp.202200291",TRUE,"<section> lished by Patrono et al. [25] No conﬂicts of interest were reported in <section> The authors declare no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> (PROSPERO ID352930). The trial was registered on PROSPERO the international prospective register for systematic reviews (ID 352 930) and can be accessed on the PROPSPERO site.",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/adtp.202300041",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/advs.202302562",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/advs.202303523",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"Supported by tabletop The research was funded by European Research Council (ERC-741350) and the German Research Foundation (CRC1340 Matrixin-Vision RTG2260 BIOQIC). Open access publishing was supported by the Open Access Publishing Fund of Leipzig University which is supported by the German Research Foundation within the program Open Access Publication Funding.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/advs.202304454",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"This work was supported by French state funds managed by the ANR within the Investissements d’Avenir program under reference ANR-11-IDEX-0004-02 speciﬁcally within the framework of the Cluster of Excellence MATISSE led by Sorbonne Université and by Fondation Collège de France and Fondation EDF.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ajh.27046",TRUE,"<section> Marc Vaisband: No potential conflicts of interest; <section> Manuel Drost: No potential conflicts of interest; <section> Petra Pichler: No potential conflicts of interest; <section> Michael Girschikofsky: No potential conflicts of interest; <section> Margarete Stampfl-Mattersberger: No potential conflicts of interest; <section> Angelika Pichler: No potential conflicts of interest; <section> Felix Keil: No potential conflicts of interest; <section> Senn: No potential conflicts of interest;",TRUE,"<section> FUND ING INFORMATION The Austrian Group for Medical Tumor Therapy (AGMT) is the sponsor for the Austrian Myeloid Registry (aMYELOIDr) and the Austrian Registry of Hypomethylating Agents and has received funding from Celgene/BMS AbbVie and Janssen Cilag. <section> Research Funding: BMS/Celgene MSD Novartis Pfizer and Roche; <section> Hasenauer: Research Funding: Böhringer-Ingelheim;",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ajh.27073",TRUE,"BJD reports the following potential competing interests. SAB: Adela Bio Aileron Therapeutics (inactive) Therapy Architects/ ALLCRON (inactive) Cepheid DNA SEQ Nemucore Medical Innovations Novartis RUNX1 Research Program; SAB & Stock: Aptose Biosciences Blueprint Medicines Enliven Therapeutics Iterion Therapeutics GRAIL Recludix Pharma; Board of Directors & Stock: <section> Amgen Vincerx Pharma; Board of Directors: Burroughs Wellcome <section> Fund CureOne; Joint Steering Committee: Beat AML LLS; Advisory <section> Committee: Multicancer Early Detection Consortium; Founder: VB Therapeutics; Sponsored Research Agreement: Enliven Therapeutics Recludix Pharma; Clinical Trial Funding: Novartis Astra-Zeneca; Royalties from Patent 6 958 335 (Novartis exclusive license) and OHSU and Dana-Farber Cancer Institute (one Merck exclusive license one CytoImage Inc. exclusive license and one Sun Pharma Advanced Research Company non-exclusive license); US Patents 4 326 534 6 958 335 7 416 873 7 592 142 10 473 667 10 664 967 11 049 247. All other authors declare no competing interests.",TRUE,"<section> Funding information Dipartimento di Medicina e Chirurgia Università degli Studi di Milano-Bicocca <section> Committee: Multicancer Early Detection Consortium; Founder: VB Therapeutics; Sponsored Research Agreement: Enliven Therapeutics Recludix Pharma; Clinical Trial Funding: Novartis Astra-Zeneca; Royalties from Patent 6 958 335 (Novartis exclusive license) and OHSU and Dana-Farber Cancer Institute (one Merck exclusive license one CytoImage Inc. exclusive license and one Sun Pharma Advanced Research Company nonexclusive license); US Patents 4 326 534 6 958 335 7 416 873 7 592 142 10 473 667 10 664 967 11 049 247.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ajmg.a.63122",TRUE,"The authors have no personal financial or institutional conflict of interest.",TRUE,"<section> Funding information Charité – Universitätsmedizin Berlin <section> FUND ING INFORMATION No specific funding for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ajmg.a.63132",FALSE,"",TRUE,"<section> Funding information The International Skeletal Dysplasia Society; University of Lausanne; DBT/Wellcome Trust; India Alliance; Sigrid Jusélius Foundation; CureKids New ZEaland; National Health and Medical Research Council of Australia Grant/Award Number: #GNT2018081 When the first “Nosology” was compiled and published would have predicted that it would gain such an genetics clinics and research to motivate an 11th later (Table 1). This work was supported by the International Skeletal Dysplasia Society (www.isds.ch) with secretarial logistics the University of Lausanne (support to Sheila Unger and Andrea Superti-Furga) the NIH/NHGRI (to Carlos R.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/alz.12915",TRUE,"<section> CONFLICTS OF INTEREST Dr. No other disclosures were reported. Author disclosures are available in the supporting information.",TRUE,"<section> Funding information German Ministry of Education and Research Grant/Award Number: 01KG0909 <section> ACKNOWLEDGMENT The study was funded by grant 01KG0909 from the German Ministry of Education and Research.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/alz.13068",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.",TRUE,"<section> Funding information National Natural Science Foundation of China Grant/Award Number: 82020108013; National Science Fund of China for Young The study was funded by the National Natural Science Foundation of China (NSFC; Major International Joint Research Project; Grant 82020108013) the National Science Fund of China for Young Scholars (82001773) Sino-German Center for Research Promotion (GZ1370; GZ1425; GZ1567 M-0759) and the German Center for Neurodegenerative Diseases (Reference number BN012). X.H. is a recipient of a research grant on the early detection of Alzheimer’s disease (Hirnliga e.V. Germany).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/alz.13561",TRUE,"<section> CONFLICT OF INTEREST STATEMENT S.S. attended scientific advisory committee meetings or consulted for AstraZeneca Atara Bristol-Myers-Squibb Merck Novartis Panalgo Pfizer and Seqirus and received speaking fees from BoehringerIngelheim and Novartis. P.B. and CAF received consulting fees from Becton Dickinson and Pendopharm respectively on topics unrelated to this work. All other authors declare no conflict of interest. Author disclosures are available in the Supporting information.",TRUE,"<section> Funding information Canadian Institutes of Health Research Grant/Award Number: CIHR #183856 <section> ACKNOWLEDGMENTS AD is the recipient of Chercheur-Boursier Junior 1 Award from the Fonds de Recherche du Québec – Santé (FRQS). The study was funded by a project grant from the Canadian Institutes of Health Research",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ame2.12311",TRUE,"<section> AC K N OW L E D G M E N T S The authors declare no competing financial interests or other associations that may pose a conflict of interest (e.g. pharmaceutical stock ownership consultancy). This study was supported by the United States-­ Israel Binational Science Foundation (BSF) grant number 2015077 German Israeli Science Foundation (GIF) grant I-­63-­410.20-­2017 Israeli Science Foundation (ISF) grant 1085/18 and core fund from TUV. <section> F U N D I N G I N FO R M AT I O N Binational Science Foundation (BSF) grant number 2015077 German Israeli Science Foundation (GIF) grant I-­63-­410.20-­2017 Israeli Science Foundation (ISF) grant 1085/18 and core fund from Tel Aviv University. <section> C O N F L I C T O F I N T E R E S T S TAT E M E N T The authors declare no competing financial interests or other associations that may pose a conflict of interest (e.g. pharmaceutical stock ownership consultancy).",TRUE,"<section> Funding information tolerance status of mice. This study was supported by the United States-­ Israel Binational Science Foundation (BSF) grant number 2015077 German Israeli Science Foundation (GIF) grant I-­63-­410.20-­2017 Israeli Science Foundation (ISF) grant 1085/18 and core fund from TUV.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ana.26602",TRUE,"<section> Potential Conﬂicts of Interest H.J.A reported personal fees from Boehringer Ingelheim the manufacturer of Alteplase which is used for intravenous thrombolysis in ischemic stroke. He also reported personal fees from NovoNordisk the manufacturer of NovoSeven (factor VIIa) a drug that is used for acute lifethreatening bleedings and with an ongoing study in patients with spontaneous intracerebral hemorrhage. The other authors have nothing to report. Full disclosures are listed in the submitted ICMJE forms.",TRUE,"<section> Data collection in the B_PROUD study was funded by the German Research Foundation and in the B-SPATIAL registry by the Federal Ministry of Education and Research via the Center for Stroke Research Berlin.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ana.26626",FALSE,"",TRUE,"<section> Acknowledgments The CHAMPION-NMOSD trial was funded by Alexion AstraZeneca Rare Disease.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ana.26669",TRUE,"<section> Potential Conﬂicts of Interest The following authors have received speaker honoraria honoraria for travel advisory board or consulting fees from Boehringer-Ingelheim which is producing and selling Actilyse ® : D.R.J. Y.B. G.K. S.W. C.W.C. P.L. V.P. A.Z. C.C. C.H.N. P.A.R. and S.T.E.",TRUE,"<section> Role of the Funding Source and Ethics The present study was not funded.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ana.26674",FALSE,"",TRUE,"This ""DBS in early stage PD"" pilot trial was supported by Vanderbilt CTSA grants UL1TR000445 and UL1TR002243 from the National Center for Advancing Translational Sciences (NCATS; NCATS/NIH award UL1TR000011 NIH R01EB006136) and Medtronic. This work was also supported by a generous gift from Phyllis G.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ana.26712",FALSE,"",TRUE,"The study was further funded by the Federal Ministry of Education and Research Germany and through the TreatHSP network (01GM1905 to L.S.). F.M.S. is supported in part by the Italian Ministry of Health (EJPRD network PROSPAX; Ricerca Finalizzata RF-201602361610; RF-2019-12370417; Ricerca Corrente RC 5x1000).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/anie.202304010",TRUE,"Conflict of Interest <section> The authors declare no conflict of interest.",TRUE,"R.B. and R.H. thank the Collaborative Research Center CRC1449 Project ID 431232613 and the German Science Foundation (DFG) for financial support. <section> Daniel Lauster for access to the picoMST device which was funded by the Federal Ministry of Education and Science (BMBF; grant number: 13XP5111).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/art.42538",TRUE,"<section> Author disclosures and graphical abstracts are available online at https:// onlinelibrary.wiley.com/doi/10.1002/art.42538.",TRUE,"<section> Supported by the Netherlands CardioVascular Research Initiative of the Netherlands Heart Foundation (MC_UU_00011/1 CVON 2011/B019 and CVON Infrastructure for the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium was supported by National Heart Lung and Blood Institute (NHLBI) NIH (grant R01-HL-105756). This project is supported by grants from the National Key Research and Development Program of China (2022YFC2505203). Avon Longitudinal Study of Parents and Children (ALSPAC) data collection was supported by the Wellcome Trust (grants <section> Sclerostin measurement in the OAI was supported by the Wellcome Trust (reference 20378/Z/16/Z) and analyses were supported by the NIH (grants R01-AR-075356 and P30-DK-072488). Kemp’s work was supported by a National Health and Medical Research Council (Australia) investigator grant (GNT1177938). <section> De Vries’s and Peyser’s work was supported by NHLBI grant R01-HL-146860. Dr. van der Laan’s work was supported by the EU Horizon 2020 project TO_AITION (grant agreement ID 848146). Malhotra’s work was supported by the NHLBI NIH (grants R01-HL-142809 and R01-HL-159514) the American Heart Association (18TPA34230025) and the Wild Family Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/art.42658",TRUE,"<section> Author disclosures and graphical abstract are available at https:// onlinelibrary.wiley.com/doi/10.1002/art.42658.",TRUE,"<section> Supported by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) as part of a clinical research unit (CRU339): Food allergy and tolerance (FOOD@–Project ID 428046232) and CRC1449 (to Dr. The OptiRef control cohort was partially supported by an unrestricted research grant from Novartis and the acute anterior uveitis cohort by an unrestricted grant from AbbVie. Strowig’s work was supported by the DFG under Germany’s Excellence Strategy–EXC 2155 “RESIST” (Project",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/art.42695",TRUE,"<section> Author disclosures are available at https://onlinelibrary.wiley.com/doi/10. 1002/art.42695.",TRUE,"<section> Supported by Novartis Pharma AG. Medical writing support for the development of this manuscript under the direction of the authors was provided by Samuel McCracken Peter Birch Christopher Strutynskyj-Stannard and Eleanor Thomas of Ashﬁeld MedComms An Inizio Company.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ase.2285",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/bdm.2357",FALSE,"",TRUE,"<section> Funding information <section> JEK has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 894536 project “TeamUp” and under the grant agreement no. 101021775 project “Med1stMR.”",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/bies.202300010",TRUE,"The authors have declared no conflict of interest.",TRUE,"<section> Funding information <section> This study was supported by a grant from the Deutsche Forschungsgemeinschaft (MU 880/16-1) to S.M. L.A. was supported by the FOXG1 Foundation (grant P.S.7905).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/bimj.202100294",TRUE,"The authors have declared no conflict of interest.",TRUE,"<section> Funding information when generalizing treatment Google Grant/Award Number: PhD the problem differently fellowship; École des Hautes Etudes en joint imputation ignoring Sciences Sociales Grant/Award Number: Doctoral fellowship imputation we also covariates as semidiscrete latter alternative rely This article has earned an open data of missing values on IM was supported by an EHESS Ph.D. fellowship and a Google Ph.D. fellowship.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/bimj.202200081",TRUE,"The authors have declared no conflict of interest.",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft available we use numerical Grant/Award Number: DFG KO 4680/4-1 simulation studies tions. <section> AC K N OW L E D G M E N T S This work was funded by the German science foundation (Deutsche Forschungsgemeinschaft) award number DFG KO 4680/4-1 and the support is greatly acknowledged.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/brb3.3230",FALSE,"",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered at ClinicalTrials.gov as NCT01833312.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/btm2.10622",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information properties and extracellular Bundesministerium für Bildung und Forschung immediate effect of mRNA Grant/Award Number: 13GW0098; Helmholtz-Gemeinschaft Program-Oriented a contributor to differences Funding; Helmholtz Graduate School of Our results demonstrate Macromolecular Bioscience Grant/Award <section> ACKNOWLEDGMENTS This work was funded by the Helmholtz Association through programoriented funding and through Helmholtz Graduate School of Macromolecular Bioscience (MacroBio VH-GS-503) as well as German Federal Ministry of Education and Research through the Program Health Research (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/btm2.10631",FALSE,"",TRUE,"<section> Funding information Innosuisse – Schweizerische Agentur für Financial support came from the Innosuisse (grants 25390.2PFLS-LS 31010.1IP-LS and 104.947 IP-LS). <section> FUND ING INFORMATION This study was financed over the (grants 25390.2PFLS-LS 31010.1IP-LS and 104.947 IP-LS) from the Innosuisse – Schweizerische Agentur für Innovationsförderung.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cam4.5574",TRUE,"The authors have no conflict of interest to declare.",TRUE,"<section> Funding information <section> FUNDING INFORMATION This work was supported by funding from the Innovation Fund of the German Federal Joint Committee.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> CLINICAL TRIAL REGISTRATION German",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/cam4.5962",FALSE,"",TRUE,"<section> Funding information KEYWORDS China Scholarship Council Grant/ chemotherapy clinical cancer Award Number: 201906550002 We are also grateful to Tara von Grebel from MELS/SIVIC of Information Technology in University of Zurich for drawing the pictures in Figure 1 for this manuscript and Anita Thomae for her support in building up this collaboration.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cam4.6033",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Frederico Costa and Bertram Wiedenmann are employees and shareholders of Autem Therapeutics. Ghassan K. Abou-­Alfa reports institutional research support from Arcus Biosciences AstraZeneca BioNtech Bristol-­Myers Squibb Celgene Flatiron Health Genentech/Roche Genoscience Pharma Incyte Polaris Pharmaceuticals Puma Biotechnology QED Therapeutics Silenseed and Yiviva and consulting support from Adicet Bio Alnylam Pharmaceuticals AstraZeneca Autem Therapeutics BeiGene Berry Genomics Boehringer Ingelheim Celgene Cend Therapeutics CytomX Therapeutics Eisai Eli Lilly and Company Exelixis Flatiron Health Genentech/Roche Genoscience Pharma Helio Health <section> Helsinn Healthcare Incyte Ipsen Merck Nerviano Medical Sciences NewBridge Pharmaceuticals Novartis QED Therapeutics Rafael Pharmaceuticals RedHill Biopharma Servier Silenseed Sobi Vector BioPharma and Yiviva. The remaining authors made no disclosures.",TRUE,"<section> Funding information Autem Therapeutics <section> FUNDING INFORMATION This work was funded by Autem Therapeutics.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cam4.6374",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Georg Lurje reports receiving travel support and speakers' fees from Astellas Pharma XVIVO Bridge to Life Aferetica S.R.L outside the submitted work.",TRUE,"<section> Tacke: Funding acquisition (supporting); resources (supporting); writing –­ review and editing (equal). <section> FUNDING INFORMATION None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cam4.6413",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding information East German Study Group Hematology of 15–­45 min whereas and Oncology Grant/Award Number: 60 min (p < 0.001). <section> ACKNOWLEDGMENTS This work was supported by the non-­profit associations German Austrian and Swiss MPN Network. <section> FUNDING INFORMATION The study was supported by the East German Study Group Hematology and Oncology (OSHO #97).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cap.10246",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ccd.30559",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ccd.30747",TRUE,"<section> CONFLIC T OF INTEREST STATEM ENT Felix Berger and Johannes Nordmeyer declare financial activities unrelated to the submitted work with several commercial entities. <section> Felix Berger has received consulting fees and travel expenses from Medtronic consulting fees travel expenses and research support from Abbott and consulting fees from Venus Medtech Europe. <section> Johannes Nordmeyer has received speaker's honoraria and travel expenses from Medtronic Abbott and Venus Medtech Europe. None of the other authors has conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ccd.30793",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ccd.30816",FALSE,"",TRUE,"<section> Funding information European Union's Horizon 2020 Research and",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ccd.30927",TRUE,"The remaining authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ccr3.7325",TRUE,"",TRUE,"<section> FUNDING INFORMATION This research received no specific grant from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cjp2.319",TRUE,"<section> No conﬂicts of interest were declared.",TRUE,"<section> This research was supported by grants from the former Prostate Cancer Canada and Prostate Cancer Research funds from the Urology Division.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cjp2.322",TRUE,"<section> No conﬂicts of interest were declared.",TRUE,"<section> Parts of this work have received funding from the Parts of this work have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. Support for the writing of this article for coauthors CG TE TRK NZ and RC was provided by the EMPAIA project which is funded by the German Federal Ministry for Economic Affairs and Climate Action (BMWK) under FKZ 01MK20002A.",FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clc.23988",FALSE,"",TRUE,"<section> Funding information acute coronary syndromes Sanofi myocardial infarction PCSK9 This work was supported by Sanofi. The work of ALC is supported in part by Ministero della Salute Ricerca corrente.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12215",FALSE,"",TRUE,"<section> Funding information Charité Universitätsmedizin Berlin; EU; Mylan‐Viatris; ALK; GSK; Novartis; Stallergènes‐Greer; Uriach Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12222",TRUE,"<section> C O N F LI C T O F IN T ER E S T S T A TE M E N T Carolin Steinert: No conflict of interests. Sherezade Moñino‐Romero: No conflict of interests. Monique Butze: No conflict of interests. <section> Scheffel: No conflict of interests in relation to this paper. Sabine Dölle‐Bierke: No conflict of interests. Josefine Dobbertin‐Welsch: No conflict of interests. Kirsten Beyer: No conflict of interests in relation to this paper. Marcus Maurer: No conflict of interest in relation to this paper. Sabine Altrichter: No conflict of interest in relation to this paper.",TRUE,"<section> Funding information Federal Ministry of Education and Research characterized. <section> Sabine Altrichter: Conceptualization (lead); Funding Acquisition (equal); Methodology (lead); Project Administration (lead); Resources (equal); Supervision (equal); Validation (equal); Writing – Original Draft Preparation (equal). <section> Kirsten Beyer: Conceptualization (supporting); Funding Acquisition (equal); Resources (equal); Writing Review & Editing (supporting). <section> Dölle‐Bierke: Conceptualization (supporting); Funding Acquisition (equal); Investigation (supporting); Resources (equal); Writing Review <section> Marcus Maurer: Funding Acquisition (equal); <section> A CK N O WL ED GM E N T S This project was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) as part of a clinical research unit (CRU) “food allergy and tolerance”—428057545; 428144812; 428447634 as well as in part by the Federal Ministry of Education and Research (CHAMP; 01GL1742C).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12226",TRUE,"Monique Butze has no conflict of interest. Sebastian Spittler has no conflict of interest.",TRUE,"<section> Funding information cebo – 0.45°C; rilonacept This investigator‐initiated trial was supported by Regeneron Pharmaceuticals interindividual variability provocation in placebo‐ cantly improved in the the placebo group (mean nacept open‐label treatment <section> Karoline Krause: Conceptualization Formal analysis Funding acquisition Methodology Project administration Writing ‐ original draft. This investigator‐initiated trial was supported by Regeneron Pharmaceuticals.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical Trial Registration: identifier: NCT02171416.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/clt2.12228",TRUE,"<section> CONFLICT OF INTEREST STATEMENT ECJ serves as ALK paediatric advisory board AK got personal fees (advisory board) from Allergopharma and Menarini AG travel grant from Stallergenes JO’BH receives research funding speaker fees and consultancy fees from Aimmune Therapeutics research funding and speaker fees from DBV Technologies and research funding from Johnson&Johnson Clemens von Pirquet Foundation Temple St Hospital Foundation and City of Dublin Skin and Cancer Hospital Charity KN was paid Nutricia/Danone and AimmuneTherapeutics in the past 3 years other co‐authors declare no conflict of interest.",TRUE,"<section> Funding information European Anaphylaxis German Federal Ministry of Education and <section> Margitta Worm: Conceptualization; Lead Data curation (Equal); Formal analysis (Equal); Funding acquisition (lead); Investigation (lead); Methodology; Supporting Project administration (lead); Resources (lead); Software (lead); Supervision (lead); Validation (lead); Writing ‐ original draft (Equal); Writing – review & editing (lead).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered prompted us to at ClinicalTrials.gov (Identifier: NCT05210543) and it was approved HEA in children to by both the ethics committee at the Charité ‐ Universitätsmedizin and treatment Berlin in Germany (EA1/079/06) as well as the ethics committees local to the participating referral centres.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/clt2.12236",TRUE,"Beck has no conflict of interest to declare. Anna Bedbrook has no conflict of interest to declare. Nikolaos Douladiris has no conflict of interest to declare. Mortz has no conflict of interest to declare. <section> Francuzik Wojciech has no conflict of interest to declare. Katarina Stevanovic has no conflict of interest to report.",TRUE,"<section> Funding information Global Allergy and Asthma European Network field of atopic dermatitis burden and many comorbidities aligned information an integrated care pathway and considering the placed on the large",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12274",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Franziska Roth‐Walter and Erika Jensen‐Jarolim declare inventorship of the patent EP 14150965.3 Year: 01/2014; US 14/204570 (Method and means for diagnosing and treating allergy; owned by Biomedical International R + D GmbH Vienna Austria) underlying the immunoBON® lozenge. Erika Jensen‐Jarolim is a shareholder of Biomedical Int. R + D GmbH Vienna Austria and collaborates with Bencard Allergie GmbH in projects and studies on holoBLG. Franziska Roth‐Walter received research funding from Biomedical International R + D GmbH Vienna Austria and lecture honoraria by Bencard Allergie GmbH Munich Germany and Vienna Austria and Allergy Therapeutics Worthing UK. Jennifer Raab Anke Graessel Thomas Zwingers and Matthias F. Kramer are employees of Allergy Therapeutics/Bencard Allergie GmbH. Karl–Christian Bergmann received honoraria for lectures from ALK AstraZeneca Bencard GSK HAL LETI Novartis Sanofi during last 2 years works for the German Pollen Information Service Foundation and is member of ECARF‐Institute GmbH. Torsten Zuberbier reports lecture honoraria from AstraZeneca ALK AbbVie Almirall Astellas Bayer health Care Bencard Berlin Chemie FAES HAL Leti Meda menarini Merck MSD Novartis Pfizer Sanofi Stallergenes Takeda Teva UCB Henkel Kryolan and LÓreal. Sylvia Becker and Sebastian Kugler report no competing interests.",TRUE,"<section> Funding information Bencard Allergie GmbH Germany; Biomedical holoBLG lozenge. The study was funded by Bencard Allergie GmbH Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12288",FALSE,"",TRUE,"<section> Funding information <section> These studies were funded by KalVista Pharmaceuticals.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12290",FALSE,"",TRUE,"<section> Funding information Firat University Coordinatorship of Scientific <section> A CK N O W LE DG M EN T S This work was supported by the Firat University Coordinatorship of Scientific Research Projects (No: TF.16.36).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clt2.12295",TRUE,"All other authors have no conflict of interest regarding this manuscript.",TRUE,"LF is supported by a grant from Dr.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12296",TRUE,"<section> CONFLICT OF INTEREST STATEMENT ST‐S reports consultancies for ALK‐Abelló AstraZeneca ERT GSK Novartis Sanofi and Roche Products outside the submitted work as well as grant of GSK outside the submitted work. JB reports personal fees from Cipla Menarini Mylan Novartis Purina Sanofi‐Aventis Teva Uriach other from KYomed‐Innov other from Mask‐air‐SAS outside the submitted work. JK reports personal fees from GlaxoSmithKline MSD Novartis Sanofi AstraZeneca Boehringer Ingelheim Chiesi and Orion Pharma outside the submitted work. AL reports personal fees from GlaxoSmithKline and CSL Behring outside the submitted work. All other authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> Methods: We used Finnish State Funding for University‐Level The study was partly supported by research grants from State funding for University‐ Level Health Research (TYH2019322) the Finnish Anti‐ Tuberculosis Foundation the Tampere Tuberculosis Foundation the Väinö and Laina Kivi Foundation the Sohlberg Foundation the MD PhD Programme of the Faculty of Medicine in University of Helsinki and the European Academy of Allergy and Clinical Immunology (travel grant).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12297",TRUE,"IM and GS report no conflict of interest.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clt2.12298",TRUE,"<section> CO N F LI C T O F IN TE R E S T S T A T EM E N T All authors have no conflicts of interest to declare.",TRUE,"<section> AC K N O W LE DG M EN T S This work was not supported by any financial grant.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clt2.12299",FALSE,"",TRUE,"<section> Laia Curto Barredo: Funding acquisition (equal); writing – review & editing (equal). <section> Norito Katoh: Funding acquisition (equal); writing – review & editing (equal).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12300",FALSE,"",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clt2.12305",TRUE,"JJT has no conflicts of interest to declare. RA has no conflicts of interest to declare. AMG Almirall Amgen AstraZeneca Avene Celldex Escient Pharmaceuticals Genentech GSK Instituto Carlos III‐ FEDER Leo Pharma Menarini Novartis Sanofi– Regeneron Thermo Fisher Scientific Uriach Pharma/Neucor. JC has no conflicts of interest to declare. CG Consultancies for Celltrion and Blueprint Medicine advisory board for Sanofi. EK is or recently was a speaker and/or advisor for and/or has received research funding from Novartis Menarini LaRoche Posey Sanofi Bayer. UL has been an advisor speaker or investigator (received grants and/or participated in clinical trials) for AbbVie ALK‐Abéllo CSL Behring Leo Pharma Meda Pharma Novartis Janssen‐Cilag Sanofi–Regeneron and Shire/Takeda. MMa is or recently was a speaker and/or advisor for and/or has received research funding from Allakos Allerdia Amgen Aralez ArgenX AstraZeneca Celldex Centogene CSL Behring FAES Genentech GIInnovation Innate Pharma Kyowa Kirin Leo Pharma Lilly Menarini Moxie Novartis Pfizer Roche Sanofi/Regeneron Third HarmonicBio UCB and Uriach. MMe has no conflict of interest to declare.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12315",FALSE,"",TRUE,"<section> Funding information <section> A C K N O WL ED GE M EN T S The study was funded by LETI Pharma GmbH (Witten Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was approved by the appropriate independent ethics committees in each country and registered in the European Clinical Trials Database (reference: EudraCT 2008‐008448‐26).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/clt2.12316",FALSE,"",TRUE,"<section> Funding information This work was supported by the French Environment and Energy Management Agency (ADEME) and the Université Paris‐Saclay.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/clt2.12321",FALSE,"",TRUE,"<section> Funding information with those obtained Stallergenes Greer consideration of the The study as well as the medical writing assistance was sponsored and funded by Stallergenes Greer.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/clt2.12323",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cmdc.202200635",TRUE,"Conflict of Interest <section> The authors declare no conflicts of interest.",TRUE,"<section> The authors acknowledge funding by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID The work was supported by the DFGfunded core facility BioSupraMol and the Zentraleinrichtung für Datenverarbeitung (ZEDAT) of Freie Universität Berlin. A.C.H. was supported by DFG (SFB-TR 84) by BMBF (NUM-COVID 19 OrganoStrat 01KX2021) by BMBF (RAPID) and by Berlin University Alliance GC2 Global Health (Corona Virus Pre-Exploration Project).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cncr.35036",TRUE,"The other authors declare no conflicts of interest.",TRUE,"<section> Funding information Bayer HealthCare Pharmaceuticals Inc; Loxo with TRK fusion sarcomas. These studies were funded by Bayer HealthCare and Loxo Oncology Inc a wholly owned subsidiary of Eli Lilly and Company.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The clinical trial registrations are NCT02122913 NCT02637687 and NCT02576431.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/cncy.22679",TRUE,"The other authors made no disclosures.",TRUE,"<section> Funding information This work was supported in part by federal funds from the National Cancer Institute National Institutes of Health (1U01CA215547 to William Fraser Symmans and Christos Hatzis) and in part by the Breast Cancer Research Foundation (BCRF‐158 to William Fraser Symmans).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cnm.3695",FALSE,"",TRUE,"<section> Funding information patientspecific modeling Deutsche Forschungsgemeinschaft Grant/Award Numbers: GRK2433",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cnm.3778",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information Horizon 2020 Framework Programme TAVI manufacturers Grant/Award Number: 101017578 cifications to the synthetic interaction models to",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cnr2.1700",TRUE,"The authors have stated explicitly that there are no conflicts of interest in connection with this article.",TRUE,"<section> Funding information cantly earlier age in probands German Research Society (DFG) Grant/Award <section> ACKNOWLEDG MENTS This work was supported by grants from the Sander Stiftung (1198-04-049-1 to Karl Sperling Krystyna H.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cnr2.1780",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/cpp.2872",TRUE,"No other disclosures were reported.",TRUE,"<section> Funding information showed that only rumination Deutsche Forschungsgemeinschaft; European hopelessness whereas Commission",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cpt.2975",TRUE,"The authors declared no competing interests for this work.",TRUE,"<section> FUNDING The study was funded by the CIHR project grant PJT-­165882.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ctm2.1471",FALSE,"",TRUE,"<section> Funding information evaluated. <section> AC K N OW L E D G E M E N T S This study was funded by F. Support for thirdparty writing assistance for this manuscript was provided by Karen Yeow (Biomedicomm Ltd.) and was funded by F.",TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: ISRCTN16847938",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/cyto.b.22117",FALSE,"",TRUE,"<section> Funding information SPARK Program of Charité University Hospital Berlin; Clinical Scientist Program of Charité University Hospital Berlin; Berlin Institute of",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/cyto.b.22126",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information <section> FUNDING INF ORMATI ON This work was supported by the German Research Foundation (DFG; CRC1382 SFB/TRR 296 and SPP2306) the Else-Kröner-FreseniusStiftung (Grant-ID 2021_EKEA.145) and Charité 3Rj Replace— Reduce—Refine.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/dad2.12463",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Silke White reports nothing to disclose. Author disclosures are available in the supporting information.",TRUE,"Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica Inc. The study was not funded by Biogen or Phillips.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/dad2.12503",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Luc Bracoud is a full-time employee of Clario Inc. (formerly known as Bioclinica Inc.).",TRUE,"<section> Funding information Three neuroradiologists F. Medical writing support for the development of the manuscript was provided by Matt Gooding PhD of Nucleus Global and funded by F. This study was funded by F.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/dmrr.3704",FALSE,"",TRUE,"<section> A C K N O WL ED GE M EN T S This study was supported by the Deutsche Forschungsgemeinschaft (DFG) to Dr. The authors declare that no funding was received for this study.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eat.24037",FALSE,"",TRUE,"<section> Funding information National Institute for Health and Care Results from Funding for eating GWASs can aid in understanding biological causes and identifying their prevalence potential drug targets. <section> Hotopf: Funding acquisition; writing – review and editing. Eley: Funding acquisition; writing – review and editing. <section> FUND ING INFORMATION This work was supported by the National Institute for Health and Care Research (NIHR) BioResource [RG94028 RG85445] NIHR Biomedical Research Centre [IS-BRC-1215-20018].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/eat.24098",TRUE,"The other authors declared no conflicts of interest.",TRUE,"<section> Funding information <section> Action Editor: Tracey Wade ment and retention [Corrections made on 19 January 2024 after adverse events; preliminary first online publication: Funding information change in %mBMI AN has been Corrected in this version.] <section> FUNDING INF ORMATI ON This work was supported by funding of the Bild hilft! He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ehf2.14329",FALSE,"",TRUE,"We acknowledge support by the Open Access Publication Funds of the Goettingen University. <section> Funding <section> Anja Sandek is supported by a grant from Oskar-Helene-Heim Stiftung.",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ehf2.14331",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ehf2.14363",TRUE,"<section> E.A.J. L.H. W.M. C.M. F.K. M.V. and U.S. report no disclosures.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ehf2.14384",FALSE,"",TRUE,"<section> Funding <section> The study was funded by Occlutech International AB (Helsingborg Sweden).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ehf2.14465",TRUE,"<section> The authors declare that there are no conﬂicts of interest related to the present analysis.",TRUE,"<section> Funding <section> HOMAGE trial was funded by the European Union 7th Framework Programme for Research and Technological Development (grant: 305507 http://www.homagehf.eu). JGFC is supported by a British Heart Foundation Centre of Research Excellence (grant number RE/18/6/34217).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ehf2.14523",FALSE,"",TRUE,"<section> Funding <section> This work was supported by ProFIT grant of the Investitionsbank Berlin/EFRE (No.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2743",TRUE,"Conflict of interest: C.F. reports consulting fees from Janssen outside of the submitted work.",TRUE,"<section> Funding <section> This study was supported by the Italian Ministry of Health (Ricerca Corrente) 20/1819.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2760",TRUE,"Conflict of interest: M.M. reports personal fees of minimal amounts since January 2021 from Actelion Amgen Livanova and Vifor pharma as member of Executive or Data Monitoring Committees of sponsored clinical trials; from AstraZeneca Bayer Boehringer Ingelheim Edwards Lifesciences Novartis for participation in advisory boards and/or speeches at sponsored meetings.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2794",TRUE,"Conflict of interest: none declared.",TRUE,"The study was funded by the European Commission’s 7th Framework program (FP7/2007–2013) under grant agreement number 241558 and fulfils all principles of the Declaration of Helsinki. Funding This work was supported by the European Commission’s 7th Framework program (FP7/2007-2013 under grant number: 241558) and by the German Center for Cardiovascular Research (DZHK).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2796",TRUE,"Conflict of interest: B.S. reports speaker fees from Abiomed and AstraZeneca outside of the submitted work.",TRUE,"<section> research support for basic translational and clinical research projects from European Union British Heart Foundation Leducq Foundation Medical Research Council (UK) and German Centre for Cardiovascular Research from several drug and device companies active in atrial fibrillation and has received honoraria from several such companies in the past but not in the last 3 years.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2797",TRUE,"Conflict of interest: S.L. has received travel compensation from Edwards LifeSciences speaker honoraria from Abbott Medical and advisory fees from Bayer.",TRUE,"<section> Funding <section> This work was supported by a grant from the German Heart Foundation (DHS) [grant number S/04/21] to Dr.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2831",TRUE,"Conflict of interest: T.J.S. has nothing to disclose.",TRUE,"<section> Funding J.J. is a trustee of the American College of Cardiology a board member of Imbria Pharmaceuticals has received grant support from Applied Therapeutics Innolife Novartis Pharmaceuticals and Abbott Diagnostics consulting income from Abbott Janssen Novartis and Roche Diagnostics and participates in clinical endpoint committees/data safety monitoring boards for Abbott AbbVie Amgen Bayer CVRx Janssen MyoKardia and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2836",TRUE,"Conflict of interest: Pieske: Research grants from Bayer Servier; consulting fees from MSD Bayer Servier AstraZeneca Bristol-Myers Squibb MedScape Daiichi-Sankyo Novartis Edwards Boston Scientific; non-financial support from MSD Bayer and Novartis.",TRUE,"<section> Funding <section> Funding for this research was provided by Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc. Rahway NJ USA and Bayer Wuppertal Germany.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2840",TRUE,"Conflict of interest: S.v.H. A.J.S.C. S.D.A. and J.S. are shareholders of Actimed Therapeutics.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2843",TRUE,"Conflict of interest: D.B. has served as a consultant to Axon Therapies and Corvia.",TRUE,"<section> Funding Borlaug is supported by R01 HL128526 and U01 HL160226 from the National Institutes of Health (NIH) and W81XWH2210245 from the United States Department of Defense (DoD).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2857",TRUE,"Conflict of interest: A.S. reports receiving research and/or personal support from Roche Diagnostics Boehringer Ingelheim Novartis Janssen AstraZeneca Novo Nordisk Servier Boston Scientific and Takeda.",TRUE,"<section> Funding <section> The EMPEROR-Preserved trial was funded by Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2859",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding <section> The research leading to these results has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N ∘ 305 507 (HOMAGE).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2860",TRUE,"Conflict of interest: Stefan D.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2861",TRUE,"Conflict of Interest: G.F. reports personal fees from Boehringer Ingelheim during the conduct of the study; personal fees from Medtronic Vifor Servier Novartis Bayer Amgen and Boehringer Ingelheim outside the submitted work.",TRUE,"<section> Funding <section> The EMPEROR-Preserved trial was funded by Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2864",TRUE,"Conflict of interest: J.B. is a consultant to Abbott Adrenomed American Regent Applied Therapeutics Array AstraZeneca Bayer Boehringer Ingelheim Cardior CVRx G3 Pharma Imbria Impulse Dynamics Innolife Janssen LivaNova Medtronic Merck Novartis NovoNordisk Relypsa Roche Sanofi Sequana Medical and Vifor.",TRUE,"S.J.G. has received research support from the Duke University Department of Medicine Chair’s Research Award American Heart Association National Heart Lung and Blood Institute Amgen AstraZeneca Bristol Myers Squibb Cytokinetics Merck Novartis Pfizer and Sanofi; has served on advisory boards for Amgen AstraZeneca Bristol Myers Squibb Cytokinetics Roche Diagnostics Sanofi and scPharmaceuticals; has received speaker fees from Boehringer Ingelheim and Cytokinetics and serves as a consultant for Amgen Bayer Bristol Myers Squibb Boehringer Ingelheim/Lilly CSL Vifor Merck PharmaIN Roche Diagnostics Sanofi Tricog Health Urovant Pharmaceuticals. S.D.A. has received grants from Abbott Vascular and Vifor International; and has received personal fees from Abbott Vascular Vifor Bayer Boehringer Ingelheim Brahms Novartis Servier Impulse Dynamics Cardiac Dimensions and Thermo Fisher Scientific; all outside the submitted work. S.D.S. has received grants from Actelion Alnylam Amgen AstraZeneca Bellerophon Bayer Bristol Myers Squibb Celladon Cytokinetics Eidos Gilead GlaxoSmithKline Ionis Lilly Mesoblast MyoKardia the National Heart Lung and Blood Institute Neurotronik Novartis Novo Nordisk Respicardia Sanofi Pasteur Theracos and Us2.ai paid to his to institution and personal fees from Abbott Action Akros Alnylam Amgen Arena AstraZeneca Bayer Boehringer Ingelheim Bristol Myers Squibb Cardior Cardurion Corvia Cytokinetics Daiichi-Sankyo GlaxoSmithKline Eli Lilly Merck MyoKardia Novartis Roche Theracos Quantum Genomics Cardurion Janssen Cardiac Dimensions Tenaya Sanofi-Pasteur Dinaqor Tremeau CellProThera Moderna American Regent Sarepta Lexicon Anacardio Akros and Puretech Health outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2867",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding Borlaug is supported by R01 HL128526 and U01 HL160226 from the National Institutes of Health (NIH) and W81XWH2210245 from the United States Department of Defense. Alogna is supported by the Clinician Scientist Program of the Berlin Institute of Health (BIH) Germany.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2869",TRUE,"Conflict of interest: U.S. is a member of speakers’ bureau and received study grant support from Vectorious Medical Technologies.",TRUE,"<section> Funding <section> This study was funded by Vectorious Medical Technologies.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2873",TRUE,"Conflict of interest: A.K.C. reports unrelated to the present work: speaker’s honoraria from Angelini Pharma AstraZeneca Bayer Bausch Health Boehringer Ingelheim KRKA Pfizer Polpharma and Servier; support for attending meetings: Servier.",TRUE,"<section> Funding C.H. reports unrelated to the present work: consulting fees from Novartis Roche Diagnostics and AnaCardio research grants from Bayer and speaker’s honoraria from MSD and Novartis; supported by the Swedish Research Council [grant M.L. is supported by Supported by Slovenian Research Agency [grant J3-3076] and reports unrelated to the present work: grants from Roche; consulting fees from Vifor AstraZeneca Bayer Boehringer Ingelheim; speaker’s honoraria from AstraZeneca Novartis Boehringer Ingelheim Bayer. L.H.L. is supported by Karolinska Institutet the Swedish Research Council [grant 523–2014-2336] the Swedish Heart Lung Foundation [grants 20 150 557 20 190 310] and the Stockholm County Council [grants",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2874",TRUE,"Conflict of interest: M.M. reports personal fees from Amgen AstraZeneca Abbott Vascular Bayer Edwards Therapeutics Livanova Vifor Pharma as member of Trials’ Committees or advisory boards or for speeches at sponsored meetings in the last 3 years.",TRUE,"J.G.F.C. is supported by a British Heart Foundation Centre of Research Excellence (grant number RE/18/6/34217) reports personal fees from Abbott Amgen Novartis Medtronic Idorsia Boehringer Ingelheim AstraZeneca Biopeutics Torrent Moderna grants and personal fees from Bayer Bristol Myers Squibb Pharmacosmos. L.H.L. is supported by Karolinska Institutet the Swedish Research Council [Grant 523-2014-2336] the Swedish Heart Lung Foundation [Grants 20150557 20190310] and the Stockholm County Council [Grants 20170112 20190525] reports grants from AstraZeneca Vifor Boston Scientific Boehringer Ingelheim Novartis MSD; consulting fees from Vifor AstraZeneca Bayer Pharmacosmos MSD MedScape Sanofi Lexicon Myokardia Boehringer Ingelheim Servier Edwards Life Sciences Alleviant; speaker’s honoraria from Abbott OrionPharma MedScape Radcliffe AstraZeneca Novartis Boehringer Ingelheim Bayer; Patent: AnaCardio; Stock ownership: AnaCardio. A.M. has received grants from Roche Diagnostics Abbott",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2888",TRUE,"Conflict of interest: M.M. reports personal fees from Actelion Amgen AstraZeneca Abbott Vascular Bayer Servier Edwards Therapeutics Livanova Vifor Pharma WindTree Therapeutics as member of Trials’ Committees or advisory boards or for speeches at sponsored meetings in the last 3 years.",TRUE,"A.M. has received grants from Roche Diagnostics Abbott Laboratories 4TEEN4 and Windtree Therapeutics; honoraria for lectures from Roche Diagnostics Bayer and MSD; is a consultant for Corteria Pharmaceuticals S-form Pharma FIRE-1 Implicity 4TEEN4 and Adrenomed; and is coinventor of a patent on combination therapy for patients having acute or persistent dyspnoea.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2894",TRUE,"Conflict of interest: S.D.A. declares grants and personal fees from Vifor and Abbott Vascular and personal fees for consultancies trial committee work and/or lectures from Actimed Amgen AstraZeneca Bayer Boehringer Ingelheim Bioventrix Brahms Cardiac Dimensions Cardior Cordio CVRx Edwards Farraday Impulse Dynamics Janssen Novartis Occlutech Pfizer Respicardia Servier Vectorious and V-Wave; he also declares that he is named co-inventor of two patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367) but he does not benefit personally from the related issued patents.",TRUE,"We would like to acknowledge the support of the Heart Failure Association of the European Society of Cardiology for organizing the workshop and the contributions of the additional collaborators listed below.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2908",TRUE,"Conflict of interest: B.S. is supported by Region Stockholm clinical postdoctoral appointment (FoUIFoUI-969 615) Swedish Heart-Lung Foundation (grants 20 220 524 and 20 190 322) and the Swedish Research Council (grant 2022–01472).",TRUE,"<section> Conflict of interest: B.S. is supported by Region Stockholm clinical postdoctoral appointment (FoUIFoUI-969 615) Swedish Heart-Lung Foundation (grants 20 220 524 and 20 190 322) and the Swedish Research Council (grant 2022–01472). M.L. is supported by Supported by Slovenian Research Agency [grant J3-3076] and reports unrelated to the present work: grants from Roche; consulting from Vifor AstraZeneca Bayer Boehringer Ingelheim; speaker’s honoraria from AstraZeneca Novartis Boehringer Ingelheim Bayer. Reports unrelated to the present work: consulting fees from Novartis Roche Diagnostics and AnaCardio research grants from Bayer and speaker’s honoraria from MSD and Novartis; supported by the Swedish Research Council [grant 20 180 899]. L.H.L. is supported by Karolinska Institutet the Swedish Research Council [grant 523-2014-2336] the Swedish Heart Lung Foundation [grants 20150557 20190310] and the Stockholm County Council [grants 20170112 20190525] and reports unrelated to the present work: grants from AstraZeneca Vifor Boston Scientific Boehringer Ingelheim Novartis MSD; consulting from Vifor AstraZeneca Bayer Pharmacosmos MSD MedScape Sanofi Lexicon Myokardia Boehringer Ingelheim Servier Edwards Life Sciences Alleviant; speaker’s honoraria from Abbott OrionPharma MedScape Radcliffe AstraZeneca Novartis Boehringer Ingelheim Bayer; Patent: AnaCardio;",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2918",TRUE,"Conflict of interest: none declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2922",TRUE,"Conflict of interest: M.B. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219 project number 322900939) and reports personal fees from Abbott Amgen AstraZeneca Bayer Boehringer Ingelheim Cytokinetics Medtronic Novartis Servier and Vifor during the conduct of the study.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2929",TRUE,"Conflict of interest: M.A.: none related to the present work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2948",TRUE,"",TRUE,"<section> Funding <section> This work was supported by research grants of the German Federal Ministry of Education and Research (grant numbers 13KQ0904A 13KQ0904B",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ejhf.2951",TRUE,"Conflict of interest: M.S.A. reports personal fees from Servier outside the submitted work.",TRUE,"<section> Funding <section> This study was partly funded by the German Center for Cardiovascular Research through research support to Dr. <section> is supported by a clinician Scientist Professorship Grant from the Else Kroener-Fresenius-Foundation and reports both personal fees and grant support from Daiichi-Sankyo Adrenomed Sphingotec and Vifor Pharma all outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2979",TRUE,"Conflict of interest: none declared.",TRUE,"<section> The results of the EXPLORER-HCM trial are supported by the VALOR-HCM phase 3 study which demonstrated that treatment with mavacamten compared with placebo for 16 weeks significantly improved symptoms and reduced eligibility for septal reduction therapy (17.9% vs.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2981",TRUE,"Conflict of interest: L.A.A. has consulting relationships with ACI Clinical Amgen Boston Scientific Cytokinetics and Novartis; and has received grant funding from the American Heart Association the National Institutes of Health and the Patient-Centered Outcomes Research Institute.",TRUE,"<section> Funding <section> L.P.G has received funding from the National Institute on Aging (K23AG049930) the Claude D. <section> Conflict of interest: L.A.A. has consulting relationships with ACI Clinical Amgen Boston Scientific Cytokinetics and Novartis; and has received grant funding from the American Heart Association the National Institutes of Health and the Patient-Centered Outcomes Research Institute.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2983",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding The InterTAK Registry is supported by the Biss Davies Charitable Trust.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.2990",TRUE,"Conflict of interest: J.H. receives salary support from T32 training grant T32HL069749.",TRUE,"<section> Funding <section> The study is supported and funded by Boehringer Ingelheim and Eli Lilly. Jude Medical now Abbott) Boston Scientific (Chair PEITHO trial) Cleveland Clinic (including for the ExCEED trial funded by Edwards) Contego Medical (Chair PERFORMANCE 2) Duke Clinical Research Institute Mayo Clinic Mount Sinai School of Medicine (for the ENVISAGE trial funded by Daiichi Sankyo; for the ABILITY-DM trial funded by Concept Medical) Novartis Population Health Research Institute; Rutgers University (for the NIH-funded MINT Trial); Honoraria: American College of Cardiology (Senior Associate Editor Clinical Trials and News ACC.org; Chair ACC Accreditation Oversight Committee) Arnold and Porter law firm (work related to Sanofi/Bristol-Myers Squibb clopidogrel litigation) Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring) Belvoir Publications (Editor in Chief Harvard Heart Letter) Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees) Cowen and Company Duke Clinical Research Institute (clinical trial steering committees including for the PRONOUNCE trial funded by Ferring Pharmaceuticals) HMP Global (Editor in Chief Journal of Invasive Cardiology) Journal of the American College of Cardiology (Guest Editor; Associate Editor) K2P (Co-Chair interdisciplinary curriculum) Level Ex Medtelligence/ReachMD (CME steering committees) MJH Life Sciences Oakstone CME (Course Director Comprehensive Review of Interventional Cardiology) Piper Sandler Population Health Research Institute (for the COMPASS operations committee publications committee steering committee and USA national coleader funded by Bayer) Slack Publications (Chief Medical Editor Cardiology Today’s Intervention) Society of Cardiovascular Patient Care (Secretary/ Treasurer) WebMD (CME steering committees) Wiley (steering committee); Other: Clinical Cardiology (Deputy Editor) NCDR-ACTION Registry Steering Committee (Chair) VA CART Research and Publications Committee (Chair); Patent: Sotagliflozin (named on a patent for sotagliflozin assigned to Brigham and Women’s Hospital who assigned to Lexicon; neither I nor Brigham and Women’s Hospital receive any income from this patent); Research Funding: Abbott Acesion Pharma Afimmune Aker Biomarine Amarin Amgen AstraZeneca Bayer Beren Boehringer Ingelheim Boston Scientific Bristol-Myers Squibb Cardax CellProthera Cereno Scientific Chiesi CinCor Cleerly CSL Behring Eisai Ethicon Faraday Pharmaceuticals Ferring Pharmaceuticals Forest Laboratories Fractyl Garmin HLS Therapeutics Idorsia Ironwood Ischemix Janssen Javelin Lexicon Lilly Medtronic Merck Moderna MyoKardia NirvaMed Novartis Novo Nordisk Owkin Pfizer PhaseBio PLx Pharma Recardio Regeneron Reid Hoffman Foundation Roche Sanofi Stasys Synaptic The Medicines Company Youngene 89Bio; Royalties: Elsevier (Editor Braunwald’s Heart Disease); Site Co-Investigator: Abbott Biotronik Boston Scientific CSI Endotronix St. M.C.P. is supported by the British Heart Foundation (BHF) Centre of Research Excellence Award (RE/13/5/30177 and RE/18/6/34217+) and receives research funding from Boehringer Ingelheim Roche SQ Innovations Astra Zeneca Advancing the Science of Engagement PCORI Funding Announcement – Cycle 1 2023. https://www. x",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3023",TRUE,"Conflict of interest: A.A. reports speaker’s honoraria from Boston Scientific and Bayer.",TRUE,"<section> Funding <section> This study was funded by Servier.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3032",TRUE,"Conflict of interest: F.S. received institutional grants from Novartis Abbott non-financial support from Medtronic and institutional fees (speaker honoraria) from Orion Pharma and Abiomed outside of the submitted work.",TRUE,"<section> Funding <section> The trial is financially supported by the DZHK (German Centre for Cardiovascular Research; DZHK; GE 2048/2-1 HA 5812/4-1 ED 196/2-1) and by the BMBF (German Ministry of Education and Research). C.H.L. declares that he is receiving royalties from Hogrefe Publishers for the German version of the Hospital Anxiety and Depression Scale; during the last 3 years he has received a lecture honorarium from Pfizer; his research is funded by the German Ministry of Education and Research the German Research Foundation and the EU Commission.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3071",TRUE,"Conflict of interest: W.D. reports consulting and speaker fees from Aimediq Bayer Boehringer Ingelheim Lilly Medtronic Vifor Pharma and research support from the EU (Horizon2020) German Ministry of Education and Research German Center for Cardiovascular Research and Vifor Pharma.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3076",TRUE,"Conflict of interest: none declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3082",TRUE,"Conflict of interest: L.F.B. reports speaker fees from Abiomed outside of the submitted work.",TRUE,"P.K. was partially supported by European Union AFFECT-AF (grant agreement 847 770) and MAESTRIA (grant agreement 965 286) British Heart Foundation (PG/17/30/32961; PG/20/22/35093; AA/18/2/34218) German Centre for Cardiovascular Research supported by the German Ministry of Education and Research (DZHK) Deutsche Forschungsgemeinschaft (Ki <section> 509 167 694) and Leducq Foundation; receives research support for basic translational and clinical research projects from European Union British Heart Foundation Leducq Foundation Medical Research Council (UK) and German Centre for Cardiovascular Research from several drug and device companies active in atrial fibrillation and has received honoraria from several such companies in the past but not in the last 3 years; is listed as inventor on two issued patents held by University of Hamburg (Atrial Fibrillation Therapy WO 2015140571 Markers for Atrial Fibrillation WO 2016012783).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3087",TRUE,"Conflict of interest: There are no conflicts of interest related to the ESC HF III Registry or to this manuscript. Outside of the submitted work there are the following disclosures: L.H.L. declares grants or contracts from AstraZeneca Vifor Pharma Novartis Boston Scientific and Boehringer Ingelheim; consulting fees for trial design and/or development/implementation strategy from Merck Vifor Pharma AstraZeneca Bayer Pharmacosmos MedScape Sanofi Lexicon Myokardia Boehringer Ingelheim and Servier; payment or honoraria for lectures from Abbott MedScape Radcliffe AstraZeneca and Novartis.",TRUE,"<section> Funding <section> This work was supported by the following companies since the start of EORP and for the period of the HF III study: Abbott Vascular Int.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejhf.3101",TRUE,"Conflict of interest: J.P.F. reports consulting fees from Boehringer Ingelheim and is a Trial Executive Committee member of the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance (trial sponsor).",TRUE,"<section> Funding <section> The EMPEROR-Reduced and EMPEROR-Preserved trials were funded by Boehringer Ingelheim and Eli Lilly (EMPEROR-Reduced ClinicalTrials.gov number NCT03057977 and EMPEROR-Preserved ClinicalTrials.gov number NCT03057951). J.L.J. is a trustee of the American College of Cardiology a board member of Imbria Pharmaceuticals has received grant support from Applied Therapeutics Innolife Novartis Pharmaceuticals and Abbott Diagnostics consulting income from Abbott Janssen Novartis and Roche Diagnostics and participates in clinical endpoint committees/data safety monitoring boards for Abbott AbbVie Amgen Bayer CVRx Janssen MyoKardia and Takeda.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250075",TRUE,"Conflicts of interest: The authors declare that there is no commercial or financial conflict of interest.",TRUE,"<section> Acknowledgements: This work is supported by the Deutsche Forschungsgemeinschaft; FOR 2497/TP02 (GH133/2-2) to K.G.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250097",TRUE,"Conflict of Interest: The authors declare no commercial or financial conflict of interest.",TRUE,"<section> Acknowledgements: This work was supported by the German Research Foundation DFG SFB738 B3 (CSF) the German Ministry for Education and Research BMBF IFB-Tx BMBF 01EO1302 (CSF) and the German Center for Infection Research DZIF TTUIICH (CSF). JI KL and AMH were enrolled in the StrucMedProgram at Hannover Biomedical Research School (HBRS) and JI received stipends from HBRS and was supported from the Berlin Institute of Health Junior Clinician Scientist Program at Charité.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250162",TRUE,"Conflict of interest: Authors declare no commercial or financial conflict of interest.",TRUE,"<section> Acknowledgments: This study was supported by funds of Department of Experimental and Clinical Medicine of University",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250210",TRUE,"Conflict of interest: The Max Delbrück Center for Molecular Medicine (MDC) and the Berlin Institute of Health at Charité (BIH@Charité) have filed a patent application in connection with this work on which M.L. F.K. L.E.S. and K.D.L.R. <section> (EP21155584.2) are inventors. All other authors declare no commercial or financial conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250229",TRUE,"Conflict of interest: The authors declare no conflict of interest.",TRUE,"<section> Acknowledgements: FR is supported by the following funding systems: Helmut Horten Fundation Grant Biostime Institute Nutrition & Care (BINC)-Geneva grant Novartis Grant and by FISM-Fondazione Italiana Sclerosi Multipla-Cod.:2020/RSingle/029 and financed or cofinanced with the “5 per mille” public funding. Laura Diaz-Marugan is supported by a Margarita Salas call from the Spanish Ministry of Universities (University of Barcelona).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202250315",TRUE,"Conflict of interest: The author declares no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202350394",TRUE,"Conflict of interest: The authors declare no commercial or financial conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/eji.202350408",TRUE,"Conflict of interest: The Max Delbrück Center for Molecular Medicine (MDC) and the Berlin Institute of Health at Charité (BIH) have filed three patent applications in connection with this work on which Mi.L. F.K. L.E.S. and K.D.L.R.",TRUE,"This work was partially supported by the Wallenberg AI Autonomous Systems and Software Program (WASP) funded by the Knut and Alice Wallenberg Foundation (to S.O.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/eji.202350433",TRUE,"Conflict of interest: The authors declare no commercial or financial conflict of interest.",TRUE,"M.F.M. received funding from the state of Berlin and the “European Regional Development Fund” (ERDF 2014-2021 EFRE 1.8/11 Deutsches Rheuma-Forschungszentrum); the Berlin Institute of Health with the Starting Grant Multi-Omics Characterization of SARS-CoV-2 infection Project 6 “Identifying immunological targets in COVID-19”; the Leibniz Association (Leibniz Collaborative Excellence TargArt and ImpACt); the German Federal Ministry of Education and Research (BMBF) projects CONAN and TReAT.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/eji.202350664",TRUE,"Conflict of interest: ASL VDA EYS VPV AAI and LIK are employees of the Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Russian Academy of Sciences where CoviVac was developed and produced. The remaining authors declare no financial or commercial conflict of interest.",TRUE,"Immunizations and animal experiments were supported by grant #075-15-2019-1660 from the Ministry of Science and Higher Education of the Russian Federation.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ejp.2221",TRUE,"Disclosure preregistration and <section> CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/epi4.12699",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The current study was financially supported by GW Pharma to fund the position of a physician to gather the necessary patient data. All other authors have indicated they have no potential conflicts of interest to disclose.",TRUE,"<section> Funding information Einstein Stiftung Berlin; GW <section> CONFLICT OF INTEREST STATEMENT The current study was financially supported by GW Pharma to fund the position of a physician to gather the necessary patient data. The study was supported by the Einstein Stiftung Fellowship through the Günter Endres Fond.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/epi4.12719",TRUE,"<section> CONFLICT OF INTEREST STATEMENT S. v. B. reports no disclosures relevant to the manuscript. D. H. reports no disclosures relevant to the manuscript. S. L. reports no disclosures relevant to the manuscript. H. T. reports no disclosures relevant to the manuscript. N. B. reports no disclosures relevant to the manuscript. F. Z. reports no disclosures relevant to the manuscript. B. reports no disclosures relevant to the manuscript. P. Y. B. A. reports no disclosures relevant to the manuscript. J. A. <section> reports no disclosures relevant to the manuscript. A. G. C. reports no disclosures relevant to the manuscript.",TRUE,"<section> Funding information Hessisches Ministerium für Wissenschaft mild ID and no known und Kunst Grant/Award Number: none Variants identified assigned The study was supported by the Federal State Hessen Germany through the LOEWE program. <section> FUNDING INFORMATION The study was supported by the Federal State Hessen Germany through the LOEWE program.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/epi4.12726",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Within the last 3 years MH received speaker's honoraria and/or consultancy fees from Angelini Bial Desitin Eisai GW Pharmaceuticals Neuraxpharm UCB and Zogenix. <section> The remaining authors have no conflicts of interest.",TRUE,"<section> FUNDING INFORMATION LH is funded by the Epilepsy Academy Berlin-­ Bethel.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/epi4.12754",TRUE,"<section> CONFLICT OF INTEREST STATEMENT MH received speaker's honoraria and/or consultancy fees from Angelini Bial Desitin Eisai Jazz Neuraxpharm UCB and Zogenix within the last 3 years. All other authors declare that they have no competing interests.",TRUE,"<section> ACKNOWLEDGMENTS There was no targeted funding for this study. BJV received funding from the German Research Foundation (DFG 422589384).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/epi4.12791",TRUE,"<section> CONFLICT OF INTEREST STATEMENT None of the authors has any conflict of interest to disclose.",TRUE,"<section> Funding information dren. <section> ACKNOWLEDGMENTS This work was supported by grants from the Einstein Stiftung Fellowship through the Günter Endres Fond and the Sonnenfeld-­Stiftung.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/epi4.12830",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Bettina Schmitz has received speaker's or consultancy fees from Angelini Pharma Desitin Eisai Precisis Sanofi and UCB-­Pharma outside the submitted work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/erv.3022",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding information Bundesinstitut für Arzneimittel und largely missing high Medizinprodukte; German Federal substance used off‐label Ministry of Education and Research The study has been supported by the Society for TDM in child and adolescent psychiatry (TDM‐KJP‐ e.V.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ggn2.202200016",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"Support was provided by EU Horizon 2020 research and innovation programme grant agreement 779257 (SOLVE-RD).",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/glia.24369",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> Funding information we could show that Bundesministerium für Bildung und Forschung Grant/Award Numbers: 01GM1908D mediated removal of 01GQ1420B; Deutsche to accumulate inside Forschungsgemeinschaft Grant/Award <section> ACKNOWLEDG MENTS This work was supported by the Einstein Foundation Berlin; by the German Center for Neurodegenerative Diseases; by the German Research Foundation Deutsche Forschungsgemeinschaft (DFG) (project 184695641—SFB 958 to C.C.G and D.S. project 327654276— SFB 1315 to D.S. project 415914819—FOR 3004 to.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/glia.24380",FALSE,"",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft; Gemeinnützige Hertie-Stiftung His research is funded by the German Ministry for Education and Research (BMBF) Deutsche Forschungsgemeinschaft (DFG) Einstein Foundation Guthy Jackson Charitable Foundation EU FP7 Framework Program Biogen Genzyme Merck Serono Novartis Bayer Alexion Roche Parexel and Almirall.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/gps.5875",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> A C KN O W L E D GM E N T The study is funded by the German Innovation Fund of the German Federal Joint Committee (Gemeinsamer Bundesausschuss.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: registry (Trial registration 2019). <section> The trial was prospectively registered with the ISRCTN number: ISRCTN55646265 registered February 15 health care utilization home‐living older adults life‐space mobility License which permits use distribution and reproduction in any medium pro- <section> Further the trial was prospectively registered with the ISRCTN registry (Trial registration number: ISRCTN55646265 registered February 15 2019).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/gps.6007",FALSE,"",TRUE,"<section> Funding information ment (MCI). The study was funded by the German Center for Neurodegenerative Diseases (DZNE) reference number BN012.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/gps.6035",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding information control group were Innovation Fund of the Federal Joint The research is funded by the Innovation Fund of the Federal Joint Committee (G‐BA) (Grant Project “DemTab” Grant‐Number 01VSF17039).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/hbm.26224",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information National Institutes of Health (NIH) enlargement has not Grant/Award Numbers: 5U01MH109977-04 <section> K24MH110807 R01MH102377; core facility MAFIL supported by the Czech-BioImaging large RI project Grant/Award Number: LM2018129; Harvard Medical School Livingston Fellowship Award; Young Investigator Grant sponsored by Mary and John Osterhaus and the Brain & Behavior Research Foundation; Evangelische This work was supported by the National Institutes of Health (NIH) (grant numbers R01MH102377) (PI: Dr. We acknowledge the core facility MAFIL supported by the CzechAward (PI: Dr. Johanna Seitz-Holland) the Young Investigator Grant sponsored by Mary and John Osterhaus and the Brain & Behavior Research Foundation (PI: Dr.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/hbm.26244",FALSE,"",TRUE,"<section> Funding information Berlin Institute of Health; Bundesministerium für Bildung und Forschung Grant/Award Jochen Fiebach was funded by the German Federal Ministry of Education and Research (01EO0801 01EO01301).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/hbm.26274",TRUE,"The authors report no competing interests.",TRUE,"<section> Funding information methods on MRI. <section> ACKNOWLEDG MENTS This work was partially funded by the King's – Charité joint research seed fund. This work is supported by the Wellcome EPSRC Centre for Medical Engineering at King's College London (WT 203148/Z/16/Z) and the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas’ NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The Alzheimer's disease data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica Inc. Computations for this project were in part enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) partially funded by the Swedish Research Council through grant agreement no. 2018-05973.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/hbm.26393",TRUE,"The authors declare no known competing financial interests of personal relationships that could affect or influence the work reported in this",TRUE,"<section> Funding information Funding acquisition. <section> Thomas Picht: Conceptualization Formal analysis Writing – review and editing Supervision Project administration Resources Funding acquisition. Fekonja: Conceptualization Methodology Validation Formal analysis Writing – review and editing Visualization Supervision Project administration Resources Funding acquisition.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/hbm.26431",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information brain regions. This work was supported by the Max Planck Society the Canadian Natural Sciences and Engineering Research Council (RGPIN-2015-04665 to Claudine J.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/hbm.26539",TRUE,"The authors declare no competing financial interests.",TRUE,"<section> Funding information magnetic resonance Fonds Recherche Québécois Nature et voxelwise LRTC and Technologies; Heart and Stroke Foundation of Canada; MaxNetAging Research School; by a retention scan Michal and Renata Hornstein Chair in motor sequence while Cardiovascular Imaging; National Science and Engineering Research Council Grant/Award movements. <section> AC KNOW LEDG EME NT S This work was supported by the Max Planck Society the MaxNetAging Research School (Max Planck Institute for Demographic Research ATJ) the NWO Vici grant (PI: Birte Forstmann) (PLB) the Heart and Stroke Foundation of Canada (CJS CJG) the Michal and Renata Hornstein Chair in Cardiovascular Imaging (CJG) the National Science and Engineering Research Council (CJS: RGPIN-2020-06812;",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/hpm.3710",TRUE,"<section> Two independent researchers (JR FP) analysed titles and abstracts to remove duplicates and non-relevant information identified potentially relevant publications and carried out the final selection of key articles by applying eligibility criteria (including absence of conflict of interest and funding condition contents). <section> CO N FLI CT OF I NTE RE ST STATE M E N T The authors have no conflict of interest to declare.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/hsr2.1735",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ijc.34473",TRUE,"All other authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> FUNDING INF ORMATI ON This work was supported by grant KFS-4842-08-2019 from the Swiss Cancer League. The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is supported by the Foundation Clinical Neuroimmunology and Neuroscience Basel.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ijc.34615",TRUE,"All other authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ijc.34760",FALSE,"",TRUE,"<section> Funding information Amgen; AIO Studien gGmbH <section> FUNDING INF ORMATI ON The legal funder (sponsor) of the trial was the AIO Studien gGmbH Berlin Germany. <section> Funding: Amgen.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ijgo.14845",FALSE,"",TRUE,"<section> Funding information <section> HS is funded by National Institute for Health Research (NIHR) doctoral research fellowship award (NIHR300907). <section> KLD is funded by a UKRI Future Leaders Fellowship (MR/ S016570/1) and the European and Developing Countries Clinical Trial Partnership (RIA2018V-­2304 -­PREPARE). This article contains information about the PREPARE study which is part of the EDCTP2 programme supported by the European Union (grant number RIA2018V-­2304-­PREPARE). <section> C O N F L I C T O F I N T E R E S T S TAT E M E N T HS has undertaken a 6 month IMPRINT network funded fellowship during which time she was employed by Imperial College London (home institution) as a Clinical Research Fellow.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/ijgo.15062",TRUE,"<section> C O N F L I C T O F I N T E R E S T S TAT E M E N T SB PD MW SM MZ IM-­H RR PV MWB and SPR declare no conflicts of interest.",TRUE,"<section> Funding information Roche Diagnostics GmbH of 54 blood-­based biomarker 45 years) with suspicion controls. <section> This study was funded by Roche Diagnostics GmbH (Mannheim Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ijgo.15169",TRUE,"The authors have no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jbio.202200394",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jbio.202300146",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jbm4.10809",TRUE,"Disclosures <section> The authors have no conﬂicts of interest to declare.",TRUE,"<section> This study was partially funded by the German Federal Ministry of Education and Research (BMBF: SyMBoD project 01ZX1910A) and the German Research Foundation (DFG) through the Collaborative Research Centre (CRC) 1444 (CH 1123/8-1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jbmr.4892",TRUE,"Disclosures <section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Tsitsilonis: Funding acquisition; writing – original draft; validation; supervision; project administration; resources. <section> Carsten Perka: Funding acquisition; writing – original draft; supervision; conceptualization; resources; project administration; writing – review and editing; methodology.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcla.24984",TRUE,"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jcsm.13247",TRUE,"All other authors declare no conﬂict of interest.",TRUE,"<section> Funding <section> This study was partly supported by the “German Center for Cardiovascular Research” through research support to MSA SH and SDA and partly supported by the German Heart Foundation/German Foundation of Heart Research through research support to MSA and MT. UW is supported by a Clinical Fellowship Grant from the BIH (Berlin Institute of Health) and has received speaker fees and/or contributions to congresses from Abbott Astra Zeneca Bayer Berlin Chemie Bristol-Myer Squibb GE Healthcare Pﬁzer Philips and Servier all outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13248",TRUE,"All other authors declare no conﬂict of interest.",TRUE,"<section> UW is supported by a Clinical Fellowship Grant from the BIH (Berlin Institute of Health) and has received speaker fees and/or contributions to congresses from Abbott AstraZeneca Bayer Berlin Chemie Bristol Myers Squibb GE Healthcare Pﬁzer Philips and Servier all outside the submitted work. <section> Funding <section> This study was partly funded by the German Center for Cardiovascular Research through research support to SH SDA and",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13249",TRUE,"All other authors have no conﬂict of interests.",TRUE,"<section> JS is a shareholder of Actimed Therapeutics and a paid consultant for Actimed Therapeutics Pephexia Therapeutics and Drexel Pharma Technologies and received grant support from Boehringer Ingelheim.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13252",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation [FI 965/9-1 and FI 965/10-1 to [JF]] and the DZHK (German Center for Cardiovascular Research) partner site Greifswald [81Z5400153 to [JF] 81Z0400103 81X2400142 and 81X2700230 to [JF and OM]]. We acknowledge support for the article processing charges from the DFG and the open access publication fund of the University of Greifswald.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13260",FALSE,"",TRUE,"Anker has received grants from Abbott Vascular and Vifor International; and has received personal fees from Abbott Vascular Actimed Vifor Bayer Boehringer Ingelheim Brahms Novartis Servier Impulse Dynamics Cardiac Dimensions and Thermo Fisher Scientiﬁc; all outside the submitted",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13306",TRUE,"Khan have no relevant disclosure.",TRUE,"Pandey is supported by the Texas Health Resources Clinical Scholarship the Gilead Sciences Research Scholars Program the National Institute on Aging GEMSSTAR Grant <section> Fudim was supported by the American Heart Association",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13315",TRUE,"<section> The authors declare that there are no conﬂicts of interest.",TRUE,"<section> This work is partly funded by the Federal Ministry of Education and Research within the Research Campus STIMULATE (grant no. 13GW0473A). SORAMIC is an investigatorinitiated trial sponsored by the University of Magdeburg. Financial support was granted by Sirtex Medical and Bayer Healthcare. <section> We acknowledge support by the Open Access Publication Fund of Magdeburg University (Project DEAL).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13321",FALSE,"",TRUE,"<section> has received funding from CRUK NIH National Cancer Institute IASLC International Lung Cancer Foundation Lung Cancer Research Foundation Rosetrees Trust UKI NETs and NIHR.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13340",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13352",TRUE,"<section> The authors declare no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13355",FALSE,"",TRUE,"<section> Funding for this project was provided by Pﬁzer Inc. as an independent educational grant.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13384",TRUE,"HW MK and HA have declared no conﬂicts of interest. AI reports lecture fees from Ono Pharmaceutical. VB reports receiving consultancy fees from Pﬁzer and Nestle and received research grant funding from Baxter Healthcare. SDA received grants and personal fees from Vifor and Abbott Vascular and personal fees for consultancies trial committee work or lectures from Actimed Amgen AstraZeneca Bayer Boehringer Ingelheim BioVentrix Brahms Cardiac Dimensions Cardior Cordio CVRx Cytokinetics Edwards Farraday Pharmaceuticals GSK HeartKinetics Impulse Dynamics Novartis Occlutech Pﬁzer Repairon Sensible Medical Servier Vectorious and V-Wave. He was named co-inventor of two patent applications regarding MR-proANP (DE 102007010834 and DE 102007022367). AC received honoraria and/or lecture fees from AstraZeneca Boehringer Ingelheim Menarini Novartis Servier Vifor Abbott Actimed Arena Cardiac Dimensions Corvia CVRx Enopace ESN Cleer Faraday Impulse Dynamics Respicardia and Viatris. The other authors have no conﬂicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13393",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jcsm.13402",FALSE,"",TRUE,"It received no external funding. FS received nothing to declare institutional grants from Novartis and Abbott non-ﬁnancial support from Medtronic and institutional fees (speaker honoraria) from Orion Pharma and AstraZeneca GmbH outside LR received a doctoral scholarship from the German Heart Foundation during the conduct of Additional supporting the project FrailtyVAD-Tx and reports share holdings of Supporting Information Allianz SE Carl Zeiss Meditec AG CompuGroup Medical SE",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE
"10.1002/jdd.13417",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Medizinische Fakultät from the pandemic Heinrich-Heine-Universität Düsseldorf assessed by conducting Grant/Award Number: Fund for quality FE and the associated enhancement in teaching (Qualitä) <section> F U N D I N G I N F O R M AT I O N The present study was partially funded by Heinrich Heine University Düsseldorf for quality enhancement in teaching (Qualitätsverbesserungsmittel für die Lehre).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jgc4.1750",TRUE,"<section> All other authors declare that they have no conflict of interest.",TRUE,"<section> Funding information After the training participants Deutsche Krebshilfe Grant/Award <section> The project iKNOWgynetics was supported by the GCA under the funding priority “patient orientation” between 01/2019 and 03/2021. <section> F U N D I N G I N FO R M AT I O N The project was supported by a grant by German Cancer Aid (grant no. 70113238).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jgm.3642",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information <section> ACKNOWLEDGEMEN TS The authors would like to thank Mitacs Canada (IT19059) and Providence Healthcare (B.T. S.H.) for their financial support. Financial support from the Canadian Institute of Health Research (CIHR PJT166035; S.H. F.M.) the LEO Foundation (LF-OC-22-000954 S.H.) and the Foundation Charité (S.H.) is greatly acknowledged.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jhbp.1323",TRUE,"<section> CONFLICT OF INTEREST STATEMENT (i) Dr Goh BK has received travel grants and honorarium from Johnson and Johnson and Transmedic the local distributor for the Da Vinci Robot.",TRUE,"<section> Funding information MSKCC P30 Cancer Center Support <section> FUNDING INFORMATION Dr Kingham was supported by the MSKCC P30 Cancer Center Support Grant (P30 CA008748).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jimd.12653",FALSE,"",TRUE,"<section> Funding information Dietmar Hopp Foundation St. This work was also supported by the Nutricia Metabolics Research Fund Danone granted to UM in 2020. UM was further supported by the Olympia Morata research fellowship of the Medical Faculty of the Ruprecht Karl University of Heidelberg (grant number F.206852).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmri.28788",FALSE,"",TRUE,"<section> Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 81901716; Contract grant sponsor: Youth Science Foundation of Peking Union Medical College Hospital; Contract grant sponsor: PTI201911744.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmri.28828",FALSE,"",TRUE,"New Contract grant sponsor: NIH NIDDK; Contract grant number: R01DK129888; From the Department of Diagnostic Molecular and Interventional Radiology Icahn School of Medicine at Mount Sinai BioMedical Engineering and Imaging Institute Charité–University Medicine Berlin Berlin Germany; Sir Peter Mansﬁeld Imaging Nottingham UK; F.M. <section> Contract grant sponsor: NIH NCI; Contract grant number: R01CA245671 School of Medicine at Mount Sinai New York City New York USA; Icahn New York City New York USA; Institute of Translational Physiology Centre School of Physics and Astronomy University of Nottingham Kennedy Krieger Institute Baltimore Maryland USA; Russell H.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jmri.29000",FALSE,"",TRUE,"<section> Funding Information <section> This work was supported by grants from the Key-Area Research and Development Program of Guangdong Province",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.28354",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jmv.28450",TRUE,"<section> CO NFL I CT OF INTERES T The authors declare no conflict of interest. <section> DISCLOSURES.PDF Victora CG Castro MC Gurzenda S Medeiros AC França GVA Barros AJD.",TRUE,"<section> Funding information This study was partly financed by CAPES–finance code 001 granted to I. F. S. <section> Computational analysis was supported by FAPESP and partially by the grants from Ontario Research Fund (#34876) Natural Sciences Research Council (NSERC#203475) Canada Foundation for Innovation (CFI #29272 #225404 #33536) and IBM granted to I. G. M. received funding from the European Union's Horizon 2020 research and innovation program under grant agreements No 733006 (PACE) and No 779293 (HIPGEN).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.28538",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Fundação de Amparo à Pesquisa do Estado de We thank Immunosciences and Cyrex Laboratories for financial support and INOVA Diagnostics for providing their diagnostic ELISA kits for autoimmunity at a significantly discounted rate.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.28652",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Frankfurter Stiftung für krebskranke Kinder 12 mpox virus isolates keratinocytes and fibroblasts signalling. Funding acquisition: Denisa Bojkova Victor M. This work was supported by the Frankfurter Stiftung für krebskranke Kinder.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.28761",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information chain reaction with Sanger Intratumral Funds of Zhejiang Cancer Hospital Internal Talent Programm; Medical and the of 361 GC and 89 Health Science Project of Zhejaing Province transcriptional activity (2019KY327); Intramural Research Program of the National Institutes of Health Center for amplification of cDNA Cancer Research (ZIASC010357) expression of virus−host 22 normal adjacent tissues GC were genotyped HPV16 E6/E7 DNA displayed HPV16 L1 virus−host RNA fusion Together our data reveal OPSCC and a possible <section> ACKNOWLEDGME NT S This study was supported by Intramural Funds of Zhejiang Cancer Hospital Internal Talent Program and the Medical and the Health Science Project of Zhejiang Province (2019KY327). Z. M. Z. was supported by the Intramural Research Program of the National Institutes of Health National Cancer Institute Center for Cancer Research (ZIASC010357).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.29042",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information States. We acknowledge the National Council for Scientific and Technological Development (CNPq) Brazil (grants: 309482/2022‐4 to OCM and 102430/2022‐5 to Lena F.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jmv.29046",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Fundação de Amparo à Pesquisa do Estado de distinct wildlife species São Paulo Grant/Award Numbers: 2019/ infection and as such 01255‐9 2021/03684‐4 2022/09684‐9 <section> ACKNOWLEDGME NT S This research was funded by the São Paulo Research Foundation (FAPESP) Brazil grants 2019/01255‐9 and 2021/03684‐4 (Young Investigator Program R.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jor.25649",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information <section> ACKNOWLEDGME NT S This work was supported by the NIH/NIA (K99AG065495) and the Zeno Karl Schindler Foundation (Master Thesis Grant).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/jpen.2495",TRUE,"<section> CONFLIC T OF INTEREST STATEM ENT None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jrsm.1653",TRUE,"The authors declare no conflicts of interest.",TRUE,"Most PAIC analyses (96.9% by (or received funding from) pharmaceutical com44.5% of analyses (n = 72) (partially) aligned the different studies to enhance the similarity of their target of analyses (n = 60) the clinical and methodological studies were extensively assessed. <insert> TABLE 1 (Continued) Characteristics (N = 162) Statistic Type of studies N (%) RCT (IPD) to RCT (AgD) 95 (58.6) RCT (IPD) to single arm (AgD) 8 (4.9) Single arm (IPD) to RCT (AgD) 21 (13.0) Single arm (IPD) to single arm (AgD) 28 (17.3) Single arm (IPD) to OS (AgD) 4 (2.5) OS (IPD) to RCT (AgD) 6 (3.7) Industry 157 (96.9) Academia 5 (3.1) Source of funding N (%) Abbreviations: AgD aggregate data; IPD individual patient data; IQR interquartile range; Med median; RCT randomized controlled trials; OS observational study. <section> Regarding sponsorship almost all eligible records (96.9% n = 157) were conducted by or received funding from pharmaceutical companies.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Since this review does not focus on health outcomes the protocol was not registered in the International Prospective Register of Systematic Reviews (PROSPERO).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/jso.27248",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information overview of the current Cellgene identify research needs. Funding acquisition: Annette Hasenburg. The study was supported by Celgene.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/jvc2.252",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/lci2.73",TRUE,"The authors declare that they have no conflicts of interest.",TRUE,"<section> F U N D I N G I N FO R M AT I O N This work was not supported by any funding.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/lio2.1050",TRUE,"The authors have no conflict of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mame.202200606",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"<section> The authors gratefully acknowledge the support from Walter Scholdei (Max Planck Institute for Polymer Chemistry Mainz Germany) for performing FTIR measurements. <section> authors also thank Sidra Medicine for the support of the internal research funds SDR200003.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mame.202300146",TRUE,"<section> The authors declare no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mdc3.13825",TRUE,"Disclosures <section> Ethical Compliance Statement: The authors conﬁrm that this work did not require approval from an institutional review board because it was based on anonymized data.",TRUE,"<section> Funding Sources and Conﬂicts of Interest: No funding was obtained for writing this article. He has received royalties from Thieme publishers and funding by the German Research Council (SFB 1261 T1). DKW und AAK: Funding by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project-ID 424778381—TRR 295. AAK: Funded by the Lundbeck Foundation (Grant No.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mds.29288",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: Alexis Brice: France Parkinson + FRC Grant (toward the identiﬁcation of novel recessive genes in Parkinson’s disease using homozygosity mapping exome sequencing and functional analysis in zebraﬁsh) Grant ANREPIG—Agence nationale de recherche (DEcipher the ComplexIty and Plasticity of epigenomic cHaracteristics under inﬂuence of Environmental factors in the pathomechanistic Regulation of Parkinson’s Disease [DecipherPD]) Grant ANR-JPND—Agence nationale de recherche (Courage PD) Institut de France (Prize Allianz 2018); Fox Foundation; all other authors report no speciﬁc funding and no conﬂict of Interest concerning the research related to the manuscript.",TRUE,"Williams-Gray: This work was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). <section> Institute; Matej Skorvanek: This work was supported by the Operational Programme Integrated Infrastructure and MS was funded by the <section> ERDF [ITMS2014+:313011V455]; Rejko Krüger: The work of RK is supported by the Fonds National de Recherche (FNR) within the following projects: National Centre for Excellence in Research on Parkinson’s disease (NCER-PD) MotaSYN (12719684) MAMaSyn MiRisk (C17/BM/11676395) and i2TRON DTU. <section> Skaalum Petersen: Funding obtained from the Faroese Health Assurance Foundation and the Faroese Parkinson Association; Ruey-Meei Wu: Ministry of Science and Technology Taiwan (R.O.C.) Alcalay: RNA is funded by the NIH DoD the Parkinson’s Foundation and The Michael. <section> Funding agency: This project was funded by The Michael J.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mds.29332",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: No ﬁnancial disclosure related to research covered in this article.",TRUE,"<section> Funding agency: This study was partly funded by Stichting Stofwisselkracht (Metabolic Power Foundation) project number 2016-11.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mds.29334",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: A.A.K. declares that she is on the advisory board of Medtronic and Boston Scientiﬁc and has received honoraria from Medtronic Boston Scientiﬁc and Teva. <section> Relevant conﬂicts of interest/ﬁnancial disclosures: Nothing to report.",TRUE,"<section> Funding agencies: This study was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)— Project ID 4247788381—TRR 295 Grant and the Lundbeck Foundation This study was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project ID 4247788381—TRR 295 Grant. <section> Funding agencies: The Michael J. This project was supported by SysMedPD (European Union’s Horizon 2020 research and innovation program under Grant Agreement 668738) intramural grants from the University of Lübeck and the State of Niedersachsen (Nierders.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mds.29347",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: M.A.N. and D.V. are consultants employed by Data Tecnica International; their participation in this work is part of a consulting agreement between the National Institutes of Health and said company. <section> Full ﬁnancial disclosures and author roles may be found in the online version of this article.",TRUE,"<section> Funding agencies: Dr. The work was supported by Deutsche Forschungsgemeinschaft (424778381-TRR",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mds.29415",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: W.J.N. received honoraria from Medtronic.",TRUE,"<section> Funding agencies: W.J.N. received funding from the European Union (ERC ReinforceBG project 101077060) Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID 424778381 – TRR 295 and the Bundesministerium für Bildung und Forschung (BMBF project FKZ01GQ1802). S.L. received support from the NIH (K23NS120037) UCSF Weill Neurohub and is PI of a RuneLabs sponsored study. G.T. received funding from the Swiss Parkinson Association the Baasch-Medicus Foundation and the Swiss",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mds.29516",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: M.S. reports grant support from Novartis Biogen Astellas Aeovian Bridgebio and Aucta. He has served on the scientiﬁc advisory boards of Novartis Roche Regenxbio SpringWorks Therapeutics Jaguar Therapeutics and Alkermes. D.E.-F. received speaker honoraria from the Movement Disorder Society and publishing royalties from the Cambridge University Press and reports research funding through a joint research agreement with Astellas Pharmaceuticals Inc. and BlackFin Bio Inc. The other authors report no conﬂict of interest.",TRUE,"<section> Funding Agencies: STIM-CP was partly funded by Boston Scientiﬁc Neuromodulation Valencia USA who had no inﬂuence on study design or conduct data collection or interpretation clinical management of patients or writing of the report. The institution of Anne Koy not Anne Koy personally received funding by Boston Scientiﬁc Neuromodulation. The institution of Lars Timmermann not Lars Timmermann personally received funding by Boston Scientiﬁc the German Research Foundation the German Ministry of Education and Research the Otto-Loewi-Foundation and the Deutsche Parkinson Vereinigung. We are deeply thankful to the participating patients and their families for supporting this trial. <section> Funding agencies: This study was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—SA 4171/1-1 to A.S. and 270949263/GRK2162 to J.E.A. the German Academic Exchange Service (DAAD)—Biomedical Education Program to J.E.A. the German National Academic Foundation to J.E.A. and M.Z. the Max Weber-Program of the State of Bavaria to J.E.A. the Bayer Foundation—Carl-Duisberg Program to M.Z. the Italian Ministry of Health (RF-2019-12370112 and RC-2022-5X1000 to F.M.S.) the Tom Wahlig Foundation to A.S. and D.E.-F. the CureAP4 Foundation to D.E.F. the CureSPG50 Foundation to D.E.-F. the Spastic Paraplegia Foundation to D.E.-F. the Manton Center for Orphan Disease Research to D.E.-F. the National Institute of Health/National Institute of Neurological Disorders and Stroke (1K08NS123552-01 to D.E.-F.) and the Boston Children’s Hospital Ofﬁce of Faculty Development to D.E.-F. The BCH Intellectual and the Developmental Disabilities Research Center is supported by the National Institutes of Health (BCH IDDRC NIH P503 HD105351).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mds.29562",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: Nothing to report. <section> Full ﬁnancial disclosures and author roles may be found in the online version of this article.",TRUE,"<section> Acknowledgments: This study was supported by a research grant from the Else Kröner-Fresenius-Stiftung as well as by inhouse institutional funding from Technische Universität München (Munich Germany) and Helmholtz Zentrum München (Munich Germany). We acknowledge grant support from the European Joint Programme on Rare Diseases (EJP RD Joint Transnational Call 2022) and the German Federal Ministry of Education and Research (BMBF Bonn Germany) awarded to the project PreDYT (PREdictive biomarkers in DYsTonia 01GM2302). This work was also supported by the National Institute for Neurological Research Czech Republic Programme EXCELES ID Project LX22NPO5107 funded by the European Union—Next Generation EU and also by the We are grateful to Annette Feuchtinger and Ulrike Buchholz (Core Facility Pathology and Tissue Analytics Helmholtz Center Munich Munich Germany) for their excellent support with analyses of proximity ligation assays.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mds.29626",TRUE,"<section> Relevant conﬂicts of interest/ﬁnancial disclosures: J.R. has received speaker honoraria from Medtronic. All other authors declare no conﬂict of interest.",TRUE,"<section> Funding agencies: Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID 424778381 – TRR 295. <section> Acknowledgment: This project was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) Project-ID 424778381 TRR 295 and under Germany’s Excellence Strategy EXC2049 390688087 (Project Neurocure-BrainLab). The project was also funded by the Lundbeck Foundation as part of the collaborative project grant “Adaptive and precise targeting of cortexbasal ganglia circuits in Parkinson’s disease” (R336-2020-1035).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mgg3.2282",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> FUNDING INFORMATION None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mgg3.2314",TRUE,"<section> CONFLICT OF INTEREST STATEMENT All authors declare no competing interests related to the study.",TRUE,"<section> FUNDING INFORMATION No funds were available for the current research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mp.16543",TRUE,"The authors have no conflict of interest to disclose.",TRUE,"<section> Funding information dynamic radial MRI Deutsche Forschungsgemeinschaft physicsinformed DL Grant/Award Number: BIOQICGRK2260",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mpr.1961",FALSE,"",TRUE,"<section> Funding information Medical Research Council Grant/Award ders. <section> Editing Funding acquisition Resources Petersen: Supervision Writing ‐ Review & Editing Funding acquisition. Moritz Herle is funded by a fellowship from the Medical Research Council UK (MR/T027843/1).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mrc.5391",FALSE,"",TRUE,"<section> Funding information <section> A C K N O WL E D G M E N T S This work is supported in part by NIH grants CA115746 AG07025 CA273010 and OD023406 and in part by MGH A.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/mrm.29699",FALSE,"",TRUE,"<section> Funding information <section> ACKNOWLEDGMENTS The authors gratefully acknowledge the cofunding from the German Research Foundation (GRK2260–BIOQIC KO 5369/1-1 CRC1340 Matrix in Vision). This work was also supported by EMPIR project 18HLT05 QUIERO and received funding from the EMPIR programme cofinanced by the Participating States and from the European Union’s Horizon 2020 research and innovation programme.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mrm.29859",FALSE,"",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mus.27818",FALSE,"",TRUE,"<section> Funding information Boris Canessa ALS Stiftung Düsseldorf Germany; Martin Herrenknecht Fonds for ALS Research (Stifterverband für die Deutsche Wissenschaft e.V. project H401 7703 5132 37604). <section> ACKNOWLEDGMENTS This work was supported by the Boris Canessa ALS Stiftung and Martin Herrenknecht Fonds for ALS Research (Stifterverband für die Deutsche Wissenschaft e.V. Project H401 7703 5132 37604).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/mus.27837",FALSE,"",TRUE,"<section> Funding information argenx BV This evidence supports and <section> FUND ING INFORMATION The study is funded by argenx BV Ghent Belgium.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/nau.25221",TRUE,"The remaining author declares no conflict of interest.",TRUE,"<section> Funding information months in all patients AbbVie",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/nbm.4931",FALSE,"",TRUE,"<section> Funding information This work was supported in part by National demonstrated the feasibility Institutes of Health Grants CA115746 (LLC) thine to spermine enzymatic CA243255 (LLC) CA273010 (LLC) AG070257 (LLC) and OD023406 (LLC) and in part by a foundation upon which MGH A. This work was supported in part by National Institutes of Health Grants CA115746 (LLC) CA243255 (LLC) CA273010 (LLC) AG070257 (LLC) and OD023406 (LLC) and in part by MGH A.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/nbm.4996",FALSE,"",TRUE,"<section> Funding information <section> ACKNOWLEDGMENTS This work was supported by the National Institutes of Health Grant 5R01AG056999",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/nbm.5003",FALSE,"",TRUE,"<section> Funding information tion [CAF]; in %). <section> This work was supported by the Deutsche p = 0.016) and PR Forschungsgemeinschaft (BIOQIC GRK 2260; SFB1340 Matrix-In-Vision). which was accompanied correlated with CAF CKD rats histopathology Collectively our results transforms softcompliant water mobility.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/nbm.5075",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding information of 0.98 coefficient of This study was funded in part (T.K. T.N.) by of 1.1% compared with the iNAMES MDC-Weizmann Helmholtz International Research School (HIRS) for quantification of acute Imaging and Data Science from the Nano to venous occlusion (5% the",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ncp.11015",FALSE,"",TRUE,"<section> Funding information intravenous supplementation Takeda Pharmaceuticals International AG nutrition fluids electrolytes surgical treatment absorptive capacity eliminated.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/nop2.1863",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> F U N D I N G I N FO R M AT I O N For the systematic review no patient contribution occurred no funding was provided.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"A protocol was registered in PROSPERO 2021 CRD42021265390 (Reick et al. 2021). <section> PROSPERO 2021 CRD42021265390 Available from: https:// <section> www.crd.york.ac.uk/prospe ro/displa y_record.php?",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/oby.23844",TRUE,"There were no industry relations funding sources and/or any conflicts of interest reported from these individuals.",TRUE,"<section> Funding information <section> FUND ING INFORMATION This manuscript is part of a project (www.imisophia.eu) that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 875534.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> approach for childhood obesity is lifestyle intervention (LI); This study aimed first to identify distinct subgroups of living with overweight and obesity and second to elucidate prethe obesity patient follow-up registry the APV (Adipositasinitiative a total of 12453 children and adoles11.5 [IQR: 9.7–13.2] years; BMI z score [BMIz]: 2.06 [IQR: living with overweight/obesity and participating in outpaLongitudinal k-means clustering was used to identify individual for up to 2 years after treatment initiation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/oby.23882",TRUE,"The authors declared no conflict of interest.",TRUE,"<section> Funding information Deutsches Zentrum für Diabetesforschung six independent cohorts <section> Genotype imputation was supported by the compute infrastructure of ScaDS (Dresden/Leipzig Competence Center for Scalable Data Services and Solutions). <section> FUNDING INF ORMATI ON LIFE-Heart and LIFE-Adult are funded by the Leipzig Research Center for Civilization Diseases (LIFE). SHIP is part of the Community Medicine Research net of the University of Greifswald Germany which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603 01ZZ0103 and 01ZZ0403) and the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania and the network “Greifswald <section> Approach to Individualized Medicine (GANI_MED)” funded by the Federal Ministry of Education and Research (grant 03IS2061A). <section> This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation – 10. The PPP-Botnia study has been financially supported by grants from the Sigrid Juselius Foundation Folkhalsan Research Foundation Ollqvist Foundation Nordic Center of Excellence in Disease Genetics European Union (EXGENESIS EUFP7-MOSAIC) Signe and Ane Gyllenberg Foundation Swedish Cultural Foundation in Finland Finnish Diabetes Research Foundation Foundation for Life and Health in Finland Finnish Medical Society Paavo Nurmi Foundation Helsinki University Central Hospital Research Foundation Perklén Foundation Närpes Health Care Foundation and Ahokas Foundation. The study has also been supported by the Ministry of Education in Finland Municipal Heath Care Center and Hospital in Jakobstad and Health Care Centers in Vasa Närpes and Korsholm.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/oto2.42",TRUE,"Competing interests: None.",TRUE,"<section> Funding: Professor Hazem M.A.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/path.6057",TRUE,"No other conﬂicts of interest were declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/path.6232",TRUE,"<section> Conﬂict of interest statement: JNK declared consulting services for Owkin France; holds shares in StratifAI GmbH and has received honoraria for lectures by AstraZeneca shares in StratifAI GmbH. No other conﬂicts of interest were declared. <section> Artiﬁcial intelligence tools disclosure",TRUE,"<section> JNK is supported by the German Federal Ministry of Health (DEEP LIVER ZMVI1-2520DAT111) and the Max-Eder-Programme of the German Cancer Aid (grant #70113864) the German Federal Ministry of Education and Research (PEARL 01KD2104C; CAMINO 01EO2101; SWAG 01KD2215A; TRANSFORM LIVER 031L0312A; TANGERINE 01KT2302 through ERA-NET Transcan) the German Academic Exchange Service (SECAI 57616814) the German Federal Joint Committee (Transplant.KI 01VSF21048) the European Union’s Horizon Europe and Innovation Programme (ODELIA 101057091; GENIAL 101096312) and the National Institute for Health and Care Research (NIHR NIHR213331) Leeds Biomedical Research Centre. SN is funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (NE 2136/3-1). <section> SF is supported by the Deutsche Forschungsgemeinschaft (DFG) (FO 942/2-1) the German Federal Ministry of Education and Research (SWAG 01KD2215A) the Mainz Research School of Translational Biomedicine (TransMed) and the Manfred-Stolte-Foundation.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pbc.30171",TRUE,"<section> CONFLICT OF INTEREST No conflict of interest has been declared by the author(s).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pbc.30289",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information epinephrine and metanephrine Villa Joep Foundation <section> ACKNOWLEDGEMENTS This work was supported by a grant from the Villa Joep Foundation.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pbc.30295",TRUE,"The authors declare no relevant conflict of interest.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pbc.30351",TRUE,"The authors declare that there is no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/pbc.30359",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Leo Kager has received fees from Novartis Amgen Agios and Bayer not related to this study. The remaining authors declare no conflicts of interest.",TRUE,"<section> Funding information Kinderhilfe e.V. Formal analyses were primarily conducted by Anne-Catherine Radauer-Plank supported by Ralph Schilling Stephanie Roll and Magdalena Balcerek. <section> The study was supported by the Kinderhilfe e.V.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pbc.30506",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Katherine A. Janeway reports fees for consulting from Bayer and Ipsen; and honoraria from Takeda and Foundation Medicine. Luis Gros reports no relevant disclosures of interest.",TRUE,"<section> Funding information cally important reduction Protherics Medicines Development Ltd. postglucarpidase measurements)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Study design is more accurate and and inclusion criteria for the four constituent clinical trials have of glucarpidase than been published previously.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,NA
"10.1002/pd.6324",TRUE,"<section> CO N F L I C T O F I N T E R E S T S T A TE M E N T There is no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pd.6433",TRUE,"<section> C ON FLI C T O F I N T E R ES T S T A T E MEN T There is no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pds.5718",FALSE,"",TRUE,"<section> Funding information approaches are compared.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> ET HICS S TAT E MENT The study protocol was approved by the ethics committee of the Charité-Universitätsmedizin Berlin (EA4/015/20) and the study was registered with the German Clinical Trial register (DRKS00021001) and listed at the WHO International Clinical Trials Registry Platform.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/pmic.202300100",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Markus Ralser is founder and shareholder of Eliptica Ltd.",TRUE,"<section> Funding information This work was supported by the German Ministry of Education and Research (BMBF) as part of the National Research Node “Mass spectrometry in Systems Medicine” (MSCoreSys) under grant agreements 031L0220A (to M.R.) and 161L0221 (to V.D.) and in part by the European Research Council (ERC) under grant agreement ERC-SyG-2020 951475 (to M.R).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pmrj.13039",FALSE,"",TRUE,"<section> Funding MGH ECOR information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pon.6132",TRUE,"<section> An international survey of 298 physicians working in oncology even revealed that younger physicians have more positive attitudes towards information disclosure to advanced cancer patients than older <section> C O N F LI C T O F I N T E R ES T S T A TE M E N T All authors declare that they have no conflict of interests. Factors influencing the attitudes and behaviors of oncologists regarding the truthful disclosure of information to patients with advanced and incurable cancer.",TRUE,"<section> Funding information <section> Bernd Alt‐Epping: Funding acquisition; Resources; Supervision; Writing – review and editing. <section> Letsch: Funding acquisition; Resources; Supervision; Writing – review and editing. <section> Peter Thuss‐Patience: Funding acquisition; Resources; Supervision; Writing – review and editing. <section> Karin Oechsle: Conceptualization; Funding acquisition; Resources; Project administration; Supervision; Writing – review and editing; <section> Corinna Bergelt: Conceptualization; Funding acquisition; Resources; Project administration; Supervision; Writing – review and editing. The study was funded by the German Cancer Aid (‘Deutsche Krebshilfe e.V.’); grant number: 70113231.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/pon.6173",TRUE,"The authors declare that they have no conflict of interests.",TRUE,"<section> Funding information <section> A C K N O WL ED GM E N T S The study was funded by Deutsche Krebshilfe Grant/Award Num-",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The main study was registered in the German Clinical Trials Registry (no. DRKS000 04860).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/pro.4798",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information Iva Luči\u0001 c was recipient of a Marie Curie Incoming International Fellowship (798696) and “Wiedereinstiegsstipendium” from the Leibniz FMP. <section> This work was funded by the DFG TRR 186 (Project A07 Projektnummer 278001972 to Andrew J. Andreas Franz was recipient of a Boehringer Ingelheim PhD Fellowship.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/pros.24592",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/pul2.12320",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information as at risk for or with Young Investigator ""Molecular <section> ACKNOWLEDGMENTS The present study was supported by the Young Investigator ""Molecular Mechanisms of Neonatal Chronic Lung Disease"" Grant NWG VH‐NG‐829 by the Helmholtz Foundation and the Helmholtz Zentrum Muenchen Germany the International Research Group “Role of BMP signaling” (01KI07110) Helmholtz Foundation (Federal Ministry of Education and Research in Germany [BMBF]) and the German Centre for Lung Research [DZL] [BMBF]) as well as the Research Training Group ""Targets in Toxicology"" (GRK2338) of the German Science and Research Organisation (DGF).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/smi.3226",TRUE,"<section> C O N F LI C T O F I N T E R ES T All authors report no conflict of interest.",TRUE,"<section> Funding information short‐term reduction Bavarian State Ministry for Health and Care benefits are unclear. needed. This review was conducted as part of the IMBAY‐2020 research initiative (Integrative Medicine in Bavaria 2020 supported by the Bavarian State Ministry for Health and Care Germany). The study was supported by the Bavarian State Ministry for Health and Care (Germany) by means of the funding program “Gesund.Leben.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"We investigated the effects of for adults with IBS on typical symptoms HRQoL and mental criteria (patients: adults with IBS; intervention: stress‐ care as usual or waitlist; outcome: patient‐relevant; study‐ we registered the study with PROSPERO (168030) and databases. Our study protocol was registered on PROSPERO in March 2020 (CRD42020168030; available from: https://www.crd.york.ac.uk/ prospero/display_record.php?",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1002/smi.3255",TRUE,"The authors declare that there is no conflict of interest.",TRUE,"<section> Funding information <section> A CK NO W L E D GE M E NT S This work was supported by the Sonnenfeld‐Stiftung (grant for Antonia Bendau).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/smi.3263",TRUE,"The authors declare that they do not have any conflicts of interest.",TRUE,"<section> Funding information The study was supported with a research fund by the Robert‐Pfleger‐Stiftung (Fonds number: 060_4967).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/smll.202306482",TRUE,"<section> The authors declare no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/smtd.202201605",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"<section> by the National Center for Tumor Diseases (NCT) Partner Site Dresden and German Cancer Research Center (DKFZ) Heidelberg within the Call for Translational Research Grants in Precision Oncology while L.D. was supported by the Deutsche Fohrschungsgemeinschaft (DFG) Grant BU 1400/5-2. D.E.S. was supported by the German Cancer Aid Max Eder program (No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/ueg2.12445",TRUE,"The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding information The development conduct and dissemination of the AwareNASH survey was supported by an independent educational grant from Pfizer inc. The authors received no specific funding to undertake the statistical analyses and preparation of this manuscript.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/wjs.12034",TRUE,"The authors declare that they have no conflict of interest.",TRUE,"<section> ACKNOWLEDGMENTS The authors report no extramural sources of direct or indirect funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/wps.21036",FALSE,"",TRUE,"<section> This work was supported by the German Ministry for Education and Research (grant no. FKZ 01KG1904). Salanti have been supported by the Swiss National Science Foundation (grant no. 179185).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/wps.21037",FALSE,"",TRUE,"<section> S. Cortese is supported by the UK National Institute for Health and Care Re­ search NIHR (grant nos. G. Michelini is supported by a Klingenstein Third Generation Foundation fellowship; L.C.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/wps.21056",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1002/wps.21068",FALSE,"",TRUE,"<section> A sensitivity analysis was performed by removing the criterion of N>1000 cases to examine the robustness of the main analysis when smaller numbers of cases were included Subgroup analyses were also performed for associations supported by class I/II evidence to test confounders identified at the primary study level. <section> G. Arrondo is supported by the European Social Fund and the Spanish Research Agency (RYC2020-030744-I/AEI/10.13039/501100011033). M. Berk is supported by National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship and Leadership 3 Investigator grants (1156072 and 2017131).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1002/wps.21069",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/978-3-031-42003-0_22",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE
"10.1007/s00011-023-01719-x",TRUE,"Conflict of interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by grants of the Stiftung OskarHelene-Heim [OHH_44] to TM; the Else Kröner-Fresenius-Stiftung [EKFS 2017_A22] to JK; the Deutsche Forschungsgemeinschaft [DFG KE 2179/2–1 TS 303/2–1] to JK and ST.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00011-023-01766-4",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"This work was supported by grants of The São Paulo Research Foundation (FAPESP) (grants 14/27198-8 to J.B.P. 15/03541-8 and 17/26427-1 to L.M.) and PROBRAL Research Program funded jointly by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and Deutscher Akademischer Austauschdienst (Finance Code 001) to L.M. W.W.A. M.F.G. R.C.A. F.Q. M.B. and JBP.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00011-023-01770-8",TRUE,"Conflict of interest The authors declare that they do not have any conflicts of interest with the content of this article. The other authors of this paper have no conflict of interest to report).",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No extramural funding was provided for this project.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00018-022-04638-y",TRUE,"Conflict of interest There are no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Deutsche Forschungsgemeinschaft (DFG): SCHN 959/6-1 and SCHN 959/3-2 to G.S.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00018-023-04717-8",TRUE,"Competing interests The authors declare no conflicting financial or non-financial interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the START program of the Medical School of the RWTH Aachen University (117/15) to P.V. and by the Deutsche Forschungsgemeinschaft DFG (VE1093/1-1 LU466/16-2) to P.V and B.L. respectively. C.G. is supported by a DFG grant within German-African Cooperation Projects in Infectiology (GO2153/3-1) by the Impulse and Networking Fund of the Helmholtz Association through the HGF-EU partnering grant PIE-008 and by funding of Berlin Institute of Health (BIH).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00018-023-04901-w",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Deutsche Forschungsgemeinschaft (DFG GO766/18‐3 GO766/22‐2 NU53/12-2 KA 5422/1-3 SFB1365) to M.G.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00056-021-00360-9",TRUE,"Conflict of interest F.H. Blankenstein U. Kielburg L. Melerowitz and M. E. D. Stelmaszczyk have no conflicts of interest to declare that are relevant to the content of this article.",TRUE,"<section> 6. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00056-023-00466-2",TRUE,"Jost-Brinkmann declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by EMS (Electro Medical Systems Munich Germany) through the provision of AIR-FLOW ® Powder Plus and AIR-FLOW ® Powder Classic and an AIR-FLOW ® Master Piezon for loan (grant number 126315). <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00056-023-00474-2",TRUE,"Conflict of interest A. Arndt-Fink and P.-G. Jost-Brinkmann declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00062-023-01310-1",TRUE,"Conflict of interest M. Huhndorf S. Peters J. Cordt N. G. Margraf M. Salehi Ravesh O. Jansen M. Synowitz and G. Cohrs declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02045-1",TRUE,"Conflict of interest F. Mehrhof P. Bergengruen J.-H. Gerds-Li A. Jahn A.K. Kluge A. Parwani D. Zips L.-H. Boldt and F. Schönrath declare that they have no competing interests.",TRUE,"<section> Funding Dr. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02057-x",TRUE,"Grün declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02082-w",TRUE,"Conflict of interest K.J. Meyer declare that they have no competing interests.",TRUE,"Select one answer: Germany; Austria; Switzerland; other [free text] Acknowledgements M.W. is supported by a scholarship of the German Consortium for Translational Cancer Research (DKTK). Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02085-7",TRUE,"Brunner declare that they have no competing interests.",TRUE,"<section> Funding No funding was received for conducting this study. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02091-9",TRUE,"Conflict of interest D. Dunst declare that they have no competing interests.",TRUE,"<section> Funding Sponsor of the study is the University Medical Center Schleswig Holstein (UKSH). <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02162-x",TRUE,"Conflict of interest M. Mäurer declare that they have no competing interests.",TRUE,"<section> The webinar program and the standardized questionnaire used for evaluation in this study were developed by representatives of the DEGRO Academy the young DEGRO the DEGRO Board and representatives of medical physics and radiation Biology. <section> Funding Matthias Mäurer was funded by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) Clinician Scientist Program OrganAge (funding number 413668513) and by the Interdisciplinary Center of Clinical Research of the Medical Faculty Jena. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00066-023-02182-7",TRUE,"Conflict of interest S. Fahlbusch declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00068-023-02289-7",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. There was no funding received for the current study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00101-023-01292-2",TRUE,"Conflict of interest. A.R. Heller T. Neidel P.J. Klotz A. Solarek B. Kowalzik K. Juncken and C. Kleber declare quent study therefore greater care should that they have no competing interests.",TRUE,"As the queries of the triage alFunding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00106-023-01299-6",TRUE,"Conflict of interest. Z. Ahmad K. Krüger J. Lautermann B. Lippert T. Tenenbaum M. Tigges and M. Tisch as Watson–Jones disease or torticollis atdeclare that they have no competing interests.",TRUE,"Funding. Open Access funding enabled and orgaIn patients with intense coagulation nized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00125-023-05926-3",FALSE,"",TRUE,"<section> Funding Work in the authors’ group is supported by Diabetes Foundation Netherlands and the European Federations for the Study of Diabetes (FR)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00125-023-06031-1",FALSE,"",TRUE,"<section> Funding Open access funding provided by Karolinska Institute.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00127-022-02419-3",TRUE,"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Campbell SB Renshaw KD (2013) PTSD symptoms disclosure and relationship distress: explorations of mediation and associations over time.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The MEHIRA study is funded by the Innovationsfond Ministry of Health (01VSF16061).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> gov (registration number: NCT03109028; registration date 11.04.2017) and adheres to the Declaration of Helsinki.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00132-023-04349-7",TRUE,"Conflict of interest. M.D. Costa S. Donner bone homeostasis. Cells 9:1–14 J. Bertrand O.-L. Pop and C.H. Lohmann declare that 19. Hattner R Epker BN Frost HM (1965) Suggested they have no competing interests. sequential mode of control of changes in cell behaviour in adult bone remodelling.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00132-023-04367-5",TRUE,"Conflict of interest. G. Schröder I.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00134-022-06949-x",TRUE,"Conflicts of interest CDS UMan UM SR BK and RB were recipients of the funding grant of the Federal Joint Committee (01NVF16011). NP SR HK CD ED EB UM BK CA and UMan report no conflict of interest.",TRUE,"This was an investigatorinitiated trial funded by the German Innovation Fund (Innovationsfonds) of the Federal Joint Committee (Gemeinsamer Bundesausschuss G-BA) grant no. 01NVF16011. <section> Funding Funding was provided by the German Innovation Fund of the Federal Joint Committee. <section> Conflicts of interest CDS UMan UM SR BK and RB were recipients of the funding grant of the Federal Joint Committee (01NVF16011).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This study is completed and registered with ClinicalTrials.gov (NCT03671447). The study was prospectively registered with ClinicalTrials.gov (NCT03671447).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00134-023-07050-7",TRUE,"Conflicts of interest GG received funding from Fischer&Paykel MSD Pfizer and received fees from Getinge Draeger Medical Cook MundiPharma Fischer&Paykel Pfizer. The remaining Authors have disclosed that they do not have any potential conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by the European Society of Intensive Care Medicine. <section> Conflicts of interest GG received funding from Fischer&Paykel MSD Pfizer and received fees from Getinge Draeger Medical Cook MundiPharma Fischer&Paykel Pfizer. CSC received funding from National Institute of Health Roche Genen Tech Quantum Leap Health Care Collaborative and received fees from Cellenkos Vasomune NGM Bio Gen1e Life Sciences. MA received funding from GE Toray and received fees from Fischer&Paykel Menarini Pfizer. JRB received funding from National Institute of Health Quantum Leap Health Care Collaborative Sedana Medical and received fees from Biomark Pharmaceutics. LDJB received funding from Amsterdam UMC Longfonds European Respiratory Society Innovative Medicine Intiative Santhera ZonMW and received fees from AstraZeneca Bayer Novartis Santhera Sobi Scailyte. LB received funding from Draeger Medical Medtronic Stimit Vitalair and received fees from Fischer&Paykel and received equipments from Fischer&Paykel Sentec. He is in the Data Safety Monitoring Board of ECMO-Rehab Study was in the Advisory Boards for Livanova Abiomed Xenios Medtronic Inspira Cellenkos and received funding from Livanova and received fees from Livanova Abiomed Xenios Inspira Medtronic Cellenkos. AD received funding from Philips French Ministry of Health Respinor Lungpacer Assistance publique – Hôpitaux de Paris and received fees from Lungpacer Respinor Lowenstein Tribunal administrative de Cergy Liberate Medical NDF is in the Advisory Board of NIH MHRC Australia Sedana Medical; he received funding from CIHR received fees from Xenios. J-PF received funding from Fischer&Paykel and received fees from Fischer&Paykel SOS Oxygène. LG received funding from GE Estor and received fees from SIDAM Grifols Advitos Apheretica Estor GE. MSH is the Committee of Canadian Critical Care Trials Group and in the Committee of Women in Critical Care of the American Thoracic Society; she received funding from Canadian Institute of Health Research and received support for travel from ESICM ISICEM. CH leads the National ECMO Registry in Australia (EXCEL Registry) and sits in International ECMO Network Executive and Scientific Committee and is member of Research Committee for ELSO; she received funding from National Health and Medical Research Council Medical Research Future Fund AND received support for travel from Fischer&Paykel. CLH is in the Advisory Board of Quantum Health and received funding from National Institute of Health American Lung Association. AK received funding from Wellcome Trust and received fees from Clinton Health Access Initiative; received equipments from Fischer&Paykel and received support for travel from ESICM. JGL received funding from Science Foundation Ireland Health Research Board Ireland and received fees from Baxter. MAM received funding from National Institute of Health Department of Defense Roche-Genentech and received fees from Novartis Gilead Pharmaceuticals Johnson and Johnson Pharmaceuticals Cellenkos. DFMA is in the Data Safety Monitoring Board of VIr Biotechnology Inc and of Faron Pharmaceuticals; he is Codirector of Research for the Intensive Care Society and is Director of EME Program of MR-NIHR; he received funding from NIHR Wellcome Trust Innovate UK MRC Northern Ireland HSC R&D Division Randox Novavax and received royalties from Queen’s University Belfast; he received fees from Bayer GlaxoSmithKline Boehringer Ingelhelm Novartis Eli-Lilly Sobi. AM is PastPresident of the Franch Society of Intensive Care; he received funding from Air Liquide Medical Systems Fischer&Paykel and received fees from Bayer Air Liquide Medical Systems Fischer&Paykel Getinge Covidien Draeger Medical. NJM is in the Data Safety Monitoring Board of Caviards and NIH Spiromics and Source Studies; he received funding from National Institute of Health Quantum Leap Health Care Collaborative and received fees from Endpoint Health Inc NYU Langone Medical Center and received support for travel from Intensive Care Society. MM is in the Advisory Board of an NIH Sponsored Trial and received funding from National Institute of Health. LM was in the Ontario COVID-19 Science Advisory Table is in the American Thoracic Society Mechanical Ventilation Guidelines Committee and in the ESICM Guidelines Committee; she is Section Editor of Intensive Care Medicine; she received funding from Leukemia and Lymphoma Society of Canada H Barrie Fairley Scholarship. MNG is member of Data Safety Monitoring Board of Regeneron and EMORY; she is Chair of ATS Critical Care Assembly; she received funding from NHLBI CDC and received fees from New York Medical College and received support for travel from ATS. BKP received funding from National Institute of HealthWalder Foundation and University of Chicago and received fees from Merk CHEST Foundation Subpoena. AP is in Advisory Board of MEGA-ROX and UK-ROX Trails; he received funding from Novo Nordisc Foundation SYGEFORSIKRINGEN Pfizer and received fees from Novartis. ER received funding from Wellcome Trust and received equipments from Fischer&Paykel. RDS was member of ATS Board of directors and is member of DSMBs of RCTs in North America and received funding from National Institute of Health and received support for travel from National Institute of Health ATS. CS received funding from NIHR Wellcome TrustUK Research and Innovation and received fees from GlaxoSmithKline Abbvie RocheSanofi-Pasteur. TBT received funding from Department of Defense National Heart Lung and Blood Instituite and received fees from Bayer Novartis Genentech. JV received funding from Instituto de Salud Carlos III Madrid Spain (CB06/06/1088 PI19/00141) The European Regional Develop‑ ment Funds and Fundación Canaria Instituto de Investigatión Sanitaria de Canarias Spain (PIFIISC21-36). LBW is the Chair of the American Thoracic Society Awards Committee and is in the DSMB of CHILL Study and SIGNET Study; he received funding from National Institute of Health Genentech Boehringer Ingelheim and received fees from Santhera Global Blood Therapeutics Boehringer Ingelheim Merck Citius Foresee Pharmaceuticals. EA received funding from MSD GE Alexion Pfizer received fees from Pfizer Alexion Mindray Sanofi and received equipments from Pfizer.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-021-06749-8",TRUE,"Conflict of interest The authors have no competing financial interests to",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by Episurf Medical EFRE (16409608 OrthoLoadLab) the German Research Foundation (DFG) (EH 422-2-1/MO 3865-1-1 TR 1657/1-1 and SFB 1444) and the OrthoLoadClub.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07432-w",TRUE,"Conflict of interest Christian Fink has received royalties from Karl Storz and Medacta Co. has received speakers fees from Karl Storz and Medacta Co. and is a paid consultant for Medacta Co..",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Funding No funding has been received for conducting this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07441-9",TRUE,"Conflict of interest Dr. Andrew D. Pearle is a consultant for Smith & Nephew and DePuy Synthes. Dr. Hendrik A. Zuiderbaan is a consultant for Smith & Nephew. The other authors declare to have no potential conflict of interest.",TRUE,"<section> Funding This study received no funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07463-3",TRUE,"Conflict of interest All authors declare that they have no conflict of interest related to this study.",TRUE,"<section> Funding Open access funding provided by HEAL-Link Greece.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07522-9",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07570-1",TRUE,"Conflict of interest None.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00167-023-07645-z",TRUE,"Conflict of interest Dr. Andrew D. Pearle is a consultant of Smith & Nephew and DePuy Synthes. Dr. Hendrik A. Zuiderbaan is a consultant for Smith & Nephew. The other authors declare to have no potential conflict of interest.",TRUE,"<section> Funding This research received no specific grant from any funding agency in the public commercial or notfor-profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00198-023-06959-5",TRUE,"Conflict of interest Dieter Haffner and Dirk Schnabel received speaker fees consultation fees and research grants from Kyowa Kirin. Helene Tietze Veronika Pott Nele Kanzelmeyer Nima Memaran Ulrich Baumann Charlotte Mindermann Adriana Suhlrie Jens Drube Anette Melk Anibh M. Das and Maren Leifheit-Nestler declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by Kyowa Kirin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00204-023-03491-7",TRUE,"Conflicts of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Sabine Gabrysch received funding from a Recruiting Grant of Stiftung Charité.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00204-023-03506-3",TRUE,"Conflict of interest The authors declare no competing or financial interests or any conflicts of interest.",TRUE,"<section> Acknowledgements This work was supported by the German Federal Ministry of Education and Research [031L0069]. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00204-023-03573-6",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements This work was supported by the German Research Foundation DFG (NE 1879/2-1 AL 1665/3-1; ‘Determination of Drugs in Dental Material’). <section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the German Research Foundation DFG (NE 1879/2-1 AL 1665/3-1; ‘Determination of Drugs in Dental Material’.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00213-023-06484-7",TRUE,"Conflict of interest GS has served as a consultant for HLS Therapeutics and Thermo Fisher and has received speaker’s fees from HLS Therapeutics. GG has served as a consultant for Allergan Boehringer Ingelheim Institute for Quality and Efficiency in Health Care (IQWiG) Janssen-Cilag Lundbeck Otsuka Recordati and ROVI. He has served on the speakers’ bureau of Gedeon Richter Janssen Cilag Lundbeck Otsuka and Recordati. He has received grant support from Boehringer Ingelheim Lundbeck and Saladax. He is a co-founder and/or shareholder of Mind and Brain Institute GmbH Brainfoods GmbH OVID Health Systems GmbH and MIND Foundation gGmbH. XMH was supported by the Overseas Research Fellow Award by the Japan Society for the Promotion of Science. All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. He has received grant support from Boehringer Ingelheim Lundbeck and Saladax. XMH was supported by the Overseas Research Fellow Award by the Japan Society for the Promotion of Science.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00216-023-04635-5",TRUE,"Conflict of interest Gordan Lauc is the founder and CEO of Genos Ltd. a company specializing in high-throughput glycomics and glycoproteomics. Siniša Habazin and Mislav Novokmet are employees of Genos Ltd. The other authors declare no competing interests.",TRUE,"<section> Funding This work was supported by the German Research Foundation (grant number: CO 1058/3–2) the German Academic Exchange Service (DAAD) the Konrad Adenauer Foundation and the European Structural and Investment Funds (Centre of Competences in Molecular Diagnostics and National Centre of Scientific Excellence in Personalised Healthcare) (grant Nos.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00246-023-03152-7",TRUE,"Conflict of interest C.K.B received grant support from Gunze Limited Humacyte and LifeMatrix.",TRUE,"<section> Funding Federal grant acknowledgements: W81XWH-22–1-0597 <section> Conflict of interest C.K.B received grant support from Gunze Limited Humacyte and LifeMatrix.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00247-023-05808-1",TRUE,"Conflicts of interest None",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00253-023-12592-3",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported in part by the BMBF project ForceYield (031B0825C).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00259-023-06145-z",TRUE,"Competing interests Julian M.M.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Tobias Penzkofer was supported by Berlin Institute of Health (Clinician Scientist Grant Platform Grant) Ministry of Education and Research (BMBF 01KX2021 68GX21001A) German Research Foundation (DFG SFB 1340/2) Horizon 2020 (952172) and reports research agreements (no personal payments outside of submitted work) with AGO Aprea AB ARC AGY-GINECO Astellas Pharma Global Inc.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00259-023-06197-1",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was partly supported by the Berliner Krebsgesellschaft (ZSF201720) and by the German Federal Ministry of Education and Research (BMBF contract 03ZIK42/OncoRay).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00259-023-06293-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00259-023-06314-0",TRUE,"Competing interests The University Hospital Zurich holds a research agreement with GE Healthcare.",TRUE,"<section> Funding Open access funding provided by University of Zurich. This work was supported by a grant from the Swiss National Science Foundation (SNSF Project No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00261-023-03991-1",TRUE,"Conflict of interest All authors declare that they have no financial or non-financial conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00264-023-05697-x",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00264-023-05738-5",TRUE,"Conflict of interest/Competing interests The authors declare no competing of interests.",TRUE,"Frank Graef: study design data analysis and wrote the manuscript Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by Dr.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00264-023-05871-1",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00264-023-05989-2",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00266-023-03286-2",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00277-023-05087-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the German Kompetenznetz Leukämien by the East German Study Group and by the German AML Cooperative Group AMLCG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00280-023-04514-x",TRUE,"Conflict of interest Dr. med. Juliane Bolbrinker has no conflict of interest. Richter) has no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00292-022-01176-z",TRUE,"Conflict of interest. Vogeser declare that they have no The IVDR is primarily aimed at manufaccompeting interests.",TRUE,"<section> Funding. <section> Eisai Grant support: Novartis BMS AstraZeneca Illu-",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00292-023-01208-2",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00296-023-05286-6",TRUE,"Conflict of interest AP and ZB have no conflict of interest to disclose.",TRUE,"Funding acquisition: FB. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00296-023-05335-0",TRUE,"Conflict of interest GC MS and AK have received grant support to their institution from GSK AstraZeneca and UCB Pharma.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00296-023-05360-z",FALSE,"",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was partially supported by Novartis Pharma GmbH Nürnberg Germany and the Deutsche Forschungsgemeinschaft (DFG—FOR 2886 “PANDORA”—Z to JK).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00296-023-05372-9",TRUE,"Conflict of interest The authors report no competing interests.",TRUE,"This research was supported by the NIHR Manchester Biomedical Research Centre (NIHR203308). <section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> This study was partially supported by the Deutsche Forschungsgemeinschaft (DFG) by project PANDORA (FOR2886).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00296-023-05443-x",TRUE,"Conflict of interest NB and HML received research grants from SOBI and Novartis and speaking honoraria from SOBI Novartis Roche MSD Abbott Pfizer Boehringer Actelion and UCB. JR received research grants from SOBI and Novartis and speaking and consulting honoraria from Abbvie Biogen BMS Chugai GSK Janssen Lilly MSD; Mylan Novartis Roche Sanofi Sobi UCB. MK received lecture honoraria from SOBI Novartis Roche Sanofi and Medac. IK MS KK BK DK MN CH declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. NB and contributing centers were funded by an unrestricted research grant by Swedish Orphan Biovitrum (SOBI).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-09510-6",TRUE,"Conflict of interest The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors state that this work has not received any funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-09608-x",TRUE,"Conflict of interest The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors state that this work has not received any funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-09669-y",TRUE,"Conflict of interest Timo Auer Dominik Geisel Raphael Mohr Bernd Hamm and Dominik Geisel received honoraria and travel expenses from Bayer Schering Pharma Berlin Germany in the past. All of the other authors who took part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors state that this work has not received any funding. All of the other authors who took part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-09707-9",TRUE,"Conflict of interest The authors of this manuscript declare relationships with the following companies: Tobias Penzkofer reports research agreements (no personal payments outside of submitted work) with AGO Aprea AB ARCAGY-GINECO Astellas Pharma Global Inc.",TRUE,"Tobias Penzkofer was supported by Berlin Institute of Health (Clinician Scientist Grant Platform Grant) Ministry of Education and Research (BMBF 01KX2021 68GX21001A) German Research Foundation (DFG SFB 1340/2) Horizon 2020 (952172). <section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors state that this work has not received any funding.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-09842-3",TRUE,"Conflict of interest The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors state that this work has not received any funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-10127-y",TRUE,"Conflict of interest Phillip Barckow is an employee of Circle Cardiovascular Imaging Inc.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-10141-0",TRUE,"Conflict of interest The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This research project is funded by the “Deutsche Forschungsgemeinschaft” (DFG German Research Foundation)—SFB 1340/1 2018",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-10223-z",TRUE,"Conflict of interest MB and VW report grant support from the FP7 Program of the European Commission for the randomized multicentre DISCHARGE trial (603266–2 HEALTH-2012.2.4.-2).",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study has received funding from a joint program of the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF 01KG1110) to PS and MD. <section> Conflict of interest MB and VW report grant support from the FP7 Program of the European Commission for the randomized multicentre DISCHARGE trial (603266–2 HEALTH-2012.2.4.-2). BLN reports grants from Siemens and HeartFlow; JK received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare Bayer Lundbeck Boehringer-Ingelheim Pfizer and Merck outside of the submitted work; RRB reports that the University Hospital Zurich holds a research agreement with GE Healthcare; PAK reports that the University Hospital Zurich holds a research agreement with GE Healthcare; GMS reports grants from the German Federal Ministry of Education and Research (BMBF) during the conduct of the study; DEN reports grants from Toshiba Medical Systems PS and MD had support from the joint programme of the German Research Foundation and the German Federal Ministry of Education and Research for the submitted work; PS has support from the German Research Foundation grants from the European Union and grants from Bayer Pharma AG; MD has received grant support from the FP7 Program of the European Commission He also received grant support from German Research Foundation (DFG) in the Heisenberg Program (DE 1361/14–1) graduate program on quantitative biomedical imaging (BIOQIC GRK 2260/1) for fractal analysis of myocardial perfusion (DE 1361/18–1) the Priority Programme Radiomics for the investigation of coronary plaque and coronary flow (DE 1361/19–1 [428222922] and 20–1 [428223139] in SPP 2177/1). He also received funding from the Berlin University Alliance (GC_SC_PC 27) and from the Digital Health Accelerator of the Berlin Institute of Health.",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-10352-5",TRUE,"Conflict of interest The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00330-023-10355-2",TRUE,"Conflict of interest B Merkely received a grant from Biotronik Medtronic and Abbott (personal fees).",TRUE,"<section> Funding <section> All the authors received funding from the EU-FP7 Framework Program (FP 2007–2013 EC-GA 603266) for this study (Mancone M Vázquez Mézquita AJ Birtolo LI Maurovich-Horvat P Kofoed KF Benedek T Donnelly P Rodriguez-Palomares J Erglis A Štěchovský C Šakalytė G Čemerlić Ađić N Gutberlet M Dodd JD Diez I Davis G Zimmermann E Kępka C Vida‑ kovic R Francone M Ilnicka-Suckiel M Plank F Knuuti J Faria R Schröder S Berry C Saba L Ruzsics B Rieckmann N Kubiak C Schultz Hansen K Müller-Nordhorn J Merkely B Sigvardsen PE Benedek I Orr C Xavier Valente F Zvaigzne L Suchánek V Jankauskas A Ađić F Woinke M Keane S Lecumberri I Thwaite E Kruk M Jovanovic V Kuśmierz D Feuchtner G Pietilä M Gama Ribeiro V Drosch T Delles C Palmisano V Fisher M Drobni ZD Kragelund C Aurelian R Kelly S Garcia del Blanco B Rubio A Boussoussou M Hove JD Rodean I Regan S Cuéllar Calabria H Becker D Larsen L Hodas R Napp AE Haase R Feger S Mohamed M Neumann K Dreger H Rief M Wieske V Douglas P Estrella M Bosserdt M Martus P Serna-Higuita LM Dewey M). K. Kofoed received grants from AP Møller og hustru Chastine McKinney Møllers Fond Danish Heart Foundation The Danish Agency for Science Technology and Innovation by The Danish Council for Strategic Research and Health Insurance Company Denmark. <section> H Theodora received grants from Romanian Ministry of European Funds the Romanian Government and the European Union (Increasing the research capacity in the field of vulnerable plaque imaging based on advanced nano‑ particles fusion imaging and computational simulation – PlaqueImage” nt no. <section> 103544/2016 contract number 26/01.09.2016). <section> E Zimmermann received grants from Deutsche Forschungsgemeinschaft (Grant: Radiomics in SPP 2177/1). <section> J Knuuti received grants from AstraZeneca (personal fees: study protocol review) and from GE Healthcare (personal fees: study protocol review). <section> C Berry received grants from AstraZeneca (grant and other: The University of Glas‑ gow has received funding for research and consultancy work in the field of ischae‑ mic heart disease undertaken by Colin Berry in the course of his employment); <section> PS Douglas has received funding from HeartFlow for research in the field of ischaemic heart disease undertaken by Professor Douglas in the course of her employment. <section> M Dewey received grant support from the German Research Foundation (DFG) in the Heisenberg Program (DE 1361/14–1 DFG project number: 213705389) for fractal analysis of myocardial perfusion (DE 1361/18–1 DFG project number: 392304398) the GUIDE-IT project on data sharing of medi cal imaging trials (DE 1361/24–1 [DFG project number: 495697118]) the Quantitative Cardiovascular Imaging (QCI) meeting (DE 1361/22–1) and the Future of Medical Imaging meeting (DE 1361/28–1). He also received funding from the Berlin University Alliance (GC_SC_PC 27) and from the Digital Health Accelerator of the Berlin Institute of Health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00345-023-04334-x",TRUE,"Conflict of interest Consultants and proctors for Boston Scientific for <section> GreenLight: KZ DSE VM ER HC BC. Surgical tutors for GreenLight Xcelerated Performance System and received honoraria for their tutorship: GF LC. Investigators and consultants for PROCEPT BioRobotics: VM TB NB KZ. All other authors do not have any relevant conflicts of interest.",TRUE,"<section> Funding No funding or financial support was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00345-023-04489-7",TRUE,"Conflict of interest TJ Brinker would like to disclose that he is the owner of Smart Health Heidelberg GmbH (Handschuhsheimer Landstr.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Federal Ministry of Health Berlin Germany (grant: Tumorverhalten-Praediktions-Initiative; grant holder: TJ Brinker German Cancer Research Centre; #2519DAT712).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00345-023-04604-8",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00347-023-01960-z",TRUE,"Conflict of interest. In accordance with Springer Igel S Pohlmann D et al (2022) Keep an eye on Medicine guidelines authors and scientiﬁc directhe back: spondyloarthritis in patients with acute tors are requested to make a full declaration of their anterior uveitis.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00380-023-02256-7",TRUE,"Conflict of interest Teresa Gerhardt reports grants from DZHK (German Center for Cardiovascular Research) and the DGK (German Cardiac Society) outside the submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was financially supported by Abbott Vascular.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00380-023-02282-5",TRUE,"Conflict of interest Emanuel Heil: EH received travel grants from Bayer and Edwards Lifesciences.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00381-023-06123-8",TRUE,"Conflict of interest The authors have no financial or non-financial interests to disclose in relation to this study.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00384-023-04379-9",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> 33.3% (n = 12) 13.9% (n = 5) 44.6% (n = 29) 13.9% (n = 9) Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00384-023-04430-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-022-02143-7",TRUE,"Conflict of interest KL MB JS EL BL BH AK MH RW AD and FE declare that they have no conflict of interest to disclose with respect to this manuscript.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the German Foundation of Heart Research [F/19/18]. Aldo-DHF was funded by the Federal Ministry of Education and Research Grant 01GI0205 [clinical trial program Aldo-",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02165-9",TRUE,"Conflict of interest The authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The B2HIR is funded by unrestricted grants of the participating",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02171-x",TRUE,"Conflict of interest S.D.A. reports receiving fees from Abbott Actimed Bayer Boehringer Ingelheim Cardiac Dimension Cordio Impulse Dynamics Novartis Occlutech Servier and Vifor Pharma and grant support from Abbott and Vifor Pharma. The other authors declare that there is no relevant conflict of interest.",TRUE,"<section> Funding BIOSTAT-CHF was funded by a grant from the European Commission (FP7-242209-BIOSTAT-CHF; EudraCT 2010–020808–29).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02177-5",TRUE,"Other conflicts of interests (Leadership or fiduciary role in other board society committee or advocacy group paid or unpaid) of Matthias Endres are European Academy of Neurology (Board of directors unpaid) German Society of Neurology (Member unpaid) International Society of Cerebral Blood Flow Metabolism (Member unpaid) American Heart Association/American Stroke Association (Member unpaid) World Stroke Organization (Member unpaid) European Stroke Organisation (Fellow unpaid) German Center of Neurodegenerative Diseases (personal contract paid).",TRUE,"The secondary use of data and biological sample from the DZHK Heart Bank is orchestrated and supported technically by the Transfer Office and procedurally and formally by the Use and Access Office. <section> Funding Open Access funding enabled and organized by Projekt DEAL. As being one of the currently six existing German Centres for Health Research the DZHK is funded by the Federal Ministry of Research and Education and the Governments of the Federal States where the partner sites are located. Rolf Wachter received funding from BMBF European Union Medtronic DFG and was financially supported by Boehringer Ingelheim Novartis Medtronic AstraZeneca and Pharmacosmos. Moritz Seiffert received funding from Abbott Vascular Boston Scientific and received honoraria from Abbott Vascular Abiomed Amgen AstraZeneca Bristol-Myers Squibb Daiichi Sankyo Edwards lifesciences Inari Medical Medtronic Pfizer Shockwave Medical and Siemens Healthineers. Ulrich Grabmaier received funding from a DZHK grant professional fee from AstraZeneca. Ulf Landmesser received funding from research grants to his institution from Abbott AmgenBayer Novartis. Eike Nagel received funding from Bayer Healthcare and Neosoft Ltd. Matthias Endres received funding from DFG under Germany´s Excellence Strategy—EXC2049—390688087 Collaborative Research Center ReTune TRR 295—424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq and reports grants from Bayer and fees paid to the Charité from Abbot Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo Sanofi Novartis Pfizer all outside the submitted work.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00392-023-02227-y",TRUE,"Conflict of interest The authors declare that they have no competing interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02240-1",TRUE,"Conflict of interest The authors received a research grant from Bayer that was used together with the Funding of DZHK for conducting the study.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This investigatorinitiated study was financially supported from the DZHK (German Centre for Cardiovascular Research COVID-Prevent 81X1100222) and Bayer who granted the study drug and partial financial support. <section> Conflict of interest The authors received a research grant from Bayer that was used together with the Funding of DZHK for conducting the study.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study protocol inclusive its amendments and adaptions were registered at clinicaltrials.gov (NCT044160048).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00392-023-02247-8",TRUE,"Conflict of interest P.S. F.S. and G.J-A report no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02250-z",TRUE,"Conflicts of Interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. There was no specific funding for this study. In general work in a group of TL was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl (Grant Agreement 771083).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02319-9",TRUE,"Conflict of interest GN: honoraria for lectures or advisory boards participation in clinical trials research funding: Bayer Boehringer <section> Ingelheim Daiichi Sankyo BMS/Pfizer; JWS: honoraria for lectures research funding: Boehringer Ingelheim Bayer Daiichi Sankyo BMS/ <section> Pfizer; TL: moderate honoraria for lectures research funding or advisory boards: Abbott Atricure Boston Scientific Biotronik Bayer Boehringer Ingelheim Daiichi Sankyo Pfizer; TG: speaker consultant fees or research grants from Astra Zeneca Bayer BMS/Pfizer Boehringer Ingelheim Daiichi Sankyo Edwards Lifescience Ferrer/ Chiesi Medtronic not related to the submitted work; TB ML JAL JS MS GH TA CS TD HB AS DS BDG BR MZ BS WJ TK AL CV MC: no disclosures related to submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The randomized ODIn-AF trial was an investigatorinitiated trial (IIT) that was financially supported by Boehringer Ingelheim (BI) Ingelheim Germany.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02332-y",TRUE,"Conflict of interest B.S. reports speaker fees from Abiomed Abbott and AstraZeneca outside of the submitted work. All other authors did not declare a conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. P.K. was partially supported by European Union AFFECT-AF (grant agreement 847770) and MAESTRIA (grant agreement 965286) British Heart Foundation (PG/17/30/32961; PG/20/22/35093; AA/18/2/34218) German Centre for Cardiovascular Research supported by the German Ministry of Education and Research (DZHK) Deutsche Forschungsgemeinschaft (Ki 509167694) and Leducq Foundation; receives research support for basic translational and clinical research projects from European Union British Heart Foundation Leducq Foundation Medical Research Council (UK) and German Centre for Cardiovascular Research from several drug and device companies active in atrial fibrillation and has received honoraria from several such companies in the past but not in the last three years; is listed as inventor on two issued patents held by University of Hamburg (Atrial Fibrillation Therapy WO 2015140571 Markers for Atrial Fibrillation WO 2016012783).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00392-023-02352-8",TRUE,"Conflict of interest HD is a member of the advisory board and has received speaker and proctoring fees from Abbott and Edwards Lifesciences; and has received research support from Abbott. VF declares relevant financial activities outside the submitted work: Medtronic GmbH Biotronik SE & Co. Abbott GmbH & Co. KG Boston Scientific Edwards Lifesciences LivaNova Berlin Heart Novartis Pharma GmbH JOTEC GmbH Zurich Heart in relation to Educational Grants (including travel support) Fees for lectures and speeches Fees for professional consultation Research and study funds. AB CH CC AH SM DML SS AU MS AH SB JL YK OP SS KS UL VS declare no conflicts of interest in relation with the submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was supported by the Center for Health Services Research of the German Cardiac Society (Deutsche Gesellschaft für Kardiologie-Zentrum für Kardiologische Versorgungsforschung; DGKZfKVF).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00393-022-01302-5",TRUE,"Conflict of interest. K. Albrecht S. Binder K. Minden D. Poddubnyy A.C. Regierer A. Strangfeld and J. Callin the prevalence estimates of Costello hoﬀ declare that they have no competing interests.",TRUE,"<section> show a signiﬁcant diﬀerence in prevalence Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00393-023-01433-3",TRUE,"Conflict of interest. <section> competing interests. 1007/s00393-022-01305-2",TRUE,"(Three most important factors) Possible responses I have a child/children I do not have a child/children but would still like to answer the questions on work and family I do not have a child/children and would like to skip the questions on family and career Fully agree Rather agree Partly agree Somewhat disagree Disagree Fully agree Rather agree Partly agree Somewhat disagree Disagree I have not taken parental leave yet I have already taken parental leave More ﬂexible working hours e.g. by having more say in the determination of working hours More predictable or regular working hours Less overtime Childcare place Allday childcare Childcare place near the workplace More consideration from colleagues Carry out parts of the work at home (documentation doctor’s letters via intranet/VPN) Optional childcare service for children or relatives in emergencies for meetings or during the school holidays Financial support Mentoring programme I am satisﬁed with the current oﬀer Number (percent) n = 37 (36.3%) n = 35 (34.3%) n = 30 (29.4%) n = 5 (6.9%) n = 20 (27.8%) n = 21 (29.2%) n = 16 (22.2%) n = 10 (13.9%) n = 29 (40.3%) n = 20 (27.8%) n = 16 (22.2%) n = 4 (5.6%) n = 3 (4.2%) n = 41 (56.9%) n = 31 (43.1%) n = 43 (21.7%) n = 29 (14.6%) n = 39 (19.7%) n = 9 (4.5%) n = 8 (4.0%) n = 4 (2.0%) n = 2 (1.0%) n = 40 (20.2%) n = 9 (4.5%) n = 4 (2.0%) n = 5 (2.5%) n = 6 (3.0%) VPN Virtual private network <section> Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00395-022-00954-3",TRUE,"Conflict of interest JB holds a patent on ""In vitro method for cardiovascular risk stratification EP2954322B1"".",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. J.B. was supported by grants from the MWK (‘Development of an indirect cardiomyocyte test for the prediction of heart failure’; AZ 32–5400/58/2) and the DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung—German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research). J.B. T.W. and B.M. were supported by the Collaborative Research Center 1550 (CRC1550 /SFB1550) ‘Molecular Circuits of Heart Disease’ – Project-ID 464424253.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00395-023-00989-0",TRUE,"Conflict of interest The authors declare no competing interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Charité 3R Replace— Reduce—Refine initiative. PLP and WMK are supported by Berlin Institute of Health (BIH). PLP is supported by the German Academic Scholarship Foundation. JG is supported by DynAge Freie Universität (FU) Berlin the German Society for Cardiology (DGK) and Charité 3R. WMK is supported by the German Federal Ministry of Education and Research (BMBF) in the framework of the projects",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00401-022-02522-4",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"Funding acquisition: SR SMP FS DJ TP MBe. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The HIT2000 trial the HIT2000interim Registry and the I-HITMED Registry were supported by the German Childhood Cancer Aid (Deutsche Kinderkrebsstiftung) with grants to SR and MM. <section> neuropathological review was supported by grants from the German Childhood Cancer Aid (Deutsche Kinderkrebsstiftung) to TP. Part of the DNA-methylation profiling data were derived from the MNP2.0 study funded by the German Childhood Cancer Aid to SMP and from a BMBF program “Molecular Diagnostics” to SR SMP TP.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Patients were eligible if they had (a) histologically confirmed MB (b) DNA-methylation profiling that was classified to belong to the methylation class family (MCF) Group 3/4 by the Heidelberg Brain Tumor classifier v11b6 with a score of ≥ 0.9 (c) had their first tumor surgery before June 2019 and (d) participated in one of the following trials or registries: the HIT2000 trial (NCT00303810) HIT2000interim registry (NCT02238899) or I-HIT-MED registry (NCT02417324) (Fig. 1a).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00401-023-02552-6",TRUE,"Conflict of interest M.S.W. received travel funding and/or speaker honoraria from Biogen-Idec Merck Serono Novartis Roche TEVA Bayer and Genzyme. The other authors declare that they have no competing interests.",TRUE,"Our research is supported by intramural grants (Startförderung) of the Universitätsmedizin Göttingen (S.H.-K. This study was supported by the ProFutura Programm of the Universitätsmedizin Göttingen (M.S.W.) and the Deutsche Forschungsgemeinschaft (WE 3547/4-1; WE 3547/51; WE3547/7-1 in association with SFB TRR 274; all M.S.W.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00401-023-02608-7",FALSE,"",TRUE,"<section> Acknowledgements This study was supported by the Deutsche Forschungsgemeinschaft (FR 1516/4-1). MF received funds by the Deutsche Krebshilfe (DKH 70113981). PDJ received funding by the German Cancer Aid (Max Eder program) and the Else Kröner Fresenius Stiftung. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00401-023-02637-2",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> This work was directly funded by the Else Kröner-Fresenius-Stiftung to CN (2023_EKEA.38). Further this work was supported by the internal research funding program of the Heinrich Heine University to CN CBS and TR. This research was supported by the Myositis Netz e.V.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-021-03981-2",TRUE,"Conflict of interests The authors have no conflicts of interest to declare that are relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-021-04112-7",TRUE,"Conflict of interest Vincent Justus Leopold Juana Conrad Robert Karl Zahn Christian Hipfl Carsten Perka and Sebastian Hardt have nothing to disclose related to this work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00402-021-04125-2",TRUE,"Conflict of interest All authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-021-04141-2",TRUE,"Conflict of interest The author(s) declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-021-04206-2",TRUE,"Conflict of interest FB receives royalties from Orthodevelopment Inc.",TRUE,"<section> Funding No funding was received to assist with the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04796-z",TRUE,"Conflict of interest On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funds grants or other support were received for the purpose of this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04844-8",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04855-5",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04936-5",TRUE,"Conflict of interest The authors declare that they don’t have any conflict",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04941-8",TRUE,"Conflict of interest Vincent J.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-04982-z",TRUE,"Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"Funding The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol of the systematic review has been registered in the international prospective register of systematic reviews (PROSPERO) under the registration number CRD42021271858.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00402-023-04985-w",TRUE,"Conflict of interest The authors declare that they do not have any conflict",TRUE,"Funding None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-05007-5",TRUE,"Conflict of interest The authors have nothing to disclose related to this work.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-05104-5",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00402-023-05160-x",TRUE,"Conflict of interest Vincent Leopold Christian Hipfl Carsten Perka Sebastian Hardt and Luis Becker have nothing to disclose related to this",TRUE,"<section> Source of funding <section> No funding was received for this study. Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-06919-8",TRUE,"Conflict of interest V.C.L. J.V.D.V A.L. M.W.S. B.S. J.S. and M.J.B. have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07075-9",TRUE,"Conflict of interest None of the authors have any conflicts of interest regarding this work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07084-8",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07110-9",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07165-8",TRUE,"Conflict of interest All authors declare to have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07177-4",TRUE,"Conflict of interest In addition to clinical and academic activities the last author (BA) owns a company for vaginal pessaries. The profit of this company exclusively supports creative projects for mothers and children within the Clara Angela Foundation. Thus the author has no personal or financial interests to disclose. The other two authors (JW & TF) declare that they have no competing interests.",TRUE,"<section> Funding The authors declare that no funds grants or other support was received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07192-5",TRUE,"Conflict of interest All the machines used in this study as well as finan‑ cial support (JM) where provided by Medizintechnik Rostock GmbH. <section> All the other authors declare no potential conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was sponsored by Medizintechnik Rostock GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00404-023-07286-0",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-022-01535-0",TRUE,"Conflict of interest None of the authors have any conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the Deutsche Forschungsgemeinschaft (DFG) (WI 3396/2-3).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01552-7",TRUE,"Conflict of interest Malek Bajbouj has served as a consultant to GH Research Janssen Bayer and Boehringer Ingelheim. Simone Grimm has served as a consultant to and received research support from Boehringer Ingelheim Pharma. No other disclosures were reported.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the German Research Foundation (GR4510/5–1 to Simone Grimm BA3578/5-1 to Malek Bajbouj) and by the European Commission (H2020-634541 to Simone Grimm).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00406-023-01555-4",FALSE,"",TRUE,"<section> Acknowledgements This research was supported by internal research funds from Charité – Universitätsmedizin Berlin (S.L.)",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01565-2",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01593-y",TRUE,"Conflict of interests The authors declare that they have no conflict of interest with regard to the content of this report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01646-2",TRUE,"Conflict of interest AS has received research support from RobertEnke-Stiftung for this specific trial. JG has received a salary from that funding of the Robert-Enke-Stiftung. All other authors declare no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This trial was supported by the “Robert-Enke-Stiftung” with no role in planning conducting analysis or publication of the study (no grant number given).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00406-023-01666-y",TRUE,"Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the Max Planck Society. Luise Victoria Claaß was funded by a doctoral scholarship from the Medical Faculty of the University of Leipzig. Florian Schlagenhauf received grants from the German Research Foundation (SCHL1969/1–2/3–1 402170461) and was funded by the Heisenberg Program (SCHL 1969/4–1/5–1). Jakob Kaminski was supported by the Clinician Scientist Program from the Berlin Institute of Health.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01672-0",TRUE,"Conflict of interest We declare to take full responsibility for the integrity of the data and accuracy of the data analysis.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by Lundbeck GmbH Hamburg Germany grant number 2007-006914-41.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Study registration was performed at the University Register of Clinical Studies (No. 2007-006914-41) and at www. c lini c altr i als. g ov (No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s00406-023-01678-8",TRUE,"Conflict of interest None of the authors have any conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the Deutsche Forschungsgemeinschaft (DFG) (WI 3396/12-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00406-023-01685-9",TRUE,"Conflict of interest M.E. reports grants from Bayer and fees paid to the Charité from Abbot Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo Sanofi Novartis Pfizer all outside the submitted work.",TRUE,"This work was supported by the Deutsche Forschungsgemeinschaft (Germany´s Excellence Strategy – EXC-2049 – 390688087 Collaborative Research Center ReTune TRR 295424778381 to M.E. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00414-023-03097-9",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-022-11535-8",TRUE,"Conflict of interest Alessandro Cagol has nothing to disclose.",TRUE,"<section> Funding Open access funding provided by University of Basel. Athina Papadopoulou received grants from the Swiss Multiple Sclerosis Society the “Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung” and the University Hospital of Basel for the submitted work. He has received travel support from Bayer AG Biogen Teva Pharmaceuticals and Sanofi Genzyme and research support from the University Hospital Basel. He is or was supported by grants of the EU (Horizon2020) German Federal Ministeries of Education and Research (BMBF) and of Economic Affairs and Energy (BMWI). <section> Jens Kuhle received speaker fees research support travel support and/ or served on advisory boards by Swiss MS Society Swiss National Research Foundation (320030_189140/1) University of Basel Progressive MS Alliance Bayer Biogen Celgene Merck Novartis Octave Bioscience Roche Sanofi. Her research was/ is being supported by the University and the University Hospital of Basel the Swiss Multiple Sclerosis Society the ‘Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung’ the ""Freie Akademische Gesellschaft"" Basel and the Swiss National Science Foundation (Project number: P300PB_174480).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11608-2",TRUE,"Conflicts of interest On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11633-1",TRUE,"Conflicts of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements This study was supported by the Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen der regierende Bürgermeister von Berlin Senatskanzlei Wissenschaft und Forschung and the Bundesministerium für Bildung und Forschung (BMBF). S.-S. moreover acknowledge financial support from the German Society of Muscular Disorders (DGM). <section> PHENODM1 study has been supported by the National Institute of Health Research NIHR under the RD-TRC programme (Grant ID PD00402); and by the Wyck Foundation. OPTIMISTIC trial was funded by the European Community’s Seventh Framework Programme (FP7/2007-2013) under Grant agreement no. 305697. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11634-0",TRUE,"Conflict of interest SJ reports no conflicts of interest. VH reports no conflicts of interest. KH reports no conflicts of interest. MH reports no conflicts of interest. PS reports no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. JH reports a grant for OCT research from the Friedrich-Baur-Stiftung personal fees and nonfinancial support from Merck Alexion Novartis Roche Santhera Biogen Heidelberg Engineering and Sanofi Genzyme and nonfinancial support from the Guthy-Jackson Charitable Foundation; he is partially funded by the German Federal Ministry of Education and Research [grant numbers 01ZZ1603[A-D] and 01ZZ1804[A-H] (DIFUTURE)]. FP has received grants from Guthy Jackson Charitable Foundation German Research Foundation German Federal Ministry of Education and Research Novartis Bayer Biogen Idec Teva Alexion Roche Horizon Sanofi-Aventis/Genzyme Merck Serono Chugai German Research Council Werth Stiftung of the City of Cologne Arthur Arnstein Stiftung Berlin EU FP7 Framework Program National Multiple Sclerosis (USA) MedImmune Shire and Alexion and has a patent on Foveal Morphometry pending to Nocturne GmbH; he is Academic Editor at PLoS ONE and Associate Editor of Neurology ® Neuroimmunology & Neuroinflammation. KR has received research support from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité (BIH Clinical Fellow Program) and Arthur Arnstein Foundation speaker honoraria from Bayer and travel grants from Guthy Jackson Charitable Foundation. She has received research funding from the Hertha-Nathorff-Program. FTB has received personal compensation for advisory board participation or speaking and through his institution has received research support for investigatorinitiated studies or for attending scientific meetings from Actelion Alexion Bayer-Schering Biogen Merck Novartis Roche Sanofi-Genzyme Teva UCB German Research Foundation (DFG) and German Federal Ministry of Education and Research (BMBF). BW has received grants from the German Ministry of Education and Research German Research Foundation Dietmar Hopp Stiftung Klaus Tschira Stiftung and Merck and personal fees from Alexion Bayer Biogen Roche.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11699-x",TRUE,"Conflict of interest Andreas Meisel has received speaker honoraria consulting fees or financial research support (paid to institution) from Alexion AstraZeneca Rare Disease Argenx Axunio Grifols Hormosan Janssen Merck Octapharma and UCB.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study and all costs associated with development of this publication were funded by Alexion AstraZeneca Rare Disease. James F Howard Jr has received research support (paid to institution) from Alexion AstraZeneca Rare Disease argenx Cartesian Therapeutics the Centers for Disease Control and Prevention (Atlanta GA USA) the Myasthenia Gravis Foundation of America the Muscular Dystrophy Association the National Institutes of Health (including the National Institute of Neurological Disorders and Stroke and the National Institute of Arthritis and Musculoskeletal and Skin Diseases) PCORI Ra Pharmaceuticals (now UCB Pharma) and Takeda Pharmaceuticals; honoraria from Alexion AstraZeneca Rare Disease argenx Immunovant Inc. Ra Pharmaceuticals (now UCB Pharma) Regeneron Pharmaceuticals Sanofi US and Viela Bio Inc. (now Horizon Therapeutics); and nonfinancial support from Alexion AstraZeneca Rare Disease argenx Ra Pharmaceuticals (now UCB Pharma) and Toleranzia AB.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11703-4",TRUE,"Conflicts of interest MM received consulting payments and/or speaker fees from Sanofi Amgen Lilly MSD Berlin-Chemie Novartis Astra BioMarin Akcea Daiichi-Sankyo Gilead Novo and Pfizer. DB had no relevant conflicts of interest to declare.",TRUE,"<section> Funding This work was supported by BioMarin Deutschland GmbH and BioMarin Pharmaceutical Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11708-z",TRUE,"Conflicts of interest KSL received travel and accommodation expenses from Acticor Biotech and Teva not related to the submitted work. <section> CR received honoraria for board membership and speaker fees Allergan/Abbvie Homeperf Lilly Lundbeck Mylan Novartis Ophtalmic Orkyn Pfizer Sanofi and Teva and travel accommodation and meeting expenses from Teva Lundbeck and Lilly all outside the submitted work. AD received honoraria for board membership and speaker fees from Allergan Abbvie Lilly Teva Lundbeck Pfizer and travel accommodation and meeting expenses from Teva and SOS Oxygène all outside the submitted work; she is associate editor of Cephalalgia. JM received travel accommodation and meeting expenses from SOS GEP Sante Lundbeck and Homeperf and received honoraria for advisory boards or speaker fees from Abbvie Teva Lilly Lundbeck and Novartis not related to the submitted work; he is a member of the redaction committee of “La Lettre du Neurologue” without financial compensation. The other authors report no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11718-x",TRUE,"Conflicts of interest CM is part of patent applications to detect and predict clinical outcomes and to manage diagnose and treat neurological conditions all of which are outside the submitted work. CHN received research grants from German Ministry of Research and Education German Center for Neurodegenerative Diseases German Center for cardiovascular Research and speaker and/or consultation fees from Abbott Alexion Astra Zeneca Bayer Pharma Bristol-Myers Squibb Daiichi Sankyo Novartis Pfizer Pharma Portola and Takeda all outside the submitted work. ME reports grants from Bayer and fees paid to the Charité from Abbott Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo GSK Sanofi Covidien Novartis Pfizer all outside the submitted work. The remaining authors have no conflicts of interest or competing interests to declare.",TRUE,"<section> Acknowledgements The study was supported by NeuroCure Clinical Research Center (NCRC) funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany´s Excellence Strategy EXC 2049-390688087. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11753-8",TRUE,"Conflicts of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11766-3",TRUE,"Conflicts of interest D. Neugebauer report no disclosures relevant to the manuscript; N.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors report no targeted funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11779-y",TRUE,"Conflicts of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funds grants or other support was received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00415-023-11804-0",TRUE,"Conflicts of interest Nothing to report.",TRUE,"<section> Funding Open Access Funding provided by Universitat Autonoma de Barcelona.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11806-y",TRUE,"Conflicts of interest The authors declare that there is no conflict of interest.",TRUE,"<section> Funding This work was supported through funds raised by the Hamburg chapter of the DMSG and by the broadcasting station NDR with the programme Hand in Hand. SR was supported by an Advanced Clinician-Scientist Fellowship from the BMBF (iSTAR) and the Hertie Network of Excellence in Clinical Neuroscience of the Gemeinnützige Hertie-Stiftung.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11828-6",TRUE,"Conflicts of interest JID and JMH declare no conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11853-5",TRUE,"Conflicts of interest NMW was supported by the DFG Research Unit 2841 “Beyond the Exome”.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11895-9",TRUE,"Conflicts of interest All other authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. HP and CF have received funding by the German Research Foundation (DFG). Funding numbers are FR 4479/1-1 and PR 1274/8-1.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11901-0",TRUE,"Conflicts of interest On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-11951-4",TRUE,"Conflicts of interest KH received financial reimbursement for consulting advisory board activities speaker fees and contributions to congresses and travel support to attend scientific meetings by Akcea Therapeuticals Inc. Alnylam Pharmaceuticals Inc. Takeda Pharmaceutical Inc. Pfizer Pharmaceuticals Inc. and Swedish Orphan Biovitrum Inc. <section> KH further received research funding by the foundation Charité (BIH clinical fellow) Alnylam Pharmaceuticals Inc. and Pfizer Pharmaceuticals. KH declared that none of this is related to the manuscript. JN reported receiving personal fees for consultancy and speaker fees from BD Bard. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-12006-4",TRUE,"Conflicts of interest All authors declare that there is no conflict of interest.",TRUE,"<section> Acknowledgements This project was supported by the German Center for Neurodegenerative Diseases (DZNE) and the German Parkinson’s Association (DPG) to GUH and SG. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-12031-3",TRUE,"Conflict of interest CM is part of patent applications to detect and predict clinical outcomes and to manage diagnose and treat neurological conditions all of which are outside the submitted work. CHN received research grants from the German Ministry of Research and Education German Center for Neurodegenerative Diseases German Center for Cardiovascular Research and speaker and/or consultation fees from Abbott Alexion Astra Zeneca Bayer Pharma Bristol-Myers Squibb Daiichi Sankyo Novartis Pfizer Pharma Portola and Takeda all outside the submitted work. ME reports grants from Bayer and fees paid to the Charité from Abbott Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo GSK Sanofi Covidien Novartis Pfizer all outside the submitted work. BH reports speaker fees from Pfizer and BMS with no relation to the submitted work. The remaining authors have no conflicts of interest or competing interests to declare.",TRUE,"<section> Acknowledgements The study was supported by the NeuroCure Clinical Research Center (NCRC) funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany´s Excellence Strategy EXC 2049-390688087. AM received funding from the German Research Foundation (SFB/TRR167; ME 1562/4-1) and Foundation Leducq (19CVD01). <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-12038-w",TRUE,"Conflicts of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00415-023-12092-4",TRUE,"Conflicts of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. We acknowledge support from the German Research Foundation (DFG: FR 4479/1-1 PR 1274/8-1 WA 4101/2-1) and from the Ministry of Science Research and Arts Baden-Württemberg (to B.W.).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00415-023-12132-z",TRUE,"Conflicts of interest Magi Andorra is an employee of Hoffman-La Roche AG. Ana Freire reports no disclosures. Eloy Martinez-Heras reports no disclosures. Melanie Rinas reports no disclosures. <section> Julio Saez-Rodriguez reports no disclosures. Steffan Bos reports no disclosures. Maria Cellerino reports no disclosures. Federico Ivaldi reports no disclosures. <section> Gemma Vila reports no disclosures. Sigrid A. de Rodez Benavent reports no disclosures. Harbo reports no disclosures. Nicole Kerlero de Rosbo reports no disclosures. Janina Behrens reports no disclosures. Ricardo Baeza-Yates reports no disclosures. Other authors do not have competing interests.",TRUE,"This work was supported by the European Commission Sys4MS project of the Eracosysmed programme (Grant ID-43) and the Instituto de Salud Carlos III Madrid Spain (AC1500052). <section> Funding Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by the European Commission (ERACOSYSMED ERA-Net programme Sys4MS project id:43) Instituto de Salud Carlos III Spain (AC1500052); the Italian Ministry of Health (WFR-PER-2013-02361136) the German Ministry of Science (Deutsches Teilprojekt B “Förderkennzeichen: 031L0083B) and the Norwegian Research Council (project 257955). Priscilla Bäcker-Koduah is funded by the DFG Excellence grant to FP (DFG exc 257) and is a Junior scholar of the Einstein Foundation. He has received funding from Deutsche Forschungsgemeinschaft (DFG Exc 257) Bundesministerium für Bildung und Forschung (Competence Network Multiple Sclerosis) Guthy Jackson Charitable Foundation EU Framework Program 7 National Multiple Sclerosis Society of the USA.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00417-022-05944-8",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00417-022-05952-8",TRUE,"Conflict of interest Oliver Zeitz received personal fees from Bayer AG grants from Novartis personal fees from Boehringer Ingelheim outside the submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00417-023-06171-5",TRUE,"Conflict of interest P.H. and E.R. report no financial interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00417-023-06272-1",TRUE,"Conflict of interest The Vision Academy is a group of over 100 international experts who through their collective expertise provide consensus guidance for managing clinically challenging situations especially in areas of controversy or with insufficient conclusive evidence.",TRUE,"<section> Funding Open access funding provided by Università degli Studi di Padova within the CRUI-CARE Agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00418-023-02211-7",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00420-022-01947-4",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This research was funded by the German Federal Ministry of Education and Research (BMBF) under the funding line “Migration and Institutional Change” (grant number: 01UM1810AY). Funding conditions allowed for the independent design and realization of the study.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00421-023-05164-w",TRUE,"Conflict of interest The authors declare that there are no competing financial interests in relation to the work described.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00423-023-02804-9",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00423-023-02953-x",TRUE,"Conflicts of interest Sebastian Knitter Linda Feldbrügge Nora Nevermann Brigitta Globke Thomas Winklmann Felix Krenzien Philipp",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00423-023-02956-8",TRUE,"Competing interests The authors declare no competing interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00423-023-03002-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The guideline was funded by the German Cancer Aid as part of the GGPO (https://www.leitlinienprogrammonkologie.de/germanguidelineprogram-inoncology/). <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00423-023-03023-y",TRUE,"Competing interests Professor Johann Pratschke received a research grant from the Intuitive Surgical Deutschland GmbH for the conduction of the present study. Furthermore he reports personal fees or other support from Johnson & Johnson Medtronic Astellas CHG Meridian AFS Medical Chiesi Falk Foundation Neovii NOGGO pharmaconsult Peterson La Fource Group Merck and promedicis. <section> Professor Moritz Schmelzle reports personal fees or non-financial support outside of the submitted work from the Merck Serono GmbH Bayer AG ERBE Elektromedizin GmbH Amgen Inc. Johnson&Johnson Medical GmbH ERBE Elektromedizin GmbH Takeda Pharmaceutical Limited Olympus K.K. Medtronic GmbH Intuitive Surgical Inc. Drs. Nora Nevermann Julia Bode Maxine Vischer Linda Feldbrügge Sebastian Knitter Felix Krenzien Uwe Pelzer Uli Fehrenbach Timo Auer Georg Lurje and Professor Wenzel Schöning have no conflicts of interest or financial ties to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00426-022-01735-2",TRUE,"Conflict of interest The authors declare that they have no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00429-023-02710-2",TRUE,"Conflict of interest Tobias Banaschewski served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. He received conference support or speaker’s fee by Janssen Medice and Takeda. He received royalities from Hogrefe Kohlhammer CIP Medien Oxford University Press; the present work is unrelated to these relationships. Dr. Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. Dr. Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding This work received support from the following sources: the European Unionfunded FP6 Integrated Project IMAGEN (reinforcementrelated behaviour in normal brain function and psychopathology) (LSHM-CT-2007-037286) the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain networkbased stratification of reinforcementrelated disorders) (695313) Human Brain Project (HBP SGA 2 785907 and HBP SGA 3 945539) the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1) the National Institute of Health (NIH) (R01DA049238 A decentralized macro and micro geneby-environment interaction analysis of substance use behavior and its brain biomarkers) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B) the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 SFB 940 TRR 265 NE 1383/14-1) the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1) the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01) NSFC grant 82150710554 and European Union funded project ‘environMEN- (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00431-023-04966-6",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00431-023-05351-z",TRUE,"Competing interests U.B. received research grants from the Federal Ministry of Education and Research (BMBF) the BMG the Bavarian State Ministry of Health and Care (StMGP) the Bavarian State Ministry of Science and the Arts (StMWK) the German Center for Infection Research (DZIF) the People for Children (Menschen für Kinder) foundation the WZS the LVS and the ME/CFS research foundation (ME/CFS RF). C.S. was consulting Roche Celltrend and Bayer; she received support for clinical trials by Bayer Fresenius and Miltenyi honoraria for lectures by Fresenius AstraZeneca BMS Roche Bayer and Novartis and research grants from the German Research Association (DFG) the BMBF the BMG the WZS the LVS and the ME/CFS RF. The other authors declare no conflict of interest.",TRUE,"<section> Acknowledgements We thank all patients who participated in the project as well as their families for supporting the participation. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Bavarian State Ministry of Health and Care (StMGP) the Federal Ministry of Health (BMG) as well as the Weidenhammer-Zoebele and the Lost Voices foundations C.S. was consulting Roche Celltrend and Bayer; she received support for clinical trials by Bayer Fresenius and Miltenyi honoraria for lectures by Fresenius AstraZeneca BMS Roche Bayer and Novartis and research grants from the German Research Association (DFG) the BMBF the BMG the WZS the LVS and the ME/CFS RF.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-022-04459-3",TRUE,"Conflict of interest F Lordick reports study funding from Astellas Pharma Inc.; grants from BMS and MSD (to institution); consulting fees from Amgen Astellas AstraZeneca BMS Daiichi Sankyo Eli Lilly MSD Roche and Zymeworks; payments or honoraria from Amgen Astellas AstraZeneca BMS Eli Lilly MSD and Roche; travel support from BMS and Roche; advisory board participation for BioNTech; and leadership or fiduciary role in the European Society for Medical Oncology (unpaid) and the International Gastric Cancer Association (unpaid).",TRUE,"Acknowledgements Financial support for this manuscript including writing and editorial assistance by Laurie LaRusso MS ELS and Carol Cadmus ELS (Peloton Advantage LLC an OPEN Health company Parsippany NJ USA) was provided by Astellas Pharma Inc. Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by Ganymed Pharmaceuticals GmbH (formerly Ganymed Pharmaceuticals AG) a wholly owned subsidiary of Astellas Pharma Inc. Declarations Conflict of interest F Lordick reports study funding from Astellas Pharma Inc.; grants from BMS and MSD (to institution); consulting fees from Amgen Astellas AstraZeneca BMS Daiichi Sankyo Eli Lilly MSD Roche and Zymeworks; payments or honoraria from Amgen Astellas AstraZeneca BMS Eli Lilly MSD and Roche; travel support from BMS and Roche; advisory board participation for BioNTech; and leadership or fiduciary role in the European Society for Medical Oncology (unpaid) and the International Gastric Cancer Association (unpaid).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04578-5",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04600-w",TRUE,"Conflict of interest The authors have non-relevant financial or nonfinancial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the German Cancer Aid (Grant number 107465) within the psychosocial oncology funding priority program.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04601-9",TRUE,"Conflict of interest The authors have no competing interests to declare.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The modeling work (Yuri Kheifetz and Markus Scholz) was performed in the framework of “ChemoTox-AI” a project funded by the German Federal Ministry of Education and Research (BMBF) within the Computational Life Science line of funding (Grant No.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04632-2",TRUE,"Conflict of interest The authors declare that they had no conflicts of interest in preparing the present work.",TRUE,"<section> Acknowledgements We greatly acknowledge support by Eva Dreyer (Department of Pathology University Hospital Lübeck) for producing the TMAs and performing the immunohistochemistry. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04647-9",TRUE,"Conflict of Interest We declare the following potential conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by GlaxoSmithKline GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04711-4",TRUE,"Conflict of interests The authors declare no conflict of interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04809-9",TRUE,"Conflict of interest The authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This project was funded by the Else-Kröner-Fresenius-Stiftung",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04937-2",TRUE,"Conflict of interest L.K. receives honoraria from AMGEN outside of the here mentioned word. All other authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-04979-6",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"We acknowledge grant support by the Charité Clinical Scientist Program funded by the Charité—Universitätsklinikum Berlin and the Berlin Institute of Health (E.K.). <section> Funding Open Access funding enabled and organized by Projekt DEAL. This research received funding by the Deutsche Forschungsgemeinschaft Si1983-4/1.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00432-023-05062-w",TRUE,"Conflict of interest No I declare that the authors have no competing interests as defined by Springer or other interests that might be perceived to influence the results and/or discussion reported in this paper.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-05145-8",TRUE,"Conflict of interest The authors declare that they have no conflicts of interest.",TRUE,"<section> Funding acquisition: TL JG. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the “Lübeck-Hilfe für krebskranke Kinder e.V.”.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00432-023-05180-5",TRUE,"Conflict of interest G.",TRUE,"A basic comparability and above all reproducibility of the results for the antibodies and platforms used and validated in the various clinical studies is given which is also supported by the results of one of the first published harmonization studies in gastric carcinoma (22C3 SP263) (Dabbagh and Sughayer 2021). <section> Funding Open Access funding enabled and organized by Projekt DEAL. GmbH; research projects are supported by Bristol-Myers Squibb GmbH und Co. A. Roche Deutschland Holding GbmH Saladax Biomedical SanofiAventis Deutschland GmbH Servier Deutschland GmbH and Synlab Holding Deutschland GmbH; research projects are supported by Bristol-Myers Squibb GmbH & Co.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-05182-3",TRUE,"Disclosure and sources In line with these results the systematic review of Davis Oh Butow et al. stated that one study had found the highest rates of disclosure for naturopathy (Davis et al. 2012). By increasing inquiry and displaying interest and the willingness to listen the participating centers increased the rate of disclosure (Davis et al. 2012). With non-disclosure being very common (Akeeb et al. 2022; Lederer et al. 2021) and patients using sources such as the internet or seminars frequently the question rises of how well information about scientific evidence and potential risks is provided by these sources. <section> As a consequence patients that use CAM or would be interested in consultation could be overlooked as a main reason for non-disclosure is non-inquiry (Davis et al. 2012; Wode et al. 2019) indicating the necessity to actively ask patients about their CAM usage. <section> In our study the prevalence of CAM use was high as well as rates of non-disclosure and insufficient knowledge of potential risks within CAM use. A standardized questionnaire may increase the rate of disclosure and induce safer usage behavior. <section> Conflict of interest The authors declare that they have no conflict of interest. <section> Evid Based Complement Alternat Med 2013:383142 Davis EL Oh B Butow PN Mullan BA Clarke S (2012) Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-05193-0",TRUE,"Conflict of interest L.L.M. is a Senior Editor of the Editorial Board of Cancer Epidemiology Biomarkers & Prevention. E.G. is funded as a Clinical Research Professor from the American Cancer Society (CRP23–1014041) and is a member of the Editorial Board of Cancer Epidemiology Biomarkers & Prevention. All of the other authors declare no potential conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors received no specific funding for this work. <section> Funding. E.G. is funded as a Clinical Research Professor from the American Cancer Society (CRP23–1014041) and is a member of the Editorial Board of Cancer Epidemiology Biomarkers & Prevention.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-05449-9",TRUE,"Conflict of interest DK received travel grants from Accuracy and is a member of the advisory board for Novocure; he has no competing interests related to the presented work. The other authors declare that they have no competing interest related to the presented work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00432-023-05507-2",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the German Cancer Aid (Deutsche",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00436-023-07878-4",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00439-023-02528-2",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"This work was supported by the India Alliance through Center for Rare Disease Diagnosis Research and Training (IA/CRC/20/1/600002) to K.M.G. by the National Institutes of Health USA (1R01HD093570-01A1) to A.S. and K.M.G. by the German Research Foundation (DFG Deutsche Forschungsgemeinschaft) under Germany’s Excellence Strategy (EXC 2067/1390729940) the DZHK (German Centre for Cardiovascular Research; partner site Göttingen) and by the Niedersächsisches Ministerium für Wissenschaft und Kultur (grant ZN3136) to B.W. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00441-023-03757-7",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Studies were funded in part by a grant from the Deutsche Forschungsgemeinschaft (CH 1838/1–1) to AC.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-09911-0",TRUE,"Disclosures Drs. Jin-On Jung Eline M de Groot B Feike Kingma Benjamin Babic Jens P Hölzen Jan W Haveman Philippe Rouanet Frank Benedix Hecheng Li Inderpal Sarkaria Gijs I van Boxel Philip Chiu Jan-Hendrik Egberts Rubens Sallum Arul Immanuel Paul Turner Donald E Low Michal Hubka Paolo Strignano Matthias Biebl and M Asif Chaudry have no conflicts of interest or financial ties to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-09933-8",TRUE,"Disclosure Christian A. Gutschow received consulting fees and/or honoraria from Medtronic B. Braun BD/Bard medical and MicroTech Europe GmbH and third party funding for his institution from B.Braun. Stephan Gerdes Sebastian F. Schoppmann and Beat P. <section> Müller-Stich have no conflict of interest or financial ties to disclose.",TRUE,"<section> Funding Open access funding provided by University of Zurich.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-09964-1",TRUE,"Disclosure The authors Matthäus Felsenstein Ann-Christin Amini Sophie Dorfer Mengwen Hu Ruonan Wang Lea Timmermann Karl Herbert Hillebrandt Christian Benzing Uli Fehrenbach Uwe Pelzer Igor Maximillian Sauer Johann Pratschke Christian Jürgensen Thomas Malinka declare no conflict of interest or financial ties related to the study.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-09996-7",TRUE,"Disclosures Professor JP: received a research grant from Intuitive Surgical Deutschland GmbH for the conduction of the present study. <section> Furthermore he reports personal fees or other support from Johnson & Johnson Medtronic Astellas CHG Meridian AFS Medical Chiesi Falk Foundation Neovii NOGGO pharma-consult Peterson La Fource Group Merck and promedicis. Professor MS: reports personal fees or non-financial support outside of the submitted work from Merck Serono GmbH Bayer AG ERBE Elektromedizin GmbH Amgen Inc. Johnson&Johnson Medical GmbH ERBE Elektromedizin GmbH Takeda Pharmaceutical Limited Olympus K.K. Medtronic GmbH Intuitive Surgical Inc. Drs. NN LF SK FK NR GL and Professor WS have no conflicts of interest or financial ties to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Disclosures Professor JP: received a research grant from Intuitive Surgical Deutschland GmbH for the conduction of the present study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-10028-7",TRUE,"Disclosures (i) Dr Brian Goh has received travel grants and honorarium from Johnson and Johnson and Transmedic the local distributor for the Da Vinci Robot. (ii) Dr Marco Marino is a consultant for CAVA robotics LLC. (iii) Johann Pratschke reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or non-financial support from Johnson & Johnson Medtronic AFS Medical Astellas CHG Meridian Chiesi Falk Foundation La Fource Group Merck Neovii NOGGO pharma-consult Peterson and Promedicis. (iv) Moritz Schmelzle reports personal fees or other support outside of the submitted work from Merck Bayer ERBE Amgen Johnson & Johnson Takeda Olympus Medtronic Intuitive. (v) Drs Felix Krenzien Nicholas Syn Iswanto Sucandy Adrian Chiow Mikel Gastaca Xiaoying Wang <section> Jae Hoon Lee Charing Chong David Fuks Gi-Hong Choi Mikhail Efanov Peter Kingham Mathieu D’Hondt Roberto Troisi Sung-Hoon Choi Robert Sutcliffe Rong Liu Cheung Tan To Chung Ngai Tang and Ho Seong Han have no conflicts of interest to declare.",TRUE,"T. P. Kingham was partially supported by the US National Cancer Institute MSKCC Core Grant Number P30 CA008747 for this study. <section> Disclosures (i) Dr Brian Goh has received travel grants and honorarium from Johnson and Johnson and Transmedic the local distributor for the Da Vinci Robot. (ii) Dr Marco Marino is a consultant for CAVA robotics LLC. (iii) Johann Pratschke reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or nonfinancial support from Johnson & Johnson Medtronic AFS Medical Astellas CHG Meridian Chiesi Falk Foundation La Fource Group Merck Neovii NOGGO pharmaconsult Peterson and Promedicis. (iv) Moritz Schmelzle reports personal fees or other support outside of the submitted work from Merck Bayer ERBE Amgen Johnson & Johnson Takeda Olympus Medtronic Intuitive. (v) Drs Felix Krenzien Nicholas Syn Iswanto Sucandy Adrian Chiow Mikel Gastaca Xiaoying Wang",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-10051-8",TRUE,"Disclosures Dr Goh BK has received travel grants and honorarium from Johnson & Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot. Federica Cipriani Qu Liu Luca Aldrighetti Rong Liu and Ho-Seong Han have no conflicts of interest or financial ties to disclose.",TRUE,"<section> Funding Dr T. P. Kingham was partially supported by the US National Cancer Institute MSKCC Core Grant number P30 CA008747 for this study. <section> Disclosures Dr Goh BK has received travel grants and honorarium from Johnson & Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-10144-4",TRUE,"Disclosure Manuel Jakob Adriana Brüggemann Nina Moser Daniel Candinas Guido Beldi and Tobias Haltmeier have no conflicts of interest or financial ties to disclose.",TRUE,"<section> Funding Open access funding provided by University of Bern.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00464-023-10300-w",TRUE,"Disclosures Wing Tech Inc. Ryschon report no other relevant conflicts of interest. Karim Alavi and Niels Komen have no conflicts of interest or financial ties to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00467-023-06058-x",TRUE,"Conflict of interest Dieter Haffner received speaker fees and research grants from Horizon and Chiesi. Jun Oh received speaker fees from Horizon and Chiesi. Burkhard Tönshoff participated in advisory boards for Chiesi. Julia Thumfart received speaker fees from Horizon. <section> Lutz T. Weber received speaker fees from Chiesi. KH was supported by the Cystinosis Foundation Germany. <section> All other authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by a research grant from Horizon USA to Dieter Haffner.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00520-022-07543-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This research was financially supported by Primavera.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00520-023-07701-x",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Our study was funded by grants from the José Carreras Leukämie-Stiftung (grant DJCLS R 14/18).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00520-023-07871-8",TRUE,"Conflict of interest Claudia M. Witt reports personal fees from Hospitals in Switzerland grants from Krebsforschung Schweiz grants from Kelm-Foundation grants from CERES from Deutsche Krebsliga outside the submitted work and received honoraria from hospitals for scientific presentation on the evidence of Integrative Oncology. The rest of the authors declare no conflict of interests.",TRUE,"<section> We would also like to thank all the cancer services from the different hospitals for supporting the recruitment of the interview partners. <section> Funding Open access funding provided by University of Lausanne This work was supported by the Fondation Leenaards.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07544-4",TRUE,"Conflict of interests Authors DAA LAS LO HH MM JZ and JS have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding No funds grants or other support was received for the submitted",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07570-2",TRUE,"Conflict of interest LO IO CMJ SNS JS EC DAA and MM have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding This research received no specific Grant from any funding agency in the public commercial or notfor-profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07579-7",TRUE,"Conflict of interest Authors DAA CE LO HH MM ETT and JS have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding No funds grants or other support was received for the submitted",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07589-5",TRUE,"Conflict of interest The authors declare that there is no conflict of interest concerning materials or methods used in this study or the findings specified in this paper.",TRUE,"<section> Funding Research reported in this publication was supported by the National Center for Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07654-z",TRUE,"Conflict of interest The authors declare that there is no conflict of interest concerning materials or methods used in this study or the findings specified in this paper. <section> Disclosures Dr.",TRUE,"Our study however did not find a significant correlation between LL and vBMD which is supported by Papadakis et al. who did not report significant associations between LL and spine aBMD [39]. <section> Funding Research reported in this publication was supported by the National Center for Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07783-5",TRUE,"Conflict of interest The authors declare that there is no conflict of interest concerning materials or methods used in this study or the findings specified in this paper. <section> Disclosure Dr.",TRUE,"<section> Funding The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07814-1",TRUE,"Conflict of interest Dr.",TRUE,"<section> Funding No funds grants or other support was received for the submitted",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07846-7",TRUE,"Conflict of interest The Authors declare that there is no conflict of interest regarding this work.",TRUE,"<section> Funding Research reported in this publication was supported by the National Center for Advancing Translational Science of the National Institute of Health Under Award Number UL1TR002384.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07858-3",TRUE,"Conflict of interest Vincent J. Heck Bastian Himpe Juan M. VinasRios Tobias Prasse Michael J. Pflüger Sven Schmidt and Michael Rauschmann declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements We thank Kristina Klug MSc Goethe University Frankfurt Department of psychology for supporting the authors with the statistical analysis. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-07871-6",TRUE,"Conflict of interest The Authors declare that there is no conflict of interest concerning materials or methods used in this study or the findings specified in this paper.",TRUE,"<section> Funding The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00586-023-07921-z",TRUE,"Conflict of interest There are no relevant conflicts nor competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00586-023-08050-3",TRUE,"Conflict of interest All authors declare that there are no financial or personal relationships with other persons or organizations that could have inappropriately influenced this study.",TRUE,"These findings are supported by the Bland and Altman limit of agreement which indicate that the agreement between the two software programs is acceptable and they can be used interchangeably. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was financially supported by the German Research",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00592-023-02187-9",TRUE,"Conflict of interest The authors declare that they have no conflict of interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-022-05469-3",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-022-05470-w",TRUE,"Competing interests No competing interests exist in the submission of the manuscript and the manuscript is approved by all authors for publication.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No special funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-023-05512-x",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-023-05683-7",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-023-05729-w",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Supported by the Ministry of Health of the Czech Republic Grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00701-023-05791-4",TRUE,"Conflict of interest The authors declare that there is no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE
"10.1007/s00702-023-02607-8",TRUE,"Conflict of interest The author(s) declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements We acknowledge support by the Open Access Publication Funds of the Georg-August-University Göttingen University. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the “Alzheimer Stiftung Göttingen” to CB and YB. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) for PET/MRI use (INST 335/454-1FUGG).",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00702-023-02719-1",TRUE,"Conflict of interest The authors declare that they were not guided by any economic interests when creating the article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00705-023-05797-4",TRUE,"Conflict of interest The authors declare no conflicts of interest.",TRUE,"<section> Funding F.M.Z. acknowledges financial support from Capes (Finance code 01) CNPq and Fapemig. Biotechnology and Biological Sciences Research Council (BBSRC); this research was funded in part by the BBSRC Institute Strategic Programme Gut Microbes and Health BB/R012490/1 and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356. B.E.D. is supported by the European Research Council (ERC) Consolidator grant 865694: DiversiPHI the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany's Excellence Strategy – EXC 2051 – Project-ID 390713860 and the Alexander von Humboldt Foundation in the context of an Alexander von HumboldtProfessorship funded by the German Federal Ministry of Education and Research. This work was supported in part through Laulima Government Solutions LLC prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. H.M.O. was supported by the University of Helsinki and Academy of Finland by funding for FINStruct and Instruct Centre FI part of Biocenter Finland and Instruct – ERIC. D.B.S. is supported by the Microbiology Society. <section> E.J.L D.M.D. and R.C.H were supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U24AI162625.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-022-04827-w",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was financially supported by “Verein für angeborene Stoffwechselstörungen (VfASS) e.V” and “Nutricia Milupa GmbH.”",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05057-4",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05095-y",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding The study was funded by the Department of Oral & Maxillofacial Surgery Medical University of Vienna Austria.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05096-x",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05178-w",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05198-6",TRUE,"Conflict of interest The authors declare no conflicts of interest.",TRUE,"<section> The aim of this retrospective investigation was to evaluate and compare clinical radiological and esthetic outcomes of prosthodontic rehabilitations supported by RAIs or natural roots after FOE. <section> To the best knowledge of the authors the present study is the first that compares restorations supported by RAIs or natural roots preserved by means of FOE. <section> Acknowledgements This investigation was supported by clinical data from the private dental office of Dr. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00784-023-05392-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Supported by the institution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00787-021-01920-5",TRUE,"Conflict of interest Not applicable.",TRUE,"<section> Funding The study was supported by an operational grant awarded to Dr.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00787-021-01926-z",TRUE,"Conflict of interest This project is funded by the Innovationsfonds and German Ministry of Health [grant number 01VSF16061]. The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Conflict of interest This project is funded by the Innovationsfonds and German Ministry of Health [grant number 01VSF16061].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00787-023-02147-2",TRUE,"Conflict of interest None.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Berlin University Alliance (PIs Sibylle M.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s00787-023-02179-8",TRUE,"Conflict of interest The MEHIRA project was funded by the Innovationsfond and German Ministry of Health [grant number 01VSF16061]. <section> All authors declare to have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Funding was provided by Innovationsfond and German Minis- <section> Conflict of interest The MEHIRA project was funded by the Innovationsfond and German Ministry of Health [grant number 01VSF16061].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s00787-023-02291-9",TRUE,"Conflict of interest The authors declare that they do not have any conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The studies as part of SKKIPPI project are supported by a grant from the Innovationsfonds/GBA Germany (No 01 VSF17027).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10014-023-00468-3",TRUE,"Conflict of interest DK received travel grants from Accuray and is a member of the advisory board for Novocure he has no competing interest related to the presented work. DC declared a patent pending for a method to classify tumors according to DNA methylation signatures. <section> The other authors declare that they have no competing interest related to the presented work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02799-8",TRUE,"Conflict of interest Dr.",TRUE,"<section> Funding Dr.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02838-4",TRUE,"Conflict of interests None.",TRUE,"<section> The study was registered with the German Clinical Trials Registry (DRKS00017410) and funded by the 2020 Research Grant from the European Hernia Society. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the Research Grant 2020 of the European Hernia Society.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02860-6",TRUE,"Conflict of interest All authors declare that they have no financial or non-financial interests that are directly or indirectly related to the submitted",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02862-4",TRUE,"Conflict of interest Dr.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02866-0",TRUE,"Competing interests FK personal fees from BD Heidelberg outside the submitted work. All other authors declare that he/she has no known competing financial interests or personal relationships that could have appeared to influence the study reported in this article.",TRUE,"<section> Funding Open access funding provided by University of Luzern.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02897-7",TRUE,"Conflict of interest The other authors declare that there is no conflict of",TRUE,"Kallinowski received financial and material support by Baxter Becton Dickinson Corza Medical Dahlhausen Ethicon FEG GEM Medtronic Olympus and pfm medical based on a Third-Party-Funding-Agreement with the Heidelberg University and/or with Asklepios proresearch. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors would like to thank for the financial support by the Heidelberger Stiftung Chirurgie (Grants 2016/22 2017/171 2018/215 2019/288 2020/376 and 2021/444).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10029-023-02901-0",TRUE,"Conflict of interest Prof.",TRUE,"<insert> References Access route for hernia surgery Bleeding Yes No Seroma Yes No Prolonged ileus or obstruction Yes No Bowel injury/anastomotic insufficiency Yes No Wound healing disorder Yes No Infection Yes No Minimally invasive Open n % n % 1.3 98.7 1.3 98.7 2.5 97.5 3.4 96.6 3.4 96.6 0.5 99.5 2.6 97.4 0.8 99.2 Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10067-023-06623-7",TRUE,"Competing Interests Eric L Matteson reports royalties from UpToDate; consulting fees from Alvotech and Boehringer Ingelheim (BI); fees for speaking from BI and Practice Point Communications; has participated on Data Safety Monitoring Boards or Advisory Boards for Horizon Therapeutics and the National Institutes of Health (NIH)/ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); has served on a Committee/Task Force for the American College of Rheumatology.",TRUE,"<section> Funding The INBUILD trial was supported by Boehringer Ingelheim International GmbH (BI).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10067-023-06649-x",TRUE,"Competing interests RA has received consulting fees from AbbVie Bristol Myers Squibb Celltrion Galapagos Gilead Janssen Lilly Novartis Pfizer and Roche; and has received grant/research support from Bristol Myers Squibb Galapagos Gilead Janssen Lilly Novartis Pfizer and Roche. BB PP AF and HN declare no competing interests.",TRUE,"<section> Funding This study was sponsored by Bristol Myers Squibb.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10067-023-06814-2",TRUE,"Competing interests FB reports receiving honoraria and grant/study support from medac Hexal and Pfizer.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was supported by medac GmbH which was involved in the design of the study interpretation of the data and writing of the manuscript.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10072-023-06598-y",TRUE,"Competing interests AAK reports honoraria and non-financial support from Medtronic honoraria from Boston Scientific Ipsen Pharma and Abbott.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10072-023-06616-z",TRUE,"Conflict of interest The authors declare that they have no financial or non-financial conflicts of interest to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10143-023-01962-0",TRUE,"Competing interests Nora F.",TRUE,"The German health system is mainly funded by the government. <section> Funding Open Access funding enabled and organized by Projekt DEAL. Dengler received public body funding from the European Commission for the project Go Safe.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10143-023-02107-z",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10143-023-02114-0",TRUE,"Competing interests DF reported receiving personal fees from and holding an equity interest in ai4medicine outside the submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. ND was funded by the institutional Rahel Hirsch and Lydia Rabinowitsch scholarships received public body funding for the project GoSafe (Horizon 2020) accepted speaker honoraria from Integra LifeSciences and serves as an advisor for Alexion Pharmaceuticals.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10143-023-02163-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10237-022-01682-2",TRUE,"Conflict of interest The authors that they have no conflict of interest.",TRUE,"<section> Acknowledgements The research reported in this publication is supported financially by the Organization for Women in Science for the Developing World (doctoral scholarship to RA) the European Mathematical Society (collaborative research visit award to RA) the South African Medical Research Council (grant SIR 328148 to TF) and the National Research Foundation of South Africa (grants UID92531 and CPRR14071676206 to TF).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10238-023-01077-2",TRUE,"Conflict of interest Stefano Iacobelli and Roberta Gentile are employees of MediaPharma SrL. The other authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by funding from the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) to C.G. L.B.D.J. is supported by the BIH Clinician Scientist program. NAKO is funded by the German Federal Ministry of Education and Research (BMBF project funding reference numbers: 01ER1301A/B/C and 01ER1511D) federal states and the Helmholtz Association with additional financial support by the participating universities and the institutes of the Leibniz Association.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10238-023-01141-x",TRUE,"Conflict of interest The authors have no competing interests to declare.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. No funds grants or other support was received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10238-023-01166-2",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10304-023-00520-7",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10334-023-01075-1",TRUE,"Conflict of interest Thoralf Niendorf is founder and CEO of MRI.",TRUE,"<section> Acknowledgements This project has received funding in part (BN TWE TN) from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement No 743077 (ThermalMR). <section> Funding Open Access funding enabled and organized by Projekt DEAL.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10389-021-01566-2",TRUE,"Conflict of interest None declared.",TRUE,"Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10389-023-01845-0",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> To answer the research questions a systematic review was conducted as part of the research project 01EL2021 funded by the German Federal Ministry of Education and Research. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10456-023-09881-w",TRUE,"Competing interests The authors have no personal financial or institutional interest in any of the drugs materials or devices described in this manuscript.",TRUE,"Funding This work was supported by the Barrow Neurological Foundation Leducq Foundation (ATTRACT) and the Department of Defense (PR161205).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10508-023-02652-0",TRUE,"Conflict of interest Kathlen Priebe Meike Müller-Engelmann Regina Steil receive honoraries for workshops and talks on DBT-PTSD and CPT.",TRUE,"The RELEASE study is a multicentre study funded by the German Federal Ministry for Education and Research. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The Release study was funded by the German Federal Ministry of Education and Research (01KR1303B).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10508-023-02662-y",TRUE,"Competing interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> The study was funded by research grants from the German Ministry of Justice (Grant numbers Z A 6—5206 I (863)—Z2 806/2007 and IIA62514BMJ011) the Senatsverwaltung für Justiz Berlin (Grant numbers P751/CHI0001 and P751/CHI0002) and the GKV Spitzenverband.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10508-023-02726-z",TRUE,"Conflicts of Interest The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the H.W.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10544-023-00676-w",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10548-023-00945-0",TRUE,"Disclosure of Potential Conflicts of Interest The authors declare that they have no known conflict of interest either financially or personally that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding Statement This work was supported by funding from EPSRC [EP/M001393/1] and core funding from the Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]. M.S. was supported by a Research grant of the Epilepsy Academy Berlin-Bethel body of the v.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10549-022-06827-6",TRUE,"Conflict of interest G Velikova: Personal Fees from Roche Eisai Novartis Seattle Genetics Sanofi; Grants from Breast Cancer Now EORTC Yorkshire Cancer Research Pfizer IQVIA (all outside the submitted work). F Cardoso: Consultancy role for: Amgen Astellas/ Medivation AstraZeneca Celgene Daiichi-Sankyo Eisai GE Oncology Genentech Gilead GlaxoSmithKline Iqvia Macrogenics Medscape Merck-Sharp Merus BV Mylan Mundipharma Novartis Pfizer Pierre-Fabre prIME Oncology Roche Sanofi Samsung Bioepis Seagen Teva Touchime (all outside the submitted work). T Stamm: grants and personal fees from AbbVie Roche Sanofi Takeda and Novartis (all outside the submitted work). M Karsten: received speaker honorary from Roche and Astra Zeneca no relationships or activities potentially influencing the submitted work. L Travado: member of the ECIBC expert group (European Commission Initiative on Breast Cancer) and member of the ABC Global Alliance. N Carney: is an employee and shareholder of F.Hoffmann-La Roche Ltd. BH de Rooij E Hedayati VR Smaardijk N Carney Y Seidler TA Stamm LB Koppert LV van de Poll-Franse are members of the H2O Health Outcomes Observatory (H2O). The other authors (KL AI CS YS YW EH) declare they have no conflict of interest to report.",TRUE,"<section> Funding This work was supported by the Innovative Medicines Initiative (IMI) 2 Joint Undertaking under grant agreement No 945345-2.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10549-023-06999-9",TRUE,"Competing interests S. Kuemmel reports personal fees/travel support from Lilly MSD Astra Zeneca Pfizer Novartis Amgen Somatex pfm medical Daiichi Sankyo Seagen Gilead Science Agendia Exact Science Roche Sonoscape as well as uncompensated relationships/ activities with AGO WSG ESMO. M. Gnant reports personal fees/ travel support from AstraZeneca DaiichiSankyo EliLilly MenariniStemline MSD Novartis PierreFabre Veracyte; an immediate family member is employed by Sandoz. A. Mueller reports personal fees/ travel support from Amgen AstraZeneca Bayer Daiichi-Sankyo Exact Sciences Gilead GlaxoSmithKline Lilly MSD Myriad Genetics Novartis Pierre Favre Pfizer Roche Tesaro. S. Muenst reports advisory role for GSK Diaceutics and Novartis. C. Kurzeder reports honoraria from Tesaro GSK Astra Zeneca Novartis PharmaMar Genomic Health Roche Eli Lilly S.A. Pfizer Daichi; consulting or advisory role for Tesaro GSK Astra Zeneca Novartis PharmaMar Genomic Health Roche Eli Lilly S.A. Merck MSD Pfizer and travel accommodations and expenses from GSK Astra Zeneca and Roche. W.P. Weber received research support from Agendia paid to the University Hospital Basel for the TAXIS study (OPBC-03 SAKK 23/16 IBCSG 57-18 ABCSG-53 GBG 101). All other authors report no conflicts of interest.",TRUE,"<section> Funding The trial was supported by research agreements with the following institutions: Swiss State Secretary for Education Research and Innovation (SERI) Swiss Cancer Research Foundation (SCR) and Swiss Cancer League (SCL) as well as Agendia. It was also supported by grants from the following organizations: Fond’Action contre le cancer Rising Tide Foundation for Clinical Cancer Research (RTFCCR) Cancer League Basel Claudia von Schilling Foundation for Breast Cancer Research Kaempf-Bötschi Foundation Cancer League Zentralschweiz Cancer League Thurgau Cancer League Wallis Cancer League Aargau Giuliana und Giorgio Stefanini Foundation Miaso foundation Krebsbekämpfung Foundation Moritz Straus-Foundation Freiwillige Akademische Gesellschaft (FAG) Association Marianne Payot J&K Wonderland Foundation SANA Foundation Fondation pour la Recherche et le Traitement Médical SPS Foundation and Domarena Foundation. Weber received research support from Agendia paid to the University Hospital Basel for the TAXIS study (OPBC-03 SAKK 23/16 IBCSG 57-18 ABCSG-53 GBG 101).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10571-023-01351-7",TRUE,"Competing interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10571-023-01405-w",TRUE,"Competing interests financial interests to disclose.",TRUE,"<section> Funding The authors were received during the",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10578-023-01506-z",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the German Federal Ministry of Health (ZMVI1-2520FSB901).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10584-023-03543-y",TRUE,"The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10637-023-01383-2",TRUE,"Competing interests Alexandra Leary has grants or contracts from Agenus Astra Zeneca BMS GSK Iovance MSD OSE Immuno Roche as principal investigator in clinical trials and from ARCAGY -GYENCO AZ Sanofi for translational research; has payment as invited speaker from Astra Zeneca Clovis GSK Kephren publishing Medscape; payment for consultancy from GLG and Orion and payment for writing engagement from Onko+; has participation in Advisory Boards from Ability Pharma Apmonia Astra Zeneca Blueprint Clovis GSK Merck Serono MSD Tesaro and Zentaris; has participation in a steering committee from MSD; was IDMC member or chair for Clovis and Pfizer; and participated in an Academic Research Project for LX Repair and Owkin. <section> disclosures.",TRUE,"<section> Funding The study was funded by Pharma Mar S.A including partial funding by grants from the Centro para el Desarrollo Tecnológico Industrial (CDTI) during the conduct of the study (grant number IDI20150006). VS is supported by a US National Institutes of Health (NIH) grant (no. R01CA242845 and R01CA273168); MD Anderson Cancer Center Department of Investigational Cancer Therapeutics is supported by the Cancer Prevention and Research Institute of Texas (no. RP1100584) the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (no. 1U01 CA180964) NCATS (Center for Clinical and Translational Sciences) Grant (no. UL1 Vivek Subbiah received grants from PharmaMar Eli Lilly/ LOXO Oncology Blueprint Medicines Corporation Turning PointTherapeutics and Boston Pharmaceuticals; and grants fromHelsinn Pharmaceuticals during the conduct of the study; in addition Vivek Subbiah received a grant and advisory board/consultant position with Eli Lilly/Loxo Oncology during the conduct of the study; research grants from Roche/Genentech Bayer GlaxoSmithKline Nanocarrier Vegenics Celgene Northwest Biotherapeutics Berghealth Incyte Fujifilm D3 Pfizer Multivir Amgen AbbVie Alfasigma Agensys Boston Biomedical Idera Pharma Inhibrx Exelixis Blueprint Medicines Altum Dragonfly Therapeutics Takeda National Comprehensive Cancer Network NCI-CTEP University of Texas MD Anderson Cancer Center Turning Point Therapeutics Boston Pharmaceuticals Novartis PharmaMar and Medimmune; an advisory board/consultant position with Helsinn Incyte QED Pharma Daiichi-Sankyo Signant Health Novartis Relay therapeutics Roche and Medimmune; travel funds from PharmaMar Incyte ASCO ESMO; and other support from Medscape all outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10637-023-01402-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding B.B. was financially supported by a grant from Bayern Innovativ Gesellschaft für Innovation und Wissenstransfer mbH (No. L.T. was financially supported by a grant from the Deanship of Scientific Research the Hashemite University (No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10653-023-01550-7",TRUE,"Conflict of interest The authors have not disclosed any competing interests.",TRUE,"<section> Funding The research was financially supported by the Ministry of Science and Higher Education of the Russian Federation project on the development of the Young Scientist Laboratory (no. LabNOTs-21-01AB). The research was supported by the Strategic Academic Leadership Program of the Southern Federal University (“Priority 2030”).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10654-023-00973-x",TRUE,"Conflict of interest The authors have no disclosures to report.",TRUE,"<section> Funding Open access funding provided by University of Bern. This project has received funding from: (i) European Union's Horizon 2020 research and innovation programme under grant agreement No. 101017915 and (ii) Swiss National Science Foundation (SNF): #320030_176216.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol was registered with the international prospective register of systematic reviews (PROSPERO) with ID: CRD42021257478.",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s10654-023-00990-w",TRUE,"Conflict of interests Daniel Maier (DM) received speaker honoraria from Free University of Berlin.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was partly funded by the German Cancer Consortium (DKTK). The DKTK is funded as one of the National German Health Centers by the Federal German Ministry of Education and Research (BMBF).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10741-023-10316-3",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10787-023-01174-4",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10875-023-01450-6",TRUE,"Conflict of Interest MA reports activity as a consultant for CSL Orchard Therapeutics and FORGE.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Fabian Hauck and Stephan Ehl are funded by the German Federal Ministry of Education and Research (BMBF 01GM1910C). Kreins is supported by the Wellcome Trust (222096/Z/20/Z). The work at Great Ormond Street Hospital was supported by LetterOne in conjunction with Great Ormond Street Hospital Children’s Charity and by the UK National Institute of Health Research and Great Ormond Street Biomedical Research Centre.",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10875-023-01468-w",TRUE,"Conflict of Interest VMC is named together with Charité—Universitätsmedizin Berlin and Euroimmun GmbH on a patent application (Methods and reagents for diagnosis of SARS-CoV-2 infection.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The work of VMC was supported by the German Ministry of Education and Research through the project VARIPath (01KI2021).",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10875-023-01470-2",TRUE,"Competing Interests Michael Borte’s institution has received research grant support from CSL Behring Octapharma and Baxalta.",TRUE,"<section> Funding This study was a collaborative research project between Baxalta Innovations GmbH a Takeda company and GWT-TUD GmbH Dresden Germany.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration number ClinicalTrials.gov NCT03054181",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s10875-023-01472-0",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"The HPO is an international ontology developed by the Monarch initiative funded by the National Institute of Health of the USA [6]. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The GAIN registry is supported by the Center for Chronic Immunodeficiency and since 2019 funded by the Federal Ministry of Education and Research (BMBF funding code 01GM1910A). <section> The documentation specialist S.E-H. was funded by the Federal Ministry of Education and Research (BMBF Support Code: 01GM1517C) by the European Society for Immunodeficiencies (ESID) 2018 by the Carefor-Rare Foundation by PROimmun e.V. and by a restricted grant from LFB CSL Behring and Grifols.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10875-023-01570-z",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding This research was partly supported by the National Institute of Allergy and Infectious Diseases Division of Intramural Research (NIAID DIR) at the National Institutes of Health (NIH).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10877-022-00967-2",TRUE,"Conflict of interest Andreas Meiser MD PhD: received consulting fees from Sedana Medical (Danderyd Sweden) and honoraria for lectures from Pall Corporation (Dreieich Germany).",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10877-023-01101-6",TRUE,"Conflict of interest MW serves as a consultant for medical device industries and has received consultant honoraria from BD.",TRUE,"<section> Funding Open access funding provided by University of Zurich. The authors declare that no other support funds or grants were received for conducting the study and preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10880-023-09937-5",TRUE,"Conflict of interest SRK is an invited speaker at conferences co-organised by Coeliac Australia (a charity) and is a Member of the Medical Advisory Committee for Glutagen Pty Ltd. SM has no sources of funding and disclosure of interests to declare. NF has no sources of funding and disclosure of interests to declare.",TRUE,"<section> Funding Open Access funding enabled and organized by CAUL its Member Institutions. SM has no sources of funding and disclosure of interests to declare. NF has no sources of funding and disclosure of interests to declare.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10903-023-01480-7",FALSE,"",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s10916-023-01977-6",TRUE,"Conflicts of Interest The authors declare not conflict of interest.",TRUE,"Funding This publication was not financially supported.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10916-023-02012-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> One of the COVID-19-focused European Commission funded research projects is ORCHESTRA. <section> Funding The ORCHESTRA project is funded under the HORI- Angelis A. Suarez Alonso C. Kyriopoulos I. Mossialos E. Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non–COVID-19 Indications 2020-2021.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s10943-023-01929-x",FALSE,"",TRUE,"<section> Funding The study was funded by the Foundation for Bahá’í Studies. No additional external funding was received for this study. FB is supported by a grant of the German Federal Ministry of Research and Education (01ZZ1802H).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11019-023-10169-5",TRUE,"Conflict of interest The authors declare that they have no conflicts of interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This research was supported by a grant from the German Federal Ministry of Education and Research (SALUS grant number 01GP1792).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11033-023-08685-x",TRUE,"Conflict of interest Authors declare that they have no conflict of interest they agreed to submit the manuscript.",TRUE,"<section> Funding The authors did not receive support from any organization for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11060-022-04203-4",TRUE,"Conflict of interest UH has received lecture and/or advisory board honoraria from Medac Novartis Daichii-Sankyo Noxxon AbbVie Bayer Janssen and Karyopharm.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The trial was funded by the German Ministry for Education and Science (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11060-023-04319-1",TRUE,"Conflict of interest VT is a full-time employee of Boehringer Ingelheim.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11060-023-04403-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The authors declare that no funds grants or other support were received during the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11065-023-09615-1",TRUE,"Competing Interests The authors declare no competing interests.",TRUE,"<section> The results of perioperative imaging studies are supported by observational studies and animalbased research on delirium outside of the surgical setting.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11102-023-01345-0",TRUE,"Conflict of interest A. Wass have no conflicts of interest.",TRUE,"<section> Funding Study partially supported by a Research Grant from Pfizer to Università Vita-Salute San Raffaele Milan Italy.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11102-023-01360-1",TRUE,"Competing interests AB MB AG and RS are Editors of Pituitary. All other authors declare no competing interests.",TRUE,"<section> Funding Open access funding provided by SCELC Statewide California Electronic Library Consortium. The 14th Acromegaly Consensus Conference was supported by unrestricted educational grants from Amolyt Pharma Amryt Pharma Basecamp Bio Crinetics Pharmaceuticals Ionis Pharmaceuticals Novo Nordisk Pfizer and Recordati Rare Diseases.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11102-023-01361-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This research received no specific grant from any funding agency in the public commercial or notfor-profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11136-022-03324-7",TRUE,"Conflict of interest The authors declare that they have no competing interests.",TRUE,"<section> The PROMIS was funded in 2004 by the United States under the National Institute of Health (NIH) Roadmap for Medical Research Initiative [9] and since then developed over 100 item banks covering different aspects of physical mental and social health. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11136-023-03402-4",TRUE,"Competing interests All authors except GL were involved in the development and/or previous validation studies of the AAQ.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study validating the Brazilian version of the AAQ was supported by a Grant from the Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq (108978/2017-6). All other studies from which the data were used were financially supported by Grants from the European Alliance of Associations for Rheumatology (EULAR Project No EPI009) the Arthritis Foundation and the Anna Foundation.",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11136-023-03403-3",TRUE,"Conflict of interest The authors have no conflicts of interest to declare.",TRUE,"<section> The MSC was funded by the German Ministry of Education and Research (BMBF No. <section> Funding Open Access funding enabled and organized by Projekt DEAL. The results in this work are the responsibility of the authors and do not necessarily represent the views of the German Innovations Fund.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11136-023-03404-2",TRUE,"Conflict of interest SN: received grant EORTC Quality of Life Group grant #001 2015 (payments were made to Charité – Universitätsmedizin Berlin Germany); was employed as a consultant/director by ICON plc from September 2018 to June 2021 and by Union Chimique Belge Biosciences GmbH from July 2021 until December 2021. The other authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This research was partly funded by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (Grant No.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11136-023-03446-6",TRUE,"Competing interests The authors have no relevant financial or nonfinancial interests to disclose.",TRUE,"Funding Open Access funding enabled and organized by Projekt DEAL. The work was supported by a research fellowship (OB 437/22 recipient: Alexander Obbarius) by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11255-023-03800-0",TRUE,"Conflict of interest The mouse monoclonal antibodies clone MSVA735 M and MSVA-734 were obtained from MS Validated Antibodies GmbH (owned by a family member of GS).",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11325-023-02937-7",TRUE,"Conflict of interest Christian Apfelbacher has received institutional funding from Dr.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11357-023-00902-6",TRUE,"Disclosures All authors approved the final manuscript and none of the authors had any personal or financial or non-financial conflict of interest.",TRUE,"6. <section> Funding Open Access funding enabled and organized by Projekt DEAL. We thank the European Commission for financial support through the FP7 largescale integrating 7.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11469-023-01035-9",TRUE,"<section> Ashley Lau Ruihua Li Chuanning Huang Jiang Du Stephan Heinzel Min Zhao and Shuyan Liu declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11469-023-01066-2",TRUE,"Conflict of Interest MS has received honoraria/has been other authors declare no conflict of interest.",TRUE,"Funding Open access funding provided by Università Agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11481-023-10059-w",TRUE,"Competing interests The authors declare no competing interests relevant to this study.",TRUE,"<section> LMA JK MA; Funding acquisition: VS; Resources: LMA JK TK AGI KSR FP; Writing: LMA JK MA VS. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by grants from the German Research Council (DFG) to VS (Heisenberg stipend SI1886/1–2) and the Gemeinnützige Hertie-Stiftung to VS (Hertie MyLab) and LMA.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11548-023-02885-3",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded and supported by Charité CFM Facility Management GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11548-023-03012-y",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Funding from the German Research Foundation (GRK2260 BIOQIC) and Bundesministerium für Bildung und Forschung (16SV8649).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11560-023-00649-3",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11560-023-00683-1",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11682-023-00812-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The study was funded by German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)) reference numbers BN006 (DESCRIBE) BN026 (DANCER) and BN012 (DELCODE).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11684-023-0993-y",TRUE,"Conflict of Interests M.E.: Personal fees travel costs and speaker’s honoraria from MSD AstraZeneca Janssen-Cilag Cepheid Roche Astellas Diaceutics; research funding from AstraZeneca Janssen-Cilag STRATIFYER Cepheid Roche Gilead; advisory roles for Diaceutics MSD AstraZeneca JanssenCilag GenomicHealth; outside the submitted work. All others authors declare no conflicts of interest.",TRUE,"E.A.T.K. received research support by the Hiege Foundation (Deutsche Hautkrebsstiftung) and by the Bavarian Cancer Research Center (BZKF).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11686-023-00712-y",TRUE,"Conflict of Interest The author declares no competing interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11695-022-06446-6",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11757-023-00793-5",FALSE,"",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11818-023-00428-1",TRUE,"Conflict of interest. Schöbel declare that they have no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11818-023-00429-0",TRUE,"Conflict of interest. A. Fansa I. Fietze T. Penzel and <section> sal deﬁnition of AMI and thus potentially S. Herberger declare that they have no competing interests.",TRUE,"<section> timeframe and used diﬀerent statistical Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11818-023-00434-3",TRUE,"Conflict of interest. B. Amra B.",TRUE,"Corresponding address © Privat Matthew Salanitro Interdisciplinary Sleep Medicine Center Charité—Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany matthew.salanitro@charite.de Funding. <section> Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11818-023-00435-2",TRUE,"Conflict of interest. Young declares that he has no competing interests.",TRUE,"<section> Funding. M. Arzt has received grant support from ResMed the ResMed Foundation Philips C. Schoebel has received grants from Astra Zeneca ResMed and Bayer consulting fees from ResMed Idorsia Bristol-Myers Squibb and Astra Zeneca and honoraria/lecture fees from Berlin Chemie Takeda and Mementor; he also has unpaid roles as treasurer of the German Sleep Society head of the Telemedicine Working Group of the German Society for Internal Medicine and treasurer of the Sleep Apnea Working Group of the German Cardiac Society.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11864-022-01042-3",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11864-023-01131-x",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding E.J.V. is funded by an NIH/ Institute. M.E. received funding from DFG under Collaborative Research Center ReTune TRR 295and Fondation Leducq. <section> Funding",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s11886-023-01872-z",TRUE,"Conflict of Interest Pierre Jais reports consulting fees member of the board and founder and shareholder for inHEART Medical. Hubert Cochet reports consulting fees from inHEART Medical; speaker fees from Biosense Webster and Biotronik; support for attending meetings and/ or travel from Siemens Healthineers and Boston Scientific; and member of the board and founder and shareholder for inHEART Medical. <section> Frederic Sacher reports speaking honorarium from Abbott Biosense Webster and Boston Scientific and salary from inHEART Medical. <section> The other authors declare that they have no conflict of interest.",TRUE,"<section> Funding National Research Agency (ANR) ANR-10-IAHU-04 Frédéric",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s11886-023-01998-0",TRUE,"Conflict of Interest UK received research grants and honoraria (speaker/advisory board) from BAYER AG and received honoraria (speaker/ advisory board) from Amarin Berlin Chemie BMS Boehringer Ingelheim Novartis Oviva Roche Sanofi and Servier.",TRUE,"<section> Funding UK is supported by the DZHK; BER 5.4 PR and the Deutsche Forschungsgemeinschaft (DFG — KI 712/10-1; SFB1470-A09).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12011-023-03585-4",TRUE,"Competing Interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by the National Natural Science Foundation of China (Grant No.81471205).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12024-023-00663-w",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12028-022-01669-y",TRUE,"Conflicts of interest The authors declare no conflicts of interest.",TRUE,"<section> Source of support Open Access funding enabled and organized by Projekt DEAL. FLRC was supported by the National Council of Science and Technology (CONACyT) of RDP was supported by a scholarship granted by the Council of Science and Technology from the State of Mexico (Reference: 2021BPS2-E0405).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12028-023-01770-w",TRUE,"Conflict of interest The authors declare that they have no conflicts of interest.",TRUE,"<section> Source of support Open Access funding enabled and organized by Projekt DEAL. This study was financially supported by Deutsche Forschungsgemeinschaft (SFB TRR43) to PV and Bundesministerium für Bildung und Forschung (Center for Stroke Research Berlin) to PV.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12028-023-01782-6",TRUE,"Conflict of interest FS reports personal fees from Bristol-Myers Squibb as well as MD Horizonte and AMEOS both outside the submitted work. MW received speakers onoria and consulting fees from Alexion Pharma GmbH (formerly Portola). AG reports personal fees from Bristol-Myers Squibb Boehringer-Ingelheim Pfizer Daichii Sankyo Ipsen Pharma and Merz. JOP MK AA NE WDN JL EG JW TL RD MW HS AB MC AM SP DB DL CP CR and DM declare that there is no conflict of interest related to the presented work.",TRUE,"<section> Source of support Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12028-023-01837-8",TRUE,"Conflict of interest NP JJG MR JH BP AR UP CS PS EL and DC report no conflicts of interest.",TRUE,"<section> Source of Support Open Access funding enabled and organized by Projekt DEAL. The study was funded by the European Society of Intensive Care Medicine with one of their NEXT Startup Grant Awards. The study received support from the National Institute for Health and Care Research (NIHR) Clinical Research Network as a study adopted onto the NIHR Research Portfolio.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study adhered to the ethical standards of the Declaration of Helsinki and its later amendments and its protocol was registered at ClinicalTrials.gov on June 12 2018 (Identifier: NCT03553719).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s12031-023-02143-w",TRUE,"Competing Interests The authors declare no competing interests.",TRUE,"<section> Funding This project has received funding from DZNE MPG the European Union’s Horizon 2020 Research and Innovation program (grant agreement No 676144 SyDAD consortium) Katharina-HardtFoundation and the Cure Alzheimer’s Fund.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12035-023-03219-9",TRUE,"Competing Interests Seven of the authors of this publication are members of the European Reference Network for Neuromuscular DiseasesProject ID N° 870177. Three authors of this study are part of the Center for Translational Neuroand Behavioral Sciences (C-NTBS). The other authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the “Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen” the “Regierenden Bürgermeister von Berlin-Senatskanzlei Wissenschaft und Forschung” and the “Bundesministerium für Bildung und Forschung.” AR received funding from The French Muscular Dystrophy Association (AFM-Téléthon; Grant: 21644). Sequencing and analysis were provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG) and were funded by the National Human Genome Research Institute the National Eye Institute and the National Heart Lung and Blood Institute grant UM1 HG008900 and in part by National Human Genome Research Institute grant R01HG009141.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12072-023-10521-0",TRUE,"Conflict of interest The authors (Silke Leonhardt Christian Jürgensen Josephine Frohme Donata Grajecki Andreas Adler Michael Sigal Julia Leonhardt Julian M. Voll Jan Matthias Kruse Roland Körner Kai‑Uwe Eckardt Hans‑Joachim Janssen Volker Gebhardt Marc D. <section> Schmittner Pa-COVID-19 collaborative study group Christian Frey Hendrik Müller‑Ide Michael Bauer Charlotte Thibeault Florian Kurth Leif Erik Sander Tobias Müller and ·Frank Tacke) declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12181-022-00592-y",TRUE,"Conflict of interest. The authors’ conﬂict of interest can be found online at the DGK homepage at http:// <section> mation of a task force for digital health leitlinien.dgk.org/ for the corresponding publication.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12200-023-00080-5",TRUE,"Conflicts of interest The authors declare no conflict of interest.",TRUE,"SGO FI SA BI TA DA ZM ED AV EA VV TA KV MM and MA were supported by grant (No. 23-75-30001) from the Russian Science Foundation DA and ED were supported by Grant (No. 21-75-10088) from the Russian Science Foundation and by Grant from the Russian Ministry of Science and High Education (No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12265-023-10356-y",TRUE,"Competing Interests M.M. received the following personal fees of minimal amounts in the last 3 years: from Actelion Amgen Livanova Servier and Vifor pharma as member of Executive or Data Monitoring Committees of sponsored clinical trials; from Astra-Zeneca Abbott vascular Bayer Boheringer Ingelhelm and Edwards Therapeutics for participation to advisory boards and/or speeches at sponsored meetings. S.D.A. reports receiving fees from Abbott Actimed Bayer Boehringer Ingelheim Cardiac Dimension Cordio Impulse Dynamics Novartis Occlutech Servier and Vifor Pharma and grant support from Abbott and Vifor Pharma. C.C.L. <section> received consultancy fees and/or research grants from Amgen Astra Zeneca MSD Novartis and Servier. A.A.V Amgen Bayer Boehringer Ingelheim Merck/MSD Novartis Roche Diagnostics Servier Trevena and Vifor. All the other authors declare no conflict of interest.",TRUE,"<section> Funding This work was supported by the Netherlands Cardiovascular",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12311-023-01625-2",TRUE,"Competing Interests <section> Fay Horak and Vrutangkumar Shah and James McNames are employees of APDM Precision Motion Clario a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by OHSU. <section> Winfried Ilg receives consultancy honoraria from Ionis Pharmaceuticals. <section> Enrico Bertini receives honoraria for Advisory Board from PTC Therapeutics Biogen Roche. <section> Christopher Gomez discloses research collaboration with APDM Precision Motion Clario. <section> Tanja Schmitz-Hübsch discloses research collaboration with a provider of a motion capture system based on Kinect technology (Motognosis GmbH Berlin Germany). <section> Helen Dawes is Director of International Affairs Physiobiometrics inc and scientific advisor for Elaros UK. <section> Kirsi M Kinnunen ist employed by IXICO London UK Hasmet Hanagasi Jane Newman Sarah Milne Clara Rentz Lukas Beichert Yi Ng Lisa Alcock Norlinah Mohamed Ibrahim Martina Minneropt Andrea H Nemeth Bedia Samanci Vrutangkumar S ­ hah Susanna Summa Gessica Vasco report no disclosures.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12325-023-02445-w",TRUE,"Disclosures. Peter C.",TRUE,"Funding. Sponsorship for this study and its publication including the journal’s Rapid Service Fee were funded by Eli Lilly and Company.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s12328-023-01899-3",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12565-023-00726-6",TRUE,"Conflict of interest The authors declare that they have no conflict of interest.",TRUE,"<section> Funding Not applicable.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12599-023-00813-y",TRUE,"For instance a joint digitalization project that integrates government data into a single repository creates a conflict of interests given the constitutional separation of powers (Jaeger 2002).",TRUE,"Round 3 helped to refine and enrich these recommendations for action PHAs have no shared vision toward their tobe digital maturity Determining a shared vision among many PHAs Digital interoperability between PHAs is not possible owing to the lack of a standardized digital infrastructure Committing to a shared maturity level that PHAs should target in mediumterm planning Public funding should be used in very targeted ways for a specific goal Funding can be applied for all relevant digitalization projects planned by PHAs for 2022 to 2025 Public organizations must report on achievements through public funding The impacts of national funding can be assessed in retrospect Practices are formulated as abstractly as necessary to allow the digitalization of all PHAs Deciding for an 80:20 mechanism that allows PHAs to reach a maturity level for a subdimension if at least 80% of the practices are fulfilled. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12640-023-00663-2",TRUE,"Conflict of Interest The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s12687-023-00640-4",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"The Ehlers Danlos Diagnostic service (EDS service) was established in 2009 for adults and children with or suspected of having a rare monogenic type of EDS and is funded by the National Health Service (NHS).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13187-023-02285-w",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Acknowledgements The authors wish to thank the European Commission for funding this study conducted in the context of the INTERACTEUROPE Project (Grant Agreement No. <section> Funding The research leading to these results has received funding from EU4Health Programme 2021–2027 as part of Europe’s Beating Cancer Plan under Grant Agreement no. 101056995.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13225-023-00526-3",TRUE,"Competing interests The authors have not disclosed any competing interests.",TRUE,"<section> Acknowledgements CT was supported by China Scholarship Council (Number 201808520089). This work was supported by the 111 Project (D20009); National Natural Science Foundation of China (NSFC; No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13318-023-00847-3",TRUE,"Conflict of Interest TS RF TJ SH JS AA RD PM RS and PG are currently employees of Novartis Pharma AG.",TRUE,"<section> Funding The study was funded by Novartis Pharma AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered on EudraCT (EudraCT number: 2017-004559-21). <section> Registration The study was registered on EudraCT (EudraCT number: 2017-004559-21).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s13346-023-01289-9",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding was enabled and organized by Projekt DEAL. This work was supported by a grant of the Federal Ministry of Education and Research Germany (grant number 03VP04510) to BS. <section> Support was also provided by the Federal Ministry of Education and Research Germany in the program Health Research (BCRT; Grant Nos.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13353-023-00757-9",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> The design of the study and collection analysis and interpretation of data and writing of the manuscript was supported by Tehran University of Medical Sciences.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13534-023-00304-9",TRUE,"Conflict of interest The authors declare that they have no conflicts of interest.",TRUE,"<section> Funding Parts of the study were financially supported by the EU Horizon 2020 project ODIN #101017331. Mi Lu was financially supported by the China Scholarship Council for her visiting PhD study at Charité University Medicine Berlin.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s13555-023-00986-0",TRUE,"Disclosures. The authors have no conflicts of interest to declare.",TRUE,"<section> Funding. No funding or sponsorship was received for this study or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s13555-023-01040-9",TRUE,"Conflict of Interest. Jonathan A.",TRUE,"<section> Funding. Funding was provided by Genentech Inc. a member of the Roche Group.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s13555-023-01057-0",TRUE,"Conflict of Interest. Sergio Vañó-Galván is an advisor for Pfizer and Eli Lilly and Company.",TRUE,"Funding. The study was funded by Eli Lilly and Company.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s15010-022-01972-y",TRUE,"Conflict of interest The authors declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-01994-0",TRUE,"Conflict of interest F.H. received fees for presentations and lectures for the German Society for Interdisciplinary Emergency and Acute Medicine (DGINA) and the German Academy of Infectious Diseases and has participated in several advisory boards. All disclosures are reported to be outside the submitted work. The authors declare no conflicts of interest.",TRUE,"<section> Supported by its antiviral mechanism and preclinical investigations recent discussions pointed out the potential of RDV administration early in SARS-CoV-2 infection [49]. <section> Funding Open Access funding enabled and organized by Projekt DEAL. M.V. received grants from Astellas Pharma Basilea Gilead Sciences MSD Organobalance Pfizer 3 M Biontech DaVolterra Evonik Glycom Immunic MaaTPharma Seres Tehrapeutics and Takeda Pharmaceutical as well as consulting fees from Alb Fils Kliniken GmbH Srederypharm Farmak Intern Holding Ferring SocraTec R&D Arderypharm Astellas Pharma DaVolterra Ferring Immunic AG MaaTPharma and MSD.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s15010-023-02022-x",TRUE,"Conflict of interests The authors have no relevant financial or nonfinancial interests to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This work has been funded in part by the Bundesministerium für Bildung und Forschung (Federal Ministry of Education and",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02033-8",TRUE,"Conflict of interest The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02040-9",TRUE,"Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> GenSurV (https://numgenomische-surveillance.de/) a collaborative project that has been initiated by the National University Medicine Research Network (NUM funded by the Federal Ministry of Education and Research (BMBF https:// <section> www.netzwerkuniversitaetsmedizin.de/) aims at providing a platform for integrating genomic surveillance data sources and expertise that exist in a decentralized and qualityassured manner across Germany. <section> Supported by additional funding made available in response to the pandemic Germany successfully leveraged existing structures at the RKI and within its academic system to implement a genomic surveillance effort. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02043-6",TRUE,"Conflict of interest TB reports personal fees from AstraZeneca GlaxoSmithKline Novartis Roche Chiesi Boehringer Ingelheim MSD and Pfizer outside the submitted work. SStö reports research grants of the Federal Ministry of Education and Research (#01EO1004; #01EO1504) speaker honoraria or advisory board honoraria of AstraZeneca Boehringer Ingelheim Novartis Pfizer Pharmacosmos and case payment fees in clinical studies of Alnylam AstraZeneca Boehringer Ingelheim IONIS MSD NovoNordisk SOBI Servier; all outside the submitted work. All other authors have no competing interests to declare.",TRUE,"<section> Data were provided by NAPKON (Nationales Pandemie Kohorten Netz German National Pandemic Cohort Network) of the Network University Medicine (NUM) funded by the Federal Ministry of Education and Research (BMBF). We acknowledge the dedicated support of clinical research support staff of the Institute of Experimental and Translational Cardiovascular Imaging including Tammy Wolf Thourier Azdad Franziska Weis Ira Krückemeier Simon Bohlender Deniz Desik and Layla Laghchioua. <section> Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the German Federal Ministry of Education and Research (BMBF) via the Network University Medicine Yanyan Shi is supported by a scholarship from the China Scholarship Council (202108140048).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s15010-023-02044-5",TRUE,"Conflict of interest MJGTV received research Grants from 3M Astellas Pharma Biontech DaVolterra Evonik Gilead Sciences Glycom Immunic MaaT Pharma Merck/MSD Organobalance Seres Therapeutics Takeda Pharmaceutical as well as speaker fees or consulting fees from Alb Fils Kliniken GmbH Arderypharm Astellas Pharma Basilea Bio-Mérieux DaVolterra Farmak International Holding GmbH Ferring Gilead Sciences Immunic AG MaaT Pharma Merck/MSD Pfizer Roche Organobalance SocraTec R&D GmbH Tillots Pharma GmbH. CFM has given talks at Ferring-sponsored symposia. AS has been lecturing for AbbVie Bristol Myers Squibb Celltrion CLS Behring De Prom Falk Foundation Ferring Janssen Kompetenznetz Darmerkrankungen MedUpdate MSD RecordatiPharma sobi rare strength Takeda and consulting activities for AbbVie Amgen Bristol Myers Squibb Consal Galapagos Gilead Janssen Lilly MSD Repha GmbH Roche Pfizer Pharmacosmos GmbH Takeda Tillots Pharma GmbH. SS has received personal fees from Abbvie Arena BMS Biogen Celltrion Celgene Falk Ferring Fresenius Kabi IMAB Galapagos Gilead Janssen MSD Mylan Pfizer Protagonist Provention Bio Sandoz Takeda and Theravance. HJE received speaker fees or consulting fees from Astellas Pharma Falk Foundation Ferring Arzneimittel MSD Tillots Pharma viiv Health care. JO and LvM stated no conflicts of interest.",TRUE,"<section> Funding This work was supported by Ferring Arzneimittel GmbH. <section> MV AS and LvM also received funding from Ferring for another independent project on hospitalization data on fecal microbiota transfer.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02060-5",TRUE,"Conflict of interest The authors have no financial or proprietary interests in any material discussed in this review.",TRUE,"Federico Gobbi and Leonardo Motta were supported by the Italian Ministry of Health “Fondi Ricerca Corrente” to IRCCS Sacro Cuore Don Calabria <section> Funding Open access funding provided by Università degli Studi di Firenze within the CRUI-CARE Agreement.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02070-3",TRUE,"Conflict of interest B.T. None competing interests for J.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Since 2013 CAPNETZ has been supported by the German Center for Lung Research (DZL): 2013–2015 funding code 82DZL00204 and 2016–2020 funding code 82DZL002A4. G. Barten-Neiner received funding for CAPNETZ from German Lung Center (DZL) and Grants from Pfizer.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02091-y",TRUE,"Conflict of interest Daniel Schwarzkopf was funded for this work by grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee and received additional funding from this source unrelated to this work; he leads the coordinating bureau of the German Quality Network sepsis—a quality initiative to improve hospital care Beate Boden has no conflict of interest. Marcus Friedrich has no conflict of interest. Gonnert has no conflict of interest. Jürgen Götz has no conflict of interest. Matthias Gründling has no conflict of interest. Markus Heim has no conflict of interest. Kirill Holbeck has no conflict of interest. <section> Ulrich Jaschinski has no conflict of interest. Christian Koch has no conflict of interest. Christian Künzer has no conflict of interest. Khanh Le Ngoc has no conflict of interest. Simone Lindau has no conflict of interest. Mehlmann has no conflict of interest. Jan Meschede has no conflict of interest. Patrick Meybohm has no conflict of interest. <section> Christian Putensen has no conflict of interest. Peter Schlattmann has no conflict of interest. Götz Schmidt has no conflict of interest. Gerhard Schneider has no conflict of interest. Ferdinand Steinsberger has no conflict of interest. Sebastian Zinn has no conflict of interest.",TRUE,"Funding acquisition was contributed by <section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by Grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee. <section> Conflict of interest Daniel Schwarzkopf was funded for this work by grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee and received additional funding from this source unrelated to this work; he leads the coordinating bureau of the German Quality Network sepsis—a quality initiative to improve hospital care <section> Norman Rose received funding from the German Innovations Fund of the Federal Joint Committee unrelated to this work. Carolin Fleischmann-Struzek received funding from the German Innovations Fund of the Federal Joint Committee unrelated to this work. Heike Dorow was funded for this work by grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee. Dominique Ouart was funded for this work by grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee. Konrad Reinhart received funding for this work by grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee is shareholder with less of 0.5% of InflaRx NV a Jena/Germanybased Biotech Company that evaluates a immunomodulatory approach for the adjunctive treatment of COVID-19.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s15010-023-02101-z",TRUE,"Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02104-w",TRUE,"Conflict of interest On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02123-7",TRUE,"Conflict of interest The study was in part funded by the German Federal State of Saxony. The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. All other authors declare no conflict of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This project was supported by a grant from the German Federal State of Saxony (PAEDSAXCOVIDD19). <section> Conflict of interest The study was in part funded by the German Federal State of Saxony.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s15010-023-02141-5",TRUE,"Disclosure of potential conflicts of interestMMA received support for research from the German Research Foundation (DFG) DZIF BMBF CEPI and a lecture honorarium from Gilead (Campus Infectiology). MD is an honorary member of the following committees/boards: Berufsverband Deutscher Internistinnen und Internisten (Board of Directors); Deutsche Gesellschaft für Innere Medizin (Weiterbildung/ Krankenhaus) Deutsche Gesellschaft für Geriatrie (President Elect) HCPWP (Health Care Professional Working Party) and HCP POG (Policy Officers Group) of the EMA for the European Union Geriatric Medicine Society.GE declares no conflicts of interest.SH received support for research from DFG LOEWE Hessen BMBF DZL DZIF Institute of Lung Health (IHL) Volkswagen Foundation and honoraria from AstraZeneca Janssen Sanofi Atriva PTx Partner Therapeutics Savara.MP received support for research from DFG BMBF Pfizer Correvio Infectopharm and honoraria from Janssen MSD Pfizer Bayer Chiesi GSK Thermofisher Infectopharm Basilea Curetis Roche Novartis Janssen. TW provides unpaid advice to Leopoldina EMA CDC and is honorary Chairman of the Board of Trustees of CAPNETZ Foundation Chairman of the Board of Trustees of the German Lung Foundation Chairman of the Board of Trustees of the German Sepsis Foundation Member of the Board of Trustees of the Fraunhofer Society Member of the Board of Trustees of the Novartis Foundation Member of the Advisory Board of the German Respiratory League Speaker of the Working Group ""Immunity and Vaccination"" of the American Thoracic Society.WW declares no conflicts of interest.MW received support for research from DFG BMBF EKFS Manchot Foundation Sonnenfeld Foundation Aptarion Biotest Pantherna Vaxxilon and honoraria from Aptarion AstraZeneca Biotest Chiesi Gilead Insmed Pantherna Vaxxilon. <section> Conflict of interest MMA received support for research from the German Research Foundation (DFG) DZIF BMBF CEPI and a lecture honorarum from Gilead (Campus Infectiology). GE declares no conflicts of interest. WW declares no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Competing interests Disclosure of potential conflicts of interestMMA received support for research from the German Research Foundation (DFG) DZIF BMBF CEPI and a lecture honorarium from Gilead (Campus Infectiology). MD is an honorary member of the following committees/boards: Berufsverband Deutscher Internistinnen und Internisten (Board of Directors); Deutsche Gesellschaft für Innere Medizin (Weiterbildung/ Krankenhaus) Deutsche Gesellschaft für Geriatrie (President Elect) HCPWP (Health Care Professional Working Party) and HCP POG (Policy Officers Group) of the EMA for the European Union Geriatric Medicine Society.GE declares no conflicts of interest.SH received support for research from DFG LOEWE Hessen BMBF DZL DZIF Institute of Lung Health (IHL) Volkswagen Foundation and honoraria from AstraZeneca Janssen Sanofi Atriva PTx Partner Therapeutics Savara.MP received support for research from DFG BMBF Pfizer Correvio Infectopharm and honoraria from Janssen MSD Pfizer Bayer Chiesi GSK Thermofisher Infectopharm Basilea Curetis Roche Novartis Janssen. SH received support for research from DFG LOEWE Hessen BMBF DZL DZIF Institute of Lung Health (IHL)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40120-023-00514-4",TRUE,"Disclosures. Please see original article for full author disclosures.",TRUE,"Funding. Alexion AstraZeneca Rare Disease funded the development of this publication and rapid",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40121-023-00785-2",TRUE,"Disclosures. Moı̈si Lutz von Mueller Holly Yu and Alexander Mellman declare that they have no competing interests.",TRUE,"<section> Funding. This study was sponsored by Pfizer and non-Pfizer authors except Friederike Maechler were funded for manuscript development. Disclosures. Stefan Hagel reports grants from the Federal Ministry of Education and Research (BMBF) lecture fees from Pfizer MSD InfectoPharm Advanz Tillotts and Philips support for attending meetings from Pfizer and Advanz.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40123-023-00839-1",TRUE,"Conflict of Interest. Seven of the authors of this publication [Dr Carla Gaggiano Prof Bruno Frediani Prof Gian Marco Tosi Dr Maria Pia Paroli Prof Uwe Pleyer Prof Luca Cantarini and Dr Claudia Fabiani] belong to institutes that are members of the European Reference Network (ERN) for Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases (RITA) [Azienda Ospedaliero-Universitaria Senese; AOU Policlinico Umberto I di Roma; Berlin Charite Universitätsmedizin]. Carla Gaggiano Vishali Gupta Rupesh Agrawal Marc De Smet Bruno Frediani Gian Marco Tosi Maria Pia Paroli Sudharshan Sridharan Carlos Pavesio Uwe Pleyer Ekaterina Denisova Kalpana Babu Alejandra de-la-Torre Peizeng Yang Janet Davis Emmett Cunningham Ester Carreño Debra Goldstein Alex Fonollosa Luca Cantarini Lucia Sobrin and Claudia Fabiani declare that they have no competing interests.",TRUE,"Funding quotas from the different <section> Funding. No funding or sponsorship was received for this study or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40200-023-01316-z",TRUE,"Competing Interests The authors declare no conflicts of interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. This article is part of a project (www.imisophia.eu) that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875534. In addition this analysis is supported by the German Diabetes Foundation (grant number FP-0446–2022) and by a financial support program for female researchers Office for Gender Equality Ulm University.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40256-022-00557-2",TRUE,"Conflicts of interest/competing interests Corina Becker and Claudia Maschke are employees of Bayer AG. <section> Frank Donath Pim Gal Gerd Mikus and Vasile Corcea declare no conflicts of interest.",TRUE,"<section> Funding This study was funded by Bayer AG and Merck Sharp & Dohme LLC a subsidiary of Merck & Co. Inc. Rahway NJ USA (MSD). Rainard Fuhr is an employee of Parexel the Clinical Research Organization that received funding from Bayer AG for the conduct of the study.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40257-023-00761-z",TRUE,"Conflict of interest DTM has received research funds and/or was advisor for Celldex Moxie Novartis and Sanofi.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40257-023-00775-7",TRUE,"Conflicts of interest/competing interest Ulrike Leiter reports research support from MSD; consulting fees and honoraria from Sun Pharma Sanofi (personal and institutional) MSD (personal and institutional) Novartis Roche and Almirall Hermal; support for attending meetings from Sun Pharma; and participation on a Data Safety Monitoring Board or Advisory Board from Sun Pharma Sanofi MSD Novartis Roche and Almirall Hermal outside the submitted work.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40257-023-00806-3",TRUE,"Conflict of Interest Eric L.",TRUE,"<section> The ECZTRA 1 and 2 trials were sponsored by LEO Pharma A/S (Ballerup Denmark) and conducted in accordance with the ethical principles derived from the Declaration of Helsinki and Good Clinical Practice guidelines and were approved by the local Institutional Review Board or Ethics Committee of each institution. <section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Funding The ECZTRA 1 and 2 clinical trials were sponsored by LEO Pharma A/S (Ballerup Denmark). <section> Ethics Approval The ECZTRA 1 and 2 trials were sponsored by LEO Pharma A/S (Ballerup Denmark) and conducted in accordance with the ethical principles derived from international guidelines including the Declaration of Helsinki and Council for International Organizations of Medical Sciences International Ethical Guidelines and in compliance with International Council for Harmonisation guidelines for Good Clinical Practice.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40259-023-00634-1",TRUE,"Conflict of interest Ali Berkant Avci has no conflicts of interest that are directly relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. <section> Funding No sources of funding were used to support the writing of this",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40263-022-00980-8",TRUE,"Conflict of interest DK has participated in advisory boards from Idorsia; DGB has participated in advisory boards from Idorsia Roche and received a research grant from MSD; GP has participated in advisory boards from Takeda Bioprojet Jazz Fidia and Idorsia; HB has participated in advisory boards from UCB Jazz and Idorsia; ST has nothing to disclose; YD participated in advisory boards from UCB Takeda Bioprojet Jazz Orexia Avadel and Idorsia; DSK PC MR and MS-S are employees of Idorsia Pharmaceuticals Ltd.",TRUE,"<section> Funding This study was supported by Idorsia Pharmaceuticals Ltd Allschwil Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40263-023-01001-y",TRUE,"Conflicts of Interest/Competing Interests Lucas Hendrik Overeem Maria Magdalena Pocora and Daniele Martinelli have no conflicts of interest that are directly relevant to the content of this article.",TRUE,"<section> Funding OpenAccess funding enabled and organized by Projekt DEAL. Uwe Reuter has served on advisory boards for Amgen Allergan Abbvie Eli Lilly Lundbeck Novartis and Teva and has received honoraria for lectures from Amgen Allergan Abbvie Eli Lilly Lundbeck Novartis electroCore Medscape StreaMedUp and Teva received honoraria for consulting services from Lundbeck Pfizer and Abbvie; received research funding from Novartis (CHERUB01) and the German Federal Ministry of Education and Research; and is an associate editor of the Journal of Headache and Pain and Frontiers in Neurology. Cristina Tassorelli has served on the advisory boards of Abbvie Dompé EliLilly Lundbeck Novartis and Teva; received lecture honoraria from Abbvie Eli-Lilly Lundbeck Novartis and Teva; honoraria for consulting services from Medscape; received research funding from the EU Commission the Italian Ministry of Health the American Migraine Foundation and Allergan; and serves on the editorial boards of Cephalalgia and the Journal of Headache and Pain.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40263-023-01009-4",TRUE,"Conflicts of interest Jose M.",TRUE,"<section> Funding Jose M. Rubio was supported in part by grant number K23MH127300. No funding was specifically received for this article. Correll has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris; provided expert testimony for Janssen and Otsuka; served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva; received grant support from Janssen and Takeda; received royalties from UpToDate; and is a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. <section> Kane has been a consultant for or received honoraria from Alkermes Forum Allergan Genentech Lundbeck Intracellular Therapies Janssen Pharmaceutica Johnson & Johnson Merck Neurocrine Otsuka Pierre Fabre Reviva Roche Sunovion Takeda and Teva; has received grant support from Otsuka Lundbeck and Janssen; and is a shareholder in Vanguard Research LB PharmaGroup and LB Pharmaceuticals Inc.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40263-023-01022-7",TRUE,"Conflict of interest Dr.",TRUE,"<section> Funding Medical writing and editorial assistance including preparing the outline and draft incorporating revisions literature searching and journal styling were provided by Debika Chatterjea PhD and Stephen Bublitz ELS of PharmaWrite LLC (Princeton NJ USA) and were funded by Sumitomo Pharma America Inc. and Otsuka Pharmaceuticals Development & Commercialization Inc. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40265-023-01857-w",TRUE,"Conflict of interest DP: research support from: AbbVie Eli Lilly MSD Novartis Pfizer; consulting fees from: AbbVie Biocad Eli Lilly Galapagos Gilead GlaxoSmithKline Janssen MSD Moonlake Novartis Pfizer Samsung Bioepis and UCB; speaker fees from: AbbVie Bristol-Myers Squibb Eli Lilly Janssen MSD Medscape Novartis Peervoice Pfizer and UCB.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40266-023-01065-x",TRUE,"Conflicts of interest/competing interests Reinhold Kreutz reports modest honoraria for consultancy and lectures and support for research from Bayer AG CinCor Menarini Merck Sanofi and Servier outside the submitted work. Eva J. Brandl has received speaker fees from Medice. Nadine Bittner Cleo S.M. Funk Alexander Schmidt Felix Bermpohl Engi E.A. Algharably and Thomas G. Riemer have no conflicts of interest that are directly relevant to the content of this article.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40520-023-02364-4",TRUE,"Conflict of interests The authors have no conflict of interest to disclose.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40615-023-01732-0",TRUE,"Conflict of Interest The authors declare no competing interest.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40620-023-01571-6",TRUE,"Conflict of interest SB has received honorarium for lectures attended expert opinion committees and received educational funds to attend international Nephrology meetings from Pharmacosmos A/S and Vifor Pharma Astellas Bayer Pfizer and GSK; PP has no conflicts of interest; CW has no conflicts of interest; SDA has received grants from Vifor Pharma and Abbott Vascular and fees for consultancy from Vifor Pharma Bayer Boehringer Ingelheim Novartis and Servier; KF has no conflicts of interest; IF has received research grants from Vifor Pharma and Pharmacosmos; PAK has received speaker fees honoraria and consultancy fees from Pharmacosmos Vifor Pharma and Takeda. D.C.W. has received honoraria and consultancy fees from Amgen Akebia AstraZeneca Bayer Boehringer Ingelheim Janssen Napp and Vifor Fresenius Medical Care; JJVM reports receiving fees (all fees from Bayer fees for serving on a steering committee fees for serving on an endpoint committee and travel support from Cardiorentis fees for serving on a steering committee and travel support from Amgen fees for serving on a steering committee and travel support from Oxford. University–Bayer fees for serving as principal investigator of a trial and travel support from Theracos fees for serving on a steering committee and travel support from AbbVie fees for serving on a steering committee from DalCor Pharmaceuticals fees for serving on a data and safety monitoring committee from Pfizer fees for serving on a data and safety monitoring committee from Merck fees for serving on an executive committee fees for serving as co-principal investigator of a trial fees for serving on a steering committee fees for serving on an executive committee travel support and advisory board fees from Novartis fees for serving as co-principal investigator for a trial fees for serving on a steering committee and travel support from GlaxoSmithKline fees for serving on a steering committee from Bristol-Myers Squibb and fees for serving on a steering committee fees for serving on an endpoint adjudication committee and travel support from Vifor Pharma–Fresenius; MR has no conflicts of interest; CRVT has no conflicts of interest; DCW has received honoraria and consultancy fees from Amgen Akebia AstraZeneca Bayer Boehringer Ingelheim Janssen Napp and Vifor Fresenius Medical Care; ICM has received speaker fees honoraria and consultancy fees from several ESA and IV iron manufacturers including Akebia AMAG Astellas Bayer FibroGen GlaxoSmithKline Pharmacosmos and Vifor Pharma.",TRUE,"<section> Funding The PIVOTAL study received funding from Kidney Research UK via an unrestricted grant from Vifor Fresenius Medical Care Renal Pharma. <section> Conflict of interest SB has received honorarium for lectures attended expert opinion committees and received educational funds to attend international Nephrology meetings from Pharmacosmos A/S and Vifor Pharma Astellas Bayer Pfizer and GSK; PP has no conflicts of interest; CW has no conflicts of interest; SDA has received grants from Vifor Pharma and Abbott Vascular and fees for consultancy from Vifor Pharma Bayer Boehringer Ingelheim Novartis and Servier; KF has no conflicts of interest; IF has received research grants from Vifor Pharma and Pharmacosmos; PAK has received speaker fees honoraria and consultancy fees from Pharmacosmos Vifor Pharma and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40629-022-00241-6",TRUE,"Conflict of interest L. Hagemann declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40629-022-00242-5",TRUE,"Conflict of interest L. Cuevas declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40629-023-00251-y",TRUE,"Conflict of interest S. Nehr R.M.B.O. Duarte A.S. Almeida L. Baus and K.-C. Bergmann declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40629-023-00254-9",TRUE,"Conflict of interest E. Jensen-Jarolim is a shareholder in Biomedical International R + D GmbH Vienna and co-inventor on patent EP 2894478 A1 “Method and means for diagnosing and treating allergy” of Biomedical Int. R + D GmbH. She is a consultant for Bencard Allergie GmbH and Allergy Therapeutics Ltd. and receives lecture fees from Bencard Allergie GmbH Sanofi Germania Pharmaceutics Meda Menarini Novartis Santen Sanofi. S.A. Jensen and K.-C. Bergmann declare no conflict of interest with the content of the publication.",TRUE,"<section> Funding The article was kindly supported by Biomedical International R + DGmbH Vienna Austria andby theDanube Allergy Research Cluster (DARC) project #08 Karl Landsteiner University Krems Austria. <section> Funding Open access funding provided by Medical University of",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40629-023-00260-x",TRUE,"Conflict of interest A.",TRUE,"<section> Funding Open access funding provided by Medical University of",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40629-023-00270-9",TRUE,"Conflict of interest E. Potapova H. Sénéchal E. Scala P.M. Matricardi and P. Poncet declare that they have no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40653-023-00586-2",TRUE,"Competing Interests The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40670-023-01833-9",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. Funded by the Brandenburg Medical School publication fund supported by the Ministry of Science Research and Cultural Affairs of the State of Brandenburg.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s40744-022-00520-2",TRUE,"Disclosures. Rieke Alten declares receiving research grants and honoraria from AbbVie BMS Galapagos Gilead Janssen Lilly and Pfizer.",TRUE,"<section> Funding. Medical writing support for this manuscript was provided by David Wateridge Ph.D. and Donna McGuire of Engage Scientific Solutions and was funded by Pfizer.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40744-023-00550-4",TRUE,"Disclosures. Uta Kiltz: received grant and research support and consultancy fees from AbbVie Amgen Biocad Biogen Chugai Eli Lilly Fresenius Gilead Grünenthal GSK Hexal Janssen MSD Novartis onkowoessen.de Pfizer Roche UCB and Viatris.",TRUE,"Funding. This work was supported by AbbVie including the Rapid Service Fee. Disclosures. Uta Kiltz: received grant and research support and consultancy fees from AbbVie Amgen Biocad Biogen Chugai Eli Lilly Fresenius Gilead Grünenthal GSK Hexal Janssen MSD Novartis onkowoessen.de Pfizer Roche UCB and Viatris.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,"<section> Clinical Registration Number: NCT04169373",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s40744-023-00576-8",TRUE,"Disclosures. Gerd R.",TRUE,"Funding. This study was sponsored by Pfizer.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40744-023-00592-8",TRUE,"Conflict of interest. Philip J.",TRUE,"<section> Funding. Gladman has received grant support from AbbVie Amgen Bristol Myers Squibb Celgene Eli Lilly Janssen Novartis Pfizer and UCB and consulting fees from AbbVie Amgen Bristol Myers Squibb Celgene Eli Lilly Galapagos Gilead Janssen Novartis Pfizer and UCB.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: Clinicaltrials.gov NCT031 58285.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s40744-023-00597-3",TRUE,"Conflict of Interest. Rieke Alten has received consulting fees payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events and patents planned issues or pending from AbbVie BMS Celltrion Galapagos Janssen Eli Lilly and Company Novartis Pfizer Roche UCB and Viatris.",TRUE,"<section> Role of Funding Source <section> The study was funded by Eli Lilly and Company. Funding. Sponsorship for this study and Rapid Service Fee were funded by Eli Lilly and Company Indianapolis IN USA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s40744-023-00619-0",TRUE,"Conflict of Interest.",TRUE,"<section> Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: NCT02889796 NCT028739",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1007/s40744-023-00627-0",TRUE,"Conflict of Interest. Denis Poddubnyy: Research support from AbbVie Eli Lilly MSD Novartis Pfizer; Consulting fees from AbbVie Biocad Bristol-Myers Squibb Eli Lilly Janssen Moonlake Novartis Pfizer and UCB; Speaker fees from AbbVie Canon DKSH Eli Lilly Janssen MSD Medscape Novartis Peervoice Pfizer and UCB; Member of the executive committee of ASAS; Member of steering committee of GRAPPA.",TRUE,"<section> Funding. No funding or sponsorship was received for this study or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s41999-023-00858-y",TRUE,"Conflict of interest Marco Solmi has received honoraria/has been a consultant for Angelini Lundbeck Otsuka Abbvie unrelated to this work. The other authors did not declare any potential conflicts of interest for this work.",TRUE,"<section> Funding Open access funding provided by Università degli Studi di Palermo within the CRUI-CARE Agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s42399-023-01465-5",TRUE,"Conflict of Interest The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s43032-023-01252-6",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding Open access funding provided by Università degli Studi della Campania Luigi Vanvitelli within the CRUI-CARE Agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s43032-023-01365-y",TRUE,"Conflict of Interest The authors declare no competing interests.",TRUE,"<section> Funding Open Access funding enabled and organized by Projekt DEAL. The study was funded by the Deutsche Forschungsgemeinschaft Research Grants Program (grant numbers: SCHW 1946/2-1 and",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s43440-023-00540-x",TRUE,"Conflict of interest The authors declare no conflicts of interest.",TRUE,"<section> Acknowledgements We gratefully acknowledge support from the grant NCN OPUS 23 2022/45/B/NZ7/02419 and the Statutory Activity of the Maj Institute of Pharmacology Polish Academy of Sciences Kraków Poland and Max-Delbrück-Center for Molecular Medicine Berlin Germany.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1007/s43440-023-00545-6",TRUE,"Conflict of interest The authors declare no competing interests.",TRUE,"<section> Funding The study received support from the EU H2020 MSCA ITN project named “Serotonin and Beyond” (N 953327) which was awarded to MB and NA. Funding was also provided through the statutory funds of the Maj Institute of Pharmacology of the Polish Academy of Sciences in Kraków Poland.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1007/s43441-023-00530-4",TRUE,"Conflict of Interest David Higgins is a visiting researcher at the Berlin Institute of Health.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.accpm.2023.101249",FALSE,"",TRUE,"Financial support was warranted by the producer of Tobramycin (Novartis Pharma GmbH Switzerland). <section> Funding <section> Financial support was warranted by the producer of Tobi 1 (Novartis Pharma GmbH Switzerland).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.actbio.2022.11.052",TRUE,"Competing Interest The authors declare that there are no competing interests that had impact on the quality or reliability of the presented data or results.",TRUE,"<section> Financial support <section> This study was supported by Karl Leibinger Medizintechnik",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.actbio.2023.01.007",TRUE,"Competing Interest <section> S.P.H. is a shareholder at Xeltis BV and LifeMatrix AG. M.Y.E. is a shareholder at LifeMatrix AG. All other authors declare no competing interests.",TRUE,"<section> Funding and author contribution E.S.F. and N.P. were supported by the SNSF MIRAvalve grant. M.Y.E. received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program grant agreement no. 852814 (TAVI4Life).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.acvd.2023.10.006",TRUE,"Disclosure of interest <section> The other authors declare that they have no competing interest.",TRUE,"<section> Sources of funding No funding was provided for this analysis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.addlet.2023.100148",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.adro.2023.101224",TRUE,"Disclosures: Felix Ehret is a participant in the BIH Charit\u0002 e Junior Clinician Scientist Program funded by the Charit\u0002 e − <section> Universit€ atsmedizin Berlin and Berlin Institute of Health (BIH). No other disclosures were reported.",TRUE,"<section> Sources of support: This work had no speciﬁc funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ahj.2023.01.007",TRUE,"Disclosures <section> Chr istian Spaulding repor ts personal fees from Medtronic Minnesota USA Abbott Illinois USA Edwards California USA Techwald Italy The European Cardiovascular Research Center (CERC) France and travelling expenses from MedAlliance Switzerland.",TRUE,"<section> Funding <section> The SELUTION DeNovo trial is funded by MedAlliance CardioVascular SA  Rue de Rive 5 1260 Nyon Switzerland.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ahj.2023.02.003",TRUE,"<section> The remaining authors report to have no disclosures.",TRUE,"<section> The FAST III trial is an investigatorinitiated study sponsored by the European Cardiovascular Research Institute (ECRI Rotterdam The Netherlands). <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajcnut.2022.10.004",TRUE,"Disclosure Statement",TRUE,"<section> Funding <section> Part of the work reported in this paper was undertaken while NK was hosted by the International Agency for Research on Cancer and funded by the John Latsis Public Beneﬁt Foundation and the International Agency for Research on Cancer. The rest of the work was conducted while she was funded by Krebsforschung Schweiz under Grant KFS-4114-02-2017 to SR. Funding for this study was also provided by the Health Research Board of Ireland project grants and HRA-POR/2013/397 (to DJH). KEB is supported by a Sir Charles Hercus Health Research Fellowship from the Health Research Council of New Zealand. KP is supported by Cancer Research UK and the Wellcome Trust Our Planet Our Health (Livestock Environment and People). <section> 2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC-UU_12015/1) and Cancer Research The national EPIC cohorts are supported by: Danish Cancer Society (Denmark); Ligue Contre le Cancer Institut Gustave Roussy Mutuelle G\u0001 en\u0001 erale de l’Education Nationale Institut National de la Sant\u0001 e et de la Recherche M\u0001 edicale (INSERM) (France); German Cancer Aid German Cancer Research Center (DKFZ) German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health Welfare and Sports (VWS) Netherlands Cancer Registry (NKR) LK Research Funds Dutch Prevention Funds Dutch ZON (Zorg Onderzoek Nederland) World Cancer Research Fund Statistics Netherlands (The Netherlands); Health Research Fund (FIS) Instituto de Salud Carlos III (ISCIII) Regional Governments of Andalucía Asturias Basque Country Murcia and Navarra and the Catalan Institute of Oncology ICO (Spain); Swedish Cancer Society Swedish Research Council and Region Skåne and Region V€ asterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C8221/ <section> We thank the National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands for their contribution and ongoing support to the EPIC Study.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ajcnut.2023.01.010",TRUE,"<section> All authors report no conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the Competence Cluster Nutrition Research Berlin-Potsdam funded by the Federal Ministry of Education and Research (BMBF funding code 01EA1408). <section> JS were supported by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajhg.2023.01.002",TRUE,"<section> Declaration of interests <section> J.B.M. is an academic associate for Quest Diagnostics Endocrine R&D.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ajhg.2023.02.004",TRUE,"<section> Declaration of interests <section> The authors declare no competing interests.",TRUE,"<section> This work was supported by the German Research Foundation (Wi 945/17-1 [project-ID 398410809]; Wi 945/18-1 [project ID 384170921]; Wi 945/19-1 [project-ID 417989143]; SFB1451 [project-ID 431549029-A01] KY96/1-2 [project ID 269018619] and GRK1960 [project ID 233886668]) the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 2012-305121 ‘‘Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)’’ and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program under the Marie Sk1odowska-Curie grant agreement No 956185 (SMABEYOND) the Center for Molecular Medicine Cologne (project No C18) to B.W.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajhg.2023.04.010",TRUE,"<section> Declaration of interests <section> The authors declare no competing interests.",TRUE,"The 100000 Genomes Project is funded by the National Institutes of Health Research and NHS England. The Wellcome Trust Cancer Research UK and the Medical Research Council have also funded research infrastructure.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajhg.2023.05.009",TRUE,"<section> Declaration of interests <section> The authors declare no competing interest.",TRUE,"This project was supported by Deutsche Forschungsgemeinschaft (DFG German Research Foundation) No. 441409627 (to M.S. A.D. B.v.d.W. and F.M.S.) as part of the PROSPAX consortium under the frame of the European Joint Programme on Rare Diseases under the EJP RD COFUND-EJP No. 825575; the US Department of Veterans Affairs Seattle Washington; the Fondazione Regionale per la Ricerca Biomedica (CP 20/2018 [Care4NeuroRare]) to F.T.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajhg.2023.07.011",TRUE,"<section> Declaration of interests <section> The authors declare no competing interests.",TRUE,"U.K. received funding from the German Federal Ministry of Education and Research (BMBF) (031L0234A ‘‘BOAC’’) the Elsbeth Bonhoff Stiftung (Zuwendungsgesuch 98) and the German Research Foundation (DFG) (KO2891/9-1).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajhg.2023.10.007",TRUE,"Disclosure of Protected Health Information’’). Proband 9 signed a consent form approved by Seattle Children’s Hospital’s IRB (‘‘Media Authorization for the Use and Disclosure of Protected Health Information’’). Proband 10 signed a consent form approved by Cincinnati Children’s Hospital Medical Center (‘‘Authorization and Release for Use and/or Disclosure of Protected Health Information for Scientific Presentation and/or Publication’’). <section> Declaration of interests <section> The authors declare no competing interests.",TRUE,"E.B.L. is supported by National Institutes of Health grant RF1AG065341. T.-F.C. is supported by National Institute of Neurological Disorders and Stroke grant R01NS102279. C.C.W. is supported by National Institute on Aging grant R01AG031867 and National Institute of Arthritis and Musculoskeletal and Skin Diseases grant K24AR073317.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajogmf.2023.101117",TRUE,"<section> The authors report no conﬂict of interest.",TRUE,"Results of this study were presented in part at the C.C.L. is supported by the UK National Institute for 32nd World Congress on Ultrasound in Obstetrics and Health and Care Research Biomedical Research Centre Gynecology London United Kingdom September based at Imperial College Healthcare National Health Ser−18 2022.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajpc.2023.100503",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study was funded by Novartis Pharmaceuticals AG Basel Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ajt.2023.02.027",TRUE,"Disclosure <section> The authors have no ﬁnancial disclosures to report described by the American Journal of Transplantation. A.P. was supported by NIH 5K12HD028827-28 29 and has served on the speaker’s bureau for Sanoﬁ Genzyme on matters unrelated to this manuscript. M.R. received funding from the German Research Foundation (Emmy-Noether Program). The remaining authors of this manuscript have no conﬂicts of interest to disclose as described by the American Journal of Transplantation.",TRUE,"<section> Funding <section> No external funding was secured for this study. A.P. was supported by NIH 5K12HD028827-28 29 and has served on the speaker’s bureau for Sanoﬁ Genzyme on matters unrelated to this manuscript. M.R. received funding from the German Research Foundation (Emmy-Noether Program).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.alit.2022.06.001",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.alit.2023.05.003",TRUE,"The rest of the authors have no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.anai.2023.03.028",TRUE,"Disclosures: Dr Lumry is a member of advisory boards Behring Intellia KalVista Pharvaris and Takeda; from BioCryst CSL Behring Ionis KalVista and Takeda; Cryst CSL Behring Fresenius Kabi Pharming and from CSL Behring Pharming and Takeda; and is the US Hereditary Angioedema Association.",TRUE,"<section> Funding: The HELP OLE Study was sponsored by Takeda Pharmaceuticals USA Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: ClinicalTrials.gov Identiﬁers: NCT02586805 (HELP Study) and NCT02741596 (HELP openlabel extension).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.annonc.2022.09.161",TRUE,"<section> DISCLOSURE Reported grants and personal fees: TS: Amgen AstraZeneca Bayer BMS Falk Foundation Pierre Fabre Servier Boehringer Ingelheim Cantargia AB Sanoﬁ Merck Serono; <section> Roche; HA: AstraZeneca MSD Servier Seattle Genetics Chugai Pharma; HF: Bayer Merck Pﬁzer Mylan; AK: Ipsen Pierre Fabre Roche CCS: Merck; MG: Amgen Lilly Merck; <section> DW: AstraZeneca Bayer BMS Eisai Falk Pharma Incyte Roche Ipsen; AT: Amgen Falk Pharma Merck Pﬁzer; LP: <section> AstraZeneca Servier; MT: CPRIT Novartis Abbvie Advance Medical/Teladoc Health AstraZeneca BMS EcoR1 Capital Eisai Elicio Therapeutics FibroGen GlaxoSmithKline Immunovia Ipsen Karyopharm Therapeutics Merck Pharmacyclics Swedish Orphan Biovitrum Ono Pharmaceutical BIOPHARM GlaxoSmithKline Pharmacyte Biotech Tocagen; <section> ACR: Amgen AstraZeneca BMS MCI Group Merck Serono MSD Roche Pierre Fabre Roche Alexion Pharmaceuticals BioNTech Rafael Pharmaceuticals Servier; TJE: AstraZeneca Bayer BMS Daiichi Sankyo Eisai Incyte Ipsen Lilly Merck Serono MSD Pierre Fabre Roche Sanoﬁ Servier. All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> The NEONAX trial was supported by an unrestricted grant from Celgene/Bristol-Myers Squibb (no grant number). <section> DISCLOSURE Reported grants and personal fees: TS: Amgen AstraZeneca Bayer BMS Falk Foundation Pierre Fabre Servier Boehringer Ingelheim Cantargia AB Sanoﬁ Merck Serono;",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,"<section> The trial is registered with ClinicalTrials.gov (NCT02047513) e005559-34).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.annonc.2022.11.002",TRUE,"<section> DISCLOSURE <section> GA reports grants from Biogen Novartis Roche Sanoﬁ Abbvie Pﬁzer and CSL Behring outside the submitted work. AA reports research grant with an unrestricted grant from Bristol Myers Squibb (BMS). All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by a grant from Investissements d’avenir and by the grant INCa-DGOS-Inserm_12560 of the SiRIC CURAMUS [grant number INCa-DGOS-Inserm_12560] the program ‘investissements d’avenir’ [grant number ANRa 10-IAIHU-06] PRT-K/INCa grant LOC-model reference 20171-RT-04 (no grant number) DRCI de l’APHP (no grant number) CRC2013_105_R1/projet Tri LOC BETPSY project overseen by the French National Research Agency as part of the second ‘Investissements d’Avenir’ program [grant number ANR-18-RHUS-0012] Foundation RAM active investments ARTC foundation (no grant number) an unrestricted grant from Bristol Myers Squibb (BMS) [grant number RDON06618] ICGex project (no grant number) and IDeATIon project with an unrestricted grant from MSD Avenir (no grant number).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.annonc.2022.11.003",TRUE,"<section> DISCLOSURE All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by ARCAGY Research AstraZeneca Merck Sharp & Dohme LLC a subsidiary of Merck & Co. Inc. Rahway NJ USA and F.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.annonc.2023.04.002",TRUE,"<section> DISCLOSURE All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by Exact Science Celgene Amgen and AOK Rheinland/Hamburg (no grant number).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.annonc.2023.05.003",TRUE,"<section> DISCLOSURE NH reported honoraria for lectures and/or consulting from Amgen AstraZeneca Daiichi Sankyo EPG Communication Gilead Lilly MEDSCAPE MSD Novartis Pierre Fabre Pﬁzer Roche Sandoz Sanoﬁ Seagen Springer Viatris Zuelligpharma; all outside the submitted work and co-director position at West German Study Group (WSG). All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by Pﬁzer (no grant number).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.annonc.2023.05.005",TRUE,"<section> DISCLOSURE All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by Association de Recherche Cancers Gynécologiques (ARCAGY) Research AstraZeneca Merck Sharp & Dohme (a subsidiary of Merck & Co. Inc. Rahway NJ U.S.A) and F.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.annonc.2023.09.3110",TRUE,"Disclosure.",TRUE,"<section> FUNDING <section> This work was funded by AstraZeneca and is part of an alliance between AstraZeneca and Merck Sharp & Dohme LLC a subsidiary of Merck & Co. Inc. Rahway NJ USA (no grant number).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.atherosclerosis.2023.01.022",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Financial support <section> This study was supported by grants of the Austrian Research Fund The GCKD study was and is supported by the German Ministry of Education and Research (Bun­ desministerium für Bildung und Forschung FKZ 01 ER 0804 01 ER Schachtl-Riess: Methodology Software Validation Formal analysis Investigation Writing – original draft Visualization Project administration Funding acquisition Writing – review & editing. <section> Kai-Uwe Eckardt: Resources Funding acquisition Writing – review & editing. <section> Anna Köttgen: Resources Funding acquisition Writing – re­ view & editing. <section> Florian Kronenberg: Conceptualization Resources Methodology Investigation Supervision Project administration Funding acquisition Writing – review & editing.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.atherosclerosis.2023.117354",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests:",TRUE,"<section> Financial support <section> This work was supported by Novartis Pharma AG Basel Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.atherosclerosis.2023.117384",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Financial support The GCKD study is supported by the German Min­ istry of Education and Research (FKZ 01 ER 0804 01 ER 0818 01 ER Further­ more this study was partially funded by the H2020-IMI2 Consortium BEAt-DKD (Biomarker Enterprise to Attack Diabetic Kidney Disease; The work of AK was supported by DFG grant",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.athplu.2023.06.001",TRUE,"<section> The authors declare the following ﬁnancial interests/personal relationships which may be considered as potential competing interests: NS was project lead of the CaRe High registry which is ﬁnanced in cooperation with Amgen GmbH and Sanoﬁ-Aventis GmbH.",TRUE,"<section> Financial support",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.autrev.2023.103290",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Ivan Castellvi’ reports a relationship with Janssen-Cilag SAS that",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.autrev.2023.103452",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding Luis Nacul is partially funded by grants from BC Women’s Health Foundation BCCDC Foundation for Population and Public Health Canada and the National Institutes of Health (NIH) US. Anna Aschenbrenner and Joa­ chim Schultze are members of the excellence cluster ImmunoSensation (EXC 2151) funded by the German Research Foundation (DFG) under grant agreement #390873048 and are supported by the DFG via the SFB <section> Academies Collection: Reports funded by National Institutes of Health.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bas.2023.102673",TRUE,"<section> Declaration of competing interest <section> TA is Chief Scientific Officer at BIT Pharma; BJ is Chief Executive Officer co-founder and shareholder at BIT Pharma; VP is consultant and shareholder at BIT Pharma. <section> The other authors declare no conflict of interests.",TRUE,"<section> Funding <section> The trial was partly supported by the Austrian research promotion",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial registration number is EudraCT number 2016-004521-",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.bas.2023.102684",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bas.2023.102707",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bbamem.2022.184081",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bbi.2023.01.006",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bbi.2023.03.023",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was supported by the DFG (WO 1418/6-1) (S.A.W.) NIH/ NINDS R01 NS088137 (OB) R21 NS104609 (OB) R21 NS101673 (OB); <section> mut Kettenmann: Writing – original draft Writing – review & editing Funding acquisition Supervision. Wolf: Conceptualization Writing – original draft Writing – review & editing Funding acquisition",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bbih.2023.100609",TRUE,"<section> Declaration of competing interest <section> All authors of the manuscript “Immunoreactivity to astrocytes in different forms of dementia: high prevalence of autoantibodies to GFAP” report no conflicts of interest.",TRUE,"<section> This work was supported by grants from the German Research Foundation (DFG) (grants FOR3004 PR1274/3-1 PR1274/5-1 and",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bbih.2023.100678",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was supported by grants from the German Research Foundation (DFG) (grants FOR3004 PR1274/4-1 PR1274/5-1 PR1274/9-1) the Helmholtz Association (HIL-A03) the German Federal Ministry of Education and Research (Connect-Generate 01GM1908D) the Einstein Stiftung Fellowship through the Günter Endres Fond and the Sonnenfeld-Stiftung.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bbih.2023.100705",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: We thank EUROIMMUN laboratory for NMDAR1-abs measurements and J. Siegerink report no disclosures related to this work.",TRUE,"<section> The PROSCIS-B study received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). <section> Heuschmann reports research grants from the German Ministry of Research and Education German Research Foundation European Union Charité Berlin Chamber of Physicians German Parkinson Soci­ ety University Hospital Würzburg Robert-Koch-Institute German Heart Foundation Federal Joint Committee (G-BA) within the Innova­ tionsfond Charité–Universitätsmedizin Berlin (within MonDAFIS; sup­ ported by an unrestricted research grant to the Charité from Bayer) University Göttingen (within FIND-AF-randomized; supported by an unrestricted research grant to the University Göttingen from BoehringerIngelheim) and University Hospital Heidelberg (within RASUNOAprime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer BMS Boehringer-Ingelheim Daiichi Sankyo) all outside of the submitted work. The PROSCIS-B study received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). Heuschmann reports research grants from the German Ministry of Research and Education German Research Foundation European Union Charité Berlin Cham­ ber of Physicians German Parkinson Society University Hospital Würzburg Robert-Koch-Institute German Heart Foundation Federal Joint Committee (G-BA) within the Innovationsfond Char­ ité–Universitätsmedizin Berlin (within MonDAFIS; supported by an unrestricted research grant to the Charité from Bayer) University Göttingen (within FIND-AF-randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim) and University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer BMS Boehringer-Ingelheim Daiichi Sankyo) all outside of the submitted work.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bcp.2023.115793",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: U.",TRUE,"<section> U. Muscha Steckelings: Conceptualization Formal analysis Writing – original draft Writing – review & editing Visualization Supervision Project administration Funding acquisition. <section> This study was funded by grants from the Danish Council for Inde­ pendent Research (4004-00485B) and the Novo Nordisk Foundation Denmark (6239) to UMS.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bcp.2023.115798",TRUE,"Competing Interest",TRUE,"<section> Financial support",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bcp.2023.115805",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Financial support",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.berh.2023.101852",FALSE,"",TRUE,"<section> The research underpinning the work presented has received funding from the following sources: The European Commission Seventh Framework Programme (EU FP7; HEALTH.2012.2.4.5e2 project number 305815; Novel Diagnostics and Biomarkers for Early Identiﬁcation of Chronic Inﬂammatory Joint Diseases). Ali Mobasheri also wishes to acknowledge funding from the European Commission through a Marie Curie Intra-European Fellowship for Career Development grant (project number 625746; acronym: CHONDRION; FP7-PEOPLE-2013-IEF) and support from the European Social Fund according to the activity “Improvement Ali Mobasheri is funded by the European Regional Development Fund through the Research Council of Lithuania according to the Programme “Attracting",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bioactmat.2022.04.012",TRUE,"<section> Declaration of competing interest <section> The study was partially funded by Biotrics bioimplants and Frank Witte is an employee of the company. All the other authors have no <section> conflict of interest to declare.",TRUE,"<section> Gordon William Blunn: Concep­ tualization Resources Writing – review & editing Supervision Funding acquisition. <section> Frank Witte: Conceptualization Methodology Resources Writing – review & editing Supervision Funding acquisition. <section> The study was partially funded by Biotrics bioimplants and Frank Witte is an employee of the company. This study was part of a PhD programme cofunded by Biotrics bioimplants AG (Berlin Germany) the German Federal Ministry of Education and Research (BMBF grant number 13GW0176A) and the University of Portsmouth (Portsmouth United Kingdom).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bioactmat.2023.01.017",TRUE,"Conflict of interest <section> Declaration of Competing interest",TRUE,"<section> Regine Willumeit-Römer: Funding acquisition Project administration Resources Supervision Writing – review & editing. <section> Jan-Marten Seitz: Conceptualization Funding acquisition Project administration Resources Supervision Writing – <section> This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie SkłodowskaCurie Grant Agreement No 811226.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bioadv.2023.213288",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Volkmar Falk: Writing – review & editing Supervision Funding acquisition. <section> Ermanni: Writing – review & editing Supervision Conceptualization Funding acquisition. <section> This work was partially funded by the ETHeart initiative from the Open ETH program by the Executive Board of ETH Zurich and the Zurich Heart project of Hochschulmedizin Zürich.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bioadv.2023.213423",TRUE,"<section> Declaration of competing interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be considered as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was funded by the Deutsche Forschungsgemeinschaft (DFG) CRC 1444 grant.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bioadv.2023.213485",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Poulikakos: Writing – review & editing Supervision Funding acquisi­ tion. <section> Edoardo Mazza: Writing – review & editing Supervision Funding acquisition. <section> Mirko Meboldt: Writing – review & editing Supervision Funding acquisition. <section> Volkmar Falk: Writing – review & editing Su­ pervision Funding acquisition. <section> Aldo Ferrari: Conceptualization Writing – original draft Supervision Funding acquisition. <section> Giampietro: Conceptualization Writing – original draft Supervision Funding acquisition. <section> Marianne Schmid Daners: Conceptualization Writing – review & editing Supervision Funding acquisition. It is financially supported by the Stavros Niarchos Foundation (SNF) and the Swiss National Science Foundation (grant SNF; 205321_188828).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bioadv.2023.213568",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Andreas Kourouklis Xi Wu Aldo Ferrari and Edoardo Mazza have filed a patent (EP20208958.7) for protection of the technology described in the manuscript.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biomaterials.2022.121971",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Hans-Dieter Volk: Supervision Conceptualization Writing – review & editing Funding acquisition. <section> This project has received funding from the European Union’s Hori­ zon 2020 research and innovation programme under Grant Agreement No. Funding was provided by the Helmholtz Association and by the Federal Ministry of Education and Research Germany in the Program Health Research (BCRT grant no. 13GW0098 and 13GW0099).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biopha.2023.115635",TRUE,"Competing Interest",TRUE,"<section> Funding sources <section> This work was supported by grants of the “Hiege Foundation against skin cancer” to U.S. and by the Comprehensive Cancer Center Mecklenburg-Western Pomerania Germany (CCC-3900) to C.C. We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of the University of Greifswald.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biopha.2023.115661",TRUE,"Competing Interest",TRUE,"<section> R. Kreutz: Conceptualization Writing – review & editing Supervision Project administration Funding adquisition. Fernández-Alfonso: Conceptualization Writing – original draft Writing – review & editing Supervision Project administration Funding adquisition. <section> This work was supported by Bayer AG by UCM Grupos Santander and by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement MINDSHIFT (ID 954798). Marta Sanz is recipient of a fellowship from Universidad Complutense de Madrid.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biopha.2023.115698",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Ulrike Stein reports financial support was provided by SPARK Berlin.",TRUE,"<section> Funding information <section> This work was supported by Spark Berlin Berlin Institute of Health (BIH) (to Ulrike Stein Dennis Kobelt Wolfgang Walther) and in part by the German Cancer Consortium (DKTK). <section> Wolfgang Walther: Conceptualization Data curation Funding acquisition Writing of the original draft; <section> aré: Conceptualization Data curation Funding acquisition Writing of the original draft; <section> Dennis Kobelt: Funding acquisition Investigation and Validation Writing of the original draft; <section> Ulrike Stein: Conceptu­ alization Data curation Funding acquisition Project administration Supervision Writing of the original draft.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biopsych.2022.05.024",TRUE,"",TRUE,"ACKNOWLEDGMENTS AND DISCLOSURES The e:Med project was funded by the Bundesministerium für Bildung und Forschung (BMBF German Federal Ministry of Education and Research; Grant No. This work was partly supported by the SFB/TRR 265 Losing and Regaining Control over Drug Intake funded by the Deutsche Forschungsgemeinschaft (German Research Foundation; Project ID 402170461 [to AH AB FK SV-K HW]) and by the Cluster of Excellence EXC 2049 Neurocure funded by the BMBF (Project No. 390688087 [to AH]). The Family History Assessment Module has been provided by the Collaborative Study on the Genetics of Alcoholism supported by NIH Grant No. We thank all study participants for supporting our research.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.biopsych.2023.01.013",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES All other authors report no biomedical ﬁnancial interests or potential conﬂicts of interest.",TRUE,"<section> ORIGINs is supported by the National Institute of Mental Health (Grant No. Cohort 1: The EBDS (Early Brain Development Research) study is supported by the National Institute of Mental Health and National Institute of Child Health and Development (Grant Nos. MH064065 MH070890 and HD053000 [to JHG]) with genotyping funded by the National Institute of Mental Health (Grant No. Cohort 2: The GUSTO study was supported by the Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme and administered by the Singapore Ministry of Health’s National Medical Research Council (Grant Nos. Cohort 3: The IBIS study (Infant Brain Imaging Study) was supported by Grant Nos. Cohort 5: The University of California Irvine study was supported by the National Institutes of Health (Grant Nos. Cohort 6: The Max Planck Institute for Human Cognitive and Brain Sciences was supported by the Jacobs Foundation and by the German Research Foundation Heisenberg (Grant No. Cohort 7: The University of North Carolina study was supported by the National Institute of Neurological Disease and Stroke (Grant No. Cohort 8: The University of North Carolina study was supported by the National Institute of Neurological Disease and Stroke (Grant No. Cohort 9: The Developing Human Connectome Project was funded through a Synergy Grant by the ERC under the European Union’s Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. Cohort 10: The Baby Connectome Project was supported by the National Institute of Mental Health (Grant No. Cohort 11: The DCHS study was funded by the Bill & Melinda Gates Foundation (Grant No. Imaging aspects of the cohort are additionally supported by the National Research Foundation by the National Institute on Alcohol Abuse and Alcoholism via Grant Nos. Cohort 12: The University of North Carolina study was supported by the National Institute on Drug Abuse (Grant No. Cohort 14: The Boston study was funded by the William Hearst Fund (Harvard University) and by the National Institute of Child Health and Development (Grant No. Cohort 16: The University of Denver study was supported by Grant Nos. <section> Cohort 17: The University of Denver study was supported by the National Institute of Child Health and Development (Grant No. <section> Cohort 18: The Rhode Island Hospital study was supported by the National Institutes of Health (Grant No. Cohort 19: The Rochester-Magee study was supported by the National Institutes of Health (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.biopsych.2023.03.026",TRUE,"",TRUE,"<section> This work was supported by the Medical Research Council (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.bja.2022.09.031",TRUE,"<section> Declaration of interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: DRKS00011206. The study was approved by the appropriate ethics committee (# EA1/151/16) and was registered with the German register for clinical trials (#DRKS00011206; Universal Trial Number: U1111-1189-2772).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.bja.2022.11.007",TRUE,"<section> Declarations of interest <section> RG is treasurer of the European Airway Management Society (EAMS). None of the other authors have declared conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: NCT02743767. The study was approved by the Cantonal Ethics Committee of Bern (approval number 092/15) and was registered with ClinicalTrials.gov (NCT02743767).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.bja.2023.04.031",TRUE,"<section> Declaration of interest <section> GW is coordinator of the BioCog consortium and is chief executive of the company Pharmaimage Biomarker Solutions GmbH (http://www.pi-pharmaimage.com). Among other academic and private partners the company is a partner of the BioCog study. CD and TP are project leaders in BioCog. IF JJ AS CS and TP declare that they have no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: NCT02265263.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.bone.2023.116912",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Bert van Rietbergen is a consultant for Scanco Medical AG. All other authors declare that they have no conflict of interest.",TRUE,"<section> Kathrin Becker: Writing – review & editing Writing – original draft Validation Supervision Software Resources Project adminis­ tration Methodology Investigation Funding acquisition Data curation Conceptualization. <section> The study was funded by the Deutsche Forschungsgemeinschaft",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bpsc.2022.10.005",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES",TRUE,"<section> This work is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) (KFO-219 KU 2665/1-2 [to JK] and Project-ID 431549029—SFB 1451 [to MT VV-V and JCB] and Project-ID 424778371—TRR 295 [to NL]).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bpsgos.2022.01.009",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES",TRUE,"<section> The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (to THH TN YF HV TH OP). This work was supported in part by Metagenopolis (Grant No. TB was supported by DFG grant KFO339.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bpsgos.2022.03.014",TRUE,"",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES The study was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy— EXC-2049 (Project No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bpsgos.2023.02.003",TRUE,"",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) FOR 1617—(Grant Nos. <section> FS was supported by the Heisenberg Program (SCHL 1969/5-1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.bpsgos.2023.04.008",TRUE,"<section> ACKNOWLEDGMENTS AND DISCLOSURES",TRUE,"<section> This work was not supported by any speciﬁc funding sources.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.brainresbull.2023.01.009",FALSE,"",TRUE,"Funding: This work was supported by the DFG in the priority program SPP2191 [#s 419138680 506373047] the Hertie Foundation [# P1200002] and by institutional funding from the Helmholtz Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.breast.2023.05.008",TRUE,"<section> Declaration of competing interest All remaining authors declare that they have no conflict of interest.",TRUE,"<section> Funding <section> This work was supported by a grant from the Swedish Breast Cancer Association (BCF). We also acknowledge the support of the Natural Sciences and Engineering Research Council of Canada (NSERC) [fund­ ing reference number PDF568028-2022]. <section> NAK has received funding from the European Union under the Ho­ rizon 2020 programme (MultipleMS grant agreement 733161.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.breast.2023.103580",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests:",TRUE,"<section> Funding <section> This study and medical writing support of this manuscript were funded by Bristol Myers Squibb. <section> This study was supported by Bristol Myers Squibb.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.brs.2023.08.020",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cardfail.2023.03.019",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study was funded by Novartis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cardfail.2023.06.024",TRUE,"Disclosures MSK reports no relevant disclosures.",TRUE,"<section> SDA has received grants from Vifor Pharma; personal fees from Bayer Brahms GmbH Cardiac Dimensions Cordio Novartis Servier and grants and personal fees from Abbott Vascular outside the submitted work. JLJ is a trustee of the American College of Cardiology a board member of Imbria Pharmaceuticals has received grant support from Applied Therapeutics Innolife Novartis Pharmaceuticals and Abbott Diagnostics consulting income from Abbott Janssen Novartis and Roche Diagnostics and participates in clinical endpoint committees/data safety monitoring boards for Abbott AbbVie Amgen Bayer CVRx Janssen MyoKardia and Takeda. <section> Sources of Funding <section> The EMPEROR-Reduced trial was funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cell.2022.12.007",TRUE,"<section> DECLARATION OF INTERESTS <section> K.C. is currently employed by AstraZeneca.",TRUE,"This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001134) the UK Medical Research Council (FC001134) and the Wellcome Trust (FC001134) and received specific funding from the European Research Council (ERC) under grant agreement ERCSyG-2020 951475 (to M.R.) the Wellcome Trust (IA 200829/Z/16/Z to M.R.)) the Ministry of Education and Research (BMBF) as part of the National Research Node ‘‘Mass spectrometry in Systems Medicine (MSCoreSys)’’ under grant agreements 031L0220 (to M.R.) and 161L0221 (to V.D.) and the European Commission (EC) as part of CoBioTech project Sycolim ID#33 (BMBF 161B0931) to MR supporting C.C.-M. S.K. M.M. C.B.M. P.T. S.J.T. S.J.V. A.F. B.M.H. L.H.-D. S.K.A. L.S. J.S.L.Y. V.D. and M.M. R.T. is also supported by the National Research Development and Innovation Office PD 128271; and B.P. is also supported by the National Research Development and Innovation Office Élvonal Program KKP 129814 the ‘‘Lendület’’ program of the Hungarian Academy of Sciences LP2009-013/2012 and the European Union’s Horizon 2020 research and innovation program grant no. 739593.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cell.2023.03.026",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by the BBSRC (nos. G.K. is funded by an MRC Career Development Fellowship (MR/T03050X/1). C.B.M. is supported by the Precision Proteomics Center Davos which receives funding through the Swiss canton of Grisons.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cell.2023.04.012",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks. This work was funded by the Max Planck Society the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) project 500335138 SFB 1381 (project-ID 403222702) and under Germany’s Excellence Strategy (CIBSS—EXC-2189—project ID 390939984) and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. ERC-2018-STG-803258).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cell.2023.07.009",TRUE,"<section> DECLARATION OF INTERESTS <section> M. Brendel received speaker honoraria from GE healthcare Roche and Life Molecular Imaging and is an advisor of Life Molecular Imaging.",TRUE,"<section> This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC CoG no. 865323 to A.E. and ERC-StG 802305 to A.L.) and Nomis Foundation (A.E.). This work was further supported by Vascular Dementia Research Foundation Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy ID 390857198 and ID 390857198 [C.P.]) grant DI-722/16-1 (project ID: 428668490) and a dedicated grant to M. M.K. has been on advisory boards for Biogen medDay Pharmaceuticals Novartis and Sanofi; has received grant support from Sanofi and Biogen; and has received speaker fees from Abbvie Almirall Biogen medDay Pharmaceuticals Merck Serono Novartis Roche Sanofi and Teva—none in relation to this study.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cell.2023.09.004",TRUE,"<section> DECLARATION OF INTERESTS <section> Z.K.-N. and M.B. are employed by DeepMind Technologies Limited.",TRUE,"T.B. is supported by a Wellcome Principal Research Fellowship (219525/Z/19/Z) a Wellcome Collaborator award (214314/Z/18/Z) and a JS McDonnell Foundation award (JSMF220020372). The Wellcome Centre for Integrative Neuroimaging and Wellcome Centre for Human Neuroimaging are each supported by core funding from the Wellcome Trust (203139/ Z/16/Z 203147/Z/16/Z).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cell.2023.09.027",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"Supported by grants from the German Research Foundation (DFG; Collaborative Research Center TRR186/A08 to V.H. and TRR186/Z04 to B.B.) from ANR and RHU-Cosy (to M.P. and O.L.-O.) postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and Leopoldina (to M.E.) and a PhD student scholarship by the Jürgen Manchot Stiftung to P.M.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.celrep.2022.111937",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> This work was supported by grants from the DFG (KR 4521/1-1 to B.K. SPP1937 to J.N. SFB/TR 57 to U.S. and J.N.) H.W. S.E. and S.L. are supported by postdoc research fellowships within the Mildred-Scheel School of Oncology-Cologne-Bonn supported by the German Cancer Aid – Project ID 70113307 (Deutsche Krebshilfe). This work was also supported by the Genomics Facility a core facility of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.celrep.2023.112269",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"M.O.J. received funding by the ARS Bridge to academic career grant. <section> M.O.J. G.B. and M.G.A. received funding by the Swiss National Science C.S.N.K. is supported by the European Research Council Starting Grant (ERCEA; 803087) and the German Research Foundation (DFG; project ID 259373024; CRC/TRR 167 FOR2599 project 5 B05 project ID 375876048; CRC/TRR 241 KL 2963/5-2 SPP1937 KL 2963/2-1 and KL 2963/3-1 to C.S.N.K.). A.D. is supported by grants from the European Research Council (ERC AdG #101055309: ILCAdapt) and the German Research Foundation (SPP1937 [DI764/9-2]; FOR2599 [project A5 DI764/10-2] CRC 1444 [project #427826188; project 11]; CRC-TRR 241 [project #375876048; project A01] CRC-TRR 156 [project A02]; CRC-TRR 84 [projects A01 und A06]).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.celrep.2023.112533",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by the Transluminal-B and IntegrateTN consortia funded by the German Cancer Aid Organisation (Translational Oncology Program Project 701134509) the Swiss Bridge Award and the Dietmar Hopp Foundation (all to A.T.). This work was further supported by a Max Eder Grant of the German Cancer Aid Organisation (Deutsche Krebshilfe 110225) (to C.H.S.). M. Reichert was supported by the Federal Ministry of Education and Research SATURN3 ‘‘Spatial and Temporal Resolution of Intratumoral Heterogeneity in 3 hardto-treat Cancers‘‘ (Project 01KD2206P).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.celrep.2023.112541",TRUE,"<section> DECLARATION OF INTERESTS <section> M.J. is currently an employee of PPD Germany GmbH & Co.",TRUE,"<section> This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to A.M.W. M.J. was supported by the Einstein Foundation Berlin (grant EZ-2014-226).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.celrep.2023.112739",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"Funding was provided by the Academy of Finland through MetaStem Center of Excellence funding to V.H. This study was facilitated by the University of Helsinki Drosophila core facility (Hi-Fly) the DNA sequencing and genomics core facility and the Light Microscopy Unit all supported by Biocenter Finland and Helsinki Institute of Life Science.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.celrep.2023.112926",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> Multifunctional Platform for Innovation (001) and appreciate Beijing PARATERA Tech Co. Ltd (https://paratera.com/) and National Super Computing Center in Zhengzhou for providing computational resources for this study. This work was funded by the Ministry of Science and Technology of China (2017YFA0504800 2018ZX09711003-003-003 and 2019ZX097 21001-004-007 to J.L. and 2018YFA0508100 to L.Y. and Q.Z.) ShanghaiTech University (to J.L.) and the National Natural Science Foundation of China (31900895 to L.Y.). It was also supported in part by the European Research Council (ERC) Advanced Grant 740537 (VOLSIGNAL) and the Deutsche Forschungsgemeinschaft (DFG) JE164/12-2 and Excellence Strategy—EXC2049—390688087 grants to T.J.J.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.celrep.2023.112934",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This project has received funding from the European Research Council (ERC) under the Union’s Horizon 2020 research an innovation program (grant agreement no. 864243) and from the Einstein Foundation Berlin (EP-2021-621).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.celrep.2023.113166",TRUE,"<section> DECLARATION OF INTERESTS <section> J.D. receives royalties from Euroimmun for the use of the NMDA receptor as an antibody <section> test.",TRUE,"The FLI is a member of the Leibniz Association and is financially supported by the Federal Government of Germany and the State of Thuringia. This work was supported by the German Research Foundation (FOR3004; GE2519/8-1 and GE2519/9-1 [to C.G.]",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.celrep.2023.113510",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by NIH grant GM115420 (to E.B.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.chom.2023.10.007",TRUE,"<section> DECLARATION OF INTERESTS <section> Related to this work Deutsches Rheuma-Forschungszentrum (DRFZ) has filed a patent application.",TRUE,"Work was supported by DFG (TRR241/B03 and TRR130 P16 to H.-D.C. A.R. and Clinical Research Unit KFO 5023 ‘‘BecauseY’’ Project number 504745852 to A.A.K.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.clinph.2022.11.011",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> MJS was funded by the Amsterdam UMC TKI-PPP grant (2021 call). BCMvW received funding from an EU Joint Programme – Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND – www.jpnd.eu: the Netherlands Organisation for Health Research and Development (ZonMw) – The Netherlands. AWGB was supported by travel stipends from the Dr.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.clinph.2023.03.010",TRUE,"Conflict of interest <section> A Benussi was partially supported by the Airalzh-AGYR2020 by Fondazione Cariplo (grant n° 2021-1516) and by the Fondation pour la Recherche sur Alzheimer. M. Hallett is an inventor of a patent held by NIH for the H-coil for magnetic stimulation for which he receives license fee payments from the NIH (from Brainsway). He is on the Medical Advisory Board of Brainsway (unpaid position). S. Kreig reports being a consultant for Brainlab and receiving honorarium for lectures provided for Nexstim and Inomed. M Massimini is a co-founder and shareholder of Intrinsic Powers a spin-off of the University of Milan Milan Italy. T. Picht served as a consultant for the TMS system manufacturer Nexstim Oy Helsinki Finland. U. Ziemann reports receiving a grant from Takeda Pharmaceutical Company Ltd. and consulting fees CorTec GmbH. The other authors have no potential conflicts of interest to",TRUE,"<section> A Benussi was partially supported by the Airalzh-AGYR2020 by Fondazione Cariplo (grant n° 2021-1516) and by the Fondation pour la Recherche sur Alzheimer.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.clinph.2023.05.012",TRUE,"Competing Interest",TRUE,"DVD: Funding acquisition; Writing – review & editing. PH: Conceptualization; Funding acquisition; Writing – review & editing. SV: Conceptualization; Supervision; Funding acquisition; Writing – review & editing. <section> This work was supported by Swiss National Science Foundation (SNSF) grant no. 192749 CRSII5_170873 and CRSII5_209470 to SV. KG was supported by German Research Foundation (DFG) grant ‘‘SPP DBS RI 2973/10-2”. GMP acknowledges the CIBM Center for Biomedical Imaging founded and supported by Lausanne University Hospital (CHUV) University of Lausanne (UNIL) École polytechnique fédérale de Lausanne (EPFL) University of Geneva (UNIGE) and Geneva University Hospitals (HUG). MS was supported by SNSF grant number CRS115-180365. PH is supported by the SNSF grant numbers CRSII5_170873 and CRSII5_209470.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.clinre.2023.102094",TRUE,"Competing Interest",TRUE,"<section> Sources of funding/grant support/This may be Funding Agency.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered in the University Medical Center (UMCG) research registry (UMCG RR#201900347) and was reviewed and approved by the UMCG ethical committee (MEC 2019-290).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.clnu.2023.06.023",TRUE,"All expert members have declared their individual conﬂicts of interest according to the rules of the International Committee of Medical Journal Editors (ICMJE).",TRUE,"A recent critical review supported by the European Renal Nutrition Group of the European Renal Association (ERN-ERA) and ESPEN also recommends that renal status be prioritized in patients with advanced CKD (stages 4 and 5) [90]. <section> Funding <section> This work was supported by the ESPEN society as well as by the Swiss National Science Foundation (SNSF Professorship PP00",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cmet.2023.01.009",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"J.J. received funding from the DFG (German Research Foundation JA1993/6-1) and SFB 1350 grant (387509280 TPB5). <section> was supported by the DFG (STE2042/2-1) D.B. and H.K. were supported by the FNR-ATTRACT program (A14/BM/7632103) and D.B. by FNR-CORE grant (C18/BM/12691266) of the Luxembourg National Research Fund. D.A.H received funding from the National Institutes of Health (NIH) (U19 AI089992 R25 NS079193 P01 AI073748 U24 AI11867 R01 AI22220 UM 1HG009390 P01 AI039671 P50 CA121974 and R01 CA227473) and the National Multiple Sclerosis Society (NMSS CA1061-A-18 and RG-1802-30153). M.K. was supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (640116); by a SALK-grant from the government of Flanders; by an Odysseusgrant (G0G1216FWO) and senior research project (G080121N) of the Research Foundation Flanders Belgium (FWO); and by a BOF grant (ADMIRE 21GP17BOF) from Hasselt University.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cmet.2023.03.018",TRUE,"<section> DECLARATION OF INTERESTS <section> N.W. J.C.F. and A.G. are co-inventors of a patent on the composition method and use for FFA screening application no: 52199-550P01US. A.G. <section> serves as a founding advisor to a new company launched by Atlas Ventures an agreement reviewed and managed by Brigham and Women’s Hospital Mass General Brigham and the Broad Institute of MIT and Harvard in accordance with their conflict of interest policies.",TRUE,"This work was supported by a seed grant from the Broad Institute of MIT and Harvard (Bn10) DK095045 DK099465 and Cure Alzheimer’s Fund (to A.G.). N.W. was supported by a Deutsche Forschungsgesellschaft Fellowship (WI 4612/1-1) and is a participant in the BIH Digital Clinician Scientist Program funded by the DFG Charité – Universit € a tsmedizin Berlin and the Berlin Institute of Health at Charité (BIH). M.D.-L. was supported by a Broad-Israeli Science Foundation Fellowship. E.S. was supported by NIH 1-R01-DK126855-01 and an American Surgical Association Foundation Fellowship. M.C. was supported by FNIH AMP-T2D RFB8b and NIDDK UM1 DK126185.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cmi.2022.11.025",FALSE,"",TRUE,"SE: the Institution received grants from the Bundesministerium für Bildung und Forschung (BMBF) Germany and the German Center for Infection Research (DZIF). FH: the institution received funds from the German Center for Infection Research (DZIF) FH: received support for attending meetings from DZIF. JR: the institution received grants from the German Center for Infection Research (DZIF) received payment or honoraria for lectures from Janssen-Cilag GmbH and support for attending conferences from Janssen-Cilag GmbG and Gilead. DT: has received grants or research support from the German Center for Infection Research (DZIF) and ThermoFisher Scientiﬁc as well as travel support from Gilead. PGH: the institution received grants from the German Center for Infection Research (DZIF). <section> The study was supported by the German Centre for Infection Research (DZIF) as TTU 08.801 and TTU 08.811.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cmi.2023.05.031",TRUE,"<section> The authors declare that they have no conﬂicts of interest.",TRUE,"<section> Funding <section> No external funding was received for conduction of the analysis and drafting of the paper. The work in the multicentre cohort was supported by the German Centre for Infection Research (DZIF).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cmpb.2023.107615",TRUE,"Competing Interest <section> The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.cont.2023.100576",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.copbio.2023.102953",TRUE,"Competing Interest The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cortex.2023.01.005",TRUE,"<section> Declaration of competing interest <section> The authors declare no conflict of interest.",TRUE,"Roel Jonkers: Conceptualization Investigation Resources Writing e Original Draft Writing e Review & Editing Supervision Funding acquisition. <section> Rofes: Conceptualization Methodology Investigation Data curation Writing e Original Draft Writing e Review & Editing Resources Supervision Funding acquisition. <section> This work was supported by a PhD scholarship (IDEALAB https://phdidealab.com/) to EN and CS. <section> AR received funding from the Dutch Research Council (NWO 406.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.critrevonc.2023.103965",TRUE,"Competing Interests MM RA RB JB SG and ZK declare no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.critrevonc.2023.104185",TRUE,"Competing Interest <section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests Guido Giordano reports a relationship with Novartis that includes: consulting or advisory.",TRUE,"<section> Funding Del Re was the recipient of the special award from the Italian Society of Pharmacology for her contribution to research in pharmacogenetics (2014) and the special award ""SIF-Farmindustria for Pharmacological Research"" (2016).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.csbj.2022.12.019",TRUE,"Competing interests <section> The authors declare that they have no competing interests.",TRUE,"<section> This work was supported by the Project of RF Government Grant No. 075–15-2022–1094 (sleep studies and physiological interpreta­ tion of results) Russian Science Foundation Grant No. 20–15-0090 (ex vivo and in vivo analysis of LDSB) Russian Science Foundation Grant No. 21–75-10088 (ex vivo and in vivo analysis of OBBB) Russian Foundation for Basic Research Grant No. A.R. and M.Zh. acknowledge support from the project MD-645.2020.9 of the Council for Grants of the President of the Russian Federation for the State Support of Young Russian Scientists (in work part of the adaptation of wavelet skeleton method and EEG data analysis of oscillatory patterns).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.csbj.2023.02.009",TRUE,"Competing Interest <section> The authors declare that they have no known competing fi­ nancial interests or personal relationships that could have appeared",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ctro.2022.100573",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ctro.2023.100626",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ctro.2023.100638",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ctro.2023.100653",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ctro.2023.100684",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ctrv.2023.102541",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests:",TRUE,"<section> Funding sources <section> This work was supported by an unrestricted medical education grant from Pierre Fabre whose only involvement was to select the chair and to fund LiNK Health Group to provide independent medical writing sup­ port to the author group.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ctrv.2023.102556",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> This work was supported by the Department of Surgery of the Uni­ versity Hospital of Basel.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.cub.2022.12.039",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> This work was supported by the Einstein-BIH program and DFG Research Unit 5289 RobustCircuit project P2 (to B.A.H. and P.R.H.) DFG Research Unit Syntophagy RP7 (Hi 1886/8) funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 101019191 (to P.R.H.) the Investissements d’Avenir program (ANR-10-IAIHU-06) Paris Brain Institute-ICM core funding the Paul G. M.A. is funded by the Fondation de la Recherche Medical (FRM) postdoctoral fellowship (ARF202005011913).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.dcn.2022.101193",TRUE,"Competing Interests",TRUE,"<section> Funding sources (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772–01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. <section> JG HG PG FN MS; Funding Acquisition: JLM MLPM GS TB HG SD",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.dcn.2023.101226",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding Source <section> This work was supported by the IFB Adiposity Diseases Federal Ministry of Education and Research (BMBF) Germany GN: 01EO1501 the German Research Foundation (DFG) as part of Collaborative Research Centre 265 “Losing and Regaining Control over drug intake”",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.dcn.2023.101232",TRUE,"Disclosure <section> potential conflicts of interest.",TRUE,"Cognitive aptitudes against thinning Supported by the relationship between performance IQ and thickness as a function of PGS-NP shown in Fig. <section> This study was supported by the project grant from the Canadian Institutes of Health Research (153010). (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.dcn.2023.101286",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Damien Fair reports a relationship with Turing Medical Inc that in­ cludes: employment and equity or stocks.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.devcel.2023.11.013",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by the Helmholtz Alliance ‘‘Aging and Metabolic Programming AMPro’’ (M.C.F. and M.B.). Work in the laboratory of D.T.O. was supported in part by an ERC-Advanced Grant (‘‘CTCFStableGenome’’) from the European Research Council (ERC). Work in the laboratory of M.B. and O.S. was supported in part by an ERC-Synergy Grant (‘‘DECODE’’) from the European Research Council (ERC).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.dib.2023.109018",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"<section> Dylan Haynes: Conceptualization Methodology Resources Supervision Funding acquisition. <section> Creation of this dataset was funded by the Bernstein Computational Neuroscience Program of the German Federal Ministry of Education and Research (BMBF Grant 01GQ0411 ) the Excellence Initiative of the German Federal Ministry of Education and Research (DFG Grant GSC86/1-2009 )",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.dib.2023.109662",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"<section> sources Supervision Funding acquisition. <section> Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number MG was supported by a travel stipend from the Rolf W.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eats.2022.11.020",TRUE,"<section> The authors report the following potential conﬂicts of interest or sources of funding: M.S. is a consultant for Arthrex and Stryker outside the submitted work. Full ICMJE author disclosure forms are available for this article online as supplementary material.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eats.2023.03.020",TRUE,"<section> The authors report the following potential conﬂicts of interest or sources of funding: M.-C.R. reports other from Steadman Philippon Research Institute (SPRI) and Arthrex outside the submitted work. Full ICMJE author disclosure forms are available for this article online as supplementary material.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104441",TRUE,"<section> Declaration of interests DAL has received support from Medtronic Ltd and Roche Diagnostics for research unrelated to this study.",TRUE,"<section> Funding A full list of funding bodies that contributed to this study can be found under Acknowledgments. <section> Declaration of interests DAL has received support from Medtronic Ltd and Roche Diagnostics for research unrelated to this study. <section> Acknowledgements This study was supported by the US National Institute of Health (R01 DK10324) the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 669545 British Heart Foundation (CS/16/4/32482 and AA/18/ 7/34219) and the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol; the latter provided J Zhao’s salary whilst working on this study. Born in Bradford is funded by the Wellcome Trust (223601/Z/21/Z and WT101597MA) a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024397/1) the British Heart Foundation (CS/16/4/32482) and the National Institute for Health Research (NIHR) under its Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humber and the Clinical Research Network (CRN). IDS is supported by the Medical Research Council (MC_UU_00006/1 Etiology and Mechanisms). RMF is supported by a Wellcome Senior Research Fellowship (WT220390). This research was funded in part by the Wellcome Trust [Grant number WT220390]. MCB was supported by a UK Medical Research Council (MRC) Skills Development Fellowship (MR/P014054/1). J Zheng is supported by the Academy of Medical Sciences (AMS) Springboard Award the Wellcome Trust the Government Department of Business Energy and Industrial Strategy (BEIS) the British Heart Foundation and Diabetes UK (SBF006\\1117). The Fenland Study is funded by the Medical Research Council (MC_UU_12015/1). We further acknowledge support for genomics from the Medical Research Council (MC_PC_13046).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ebiom.2023.104470",TRUE,"<section> Declaration of interests <section> 23 Davis The authors declare that the research was conducted in the absence of Nurs.",TRUE,"The work in the group of 26 Chen A.R. was funded by Dr. Funding sources had glioblastoma: no role in study design interpretation or writing of the report.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104546",TRUE,"<section> Declaration of interests CO has two patents/patent applications in the ﬁeld of probiotics and bone health. All other authors declare that they have no conﬂict of interest.",TRUE,"<section> Funding Found in acknowledgements. This study was supported by the Swedish Research Council (2016-01001 2018-02921 2020-01392 202201156) the Swedish Foundation of Strategic Research (FFL15-0188) the Swedish state under the agreement between the Swedish government and the county councils the ALF agreement in Gothenburg (ALFGBG720331 ALFGBG-965235 ALFGBG-721621 ALFGBG-965362) the IngaBritt and Arne Lundberg Foundation (LU2017-0081 LU2021-0096) the Knut and Alice Wallenberg Foundation (KAW 2015.0317) and the Novo Nordisk Foundation (NNF15OC0015080 NNF190C0055250 NNF20OC0063954). The MEGASTROKE project received funding from sources speciﬁed at http://www.megastroke.org/acknowledgements.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104583",TRUE,"<section> Declaration of interests RK has received consulting fees from GenCirq Inc DayTwo Ltd and JGilbert Consulting LLC payment for lectures from BP Technology Ventures Inc and Hamilton College support for attending meetings and/or travel from the Chilean Senate the University of Melbourne the Shenzhen Society of Science and Technology the Norwegian Institute of Public Health and participated on a data safety monitoring board for Diversigen GenCirq Inc DayTwo Ltd Cybele Microbiome Inc BiomeSense Inc Micronoma Inc.",TRUE,"<section> Funding This study was funded by European Research Academy of Finland Finnish Medical Foundation and the Aaltonen Foundation and the Paavo Nurmi Foundation. <section> Declaration of interests RK has received consulting fees from GenCirq Inc DayTwo Ltd and JGilbert Consulting LLC payment for lectures from BP Technology Ventures Inc and Hamilton College support for attending meetings and/or travel from the Chilean Senate the University of Melbourne the Shenzhen Society of Science and Technology the Norwegian Institute of Public Health and participated on a data safety monitoring board for Diversigen GenCirq Inc DayTwo Ltd Cybele Microbiome Inc BiomeSense Inc Micronoma Inc. <section> Acknowledgements RBS has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 648131 from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 847770 (AFFECT-EU) and German Center for Cardiovascular Research (DZHK e.V.) ASH has received funding from the Academy of Finland (321356). TN has received funding from the Academy of Finland (321351) the Emil Aaltonen Foundation and Finnish Medical Foundation and the Finnish Foundation for Cardiovascular Research. LL has received funding from the Academy of Finland (295741). SKF has received funding from the German Center for Cardiovascular Research (DZHK e.V. Standort Berlin MDC) (81Z0100113) and the German Research Foundation (DFG SFB1470).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104616",TRUE,"<section> Declaration of interests MDR reports consulting fees from Roche Diagnostics and Medtronic; leadership or ﬁduciary role in the European Society of Gastrointestinal Endoscopy (ESGE) and World Endoscopy Organization (WEO). All other authors report no conﬂict of interest.",TRUE,"<section> Funding German Research Foundation (DFG). <section> Acknowledgments This study was supported by the German Research Foundation (DFG) (SCHU 1596/6–1 KN 378/3–1 LO 1147/1-1 and VE 917/1-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104644",TRUE,"Declaration of interests SF received personal fees from Kyowa Kirin and Takeda Pharmaceuticals institutional grants from NeraCare SkylineDx and BioNTech all outside the submitted work. <section> other authors report no potential conﬂicts of interest.",TRUE,"<section> Funding See a detailed list of funding bodies in the Acknowledgements section at the end of the manuscript. Declaration of interests SF received personal fees from Kyowa Kirin and Takeda Pharmaceuticals institutional grants from NeraCare SkylineDx and BioNTech all outside the submitted work. MR and EC by the Deutsche Forschungsgemeinschaft (DFG) and MR received funding from the Wilhelm Sander(2020.100.1). DW was supported by a Federal Ministry of and Research BMBF e:Med Junior Research Alliance FM received a NCT Proofof-Concept Trial Grant and a NCT Translational Research Grant in PreciThis work was partly funded by a sponsored research to DLR from Navigate Biopharma.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ebiom.2023.104657",TRUE,"<section> Declaration of interests The authors declare no conﬂicts of interest.",TRUE,"<section> Funding This work was supported by Berlin Institute of Health (JCS Program) DKTK Berlin (Young Investigator Grant 2022) German Research Foundation (493697503 and 314905040 – <section> This work was supported by Berlin Institute of Health (JCS Program) and DKTK Berlin (Young Investigator Grant 2022) to M.P.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104735",TRUE,"Declaration of interests HEM received public sector funding through the German Research Council (DFG) grants TRR130 TP24 and ME 3644/8-1; and through the Berlin Senate. SR received public sector funding through the German Federal Ministry of Education and Research (BMBF) grand SFB-1444 C01 Central Service Project–Cell and Tissue Harvesting: supply of functionally and immunologically characterised human samples for the CRC research projects. All other authors indicate that they have no competing interests.",TRUE,"<section> Funding The study was supported by funding by the DFG grants TRR130 SR received funding from DFG SFB-1444 C01 Central Service Project. Declaration of interests HEM received public sector funding through the German Research Council (DFG) grants TRR130 TP24 and ME 3644/8-1; and through the Berlin Senate.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104774",TRUE,"<section> Declaration of interests Jürgen C. <section> other authors did not report conﬂicts of interest.",TRUE,"<section> Funding Bristol-Myers Squibb (ADOREG/TRIM NCT05750511); Scientist Program UMEA); Else Kröner-Fresenius-Stiftung <section> Ralf Gutzmer reported Personal Honoraria from Roche BMS MSD Novartis Amgen Merck Serono Almirall SUN Sanoﬁ Pierre-Fabre; Consultant or Advisory Role (personal) for BMS Roche Novartis Almirall MSD Amgen SUN Sanoﬁ Pierre-Fabre 4SC Immunocore; Research Funding (to institution) from Novartis Pﬁzer Amgen Merck-Serono SUN KyowaKirin Almirall; and Travel Accommodations Expenses from SUN Pierre-Fabre Boehringer-Ingelheim; outside the submitted work. Michael Weichenthal received grants from Bristol-Myers Squibb and Merck Sharp & Dohme consulting fees from Merck Sharp & Dohme Immunocore and Novartis lecture honoraria from BristolMyers Squibb and Merck Sharp & Dohme and Pierre-Fabre and advisory board honoraria from Merck Sharp & Dohme. <section> of funders: This work was in part supported by Bristol Myers the multicenter translational study Tissue Registry in Melawithin the framework of the skin cancer registry of the German Dermatologic Cooperative Oncology Group role: support in data collection. <section> JCB and DS received funding from the Else-Kröner-Fresenius (EKFS; University Medicine Essen Medical Scientist Academy role: support in data analysis interpretation and writing of received funding from the German Research Foundation SP4 EN984/15–1 and 16–1 TR296 P09; TR332 A3 and support in data analysis and interpretation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104782",FALSE,"",TRUE,"<section> Funding Supported by the Ministry of Health of the Czech Republic under grant NV19-06-00031. All authors declare no support from any organization for the submitted work; no ﬁnancial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have inﬂuenced the submitted work. <section> Elizabeth Supported by the Ministry of Health of the Czech Republic under grant March NV19-06-00031.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ebiom.2023.104795",TRUE,"<section> Declaration of interests stratifying Karl-Patrik Kresoja: travel grants from Edwards Lifesciences.",TRUE,"<section> Funding See Acknowledgements section at the end of the manuscript. <section> Role of funders No funding was received for this speciﬁc retrospective analysis. <section> Declaration of interests stratifying Karl-Patrik Kresoja: travel grants from Edwards Lifesciences. <section> The Aldo-DHF study was supported by the German Competence complete Network of Heart Failure. NCT00108251. pensation The TOPCAT trial was funded by the National Heart Lung and Heart Blood Institute; TOPCAT ClinicalTrials.gov number NCT00094302.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ebiom.2023.104797",TRUE,"<section> Declaration of interests <section> Outside of submitted work: IBB: Institutional grant from Biontech.",TRUE,"<section> Funding Found in Acknowledgement. Horak 37/1049-1) funded by the Deutsche Forschungsgemeinschaft cation German Research Foundation) – Project-ID 286/2020B01— joint Additionally this work is funded by the Horizon Europe cancer (Project number 101096667). cancer Sun",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.eclinm.2023.101827",TRUE,"<section> Declaration of interests H.-J.L. reports receiving honoraria from consultant/advisory board membership for Merck Serono Bayer and Genentech. S.S. reports receiving honoraria for talks and advisory board role: AMGEN Bayer BMS Pierre-Fabre Merck KGaA; MSD Leo-Pharma Lilly Sanoﬁ Servier Roche Takeda Taiho. A.F reports receiving honoraria as consultant/advisory board for Amgen Bayer Bristol Daiichi Sankyo Incyte Lilly Merck MSD Pierre-Fabre Roche Servier. C.M was a full time employee of Roche/Genentech when the MAVERICC data was generated. All remaining authors have declared no conﬂicts of interest.",TRUE,"<section> Funding This work was supported by the National Cancer WunderGlo Foundation Dhont Family Foundation Victoria Peninsula Cancer Guild Ming Hsieh Research Fund Eddie Program (22YF1407000) China National Postdoctoral Postdoctoral Science Foundation (2022M710768) National This work was supported by the National Cancer Institute [P30CA 014089 to H.-J.L.] Gloria Borges WunderGlo Foundation Dhont Family Foundation Victoria and Philip Wilson Research Fund San Pedro Peninsula Cancer Guild Ming Hsieh Research Fund Eddie Mahoney Memorial Research Fund Shanghai Sailing Program (22YF1407000) China National Postdoctoral Program for Innovative Talents (BX20220084) China Postdoctoral Science Foundation (2022M710768) National Natural Science Foundation of China (82202892).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.101865",TRUE,"<section> Declaration of interests BS declares receiving an unrestricted grant from Moderna (2022) for a study outside the submitted work. All other authors declare no competing interests.",TRUE,"<section> Funding Swiss National Science Foundation the Gottfried Jacobson Foundation the Hemmi-Foundation the University <section> Declaration of interests BS declares receiving an unrestricted grant from Moderna (2022) for a study outside the submitted work. Sources of funding for each author: BW: supported by a grant by the Swiss National Science Foundation (grant PZ00P3_193206) the Gottfried Julia Bangerter-Rhyner Foundation the Goldschmidt-Jacobson Foundation the HemmiFoundation and by funds of the University of Basel. SL: research was funded by the Department of Internal Medicine of the University Hospital of Basel the Gottfried Julia Bangerter-Rhyner Foundation and the Swiss Academy of Medical Sciences. BS: supported by the Research Foundation of the University of Basel he received an unrestricted grant from Moderna (2022) for a study outside the submitted work. We thank support staff study and laboratory personnel at the University Hospital Basel especially Nina Hutter Joyce Santos de Jesus Milica Popovic Cihan Atila Karin Wild Silke Purschke Vanessa Durandin Klaus Ehrlich Patrick Simon Uta Engler Silvia Caviola Nathalie Klaus and Nicole Salvisberg and all members of the clinical neuroendocrinology research team for their most helpful support during the study.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.101874",TRUE,"<section> Declaration of interests Dr. Chien reports personal fees from Bayer grants from Novartis outside the submitted work. Dr. Bellmann-Strobl reports personal fees from Bayer Healthcare personal fees from sanoﬁ-aventis/ Genzyme personal fees from Roche outside the submitted work. Dr. Paul reports personal fees and non-ﬁnancial support from SanoﬁGenzyme personal fees non-ﬁnancial support and other from BiogenIdec personal fees and non-ﬁnancial support from MedImmune personal fees and non-ﬁnancial support from Shire personal fees and non-ﬁnancial support from Alexion grants personal fees and non-ﬁnancial support from Bayer grants and personal fees from Novartis grants and personal fees from Teva grants and personal fees from Merck Serono personal fees from Actelion personal fees from Chugai personal fees from Roche personal fees from Celgene grants from Sanoﬁ-Aventis/Genzyme grants from Alexion grants from German Research Council (DFG Exc 257) grants from Werth Stiftung of the City of Cologne grants from German Ministry of Education and Research (BMBF Competence Network Multiple Sclerosis) grants from Arthur Arnstein Stiftung Berlin grants from EU FP7 Framework Program (combims.eu) grants from Guthy Jackson Charitable Foundation grants from National Multiple Sclerosis Society of the USA outside the submitted work. All other authors declare no competing interests.",TRUE,"<section> Funding Deutsche Forschungsgemeinschaft (DFG) and German Ministry of Education and Research (BMBF). <section> Acknowledgments Funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant numbers 327654276 (SFB 1315) FI 2309/ 1-1 (Heisenberg Program) and FI 2309/2-1; and the German Ministry of Education and Research (BMBF) grant number 01GM1908D (CONNECT-GENERATE).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.101936",TRUE,"<section> Declaration of interests R Ancuceanu reports consulting fees from Abbvie; payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Abbvie B.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. A Cohen was supported by the Health Effects Institute Boston MA USA. C Herteliu is partially supported by a grant of the Romanian Ministry of Research Innovation and Digitalization MCID project number ID-585-CTR-42-PFE-2021. BF Hwang was partially supported by China Medical University (CMU111-MF-55). H Kandel is supported by the Kornhauser Research Fellowship at The University of Sydney. M Khan is the recipient of College of Medicine and Health Sciences research grant Grant numbers G00003634 G00003569 and UAEU Sustainable Development Goals Grant Grant number 1976. MC Li was supported by the National Science and Technology Council in Taiwan (NSTC 111-2410-H-003-100-SSS). E Mathews is supported by a Clinical and Public Health Early Career Fellowship (grant number IA/CPHE/17/1/ 503345) from the DBT India Alliance/Wellcome Trustâ€ Department of Biotechnology India Alliance. L Monasta was supported by the Italian Ministry of Health through a contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy. M Moniruzzaman was supported by The University of Queensland Postdoctoral Fellowship. K E Rudd is supported by NIH/ NIGMS grant 1K23GM141463-02. A M Samy acknowledges the support from Ain Shams University and the Egyptian Fulbright Mission Program F Thienemann is supported by the European Union (grant number RIA2017T2004-StatinTB). X Xu is supported by Scientia Program at the University of New South Wales Australia. This study was solely funded by the Bill & Melinda Gates Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.101958",TRUE,"<section> Declaration of interests The authors declare that they have no conﬂict of interest.",TRUE,"<section> Funding Federal Ministry of Education and Research of Germany <section> Role of funding source The study was funded primarily by the German Federal Ministry of Education and Research (Bundesministerium für Bidung und Forschung) within the framework of InfectControl 2020 (Project KARMIN – 03Z0818C) and was partly funded by the Bill and Melinda Gates foundation (Investment ID INV-004308).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.101993",TRUE,"<section> Declaration of interests All authors report support for the present manuscript from Bayer for medical writing funding to Open Health.",TRUE,"<section> Funding Bayer HealthCare. <section> Declaration of interests All authors report support for the present manuscript from Bayer for medical writing funding to Open Health. Higano reports support for the present manuscript from Bayer for clinical trial funding to institution; grants or contracts from AbbVie (Contract to develop unbranded educational slide set) Vaccitech (Clinical trial consulting contract no payments yet) and Verity; consulting fees from the Prostate Cancer Clinical Trials Consortium (Consulting PCCCTC medical monitor for trials sponsored by ESSA and Bayer) Prostate Cancer Supportive Care Program (Consulting Medical Director) and Astellas AstraZeneca Ferring Genentech Merck Sharp & Dohme Myovant Pﬁzer Tolmar and Vaccitech (all advisory boards); payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Tolmar (medical writing); payment for expert testimony from Ferring; participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca Exelixis Advantagene/Candel and Alliance Foundation (all DSMBs). <section> Acknowledgements This study was supported by Bayer HealthCare (Whippany NJ USA).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.eclinm.2023.102146",TRUE,"<section> Declaration of interests The authors declare no competing interests.",TRUE,"<section> Funding C. S. was supported by a grant from the Weidenhammer-Zoebele Foundation. C. S. was supported by a grant from the Weidenhammer-Zoebele Foundation.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102190",TRUE,"<section> Declaration of interests All authors have no disclosures.",TRUE,"<section> Funding None. <section> Role of the funding social We received no funding for this research process. <section> Hübel; Funding acquisition: n.a.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.eclinm.2023.102193",TRUE,"<section> Declaration of interests K Abuabara reports grants or contracts from Pﬁzer and Cosmetique Internacional SNC to their institution University of California San Francisco; consulting fees from TARGET RWE; outside the submitted work.",TRUE,"<section> Funding The Global Burden of Disease Study is funded by the Bill and by Scientiﬁc Research Fund of Sichuan Academy of Medical Sciences <section> Declaration of interests K Abuabara reports grants or contracts from Pﬁzer and Cosmetique Internacional SNC to their institution University of California San Francisco; consulting fees from TARGET RWE; outside the submitted work. R Buchbinder is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Fellowship. H Kandel is supported by a Kornhauser Research Fellowship at The University of Sydney. A G Mathioudakis was supported by the National Institute for Health and Care Research Manchester Biomedical Research Centre and an NIHR Clinical Lectureship in Respiratory Medicine. A Raggi is supported by the Italian Ministry of Health (RRC). R Tabarés-Seisdedos is supported by the Spanish Ministry of Science and Innovation Institute of Health Carlos III CIBERSAM and INCLIVA.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102199",TRUE,"<section> Declaration of interests OA received consulting fees from Cortechs. ai and payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Janssen Sunovion Lundbeck (all to him personally). No other disclosures were reported. All other authors declare no competing interests.",TRUE,"<section> Funding This research did not receive any speciﬁc grant provided by Le Vinatier Psychiatric Hospital. OA declared support for the present manuscript through payments made to institution from KG Jebsen Stiftelsen Research Council Norway EU H2020 and Horiz Europe NIMH Regional Health Authorities and NordForsk. MS declared support for the present manuscript through initial data collection supported by Grant No. RR declared support for the present manuscript from Canada First Research Excellence Fund Grant doe Healthy Brains for Healthy Lives; Fonds de recherche du Québec – Santé.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol for conducting this IPDMA was preregistered on PROSPERO accessible via the ID CRD42022329172.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102234",TRUE,"<section> Declaration of interests VW has received grants from Celgene Janssen Pﬁzer Biogen Gilead Corbus Pharmaceuticals Genentech AstraZeneca Viela Syntimmune Amgen Regeneron Argenx CSL Behring Ventus q32 Bio BMS Horizon Rome Pharmaceuticals and Priovant; royalties for licenses from the University of Pennsylvania; consulting fees from Celgene Genentech Janssen Lilly Pﬁzer Biogen BMS Gilead Amgen Medscape Nektar Incyte EMD Sorona CSL Behring Principia Crisalis Viela Bio Argenx Kwoya Kirin Regeneron Principia AstraZeneca Abbvie Octapharma GSK Astra-Zeneca Cugene UCB Corcept Beacon Bioscience Rome Pharmaceuticals Horizon Gilead Merck Kezar Sanoﬁ Bayer Akari Calyx and Cabaletta Bio; and has participated in a Data Safety Monitoring Board or Advisory Board for Astra Zeneca.",TRUE,"<section> Funding This study was sponsored by Octapharma Pharmazeutika Produktionsges m.b.H. <section> Role of the funding source The trial was sponsored designed and conducted by Octapharma Pharmazeutika with the authors of this <section> Declaration of interests VW has received grants from Celgene Janssen Pﬁzer Biogen Gilead Corbus Pharmaceuticals Genentech AstraZeneca Viela Syntimmune Amgen Regeneron Argenx CSL Behring Ventus q32 Bio BMS Horizon Rome Pharmaceuticals and Priovant; royalties for licenses from the University of Pennsylvania; consulting fees from Celgene Genentech Janssen Lilly Pﬁzer Biogen BMS Gilead Amgen Medscape Nektar Incyte EMD Sorona CSL Behring Principia Crisalis Viela Bio Argenx Kwoya Kirin Regeneron Principia AstraZeneca Abbvie Octapharma GSK Astra-Zeneca Cugene UCB Corcept Beacon Bioscience Rome Pharmaceuticals Horizon Gilead Merck Kezar Sanoﬁ Bayer Akari Calyx and Cabaletta Bio; and has participated in a Data Safety Monitoring Board or Advisory Board for Astra Zeneca. <section> Acknowledgements This study was sponsored and funded by Octapharma Pharmazeutika Produktionsges m.b.H.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102237",TRUE,"<section> Declaration of interests G.R. reports personal fees from Astra Zeneca Atriva Therapeutics Boehringer Ingelheim GSK Insmed MSD Sanoﬁ Novartis and Pﬁzer for consultancy during advisory board meetings and personal fees from Astra Zeneca Berlin Chemie BMS Boehringer Ingelheim Chiesi Essex Pharma Grifols GSK Insmed MSD Roche Sanoﬁ Solvay Takeda Novartis Pﬁzer and Vertex for lectures including service on speakers’ bureaux.",TRUE,"<section> Funding Atriva Therapeutics GmbH and the Federal Ministry <section> Acknowledgements This study was funded by Atriva Therapeutics GmbH with support from the Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research Germany; BMBF).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102258",TRUE,"<section> Declaration of interests RS reports participation on advisory boards with Ascendis and BioMarin and consulting role for BridgeBio.",TRUE,"<section> Funding Ascendis Pharma A/S. The trial was funded by Ascendis Pharma.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102283",TRUE,"<section> Declaration of interests Sylwia Bujkiewicz is a member of the NICE Decision Support Unit (DSU) and NICE Guidelines Technical Support Unit (TSU) has served as a paid consultant providing methodological advice to NICE Roche IQVIA and RTI Health Solutions received payments for educational events from NICE and Roche and has received research funding from European Federation of Pharmaceutical Industries & Associations (EEPIA) and Johnson & Johnson.",TRUE,"<section> Funding SPIRIT-SURROGATE/CONSORT-SURROGATE <section> Role of funding The research was funded as part of development of SPIRIT and CONSORT extensions has been funded by the UK Medical Research Council (grant number MR/ V038400/1). Sylwia Bujkiewicz was supported by UK Medical Research Council (MR/T025166/1) and Leicester NIHR Biomedical Research Centre. Robin Christensen wants to acknowledge that Section for Biostatistics and Evidence-Based Research the Parker Institute Bispebjerg and Frederiksberg Hospital is supported by a core grant. <section> Declaration of interests Sylwia Bujkiewicz is a member of the NICE Decision Support Unit (DSU) and NICE Guidelines Technical Support Unit (TSU) has served as a paid consultant providing methodological advice to NICE Roche IQVIA and RTI Health Solutions received payments for educational events from NICE and Roche and has received research funding from European Federation of Pharmaceutical Industries & Associations (EEPIA) and Johnson & Johnson.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.eclinm.2023.102294",TRUE,"<section> Declaration of interests CUC has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Biogen Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Denovo Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Neurelis Newron Noven Novo Nordisk Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways Denovo Lundbeck Relmada Reviva Rovi Sage Supernus Tolmar and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax LB Pharma PsiloSterics and Quantic. All other authors declare no competing interests.",TRUE,"<section> Funding None. <section> Role of the funding source There was no funding source for this study. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eclinm.2023.102309",TRUE,"<section> Declaration of interests TK is afﬁliated with the Centre for Digital Health Interventions (CDHI) a joint initiative of the Institute for Implementation Science in Health Care University of Zürich the Department of Management Technology and Economics at ETH Zürich and the Institute of Technology Management and School of Medicine at the University of St.",TRUE,"<section> Funding National Research Foundation Prime Minister’s lence and Technological Enterprise (CREATE) Programme It is supported by the National Research Foundation Prime Minister’s Ofﬁce Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme. It is also supported by the PANDA (Physical Activity and Nutrition Determinants in Asia) Research Programme at the Saw Swee Hock School of Public Health National University of Singapore.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ecoenv.2023.114801",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"By contrast eating highly contaminated vegetables may increase the exposure to OP pesticides and thus contribute to accelerated telomere attrition (Gong et al. 2018; Funding This work was supported by the United States Agency for Interna­ tional Development [grant number M27–028]. The work of Zohar Barnett-Itzhaki was supported by the Environment and Health Fund Jerusalem Israel.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejca.2022.09.024",TRUE,"<section> The authors declare the following financial interests/ personal relationships which may be considered as potential competing interests:",TRUE,"Support for thirdparty writing assistance for this manuscript furnished by Alison McGonagle PhD of Health Interactions was provided by F.",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ejca.2022.11.030",TRUE,"<section> The authors declare the following financial interests/ personal relationships which may be considered as potential competing interests: N.G. reports honoraria from AbbVie AstraZeneca GSK Hexal and MSD; travel grants from Janssen; and participation on an advisory board to AstraZeneca. <section> and H.H.W. have no conflicts of interest to declare.",TRUE,"<section> Funding <section> No external funding was provided for any part of the writing process of this guideline.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejca.2023.04.024",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study (NCT02655016) was supported by GSK.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ejca.2023.112950",TRUE,"Competing Interest <section> IG is an employee of Merck Serono Ltd Feltham UK an affiliate of Merck KGaA Darmstadt Germany. TJU is an employee of Repare Therapeutics Cambridge MA USA. TJH is an employee of GSK Collegeville PA USA. BRD is an employee of AstraZeneca Cambridge UK. JC is an employee of Pfizer Tadworth UK. RB is an employee of Genentech a Member of the Roche Group South San Francisco CA USA. ADJP has consulted for Lilly Norgine and Developmental Therapeutics Consortium Limited and been an advisor for Amgen. All remaining authors have declared no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejca.2023.112986",TRUE,"<section> The authors declare the following financial interests/ personal relationships which may be considered as po­ tential competing interests: Carola Berking reports honoraria for talks from Bristol-Myers Squibb MSD Novartis and Sanofi and for advisory boards from Bristol-Myers Squibb Immunocore InflaRx MSD Novartis Pierre Fabre Regeneron and Sanofi.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejca.2023.112988",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> The study was funded by the Luxembourg Cancer Foundation (grant FC/2018/07) and the Consolidator Grant approved by the European Research Council (ERC FAT-BC 101003153). <section> funded by FWO through a research fellowship. Finally KVB is funded by the KU Leuven Fund Nadine de Beauffort and a Conquer Cancer – Lobular Breast Cancer Alliance Young Investigator Award for Invasive Lobular Carcinoma Research supported by the Lobular Breast Cancer Alliance. <section> Marion Maetens: Project administration; Funding ac­ quisition; Writing – review & editing. <section> Christine Desmedt: Conceptualization; Methodology; Supervision; Funding acquisition; Writing – review & editing.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ejca.2023.113294",TRUE,"Competing Interest <section> TJB would like to disclose that he is the owner of Smart Health Heidelberg GmbH (Handschuhsheimer Landstr. <section> 9/1 69120 Heidelberg Germany) outside of the scope of the submitted work. The other authors declare that they have no conflicts of interest.",TRUE,"<section> Funding <section> This study was funded by the Federal Ministry of Health Berlin Germany (grant: Skin Classification Brinker: Initiation Conceptualization Investigation Methodology Supervision Funding Writing of initial draft Writing – review & editing Resources.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ejca.2023.113347",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work has received funding from the European Union’s Horizon 2020 research and innovation pro­ gramme under the Marie Skłodowska-Curie grant agreement No. In ad­ dition this project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation pro­ gramme under grant agreement No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejca.2023.113398",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ejim.2023.07.027",TRUE,"Competing Interest <section> The authors declare they have no conflict of interest",TRUE,"<section> Funding <section> This work was supported by the Medical University of Graz (START Grant 2019) and the Austrian Society of Cardiology (President Grant",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ejrad.2023.110908",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"ME received funding from DFG under Germaný s Excellence Strategy – EXC-2049 – 390688087 BMBF DZNE DZHK EU Corona Foundation and Fonda­ tion",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2022.10.024",TRUE,"<section> DISCLOSURE <section> All the authors declared no competing interests.",TRUE,"<section> Funding <section> MPB was supported in part by an intramural grant from the University of Cologne (Gerok program). PTB was supported by a DFG fellowship BR2955/6-1) and the clinical research unit (KFO 329 BR 2955/8-1).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2022.12.022",TRUE,"<section> DISCLOSURE <section> KUE reports supporting the GCKD study by Bayer FMC Evotec AstraZeneca and Vifor and consulting or lecture fees from AstraZeneca Akebia and FMC. PE reports funding from DFG Jäckstädt Stiftung and BIH as well as lecture fees from GSK AstraZeneca Bayer Akakdemie der Nieren and NAW Berlin. All the other authors declared no competing interests.",TRUE,"<section> This research was cofunded by the German Federal Ministry of Education and Research in a project named Sri-KidH O (Grant Number 01DP17042) to RC NN CZ KA PE and JB and by the Deutsche Forschungsgemeinschaft (German Research Foundation) project number 387509280 SFB 1350 TP C2 to CD and KA.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2023.01.013",TRUE,"<section> DISCLOSURE <section> The authors JS JK MB AR KE SE SP SB RK ADS and AS declare no conﬂicts of interest.",TRUE,"<section> Funding <section> Funding for this project was received from “Translational kidney research–from physiology to clinical application” (TRENAL) Berlin Institute of Health and Deutscher Akademischer Austauschdienst (DAAD). <section> This work was supported by grant SCHR 771/8-1 from the Deutsche Forschungsgemeinschaft to AS grant 394046635–SFB 1365 from the Deutsche Forschungsgemeinschaft to AS and an ECRC grant to AS.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2023.02.1073",TRUE,"<section> DISCLOSURE <section> RDP received research funding from Otsuka Kadmon Corporation Palladio Bio Sanoﬁ-Genzyme and Reata; has been a consultant to Palladio Bio Reata SanoﬁGenzyme Navitor Carraway and Otsuka and is section editor for Renal Cystic Diseases UpToDate.",TRUE,"<section> Funding <section> This study was funded by Otsuka Pharmaceutical Development & Commercialization Inc (Rockville MD USA) and Otsuka Pharmaceuticals (Tokyo Japan). Writing and editorial services for this manuscript were provided by BioScience Communications Inc activities that were funded by Otsuka.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2023.07.032",TRUE,"<section> DISCLOSURE All other authors declare no competing interests.",TRUE,"<section> MC is supported by a KRESCENT New Investigator Award. <section> This work was supported by an unrestricted grant from GSK inkind administrative support from the ISN and inkind analytical support from BC Renal.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2023.08.004",TRUE,"<section> DISCLOSURE <section> CB is an employee of B.",TRUE,"<section> The CONVINCE study was supported by the European Commission Research and Innovation Horizon 2020 Call",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ekir.2023.08.038",TRUE,"<section> DISCLOSURE <section> CS CN SMK JN KUE MS and MZ have no conﬂicts of interest to report concerning the present publication.",TRUE,"The GCKD study is supported by the German Ministry of Education and Research (Bundesministerium für Bildung und Forschung FKZ 01ER 0804 01ER 0818 01ER 0819 01ER 0820 and 01ER 0821) and the KfH Foundation for Preventive Medicine (Kuratorium für Heimdialyse und Nierentransplantation e.V. <section> suPAR analyses were funded by the Renal Center Heidelberg Germany. SSH is supported by NHLBI R01HL153384 NIDDK R01DK128012 and the Gilead Sciences Research Scholar Program. US was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant 01ZX1912B).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was approved by local ethics committees and registered in the national registry for clinical studies (DRKS 00003971) and conducted in accordance with the principles of the Declaration of Helsinki.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.ekir.2023.10.004",TRUE,"<section> DISCLOSURE <section> BH and CM-H are consultants to Dicerna/Novo Nordisk. BH is a consultant to Avanzanite and Arbor Biotech. CM-H MPB and BBB received consulting fees from Alnylam Pharmaceuticals. CJS has received honoraria from Alnylam and Genesis Pharma. CPS has received research funding (investigator initiated studies) from Baxter advisory fees from Baxter and lecturing honoraria from Fresenius. All other authors declare no competing interests.",TRUE,"CM-H was funded by a Juan de la Cierva postdoctoral grant from the Spanish Ministry of Science (Reference FJC2018-036199-I) the German primary hyperoxaluria selfsupport group (PH-Selbsthilfe) and Fundación Disa.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.eng.2022.08.013",TRUE,"Mol and Yongyong Shi declare that they have no conflict of interest or financial conflicts to",TRUE,"<section> This study was supported by the National key Research and Development Program of China (2019YFC1709500); the National Collaboration Project of Critical Illness by Integrating Chinese Medicine and Western Medicine; the Project of Heilongjiang Province Innovation Team ‘‘TouYan;” the Yi-Xun Liu and Xiao-Ke Wu Academician Workstation; the Innovation Team of Reproductive Technique with Integrative Chinese Medicine and Western Medicine in Xuzhou City China; Heilongjiang University of Chinese Medicine from the National Clinical Trial Base; Heilongjiang Provincial Clinical Research Center for Ovary Diseases; the Research Grant Council (T13-602/21-N C5045-20EF and 14122021); and Food and Health Bureau in Hong Kong China (06171026). Mol is supported by a National Health and Medical Research Council (NHMRC) Investigator grant (GNT1176437).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.envint.2023.108089",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"LPC and SUP acknowledge funding from IDRC International Development Research Centre IDRC (grant 109304-001; under the frame of EMBARK) and the Shanghai Municipal Science and Technology Major Project (grant 2018SHZDZX01). SKF and VHJD are funded by the Deutsche Forschungsgemeinschaft (DFG) grant “Integra­ tive evolutionäre und ökologische Analyse von Antibiotikaresistenzen: Auftreten und Verbreitung vom bakteriellen Genom bis zur geo­ graphischen Landschaft” (FO 1279/6-1). EKR ALW ADO and YW acknowledge funding from The Research Council of Norway (grant 320349).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.envres.2023.115422",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.envres.2023.116413",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding <section> This work was funded by the German Environment Agency (Umweltbundesamt FKZ 3717622040).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.envres.2023.117001",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement number 874703.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.esmoop.2022.100761",TRUE,"However the variance in the treatment recommendation in elderly patients is substantial and did not differ signiﬁcantly after the disclosure of GA results. <section> DISCLOSURE All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> This work was supported by the institution (Technical University Dresden/University Hospital Carl Gustav Carus).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.esmoop.2023.101568",TRUE,"<section> DISCLOSURE All other authors have declared no conﬂicts of interest.",TRUE,"<section> FUNDING <section> Fabre Research Funding: Pierre Fabre Roche Molecular Diagnostics Merck Serono; travel accommodations expenses: Merck KGaA Roche Sanoﬁ Bayer Sirtex Medical Amgen Lilly Takeda Pierre Fabre.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial is registered with ClinicalTrials.gov (NCT01991873).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.esmoop.2023.101572",TRUE,"<section> DISCLOSURE <section> All other authors have declared no conﬂicts of interest.",TRUE,"<section> Financial funding for the MATEO trial was provided by Taiho Pharmaceutical (Tokyo Japan) and study medication was provided by Nordic Pharma (Paris France). <section> FUNDING <section> This work was supported by a grant provided by Taiho Pharmaceutical and study medication (S-1) was provided by Nordic Pharma (no grant number). Funding for investigatorinitiated research projects was provided by Nordic Pharma Taiho Pharmaceutical MSD Sharp & Dohme.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.euroneuro.2023.05.004",TRUE,"Competing Interest No other disclosures were reported.",TRUE,"<section> Dr Jeppesen reported received grants from the TrygFonden and Lundbeckfonden. <section> The Mind My Mind project was initiated by Psykiatrifonden and sponsored through unrestricted grants from the Danish TrygFonden and the Lundbeckfonden.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.euroneuro.2023.07.011",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The review protocol was registered on PROSPERO in December 2022 (CRD 42022220190).",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.euros.2022.11.008",TRUE,"<section> Financial disclosures: Lorenzo Marconi certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: None.",TRUE,"<section> Financial disclosures: Lorenzo Marconi certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: None. <section> Funding/Support and role of the sponsor: None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.euros.2023.04.018",TRUE,"<section> Financial disclosures: Stefanie Zschäbitz certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Stefanie Zschäbitz serves on advisory boards for Astellas AstraZeneca Bayer Bristol-Myers Squibb Janssen Cilag Merck Healthcare MSD Pfizer Roche and Sanofi Aventis; has received honoraria from Astellas Bayer Bristol-Myers Squibb Janssen Cilag Merck Healthcare MSD Pfizer and Roche; and has received travel costs and congress registration fees from Janssen Cilag Merck Healthcare MSD and Pfizer.",TRUE,"<section> Funding/Support and role of the sponsor: For the publication fee we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding program ‘‘Open Access Publikationskosten’’ as well as by Heidelberg University.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.euros.2023.10.002",TRUE,"<section> Financial disclosures: Enrique Grande certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Enrique Grande has received grants or contracts from Astellas AstraZeneca Ipsen Lexicon Merck KGaA MTEM/Threshold/Tersera Nanostring Technologies Pfizer and Roche; payment or honoraria for lectures presentations speaker bureaus manuscript writing or educational events from Advanced Accelerator Applications Amgen Angelini Astellas AstraZeneca Bayer Blueprint BMS Caris Life Sciences Celgene Clovis Oncology Dr.",TRUE,"<section> Financial disclosures: Enrique Grande certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Enrique Grande has received grants or contracts from Astellas AstraZeneca Ipsen Lexicon Merck KGaA MTEM/Threshold/Tersera Nanostring Technologies Pfizer and Roche; payment or honoraria for lectures presentations speaker bureaus manuscript writing or educational events from Advanced Accelerator Applications Amgen Angelini Astellas AstraZeneca Bayer Blueprint BMS Caris Life Sciences Celgene Clovis Oncology Dr. <section> Se Hoon Park declares honoraria from Merck Ono Pharmaceuticals and Pfizer; a consulting or advisory role with Janssen Oncology and Research Funding from Ono Pharmaceutical and Sanofi. <section> Funding/Support and role of the sponsor: This study was sponsored by F. This study was sponsored by F. Davis is supported in part by an Australian National Health and Medical Research Council Investigator Grant (2016274).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.eururo.2023.03.014",TRUE,"<section> Financial disclosures: Giancarlo Marra certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Malcolm D.",TRUE,"<section> Financial disclosures: Giancarlo Marra certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Malcolm D. Erik Briers has received grants and research support from Ipsen the European Association of Urology and Bayer; is an ex officio board member for Europa UOMO; is an ethics committee and advisory group member for REQUITE; is a patient advisory board member for PAGMI; and is a member of SCA and EMA PCWP. <section> Funding/Support and role of the sponsor: None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.fct.2023.113632",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was primarily supported by the German Research Foun­ dation (Deutsche Forschungsgemeinschaft DFG) HE 2509/15-11. Hengstler: Funding acquisition Writing – review & editing Supervision.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.freeradbiomed.2023.07.007",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding <section> This work was supported by: MM was supported by grants from the Medical Faculty of Lund University Skane University Hospital the Crafoord Foundation the Ernhold Lundstroms Research Foundation the Region Skane the Hulda and Conrad Mossfelt Foundation the South­ west Skanes Diabetes Foundation the Kockska foundation the Research Funds of Region Skåne a the Swedish Heart and Lung foundation a the Wallenberg Center for Molecular Medicine Lund University and the Swedish Research Council all Swedish. OM was supported by grants from Knut and Alice Wallenberg Foundation Göran Gustafsson Foundation the Swedish Heartand Lung Foundation the Swedish Research Council the Novo Nordisk Foundation Region Skåne Skåne University Hospital and the Swedish Foundation for Strategic Research Dnr IRC15-0067.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.freeradbiomed.2023.08.025",TRUE,"<section> Declaration of competing interest <section> The authors declare no conflict of interest.",TRUE,"<section> This study was supported by the funding from National Natural Science Foundation of China (82170681 and 81670621) to Yi Yang Primary Research and Development Plan of Zhejiang Province (2020C03034) to Fei Han.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.freeradbiomed.2023.10.401",TRUE,"<section> Declaration of competing interest <section> Lutz Schomburg is the founder of selenOmed GmbH a company involved in improving Se diagnostics. The other authors declare no competing interests.",TRUE,"; Funding acquisition D.J.H. M.J. L.S. V.F. and C.M. Funding support for the EPIC study is described in the acknowledgements; there were no financial relationships with any organizations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work. <section> Funding for this study was provided by the Health Research Board of Ireland health research award HRA-PHS/2015/1142 (principal investi­ gator: D.J.H.). The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and by the Department of Epidemiology and Biostatistics School of Public Health Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by: Danish Cancer Society (Denmark); Ligue Contre le Cancer Institut Gustave Roussy Mutuelle Générale de l’Education Nationale Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid German Cancer Research Center (DKFZ) German Institute of Human Nutrition PotsdamRehbruecke (DIfE) Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health Welfare and Sports (VWS) Netherlands Cancer Registry (NKR) LK Research Funds Dutch Prevention Funds Dutch ZON (Zorg Onderzoek Nederland) World Cancer Research Fund (WCRF) Statistics Netherlands (The Netherlands); Health Research Fund (FIS) Instituto de Salud Carlos III (ISCIII) Regional Governments of Andalucía Asturias Basque Country Murcia and Navarra and the Catalan Institute of Oncology ICO (Spain); Swedish Cancer Society Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk;",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.gerinurse.2023.10.032",TRUE,"Competing Interest",TRUE,"<section> Jan Kottner: Conceptualization Methodology Investigation Resources Writing review & editing Supervision Project administration Funding acquisition. <section> Funding information <section> This work was supported by the German Federal Ministry of Education and Research (Bundesministerium f € u r Bildung und Forschung",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.gim.2022.11.019",TRUE,"All other authors declare no conﬂicts of interest.",TRUE,"<section> Funding <section> This research is supported by a grant from the National Institutes of Health (NIH) to F.H. A.J.M. was supported by the NIH (T32DK-007726 5K12HD052896-13 1K08DK125768-01A1) Harvard Stem Cell Institute (F-KP0003-17-00) American Society of Nephrology (Jared J. <section> was supported by the Leopoldina Fellowship Program German National Academy of Sciences Leopoldina (LPDS 2015-07). The Yale Center for Mendelian Genomics (UM1HG006504) is funded by the National Human Genome Research Institute. C.-H.W.W. was supported by funding from the American College of Medical Genetics and Genomics Foundation (ACMG/Takeda Next-Generation Biochemical Genetics Award) and NIH (grant T32GM007748). J.A.S. is supported by the Medical Research Council the Northern Counties Kidney Research Fund and Kidney Research UK (Paed_RP_001_20180925). The NIHR Newcastle Biomedical Research Centre is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University funded by the National Institute for Health and Care Research (NIHR). F.B. was supported by a fellowship grant (404527522) from the German Research Foundation (DFG). T.J.-S. received funding by the IZKF Erlangen (J70) German Research Foundation (DFG 281319475) and Else KrönerFresenius Stiftung (RECORD program). S.L.A. is a consultant to and received funding from Quest Diagnostics Inc.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.gim.2023.100856",FALSE,"",TRUE,"This study makes use of DECIPHER (https://www.deciphergenomics.org) which is funded by Wellcome. <section> Funding <section> This study was funded by the Chaire Jeanne et Jean-Louis Lévesque (J.L.M.) Chaire Jonathan-Bouchard (J.L.M.) the E-rare Transnational research program on rare disorders with support from Fonds de la Recherche du Québec – Santé and the Canadian Institutes for Health Research (CIHR) (J.L.M) US National Institutes of Health (S.S.: 1K23NS119666; J.R.L.: HG011758 NS105078) Spastic Paraplegia Foundation Research Grant (J.R.L.) Muscular Dystrophy Association Development Grant 873841 (D.G.C.) Baylor College of Medicine Chao PhysicianScientist Award and 5T32GM007526 Medical Genetics Research Program (D.G.C.) and CIHR (A.T.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.gim.2023.100950",TRUE,"All other authors declare no conﬂicts of interests.",TRUE,"Also we acknowledge TUDP for performing exome sequencing of Fam-21 with the Telethon project GSP15001. <section> Funding <section> B.P. is supported by the Deutsche Forschungsgemeinschaft (DFG) through grant PO2366/2–1. A.R. received support from the German Federal Ministry of Research and Education (01GM1520A) as part of the Chromatin-Net Consortium.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.healthpol.2023.104752",TRUE,"Conflicts of interest. Conflicts of interest were described as another potential barrier for the successful implementation of retro­ spective evaluation. According to the interviewees conflicts of interest could arise between e.g. scientists the pharmaceutical industry and insurance companies (E29). Starting with this subgroup of ITAs also has a strong ethical rationale as such highly experimental ITAs come with particularly high uncertainty about the risk-benefit ratio [2] and often involve substantial conflicts of interest because those applying the experimental treatments can also be involved academically or even financially in the treatment’s development. In these cases it is particularly difficult for physicians to correctly assess the risks and benefits and conflicts of interest could be more severe [37]. <section> Declaration of Competing Interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding statement <section> The project received intramural funding from the Berlin Institute of Health (BIH) (no grant number available) and no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.healthpol.2023.104753",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.heliyon.2023.e13087",TRUE,"Disclosures <section> Y.D. L.Z. P.L. E.S. S.O. T.P. and H.F. filed a patent on long noncoding RNAs for diagnosic prognostic and therapeutic uses for pathologies and toxicities inducing heart disorders (WO2018229046).",TRUE,"<section> Funding <section> This work is supported by funding from the EU Horizon 2020 project COVIRNA (Grant Agreement # 101016072) the National Research Fund (grants # C14/BM/8225223 C17/BM/11613033 and COVID-19/2020-1/14719577/miRCOVID) the Ministry of Higher Education and Research and the Heart Foundation-Daniel Wagner of Luxembourg to Y.D.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e14658",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> The study was supported by Bundesministerium für Bildung und Forschung [BMBF “NaFoUniMedCovid19”",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e17231",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> SU was supported by a Marie Sklodowska-Curie grant (number 657605) from the European Union’s Framework Programme Horizon 2020. KG was funded by DFG grants GRK1589/1 and FK:JA945/3-1. JDH was funded by the Bernstein Computational Neuroscience Program of the German Federal Ministry of Education and Research BMBF (Grant 01GQ0411) and by the Excellence Initiative of the German Federal Ministry of Education and Research and DFG (Grants GSC86/1-2009 KFO247 HA 5336/1-",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.heliyon.2023.e17344",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This research was funded by internal research funds from Charité –",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.heliyon.2023.e18250",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This research was funded by: FCT Fundação para a Ciência e Tecnologia Portugal ref. grant: SFRH/BD/149758/2019 (J.M.) and UIDB/00006/2020 (T.D.D. J.M. H.M. NS); the Polish National Agency for Academic Exchange (NAWA) ref. grant: PPN/ULM/2020/ 1/00069/U/00001 (N.S.). Research reported in this manuscript was supported by the National Institutes of Health (NIH) under award number 2R01AI103629.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e18432",TRUE,"<section> Declaration of competing interest <section> CM is part of patent applications to detect and predict clinical outcomes and to manage diagnose and treat neurological condi­ tions all of which are outside the submitted work. CHN received research grants from German Ministry of Research and Education German Center for Neurodegenerative Diseases German Center for cardiovascular Research and speaker and/or consultation fees from Abbott Alexion Astra Zeneca Bayer Pharma Bristol-Myers Squibb Daiichi Sankyo Novartis Pfizer Pharma Portola and Takeda all outside the submitted work. ME reports grants from Bayer and fees paid to the Charité from Abbott Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo GSK Sanofi Covidien Novartis Pfizer all outside the submitted work. The remaining <section> authors have no conflicts of interest or competing interests to declare.",TRUE,"<section> The study was supported by NeuroCure Clinical Research Center (NCRC) funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy EXC 2049–390688087.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e19334",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was supported by the European Commission under the Framework Programme (Grant Number: 278901). Karlijn Meeks. is supported by the Intramural Research Program of the National Institutes of Health in the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is supported by the National Human Genome Research Institute the National Institute of Diabetes and Digestive and Kidney Diseases the Center for Information Tech­ nology and the Office of the Director at the National Institutes of Health (1ZIAHG200362). <section> Karlijn Meeks is supported by the Intramural Research Program of the National Human Genome Research Institute of the National The CRGGH was supported by the National Institute of Diabetes and Digestive and Kidney Diseases and the Office of the Director at the NIH (Z01HG200362).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.heliyon.2023.e20919",TRUE,"<section> Declaration of competing interest",TRUE,"The diverse observational studies have recently been supported by a randomized intervention trial (RCT) indicating significantly enhanced immune responses in subjects receiving Se and Zn supplementation [60]. <section> Funding <section> The research has been supported by the Deutsche Forschungsgemeinschaft (DFG) Research Unit FOR-2558 “TraceAge” <section> Lutz Schomburg: Conceptualization Formal analysis Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e21268",TRUE,"<section> Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing in­ terests:Gerhard Hindricks has received grants through the Leipzig Heart Institute from Boston Scientific (Boston Scientific Corporation Marlborough Massachusetts USA) and Abbott/St.",TRUE,"<section> Laura Ueberham: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Visualization Writing – <section> Funding <section> This study was supported through a grant provided by ProCordis –",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.heliyon.2023.e21903",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding and role of funding source. <section> This work was supported by the Thailand Science Research and Innovation Fund and the University of Phayao (Grant No. <section> editing Methodology Funding acquisition Conceptualization Asst Prof.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This report follows the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) statement 2020 (Supple­ mental Table 1) [19] and the study has been registered in the PROSPERO database (CRD42022364982).",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.heliyon.2023.e22589",TRUE,"<section> Declaration of competing interest <section> The authors declare the following financial interests/personal relationships which may be considered as potential competing in­ terests: Suchittra Phoyen reports financial support was provided by Thailand Research Fund under the Royal Golden Jubilee Ph.D.",TRUE,"<section> Funding <section> The study was financially supported by the Ratchadapiseksompotch Fund Faculty of Medicine Chulalongkorn University (GA65/ 29) and the Ratchadaphiseksomphot Matching Fund from the Faculty of Medicine Chulalongkorn University (to C.B.). N.H. was supported by the Ratchadaphiseksomphot Matching Fund from the Faculty of Medicine Chulalongkorn University. <section> original draft Supervision Resources Project administration Funding acquisition Formal analysis Conceptualization.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.hermed.2023.100725",TRUE,"Competing Interest <section> The authors declared no conflicts of interest. <section> Acknowledgments <section> We would like to thank to Fernando Estevez-Lopez and Borja Martinez-Tellez for the internal discussion of the meta-analyses and implications of the present study. <section> Appendix <section> Disclosure of protocol discrepancies.",TRUE,"<section> Financial support statement <section> This study was supported by the Spanish Ministry of Education (FPU19/ 01609) and the University of Granada Plan Propio de Investigación 2016-",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Abbreviations: BMI body mass index; PSA prostate-specific antigen; SMD standardized Trial registration: PROSPERO systematic review registration number: CRD42020183587 The protocol was registered with PROSPERO in July 2020 (ID: CRD42020183587) (Appendix). <section> The registered protocol in Prospero in July 2020 (ID: CRD42020183587) indicates that the main outcome of the study was:",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.hpb.2023.07.897",TRUE,"<section> Conﬂict of Interest The authors declare no Conﬂict of Interest for this article.",TRUE,"<section> Funding/ﬁnancial support statement None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.hroo.2022.11.005",TRUE,"Disclosures: Dr Lau declares support by Mid-Career Fellowships from The Hospital Research Foundation and reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Abbott Medical Boehringer Ingelheim Biotronik Medtronic MicroPort CRM and Pﬁzer.",TRUE,"<section> Funding Sources: The study was supported by Biotronik SE & Co KG Berlin Germany. <section> Disclosures: Dr Lau declares support by Mid-Career Fellowships from The Hospital Research Foundation and reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Abbott Medical Boehringer Ingelheim Biotronik Medtronic MicroPort CRM and Pﬁzer.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,"<section> Clinical trial registration numbers: NCT04025710 and NCT04075084.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.humpath.2023.09.001",TRUE,"Competing interests: The authors do not have competing financial interests concerning the present study.",TRUE,"<section> Funding/Support: This work was financially supported by the TRANSCAN-2 project (grant no.: 2014-121). Dragomir’s work is funded by a DKTK Berlin Young Investigator Grant 2022 and Berliner Krebsgesellschaft (DRFF202204). Bischoff’s work is funded by a DKTK Berlin Young",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ibmed.2023.100104",TRUE,"<section> Declaration of competing interest <section> The author has no conflicts of interests to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.identj.2022.06.007",TRUE,"Conflict of interest None disclosed.",TRUE,"<section> Funding <section> This study was supported by the Comit \u0001 e Nacional para el Desarrollo de la Investigaci \u0001 o n (CONADI) of Universidad Cooperativa de Colombia.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijcard.2022.10.166",TRUE,"Competing Interest",TRUE,"<section> Funding <section> The TiCAB trial was sponsored by Deutsches Herzzentrum München Germany and financial support was provided by AstraZeneca. No funding was provided for this work.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijchp.2023.100412",TRUE,"Conflict of interest:No conflicts of interest to report. <section> Declaration of Competing Interest <section> The authors have no conflicts of interest to report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijid.2023.03.018",TRUE,"<section> Declaration of competing interest <section> The authors have no competing interests to declare.",TRUE,"<section> Funding <section> This study was funded by the German Federal Ministry for Economic Affairs and Energy (BMWi ZIM program project",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ijmm.2023.151593",TRUE,"Conflicts of Interest <section> The authors declare no competing interests.",TRUE,"<section> Funding <section> The study was funded by the German Innovations Fund of the Fed­ eral Joint Committee in Germany (G-BA) (grant number: 01VSF17010).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijnurstu.2023.104472",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"<section> Funding <section> The trial was funded by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF support code 01GL1801). <section> Balzer: Conceptualization Methodology Writing – review & editing Project administration Funding acquisition. <section> Jan Kottner: Conceptualization Methodology Formal analysis Investigation Resources Writing – original draft Writing – review & editing Supervision Project administration Funding acquisition.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijnurstu.2023.104495",TRUE,"Competing Interest Konya I. Nishiya K. Yano R. 2021.",TRUE,"<section> Jan Kottner: Conceptualisation Methodology Writing – Original Draft Writing – Review & Editing Supervision Project administration Funding acquisition.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ijregi.2023.04.009",FALSE,"",TRUE,"<section> Funding <section> This study was funded by the Task Force for Global Health [US Centers for Disease Control and Prevention (CDC) Cooperative Agreement #NU51IP000873) and the WHO Regional Oﬃce for Europe.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ijrobp.2022.12.038",TRUE,"Disclosures: A.U.K. reports funding support from grant P50CA09213 from the Prostate Cancer National Institutes of Health Specialized Programs of Research Excellence and grant W81XWH-22-1-0044 from the Department of Defense as well as grant RSD1836 from the Radiologic Society of North America the STOP Cancer organization the Jonsson Comprehensive Cancer Center and the Prostate Cancer Foundation.",TRUE,"<section> This study is supported by the German Federal Ministry of Education and Research (BMBF) as part of the ERA PER Joint Funding Call 2019 (grant no. Med-Call/JTC2019-299 01KU2015). <section> Disclosures: A.U.K. reports funding support from grant P50CA09213 from the Prostate Cancer National Institutes of Health Specialized Programs of Research Excellence and grant W81XWH-22-1-0044 from the Department of Defense as well as grant RSD1836 from the Radiologic Society of North America the STOP Cancer organization the Jonsson Comprehensive Cancer Center and the Prostate Cancer Foundation. C.Z. received funding from the Klaus Tschira foundation Naslund Medical and from the German Research Foundation. This project represents independent research supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research London.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.immuni.2023.01.029",TRUE,"<section> DECLARATION OF INTERESTS <section> D.D.P. is a founder consultant and shareholder of Hookipa Pharma Inc.",TRUE,"Funding: this work was supported by the Swiss National Science Foundation (grant no. 310030_185318/1 to D.D.P. no. 310030_200898 to W.H. no. 310030_185226/1 to S.A.L. and no. CRSII3_160772/1 to D.M. S.A.L. M.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.immuni.2023.04.002",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by TO1052/1-1 (to N. N. Torow was supported by the START-Program of the Faculty of Medicine RWTH Aachen (to N. H.L. was supported by the French National Research Agency ANR-20-CE15-0016 and used the PICSL imaging facility of the CIML (ImagImm) member of the national infrastructure France-BioImaging",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.immuni.2023.04.014",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.immuni.2023.05.017",TRUE,"<section> DECLARATION OF INTERESTS <section> A.L.S. and J.M.M. contribute to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma.",TRUE,"T. <section> Luedde was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program through the ERC Consolidator Grant ‘‘PhaseControl’’ (grant agreement 771083). T. <section> Luedde M.V. and A.S. received funding from the Ministry of Culture and Science of the State of North Rhine-Westphalia (CANTAR—NW21-062E). <section> was supported by the German Research Foundation (SFBTR-179 project ID 272983813 SFBTR-209 project ID 314905040 SFB-1479 project ID: 441891347-P10 and SFB-TR209) and an ERC Consolidator grant (LiverHepatoMetabopath) under grant agreement no 667273. A.G. J.G.H. and JG.B. were funded by the Federal Ministry of Education and Research (BMBF Germany) Liver-LiSyM grant FKZ 031L0052 (to A.G.) FKZ 031L0045 and 031L0257D (to J.G.H) and C-TIP-HCC 031L0257G (to J.G.B.). A.L.S. was supported by National Health and Medical Research Council of Australia (NHMRC; grant 2002965) and J.M.M. by NHMRC grants 1172929 and 9000719. M.S.J. was supported by a Mildred Scheel Postdoc fellowship (57584079). A.L.L and A.W. were funded by the Swiss National Science Foundation (SNF 320030-182764).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.is.2023.102253",TRUE,"<section> The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Johann-Christoph Freytag collaborated with Gottfried Vossen (https://dl.gi.de/bitstream/handle/20.500.12116/20491/ln",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.105998",TRUE,"<section> DECLARATION OF INTERESTS Y.W. owns PhenoSys equity. <section> no conflict of interest.",TRUE,"<section> This work was funded by a DFG grant (RI 2474/2-1 to Marion Rivalan and AL 1197/5-1 to Natalia Alenina). Funding acquisition:",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.106198",TRUE,"OF INTERESTS declare no competing interests.",TRUE,"<insert> KEY RESOURCES TABLE RESOURCE AVAILABILITY B Lead contact B Materials availability B Data and code availability EXPERIMENTAL MODEL AND SUBJECT DETAILS METHOD DETAILS B Chip production B Hydrogel fabrication and chip seeding B Immunostaining and imaging B Gene expression: Nextgeneration sequencing QUANTIFICATION AND STATISTICAL ANALYSIS INFORMATION information can be found online at https://doi.org/10.1016/j.isci.2023.106198. was supported by the Swiss National Science Foundation grant number 185365. <section> Funding",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.106323",TRUE,"<section> DECLARATION OF INTERESTS The German Center for Neurodegenerative Diseases filed a patent application (application number: SARS-CoV-2 infection on which J.K. S.M.R. H.-C.K. tors.",TRUE,"This work was supported by the German ; Funding Acquisition: J.T. D.S. and H.P.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.106395",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"This study was supported by DFG grants to mural funding to D.K. as well as the BMBF to F.K.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.106412",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"<section> This study was funded by the German Research Foundation supported by the German Ministry for Research",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.106459",TRUE,"<section> DECLARATION OF INTERESTS Marcus E. Kleber and Winfried März are employed The other authors do not report any conflict of interest.",TRUE,"Sources of funding: This work was supported by the 6th Framework Program (integrated project Bloodomics grant LSHM-CT-2004-503485) and the 7th Framework Program (integrated project Atheroremo grant agreement number 201668 RiskyCAD grant agreement number 305739) of the European Union by the INTERREG IV Oberrhein Program (Project A28 Genetic mechanisms of cardiovascular diseases) with support from the European Regional Development Fund (ERDF) and the Wissenschaftsoffensive TMO and by",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.106593",TRUE,"<section> DECLARATION OF INTERESTS The authors P.J. H.V.R. and U.L. are listed as co-inventors Medicine Berlin that relates to the miRNAs described",TRUE,"This work was supported by the DZHK (German Center for Cardiovascular Research) and the BMBF (German Ministry of Education and Research) (B15-066) Germany (Drs. Jakob was supported by Berlin Institute of Health (BIH) as part of the Clinician Scientist Program. Renikunta was supported from Berlin-Brandenburg School for Regenerative Therapies as part of the doctoral (Ph.D.) program.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.106941",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"CC was partially funded by Research Foundation) grant number 327654276 experiments C.C. run and analyzed the experiments is currently an employee of Miltenyi Biotec Bergisch",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.106969",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing conflicts of interest.",TRUE,"Funding information: Sample collection and data acquisition was supported by the joint United States National Science Foundation and United States – Israel Binational Science Foundation (NSF #1937770 to GG-G; BSF #2019653 to TM). The experiment was performed in a controlled aquaria system funded by Institutional ISF grant 2288/16.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.107085",TRUE,"<section> DECLARATION OF INTERESTS <section> D.W. K.C. and P.R.Y are listed as inventors of ‘Molecular <section> Received: February 9 2023",TRUE,"Funding. This work was supported by NHMRC MRFF Coronavirus Research Response grant APP1202445 to D.W. K.C. P.R.Y. and T.M. D. S. <section> was supported by the German Research Foundation (DFG) Emmy Noether Programme (SCHW1851/1-1) and by an EMBO Advanced grant (aALTF-1650). DB is funded by UKRI Biotechnology and Biological Sciences Research Council (UKRI BBSRC https://www.ukri.org/) Institute Strategic Program Grant (ISPG) to The Pirbright Institute (BBS/E/ I/00007034 BBS/E/I/00007030 and BBS/E/I/00007039).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.107225",TRUE,"DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"This work was supported by the German Research Foundation (DFG) (AN: FOR2722-407176282/TP7 (AN1083/4-1) MP: FOR2722-407164210/TP3 (PA660/12-1) BB: FOR2722-407146744/TP1 (BR2304/12-1) 270922282 (BR2309/9-2) MK FOR2722-407164333/TP4 (KO2247/8-1) JSBMR Frontier Scientist Grant and the Morinaga Foundation For Health and Nutrition (YI) and by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 721432 (GO AP and BB). ; Funding Acquisition B.B. G.O. and M.K.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.107405",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.isci.2023.107679",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"The work was supported by to F.P. 389563835 and CRC 1404–414984028 to K.R.) <section> S.H. F.E. T.S.H. J.B.S. J.C. S.M.G. F.P. K.R. and Funding Acquisition F.P. K.R. and M.W.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.107761",TRUE,"<section> DECLARATION OF INTERESTS J.K. and S.T. disclose support for the research of this",TRUE,"<section> DECLARATION OF INTERESTS J.K. and S.T. disclose support for the research of this Graphical abstract work was supported by the German Research Foundation [grant numbers KE 2179/2-3 the data and edited the manuscript.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.108050",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was funded by the Max Planck Society (I.B. G.K.D. M.T. R.S. <section> Foundation (M.T.H.) Fritz Thyssen Stiftung (M.T.H.) the Ingeborg Ständer Fouindation ERA-NET NEURON (TopDown PTSD) (M.T.H) Grant PCIN-2017-120 MCIN/AEI/10.13039/501100011033/ERDF/ NextGenerationEU/PRTR’’ (M.T.H.) Grant PID2021-124013OB-I00 MCIN/AEI/10.13039/501100011033 (M.T.H.) RTI2018-101624-B-I00 (M.T.H.) and National Institute of Health (M.T.H.) Spanish Ministry of Science and Innovation (BFU2017-82375-R) the Junta de Andalucı́a (Spain BIO-122) the Spanish Tatiana Pérez de Guzmán el Bueno Foundation to A.G. and J.M.D.-G and I.B. received funding from the ; Writing– Review & Editing M.T.H. I.B. M.C. M.E.L. and R.S; Funding Acquisition R.S. J.M.D.G and M.T.H; Resources R.S. and J.M.D.G; Supervision M.T.H.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.isci.2023.108409",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.it.2023.08.004",TRUE,"<section> Declaration of interests The authors declare no competing interests.",TRUE,"The project was supported by the Initiative and Networking Fund of the Helmholtz Association (to M.D.V.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jaad.2023.02.040",TRUE,"Conflicts of interest The authors met the criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE).",TRUE,"<section> Funding sources: The study was supported and funded by c St John’s Institute of Boehringer Ingelheim.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jacbts.2022.12.008",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> This work was supported by the Stavros Niarchos Foundation (SNF).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2022.10.028",TRUE,"<section> in FUNDING SUPPORT AND AUTHOR DISCLOSURES outDr Anker has received grants from Vifor International and Abbott; and has received consulting fees from AstraZeneca Bayer Boehringer",TRUE,"<section> in FUNDING SUPPORT AND AUTHOR DISCLOSURES outDr Anker has received grants from Vifor International and Abbott; and has received consulting fees from AstraZeneca Bayer Boehringer Dr Morris has received research support kidfrom the National Heart Lung and Blood Institute the Agency for Healthcare Research and Quality the Woodruff Foundation and the Association of Black Cardiologists; and has served as a consultant for Acorai Boehringer Ingelheim Lilly Cytokinetics and Ionis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.01.029",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> This study was supported by a grant agreement (602202) from the Zeymer It was 79 67063 also supported by the German Center for Cardiovascular Research (DZHK). Dr Zeymer has received grants from the European Union Zeymer@tonline.de. Dr Desch has received grants from the European Union during the conduct of the TRANSLATIONAL study.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.02.039",TRUE,"<section> SUPPORT AND AUTHOR DISCLOSURES",TRUE,"These FUNDING patients tend to have a globally reduced performance status and a reduced 1-yearoverall-survival. Dr Wilkenshoff is supported by a Clinical Grant from the Berlin Institute of Health; and has received and/or contributions to congresses from Abbott AstraBerlin Chemie Bristol Myers Squibb GE Healthcare and Servier all outside the submitted work.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.03.390",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES The manuscript was sponsored by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance. Dr Januzzi is a trustee of the American College of Cardiology; is a board member of Imbria Pharmaceuticals; has received grant support from Applied Therapeutics Innolife Novartis Pharmaceuticals and Abbott Diagnostics; has received consulting income from Abbott Janssen Novartis and Roche Diagnostics; and participates in clinical endpoint committees/data safety monitoring boards for Abbott AbbVie Amgen Bayer CVRx Janssen MyoKardia and Takeda. Dr Anker has received grants from Abbott Vascular and Vifor (International) Ltd; has received consulting fees from Abbott hospitalization",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jacc.2023.03.429",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> The Women’s Health Study is funded by grants Cancer Institute (CA047988 and UM1 CA182913) Heart Lung and Blood Institute (HL043851 HL099355). Dr Rist was supported by a Career Development from the National Heart Lung and Blood Institute This project was supported by a grant from the Society. Dr Rist received support from the American Society for this work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.04.034",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES Pharma Recardio Sanoﬁ",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES Pharma Recardio Sanoﬁ Dr Bhatt has served on Board for Angiowave Bayer Boehringer Ingelheim Cereno Scientiﬁc Elsevier Practice Update High Enroll Janssen Level Ex McKinsey Medscape Merck MyoKardia NirvaMed Novo Nordisk PhaseBio Regado Biosciences and Stasys; has served on the Board for Angiowave (stock options) Boston VA Research Bristol Myers Squibb (stock) DRS.LINQ (stock options) (stock) Society of Cardiovascular Patient Care and Inaugural Chair of American Heart Association Quality Committee; has been a consultant for Broadview Ventures; on the Data Monitoring Committee for Acesion Pharma Publique–Hôpitaux de Paris Baim Institute for Clinical Harvard Clinical Research Institute for the PORfunded by St Jude Medical now Abbott) Boston Scientiﬁc trial) Cleveland Clinic (including for the ExCEED by Edwards) Contego Medical (Chair PERFORMANCE Research Institute Mayo Clinic Mount Sinai School (for the ENVISAGE trial funded by Daiichi-Sankyo; and trial funded by Concept Medical) Novartis PopuResearch Institute and Rutgers University (for the NIHTrial); has received honoraria from the American Col(Senior Associate Editor Clinical Trials and News Chair ACC Accreditation Oversight Committee) Arnold law ﬁrm (work related to Sanoﬁ/Bristol Myers Squibb litigation) and Baim Institute for Clinical Research Harvard Clinical Research Institute for Clinical Trial for RE-DUAL PCI (funded by Boehringer IngelExecutive Committee for AEGIS-II (funded by CSL Behrfrom Belvoir Publications (Editor in Chief Harvard Heart Medical and Surgical Knowledge Translation Group (Clinical Trial Steering Committees) Cowen and Duke Clinical Research Institute (Clinical Trial Steering including for the PRONOUNCE trial funded by Ferring HMP Global (Editor in Chief Journal of Invasive Journal of the American College of Cardiology (Guest Editor) K2P (Co-Chair Interdisciplinary CurricuEx Medtelligence/ReachMD (CME Steering Committees) Sciences Oakstone CME (Course Director Comprehensive Cardiology) Piper Sandler Population Health (for the COMPASS Operations Committee PubliSteering Committee and USA national coleader Bayer) Slack Publications (Chief Medical Editor CardiolIntervention) Society of Cardiovascular Patient Care WebMD (CME Steering Committees) and Wiley Committee); Deputy Editor Clinical Cardiology Registry (Chair) for NCDR-ACTION Research and Publi(Chair) for VA CART; named on patent for sotaincome) assigned to Brigham and Women’s Hospital (no assigned to Lexicon; has received research funding Acesion Pharma Aﬁmmune Aker Biomarine Amarin Bayer Beren Boehringer Ingelheim Boston Bristol Myers Squibb Cardax CellProthera Cereno ScienCinCor CSL Behring Eisai Ethicon Faraday PharmaFerring Pharmaceuticals Forest Laboratories Fractyl Therapeutics Idorsia Ironwood Ischemix Janssen Lilly Medtronic Merck Moderna MyoKardia NirNovo Nordisk Owkin Pﬁzer PhaseBio PLx Regeneron Reid Hoffman Foundation Roche Synaptic The Medicines Company Youngene and received royalties from Elsevier (Editor Braunwald’s Heart site coinvestigator for Abbott Biotronik Boston ScientiSt Jude Medical (now Abbott) Philips SpecSvelte and Vascular Solutions; is a trustee of American Dr Fonarow received research support from the National Institutes of Health; has consulted for Abbott Amgen AstraZeneca Bayer Cytokinetics Janssen Medtronic Merck and Novartis. Dr Januzzi is a Trustee of the American lege of Cardiology; is a board member of Imbria Pharmaceuticals; received grant support from Abbott Diagnostics Applied Therapeutics Innolife and Novartis; has received consulting income Abbott Diagnostics Boehringer Ingelheim Janssen Novartis Roche Diagnostics; and participates in clinical endpoint committees/ data safety monitoring boards for AbbVie Siemens Takeda Vifor. Dr and has Verma has received personal fees from AstraZeneca Sun Pharmahas ceuticals and Toronto Knowledge Translation Working Group; has and received grants and personal fees from Amgen AstraZeneca Bayer Boehringer Ingelheim and Merck; has received grants from Bristol received Myers Squibb; and has received personal fees from Eli Lilly Janssen Novartis Novo Nordisk and Sanoﬁ.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.04.057",TRUE,"<section> SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING <section> has received research support from the Duke University of Medicine Chair’s Research Award American Heart (#929502) National Heart Lung and Blood Institute Bristol Myers Squibb Cytokinetics Merck and Pﬁzer and Sanoﬁ; has served on advisory boards for Boehringer Ingelheim and Eli Lilly Bristol Cytokinetics Roche Diagnostics scPharmaceuticals Dr Brugts has received grants from Abbott Vifor Pharma; and has received speaker fees or has served on advisory boards for Abbott Bayer Boehringer Novartis and Vifor Pharma. <section> Dr Lam is supported by a Clinician Scientist Award from the Medical Research Council of Singapore; has received research from Bayer and Roche Diagnostics; has served as consultant or Advisory Board/Steering Committee/Executive Committee for lion Alleviant Medical Allysta Pharma Amgen AnaCardio Applied Therapeutics AstraZeneca Bayer Boehringer Ingelheim Boston Scientiﬁc Cytokinetics Darma Inc EchoNous Inc Impulse Dynamics Ionis Pharmaceutical Janssen Research Development LLC Medscape/WebMD Global LLC Merck Novartis Novo Nordisk ProSciento Inc Radcliffe Group Ltd Roche agnostics Sanoﬁ Siemens Healthcare Diagnostics and Us2.ai; serves as cofounder and nonexecutive director of Us2.ai. Dr Lund received grants from AstraZeneca Vifor Pharma Boston Scientiﬁc Boehringer Ingelheim and Novartis; has served as a consultant Merck Vifor Pharma AstraZeneca Bayer Pharmacosmos MedScape Sanoﬁ Lexicon Pharmaceuticals Inc Myokardia Boehringer heim and Servier; has received speaker honoraria from MedScape Radcliffe AstraZeneca Novartis AnaCardio AB; stock ownership in AnaCardio AB.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacc.2023.10.007",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> This study was sponsored by Novartis Pharma AG. Dr Ray has received support from the National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre; his institution (Imperial College London) receives support from the National Institute for Health and Care Research Applied Research Collaboration Northwest London; has received lecture fees from Aegerion Pharmaceuticals Kowa Cipla Algorithm and Zuelling Pharma; has received grant support paid to his institution lecture fees and advisory board fees from Amgen Regeneron Pharmaceuticals/Sanoﬁ and Pﬁzer; has received lecture fees and fees for serving on steering committees for trials from AstraZeneca and Eli Lilly; has received fees for serving on steering committees for trials from Cerenis Therapeutics The Medicines Company and Esperion; has received advisory board fees from Akcea Therapeutics Novartis Silence Therapeutics Bayer and Daiichi-Sankyo; has received lecture fees and advisory board fees from Takeda Boehringer Ingelheim and Dr Reddy’s Laboratories; has received grant support and advisory board fees from Merck Sharp and Dohme; has received fees for serving on a clinical events adjudication committee from AbbVie; and has received fees for serving as principal investigator for a trial from Resverlogix.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jacep.2022.07.014",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> has no disclosures.",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES No funding was provided this analysis. Dr Gray has served as a consultant for received grant support from Boston Scientiﬁc Cook Medical tronic Surmodics and Philips.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jaci.2022.12.818",TRUE,"Disclosure of potential conflict of interest: P. The rest of the authors declare that they have no relevant conflicts of interest.",TRUE,"<section> Supported by the UK Medical Research Council (award MR/S036954/1 [to P.J.T.]) National Institute for Health and Care Research/Imperial Biomedical Research Ccntre (to P.J.T.) and JM Charitable Foundation (to P.J.T.).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jaci.2023.02.017",TRUE,"Disclosure of potential conflict of interest: T.",TRUE,"<section> This review was led and supported by the European Society for Blood and Marrow Transplantation-(EBMT)-Autoimmune Diseases Working Party.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jad.2023.01.045",TRUE,"Conflict of interest <section> Dr.",TRUE,"<section> Funding Catalan has received personal fees from Janssen and grants support from the Instituto de Salud Carlos III Spanish Ministry of Economy and Competitiveness. Prof González-Pinto has received grants from or served as a consultant advisor or CME speaker for the following entities: Janssen-Cilag Takeda Faes Farma Lundbeck Otsuka SanofiAventis Servier the Spanish Ministries of Science and Innovation (through CIBERSAM) and of Science (through the Carlos III Institute of Health) the Basque Government the Stanley Medical Research Insti­ tute and Wyeth. Prof Birmaher’s research is funded by the National Institute of Mental Health. He has received grant support from Janssen and Takeda. Prof Fusar-Poli received support for this study from the PSYSCAN project through the European Commission Prof Fusar-Poli reports research fees from Lundbeck and honoraria from Lundbeck Angelini Pharma Menarini and Boehringer Ingelheim",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This study (protocol: PROSPERO CRD42022346515) was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) (Moher et al. 2009) (eTable 1–2) state­ ments.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.jad.2023.01.108",TRUE,"Conflict of interest <section> GMG is emeritus NIHR Senior Investigator and has consulted for Beckley Psytech Boehringer Ingelheim Clerkenwell Health EVApharm H Lundbeck A/S Janssen Global Services Novartis Ocean Neurosci­ ences P1vital Sage Therapeutics Servier Takeda and WebMD.",TRUE,"<section> Funding <section> This work was funded by COMPASS Pathfinder Ltd. BWD has received grant funding from Boehringer Ingelheim COMPASS Pathways Otsuka America Pharmaceutical and the Usona Institute.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jad.2023.05.011",TRUE,"<section> Declaration of competing interest",TRUE,"How­ ever many medication trials are sponsored by the industry and this may also affect outcomes. <section> No funding was received for this study.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jaim.2023.100809",TRUE,"<section> Declaration of competing interest <section> The authors declare that the research was conducted without any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Funding agencies <insert> Table 8 Funding agencies based on publications. <section> Funding <section> No funding was received for this research study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jaip.2022.11.036",TRUE,"The rest of the authors declare that they have no relevant conﬂicts of interest.",TRUE,"<section> o Asthma UK Centre in Allergic Mechanisms of Asthma London UK p Novartis Pharma AG Basel Switzerland This work was funded by Novartis Pharma AG Basel Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This protocol is registered in the International Prospective Register of Systematic Reviews (PROSPERO; number CRD42021245895).",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.jaip.2023.02.021",TRUE,"The rest of the authors declare that they have no relevant conﬂicts of interest.",TRUE,"Valent was supported by the Austrian Science Fund (FWF) grant P32470. Hartmann was supported by the Swiss National Science Foundation (SNSF) grant 310030_207705. V. Sabato was supported by Flemish Research Foundation (grant. 63 These OIS projects were supported by members of the ECNM and AIM and used by patients to provide valuable recommendations concerns and other feedback to the scientiﬁc community.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jaip.2023.03.026",TRUE,"The rest of the authors declare that they have no relevant conﬂicts of interest.",TRUE,"This work is partially supported by funds to M. I. Maris received grant funding related to this work from the National Children’s Research Centre Dublin Ireland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jaip.2023.08.008",TRUE,"The rest of the authors declare that they have no relevant conﬂicts of interest.",TRUE,"<section> P. Valent was supported by the Austrian Science Fund (FWF) grant P32470-B. K. <section> Hartmann was supported by the Swiss National Science Foundation (SNSF) grant 310030_207705. D. Metcalfe were supported by the Division of Intramural Research NIAID NIH. S. J. Galli was supported by NIH/NIAID U19 AI104209 and NIH R01 AI165373.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jaut.2023.103024",TRUE,"<section> Declaration of competing interest <section> All authors have no competing interests directly related to this manuscript.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jbc.2022.102865",TRUE,"I. <section> Conﬂict of interest—The authors declare that they have no conﬂicts of interest with the contents of this article.",TRUE,"<section> Funding and additional information—K. This work was supported by Japan Society for the Promotion of Science KAKENHI Grantin-Aid for Scientiﬁc",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jbc.2023.104812",TRUE,"<section> Conﬂict of interest—The authors declare that they have no conﬂicts of interest with the contents of this article.",TRUE,"<section> Funding and additional information—This work was supported by grants from the NSFC for Young Scientists of China (Grant 31900548 to W.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jbi.2023.104305",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Brian S. Alper is the project lead for the EBMonFHIR project and owns Computable Publishing LLC which produces and hosts the FEvIR Plat­ form. Otherwise the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> The COVID-19 Evidence Ecosystem (CEOsys) project is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) Grant No 01KX2021. The CODEX + project is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)) grant number 01KX2121. <section> Funding acquisition. <section> Martin Boeker: Investigation Writing – review & editing Funding acquisition. <section> – review & editing Funding acquisition. <section> Supervision Funding acquisition.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jbi.2023.104437",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jbtep.2023.101893",TRUE,"<section> • conflict of interest <section> The authors of ten studies declared no conflicts of interest (Bouchard et al. 2017; Freeman et al. 2018; Gujjar et al. 2019; Jiang et al. 2020; Kampmann et al. 2016; Levy et al. 2016; Lima et al. 2018; Lorenzo et al. 2011; Meyerbroeker et al. 2013; Rus-Calafell et al. 2013). In Lindner et al. (2019)(Lindner et al. 2019) one out of eight authors and in Maskey et al. (2019)(Maskey et al. 2019) two out of eleven authors declared a conflict of interest. The remaining studies provide no infor­ mation regarding conflict of interest(Anderson et al. 2013; Miloff et al. 2019; Minns et al. 2019; Pelissolo et al. 2012; Pitti et al. 2015). <section> Declaration of competing interest <section> All authors declare that they have no conflicts of interest.",TRUE,"<section> Funding <section> All other authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jcf.2022.10.002",FALSE,"",TRUE,"<section> Article history: Cystic ﬁbrosis (CF) has entered Received 15 June 2022 the Cystic Fibrosis Transmembrane Revised 6 October 2022 speciﬁc therapy available have Accepted 10 October 2022 The latest standards of care Available online 28 October 2022 speciﬁc therapy as CFTR modulators Funding sources: ECFS funded editorial interim standards to guide healthcare support for this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jchf.2022.11.005",TRUE,"<section> SUPPORT AND AUTHOR DISCLOSURES",TRUE,"Ultimately patients the decision about the best LV unloading strategy in a ﬁndings given CS patient should be based on a discussion in an controlled interdisciplinary shock team which by itself has been will address shown to be associated with favorable outcomes. 2223 severe CS The main strengths of this study are the large inECMO vs ternational multicenter registry of CS patients treated with and without active LV unloading as well FUNDING as the thorough documentation of the implantation interval which allowed us to investigate this topic. <section> and Westermann were funded by the German Center for Research and Dr Schrage is also funded by the Else This study was funded by an unrestricted from Abiomed. Dr Eckner has received speaker fees Bayer and Daiichi Sankyo outside of the submitted Kirchhof has received research support for basic transclinical research projects from the European Union Foundation Leducq Foundation Medical Research Kingdom) and German Center for Cardiovascular has received research support from several drug and device active in atrial ﬁbrillation; has received honoraria from companies in the past but not in the last 3 years; and is on 2 patents held by the University of Birmingham Therapy WO 2015140571 Markers for Atrial Fibril2016012783; unrelated to the submitted work).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2022.11.015",TRUE,"0.004 <0.001 Change in KCCQ-OSS <0.001 b 0to 4-point change 74 (25.3) 53 (18.7) 10 (23.3) 5to 9-point increase 41 (14.0) 38 (13.4) 8 (18.6) 10þ point increase 116 (39.6) 161 (56.9) 9 (20.9) 5to 9-point decrease 19 (6.5) 8 (2.8) 3 (7.0) 10þ point decrease 43 (14.7) 23 (8.1) 13 (30.2) Description of planned arm FUNDING SUPPORT AND AUTHOR DISCLOSURES The VITALITY-HFpEF trial was funded by Bayer and Merck Sharp and Dohme Corp a subsidiary of Merck and Co Inc.",TRUE,"0.004 <0.001 Change in KCCQ-OSS <0.001 b 0to 4-point change 74 (25.3) 53 (18.7) 10 (23.3) 5to 9-point increase 41 (14.0) 38 (13.4) 8 (18.6) 10þ point increase 116 (39.6) 161 (56.9) 9 (20.9) 5to 9-point decrease 19 (6.5) 8 (2.8) 3 (7.0) 10þ point decrease 43 (14.7) 23 (8.1) 13 (30.2) Description of planned arm FUNDING SUPPORT AND AUTHOR DISCLOSURES The VITALITY-HFpEF trial was funded by Bayer and Merck Sharp and Dohme Corp a subsidiary of Merck and Co Inc. Dr Lam has received research grant support from Bayer the National Medical Research Council of Singapore Boston Scientiﬁc Roche Diagnostics Med0.809 b tronic Vifor Pharma and AstraZeneca; has received consulting Placebo 103 (34.6) 104 (36.5) 12 (27.3) fees from Merck Bayer Boston Scientiﬁc Roche Diagnostics Vifor Vericiguat titration to 10 mg 97 (32.6) 91 (31.9) 17 (38.6) Pharma AstraZeneca Novartis Amgen Janssen Research and Vericiguat titration to 15 mg 98 (32.9) 90 (31.6) 15 (34.1) Development LLC Menarini Boehringer Ingelheim Abbott Diagnostics Corvia Stealth BioTherapeutics Novo Nordisk JanaCare Values are mean \u0001 SD or n (%). Dr Spertus has received research grant support from the National Institutes of Health Abbott Vascular and American College of Cardiology Foundation; has criteria. Dr Anstrom has received research grant support from populations given the relatively short time from HF Merck and Co Inc and the National Institutes of Health.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2022.11.026",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES concerns Although",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES concerns Although <section> Dr Harrington has received salary support from T32 training grant medications T32HL069749.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2022.12.011",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> This work was supported by the European Commission Program 7 (EU-FP7; Brussels Belgium [grant number: the Deutsche Forschungsgemeinschaft (DFG) through ternational Graduate School of Science and Engineering Garching Germany) (Flavia Baldassarri Stephan Duvinage and Haykowsky); and the Flanders Research (FWO; Brussels Belgium) (senior clinical investigator Craenenbroeck). Dr Haykowsky has received grants from Novartis and personal fees from Abbott (adviindex sory board) AstraZeneca Bayer Berlin Chemie-Menarini Boehringer endothelial Ingelheim Bristol-Myers Squibb Daiichi-Sankyo Novartis Roche endotheliumSanoﬁ and Pﬁzer; and serves as an advisor for Medical Park SE values and Germany; outside the submitted work. Dr Van Craenenbroeck has received grants from Vifor Pharma outside the submitted work.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2023.01.018",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES Zeneca Boehringer Cytokinetics",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES Zeneca Boehringer Cytokinetics <section> Novartis ParatusRx The EMPEROR-Reduced and Preserved trials were funded by BoehTheravance ringer Ingelheim and Eli Lilly (EMPEROR-Reduced [NCT03057977] authors have and EMPEROR-Preserved [NCT03057951]). <section> SKILLS: Director at Jana Care; has received grant support from Abbott Applied Therapeutics HeartFlow Innolife and Roche Diagnostics; early has received consulting income from Abbott Beckman Bristol Myers ﬁrst HF Squibb Boehringer Ingelheim Janssen Novartis Pﬁzer Merck Roche Diagnostics and Siemens; and has participated in clinical TRANSLATIONAL endpoint committees/data safety monitoring boards for Abbott AbbVie CVRx Intercept and Takeda.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2023.02.007",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> Dr Schiattarella is supported by grants from the German Centre for Dr Taegtmeyer is Most supported by the grant from the National Heart Lung and Blood Institute (R01-HL061483).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jchf.2023.06.020",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> The VICTORIA trial was funded by Merck Sharp and Dohme subsidiary of Merck and Co Inc (Rahway New Jersey USA) and AG (Wuppertal Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jchromb.2023.123891",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence of spiked tattoo ink the PABA metabolite ACD was identified according to the acid by a standard substance.",TRUE,"<section> 5. <section> Funding <section> This work was supported by the intramural research projects SFP",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcin.2022.10.050",TRUE,"<section> SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> cause coronary obstruction (chimney or snorkel technique) is the most common and straightforward FUNDING approach for preventing coronary obstruction in this population.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcin.2023.01.376",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> Dr Meier is supported by the Swiss National Science Foundation (grant P2LAP3_199561). Dr Waksman has been a consultant for Abbott Vascular Amgen Boston Scientiﬁc Medtronic Philips Volcano Pi-Cardia. and Transmural Solutions; has been an advisory board member for Abbott Vascular Amgen Boston Scientiﬁc Medtronic Philips Volcano and Pi-Cardia; has received speaker honoraria from AstraZeneca and Chiesi; has received grant support from Biotronik AstraZeneca and Chiesi; and holds investments in MedAlliance and Transmural Solutions.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcin.2023.02.029",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES PERSPECTIVES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES PERSPECTIVES",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcin.2023.07.038",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jclinepi.2023.03.013",TRUE,"<section> The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Conrad Harrison reports financial support was provided by National Institute for Health and Care Research.",TRUE,"<section> The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Conrad Harrison reports financial support was provided by National Institute for Health and Care Research. <section> We would like to acknowledge and thank Oxford-Berlin Research Partnership and Rosetrees Trust for supporting the Oxford-Berlin Partnership for Enhancing Measurement in Clinical Trials as well as all patients who have contributed data to the NHS PROMs program and the opensource R community for making such software advances possible.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jclinepi.2023.04.007",TRUE,"Conflict of interest: G.L. F.H.F. M.L.B. and G.S. have no conflict of interest.",TRUE,"<section> Funding: The CONVINCE study was supported by the European Commission Research & Innovation Horizon 2020 Call H2020-SC1-2016-2017 under the topic SC1-PM-10-2017: Comparing the effectiveness of existing healthcare interventions in the adult population (grant no. 754803-2).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jclinepi.2023.04.008",TRUE,"<section> Declaration of interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Conrad Harrison reports financial support was provided by National Institute for Health and Care Research.",TRUE,"<section> Funding: Conrad J. Harrison is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (NIHR300684) and the Rosetrees Clinical Trials Fellow. Rodrigues is funded by a NIHR postdoctoral fellowship (PDF-2017-10-075). Sabah is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (NIHR301771). This document presents independent research funded by the NIHR the Rosetrees Trust and the Oxford-Berlin Research Partnership. <section> Declaration of interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Conrad Harrison reports financial support was provided by National Institute for Health and Care Research. J.R.: Funding acquisition writingereview and editing and supervision. D.J.B.: Funding acquisition writingereview and editing and supervision. F.F.: Funding acquisition methodology project administration resources software writingereview and editing and supervision. <section> We would like to acknowledge and thank Oxford-Berlin Research Partnership and Rosetrees Trust for supporting the Oxford-Berlin Partnership for Enhancing Measurement in Clinical Trials as well as all patients who have contributed data to the NHS PROMs program and the opensource R community for making such software advances possible.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jclinepi.2023.05.023",TRUE,"<section> Declaration of competing interest <section> One included non-Cochrane review was co-authored by a project participant (L.G.H.) who did not appraise data or resolve conflicts for these reviews. All other authors declare no relevant conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jclinepi.2023.06.007",TRUE,"Competing Interest <section> None of the authors has any competing interest regarding the topic of this research.",TRUE,"<section> Funding: This project was supported by internal funds of Cochrane Austria.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jcmg.2022.10.005",TRUE,"<section> disease in addition to FUNDING SUPPORT AND AUTHOR DISCLOSURES performance.",TRUE,"<section> disease in addition to FUNDING SUPPORT AND AUTHOR DISCLOSURES performance. <section> have been evaluated for HCMR was supported by the National Institutes of Health the Naadverse events in HCM. Dr Antiochos has received research funding from the Swiss of serum NT-proBNP levels have National Science Foundation (grant P2LAP3_184037) the Novartis with diffuse subclinical Foundation for Medical-Biological Research the Bangerter-Rhyner NT-proBNP and troponin Foundation and the SICPA Foundation.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmg.2022.10.021",TRUE,"<section> on each site’s FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> on each site’s FUNDING SUPPORT AND AUTHOR DISCLOSURES",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmg.2022.11.025",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES",TRUE,"<section> FUNDING SUPPORT AND AUTHOR DISCLOSURES <section> The SPINS Registry was funded by the Society for Cardiovascular Magnetic Resonance (SCMR) using a research grant jointly sponsored by Siemens Healthineers and Bayer. Dr Antiochos has received research funding from the Swiss National Science Foundation (grant P2LAP3_184037) the Novartis Foundation for Medical-Biological Research the Bangerter-Rhyner Foundation and the SICPA Foundation. Dr Shenoy was supported by a National Institutes of Health grant (K23HL132011).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmgh.2022.11.008",FALSE,"",TRUE,"<section> Funding <section> Supported by ASEAN grant CRD/2019/000120 from the Department of Science and Technology India (S.K.) by National Institutes of Health grants 1R01AA027189-01A1 and P20 GM104320 to the Nebraska Center for the Prevention of Obesity Diseases grant P20 GM113126 to the Nebraska Center for Integrated Biomolecular Communication and a Nebraska Supported by grantsin-aid for scientiﬁc research from the Japan Society for the Promotion of Science JSPS-22K08083 and 22H03061 and a grant for the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED-JP22fk0210107) (L.T.T.T.). Funded by US Public Health Service grant R01 DK111677 from the National Institute of Diabetes and Digestive and Kidney Diseases grant R01AA025907 from the National Institute on Alcohol Abuse and Alcoholism and US Veterans Administration grant I01BX005093 from the Biomedical Laboratory Research and Development (N.N.). <section> Supported by the McKnight Philanthropic Bequest and National Health and Medical Research Council (V.C.C.); by National Natural Science Foundation of China grant 82030021 (W.-F.X.); by German Research Foundation grants DFG SFB/TRR 296 and CRC1382 (project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium) (F.T.); and by Instituto de Salud Carlos III grant FIS PI20/00220 (cofunded by the European Union) the CIBEREHD Swiss National Science Funds 320030_189252 the Novartis Foundation for Medical-Biological Research and the Foundation Suisse Contre le Cancer du Foie (J.G.-S.).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmgh.2023.01.014",FALSE,"",TRUE,"<section> Funding <section> Supported by Deutsche Forschungsgemeinschaft-Emmy Noether Program (M.R.) and Einstein foundation strategic professorship and a core grant from the Berlin Institute of Health (L.V.). This work was funded by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF ImmunAvatar consortium).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmgh.2023.02.010",TRUE,"<section> Conﬂicts of interest The authors disclose no conﬂicts.",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (CRC1382 SPP2306).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmgh.2023.03.002",FALSE,"",TRUE,"<section> Funding <section> This work was funded by the German Research Foundation (CRC1382 project ID 403224013 and SFB/TRR 296) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcmgh.2023.05.008",TRUE,"<section> Conﬂicts of interest The authors disclose no conﬂicts.",TRUE,"<section> Henrik Oster (Conceptualization: Lead; Funding acquisition: Lead; <section> Funding <section> This work was supported by grants 353-10/1 GRK-1957 and CRC/TR LOCOTACT (TP-13) from the German Research Foundation (H.O.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jcyt.2023.04.010",TRUE,"Competing Interest",TRUE,"<section> Funding <section> Jasper Iske was supported by the Junior Clinician Scientist Program of the Berlin Institute of Health. Yeqi Nian was supported by a grant (82101874) from the National Natural Science Foundation of China and an internal grant from Tianjin First Central Hospital.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jdsr.2023.09.003",TRUE,"Conflict of Interest <section> The authors declare no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jebdp.2022.101794",TRUE,"The authors have no actual or potential conflicts of interest.",TRUE,"<section> SOURCE OF FUNDING: This study was supported by the",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jenvp.2023.102142",FALSE,"",TRUE,"<section> Funding <section> This work was supported by Deutsche Forschungsgemeinschaft (DFG) [Project number 437818133 and 438075992] and partly funded by a research grant from Servier Deutschland GmbH and payments by the German Environment Agency. Martin Knöll: Conceptu­ alization Writing review & editing Supervision Funding acquisition.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jgar.2022.12.004",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding <section> This work was supported by an unrestricted research grant from Allergan to investigate CVC in the condition of Covid-19.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhep.2022.09.021",FALSE,"",TRUE,"<section> Financial support EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2. FT lab’ work has been supported by the German Research Foundation (DFG CRC/ TR 362) and research grants from Gilead Allergan Bristol-Myers Squibb <section> Grant Funding: Allergan/Tobira AstraZeneca Boehringer-Ingelheim Glaxo SmithKline Glympse Bio Intercept NovartisPharma AG Pﬁzer Ltd. VR consults for and Intercept Novo Nordisk Galmed Poxel NGM Madrigal Enyo Sagimet 89 Bio Prosciento Terns and Theratechnologies and received grants from Intercept",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jhep.2022.12.018",TRUE,"<section> All authors disclose any conﬂicts of interest related to the present work. <section> Please refer to the accompanying ICMJE disclosure forms for further details.",TRUE,"<section> The STOP-NUC trial was a prospective multicenter randomized controlled trial (EudraCT 2013-004882-15 German Clinical Trial Register DRKS00006240) (Fig. 1) funded by the German Federal Ministry of Education and Research (BMBF 01KG1308) that was conducted across 25 German sites. <section> Financial support <section> The STOP-NUC trial (EudraCT 2013-004882-15 German Clinical Trial Register DRKS00006240) was funded by the German Federal Ministry of Education and Research (BMBF 01KG1308).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhep.2023.02.041",FALSE,"",TRUE,"<section> Financial support <section> This work was funded by the Center for Disease Analysis Foundation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhep.2023.04.037",TRUE,"The authors declare no conﬂicts of interest that pertain to this work. <section> Please refer to the accompanying ICMJE disclosure forms for further details.",TRUE,"<section> Financial support <section> M.H. was supported by an European Research Council (ERC) Consolidator grant (HepatoMetaboPath) SFBTR179 project ID 272983813 SFB/TR 209 project ID 314905040 SFBTR1335 project ID 360372040 SFB 1479 (Project ID: 441891347) the Wilhelm Sander-Stiftung the Rainer Hoenig Stiftung a Horizon 2020 grant (Hep-Car) Research Foundation Flanders (FWO) under grant 30826052 (EOS Convention MODEL-IDI) Deutsche Krebshilfe projects 70113166 and 70113167 German-Israeli Cooperation in Cancer Research (DKFZ-MOST) and the Helmholtz-Gemeinschaft Zukunftsthema ‘Immunology and Inﬂammation’ (ZT-0027). Q.M.A. and OG are supported by the LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis) project which has received funding from the Innovative Medicines Initiative (IMI2) Program of the European Union under Grant Agreement 777377; this Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. N.C.H. is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (ref. A.D.G was supported by European Respiratory Society/short term fellowship (to A.D.G) Else Kröner Memorial Stipendium (to A.D.G) Werner Otto Stiftung (to A.D.G) Erich und Gertrud Roggenbuck Stiftung (to A.D.G) Hamburger Krebsgesellschaft Stiftung (to A.D.G).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhepr.2022.100650",TRUE,"<section> Conﬂicts of interest The authors declare no conﬂict of interest concerning the content of this manuscript. <section> Please refer to the accompanying ICMJE disclosure forms for further details.",TRUE,"<section> Study design and patients The investigatorinitiated HepNet acute HCV-V study was designed as a phase II national multicentre prospective singlearm pilot study and was coordinated by the HepNet StudyHouse a project of the German Liver Foundation funded by the German Center for Infection Research (DZIF). <section> Financial support The study was funded by a grant of the DZIF (German Center for Infection Research TTU Hepatitis) to the HepNet Study-House of the German Liver Foundation (DLS) and Gilead Sciences.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol was registered at ClinicalTrial.gov (NCT03818308).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.jhepr.2023.100686",FALSE,"",TRUE,"<section> Financial support There was no speciﬁc ﬁnancial support to be reported. KS received grants from Gilead; honoraria for lectures from Gilead Abbvie and MSD; support for attending meetings and/or travel from Gilead and Abbvie; participated in advisory boards from Gilead.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhepr.2023.100785",TRUE,"All conﬂicts of interest related to this position statement were requested and disclosed. MB MP MI YJW FGN RT CNF AEM KP TT and SPS declared no potential conﬂicts of interest concerning the publication of this article. LR HM EC GBLS LY S YY EV and AK declared no potential conﬂicts of interest concerning the publication of this article. AOB declared no potential conﬂicts of interest concerning the publication of this article. MB declared the following potential conﬂicts of interest with respect to the publication of this article: personal fees from CLS Behring GmbH (consultant speaker) Grifols SA (consultant speaker) Takeda (consultant speaker) PPTA (speaker) and Octapharma (speaker). XQ declared no potential conﬂicts of interest concerning the publication of this article. <section> Please refer to the accompanying ICMJE disclosure forms for further details.",TRUE,"<section> Financial support This work is partially funded by the Young and Middleaged Scientiﬁc and Technological Innovation Talents Support Plan Project of Shenyang (RC210011) and the Outstanding Youth Foundation of Liaoning Province FW received grant support from Grifols.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jhepr.2023.100883",TRUE,"<section> Conﬂicts of interest statement The authors declare no conﬂicts of interest that pertain to this work. <section> Please refer to the accompanying ICMJE disclosure forms for further details.",TRUE,"<section> Financial support This study was ﬁnancially supported by Shenzhen Science and Technology Program (JCYJ20210324121802008) the National Natural Science Foundation of China (32270833) the Natural Science Foundation of Fujian Province (2022J01014 2022R1001002) and the Natural Science Foundation of Xiamen City (3502Z20227164).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jhin.2023.07.020",TRUE,"Conflict of interest statement The authors declare that they have no conflicts of interest.",TRUE,"<section> Funding sources This work was supported by the rd JPI AMR framework (Joint Programming Initiative on Antimicrobial Resistance) cofound grant no 681055 for the consortium EMerGE-Net (Effectiveness of infection control strategies against intraand interhospital transmission of MultidruG-resistant Enterobacterales) funded by the German Federal Ministry of Education and Research (FKZ 01KI1704A and 01KI1704B).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jid.2022.10.016",TRUE,"The authors state no conflict of interest.",TRUE,"Our study was supported by grants from the National Natural Science Foundation of China (numbers 81930089 82230104 81773318). <section> AUTHOR CONTRIBUTIONS Conceptualization: XYC FX; Formal Analysis: XYC XYM JQC; Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jid.2023.01.016",TRUE,"The authors state no conflict of interest.",TRUE,"This work was supported by the Deutsche Forschungsgemeinschaft TTR156/2 246807620 to AD AW BS CW and FCK. <section> AUTHOR CONTRIBUTIONS Funding Acquisition: AD AW CW BS FCK; Investigation: SM TR FW YT LTA JH APH LB KB KEM CR; Resources: IP CR AD; Writing e Review and",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jinf.2023.03.021",TRUE,"Competing Interest <section> None.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jlr.2023.100473",TRUE,"The authors declare that they have no conflicts of interest with the contents of this article.",TRUE,"<section> Funding and additional information This research was funded in whole or in part by the Austrian Science Fund (FWF) [P33511].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jmoldx.2023.06.011",TRUE,"Disclosures: The EuroClonality-NGS EuroClonality Consortium which is an independent that aims at innovation standardization diagnostic clonality analysis.",TRUE,"<section> Supported by the Dutch Health Insurers’ (M.v.d.B.); and the revenues of the previously NL2003/000690) which is owned collectively BIOMED-2 Consortium and licensed to Disclosures: The EuroClonality-NGS EuroClonality Consortium which is an independent that aims at innovation standardization diagnostic clonality analysis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jneumeth.2023.109981",TRUE,"Competing Interest <section> P.F. has a patent on thin-film electrodes and is a member of the Advisory Board of CorTec GmbH (Freiburg Germany). All other authors <section> do not have any conflict of interests to declare.",TRUE,"This work was supported by funding of the BMBF",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.joca.2023.07.013",TRUE,"Competing Interest <section> The authors declare no competing interests for the work pre­ sented in this paper.",TRUE,"<section> The authors acknowledge generous funding support that provided direct research costs for this study and salaries for research personnel that enabled and contributed to this research directly and through de­ velopment of different ptOA models and histopathology scoring methods: Deutsche Forschungsgemeinschaft (DFG-HA 8481/1-1) the Raymond E Purves Research Foundation the Hillcrest Foundation through Perpetual Philanthropies (project grants IPAP2018/1270 and IPAP2019/0645) Arthritis Australia the Institute of Bone and Joint Research Sydney Medical School Foundation and the University of Sydney.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jri.2022.103777",TRUE,"Conflict of interest statement The remaining authors declare no conflict of interest. The authors declare no other conflict of interest. <section> Conflict(s) of interest/Disclosure(s)",TRUE,"<section> Funding: Lydia Lande Linge received a medical student research grant from the University of Oslo through The Research Council of Norway.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jseint.2022.09.001",TRUE,"<section> Conﬂicts of interest: The authors received payments from Zimmer Biomet which is related to the subject of this work.",TRUE,"<section> Funding: This study was ﬁnancially supported by Zimmer Biomet (Warsaw IN USA).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jseint.2023.06.011",TRUE,"<section> Conﬂicts of interest: The authors their immediate families and any research foundation with which they are afﬁliated have not received any ﬁnancial payments or other beneﬁts from any commercial entity related to the subject of this article.",TRUE,"<section> Funding: No funding was disclosed by the authors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.jseint.2023.06.017",TRUE,"<section> Conﬂicts of interest: The authors their immediate families and any research foundation with which they are afﬁliated have not received any ﬁnancial payments or other beneﬁts from any commercial entity related to the subject of this article.",TRUE,"<section> Funding: Support for this research was provided by Schulthess Clinic.",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jtauto.2023.100221",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"Sara Cannizzo: Funding acquisition. Andrea Gaglioti: Funding acquisition. Diana Marinello: Conceptualization Methodology Funding acquisition. Rosaria Talarico: Conceptualization Methodology Funding acquisition Project administration Writing – review & editing. <section> Mosca: Conceptualization Methodology Funding acquisition Project administration Supervision Writing – review & editing. <section> Funding <section> This publication was funded by the European Union’s Health Pro­ gramme (2014–2020).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jtbi.2022.111327",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jtha.2022.11.010",TRUE,"All other authors report no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jtha.2023.07.010",TRUE,"<section> DEC LA RA TI O N OF C O MPET IN G I NTER E STS None of the authors report any conﬂicts of interest with respect to the content of this article. P.S.W. reports grants from Bayer AG within the submitted work. <section> Outside the submitted work he reports nonﬁnancial grants from Philips Medical Systems grants and consulting fees from Boehringer Ingelheim Novartis Pharma Sanoﬁ-Aventis Daiichi Sankyo Europe grants consulting and lecturing fees from Bayer Health Care lecturing fees from Pﬁzer Pharma and Bristol-Myers Squibb consulting fees from Astra Zeneca consulting fees and nonﬁnancial support from Diasorin and nonﬁnancial support from I.E.M. P.S.W. was funded by the Ministry of Education and Research (BMBF 01EO1003 and 01EO1503). J.H.P. has received honoraria for lectures from Bayer AG Boehringer Ingelheim Daiichi Sankyo GmbH and Sanoﬁ-Aventis GmbH and research grants from the Federal Ministry of Education and Research (BMBF 01EO1503) and the German Center for Cardiovascular Research (DZHK) outside the topic of the present study. S.K. reports grants and consulting fees from Bayer AG Daiichi-Sankyo Boston Scientiﬁc and Inari Medical and lecture fees from Pﬁzer – Bristol-Myers Squibb and MSD. The remaining authors report no conﬂict of interest.",TRUE,"<section> Funding information The cohorts in this article were funded by interpret their mechanistic the German Federal Ministry of Education A.P.R. received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant (no. 813409). P.S.W. was funded by the Ministry of Education and Research (BMBF 01EO1003 and 01EO1503).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jval.2022.08.002",TRUE,"Disclosures: Drs Seidl Schunk Le Syunyaeva Streitwieser Berger Mansmann Szentes Bausewein and Schwarzkopf reported receiving grants from the German Federal Ministry of Education and Research during the conduct of the study.",TRUE,"<section> Conﬂict of Interest Disclosures: Drs Seidl Schunk Le Syunyaeva Streitwieser Berger Mansmann Szentes Bausewein and Schwarzkopf reported receiving grants from the German Federal Ministry of Education and Research during the conduct of the study. <section> Funding/Support: The German Federal Ministry of Education and Research funded this study (grant reference number: 01GY1331).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jval.2022.09.2477",TRUE,"Disclosures: Dr Kurth reported receiving research grants from the Gemeinsamer Bundesausschuss (G-BA – Federal Joint Committee) and the Bundesministerium für Gesundheit (BMG – Federal Ministry of Health). He also reported receiving personal compensation from Eli Lilly & Company Teva Pharmaceuticals TotalEnergies S.E. the BMJ and Frontiers outside the submitted work. Dr Panteli started working for the European Observatory on Health Systems and Policies on October 1 2020 a partnership hosted by the World Health Organization. The submitted work is independent of this relationship. <section> For current employment Dr Panteli reported receiving consulting fees from World Health Organization (European Observatory on Health Systems and Policies) not related to this project. Her previous employer was the Technische Universität Berlin where the Department receives a range of research grant funding none directly related to this work. No other disclosures were reported.",TRUE,"<section> Conﬂict of Interest Disclosures: Dr Kurth reported receiving research grants from the Gemeinsamer Bundesausschuss (G-BA – Federal Joint Committee) and the Bundesministerium für Gesundheit (BMG – Federal Ministry of Health). <section> Funding/Support: The authors received no ﬁnancial support for this research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,"<section> This review was registered in PROSPERO 2020 CRD42020188130.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.jval.2022.12.009",TRUE,"Disclosures: Dr Nolte reported receiving grants from EORTC Quality of Life Group during the conduct of the study and personal fees from ICON plc and Union Chimique Belge Biosciences GmbH outside the submitted work. Dr Liegl reported receiving personal fees from IQTIG outside the submitted work. Dr Gamper reported receiving grants from EORTC (grant 1622) during the conduct of the study. Dr Norman is an editor for Value in Health and had no role in the peer-review process of this article. No other disclosures were reported.",TRUE,"<section> Conﬂict of Interest Disclosures: Dr Nolte reported receiving grants from EORTC Quality of Life Group during the conduct of the study and personal fees from ICON plc and Union Chimique Belge Biosciences GmbH outside the submitted work. <section> Funding/Support: This work was funded by a research grant of the",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jvir.2022.11.013",TRUE,"None of the other authors have identiﬁed a conﬂict of interest.",TRUE,"<section> This project was supported in part by the Yale Liver Center award NIH P30 DK034989 Microscopy core. Research reported in this publication was funded by the National Institutes of Health (R01 CA206180 and R01 EB023366) and the Society of Interventional Oncology (19-001324).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.jvir.2022.11.026",TRUE,"<section> None of the other authors have identiﬁed a conﬂict of interest.",TRUE,"Research reported in this publication was funded by the National Institutes of Health (R01 CA206180 and R01 EB023366) and the Society of Interventional Oncology (19-001324). <section> This project was supported in part by the Yale Liver Center award NIH P30 DK034989 Microscopy core.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.kint.2023.05.025",TRUE,"<section> DISCLOSURE <section> All the authors declared no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.labinv.2022.100037",TRUE,"Competing Interest <section> The authors declare no competing ﬁnancial interests in relation to the work described.",TRUE,"<section> Funding <section> This research was funded by Telethon-Italy (GEP12053 to C.B.) the Italian Ministry of Health (RF 2016e02364503 to C.B.) and Fondazione Compagnia di San Paolo (ROL 32561 to L.R. and S.Bruzzone).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.labinv.2023.100244",TRUE,"Competing Interest <section> The authors declare no conﬂicts of interest.",TRUE,"<section> Funding <section> This work was supported by the German Federal Ministry for Economic Affairs and Climate Action via the EMPAIA project (grant numbers 01MK20002A [N.Z. R.C. and T.-R.K.] and 01MK20002B [A.H. and L.O.S.]).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.lana.2023.100541",TRUE,"<section> reported receiving consulting fees from Pﬁzer and Roche and payment or honoraria from Roche Lilly and authors report no potential conﬂict of interest.",TRUE,"<section> Funding The authors received no ﬁnancial support for this research. <section> Role of the funding source The authors received no funding for this study. <section> Acknowledgments Role of the funding source: The authors received no funding for the present study. KUS is supported by the Mexican Council “Consejo Nacional de Ciencia y Tecnología” (CONACyT).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.lana.2023.100609",TRUE,"<section> Declaration of interests All authors declare no competing interests.",TRUE,"<section> Funding NIH grants U2COD023375 U24OD023382 U24OD023319 UH3OD023320 UH3OD023305 UH3OD023349 UH3OD023313 UH3OD023272 UH3OD023328 UH3OD023290 K08MH117452 and NARSAD Young Investigator Award 28545. <section> Funding and Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the ofﬁcial views of the National Institutes of Health. <section> Research reported in this publication was supported by the Environmental inﬂuences on Child Health Outcomes (ECHO) Program Ofﬁce of the Director National Institutes of Health under Award Numbers U2COD023375 (Coordinating Center) U24OD023382 (Data Analysis Center) U24OD023319 with cofunding from the Ofﬁce of Behavioral and Social Science Research (PRO Core) UH3OD023320 (Aschner) UH3OD023305 (Trasande) UH3OD023349 (O’Connor) UH3OD023313 (Koinis Mitchell) UH3OD023272 (Schantz) UH3OD023328 (Duarte). This work was additionally supported in part by awards K08MH117452 (PI: Lugo-Candelas) NARSAD Young Investigator Award 28545 (PI: Lugo-Candelas).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.lanepe.2023.100599",TRUE,"Declaration of interests AA reports having received payments or honoraria by Saarland University (Homburg). HJL reports having received payments or honoraria by CSL Behring and support for attending meetings and/or travel by Pﬁzer Roche Bayer Sobi and CSL Behring. TL reports having received consulting fees by Gilead Sciences Merck/MSD Pﬁzer Mundipharma Roche; and payments or honoraria by Merck/MSD Sanoﬁ Gilead Sciences and Pﬁzer. LM reports being on the advisory board of and having received payments by Shionogi and having received payments or honoraria by the German Pediatric Society for Infectious Diseases and the Professional Association of Pediatricians. The remaining authors declare no conﬂicts of interest.",TRUE,"<section> Funding European Society of Clinical Microbiology and Infectious Infektiologie Deutsche Gesellschaft für Krankenhaushygiene Acknowledgments This study has been funded by a 2021 CAREer Grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to CP.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.lanepe.2023.100770",TRUE,"<section> Declaration of interests TS declared that he had received funding for other research projects from government bodies and for the development of the guideline from the German Association for Psychiatry and Psychotherapy (DGPPN). All other authors declared that they had no conﬂicts of interests.",TRUE,"<section> Funding The study was funded by the German Innovationsfonds beim Gemeinsamen Bundesausschuss (project no. 01VSF19037). <section> Declaration of interests TS declared that he had received funding for other research projects from government bodies and for the development of the guideline from the German Association for Psychiatry and Psychotherapy (DGPPN).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.lanwpc.2023.100918",FALSE,"",TRUE,"<section> Funding Singapore National Research Foundation Singapore Institute for Clinical Sciences Agency for Science <section> Funding: dation <section> being part of an academic consortium that has received funding from Nestle Research unrelated to the present JYB is supported by a grant from the Agence Nationale de la (ANR) (iSCAN project ANR-20-CE36-0001). <section> The study is supported by the National Research Foununder the Open Fund-Large Collaborative Grant (OF-LCG; administered by the Singapore Ministry of Health’s NaResearch Council (NMRC) and the Agency for Science and Research (ASTAR).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.matt.2023.05.025",TRUE,"<section> DECLARATION OF INTERESTS S.P.H. is shareholder at Xeltis BV and LifeMatrix",TRUE,"<section> This work was sponsored by the John A.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.mce.2023.112037",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding <section> The study was supported by the National Science Centre project number 2019/35/N/NZ7/00738 (Natalia Leciejewska). <section> Natalia Leciejewska: Conceptualization Investigation Funding acquisition Writing – original draft.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.media.2023.102913",TRUE,"Disclosure <section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> The study was supported in part by the German Center for Neurodegenerative Diseases (DZNE) Study-ID: DZNE BN012 In general a Gaussian process (GP) describes a (prior) distribution over functions which is fully specified by its mean \U0001d45a and covariance \U0001d458 (for a technical introduction see Rasmussen and Williams 2006)",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.mehy.2023.111191",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Financial support <section> CH is currently funded by the Fonds National de Recherche (FNR) Luxembourg by grant C19/SC/13650569 “ALAC”. MM was funded by the Fonds National de Recherche Luxembourg: FNR-PRIDE (PRIDE/ 11012546/NEXTIMMUNE).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.metabol.2023.155655",TRUE,"<section> Declaration of competing interest <section> SF SS MF have received funding from the German Federal Ministry for Education and Research for the presented study (Grants #01E01004 #01E01504). <section> ACK has received a grant from Bayern Innovativ (MED-1811-0027) consulting fees from Daiichi-Sankyo and payment for presentations from AstraZeneca Sanofi Novartis NovoNordisk Amarin Amgen. <section> CM has received consulting fees from Boehringer Ingelheim and lecture fees from Amgen TOMTEC Imaging Systems GmbH Alnylam <section> AKCEA Sobi Alexion Janssen Pfizer. <section> UD has received grants from NovoNordisk and the IZKF Würzburg honoraria for lectures from Alnylam and participated on the Recordati Rare Diseases Advisory Board. <section> SF has received a grant from the DFG fees for lectures and support for attending meetings and/or travel from Abbott Abiomed Amarin Amgen AstraZeneca Bayer Berlin-Chemie Biotronik Boehringer Bristol-Myers Squibb Daiichi-Sankyo Edwards Lilly Novartis Pfizer Sanofi-Aventis Siemens Vifor Zoll participated on an advisory board of Boehringer and the guideline committee of the German Cardiac So­ ciety and the German Society of Internal Medicine. <section> The other authors declare that no conflicts of interest exist.",TRUE,"<section> Funding: The German Federal Ministry of Education and Research. <section> SF SS MF have received funding from the German Federal Ministry for Education and Research for the presented study (Grants #01E01004 #01E01504). <section> UD has received grants from NovoNordisk and the IZKF Würzburg honoraria for lectures from Alnylam and participated on the Recordati Rare Diseases Advisory Board. <section> This work was supported by the German Federal Ministry of Research and Education within the Comprehensive Heart Failure Centre Würzburg (BMBF 01EO1004 and 01EO1504).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.mex.2023.102041",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to",TRUE,"<section> This work was partially funded by Iniciativa Cientíﬁca Milenio ICN09_015.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.midw.2023.103809",TRUE,"Competing Interest <section> We declare that there is no potential conflict of interests including any financial personal or other relationships with other individuals or organisations that could inappropriately influence or be perceived to influence our work.",TRUE,"<section> The suitability of the data set for factor analysis was supported by the Kaiser-Meyer-Olkin (KMO) measures of sampling adequacy and the Bartlett’s Test of Sphericity. <section> Funding sources",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.modpat.2023.100327",TRUE,"Competing Interests <section> All authors report no relevant conﬂicts of interest related to this",TRUE,"<section> DFG-funded (Funding number: INST 216/512/1FUGG) highperformance computing (HPC) system CHEOPS and support. <section> Funding <section> This project was funded by North Rhine-Westphalia state (European Fond for Regional Development (EFRE) 2014-2020;",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.molcel.2023.01.023",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"N.H. was supported by a grant from the Leducq Foundation an ERC Advanced Grant under the European Union Horizon 2020 Research and Innovation Program (AdG788970) and a British Heart Foundation and a Deutsches Zentrum f € u r Herz-Kreislauf- E.W.D. R.L.M. and Z.S. were supported by the National Institutes of Health grants R01 GM087221 and U19 AG023122 and by the National Science Foundation grant DBI-1933311. <section> was supported by the National Human Genome Research Institute of the National Institutes of Health under award number 2U41HG007234 and the European Molecular Biology Laboratory. S.v.H. was supported by a DZHK (German Centre for Cardiovascular Research) Excellence Program PostDoc Startup Grant (81X3100106). This work was also supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under grant agreement SFB 1470 ‘‘HFpEF’’ (projects B03 B04 and B05) to N.H. M.G. and P.M.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.molimm.2022.12.010",TRUE,"<section> Declaration of interest <section> The authors declare that they have no conflict of interest with the contents of this article.",TRUE,"This work was supported by a grant from the Wilhelm Sander-Stiftung (",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.molmet.2023.101707",TRUE,"<section> CONFLICTS OF INTEREST None <section> declared.",TRUE,"We recognize that this task can be challenging and requires the concerted contribution of several contributors including (1) Researchers (2) the Editorial Board of scientiﬁc journals (3) Funding Bodies and (4) Animal Suppliers. <section> FUNDING MP-V was recipient of a postdoctroral fellowship from CON-",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.msard.2023.104844",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study is funded by Biogen GmbH Munich Germany. <section> This study is funded by Biogen GmbH Munich Germany. <section> Juliane Klehmet: Conceptualization Methodology Investigation Writing – original draft Writing – review & editing Visualization Funding acquisition.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Registration: NCT04655222",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.msard.2023.104846",TRUE,"Competing Interest <section> The authors declare that there are no conflicts of interest regarding the publication of this article.",TRUE,"Brandt: Concep­ tualization Methodology Validation Supervision Writing – review & editing Funding acquisition. <section> Friedemann Paul: Conceptualization Methodology Validation Supervision Writing – review & editing Re­ sources Funding acquisition. <section> – review & editing Funding acquisition. <section> Funding <section> The study was funded in part by a grant from Einstein Foundation (Einstein Junior Scholar (EJS-2018-446)) to RK.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nbd.2023.106143",TRUE,"Competing Interest <section> The authors declare no competing financial interests.",TRUE,"<section> Funding <section> JGZ was funded by the National Natural Science Foundation of China (81830033 61761166004). ACY was funded by the National Natural Science Foundation of China (81870888) and the Capital Medical Development Research Fund (2018-2Z-1076). NZ was funded by the National Key Research and Development Program of China (2020YFC2005300).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nbd.2023.106246",TRUE,"Competing Interest <section> The authors have declared no conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the Else-Kröner-Fresenius Foundation and the German Research Foundation (Ri817/13-1) as well as the Clinical Research Group KFO5001 ResolvePAIN (HLR). XH received funding from the China Scholarship Council.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered at the German Clinical Trials Register (DRKS00017731).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.nbscr.2023.100091",TRUE,"<section> Declaration of competing interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by US PHS (NIH) grants R01 HD-060628 R01 MH-091351 UH3 OD-023349 U54HD079124-05 the National Institute of Child Health and Human Development grant K99 HD100593 ERC grant ERC-Stg 639766 and the Deutsche For­ schungsgemeinschaft (DFG German Research Foundation) – Project number 327654276 SFB1315/2 subproject B04). Gilmore: Formal analysis Funding acquisition. <section> Styner: Formal analysis Funding acquisition. <section> Sonja Entringer: Re­ sources Supervision Project administration Funding acquisition Writing – review & editing. Wadhwa: Resources Supervi­ sion Project administration Funding acquisition Writing – review & editing. <section> Claudia Buss: Conceptualization Methodology Formal anal­ ysis Resources Writing – review & editing Supervision Project administration Funding acquisition.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nedt.2022.105695",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neo.2023.100934",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"Dragomir: Data curation Formal analysis Funding acquisition Investigation Methodology Writing – original draft Writing – review & editing. <section> Philip Bischoff: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Writing – original draft Writing – review & editing. <section> Funding M.P.D.’s work is funded by a DKTK Berlin Young Investigator Grant 2022 and Berliner Krebsgesellschaft (DRFF202204). PB’s work is funded by a DKTK Berlin Young Investor Grant 2022.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neo.2023.100945",TRUE,"Competing Interest <section> The authors report no conflict of interest.",TRUE,"<section> Funding <section> This research was funded by the START-Program of the Faculty of Medicine RWTH Aachen. NB was supported by the German Federal Ministry of Education and Research (BMBF) as part of the LiSyM-Cancer <section> Andreas Kroh: Conceptualization Methodology Formal analysis Investigation Data curation Writing – original draft Writing – review & editing Visualization Funding acquisition. <section> Fabian Kiessling: Resources Supervision Funding acquisition. <section> Nikolaus Berndt: Methodology Software Data curation Visualization Funding acquisition.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neubiorev.2023.105087",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a <section> potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neubiorev.2023.105149",TRUE,"Conflict of interest <section> The other authors have no conflicts of interest to declare.",TRUE,"Tolerability: 0 serious AE in both dasotraline arms; 1 serious AE (1.795) in placebo arm In children and adolescents with ADHD and without mGluR mutations Tolerability: 1 (2.94%) and 0 serious AE in fasoracetam and placebo arm respectively In children and adolescents with ADHD and without mGluR mutations Tolerability: 0 serious AE in both arms NCT03260205 USA September 2017 Superior Placebo 6–12 Oregon Health and Science University 31–1 NCT03252522 USACanada April 2018 Superior on one of the two primary outcomes Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase Coenzyme antioxidant + norepinephrine reuptake inhibitor Placebo + Coenzyme Q 2–18 months Sherief AbdElsalam Tanta University Serotoninnorepinephrinedopamine reuptake inhibitor (SNDRI) Placebo 6–12 Dasotraline 2 mg/ day Placebo 6–12 Dasotraline 4 and 6 mg/day Placebo Placebo ADHD Coenzyme Q + Atomoxetine doses not specified Dasotraline (SEP225289) 2 mg/ day; 4 mg/day Fasoracetam (AEVI001) Lisdexamfetamine dimesylate (SPD489) 5102030 mg/ day Micronutrient capsules dose not specified Glutamate receptor agonist Inhibits dopamine and NE transporters; increases vesicular dopamine release Unknown FDA approved in ≥ 6 yearold. <section> S. <insert> Table 1 (continued ) Compound/Dose Omega-3 Fatty Acids; DHA Richoil 250 mg pearl (DMF srl) twice daily Mechanism of Action Alters arachidonic acid metabolism and oxidative reactions ANXIETY DISORDERS Guanfacine 1–6 Second generation mg/d alpha-2 agonist Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Placebo 6–14 months IRCCS Eugenio Medea/DMF srl (Dietetic Metabolic Food) NCT01796262 Italy June 2012 Not superior Placebo 6–17 Shire NCT01470469 USA January 2012 Not superior Comments micronutrient group and in 18% of the placebo group (p < 0.001). Reported in: doi: 10.1038/ tp.2012.124 Efficacy: No change from baseline to week 11 in Social Responsiveness Scale (SRS) Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase Bumetanide (S95008) 0.5 mg BID Decreases the reabsorption of sodium by the kidneys Placebo 2–6 months Institut de Recherches Internationales Servier Bumetanide 0.5 mg/ml dose not specified Placebo 7–15 Bumetanide 0.5 1.0 or 2.0 mg BID or 0.02 0.04 or 0.08 mg/kg BID if bodyweight < kg. <section> S. <insert> Compound/Dose Mechanism of Action Total n of active arms Control Total n subjects Age range Trial Duration inhibitor and antibiotic Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Department of Defense Folinic acid (Folinoral) mg/day Counteracts the effects of folic acid antagonists and enhance the effects of fluoropyrimidines Guanfacine XR (Intuniv) up to mg/day Secondgeneration alpha-2 agonist 4–15 months Erasmus Medical Center|Utrecht University Placebo 3–10 Central Hospital Nancy France Placebo 5–14 Yale University 2/3 superior at wk compared to placebo (No ES reported p = 0.45). <section> S. <insert> Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Lurasidone 20 and 60 mg/day daily Dopamine D2 5HT2A 5-HT7 alpha2Aand alpha2Cadrenoceptor antagonist Placebo 6–17 Sunovion Melatonin (NPC15) 1 mg or 4 mg at bedtime MT1 and MT2 receptor agonist 5HT2C receptor antagonist Placebo 6–15 Memantine full dose vs reduced dose. <section> S. <insert> Compound/Dose Mechanism of Action Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Inhibits mitochondrial respiratory chain; activates AMPactivated protein kinase Placebo 6–17 Massachusetts General Hospital| Vanderbilt University| University of Pittsburgh| Nationwide Children’s Hospital|Ohio State University NCT01825798 USACanada April 2013 Superior to placebo Methylcobalamin (Methyl B12) µg/Kg subcutaneously injected once every 3 days Enhances myelin production Placebo 3–7 University of California San Francisco 1–3 NCT01039792 USA January 2010 Superior to placebo Mirtazapine up to 15 mg/week Antagonist of alpha 2 A alpha 2B and alpha 2 C adrenergic receptors serotoninergic 5HT 2a and 2 C receptors and histamine H1 receptors Placebo 5–17 Massachusetts General Hospital| Autism Speaks NCT01302964 USA August 2010 Not superior Omega-3 fatty acids (Nutra Sea HP) 1.5 g of EPA + DHA daily Alters arachidonic acid metabolism and oxidative reactions Placebo 2–5 Holland Bloorview Kids Rehabilitation Hospital The Hospital for Sick Children NCT01248728 Canada November 2010 No effect (No ES reported pvalues from 0.32 to 0.96). <section> S. <insert> Compound/Dose Mechanism of Action Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Placebo 5–8 Hugo W. <section> S. <insert> Compound/Dose Mechanism of Action Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase Oxytocin 24IU BID (3 ×0.1 ml [4IU] Placebo 6–12 Stanford University Oxytocin (Syntocinon) IU BID intranasally. <section> S. <insert> Table 2 (continued ) Compound/Dose Mechanism of Action Total n of active arms Control Total n subjects Age range Trial Duration 90–110 lb µmol/day 110–130 lb µmol/day) Suramin 20 mg/kg IV single dose Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Hopkins University Antimalarial Placebo 4–17 University of California San Diego 1| NCT02508259 USA May 2015 Superior on one of the two primary outcomes Comments respectively – all with pvalues >0.05). Results in doi: 10.1542/ Total n subjects Age range Trial Duration Funding/ Manufacturer Phase 3 Active comparator arms; Omega3 + Placebo Inositol + Placebo and Omega-3 + Inositol. <section> S. <insert> Compound/Dose Mechanism of Action DEPRESSIVE DISORDERS Agomelatine Agonist at melatonin and 25 mg/day receptors and an antagonist at serotonin-2 C (5-HT2C) receptors Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) peds.2015–0743 and 10.1016/j. jaac.2018.07.901 Placebo 7–18 Institut de Recherche International Servier 2015–002181–23 Multiple February 2016 10 mg/day: Not superior 25 mg/day: superior Serotoninergic and norepinephrinergic reuptake inhibitor Placebo 7–17 Pfizer NCT01371734; 2008–001875–32 Multiple August 2011 Not superior Desvenlafaxine sustained release (DVS SR) 25 35 or 50 mg/day Placebo 7–17 Pfizer NCT01372150 Multiple November 2011 Not superior Duloxetine dose not specified Ketamine 0.5 mg/ kg Serotoninergic and norepinephrinergic reuptake inhibitor Glutamate antagonist Placebo 9–17 Shionogi NCT03315793 Japan December 2017 Not superior Midazolam 13–17 Yale University NCT02579928 USA October 2015 Superior Additional active arm: fluoxetine 10–20 mg/ day. <section> S. <insert> Compound/Dose Levomilnacipran 10 20 and 40 mg/day Mechanism of Action Norepinephrinergic and serotoninergic reuptake inhibitor Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) 7–17 Allergan NCT03569475 USA July 2018 Not superior Levomilnacipran 40 mg/day Placebo 12–17 Forest Laboratories NCT02431806 USA June 2015 Not superior Vilazodone 5 10 20 mg/day Vilazodone 15 and 30 mg/day Serotoninergic modulator Placebo 7–17 Forest Laboratories NCT02372799 USACanada February 2015 Not superior Placebo 12–17 Forest Laboratories NCT01878292 USA July 2013 Not superior midazolam (MADRS score: midazolam mean=24.13 SD=12.08 95% CI=18.21 30.04; ketamine mean=15.44 SD=10.07 95% CI=10.51 20.37; mean difference=− 8.69 SD=15.08 95% CI=− 16.72 0.65 df=15; effect size=0.78). <section> S. <insert> Table 3 (continued ) Compound/Dose Vortioxetine and 20 mg/day Mechanism of Action Serotoninergic modulator Vortioxetine and 20 mg/day Total n of active arms Control Total n subjects Age range Trial Duration Funding/ Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) 7–11 H. Drug/Dose Mechanism of Action Total n of active arms INTELLECTUAL and DEVELOPMENTAL DISABILITY AFQ056 25 50 or 100 mg BID mGluR5 negative modulator Total n Age subjects range Trial Funding/ Duration Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Comments Placebo 12–17 Novartis Pharmaceuticals NCT01357239; 2010–022638–96 Multiple May 2011 Not superior 1–3 NCT03614663 Multiple June 2018 Not superior for the full analysis subset but superior for the ad hoc analysis subset. <section> S. <insert> Cortese et al. Table 4 (continued ) Drug/Dose Mechanism of Action Total n of active arms Control Total n Age subjects range Trial Funding/ Duration Manufacturer NMDA receptor antagonist Placebo 1–10 months Everolimus 5–10 ng/ ml Kinase inhibitor Placebo 4–15 months Ganaxolone (GNX also known as GNX OS) 3–12 mg/kg maximum 1500 mg/ day. <section> S. <insert> Cortese et al. Table 4 (continued ) Drug/Dose Oxytocin (Syntocinon) 16 IU/day intranasally Mechanism of Action Hormonal activity Oxytocin (Syntocinon) 4 IU/day intranasally Total n of active arms Control Total n Age subjects range Trial Funding/ Duration Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) 5–18 Montefiore Medical Cente NCT02629991 USA October 2015 Superior for Hyperphagia Questionnaire (HQ)Drive Factor Score. <section> S. <insert> Cortese et al. Table 4 (continued ) Drug/Dose Mechanism of Action Total n of active arms Control Total n Age subjects range Trial Funding/ Duration Manufacturer Phase NCT/ EUDRACT number Country Start date Descriptive Results (primary outcome) Comments no other participants with serious AE in the other arms For PANDAS Efficacy: Change in CY-BOCS at week 6: Mean difference 1.97; p = 0.044 Tolerability: no serious AE in either arm Result also in DOI: 10.1016/j.jaac.2016.06.017 Tolerability: no serious AE in either arm Immunoglobulin Placebo 4–13 National Institute of Mental Health (NIMH) NCT01281969 USA January 2011 Not superior N-acetylcysteine mg up to 3 times/ day Prodrug to L-cysteine; increases the concentration of glutathione. <section> Funding/ Phase NCT/ Country Start date Descriptive Comments Manufacturer He has received grant support from Janssen and Takeda. E Grunblatt received grant support from MEDICE Arzneimittel Pütter GmbH & Co KG. <section> C Arango has received funding from the Spanish Ministry of Science and Innovation Instituto de Salud Carlos III (ISCIII) cofinanced by the European Union ERDF Funds from the European Commission “A way of making Europe” financed by the European Union NextGenerationEU (PMP21/00051) PI19/01024. <section> I Baeza has received grants from the Spanish Ministry of Health Instituto de Salud Carlos III supported by ERDF Funds from the Euro­ pean Commission (PI18/0242/PI21/0391) “A way of making Europe” Plan Nacional sobre Drogas and Fundación Alicia Koplowitz. <section> J Buitelaar has been supported by the EU-AIMS (European Autism Interventions) and AIMS-2-TRIALS programmes which receive support from Innovative Medicines Initiative Joint Undertaking Grant No. <section> J Castro-Fornieles has received funding from the Spanish Ministry of Science and Innovation Instituto de Salud Carlos III (ISCIII) cofinanced by the European Union CIBERSAM European Union Structural Funds European Union Seventh Framework Program European Union H2020 Program under the Innovative Medicines I Project AIMS-2-TRIALS (Grant agreement No 777394) PERIS and SGR program from de Cata­ lonia Governement Fundació Marató de TV3 and Fundación Alicia Koplowitz. <section> C Moreno has received funding from the Spanish Ministry of Science and Innovation Instituto de Salud Carlos III (ISCIII) CIBER -Consorcio Centro de Investigación Biomédica en Red(CB/07/09/0023) cofinanced by the European Union and ERDF Funds from the European Commission “A way of making Europe” financed by the European Union NextGenerationEU (PMP21/00051 PI21/01929) Madrid Regional Government (B2017/BMD-3740 AGES-CM-2) European Union Structural Funds EU Seventh Framework Program H2020 Pro­ gram under the Innovative Medicines Initiative 2 Joint Undertaking: Project c4c (Grant agreement No. 777389) and Horizon Europe (Project <section> M Parellada has received funding from the Spanish Ministry of Sci­ ence and Innovation Instituto de Salud Carlos III (ISCIII) CIBER -Con­ sorcio Centro de Investigación Biomédica en Red(CB/07/09/0023) cofinanced by the European Union and ERDF Funds from the European Commission “A way of making Europe” financed by the European Union NextGenerationEU (PMP21/00051) Madrid Regional Govern­ ment (B2017/BMD-3740 AGES-CM-2) European Union Structural Funds EU Seventh Framework Program H2020 Program under the <section> AM Persico’s work is funded by the Italian Ministry of Health the Fondazione di Modena & UNIMORE (Missionoriented) and the Italian Autism Foundation. <section> V Roessner has received funding from the Federal Ministry of Edu­ cation and Research (01GL1741C) the Innovation Fund of the Federal Joint Committee (01NVF17046 01VSF19027) the German Research Foundation (RO 3876/11-1 RO 3876/11-2 TE 280\\18-1 FR 2069/81) MSE Pharma and Takeda (IIR-DEU-002258).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neubiorev.2023.105300",TRUE,"Competing Interest <section> Marco Solmi has received honoraria/has been a consultant for Abbvie Angelini Lundbeck and Otsuka. Michael A. Nitsche is a member of the scientific advisory board of Neuroelectrics. Andre R Brunoni holds a small equity of FlowNeuroscience and has been scientific advisor of the company between 2016 and 2018. He also receives research grants from the São Paulo Research State Foundation (19/06009–6) and the Acad­ emy of Medical Sciences (NAFR 12/1010) and in-kind support from MagVenture and SoterixMedical. Othman Sentissi has received advisory board honoraria from Otsuka Lilly Lundbeck Sandoz and Janssen in an institutional account for research and teaching. André Aleman Luc Mallet Jonathan Downar Marom Bikson Valerie Brandt Chaomei Chen Adi Sulstarova Emmanuel Poulet Joshua Hyde Samuele Cortese and Michel Sabe report no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2022.119810",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study was supported by LIFE – Leipzig Research Center for Civilization Diseases University Leipzig. Part of this work has been supported by the German Research Foundation (SCHR 774/5-1 to MLS).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.119862",FALSE,"",TRUE,"B.H. received support via a scholarship issued by the Einstein Center for Neurosciences Berlin. <section> was supported by an Australian Government Research Training Program Scholarship. L.L.G. was supported by the BIH Charité Junior Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) MDF was supported by the NIH ( R01MH113929  R21MH126271  R56AG069086  T.A.D. is supported by the Cologne Clinician Scientist Program (CCSP)  Faculty of Medicine University of Cologne and the German Research Foundation (DFG FI 773/15-1 ). T.A.K.N. was supported by the Swiss National Science Foundation ( 186142 ).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.119929",FALSE,"",TRUE,"<section> Mohamad Habes : Conceptualization Formal analysis Funding acquisition Methodology Project administration Resources Supervision Writing – original draft Writing – review & editing. <section> This study was supported in part by the National Institute of Health (NIH) grant P30AG066546 (South Texas Alzheimer’s Disease Research Center) and grant numbers 5R01HL127659 1U24AG074855 1R01AG080821 and the San Antonio Medical Foundation grant SAMF",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120134",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"SQP was supported by the German Federal Ministry of Education and Research and the Federal State of Brandenburg (BMBF)  DZD grant 82DZD03D03 and DZD Grant 82DZD03C2G and by German Research Foundation Grant/Award Number INST 392/125 (SFB TR134 C7) and PA2682/1–1 KG was supported by the German Research Foundation (DFG EXC 2002/1 “Science of In-",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neuroimage.2023.120149",TRUE,"Competing Interest",TRUE,"<section> This work was funded by the Bernstein Computational Neuroscience Program of the German Federal Ministry of Education and Research",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120187",TRUE,"Competing Interest <section> The authors declare no competing interests.",TRUE,"Soekadar: Conceptualization Visualization Funding acquisition Project administration Resources Supervision Writing – original draft Writing – review & editing. <section> This research was supported in part by the European Research Council (ERC) under the project NGBMI (759370) and TIMS (101081905)  the Deutsche Forschungsgemeinschaft (DFG) Germany under the project SO932/7-1) ERA-NET Neuron under the project HYBRIDMIND (01GP2121B) and the Einstein Stiftung Berlin",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neuroimage.2023.120218",TRUE,"Competing Interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"<section> Stefan Haufe: Conceptualization Methodology Validation Investigation Resources Writing – review & editing Supervision Project administration Funding acquisition. <section> This project was supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 758985) and through Deutsche Forschungsgemeinschaft (DFG German Research Foundation) ProjectID 424778381 TRR 295.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120326",TRUE,"Competing Interest <section> The authors declare no conflict of interest.",TRUE,"<section> Jin-Tao Zhang: Conceptualization Resources Writing – re­ view & editing Supervision Funding acquisition. <section> This research was supported by the National Natural Science Foun­ dation of China (No. 32171083 and No. N.W.S. was funded by a Starting Grant from the European Union (ERC-StG-REPLAY852669) and an Independent Max Planck Research Group grant awar­ ded by the Max Planck Society (M.TN.A.BILD0004) and the Excellence Strategy of the Federal Government and the Länder.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120337",TRUE,"Competing Interest <section> Authors declare that they have no conflict of interest..",TRUE,"Michel: Data curation Funding acquisition Writing – review & editing. <section> Gijs Plomp: Funding acquisition Supervi­ sion Writing – review & editing. <section> Stephan Eliez: Conceptualization Formal analysis Funding acquisition Project administration Supervi­ sion Writing – review & editing. <section> Patric Hagmann: Conceptualization Formal analysis Funding acquisition Project administration Supervi­ <section> The authors would like to thank the funding agency Swiss National Science Foundation Sinergia for their Grant CRSII5_170873 and CRSII5_209470 to Patric Hagmann PP00P1_183714 PP00P1_190065 to Gijs Plomp and the funding agency NCCR Synapsy for the Grant 51NF40-185897 to Stephan Eliez and Christoph Michel.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120412",TRUE,"Competing Interest <section> Dr. Thompson received partial grant support from Biogen Inc. and Amazon Inc. for work unrelated to the current study; Dr. Lebois reports unpaid membership on the Scientific Committee for International So­ ciety for the Study of Trauma and Dissociation (ISSTD) grant support from the National Institute of Mental Health K01 MH118467 and the Julia Kasparian Fund for Neuroscience Research McLean Hospital. Dr. <section> Lebois also reports spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. ISSTD and NIMH were not involved in the analysis or preparation of the manuscript; Dr. Etkin reports salary and equity from Alto Neuroscience equity from Mindstrong Health and Akili Interactive. <section> Other authors have no conflicts of interest to declare.",TRUE,"<section> Editing: Benjamin Suarez-Jimenez Sigal Zilcha-Mano Amit Lazarov Seonjoo Lee Melanie Wall Resources Data Curation Project administration Funding acquisi­ tion and Writing Review & Editing: Chadi G. Zhu is supported by NIH K01MH122774 and by a NARSAD Young Investigator Grant from the Brain & Behavior Research Founda­ tion 27040; Dr. Dennis is supported by NIH R61NS120249; Dr. Fani is supported by NIH AT011267 and MH111671; Dr. Lebois is supported by NIH K01MH118467; Dr. Bruce is supported by NIH K23 MH090366; Dr. Bryant is supported by National Health and Medical Research Council #1073041; Dr. Ross is supported by the NIH",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuroimage.2023.120463",TRUE,"Competing Interest <section> The authors declare no competing interests.",TRUE,"<section> The ABCD Study® is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers U01DA041048 U01DA050989 U01DA051016 U01DA041022 U01DA051018 U01DA051037 U01DA050987 U01DA041174 U01DA041106 U01DA041117 U01DA041028 U01DA041134 U01DA050988 U01DA051039 U01DA041156 U01DA041025 U01DA041120 U01DA051038 U01DA041148 U01DA041093 U01DA041089 U24DA041123 U24DA041147. <section> Tianye Jia: Conceptualization Supervision Funding acquisition Methodology Writing – review & editing. <section> Feng: Conceptualization Writing – review & editing Supervision Project administration Funding acquisition. <section> This work received support from the following sources: National Key Research and Development Program of China (2019YFA0709501 2022CSJGG1000 2021YFC2501402 2018YFC1312900 2019YFA0709502 and 2018YFC1312904) the National Science Foundation of China (T2122005 and 81801773) the Shanghai Pujiang Project (18PJ1400900) Guangdong Key Research and Development Project (2018B030335001) the 111 Project (B18015) the key project of Shanghai Science and Technology (16JC1420402) Shanghai Municipal Science and Technology Major Project (2018SHZDZX01) Zhang Jiang Lab and Shanghai Center for Brain Science and Brain-Inspired Technology.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neuron.2022.12.010",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This work was supported by the Max Planck Society the German Research Foundation (LE 3804/3-1 LE 3804/4-1 and LE 3804/7-1 to J.J.L.) a Marie Sk1odowskaCurie Fellowship (840701 to A.S.) two EMBO Long-Term Fellowships (ALTF 882-2018 to A.S. and ALTF 157-2022 to A.I.G.) and an Alexander von Humboldt Fellowship (to A.S.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuron.2022.12.026",TRUE,"<section> DECLARATION OF INTERESTS <section> A.K. is a cofounder consultant and member of the board of Neurona Therapeutic a company studying the potential therapeutic use of interneuron transplantation.",TRUE,"<section> This work was funded by the Gladstone Institutes (K.S.P.) Schmidt",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neuron.2023.04.025",TRUE,"<section> DECLARATION OF INTERESTS <section> S.D.L. is a consultant for Kallyope.",TRUE,"E.D.L. was supported by a Travelling Fellowship from the Company of Biologists (grant no. DEVTF2103518) and an MDC Internal PhD Fellowship. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) under Germany’s Excellence Strategy (EXC-2049 – 39068808) and by the Helmholtz Association (to C.B.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuron.2023.06.016",TRUE,"<section> DECLARATION OF INTERESTS <section> REFERENCES <section> 1. Holtmaat A. and Caroni P.",TRUE,"A.T. is supported by the DFG with the SFB1315-2 TP A01 Brenda Milner Award and the Einstein Center for Neurosciences Berlin PhD Fellowship. P.P. is supported by the NIH (1R01MH124867-02) the European Commission (H2020-FETOPEN-2018-2019-2020-01 FET-Open Challenging Current Thinking NEUREKA GA-863245) and the Einstein Foundation Berlin Germany visiting fellowship EVF-2019-508.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.neuron.2023.06.018",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> This work was supported by Humboldt-Universit € a t zu Berlin Bernstein Center for Computational Neuroscience Berlin NeuroCure Cluster of Excellence (Exc 2049-390688087) Einstein Center for Neurosciences Berlin Deutsche Forschungsgemeinschaft (SPP 1665 BR 3479/12-1 and SFB1315) and the European Research Council (BrainPlay ERC Synergy Grant).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.neuropsychologia.2023.108588",TRUE,"<section> Declaration of competing interest <section> The authors declare no conflict of interest.",TRUE,"<section> Isabella Boux: Conceptualization Methodology Formal analysis Investigation Data Curation Writing Original Draft and Review & Editing Visualization Project administration; Friedemann Pulver­ müller: Conceptualization Methodology Resources Writing – Original Draft and Review & Editing Supervision Funding acquisition Project administration. <section> This work was supported by the Deutsche Forschungsgemeinschaft Germany via the grants “Brain Signatures of Communication BraiSiCo” [Pu 97/23–1] and by the European Research Council via the Advanced Grant “Material Constraints Enabling Human Cognition” (ERC-2019ADG-883811). In addition it was supported by the Einstein Center for Neurosciences Germany and by the Freie Universität Berlin Germany.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.nicl.2022.103286",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (SO 1336/1-1 to C.S.) German Federal Ministry of Education and Research (BMBF 01ER0801 to P.B. and D.W. BMBF 01ER0803 to C.S.) the RECAP preterm project an EU Horizon 2020 study (supported by grant 733280; D.W. and P.B.) and the Kommission für Klinische For­ schung Technische Universität München (KKF 8765162 to C.S. KKF 8700000474 to D.M.H. and KKF 8700000620 to B.S.-K.). Hongwei Bran Li is supported by Forschungskredit (Grant NO. <section> Hongwei Bran Li: Methodology Software Investigation Writing – review & editing Funding acquisition. <section> Schmitz-Koep: Investigation Writing – review & editing Funding acquisition. <section> Bartmann: Investigation Writing – review & editing Funding acqui­ sition. <section> Dieter Wolke: Investigation Writing – review & editing Funding acquisition. Hedderich: Conceptualization Methodol­ ogy Investigation Writing – original draft Writing – review & editing Supervision Funding acquisition. <section> Christian Sorg: Conceptualization Methodology Investigation Writing – original draft Writing – review & editing Supervision Funding acquisition. <section> Data was provided by the developing Human Connectome Project KCL-Imperial-Oxford Consortium funded by the European Research Council under the European Union Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. [319456].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.nicl.2023.103401",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> T. Fydrich: Funding acquisition Supervision Validation. <section> A. Ströhle: Funding acquisition Validation. <section> A. Heissel: Conceptualization Funding acquisition Project administration. <section> S. <section> Heinzel: Conceptualization Project administration Funding acquisi­ <section> Financial support. This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG grants HE7464/2- A.H. was partly funded by a grant at the Potsdam Graduate School University of Potsdam.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nicl.2023.103436",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> Peter Vajkoczy: Funding acquisition Re­ sources Supervision. <section> Thomas Picht: Conceptualization Funding acquisition Methodology Project administration Resources Supervi­ sion Writing – review & editing.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nicl.2023.103439",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Laura Göschel: Conceptualization Methodology Formal analysis Investigation Data curation Writing – original draft Visualization Project administration Funding acquisition. <section> Ariane Fillmer: Investigation Writing – review & editing Supervision Funding acqui­ sition. <section> Agnes Flöel: Writing – review & editing Su­ pervision Funding acquisition. <section> This work was supported by the EMPIR programme cofinanced by the Participating States and from the European Union’s Horizon 2020 research and innovation programme under grant numbers 15HLT04 NeuroMET and 18HLT09 NeuroMET2 and by the German Research Foundation (327654276-SFB 1315).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nicl.2023.103449",TRUE,"Competing Interest <section> The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to 379 (23) 2237–2245. https://doi.org/10.1056/NEJMRA1706158/ SUPPL_FILE/NEJMRA1706158_DISCLOSURES.PDF.",TRUE,"<section> Funding Kühn: Conceptualization Funding acquisition Project administration Supervision Writing – review & editing. <section> Koy: Conceptualization Funding acquisition Project administration",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nicl.2023.103520",TRUE,"Competing Interest <section> Dr Banaschewski served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. He received conference support or speaker’s fee by Janssen Medice and Takeda. He received royalities from Hogrefe Kohlhammer CIP Medien Oxford University Press; the present work is unrelated to these relationships. Dr Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. Dr Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors declare that they have no known competing financial in­ terests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Florian Schlagenhauf: Writing – review & editing Funding acquisition. <section> Andreas Heinz: Writing – review & editing Funding acquisition. <section> Kerstin Ritter: Supervision Project administration Funding acquisition Conceptualization Writing – re­ <section> Funding <section> This work was funded by the SFB/TRR 265 Losing and Regaining Control over Drug Intake (German Research Foundation; Project ID 402170461). (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1); the NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This paper is based on independent research commissioned and funded in England by the National Institute for Health Research (NIHR) Policy Research Programme (project ref. The views expressed in this article are those of the authors and not necessarily those of the national funding agencies or ERANID.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.nicl.2023.103544",TRUE,"Competing Interests A. B. Fiebach declared no competing interests. <section> Declaration of Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.nmd.2023.01.002",TRUE,"Competing Interest",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.nmd.2023.02.002",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This research was funded by UCB Pharma GmbH and conducted by Ingresshealth HWM GmbH in accordance with Good Publication Practice (GPP3) guidelines.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.nmni.2023.101136",TRUE,"<section> Declaration of competing interest <section> All authors report no conﬂicts of interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ocarto.2023.100365",TRUE,"<section> Declaration of competing interest",TRUE,"<section> The cartilage thickness analysis was funded by an ancillary study to the OAI held by the Division of Rheumatology Feinberg School of Medicine Northwestern University (R01 AR52918). The cartilage T2 analysis was funded by the Bundesministerium für Bildung und Forschung (BMBF – 01EC1408D (OVERLOAD-PREVOP)). Funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation GlaxoSmithKline; and Pﬁzer Inc. <section> We also would like to thank the funders of the current analysis: The cartilage thickness analysis was funded by an ancillary study to the OAI held by the Division of Rheumatology Feinberg School of Medicine Northwestern University (R01 AR52918). The cartilage T2 analysis was funded by the Bundesministerium für Bildung und Forschung (BMBF – 01EC1408D (OVERLOAD-PREVOP). A.G.C is a recipient of a National Health and Medical Research Council (NHMRC) of Australia Early Career Fellowship (Neil Hamilton Fairley Clinical Fellowship GNT1121173).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.omtn.2023.02.005",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> The project was funded by Foundation Gisela Krebs and with a travel",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.omtn.2023.102066",TRUE,"<section> DECLARATION OF INTERESTS P.R. has licensed the PGK:FANCAWpre* LV medicinal product and receives funding and equity from Rocket Pharmaceuticals Inc. patents and royalties research & consulting funding.",TRUE,"The study was also supported by the Consejería de Universidad Investigación e Innovación under Plan Andaluz de Investigación Desarrollo e Innovación (PAIDI 2020) (ProyExcel_ 00875) de la junta de Andalucía and by Consejería de Salud y familia de la Junta de Andalucia/FEDER (PECART-0027-2020) K.B. held Nicolas Monardes contract from Consejería de Salud y Consumo de la Junta de Andalucía.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.omtn.2023.102068",TRUE,"<section> DECLARATION OF INTERESTS J.K. und K.G. have interests in Pantherna Therapeutics GmbH.",TRUE,"<section> ACKNOWLEDGMENTS This work was supported by ProFIT Brandenburg (Antragsnummer 80258140); Europäischer Fonds für regionale Entwicklung (EFRE) Land Brandenburg granted to Pantherna Therapeutics GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.onehlt.2023.100528",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interest and personal relationship that could inappropriately influence",TRUE,"<section> Funding <section> This study was supported by a grant from the German Federal Min­ istry of Health (BMG) regarding a decision of the German Bundestag by the Federal Government (NiCaDe-Project Phase I and II grant No: ZMVI2519GHP711 and CHED-Project grant No: ZMVI1-2518FSB705). B.A. is supported by ProFIT grant of the Investitionsbank Berlin Germany (IBB ProFIT No. 10169028 / cofunded by EFRE (No. <section> C. <section> Thomas Bock: Conceptualization Methodology Project administra­ tion Resources Supervision Validation Funding acquisition Writing review & editing.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.pec.2023.107883",TRUE,"Competing Interest <section> The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This work was supported by an ERAPerMed Grant for the project MEET-AML within the Joint Transnational Call for Proposals (2019) for <section> Martinelli Giovanni: Conceptualization Data cura­ tion Funding acquisition Supervision Writing – review & editing. <section> Kihlbom Ulrik: Conceptualization Formal analysis Funding acquisition Supervision Writing – review & editing. <section> Heckman Caroline A.: Conceptualization Funding acquisition Su­ pervision Writing – review & editing. <section> Bullinger Lars: Conceptualiza­ tion Data curation Funding acquisition Supervision Writing – review <section> & editing Conceptualization Funding acquisition Investigation. <section> tro Mika: Conceptualization Data curation Funding acquisition Methodology Writing – review & editing.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.pharmthera.2023.108489",TRUE,"Competing Interest Acknowledgments References. <section> Declaration of Competing Interest",TRUE,"<section> The research of J.L. is or was supported by the Swiss National Science Foundation 310030_143929/1 the Swiss National Centre for Competence in Research “Kidney.CH” and the clinical research priority program HYRENE of the medical faculty of the University of Zurich.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.phro.2022.12.003",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Dr. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.phrs.2023.106971",TRUE,"Competing Interest",TRUE,"<section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (German Research Foundation) through SFB1423 Project-ID 421152132 subprojects A01 (to P.S.) A05 (to T.S. C.M.T. <section> Schöneberg: Conceptualization Visualization Investigation Supervi­ sion Formal analysis Resources Funding acquisition Writing – original draft Writing – review & editing Project administration. <section> Scheerer: Conceptualization Visualization Investigation Supervision Formal analysis Resources Funding acquisition Writing – original draft Writing – review & editing Project administration.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.phymed.2023.154838",TRUE,"Competing Interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.placenta.2023.06.008",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Juergen Pollheimer reports financial support was provided by Aus­ trian Science Fund.",TRUE,"Funding acquisition J.P. <section> This work was supported by the Austrian Science Fund (P33485 to J.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.preteyeres.2022.101116",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.psychres.2023.115480",TRUE,"Competing Interest",TRUE,"<section> Isabel Maurus: Data curation Funding acquisition Investigation Project administration Writing – original draft Writing – review & editing. <section> Berend Malchow: Conceptualization Funding acquisition Supervision Writing – review & editing. <section> Walter: Funding acquisition Supervision Writing – review & editing. <section> Wolfgang Wölwer: Funding acquisition Supervision Writing – review & editing. <section> Karsten Henkel: Funding acquisition Supervision Writing – review & editing. <section> Andrea Schmitt: Conceptuali­ zation Funding acquisition Methodology Project administration Supervision Writing – review & editing. <section> Alkomiet Hasan: Conceptu­ alization Funding acquisition Methodology Project administration Supervision Writing – review & editing. <section> Andreas Meyer-Lindenberg: Conceptualization Funding acquisition Methodology Project admin­ istration Supervision Writing – review & editing. <section> Peter Falkai: Conceptualization Funding acquisition Methodology Supervision <section> Funding <section> The work was supported by the German Federal Ministry of Educa­ tion and Research (BMBF) through the research network on psychiatric diseases ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments; coordinator Andreas Meyer-Linden­ berg; grant number 01EE1407E) to AML PF AH and AS and 01EE1407G to HW.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.psychres.2023.115488",TRUE,"Competing Interest <section> M. Solmi received honoraria/has been a consultant for Angelini Lundbeck Otsuka. The other authors have no conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.psychres.2023.115539",TRUE,"Competing Interest",TRUE,"<section> Funding statement",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.pulmoe.2023.07.004",FALSE,"",TRUE,"<section> Funding information and role of the sponsors <section> MASK-air has been supported by EU grants (POLLAR EIT Health; Structural and Development Funds Twinning EIP on AHA H2020 and Horizon Europe) and by educational grants from Mylan-Viatris ALK GSK Novartis and Uriach.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.radcr.2023.01.023",TRUE,"Competing Interests: The authors declare that they have no competing",TRUE,"<section> Funding: No funding was received for this case report.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.radcr.2023.02.047",TRUE,"Competing Interests: The authors declare that they have no known have appeared to influence the work reported in this paper. <section> competing financial interests or personal relationships that could",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.radonc.2023.109949",TRUE,"Disclosures <section> PGP received funding from the Dutch Heart Foundation grant 03–003-2021-T061. <section> Declaration of Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This project has received funding from the European Union’s Horizon-2020 research and innovation programme under grant agree­ ment No 945119. <section> PGP received funding from the Dutch Heart Foundation grant 03–003-2021-T061.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.rbmo.2023.04.006",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.redox.2023.102728",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no conflicts of interest with respect to the research authorship and/or publication of this article in Redox",TRUE,"<section> Funding <section> Funding was received from the Swedish Foundation for Strategic Research Swedish Research Council Swedish Cancer Society the Mrs. <section> Berta Kamprad Foundation Knut and Alice Wallenberg Foundation VINNOVA Governmental Funding of Clinical Research within National Health Service Crafoord Foundation Gunnar Nilsson Cancer Founda­ tion Lund University Medical Faculty Skåne University Hospital Foundation BioCARE Research Program King Gustav Vth Jubilee Foundation and the Krapperup Foundation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.redox.2023.102796",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"Among the phenotypes of the affected subjects was a delay in bone growth and maturation Funding The research in the lab of LS was supported by the Deutsche For­ <section> Research in the lab of EO was supported by a grant from Generalitat valenciana; CIAICO/2021/103. Elisa Oltra: Re­ sources Formal analysis Investigation Funding acquisition Writing – Review & Editing. <section> Lutz Schomburg: Conceptualization Resources Supervision Funding acquisition Project administration Writing – Original Draft.",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.redox.2023.102803",TRUE,"<section> Declaration of competing interest <section> All authors declare that there are no conflicts of interest to be disclosed.",TRUE,"<section> This study was supported by research grants of the German Research Foundation (DFG) to TG (GR1240/20-1) and KHW (WE2908/13-1). The study was also supported by the Ministry of Science Research and Culture of the State of Brandenburg.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.redox.2023.102823",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding <section> The research has been supported by the Deutsche For­ schungsgemeinschaft (DFG) Research Unit FOR-2558 “TraceAge” (Scho This article uses data from the Berlin Aging Study II (BASE-II) which was supported by the German Federal Ministry of Education and Research (BMBF) under grant numbers #01UW0808; #16SV5536K",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.redox.2023.102908",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding <section> This work was supported by the Research Foundation-Flanders (FWO) (Postdoctoral fellowships grant number 1227020N to JH",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.resuscitation.2023.109946",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.rpth.2023.100280",TRUE,"<section> R EL AT I O NSH IP D I S CL O SUR E None of the authors reports a relationship with industry and other relevant entities ﬁnancial or otherwise that might pose a conﬂict of interest in connection with the submitted article.",TRUE,"<section> This study was supported by the German Federal Ministry of Education and Research (BMBF 01EO1503). The authors disclose the following additional funding sources: Berlin Chemie Germany; Corvia United States; Impulse Dynamics United States; Springer International Publishing Switzerland; Bayer Germany; Boston Scientiﬁc United States; Inari Medical United States; MSD United States; and Actelion Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.rpth.2023.102181",TRUE,"All other authors did not have competing interests to disclose.",TRUE,"<section> The FRONTIER1 SAD and 4882 PK studies were supported by",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.schres.2023.02.011",TRUE,"<section> Declaration of competing interest",TRUE,"<section> Funding <section> This study was supported by project 215793/Z/19/Z from the Wellcome Trust and award MR/T003138/1 from the Medical Research",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scitotenv.2023.165800",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scitotenv.2023.167095",TRUE,"<section> Declaration of competing interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scog.2023.100285",TRUE,"Conflict of interest <section> None of the authors has any financial or personal conflicts of interest to",TRUE,"<section> Funding sources <section> This study is publicly funded by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und For­ schung BMBF) grant number 01EE1407F. <section> Meyer-Lindenberg: Methodology Funding acquisition Supervision. <section> Wolfgang Wölwer: Conceptualization Methodology Funding acquisi­ tion Supervision Writing – original draft.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103030",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"The research was also supported by the BrainLab II project funded by grants of the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany’s Excellence Strategy—EXC-2049—390688087 to M.S.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103056",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103070",TRUE,"Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This project was supported by grants from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103071",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This project was supported by grants from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.scr.2023.103105",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"This work was supported by the German Research Foundation (DFG): project number 417880571 to L.C.; project number 501985000 to L.C.; project number 193793266 Collaborative Research Centre 1002 S01 to L.C.; project number 390729940 Germany’s Excellence Strategy EXC 2067/1 to A.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103184",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding <section> This project was supported by grants from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung The study was furthermore supported by Nothing is Forever e.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103253",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> This work was supported by Animalfree Research Switzerland and Charité 3R — Replace — Reduce — Refine.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.scr.2023.103256",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Harald Stachelscheid reports financial support was provided by German Research Foundation.",TRUE,"<section> Peter Kühnen: Conceptualization Funding acquisition Project administration Supervision. <section> chelscheid: Conceptualization Funding acquisition Project adminis­ tration Supervision. <section> This work was funded by Deutsche Forschungsgemeinschaft Ger­ many (DFG)—Project-ID 424957847-TRR 296 LOCOTACT (P.K. H.S.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.seizure.2023.02.015",TRUE,"Competing Interest <section> All authors declare that they have no conflicts of interest.",TRUE,"<section> Abbreviations: ASM antiseizure medication; BMI body mass index; CI confidence epidemiological surveillance of congenital anomalies; ETOP elective termination abortion; SDS standard deviation score; STROBE Strengthening of the Reporting This work was performed with financial support from the German Federal Institute The sponsor had no involvement in the collection analysis and interpretation of publication.The results of this study are part of the thesis of Sofia Slimi and parts Teratology information services (ENTIS) 2019 <section> Sources of funding <section> This work was supported by the German Federal Institute for Drugs and Medical Devices (BfArM)and German Research Foundation (DFG).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study protocol was approved by the ethics committee of the Charité-Universitätsmedizin Berlin (EA4/015/20) and the study was registered with the German Clinical Trial register (DRKS00021001) and listed at the WHO International Clinical Trials Registry Platform.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.seizure.2023.06.002",TRUE,"Competing Interest",TRUE,"TL has received funding from Empatica in the past has received device donations from Empatica in the past and is part of pending and approved patents related to seizure detection seizure prediction and epilepsy diagnosis. TL has received funding from Empatica in the past has received device donations from Empatica in the past and is part of pending and approved patents related to seizure detection seizure prediction and epilepsy diagnosis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.semarthrit.2023.152259",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This study was funded by Novartis Pharma AG Basel Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.semnephrol.2023.151426",TRUE,"Conflict of interest statement: none.",TRUE,"<section> Financial support: Editorial assistance in the form of formatting the article according to the journal’s instructions to authors was provided by Lisa Moore PhD of Envision Pharma Group funded by Bayer Corporation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.semperi.2023.151719",TRUE,"12 Due to a high shunt volume a hemodynamically significant PDA (hsPDA) may be associated with several neonatal complications such as pulmonary edema or hemorrhage necrotizing enterocolitis (NEC) renal impairment and bronchopulmonary dysplasia (BPD) among None of the above authors has a conflict of interest related to this article or financial conflict related to this manuscript.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.sleep.2022.11.041",TRUE,"<section> Declaration of competing interest <section> DZ OKB JV SS P. Sliwinski P. Steiropoulos CL HH JLP GP and WTM declare no competing interests related the current work.",TRUE,"<section> Jan Hedner: Conceptualization Methodology Investigation Resources Data curation Writing e original draft Supervision Funding acquisition. <section> The ESADA network has received support from the European Union COST action B26 (2005e2009) and the European Respiratory Society funded Clinical Research Collaboration (CRC; 2015e2020). The current study was supported by the Swedish Heart and Lung Foundation (project 20180585) and partially supported by MIAI @ Grenoble Alpes (ANR-19-P3IA-0003).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.sleep.2023.04.024",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing ﬁnancial interests or personal relationships that could have appeared to inﬂuence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.sleep.2023.05.002",TRUE,"<section> Declaration of competing interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ssci.2023.106283",TRUE,"Competing Interest quality of meta-analyses.",TRUE,"<section> Funding <section> Funding: This research received no specific grant from funding von Elektrokleinstfahrzeugen am Straßenverkehr 1.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.stem.2023.04.001",TRUE,"<section> DECLARATION OF INTERESTS <section> The Department of Medicine V (Director C.M.-T.) receives research funding from multiple pharmaceutical and biotech companies especially for clinical trials but also for translational research.",TRUE,"This work was financially supported by the German Bundesministerium f u € r Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin ‘‘LeukoSyStem’’ (FKZ 01ZX1911D to L.V. and S.R.) as well as the Verbundprojekt SMARTCARE (031L0212A to C.M.-T.) the Emerson foundation grant 643577 (to L.V.) grant PID2019-108082GA-I00 and PRE2020-093229 by the Spanish Ministry of Science Innovation and Universities (MCIU/AEI/FEDER UE) the German Research Foundation (DFG; projects MU1328/18-1 and MU1328/ 21-1 and MU1328/23-1 to C.M.-T.) and the German Cancer Aid (DKH; project 70113908 to C.M.-T.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.stemcr.2022.12.003",TRUE,"<section> CONFLICT OF INTERESTS <section> L.S.L. is a consultant to Cartography Biosciences with no competing interests related to this manuscript.",TRUE,"L.S.L. is supported by the Berlin Institute of Health at Charité Universitätsmedizin Berlin an Emmy Noether fellowship by the German Research Foundation (Deutsche Forschungsgemeinschaft LU 2336/2-1); a Longevity Impetus grant; the National Institutes of Health (1UM1HG012076-01); and a Hector Research Career Development Award by the Hector Fellow Academy.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.stemcr.2023.03.005",TRUE,"The authors declare no competing interests.",TRUE,"The clinical study database is continuously updated by keyword searches and manual screening of public resources and includes clinical studies listed at ClinicalTrials.gov (clinicaltrials.gov) the International Clinical Trials Registry Platform (ICTRP) maintained by the World Health Organization (WHO) and multiple other sources (for methods see Kobold et al. 2020). This work was supported by the European Union Horizon 2020 Societal Challenges and Horizon Europe programmes under grant agreements 726320 and",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.stemcr.2023.08.003",TRUE,"<section> CONFLICT OF INTERESTS <section> This work was supported by the Burroughs Wellcome Fund the Doris Duke Charitable Foundation and the Simons Foundation Autism Research Initiative.",TRUE,"This can provide researchers confidence that a particular line was properly consented for their jurisdiction donor restrictions and requirements are being adhered to within the laboratory and any requirements of funding bodies local governance and/or national jurisdictions are being met. The obligation of conducting rigorous and reproducible science rests with the collective efforts of the scientific community (scientists funding agencies journal editors and others). <section> This work was supported by the Burroughs Wellcome Fund the Doris Duke Charitable Foundation and the Simons Foundation Autism Research Initiative. ; The Francis Crick Institute which receives its funding from Cancer Research UK (CC0199 to L.E.H.); the UK Medical Research Council (CC0199 to L.E.H.); the Wellcome Trust (CC0199 to L.E.H.); the Medical Research Council (MC_UP_1201/9) and the European Research Council (ERC STG 757710) (M.A.L.); the Korean Fund for Regenerative Medicine (funded by Ministry of Science and ICT) and Ministry of Health and Welfare Republic of Korea (RS-2022-00070674 to J.S.); and the National Research Foundation of Korea grant funded by the Korean government (MSIT) (no. 2020M3A9E4037903 to J.S.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.stemcr.2023.09.002",TRUE,"<section> DECLARATION OF INTERESTS <section> T.E. is a member of the DiNAQOR Scientific Advisory Board and holds shares in DiNAQOR.",TRUE,"This study was supported by the European Research Council (ERC-AG IndivuHeart) Deutsche Forschungsgemeinschaft (DFG Es 88/12-1 DFG HA 3423/5-1) the German Ministry of Education and Research (BMBF PRAEDIKARD FKZ031L0236) the Centre for Cardiovascular Research (DZHK 81Z0710101 81Z0710115 81X2710176) and the Freie und Hansestadt Hamburg.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.tacc.2023.101310",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Financial support and sponsorship: The Simulation Committee and the Trainees Committee of the European Society of Anaesthesiology and",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.tins.2023.03.009",TRUE,"<section> Declaration of interests The authors declare the following ﬁnancial interests/personal relationships that may be considered as potential competing interests.",TRUE,"All authors received funding from Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID 424778381 – TRR 295. WJN received funding from the European Union (ERC ReinforceBG project 101077060). WJN and AAK received funding from the Bundesministerium für Bildung und Forschung (BMBF project FKZ01GQ1802). AH received funding from Deutsches Zentrum für Luftund Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research JPND) the National Institutes of Health (R01 13478451 1R01NS127892-01 & 2R01 MH113929) as well as the New Venture Fund (FFOR Seed Grant).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.tmaid.2023.102583",TRUE,"<section> Declaration of competing interest <section> None of the authors has any conflict of interest to declare.",TRUE,"<section> Funding <section> This project was supported by GeoSentinel the emerging infectious diseases surveillance and research network of the International Society of Travel Medicine (ISTM) through a cooperative agreement (1 U01CK000632-01-00) from the Centers for Disease Control and patients) and from March 2020 (n = 4999 diagnoses in 4183 patients).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.tmaid.2023.102655",TRUE,"<section> Declaration of competing interest",TRUE,"The authors explained the rise in scabies cases by a steadily increasing number of migrants/refugees from Afghanistan crossing the Iran-Turkey border. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.trsl.2022.10.003",TRUE,"The other authors declare no conﬂicts of interest. All authors have read the journal’s policy on disclosure of potential conﬂicts of interest.",TRUE,"<section> This research was funded by Takeda (IISR-2017-102273) and the German Research Foundation (Deutsche Forschungsgemeinschaft ZU377/4-1 TRR241 B08). <section> The research of IA TMM RA MFN and SZ was supported by the Interdisciplinary Center for Clinical Research (IZKF) and the ELAN program of the University Erlangen-Nuremberg the Else-Kr € o ner-FreseniusStiftung the Thyssen-Stiftung the Fritz Bender-Stiftung the Dr. The research of BS is supported by the DFG through the TRR241 SFB 1449 and the SFB 1340.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ttbdis.2022.102087",TRUE,"Competing Interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding <section> The work was funded by the Deutsche Forschungsgemeinschaft (JU 2857/9–1 to S.J.) and the German Center for Infection Research (DZIF) Germany (TTU 01.801). Ogola was supported by a German Academic Exchange Service (DAAD) through the icipe ARPPIS-DAAD scholarship and a UP postgraduate bursary. We gratefully acknowledge the financial support for this research by the following organizations and agencies: Swedish International Development Coop­ eration Agency (Sida) Swiss Agency for Development and Cooperation (SDC) Australian Centre for International Agricultural Research (ACIAR) Federal Democratic Republic of Ethiopia and the Government of the Republic of Kenya.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.tvr.2023.200269",TRUE,"<section> The authors declare the following financial interests/personal re­ lationships which may be considered as potential competing interests: Peter A. Fasching received grants from BioNTech and Cepheid and personal fees from Novartis Roche Pfizer Daiichi-Sankyo Eisai AstraZeneca Merck Sharp & Dohme Pierre Fabre SeaGen Hexal Agenida and Lilly during the conduct of our study. This funding had no connection to this study and did not influence our study design and results. All other authors declare no conflicts of interest in the writing or preparation of this manuscript.",TRUE,"<section> Funding statement D.R. received funding from the Tumor­ stiftung at Hannover Medical School. T.D. received funding from the Bruno and Helene Jöster foundation. Runnebaum Peter Hillemanns: Resources Data curation Writing original draft; Thilo Dörk: Concep­ tualization Data curation Funding acquisition Resources Supervision Writing original draft Writing review & editing; Dhanya Ram­ achandran: Conceptualization Formal analysis Funding acquisition Investigation Resources Supervision Visualization Writing original Fasching received grants from BioNTech and Cepheid and personal fees from Novartis Roche Pfizer Daiichi-Sankyo Eisai AstraZeneca Merck Sharp & Dohme Pierre Fabre SeaGen Hexal Agenida and Lilly during the conduct of our study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.vaccine.2023.03.038",TRUE,"<section> The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Pierre M.",TRUE,"<section> Funding <section> Funding <section> This work was supported in whole by the Bill & Melinda Gates Foundation [INV008443].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This review was registered in PROSPERO (CRD42021234185). The operative definition of each specific AE has been reported elsewhere (PROSPEROCRD42021234185).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.vaccine.2023.08.004",TRUE,"Competing Interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",TRUE,"<section> Funding <section> This project is part of the EDCTP2 Programme supported by the European and Developing Countries Clinical Trials Partnership (grant number TMA2019CDF-2734 – TIMELY). OW was also supported by an Imperial College London Wellcome Trust Institutional Strategic Support Fund (ISSF) (grant no RSRO_P67869). KM is supported by joint Centre funding from the UK Medical Research Council and Department for In­ ternational Development [MR/R0156600/1].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.waojou.2023.100744",TRUE,"<section> Declaration of competing interest The authors declare that they have no conﬂicts of interest.",TRUE,"<section> Funding <section> This study was supported by the Chinese central government (Key Project of Public Health Program) and the National Key Research and Development Program of China (2018YFC1311700).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.waojou.2023.100746",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.waojou.2023.100788",TRUE,"<section> Declaration of competing interest",TRUE,"The study and the writing support was funded by Novartis Pharma AG Basel Switzerland).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.waojou.2023.100821",TRUE,"<section> Declaration of competing interest The authors declare that they do not have any conﬂict of interests related to the contents of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.waojou.2023.100838",TRUE,"Disclosure of potential conﬂict of interest Polina Pyatilova has no relevant conﬂict of interest in relation to this work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.waojou.2023.100844",TRUE,"<section> Declaration of competing interest HS reports fees for lectures or consultations from Astrazeneca GSK Novartis Sanoﬁ all outside the submitted work.",TRUE,"<section> Funding <section> EH is funded by the German Ministry of Education and",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.wneu.2023.01.082",TRUE,"Conflict of interest statement: The authors declare that the Application of neuroendoscopy to intraventricular article content was composed in the absence of any lesions. Neurosurgery. 2008;62(Suppl 2):575-598. commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xagr.2022.100138",TRUE,"<section> The authors report no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xcrm.2022.100877",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"Funding was provided by the Max Planck Society for the Advancement of Science and the German Research Foundation DFG under project IDs 360372040 (SFB 1335) 408885537 (TRR 274) and 390873048 (EXC 2151 ImmunoSensation2).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.xcrm.2023.100992",TRUE,"<section> DECLARATION OF INTERESTS <section> A.F. J.V. I.M. K.",TRUE,"<section> This work was supported by Bayer AG. Work in the Susztak lab is supported by NIH grants DK076077 DK087635 DK105821 and DK132630. M.S.B. is supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft DFG BA 6205/2-1) Else Kroner-Fresenius Foundation and the Berlin Institute of Health at Charité – Universitätsmedizin Berlin Clinician Scientist Program. We thank the University of Pennsylvania Diabetes Research Center (DRC) for the use of the nextgeneration sequencing core (P30-DK19525).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.xgen.2022.100232",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"This study was supported by the COFONI (COVID19 Research Network of the State of Lower Saxony) with funding from the Ministry of Science and Culture of Lower Saxony Germany (14-76403-184) to Y.L. R.F. T.I. and J.H.; the Network Universities of Medicine (NUM) CODEX+ fund from the Federal Ministry of Education and Research (BMBF) to Y.L.; the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany’s Excellence Strategy—EXC 2155 project number 390874280 to Y.L.; and the Helmholtz Centre for Infection Research network fund (NASAVIR) to Y.L. and J.H. Y.L. was also supported by a European Research Council (ERC) Starting Grant (948207) and the Radboud University Medical Center Hypatia Grant (2018) for Scientific Research. <section> was supported by a joint scholarship by the University of Groningen and China Scholarship Consortium (CSC201706350277) and Singh-ChhatwalPostdoctoral Fellowship at the Helmholtz Centre for Infection Research. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by the National Cancer Institute (NCI) National Human Genome Research Institute (NHGRI) National Heart Lung and Blood Institute (NHLBI) National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) and National Institute of Neurological Disorders and Stroke (NINDS).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.xgen.2023.100281",TRUE,"<section> DECLARATION OF INTERESTS <section> E.B. is a paid consultant and shareholder of ONT.",TRUE,"The present contribution is supported by the Helmholtz Association under the joint research school HIDSS4Health Helmholtz Information and Data Science School for Health. A.E. received funding from the DFG (project number 460595631) and from the Wilhelm Sander Foundation (project number 2020.115.1). J.O.K. received funding from the BMBF (031L0184C) and from the NIH (1R01HG010169-01 and 2U24HG007497-05). A.L. has received financial support from ONT for consumables during the course of the project and is currently an employee of ONT.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.xgen.2023.100347",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"<section> was supported by the Starr Centennial Scholarship at the CSHL of Biological Sciences. B.R.W. is supported by a Wellcome Investigator Award (107049/Z/15/Z). S.B. was supported by a Medical Research Council PhD studentship. This work was further supported by the Ministry of Education and Research (BMBF) as part of the National Research Node ‘‘Mass spectrometry in Systems Medicine’’ (MSCoreSys) under grant agreements 031L0220A (to M.R.) and 161L0221 (to V.D.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered at ClinicalTrials.gov with identifier NCT02152553.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/j.xgen.2023.100402",TRUE,"<section> DECLARATION OF INTERESTS <section> The authors declare no competing interests.",TRUE,"A.G.H. is supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation 398299703) and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 949172). A.G.H. is supported by the Deutsche Krebshilfe (German Cancer Aid) Mildred Scheel Professorship program – 70114107. This project received funding from the NIH/CRUK (398299703 the eDynamic Cancer Grand Challenge). This project was supported by the Berlin Institute of Health at Charité – Universitätsmedizin Berlin within the collaborative research projects TERMINATE-NB (CRG04) and PeDiOn.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.xhgg.2023.100200",TRUE,"Disclosure of the full (raw and annotated) datasets are restricted by the level of consent for data sharing provided by the participants. <section> Declaration of interests <section> The authors declare no competing interests.",TRUE,"This work was financially supported by Aspasia grants of the Dutch Research Council (015.014.036 to T.K. and 015.014.066 to L.V.) and Netherlands Organization for Health Research and Development (91718310 to T.K.). The collaborations in this study were facilitated by ERN ITHACA one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States cofunded by the European Commission. The aims of this study contribute to the Solve-RD project (E.d.B. A.H. T.K. L.V.) which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xinn.2023.100503",TRUE,"<section> DECLARATION OF INTERESTS The authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGMENTS This work was supported by the National Natural Science Foundation of China (grant nos.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100628",FALSE,"",TRUE,"<section> Support: Dr Potok was supported by grant 1K23DK128604-01. Dr Ix was supported by grant K24 DK110427. Dr Rifkin was supported by the Veterans Affairs Merit award H160180 (Health Services Research and Development). The Berlin Initiative Study was supported by a grant from the Kuratorium für Dialyse und Nierentransplantation Foundation of Preventive Medicine. <section> Financial Disclosure: Dr Ix is a consultant for Alpha Young; received honorarium from Bayer AstraZeneca Akebia Ardelyx and Jnana Pharmaceuticals; and received grants from National Institutes of Health and Baxter International. Dr Shlipak is a consultant for Cricket Health; received honorarium from Bayer Pharmaceuticals AstraZeneca and Boeringer Ingelheim; and received grants from National Institutes of Health Veterans Affairs and Bayer.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100666",FALSE,"",TRUE,"<section> Support: The study was funded by Akebia Therapeutics Inc. K-UE has received grant support from Amgen and Fresenius; lecture fees from Astellas Pharma; grant support and lecture fees from AstraZeneca Bayer and Genzyme; consulting fees from Boehringer Ingelheim; advisory board fees from Retrophin; and grant support advisory board fees and lecture fees from Vifor Pharma. EFL has received grant support from Akebia Therapeutics Inc. KM has received grant support and consulting fees from Kyowa Kirin and grant support and honoraria from Fukuda Denshi and consulting fees from Akebia Therapeutics Inc. <section> Funding: Akebia Therapeutics Inc and Otsuka Pharmaceutical.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100667",FALSE,"",TRUE,"<section> Funding: Akebia Therapeutics Inc. <section> Support: This study was funded by Akebia Therapeutics Inc. KUE has received grant support from Amgen and Fresenius; lecture fees from Astellas Pharma; grant support and lecture fees from AstraZeneca Bayer and Genzyme; consulting fees from Boehringer Ingelheim; advisory board fees from Retrophin; and grant support advisory board fees and lecture fees from Vifor Pharma. EFL has received grant support from Akebia Therapeutics Inc. KM has received grant support and consulting fees from Kyowa Kirin grant support and honoraria from Fukuda Denshi and consulting fees from Akebia Therapeutics Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100704",FALSE,"",TRUE,"<section> Funding: Bayer AG <section> Support: This analysis was supported by Bayer AG who funded the FIDELIO-DKD and FIGARO-DKD studies and the combined analysis. <section> Financial Disclosure: SER reports research support from AstraZeneca and Bayer.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100725",FALSE,"",TRUE,"The GCKD study is supported by the German Ministry of Education and Research (Bundesministerium für Bildung und Forschung FKZ 01ER 0804 01ER 0818 01ER 0819 01ER 0820 and 01ER 0821) and the KfH Foundation for Preventive Medicine (Kuratorium für Heimdialyse und Nierentransplantation e.V. – Stiftung Pr€ aventivmedizin) and corporate sponsors (www.gckd. org).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xkme.2023.100730",FALSE,"",TRUE,"<section> Funding: Bayer AG. <section> Support: This work was supported by Bayer AG which funded the FIDELIO-DKD and FIGARO-DKD studies the combined FIDELITY analysis and additional subanalyses. Dr Toto’s contribution to this work is supported by the endowments from the Mary M. <section> Financial Disclosure: Dr Flack reports research funding from Bayer GlaxoSmithKline Idorsia Quantum Genomics ReCor Medical and Vascular Dynamics.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.xpro.2023.102406",TRUE,"<section> DECLARATION OF INTERESTS N.T. is an IotaSciences employee.",TRUE,"<section> ACKNOWLEDGMENTS This work was supported by funding from the Max Pluripotent stem cells Berlin and DZHK (German Berlin the Berlin Institute of Health at Charite",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.yebeh.2023.109435",TRUE,"<section> The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: EBM has received consulting fees/and or honoraria from",TRUE,"<section> OB Pharma is the CEO of PrevEp Inc and has received research support from CURE/Department of Defense and from the NIH/SBIR.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.yexmp.2023.104860",TRUE,"Competing Interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ygyno.2023.09.013",TRUE,"Competing Interest Han Amit Oza Nicoletta Colombo Andrea Jewell Jonathan Krell JeanFrançois Baurain Rachel Neuwirth and Giovanni Scambia have no disclosures to",TRUE,"<section> Funding This work was supported by funding from Takeda Development Center Americas Inc. This study was funded by Takeda Development Center Americas Inc.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.yjmcc.2023.09.008",TRUE,"Competing Interest",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft with grants KR1187/22-1 KR1187/22-2 and KR1187/21-2 to TK and MO2238/2-2 to JM and by ERA-CVD SCALE to JM.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ymben.2023.01.011",TRUE,"<section> Declaration of competing interest <section> The authors declare no conflict of interest.",TRUE,"<section> Arren Bar-Even: Conceptualization; Supervision; Funding acquisition <section> view & Editing; Supervision; Funding acquisition. <section> This study was funded by the Max-Planck-Society (Arren Bar-Even and Tobias J.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ymgme.2023.107564",TRUE,"Competing Interest",TRUE,"<section> Funding <section> The faceto-face and virtual meetings leading up to this manuscript as well as assistance in development of the current manuscript were funded by BioMarin Deutschland GmbH and BioMarin Pharmaceutical Inc.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ynirp.2022.100155",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> This work was supported by the Max Planck Society and the Max Planck Institute for Human Development and is part of the BMBF-funded EnergI Consortium (01GQ1421B).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/j.ynirp.2023.100184",TRUE,"<section> Declaration of competing interest <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/j.ynstr.2023.100576",TRUE,"<section> Declaration of competing interest <section> None of the authors declare competing interests.",TRUE,"<section> This study was funded by the Federal Ministry of Education & Research (BMBF) <section> Claudia Buss: Conceptualization Methodology Formal anal­ ysis Funding acquisition Investigation Supervision Writing – review & editing. <section> Funding acquisition Investigation Supervision Writing – review & editing. <section> Elisabeth Binder: Conceptualization Funding acquisition Writing – review & editing. <section> John-Dylan Haynes: Conceptualization Methodology Funding acquisition Supervision. <section> Christine Heim: Conceptualization Method­ ology Funding acquisition Project administration Investigation Re­",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s0140-6736(23)00860-7",TRUE,"<section> Declaration of interests AS acknowledges AKD reports payment or honoraria for lectures presentations speakers MRT-P acknowledges bureaus; manuscript writing or educational events from speakers Technical bureaus Stryker Integra and Safe (orthopedics); leadership or fiduciary Research Training roles in board society committee or advocacy groups unpaid with the African Network European Association of Neurosurgical Societies the Board of Global the EU and Neuro Foundation and the Steering Committee of AO Spine Knowledge Horizon 2020 Forum Degenerative outside the submitted work.",TRUE,"<section> Funding The Australian National Health and Medical Research Council Investment in Global Adolescent Health and the Bill & Melinda Gates JAL reports support for the present manuscript from Researchers Base Funding UIDB/00511/2020 of the Laboratory for Process support from Engineering Environment Biotechnology and Energy funded by Support Program. Murdoch Research Institute researchers were supported by the Australian Operational Infrastructure Support Program. PSA is supported by a Investigator grant GNT 2008574. AZ acknowledges support from The Panon Emerging and Re-Emerging Infections supported by Developing Countries Clinical Trials Partnership the EU Framework Programme and from UK National Institute for Care Research as a Senior Investigator Award and Mahathir winner and The European and Developing Countries Partnership (EU) Pascoal Mocumbi Prize Laureate.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s1474-4422(23)00195-3",TRUE,"<section> Declaration of interests UAB Cochrane K Akinosoglou reports payment or honoraria for lectures presentations Meta-analysis speakers’ bureau fees manuscript writing or educational events from in TPT Global Pfizer Hellas Gilead Sciences Merck Sharp and Dohme Adaptimmune Glaxosmithkline Greece as payments to the University of Patras; and Enzolytics support for attending meetings or travel or both to Pfizer Hellas Gilead Web Holdings Sciences Merck Sharp and Dohme Glaxosmithkline Greece and Norma and Moderna Hellas; all outside the submitted work.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. N A Feasey is funded by a NIHR Global Health P A Gaal acknowledges support from the National Development and Innovation Office of Hungary under grant (Datadriven Health Division of Health Security V K Gupta acknowledges funding support from and Medical Research Council Australia. S Hussain support from Operational Programme Research and Education Project Postdoc2MUNI (No.CZ.02.2.69/0.0 M T Imam is supported via funding from Bin Abdulaziz University (project number H Kandel is supported by the Kornhauser Research Fellowship at the University of Sydney. L Monasta received support from the Italian Ministry of Health (Ricerca Corrente 34/2017) payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo. A Mousavi Khaneghah received support from the Department of Technology of Chemistry Azerbaijan State Oil and Industry University Baku Azerbaijan. A Riad acknowledges support from the NPO “Systemic Risk Institute” number LX22NPO5101 funded by European Union Next Generation EU (Ministry of Education Youth and Sports NPO: EXCELES).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s1474-4422(23)00287-9",TRUE,"All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2213-2600(22)00504-5",TRUE,"<section> Declaration of interests present study.",TRUE,"<section> Funding Vertex Pharmaceuticals. <section> AZU received grants from the Cystic Fibrosis Foundation and the VI received grant support from CF TDN for the present work; Fibrosis Foundation consulting fees from Mylan for CF—TOBI podhaler advisory board; and European grant support from CFF for meeting attendance. ET received the present work and grants for doing clinical trials from received payment and reimbursement from her role on a steering committee and for presentations at events. JB received funding from Vertex Pharmaceuticals for work. AH received funding from Vertex Pharmaceuticals for work; grant support from NIHR CF Trust CF Foundation Research Council; payments for educational lectures from and for an advisory board from Mylan; medical from Vertex; served as Chair of the UK CF Clinical Trials Platform and as a board member of the UK CF Medical LMY received salary support from mgH TDN for clinical for the present work. Grant support was provided to the of Alabama at Birmingham by the National Institutes of R35HL135816 and UL1TR003096) and the Cystic (ROWE19R0).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2213-8587(22)00353-9",TRUE,"<section> Declaration of interests KKR reports grants from Amgen Sanofi Daiichi Sankyo Regeneron and Pfizer; consulting fees from Daiichi Sankyo Silence Therapeutics Novartis SCRIBE CRISPR VAXXINITY Cargene Novo Nordisk Sanofi Astra Zeneca Eli Lilly Silence Therapeutics Resverlogix New Amsterdam Kowa Bayer Amarin and Esperion; and personal fees from Novartis Amgen Viatris Novo Nordisk Boehringer Ingelheim Daiichi Sankyo Kyrka and Astra Zeneca. RPTT reports grants from Amgen Esperion KOWA CLS Behring DalCor Pharma UK Astra Zeneca Medtronic Biotronik Boehringer Ingelheim and Celecor Therapeutics. <section> SRW report consulting fees from Boehringer Ingelheim. SV ZT XZ PM and AL were employed by Novartis at the time of manuscript development. UL reports grants from Novartis; consulting fees from Novartis Amgen Sanofi and Bayer; and personal fees from Novartis Amgen Sanofi Bayer and Daiichi Sankyo. FLJV and LAL report no competing interests.",TRUE,"<section> Funding Novartis Pharma. <section> Declaration of interests KKR reports grants from Amgen Sanofi Daiichi Sankyo Regeneron and Pfizer; consulting fees from Daiichi Sankyo Silence Therapeutics Novartis SCRIBE CRISPR VAXXINITY Cargene Novo Nordisk Sanofi Astra Zeneca Eli Lilly Silence Therapeutics Resverlogix New Amsterdam Kowa Bayer Amarin and Esperion; and personal fees from Novartis Amgen Viatris Novo Nordisk Boehringer Ingelheim Daiichi Sankyo Kyrka and Astra Zeneca.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,"ORION-3 is registered with ClinicalTrials.gov NCT03060577.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/s2214-109x(22)00549-6",TRUE,"<section> Declaration of interests <section> Reiner <section> JG and MM report grants from PanTheryx during the conduct of the inequalities study; NP reports grants from GlaxoSmithKline during the conduct of low-income the study; the remaining authors declare no competing interests.",TRUE,"<section> Funding NASA National Institutes of Health–The National Institute MNK and BFZ secured funding for the research and Shigella provided review and editing.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2214-109x(23)00007-4",TRUE,"<section> Declaration of interests S Bhaskar reports support for the present manuscript from leadership or fiduciary roles in board society committee or advocacy groups paid or unpaid with the Rotary Club of Sydney and Global Health and Migration Hub Community Global Health Hub Germany as a Board Director and Co-Manager. All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. Funding flows for global health security are tracked from 2014 to 2022 and reported at the country level. <section> Declaration of interests S Bhaskar reports support for the present manuscript from leadership or fiduciary roles in board society committee or advocacy groups paid or unpaid with the Rotary Club of Sydney and Global Health and Migration Hub Community Global Health Hub Germany as a Board Director and Co-Manager. A Guha reports being the recipient of the American Heart Association Strategically Focused Research Network Grant consulting fees from Myovant and Pfizer payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from the Association of Community Cancer Centers Ohio State University and the University of Kentucky outside the submitted work. K Krishan is supported by the UGC Centre of Advanced Study (phase II) awarded to the Department of Anthropology Panjab University Chandigarh India outside the submitted work. L Monasta received support for the present manuscript from the Italian Ministry of Health (Ricerca Corrente 34/2017) payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo. <section> Acknowledgments This work was supported by Research Management Centre Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). H Kandel is supported by the Kornhauser Research Fellowship at The University of Sydney. J Nitin would like to thank Kasturba Medical College Mangalore Manipal Academy of Higher Education Manipal for their encouragement and support in doing research work. The work reported herein was made possible through funding by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Mid-Career Scientist Programme from funding received from the South African National Treasury.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2214-109x(23)00384-4",TRUE,"<section> Declaration of interests We declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/s2214-109x(23)00408-4",TRUE,"<section> Declaration of interests JGFC reports grants and personal fees from Amgen Bayer Bristol Myers Squibb and Torrent Pharmaceuticals; personal fees from AstraZeneca Myokardia Servier and Abbott; grants personal fees and non-financial support from Medtronic Novartis and Vifor; and grants and non-financial support from Pharmacosmos and PharmaNord. All other authors declare no competing interests.",TRUE,"<section> Funding Novartis Pharma. <section> Declaration of interests JGFC reports grants and personal fees from Amgen Bayer Bristol Myers Squibb and Torrent Pharmaceuticals; personal fees from AstraZeneca Myokardia Servier and Abbott; grants personal fees and nonfinancial support from Medtronic Novartis and Vifor; and grants and nonfinancial support from Pharmacosmos and PharmaNord. CSPL is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board Steering Committee or Executive Committee for Actelion Alleviant Medical Allysta Pharma Amgen AnaCardio Applied Therapeutics AstraZeneca Bayer Boehringer Ingelheim Boston Scientific Cytokinetics Darma EchoNous Eli Lilly Impulse Dynamics Ionis Pharmaceutical Janssen Research & Development Medscape WebMD Global Merck Novartis Novo Nordisk Prosciento Radcliffe Group Roche Diagnostics Sanofi Siemens Healthcare Diagnostics and Us2.ai; and serves as cofounder and nonexecutive director of Us2.ai. TG was part of the Berlin Institute of Health Junior Clinician Scientist Program was supported by Förderkreis der Dresdner Herz-Kreislauf-Tage was supported by a Postdoc Startup Grant by the German Center for Cardiovascular Research and is supported by a fellowship of the German Research Foundation (DFG; GE 3588/1-1). LMSG was supported by a postdoctoral fellowship of the DFG (GE 3179/1-1) and is supported by the clinician scientist programme of the German Society of Internal Medicine. JT is supported by the National University of Singapore startup grant the tier 1 grant from the Ministry of Education and the CS-IRG New Investigator Grant from the National Medical Research Council.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/s2215-0366(23)00262-6",TRUE,"<section> Declaration of interests pdf (accessed All other authors competing interests.",TRUE,"<section> Funding National Institute for Health and Care <section> Therapies Janssen Johnson & Johnson Karuna Lundbeck MedAvante-ProPhase MedInCell Merck Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Nordisk Otsuka Pharmabrain PPD Biotech Recordati Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Takeda Teva and Viatris; has provided expert testimony for Otsuka; has served on a data safety monitoring board for Pathways Lundbeck Relmada Reviva Rovi Supernus and received grant support from Janssen and Takeda; has received UpToDate; and is a stock option holder of Cardio MindPax LB Pharma and Quantic. RAMcC is supported by a Wellcome Research Career Development fellowship (award number ODH is supported by the UK Medical Research Council MC_A656_5QD30_2135) Maudsley Charity (grant Wellcome Trust (grant number 094849/Z/10/Z) and the Research Centre at South London and Maudsley Service (NHS) Foundation Trust and King’s College is funded by the NIHR Biomedical Research Centre at South Maudsley NHS Foundation Trust and King’s College is partly supported by the NIHR Biomedical Research South London and Maudsley NHS Foundation Trust and London the Maudsley Charity and the NIHR Applied Collaboration South London at King’s College Hospital NHS Trust. The independent research of AHY is funded by the Biomedical Research Centre at South London and NHS Foundation Trust and King’s College London.",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> To our systematic umbrella review of published meta-analyses following a prespecified protocol registered with and anti­ PROSPERO (CRD42022372142; appendix pp 2–5).",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1016/s2352-3026(23)00160-6",TRUE,"<section> Declaration of interests Consortium S Afzal reports participation on a data safety monitoring board or of Higher advisory board with the National Bioethics Committee of Pakistan and/or travel King Edward Medical University Institutional Review Board and the Nehru Medical Ethics Review Board in Board of Studies; a leadership or fiduciary role Medical Sciences with the Pakistan Association of Medical Editors as a Fellow of Faculty T Richards of Public Health (FFPH) Royal Colleges UK and an advocacy role in PREVENT the Society of Prevention and Advocacy Research with King Edward clinical trial Medical University Lahore Pakistan all outside the submitted work. speakers R Agustina reports leadership or fiduciary roles with the Multiple Pharmacosmos Micronutrient Supplementation Technical Advisory Group of the for the IRONWOMAN New York Academy of Sciences and with the Indonesia Technical Pfizer Pharmacosmos Advisory Board for Multimicronutrient Supplemenation outside the NATA; and submitted work. All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. <section> Acknowledgments This project was supported by the Bill & Melinda Gates Foundation. A Badawi is supported by the Public Health Agency of Canada. J C Glasbey is supported by a National Institute for Health and Care Research Doctoral Research Fellowship (NIHR300175). S Hussain was supported by Operational Program Research Development and Education project Postdoc2MUNI (number CZ.02.2.69/0.0/0.0/18_053/0016952). <section> S M S Islam is funded by the NHMRC and has received funding from the National Heart Foundation of Australia. H Kandel is supported by a Kornhauser Research Fellowship at The University of Sydney Sydney NSW Australia. Y J Kim was supported by the Research Management Centre Xiamen University Malaysia Sepang Malaysia (grant numbers XMUMRF/2020-C6/ ITCM/0004]. L Monasta received support from the Italian Ministry of Health (Ricerca Corrente 34/2017) as payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy. J R Padubidri A Shetty B S K Shetty P H Shetty and B Unnikrishnan acknowledge the support given by Kasturba Medical College Mangalore Manipal Academy of Higher Education Manipal India. G Pereira was supported with funding from NHMRC Project and Investigator Grants (1099655 and 1173991). D Vervoort is supported by the Canadian Institutes of Health Research Vanier Canada Graduate Scholarship. X Xu is supported by a postdoctoral fellowship funded by the Heart Foundation of Australia (award number 102597) and Scientia Program at the University of New South Wales Sydney NSW Australia.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2468-1253(22)00385-5",TRUE,"<section> Declaration of interests EL has received educational and research grants from Janssen Pfizer AbbVie and Takeda Fresenius-Kabi; speaker fees from AbbVie Dr Falk Pharma Ferring Janssen Pfizer Celgene Bristol Myers Squibb (BMS) Galapagos and Takeda; advisory board fees for AbbVie Celgene Ferring Janssen BMS Pfizer Takeda Gilead-Galapagos Arena and Elli Lilly; and consultancy fees from AbbVie. <section> All other authors declare no competing interests.",TRUE,"<section> HépatoFunding European Union’s Horizon 2020. <section> Declaration of interests EL has received educational and research grants from Janssen Pfizer AbbVie and Takeda Fresenius-Kabi; speaker fees from AbbVie Dr Falk Pharma Ferring Janssen Pfizer Celgene Bristol Myers Squibb (BMS) Galapagos and Takeda; advisory board fees for AbbVie Celgene Ferring Janssen BMS Pfizer Takeda Gilead-Galapagos Arena and Elli Lilly; and consultancy fees from AbbVie. CAL has received grants from Genentech AbbVie Eli Lilly Pfizer Roche UCB Biopharma Sanofi Aventis Biogen IDEC Orion OYJ and AstraZeneca; grants and personal fees from Janssen Takeda and Ferring; and personal fees from Dr Falk Pharma outside the submitted work. <section> Acknowledgments This trial was funded by the European Union’s Horizon 2020 research and innovation programme under the grant agreement number 633168 — BIOCYCLE (PHC-13-2014).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2468-2667(23)00025-7",TRUE,"<section> Declaration of interests CSD AEH HNS TGO RKM CB ESB EO CKB MBE RJW SCLD TMB NRB and JP report funding from the National Institutes of Health (NIH). RKM reports research support from the Health Resources and Services Administration and the New York State Department of Health and participation as Chair of the Scientific Advisory Committee for the GlaxoSmithKline Bieimumab Pregnancy Registry. SCLD reports consulting fees from Nestlé Nutrition. JP reports research support from Takeda (formerly Shire) and Aevi Genomics and consulting fees from Innovative Science. ESB reports honoria from the NIH Study Sections. <section> All other authors declare no competing interests.",TRUE,"<section> Funding Environmental influences on Child Health Outcomes Program Office of the Director National Institutes of <section> Declaration of interests CSD AEH HNS TGO RKM CB ESB EO CKB MBE RJW SCLD TMB NRB and JP report funding from the National Institutes of Health (NIH). <section> Acknowledgments We acknowledge support by the ECHO Program Office of the Director National Institutes of Health (U2COD023375 U24OD023382 U24OD023319 UH3OD023320 UH3OD023332 UH3OD023313 UH3OD023328 UH3OD023289 UH3OD023282 UH3OD023287 UH3OD023244 UH3OD023389 UH3OD023288 UH3OD023342 UH3OD023349 UH3OD023286 UH3OD023337 4UH3OD023282-03 UH3OD023271 and UH3OD023305).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2468-2667(23)00149-4",TRUE,"<section> Declaration of interests Razavi-Shearer J V Lazarus reports grants or contracts from AbbVie Gilead Sciences prevalence MSD and Roche Diagnostics; royalties and licenses from Novavax; in 2016: payment or honoraria for lectures from AbbVie Gilead Sciences 3: 383–403. <section> Articles <section> Janssen and Novo Nordisk; participation on a data safety board or advisory board for the study “Same-visit hepatitis C treatment to accelerate cure among people who inject drugs <section> Study): a cluster randomised control trial” (Australia); or fiduciary roles in board society committee groups paid or unpaid with the European Association for of the Liver Public Health and Policy Committee as a member as a co-chair and SHARE Global Health Foundation; the submitted work. P C Matthews reports support for the from The Francis Crick Institute London UK; contracts from The Wellcome Trust and University College National Institute for Health and Care Research Research Centre; and funding from GSK for a PhD student A-F A Mentis reports grants and contracts from MilkSafe to enrich formula milk using omics technologies) by the European Regional Development Fund of Greek national funds through the Operational Program Entrepreneurship and Innovation under the call <section> (project code T2EDK-02222) as well (Hellenic Foundation for Research and Innovation payment for expert testimony from serving as external peerFondazione Cariplo Italy; leadership or fiduciary roles in committee or advocacy groups paid or unpaid as an member for Systemic Reviews and Annals of Epidemiology Editor for Translational Psychiatry; other financial or support from the BGI group as a scientific officer; outside work. M J Postma reports stock or stock options in Netherlands) and HealthEcore (Zeist All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. <section> Declaration of interests Razavi-Shearer J V Lazarus reports grants or contracts from AbbVie Gilead Sciences prevalence MSD and Roche Diagnostics; royalties and licenses from Novavax; in 2016: payment or honoraria for lectures from AbbVie Gilead Sciences 3: 383–403. I M Ilic acknowledges project number 175042 supported by the Ministry of Science and Technological Development Republic of Serbia D Ilic acknowledges support from the Ministry of Science Development and Innovation of the Republic of Serbia M Jakovljevic acknowledges support (OI 175 014) from the Ministry of Science of the Republic of Lazarus acknowledges support from the grant CEX2018funded by MCIN/AEI/10.13039/501100011033 and support de Catalunya through the CERCA Program.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2468-2667(23)00185-8",TRUE,"<section> Declaration of interests S Afzal reports payment or honoraria from educational events and webinars with King Edward Medical University Lahore Pakistan and collaborative partners including: Johns Hopkins University Baltimore MD USA; University of California CA USA; University of Massachusetts Boston MA USA; and University of Lahore Lahore Pakistan; participation on a data safety monitoring board or advisory board with the National Bioethics Committee Pakistan King Edward Medical University Institutional Ethical Review Board Fatima Jinnah Medical University Lahore Pakistan; and Sir Ganga Ram Hospital Delhi India; leadership or fiduciary roles in board society committee or advocacy groups paid or unpaid with the Pakistan Association of Medical Editors Fellow of Faculty of Public Health Royal Colleges UK Society of Prevention Advocacy and Research King Edward Medical University and as a member of the Pakistan Society of Infectious Diseases; outside the submitted work.",TRUE,"<section> Funding Bill & Melinda Gates Foundation. The findings of this study are supported by data available in public online repositories data publicly available upon request of the data provider and data not publicly available due to restrictions by the data provider. <section> Acknowledgments This study is funded by the Bill & Melinda Gates Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2542-5196(22)00253-4",TRUE,"<section> Declaration of interests TG works for the Planetary Health Academy as a member of the organising team. SGe and HO previously worked for the Planetary Health Academy as members of the organising team. SGe and KW work at the Centre for Planetary Health Policy which receives institutional funding from Stiftung Mercator. All other authors declare no competing interests.",TRUE,"The quantitative analysis was carried out by FS with support from TG and CS the qualitative analysis was carried out by KW and FvG.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2589-7500(22)00195-9",TRUE,"58 Implementers therefore need to weigh privacy requirements against the disclosure risks specific to different modelling strategies. <section> Declaration of interests We declare no competing interests.",TRUE,"<section> Acknowledgments This work has been made possible by the funding received as part of the NFDI4Health project financed by Deutsche Forschungsgemeinschaft (grant number 442326535).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2589-7500(22)00214-x",FALSE,"",TRUE,"<section> Funding Deutsche Forschungsgemeinschaft through NeuroCure Clinical Role of the funding source This study was funded by the Deutsche Forschungs­ gemeinschaft through the nonprofit sponsors NeuroCure Clinical Research Center and TRR 295 which provided personnel as well as structural and administrative support to conduct the study but had no role in study design data collection data analysis data interpretation or writing of the report. Funding was acquired AAK. <section> Speaker honoraria from Medtronic Boston Scientific AH has received grants from the German Research (Emmy Noether Stipend 410169619 and Transregio CRC 295) as well as the German Aerospace Center the of Health (2R01 MH113929) and the Foundation for (FFOR). AAK has received grants from the German Foundation (Transregio CRC 424778381—TRR 295) and the AAK is on the advisory board of Boston Scientific and has received honoraria from Boston Scientific Zambon and Stadapharm. JR was supported by the Einstein Center for TAD was supported by the Cologne Clinician Scientist Faculty of Medicine University of Cologne funded by AH was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft Emmy Noether Stipend 410169619 and 424778381—TRR 295) Deutsches Zentrum für Luftund Raumfahrt (DynaSti grant within the EU Joint Program—Neurodegenerative Disease Research JPND) the National Institutes of Health (2R01 MH113929) and the Foundation for OCD Research (FFOR).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2589-7500(23)00020-1",TRUE,"<section> Declaration of interests IA is an associate editor for Allergy and Clinical and Translational Allergy journals. All other 15 Vieira authors declare no competing interests. allergic",TRUE,"<section> Funding <section> Role of the funding source VAS There was no funding source for this study. <section> has been supported by EU grants (from the Impact of air on Asthma and Rhinitis project of the European Institute of and Technology Health; Structural and Development Funds Roussillon and Provence-Alpes-Côte d’Azur; European Innovation Partnership on Active and Healthy Santé and DG Connect; H2020 and Horizon Europe) and grants from Mylan-Viatris Allergologisk Laboratorium GlaxoSmithKline Novartis Stallergenes and Uriach.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1016/s2589-7500(23)00027-4",TRUE,"<section> Declaration of interests YT has received consultancy fees from and has a royalty agreement with Indica Labs. All other authors declare no competing interests.",TRUE,"<section> Funding North Rhine-Westphalia state Federal Ministry of Education <section> Acknowledgments This study was funded by the North Rhine-Westphalia Government (via the European Regional Development Fund 2014-2020 REACT-EU and DIGI-PATH) the Federal Ministry of Education and Research of Germany (FED-PATH) and the Wilhelm Sander Foundation (grant 2022.040.1). We thank the Regional Computing Center of the University of Cologne for providing computing time and support on the German Research Societyfunded (INST 216/512/1FUGG) highperformance computing system CHEOPS.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2589-7500(23)00109-7",TRUE,"<section> All other authors declare no competing interests.",TRUE,"<section> Funding National Multiple Sclerosis Society (USA). JMB has served on the Novartis unbranded speakers’ bureau and has received grant support from Genzyme. <section> Acknowledgments This investigation was supported by a research grant (RG-15070–5418) from the NMSS. RM-M is in part funded by the UK Department of Health via the National Institute for Health Research Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation and the Institute of Psychiatry at King’s College London London UK. We also greatly appreciate the administrative support of the NeuroCure Clinical Research Center Charité–Universitätsmedizin Berlin Berlin Germany.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2589-7500(23)00156-5",TRUE,"<section> Declaration of interests AK declares funding from the Innovative Medicines Initiative 2 Joint Milieu records Undertaking under grant agreement number 820820. <section> EP 16174268.9 (gait assessment) with Portabiles HealthCare All other authors declare no competing interests.",TRUE,"<section> Declaration of interests AK declares funding from the Innovative Medicines Initiative 2 Joint Milieu records Undertaking under grant agreement number 820820. RR and AZ acknowledge funding provided by Ministry for Economic Affairs and Climate Action under 68GX21004F (TEAM-X). RE and HW acknowledge funding provided Ministry for Economic Affairs and Climate Action of Germany number 68GX21001A (HEALTH-X). This work was supported by the Mobilise-D project funding from the Innovative Medicines Initiative (IMI) under grant agreement number 820820.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2665-9913(23)00098-x",TRUE,"<section> Declaration of interests B Antony reports grants or contacts from Royal Hobart Hospital Foundation as an Investigator who initiated clinical trial funding to institute; Speaker fee paid as travel fee from IRACON 2022; all outside the submitted work. T W Bärnighausen reports research grants from the European Union (Horizon 2020 and EIT Health) German Research Foundation (DFG) US National Institutes of Health German Ministry of Education and Research Alexander von Humboldt Foundation Else-Kröner-Fresenius-Foundation Wellcome Trust Bill & Melinda Gates Foundation KfW UNAIDS WHO; consulting fees from KfW on the OSCAR Initiative in Vietnam; participation on the following data safety monitor boards and advisory boards: NIH-funded study “Healthy Options” (PIs: Smith Fawzi Kaaya) Chair Data Safety and Monitoring Board (DSMB) German National Committee on the “Future of Public Health Research and Education” Chair of the scientific advisory board to the EDCTP Evaluation Member of the UNAIDS Evaluation Expert Advisory Committee National Institutes of Health Study Section Member on Population and Public Health Approaches to HIV/AIDS (PPAH) US National Academies of Sciences Engineering and Medicine’s Committee for the “Evaluation of Human Resources for Health in the Republic of Rwanda under the President’s Emergency Plan for AIDS Relief (PEPFAR)” University of Pennsylvania (UPenn) Population Aging Research Center (PARC) External Advisory Board Member; and is co-chair of the Global Health HUB Germany; all outside the submitted work. A M Briggs reports grants or contracts from Bone and Join Decade Foundation AO Alliance Canadian Memorial Chiropractic College Australian Rheumatology Association Pan-American League of Associations for Rheumatology World Federation of Chiropractic Asia Pacific League of Associations for Rheumatology paid to their institution; consulting fees from WHO; payment for honoraria for lectures presentations speakers bureaus manuscript writing or educational events from the American College of Rheumatology; support for attending meetings and/or travel from WHO; all outside the submitted work. I Filip and A Radfar report financial support from the Avicenna Medical and Clinical Research Institute; outside the submitted work. R C Franklin reports grants or contracts from Heatwaves in Queensland – Queensland Government Arc Flash – Human Factors – Queensland Government and Agricultural Machinery Safety – Agrifutures; honoraria from World Safety Conference 2022 – Conference Convener; support for attending meetings and/or travel from ACTM – Tropical Medicine and Travel Medicine Conference 2022; Leadership or fiduciary role in other board society committee or advocacy group paid or unpaid with President – Kidsafe Director – Farmsafe Director – Auschem PHAA Injury Prevention SIG Convenor and ISASH – Governance Committee; all outside the submitted work. A-F A Mentis reports grants or contracts from MilkSafe (A novel pipeline to enrich formula milk using omics technologies) a research co-financed by the European Regional Development Fund of the EU and Greek national funds through the Operational Program Competitiveness Entrepreneurship and Innovation under the call RESEARCH CREATE INNOVATE (project code: T2EDK-02222) as well as from ELIDEK (Hellenic Foundation for Research and Innovation MIMS-860); payment as an external peerreviewer for Donazione Cariplo Italy; serves as an editorial board member for “Systematic Reviews” journal and “Annals of Epidemiology” and is an associate editor for “Translational Psychiatry”; stocks in a family winery; other financial or non-financial support from the BGI group as a scientific officer. J A Singh reports consulting fees from Crealta/Horizon Medisys Fidia PK Med Two Labs Inc. Adept Field Solutions Clinical Care Options Clearview Healthcare Partners Putnam Associates Focus Forward Navigant Consulting Spherix MedIQ Jupiter Life Science UBM Trio Health Medscape WebMD and Practice Point Communications the National Institutes of Health and the American College of Rheumatology; payment or honoraria for speakers’ bureaus from Simply Speaking; support for attending meetings or travel from the steering committee of OMERACT; participation on a Data Safety Monitoring Board or Advisory Board with the US Food and Drug Administration Arthritis Advisory Committee; leadership or fiduciary role in board society committee or advocacy group paid or unpaid with OMERACT as a steering committee member with the Veterans Affairs Rheumatology Field Advisory Committee as Chair (unpaid) and with the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis and editor and director (unpaid); stock or stock options in TPT Global Tech Vaxart Pharmaceuticals Aytu BioPharma Adaptimmune Therapeutics GeoVax Labs Pieris Pharmaceuticals Enzolytics Seres Therapeutics Tonix Pharmaceuticals and Charlotte’s Web Holdings and previously owned stock options in Amarin Viking and Moderna Pharmaceuticals; all outside the submitted work. H Slater reports grants from the Department of Health Australian Government Medical Research Future Fund Department of Health Western Australian Government Bone and Join Decade Foundation of Sweden Curtin University Institute for Bone and Joint Research of Australia Canadian Memorial Chiropractic College paid directly to their institution; and support for attending meetings/ travel from the Australian Pain Society; all outside the submitted work. <section> M Solmi reports payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Angelini Lundbeck and Otsuka; all outside the submitted work. <section> All other authors declare no competing interests.",TRUE,"<section> Funding Bill and Melinda Gates Foundation. <section> Declaration of interests B Antony reports grants or contacts from Royal Hobart Hospital Foundation as an Investigator who initiated clinical trial funding to institute; Speaker fee paid as travel fee from IRACON 2022; all outside the submitted work. I Filip and A Radfar report financial support from the Avicenna Medical and Clinical Research Institute; outside the submitted work. The findings of this study are supported by data available in public online repositories data publicly available upon request of the data provider and data not publicly available due to restrictions by the data provider. <section> Acknowledgments T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award funded by the German Federal Ministry of Education and Research. <section> R Buchbinder is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Fellowship. S M S Islam is funded by the National Health and Medical Research Council of Australia (NHMRC) and has received funding from the National Heart Foundation of Australia. J Khubchandani has received funding from TEVA Pharmaceuticals for Migraine related research. Y J Kim was supported by Research Management Centre Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). T Lallukka is supported by the Academy of Finland (Grant #330527) and the Social Insurance Institution of Finland (grant 29/26/2020). L Monasta was supported by the Italian Ministry of Health through a contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy. P Pedersini was supported and funded by the Italian Ministry of Health Ricerca Corrente 2021. S Sharma is supported by the International Association for the Study of Pain John J Monica Postdoctoral Fellowship. A Singh is supported by International Graduate Research Scholarship University of Tasmania.",FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2665-9913(23)00163-7",TRUE,"<section> Declaration of interests BA reports an investigator-initiated trial grant from Rebecca Cooper Foundation and an investigator-initiated trial biomarkers assessment support grant from Nat Rem and payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Nat Rem and IRACON all outside the submitted work. <section> AMB reports grants or contracts paid to his institution from the Bone and Joint Decade Foundation AO Alliance Canadian Memorial Chiropractic College Australian Rheumatology Association Pan-American League of Associations for Rheumatology World Federation of Chiropractic and Asia Pacific League of Associations for Rheumatology consulting fees from WHO payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from the American College of Rheumatology and support for attending meetings and travel from WHO all outside the submitted work. IF and AR report payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Avicenna Medical and Clinical Research Institute to provide critical feedback and comments on important intellectual content on Global Burden of Disease manuscripts before publication. <section> A-FAM reports grants or contracts for MilkSafe a novel pipeline to enrich formula milk using omics technologies research cofinanced by the European Regional Development Fund of the EU and Greek national funds through the Operational Program Competitiveness Entrepreneurship and Innovation under the call Research Create Innovate (project code T2EDK-02222) and from ELIDEK (Hellenic Foundation for Research and Innovation MIMS-860) payment for expert testimony from Fondazione Cariplo Italy for having served as an external peer reviewer; leadership or fiduciary roles in board society committee or advocacy groups paid or unpaid with Sytematic Reviews and Annals of Epidemiology as an Editorial Board Members and with Translational Psychiatry as an Associate Editor stock or stock options in a family winder and other financial or non-financial support from BGI Group for serving as a scientific officer all outside the submitted work. <section> JAS reports consulting fees from Crealta-Horizon Medisys Fidia PK Med Two labs Adept Field Solutions Clinical Care options Clearview Healthcare Partners Putnam associates Focus Forward Navigant consulting Spherix MedIQ Jupiter Life Science UBM LLC Trio Health Medscape WebMD and Practice Point Communications and the National Institutes of Health and the American College of Rheumatology payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from the speaker’s bureau of Simply Speaking support for attending meetings and travel from the steering committee of OMERACT participation on a Data Safety Monitoring Board or Advisory Board as a member of the FDA Arthritis Advisory Committee leadership or fiduciary roles in board society committee or advocacy groups paid or unpaid as a steering committee member of the OMERACT with the Veteran Affairs Rheumatology Field Advisory Committee as a Chair and with the UAB Cochrane Musculoskeletal Group Satellite Center on Network Metaanalysis as an Editor stock or stock options in Atai Life Sciences Kintara Therapeutics Intelligent Biosolutions Acumen pharmaceutical TPT Global Tech Vaxart Pharmaceuticals Atyu Biopharma Adaptimmune Therapeutics GeoVax Labs Pieris Pharmaceuticals Enzolytics Seres Therapeutics Tonix Pharmaceuticals Holding Corp. and Charlotte’s Web Holdings and previously owned stock options in Amarin Viking and Moderna Pharmaceuticals all outside the submitted work. STS reports grants or contracts from the European Research Council paid to the university from the EU Horizon 2020 research innovation program (grant agreement 801790) the EU Horizon 2020 research innovation program paid to the hospital (grant agreement 945377) Region Zealand paid to the hospital as a program grant from Region Zealand (Exercise First) royalties from Munksgaard for book chapters and TrustMe-Ed for an online lecture an honorarium from Nestlé Health Science for a webinar presentation on osteoarthritis and other financial or non-financial interests as co-founder of GLA:D a notfor profit initiative hosted at University of Southern Denmark aimed at implementing clinical guidelines for osteoarthritis in clinical practice all outside the submitted work. HS reports grants or contracts paid to her institution from the Australian Government (Department of Health Grant) Medical Research Future Fund Western Australian Government Department of Health Bone and Joint Decade Foundation (Sweden) Curtin University (Australia) Institute for Bone and Joint Research (Australia) Canadian Memorial Chiropractic College (Canada) and support for attending meetings and travel from the Australian Pain Society all outside the submitted work. All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation Institute of Bone and <section> Declaration of interests BA reports an investigatorinitiated trial grant from Rebecca Cooper Foundation and an investigatorinitiated trial biomarkers assessment support grant from Nat Rem and payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Nat Rem and IRACON all outside the submitted work. The findings of this study are supported by data available in public online repositories data publicly available upon request of the data provider and data not publicly available due to restrictions by the data provider. IMI acknowledges project number 175042 supported by the Ministry of Education Science and Technological Development Republic of Serbia 2011–23. <section> Council for Scientific and Technological Development Brazil as Turkiewicz grantee of the Research Productivity Scholarship Level 1D (Medicine). impact acknowledges support and funding by the Italian Ministry of Health with Corrente 2023.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2665-9913(23)00211-4",TRUE,"<section> Declaration of interests B Antony reports grants or contracts from Rebecca Cooper Foundation and a Nat Rem grant for an investigator-initiated trial biomarkers assessment support; payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Nat Rem through a speaker fee and IRACON through travel support; all outside the submitted work. All other authors declare no competing interests.",TRUE,"<section> Funding Bill & Melinda Gates Foundation Institute of Bone and Additionally underresourced populations from highincome countries might also be underreported as many migrant workers in these countries might not have access to health insurance or healthcare services. <section> Declaration of interests B Antony reports grants or contracts from Rebecca Cooper Foundation and a Nat Rem grant for an investigatorinitiated trial biomarkers assessment support; payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Nat Rem through a speaker fee and IRACON through travel support; all outside the submitted work. <section> The findings of this study are supported by data available in public online repositories data publicly available upon request of the data provider and data not publicly available due to restrictions by the data provider. <section> Acknowledgments A Badawi is supported by the Public Health Agency of Canada. A Bhat J R Padubidri and A Shetty acknowledge support from Kasturba Medical College Mangalore Manipal Academy of Higher Education. R Buchbinder is supported by an NHMRC Investigator Fellowship. I Filip and A Radfar acknowledge support from Avicenna Medical and Clinical Research Institute. I M Ilic is supported by Ministry of Education Science and Technological development Republic of Serbia 2011–2023. S M S Islam is funded by the NHMRC Emerging Leadership Fellowship and has received grants from the National Heart Foundation of Australia. I Qattea acknowledge support from Aletaha University Medical Center and Cleveland Clinic Foundation. classification M M Redwan acknowledges support from King Abdulaziz University European and King Abdulaziz City for Science & Technology Saudi Arabia Arthritis & Technology Development Fund and US-Egypt Vos T & Technology joint Fund and The Academy of Scientific injuries & Technology Egypt. A Riad was supported by the NPO analysis Risk Institute” funded by European Union Next Generation 396: (Ministry of Education Youth and Sports NPO: EXCELES). A Singh is supported by International 195 countries Research Scholarship University of Tasmania.",FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1016/s2665-9913(23)00232-1",FALSE,"",TRUE,"<section> Funding Bill & Melinda Gates Foundation. <section> of this study are supported by data available in public data publicly available upon request to the data data not publicly available owing to restrictions by the data available data were used under license for the but may be available from the authors upon reasonable with permission of the data provider.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1017/cts.2023.590",TRUE,"Competing interests. The authors have no conflicts of interest to declare.",TRUE,"Bundesministerium für Gesundheit (the German Federal Ministry of Health) was removed because even though it had funded at least one COVID-19 trial in the early stages of the pandemic it does not routinely directly fund clinical trials. <section> Funding statement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/gmh.2023.17",TRUE,"Competing interest. The authors declare that they have no competing interests.",TRUE,"<section> Financial support. Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under award number P30AG024409.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/ice.2022.285",TRUE,"Conflicts of interest. All authors report no conflicts of interest relevant to this article.",TRUE,"<section> Financial support. This study was part of the European R-GNOSIS ‘Resistance in Gram-Negative Organisms: Studying Intervention Strategies’ collaborative research project funded by the European Commission under the Seventh Framework Programme (no. FP7/2007) for Research and Technology (grant no. <section> 282512).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"10 The original study was registered (no. ISRCTN57648070).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1017/mdh.2023.27",TRUE,"Competing interest. The authors declare that no competing interests exist.",TRUE,"<section> Funding. Ludger Wimmelbücker’s research was supported by the German Research Foundation (DFG) project no. 251152024.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/neu.2023.29",TRUE,"Competing interests. There were no conflicts of interest.",TRUE,"<section> Financial support. This study was funded by a grant from Grand Challenges",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1017/psa.2023.167",FALSE,"",TRUE,"Adrian Kind’s work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) –",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s0033291721003378",TRUE,"Conflict of interest. Dr Banaschewski served in an advisory or consultancy role for Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Shire.",TRUE,"<section> Financial support. Dr Conrod is supported by a Tier 1 Canada Research Chair and this research was supported by a CIHR catalyst grant FRN155406 and the Canadian Cannabis and Psychosis Research Team Grant (CIHR FRN CA7170130) and National Institute on Drug Abuse Grant/Award Numbeer: 1R01DA047119-01. This study received support from the following sources: the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated behaviour in normal brain function and psychopathology) (LSHM-CT2007-037286) the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain networkbased stratification of reinforcementrelated disorders) (695313) ERANID (Understanding the Interplay between Cultural Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004) BRIDGET (JPND: BRain Imaging cognition Dementia and next generation GEnomics) (MR/N027558/1) Human Brain Project (HBP SGA 2 785907) the FP7 project MATRICS (603016) the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalising Disorders and Addictions) (MR/ N000390/1) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A 01EE1406B) the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 SFB 940/2) the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1) the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01). <section> AF12-NEUR0008-01 – WM2NA and ANR-12-SAMA-0004) the Eranet Neuron (ANR-18-NEUR00002-01) the Fondation de France (00081242) the Fondation pour la Recherche Médicale (DPA20140629802) the Mission Interministérielle de Luttecontre-les-Drogueset-les-Conduites-Addictives (MILDECA) the Assistance-Publique-Hôpitauxde-Paris and INSERM (interface grant) Paris Sud University IDEX 2012 the fondation de l’Avenir (grant AP-RM-17-013); the National Institutes of Health Science Foundation Ireland (16/ERCD/3797) USA (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. Funding for the Utrecht cannabis cohort was provided by NWO the Dutch council for scientific research (ZonMW TOP grant no. 91207039).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s0033291723000697",TRUE,"Conflict of interest. On behalf of all authors there are no conflicts of interests",TRUE,"<section> Financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1017/s0033291723001319",TRUE,"Conflict of interest. K. Leopold has been a consultant and/or advisor to or has received honoraria from: Janssen/J&J Lundbeck Otsuka Recordati and ROVI. She has received grant support from Janssen/J&J and Otsuka. All other authors declared no conflict of interest.",TRUE,"<section> Financial support. Early-BipoLife is funded by the Federal Ministry of M. M. was supported by the Deutsche Forschungsgemeinschaft (DFG grant Nos. She has received grant support from Janssen/J&J and Otsuka.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s0033291723003045",TRUE,"Competing interest. None.",TRUE,"<section> Marburg: This work was funded by the German Research Foundation (DFG grant FOR2107 KI588/14-1 and FOR2107 KI588/14-2 to Tilo <section> Muenster: This work was funded by the German Research Foundation (DFG grant FOR2107 DA1151/5-1 and DA1151/5-2 to Udo Dannlowski; SFB-TRR58 Projects C09 and Z02 to Udo Dannlowski) and the Interdisciplinary Centre for Clinical Research (IZKF) of the medical faculty of Münster (grant Dan3/012/17 to Udo Dannlowski). <section> IGP: The Imaging Genetics in Psychosis (IGP) study was funded by Project Grants from the Australian National Health and Medical Research council (NHMRC; #630471 and #1081603) awarded to Melissa J. <section> Zurich: This study was financially supported by the Donald C. <section> Paris: This study was supported by the French ANR ‘Agence Nationale pour la Recherche’ (ANR MNP VIP and Labex BioPsy). <section> London: This work was supported by a Brain and Behavior Research Foundation NARSAD Young Investigator Grant (#21200 Lieber Investigator) and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (#202397/Z/16/Z) both awarded to Gemma Modinos. <section> Roehampton: This work was supported by a British Academy grant awarded to Dr James Gilleen (#SG150457). <section> Funding statement. Tim Hahn was funded by the German Research Foundation (DFG grants HA7070/2-2 HA7070/3 HA7070/4). Emiliana Tonini was supported by the Australian Government Research Training Program (RTP) Scholarship (administered by UNSW Sydney) and a supplementary scholarship administered by Neuroscience Research Australia (NeuRA).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s0033291723003094",TRUE,"Competing interests. CK is a trained behavioral therapist and state-licensed supervisor for psychotherapy. TB is a candidate applicant for behavioral therapy. FB and DE declare no conflicts of interests.",TRUE,"<section> Funding statement. This research was partly funded by the German Federal Ministry for Economic Affairs and Climate Action (FB DE: project AIR_PTE; funding code 01MJ 20 001B).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s0950268823000031",TRUE,"Conflict of interest. The authors declare that they have no competing interests.",TRUE,"The authors would also like to acknowledge the networking support from COST Action CA18218 (European Burden of Disease Network; www. <section> burdeneu.net) supported by COST (European Cooperation in Science and Technology; www.cost.eu). <section> Financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"A protocol was registered on PROSPERO under ID CRD42020177477.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1017/s0954579421000572",TRUE,"Conflicts of Interest. None.",TRUE,"<section> Funding Statement. Funding for this study was provided by the Volkswagen Foundation (Schumpeter Fellowship II/84 452). S.G. was supported by a NeuroCure PhD Fellowship (Deutsche Forschungsgemeinschaft EXC257).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s1047951123000872",TRUE,"Conflicts of interest. None.",TRUE,"<section> Financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1017/s2045796023000574",TRUE,"Competing interests. We declare no competing interests.",TRUE,"<section> Financial support. This research was supported by a grant of the R&D project funded by the National Center for Mental Health (grant number: MHER22A01).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.analchem.2c05141",TRUE,"<section> The authors declare the following competing financial interest(s): YH WB RH and RV are employees of Thermo Fisher Scientific.",TRUE,"<section> The work was supported by the European Research Council (ERC) Starting grant (ERC-STG no. 949184) and the Leibniz− Forschungsinstitut fü r Molekulare Pharmakologie (FMP).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.analchem.3c00842",TRUE,"<section> The authors declare the following competing financial interest(s): B.C.S. is a founder and shareholder in Proteome Software which operates in the field of proteomics.",TRUE,"<section> Funding <section> This work was supported in part by the Pelotonia Institute for Mass spectrometry analysis at the DTU proteomics core was funded by a grant from the Novo Nordisk Foundation to E.M.S. with reference number NNF21OC0071016. Work at CPR was funded in part by a grant from the Novo Nordisk Foundation (NNF14CC0001).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.analchem.3c01673",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany′s Excellence Strategy − EXC 2008 − 390540038 − UniSysCat and project 449713269. The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (Grant number 203149).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.analchem.3c02924",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> All authors; Funding acquisition: R.G. J.D.M. <section> The authors would like to acknowledge the following funding sources: C.D.B. is a member of the CSU Analytical Resources Core (RRID: SCR_021758) with funding from NIH 5U01CA235507-03; LLC NIH R01AG070257 R01CA273010; LM; J.A.K. was supported by the Bundesministerium fuer Bildung und Forschung funding MSTARS 031L0220A; JK Carlos III Health Institute (Spain) grant number: CPII21/00003; R.G. and W.B.D. thank the UK MRC for support (MR/S010483/1); M.E.M. acknowledges CONI- M.E.M. is a research staff member from CONICET; R.C. acknowledges that “this project received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No (798038)” and support from ISCIII DTS21/00113 AEI PID2021126543OB-C22 and RTI2018-098577-B-C21 AGAUR 2021LLAV00050 2021XARDI00021 2021XARDI00008 2018XARDI00016 and 100036ID6 and FCRI 415; S.D.S.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.biomac.3c00602",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> We acknowledge the financial support from the Federal Ministry of Research and Education (BMBF FKZ 13N13523 M.W.) and the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) for SFB 1449 (Project ID 431232613 M.W. K.P. B.K.) and the Cluster of Excellence Matters of Activity Image Space Material (M.W. I.M.S.) under Germany′s Excellence Strategy − EXC 2025.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.inorgchem.3c01638",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> We gratefully acknowledge financial support from the DFG (Deutsche Forschungsgemeinschaft: Graduate School BIOQIC). Structural and Redox Variations in Technetium Complexes Supported by mTerphenyl Isocyanides.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jmedchem.2c01689",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> Funding <section> This work was funded by an IPODI fellowship to A.M.P.-L. <section> The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (Grant 203149).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1021/acs.jmedchem.2c01817",TRUE,"<section> The authors declare the following competing financial interest(s): K.A.D is a consultant to Kronos Bio and Neomorph Inc. All other authors declare no competing financial interest.",TRUE,"<section> Funding <section> We acknowledge the support by the Slovenian Research Agency (ARRS) (Program P1-0208 and grant J1-2485 to I.S.) and the DFG (Emmy-Noether Program Kr-3886/2-1 and SFB- We also thank Eric Fischer and the Fischer Lab Degradation Proteomics Initiative for the collection of the global proteomics data supported by NIH CA214608 and CA218278.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1021/acs.jmedchem.3c00851",TRUE,"<section> The authors declare the following competing financial interest(s): Metabolic stability analyses in human liver microsomes were performed by Pharmacelsus (Saarbrucken Germany).",TRUE,"; Funding Acquisition: C.S. F.K.H. M.G. I.S. J.Krö nke M.D.H. <section> Funding <section> Open access funded by Max Planck Society. C.S. received financial support from the Fonds der Chemischen Industrie (FCI).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jmedchem.3c01319",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> Furthermore we acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant 620046-NA1274/1-1 and by the European Union’s Horizon 2020 Research and Innovation programme under the Marie-Skłodowska-Curie grant agreement no. 956314 (AL-",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jmedchem.3c01454",TRUE,"<section> The authors declare the following competing financial interest(s): E.S. S.M. A.S. K.M. M.N. and M.B. are coinventors on a patent application filed by the Max-DelbruckCenter for Molecular Medicine in the Helmholtz Association and the Leibniz-Forschungsinstitut fur Molekulare Pharmakologie.",TRUE,"<section> Funding <section> The study was funded by the VIP (03 V0276) VIP+ (03VP08051) and Targetvalidation (16GW0298) programs of the German Federal Ministry for Education and Research (BMBF) and the ZIM program of the German Federal Ministry for Economics and Climate Action (BMWK) (16KN073251). In addition the study was funded by the internal SPOT (Spinoff Support) program of Max-Delbrü ckCenter for Molecular Medicine in the Helmholtz Association (MDC). The Protein Production and Characterization Technology Platform at the Max Delbrü ck Center is funded by the Helmholtz Association of German Research Centers.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jnatprod.3c00107",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> This research project is supported by Second Century Fund (C2F) Chulalongkorn University to V.K. P.P. and B.S. and funded by Thailand Science Research and Innovation Fund Chulalongkorn University (CU_FRB65_hea (57) 066_33_10).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jpcb.3c06662",TRUE,"<section> The authors declare the following competing financial interest(s): J.D.C. is a current member of the Scientific Advisory Board of OpenEye Scientific Software Redesign Science Ventus Therapeutics and Interline Therapeutics and has equity interests in Interline Therapeutics.",TRUE,"The Chodera laboratory receives or has received funding from multiple sources including the National Institutes of Health the National Science Foundation the Parker Institute for Cancer Immunotherapy Relay Therapeutics Entasis Therapeutics Silicon Therapeutics EMD Serono (Merck KGaA) AstraZeneca Vir Biotechnology Bayer XtalPi Interline Therapeutics the Molecular Sciences Software Institute the Starr Cancer Consortium the Open Force Field Consortium Cycle for Survival a Louis V. <section> Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number GM140090 (P.E. T.E.M. J.D.C. G.D.F.). S.F. and J.M. acknowledge support from the Engineering and Physical Sciences Research Council under grant award EP/W030276/1.",FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jpclett.2c03110",TRUE,"The authors declare no competing financial interest.",TRUE,"Y.H. and J.T.M.K. were supported by the Chemical Sciences Council of The Netherlands Organization for Scientific Research (NWO−CW) through a VICI grant and a Middelgroot investment grant to J.T.M.K.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jproteome.2c00424",TRUE,"The authors declare no competing financial interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.jproteome.3c00596",TRUE,"The authors declare no competing financial interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acs.nanolett.3c00408",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> The authors acknowledge financial support by the Collaborative Research Center 765 and 1449 of the Deutsche Forschungsgemeinschaft (DFG) and Berlin University Alliance (BUA).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsabm.3c00024",TRUE,"<section> The authors declare no competing financial interest. <section> ■ <section> ACKNOWLEDGMENTS <section> This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG: H.D.: DO 1375/21; K.D.: DA 310/8-1; R.H.: HA 2549/22-1). The authors kindly thank Dr. Heiko Ziervogel (Medizin im Grü nen Wendisch Rietz Germany) for providing native porcine mucosal tissue samples. Further we would like to kindly thank Nicole Krohn Marion von Zitzewitz and Barbara Brecht-Jachan for excellent technical assistance and Dr. <section> Keerthana Rajes for helpful notes and suggestions on the manuscript. The authors declare no conflict of interest.",TRUE,"<section> This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG: H.D.: DO 1375/21; K.D.: DA 310/8-1; R.H.: HA 2549/22-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsabm.3c00392",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> This work was supported by the Science Research Promotion Fund from Promotion and Mutual Aid Corporation for Private Schools of Japan a Joint Research Grant from the Institute of Science and Engineering Chuo University and a Grant from Deutsche Forschungsgemeinschaft (DFG; BA 1545/8-1).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsami.3c01481",TRUE,"The authors declare no competing financial interest.",TRUE,"XX WW JZ KK NM AL Conceptualization and study design; AL NM Funding acquisition; XX WW JZ ZD KK Investigation; Formal analysis; XX WW JZ KK NM AL Methodology; NM AL Supervision; XX WW JZ NM Writing−original draft ; XX WW JZ NM AL Writing−review and editing. This work was financially supported by the Helmholtz Association of German Research Centers through programoriented funding Helmholtz Cross Program Initiative “Technology and Medicine Adaptive Systems” Helmholtz Virtual Institute Multifunctional Biomaterials for Medicine (grant no. VH-VI-423) and I B Funds (Project: highresolution imaging and computational analysis to study the dynamics of stem cellbiomaterial interaction) as well as by the Federal Ministry of Education and Research Germany for funding through the Program Health Research (grant no. 13GW0098 as well as project number 0315696A “Poly4BioBB”).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsanm.3c03625",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsanm.3c04272",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> Funding <section> Funding to S.M. and P.B.S. was provided by the German Federal Ministry of Education and Research (BMBF) under the ERA-NET NEURON scheme (01EW2305) and the German Research Foundation (DFG Project BO 4484/2-1 and EXC-2049-390688087 NeuroCure).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acschemneuro.2c00558",TRUE,"The authors declare no competing financial interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsmacrolett.3c00173",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> The project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsnano.3c02847",TRUE,"<section> The authors declare the following competing financial interest(s): G.M. is founder director and shareholder in Portal Biotech Limited a nanopore engineering company.",TRUE,"This work was not supported by Portal Biotech Limited. This project was financially sponsored by VICI (no. 192068) and",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/acsnano.3c08644",TRUE,"<section> The authors declare the following competing financial interest(s): KA DW JK are employees of NanoVation Therapeutics. PRC has a financial interest in Acuitas Therapeutics and NanoVation Therapeutics as well as being Chair of NanoVation Therapeutics. EJ is a co-founder of NanoVation.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Financial support of the Canadian Institute of Health Research (CIHR PJT-166035; S.H. J.B. F.M. and D.L.) the Faculty of Pharmaceutical Sciences at the University of British Columbia (S.H.) the Nanomedicines Innovation Network (NMIN; D.W. J.K. J.L. P.C. and S.H.) the LEO Foundation (LFOC-22-000954 S.H. D.B. A.N. G.S.) and the Foundation Charité (S.H.) is greatly acknowledged. Further D.W. was supported by the Swiss National Science Foundation (#183923).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1021/jacsau.2c00664",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> R.P.d.V. is a recipient of an ERC Starting grant from the European Commission (802780) and a Beijerinck Premium of the Royal Dutch Academy of Sciences.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1021/jacsau.3c00199",TRUE,"The authors declare no competing financial interest.",TRUE,"<section> This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany′s Excellence Strategy−EXC 2008−390540038−UniSysCat and projects 426290502 and 449713269. The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust [203149] and Royal Society (Sir Henry Dale Fellowship to T.L. 206211/A/17/Z).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1024/0301-1526/a001057",TRUE,"Conflict of Interest The authors declare no conflict related to the current study.",TRUE,"<section> Acknowledgment The authors appreciate the support of the German Society for Vascular Surgery and Vascular Medicine (DGG) and the Scientific Committee for Peripheral Arterial Disease and Diabetic Foot Syndrome. <section> Funding <section> This work was supported by the German Federal Joint Committee (grant number 01VSF18035 to CAB).",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1024/0939-5911/a000832",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1024/0939-5911/a000833",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1024/1016-264x/a000374",TRUE,"Conflict of Interest The authors AKS DS LK KK AR YG DM LS FS CF SJ and FM have no relevant financial or nonfinancial interests to disclose.",TRUE,"<section> Funding <section> The research leading to these results received funding from the German Research Foundation under grant nos.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1026/0942-5403/a000431",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1027/1015-5759/a000781",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1037/pas0001181",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1037/pas0001199",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1037/tra0001516",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s12276-023-00963-9",TRUE,"The authors declare no competing interests.",TRUE,"This research was funded by the SFB-TR/19 the CRC1470 a DZHK TRG grant (to M.G.) and DFG research grants (to M.G. and R.F.). <section> FUNDING",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41366-023-01271-y",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> This study was supported in part by grants from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V. 01GI0925) AM is currently funded by a clinician scientist program from the medical faculty of the University of Tübingen. The study was supported by the German Diabetes Society (Allgemeine Projektförderung 2015 OPR) by the German Center for Diabetes Research (DZD grant 82DZD0019G OPR) and by the Morgagni Prize of the European Association for the Study of Diabetes 2020 (OPR).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered at Clinicaltrials.gov as trial number NCT03151590.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41371-022-00793-8",TRUE,"<section> COMPETING INTERESTS RK reports support for research by Bayer honoraria for lectures or consultancy from Bayer Berlin-Chemie/Menarini Daiichi Sankyo Ferrer Merck Sanoﬁ and Servier outside this work. CT reports honoraria for lectures or consultancy fees from Menarini Berlin-Chemie and Medtronic all outside this work. The remaining author declares no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41371-023-00826-w",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> This paper is based upon work from the European COST ACTION-Network for Research in Vascular Ageing CA18216 supported by COST (European Cooperation in Science and Technology) and endorsed by the German Society of Gender Medicine (DGesGM). AG has received funding from Spanish Ministry of Science Innovation and Universities (IJC2018-037349-I) and from “la Caixa” Foundation (LCF/BQ/PR22/ 11920008).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01824-0",TRUE,"<section> COMPETING INTERESTS LR has participated in scientiﬁc advisory boards for Janssen Celgene/Bristol-Myers Squibb GlaxoSmithKline Pﬁzer and Sanoﬁ has received research support from Skyline Dx and has received honoraria from Janssen Celgene/Bristol-Myers Squibb Amgen Pﬁzer and Sanoﬁ. HE has participated in scientiﬁc advisory boards for Janssen Celgene/Bristol-Myers Squibb Amgen Novartis and Takeda has received research support from Janssen Celgene/Bristol-Myers Squibb Amgen and Novartis and has received honoraria from Janssen Celgene/Bristol-Myers Squibb Amgen Novartis and Takeda. The other authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41375-023-01829-9",TRUE,"<section> COMPETING INTERESTS The authors declare the following potential conﬂicts of interest: AH received institutional research support from Novartis Bristol Myers Squibb Incyte and Pﬁzer and personal fees from Novartis and Incyte. AT declares no competing ﬁnancial interests.",TRUE,"<section> ACKNOWLEDGEMENTS This study was sponsored and funded by Novartis Pharmaceuticals Corporation. <section> FUNDING CB received grants from Novartis during the conduct of the study. EL received grants from Novartis and personal fees and non-ﬁnancial support from Novartis Pﬁzer and Bristol Myers Squibb. D-WK received grants from Novartis Bristol Myers Squibb Pﬁzer ILYANG and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01832-0",TRUE,"The authors declare no competing interests.",TRUE,"This work was supported by grants of the German Cancer Aid (Deutsche Krebshilfe 70112607) by the Thuringian state program ProExzellenz (RegenerAging–FSU-I-03/14) of the Thuringian Ministry for Research and by a Research Fellowship grant of the European Hematology Association (EHA) to FHH. The work was further supported through NHMRC Project Grant 1098470 and NHMRC investigator grant 1195987 awarded to SWL.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01860-w",TRUE,"<section> COMPETING INTERESTS MJM: Bristol Myers Squibb Takeda and Pﬁzer: personal fees.",TRUE,"Financial support for medical editorial assistance was provided by Novartis. MCH received partial salary support from the following sources: a research grant from the Jonathan David Foundation a VA Merit Review Grant (I01BX005358) and an NCI R21 grant (R21CA263400). <section> FUNDING <section> This study was sponsored and funded by Novartis Pharmaceuticals.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01877-1",TRUE,"The authors declare no competing interests.",TRUE,"RM was supported by grants from the DFG (Ma 1876/12–1) and Wilhelm Sander foundation (2018.070.2). JT and JZ are supported by grant LX22NPO5102 from the Next Generation EU NICR. <section> FUNDING",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01895-z",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> This work has been funded in part by DFG grant MA 1876/12-1 and Wilhelm Sander foundation grant 2020.070 to RM and in part by ERA-NET TRANSCAN EJC Foundation ARC France to HC.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01936-7",TRUE,"<section> COMPETING INTERESTS <section> EMO: Honoraria – Amgen BMS/Celgene GSK Janssen MSD Oncopeptides Sanoﬁ Takeda.",TRUE,"<section> FUNDING <section> This study was sponsored by Sanoﬁ.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-01999-6",TRUE,"<section> COMPETING INTERESTS EJ: Employment with AstraZeneca; MS MG PL AR CP NJ CW KH NS JK AB SN have nothing to disclose; PF: Honoraria from BMS Novartis Jazz Abbvie Agios Servier Research support (as Groupe Francophone des Myélodysplasies chairperson) BMS Novartis Jazz Abbvie Agios Servier GJR: Consultancy: Abbvie Amgen Argenx AstraZeneca Bluebird Bio Blueprint Medicines Bristol-Myers Squibb Caribou Biosciences Celgene Daiichi Sankyo Ellipses Pharma GlaxoSmithKline Janssen Jasper Pharmaceuticals Jazz Pharmaceuticals Molecular Partners Novartis Pﬁzer Roche Syndax Takeda (IRC Chair); LB advisory role or expert testimony – Abbvie Bristol-Myers Squibb Celgene Daiichi Sankyo Gilead Hexal Janssen Jazz Pharmaceuticals Menarini Novartis Pﬁzer; Honoraria – Abbvie Amgen Astellas Bristol-Myers Squibb Celgene Daiichi Sankyo Janssen Jazz Pharmaceuticals Novartis Pﬁzer Sanoﬁ; Financing of scientiﬁc research – Bayer Jazz Pharmaceuticals.",TRUE,"C.P. is supported by Research Group FOR 2674 (project A01) and by Collaborative Research Center SFB 1074 (project B11) both funded by the Deutsche Forschungsgemeinschaft (DFG); K.D. L.B. and H.D. are supported by Research Group FOR 2674 (project A02) and by Collaborative Research Center SFB 1074 (projects B3 B12 Z02). This project was generously supported by a grant from Astex Pharmaceuticals. <section> FUNDING <section> This project was generously supported by a grant from Astex Pharmaceuticals.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-02005-9",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> This work was supported by grants of the German Research Council (DFG) (HE6233/ 2-1) by the Thuringian state program ProExzellenz (RegenerAging FSU-I-03/14) of the Thuringian Ministry for Research in part by grants of the German Cancer Aid (Deutsche Krebshilfe 70112607) and by a Research Fellowship grant of the European Hematology Association (EHA) to FHH as well as a stipend of the German JoseCarreras Leukemia Foundation (DJCLS 03 FN/2019) to TE.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41375-023-02013-9",TRUE,"<section> COMPETING INTERESTS FB received honoraria from Ipsen Pharma and funding from Novartis both unrelated to the project. DN received honoraria from Incyte Biosciences and Gilead. RR received honoraria from AbbVie AstraZeneca Janssen Illumina and Roche. LB has received honoraria from AbbVie Amgen Astellas BristolMyers Squibb Celgene Daiichi Sankyo Gilead Hexal Janssen Jazz Pharmaceuticals Menarini Novartis Pﬁzer Roche Sanoﬁ and Seattle Genetics and has received research support from Bayer and Jazz Pharmaceuticals. FD reports personal fees from AbbVie AstraZeneca Gilead Incyte Novartis and Roche outside the submitted work. The other authors declare that they have no competing ﬁnancial interests.",TRUE,"<section> FUNDING <section> This study was supported by grants from the Brigitte and Dr. FB was supported by the DKTK School of Oncology program. DN received support by the BIH clinician scientist program Lady Tata Memorial Trust and Deutsche Forschungsgesellschaft (#NO1454/1-1). This work was partially funded by the Hungarian National Research Development and Innovation Ofﬁce (NKFIH K21-137948) and the EU’s Horizon 2020 research and innovation program (No. This work was partially supported by grants from the Swedish Cancer Society the Swedish Research Council the Knut and Alice Wallenberg Foundation Karolinska Institutet Karolinska University Hospital and Radiumhemmets Forskningsfonder Stockholm all awarded to RR. This work was partially sponsored by MEXT/JSPS KAKENHI (JP26221308 JP26253060) Scientiﬁc Research on Innovative Areas (15H05909 15H05912) JSPS Coreto-Core Program MEXT as “Priority Issue on Post-K computer” Grantsin-Aid from the Japan Agency for Medical Research and Development AMED (JP15cm0106056 JP19cm0106501 JP16ck0106073 JP19ck0106250) all awarded to SO.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41375-023-02042-4",TRUE,"<section> COMPETING INTERESTS This study was funded by Novartis Pharma GmbH.",TRUE,"<section> FUNDING <section> COMPETING INTERESTS This study was funded by Novartis Pharma GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41375-023-02105-6",TRUE,"<section> COMPETING INTERESTS The authors declare the following potential conﬂicts of interest: EKM: consulting or advisory role honoraria research funding and travel accommodations/expenses from Bristol Myers Squibb/Celgene GlaxoSmithKline Janssen-Cilag Sanoﬁ Stemline and Takeda. TH and UB: no competing interests.",TRUE,"The GMMG-HD7 trial was supported by Sanoﬁ and BMS/Celgene. Mai was funded by the International Myeloma Society (IMS) Career Development Award 2021. <section> FUNDING <section> The HOVON-65/GMMG-HD4 trial was supported by the German Federal Ministry of Education and Research (BMBF) the Dutch Cancer Foundation Janssen-Cilag-Ortho Biotech Novartis Amgen Chugai and Roche. The GMMG-MM5 trial was supported by Celgene Janssen-Cilag Chugai and Binding Site. The GMMG-HD6 trial was supported by BMS Celgene and Chugai. The EMN02/HO95 trial was supported by Janssen and Celgene. The GMMG-HD7 trial was supported by Sanoﬁ and BMS/ Celgene.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41378-023-00589-x",TRUE,"Competing interests C.A.F. C.G.F. D.B. V.S. and S.C. are inventors on a patent application related to the plate design (PT118273).",TRUE,"C.G.F. was supported by a PhD fellowship from the doctoral program Bioengineering: Cellular Therapies and Regenerative Medicine funded by Fundação para a Ciência e Tecnologia (PD/BD/128375/2017).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-01977-5",TRUE,"<section> COMPETING INTERESTS GvW received research funding from Philips. The other authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS This work was supported by the Netherlands Organization for Scientiﬁc Research (NWO; 628.011.023); Philips Research; ZonMW (Vidi; 016.156.318). Data collection was supported by Swedish Research Council; ALF grant from Region Östergötland; the Phyllis and Jerome Lyle Rappaport Foundation Ad Astra Chandaria Foundation BIAL Foundation Brain and Behavior Research Foundation Anonymous donors and the Center for Depression Anxiety and Stress Research at McLean Hospital; The German Research Foundation (DFG grant FOR2107 DA1151/5-1 and DA1151/5-2 to UD; SFB-TRR58 Projects C09 and Z02 to UD) and the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster (grant Dan3/012/17 to UD); European Commission (grant number H2020-634541); German Research Foundation",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-01991-7",TRUE,"<section> COMPETING INTERESTS RM has received honoraria for talks from Otsuka and Janssen.",TRUE,"OH is funded by Medical Research Council-UK (no. <section> MC_A656_5QD30_2135) Maudsley Charity (no. 666) and Wellcome Trust (no. 094849/Z/10/Z). This study presents independent research funded in part by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King’s College <section> FUNDING <section> This work was supported by MRC Grant Reference MR/S003436/1 (TD) and Medical © The Author(s) 2023 Research Council grant MR/L003988/1 (AE). RM is funded by an NIHR Division of Psychiatry UCL Institute of Mental Health London UK.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02003-4",TRUE,"<section> COMPETING INTERESTS CU Correll has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan <section> Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. Marco Solmi received honoraria/has been a consultant for Angelini Lundbeck Otsuka. All other authors declare no competing interests.",TRUE,"<section> FUNDING <section> This work was funded by the FondaMental Foundation Assistance Publique – Hôpitaux Marseille (APHM) and Aix-Marseille University (AMU). He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Study registration: PROSPERO (5 continents) published between 2007 and 2020 were included used two scales with total scores ranging 1–4. This project was registered in PROSPERO (reference number CRD42020185030).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41380-023-02029-8",TRUE,"<section> COMPETING INTERESTS MS received honoraria/has been a consultant for Angelini Lundbeck Otsuka. PFP has received research funds or personal fees from Lundbeck Angelini Menarini Sunovion Boehringer Ingelheim Mindstrong Proxymm Science outside the current study. GSdP reports honoraria from Janssen-Cilag and Angelini. GSdP is supported by the Alicia Koplowitz Foundation. All other authors have no competing interests.",TRUE,"<section> FUNDING <section> This study was funded by the WT grant ENTER (Developing an E-Mental Health Detection Tool for Early-Stage Psychosis in the Community) [Grant Number 215793/Z/19/Z].",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02074-3",TRUE,"The authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS The research of the author is funded by the Deutsche Forschungsgemeinschaft (DFG) grants MU 2789/7-2 MU 2789/8-2 MU 2789/18-1 KO 947/13-3 KO 947/15-2 and KO 947/20-1 TRR265 Project-ID 402170461 [218 219] and by funding from the Federal Ministry of Education and Research (BMBF) e:Med Program Target-OXY (031L0190B) and AhEAD (01KC2004B). <section> FUNDING",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02077-0",TRUE,"<section> COMPETING INTERESTS AA consults and holds equity with Neumora Therapeutics (formerly BlackThorn Therapeutics) and Manifest Technologies.",TRUE,"Additional funding was supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI Grant No. CM21/00278 (cofunded by the European Social Fund) to SBT Grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02109-9",TRUE,"<section> COMPETING INTERESTS MS has received honoraria/has been a consultant for Angelini Lundbeck Otsuka.",TRUE,"LSR was supported by CAPES Scholarship 88887.475730/ 2020-00 during the preparation of this manuscript.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02138-4",TRUE,"<section> COMPETING INTERESTS MS received honoraria/has been consultant for AbbVie Angelini Lundbeck Otsuka. Other authors have no conﬂict of interest",TRUE,"He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02143-7",TRUE,"<section> COMPETING INTERESTS In the past year SVF received income potential income travel expenses continuing education support and/or research support from Aardvark Aardwolf Akili Atentiv Corium Genomind Ironshore Medice Noven Otsuka Sandoz Sky Therapeutics Supernus Tris and Vallon. With his institution he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years he received support from: Alcobra Arbor Aveksham Axsome CogCubed Eli Lilly Enzymotec Impact Janssen KemPharm Lundbeck/Takeda Shire/ Takeda McNeil NeuroLifeSciences Neurovance Novartis Pﬁzer Rhodes Shire and Sunovion. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health; Oxford University Press: Schizophrenia: The <section> Facts; and Elsevier: ADHD: Non-Pharmacologic Interventions. In addition he is the program director of www.adhdinadults.com. SVF is supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965381; NIMH grants U01AR076092-01A1 1R21MH1264940 R01MH116037; <section> 1R01NS128535 – 01; Oregon Health and Science University Otsuka Pharmaceuticals Noven Pharmaceuticals Incorporated and Supernus Pharmaceutical Company. SC declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-proﬁt associations: Association for Child and Adolescent Central Health (ACAMH) Canadian ADHD Alliance Resource (CADDRA) and British Association of Pharmacology (BAP) for educational activity on ADHD. All other authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS No funding has been received for the present study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> METHOD: Based on a pre-registered protocol (PROSPERO: CRD42022328485) Ovid Medline Embase and APA PsycINFO up to th February 2022 observational studies 1) reporting at least one measure of vision in criteria or ADOS; or 2) reporting the prevalence of ASD in people with the Appraisal tool for Cross-Sectional Studies (AXIS). <section> PROSPERO REGISTRATION: CRD42022328485. <section> We pre-registered the study on PROSPERO (CRD42022328485) and followed the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [28].",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41380-023-02148-2",TRUE,"<section> COMPETING INTERESTS Dr TB has served as an advisor or consultant to Bristol-Myers Squibb Desitin Arzneimittel Eli Lilly Medice Novartis Pﬁzer Shire UCB and Vifor Pharma; he has received conference attendance support conference support or speaking fees from Eli Lilly Janssen McNeil Medice Novartis Shire and UCB; and he is involved in clinical trials conducted by Eli Lilly Novartis and Shire; the present work is unrelated to these relationships. The other authors report no biomedical ﬁnancial interests or potential competing interests.",TRUE,"<section> Testosterone and Mental Health during Adolescence; R01 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This paper is based on independent research commissioned and funded in England by the National Institute for Health Research (NIHR) Policy Research Programme (project ref. The views expressed in this article are those of the authors and not necessarily those of the national funding agencies or ERANID. Dr Albaugh is supported by K08 MH121654-01A1 and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02149-1",TRUE,"<section> COMPETING INTERESTS Eduard Vieta has received grants and served as consultant advisor or CME speaker for the following entities: AB-Biotics Allergan Angelini AstraZeneca Bristol-Myers Squibb Dainippon Sumitomo Pharma Farmindustria Ferrer Forest Research Institute Gedeon Richter GlaxoSmith-Kline Janssen Lundbeck Otsuka Pﬁzer Roche Sanoﬁ-Aventis Servier Shire Sunovion Takeda the Brain and Behaviour Foundation the Spanish Ministry of Science and Innovation (CIBERSAM) and the Stanley Medical Research Institute. The other authors have no other conﬂict of interest to disclose.",TRUE,"<section> FUNDING <section> AT Amare received the 2019–2021 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant from the Brain & Behaviour Research Foundation (BBRF) and is currently supported by National Health and Medical Research Council (NHMRC) Emerging Leadership (EL1) Investigator Grant (APP2008000). The genotyping was in part funded by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under the auspices of the e:Med Programme (grants awarded to Thomas G. Improving Recognition and Care in Critical Areas of Bipolar Disorders (BipoLife) study was funded by Bundesministerium für Bildung und Forschung (BMBF): PIs – Felix Bermpohl Philipp Ritter Michael Bauer Andreas Reif Sarah Kittel-Schneider Thomas G. This work was supported by the NIH grants P50CA89392 from the National Cancer Institute and 5K02DA021237 from the National Institute of Drug Abuse. The Canadian part of the study was supported by the Canadian Institutes of Health Research grant (#166098) as well as Genome Canada and Research Nova Scotia grants to MA. Fullerton and Adam Wright was funded by an Australian NHMRC Program Grant (No.1037196). The collection of the Geneva sample was supported by the Swiss National Foundation (grants Synapsy 51NF40-158776 and 32003B-125469). The collection of the Romanian sample was supported by U.E.F.I.S.C.D.I. Romania grant awarded to Maria Grigoroiu-Serbanescu. Michael Bauer has received grants from the Deutsche Forschungsgemeinschaft (DFG) and Bundesministeriums für Bildung und Forschung (BMBF) and served as consultant advisor or CME speaker for the following entities: Allergan Aristo Janssen Lilly Lundbeck neuraxpharm Otsuka Sandoz Servier and Sunovion outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02180-2",TRUE,"<section> COMPETING INTERESTS The authors declare the following competing interests: AS is an employee and option holder of SkylineDx B.V.. Dennis Mook-Kanamori works as a part-time clinical research consultant for Metabolon Inc. HJG has received travel grants and speakers’ honoraria <section> from Fresenius Medical Care Servier Neuraxpharm and Janssen Cilag. HJG has received research funding from the German Research Foundation (DFG) the German Ministry of Education and Research (BMBF) the DAMP Foundation Fresenius Medical Care the EU ""Joint Programme Neurodegenerative Disorders (JPND) and the European Social Fund (ESF)"". G.K. is co-inventor (through Duke University/Helmholtz Zentrum München) on patents on applications of metabolomics in diseases of the central nervous system; G.K. holds equity in Chymia LLC and IP in PsyProtix and Atai that are exploring the potential for therapeutic applications targeting mitochondrial metabolism in depression. The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Rotterdam Study: The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University Rotterdam Netherlands Organization for the Health Research and Development (ZonMw) the Research Institute for Diseases in the Elderly (RIDE) the Ministry of Education Culture and Science the Ministry for Health Welfare and Sports the European Commission (DG XII) and the Municipality of Rotterdam. <section> Trend: This work was funded by grants from the German Federal Ministry of Education and Research (BMBF grants 01ZZ0403 01ZZ0103 01GI0883 AtheroSysMed 03IS2061B) the Ministry for Education Research and Cultural Affairs as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). This work was also funded by the German Research Foundation (DFG: GR1912/11-1). KORA: The KORA study was initiated and ﬁnanced by the Helmholtz Zentrum München – German Research Center for Environmental Health which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore KORA research was supported within the Munich Center of Health Sciences (MC-Health) Ludwig-Maximilians-Universität as part of LMUinnovativ. K.S. was supported by the Biomedical Research Program at Weill Cornell Medicine in Qatar a program funded by the Qatar Foundation. <section> 10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 MC-UU_12015/1 and MC_UU_00006/1) and Cancer Research UK (C864/A14136). Metabolite measurements in the EPIC-Norfolk study were supported by the MRC Cambridge Initiative in Metabolic Science (MR/L00002/1) and the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement no. 115372. NEO study: The NEO study is supported by the participating Departments the Division and the Board of Directors of the Leiden University Medical Centre and by the Leiden University Research Proﬁle Area ‘Vascular and Regenerative Medicine’. Dennis Mook-Kanamori is supported by Dutch Science Organization (ZonMW-VENI Grant 916.14.023). <section> Funding for the PReDICT study derives from two grants from the National Institute of Mental Health. HJG has received research funding from the German Research Foundation (DFG) the German Ministry of Education and Research (BMBF) the DAMP Foundation Fresenius Medical Care the EU ""Joint Programme Neurodegenerative Disorders (JPND) and the European Social Fund (ESF)"".",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02181-1",TRUE,"The authors declare no competing interests.",TRUE,"Funding was provided by Alberta Innovates Health Solutions (AIHS) and Natural Sciences and Engineering Research Council of Canada (NSERC) to ZHTK (04126-2017) and ABP (05299-2020). AHG was funded by an Eyes-High Postdoctoral Award from the University of Calgary.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02185-x",TRUE,"<section> COMPETING INTERESTS Marco Solmi has received honoraria/has been a consultant for Angelini Lundbeck Otsuka. Other authors declare no competing interests.",TRUE,"<section> FUNDING P.T. was supported by a PSI Graham Farquharson Knowledge Translation Fellowship. This study was supported by the University of Ottawa site of ICES which is funded by an annual grant from the Ontario Ministry of Health and Ministry of Long-Term Care. This study also received funding from Canadian Institutes for Health Research Project Grant (452360).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02187-9",TRUE,"The authors declare no competing interests.",TRUE,"<section> supported by operating grants from the Canadian Institutes of Health (MOP-106573 to P.D.A. MOP–93696 to R.J.S. PJT-159462 to J.C. and PJT-165876 to J.C.). The ABCD Study® is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041048 U01DA050989 U01DA051016 U01DA041022 U01DA051018 U01DA051037 U01DA050987 U01DA041174 U01DA041106 U01DA041117 U01DA041028 U01DA041134 U01DA050988 U01DA051039 U01DA041156 U01DA041025 U01DA041120 U01DA051038 U01DA041148 U01DA041093 U01DA041089 U24DA041123 U24DA041147. <section> FUNDING <section> MAB was supported by a National Health and Medical Research Council of Australia Senior Research Fellowship. AA was funded by a grant from the Australian Research Council (ARC) under its Linkage Project scheme (LP160101592).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02202-z",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02228-3",TRUE,"<section> COMPETING INTERESTS Dr.",TRUE,"<section> ACKNOWLEDGEMENTS This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare Republic of Korea (grant number: HI22C1976; DKY) and National Research Foundation of Korea (NRF MSIT; RS-2023-00248157; DKY).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02261-2",TRUE,"No other disclosures were reported. <section> COMPETING INTERESTS The authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS This work was funded by Natural Science Foundation of China (82030053) Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-001A) and TsinghuaToyota Joint Research Fund.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02266-x",TRUE,"<section> COMPETING INTERESTS CUC reported receiving personal fees from Alkermes plc Allergan plc Angelini Pharma Gedeon Richter Gerson Lehrman Group Intra-Cellular Therapies Inc Janssen Pharmaceutica/Johnson&Johnson LB Pharma International BVH Lundbeck A/S MedAvante-ProPhase Medscape Neurocrine Biosciences Noven Pharmaceuticals Inc Otsuka Pharmaceutical Co Inc Pﬁzer Inc Recordati Rovi Sumitomo Dainippon Pharma Sunovion Pharmaceuticals Inc Supernus Pharmaceuticals Inc Takeda Pharmaceutical Company Limited Teva Pharmaceuticals Acadia Pharmaceuticals Inc Axsome Therapeutics Inc Indivior Merck&Co Mylan NV MedInCell and Karuna Therapeutics and grants from Janssen Pharmaceutica Takeda Pharmaceutical Company Limited Berlin Institute of Health the National Institute of Mental Health Patient Centered Outcomes Research Institute and the Thrasher Foundation outside the submitted work; receiving royalties from UpToDate; and holding stock options in LB Pharma. No other disclosures were reported. AdB has received research support from Janssen Lundbeck and Otsuka and lecture fees for educational meeting from Chiesi Lundbeck Roche Sunovion Viatris Recordati Angelini and Takeda; he has served on advisory boards for Eli Lilly Jansen Lundbeck Otsuka Roche and Takeda Chiesi Recordati Angelini Vitria. MS has received honoraria/has been a consultant for Angelini Lundbeck and Otsuka. MF received honoraria from the American Society of Clinical Psychopharmacology (ASCP) Angelini Lundbeck Bristol Meyer Squibb and Boehringer-Ingelheim for his speaker activities. GP has received research grants and/or has been a consultant for and/or has been a speaker for: Angelini Lundbeck Janssen Otsuka Pﬁzer Roche Eisai. DS is funded in part by an NHMRC EL2 Fellowship GNT1194635. FS has received honoraria/has been a consultant for Janssen (past ﬁve years). The other authors report no conﬂict of interest.",TRUE,"DS is funded in part by an NHMRC EL2 Fellowship GNT1194635.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41380-023-02298-3",TRUE,"<section> COMPETING INTERESTS CUC has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Denovo Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Novo Nordisk Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Department of Child and Adolescent Psychiatry Charité Universitätsmedizin Berlin Berlin On Track: The Champlain First Episode Psychosis Program Department of Mental Health (OHRI) Clinical Epidemiology Program University of Ottawa Ottawa ON Canada.",TRUE,"<section> FUNDING <section> CR is supported by a grant from the Lundbeck Foundation (grant number: R3582020-2342) and grants from the Novo Nordisk Foundation (grant numbers: NNF17SA0031406 and NNF14OC0011633). SC is currently supported by funding from the National Institute for Health and Care Research NIHR (grants NIHR203684 NIHR203035 NIHR130077 NIHR128472 RP-PG-0618-20003) Solent NHS Trust (Researh Capability Funding 2022) University of Southampton (Knowledge and Exchange Enterprise Fund 2023 Enterprise Development Fund 2022) and European He has received grant support from Janssen and Takeda.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41380-023-02303-9",TRUE,"The authors declare no competing interests.",TRUE,"This work was supported by the German Research Foundation (Clinical Research Unit KFO 5023 'BecauseY' / Project number 504745852). <section> FUNDING",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41386-023-01588-2",TRUE,"The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41386-023-01605-4",TRUE,"The authors declare no competing interests.",TRUE,"This work was funded by Boehringer Ingelheim Pharma GmbH & Co. <section> FUNDING",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41386-023-01763-5",TRUE,"<section> COMPETING INTERESTS LAML reports unpaid membership on the Scientiﬁc Committee for the International Society for the Study of Trauma and Dissociation (ISSTD) and spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work.",TRUE,"<section> FUNDING <section> The study was supported by ZonMw the Netherlands organization for Health Research and Development (40-00812-98-10041) and by a grant from the Academic Medical Center Research Council (110614) (Miranda Olff); NIMH K01 MH118428-01 (BS-J); NARSAD 27040 (XZ); R01 MH105355 (YN); RO1 MH111671 and VISN6 MIRECC (RAM); Grant 01J05415 from the Special Research Fund (BOF) at Ghent University (SCM); K01 MH118467 Julia Kasparian Fund for Neuroscience Research (LAML); R21 MH112956 R01 MH119227 McLean Hospital Trauma Scholars Fund Barlow Family Fund Julia Kasaparian Fund for Neuroscience Research (MLK); The Natural Science Foundation of Jiangsu Province (No. BE2022705) (RQ); grant no. AZV NV18-7 0400559 from the Ministry of Health of the Czech Republic (PŘ); NIH U54 EB020403 R01 MH116147 R01 MH129742 (CRKC); R01 MH111671 R01 MH117601 R01 AG059874 MJFF 14848 (NJ); Department of Defense award number W81XWH-12-2-0012; ENIGMA was also supported in part by NIH U54 EB020403 from the Big Data to Knowledge (BD2K) program R56 AG058854 R01 MH116147 R01 MH111671 and P41 EB015922 (PMT); funding from the SAMRC Unit on Risk & Resilience in Mental Disorders (DJS); the South African Research Chairs Initiative in Posttraumatic Stress Disorder through the Department of Science and Technology and the National Research Foundation (SS); the South African Medical Research Council for the “Shared Roots” Flagship Project Grant no. MRC-RFA-IFSP-01-2013/SHARED ROOTS” through funding received from the South African National Treasury under its Economic Competitiveness and Support Package (SdP); funding by the South African Medical Research Council through its Division of Research Capacity Development under the SAMRC CLINICIAN RESEARCHER (M.D PHD) SCHOLARSHIP PROGRAMME from funding received from the South African National Treasury (LLvdH); the National Natural Science Foundation of China (No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41387-023-00245-3",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered at ClinicalTrials.gov (NCT00850629).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41388-023-02758-8",TRUE,"<section> COMPETING INTERESTS All authors have read the journal’s authorship agreement and policy on disclosure of potential conﬂicts of interest and report the following conﬂict of interests: NH:",TRUE,"<section> FUNDING This work was supported by the Fellinger Krebsforschungsverein (project: “The role of p53 prions in ovarian cancer and possible implications” to EM); and the Sixth Framework Programme (FP6) Project of the European Union called “Ovarian Cancer: Diagnosis of a silent killer–OVCAD” (grant number LSHC-CT-2005-018698). The autoantibody assays were supported by the National Cancer Institute (NCI) Early Detection Research Network (grant number 5 U01 CA200462-02 to RCB Jr); MD Anderson Ovarian SPOREs (grant numbers P50 CA83639 P50CA217685 to RCB Jr); National Cancer Institute Department of Health and Human Services; the Cancer Prevention Research Institute of Texas (grant number RP160145 to RCB Jr); and generous donations from the Ann and Henry Zarrow Foundation the Mossy Foundation the Roberson Endowment Stuart and Gaye Lynn Zarrow Barry Elson Arthur and Sandra Williams. The Switch laboratory was supported by the Flanders Institute for Biotechnology (VIB grant number C0401); KU Leuven (grant number C24E/19/070); <section> Research Funding: AstraZeneca Bayer GSK MSD-Merck Roche Diagnostics; IV:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41388-023-02839-8",TRUE,"<section> COMPETING INTERESTS CC TP AE and M-HS are co-inventors of the ShallowHRDv2 method (European Patent Application number EP23170829 ﬁled on April 28th 2023 and entitled",TRUE,"This project was supported in part by the ARC Foundation— DefImmunPD1 project [PGA1 RC20170205307].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41388-023-02883-4",TRUE,"The authors declare no competing interests.",TRUE,"Funding acquisition: JD CAS WWC. <section> FUNDING <section> This study was supported by the National Natural Science Foundation of China (31900441 82373097 82172565 and 81903102; to JD YW and JD) Natural Science Foundation of Shandong Province (ZR2019MC026 ZR2023QH080 and ZR2022QH192; to JD FW and WWC) Funds of Shandong Traditional Chinese Medicine Science and Technology Development Project (2019-0514; to JD) Qilu Outstanding Young Talents in Health Project (to JD) Double-Hundred Project and Taishan Scholarship (WSG2018019; to CAS and JD) Research Foundation of Binzhou Medical University Hospital (2022-01; to FW).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41390-023-02750-8",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> Research reported in this publication was supported by the Environmental inﬂuences on Child Health Outcomes (ECHO) program Ofﬁce of the Director National Institutes of Health under Award Numbers U2COD023375 (Coordinating Center) U24OD023382 (Data Analysis Center) U24OD023319 (PRO Core) UH3OD023251 (A.N.A.) UH3OD023320 (J.A.) UH3OD023313 (S.D.) UH3OD023282 (J.G.) UH3OD023244 (A.E.H.) UH3OD023268 (S.W.) UH3OD023342 (K.L.) UH3OD023349 (T.G.O’C.) UH3OD023272 (S.S.) and UH3OD023337 (R.J.W.).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41392-023-01634-x",TRUE,"Competing interests: The authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS This work was supported by the National Natural Science Foundation of China (81970036) the Natural Science Foundation of Beijing (7202130) and the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-049 and 2022-I2M-C&T-B-107).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41397-023-00305-y",TRUE,"<section> COMPETING INTERESTS KY has received paper fees from Sumitomo Dainippon Pharma Brain & Behavior",TRUE,"The CATIE sample was funded by the National Institute of Mental Health to compare the effectiveness of secondgeneration antipsychotics (SGAs) in SCZ and it has been detailed elsewhere [25]. <section> ACKNOWLEDGEMENTS AKT is supported by the Tanenbaum Centre for Pharmacogenetics and McLaughlin Centre Accelerator Grant (2019–2020) Canada. HYM has received grant support from the National Institute of Mental Health ACADIA Eli Lilly Neurocrine Sepracor Dainippon Sumitomo and Janssen.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41398-023-02334-4",TRUE,"<section> COMPETING INTERESTS FC reports grants from Ontario Ministry of Health Innovation Grant grants from ResMed Foundation and University Health Network Foundation and consultation fees from Takeda Pharma outside the submitted work.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41398-023-02339-z",TRUE,"Further Scheele et al. [69] found the effect of oxytocin to be dependent on trauma disclosure in PTSD patients. Suggesting that trauma disclosure facilitates social support and the effect of social support in turn is mediated by oxytocin. Scheele D Lieberz J Goertzen-Patin A Engels C Schneider L Stoffel-Wagner B et al. Trauma disclosure moderates the effects of oxytocin on intrusions and neural responses to fear. <section> COMPETING INTERESTS The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Trial registration: NCT03875391.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,NA,NA,NA,NA
"10.1038/s41398-023-02362-0",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Patients with MDD from our inand outpatient units and healthy control subjects matched for age BMI and smoking status were recruited for the clinical observational study on RA homeostasis in neuropsychiatric disorders (RAHND; ClinicalTrials.gov Identiﬁer: NCT02439099) between 2015 and 2019.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,NA,NA
"10.1038/s41398-023-02368-8",TRUE,"<section> COMPETING INTERESTS HU: Speaker fees from Bayer AG Bracco Eisai Stryker and UCB Pharma. KD: Steering Committee Neurosciences Janssen. Speaker fees from Janssen. LTvE: Advisory boards lectures or travel grants within the last three years: Roche Eli Lilly JanssenCilag Novartis Shire UCB GSK Servier Janssen and Cyberonics. All other authors have no potential conﬂicts of interest to declare.",TRUE,"KR was funded by the Berta-Ottenstein-Programme for Clinician Scientists Faculty of Medicine University of Freiburg. <section> FUNDING <section> The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science Research and Art and the University of Freiburg in the funding programme Open Access Publishing.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41398-023-02491-6",TRUE,"<section> COMPETING INTERESTS Aarhus University The Feinstein Institute for Medical Research and MedAvanteProPhase Inc. each hold one-third of the copyright for the Simpliﬁed Negative and Positive Symptoms Interview (SNAPSI).",TRUE,"This study is supported by postdoctoral grants from the Lundbeck Foundation (grant number R303-2018-3429) and the Swedish Research Council (grant number 2020-00591) to FH. <section> FUNDING <section> He has received grant support from Janssen and Takeda.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41398-023-02705-x",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41408-022-00772-9",TRUE,"<section> CONFLICT OF INTEREST E.K.M.: Consulting or Advisory Role Honoraria Research Funding and Travel Accommodations and Expenses—Bristol Myers Squibb/Celgene GlaxoSmithKline Janssen-Cilag Sanoﬁ Stemline and Takeda. Oscar Berlanga is an employee of The Binding Site Group Ltd. UK. M.H.: Consulting or Advisory Role Honoraria: Amgen Bayer Vital Celgene Gilead Glaxo Smith Kline Jazz Pharmaceuticals Novartis Roche Takeda. H.J.S.: Honoraria: AbbVie Amgen AstraZeneca BMS Celgene Chugai GSK Janssen Oncopeptides Pﬁzer Sanoﬁ Sebia TAD Takeda; Travel accommodations expenses: Amgen BMS Celgene Janssen and Sanoﬁ. The remaining authors declare no conﬂict of interest.",TRUE,"<section> ACKNOWLEDGEMENTS This project was supported by the Dietmar-Hopp Foundation. The GMMG-MM5 trial was supported by grants from Celgene Janssen-Cilag Chugai and The Binding Site. E.K.M. was funded by the International Myeloma Society (IMS) Career Development Award 2021. <section> FUNDING <section> CONFLICT OF INTEREST E.K.M.: Consulting or Advisory Role Honoraria Research Funding and Travel Accommodations and Expenses—Bristol Myers Squibb/Celgene GlaxoSmithKline Janssen-Cilag Sanoﬁ Stemline and Takeda.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41409-023-02077-2",TRUE,"<section> COMPETING INTERESTS MM received research support and honoraria for lectures from Amgen Astellas BMS GSK Janssen Jazz Pharmaceuticals Pﬁzer Takeda Oncopeptides Adaptive and Sanoﬁ. NK served as consultant and received honoraria from Jazz Pharmaceuticals. <section> OP received research and travel support and served as a member of advisory board of Jazz Pharmaceuticals. HS reports having received personal fees from Incyte Janssen Novartis Sanoﬁ and from the Belgian Hematological Society (BHS) as well as research grants from Novartis and the BHS both paid to her institution. She has received non-ﬁnancial support from Gilead Pﬁzer the EBMT (European Society for Blood and Marrow Transplantation) and the CIBMTR (Center for International Bone Marrow Transplantation Research). She has also frequently served as a volunteer for EBMT CIBMTR and EUPATI. RFD received honoraria as speaker for Jazz Pharmaceuticals. TR IM TS JHB AR and GB received honoraria from Jazz Pharmaceuticals. CP MH EP NS JP GGW AG SS MA US AECB JM KH TZ HL-W CK and ZP declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02095-0",TRUE,"The authors declare that they have no relevant conﬂict of interest and no competing ﬁnancial interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02135-9",TRUE,"<section> COMPETING INTERESTS K-WS: speaker fees Jazz research and travel grants medac travel grant Neovii. PB: no relevant disclosures. JS: no relevant disclosures. Ansgar Schulz: no relevant disclosures. JG: no relevant disclosures. JG: no relevant disclosures. DR: no relevant disclosures. JS: no relevant disclosures. FF: no relevant disclosures. FL: no relevant disclosures. Simona Piras: no relevant disclosures. PS: no relevant disclosures. SB: no relevant disclosures. MZ: no relevant disclosures. MC: no relevant disclosures. SC: no relevant disclosures. MM: no relevant disclosures.",TRUE,"This work was supported by an unrestricted grant from medac GmbH Wedel Germany which was the clinical trial sponsor. <section> FUNDING",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02139-5",TRUE,"The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02147-5",TRUE,"The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02154-6",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41409-023-02167-1",TRUE,"The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41413-023-00291-8",TRUE,"Competing interests: The authors declare no competing interests.",TRUE,"The GCKD study is supported by grants from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung; BMBF; www.bmbf.de; FKZ 01ER 0804 01ER 0818 01ER 0819 01ER 0820 and 01ER 0821) the Foundation for Preventive Medicine of the KfH (Kuratorium für Heimdialyze und Nierentransplantation e.V. Stiftung Präventivmedizin) and corporate sponsors. This work was further supported by the German Research Foundation (SFB/TRR219 project C1—Project-ID 322900939). TS is supported by the clinician scientist program of the German Society of Internal Medicine (DGIM) and the Else Kröner-FreseniusStiftung Excellence Fellowship (2022_EKES.03). KCR was supported by a clinician scientist position funded by the German Research Council (DFG) within the clinical research unit 344 (CRU344). The work of UTS and FK was supported by BMBF within the framework of the e:Med research and funding concept (grant 01ZX1912B). <section> FUNDING",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41416-022-02108-7",TRUE,"<section> COMPETING INTERESTS EB ER GF and RF report grants from PharmaMar to their Institution for the conduct of the study. The remaining authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov number NCT01379989. <section> The study is registered with ClinicalTrials.gov number NCT01379989 and European Clinical Trials database EudraCT 2010-022949-17.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41416-023-02208-y",TRUE,"The authors declare no competing interests.",TRUE,"This work was further supported by the Deutsche Forschungsgemeinschaft (DFG; grant no. FI 1926/2-1 to MF) the Förderverein für krebskranke Kinder e.V. <section> FUNDING",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"It has to be noted though that the vast majority of patients had been treated within the trial NB2004 and the subsequent registry NB2016 which kept the therapeutic concept of NB2004 resulting in homogeneous treatment of most patients included in this study.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41419-023-06077-4",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> was funded by the START program of the Medicine Faculty of the RWTH Aachen Grant No. C.Lin was funded by a CSC stipend (ID: 202008320329). <section> FUNDING",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41420-023-01442-w",TRUE,"The authors declare no competing interests.",TRUE,"This study was supported by the National Natural Science Foundation of China (31900441 82172565 81903102) Natural Science Foundation of Shandong Province (ZR2019MC026 ZR2022QH192) Projects of Medical and Health Technology Development Program of Shandong Province (2017WS155 2019WS321) Funds of Shandong Traditional Chinese Medicine Science and Technology Development Project (2019-0514) and funding granted to JD by Qilu Outstanding Young Talents in Health Project Taishan Scholarship and Double Hundred Project (WSG2018019). CAS: Funding acquisition; Conceptualization; Writing—review and editing. JD: Funding acquisition; Supervision; Conceptualization; Writing—review and editing.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41431-023-01296-x",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> This work was supported by the Dutch Kidney Foundation (18OKG19). The collaboration project is cofunded by the PPP Allowance made available by HealthHolland Top Sector Life Sciences & Health to stimulate publicprivate partnerships. <section> The Yale polycystic kidney and liver disease cohort and its analysis is supported by the US National Institutes of Health (NIH) K08DK119642 and PKD Foundation Research Grant and Fellowship to Dr. The 100000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust Cancer Research UK and the Medical Research Council (MRC) have also funded research infrastructure. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Ofﬁce of the Director of the National Institutes of Health (commonfund.nih.gov/GTEx).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41431-023-01299-8",TRUE,"<section> The decision on disclosure of the ﬁnding to the donor is based on generally accepted guidelines and professional experience [2 8 28 29]. The position European biobanks take ranges from ruling out any return of research results to full disclosure of all observations to the sample donor [37 38]. By a sequence of checks and controls a well balanced decision on the disclosure of the incidental ﬁnding is ascertained. Ethical values supporting the disclosure of incidental and secondary ﬁndings in clinical genomic testing: a qualitative study. <section> COMPETING INTERESTS The authors declare no competing interests.",TRUE,"<section> FUNDING <section> The following authors receive funding from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF Germany): RB: grant",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41431-023-01382-0",TRUE,"<section> COMPETING INTERESTS J.R.L. has stock ownership in 23andMe is a paid Consultant for Genome International and is a co-inventor on multiple U.S. and European patents related to molecular diagnostics for inherited neuropathies genomic disorders eye diseases and bacterial genomic ﬁngerprinting.",TRUE,"<section> FUNDING The sequencing for individual 4 was performed under the Care4Rare Canada Consortium funded by Genome Canada and the Ontario Genomics Institute (OGI-147) the Canadian Institutes of Health Research Ontario Research Fund Genome Alberta Genome British Columbia Genome Quebec and Children’s Hospital of Eastern Ontario Foundation.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41431-023-01425-6",TRUE,"The authors declare no competing interests.",TRUE,"BP is supported by the Deutsche Forschungsgemeinschaft (DFG) through grant PO2366/2–1. <section> FUNDING <section> BP is supported by the Deutsche Forschungsgemeinschaft (DFG) through grant PO2366/2–1.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41431-023-01431-8",TRUE,"<section> COMPETING INTERESTS Dr. Breen has received grant funding from and served as a consultant to Eli Lilly has received honoraria from Illumina and has served on advisory board for Otsuka and is a scientiﬁc advisor for COMPASS Pathways. CM Bulik reports: Lundbeckfonden (grant recipient); Pearson (author royalty recipient). All other authors have indicated they have no conﬂicts of interest to disclose.",TRUE,"<section> FUNDING <section> This study represents independent research funded in part by the UK National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. This work was supported by the UK Medical Research Council and the Medical Research Foundation (ref: MR/R004803/1). NM and CB acknowledge funding from the National Institute of Mental Health (R21 MH115397). <section> CMB is supported by NIMH (R01MH120170; R01MH124871; R01MH119084; R01MH118278; R01 MH124871); Brain and Behavior Research Foundation Distinguished Investigator Grant; Swedish Research Council (Vetenskapsrådet award: 5382013-8864); CMB and CH are supported by Lundbeck Foundation (Grant no. R2762018-4581). MH is supported by a fellowship from the Medical Research Council UK (MR/T027843/1). NM was supported by a Brain and Behavior Research Foundation Independent Investigator award.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41433-023-02802-7",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41443-023-00729-x",TRUE,"The authors declare no competing interests.",TRUE,"<section> ACKNOWLEDGEMENTS We thank our cooperation partners for supporting the data collection process. <section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-022-35563-0",TRUE,"Competing interests Subsequent to this work being carried out Peter Joshi became an advisor to Global Gene Corp and Humanity Inc. The remaining authors declare no competing interests.",TRUE,"L.K. was supported by an RCUK Innovation Fellowship from the National Productivity Investment Fund (MR/R026408/1). Z.K. was supported by the Swiss National Science Foundation (310030-189147). N.M.M. was supported by a Wellcome Trust New Investigator Award (100981/Z/13/Z). <section> Speciﬁcally we thank the UK Biobank Resource approved under application 19655. The EPIC-Norfolk study (https://doi.org/10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MCUU_12015/1) and Cancer Research UK (C864/A14136). The genetics work in the EPIC-Norfolk study was funded by the Medical Research Council (MC_PC_13048). The Fenland Study (10.22025/2017.10.101.00001) is funded by the Medical Research Council (MC_UU_12015/1). We further acknowledge support for genomics from the Medical Research Council (MC_PC_13046).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-022-35717-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-022-35741-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by DFG FOR 2497 TP5 to JW and TP6 to FV and the FöFoLe program of the LMU to <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-36120-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This study was primarily supported by grants from wakeup narcolepsy Jazz Pharmaceuticals donations from narcoleptic patients and peripherally by a previously funded NIH-23724 grant (EM). Work was also supported by Academy of Finland (#309643) Sigrid Juselius Foundation Finnish Cultural Foundation Orion Farmos Research Foundation Instrumentarium Science Foundation Oskar Öfflund Foundation Yrjö Jahnsson Foundation and Jalmari and Rauha Ahokas Foundation (HMO). This work was also supported by the United States Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) program and by Stanford University through the Stanford Graduate Fellowship program. <section> The work has been supported by the National Institute of Mental Health Grant 5RC2MH089916 for the Depression Genes and Networks Project. <section> The Swedish postpandemrix Narcolepsy genetics with Tomas Olsson and Ingrid Kockum as PIs received support from the Swedish medical product agency. Han Fang was supported by the Ministry of Science and Technology (2015CB856405) and NSFC (8142010800281670087). <section> Selina Yogeshwar received funding from the Einstein Center for Neurosciences and the German-Academic Exchange Service (DAAD). We would like to thank Stanford University and the Stanford Research Computing Center for providing computational resources and support that contributed to these research results. The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie Inc. AstraZeneca UK Ltd Biogen MA Inc. Bristol Myers Squibb (and Celgene Corporation & Celgene International II Sàrl) Genentech Inc. Merck Sharp & Dohme Corp Pﬁzer Inc. GlaxoSmithKline Intellectual Property Development Ltd. Sanoﬁ US Services Inc. Maze Therapeutics Inc. Janssen Biotech Inc Novartis AG and Boehringer Ingelheim.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-36333-2",TRUE,"Competing interests holder. To view a copy of this license visit http://creativecommons.org/ L.P. is afﬁliated with BioDecipher GmbH a company which develops licenses/by/4.0/. <section> systems for multiplexed ﬂuorescence microscopy. The remaining authors declare no competing interests.",TRUE,"This study was supported by funding from the Deutsche Forschungsgemeinschaft HA5354/101 HA5354/12-1 SPP1937 (HA5354/8-2) and TRR130 P17 to A.E.H. TRR 130 C01 and SFB 1444 P14 (to A.E.H. and R.A.N.). A.C.H. was supported by Berlin University Alliance GC2 Global Health (Corona Virus Pre-Exploration Project) BMBF (RAPID and M.-F.M was supported by grants from the Leibniz Association (Leibniz Collaborative Excellence TargArt and ImpACt) the Berlin Institute of Health (BIH) with the Starting Grant-Multi-Omics Characterization of SARS-CoV-2 infection Project 6 Identifying Immunological Targets in Covid-19 the state of Berlin and the European Regional Development Fund (ERDF 2014–2021 EFRE 1.8/11 Deutsches Rheuma-Forschungszentrum) and the German Federal Ministry of Education and Research (CONAN and TReAT). <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-36491-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was funded by the National Key R&D Program of China (No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-36607-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was funded by Bundesministerium für Bildung und Forschung (BMBF 16GW0300 to C.M.T.S.) and the Human Frontier Science Program Organization (HFSP-Ref. In addition this work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the cluster of excellence Unifying Systems in Catalysis (UniSysCat) under Germany´s Excellence Strategy-EXC 2008-390540038 (to A.B. C.M.T.S. and P.S.). <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-36735-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"We acknowledge the use of the Integrated Genomics Operation Core funded by the NCI Cancer Center Support Grant (CCSG P30 CA08748) Cycle for Survival and the Marie-Josée and Henry R. This research was supported by the following funding agencies: the Belgian Foundation against Cancer (project 2015-146 and F/2018/1246) to F.S. Ghent University (BOF10/GOA/019 BOF16/GOA/23 and BOF/24 J/2021/ 150) to F.S. the Belgian Program of Interuniversity Poles of Attraction (IUAP Phase VII P7/03) to F.S. the Fund for Scientiﬁc Research Flanders (Research projects G053012N G050712N and G051516N to F.S. G021415N to K.D and F.S.) ‘Kom op tegen Kanker’ (Stand up to Cancer) the Flemish cancer society (Research grant to F.S.) the European Union H2020 (OPTIMIZE-NB GOD9415N and TRANSCAN-ON THE TRAC GOD8815N to F.S.) and FP7 (ENCCA 261474 and ASSET 259348 to F.S.) ‘Kinderkankerfonds’ (Research grant to F.S.) Olivia Fund to F.S. and Villa Joep to F.S. The following authors B.D. A.L. and S.V. were supported by an FWO grant (FWO3F02013001701/02 FWO.3F0.2019.0033.01 and FWO.3F0.2019.0041.01 respectively). M.W.Z. was supported by grants from the Alex’s Lemonade Stand Foundation Charles A.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-36864-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements The work of M.W. and A.K. was supported by German Research Foundation (Deutsche Forschungsgemeinschaft DFG) Project ID 431984000 SFB 1453. <section> was supported by the National Institutes of Health grant R01 HG009976. M.L. was funded by an International Mobility grant of the Autonomous Province of Bolzano under Project number D54I18000150003. <section> Funding",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37057-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This study was supported by grants from the Deutsche Forschungsgemeinschaft (MU 880/16-1 MU 880/20-1) to S.M. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37233-1",TRUE,"Competing interests B.K.K. is a co-founder of and consultant for ConfometRx Inc. The remaining authors declare no competing interests.",TRUE,"We thank the North-German Supercomputing Alliance (HLRN bec00196) for the allocation of computing time in the Emmy cluster. <section> This study was supported by The Beijing Advanced Innovation Center for Structural Biology Beijing Frontier Research Center for Biological Structure Tsinghua-Peking Joint Center for Life Sciences School of Medicine Tsinghua University (to J.H. J.W.Z. and C.L.C.)",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37579-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37585-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was supported by the German Federal Ministry of Education and Research (BMBF 031L0234B) the European Union’s Horizon 2020 research and innovation program (Grant No. 779293) and the German Research Foundation (DFG) through funding of the Research Group 2165 (GE2512/2-2) (SFB1444) to P.K. and the Collaborative Research Center 1444. Genome sequencing was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by NHGRI and NHLBI grants UM1 HG006493 and U24 HG008956. This study was also supported by Ministero dell’Istruzione dell’Università e della Ricerca—MIUR “Dipartimenti di Eccellenza 2018–2022” to Department of Medical Sciences University of Torino (Project no. D15D18000410001) and Italian Ministry of Health (5 × 1000) Fondazione Bambino Gesù (Vite Coraggiose) to M.T. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37627-1",TRUE,"Competing interests The author declares no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37671-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by the Max Planck Society and by the Collaborative Research Center 1531 of the German Research Foundation (S.O.). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-37991-y",TRUE,"Competing interests K.Z. is founder and CEO of Zatloukal Innovations GmbH. The remaining authors declare no other competing interests.",TRUE,"<section> Acknowledgements This work has been supported by EOSC-Life project supported by EU Horizon 2020 grant agreement no. 824087 as a part of WP1 Demonstrators under APPID 1228 “Cloudiﬁcation of BBMRI-ERIC CRC-Cohort and its Digital Pathology Imaging”; by the Czech Ministry of Health (MMCI 00209805) and the Czech Ministry of Education Youth and Sports (LM2018125 – BBMRI-CZ); the Austrian Federal Ministry for Education Science and Research (BMBWF-10.470/0010-V3c/2018; BBMRI.at); the SVDC project (funded by the Sardinian Regional Authority); the Czech Science Foundation Grant No.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38044-0",TRUE,"Competing interests Derek Reid Kristin Sikkink and Anthony Schmitt are employees of Arima Genomics Inc. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements This work is supported by a generous endowment by the Clayes foundation to the Research Center for Neuro-Oncology and Genomics within the Rady Children’s Institute for Genomic Medicine a Hannah’s Heroes St. The pediatric brain proﬁling at NYU in M.S. laboratory was in part supported by grants from the Friedberg Charitable Foundation and the Making Headway Foundation. Work in the laboratory of J.R.D. was supported by a NIH Early Independence Award (DP5 Discovery Environment (XSEDE) which is supported by National Science Foundation grant number ACI-1548562.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38383-y",TRUE,"Competing interests Dr. Klarin is a scientiﬁc advisor and reports consulting fees from Bitterroot Bio Inc unrelated to the present work. All other authors declare no competing interests.",TRUE,"Data usage: We used data from the Genotype-Tissue Expression (GTEx) Project (gtexportal.org) The GTEx project was supported by the Ofﬁce of the Director of the National Institutes of Health and by NCI NHGRI NHLBI NIDA NIMH and NINDS. The study was supported by grants from Stockholm County Council (Region Stockholm) to J.O. The RETROVE study was supported by grants PI12/00612 and PI15/0026. Genotyping of the RETROVE samples was supported by grant PT17/0019 of the PE I + D + i 20132016 funded by ISCIII and ERDF. The EPIC-Norfolk study (DOI 10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 MC-UU_12015/1 and MC_UU_00006/1) and Cancer Research UK (C864/ A14136). The genetics work in the EPIC-Norfolk study was funded by the Medical Research Council (MC_PC_13048). Proteomics measurements in EPIC-Norfolk work was supported in part by MRC Rapid Call (MC_PC_21036) and HDRUK Multi-Omics (G107794) grants and the UKRI/ NIHR Strategic Priorities Award in Multimorbidity Research for the Multimorbidity Mechanism and Therapeutics Research Collaborative (MR/ V033867/1). Proteomics measurements were also supported by a collaboration agreement between the University of Cambridge and Olink. C.L. M.P. are funded by the Medical Research Council (MC_UU_00006/1). MK is supported by Gates Cambridge Trust. <section> Funding acquisition: J.O. D.-A.T. L.M.B. P.-E.M. M.U. T.R. J.-F.D. J.E. D.M.S. J.M.S.F. S.M.D. M.F. M.K. M.P. C.L. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38580-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"LAST was supported by a postdoctoral fellowship of the H2020 Marie Skłodowska-Curie Actions (PreCoASD).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-38626-y",TRUE,"Competing interests The authors M.S. and P.R. declare the following competing interests: the authors M.S. and P.R. are ﬁling a patent application entitled Tuning a Biological Network Model (227EP 3414) for the ﬁtting algorithm described in this paper. The remaining author declares no competing interests.",TRUE,"<section> Acknowledgements We gratefully acknowledge the Swiss National Supercomputing Center CSCS for supporting this project by providing computing time through the Interactive Computing E-Infrastructure (ICEI) on the Supercomputer Piz Daint of the Fenix Infrastructure (projects ich10 ich12) and the Gauss Centre for Supercomputing e.V. (www.gausscentre.eu) for supporting this project by providing computing time through the John von Neumann Institute for Computing (NIC) on the GCS Supercomputer JUWELS at Jülich Supercomputing Centre (JSC). This work was supported by the Virtual Research Environment at the Charité Berlin – a node of EBRAINS Health Data Cloud. We gratefully acknowledge support by Digital Europe Grant TEF-Health # 101100700 (P.R.) Funding acquisition: P.R. <section> Funding",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38709-w",TRUE,"Competing interests M.M.G. is employee of Aya Technologies Ltd. The rest of the authors declare no competing interests.",TRUE,"<section> Acknowledgements N.W.S. was funded by an Independent Max Planck Research Group grant awarded by the Max Planck Society (M.TN.A.BILD0004) and a Starting Grant from the European Union (ERC-2019-StG REPLAY-852669) and the Federal Ministry of Education and Research (BMBF) and the Free and Hanseatic City of Hamburg under the Excellence Strategy of the Federal Government and the Länder. N.M. was funded by and is grateful for a scholarship from the Ernst Ludwig Ehrlich Studienwerk (ELES) and Einstein Center for Neuroscience (ECN) Berlin throughout this study. <section> Funding",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38747-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"S.F. was supported during work by a grant from the Berliner Krebsgesellschaft e.V. (grant no. FUFF201721KK) the Stiftung Tumorforschung Kopf-Hals (Wiesbaden Germany) and the Deutsche Forschungsgemeinschaft (DFG German Research Foundation grant no. 439441203). A.G.H. is supported by the DFG (Emmy-Noether grant 398299703) and the EU-H2020 European Research Council (ERC Starting Grant agreement No. H.E.D. is supported within the ERA-NET LIQUIDHOPE consortium cofunded by the EU and Federal Ministry of Education and Research (BMBF grant no. 01KT1902). F.M was supported by grants from Inserm l’association Eva pour la vie the Federation Grandir Sans Cancer and from the French Ministry of Health and the French National Cancer lnstitute (CIRComa 2022 grant no. ex PRT-K 21-22-184). This project was supported by the BIH within the collaborative research project TERMINATE-NB (CRG04) and the BMBF-funded de.NBI Cloud within the German Network for Bioinformatics Infrastructure (031A532B 031A533A 031A533B 031A534A 031A535A 031A537A 031A537B 031A537C 031A537D 031A538A). <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-38780-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The work was supported by the DFG Emmy Noether Grant to M.S. H.L. is a recipient of an EMBO Postdoctoral Fellowship (ALTF 489-2021). <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-38910-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements Research reported in this publication was supported by the Bundesministerium für Bildung und Forschung Grant/Award Number: 01GQ1424A (AF); the Deutsche Forschungsgemeinschaft Grant/Award <section> Funding",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39147-4",TRUE,"Competing interests The authors declare no competing interests",TRUE,"; Funding acquisition M.B. S.Pe. S.Pö. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39245-3",TRUE,"Competing interests L.S. holds shares of selenOmed GmbH a company involved in selenium status assessment. The remaining authors declare no competing interests.",TRUE,"This work was supported by the German Research Foundation (DFG) [FOR 2558; H.H. T.G. M.B.S. T.S. L.S. A.P.K.] the Carl Zeiss Foundation (IMPULS; A.P.K.) by the Swedish Research Council (2018-02318 and 2021-03138; V.S.) and by the Swedish Society for Medical Research (S18-034; V.S.). We are very grateful to E. for supporting this project. <section> Funding Acquisition: H.H. T.G. M.B.S. T.S. V.I.S. L.S. A.P.K. <section> Funding licenses/by/4.0/.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-39253-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This research is supported by funding from the Department of Veterans Affairs Ofﬁce of Research and Development Million Veteran Program Grant I01 CX001737 (PI: Phillips) and I01-BX004821 (PI: Wilson/Cho). We also acknowledge the VA Merit Grant I01CX001025 (PI: Wilson/Cho). The Fenland Study (10.22025/ 2017.10.101.00001) is funded by the Medical Research Council (MC_UU_12015/1). We further acknowledge support for genomics from the Medical Research Council (MC_PC_13046). Proteomic measurements were supported and governed by a collaboration agreement between the University of Cambridge and SomaLogic. P.B.M. and S.E.P. acknowledge the support of the National Institute for Health and Care Research Barts Biomedical Research Centre (NIHR203330); a delivery partnership of Barts Health NHS Trust Queen Mary University of London St George’s University Hospitals NHS Foundation Trust and St George’s University of London. L.S.P. is supported in part by VA awards CSP #2008 I01 CX001899 I01 CX001737 and I01 BX005831; NIH awards R01 DK127083 R21 AI156161 UL1 TR002378 and U18DP006711; and a Cystic Fibrosis Foundation award PHILLI12A0.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39352-1",TRUE,"",TRUE,"<section> Acknowledgements We sincerely acknowledge the Laboratory Animal Resources (LAR) facility at EMBL for supporting the mouse experiments. This work was mainly funded by the Bundesministerium für Bildung und Forschung (BMBF) the Else Kröner-Fresenius-Stiftung (EKFS) the CRC 1550 “Molecular Circuits of Heart Disease” and the Leducq Foundation. M.G. has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-39570-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"We thank the NCT Molecular Precision Oncology Program for technical support and funding through project number A.M.K. was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—SFB-TRR 338/1 2021–452881907 (to A.M.K. /A03) and the German Cancer Consortium (DKTK) Joint Funding Program (ImmuNEO MASTER). N.v.B. was supported by the DFG (Project ID 386260575) and the German Federal Ministry of Education and Research (BMBF) within the OUTLIVE consortium (Project ID 01KD2103A). S.F. was supported by the NCT Molecular Precision Oncology Program and the DKTK Joint Funding Program. <section> Funding",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-39651-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Fieldwork and sequencing costs were funded by the University of Technology Chancellor’s Postdoctoral Research Fellowship and Australian Research Council Discovery Early Career Research Award (DE190100142) awarded to E.F.C. The contribution of C.B. and A.D. to the project was funded by a Rolex Award for Enterprise (to E.F.C). The contribution of F.S. P.Z. and T.M. was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 755876 to T.M.).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39824-4",TRUE,"Competing interests K.C. is a consultant for Danone Research Ysopia and CONFO therapeutics for work not associated with this study. K.C. held a collaborative research contract with Danone Research in the context of MetaCardis project. F.B. is a shareholder of Implexion Pharma AB. M.B. received lecture and/or consultancy fees from AstraZeneca Boehringer-Ingelheim Lilly Novo Nordisk Novartis and Sanoﬁ. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by European Union’s Seventh Framework Program for research technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (METACARDIS). P.A. and K.Ch. are recipients of a Wellcome ISSF Fellowship (ISSF204834/Z/16/Z). M.-E.D. is supported by the NIHR Imperial Biomedical Research Centre GutsUK Diabetes UK and by grants from the French National Research Agency (ANR-10-LABX-46 European Genomics Institute for Diabetes) from the National Center for Diabetes Precision Medicine—PreciDIAB which is jointly supported by the French National Agency for Research (ANR-18-IBHU-0001) by the European Union (FEDER) by the Hautsde-France Regional Council (Agreement 20001891/NP0025517) and by the European Metropolis of Lille (MEL Agreement 2019_ESR_11) and by Isite ULNE (R-002-20-TALENT-DUMAS) also jointly funded by ANR (ANR16-IDEX-0004-ULNE) the HautsdeFrance Regional Council (20002845) and by the European Metropolis of Lille (MEL). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research institution at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39837-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by the National Institutes of Health (K25 AI155224 to D.B.R. K23 A137522 to M.J.P. UM1 AI100663 and R01AI129795 to M.C.N.); the UW/Fred Hutch Center for AIDS Research (P30 AI027757). the Einstein-Rockefeller-CUNY Center for AIDS Research (1P30 AI124414-01A1); and the Robertson Fund.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39869-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was funded in part by NIH grants R01-GM-094231 U24CA210967 U24-CA271037 received by F.Y. G.C.T. A.T.K. G.X.L. A.I.N. <section> This work was also funded in part by German Ministry of Education and Research (BMBF) as part of the National Research Node “Mass spectrometry in Systems Medicine” (MSCoreSys) under grant agreement 161L0221 received by V.D.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39934-z",TRUE,"Competing interests N.R.V. holds signiﬁcant equity in Elastrin Therapeutics Inc. which has licensed elastin-targeted nanoparticle therapy for cardiovascular and pulmonary conditions. V.F. receives remuneration consultancy fees and/or travel support outside the submitted work from Abbott GmbH & Co. KG Novartis Pharma GmbH Medtronic GmbH Biotronic SE &Co. Boston Scientiﬁc Edwards Lifesciences Berlin Heart JOTEC GmbH Zurich Heart. M.M.K. W.M.K. and C.K. have ﬁled a European Patent application (P30606WO) on “Pentagalloyl glucose (PGG) for use in the treatment of pulmonary hypertension”. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements This study was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research) to C.K; by the German Research Foundation (SFB-TR84 A02 & C09 SFB1449 B01 SFB1470 A04 KU1218/11-1 and KU1218/12-1) the DZHK and the BMBF the BMBF in the framework of SYMPATH (01ZX1906A) to W.M.K and by German Heart Foundation/German Foundation of Heart Research (DSHF F/23/20) to M.M.K. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-39965-6",TRUE,"",TRUE,"; The Zurich ACM Program is supported by the Georg und Bertha Schwyzer-Winiker Foundation Baugarten Foundation USZ Foundation (Dr. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-40068-5",TRUE,"Competing interests M.A. is an inventor on patents related to MIBI technology (US20150287578A1 WO2016153819A1 and US20180024111A1). M.A. is a consultant board member and shareholder in Ionpath Inc. The remaining authors declare no competing interests.",TRUE,"This work was supported by NIAID F31AI165180 (C.C.L.) the Stanford Graduate Fellowship (C.C.L.)",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-40079-2",TRUE,"Competing interests Tobias Banaschewski served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. He received conference support or speaker’s fee by Janssen Medice and Takeda. He received royalities from Hogrefe Kohlhammer CIP Medien Oxford University Press; the present work is unrelated to these relationships. Dr. Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. Dr. Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships.The other authors report no biomedical ﬁnancial interests or potential nonﬁnancial competing interests.",TRUE,"This work received support from the following sources: National Key R and D Program of China (2021YFC2501402 [to T.J.] 2022CSJGG1000 [to T.J.] 2019YFA0709501 [to T.J.] 2019YFA0709502 [to J.F.] 2018YFC1312900 [to T.J.] and 2018YFC1312904 [to J.F.]) the National Natural Science Foundation of China (T2122005 [to T.J.] 82150710554 [to G.S.] and 81801773 [to T.J.]) the Shanghai Pujiang Project (18PJ1400900 [to T.J.]) Guangdong Key Research and Development Project (2018B030335001 [to J.F.]) the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated behaviour in normal brain function and psychopathology) (LSHMCT2007-037286 [to G.S.]) the 111 Project (B18015 [to J.F.]) the key project of Shanghai Science and Technology (16JC1420402 [to J.F.]) Shanghai Municipal Science and Technology Major Project (2018SHZDZX01 [to J.F.]) Zhangjiang Lab [to J.F.] Shanghai Center for Brain Science and Brain-Inspired Technology [to J.F.] the European Research Area Network on Illicit Drugs (ERANID) (Understanding the Interplay between Cultural Biological and Subjective Factors in Drug Use Pathways PR-ST-041610004 [to G.S.]) Human Brain Project (HBP SGA 2 785907 and HBP SGA 3 945539 [to G.S.]) the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions MR/N000390/1 [to G.S.]) the National Institute of Health (NIH) (A decentralized macro and micro geneby-environment interaction analysis of substance use behavior and its brain biomarkers R01DA049238 [to G.S.]) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711 [to G.S.]; the European Union and UKRI funded project ‘environMENTAL’ (grants 101057429 [to G.S.] and 10038599 [to S.D.]) The views expressed in this article are those of the authors and not necessarily those of the national funding agencies or ERANID.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-40129-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported in part by National Institutes of Health grants R01-GM-094231 U24-CA210967 and U24-CA271037 received by K.L.Y. F.Y. G.C.T. K.L. and A.I.N.; and the Proteogenomics of Cancer Training Program 5T32-CA140044-12 received by K.L.Y. and A.I.N.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-40213-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The work was supported by grants from Karolinska Institutet the Swedish Research <section> This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875510. <section> Technology (PDC) in Stockholm (G.S.: SNIC 2021/5-490 M.M.S.: SNIC 2022/22-558) partially funded by the Swedish Research Council through grant agreements no. 2022-06725 and no. 2018-05973. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-40220-1",TRUE,"Competing interests B.D.H. T.R. C.R. and M.E.B. are listed as inventors on a patent application (PCT/US23/68073) covering peptides identiﬁed in this study. M.E.B. is an equity holder in 3T Biosciences and is a co-founder equity holder and consultant of Kelonia Therapeutics and Abata Therapeutics. <section> The remaining authors declare no competing interests.",TRUE,"This work was supported in part by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. This work was supported by National Institute of Health (U19-AI110495) the Melanoma Research Alliance Foundation and the Packard Foundation to M.E.B; a National Science Foundation Graduate Research Fellowship to B.D.H; Deutsche Forschungsgemeinschaft (DFG) grants SPP 1937 (RO3565/4-2) and SFB TRR241 B02 to C.R.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-40235-8",TRUE,"Competing interests O.W. and T.M. were supported by research grants from Biomed Valley Discoveries Inc. and Day One Biopharmaceuticals. The remaining authors declare no competing interests.",TRUE,"<section> Funding <section> Competing interests O.W. and T.M. were supported by research grants from Biomed Valley Discoveries Inc. and Day One Biopharmaceuticals.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-40250-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by the Interdisciplinary Centre for Clinical Research (IZKF) of the medical faculty of Münster (Gro3/001/19 awarded to JG). ; Funding Acquisition D.S.K. A.V. J.G. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-40584-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements L.J. was supported by a Heidelberg School of Oncology (HSO2) fellowship from the National Center for Tumor Diseases (NCT) Heidelberg and by the International Myeloma Working Group. This project was supported by the Black Swan Research Initiative the Dietmar-Hopp Foundation and DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO) funding. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-40758-0",TRUE,"Competing interests J.S.H. H.R.S. A.N. H.-G.R. and J.S.W. are listed as inventors on a patent related to the SARS-CoV-2 T-cell epitopes included in CoVac-1. H.-G.R. <section> and K.-H.W. are listed as inventor on a patent related to the adjuvant XS15 included in CoVac-1. The other authors declare no competing interests.",TRUE,"<section> The trial was openlabel without a control arm and funded by the Federal Agency of Science Research and the Arts (BMBF) Germany and the Ministry of Science Research and the Arts Baden-Württemberg (MWK) Germany. This work was supported by the Ministry of Science Research and the Arts Baden-Württemberg Germany (MWK Sonderfördermassnahme COVID19 TÜ17 J.S.W.) Federal Agency of Science Research and the Arts Germany (BMBF FKZ:01KI20130 and FKZ:16LW0004K J.S.W.) the Deutsche Forschungsgemeinschaft (DFG German Research Foundation Grant WA 4608/1-2 J.S.W.) the Deutsche Forschungsgemeinschaft under Germany’s Excellence Strategy (Grant EXC2180-390900677 H.-G.R. H.R.S. and J.S.W.) the German Cancer Consortium (DKTK H.-G.R. H.R.S. and J.S.W.) the Wilhelm Sander Stiftung (Grant 2016.177.2 J.S.W.) the José Carreras Leukämie-Stiftung (Grant DJCLS 05 R/2017 J.S.W.) the Robert Bosch Stiftung (C.M. S.U.J.) the BIH-Charité Clinician Scientist Program funded by the Charité –Universitätsmedizin Berlin and the Berlin Institute of Health (S.M.R. S.H. and C.A.P.) the Ernst-Jung-Preis für Medizin and the Landesforschungspreis Baden-Württemberg both awarded to H.-G. We acknowledge support from the Open Access Publication Fund of the University of Tübingen. <section> Funding",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-41011-4",TRUE,"Competing interests A.S. served on advisory boards for BMS and Novocure received honoraria for talks by Roche Servier and Taiho Pharmaceuticals and The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. The transcriptomebased microarray for gene expression using Xcel® Array received funding from Almac Ltd Belfast UK. The FoundationOne® based sequencing analysis (MSI) received funding from Roche Pharma AG Grenzach Germany (grant numbers: n/ a <section> Funding C.B.W. has received honoraria from Amgen Bayer Chugai Celgene GSK MSD Merck Janssen Ipsen Roche Servier SIRTeX Taiho; served on advisory boards for Bayer BMS Celgene Servier Shire/Baxalta Rafael Pharmaceuticals RedHill Roche has received travel support by Bayer Celgene RedHill Roche Servier Taiho and research grants (institutional) by Roche.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-41074-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"Computations were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project SNIC 2022/5−451 partially funded by the Swedish Research Council through grant agreement no. 2018-05973. This work was supported by the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) coordinated by Rémy Burcelin the respective national/regional funding organizations: Svenska Forskningsrådet FORMAS (2017-02001). This work was further supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) as part of the clinical research unit (CRU339); Food allergy and tolerance (FOOD@) —409525714. This work was also partially supported by research grants FIS (PI18/01022 and PI21/01361) and the project PI20/01090 (cofunded by the European Union under the European Regional Development Fund <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-41128-6",TRUE,"Competing interests W.-J.N. received honoraria for talks unrelated to this manuscript from Medtronic which is a manufacturer of deep brain stimulation devices. A.A.K. is on the advisory board of Boston Scientiﬁc and Medtronic and has received honoraria unrelated to this manuscript from Boston Scientiﬁc Medtronic Stadapharm and Teva companies manufacturing deep brain stimulation or pharmaceutical therapies. H.B. is a consultant of Alpha Omega and has received travel honoraria from Boston Scientiﬁc and Medtronic unrelated to this manuscript. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements J.G.Z. is supported by the National Nature Science Foundation of China (81830033 61761166004). <section> received funding from the Lundbeck Foundation project grant “Adaptive and precise targeting of cortexbasal ganglia circuits in Parkinson’s Disease” (Grant No.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-41180-2",TRUE,"Competing interests K.M.G. has received reimbursement for speaking at conferences sponsored by companies selling nutritional products and is part of an academic consortium that has received research funding from Abbott Nutrition Nestec BenevolentAI Bio Ltd. and Danone.",TRUE,"<section> Acknowledgements For this work A.B.-A. S.J.B. and L.P. were funded by the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. LP received funding from the British Skin Foundation (8010 Innovative Project) and the Academy of Medical Sciences Springboard Award which is supported by the Wellcome Trust The Government Department for Business Energy and Industrial Strategy the Global Challenges Research Fund and the British Heart Foundation [SBF003\\1094]. S.H. is supported by a Vera Davie Study and Research Sabbatical Bursary NRF Thuthuka Grant (117721) NRF Competitive Support for Unrated Researcher (138072) MRC South Africa under a Selfinitiated grant. M.S. has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-41502-4",TRUE,"Competing interests Sam Benson and Marc Vendrell declare the following competing interests: the SCOTﬂuor-based ﬂuorescent reagent (SCOTﬂuor510 lactate) is covered by a patent and it is commercialized by the company Tocris Bioscience. Patent applicant: The University of Edinburgh; Name of the inventor(s): Sam Benson and Marc Vendrell. Application number: WO/ 2020/187919. Status: Granted patent. All other authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by grants from the Swiss National Science Foundation (SNSF 310030_197940) the Dementia Research Switzerland",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-41876-5",TRUE,"Competing interests Mu. P. has received partnership funding for the following: MRC Clinical Pharmacology Training Scheme (co-funded by MRC and Roche UCB Eli Lilly and Novartis); and a Ph.D. studentship jointly funded by EPSRC and Astra Zeneca. Mu. P. also has unrestricted educational grant support for the UK Pharmacogenetics and Stratiﬁed Medicine Network from BristolMyers Squibb. Mu. P. has developed an HLA genotyping panel with MC Diagnostics but does not beneﬁt ﬁnancially from this. He is part of the IMI Consortium ARDAT (www.ardat.org). None of the funding outlined above is related to the current paper. None of the other authors have competing interests.",TRUE,"P. wishes to thank the MRC (MR/L006758/1 MR/ V033867/1) and NIHR (NIHR202349) for their support. B.M.J. is funded by a Medical Research Council (MRC) Clinical Research Training Fellowship (CRTF) jointly supported by the UK MS Society (B.M.J.; grant reference MR/V028766/ 1) and by Barts Charity. Genes & Health is/has recently been corefunded by Wellcome (WT102627 WT210561) the Medical Research Council (UK) (M009017 MR/X009777/1) Higher Education Funding Council for England Catalyst Barts Charity (845/1796) Health Data Research UK (for London substantive site) and research delivery support from the NHS National Institute for Health Research Clinical Research Network (North Thames). P. Funding acquisition: C.L. and H.H. <section> Funding",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-41954-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"Support for infrastructure has been provided by the KinderKrebsInitiative Buchholz/Holm-Seppensen. R.S. and M.G. received funding from the European Union′s Horizon 2020 research and innovation program under grant agreement No 952304. O.F. and W.W.W. were supported by grants from the Canadian Institutes of Health Research (PJT162120) Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2017-06824) and BC Children′s Hospital Foundation and Research Institute. This study was in part supported by grants from the Brigitte and Dr. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-42085-w",TRUE,"Competing interests The authors declare no conﬂicts of interest.",TRUE,"<section> Acknowledgements The work is supported by the German Research Foundation (DFG KU 3222/2-1) Sofja Kovalevskaja Award from Alexander von Humboldt Foundation to MK; the Heisenberg Award from the DFG (KU3222/3-1) to MK; support by the Josef Buchmann Family Foundation to NB a starter fellowship from SFB807 (D.F.G.) to R.M.S. <section> CFcryoEM was supported by the German Research Foundation (D.F.G.) through grant No. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-42188-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was supported by US NIH grants RC2-DK118620 R01-DK55758 R01-DK099110 R01-DK127274 and R01-DK131537 to P.E.S. We would also like to acknowledge support of the UTSWNORC grant under NIDDK/NIH award number P30-DK127984.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-42588-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This project received funding from European Social Fund (project No 09.3.3-LMT-K-712-17-0008) under grant agreement with the Research Council of Lithuania (LMTLT) to A.P. The project was also supported by grants from Brain Canada and the CAMH Foundation Project #554 from the Canadian Institutes of Health Research: TGH-158223 and PJT-148719 and the Krembil Foundation (CAMH Foundation Project #186) to A.P.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-42855-6",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-43372-2",TRUE,"Competing interests The authors of this manuscript have potential competing interests to disclose. The other authors report no competing interests.",TRUE,"<section> Acknowledgements This study was supported by the Bundesministerium für Bildung und Forschung (BMBF) through grant 031L0027 (DWB) by the Deutsche Forschungsgemeinschaft (DFG) grant FU 356/12-1 (ATT) by the Stiftung Universitätsmedizin Essen (ATT) and by the open access publication fund of the University Duisburg-Essen via project DEAL. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-43509-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This research was supported by Russian Science Foundation grant 22-15-00236 (AN DV RK GBZ KC) (electrophysiological experiments and data analysis in rodents); Deutsche Forschungsgemeinschaft grants DFG DR 323/5-1 and DFG DR 323/10-2 and Bundesministerium fuer Bildung und Forschung grant Era-Net Neuron EBio2 (JPD) (electrophysiological recordings and data analysis in patients); Ministerio de Ciencia e Innovación of Spain (MICINN) grant PID2019-111587RB-I00 (OH) (decomposition of cortical generators) and performed in the framework of the PRIORITY-2030 program of the Kazan Federal University. ; Funding acquisition: R.K. J.P.D. O.H.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-43553-z",TRUE,"Competing interests F.P. received research support for this study from F. Hoffmann-La Roche Ltd. Alexion Pharma Germany GmbH and Horizon Therapeutics Ireland DAC. The remaining authors declare no competing interests.",TRUE,"J.B. L.L. and A.T. were funded by the Federal Ministry of Health through a resolution of the German Bundestag (Charité Corona Cross (CCC) 2.0 and 2.1 and Charité Corona Protect (CCP)). <section> Funding",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-43614-3",TRUE,"Competing interests © The Author(s) 2023 The authors declare no competing interests.",TRUE,"J.K. was supported by the Deutsche Forschungsgemeinschaft (DFG Emmy-Noether Program Kr3886/2-2 and SBF-1074).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-43672-7",TRUE,"Competing interests Data presented in this manuscript are contained in the patent application WO2023143988A1 with ETH Zürich as applicant and E.M.C. M.R. C.T. and R.E. as inventors. E.M.C. M.R. C.T. and R.E. declare no additional competing interest. The remaining authors declare no competing interests.",TRUE,"<section> C. elegans strains used in this work were provided by the Caenorhabditis Genetics Centre (Univ. of Minnesota USA) which is funded by NIH Ofﬁce of Research Infrastructure Programs (P40 OD010440). We thank Functional Genomics Center Zurich (FGCZ) for support in acquisition and analysis of mass spectrometry data. This work was funded by the Swiss National Science Foundation (Schweizerischer Nationalfonds SNF 31003A_156031 31003A_176127 and 310030_204511 all to M.R.) and ETH Zürich. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-43741-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41467-023-43751-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by Deutsche Forschungsgemeinschaft (DFG grants MU-1764/6-Project ID:465470262 and MU-1764/7-Project ID:494535244) and by the Clusterproject ENABLE funded by the Hessian Ministry for Science and the Arts to S.M. DFG grants KE 222/10-1 and KE 222/11-1 to U.K. SFB1565 (Project ID:469281184) to K.E.B. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-43781-3",TRUE,"Competing interests MG and AU are co-inventors in patent applications related to the generation of a self-organizing neuromuscular junction cell culture model <section> ﬁled in USA (18/335765); Singapore (10202301703 V); Canada (P4410CA). The remaining authors declare no competing interests.",TRUE,"The work was supported by the Max Delbrück Center (MDC) which receives its core funding from the Helmholtz-Association. M.G. is funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (101002689) the Einstein Stiftung Berlin (Einstein Center 3 R EZ-2020-597-2) and the European Molecular Biology Organization Young Investigator program award. L.V.N.N. was supported by an ECRT PhD fellowship. The generation of SMA iPSCs was supported by NIH R01NS091749 to W.R. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-43881-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"We acknowledge the members of the tumor genetics laboratories at the Institutes of Human Genetics in Ulm and formerly Kiel (Germany) for their support and the members of the ICGC MMML-Seq consortium for contributing to BL cell line analyses. The study was funded by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics National Cancer Institute (NCI) (Contracts HHSN261201100063C and HHSN261201100007I) the Intramural Research Program National Institute of Allergy and Infectious Diseases (SJR) National Institutes of Health (NIH) Department of Health and Human Services and DFG via SFB1074 (Project B9). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-44033-0",TRUE,"Competing interests R.B.D. is a scientiﬁc advisor for Immagene B.V. C.K. serves as a medical advisor to Centogene for the validation of genetic testing reports in the ﬁeld of movement disorders and dementia excluding Parkinson’s disease and Retromer Therapeutics and received speakers’ honoraria from Bial and Desitin. The remaining authors declare no competing interests.",TRUE,"This work was supported by the German Research Foundation (WI/2111-4 WI/ 2111-6 WI/2111-8 FOR 2848 to KFW) and Germany’s Excellence Strategy SR-SIM microscopy was funded by the German Research Foundation and the State Government of North RhineWestphalia (INST 213/840-1 FUGG). Funding acquisition: K.F.W. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41467-023-44247-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was funded by the Max Planck Society. Tong Wu and Hai He were also funded by the China Scholarship Council. ; Funding Acquisition T.J.E. and A.B.-E. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41477-023-01407-y",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"J.S. is supported by the German Research Foundation (DFG) through grant no. 416210002 to C.M.T.S. R.Z. is supported by the DFG through grant nos ZO 302/5-1 and SFB-TRR 175 (A04). The CFcryoEM was supported by the DFG through grant no. INST 335/588-1 FUGG and the Berlin University Alliance. We acknowledge the support of the North-German Supercomputing Alliance for computation time. <section> Funding",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41514-023-00118-0",TRUE,"The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41523-023-00525-2",TRUE,"<section> COMPETING INTERESTS <section> All other authors declare no competing interests.",TRUE,"This analysis was funded by GBG. <section> FUNDING",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41526-023-00273-4",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING mitochondrial biogenesis in muscle by endurance exercise. The work in the group of A.R. was funded by the Dr. M.Y. was additionally funded by the Berlin School of Integrative Oncology reprints (BSIO) graduate program of the Charité Medical University Berlin and by the Einstein Foundation. D.B. and B.S. were supported by a grant from the Federal Department of",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41526-023-00295-y",TRUE,"Protocols should be established for the disclosure of operational performance data to qualiﬁed researchers. <section> COMPETING INTERESTS 17 The authors declare no competing interests.",TRUE,"H. Bed rest and intermittent cenThis research was supported by the European Space Agency (ESA).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41531-022-00443-3",TRUE,"<section> COMPETING INTERESTS <section> F.I. C.B. J.H. and L.O. report no conﬂicts of interest outside the submitted work.",TRUE,"The work was supported by Deutsche Forschungsgemeinschaft (Project-ID 424778381—TRR 295 Retune). <section> FUNDING",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41531-023-00540-x",TRUE,"The authors declare no competing interests.",TRUE,"This work was supported by the Medical Research Council (MC_UU_00003/2 and MR/V00655X/1) the Rosetrees Trust and by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID S.H. was supported by the BRAIN Non-Clinical Post-Doctoral Fellowship (HMR04170). Funding acquisition: H.T. and A.A.K.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41531-023-00545-6",TRUE,"<section> COMPETING INTERESTS <section> The authors have no conﬂict of interest to report regarding this manuscript. <section> Disclosures are as follows: Prof. <section> Schwarz report no disclosures.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41536-023-00291-6",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING A. A Wntwas funded by the German Federal Ministry of Education and Research (BMBF TGFβ2 axis induces a ﬁbrogenic program in muscle stem cells from dystrophic 031L0234B) European Union’s Horizon 2020 research and innovation program (Grant mice.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41537-023-00334-3",TRUE,"<section> COMPETING INTERESTS <section> B.E. M.H.L. L.M. I.G. and P.L. are employees of Analysis Group Inc. a consulting company that has provided paid consulting services to Janssen Scientiﬁc Affairs LLC which funded the development and conduct of this study and manuscript.",TRUE,"<section> This study was supported by Janssen Scientiﬁc Affairs LLC. He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41537-023-00341-4",TRUE,"<section> COMPETING INTERESTS <section> Dr.",TRUE,"We thank both the participants and patients who took part in the study and the research assistants of the YouR-study for supporting the recruitment and assessment of CHR participants. The study was supported by the Medical Research Council (MR/L011689/1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41537-023-00372-x",TRUE,"<section> COMPETING INTERESTS <section> C.U.C. has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Denovo Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Neurelis Newron Noven Novo Nordisk Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways Denovo Lundbeck Relmada Reviva Rovi Supernus and Teva. <section> He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. The other authors declare that they have no competing interests.",TRUE,"<section> FUNDING <section> The DiAPAson project is funded by the Italian Ministry of Health (Bando per la ricerca <section> He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41537-023-00378-5",TRUE,"<section> COMPETING INTERESTS The remaining authors declare no conﬂicts of interest.",TRUE,"<section> This study was funded by a grant from Independent Research Fund Denmark to S.D.Ø. (grant number: 7016-00048B). He has received grant support from Janssen and Takeda.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41537-023-00405-5",TRUE,"<section> COMPETING INTERESTS <section> Dr. C.U.C. has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Axsome Cardio Diagnostics Compass Damitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/ J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Medscape Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Noven Otsuka Pﬁzer Pharmabrain Recordati Relmada Reviva Rovi Seqirus Servier SK Life Science Sumitomo Dainippon Sunovion Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax and LB Pharma. Dr. A.B. does not have any competing interests to declare.",TRUE,"This study was funded by Lundbeck GmbH and Otsuka Pharma GmbH. He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41537-023-00420-6",TRUE,"<section> COMPETING INTERESTS <section> C.U.C. has been a consultant and/or advisor to or has received honoraria from Acadia Alkermes Allergan Angelini Axsome Gedeon Richter Gerson Lehrman Group Indivior IntraCellular Therapies Janssen/J&J LB Pharma Lundbeck MedAvanteProPhase Medscape Merck Neurocrine Noven Otsuka Pﬁzer Recordati Rovi Servier Sumitomo Dainippon Sunovion Supernus Takeda and Teva. He provided expert testimony for Janssen and Otsuka and served on a Data Safety Monitoring Board for Lundbeck Rovi Supernus and Teva. He has also received grant support from Janssen and Takeda and is a stock option holder of LB Pharma. S.D.O. received the 2020 Lundbeck Foundation Young Investigator Prize. Furthermore S.D.O owns units of mutual funds with stock tickers DKIGI NBIDE and WEKAFKI as well as units of <section> exchange traded funds with stock tickers TRET 2B76 and L0CK. The remaining authors declare no conﬂicts of interest.",TRUE,"This work was supported by grants from the Independent Research Fund Denmark the Aarhus University Research Foundation the Riisfort Foundation and the Faculty of Health— Aarhus He has also received grant support from Janssen and Takeda and is a stock option holder of LB Pharma.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41538-022-00176-w",TRUE,"The authors declare no competing interests.",TRUE,"Funding was provided by the Max Planck Society and a promotion stipend by the German Federal Environmental Foundation (EM).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41540-023-00287-4",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING <section> The work in the group of AR was funded by the Dr.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41540-023-00319-z",TRUE,"The authors declare no further competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41541-023-00713-y",TRUE,"The other co-authors declare no conﬂict of interest. To view a copy of this license visit http:// <section> COMPETING INTERESTS creativecommons.org/licenses/by/4.0/.",TRUE,"<section> This work was supported by South-Eastern Regional Health Authority Norway; the Research Council of Norway through its Centres of Excellence scheme project number 332727 and through grant #316060; the Norwegian Cancer Society #216135-2020; Stiftelsen Kristian Gerhard Jebsen; European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 865805); the University of Oslo and Oslo University Hospital and Novo Nordisk Foundation (to J.O.); the Deutsche Forschungsgemeinschaft (project number: 409512914) the David and Etta Jonas Center for Cellular Therapy at The University of Chicago the German Cancer Consortium the Einstein Foundation Berlin and the NIH grant R01-CA22677 (to M.L.). M.L. is a recipient of grant/research support from T-knife",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41551-023-01067-5",TRUE,"Competing interests M.R. is founder and shareholder of Eliptica Ltd. <section> on these points even when the disclosure is negative.",TRUE,"<section> Funding This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001134) the UK Medical Research Council (FC001134) and the Wellcome Trust (FC001134). Part of this research was funded by the European Research Council (ERC) under grant agreement ERC-SyG-2020 951475 the Wellcome Trust (IA 200829/Z/16/Z) and by the Ministry of Education and Research (BMBF) as part of the National Research Node ‘Mass spectrometry in Systems Medicine (MSCoresys) under grant agreement 161L0221 & 031L0220. C.B.M. was supported by the Precision Proteomic Center Davos which receives funding through the Swiss canton of Grisons.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41562-023-01707-5",TRUE,"Competing interests C.E.S. reports consulting fees from Jazz Pharmaceuticals and is now a full-time employee of the US Alzheimer’s Association. The rest of the authors report no competing interests. <section> on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements The Lifebrain consortium is funded by the EU Horizon 2020 grant agreement no. 732592 (Lifebrain). The different substudies are supported by different sources. LCBC is supported by the European Research Council under grant agreements no. 283634 and no. 725025 (to A.M.F.) and no. 313440 (to K.B.W.) as well as the Norwegian Research Council (to A.M.F. and K.B.W.) and the National Association for Public Health’s dementia research programme Norway (to A.M.F.). Betula is supported by a scholar grant from the Knut and Alice Wallenberg foundation to L.N. Barcelona is partially supported by a Spanish Ministry of Economy and Competitiveness grant to D.B.-F. (grant no. PSI2015-64227-R (AEI/FEDER UE)); by the Walnuts and Healthy Aging study (http://www.clinicaltrials.gov; grant no. NCT01634841) funded by the California Walnut Commission Sacramento California; and by an ICREA Academia 2019 award. <section> BASE-II has been supported by the German Federal Ministry of Education and Research under grant nos 16SV5537 16SV5837 16SV5538 16SV5536K 01UW0808 01UW0706 01GL1716A and 01GL1716B and by the European Research Council under grant agreement no. 677804 (to S.K.). Work on the Whitehall II Imaging Substudy was mainly funded by Lifelong Health and Wellbeing Programme grant no. G1001354 from the UK Medical Research Council (‘Predicting MRI Abnormalities with Longitudinal Data of the Whitehall II Substudy’) to K.P.E. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from award no. 203139/Z/16/Z from the Wellcome Trust.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41564-022-01304-8",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> This work was supported by the Berlin University Alliance (no. <section> 501_Massenspektrometrie 501_Linklab to M.R.) and the German Research Foundation (no. INST 335/797-1 to M.M. V.D. and M.R.). <section> This work was further supported by the Ministry of Education and Research as part of the National Research Node ‘Mass Spectrometry in Systems Medicine’ under grant agreement nos. <section> 161L0221 (to V.D.) and 031L0220 (to M.R.) and by the European Commission as part of CoBioTech project SyCoLim funded by BMBF (no. 161B0931 to M.R.) the European Research Council (ERC) under grant agreement ERC-SyG-2020 951475 (to M.R.) and the Wellcome Trust (IA 200829/Z/16/Z) to M.R. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41564-023-01352-8",TRUE,"Competing interests Related to this work Freie Universität Berlin has filed a patent application (FU227EP 22193939.01111 Freie Universität Berlin Germany) for the use of sCPD9 as vaccine in humans. In this application J.T. N.O. and D.K. are named as inventors of sCPD9. <section> Freie Universität Berlin is collaborating with RocketVax Inc. for further development of sCPD9 and receives funding for research. <section> Independent of this work G.N. has received project funding from Biotest AG; and M.W. received funding for research from Bayer Health Care Biotest Pantherna and Vaxxilon and for lectures and advisorship from Alexion Aptarion Astra Zeneca Bayer Health Care Berlin Chemie Biotest Boehringer Ingelheim Chiesi Glaxo Smith Kline Insmed Novartis Teva and Vaxxilon. The other authors declare no competing interests.",TRUE,"Funding was provided by: the European Union’s Horizon 2020 Research and Innovation Programme EVA-GLOBAL grant 871029; Deutsche Forschungsgemeinschaft grant OS 143/16-1 (N.O.) <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41564-023-01405-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by: BIH Grant: Multiscale Omics Projects (M.L). T.M.P. is financially supported by the Berlin School of Integrative Oncology through the GSSP programme of the German Academy of Exchange Service (DAAD) and by the Add-On Fellowship of the Joachim Herz Foundation. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41564-023-01433-8",TRUE,"Competing interests F.L. is a scientific advisory board member of Absea Biotechnology and VantAI. The remaining authors declare no competing interests.",TRUE,"Funding was provided by <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41569-022-00828-0",TRUE,"Competing interests M. Gotthardt has a consultancy agreement with River BioMedics and has received speaker honoraria from Bayer. V.N.P. reports a sponsored research agreement with BioMarin and consulting relationships with Constantiam and viz.ai. E.A. reports sponsored research from Bristol Myers Squibb has ownership interest in DeepCell Nuevocor and Personalis and is a board member of AstraZeneca. M.C.-F. is a cofounder and scientific adviser of GenoMed a molecular diagnosis company. B.M. holds stocks in biotech and pharma has received speaker honoraria from Bayer Bristol Myers Squibb Daiichi Sankyo Novartis and Pfizer and is on the Scientific Advisory Boards of Bristol Myers Squibb/Myokardia and Fleischhacker. L.S. <section> is a co-founder of SOPHiA Genetics as well as co-founder and board member of LevitasBio and Recombia Biosciences and receives research support from GlaxoSmithKline. L.L. has sponsored research agreements from Bristol Myers Squibb and Edgewise Therapeutics and is on the scientific advisory boards of Bristol Meyers Squibb/MyoKardia and Edgewise Therapeutics. The other authors declare no competing interests.",TRUE,"<section> This work was funded by Leducq TAN CASTT grant 21CVD02.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41569-023-00880-4",TRUE,"Competing interests <section> The other authors declare no competing interests.",TRUE,"This work was also supported by the DFG through its graduate programme on quantitative biomedical imaging (BIOQIC GRK 2260/1 DFG project number: 289347353) the DFG Priority Programme",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41569-023-00900-3",TRUE,"Competing interests The other authors declare no competing interests.",TRUE,"<section> We thank the German Research Foundation (grant number DE 1361/22-1) for funding the Heart Foundation (FS/ICRF/20/26002). D.R. is supported by the ERC Advanced Grant Deep4MI as well as by grants from the British Heart Foundation Bundesministerium für Bildung und Forschung Deutsche Forschungsgemeinschaft EU Horizon 2020 Engineering and Physical Sciences Research Council and InnovateUK. J.A.S. is supported by a Helmholtz Distinguished Professorship and a TUM Liesel Beckmann Professorship as well as by grants from the British Heart Foundation Bundesministerium für Gesundheit Cancer Research UK Engineering and Physical Sciences Research Council InnovateUK The Royal Society and The Wellcome Trust. D.E.N. has received research funding from the British Heart Foundation Chest Heart Stroke Scotland Chief Scientist Office Medical Research Council and The Wellcome Trust. <section> is supported by the British Heart Foundation (FS/SCRF/21/32010) and is the recipient of the Sir Jules Thorn Award for Biomedical Research 2015 (15/JTA). M.D. has received grant support from the FP7 Programme of the European Commission for the DISCHARGE trial (EC-GA 603266 in HEALTH.2013.2.4.2-2) and has also received grant support from the German Research Foundation in the Heisenberg Programme (DE 1361/14-1 DFG project 213705389) the graduate programme on quantitative biomedical imaging (BIOQIC GRK 2260/1 DFG project 289347353) and for fractal analysis of myocardial perfusion (DE 1361/18-1 DFG project 392304398) the DFG Priority Programme Radiomics (DFG project 402688427) for the investigation of coronary plaque and coronary flow (DE 1361/19-1 (DFG project 428222922) and DE 1361/20-1 (DFG project 428223139) in SPP 2177/1) the GUIDE-IT project on data sharing of medical imaging trials (DE 1361/24-1 (DFG project 495697118)) the Quantitative Cardiovascular Imaging meeting (DE 1361/22-1) and the Future of Medical Imaging meeting (DE 1361/28-1). He has also received funding from the Berlin University Alliance (GC_SC_PC 27) and from the Digital Health Accelerator of the Berlin Institute of Health.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41572-023-00454-1",TRUE,"Competing interests <section> M.S. has received honoraria from and has been a consultant for AbbVie Angelini Lundbeck and Otsuka.",TRUE,"<section> M.B. is supported by an NHMRC Senior Principal Research Fellowship and Leadership Investigator grant (1156072 and 2017131). W.M. is currently funded by an NHMRC Investigator Grant (#2008971). J.F. is supported by UK Research and Innovation Future Leaders Fellowship (MR/T021780/1). M.B. has received grant and research support from the National Health and Medical Research Council Wellcome Trust Medical Research Future Fund Victorian Medical Research Acceleration Fund Centre for Research Excellence CRE Victorian Government Department of Jobs Precincts and Regions and Victorian COVID-19 Research Fund.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41573-023-00750-1",TRUE,"Competing interests <section> P.K. received speaker’s fees honoraria or travel support from Novartis ValenzaBio Roche and Takeda.",TRUE,"J.M. is or has been a member of national and international scientific advisory boards consulted and received fees for lectures and grants for research projects or clinical trials from AstraZeneca Genentech-Roche GSK LETI Menarini MSD Mitsubishi-Tanabe Viatris/MEDA Pharma Novartis OPTINOSE Proctor & Gamble Sanofi-Genzyme & Regeneron UCB Pharma and NOUCOR/Uriach Group; received financial support from AGAUR and ISCiii; and is Editorin-Chief of Current Treatment Options in Allergy. H.R. is supported by the German Lung Center (DZL) and the Universities Giessen and Marburg Lung Center (UGLMC) the MIRACUM Consortium of the Medical Informatics Initiative the Stiftung Pathobiochemistry and DAAD and GIZ Hospital Partnership Programme the DFG BMBF EU and Land Hessen; has received speakers’ honorarium from Allergopharma Novartis ThermoFisher Danone Bencard and Stallergenes; has consulted for Sternabiologicals (cofounder); and is Associate Editor of Journal of Allergy and Clinical Immunology (JACI).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41573-023-00774-7",TRUE,"Competing interests J.J.J.v.d.H. is a member of the scientific advisory board of NAICONS Srl. Milan Italy. C.A.D. <section> is a founding member of Adapsyn Bioscience. M.A.S. is a consultant to Adapsyn Bioscience. M.H.M. is on the scientific advisory board of Hexagon Bio and co-founder of Design Pharmaceuticals. The other authors declare no competing interests.",TRUE,"<section> Acknowledgements All authors thank the Lorentz Center and Leiden University for funding the Lorentz Workshop ‘Artificial Intelligence for Natural Product Drug Discovery’ that laid the foundation for this Review. M.W.M. was supported by funds from the Duchossois Family Institute at the University of Chicago. K.R.D. was supported by the UK Research and Innovation Biotechnology and Biological Sciences Research Council (BB/R022054/1). N.G. was supported by an NSF CAREER award (award number 2047235). J.J.J.v.d.H. was supported by an ASDI eScience grant from the Netherlands eScience Center (award number ASDI.2017.030). N.I.M. is supported by funding from the European Research Council (ERC consolidator grant agreement no. 725523). K.B. was supported by a Novo Nordisk Foundation grant NNF20CC0035580. E.J.N.H. was supported by the LOEWE Center for Translational Biodiversity Genomics and the Funds of the Chemical Industry Germany. M.A.B. was supported by the National French Agency (ANR grants 15-CE29-0001 and 20-CE43-0010). C.M.C. was supported by a National Library of Medicine training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM 5T15LM007359). H.K. was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (grants NRF 2018R1A5A2023127 and NRF 2022R1F1A107462311). J.M. was supported by a grant from the Research Foundation – Flanders (G061821N). E.R.R. was supported by the US National Science Foundation (DBI-1845890). D.R. was supported in part by a Flash Grant from NC Biotech (2021-FLG-3819) a UNC CGIBD Pilot Award (NIH NIDDK DK034987) a Duke Cancer Institute and Duke Microbiome Center Pilot Award (NIH NCI CA014236) the Engineering Research Center for Precision Microbiome Engineering (NSF EEC-2133504) and the Duke Science and Technology Initiative. P.S. acknowledges support from the NCCR Catalysis (grant number 180544) a National Centre of Competence in Research funded by the Swiss National Science Foundation. H.U.K. was supported by the KAIST Key Research Institute (Interdisciplinary Research Group) Project. R.G.L. was supported by the US NIH (U41-AT008718 and U24-AT010811). M.H.M. was supported by the Leiden University ‘van der Klaauw’ chair for theoretical biology and an ERC Starting Grant (DECIPHER-948770).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41575-023-00759-2",TRUE,"Competing interests D.Q.H. has served as an advisory board member for Eisai and Gilead.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41575-023-00807-x",TRUE,"Competing interests <section> F.T.’s laboratory has received research funding from Allergan Bristol-Myers Squibb Gilead and Inventiva (funding to the institution). F.T. has received honoraria for consulting or lectures from Astra Zeneca Gilead AbbVie BMS Boehringer Madrigal Intercept Falk Ionis Inventiva Merz Pfizer Alnylam NGM CSL Behring Novo Nordisk and Novartis. L.H. declares no competing interests.",TRUE,"<section> L.H. is supported by the German Research Foundation (DFG SPP2306) and the Else-KroenerFresenius-Stiftung (grant ID 2021_EKEA.145). F.T. is supported by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 project ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium BMBF Immun Avatar consortium).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41575-023-00872-2",TRUE,"Conflict of interest statements were collected from all panel members before and after the development of the present guidelines and authors with specific conflicts of interest were excluded from voting. <section> The guideline methodologist had no conflicts of interest. <section> Competing interests The other authors declare no competing interests.",TRUE,"<section> This study was partially funded by the Italian Ministry of Health Current Research IRCCS.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41577-023-00942-1",TRUE,"Competing interests <section> D.A. has contributed to scientific advisory boards at Pfizer Takeda FARE and the KRF. A.N.J.M. <section> is on the scientific advisory board of SinoMab. The other authors declare no competing interests.",TRUE,"<section> This work was supported by grants from the European Research Council Starting Grant (ERCEA; 803087 to C.S.N.K.) the German Research Foundation (DFG; project ID 259373024– CRC/TRR 167 project ID 322359157–FOR2599 project ID 375876048–CRC/TRR 241 and SPP1937 KL 2963/5-2 KL 2963/2-1 and KL 2963/3-1 to C.S.N.K.) and the US National Institutes of Health (DK126871 AI151599 AI095466 AI095608 AI142213 AR070116 AI172027 DK132244) the Crohn’s and Colitis Foundation Cure for IBD Jill Roberts Institute the Sanders Family and the Rosanne H. A.N.J.M. is supported by the Medical Research Council as part of UK Research and Innovation (MRC grant U105178805) and Wellcome Trust (220223/Z/20/Z).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41581-023-00731-y",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"The work of the authors is funded by the Deutsche Forschungsgemeinschaft (grant ID 318374368).",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41582-023-00808-z",TRUE,"Competing interests All authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41582-023-00842-x",TRUE,"Competing interests C.W. and M.A.M. declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41583-023-00723-8",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> This work received support from the European Research Council (ERC) the New York Stem Cell Foundation (NYSCF) the Human Frontier Science Program (HFSP) the Fondation pour la Recherche Médicale (FRM) the Fondation Bettencourt-Schueller (FBS) the Fondation Schlumberger pour l’Education et la Recherche (FSER) and the Marie Skłodowska-Curie European Training Network initiative.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41583-023-00769-8",TRUE,"Competing interests The authors declare no competing financial interests.",TRUE,"F.L.H. also received funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy — EXC-2049 — 390688087 and through HE 3130/6-1 as well as from the German Center for Neurodegenerative Diseases (DZNE) Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41584-022-00887-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> The authors acknowledge funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) (SFB 1444).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41586-022-05546-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"F.D.B. is funded by AI045008 AI120489 R33HL137063 CA219871 AI139240 and the PennCHOP Microbiome Program. W.M.d.V. is supported by the Gravitation grant 024.002.002 of the Netherlands Organization for Scientific Research. W.M.d.V. and A.S. are supported by the Academy of Finland (grants 1308255 and 1325103). A.M.E. is funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health Department of Health and Human Services under grant number U19AI110818 to the Broad Institute. M.G.G. and D.M.S are funded by the Canada Research Chairs Program. L.J.H. is supported by Wellcome Trust Investigator Awards 100974/C/13/Z and 220876/Z/20/Z and by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Gut Microbes and Health BB/R012490/1 and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356. M.W.H. has received funding from the ERC under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 101019157). S.L. has received funding from the ERC under the European Union’s Horizon 2020 research and innovation programme (grant agreement 852600 Lacto-Be). Work in the laboratories of P.W.O. L.O. and J.W. is supported by Science Foundation Ireland (SFI) through a Centre award (APC/SFI/12/RC/2273_P2) to APC Microbiome Ireland. D.M.S. is funded by the Canadian Institute for Health Research and the Canada Research Chairs Program. M.Y. is supported by the Azrieli Faculty Fellowship.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41586-022-05682-1",TRUE,"Competing interests D. The other authors declare no competing interests.",TRUE,"Dragun and funded by the Berlin Institute of Health and the Charité–Universitätsmedizin Berlin. This work was partially funded by the Max Planck Society. Work in the Hnisz Lab is supported by the Deutsche Forschungsgemeinschaft (DFG) Priority Program Grants HN 4/1-1 and HN 4/3-1 and a Worldwide Cancer Research grant (20-0232). M.S. is supported by grants from the DFG (SP1532/3-2 SP1532/4-1 and SP1532/5-1) and the Deutsches Zentrum für Luftund Raumfahrt (DLR 01GM1925). H. Niskanen is supported by fellowships from the Orion Research Foundation and the Instrumentarium Science Foundation. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). <section> Funding Open access funding provided by Max Planck Society.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41586-023-05705-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by the European Research Council (ERC2015-CoG-682422 J.F.A.P.) the European Union (3x3Dimaging 323945 J.F.A.P.) the Deutsche Forschungsgemeinschaft (FOR 2143 J.F.A.P. <section> Funding Open access funding provided by Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41586-023-05755-9",TRUE,"Competing interests S.F.C. is a consultant for and holds equity interest in Imago Biosciences. The remaining authors declare no competing interests.",TRUE,"<section> was supported by a Scholar Award from the American Society of Hematology a Momentum Fellowship Award from The Mark Foundation for Cancer Research a Young Investigator Award from the Edward P. S.A.A. was supported by NIH grants CA176745 CA206963 CA204639 and CA066996. S.A.A. and R.M.S. were supported by a SPORE grant in myeloid malignancies (P50CA206963). R.L.L. was supported by a Cycle For Survival Innovation grant NCI grants R35 CA197594 and R01 CA173636 a grant from the Samuel Waxman Cancer Research Foundation funding support from the Martino Family Foundation and SCOR grants from the Leukemia and Lymphoma Society. C.M. was funded by a Momentum Fellowship award by the Mark Foundation for Cancer Research. E.S.F. was supported by NIH grants CA214608 and CA066966. H.R. was supported by a Fellow award from the Leukemia and Lymphoma Society. The Chodera laboratory receives or has received funding from the NIH the National Science Foundation the Parker Institute for Cancer Immunotherapy Relay Therapeutics Entasis Therapeutics Silicon Therapeutics EMD Serono (Merck KGaA) AstraZeneca Vir Biotechnology XtalPi Interline Therapeutics the Molecular Sciences Software Institute the Starr Cancer Consortium the Open Force Field Consortium Cycle for Survival a Louis V.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41586-023-05844-9",TRUE,"Competing interests During the drafting of the manuscript P.R.H.J.T. became a part-time employee of BioAge Labs P.S. became a full-time employee of GSK and D.S.P. became a full-time employee of AstraZeneca.",TRUE,"The academic coordinating centre for INTERVAL was supported by core funding from the: NIHR Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics (NIHR BTRU-2014-10024) NIHR BTRU in Donor Health and Behaviour (NIHR203337) UK Medical Research Council (MR/L003120/1) British Heart Foundation (SP/09/002; RG/13/13/30194; RG/18/13/33946) and NIHR Cambridge BRC (BRC-1215-20014; NIHR203312). INTERVAL Metabolon assays were funded by the NIHR BioResource Wellcome Trust grant number 206194 BioMarin Pharmaceutical and the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). INTERVAL Nightingale Health NMR assays were funded by the European Commission Framework Programme 7 (HEALTH-F22012-279233). The MEC is funded by individual research and clinical scientist award schemes from the Singapore National Medical Research Council (NMRC including MOH-000271-00) and the Singapore Biomedical Research Council (BMRC) the Singapore Ministry of Health (MOH) the National University of Singapore (NUS) and the Singapore National University Health System (NUHS). This work on omics polygenic score transferability is supported by the NUS–Cambridge Seed Grant July 20201 (NUSMEDIR/ Cambridge/2021-07/001). NPM made use of data and samples collected in the following cohorts in Singapore: (1) the Health for Life in Singapore (HELIOS) study at the Lee Kong Chian School of Medicine Nanyang Technological University Singapore (supported by grants from a Strategic Initiative at Lee Kong Chian School of Medicine the Singapore Ministry of Health (MOH) under its Singapore Translational Research Investigator Award (NMRC/STaR/0028/2017) and the IAF-PP: H18/01/a0/016); (2) the Growing up in Singapore Towards Healthy Outcomes (GUSTO) study which is jointly hosted by the National University Hospital (NUH) KK Women’s and Children’s Hospital (KKH) the National University of Singapore (NUS) and the Singapore Institute for Clinical Sciences (SICS) Agency for Science Technology and Research (A*STAR) (supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health’s National Medical Research Council (NMRC) Singapore-NMRC/ TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by SICS and IAF-PP H17/01/a0/005); (3) the Singapore Epidemiology of Eye Diseases (SEED) cohort at Singapore Eye Research Institute (SERI) (supported by NMRC/CIRG/1417/2015; NMRC/CIRG/ 1488/2018 and NMRC/OFLCG/004/2018); (4) the MEC cohort (supported by NMRC grant 0838/2004 BMRC grants 03/1/27/18/216 05/1/21/19/425 and 11/1/21/19/678 Ministry of Health Singapore National University of Singapore and National University Health System Singapore); (5) the SingHealth Duke–NUS Institute of Precision Medicine (PRISM) cohort (supported by NMRC/CG/M006/2017_NHCS NMRC/StaR/0011/2012 NMRC/StaR/ 0026/2015 Lee Foundation and Tanoto Foundation); (6) the TTSH Personalised Medicine Normal Controls (TTSH) cohort (supported by NMRC/CG12AUG17 and CGAug16M012). <section> Proteomic measurements were supported and governed by a collaboration agreement between the University of Cambridge and SomaLogic. The Fenland Study (10.22025/ 2017.10.101.00001) is funded by the Medical Research Council (MC_UU_12015/1). We further acknowledge support for genomics from the Medical Research Council (MC_PC_13046). <section> ORCADES was supported by the Chief Scientist Office of the Scottish Government (CZB/4/276 and CZB/4/710) a Royal Society URF to J.F.W. the MRC Human Genetics Unit quinquennial programme ‘QTL in Health and Disease’ Arthritis Research UK and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Viking Health Study Shetland (VIKING) was supported by the MRC Human Genetics Unit quinquennial programme grant ‘QTL in Health and Disease’. We acknowledge support from the MRC Human Genetics Unit programme grant ‘Quantitative traits in health and disease’ (U. Wholegenome sequencing for the Trans-Omics in Precision Medicine (TOPMed) program was supported by the National Heart Lung and Blood Institute (NHLBI). The Jackson Heart Study (JHS) is supported and conducted in collaboration with Jackson State University (HHSN268201800013I) Tougaloo College (HHSN268201800014I) the Mississippi State Department of Health (HHSN268201800015I) and the University of Mississippi Medical Center (HHSN268201800010I HHSN268201800011I and HHSN268201800012I) contracts from the NHLBI and the National Institute on Minority Health and Health Disparities (NIMHD). This work was also funded by the Swedish Research Council (2019-01497) and the Swedish Heart-Lung foundation (20200687). <section> are funded by a BHF Programme Grant (RG/18/13/33946). C.L. M.P. and J.L. were funded by the Medical Research Council (MC_UU_00006/1 – Aetiology and Mechanisms). S.A.L. was supported by a Canadian Institutes of Health Research postdoctoral fellowship (MFE-171279). U.A.T. is supported by a US National Institutes of Health Mentored Clinical Scientist Development Award program (1K08HL161445-01A1). J.E.P. was supported by a Medical Research Foundation grant (MRF-042-0001-RG-PETE-C0839). E.E.D. is supported by a Wellcome Trust grant (206194 220540/Z/20/A). R.E.G. is supported by a US National Institutes of Health grant for proteomics in the Jackson Heart Study (R01 HL133870) and an NIH contract to perform proteomics and metabolomics in multiple cohorts (HHSN268201600034I). This study was supported by the Victorian Government’s Operational Infrastructure Support (OIS) program. This work was supported by Health Data Research UK which is funded by the UK Medical Research Council Engineering and Physical Sciences Research Council Economic and Social Research Council Department of Health and Social Care (England) Chief Scientist Office of the Scottish Government Health and Social Care Directorates Health and Social Care Research and Development Division (Welsh Government) Public Health Agency (Northern Ireland) British Heart Foundation and Wellcome. This research was supported by an HDRUK Director’s Innovation Award (HDRUK2022.0130).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41586-023-06003-w",TRUE,"Competing interests .",TRUE,"The work was part funded by the NIHR Blood and Transplant Research Unit in Genomics to Enhance Microbiology Screening (GEMS) the National Institute for Health and Care Research (CO-CIN-01) or jointly by NIHR and UK Research and Innovation (CV220-169 MC_PC_19059). J.B. receives NIHR Senior Investigator Funding. M.N. J.B. and G.P. are supported by the NIHR University College London Hospitals Biomedical Research Centre.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41586-023-06311-1",TRUE,"Competing interests In the past 3 years S.A.T. has consulted or been a member of scientific advisory boards at Roche Genentech Biogen GlaxoSmithKline Qiagen and ForeSite Labs and is an equity holder of Transition Bio. The remaining authors declare no competing interests. <section> on these points even when the disclosure is negative.",TRUE,"<section> Trust Tissue Bank is funded by the National Institute for Health Research (NIHR) Biomedical Research",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41586-023-06548-w",TRUE,"Competing interests J.S. is a scientific advisory board member consultant and/or co-founder of Cajal Neuroscience Guardant Health Maze Therapeutics Camp4 Therapeutics Phase Genomics Adaptive Biotechnologies Scale Biosciences Pacific Biosciences Prime Medicine and Sixth Street Capital. All other authors declare no competing interests. <section> All studies must disclose on these points even when the disclosure is negative. <section> All studies must disclose on these points even when the disclosure is negative. <section> All studies must disclose on these points even when the disclosure is negative.",TRUE,"Lawrence Berkeley National Laboratory was supported by US NIH grants to L.A.P. and A.V. M.S. is a DZHK principal investigator and is supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SP1532/3-1 SP1532/4-1 and SP1532/5-1) and the Deutsches Zentrum für Luftund Raumfahrt (DLR 01GM1925). D.R.B. was supported by R01HD36404 from the National Institute of Child Health and Human Development. J.C. is supported by the NIH (grant DP2 HG012522-01 and RM1HG011014) and the Rockefeller University. M.H.d.A. and work at the German Mouse Clinic were supported by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012); German Center for Diabetes Research (DZD). <section> Funding Open access funding provided by Universität zu Lübeck.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Policy information about clinical studies All manuscripts should comply with the ICMJE guidelines for publication of clinical research Clinical trial registration Provide the trial registration number from ClinicalTrials.gov Study protocol Note where the full trial protocol can be accessed OR Data collection Describe the settings and locales of data collection Outcomes Describe how you pre-defined primary and secondary",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41586-023-06585-5",TRUE,"Competing interests The authors declare no competing interests. <section> All studies must disclose on these points even when the disclosure is negative.",TRUE,"This work was supported by the Excellence Cluster Cardio Pulmonary System (CPI) the DFG Transregional Collaborative Research Centres 81 (TP A02) and 267 (TP A05) the DFG Collaborative Research Centres 1213 (TP A02 and B02) and 1531 (TP B08) and the German Centre for Cardiovascular Research. The work of M.P. was supported by the European Research Council Consolidator Grant EMERGE (no. 773047). <section> Funding Open access funding provided by Max Planck Society.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41586-023-06704-2",TRUE,"Competing interests A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories. All other authors declare no competing interests.",TRUE,"C.A.L. is supported by a Stanford Science Fellowship a Parker Institute for Cancer Immunotherapy Scholarship a seed award from the Center for Human Systems Immunology and NIH K99 HG012076. A.T.S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists the Parker Institute for Cancer Immunotherapy a Pew-Stewart Scholars for Cancer Research Award a Cancer Research Institute Lloyd J. S.L. is supported by the NCI Research Specialist Award (R50CA251956). This work was supported by a sponsored research agreement with Allogene Therapeutics. Part of the analysis was carried out by the Center for Translational Immunology and Immunotherapy (CeTI ) which is supported by St.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41587-023-01704-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy— EXC 2008—390540038 (J.R.)—UniSysCat and project 329673113 (J.R.) and under Germany’s Excellence Strategy—EXC 2002/1 ‘Science of Intelligence’—project number 390523135 (O.B.). This research was funded in part by the Wellcome Trust (grant number 203149) (J.R.). <section> The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (203149) (J.R.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41587-023-01881-x",TRUE,"Competing interests H.H. is a cofounder and equity holder of Omniscope a Scientific Advisory Board member of MiRXES and a consultant to Moderna. The remaining authors declare no competing interests.",TRUE,"This publication is also supported as part of a project (BCLLATLAS and ESPACE) that has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement numbers 810287 and 874710). This work was supported by a European Research Council Consolidator grant to S.A. (724226_cis-CONTROL) KU Leuven (C14/22/125 to S.A.) Foundation Against Cancer (F/2020/1396 to S.A.) F.W.O. (grants G0I2722N G0B5619N and G094121N to S.A. and a PhD fellowship to F.D.) and Aligning Science Across Parkinson’s (grant number ASAP-000430 to S.A.). K.B.M. and S.A.T. are supported by Wellcome (WT211276/Z/18/Z and Sanger core grant WT206194). M.R.C. is supported by the National Institutes on Aging K99/R00AG059918. This work was supported by funding from the Rita Allen Foundation (W.J.G.) and the Human Frontiers Science Program (RGY006S; W.J.G.). <section> received financial support by Swiss National Science Foundation 310030_197082 and the EPFL. A.C.A. is supported by National Institutes of Health grants RF1-MH128842 R35-GM124704 and R01-DA047237 as well as a Silver Family Foundation Innovator Award.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41588-022-01270-1",TRUE,"Competing interests J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. All other authors declare that there are no conflicts of interest.",TRUE,"<section> Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 94473 and the Canada Foundation for Innovation and the following provinces Newfoundland Nova Scotia Quebec Ontario Manitoba Alberta and British Columbia. <section> The Richards research group is supported by the Canadian Institutes of Health Research (CIHR: 365825 409511 and 100558) the Lady Davis Institute of the Jewish General Hospital the Canadian Foundation for Innovation the NIH Foundation Cancer Research UK (grant number C18281/A29019) Genome Québec the Public Health Agency of Canada Genome Québec McGill University and the Fonds de Recherche Québec Santé (FRQS). J.B.R. is supported by an FRQS Clinical Research Scholarship. TwinsUK is funded by the Welcome Trust Medical Research Council European Union the National Institute for Health Research (NIHR)-funded BioResource Clinical Research Facility and Biomedical Research Center based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. T.L. has been supported by a Vanier Canada Graduate Scholarship an FRQS. doctoral training fellowship and a McGill University Faculty of Medicine studentship. T.N. is supported by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists. C.-Y.S. has been supported by the Lady Davis Institute/TD Bank Studentship Award. S.Z. has been supported by a CIHR fellowship and an FRQS. fellowship. Funding acquisition: J.B.R.",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41588-023-01314-0",TRUE,"Competing interests M.D.T. and L.V.W. have previously received funding from GSK for collaborative research projects outside of the submitted work. The other authors declare no competing interests.",TRUE,"This study was supported by BREATHE–The Health Data Research Hub for Respiratory Health (grant no. MC_PC_19004). This study was partially supported by the NIHR Leicester Biomedical Research Centre and the NIHR Nottingham Biomedical Research Centre; views expressed are those of the author(s) and not necessarily those of the NHS the NIHR or the Department of Health. This research was funded in part by the Wellcome Trust. This study was also supported by specific personal funding from the following: Wellcome Trust Institutional Strategic Support Fund (grant no. 204801/Z/16/Z) and BHF Accelerator Award AA/18/3/34220 to A.L.G. <section> Competing interests M.D.T. and L.V.W. have previously received funding from GSK for collaborative research projects outside of the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41588-023-01386-y",TRUE,"Competing interests R.P.K. and A.G.H. are founders of Econic Biosciences Ltd.",TRUE,"<section> Acknowledgements A.G.H. is supported by the Deutsche Forschungsgemeinschaft (DFG) (grant no. 398299703). This project has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (grant no. 949172). A.G.H. is supported by the Deutsche Krebshilfe Mildred Scheel Professorship program no. 70114107. This project was supported by the Berlin Institute of Health (BIH). R.F.S. is a Professor at the Cancer Research Center Cologne Essen funded by the Ministry of Culture and Science of the State of North Rhine-Westphalia. <section> This work was partially funded by the German Ministry for Education and Research as BIFOLD (Berlin Institute for the Foundations of Learning and Data) (refs. This work was delivered as part of the eDyNAmiC team supported by the Cancer Grand Challenges partnership funded by Cancer Research UK (H.Y.C. no. CGCATF-2021/100012 A.G.H. no. CGCATF-2021/100017) and the National Cancer Institute (H.Y.C. no. OT2CA278688 A.G.H. no. OT2CA278644).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41588-023-01408-9",TRUE,"Competing interests I.B. and spouse declare stock ownership in GlaxoSmithKline Incyte Ltd. and Inivata Ltd. All other authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by NCI NHGRI NHLBI NIDA NIMH and NINDS. Further details about The Genotype-Tissue Expression (GTEx) Project was supported Health and by NCI NHGRI NHLBI NIDA NIMH and NINDS.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41588-023-01409-8",TRUE,"Competing interests R.P.M. and E.D.K. are employees of Metabolon and as such have affiliations or financial involvement with Metabolon. All other authors declare no competing interests.",TRUE,"<section> Acknowledgements The work of Y.L. was supported by grant KO 3598/4-2 (to A.K.). Schlosser was supported by the German Research Foundation (DFG) project ID 1050086601 (SCHL 2292/2-1 Walter Benjamin Fellowship) and the EQUIP Program for Medical Scientists Faculty of Medicine University of Freiburg. Kotsis and U.T.S. was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant 01ZX1912B). The work of A.K. M.K. and M.S. was supported by Germany’s Excellence Strategy (CIBSS EXC-2189 project ID 390939984). The work of M.S. was supported by the ERC starting grant TREATCilia grant agreement no. 716344. The work of Y.C. was supported by the DFG SFB 1479 (project ID 441891347-S1). <section> and J.C. was supported by grant R01DK124399. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement no. 115974. The GCKD study was and is supported by the BMBF (FKZ 01ER 0804 01ER 0818 01ER 0819 01ER 0820 and 01ER 0821) and the KfH Foundation for Preventive Medicine. The ARIC study has been funded in whole or in part with federal funds from the National Heart Lung and Blood Institute National Institutes of Health Department of Health and Human Services under contract nos. Funding was also supported by R01HL087641 and R01HL086694 National Human Genome Research Institute contract U01HG004402 and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by grant no. UL1RR025005 a component of the National Institutes of Health Roadmap for Medical Research.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Patients regularly seen by nephrologists with eGFR between 30 and 60 ml min −1 per 1.73 m 2 or eGFR >60 ml min −1 per 1.73 m 2 with UACR > 300 mg per g (or urinary protein/creatinine ratio > 500 mg per g) were included This study used biomaterials collected at the baseline visit shipped frozen to a central biobank and stored at −80 °C A more detailed description of the study design standard operating procedures and the recruited study population has been published 5355 The GCKD study was registered in the national registry for clinical studies (DRKS 00003971) and approved by local ethic committees of the participating institutions (universities or medical faculties of Aachen Berlin Erlangen Freiburg Hannover Heidelberg Jena München and Würzburg) All participants provided written informed consent.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41588-023-01422-x",TRUE,"Competing interests B.A.J. and J. The other authors report no competing interests.",TRUE,"This work was supported by the following institutions grants and funding agencies: Columbia University Columbia Glomerular Center IGA Nephropathy Foundation of America and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants R01-DK105124 (to K.K. J. J.B.H. S.P. L.K. and M.W. were supported by R01HG010730 U01AI130830 R01NS099068 R01AI024717 R01AR073228 U01AI150748 R01AI148276 P01AI150585 and the US Department of Veterans Affairs Merit Award I01-BX001834 to J.B.H. The German STOP-IgAN study was supported by the DFG (German Research Foundation)— CRU 5011—Project-ID 445703531 (to J.F. T.R.). The GCKD study was funded by grants from the German Ministry of Education and Research (BMBF 01ER0804) and the KfH Foundation for Preventive Medicine. The recruitment of Polish cases with IgAN was sponsored by the Polish Kidney Genetics Network (POLYGENES) a collaborative effort between Columbia University and Poznań University of Medical Sciences Poland. The recruitment of Czech patients with IgAN was supported by the research project of General University Hospital in Prague (RVO-VFN64165). The recruitment of the Russian cohort was supported by the Government Assignment of the Russian Ministry of Health Assignment 200080056 of the Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University. The recruitment of the Swedish cohort was supported by the Nephrology and Rheumatology Departments at Karolinska University Hospital and Karolinska Institutet Stockholm and grants from the Swedish Society of Medicine. The recruitment of the Korean cohort was supported by the Seoul National University Hospital Human Biobank a member of the National Biobank of Korea financed by the Ministry of Health and Welfare Republic of Korea.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41588-023-01433-8",TRUE,"Competing interests The Broad Institute has filed for a patent relating to the use of the technology described in this paper where C.A.L. L.S.L. C.M. A.R. The remaining authors declare no competing interests.",TRUE,"Patient samples and data from adult donors with KSS and CPEO were provided by the North American Mitochondrial Disease Consortium (NAMDC) which is funded by a grant from NIH (U54NS078059). Shimamura (Boston Children’s Hospital) and the Boston Children’s Hospital Bone Marrow Failure and Myelodysplastic Syndrome program for their support in this study (supported by NIH grant RC2DK122533). We acknowledge support from the Broad Institute and the Whitehead Institute Flow Cytometry core facilities. This work was supported by NIH K99 HG012579 (to C.A.L.) RC2 DK122533-01 (to M.D.F.) R01 DK103794 (to V.G.S.) R33 HL120791 (to V.G.S.) R01 DK107716 (to S.A.) R33 HL154133 (to S.A.) and UM1 HG012076 (to C.A.L. A.T.S. and L.S.L.). <section> This research was supported by a Stanford Science Fellowship (to C.A.L.) BroadIgnite Award (to L.S.L.) an Emmy Noether fellowship by the German Research Foundation (D.F.G.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41588-023-01444-5",TRUE,"Competing interests J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. The remaining authors declare no competing interests.",TRUE,"The Richards research group is supported by the Canadian Institutes of Health Research (CIHR: 365825; 409511 100558) the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) the Lady Davis Institute of the Jewish General Hospital the Jewish General Hospital Foundation the Canadian Foundation for Innovation the NIH Foundation Genome Québec the Public Health Agency of Canada McGill University and the Fonds de Recherche Québec Santé (FRQS). S.Z. is supported by a CIHR fellowship and a FRQS postdoctoral scholarship. TwinsUK is funded by the Welcome Trust Medical Research Council European Union the National Institute for Health Research (NIHR)-funded BioResource Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. This research received funding from Regeneron Pharmaceuticals Inc.",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41588-023-01462-3",TRUE,"Competing interests A.T. has received grant funding from Sun Pharmaceuticals and Eli Lilly. The other authors declare no competing interests. <section> on these points even when the disclosure is negative.",TRUE,"We are supported by the following: the Medical Research Council (grants MR/L01341X/1 to P.E. MR/R010676/1 to B.J. MR/R010676/1 to A.T.)",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41588-023-01485-w",TRUE,"Competing interests G.L.C. is in receipt of research funding from Congenica and Janssen Pharmaceuticals and has conducted consultancy for Ono Pharmaceuticals. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> This study received support from Science Foundation Ireland (SFI; 16/RC/3948) cofunded under the European Regional Development Fund the Research Unit FOR-2715 of the German Research Foundation (MN: NO755/6-1 and NO755/13-1) from Wellcome Trust (grant 084730) European Union’s Seventh Framework Program (FP7/2007-2013) under grant agreement 279062 (EpiPGX) The Muir Maxwell Trust and the Epilepsy Society UK and Fonds National de la Recherche Luxembourg (Research Unit FOR-2715 FNR grant INTER/ DFG/21/16394868 MechEPI2) to P.M. and R. Part of this work was undertaken at University College London Hospitals which received a proportion of funding from the NIHR Biomedical Research Centers funding scheme. <section> This work is part of the Centers for Common Disease Genomics (CCDG) program funded by the National Human Genome Research Institute (NHGRI) The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart Lung and Blood Institute (NHLBI). CCDG-funded Epi25 research activities at the Broad Institute including genomic data generation in the Broad Genomics Platform were supported by NHGRI grant UM1 HG008895 (PIs: E. The Genome Sequencing Program efforts were also supported by NHGRI under grant 5U01HG009088-02. We thank the Stanley Center for Psychiatric Research at the Broad Institute for supporting the genomic data generation efforts as well as the aggregation of control samples and cohorts to contribute to the Epi25 GWAS analyses. The FINRISK controls were part of the FINRISK studies supported by the THL (formerly KTL: National Public Health Institute) through budgetary funds from the government with additional funding from institutions such as the Academy of Finland the European Union ministries and national and international foundations and societies to support specific research purposes. The collection of the Hong Kong Osteoporosis Study (HKOS) control samples was funded by the Bone Health Fund and Research Grants Council—Early Career Scheme (project 27100416). The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie AstraZeneca UK Biogen MA Bristol Myers Squibb (and Celgene Corporation & Celgene International II Sàrl) Genentech Merck Sharp & Dohme Corp S.F.B. received funding from UCB Pharma and Eisai and has been a consultant for Praxis Precision Medicines and Sequiris.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41588-023-01561-1",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements Research in the Basu Lab is supported by grants to U.B. J.B. was funded by NIH 5T32AI148099. <section> Research in the Wang Lab is supported by the National Natural Science Foundation of China (NSFC) Excellent Young Scientists Fund (31922088) Hong Kong Research Grants Council (16101021 CRS_HKUST605/22) Hong Kong Innovation and Technology Commission (MHP/004/19 ITCPD/17-9) Padma Harilela Professorship and Project of Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone (HZQB-KCZYB-2020083). Lab is funded by the Hirschl Family Trust and NIH grant R35 GM124633. We acknowledge the support from Hong Kong RGC-CRF equipment grant C5033-19E (to Q.Z.). <section> Confocal microscopy was performed in the Confocal and Specialized Microscopy Shared Resource with tissue processing TMA creation and staining carried out in the Molecular Pathology Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University supported by NIH/NCI Cancer Center Support Grant P30CA013696.",FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41589-023-01326-1",TRUE,"Competing interests E.L. J.A. T.M. and C.J.K. are employees and shareholders of Kezar Life Sciences. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements The research was supported by funding to V.O.P. from the Academy of Finland (338836 and 314672) the Sigrid Juselius Foundation and the Jane and Aatos Erkko Foundation. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41589-023-01341-2",TRUE,"Competing interests All authors declare no competing interests.",TRUE,"<section> Acknowledgements R.L-A. received funding from BBSRC (BB/R01602X/1 BB/T013176/1 BB/T011408/1—19-ERACoBioTech-33 SyCoLim) British Council (527429894) Newton Advanced Fellowship (NAF\\R1\\201187) Yeast4Bio Cost Action 18229 European Research Council (ERC; DEUSBIO—949080) and the Biobased Industries Joint (PERFECOAT—101022370) under the European Union’s Horizon 2020 research and innovation program. This work was also supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001134) the UK Medical Research Council (FC001134) and the Wellcome Trust (FC001134). This research was further funded in part by the ERC under grant agreement ERC-SyG-2020 951475 and the Wellcome Trust IA 200829/Z/16/Z (to M.R.) supporting S.K.A S.V. L.H.-D. and M.R. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41590-022-01386-w",TRUE,"Competing interests A patent application has been filed by the authors. Otherwise the authors declare no competing interests.",TRUE,"This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) through grant no. SFB 1054 (project ID 210592381 to C.E.Z.) TRR/SFB 124 (project ID 210879364 to C.E.Z. and M.S.G.) Leibniz Center for Photonics in Infection Research (grant no. LPI-BT6 to C.E.Z.) GRK 2606 (project ID 423813989 to O.G.) Germany’s Excellence Strategy (Balance of the Microverse to C.E.Z) Emmy Noether Program (project no. 434385622/GR 5617/1-1 to M.S.G.) the German Center of Infection Research (to C.E.Z.) Carl-Zeiss Stiftung (to C.E.Z.) and by the European Research Council (grant nos. 337689 and 966687 to O.G.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41590-023-01420-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by grants from the Wilhelm Sander Stiftung (2020.066.1; T.B. and T.K.) from the European Union (ERC Advanced Grant 882963; T.B.) and from the Deutsche Forschungsgemeinschaft SFB1160 A07 and B04 (P.A.) and SFB TR36 (T.B. and T.K.). <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41590-023-01493-2",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"This work was supported by the Max Planck Society (T.L. and D.G.) the Deutsche Forschungsgemeinschaft (German Research Foundation; project IDs 248768892 (T.L.) 431347925 (T.L.) and 322359157 (A.R.)) the Else Kröner-Fresenius-Stiftung (2015_A237 M.S.-S.) the Agence nationale de la recherche (ANR-19-CE15-0030 M.B.) and the European Research Council (ERC-2018-COG ImmuNiche 818846 D.G.). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41590-023-01517-x",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"Our research is supported by the National Health and Medical Research Council of Australia (APP1124815 APP1071916 APP1103895 and APP1154540) the Sylvia & Charles Viertel Charitable Foundation a 350th Anniversary Research Grant from Merck KgGA The Advanced Genomic Collaboration and the International Research Training Group (IRTG2168) funded by the German Research Council and The University of Melbourne. E.L. and S.V.S were supported by the German Federal Ministry of Education and Research through the COVIMMUN project (grant 01KI20343). Furthermore E.L. received support by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant 397484323 TRR259. Funding acquisition: S.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41590-023-01620-z",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"We acknowledge the use of the Integrated Genomics Operation Core funded by the National Cancer Institute Cancer Center Support Grant (P30CA008748) Cycle for Survival and the Marie-Josée and Henry R. J.N.F. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute (award CRI4186). K.C.H. and J.-B.L.L were supported by funding from the National Institutes of Health (R01 AI150999 R01HL155741 U01AI069197). J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy the American Cancer Society the Burroughs Wellcome Fund and the National Institutes of Health (AI100874 AI130043 AI155558 and P30CA008748).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02223-9",TRUE,"Competing interests Hazen reports being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics being a paid consultant formerly for Procter and Gamble and currently with Zehna Therapeutics.",TRUE,"<section> Acknowledgements This work is supported by grants from the NIH and Office of Dietary Supplements P01 HL147823 R01 HL103866 (S.L.H.) the Leducq Foundation 17CVD01 (S.L.H. and U.L.) and the Deutsche Forschungsgemeinschaft WI 5229/1-1 (M.W.). <section> The LipidCardio Study was partially funded by the Sanofi-Aventis Deutschland GmbH (I.D. and U.L.). P.P.S. was supported in part by an AHA postdoctoral grant 20POST35210937.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02225-7",TRUE,"Competing interests I.B. consults to BlueDot a social benefit corporation that tracks emerging infectious diseases and to the NHL Players’ Association. <section> The authors declare no competing interests.",TRUE,"<section> is grateful for institutional support from Stanford Data Science and Biomedical Informatics Training Program at Stanford 2T15LM007033. F.C.P. was supported by the Spanish Ministry of Sciences Innovation and Universities under Projects RTI-2018-101674-B-I00 and M.S. was supported by the ERP scholarship funded by the German Federal Ministry for Economic Affairs and Climate Action and Studienstiftung des deutschen Volkes (German Academic Scholarship Foundation). P.G. is a Chan Zuckerberg Biohub investigator and was supported by NIH grant DP2AI171011. J.L.S. was supported by NIH grant 5R25AI147369-03. <section> Funding <section> This project has been supported by funding from the German Federal Ministry for Economic Affairs and Climate Action (BMWi) under the project DAKI-FWS (BMWi 01MK21009E).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02255-1",TRUE,"Competing interests D.C. M.S. D. All other authors declare no competing interests. <section> on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements This work was supported by the German Childhood Cancer Foundation (‘Neuropath 2.0—Increasing diagnostic accuracy in pediatric neurooncology’; DKS 2015.01; S.M.P.) and the Everest Centre for Low-Grade Paediatric Brain Tumour Research (The Brain Tumour Charity United Kingdom; GN-000382; D.T.W.J.). The Neuroradiological Reference Center for the HIT Studies is supported by the German Childhood Cancer Foundation (DKS 2014.15 2017.07; M.W.-M. and B.B.). This work was in part supported by an Illumina Medical Research Grant to S.M.P. Australian and New Zealand participation in the Molecular Neuropathology 2.0 study was supported by project funding from the Australian Government through Cancer Australia the Robert Connor Dawes Foundation and Carrie’s Beanies for Brain Cancer and the Victorian Government’s Operational Infrastructure Support Program (C.L.W. E.M.A. J.R.H. and N.G.G.). Sturm: Conceptualization Investigation Formal analysis Data curation Writing—Original Draft Writing—Review & Editing Visualization Funding acquisition. F.S.: Methodology Investigation Resources Data curation Writing—Original Draft Writing—Review & Editing Supervision Funding acquisition. S.M.P.: Conceptualization Writing—Original Draft Writing—Review & Editing Supervision Funding acquisition. D.T.W.J.: Methodology Investigation Resources Data curation Writing—Original Draft Writing—Review & Editing Supervision Funding acquisition. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02315-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Quality improvement supported by continuous monitoring and evaluation of performance is vital for cancer screening programs. <section> Acknowledgements This study is supported by the IARC intramural funding; European Union Public Health Programme (scientific and technical support to the European Partnership for Action Against Cancer and followup of the implementation of the Council Recommendation on Cancer Screening); Centre for Global Health Inequalities Research Norway; American Cancer Society; National Cancer Institute United States of America; and Medical Research Council United Kingdom.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02317-4",TRUE,"Competing interests T.B. served in an advisory or consultancy role for Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH and Shire. All other authors declare no competing interests.",TRUE,"<section> Acknowledgements This work received support from the following sources: the National Natural Science Foundation of China (T2122005 and 81801773 to T.J. 82150710554 to G.S.) Ministry of Education (MOE) Frontiers Center for Brain Science (to C.X.) National Key R&D Program of China (2022CSJGG1000 2019YFA0709501 2021YFC2501402 and 2018YFC1312900 to T.J.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02323-6",TRUE,"Competing interests A.L. holds shares in Cibiltech a software company that is not involved in the present research. The other authors declare no competing interests.",TRUE,"The KTD-Innov study was funded by the French government with financial support managed by the National Research Agency under the program ‘Investissements d’avenir’ under grant agreement no. ANR-17-RHUS-0010. The EU-TRAIN study was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement no. 754995. Academic grant support was provided by the nonprofit organizations MSD Avenir and OrganX.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02365-w",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02397-2",TRUE,"Competing interests A.G.B is a scientific cofounder and is on the scientific advisory board of TenSixteen Bio. The remaining authors declare no competing interests.",TRUE,"<section> S.J. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists Fondation Leducq (TNE-18CVD04) the Ludwig Center for Cancer Stem Cell Research at Stanford University The Phil and Penny Knight Initiative for Brain Resilience at Stanford University and the National Institutes of Health (DP2HL157540). T.J.M. is supported by the National Institutes of Health (AG053959 AG077443). C.D.K. is supported by the Nancy and Buster Alvord Endowment. <section> is supported by the National Institutes of Health K08CA230188 and the Burroughs Wellcome Fund Career Award for Medical Scientists. P.N. is supported by the National Institutes of Health (R01HL142711 R01HL148050 R01HL151283 R01HL148565 R01HL135242 R01HL151152 R01DK125782) Fondation Leducq (TNE-18CVD04) and MGH (Fireman Endowed Chair in Vascular Medicine). A.B. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists (DP5 OD029586). <section> C.L.S is supported by the National Institutes of Health (AG059727) (UH2 NS100605). S.S. is supported by the National Institutes of Health (U01 AG052409). The following are studyspecific acknowledgements: TOPMedWGS for the TOPMed program was supported by the National Heart Lung and Blood Institute (NHLBI). The FHS was also supported by grants from the National Institutes of Aging (AG054076 and AG058589). Vasan is supported in part by the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine Boston University School of Medicine. <section> CHSThis research was supported by contracts HHSN268201200036C HHSN268200800007C HHSN268201800001C N01HC55222 N01HC85079 N01HC85080 N01HC85081 N01HC85082 N01HC85083 N01HC85086 and 75N92021D00006 and grants U01HL080295 and U01HL130114 from the NHLBI with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). <section> ADSPThe ADSP is comprised of two AD genetics consortia and three National Human Genome Research Institute (NHGRI) funded Large Scale Sequencing and Analysis Centers (LSAC). <section> The CHARGE cohorts are supported in part by NHLBI infrastructure grant HL105756 (B. Boerwinkle) and the neurology working group is supported by the National Institute on Aging (NIA) R01 grant AG033193 and RF1 AG059421. ASPS is funded by the Austrian Science Fond (FWF) grant numbers P20545-P05 and P13180 and the Medical University of Graz. PRODEM-Austria is supported by the Austrian Research Promotion Agency (FFG; Project No. 827462) and by the Austrian National Bank (Anniversary Fund project 15435). <section> ARIC research is carried out as a collaborative study supported by NHLBI contracts (HHSN268201100005C HHSN268201100006C HHSN268201100007C HHSN268201100008C HHSN268201100009C HHSN268201100010C HHSN268201100011C and HHSN268201100012C). CHS research was supported by contracts HHSN268201200036C HHSN268200800007C N01HC55222 N01HC85079 N01HC85080 N01HC85081 N01HC85082 N01HC85083 and N01HC85086 and grants U01HL080295 and U01HL130114 from the NHLBI with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). FHS research is supported by NHLBI contracts N01-HC-25195 HHSN268201500001I and 75N9201900031. This study was also supported by additional grants from the NIA (P30 AG066546 R01s AG054076 AG049607 The ERF study as a part of European Special Populations Research Network was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the program ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). <section> Highthroughput analysis of the ERF data was supported by a joint grant from the Netherlands Organization for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). <section> The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University Rotterdam the Netherlands Organization for Health Research and Development (ZonMw) the Research Institute for Diseases in the Elderly (RIDE) the Ministry of Education Culture and Science the Ministry for Health Welfare and Sports the European Commission (DG XII) and the municipality of Rotterdam. Biological samples and associated phenotypic data used in primary data analyses were stored at Study Investigators institutions and at the NCRAD (U24AG021886) at Indiana University funded by NIA. Associated Phenotypic Data used in primary and secondary data analyses were provided by Study Investigators the NIA-funded Alzheimer’s Disease Centers (ADCs) and the National Alzheimer’s Coordinating Center (NACC U01AG016976) and the National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (U24AG041689) at the University of Pennsylvania funded by NIA and at the Database for Genotypes and Phenotypes (dbGaP) funded by NIH. This research was supported in part by the Intramural Research Program of the National Institutes of Health National Library of Medicine. <section> NACCThe NACC database is funded by NIA/NIH Grant U24 AG072122.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02420-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"A.D.H. is funded by the NIHR University College London Hospitals NHS Trust Biomedical Research Centre.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02555-6",TRUE,"",TRUE,"This study was supported by the Hertie Foundation (P1200013 to K.S.) the Helmholtz Institute for Translational Oncology HI-TRON (to E.W.G. M.P. and K.S.) the German Research Foundation (EB 187/8-1 to N.G. project 445549683 SFB1366-TPC01 to K.S. and M.P. project 39404578 GRK2727-TPB1.1 to M.P. and K.S. project 404521405 SFB1389-TPB06 to M.O.B. and K.S. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02556-5",TRUE,"Competing interests Since January 2023 E.R. has been an employee of GlaxoSmithKline. <section> The remaining authors declare no competing interests.",TRUE,"This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) under Germany’s Excellence Strategy: EXC2167-Project ID 390884018 ‘Precision Medicine in Chronic Inflammation’ (to W.L. J.R. K.A. A.F. A.S. S. This project received funding from the European Union (European Research Council (ERC) starting grant 2021 no. 101040023 ‘MicroT’ to P.B.). <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02668-y",TRUE,"Competing interests L.B.K. has received consulting fees from Blueprint Medicine as DSMB Chair and has contracted institutional research with Novartis Regeneron Pharmaceuticals Day One Biopharmaceuticals Spring Works Therapeutics Bristol Myers Squibb and SonALAsense. All remaining authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements This trial was funded by Day One Biopharmaceuticals. D.S.Z. is supported by grants from the National Health and Medical Research Council (Synergy Grant 2019056 and Leadership Grant APP2017898) and Cancer Institute New South Wales Program Grant TPG2037. D.H. is supported by funding from the National Institute for Health and Care Research (NIHR) Great Ormond Street Hospital Biomedical Research Centre.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41591-023-02673-1",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The Lighthouse Core Facility is funded in part by the Medical Faculty University of Freiburg (project nos. R.S. is supported by the IMMediate Advanced Clinician Scientist-Program Department of Medicine II Medical Center University of Freiburg and Faculty of Medicine University of Freiburg funded by the Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EO2103. P.S. is a member of the KFO5024–505539112 (A04) and the research training group GRK2162 (270949263/GRK2162) funded by the DFG and is supported by the University Hospital Erlangen (IZKF project J94 IZKF clinician scientist programme). J.P. received additional funding from the DFG (PR 683/8-1 and SFB/TRR265 B04) and the UK DRI (Programme Award). R.Z. was supported by SFB-1479 project ID 441891347 CIBSS EXC-2189 project ID 390939984 and ERC Advanced grant (101094168 AlloCure). We received no specific funding for this work.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41591-023-02722-9",TRUE,"Competing interests O.A.S. reports personal fees and honoraria from AbbVie Adaptive Ascentage AstraZeneca BeiGene Genmab Gilead Janssen Eli Lilly and Roche; and research funding from AbbVie BeiGene Janssen and Roche. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements The study was supported by BeiGene which was not involved in the study design or analysis; the study sponsor was the University of Cologne. We are grateful to the physicians study nurses and study teams for supporting the conduct of the RT1 trial. <section> The study was also supported in part by the Deutsche Forschungsgemeinschaft (German Research Foundation) project no. 467697427 (O.A.S.) SFB 1530 project C04 (K.F.) SFB 1530 project Z01/B01 (M.H.) SFB 1530 project C05 (B.E. and B.C.) and SFB 1074 subproject B1 and B2 (E.T. C.S. and S.S.). <section> Funding <section> received research funding from Novo Nordisk Foundation grant NF16OC0019302 and research support consultancy fees and/or travel grants from AbbVie Gilead Janssen Roche CSL Behring Genmab Sunesis and Acerta/AstraZeneca.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41592-023-01903-1",TRUE,"Disclosure of a structural milieu for the proximity ligation reveals the elusive nature of an active chromatin hub. <section> Competing interests A.P. M.N. R.A.B. and A.S. hold a patent on ‘Genome Architecture All other authors have no competing interests.",TRUE,"A.P. and M.N. acknowledge support from the National Institutes of Health Common Fund 4D Nucleome Program grant U54DK107977 and the Berlin Institute of Health (BIH). <section> Some computational work was supported by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z with additional support from the <section> Funding",FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41592-023-01986-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"I.L. was a recipient of an EMBO Long Term Fellowship when this work was started (grant no. ALTF 1235-2016). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41592-023-02005-8",TRUE,"Competing interests Y.-G.Y. M.E. and S.H. declare the following competing interests.",TRUE,"This research was supported by National Research Foundation of Korea (NRF) grant nos. <section> (Y.-G.Y.) 2021M3F3A2A01037808 (Y.-G.Y.) 2021M3A9I4026318 (Y.-G.Y. and J.-B.C.) NRF2021R1A4A102159411 (Y.-G.Y. and S.C.) and 2022M3H9A2096201 (J.-B.C.) the BK21 plus program through the NRF funded by the Ministry of Education of Korea (Y.-G.Y.) Brain Research Foundation (A.E.C. and P.P.) the Harvard Brain Science Initiative (A.E.C. and P.P.) and National Institutes of Health grant no. <section> 1-R01-NS126043 (A.E.C. and P.P.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41593-022-01243-x",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements N.v.K. is supported by the MDC PhD fellowship; S.M. by the DAAD PhD fellowship; S.D. by the Honjo International PhD; and L. Work in the Igor Ulitsky laboratory was supported by Israeli Science Foundation grant ISF 852/19 and the Nella and Leon Benoziyo Center for Neurological Diseases. This work is supported by a grant from the German Israeli Foundation to I.U. and M.C. and a Deutsche Forschungsgemeinschaft (DFG) grant to M.C. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41593-023-01286-8",TRUE,"Competing interests A.S. is an employee of Bruker the manufacturer of preclinical MRI systems used for the acquisition of most of the datasets in this collection. The other authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements This research was enabled in part by support provided by Compute Ontario (https://www.computeontario.ca/) and Compute Canada (www.computecanada.ca). This research was funded by: the National Institutes of Health (K01EB023983 R03DA042971 R21AG065819 K25DA047458 I015I01CX000642-04 R01NS085200 R01MH098003 RF1MH114224 T32AA007573 R01MH067528 P30NS05219 T32GM007205 R01MH111416 R01NS078095 R01EB029857 F31 MH115656 and 1R21MH11647301A1); the Wellcome Trust (212934/Z/18/Z 109062/Z/15/Z 110027/Z/15/Z 204814/Z/16/Z and 203139/Z/16/Z); the Dutch Research Council (OCENW.KLEIN.334 021.002.053 016.130.662 and 016.168.038); the German Research Foundation (SA 1869/15-1 SA 2897/2-1 SFB 1436/B06 SFB874/B3 project no.: 122679504 SFB 1280/A04 project no.: 316803389); the French National Research Agency (ANR-15-IDEX-02 and ANR-11-INBS-0006); Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (IN212219 IA202120 and IA201622); the UK Medical Research Council (MR/N013700/1 and 1653552); the Portuguese Foundation for Science and Technology (LISBOA-01-0145-FEDER-022170 and 275-FCT-PTDC/BBB/IMG/5132/2014); the Swiss National Science Foundation (PCEFP3_203005 and PCEFP2_194260); King’s College London Biotechnology and Biological Sciences Research Council (BB/N009088/1); the European Community’s Seventh Framework Program (FP7/2007-2013); TACTICS (278948); the Brain and Behaviour Foundation (NARSAD 25861); the Dutch Brain Foundation (F2014(1)-06); the National Science Foundation (DMR-1644779 DMR-1533260 DMR-2128556); the Human Brain Project (945539); the Canadian Institutes of Health Research (PJT-148751 PJT-173442 and MOP-102599); the Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-05917 RGPIN-375457-09 and RGPIN-2015-05103); the Horizon 2020 Framework Programme of the European Union (740264 and 802371); the Academy of Finland (298007); the European Research Council (679058 and 802371); Innosuisse (18546.1); the Research Foundation – Flanders (12W1619N FWO-G048917N and G045420N); the Stichting Alzheimer Onderzoek (SAO-FRA-20180003); Special Research Programmes (1158); CIBER-BBN; Instituto de Salut Carlos III FEDER (PI18/00893); Versus Arthritis (20777); the Brain Behavior Foundation (25861); the Telethon Foundation (GGP19177); Eurostars (E!",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41593-023-01410-8",TRUE,"Competing interests T.B. served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. The other authors report no potential conflicts of interest. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"<section> Acknowledgements N.E.H. and T.B. gratefully acknowledge grant support from the German Research Foundation (grants DFG HO 5674/2-1 and GRK2350/1).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41593-023-01435-z",TRUE,"Competing interests The authors declare no competing interests. <section> studies must disclose on these points even when the disclosure is negative.",TRUE,"This work has received funding from the Swiss National Science Foundation (Ambizione grant PZ00P3_193330 to S.M. and 733 310030_170320 310030_188450 and CRSII5_183478 to B.B.) European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. <section> 882424 to B.B.) Research Talent Development Fund zur Förderung des akademischen Nachwuchses (FAN; to S.M.) Forschungskredit Postdoc fellowship University of Zurich grant no. K-41302-11-01 (to S.M.) Dr.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41593-023-01501-6",TRUE,"Competing interests The authors declare no conflicts of interest. <section> on these points even when the disclosure is negative.",TRUE,"<section> ORIGINs is supported by the National Institute of Mental Health (R01MH123716 to R.K.). The ENIGMA consortium is supported by the National Institutes of Health (NIH) Big Data to Knowledge award for foundational support and consortium development (grant number U54 EB020403 to P.M.T.). M.A.S. is supported by a Heisenberg Program Grant of the German Research Foundation (project number 433758790) and a Research Fellowship of the Jacobs Foundation (fellowship number 2020136212). The GUSTO study was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health’s National Medical Research Council (NMRC; NMRC/ TCR/004-NUS/2008 and NMRC/TCR/012-NUHS/2014). The Drakenstein Child Health Study was funded by the Bill and Melinda Gates Foundation (OPP 1017641) the South African Medical Research Council and the National Research Foundation of South Africa. <section> received support from the Academy of Medical Sciences Newton Advanced Fellowship (NAF002/1001) funded by the UK Government’s Newton Fund National Institute on Alcohol Abuse and Alcoholism via R21AA023887 the Collaborative Initiative on Fetal Alcohol Spectrum Disorders developmental grant (U24 AA014811) the US Brain and Behavior Foundation Independent Investigator grant (24467) and the Carnegie Corporation of New York. K.A.D. D.J.S. and H.J.Z. received financial support from the South African Medical Research Council. A.R. was supported by the National Research Foundation of South Africa. J.H.G. was supported by grants from the NIH (MH070890 HD053000 and MH064065). The IBIS study was supported by grants from the NIH (R01-HD055741 P30-HD003110 and T32-HD040127) and the Simons Foundation (140209). <section> The UCI study was supported by US PHS (NIH) grants R01 HD-060628 R01 MH-105538 and UH3 OD-023349 and European Research Council grant ERC-Stg 639766. P.D.W. was supported by NIH R01 MH-091361 R01 MH-105538 and UH3 OD-023349. The Boston study was funded by NIH NICHD R01 HD065762-10 the William Hearst Fund (Harvard University) and the Harvard Catalyst/NIH (5UL1RR025758).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41596-022-00795-3",TRUE,"Competing interests <section> The Broad Institute has ﬁled <section> a patent relating to the use of the technology described in this paper for which C.A.L. L.S.L. C.M. A.R. and V.G.S. are named as inventors (US Patent App.",TRUE,"This research was supported by a Stanford Science Fellowship (to C.A.L.) and a Parker Institute of Cancer Immunotherapy Scholarship (to C.A.L.) a Stanford Artiﬁcial Intelligence in Medicine and Imaging seed grant (to C.A.L.) a BroadIgnite Award (L.S.L.) R01 DK103794 (to V.G.S.) R33 HL120791 (to V.G.S.) a gift from the Lodish Family to Boston Children’s Hospital (to V.G.S.) the New York Stem Cell Foundation (NYSCF; to V.G.S.) and the Howard Hughes Medical Institute and Klarman Cell Observatory (to A.R.). L.N. is funded by a fellowship from the MDC-NYU exchange program and is an Associated Fellow of the Hector Fellow Academy. L.S.L. is supported by the Berlin Institute of Health an Emmy Noether fellowship by the German Research Foundation (DFG LU 2336/2-1) and a Hector Research Career Development Award. <section> is supported by the National Institutes of Health (NIH) U01CA260852 the Parker Institute for Cancer Immunotherapy a Career Award for Medical Scientists from the Burroughs Wellcome Fund and a Pew-Stewart Scholars for Cancer Research Award.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41597-023-02153-8",TRUE,"Competing interests The authors declare no competing financial interests.",TRUE,"<section> Acknowledgements This work was supported by the EMPIR project 18HLT07 MedalCare. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41597-023-02377-8",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> developmental dataset As part of an lifespan brain charts  CCNP contributes normative brain charts for the human appreciated by collaborative studies the INDI-CoRR-IPCAS7 or CCNC can should acknowledge the contributions on the Science Data Bank website (https://doi.org/10.57760/sciencedb.07478 encedb.07860). <section> Supervision and Cohort Funding: X.-N.Z.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41597-023-02560-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This work was supported by the German Federal Ministry of Education and Research (BMBF) within the ‘Medical Informatics Funding Scheme’ grant numbers 01ZZ1801(A-Z) 01ZZ1802(A-Z) 01ZZ1803(A-Z) 01ZZ1804(A-Z). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41597-023-02726-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project number 442326535. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-022-25322-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> The study was funded by the following foundations: Mahle Stiftung Stuttgart Germany Christophorus Stiftung Stuttgart Germany Dr. MK DP and RZ received financial support by Humanus Institute Berlin Germany and Software AG Stiftung Darmstadt Germany. AB received financial support by Software AG Stiftung Darmstadt Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-27699-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This research was partially funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy—The Berlin Mathematics Research Center MATH+ (EXC-2046/1 project ID: 390685689) by DFG-STE 477/19-1 DFG-STE 477/21-1 DFG-FOR 5177 and via Project C03 of <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-27792-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This study was supported by research grants from Wilhelm Sander-Stiftung (Funding 2016.019.1) Alfred und Angelika Gutermuth-Stiftung and Deutsches Konsortium für Translationale Krebsforschung (DKTK) to CDB. Funding from Berliner Krebsgesellschaft e.V.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-28203-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-28732-8",TRUE,"Competing interests <section> The Rockefeller University has filed a patent related to this work on which S.S. and S.K are inventors. All other authors have no competing interests.",TRUE,"A.V. is supported by an EMBO longterm fellowship (ALTF 711-2019) and S.K. is supported by the Robertson Foundation.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-28975-5",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> This study was supported by the BMBF (Bundesministerium für Bildung und Forschung)/DZHK (German Centre for Cardiovascular Research) via project FKZ81Z0100208 and complies with the declaration of Helsinki. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-29028-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-29204-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-29410-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by federal funds from the DZIF (funding number 8000 201-3).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-29545-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-29632-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"; Funding acquisition P.M. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-29871-8",TRUE,"Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-30179-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft grant number HE 7661/1-1 to Y.H.) the IFORES program of the Faculty of Medicine University of Duisburg-Essen (to Y.H.) and the Joachim Herz Foundation (Addon Fellowship to A.S.). <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-30613-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy—EXC 2117—422037984. We gratefully acknowledge financial support provided by the Zukunftskolleg of the Universität Konstanz to H.G. and A.S.P. and by the Graduate School of Decision Sciences at the Universität Konstanz to F.G. and N.G. H.G. received additional funding from DFG Grant Number <section> Funding",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-30633-9",TRUE,"Competing interests <section> Oliver Hartmann and Birte Arlt are employed by sphingotec GmbH a company holding patent rights of the bio-ADM assay.",TRUE,"<section> This research was partially supported by private donations to the Center for Stroke Research Berlin. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-30641-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was funded by Charite3R Charité-Universitätsmedizin Berlin (RefineMOMo 2.0; RefineLab) and a grant from Interpharma Basel. This work was further supported in part by the Willy Robert Pitzer Foundation (Pitzer Laboratory of Osteoarthritis Research at DRFZ Berlin) and the Dr. We acknowledge support by the Open Access Publication Fund of the Freie Universität Berlin. <section> Funding",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was pre-registered in the Animal Study Registry (Bf3R Germany; https://doi.org/10.17590/asr.0000221).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41598-023-30756-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The NEUPRODEX study received funding from Orion Corporation (Espoo Finland).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-31642-4",TRUE,"Competing interests Anja Bosy-Westphal serves a consultant for seca gmbh & co.kg. The other authors declare no competing interests.",TRUE,"<section> Funding This work was supported by a grant for seca gmbh & co.kg. Germany (2019/2020).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-31850-y",TRUE,"Competing interests J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital and is the Founder of 5 Prime Sciences. <section> The Lady Davis Institute has previously received funding from GlaxoSmithKline Eli Lilly and Biogen for research programs at Dr. Richards’ laboratory unrelated to this manuscript. C.P. and M.H. are employees of SomaLogic. <section> All other authors do not have any conflict of interest.",TRUE,"<section> The Richards research group is supported by the Canadian Institutes of Health Research (CIHR: 365825; 409511 100558) the Lady Davis Institute of the Jewish General Hospital the Jewish General Hospital Foundation the Canadian Foundation for Innovation the NIH Foundation Cancer Research UK Genome Québec the Public Health Agency of Canada McGill University Cancer Research UK [grant number C18281/A29019] and the Fonds de Recherche Québec Santé (FRQS). The Kaufmann lab’s COVID-19 work is supported by the Canadian Institutes of Health Research /CITF (VR2-173203 and VS1-175561) the American Foundation for AIDS Research (AmFAR 110068-68-RGCV) the Canadian Foundation for Innovation and FRQS. TwinsUK is funded by the Welcome Trust Medical Research Council European Union the National Institute for Health Research (NIHR)-funded BioResource Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. C.-Y.S. is supported by a Lady Davis Institute / TD Bank Studentship Award. <section> S.Z. is supported by a CIHR fellowship and an FRQS postdoctoral scholarship. G.B.L. is supported by a CIHR scholarship and a joint FRQS and Québec Ministry of Health and Social Services scholarship. T.N. is supported by Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists. <section> is supported by a clinicianresearcher salary award from the FRQS. S.G. was supported by grants CA224319 DK124165 and CA196521. ; Funding acquisition: V.M. T.M. S.G. S.K.S. A.C. M.M. D.E.K. and J.B.R. <section> The Lady Davis Institute has previously received funding from GlaxoSmithKline Eli Lilly and Biogen for research programs at Dr.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-32208-0",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding <section> Part of the work was done in the 15HLT04 NeuroMET and 18HLT09 NeuroMET2 projects received funding from the EMPIR programme cofinanced by the Participating States (VINNOVA the Swedish innovation agency in the present case) and from the European Union’s Horizon 2020 research and innovation programme.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-33013-5",TRUE,"Competing interests <section> TP reports grants from Cidelec Löwenstein Medical Novartis ResMed and personal fees from Bayer Healthcare Cerebra Jazz Pharma outside the submitted work. IF reports personal fees from ResMed grants from <section> Weinmann personal fees from Philips grants from Fisher Paykel outside the submitted work. None other financial disclosures. JS NL MG MZ AD and KL do not have competing interests.",TRUE,"We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding The project was funded by the German Aerospace Center e.V (Deutsches Zentrum für Luftund Raumfahrt e.V.—DLR #40 WB 1532) and by the Russian Federation RF Government (#075-15-2019-1885).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-33219-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Christoph Strecker have received funding from Deutsche Forschungsgemeinschaft (DFG) Bonn Germany grant #HA5399/5-1. Andreas Harloff was supported by the Berta-Ottenstein-Program for Advanced Clinician Scientists Faculty of Medicine University of Freiburg Germany.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-33981-8",TRUE,"Competing interests <section> SJS received non-financial support from national and international societies (and their congress organizers) in the field of anaesthesiology and intensive care medicine outside the submitted work. Dr Schaller holds stocks in small amounts from Alphabet Inc. Bayer AG and Siemens AG; these holdings have not affected any decisions regarding his research or this study. MG received lecture fees from HIM. The other authors declare no competing interests.",TRUE,"<section> Funding The project was funded by the Central Innovation Program for small and mediumsized enterprises of the German Federal Ministry for Economic Affairs and Energy (ZF4544901TS8) as a joint project between TUM and HIM (Health Information Management GmbH Bad Homburg Germany) acting as cooperation partners.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-34439-7",TRUE,"Competing interests <section> MingDe Lin receives a salary from Visage Imaging Inc.",TRUE,"<section> Funding <section> This work was supported by the NIH/NCI [R01CA206180].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35030-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"We acknowledge the support by the Open Access Publication Fund of Humboldt-Universität zu Berlin. This work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy—EXC-2049—390688087 and supported by Humboldt-Universität zu Berlin Bernstein Center for Computational Neuroscience Berlin Einstein Center for Neurosciences Berlin European Research Council (BrainPlay ERC Synergy Grant) and the Gottfried Wilhelm Leibniz Prize of the DFG. <section> Funding",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35370-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This work was partly funded by the German Federal Ministry for Education and Research as Patho234 (ref. <section> Funding This work was partly funded by the German Federal Ministry for Education and Research as Patho234 (ref.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35376-1",TRUE,"Competing interests <section> The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35515-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This study was supported by the European Union through the European Regional Development Fund under grant agreement No.KK.01.1.1.04.0085 project “Genomic engineering and gene regulation in cell lines and model organisms by CRISPR/Cas9 technology—CasMouse”; by the European Union through the European Regional Development Fund under Grant Agreement No.KK.01.1.1.07.0071 project “Sinergy of molecular markers and multimodal in vivo imaging during preclinical assessment of the consequences of the ischemic stroke (SineMozak)”; the European Union through the European Regional Development Fund as the Scientific Centre of Excellence for Basic Clinical and Translational Neuroscience under Grant Agreement No.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35816-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The study was part of the COVID-Heim project which was funded by the National Association of Statutory Health Insurance Funds. <section> Funding This work was funded by the National Association of Statutory Health Insurance Funds (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-35941-8",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"This work was supported by the Federal Ministry of Education and Research (BMBF) Germany FKZ: 01EO1501 and the Deutsche Forschungsgemeinschaft (DFG) HA 6908/2-1. Furthermore JH received funding from Else-Kröner Fresenius Foundation (EKFS) and Fritz Thyssen Foundation (FTS) as well as ongoing funding from DFG (HA 6908/3-1 HA 6908/4-1 Heisenberg Program; HA 6908/7-1 and HA 6908/8-1). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-36063-x",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> MW was supported by the Ernst Ludwig Ehrlich Scholarship (ELES) and the Berlin University Alliance (BUA). <section> Funding",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-36226-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"We also thank the funding institutions: the Polish National Agency for Academic Exchange (PPN/BEK/2020/1/00182) National Science Centre (NN404 273440; 2013/11/N/NZ7/00364; 2017/25/B/NZ7/01509); the Ministry of Science and Higher Education (N43/DBS/000207); and Salus Publica Foundation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-36831-9",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding <section> Financial support for this research provided by the following sources: Funding for this study was provided by: HHSN275201200007I-HHSN27500005. This work was also supported in part by US PHS (NIH) grants R01 MH-105538 UH3 OD-023349 and ERC grant ERC-Stg 639766.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-36924-5",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). This article uses data from the Berlin Aging Study II (BASE-II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under grant numbers #01UW0808; #16SV5536K #16SV5537 #16SV5538 #16SV5837 #01GL1716A and #01GL1716B.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37083-3",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding This work was partially supported by the German Research Foundation (DFG Project-ID 402170461–TRR 265; 390688087–EXC 2049).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37208-8",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Resources Supervision Writing—review & editing;S.H.: Writing—review & editing;V.L.: Conceptualization Investigation Data curation Writing——review & editing;M.P.: Funding acquisition Project administration Resources Supervision Writing—review & editing. <section> Funding This study was financially supported by the German Research Foundation (DFG SCHM 2572/13-1 PU 762/1-1) Bonn Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37494-2",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding This study was supported by the European Commission under the 7th Framework Program (Grant Number 278901) and by Region Västerbotten Umeå University Sweden to OR. KACM is supported by the Intramural Research Programme of the National Institutes of Health in the Centre for Research on Genomics and Global Health (CRGGH). CA is supported by the European Research Council Consolidation (grant number 772244). Ina Danquah is supported by the Robert Bosch Foundation (grant number 01000035-002).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37689-7",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37835-1",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding JNK is supported by the German Federal Ministry of Health (DEEP LIVER ZMVI1-2520DAT111) and the Max-Eder-Programme of the German Cancer Aid (grant #70113864). DT is supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (TR 1700/7-1). STA is supported (partially) by the RACOON network under BMBF grant number 01KX2021.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-37979-0",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-38027-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The work was funded by Scholarship from the G-max Precision Co. Ltd. and Taiwanese Government Scholarship to Study Abroad to Shih-Ying Scott Chang a DFG Project grant to KU 3221/2-1 the Heisenberg Award KU3221/3-1 the Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation to Misha Kudryashev. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-38242-2",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding This study was funded by the B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-38353-w",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy-EXC 2117-422037984. H.G. received additional funding from DFG Grant Number <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-38490-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This work was partially funded by the Center for Advanced Systems Understanding (CASUS) which is financed by Germany’s Federal Ministry of Education and Research (BMBF) and by the Saxon Ministry for Science Culture and Tourism (SMWK) with tax funds on the basis of the budget approved by the Saxon State Parliament. MK was supported by the Heisenberg award from the DFG (KU 3222/2-1) as well as funding from the Helmholtz Association. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-38673-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements The authors acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG). Funding acquisition: G.W. C.S. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-39260-w",TRUE,"Competing interests Jolanda Lambert was an employee of Danone Nutricia Research.",TRUE,"<section> Funding <section> This study was part of the EARLYFIT project (Partnership programme NWO Domain AES-Danone Nutricia Research) funded by the Dutch Research Council (NWO) and Danone Nutricia Research (project number: 16490).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-39466-y",TRUE,"Competing interests <section> C. G. has received a research grant from Corvidia Therapeutics (Waltham MA USA) and has acted as a consultant/speaker for AbbVie and NovoNordisk. All other authors declare no competing interests.",TRUE,"This work was funded by a Grant from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project Number 125440785 – SFB 877 (Project A10 to C.G.) and a Grant from the Center for Molecular Medicine Cologne (CMMC) to P. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-39487-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This research project was in part supported by the START-Program (#136/17 and #23/19) of the Faculty of Medicine RWTH Aachen and by the Excellence Initiative of the German federal and state governments (G:(DE-82) ZUK2-SF-OPSF443) without involvement of the funders in study design data collection data analysis manuscript preparation or decision to publish.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-39826-8",TRUE,"Competing interests The automated lesion segmentation algorithm is a product of scalable minds GmbH. TH LW GW and NR are employed by scalableminds GmbH. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"This study was supported by the Brandenburg Ministry of Economic Affairs Labour and Energy (Brandenburgischer Innovationsgutschein) and the European Regional Development Fund. Funding to JA SM SPK and PBS was provided by the German Federal Ministry of Education and Research under the ERA-NET NEURON scheme (BMBF 01EW1811) the German Research Foundation (DFG Project HO5277/3-1 Project Number 417284923 to CJH HA5741/5-1 Project Number 417284923 to CH Project-ID 424778381 -TRR to CH BO4484/2-1 Project Number 428869206 to PBS the Open Access Publication Fund of Charité Universitätsmedizin Berlin and EXC-2049 390688087 NeuroCure) and by a Grant from the Fondation Leducq (17 CVD 03) to CH. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-39841-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This research was funded by the Deutsche Forschungsgemeinschaft (DFG) Research Unit FOR-2558 TraceAgeDFG Research Unit on Interactions of essential trace elements in healthy and diseased elderly Potsdam-BerlinJena (HA 4318/4-2 Scho 849/6-2). <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-39987-6",TRUE,"Competing interests DA reports personal fees from MASK-AIR SAS outside the submitted work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-40007-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"J.A.: Conceptualization Methodology Resources Funding acquisition Supervision Writing—Review & Editing. U.H.: Conceptualization Methodology Resources Funding acquisition Supervision Writing—Review & Editing. <section> Funding <section> This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation #DFG 431077921) and by inhouse funding of the Professorship of Child and Youth Psychology and Psychotherapy at Humboldt-Universität zu Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-40202-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-40290-7",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"We thank all clinic managers of participating ICUs for supporting this project. FB: Conceptualization Supervision Funding acquisition Writing Review & Editing. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-40330-2",TRUE,"Competing interests <section> HZ declares that he was majority owner of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH Berlin and owner and managing director of IQVD GmbH Institut fuer Qualitaetssicherung Berlin. HPG declares that he was minority owner of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH Berlin. HZ and HPG declare that they were managing directors of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH Berlin during the study. This does not alter our adherence to Nature Scientific Reports policies on sharing data and materials. <section> All other authors have declared that no competing interests exist. The work from SF and AK was partially funded by EURAMET in the project 18HLT03 SEPTIMET. The funder had no role in study design data collection and analysis decision to publish or preparation of the manuscript. All other authors have no conflict of interest.",TRUE,"<section> Funding <section> The work from SF and AK was partially funded by EURAMET in the project 18HLT03 SEPTIMET. The work from SF and AK was partially funded by EURAMET in the project 18HLT03 SEPTIMET.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-40803-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by An NSERC Discovery Grant awarded to S Sheldon (#RGPIN-04241).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-40940-w",TRUE,"Competing interests JI reports no conflicts of interest and funding by the Bundesinstitut für Risikobewertung (BfR) LM received honoraria from Biogen and Merck as well as research funding from the Deutsche Multiple Sklerose Gesellschaft MP received honoraria for lecturing from Argenx Alexion Novartis Bayer Health Care Sanofi-Aventis Biogen and Merck; SS received no financial compensation or support from any organization or entity that may have an interest in the content of this manuscript; MW declares nor conflict of interest and nor funding received for the preparation of this report; OA has received with approval of the Heinrich Heine University advisor fees honoraria or travel reimbursements from Alexion Almirall Biogen Horizon MedImmune Merck Novartis Roche and Teva; research support from the German Science Foundation (DFG) the German Ministry of Education and Research (BMBF) Biogen and Novartis.",TRUE,"<section> Funding His research is funded by the German Ministry for Education and Research (BMBF) Bundesinstitut für Risikobewertung (BfR) Deutsche Forschungsgemeinschaft (DFG) Else Kröner Fresenius Foundation Gemeinsamer Bundesausschuss (G-BA) German Academic Exchange Service Hertie Foundation Interdisciplinary Center for Clinical Studies (IZKF) Muenster German Foundation Neurology and by Alexion Almirall Amicus Therapeutics Germany Biogen Diamed Fresenius Medical Care Genzyme HERZ Burgdorf Merck Serono Novartis ONO Pharma Roche and Teva; PA received research grants from BMS Celgene German Research Association EFRE NRW Ipsen Merck Merz Novartis and speaker honoraria travel support and recompensation for serving on advisory boards from Allergan Abbvie BMS Celgene Ipsen Hexal Janssen Cilag Lilly Merck Merz Novartis Sanofi TEVA.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-41390-0",TRUE,"Competing interests <section> MSA reports personal fees from Servier outside the submitted work. All authors declare no conflict of interest with respect to this work.",TRUE,"<section> Funding This study was partly funded by the German Center for Cardiovascular Research (CD SH MSA SvH).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-42156-4",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-42259-y",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> The work is a part of and was partially funded by the ETHeart initiative of the Swiss Federal Institute of Technology (ETH Zurich).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-42294-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This work was supported by a grant from the Alfred und Angelika Gutermuth Stiftung Frankfurt to TB. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-42608-x",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-44555-z",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-45511-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-45841-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The trial was partially funded with a research grant for JD provided by the Karl and Veronica Carstens Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-46354-y",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-46405-4",TRUE,"Competing interests Holger Amthauer declares research grants travel grants and lecture fees from Sirtex Medical Europe; Dr.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-46631-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This study was funded by the ‘German Research Foundation’ (DFG) project WU392/9-1. In addition the study was supported by the DGPs section ‘Biological Psychology and Neuropsychology’ (research fellowship during corona pandemic to M.G. and H.L.P.) the ‘Financial Incentive System to Promote Gender Equality’ (FAS) of the University of Regensburg (to M.G. and H.L.P.) and the ‘Bavarian Programme to Realise Equal Opportunities for Women in Research and Teaching 2021’ (to H.L.P.). <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-46766-w",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> This work was funded by a Berlin Alliance – University of Melbourne Strategic Grant to S.B. H.R.H. K.W. C.D.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-47124-6",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-47500-2",TRUE,"Competing interests JNK declares consulting services for Owkin France; DoMore Diagnostics Norway and Panakeia UK and has received honoraria for lectures by Eisai Roche MSD and Fresenius. The other authors report no competing interests.",TRUE,"<section> Funding JNK is supported by the German Federal Ministry of Health (DEEP LIVER ZMVI1-2520DAT111) and the Max-Eder-Programme of the German Cancer Aid (grant #70113864) the German Federal Ministry of Education and Research (PEARL 01KD2104C; CAMINO 01EO2101; SWAG 01KD2215A; TRANSFORM LIVER 031L0312A; TANGERINE 01KT2302 through ERANET Transcan) the German Academic Exchange Service (SECAI 57616814) the German Federal Joint Committee (Transplant.KI 01VSF21048) the European Union’s Horizon Europe and innovation programme (ODELIA 101057091; GENIAL 101096312) and the National Institute for Health and Care Research (NIHR NIHR213331) Leeds Biomedical Research Centre. SN is funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (NE 2136/3-1).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-47532-8",TRUE,"Competing interests J.R. and A.A. are employees of Biotronik and A.S. is an employee of 1000shapes.",TRUE,"<section> Funding This work has been funded under the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-47766-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"; Funding acquisition: S.C. T.K. <section> Funding NAKO is funded by the German Federal Ministry of Education and Research (BMBF) the Helmholtz Association and federal states. Funding references: 01ER1301A/B/C and 01ER1511D.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-47767-5",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-47857-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-48235-w",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-48325-9",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"We thank Martina Traub for supporting the work related to QR code import to the hospital information system. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-48581-9",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"Work undertaken in this study was supported by a pilot project and special research funding provided by the German Federal Ministry of Health. <section> Funding",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-48706-0",TRUE,"Competing interests <section> B.K.H. commercially provides access to the online mindfulness training that was used as the experimental treatment in this study. The other authors do not have competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-48892-x",TRUE,"Potential conflict of interest due to financial support from or employment by the test manufacturer was present in 17 studies (34.7%) 262832383947515556585961–63 In studies focusing on self-sampling 30 out of 36 datasets reported IFU-conform conduct of the test even though sampling was explicitly observed in only 22 datasets (61.1%). <section> Competing interests The authors declare no competing interests.",TRUE,"<section> Assessment of independence from manufacturers We examined whether a study received financial support from a test manufacturer (including free provision of Ag-RDTs) whether any study authors were affiliated with the manufacturer and whether a respective conflict of interest was declared. <section> Funding <section> This work was supported by the Ministry of Science Research and Arts of the State of Baden-Wuerttemberg Germany (no grant number; https://mwk.badenwuerttemberg.de/de/startseite/) and internal funds from the Heidelberg University Hospital (no grant number; https://www.heidelberguniversity-hospital.com/de/) to CMD. Further this project was funded by United Kingdom (UK) aid from the British people (grant number: 3003410102; Foreign Commonwealth & Development Office (FCMO) former UK Department of International Development (DFID); www. g ov. u k/ f cdo) and supported by a grant from the World Health Organization (WHO; no grant number; https://www.who.int) and a grant from Unitaid (grant number: 2019-32-FIND MDR; https:// <section> unita i d. o rg) to Foundation of New Diagnostics (FIND; JAS SC SO AM BE).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: PROSPERO: CRD42021250706. <section> The methods were adapted from a living systematic review our group had previously p ublished 814 The systematic review protocol (Supplement S1 Text Study Protocol) is registered on PROSPERO (CRD42021250706).",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41598-023-49260-5",TRUE,"Conflict of interest for all other authors do not exist.",TRUE,"<section> Funding JMS is supported by the National Institute of Neurological Disorders and Stroke (Grant No. R01NS118200) and received funding support from the National Institutes of Neurological Disorders-NIH (Grant R01NS118200) the Craig H.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-49325-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by the German Centre for Cardiovascular Research (DZHK) funded by the German Federal Ministry of Education and Research the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)-CRC-1470-B06 and the Charité— Universitätsmedizin Berlin Germany as well as the German Heart Institute Berlin Germany and Myocardial Solutions. Our research was also supported by an unrestricted research Grant from Philips Healthcare.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration The study was registered The study was registered at the German Clinical Trials Register (DRKS registration number: DRKS00015615).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41598-023-49505-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The project has been registered with the BioProject database under BioProject accession number: PRJNA884282. web link: https://www.ncbi.nlm.nih.gov/sra/PRJNA884282.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1038/s41598-023-49569-1",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"The NAKO Health Study is funded by the Federal Ministry of Education and Research (BMBF) [project funding reference numbers: 01ER1301A/B/C and 01ER1511D] federal states and the Helmholtz Association with additional financial support by the participating universities and the institutes of the Leibniz Association. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-49661-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860960. <section> Funding",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-49720-y",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> Funding This work was funded by a research grant of the Stiftung Oskar-Helene-Heim (OHH_44) to TM. This study was partly funded by the DFG Collaborative Research Center 1444 and the European Union under Grant Agreement Nr.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41598-023-49745-3",TRUE,"Competing interests <section> The authors declare no competing interests.",TRUE,"<section> This work was supported by the German Federal Ministry of Education and Research (BMBF) within the projects “VIMRE” and “CORSA” under Grants 03ZZ0146A-D and 03COV10C. ; Funding acquisition: J.S. S.B.L. M.C.M. P.Z. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s41598-023-49902-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was supported by Vinmec grant ISC.19.11.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s41746-023-00864-1",TRUE,"<section> COMPETING INTERESTS <section> C.U.C. has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Damitsa Denovo Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris.",TRUE,"<section> FUNDING He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s42003-023-04410-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This project has received funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy—EXC-2049— 390688087 as well as HE 3130/6-1 to F.L.H. the German Center for Neurodegenerative Diseases (DZNE) Berlin and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. S.S. was funded by a PhD fellowship of the NeuroCure Excellence Cluster EXC-2049. <section> Funding",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-04652-1",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This work was made possible by funding for GND within the DFG CRC 1444 by support through a BIH translational Ph.D. project grant and by the BCRT through funding by the German Federal Ministry of Education and Research (BMBF). <section> Funding",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-05363-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements We thank Sean Colloms (University of Glasgow) for providing the plasmids pK2151200 and pK2151201 and Kelly T. This work was supported in part by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant to M.E.; agreement no. 864971). <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-05429-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements S.Q.P. is supported by the German Research Foundation Grants INST 392/125-1 PA 2682/1-1 PA 2682/2-1 and by a grant from the German Ministry of Education and Research (BMBF) and the State of Brandenburg (DZD grant FKZ 82DZD00302).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-05454-1",TRUE,"Competing interests E.W. is now an employee of AstraZeneca. M.K. is supported by the Wellcome Trust (221854/Z/20/Z) the UK Medical Research Council (MR/S011676/1) the US National Institute on Aging (R01AG056477) and the Academy of Finland (329202 350426). B.P. <section> serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. J.C. serves as a Scientiﬁc Advisor to SomaLogic and receives grant support from NIH. Other coauthors have nothing to disclose. L.J. is an employee and stockholder of Novartis. All other authors declare no competing interests.",TRUE,"<section> Acknowledgements The ARIC study has been funded in whole or in part with Federal funds from the National Heart Lung and Blood Institute National Institutes of Health Department of Health and Human Services (contract numbers HHSN268201700001I HHSN268201700002I HHSN268201700003I HHSN268201700004I and HHSN268201700005I) R01HL087641 R01HL059367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Funding was also supported by 5RC2HL102419 R01NS087541 and R01HL131136. <section> Infrastructure was partly supported by Grant Number UL1RR025005 a component of the National Institutes of Health and NIH Roadmap for Medical Research. Infrastructure was partly supported by Grant Number UL1RR025005 a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Cardiovascular Heath Study (CHS) research was supported by NHLBI contracts HHSN268201200036C HHSN268200800007C HHSN268201800001C N01HC55222 N01HC85079 N01HC85080 N01HC85081 N01HC85082 N01HC85083 N01HC85086 75N92021D00006; and NHLBI grants U01HL080295 R01HL087652 R01HL105756 R01HL103612 R01HL120393 R01HL085251 R01HL144483 and U01HL130114 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). The Framingham Heart Study is conducted and supported by the National Heart Lung and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. This work was also supported by grant R01AG063507 R01AG054076 R01AG049607 R01AG059421 R01AG033040 R01AG066524 P30AG066546 U01 AG052409 U01 AG058589 from from the National Institute on Aging and R01 AG017950 UH2/3 NS100605 UF1 NS125513 from National Institute of Neurological Disorders and Stroke and R01HL132320. AGES has been funded by NIA contracts N01-AG012100 and HSSN271201200022C NIH Grant No. <section> Meirelles are funded by the National Institute on Aging Intramural Research Program. This study was funded in part by the National Institute on Aging Intramural Research Program. LBC1936 is supported by the Biotechnology and Biological Sciences Research Council and the Economic and Social Research Council [BB/W008793/1] Age UK (Disconnected Mind project) and the University of Edinburgh. The Olink® Neurology Proteomics assay was supported by a National Institutes of Health (NIH) research grant R01AG054628. The MESA projects are conducted and supported by the National Heart Lung and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for the Multi-Ethnic Study of Atherosclerosis (MESA) projects are conducted and supported by the National Heart Lung and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001 HHSN268201500003I N01-HC-95159 75N92020D00005 N01-HC95160 75N92020D00002 N01-HC-95161 75N92020D00003 N01-HC-95162 75N92020D00006 N01-HC-95163 75N92020D00004 N01-HC-95164 75N92020D00007 N01-HC-95165 N01-HC-95166 N01-HC-95167 N01-HC-95168 N01-HC-95169 UL1TR-000040 UL1-TR-001079 UL1-TR-001420 UL1TR001881 DK063491 and R01HL105756. The Rhineland Study is funded by the German Center for Neurodegenerative Disease (DZNE). This work was further partly supported by the German Research Foundation (DFG) under Germany’s Excellence Strategy (EXC2151-390873048) and SFB1454 project number 432325352; the Federal Ministry of Education and Research under the Diet-Body-Brain Competence Cluster in Nutrition Research (grant numbers 01EA1410C and 01EA1809C) and in the framework “PreBeDem Mit Prävention und Behandlung gegen Demenz” (grant numbers 01KX2230); and the Helmholtz Association under the Initiative and Networking Fund (grant number RA-285/ 19) and the 2023 Innovation Pool. The 3 C Study is supported by a grant overseen by the French National Research Agency (ANR) as part of the “Investment for the Future Programme” ANR-18-RHUS-0002. It has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667375. The project also received funding from the French National Research Agency (ANR) through the VASCOGENE and SHIVA projects and from the Leducq TNE 2012 on small vessel disease (PI A Joutel M Nelson). Funding support for additional computer resources has been provided to S.D. by the Fondation Claude Pompidou. The 3 C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salariés Direction Générale de la Santé Mutuelle Générale de l’Education Nationale (MGEN) Institut de la Longévité Conseils Régionaux of Aquitaine and Bourgogne Fondation de France and Ministry of Research–INSERM Programme “Cohortes et collections de données biologiques.” This PhD program is supported within the framework of the PIA3 (Investment for the future). M.K. is supported by the Wellcome Trust (221854/Z/20/Z) the UK Medical Research Council (MR/S011676/1) the US National Institute on Aging (R01AG056477) and the Academy of Finland (329202 350426).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s42003-023-05521-7",TRUE,"Competing interests R.C.R. is an Editorial Board Member for Communications Biology but was not involved in the editorial review of nor the decision to publish this article. X.W. and the 23andMe Research Team are employees of 23andMe Inc. and own stock and/or stock options in 23andMe Inc. K.H. is a former employee of 23andMe Inc. and holds stock and/or share options in 23andMe Inc. L.H. is a current employee and stockholder of GlaxoSmithKline. C.V. is a current employee of IQVIA GmbH. The remaining authors declare no competing interests.",TRUE,"R.C.R. L.H. J.L. D.A.L. and G.D.S. are members of the MRC Integrative Epidemiology Unit at the University of Bristol funded by the Medical Research Council (MM_UU_00011/1 and MC_UU_00011/6). K.H. is supported by a Humboldt Research Fellowship from the Alexander von Humboldt Stiftung. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol and the NIHR Manchester Biomedical Research Centre.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-05522-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"This study was funded by the Deutsche Forschungsgemeinschaft DFG German Research Foundation—Project number 327654276—SFB 1315. ; Funding: C.J.P. and C.F. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s42003-023-05553-z",TRUE,"Competing interests The authors declare no competing interests",TRUE,"KH received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No101033485 (Individual Fellowship). Last this work was funded in part by Helmholtz Association’s Initiative and Networking Fund under the Helmholtz International Lab grant agreement InterLabs- <section> Funding",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42003-023-05585-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42255-023-00753-7",TRUE,"Competing interests E.W. is now an employee of AstraZeneca. All other authors have no competing interests.",TRUE,"<section> received funding from the Medical Research Council (MR/N003284/1 MC-UU_12015/1 and MC_UU_00006/1 to N.J.W.) and Cancer Research UK (C864/A14136. to N.J.W.). The genetics work in the EPIC-Norfolk study was funded by the Medical Research Council (MC_PC_13048 to N.J.W.). This work was supported in part by MRC Rapid Call (MC_PC_21036 to N.J.W. and C.L.) and HDRUK Multi-Omics (G107794 to C.L.) grants and the UKRI/ NIHR Strategic Priorities Award in Multimorbidity Research for the Multimorbidity Mechanism and Therapeutics Research Collaborative (MR/V033867/1 to C.L.). Proteomics measurements were also supported by a collaboration agreement between the University of Cambridge and Olink. M.K. is supported by Gates Cambridge Trust.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1038/s42255-023-00781-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s42255-023-00863-2",TRUE,"Competing interests J.D.R. is an advisor and stockholder in Colorado Research Partners LEAF Pharmaceuticals Empress Therapeutics and Bantam Pharmaceutical; a paid consultant of Pfizer and Third Rock Ventures; a founder director and stockholder of Farber Partners Raze Therapeutics and Sofro Pharmaceuticals; a cofounder and stockholder in Marea Therapeutics; and a director of the Princeton University–PKU Shenzhen collaboration. All other authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was funded by NIH R01CA163591 NIH DP1DK113643 Ludwig Cancer Research and Stand Up to Cancer SU2CAACR-DT-20-16 to J.D.R; NIH R35GM147014 to J.F.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s43587-023-00513-y",TRUE,"Competing interests The authors declare no competing financial interests.",TRUE,"This work was funded by the Max Planck Society (P.T. and T.W.) the BOOST program of the Max Planck Society (C.N.) and the Deutsche Forschungsgemeinschaft (German Research Foundation; project no. 415274764 (V.K. and F.S.) and under Germany’s Excellence Strategy – EXC 2030 – 390661388 (P.T.)) <section> Funding Acquisition: A.T. and P.T. <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s43856-023-00250-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by grants of the Deutsche Forschungsgemeinschaft (grant number DE 842/7-1 to I.D.) the ERC (as part of the Lifebrain project to L.B.) and the Cure Alzheimer’s Fund (as part of the CIRCUITS consortium to L.B.). This article uses data from the Berlin Aging Study II (BASE-II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under grant numbers #01UW0808; #16SV5536K #16SV5537 #16SV5538 #16SV5837 #01GL1716A and #01GL1716B. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s43856-023-00298-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s43856-023-00309-6",TRUE,"Competing interests The authors declare the following competing interests: B.K. reports grants from the MRC UK Research & Innovation (UKRI) United Kingdom; Wellcome Trust United Kingdom and Bill and Melinda Gates Foundation (BMGF) United States for a variety of projects related to vaccines and maternal/newborn health. B.K. attended the Gates Global Challenge Meeting in 2022 supported by BMGF and is also on the Data Safety Monitoring Board for a COVID producing vaccine company. Td.S. is an Editorial Board Member for Communications Medicine but was not involved in the editorial review or peer review nor in the decision to publish this article. The other authors have no competing interests.",TRUE,"<section> Competing interests The authors declare the following competing interests: B.K. reports grants from the MRC UK Research & Innovation (UKRI) United Kingdom; Wellcome Trust United Kingdom and Bill and Melinda Gates Foundation (BMGF) United States for a variety of projects related to vaccines and maternal/newborn health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s43856-023-00381-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) within CRC1366 “Vascular Control of Organ Function” project number 39404578 to K.S. and M.P. (project C1) and the Hertie Foundation (P1200013) to K.S. <section> Funding",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1038/s44161-023-00401-z",TRUE,"Competing interests All authors declare no competing financial interests.",TRUE,"LCF is funded in part by the Medical Faculty University of Freiburg (project nos.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d2cb00223j",TRUE,"Conflicts of interest <section> There are no conflicts to declare.",TRUE,"T. K. was supported by a fellowship from the Jürgen Manchot Foundation.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d2dd00099g",TRUE,"Conflicts of interest <section> The authors declare no con\ue104ict of interest.",TRUE,"NJ acknowledges funding from the Swiss National Funding Agency [CRSII5_193832].",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d3lc00154g",TRUE,"Conflicts of interest <section> There are no conflicts to declare.",TRUE,"Funding acquisition GS MRS and FS. <section> This work was supported by an internal BfR research funding program (Sonderforschungsprojekt 1322-706). In addition this project received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d3na00574g",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d3nr01977b",FALSE,"",TRUE,"This research was supported by the Australian Research Councils Linkage Infrastructure Equipment and Facilities (LE180100066) grant. This work was partly supported by a Rebecca Cooper Foundation for Medical Research Project Grant (PG2019396) to J.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d3ra01394d",FALSE,"",TRUE,"<section> Research funding: this project was partially funded by the German Research Foundation (DFG) within the research grant “Cell-MPI” (455706279) and the collaborative research 398 centre “Matrix in Vision” (SFB 1340/2 2022 no 322486779 projects A02 and B02).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1039/d3sc03739h",FALSE,"",TRUE,"This work was supported by Deutsche Forschungsgemeinscha\ue09d (DFG German Research Foundation) through grants CRC 1423 project number 421152132 (subproject Z03) to P. S. Research in Oxford was supported by the Biological and Biotechnological Sciences Research Council (Grants BB/I022309 and BB/L009722).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1042/cs20220494",TRUE,"Competing Interests The authors declare that there are no competing interests associated with the manuscript.",TRUE,"<section> Funding <section> This work was supported by funding from an Alzheimer’s Research UK Pilot Grant [grant number ARUK-PPG2020A-029 (to K.H.)] Malcolm Macleod: Conceptualization Supervision Funding acquisition Methodology Project administration Writing—review & editing.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1042/cs20220594",TRUE,"Competing Interests The authors declare that there are no competing interests associated with the manuscript.",TRUE,"<section> Funding <section> S.K.M. and F.C. were supported by the German Federal Ministry of Education and Research (BMBF) under the Confirmatory Preclinical Studies and Systematic Reviews Initiative [grant number 01KC190].",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1042/cs20220819",TRUE,"Competing Interests The authors declare that there are no competing interests associated with the manuscript. <section> Disclosures",TRUE,"<section> Funding <section> RLVP was a recipient of a PhD CNPq fellowship. This study was supported by Ministério de Ciência e Tecnologia/Conselho Nacional de Pesquisa/Fundação de Amparo à Pesquisa do Estado Minas Gerais (MCT/CNPq/FAPEMIG) Instituto Nacional de Ciência e Tecnologia em Nanobiofarmacêutica (INCT/ Nanobiofar) PRONEX and CAPES/DAAD (PROBRAL). <section> Bader: Conceptualization Resources Supervision Funding acquisition Validation Writing—original draft Project administration Writing—review & editing. <section> Robson Augusto Souza Santos: Conceptualization Resources Data curation Software Formal Analysis Supervision Funding acquisition Validation Investigation Visualization Methodology Writing—original draft Project administration Writing—review & editing.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1053/j.jrn.2023.04.006",FALSE,"",TRUE,"<section> Support: The GCKD study was supported by the German Ministry of Education and Research (Bundesministerium f€ ur Bildung und Forschung FKZ 01ER 0804 01ER 0818 01ER 0819 01ER 0820 and 01ER 0821) KfH Foundation for Preventive Medicine Innovative Medicines Initiative 2 Joint Undertaking (BEAt-DKD grant number 115974) and corporate sponsors (www.gckd.org). Schultheiss: Writing – review & editing Investigation Data curation Funding acquisition. <section> Kai-Uwe Eckardt: Project administration Funding acquisition Writing – original draft Writing – review & editing Investigation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1055/a-0960-9846",TRUE,"Conflict of interest <section> The authors declare no conflict of interest.",TRUE,"Human neuroimaging studies have supported this idea by revealing a relationship between altered memoryrelated hippocampal activation and functional connectivity patterns in patients with schizophrenia and positive symptoms (i. e. delusions and hallucinations) [22 27].",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1511-8293",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> Funding <section> CCL is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1530-5240",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1542-9192",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1543-6156",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> The trial was funded by Siemens Medical Solutions USA Inc. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1651-0943",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1658-1038",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1821-9009",TRUE,"Conflict of Interest <section> CM has received honoraria for scientific talks and advice from SanofiGenzyme Takeda-Shire Alexion MDS Abbvie and Falk. HMF has received Honorarium for scientific talk from Sanofi-Genzyme. MM has received research grants lecture honoraria travel recompensations from Sanofi Amgen Lilly MSD Berlin-Chemie Astra Novartis Akcea Biomarin Daiichi-Sankyo Gilead and Novo. CL has received honoraria speakers fee and travel support from BioMarin Takeda Sanofi Amicus Chiesi Regenxbio Alexion. EM has received research grants consultation honoraria and speakerʼs fee from Sanofi Takeda Amicus Idorsia Prevail Orphazyme Cyclo Therapeutics and Sio Therapeutics. JPK has received travel recompensations from Biomarin. SVD has received research grants lecture honoraria travel recompensations from and worked in advisory boards and steering committees for Pfizer Sanofi-Genzyme Shire-Takeda Actelion Vitaflo Nutricia Dr. Schaer BioMarin and Recordati. CS CR AZ CB NM and AG declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1986-7676",TRUE,"Conflict of Interest <section> Andreas Geier: Steering Committee: Falk Gilead Intercept Novartis; <section> Consultant: AbbVie Alexion Bayer BMS Eisai Gilead Heel Intercept Ipsen Merz MSD Novartis Pfizer Roche Sanofi-Aventis Sequana;",TRUE,"The German NAFLD-Registry is financially supported by Advanz Pharma Specialty Medicine Deutschland GmbH/Intercept Pharma Europe Ltd. and Gilead Sciences GmbH (grants to Deutsche Leberstiftung) as well as Novo Nordisk Pharma GmbH (directly via Leberstiftungs-GmbH). Jörn Schattenberg: Consultant: Apollo Endosurgery Albireo Pharma Inc Bayer BMS Boehringer Ingelheim Gilead Sciences GSK Intercept Pharmaceuticals Ipsen Inventiva Pharma Madrigal MSD Northsea Therapeutics Novartis Novo Nordisk Pfizer Roche Sanofi Siemens Healthcare GmbH; Research Funding: Gilead Sciences Boehringer Ingelheim Siemens Healthcare GmbH; Speaker Honorarium: Boehringer Ingelheim Echosens MedPublico GmbH Novo Nordisk Madrigal Pharmaceuticals.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1987-5716",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-1996-2980",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2006-1086",TRUE,"<section> Conﬂict of Interest None declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2029-2935",TRUE,"Competing Interests <section> M. Hollenbach has received honoraria for lectures and expert panel from FUJIFILM.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1055/a-2066-2051",TRUE,"Conflict of Interest <section> The conflicts of interest of the authors are listed in the long German-language version of the guideline.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2066-2068",TRUE,"Conflict of Interest <section> The conflicts of interest of the authors are listed in the long German-language version of the guideline.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2077-1387",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2102-7694",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2103-8329",TRUE,"Conflict of Interest <section> Patrick Stelzl has a part-time job agreement as consultant and speaker and is member of the Steering Committee in concerns of the LION (“Labour Induction Outcomes Network”) project for Angusta 25 µg tablets from Norgine Pharma GmbH. The other authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2108-2164",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> Funding <section> This research was funded by Shanghai Municipal Science and Technology Major Project (2018SHZDZX05) Shanghai Clinical Research Center for Mental Health (M.Z. 19MC1911100) and Shanghai Shenkang Hospital Development Center (M.Z. SHDC2020CR3045B); National Nature Science Foundation of China (8187051622 8217050343 to J.D) Science and Technology Commission of Shanghai Municipal (21DZ2201000 to J.D).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2117-5200",TRUE,"The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2118-0633",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2150-0835",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2177-3056",TRUE,"",TRUE,"<section> Alkomiet Hasan received funding for this work by a grant from the Bavarian Ministry of Science and Art.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2178-6508",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2185-8264",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2185-8472",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2193-1970",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2194-9965",TRUE,"Conflict of Interest <section> The authors received no honoraria for their authoring activities but have received honoraria (speaking and/or consulting activities) from PentixaPharm for the participation in the expert meeting. The authors have no other conflicts of interest in relation to this paper.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2196-6224",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> Fundings",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1055/a-2198-0545",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> doi:10.1002/cam4.6278 [6] Hatt M Krizsan AK Rahmim A et al. Joint EANM/SNMMI guideline on radiomics in nuclear medicine Jointly supported by the EANM Physics Committee and the SNMMI Physics Instrumentation and Data Sciences Council.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1055/a-2200-2145",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1055/a-2204-5814",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2214-7217",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",TRUE,"Funding Acquisition: M.A. <section> Funding Information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2273-2672",TRUE,"Conflict of Interest <section> The authors declare that they have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/a-2282-4565",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/s-0043-1764215",TRUE,"<section> Conﬂict of Interest None declared.",TRUE,"<section> Funding <section> The study was supported by the German Research Foundation (DFG SFB1315 FOR3004) and the Einstein Stiftung Fellowship through the Günter Endres Fond and the Sonnenfeld-Stiftung.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/s-0043-1772169",TRUE,"<section> Conﬂict of Interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/s-0043-1777859",TRUE,"<section> Conﬂict of Interest None declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1055/s-0044-1780529",FALSE,"",TRUE,"<section> Funding <section> This work was funded by Bayer AG as an investigatorinitiated study.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2203769",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"<section> The study was funded by the Swedish Research Council. <section> Supported by a grant (2019-00198) from the Swedish Research Council.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2214963",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"<section> Trial Oversight and Conduct The trial was sponsored by Servier and Taiho Oncology and designed by the last author and representatives of Servier. <section> The first draft of the manuscript was written by a medical writer funded by the sponsors. <section> Supported by Servier and Taiho Oncology.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2216480",TRUE,"Disclosure",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2300080",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"<section> Supported by Abbott Medical.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2303452",TRUE,"Disclosure safety profile of sarilumab.",TRUE,"<section> The trial was sponsored by Sanofi and Regeneron Pharmaceuticals.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2304753",TRUE,"Disclosure the",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2304820",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"<section> Adult The trial which was funded by the European inclusion Commission Research and Innovation Horizon ney failure <section> Supported by the European Commission Research and Innovation Horizon 2020 (H2020-SC1-2016-2017) under the topic SC1-PM-10-2017: Comparing the effectiveness of existing health care interventions in the adult population (grant no. 754803-2).",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2305861",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"<section> Supported by Abbott.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2306037",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"6 The trial was supported by an tients unrestricted educational grant from Else Krönerlist of Fresenius-Stiftung a foundation that had no role ria is in the design or execution of the trial or in the preparation of the manuscript. <section> Supported by Else Kröner-Fresenius-Stiftung.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2307227",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"11 The trial was supported by <section> Supported by the Else Kröner Fresenius Foundation the Ger-",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1056/nejmoa2308795",TRUE,"Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",TRUE,"The first draft of the manuscript was written by a medical writer funded by the sponsor with input from all the authors. <section> Supported by Amgen.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2122053120",TRUE,"Competing interest statement: G.A.C. is the scientific founder of Ithax Pharmaceuticals.",TRUE,"Calin’s laboratory is supported by the NCI grants 1R01 CA182905-01 and 1R01CA222007-01A1 an NIGMS 1R01GM122775-01 grant a DoD Idea Award W81XWH-21-1-0030 a Team DOD grant in Gastric Cancer W81XWH-21-1-0715 a Chronic Lymphocytic Leukemia Moonshot Flagship project a CLL Global Research Foundation 2019 grant a CLL Global Research Foundation 2020 grant a CLL Global Research Foundation 2022 grant The G. B.P. was supported by a Fulbright Research Scholarships (year 2018). M.F. is supported by the NIH/NCI grants R01CA21575301A1 and R01CA219024-01A1. M.P.D. is a participant in the BIH-Charité Junior Clinical Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health and is supported by a DKTK Berlin Young Investigator Grant 2022 and by the Berliner Krebsgesellschaft (DRFF202204). A.M.T. was supported by the CPRIT Research Training Program (RP170067).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2206324120",TRUE,"The authors declare no competing interest.",TRUE,"This work was supported by the Association Monegasque contre les Myopathies (AMM Monaco) the Université Franco-Allemande (CDFA-06-11 UFA) the Association Française contre les Myopathies (AFM France) and the Agence National de la Recherche",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2207993120",TRUE,"The authors declare no competing interest.",TRUE,"This work was supported by the Willy Robert Pitzer Foundation (Pitzer Laboratory of Osteoarthritis Research) the Dr. X.L. and Y.D. were supported by scholarships from the China Scholarship Council.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1073/pnas.2211087120",TRUE,"The authors declare no competing interest.",TRUE,"This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) Clinical research unit (KFO 329 AL901/2-1 and AL901/3-1) to J.A. and Clinical research unit (KFO 329 BE6072/2-1 and BE6072/3-1) to B.B.B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2218782120",TRUE,"The authors declare no competing interest.",TRUE,"Funding from the different studies",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2219439120",TRUE,"The authors declare no competing interest.",TRUE,"This work was supported by the Clinical Research Cooperation Program MDC/Charité/ECRC (C12/03) to K.R. and M.J. the Deutsche Krebshilfe (grant #70112800) to K.R. and M.J. the Mildred Scheel MD student program (Deutsche Krebshilfe; #70113398) to M.W. and the Berlin School of Integrative Oncology (BSIO) to C.F.D.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2302720120",TRUE,"Competing interest statement: A patent application | Parkinson’s disease | neurodegeneration | autoimmunity was filed by G.L. and E.M. on this discovery.",TRUE,"This work was supported by the Michael J.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2304323120",TRUE,"The authors declare no competing interest.",TRUE,"Funding to S.M. S.P.K. and P.B.S. was provided by the German Federal Ministry of Education and Research (BMBF) under the ERA-­NET NEURON scheme (01EW1811) and the Deutsche Forschungsgemeinschaft (Project BO 4484/2-­1 and EXC-­",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2306761120",TRUE,"The authors declare no competing interest.",TRUE,"This work was supported by the Italian Association for Cancer Research (AIRC)",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2306990120",TRUE,"Competing interest statement: T.B. served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. He received conference support or speaker’s fee by Janssen Medice and Takeda. <section> He received royalties from Hogrefe Kohlhammer CIP Medien Oxford University Press. <section> The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"This research was specifically funded by Wellcome Trust and MRC (076467/Z/05/Z). This research was supported by a grant from the NIH (R01MH085772 to T.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1073/pnas.2308670120",TRUE,"The authors declare no competing interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/00015458.2022.2122006",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the",TRUE,"<section> The study was registered with the German clinical trial registry DRKS (DRK00016669) and funded by the Helios Research Center (ID 045544). <section> Funding <section> This study was funded by Helios Research Center Research Center [ID 045544].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study was registered with the German clinical trial registry DRKS (DRK00016669) and funded by the Helios Research Center (ID 045544).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1080/00029157.2022.2117680",TRUE,"Disclosure Statement <section> No potential conflict of interest was reported by the author(s).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/00223891.2022.2048843",TRUE,"<section> Declaration of interest <section> All authors confirm that there was no conflict of interest.",TRUE,"<section> Funding The MPP-S study is supported by Deutsche Gesellschaft f€ ur Psychoanalyse Psychotherapie Psychosomatik und Tiefenpsychologie (DGPT e.V.) and by K€ ohler Stiftung (Grant number: S112/10211/16).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/00224499.2023.2280994",TRUE,"Disclosure Statement <section> No potential conflict of interest was reported by the authors.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/00913847.2023.2256210",TRUE,"Disclosure statement <section> The authors report there are no competing interests to declare.",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/0142159x.2023.2271156",TRUE,"Disclosure statement <section> The authors report no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/01616412.2022.2129762",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This work was supported by the Charité – Universitätsmedizin Berlin [Rahel Hirsch scholarship].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/01616412.2022.2151115",TRUE,"Disclosure statement <section> Nora F.",TRUE,"Dengler was funded by the institutional Rahel Hirsch and Lydia Rabinowitsch scholarships and received public body founding for the project GoSafe (Horizon 2020 870144). <section> Funding <section> The author(s) reported that there is no funding associated with the work featured in this article.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/02640414.2023.2283289",TRUE,"Disclosure statement <section> The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/02656736.2023.2236337",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This project was supported by the H2020 Marie Sklodowska–Curie program—HYPERBOOST (project number 955625). The trial is financialy supported by Thermosome GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/02656736.2023.2244208",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/02688697.2019.1661968",TRUE,"Disclosure statement <section> All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership employment consultancies stock ownership or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships affiliations knowledge or beliefs) in the subject matter or materials discussed in this manuscript.",TRUE,"<section> Funding <section> No funding was received for this research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/02699052.2023.2237889",TRUE,"Disclosure statement <section> The authors report there are no competing interests to declare.",TRUE,"<section> Funding <section> This work was supported by the National Science Centre grant (OPUS scheme 2020/37/B/HS6/00288) awarded to AO and by the Medizinische Fakultät Carl Gustav Carus Technische Universität Dresden (MedDrive) to",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/02770903.2023.2185154",TRUE,"Conflict of interests <section> The authors declare that they have no competing interest.",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/0284186x.2023.2271165",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The collection of the data published in 2019 was funded by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) awarded to SN grant number 001 2015.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/0284186x.2023.2277344",TRUE,"Disclosure statement <section> The rabbit recombinant p53 antibody MSVA-053R and the rabbit recombinant p16 antibody MSVA-016R were purchased from MS Validated Antibodies GmbH (owned by a family member of GS).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/03007995.2023.2258777",FALSE,"",TRUE,"<section> Declaration of funding <section> This work was supported by Engelhard Arzneimittel GmbH & Co. LU and CPW are employees of Cambridge – a Prime Global Agency which received funding from Engelhard Arzneimittel GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/07317115.2022.2091499",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This work was supported by the German Innovation Fund of the German Federal Joint Committee (Gemeinsamer Bundesausschuss G-BA) [01VSF17048].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/08037051.2022.2161998",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/08037051.2023.2255704",TRUE,"Disclosure statement <section> T.L.B. A.P. and N.P. advise SOMNOmedics on blood pressure measurement and received travel support. M.H-W. and B.B. have no competing interests.",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/08037051.2023.2269431",FALSE,"",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/08039488.2022.2096112",TRUE,"Disclosure statement <section> M.F. Laursen has received speaking fees from Lundbeck. <section> M. Rodrigo-Domingo has reported no biomedical financial interests or potential conflicts of interest. <section> A.K.Pagsberg has reported no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding <section> The study was funded by the Unit for Psychiatric Research Psychiatry Aalborg University Hospital Aalborg Denmark and Department of Clinical Medicine Aalborg University Hospital Aalborg Denmark.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Results: Symptoms of ADHD (19%) comorbid ADHD (15%) iety (4%) suicidal thoughts (50%) suicide attempts (8%) cutting criminal activity (10%) were reported before incident BD diagnosis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,NA,NA
"10.1080/09273948.2021.2023581",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the authors.",TRUE,"<section> Funding <section> The authors reported that there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/09286586.2023.2280983",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/09540261.2022.2155033",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"The authors found that all migrant workers were significantly more likely to experience racialised discrimination.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/09540261.2022.2164180",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The first author was supported by a PhD scholarship from the Ernst Ludwig Ehrlich Studienwerk.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/09540261.2022.2164181",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/09540261.2023.2181059",TRUE,"Disclosure statement <section> The authors disclose receipt of the following financial support for the research: Open Access funding provided by the German Federal Ministry for Family Affairs Senior Citizens Women and Youth (BMFSFJ).",TRUE,"<section> The authors disclose receipt of the following financial support for the research: Open Access funding provided by the German Federal Ministry for Family Affairs Senior Citizens Women and Youth (BMFSFJ).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/09540261.2023.2190409",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"In comparing the two groups of migrants on variables of interest (Social Support Resilience Discrimination and general mental health) results suggested that migrants without citizenship reported less social support less resilience and more discrimination.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/0954898x.2023.2263083",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This research was (partially) funded by the HPI Research School on Data Science and Engineering.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/09602011.2023.2256957",TRUE,"Disclosure statement <section> No potential conﬂict of interest was reported by the author(s).",TRUE,"<section> This research was supported by the German Federal Ministry of Education and Research under grant number 136W0206 and originated within the consortium of the research project “Virtual <section> Funding <section> This research was supported by the German Federal Ministry under grant number 136W0206.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: German Clinical Trials Register identiﬁer: DRKS00024005.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1080/10255842.2023.2206934",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the authors.",TRUE,"<section> Funding <section> PK received funding from Deutsche Forschungsgemeinschaft (TR 1657/1-1).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10400419.2023.2289757",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The research was partially supported by the CREAM project funded by the European Commission Grant 612022.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10400435.2022.2067914",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10503307.2023.2290029",TRUE,"Conflict of interest C.4. <section> (b) \anot requiring supervisees or trainees to disclose their personal information unless self-disclosure is a normal expectation of a given training procedure and informed consent has been obtained from participants prior to training. <section> allows disclosure of client information if: the entity (psychologist) reasonably believes that the collection use or disclosure is necessary to lessen or prevent a serious threat to the life health or safety of any individual or to public health or safety. <section> Situations which meet the criteria for allowable disclosures are listed in Sections 16A and 16B of the Privacy Act. \aWhen a standard of this Code allows psychologists to disclose information obtained in the course of the provision of psychological services they disclose only that information which is necessary to achieve the purpose of the disclosure and then only to people required to have that information. <section> and avoid potential conflicts of interest. Conflict of interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10543406.2022.2080691",TRUE,"Disclosure statement <section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG) 2347/4-2.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG) 2347/4-2.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10749357.2023.2188756",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10826084.2023.2215320",TRUE,"Disclosure statement of interests statement",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/10872981.2022.2143298",TRUE,"Disclosure of items used in multiple-choice-question decrease student anxiety and improve transparency feedback but potentially compromises the reliability and fairness reused. Evidence regarding whether disclosure and reuse metrics is scarce and inconclusive. <section> Assessment; formative coefficients of 10148 assessment; multiple-choice large European medical school in questions; item reuse; categorised items as ‘new’; ‘reused disclosure; feedback; calculated the difference from their progress testing Thus the possibility of pro­ viding feedback is one argument for item disclosure. <section> Further arguments for disclosure include the increased overall transparency of the process of administering exams the reduced effort required of examiners to ensure test items are kept confidential the opportunity for examinees to better prepare for the test and the reduction of student anxiety [11–14]. <section> Conversely the main argument against disclosure is that examinees may more easily obtain previous ori­ ginal test items so that they will eventually test better than earlier cohorts and in consequence compro­ mise reliability [7]. For example Yang et al. <section> investigated effects of disclosure of items answers and performance data in South Korea’s medical licensing examination [15]. It remains unclear whether official disclosure of items would have an additional effect on item psychometrics if students apparently have access to original items anyway. <section> Hence given the widespread use of MCQ items and the inconsistent evidence concerning the effects of disclosure and reuse a more systematic analysis of the problem is obviously a desideratum. For reasons of practicality and transparency our medical school implemented a radical policy change regarding the disclosure of items. Changing from a previously very restrictive practice that allowed no disclosure of items whatso­ ever from fall 2017 students were allowed to take home their tests and were provided with the answer keys thus making it much easier to provide feedback. <section> This policy change offers an exceptional opportu­ nity to examine the effect of disclosure and reuse of test items by comparing the results of exams prior to and after the disclosure of test items. Such a constellation comes close to an experimental setting in which the results prior to disclosure act as the control group. To better assess the effect of disclosure we analysed the changes in item psychometrics of reused (both disclosed and not disclosed) items compared to their first ever use (i.e. when they were new items). <section> In line with previous smaller scale research [6] we hypothesised that items would become easier to solve correctly and less discriminating on reuse and even more so on reuse after disclosure as students theore­ tically had no access to original test items before this policy change and would now possibly obtain them more <section> Reused not disclosed: Last used before disclosure of exam content (i.e. last used in spring 2017 or earlier). <section> Reused disclosed: last used after disclosure of exam contents (i.e. last used in fall 2017 or later). <section> To assess the relative impact of reuse without dis­ closure versus reuse after disclosure on item difficulty and discrimination we calculated the differences in difficulty and discrimination coefficients (a) between an item’s first use (i.e. when it was a new item) and when it was reused (delta reused not disclosed – new) and (b) between an item’s first use and when it was reused and disclosed (delta reused disclosed – new). <section> To better assess the effect of disclosure on items we focused on the groups of reused items and analysed their item psychometrics as compared to their first ever use that is when they were new items. Difficulty coefficients decreased by M = −0.01 in reused not disclosed items and increased by M = 0.11 in reused disclosed items indicating a medium to large effect of disclosure on item difficulty t(4699.79) = −29.69 Discrimination coefficients increased by M = 0.03 in reused not disclosed items and by M = 0.07 in reused disclosed items indicating a negligible to small effect of disclosure on item discrimination t <section> However the combination of item disclosure and reuse facilitates cheating in the form of content sharing with subsequent examinees thus potentially jeopardis­ ing item validity and exam reliability [7]. Before con­ sidering providing feedback through item disclosure examiners need to know the effects of this measure on item psychometrics. These results suggest first that the observed change in difficulty coeffi­ cients is indeed mostly due to disclosure of items and students using the disclosed items to prepare for their exams. <section> We conclude that items still discriminate correctly between higher and lower performing students and thus item disclosure seems not to interfere with correct student ranking. <section> Thus the effects of item disclosure may be more pronounced in institutions that do not generate as many test items as our institution has done. In high-stakes career-deciding exams such as medical licensure exam­ inations even small changes in reliability induced by disclosure and reuse of items may be too big to tolerate. <section> In formative assessment settings in which discrimina­ tion and feedback are more important than weeding out students through reliable passing scores a drop in item psychometrics may be outweighed by the benefits of disclosure and reuse. <section> Thus progress testing may be a viable alternative to frequent assessment and disclosing items [2930] as progress testing shares many of the advantages of item disclosure such as better feedback options increased transparency and reduced student anxiety but also the ensuing need for large item banks. <section> As the assumed positive effects of disclosure for exam­ ple reduced anxiety and test-enhanced learning have been shown only in other settings student surveys or correlation with dropout rates and licensure examina­ tion results would be interesting for further research. <section> Our study provides evidence supporting the argu­ ment that item disclosure in combination with item reuse decreases item difficulty and increases discrimi­ nation. Thus disclosure may compromise exam relia­ bility to a moderate extent. Our results may help educators weigh the observed disadvantages of item disclosure against the obvious benefits such as increased transparency reduced student anxiety and the opportunity to provide better feedback. <section> Disclosure statement <section> No potential conflict of interest was reported by the author(s). Three controversies over item disclosure in medical licensure examinations.",TRUE,"<section> We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/10872981.2023.2220920",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the authors.",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/13543784.2023.2212155",FALSE,"",TRUE,"Funding for medical writing support for this article was provided by Celltrion Inc. <section> Funding <section> This manuscript was funded by Celltrion Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/13543784.2023.2230115",TRUE,"<section> TP is supported by the BIH clinician scientist program and declares no conflict of interest. FT is supported by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium BMBF Immun Avatar consortium). <section> Declaration of interest <section> The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment consultancies honoraria stock ownership or options expert testimony grants or patents received or pending or royalties. declares no conflict of interests.",TRUE,"<section> Funding <section> TP is supported by the BIH clinician scientist program and declares no conflict of interest. FT is supported by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium BMBF Immun Avatar consortium).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/13543784.2023.2288075",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/1354750x.2023.2284122",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the authors.",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/13645706.2022.2154166",TRUE,"<section> Declaration of interest <section> No potential conflict of interest was reported by the author(s).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/13813455.2020.1846204",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This work was supported by the Austrian Research Promotion Agency",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/13814788.2023.2190094",TRUE,"Disclosure statement <section> The authors report no conflicts of interest.",TRUE,"We acknowledge financial support from the Open Access Publication Fund of Charit \u0001 e Universit € atsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/14656566.2023.2181073",TRUE,"<section> Declaration of interests <section> PM Haddad has received honoraria for lecturing from Janssen NewBridge Pharmaceuticals and Otsuka and royalties from edited textbooks (Cambridge University Press Oxford University Press). <section> CU Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. <section> The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. <section> Reviewer disclosures",TRUE,"<section> Funding He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/14656566.2023.2228686",TRUE,"<section> Financial and competing interest disclosure: Dr.",TRUE,"Phone: (718) 470-4812 Fax: (718) 343-1659 Email: ccorrell@northwell.edu Funding: This manuscript has not been funded. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/14656566.2023.2242786",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/14670100.2023.2202940",FALSE,"",TRUE,"<section> Funding This work was supported by Cochlear Deutschland GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/14670100.2023.2274199",TRUE,"Disclosure statement No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The author(s) reported there is no funding associated",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/14728222.2023.2206954",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/14767058.2022.2160628",TRUE,"Disclosure statement <section> George Daskalakis Vasilios Pergialiotis Ariadne MalamitsiPuchner Elko Gliozheni Artur Beke Katarzyna Kosi n \u0002 skaKaczy \u0002 n ska Ana Luisa Areia and Simona Vladareanu have no conflicts of interest. No conflicts of interest. No conflicts of interest to declare related to the topic of this guideline. Kristiina Rull has no conflicts of interest to declare.",TRUE,"<section> Rull is the Member of board of Estonian Perinatology Society (2019–2022) and Member of board of Estonian Gynecologists’ Society (since 2022) Research project financed by the Clinical Medicine Institute University of Tartu Estonia “Fetal malformations and genetic defects: prevalence prenatal detection rate prognosis and treatment in Estonia 2019–2023. <section> Funding <section> The author(s) reported there is no funding associated with the work featured in this article.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/15622975.2022.2104457",TRUE,"Disclosure statement <section> KD: Steering Committee Neurosciences Janssen. LTvE: Advisory boards lectures or travel grants within the last three years: Roche Eli Lilly Janssen-Cilag Novartis Shire UCB GSK Servier Janssen and Cyberonics. All other authors declare that they do not have any conflicts of interest.",TRUE,"<section> MAS was supported by the Medical-Scientist-Programme Faculty of Medicine University of Freiburg. <section> Funding <section> The article processing charge was funded by the BadenWuerttemberg Ministry of Science Research and Art and the University of Freiburg in the funding programme Open Access Publishing.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/17441692.2023.2274436",TRUE,"Disclosure statement <section> Funding <section> The authors gratefully acknowledge the ﬁnancial",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/1744666x.2023.2214729",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/17460441.2023.2251886",TRUE,"<section> Declaration of interest <section> N Drude is an external consultant and animal welfare officer at Medizinisches Kompetenzzentrum c/o HCx Consulting Brandenburg Germany. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. <section> Reviewer Disclosures",TRUE,"<section> Funding <section> This work was supported by the Bundesministerium für Bildung und Forschung (BMBF) under Grant 01KC1901A; the Einstein Foundation under Grant EC3R EZ-2020-597-2; and by Charité 3 R|Replace Reduce Refine.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/19490976.2023.2172667",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 956279 to C.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/19490976.2023.2233689",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"<section> Funding <section> MS received funding from the DFG (Si 1983 3/1 and Si1983 4/ 1) European Research Council (ERC-Starting Grant REVERT) and the BMBF (PACE Therapy Consortium).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/19490976.2023.2259316",TRUE,"Disclosure statement <section> No potential conflict of interest was reported by the author(s).",TRUE,"T.B. is supported by Deutsche Forschungsgemeinschaft grant no. BR2925/10-1. A.P. is supported by Deutsche Forschungsgemeinschaft grant no. PL241/16-1. <section> Funding <section> The work was supported by the Canada Research Chairs Canadian Institutes of Health Research Deutsche Forschungsgemeinschaft [PL241/16-1]; Deutsche Forschungsgemeinschaft [BR2925/10-1]; Molly Towell Perinatal Research Foundation. ; Funding Acquisition T.B. and D.M.S.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1080/2000656x.2022.2070182",TRUE,"Disclosure statement <section> The author(s) declare no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Methods: The systematic review was registered in the international reviews (PROSPERO): CRD42020164301. The protocol of this systematic review has been published and registered in the international prospective register of systematic reviews (PROSPERO) under the registration number: CRD42020164301. <section> Registration number: PROSPERO 2020 CRD42020164301",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1080/20008066.2023.2257434",TRUE,"Disclosure statement <section> No potential conﬂict of interest was reported by the author(s).",TRUE,"<section> Funding <section> The study was funded by the German Federal Ministry of Education and Research (01KR1303B).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Clinical trial The data for this study originate from the RELEASE study (RELEASE study German Clinical Trials Registration ID: DRKS00006095).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1080/20008066.2023.2260293",TRUE,"Disclosure statement <section> Clara Dittmann Kathlen Priebe Meike Müller-Engelmann and Regina Steil receive honoraries for workshops and talks on DBT-PTSD and CPT. No potential conﬂict of interest was reported by the remaining authors.",TRUE,"<section> This study was funded by the German Federal Ministry of Education and Research (01KR1303B). <section> Funding <section> The study was funded by the German Federal Ministry of Education and Research [01KR1303B].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trials Registration ID: DRKS00006095).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1080/20008066.2023.2282003",TRUE,"Disclosure statement <section> No potential conﬂict of interest was reported by the author(s).",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/21645515.2023.2209000",TRUE,"Disclosure statement <section> Catherine Weil-Olivier declares grants or contracts and payment or honoraria for lectures presentations speakers bureaus manuscript writ­ ing or educational events with Astra Zeneca GSK Janssen Medimmune Pfizer Sanofi and Sanofi-Aventis; Consulting fees as punctual consultant or directly as independent expert with Astra Zeneca GSK Janssen Medimmune MSD Pfizer Sanofi and Sanofi-Aventis; Leadership or fiduciary role in Coalition for Life Course Immunisation and InfovacFrance.",TRUE,"<section> Funding <section> The work was supported by the Sanofi Pasteur. CVA received funding from Sanofi to support the expert meeting organization medical writing and editorial support.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/21688370.2022.2077620",TRUE,"Disclosure statement No potential conflict of interest was reported by the author(s).",TRUE,"<section> This project is funded by National Research Council of Thailand (NRCT) (Grant No. This work is supported by Chulabhorn Royal Academy (Project code ISFO2-004/2565) (to PP) the Mahidol Medical Scholars Program (to WS) Mahidol University (Basic <section> Funding <section> This work was supported by the National Research Council of Thailand [N42A650225]; Office of the Permanent Secretary Ministry of Higher Education Science Research and Innovation [RGNS 64-177]; Chulabhorn Royal Academy [ISFO2-004/2565].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/22221751.2023.2259001",TRUE,"Disclosure statement <section> We have no conﬂicts of interest to disclose.",TRUE,"<section> Funding <section> This work was supported by the German Federal Ministry for Economic Cooperation and Development (BMZ) through the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) to JFD (project number 81272349).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/22221751.2023.2276342",TRUE,"Disclosure statement <section> No potential conﬂict of interest was reported by the author(s).",TRUE,"<section> Funding <section> This study has been funded by Insmed Germany GmbH Grant ID 67852717 and by institutional research budget of the IML red GmbH.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1080/23311908.2023.2227443",TRUE,"Disclosure statement No potential conflict of interest was reported by the author(s).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1083/jcb.201902050",TRUE,"Disclosures: The authors declare no competing interests exist.",TRUE,"<section> This work was supported by Canadian Institutes of Health Research Foundation (D.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1083/jcb.202204001",TRUE,"Disclosures: H. Clevers reported a patent to PCT/NL2010/ <section> 000017 WO2010/090513 issued “Foundation HUB”; and “Since March 2022 I am a full-time member of the executive board of F. Hoffmann-La Roche Ltd. as head of Pharma Research and Early Development (pRED) in Basel Switzerland.” No other disclosures were reported.",TRUE,"Klotz; Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1083/jcb.202208155",TRUE,"Disclosures: The authors declare no competing interests exist.",TRUE,"Wu is funded by an Ontario Graduate Scholarship. Grinstein are supported by grants PJT-169180 and FDN-143202 from Canadian Institutes of Health Research. Funded in part by grants of the Deutsche Forschungsgemeinschaft (FOR 2652 (Je164/14-1) and under Germany’s Excellence Strategy—EXC-2019-390688087 “Neurocure” to T.J. Jentsch: Resources Funding acquisition Writing Editing and Supervision. S. Grinstein: Conceptualization Resources Funding acquisition Project administration Writing Editing and Supervision. Freeman: Conceptualization Resources Funding acquisition Project administration Writing Editing and Supervision.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1084/jem.20220170",TRUE,"Disclosures: C. Flores reported grants from Instituto de Salud Carlos III Spanish Ministry of Science and Innovation and Cabildo Insular de Tenerife outside the submitted work. J. Pachlopnik Schmid reported personal fees from University Children’s Hospital Zurich and University of Zurich Switzerland; grants from ITINERARE (University of Zurich Switzerland) SNF 320030_205097 (Swiss National Science Foundation) and CRPP (University of Zurich Switzerland); and personal fees from Pharming. J. Pachlopnik Schmid is a member of a datamonitoring committee outside the submitted work. I. Meyts reported grants from CSL Behring paid to the institution and “other” from Boehringer-Ingelheim outside the submitted work. J.-L. Casanova reported a patent to PCT/US2021/04274 pending. <section> No other disclosures were reported.",TRUE,"<section> The study was funded by Instituto de Salud Carlos III (COV20_01333 COV20_01334 PI16/00759 PI18/00223 PI19/ 00208 PI20/00876 and PI21/00211) the Spanish Ministry of Science and Innovation (RTC-2017-6471-1; AEI/FEDER) the Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC19/43 and FIISC22/27) Grupo DISA (OA18/017 and OA22/035) Fundación MAPFRE Guanarteme (OA21/131) Cabildo Insular de Tenerife (CGIEU0000219140 and “Apuestas cientı́ficas del ITER para colaborar en la lucha contra la COVID19”) a 2022 Convocatòria de Beques de Recerca IRSJD—Carmen de Torres 2022 (2022AR-IRSJD-CdTorres) CERCA Programme/ Generalitat de Catalunya the Else Kröner-Fresenius Stiftung (EKFS 2017_A110) the German Federal Ministry of Education and Research (01GM1910C) the Intramural Research Program of the National Institute of Allergy and Infectious Diseases National Institutes of Health and the Horizon Europe Framework Programme of the European Union under Grant Agreement no. 101057100.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1088/1361-6579/acb8fd",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1088/1758-5090/acd95e",TRUE,"Conflict of interest <section> The authors declare no conflicts of interest.",TRUE,"<section> This project received funding by the SET (Stiftung zur Förderung der Erforschung von Ersatzund Ergänzungsmethoden zur Einschränkung von Tierversuchen Frankfurt Germany) and the Saarland University TANDEM graduate school.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/aivt.2022.0016",TRUE,"Disclosure Statement <section> The authors A.G.W. B.B. V.G. S.S. D.F.-W. and R.L. <section> are employees of BASF SE a chemical company which may use the DIO1 assay to develop and register commercial products in the future. S.H. S.C. and K.R. declare no conflict of interests.",TRUE,"<section> Funding Information <section> This work was funded by BASF SE Key Technology Capability building Alternative Toxicological Methods.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1089/end.2023.0137",TRUE,"Disclosure Statement <section> No competing financial interests exist.",TRUE,"<section> Funding Information <section> No funding was received for this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/jicm.2022.0699",TRUE,"Disclosure Statement <section> The authors declare no conflicts of interest regarding this study.",TRUE,"<section> The authors thank Marco Spiegel and the Center for Outpatient Rehabilitation (ZAR) at Gartenstrasse 5 10115 Berlin for their cooperation. <section> Funding Information <section> This study was an investigatorinitiated trial that was funded partly by the German Neurodermatitis Foundation (Deutsche Neurodermitis Stiftung) and partly by funds from the investigating institute.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/jicm.2022.0755",TRUE,"Disclosure Statement <section> The authors declare no conflict of interest related to this article.",TRUE,"<section> Funding Information <section> There was no funding for the preparation of this case report.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/jir.2023.0105",TRUE,"Disclosure Statement",TRUE,"<section> Funding Information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/jpm.2022.0476",TRUE,"Disclosure Statement <section> No competing financial interests exist.",TRUE,"<section> Funding Information <section> This research was supported by the Federal Ministry of Education and Research (registered at German Clinical Trials",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1089/neu.2022.0251",TRUE,"<section> Author disclosure statement <section> All the other co-authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> The NEMO project was funded by the Flemish Government Agency for Innovation by The collection of the CENTER-TBI Database was supported by the FP7 program of <section> Funding",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/neu.2022.0320",TRUE,"Disclosure Statement <section> DM received personal fees from Lantmannen AB GlaxoSmithKline plc Calico Life Sciences LLC PresSura Neuro Integra Neurosciences and NeuroTrauma Sciences LLC; grants from GlaxoSmithKline plc; and a shared National Institutes of Health grant from Gryphon Collaborators on a grant application outside the presented work. VFJN holds grants from Roche Pharmaceuticals for an analysis outside the presented work. AIRM declares personal fees from NeuroTrauma Sciences and Novartis and participated on the <section> DSMB of PresSura Neuro during the conduct of the study. <section> For the other authors no competing financial interests",TRUE,"<section> Funding Information <section> The authors Mikolic Steyerberg Polinder Wilson Zeldovich Steinbuechel Newcombe Menon Lingsma and Maas were supported by the European Union 7th Framework programme (EC grant 602150).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/neu.2023.0026",TRUE,"Disclosure Statement",TRUE,"<section> Funding Information <section> Funded was provided by the Wings for Life Spinal Cord Research Foundation (research grant; SS MCP) Neurosciences Research Foundation (McKissock Fellow; RV) Royal College of Surgeons of England (Research Fellow;",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/ten.tea.2023.0014",TRUE,"Disclosure Statement <section> All authors have read the journal’s authorship agreement and policy on potential conflicts of interest and concluded that there were no relevant conflicts of interest to declare.",TRUE,"<section> Funding Information <section> This work was funded by institutional financial support of the Charité–Universitätsmedizin Berlin and by the German",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1089/ten.tec.2022.0193",TRUE,"Disclosure Statement <section> No competing financial interests exist.",TRUE,"Funding acquisition by N.R. and I.M.S. <section> Funding Information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1089/ten.tec.2023.0045",TRUE,"Disclosure Statement <section> L.H. is BIH-Medical Doctoral Research scholarship holder funded by the Charité–Universitätsmedizin Berlin <section> and the Berlin Institute of Health. Dr K.H.H. E.K. and S.M. <section> are participants in the BIH-Charité Clinician Scientist Program funded by the Charité–Universitätsmedizin Berlin and the Berlin Institute of Health. The authors declare that they have no competing interests.",TRUE,"<section> Funding Information <section> This work was supported by the BMBF (Bundesministerium für Bildung und Forschung) project 031B0648B Bio Production Line.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1089/thy.2023.0169",TRUE,"",TRUE,"No external funding from industry was received by the ATA or by authors for TFT Writing Group special article. <section> FUNDING INFORMATION <section> No funding was received for this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ageing/afac324",FALSE,"",TRUE,"We thank Johanna Biermann for supporting the literature research. <section> Declaration of Sources of Funding: This project was conducted with data from the German National Cohort (NAKO www.nako.de). The NAKO is funded by the Federal Ministry of Education and Research (BMBF project funding reference numbers: 01ER1301A/B/C and 01ER1511D) federal states and the Helmholtz Association with additional ﬁnancial support by the participating universities and the institutes of the Leibniz Association.The KORA study was initiated and ﬁnanced by the Helmholtz Zentrum München – German Research Center for Environmental Health which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ageing/afad063",FALSE,"",TRUE,"<section> Acknowledgements: We thank the colleagues at the study sites in Berlin for supporting our work and providing the necessary infrastructure for the study. <section> Declaration of Sources of Funding: This study was supported by the Kuratorium für Dialyse und Nierentransplantation (KfH) Foundation of Preventive Medicine (http:// <section> www.kfhstiftung-praeventivmedizin.de) and the DDnÄ— Institut für Disease Management e.V. (all granted to ES).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/aje/kwad061",TRUE,"None of the other authors have any potential conflicts of interest to declare.",TRUE,"<section> M.P. and J.L.R. report having received financial support from Novartis Pharma GmbH (Nuremberg Germany) for conducting a selfinitiated research project on migraine remission unrelated to this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/aje/kwad071",TRUE,"Conflict of interest: J.E.G. has served as a consultant to Astra/Zeneca and Meissa Vaccines Inc has stock options in Meissa Vaccines Inc and has patents related to rhinovirus production methods.",TRUE,"<section> In 2016 the National Institutes of Health (NIH) Office of the Director funded the Environmental Influences on Child Health Outcomes (ECHO) Program which includes the ECHO-Wide Cohort Study (EWC) and the IDeA States Pediatric Clinical Trials Network (1). Funding was also provided to the Human Health Exposure Analysis Resource for conducting chemical bioassay analyses (2) and the Center for Inherited Disease Research for genotyping (3). <section> Research reported in this publication was supported by the Environmental Influences on Child Health Outcomes (ECHO) program Office of the Director National Institutes of Health under award numbers U2COD023375 (Coordinating Center) U24OD023382 (Data Analysis Center) U24OD023319 with cofunding from the Office of Behavioral and Social Science Research (PROCore) U24ES026539 (HHEAR O’Brien) U2CES026533 (HHEAR Peterson) U2CES026542 (HHEAR Parsons Kannan) U2CES030859 (Arora) U2CES030857 (HHEAR Fennell Sumner Du) U2CES026555 (HHEAR Teitelbaum) U2CES026561 (HHEAR Wright) U2CES030851 (HHEAR Stapleton Ferguson) and UH3OD023251 (A.N.A.) UH3OD023320 (J.L.A.) UH3OD023332 (L.T.) UH3OD023253 (C.A.C.) UH3OD023248 (D.D) UH3OD023313 (D.K.M.) UH3OD023328 (C.S.D.) UH3OD023318 (A.L.D.) UH3OD023279 (A.J.E.) UH3OD023289 (A.F.) UH3OD023282 (J.E.G.) UH3OD023287 (C.V.B.) UH3OD023365 (I.H.P.) UH3OD023244 (A.E.H.) UH3OD023275 (M.R.K.) UH3OD023271 (C.J.K.) UH3OD023347 (B.M.L.) UH3OD023389 (L.D.L.) UH3OD023344 (MacKenzie) UH3OD023268 (S.T.W.) UH3OD023288 (C.T.M.) UH3OD023342 (K.L.) UH3OD023349 (T.G.O.C.) UH3OD023286 (E.O.) UH3OD023348 (M.O.S.) UH3OD023285 (J.M.K.) UH3OD023290 (J.B.H.) UH3OD023272 (S.L.S.) UH3OD023249 (J.B.S.) UH3OD023305 (L.T) UH3OD023337 (R.J.W.). <section> Child Health Outcomes (ECHO) Program: Funding. https:// www.nih.gov/echo/funding.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/aje/kwad091",TRUE,"Conflict of interest: R.W.P. has received personal fees from Amgen Analysis Group Biogen Merck Nant Pharma Pfizer and Reckitt Benckiser all outside of the submitted work.",TRUE,"<section> This project was funded by Canadian Institutes of Health Research (CIHR; grant number CIHR-425772). A.D. is supported by a salary support award from the Fonds de recherche du Québec—santé (FRQS; Quebec Foundation for Research—Health). K.B.F. is supported by a salary support award from the FRQS and holds a William Dawson Scholar award from McGill University. <section> The views expressed in this article are those of the authors and do not reflect views from any funding agencies.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/alcalc/agad069",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> This research was funded by the Berlin University Alliance as part of the Excellence Strategy of the German federal and state governments (grant to S.L. and S.H.) and by the subproject C05 at the collaborative research center of the German Research Foundation (grant TRR265 to",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/bioadv/vbad056",TRUE,"Conflict of Interest: none declared.",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (grant Ll 1676/2-2) and by the National Institutes of Health awards P41EB023912 and R35GM119771.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bioadv/vbad063",TRUE,"Conflict of interest: All authors declare that they have no conflicts of interest.",TRUE,"<section> Chia-Yu Chen (Conceptualization [equal] Formal analysis [lead] Investigation [lead] Methodology [equal] Project administration [lead] Software [lead] Validation [lead] Visualization [lead] Writing—original draft [lead] Writing—review & editing [equal]) Ulrike Löber (Conceptualization [supporting] Methodology [supporting] Software [supporting] Supervision [supporting] Writing—review & editing [equal]) and Sofia Forslund (Conceptualization [equal] Formal analysis [supporting] Funding acquisition [lead] Investigation [supporting] Methodology [equal] Project administration [supporting] Resources [lead] Software [supporting] Supervision [lead] Validation [supporting] Visualization [supporting] Writing—original draft [supporting] Writing—review & editing [equal]). <section> Funding <section> This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) Collaborative Research Center (CRC) 1365 ‘Renoprotection’; the DFG as part of a Clinical Research Unit (CRU) ‘Food Allergy and Tolerance’ [428049112]; and the German Federal Ministry of Education and Research [EMBARK; 01KI1909B] under the frame of JPIAMR [EMBARK; JPIAMR2019-109] to U.L.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/bioinformatics/btad004",TRUE,"Conflict of Interest: none declared.",TRUE,"<section> Funding <section> This work was supported by the Stanley Center ‘Psychiatric Genomics",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bioinformatics/btad176",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> This work was supported by Deutsche Forschungsgemeinschaft (DFG German Research Foundation) through CRC 1423 [421152132; subproject Z04] as well as through the Open Access Publishing Fund of Leipzig University within the DFG program Open Access Publication Funding.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bioinformatics/btad280",TRUE,"Conflict of interest None declared.",TRUE,"<section> Funding K.U.L. is supported by the Emmy-Noether program of the German Research Foundation (DFG; LU 1944/3-1).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljac027",TRUE,"Conflicts of interest <section> S.S.-B. has received honoraria for participation in advisory boards in clinical trials and/or as speaker from AbbVie Inc AbbVie Deutschland GmbH & Co.",TRUE,"<section> Funding sources <section> The financial support for the study was provided by AbbVie.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljac059",TRUE,"Conflicts of interest <section> B.K. has served on advisory boards and/or is a consultant and/or is a clinical trial investigator for AbbVie AltruBio Inc Almirall AnaptysBio Arena Pharmaceuticals Bioniz Therapeutics Bristol Myers Squibb Concert Pharmaceuticals Inc Equillium Horizon Therapeutics Eli Lilly and Company Incyte Corp Janssen Pharmaceuticals LEO Pharma Otsuka/Visterra Inc Pfizer Inc Regeneron Sanofi Genzyme TWi Biotechnology Inc and Viela Bio.",TRUE,"<section> Funding sources <section> This study was funded by Eli Lilly and Company under license from Incyte Corporation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljac089",TRUE,"Conflicts of interest <section> G.K.: received travel grants or honoraria or has been a consultant member of advisory boards and speaker bureaus or has served as investigator for AbbVie Actelion Almirall Amgen Basilea Biogen Boehringer Ingelheim Bristol Myers Squibb Celgene Hexal-Sandoz JanssenCilag LEO Pharma Eli Lilly MSD Novartis Pfizer Sanofi and UCB Pharma.",TRUE,"<section> Funding sources <section> These studies were sponsored by UCB Pharma. Support for thirdparty writing assistance for this article provided by Robert Jones PhD and Claire Hews PhD Costello Medical UK was funded by UCB Pharma in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp. org/gpp3).",TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljac145",TRUE,"Conflicts of interest <section> There are no conflicts of interest to declare from any members of the Steering Group.",TRUE,"<section> Funding sources <section> This study was developed with support from the UK Dermatology Clinical Trials Network (UK DCTN) via the 2018 ‘Themed Call’ award. The UK DCTN is grateful to the British Association of Dermatologists and the University of Nottingham for financial support of the Network.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljad077",TRUE,"Conflicts of interest <section> E.W.H.K. T.W. S.W. P.C.v.d.A. B.H. A.M.G.P. and M.L. <section> declare that they have no conflicts of interest regarding the scope of this work.",TRUE,"<section> Funding sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljad191",TRUE,"Conflicts of interest <section> All authors have completed the International Committee of Medical Journal Editors (ICMJE) uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following: F.S. was or currently is a speaker and/or advisor and has received honoraria and/or funding for research from Allakos Blueprint Celldex Cogent Genentech Novartis Sanofi/ Regeneron and Uriach. M.H. and E.G.M. declare no conflicts of interest.",TRUE,"<section> Funding sources <section> The study was sponsored and funded by Allakos Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljad314",TRUE,"Conflicts of interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding sources <section> This work was supported by a grant from the German-Israeli Foundation for Scientific Research and Development (GIF) to R.C.B. and by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) under the auspices of the German Excellence Strategy (EXC2151–390873048) to M.M.N. and R.C.B.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/bjd/ljad345",TRUE,"Conflicts of interest <section> J.G.K. has been a consultant and/or received honoraria from AbbVie Aclaris Therapeutics Allergan Almirall Amgen Arena Aristea Artax Biopharma Asana Aurigene Biogen Idec Boehringer Ingelheim Bristol Myers Squibb Escalier Galapagos Janssen Kyowa Kirin Lilly MoonLake Immunotherapeutics Nimbus Novartis Pfizer Sanofi Sienna Biopharmaceuticals Sun Pharma Target-Derm UCB Valeant and Ventyx Biosciences. J.F. <section> has conducted advisory work for Janssen Boehringer Ingelheim Pfizer Kyowa Kirin LEO Pharma Regeneron ChemoCentryx AbbVie and UCB; participated in trials for Pfizer UCB Boehringer Ingelheim Eli Lilly and CSL; and received research support from Ortho Dermatologics and Sun Pharma. G.B.E.J. reports grants and/or personal fees from AbbVie Coloplast ChemoCentryx LEO Pharma LEO Foundation AFYX Incyte InflaRx Janssen-Cilag Novartis UCB CSL Behring Regeneron Sanofi Kymera and Viela Bio. A.B.K.’s institution received grants from AbbVie Admirx AnaptysBio Aristea Bristol Myers Squibb Eli Lilly Incyte Janssen MoonLake Immunotherapeutics Novartis Pfizer UCB and Sonoma Bio. A.B.K. has received consulting fees from AbbVie Alumis Bayer Bristol Myers Squibb Boehringer Ingelheim Eli Lilly FIDE Janssen MoonLake Immunotherapeutics Novartis Pfizer Priovant Therapeutics Sonoma Bio Sanofi UCB Target RWE and Ventyx Biosciences; royalties from BIDMC; holds stock in Ventyx Biosciences; and serves on the board of directors of Almirall. B.K. has acted as an investigator or received grants and/or honoraria from AbbVie Almirall Amgen AstraZeneca Biogen Bristol Myers Squibb Celgene Janssen Lilly LEO Pharma Merck MoonLake Immunotherapeutics Novartis Pfizer and UCB Pharma. F.G.B. has received honoraria for participation in advisory boards in clinical trials and/or as a speaker from AbbVie AbbVie Deutschland Boehringer Ingelheim Pharma Novartis Pharma UCB Pharma Incyte MoonLake Immunotherapeutics Mölnlycke and JanssenCilag. K.N. declares no conflicts of interest.",TRUE,"<section> Funding sources A.B.K.’s institution received grants from AbbVie Admirx AnaptysBio Aristea Bristol Myers Squibb Eli Lilly Incyte Janssen MoonLake Immunotherapeutics Novartis Pfizer UCB and Sonoma Bio.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjd/ljad525",TRUE,"Conflicts of interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/bjs/znad057",TRUE,"Disclosure <section> The authors declare no conflict of interest.",TRUE,"<section> Funding <section> The authors have no funding to declare.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/bjs/znad233",TRUE,"Disclosure The authors declare no other conflict of interest.",TRUE,"<section> Funding <section> The authors have no funding to declare. A.J.H. and C.F. have received research funding from Guanguong Shunde Innovative Design Institute and Instituto de Salud Carlos III. T.R. received grant support from Abbvie Boehringer-Ingelheim Gilead Intercept MSD Myr Pharmaceuticals Philips Healthcare Pliant Siemens and W.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/bjs/znad311",TRUE,"Disclosure <section> The TENTACLE-Rectum study was funded by Medtronic External Research Program. The authors declare no other conflict of interest.",TRUE,"<section> Funding <section> The TENTACLE-Rectum study was funded by Medtronic. <section> Nynke Greijdanus (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—original draft Writing—review & editing) Kiedo Wienholts (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—original draft Writing—review & editing) Sander Ubels (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Kevin Talboom (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Gerjon Hannink (Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Supervision Validation Visualization Writing—original draft Writing—review & editing) Albert Wolthuis (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) F. Perez (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Tsuyoshi Konishi (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Yves Panis (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Martin Rutegård (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Roel Hompes (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Validation Visualization Writing—review & editing) Camiel Rosman (Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Validation Visualization Writing—review & editing) Frans van Workum (Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Supervision Validation Visualization Writing—review & editing) Pieter Tanis (Conceptualization Data curation Formal analysis Investigation Methodology Project administration Supervision Validation Visualization Writing— original draft Writing—review & editing) and Johannes De Wilt (Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Supervision Validation Visualization Writing—original draft Writing—review & editing). <section> The TENTACLE-Rectum study was funded by Medtronic External Research Program.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study was registered at ClinicalTrials.gov (NCT04127734) and was conducted in agreement with the STROBE guidelines for reporting of observational studies",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/bjsopen/zrad080",TRUE,"<section> Individual financial conflict of interest: M. <section> The remaining authors declare no relevant conflict of interest. <section> Individual intellectual conflict of interest: M.",TRUE,"<section> Writing—original draft Writing—review & editing) David Chen (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Andrew de Beaux (Conceptualization Formal analysis Funding acquisition Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Barbora East (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Josep García Alamino (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Nadia A Henriksen (Conceptualization Data curation Formal analysis Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Ferdinand Koeckerling (Conceptualization Funding acquisition Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Jan Kukleta (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Maarten Loos (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Manuel López-Cano (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Ralph Lorenz (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Marc Miserez (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Agneta Montgomery (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Salvador Morales-Conde (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Chris Oppong (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Maciej Pawlak (Conceptualization Formal analysis Investigation Methodology Visualization Writing—original draft Writing—review & editing) Mauro Podda (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Wolfgang Reinpold (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) David Sanders (Conceptualization Investigation Methodology Validation Visualization Writing— original draft Writing—review & editing) Alberto Sartori (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Han Tran (Conceptualization Funding acquisition Methodology Visualization Writing—original draft Writing—review & editing) Mireia Verdaguer-Tremolosa (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing— review & editing) Reiko Wiessner (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Michael Yeboah (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) Willem Zwaans (Conceptualization Formal analysis Investigation Methodology Validation Visualization Writing—original draft Writing—review & editing) and Maarten Simons (Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing—original draft Writing—review & editing). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Open surgery (Lichtenstein) In total five new RCTs 114–118  one systematic review with meta-analysis (including the RCTs) 119 and two registry-based studies (Swedish Hernia Register) 120121 comparing LWM to HWM in open hernia repair were identified.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/brain/awac276",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding <section> This work was supported by the Bundesministerium für Bildung und Forschung (CONNECT-Generate 01GM1908) and the French National Research Agency (ANR) ‘Programme d´Investissements d´Avenir (PIA)’ (ANR-18-RHUS-0012-BETPSY Honnorat).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awac497",TRUE,"Competing interests <section> H.P. has a patent application pending for the use of similar NMDAR-Fc chimeras in autoimmune diseases.",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (HA6386/9-1 to S.H. and M.H. HA6386/10-1 to S.H. GE2519/8-1 and GE2519/9-1 to C.G. PR1274/4-1 and PR1274/5-1 to H.P. and HA2686/ 19-1 to V.H.) the European Research Council (ERC CoG 865634 to S.H. and ERC AdG 884 281 to V.H.) the Bundesministerium für Bildung und Forschung (Connect-Generate 01GM1908D to H.P. 01GM1908B and 01EW1901 to C.G.) by the Helmholtz Association (HIL-A03 to H.P.) and the Hermann und Lilly Schilling-Stiftung für Medizinische Forschung (to C.G.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awad005",TRUE,"Competing interests <section> R.P. has received honoraria for advisory boards and speaker engage­ ments from Roche EISAI Eli Lilly Biogen Janssen-Cilag Astra Zeneca Schwabe Grifols Novo Nordisk and Tabuk; and was princi­ pal investigator on the aducanumab phase-III trials.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awad010",TRUE,"Competing interests <section> A.G.C. has received honoraria for research support and lectures from PTC Therapeutics honoraria for lectures from Biomarin Immedica and Recordati Rare Diseases Foundation and is a cofounder of the Hospital Sant Joan de Déu start-up ‘Neuroprotect Life <section> Sciences’.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awad092",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"The work of C.M. was supported by the German Research Foundation– Project-ID 259373024—TRR 167. R.C.H. received funding support from the Elsa-Neumann-Scholarship program (Grant Number H57021). The work of J.M.S. is supported by the National Institute of Disability Independent Living and Rehabilitation Research (NIDILRR Grant 90SI5020) the National Institutes of Neurological Disorders-NIH (Grant R01 NS118200) the European Union (EU Era Net—Neuron Program SILENCE Grant 01EW170A) the Craig H Neilsen Foundation (Grant 596764) the Wings for Life Spinal Cord Research Foundation and the William E. <section> Funding <section> The trial was supported by grants from the German Research Council Cluster of Excellence NeuroCure the Berlin-Brandenburg Center for Regenerative Therapies (BCRT Grant number 81717034) and the Wings for Life Spinal Cord Research Foundation (Grant Number WfL-DE-006/12 WfL-DE-16/16 WfL-DE-11/20).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awad123",TRUE,"Competing interests <section> J.J. has received conference travel support from Abbvie and Abbott and lecturer honoraria from Lundbeck and Novartis.",TRUE,"<section> Funding M.D.F. was supported by grants from the National Institutes of Health (R01MH113929 R21MH126271 R56AG069086 R21NS123813 R01NS127892) the Kaye Family Research Endowment the Ellison/Baszucki Family Foundation and the Manley Family.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/brain/awad239",TRUE,"Competing interests <section> W.J.N. and L.M. have received honoraria for talks unrelated to this manuscript from Medtronic which is a manufacturer of deep brain stimulation devices.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/braincomms/fcad080",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding <section> This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (German Research Council) (DFG DR 323/5-1 to O.W.S. H.V. P.V. J.W. P.M. and J.P.D.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/braincomms/fcad087",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding <section> No funding was received towards this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/braincomms/fcad105",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding <section> J.-J.Z. and E.E. are funded by the Deakin University Postgraduate Research Scholarship. J.M.-H. is funded by the Australian Government Research Training Program scholarship. J.J. has received research funding from the Finnish Medical Foundation Instrumentarium Research Foundation Sigrid Juselius Foundation Finnish Foundation for Alcohol Studies and University of Turku and Turku University Hospital and received lecturer honor­ aria from Lundbeck and conference travel expenses from AbbVie and Abbott.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/braincomms/fcad143",TRUE,"Competing interests <section> F.P. has received honoraria and research support from Alexion Bayer Biogen Chugai MerckSerono Novartis Genzyme MedImmune Shire Teva and serves on scientific advisory boards for Alexion MedImmune and Novartis. M.M.S. serves on the editorial board of Neurology and Frontiers in Neurology receives research support from the Dutch MS Research Foundation Eurostars-EUREKA ARSEP Amsterdam Neuroscience MAGNIMS and ZonMW and has served as a consultant for or received re­ search support from Atara Biotherapeutics Biogen Celgene/Bristol Meyers Squibb Genzyme MedDay and Merck. N.S. S.K. S.P.K. T.B. D.S.B. D.L.S. and C.F. <section> have no competing interests.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation 327654276 (SFB 1315) FI 2309/1–1 FI 2309/ 2-1 and PR 1274/6-1 to C.F.); and Deutsches Ministerium für Bildung und Forschung (BMBF German Ministry of Education and Research 01GM1908D CONNECTGENERATE). F.P. received funding from Deutsche Forschungsgemeinschaft (DFG German Research Foundation Exc 257) Deutsches Ministerium für Bildung und Forschung (BMBF German Ministry of Education and Research Competence Network Multiple Sclerosis) Guthy Jackson Charitable Foundation EU Framework Program 7 National Multiple Sclerosis Society of the USA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/braincomms/fcad152",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/braincomms/fcad270",TRUE,"Competing interests <section> The authors report no competing interests.",TRUE,"<section> Funding <section> No funding was received towards this work. This study was financed solely by institutional resources of both University Hospital of Psychiatry University of Bern and CharitéUniversitätsmedizin Berlin.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cercor/bhac500",TRUE,"<section> Conf lict of interest statement: None declared.",TRUE,"<section> Funding <section> This research was supported by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cercor/bhad051",TRUE,"<section> Conf lict of interest statement: None declared.",TRUE,"<section> Ellen Knierim (Formal analysis Investigation Visualization Writing—review & editing) Johannes Vogt (Conceptualization Formal analysis Funding acquisition Investigation Visualization Writing—original draft Writing—review & editing) Michael Kintscher Formal analysis Investigation Methodology Writing— review & editing) Alexey Ponomarenko (Formal analysis Investigation Methodology Writing—review & editing) Jan Baumgart (Formal analysis Investigation Writing—review & editing) Prateep Beed (Formal analysis Investigation Writing—review & editing) Tatiana Korotkova (Formal analysis Investigation Writing—review & editing) Thorsten Trimbuch (Formal analysis Investigation Writing—review & editing) Axel Panzer (Resources Writing—review & editing) Ortrud Steinlein (Resources Writing— review & editing) Ulrich Stephani (Resources Writing—review & editing) Andrew Escayg (Resources Writing—review & editing) Mahmoud Koko (Formal analysis Investigation Writing—review & editing) Yuanyuan Liu (Formal analysis Investigation Writing—review & editing) Holger Lerche (Data curation Resources Supervision Validation Writing—review & editing) Dietmar Schmitz (Conceptualization Data curation Funding acquisition Project administration Resources Supervision Visualization Writing—review & editing) Robert Nitsch (Conceptualization Project administration Resources Supervision Writing— original draft Writing—review & editing) and Markus Schuelke (Conceptualization Data curation Formal analysis Funding acquisition Investigation Project administration Resources Software Supervision Validation Visualization Writing—original draft Writing—review & editing) <section> Funding <section> This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG project 12959370—SFB 665 to MS RS DS SFB 1451 to JV RN and TK and under Germany’s Excellence Strategy—EXC-2049-390688087 to TK AP DS and MS and EXC-2030-390661388 to JV) and by the European Research Council (ERC; LiPsyD and ERC-PoC PsychAid to RN).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cercor/bhad371",TRUE,"<section> Conf lict of interest statement: None declared.",TRUE,"Eickholt (Resources Writing—review & editing) Dieter Jaeger (Funding acquisition Writing—review & editing) Matthew E. Larkum (Funding acquisition Writing—review & editing) <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ckj/sfad194",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> The authors J.N. F.K. H.S. V.K. C.S. I.L. T.Saritas T.Sitter M.P.S. M.S. and G.W. have no competing conflict of interest to declare.",TRUE,"<section> The current discussion concerning the use of combined cardiorenal outcomes in future clinical trials is supported by our data as the single endpoint HHF may be an equal reflection of both cardiac and renal damage in patients with DM [ ]. <section> FUNDING <section> The GCKD study was/is funded by grants from the German Ministry of Education and Research ( BMBF grant number 01ER0804 and for the authors F.K. and U.T.S. <section> NEJMoa1504720 Tuttle KR Brosius FC III Cavender MA et al. SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a Scientific Workshop Sponsored by the National Kidney Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ckj/sfad218",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> N.E. received fees from Bayer AG Leverkusen as a member of an editorial advisory board outside the submitted work. E.S. received a research grant from Bayer unrelated to the topic of the article and receives a stipend from the National Kidney Foundation. The other authors declare no conflicts of interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ckj/sfad231",TRUE,"<section> CONFLICT OF INTEREST STATEMENT",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ckj/sfad260",TRUE,"<section> CONFLICT OF INTEREST STATEMENT",TRUE,"<section> FUNDING <section> S.S. received funding through a MetaRot fellowship and is currently supported by German Research Foundation ( Deutsche Forschungsgemeinschaft DFG) grant SE 3451/1–1. F.P. is funded by DFG grant PE 3135/1–1.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cvr/cvab317",TRUE,"Conflict of interest: M.C.P. reported receiving lecture fees from AstraZeneca Novartis and Eli Lilly grant support advisory board fees and fees for serving on an endpoint committee from Boehringer Ingelheim advisory board fees lecture fees and fees for serving on an endpoint committee from Novo Nordisk advisory board fees from Napp Pharmaceuticals and fees for serving on an endpoint committee from Takeda Pharmaceutical and Bayer.",TRUE,"<section> Funding <section> This work was supported by the Kidney Research UK which was supported by an unrestricted grant from Vifor Fresenius Medical Care Renal Pharma.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cvr/cvac115",TRUE,"Conflict of interest: F.W.A. P.A. B.J.J.M.B. S.M.D. M.F. M.G. S.V.L. R.M. C.P. M.P. G.G.S. S.S. C.G.-T. T.K.: no conflicts to disclose.",TRUE,"<section> Funding <section> This work was supported by: University College London Hospitals Biomedical Research Centre to F.W.A.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/cvr/cvad040",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> A-M.S. and H.W. were supported by the Research Council of Norway (grant no. 262079) the Western Norway Regional Health Authority (nos F-12546 and 912168) and the Norwegian Health Association.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cvr/cvad042",TRUE,"Conflict of interest: A.A.V. received consultancy fees and/or research grants from AstraZeneca Bayer Boehringer Ingelheim BMS Cytokinetics Merck Novo Nordisk Novartis and Roche diagnostics. P.v.d.M. received consultancy fees and/or grants from Novartis Corvidia Singulex Servier Vifor Pharma AstraZeneca Pfizer and Ionis. R.A.d.B. re­ ceived grants from AstraZeneca Abbott Boehringer Ingelheim Cardior Pharmaceuticals Gmbh Ionis Pharmaceuticals Inc. Novo Nordisk and Roche and speaker fees from Abbott AstraZeneca Bayer Novartis and Roche. F.Z. received personal fees for trial oversight committees ad­ visory boards or speakers’ bureau from Acceleron Amgen Applied Therapeutics AstraZeneca Bayer Boehringer Cardior Cereno Scientific CellProthera CVRx G3 Pharmaceuticals Merck Merck AG Novartis Novo Nordisk Pfizer Servier and Vifor Fresenius and is the cofounder of CardioRenal and CVCT. J.G.F.C. received consultancy fees and/ or research grants from Abbott Amgen AstraZeneca Bayer Boehringer Ingelheim Bristol Myers Squibb Cytokinetics Idorsia Johnson & Johnson Medtronic MyoKardia Novartis NI Medical Pharmacosmos Pharma Nord Philips Respicardia Servier Torrent Vifor and Viscardia. M.M. reports fees from Actelion Amgen AstraZeneca LivaNova Servier Vifor Pharma and Windtree Therapeutics as a member of clinical trial committees or advisory boards and from Abbott vascular Bayer Boehringer Ingelheim and Edwards Therapeutics for speeches at spon­ sored meetings in the last 3 years. W.B.M. P.S. and P.L. are founders of ImmunometriX. W.B.M. and L.S. are listed as inventors on a patent appli­ cation. All other authors have no relationships to disclose that could be construed as a conflict of interest with regard to this manuscript.",TRUE,"<section> Funding <section> BIOSTAT-CHF was funded by the European Commission (FP7-242209-BIOSTAT-CHF; EudraCT 2010-020808-29). The analytical work was supported by the German Federal Ministry for Economic Affairs and Energy (BMWi) and the European Social Fund (ESF);",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cvr/cvad099",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> This work was supported by the Dutch Heart Foundation grant number 2018T051 to A.C.F. 2019T067 to I.B. CVON2017-20: Generating the best evidencebased pharmaceutical targets and drugs for atherosclerosis (GENIUS II) to J.K. and the European Research Area Network on Cardiovascular Diseases (ERA-CVD) B-eatATHERO consortium; Dutch Heart Foundation grant number 2019T107 to A.C.F. Austrian Science Fund (FWF) grant number I4647 to D.T. Bundesministerium für Bildung and Forschung (BMBF) grant number 01KL2003 to J.K.P. and the Fondation Leducq grant number TNE-20CVD03 to C.J.B.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/cvr/cvad154",TRUE,"Conflict of interest: All authors declare to have no conflict of interest related to this manuscript.",TRUE,"<section> Funding <section> The study was funded by a Berlin Institute of Health (BIH) twinning re­ search grant to S.K. and N.H.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ecco-jcc/jjad088",TRUE,"Conflict of Interest <section> M.F.N. has served as an advisor for Pentax Giuliani MSD Abbvie Janssen Takeda and Boehringer. S.Z. received speaker’s fees from Takeda Roche Galapagos Ferring Lilly Falk and Janssen. M.F.N. and S.Z. received research support from Takeda Shire [a part of Takeda] and Roche. D.P. and D. S. are employees of Takeda and own stock and/or stock options in Takeda. B.S. has served as consultant for Abbvie Arena BMS Boehringer Celgene Falk Galapagos Janssen Lilly Pfizer Prometheus and Takeda and received speaker’s fees from Abbvie CED Service GmbH Falk Ferring Janssen Novartis Pfizer and Takeda [served as representative of the Charité]. The other authors declare no conflicts of interest.",TRUE,"<section> Funding <section> This work was supported through a grant by Shire a Takeda company. This work was further supported by the Deutsche Forschungsgemeinschaft [DFG German Research Foundation; ZU 377/4-1 STU 238/101 TRR 241 – 375876048 projects A06 B01 B08 C04 Z03] and the Else Kröner-Fresenius-Stiftung [2021_EKCS.23] as well as the Coronafunding initiative of the Bavarian Ministry of Science and Arts to MS. <section> The research of T.M.M. I.A. M.S. M.L. R.A. M.F.N. and S.Z. was supported by the Interdisciplinary Center for Clinical Research [IZKF] and the ELAN programme of the Universität Erlangen-Nürnberg the Fritz-Bender-Stiftung the Ernst JungStiftung the Else Kröner-Fresenius-Stiftung the ThyssenStiftung the German Crohn’s and Colitis Foundation [DCCV] the DFG topic programme on Microbiota the Emerging Field Initiative the DFG Collaborative Research Centers 643 796 1181 and TRR241 [Project-ID 375876048—TRR 241] the Rainin Foundation and the Litwin IBD Pioneers programme of the Crohn’s and Colitis Foundation of America [CCFA].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ecco-jcc/jjad097",TRUE,"Conflict of Interests <section> PE: Received lecture fees consultancy fees or travel educational grants from Takeda Janssen Pfizer and Bristol Myers Squibb. BW: Research support from AbbVie Biora Therapeutics Pfizer Sossei Heptares and Takeda. Speaker’s fees from Abbvie Biogen Bristol Myers Squibb Celltrion Chiesi Falk Ferring Galapagos Janssen MSD Pfizer R-Biopharm Takeda Truvion and Viatris. Consultancy fees from Abbvie Alimentiv Applied Strategic Atheneum Biora Therapeutics Bristol Myers Squibb Galapagos Guidepont Mylan Inotrem Ipsos Janssen Progenity Sandoz Sosei Heptares Takeda Tillots Pharma and Viatris. EC: Consultancy fees from Zenus Biopharma Horizon Therapeutics Sanofi Moderna and Falk Pharma and is supported by the National Institute Health Research [NIHR] Oxford Biomedical Research Centre [BRC]. <section> GD LIK JW AGGP MK HL MT GO DRG TS AB JFR DP CFV TJ LL SO PP IG MJ KM NP ABGS ŁSz RTW YS EZ IM DD PEl: Declare no conflict of interest.",TRUE,"EC: Consultancy fees from Zenus Biopharma Horizon Therapeutics Sanofi Moderna and Falk Pharma and is supported by the National Institute Health Research [NIHR] Oxford Biomedical Research Centre [BRC]. TL: Grant support from Abbvie Mylan MSD Mundipharma Biogen Janssen Pfizer and Takeda. PB: Financial support for research from Abbvie Amgen Celltrion Mylan Pfizer and Takeda; advisory board fees from Abbvie Arena pharmaceuticals BMS Celltrion CIRC Dr Falk Galapagos Janssen Lilly Pentax PSI-CRO Roche Takeda and Tetrameros; lecture fees from AbbVie Celltrion EPGS Galapagos Janssen Lilly Materia Prima Pentax Scope and Takeda. <section> The participation of Dr Emma Culver in the project was supported by the National Institute Health Research [NIHR] Oxford Biomedical Research Centre [BRC].",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ecco-jcc/jjad122",TRUE,"Conflict of Interest <section> The authors have nothing to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ecco-jcc/jjad192",TRUE,"Conflict of Interest <section> BV has received grants from Abbvie Biora Therapeutics Landos Pfizer Sossei Heptares and Takeda; speaker’s fees from Abbvie Biogen Bristol Myers Squibb Celltrion Chiesi Falk Ferring Galapagos Janssen MSD Pfizer R-Biopharm Takeda Truvion and Viatris; consultancy fees from Abbvie Alimentiv Applied Strategic Atheneum Biora Therapeutics Bristol Myers Squibb Galapagos Guidepoint Landos Mylan Inotrem Ipsos Janssen Progenity Sandoz Sosei Heptares Takeda Tillots Pharma and Viatris.",TRUE,"Role of the funding source This study was funded by Landos Biopharma Inc. Blacksburg VA USA. <section> Funding <section> This work was supported by Landos Biopharma Inc. <section> BV has received grants from Abbvie Biora Therapeutics Landos Pfizer Sossei Heptares and Takeda; speaker’s fees from Abbvie Biogen Bristol Myers Squibb Celltrion Chiesi Falk Ferring Galapagos Janssen MSD Pfizer R-Biopharm Takeda Truvion and Viatris; consultancy fees from Abbvie Alimentiv Applied Strategic Atheneum Biora Therapeutics Bristol Myers Squibb Galapagos Guidepoint Landos Mylan Inotrem Ipsos Janssen Progenity Sandoz Sosei Heptares Takeda Tillots Pharma and Viatris. SV has received grants from AbbVie J&J Pfizer Takeda and Galapagos; consulting and/or speaking fees from AbbVie Abivax AbolerIS Pharma AgomAb Alimentiv Arena Pharmaceuticals AstraZeneca Avaxia BMS Boehringer Ingelheim Celgene CVasThera Cytoki Pharma Dr Falk Pharma Ferring Galapagos Genentech-Roche Gilead GSK Hospira Imidomics Janssen J&J Lilly Materia Prima MiroBio Morphic MrMHealth Mundipharma MSD Pfizer Prodigest Progenity Prometheus Robarts Clinical Trials Second Genome Shire Surrozen Takeda Theravance Tillots Pharma AG and Zealand Pharma. BS has received grant support from Pfizer [to institution]; served as a consultant [served as a representative of Charité] for AbbVie Arena BMS Boehringer Celgene Endpoint Health Falk Galapagos Janssen Landos Lilly Pfizer PredictImmune and Takeda; and has received speaker’s fees [served as a representative of Charité] from AbbVie CED Service GmbH Falk Ferring Galapagos Janssen Lilly Pfizer and Takeda; support for attending meetings/travel from Falk; and served as president of ECCO.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"ClinicalTrials.gov: NCT04862741.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,NA,NA
"10.1093/ecco-jcc/jjad195",TRUE,"Conflicts of Interest <section> NC and IC are employees and shareholders of F.",TRUE,"<section> Funding <section> This work was supported by the Innovative Medicines Initiative [IMI] 2 Joint Undertaking [945345-2]. CH received speaker’s fees from Takeda Ferring AbbVie and Janssen; and consultancy fees from Pfizer; she has acted as local principal investigator for clinical trials for Janssen and GlaxoSmithKline; she is PI on projects at the Karolinska Institutet partly funded by investigatorinitiated grants from Takeda and Tillotts. MJ has served as a consultant for Ferring and Takeda Pharma; and received speaker’s fee from MSD Ferring and Takeda Pharma; she is the PI on projects at Aarhus University Hospital partly funded by investigatorinitiated grants from Takeda Pharma.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ehjacc/zuad027",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> R.J.T. is supported by an Academic Clinical Fellowship from the National Institutes of Health Research. A.P. is funded by the Medical Research Council (grant number MR/W03011X/1).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjacc/zuad129",TRUE,"Conflict of interest: Dr Bernhardt reports personal fees from Abbott personal fees from Abiomed personal fees from Astra Zeneca personal fees from Berlin Heart personal fees from Fine Heart personal fees from Medtronic outside the submitted work; Dr Morrow reports grants and personal fees from Abbott Laboratories grants from Abiomed grants from Amgen grants from Anthos Therapeutics grants from ARCA Biopharma grants from AstraZeneca grants from Bayer Healthcare grants from Eisai grants and personal fees from Merck grants and personal fees from Novartis grants from Pfizer grants from Regneron Pharmaceuticals grants and personal fees from Roche Diagnostics grants from Siemens personal fees from InCardia personal fees from Inflammatix outside the submitted work; Dr Varshney reports person­ al fees from Broadview Ventures outside the submitted work. The other authors report no conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by the University Heart and Vascular Center at the University Medical Center Hamburg-Eppendorf. BS received funding from the Else Kröner-Fresenius-Stiftung.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjci/jead062",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> Work for this manuscript was supported by research grants from the P.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjci/jead154",TRUE,"Conflict of interest: D.M.L. received lecture honoraria from Amgen Abbott Vascular AstraZeneca and Novo Nordisk. M.J. received consulting fees from Biotronik TriCares Veryan and Shockwave and is in the Steering Committee of Biotronik and Edwards Lifesciences. T.D.T. received pay­ ment honoraria from Novartis AstraZeneca Berlin Chemie Abbott NeoVasc and Amgen. U.L. reports lecture and advisory honorary from Abbott. All other authors report no conflicts of interest.",TRUE,"<section> Funding <section> The OPTICO-ACS trial was funded by a CRU grant from the Berlin Institute of Health (BIH Berlin Germany) as well as from the Deutsches Zentrum für Herzkreislaufforschung (“German Centre for Cardiovascular",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjci/jead186",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> G.C. is supported by the British Heart Foundation (BHF SP/20/2/34841) the BHF Accelerator Award (AA/18/6/34223) and the National Institute of Health Research (NIHR) UCL Hospitals BRC. <section> are supported by the Barts Charity HeartOME1000 Grant (MGU0427/ G-001411). J.C.M. is supported by the University College London Hospitals NIHR Biomedical Research Center and indirectly supported by the Biomedical Research Unit at Barts Hospital. P.S. is funded by the University College London Hospitals NIHR Biomedical Research Center and his research is supported by the Fondation Leducq.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjcvp/pvad001",TRUE,"Conflict of interest: G.F. reports lecture fees and/or that he is a committee member of trials and registries sponsored by Amgen Bayer Boehringer Ingelheim Medtronic Novartis Servier and Vifor Pharma. C.J.K. has no conflict of interest to declare.",TRUE,"<section> Funding <section> This work was supported by Bayer AG Berlin Germany who funded the FIDELIO-DKD and FIGARO-DKD studies and pooled analysis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ehjdh/ztad005",TRUE,"Conflict of interest: K.C.S.L. and A.U. report employment by Sanofi and may hold shares and/or stock options in the company. This arrangement has been reviewed and approved by Johns Hopkins University in ac­ cordance with its conflict-of-interest policies. <section> The authors report no other conflicts of interest.",TRUE,"20 However given the relative novelty of mobile technologies in CR most published studies are limited to re­ search settings usually within academic research centres and funded by external grants. <section> Funding <section> has received research funding grants from the German Federal Ministry of Education and Research and grants from the Federal Ministry of Economic Affairs and Energy for conducting research and clinical trials in remote patient management.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ejcts/ezac516",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad013",TRUE,"Conflict of interest: E.",TRUE,"<section> Funding The authors received no direct financial support of funding for the presented study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad095",TRUE,"Conflicts of interest: Porf Soliman is the co-founder and medical director of the CORRIB Core Lab. He reports several Institutional research grants from industry including clinical services related to his work as the Chairman of non-invasive imaging Core Lab for several industry-sponsored clinical trials for which he receives no direct compensation. All other authors have declared that no conflicts of interest exist.",TRUE,"<section> FUNDING <section> The EUROMACS Registry is organized and funded by the European Association for Cardio-Thoracic Surgery which supported this study by making resources available to enable its execution. AJS is funded by Science Foundation Ireland grant 19/",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad112",TRUE,"Conflict of interest: The authors declare that there are no potential conflicts of interest regarding this particular study.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad147",TRUE,"Conflict of interest: Nikolaos Bonaros received scientific grants 0.5 1.235 0.690–2.210 from Edwards Lifesciences and Corcym and speaker’s honoraria 0.2 1.235 0.876–1.741 from Edwards Lifesciences Medtronic and Vascular Graft",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad157",TRUE,"Conflict of interest: The authors hereby declare that there is no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ejcts/ezad212",TRUE,"Conflict of interest: All authors meet all the criteria for authorship and declare that they have no competing interests.",TRUE,"<section> Funding <section> No funding was provided for the present study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad305",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad327",TRUE,"Conflict of interest: Etem Caliskan is an investigator of the ongoing clinical of the DuraGraft registry (NCT02922088) and a member of the scientific registry advisory committee (RAC).",TRUE,"<section> Funding <section> This work was supported by the Society of Friends of the German Emmert: Conceptualization; Formal analysis; Funding acquisition; Project administration; Resources; Supervision; Writing—review & editing.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejcts/ezad336",TRUE,"Conflict of interest: Nikolaos Bonaros receives speaker’s honoraria from Edwards Lifesciences and Medtronic; institutional grant from Edwards Lifesciences and Corcym; and travel grants from Abbott Medtronic and Edwards Lifesciences.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ejendo/lvad007",TRUE,"Conflict of interest: The authors declare no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ejendo/lvad043",TRUE,"Conflicts of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.",TRUE,"<section> Funding <section> This work is part of the German Cushing’s Registry CUSTODES and has been supported by a grant from the Else Kröner-Fresenius Stiftung to MR (2012_A103 and 2015_A228). L.B. is supported by the Clinician Scientist Program RISE (Rare Important Syndromes in Endocrinology) supported by the Else-Kröner-Fresenius Stiftung and Eva Luise und Horst Köhler Stiftung.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ejendo/lvad054",TRUE,"Conflicts of interest: K.M. received research support by Ipsen (paid to the University Hospital Würzburg) and consulting fees or speaker honoraria by HRA Pharma Roche Eisai Bayer Advanz Pharma and Recordati. The University Hospitals in Würzburg and Munich are participating in a clinical trial spon­ sored by Enterome Paris France. S.F. received research fund­ ing from AstraZeneca Pfizer PharmaMar and Roche; consulting fees from Bayer Illumina and Roche; honoraria from Amgen Eli Lilly PharmaMar and Roche; and travel or accommodation expenses from Amgen Eli Lilly Illumina PharmaMar and Roche. F.M. received research grants from Enterome MSD and Recordati and consulting fee (paid to the University Hospital Würzburg) from HRA Pharma and Bayer Pharma. K.C.A. received speaker honoraria by Ipsen. <section> The other authors declare to have no competing interests.",TRUE,"<section> Funding <section> This work has been supported by the DFG German Research Foundation Project 314061271-TRR 205 by the European Reference Network on Rare Endocrine Conditions (Endo-ERN) and the European Reference network on rare adult solid cancers (EuRaCan). This work was supported by the National Center for Tumor Diseases (NCT) Molecular <section> Conflicts of interest: K.M. received research support by Ipsen (paid to the University Hospital Würzburg) and consulting fees or speaker honoraria by HRA Pharma Roche Eisai Bayer Advanz Pharma and Recordati.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/eurheartj/ehad170",TRUE,"Conflict of interest <section> All authors declare no conflict of interest for this contribution.",TRUE,"<section> Funding Research by A.L. and C.F.-L. is funded by the Spanish Ministry of Economy and Competitiveness and Fondos FEDER (grants #PI18/00139 and PI20/00605) and by the Wereld Kanker Onderzoek Fonds as part of the World Cancer Research Fund International grant pro­ gramme (grant #IIG_FULL_2021_007).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad171",TRUE,"Conflict of interest <section> H.G.C.V.S. leads trials with routinely available data with funding from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.",TRUE,"S.J.G. has received research support from the Duke University Department of Medicine Chair’s Research Award American Heart Association Amgen AstraZeneca Bristol Myers Squibb Cytokinetics Merck Novartis Pfizer and Sanofi; has served on advisory boards for Amgen AstraZeneca Bristol Myers Squibb Cytokinetics and Sanofi; and serves as a consultant for Amgen Bayer Bristol Myers Squibb Merck and Vifor. <section> Funding <section> All authors declare no funding for this contribution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/eurheartj/ehad333",TRUE,"Conflict of interest <section> Dr.",TRUE,"<section> Funding <section> This work is supported by grants from the National Institutes of Health (NIH) and the Office of Dietary Supplements (P01 HL147823 R01HL103866 and R01HL160747) and the Foundation Leducq (17CVD01). K.A.R. was supported in part by training grant T32HL134622 from the National Heart Lung and Blood Institute (NHLBI) of the NIH. M.W. was supported in part by an award from the Deutsche Forschungsgemeinschaft (WI 5229/1-1).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad334",TRUE,"Disclosure of Interest <section> We thank the FÖRDERKREIS DER DRESDNER HERZ-KREISLAUFTAGE e.V. for a generous research award given to T.G.",TRUE,"P.L. has received funding support from the National Heart Lung and Blood Institute the American Heart Association the RRM Charitable Fund and the Simard Fund outside of the current work; has served as an unpaid consultant to or been in­ volved in clinical trials for Amgen AstraZeneca Baim Institute Beren Therapeutics Esperion Therapeutics Genentech Kancera Kowa Pharmaceuticals Medimmune Merck Novo Nordisk Novartis Pfizer and Sanofi-Regeneron; and has served as a member of scientific advisory board for Amgen Caristo Cartesian Corvidia Therapeutics CSL Behring DalCor Pharmaceuticals Dewpoint Kowa Pharmaceuticals Olatec Therapeutics Medimmune Novartis PlaqueTec and XBiotech; his laboratory has received research funding in the last 2 years from Novartis; has served on the Board of Directors of XBiotech Inc.; and has a financial interest in XBiotech a company de­ veloping therapeutic human antibodies. <section> Funding <section> This study was supported by a CRU grant from the Berlin Institute of Health (BIH) and the German Centre for Cardiovascular Research (DZHK; FKZ: 81Z2100202) to D.M.L. This work was additionally supported by a re­ search fellowship by the German Cardiac Society (#DGK12/2020) and a Vascular Biomedicine Grant by the Berlin Center for Translational Vascular Biomedicine (BIH Charité Max Delbrück Center [MDC] Berlin) to T.G. and U.L. P.S. was supported by an Otto-Hess-Promotionsstipendium (German Cardiac Society). C.W. was supported by a DZHK-Doctoral Scholarship.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad379",TRUE,"Disclosure of Interest <section> Abbott Amgen AstraZeneca and Daiichi Sankyo (UL FC GL DL) NovoNordisk Sanofi Amarin Berlin-Chemie Novartis Pfizer <section> CRISPR Therapeutics Bayer Boeringer Ingelheim and Cardiac Dimensions (UL) Menarini and Chiesi (FC).",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/eurheartj/ehad445",TRUE,"Disclosure of Interest <section> F.C.: Grants or contracts from King Gustav V and Queen Victoria Foundation City Pharmacy Abu Dhabi Swedish Research Council and Swedish Heart & Lung Foundation; consulting fees from Astra Zeneca MSD Pfizer and Novo Nordisk; payment or honoraria from Astra Zeneca Bristol Meyers Squibb Merck Sharp & Dohme Novo Nordisk Boehringer Ingelheim Pfizer and Berlin Chemie; and <section> leadership or fiduciary role with European Society of Cardiology Advocacy Committee co-chair.",TRUE,"<section> Funding <section> All authors declare no funding for this contribution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad586",TRUE,"Disclosure of Interest <section> P.P. reports research grants consulting fees speaker’s bureau for Bayer MSD Servier Novartis Vifor Pharma Ltd. BMS Boehringer Ingelheim Respicardia AstraZeneca Berlin Chemie. R.J.M. has received research support and honoraria from Abbott American Regent Amgen AstraZeneca Bayer Boehringer Ingelheim/Eli Lilly Boston Scientific Cytokinetics Fast BioMedical Gilead Innolife Medtronic Merck Novartis Relypsa Respicardia Roche Sanofi Vifor Windtree Therapeutics and Zoll. A.F.H. reports research grants from American Regent Amgen AstraZeneca Bayer Boehringer Ingelheim Boston Scientific Bristol Myers Squibb Merck Novo Nordisk Novartis Pfizer Verily and consulting from Amgen AstraZeneca Bayer Boehringer Ingelheim Boston Scientific Bristol Myers Squibb Cytokinetics Eidos Intercept Myokardia and Novo Nordisk. J.B. re­ ports serving as a consultant to Abbott American Regent Amgen Applied Therapeutic AstraZeneca Bayer Boehringer Ingelheim Bristol Myers Squibb Cardiac Dimension Cardior CVRx Cytokinetics Edwards Element Science Innolife Impulse Dynamics Imbria Inventiva Lexicon Lilly LivaNova Janssen Medtronics Merck Occlutech Novartis Novo Nordisk Pfizer Pharmacosmos Pharmain Roche Sequana SQ Innovation 3live and Vifor. MSK de­ clares no competing interests.",TRUE,"<section> Funding <section> Funding for the analysis and support of medical writing to was provided by",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/eurheartj/ehad591",TRUE,"Disclosure of Interest B.M. reports grants from Boston Scientific NRDIF Hungary and National Heart Program during the conduct of the study; personal fees from Biotronik Abbott AstraZeneca Novartis and Boehringer-Ingelheim; and grants from Medtronic outside the submitted work. <section> no conflict of interest for this contribution.",TRUE,"<section> Disclosure of Interest B.M. reports grants from Boston Scientific NRDIF Hungary and National Heart Program during the conduct of the study; personal fees from Biotronik Abbott AstraZeneca Novartis and Boehringer-Ingelheim; and grants from Medtronic outside the submitted work. <section> Funding The trial was supported by the ‘National Heart Program’ (Project no. <section> NVKP_16-1–2016-0017) with support provided by the National Research Development and Innovation Fund of Hungary financed un­ der the NVKP_16 funding scheme. <section> were supported by the Bolyai Janos Research Scholarship by the Hungarian Academy of Sciences.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad658",TRUE,"Disclosure of Interest <section> Garbade has nothing to disclose Finn Gustafsson declares consulting fees from Abbott Corwave FineHeart; Michiel Morshuis has nothing to declare; Daniel Zimpfer declares grants and speaker’s fees from Medtronic Abbott Edwards Berlin Heart and support for attending meeting and/or travel from Medtronic Edwards Abbott Berlin Heart Abiomed; Jacob Lavee has nothing to disclose; Yuriy Pya has nothing to disclose; Michael Bertchtold-Herz has nothing to disclose; AiJia Wang is an Abbott employee; Carlo Gazzola is an Abbott employ­ ee; Evgenij Potapov declares grants consulting fees expert testimony speaker’s fees advisory board/data safety monitoting board fees sup­ port for attending meeting and/or travel from Abbott Medtronic <section> Abiomed; Diyar Saeed has nothing to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad664",TRUE,"Disclosure of Interest <section> potential conflicts of interest to declare.",TRUE,"<section> Funding <section> All authors declare no funding for this contribution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad666",TRUE,"Disclosure of Interest P.S.W. reports grants and personal fees from Boehringer Ingelheim grants from Philips Medical Systems grants and personal fees from sanofi-aventis grants and personal fees from Bayer Vital grants from Daiichi Sankyo Europe personal fees from AstraZeneca personal fees and non-financial support from DiaSorin non-financial support from I. E. M. and grants from Evonik. J.H.P. received support for lectur­ ing from Bayer Health Care Boehringer Ingelheim and Daiichi-Sankyo outside the topic of the present study. P.S.W. is principal investigator of the DIASyM research core of the MSCoreSys consortium (BMBF 161L0217A). H.H. and K.S.-F. are codirectors of CellTrend. G.R. is an advisor of CellTrend and earned honoraria for her advice between 2011 and 2015. The other authors declare no competing interests.",TRUE,"<section> Disclosure of Interest P.S.W. reports grants and personal fees from Boehringer Ingelheim grants from Philips Medical Systems grants and personal fees from sanofiaventis grants and personal fees from Bayer Vital grants from Daiichi Sankyo Europe personal fees from AstraZeneca personal fees and nonfinancial support from DiaSorin nonfinancial support from I. <section> Funding <section> This work was supported by the government of Rhineland-Palatinate (‘Stiftung Rheinland Pfalz für Innovation’ contract no. AZ 961-386261/ 733) the research programmes ‘Wissen schafft Zukunft’ and ‘Schwerpunkt Vaskuläre Prävention’ of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Economy Rhineland-Palatinate by the Ministry of Health and the Ministry of Economics Rhineland-Palatinate Germany (AZ.623-1) and the Federal Ministry of Education and Research Germany (BMBF 01EO1003). F.S.M. is supported by a rotation grant of the foun­ dation Heart of Mainz.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad783",TRUE,"Disclosure of Interest The remaining authors have no disclosures to report.",TRUE,"<section> Funding <section> All authors declare no funding for this contribution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartj/ehad828",TRUE,"Disclosure of Interest <section> J.S. is on the advisory board and a consultant for Abbott Boston Scientific and Baylis; M.A.A. is on the advisory board for Boston Scientific and Abbott; U.L. has received lecture and consultancy honor­ ary from Abbott and Boston Scientific; A.T. is a clinical proctor for <section> Abbott.",TRUE,"<section> Funding <section> All authors declare no funding for this contribution.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartjsupp/suad127",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding <section> This work has been supported by the Abiomed Europe GmbH to cover publication costs as well as professional language editing of each manuscript. This paper was published as part of a supplement financially supported by Abiomed GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartjsupp/suad131",TRUE,"Conflict of interest: A.M.B. has received consulting fees from Abbott Abiomed AstraZeneca Berlin Heart FineHeart Medtronic and Novartis.",TRUE,"<section> Funding <section> This work has been supported by Abiomed Europe GmbH to cover publication costs as well as professional language editing of each manuscript. <section> This paper was published as part of a supplement financially supported by Abiomed GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurheartjsupp/suad132",TRUE,"Conflict of interest: B.S. has received research funding from the German Research Foundation the Else Kröner-Fresenius-Stiftung and Abiomed and speaker fees from Abbott Abiomed and AstraZeneca.",TRUE,"<section> Funding <section> This work has been supported by the Abiomed Europe GmbH to cover publication costs as well as professional language editing of each manuscript. This paper was published as part of a supplement financially supported by Abiomed GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurjcn/zvad019",TRUE,"Conflicts of interest: F.K. has received fees for presentation from AMGEN GmbH Sanofi-Aventis Deutschland GmbH Abbott Medical",TRUE,"<section> Funding <section> This work was supported by a research grant of the German Federal Ministry of Education and Research (grant numbers 13KQ0904A 13KQ0904B 13KQ1104A) in the context of the TIM-HF2 study.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurjpc/zwad151",TRUE,"Conflict of interest: O. Chioncel declare no conflict of interest related to present work; ESC meeting support from Servier. L. Benson declare no conflict of interest. Rosano declare no conflict of interest.",TRUE,"<section> Funding Lund is supported by Supported by Karolinska Institutet the Swedish Research Council [grant 523-20142336] the Swedish Heart Lung Foundation [grants 20150557 20190310] and the Stockholm County Council [grants 20170112 20190525] and reports unrelated to the present work: Grants: AstraZeneca Vifor Boston Scientific Boehringer Ingelheim Novartis MSD; Consulting: Vifor AstraZeneca Bayer Pharmacosmos MSD MedScape Sanofi Lexicon Myokardia Boehringer Ingelheim Servier Edwards Life Sciences Alleviant; Speaker’s honoraria: Abbott OrionPharma MedScape Radcliffe AstraZeneca Novartis Boehringer",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurjpc/zwad152",TRUE,"Conflict of interest: G.B.Z. has consulted for Cardionovum Crannmedical Innovheart Guidotti Meditrial Opsens Medical Replycare Teleflex and Terumo.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurjpc/zwad192",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euac123",TRUE,"Conflicts of interest: The authors have provided declaration of inter­ est information for all relationships that might be perceived as real or <section> potential sources of conflicts of interest. The full disclosures can be viewed in the supplementary material for this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euac238",TRUE,"Conflict of interests: D.K. has received honoraria from Merck Sharp & Dohme and Pfizer as well as research funding from Merck KGaA all outside of the submitted work. M.A. is a consultant for Biosense Webster and Boston Scientific has received educational grants from Abbott and is a proctor for Medtronic. J.B.-H. received personal fees from EBAMed SA Switzerland outside the submitted work. O.E. received honoraries for par­ ticipation on advisory board meetings from Merck Serono MSD and AstraZeneca concerning oncologic treatments and also received project funding for clinical trials from non-profit organizations all outside of the submitted work. T.R. gets research grants from the Swiss National Science Foundation the Swiss Heart Foundation and the Sitem Insel sup­ port fund. Speaker/consulting honoraria or travel support from Abbott/ SJM Bayer Biosense Webster Biotronik Boston Scientific Daiichi Sankyo Farapulse Medtronic and Pfizer-BMS. Support for the institution’s fellowship programme from Abbott/SJM Biosense Webster Biotronik Boston Scientific and Medtronic. A.S. received educational grants through his institution from Abbott Bayer Healthcare Biosense Webster Biotronik Boston Scientific BMS/Pfizer and Medtronic; and speaker/advis­ ory board fees from Abbott Bayer Healthcare Daiichi Sankyo Medtronic and Novartis. All other authors declare no conflict of interests.",TRUE,"This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/europace/euad061",TRUE,"Conflict of interest: D.T. is a consultant of Boston Scientific and has re­ ceived research grants from Biotronik and Boston Scientific. M.A. has re­ ceived speaker fees and conducts research sponsored by Biotronik. J.M. is an investigator in the Bio|Stream.HF study sponsored by Biotronik. I.D. <section> has received speaker fees from Biotronik and Boston Scientific and con­ ducts research sponsored by Abbott Biotronik Boston Scientific and Medtronic. T.T. is an employee of Biotronik. The other authors declare no competing interests.",TRUE,"<section> Funding <section> The study was supported by Biotronik SE & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad206",TRUE,"Conflict of interest: V.T. received speaker’s honoraria from Medtronic Biotronik Novartis and Pfizer. P.A. received speaker’s honoraria from Medtronic and Biotronik and study sponsoring from Abbott. P.N. received speaker’s honoraria from Abbott Biotronik and Zoll. U.L. has received speaker’s honoraria and consulting fees from Amgen Abbott AstraZeneca Bayer Boehringer Ingelheim Cardiac Dimensions Daiichi Sankyo Novartis NovoNordisk Pfizer Sanofi Amarin and Berlin-Chemie. M.H. received speaker’s honoraria from Biosense Webster and Novartis. All remaining authors have declared no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad233",TRUE,"Conflict of interest: N.V.: Research/Consulting for Abbott Biotronik and Impulse Dynamics; Pacemate; Implicity; and JB Research/Consulting",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad276",TRUE,"Conflict of interest: E.F. reports receiving full salary funding from Medtronic.",TRUE,"<section> Funding <section> This work is supported in part by grants from the Instituto de Salud Carlos III Spanish Government Madrid Spain (FIS_PI16/00435 – FIS_CIBER16; to L.M.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad316",TRUE,"Conflict of interest: M.G. has received research funding from Attune Medical and workshop fee from Cook Medical and has acted as a consultant and a paid speaker for Biosense Webster Cook Medical and Adagio. C.T.S. <section> has received consulting fees and travel expenses from Medtronic; consulting fees and research support from Biotronik; research support from Abbott; workshop fees consulting fees educational grants and research support from Cook Medical; consulting fees from Spectranetics/Philipps; and con­ sulting fees from AngioDynamics. M.S. has received research funding from Abbott and workshop fee from Cook Medical. Z.A. has received a workshop fee from Cook Medical. All remainder authors have declared no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad323",TRUE,"Conflict of interest: K.G.H. reports speaker’s honoraria consulting fees lecture honoraria and/or study grants from Abbott Alexion Amarin AstraZeneca Bayer Healthcare Biotronik Boehringer Ingelheim Boston Scientific Bristol-Myers Squibb Daiichi Sankyo Edwards Lifesciences Medtronic Novartis Pfizer Portola Premier Research Sanofi SUN Pharma and W.L. All other authors declare that there is no conflict of interest.",TRUE,"The trial sponsor was executed by the Clinical Research Institute Munich Germany and sponsored by the <section> Funding AXAFA-AFNET 5 was partially funded by Pfizer and Bristol Myers Squibb (grant number: CV185-244) and from the German Centre for Cardiovascular Research (grant number: 81X2800110) supported by the Bundesministerium für Bildung und Forschung. This work received additional support from the European Union [grant agreement no. 633196 (CATCH ME)] BigData@Heart (grant agreement EU IMI 116074) British Heart Foundation (FS/13/43/30324) and Leducq Foundation. P.U.H. reports research grants from the German Ministry of Research and Education German Research Foundation European Union Charité—Universitätsmedizin Berlin German Parkinson Society University Hospital Würzburg Robert Koch Institute German Heart Foundation Federal Joint Committee (G-BA) with­ in the Innovationfond University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer BMS Boehringer-Ingelheim Daiichi Sankyo) Charité—Universitätsmedizin Berlin (within Mondafis; sup­ ported by an unrestricted research grant to the Charité from Bayer) and University Göttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University Göttingen from BoehringerIngelheim) outside the submitted work. P.K. receives research support for basic translational and clinical research projects from the European Union British Heart Foundation Leducq Foundation Medical Research Council (UK) and German Centre for Cardiovascular Research from several drug and device companies active in atrial fibrillation and has received honoraria from sev­ eral such companies in the past.",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/europace/euad331",TRUE,"Conflict of interest: M.M.G. has received research funding from Medtronic and Attune Medical; has acted as a consultant and paid speaker for Adagio Biosense Webster and Cook Medical; and received workshop fee from Cook Medical. C.T.S. has received consulting fees and travel expenses from Medtronic; consulting fees and research support from Biotronik; re­ search support from Abbott; workshop fees consulting fees educational grants and research support from Cook Medical; consulting fees from Spectranetics/Philipps; and consulting fees from AngioDynamics. M.S. has re­ ceived research funding from Abbott Medical and workshop fee from Cook Medical. Z.A. has received workshop fee from Cook Medical. The other authors have no conflicts of interest to declare.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euad367",TRUE,"Conflict of interest: none declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/europace/euae005",TRUE,"Conflict of interest: none declared.",TRUE,"<section> Funding <section> This study was supported by the German Research Foundation (grant num­ ber HO 5647/4-1 and SFB1470 B01/A01 to F.H.) the German Centre for Cardiovascular Research (to F.H.) and the European Union Horizon 2020 Framework (Grant Agreement 945119 STOPSTORM to F.M.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/eurpub/ckad070",TRUE,"Conflicts of interest: None declared.",TRUE,"<section> We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/geronb/gbad006",TRUE,"Conflict of Interest None declared.",TRUE,"<section> Funding <section> BASE-II is supported by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF) under grant numbers #01UW0808; This project is also funded by the VolkswagenStiftung (Volkswagen foundation).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/gigascience/giad024",TRUE,"Competing interests <section> The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/gigascience/giad052",TRUE,"Competing Interests <section> The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This work has been supported by the Ministry of Education and Research (BMBF) as part of the National Research Initiativ e “Mass Spectr ometry in Systems Medicine” (MSCor eSys) grant-ID 031L0220A (MSTARS) and by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—project-ID <section> Conceptualization: M.N M.H. D.B Funding acquisition: D.B Methodology: M.H. M.N.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/heapro/daac182",FALSE,"",TRUE,"<section> Funding as important but are more under the influence of the This employer in terms of safety and health information or Ministry risk assessments or also social influence and company grant culture. <section> work was supported and funded by the Federal of Education and Research Germany (BMBF; number 02L16D010).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/heapro/daad141",FALSE,"",TRUE,"<section> FUNDING the present experiences as refugees in a host country namely Germany we interviewed Arabicspeaking No refugees and by treating them as one group we did Financial not account for the cultural societal historical and vided political diversity within this group. <section> authors thank all participants for their time https://academic.oup.com/heapro/article/38/5/daad141/7331259",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/hmg/ddad079",TRUE,"<section> Conf lict of Interest statement. Dr Menzies reports personal consultancy fees from Mendelian Ltd a rare disease digital health company outside the submitted work. The other authors have no competing interests to declare.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/icvts/ivac269",TRUE,"Conflict of interest: The authors hereby declare that there is no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/icvts/ivad011",TRUE,"<section> DISCLOSURES None of the authors has anything to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/icvts/ivad088",TRUE,"Conflict of interest: LW: None.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/icvts/ivad203",TRUE,"Conflict of interest: M.",TRUE,"<section> FUNDING <section> This work was supported by a grant from AtriCure Europe BV De I 260 1101 EE Amsterdam Z. All other authors have nothing to disclose regarding commercial support. <section> Jochen Senges: Conceptualization; Funding acqui­ sition; Methodology; Project administration; Resources; Writing—review & editing. <section> Torsten Hanke: Conceptualization; Funding acquisition; Methodology; Project administration; Supervision; Writing—review & editing.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ijnp/pyad011",FALSE,"",TRUE,"Dr Correll has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk Intra-Cellular Therapies Janssen/Johnson & Johnson Karuna Therapeutics LB Pharma Lundbeck MedAvanteProPhase MedinCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Biosciences Newron Noven Otsuka Pharmabrain PPD Recordati Relmada Reviva ROVI Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris; has provided expert testimony for Janssen and Otsuka; has served on a data safety monitoring board for Lundbeck Relmada Reviva ROVI Supernus and Teva; has received grant support from Janssen and Takeda; has received royalties from UpToDate; and is a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ijnp/pyad029",FALSE,"",TRUE,"<section> This work was supported by Alkermes Inc. He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/infdis/jiad153",TRUE,"Potential conflicts of interest. O. R. and M. C. are employees of the GSK group of companies. GSK Vaccines Institute for Global Health Srl is an affiliate of GlaxoSmithKline Biologicals SA. O. R. reports ownership of GSK share options. <section> All other authors report no potential conflicts. <section> All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.",TRUE,"<section> Financial support. This work was supported by the Wellcome Trust in part by an Intermediate Clinical Fellowship (grant number 110058/Z/15/Z to T.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical Trials Registration.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/infdis/jiad244",TRUE,"Potential conflicts of interest.",TRUE,"<section> Financial support. This work was supported by the Max Planck Society (Berlin Germany). Funding to pay the Open Access publication charges for this article was provided by the Max Planck Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/intimm/dxad025",TRUE,"Conflict of interest statement: A.S. is an employee of MVZ Institut für Mikroökologie GmbH a SME that produced the E. faecalis probiotic used for this study. M.L.C. received funding from MVZ Institut für Mikroökologie GmbH for the experiments conducted in this study. <section> Other authors declare no competing financial interest.",TRUE,"<section> Funding <section> Funding for this study was provided by the MVZ Institut für Mikroökologie GmbH and the Deutsche Forschungsgemeinschaft (DFG—grant CO 1058 3-2). M.L.C. received funding from MVZ Institut für Mikroökologie GmbH for the experiments conducted in this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jac/dkad132",TRUE,"<iend> data on study characteristics outcome measures financial support and sponsoring and disclosure of conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The protocol for this systematic review was registered on the International prospective register of systematic reviews (PROSPERO iden­ tifier CRD42022306644) and made publicly available on 25 January 2022.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/jac/dkad143",TRUE,"A.Y.C. has no relevant conflicts of interest with regard to the topic of this guideline. M.Ko. has no relevant conflicts of interest with regard to the topic of this guideline. All other authors declare no conflict of interest.",TRUE,"<section> Funding M.H. has received research funding from MSD Astellas Pfizer Scynexis F2G Euroimmun Mundipharma Gilead and NIH.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jac/dkad218",TRUE,"<section> All authors declare no conflict of interest.",TRUE,"<section> Funding The work of the NRC is funded by a grant from the Federal Ministry of Health Germany (current period 2018–2022).",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/jac/dkad232",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the German Centre for Infection Research (DZIF) (grant number TTU 08.811). H.S.’s institution has received funding from the German Centre for Infection Research (DZIF) consulting fees from Debiopharm and Shionogi and payments for lectures or presenta­ tions from Eumedica Gilead MSD and Shionogi. S.V.W.’s institution has received funding from the German Centre for Infection Research (DZIF) and consulting fees from the Institute for Quality and Efficiency in Health Care (IQWiQ). W.V.K.’s institution has received funding from the German Centre for Infection Research (DZIF) consulting fees from Gilead and Stiftung Warentest and payment for lectures from Landesärztekammer Baden-Württemberg Akademie für Infektionsmedizin Berufsverband Deutscher Internisten and SANA Kliniken AG.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/jamia/ocad061",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> ST is vice chair of HL7 Germany. The other authors declare no competing interests.",TRUE,"<section> FUNDING <section> This work was supported by the German Federal Ministry of Education and Research grant numbers 01ZZ1805 and 01ZZ1802.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/jas/skad335",TRUE,"Conflict of Interest Statement <section> All authors declare no real or perceived conflicts of interest.",TRUE,"<section> This study was funded by the H.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jnci/djad001",TRUE,"Disclosures: A.U.K. has received personal fees from Varian Medical Systems Inc ViewRay Inc Janssen Inc and Intelligent Automation Inc. P.C.B. sits on the Scientific Advisory Boards of Sage Bionetworks BioSymetrics Inc and Intersect Diagnostics Inc. <section> All other authors declare they have no conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by Prostate Cancer Canada and is proudly funded by the Movember Foundation (grant #RS2014-01 to P.C.B.). P.C.B. was supported by a Terry Fox Research Institute This project was supported by Genome Canada through a Large-Scale Applied Project contract to P.C.B. R. This work was supported by the National Institutes of Health/National Cancer Institute (NIH/ NCI) under award number P30CA016042 by an operating grant from the National Cancer Institute Early Detection Research Network (U01CA2141941) and by support from the Informatics Technology for Cancer Research (ITCR) (U24CA248265). This work is supported by a Terry Fox New Frontiers Program Project Grant (1090 P3 to H.H.H.). This work was supported by a Prostate Cancer Foundation Special Challenge Award to PCB (Award ID #: 20CHAS01) made possible by the generosity of Mr Larry Ruvo. B.J.P. was supported by a Victorian Health and Medical Research Fellowship. S.M.W. was supported by the Research Council of Norway (187615) the South-Eastern Norway Regional Health Authority and the University of Oslo.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jscr/rjad168",TRUE,"The authors declare no competing interests.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jscr/rjad389",TRUE,"<section> CONFLICT OF INTEREST STATEMENT",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jscr/rjad671",TRUE,"Conflict of interest statement",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/jsxmed/qdad143",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/jtm/taad001",FALSE,"",TRUE,"<section> Funding <section> This research was funded in part by Deutsche Forschungs Gemeinschaft as part of IRTG 2290 Molecular Interactions in Malaria.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered at the WHO International Clinical Trials Registry Platform (DRKS00007104).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/nar/gkac1212",TRUE,"Conflict of interest statement.",TRUE,"Funding: K.R.M. F.K. <section> FUNDING <section> Funding for open access charge: Institute of Pathology Munich.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nar/gkad1005",TRUE,"Conflict of interest statement",TRUE,"<section> Funding <section> Development of the HPO is funded by the NIH / NGHRI [5U24HG011449-03]; the French translation of the HPO is carried out by Orphanet INSERM US 14 (Paris France) funded by the French Ministry of Health Direction Générale de la Santé in the framework of the French National Plan for Rare Diseases; support for the EHR work is funded by NIH NHGRI [7RM1HG010860- <section> WY / 1-1]; NLM [T15LM009451NLM T15LM007079]; Canadian Institutes of Health Research Sex and Gender Science Chair [GSB 171373]; C.J.M. N.L.H. J.R. H.H. J.H.C. S.J.C. were supported in part by the Director Office of Science Office of Basic Energy Sciences of the U.S. Funding for open access charge:",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nar/gkad1017",TRUE,"Conflict of interest statement",TRUE,"<section> Funding Funding for open access charge: University funds.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nar/gkad121",TRUE,"Conflict of interest statement. E.M.N. has recei v ed trav el e xpenses from ONT to participate in nanopor e confer ences. <section> I.M. has recei v ed a trav el bursary from ONT to present his work in international conferences E.M.N is Scientific Advisory Board member for IMMAGINA Biotech. The authors declare that they have no competing interests.",TRUE,"<section> FUNDING The CRG / UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17 / 0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/nar/gkad703",TRUE,"Conflict of interest statement.",TRUE,"<section> FUNDING <section> V.T. was supported by the DFG [TA / 11-1]; In utero electroporation experiments were funded by the 10th Russian Science Foundation (RSF) [22-14-00232]; I.W. was funded by the PhD fellowship of the Boehringer Ingelheim Fonds and a stipend from Charit é Uni v ersit ätsmedizin Berlin. Funding for open access charge: Lab funding.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nargab/lqad061",TRUE,"Conflict of interest statement.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nargab/lqad102",TRUE,"Conflict of interest statement",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/nc/niad003",TRUE,"Conflict of interest statement",TRUE,"<section> Funding <section> E.P.-P. and P.H. were supported by a joint grant from the John Templeton Foundation and the Fetzer Institute.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/nc/niad011",TRUE,"Conflict of interest statement",TRUE,"I acknowledge support by the Open Access Publication Fund of Magdeburg University. <section> Funding <section> This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation)—337619223/RTG2386.",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfab167",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The contents of this manuscript have not been published in whole or in part.",TRUE,"<section> FUNDING A.O.: FIS/Fondos FEDER (PI17/00257 PI18/01386 PI19/ 00588 and PI19/00815) DTS18/00032 ERA-PerMedJTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071 ISCIII-RETIC REDinREN RD016/0009) Sociedad Espa~ nola de Nefrologı́a FRIAT Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad053",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad073",TRUE,"<section> All authors declare that they have no competing interests.",TRUE,"<section> No funds grants or other financial support was received for conducting this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad074",FALSE,"",TRUE,"<section> These studies were funded by Akebia Therapeutics Inc. <section> AU T HOR S ’ C ON T R I BU T ION S The INNO 2 VATE DD-CKD trials were conducted and funded by Akebia Therapeutics Inc. K.-U.E. has received grant support from Amgen and Fresenius; lecture fees from Astellas Pharma; grant support and lecture fees from AstraZeneca Bayer and Genzyme; consulting fees from Boehringer Ingelheim; advisory board fees from Retrophin; and grant support advisory board fees and lecture fees from Vifor Pharma.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad095",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> B.F.F. has received grants from Esteve and Mundipharma and consultancy or speaker fees or travel support from Springer AstraZeneca Bayer Menarini Novo Nordisk Boehringer Ingelheim and Mundipharma and is Editor for Nefrologia Editorial Board (Nefroplus). M.A. has received payment or honoraria for lectures presentations speakers’ bureaus publication writing or educational events from Amgen AstraZeneca Bayer Boehringer Ingelheim Menarini MSD Novo Nordisk Sandoz and <section> Sanofi. A.S. has received honoraria lecture fees research funding training fees and consultancy fees from Abbott Shockwave Amgen and Boston Scientific and proctoring fees from Abbott and Bentley. The other authors disclose that they do not have any financial or other relationships that might lead to a conflict of interest regarding this article.",TRUE,"<section> FUNDING <section> B.F.F. has received grants from Esteve and Mundipharma and consultancy or speaker fees or travel support from Springer AstraZeneca Bayer Menarini Novo Nordisk Boehringer Ingelheim and Mundipharma and is Editor for Nefrologia Editorial Board (Nefroplus).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad130",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> The following authors of this manuscript have conflicts of interest do disclose as described by the American Journal of Transplantation : C.H. received grant support consulting fees and lecture fees from Astellas Sanofi Genzyme Roche Pharma Novartis and Wyeth/Pfizer. C.K. received consulting fees and lecture fees from Astellas Chiesi Novartis and Sanofi-Genzyme. J.W.-M. received grant support consulting fees and lecture fees from Vifor GSK Novartis AstraZeneca and Boehringer Ingelheim. O.W. has received research grants for clinical studies speaker’s fees honoraria and travel expenses from Amgen Alexion Astellas Basilea Biotest Bristol-Myers Squibb Correvio Chiesi Gilead Hexal Janssen Dr F. Köhler Chemie MSD Novartis Roche Pfizer Sanofi Takeda TEVA and UCB. B.B. received grant support consulting fees and lecture fees from Astellas Bayer Chiesi and Novartis. J.S. received lecture fees from Astellas Boehringer-Ingelheim and Fresenius Medical Care. <section> All other authors of this manuscript have no conflicts of interest to be disclosed.",TRUE,"<section> O.W. is supported by an unrestricted grant of the RudolfAckermann-Stiftung (Stiftung für Klinische Infektiologie). <section> FUNDING <section> The Harmony FU trial had been financially supported by Astellas and <section> The following authors of this manuscript have conflicts of interest do disclose as described by the American Journal of Transplantation : C.H. received grant support consulting fees and lecture fees from Astellas Sanofi Genzyme Roche Pharma Novartis and Wyeth/Pfizer.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad149",TRUE,"<section> CONFLICT OF INTEREST STATEMENT",TRUE,"<section> FUNDING <section> C.L. was supported by a research grant from the Valdecilla Biomedical Research Institute (IDIVAL).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ndt/gfad226",TRUE,"<section> CONFLICT OF INTEREST STATEMENT <section> The authors of this manuscript have conflicts of interest to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/neuonc/noad008",TRUE,"Disclosure Statement <section> DC has received research support from Novocure.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad027",TRUE,"Conflict of interest statement <section> AvB has a consulting or advisory role for Bayer and Novartis and travel accommodations and expenses by Servier. FS has received honoraria from Illumina and Bayer. SP receives grant support in the framework of an IMI-2 funded project from EliLilly Bayer Roche Pfizer PharmaMar Astra Zeneca Amgen Servier Sanofi and JnJ. SP and MS hold a patent on DNA methylation-based method for classifying tumor species of the brain (EP3067432A1) which was developed with support by the German Childhood Cancer Foundation (“Neuropath 2.0— Increasing diagnostic accuracy in pediatric neurooncology”; DKS 2015.01). SR received fees for advisory board roles from Bayer Novartis BMS and Roche; for DMSC from Celgene; and for trial support by Riemser Pharma GmbH. The other authors have no competing interests to declare that are relevant to the content of this article.",TRUE,"<section> Funding MM and MB received support from the German Cancer Aid via the Mildred Scheel Cancer Research Center Hamburg. The Austrian HIT trial center is funded by the Styrian Childhood Cancer Foundation. <section> MB was supported in part by University Medical Center Hamburg-Eppendorf.",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad030",TRUE,"Conflict of interest statement: D.C. declares a patent on DNA methylation-based methods for molecular classification of tumor species and holds shares of Heidelberg Epignostix GmbH Heidelberg Germany. The other authors have no conflicts of interest to declare.",TRUE,"<section> Funding <section> This study was supported by the Berlin Cancer Society (Berliner Krebsgesellschaft e.V.) and the German Consortium for Translational Cancer Research (DKTK) partner site Berlin.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad053",TRUE,"Conflict of interest statement",TRUE,"<section> Funding <section> C.K. M.B. and A.W. are sponsored by a fellowship of the Mildred Scheel Cancer Career Center Hamburg/Deutsche Krebshilfe.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad078",TRUE,"Conflict of interest statement. No potential conflicts of interest were disclosed by the other authors.",TRUE,"<section> Funding <section> This work was supported by the Everest Centre for Lowgrade Paediatric Brain Tumours (GN-000707 The Brain Tumour Charity UK) and the PLGA Fund at the Pediatric Brain Tumor Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad100",TRUE,"Conflict of interest statement: FS: Co-inventor on patents filed related to methylation profiling co-founder of Heidelberg Epignostix.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/neuonc/noad114",TRUE,"Conflict of Interest <section> O.W. and T.M. received research funding from Biomed Valley and Day One Therapeutics.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad197",TRUE,"Conflict of interest statement",TRUE,"<section> Funding <section> This work was supported by the Landesforschungsförderung Hamburg LFF GK10. KJW received funding from the Mildred Scheel Young Investigator Program by Deutsche Krebshilfe. FR received funding from Illumina.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad198",TRUE,"Conflict of interest statement <section> L.M.J. R.M. C.U. P.K. N.F. S.F. D.K. C.S. L.G.R. S.K.M. F.T.N. and M.E. have declared that no conflict of interest exists related to the submitted work.",TRUE,"<section> Funding <section> receives funding from the Else-Kröner-Fresenius-Stiftung (2020_ EKEA.80) and is recipient of a Rahel-Hirsch stipend granted by Charité Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/neuonc/noad230",TRUE,"Conflict of interest statement",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/noajnl/vdad057",TRUE,"Conflict of interest statement:",TRUE,"<section> Funding <section> J.R.H. is supported by grants from the McClurg Foundation Hospital Research Foundation Robert Connor Dawes Foundation and My Room Children’s Cancer Charity; Analysis of Australian and New Zealand patients was supported by project funding from the Australian Government through Cancer Australia the Robert Connor Dawes Foundation Carrie’s Beanies for Brain Cancer and the Victorian Government’s Operational Infrastructure Support Program.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/ofid/ofad479",TRUE,"Potential conflicts of interest.",TRUE,"<section> Financial support. This study was funded by Task Force for Global Health and World Health Organization Regional Office for Europe.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ofid/ofad491",TRUE,"Potential conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/oncolo/oyad070",TRUE,"Conflict of Interest <section> The authors indicated no financial relationships.",TRUE,"<section> Funding <section> This work was supported by the National Natural Science Foundation of China (82172604) the Science Foundation of Peking University Cancer Hospital (2022-18) and the Beijing Xisike Clinical Oncology Research Foundation (Y-Young2022-0204).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/oncolo/oyad138",TRUE,"Conflict of Interest <section> John Strickler reports grants or contracts to research institution from AstraZeneca Bayer Seagen Amgen Inc. DaiichiSankyo Nektar Abbvie Erasca and Gossemer Bio AStar D3 Curegenix Sanofi Roche/ Genentech and Silverback Therapeutics consulting fees from Abbvie Amgen Inc. AstraZeneca Bayer Inivata Natera GlaxoSmithKline(GSK) Mereo Biopharma Pionyr Immunotherapeutics Seagen Pfizer Silverback Therapeutics and Viatris support for attending meetings and/or travel from Seagen and participation on a Data Safety Monitoring Board or Advisory Board for Abbvie and Pionyr Immunotherapeutics.",TRUE,"<section> Funding <section> This study was funded by Amgen Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/pm/pnad031",TRUE,"Conflicts of interest: The authors have nothing to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Moreover further analyses revealed indexed by pressure pain threshold remained significantly decreased which Conclusion: The present study provides evidence that tDCS is an effective results support the notion that CPP is developed and maintained in the central Trial registration: www.ClinicalTrials.gov ID: NCT05231239.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/pnasnexus/pgad247",TRUE,"Competing Interest: The authors declare no competing",TRUE,"<section> Funding <section> This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) BL1115/4-1 Heisenberg Program (BL1115/3-1 BL1115/7-1 and BL1115/11-1) and Heike Wolfgang Mühlbauer Stiftung to S.M.B; DFG DE631/15-1 to R.D. Else Kröner-Fresenius-Stiftung (Project 2017_A123) to N.F. Y.X. F.Z. and Y.W. was supported by China Scholarship Council (CSC) Program.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ptj/pzad032",TRUE,"Conflicts of Interest. F. Paul disclosed receiving honoraria for lectures from Alexion during this study. J. Sosnoff has ownership in Sosnoff Technologies LLC receives speaking fees from BrainWeek and receives consulting fees from Xavor Inc. The other authors made no disclosures.",TRUE,"<section> Role of the Funding Source The funders played no role in the design conduct or reporting of <section> Funding <section> This study was supported in part by 2 grants from the National Multiple Sclerosis Society (RG-1507-05433 and MB-1807-31633). Hausdorff have received funding from Mobilise-D from the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement no. 820820). J. Sosnoff also has received funding from MS Run the United States.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/qjmed/hcad179",TRUE,"Conflict of interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/rheumatology/kead021",TRUE,"Disclosure statement: S.R.: research grants and/or consultancy fees: AbbVie Eli Lilly Galapagos MSD Novartis Pfizer UCB Sanofi.",TRUE,"<section> Funding <section> BIODAM was financially supported by an unrestricted grant from AbbVie. <section> Disclosure statement: S.R.: research grants and/or consultancy fees: AbbVie Eli Lilly Galapagos MSD Novartis Pfizer UCB Sanofi.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead023",TRUE,"Disclosure statement: M.K. reports grants and personal fees from Boehringer Ingelheim and Roche and personal fees from Galapagos. <section> have declared no conflicts of interest.",TRUE,"<section> Funding <section> Disclosure statement: M.K. reports grants and personal fees from Boehringer Ingelheim and Roche and personal fees from Galapagos.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead062",TRUE,"Disclosure statement: G.R.B. received consulting fees from AbbVie Amgen BMS Boehringer Ingelheim Galapagos Roche Gilead Janssen Kiniksa Lilly MSD Pfizer and Sanofi; and speakers’ bureau/honoraria from AbbVie Amgen BMS Galapagos Roche Gilead Janssen Lilly MSD Pfizer and Sanofi.",TRUE,"<section> Funding <section> This work was supported by Sanofi. The studies were sponsored by Sanofi and Regeneron. Medical writing support for this manuscript was provided by Dhaval Sanchala and Sindhu Doppalapudi of",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> during the initial blinded trials were maintained throughout the OLE assessment Conclusions: Long-term sarilumab treatment with/without csDMARDs HRQOL were maintained or further increased over the open-label assessment Trial registration: EXTEND ClinicalTrials.gov https://www.clinicaltrials.gov/ct2/show/NCT01146652",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/rheumatology/kead088",TRUE,"Disclosure statement: A.P. Z.B. R.C. S.M.N. J.K. and L.H. <section> have no conflicts of interest to disclose.",TRUE,"<section> Funding <section> identifier NCT02585258) and has received funding from the European Union’s Horizon 2020 Framework Programme for Research and Innovation under grant agreement No. <section> The Section for Biostatistics and Evidence-Based Research The Parker Institute (S.M.N. and R.C.) is supported by a core grant from The Oak Foundation (OCAY-18–774-OFIL) a group of philanthropic organizations giving grants to notforprofit organizations around the world.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead142",TRUE,"Disclosure statement: T.D. reports speaker fees from Canon Medical Systems Novartis MSD BIOCAD UCB and Roche and advisory board member fees from Eli Lilly outside the submitted work. D.P. reports research support from AbbVie Eli Lilly MSD Novartis and Pfizer; consulting fees from AbbVie BIOCAD Eli Lilly Gilead GlaxoSmithKline Janssen MSD Moonlake Novartis Pfizer Samsung Bioepis and UCB and speaker fees from AbbVie Bristol-Myers Squibb Eli Lilly Janssen MSD Medscape Novartis Peervoice Pfizer and UCB. F.P. reports grants and personal fees from Novartis Eli Lilly and UCB and personal fees from AbbVie Amgen Bristol-Myers Squibb Hexal MSD Pfizer and Roche all outside the submitted work. K.Z. reports funding from the ASAS outside the submitted work. The remaining authors report no conflicts of interest.",TRUE,"<section> Funding <section> No specific funding was received from any bodies in the public commercial or notfor-profit sectors to carry out the work described in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead240",TRUE,"Disclosure statement: The authors have declared no conflicts of",TRUE,"<section> Funding <section> No specific funding was received from any bodies in the public commercial or notfor-profit sectors to carry out the work described in this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Protocol and registration A study protocol was registered at PROSPERO (CRD420233",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/rheumatology/kead360",TRUE,"Disclosure statement: O.D. has/had a consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for SSc and its complications in the last 3 calendar years: AbbVie Acceleron Alcimed Amgen AnaMar Arxx AstraZeneca Baecon Blade Bayer Boehringer Ingelheim Corbus CSL Behring 4P Science Galapagos Glenmark Horizon Inventiva Janssen Kymera Lupin Medscape Miltenyi Biotec Mitsubishi Tanabe MSD Novartis Prometheus Redxpharma Roivant Sanofi and Topadur. The remaining authors have declared no conflicts of interest.",TRUE,"<section> Funding <section> COMPERA is funded by unrestricted grants from Acceleron Bayer GlaxoSmithKline Janssen and OMT. <section> Disclosure statement: O.D. has/had a consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for SSc and its complications in the last 3 calendar years: AbbVie Acceleron Alcimed Amgen AnaMar Arxx AstraZeneca Baecon Blade Bayer Boehringer Ingelheim Corbus CSL Behring 4P Science Galapagos Glenmark Horizon Inventiva Janssen Kymera Lupin Medscape Miltenyi Biotec Mitsubishi Tanabe MSD Novartis Prometheus Redxpharma Roivant Sanofi and Topadur. J.B. has received grants from Actelion AstraZeneca Bayer Biogen Boehringer Ingelheim Galapagos Novartis Roche and Sanofi/Genzyme.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead471",TRUE,"Disclosure statement: L.F.: nothing to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead564",TRUE,"Disclosure statement: S.T.U. is a participant in the BIHCharité Junior Digital Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health.",TRUE,"<section> Funding All other authors report no funding. <section> The authors thank the Berlin Institute of Health for personal funding (S.T.U. J.R. and T.D.) and providing essential infrastructure for data collection.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/rheumatology/kead566",TRUE,"Disclosure statement: M.M.L.G. reports research support from AbbVie; consulting fees from AbbVie Janssen Novartis and Pfizer; speaker fees from AbbVie Amgen Eli Lilly Janssen Novartis and Pfizer.",TRUE,"<section> Funding <section> Disclosure statement: M.M.L.G. reports research support from AbbVie; consulting fees from AbbVie Janssen Novartis and Pfizer; speaker fees from AbbVie Amgen Eli Lilly Janssen Novartis and Pfizer.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/rheumatology/kead665",TRUE,"Disclosure statement: D.P.: speakers bureau: AbbVie BMS Celgene Janssen Lilly MSD Novartis Pfizer Roche and The remaining authors have declared no conflicts of interest.",TRUE,"<section> Funding L.W.: no personal funding but ASIF has received funding from Novartis UCB Lilly Abbvie Boehringer Ingleheim Pfizer Jansse.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/schbul/sbac212",TRUE,"Conflict of Interests <section> TB served in an advisory or consultancy role for ADHS digital Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. <section> He received conference support or speaker’s fee from Medice and Takeda. He received royalties from Hogrefe Kohlhammer CIP Medien and Oxford University Press; this work is unrelated to these relationships. The other authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This work was funded by a project grant from the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) (no. 386926655) and a DFG Heisenberg professorship (no. 389624707) to UR.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/schbul/sbad029",TRUE,"All other authors have declared that there are no conflicts of interest in relation to the subject of this study.",TRUE,"Jürgen Gallinat has received speaker fees from Lundbeck Janssen-Cilag Lilly and Otsuka and research funding from the German Federal Ministry of Education and Research and the German Science Foundation. <section> Pfizer has received a research grant from AstraZeneca Cerbomed I3G and AOK (health insurance company) and received research support from the German Research Foundation and the Federal Ministry of Education and Research. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/schbul/sbad030",TRUE,"Disclosures <section> E. Wagner has been invited to advisory boards from Recordati. D. Siskind reports no conflict of interest.",TRUE,"<section> Funding <section> DS is supported by an NHMRC Investigator Grant Emerging Leadership Fellowship GNT 1194635. He has received grant support from Janssen and Takeda. He has received grant support from Janssen Otsuka Lundbeck and Sunovion.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/schbul/sbad113",TRUE,"Disclosure Statement <section> LR DK BP ML IP DG SM TSA ES CT BV SM CH AR KKV BW SS KH BW WT HW DH and IM report no conflicts of interest.",TRUE,"<section> Funding <section> The work was supported by the German Federal Ministry of Education and Research (BMBF) through the research network on psychiatric diseases ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments; coordinator Andreas MeyerLindenberg; grant number 01EE1407E). The study was supported by the Else Kröner-Fresenius Foundation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Clinical Trials Registration: <section> The underlying study of this manuscript was registered in the International Clinical Trials Database ClinicalTrials.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1093/schizbullopen/sgac074",TRUE,"<section> All authors report no potential conflicts of interest or biomedical financial interest.",TRUE,"<section> Funding <section> This work was supported by research grants of the German Research Foundation awarded to Florian Schlagenhauf (SCHL 1969/1-1/1-2/3-1) by the Heisenberg program from the German Research Foundation (SCHL 1969/51). Sophie Fromm was supported by the Einstein Center for Neurosciences Berlin and by the Bernstein Center for Computational Neurosciences Berlin.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/sexmed/qfad013",TRUE,"Conflicts of interest: None declared.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/sleep/zsad128",TRUE,"Disclosure Statement <section> Financial disclosure: MRC has received research funding from Brain Research UK and is a consultant for Signifier Medical Technologies. JCO is employed by Nox Health Inc and has served as a consultant to Headspace Inc Vox Media LLC. These activities are not related to this study. The other authors have no conflict of interests to report.",TRUE,"<section> Funding <section> This research was supported by a National Heart Lung and Blood Institute (NIH) Research Grant (R01HL114529) awarded to JCO and Supplements to Promote Diversity in Health-Related Research (R01HL114529-03S1) awarded to ADT. <section> Financial disclosure: MRC has received research funding from Brain Research UK and is a consultant for Signifier Medical Technologies.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/sleep/zsad130",TRUE,"Disclosure Statement None declared.",TRUE,"<section> Funding <section> This work was supported by the Max Kade Foundation the National Institutes of Health (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1093/stcltm/szad002",TRUE,"Conflict of Interest <section> S.P.H. is shareholder at Xeltis BV and LifeMatrix AG. <section> M.Y.E. <section> is a shareholder at LifeMatrix AG. The other authors have no potential conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1093/ve/vead024",TRUE,"Conflict of interest: None declared.",TRUE,"<section> Funding <section> The fieldwork was supported by the Deutsche Forschungsgemeinschaft (DFG Ga 342/19; Priority Program SPP 1596/2 Ecology and Species Barriers in Emerging Infectious Diseases DR 772/8-1 SO 428/9-1) and the Landesforschungsf orderung Hamburg. V.M.C. is supported by the Berlin Institute of Health (BIH) Charité Clinician Scientist program.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1096/fj.202301495r",TRUE,"<section> DISCLOSURES The authors have stated explicitly that there are no conflicts of interest in connection with this article.",TRUE,"<section> Funding information vivo inflammation using German Federal Ministry of Education <section> ACKNOWLEDGMENTS This study was supported by the Italian Cystic Fibrosis Foundation (FFC) (FFC#19/2020 and FFC#20/2021 to AR.) and the German Federal Ministry of Education and Research (82DZL009B1 to M.A.M.) and the German Research Foundation (CRC 1449 –­ 431232613 Z02 to M.A.M.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/aln.0000000000004553",TRUE,"Competing Interests <section> The authors declare no competing interests.",TRUE,"<section> Supported by Deutsche Forschungsgemeinschaft grants 408355133 (to Dr.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/bor.0000000000000925",TRUE,"Conflicts of interest <section> There are no conflicts of interest.",TRUE,"<section> Financial support and sponsorship",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/brs.0000000000004683",TRUE,"The remaining authors report no conﬂicts of interest.",TRUE,"The institutional Research reported in this publication was supported by the National Center For Award Number UL1TR002384.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/brs.0000000000004722",TRUE,"<section> The authors report no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/brs.0000000000004767",TRUE,"The remaining authors report no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/brs.0000000000004826",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/ccm.0000000000005742",TRUE,"Cittadino Krampe and Denke declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/ccm.0000000000005887",TRUE,"The remaining authors have disclosed that they do not have any potential conflicts of interest.",TRUE,"Hill received funding from Fresenius Kabi; she disclosed that she is currently supported by the Medical Faculty RheinischWestfälische Technische Hochschule Aachen University (“Habilitationsstipendium”). Jeschke received support for article research from the National Institutes of Health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/eja.0000000000001837",TRUE,"Conflicts of interest: VD received lecture fees and travel costs reimbursements from Orion Pharma and Edwards Lifesciences SO received research and study funds from Novartis Pharma GmbH MM received lecture fees from Biom\u0001 erieux FMC and Baxter and AZ received lecture and consultancy fees and grant support from AM Pharma Baxter Guard Therapeutics Bayer Novartis Fresenius and BioMerieux. The remaining authors declare that they have no conflicts of interest.",TRUE,"<section> Financial support and sponsorship: the trial was supported by the European Society of Anaesthesiology and Intensive Care (Young Investigator Startup Grant 2020) <section> Conflicts of interest: VD received lecture fees and travel costs reimbursements from Orion Pharma and Edwards Lifesciences SO received research and study funds from Novartis Pharma GmbH MM received lecture fees from Biom\u0001 erieux FMC and Baxter and AZ received lecture and consultancy fees and grant support from AM Pharma Baxter Guard Therapeutics Bayer Novartis Fresenius and BioMerieux.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/eja.0000000000001849",TRUE,"Conflicts of interest: none.",TRUE,"<section> Financial support and sponsorship: this survey is a part of the Fatigue project by the Workforce Working Conditions Welfare Standing Committee of the European Board of Anaesthesiology (EBA-UEMS). The survey was supported by the Trainees Committee of the European Society of Anaesthesiology and Intensive Care (ESAIC) and the representatives of National Anaesthesiologists Societies Committee (NASC) of the ESAIC and the representatives of the EBA-UEMS.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/eja.0000000000001863",TRUE,"Conflicts of interest: none related to this study.",TRUE,"<section> Financial support and sponsorship: this work was supported by the Charit\u0013 e – Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health Department of Anesthesiology and Intensive Care Medicine Campus Charit\u0013 e Mitte Campus Virchow-Klinikum.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/ftd.0000000000001014",TRUE,"The remaining authors declare no conﬂict of interest.",TRUE,"He also received grant support from Astellas Pharma received lecture fees from Astellas Pharma Novartis Pharma and Otsuka Pharma.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/gox.0000000000004994",TRUE,"Disclosure statements are at the end of this article the terms of the Creative following the correspondence information. <section> DISCLOSURES The authors have no financial interest to declare in relation to the content of this article.",TRUE,"This study was funded by the German Armed Forces as a special research project (SoFo 08K4-S-121415) of the Department of Defence Medical Research and Development.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/gox.0000000000005249",TRUE,"Disclosure statements are at the end of this article the terms of the Creative following the correspondence information. <section> DISCLOSURES Barbara Kern is participant in the BIH – Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health.",TRUE,"This study was funded by Stiftung Charité in cooperation with Einstein Foundation Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hc9.0000000000000012",TRUE,"The remaining authors declare that they have no financial conflict of interest.",TRUE,"<section> Funding information This work was supported through institutional German liver transplantation funding of the Charité—Universitätsmedizin analysis of liver transplantations Berlin. <section> ACKNOWLEDGMENTS We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> C O N FL I C T O F I N T E R ES T A.W. received grants from GBA of the federal government of Germany.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hc9.0000000000000102",TRUE,"<section> CONFLICTS OF INTEREST Oliver Krenkel received compensation from Boehringer Ingelheim.",TRUE,"<section> F U N D I N G IN F O R M A T I O N This work was funded by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium). <section> Moritz Peiseler is supported by the Berlin Institute of Health (BIH) Clinician Scientist Program. Frank Tacke consults advises is on the speakers’ bureau and received grants from Gilead. He consults advises and received grants from Allergan Bristol-Myers Squibb and Inventiva.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hc9.0000000000000156",TRUE,"<section> CONFLICTS OF INTEREST Frank Tacke consults advises is on the speakers’ bureau and received grants from Gilead.",TRUE,"<section> FUNDING INFORMATION Michael Sigal has received funding from the German Research Foundation (DFG Si 1983/4-1). <section> CONFLICTS OF INTEREST Frank Tacke consults advises is on the speakers’ bureau and received grants from Gilead. He consults advises and received grants from Allergan Bristol-Myers Squibb and Inventiva.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hc9.0000000000000165",TRUE,"<section> CONFLICTS OF INTEREST Max Seidensticker advises and received grants from Bayer.",TRUE,"<section> F U N D I N G IN F O R M A T I O N SORAMIC is an investigatorinitiated trial sponsored by the University of Magdeburg. Financial support was granted by Sirtex Medical and Bayer Healthcare. Jens Ricke received grants from Sirtex and Bayer and personal fees from Sirtex and Bayer. <section> CONFLICTS OF INTEREST Max Seidensticker advises and received grants from Bayer. He received grants from Sirtex. Chris Verslype advises is on the speakers’ bureau and received grants from Bayer. Bernhard Gebauer received grants from Sirtex. Holger Amthauer consults and received grants from Sirtex. Bruno Sangro consults advises is on the speakers’ bureau and received grants from Bristol-Myers Squibb and Sirtex. Peter Malfertheiner consults for Aboca and Bayer advises Allergosan is on the speakers’ bureau for Biocodex and Malesci and received grants from Menarini.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hc9.0000000000000208",TRUE,"<section> CONFLICTS OF INTEREST Julio Saez-Rodriguez has received funding from GSK Pfizer and Sanofi and fees/honoraria from Travere Therapeutics Stadapharm Astex Pfizer and Grunenthal.",TRUE,"<section> F U N D I N G IN F O R M A T I O N This work was supported by grants from the Deutsche Forschungsgemeinschaft in particular through the collaborative research center SFB 974 project number 190586431 (JGB). <section> CONFLICTS OF INTEREST Julio Saez-Rodriguez has received funding from GSK Pfizer and Sanofi and fees/honoraria from Travere Therapeutics Stadapharm Astex Pfizer and Grunenthal.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hc9.0000000000000317",FALSE,"",TRUE,"Editorial support for this manuscript under the direction of the authors was provided by Katie Williams MSc and Sean Littlewood MRes of inScience Communications Springer Healthcare Ltd United Kingdom and was funded by Roche Diagnostics GmbH. <section> FUNDING INFORMATION This work was funded by Roche Diagnostics GmbH. <section> C O N F L I C TS O F IN T E R E S T Teerha Piratvisuth is on the speakers’ bureau and received grants from Gilead. He received grants from Roche Jannsen FibroGen and VIR. Jinlin Hou advises is on the speakers’ bureau and received grants from Gilead. He received grants from Bristol Myers Squibb. Tawesak Tanwandee received grants from Gilead Roche Vir Merck and Altimune. <section> speakers’ bureau and received grants from Bristol Myers Squibb. He consults and received grants from AstraZeneca Bayer Eli Lilly and Roche. He received grants from ArQule and Celsion. He advises and received grants from Ono. He is on the speakers’ bureau and received grants from EA Pharma. He received grants from AbbVie Gilead Ono Otsuka Sumitomo Dainippon Pharma Taiho and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hep.0000000000000238",TRUE,"Conflicts of interest: B.S. has been consulting for Ambys Medicines Ferring Research Institute Gelesis HOST Therabiomics Intercept Pharmaceuticals Mabwell Therapeutics Patara Pharmaceuticals and Takeda.",TRUE,"<section> Financial Support: C.H. is supported by T32 DK007202.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hep.0000000000000270",TRUE,"<section> CONFLICTS OF INTEREST Milessa da Silva Afonso owns stock in and is employed by Gilead Sciences.",TRUE,"<section> F U N D I N G IN F O R M A T I O N This work was funded by the German Research Foundation (SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium). Adrien Guillot was a recipient of the Humboldt Research Fellowship for Postdoctoral Researchers. Johannes Eschrich and Moritz Peiseler are supported by the Clinician Scientist Program of the Berlin Institute of Health at the Charité Universitätsmedizin Berlin. Bin Gao lab is supported by the intramural program of the NIAAA NIH. Franke Tacke advises is on the speakers’‘ bureau for and received grants from Gilead Sciences. He advises and received grants from Allergan BMS and Inventiva.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hep.0000000000000386",TRUE,"<section> CONFLICTS OF INTEREST Frank Tacke’s lab received grants from Allergan Bristol-Myers Squibb Gilead and lnventiva.",TRUE,"Adolph is supported by the Austrian Science Fund (FWF P33070) and the European Research Council (ERC – Frank Tacke is supported by the German Research Foundation (DFG SFBfTRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEPHCC consortium BMBF lmmun Avatar consortium). <section> CONFLICTS OF INTEREST Frank Tacke’s lab received grants from Allergan Bristol-Myers Squibb Gilead and lnventiva.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hep.0000000000000514",FALSE,"",TRUE,"<section> FUNDING INFORMATION Daniel Todt was supported by grants from the German Ministry of Education and Research (BMBF project VirBio; 01KI2106). Eike Steinmann was supported by grants from the German Federal Ministry of Health (ZMVI1-2518FSB705) the German Research Foundation (DFG grant number: 398066876-GRK 2485/1) and the German Ministry of Education and Research (BMBF project SILVIR: 16GW0202). Markus Cornberg Heiner Wedemeyer Patrick Behrendt and Eike Steinmann were funded by a grant from the German Centre for Infection Research (DZIF). Heiner Wedemeyer and Eike Steinmann were funded by the German Ministry of Education and Research (HepEDiaSeq.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hep.0000000000000545",TRUE,"<section> CONFLICTS OF INTEREST Jeffrey V.",TRUE,"<section> F U N D I N G IN F O R M A T I O N The data collection and analysis were funded by the European Association for the Study of the Liver (EASL) with support from Takeda MSD Bristol-Myers-Squibb Company and Apollo Endo. He received grants from AbbVie Gilead MSD and Roche. <section> Allen consults advises and received grants from Novo Nordisk. She received grants from Pfizer and Target Pharma. Patrizia Carrieri received grants from Intercept and MSD. Mazen Noureddin consults advises and received grants from Echosens Gilead GlaxoSmithKline Madrigal Novo Nordisk OWL Pfizer Roche Siemens Terns and Takeda. He received grants from Allergan Akero Bristol Myers Squibb Conatus Corcept Enanta Gilead Galectin GENFIT Novartis Shire and Zydus. William Alazawi consults advises is on the speakers’ bureau and received grants from Gilead. He consults advises and received grants from AstraZeneca GlaxoSmithKline. Naim Alkhouri consults is on the speakers’ bureau and received grants from AbbVie/Allergan Gilead Intercept and Perspectum. <section> He consults and received grants from Madrigal Novo Nordisk Pfizer and Zydus. He received grants from 89Bio Akero Arbutus Better Therapeutics Boehringer Ingelheim Bristol Myers Squibb Corcept DSM Galectin Genentech Genfit Hepagene Healio Inventiva Ionis Merck NGM Noom NorthSea Poxel and Viking. He received grants from AstraZeneca Boehringer Ingelheim and Intercept. He consults is on the speakers’ bureau and received grants from MSD/Merck Novartis Orphalan and Sequana Medical. He consults and received grants from Humedics. He received grants from Bristol Myers Squibb Merz and Norgine. Kenneth Cusi consults and received grants from Novo Nordisk. He received grants from Cirius Echosens Inventiva LabCorp National Institute of Health Nordic Bioscience Novartis Poxel and Zydus. Francque consults is on the speakers’ bureau and received grants from GENFIT Gilead Inventiva and Merck Sharp & Dome. He consults and received grants from Astellas Janssen and Roche. He received grants from Falk Pharma GlympsBio Pfizer and Research Foundation Flanders. Hannes Hagström consults and received grants from AstraZeneca. He received grants from EchoSens Gilead MSD and Pfizer. He received grants from AstraZeneca the Danish National Research Foundation Echosense EU Horizon 20 Innovation Fund Denmark and the Novo Nordisk Foundation. Marcelo Silva consults advises and received grants from Zydus. He received grants from AstraZeneca GlaxoSmithKline Inventiva Merck and MSK. She received grants from Durect Corp Genentech-Roche Gilead GlaxoSmithKline Helio Health and the National Institutes of Health. Luca Valenti consults advises is on the speakers’ bureau and received grants from Gilead. He consults is on the speakers’ bureau received grants from Boehringer Ingelheim. He received grants from and Siemens Healthcare GmbH.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hep.0000000000000554",FALSE,"",TRUE,"Neumann is on the speakers’ bureau and received grants from AstraZeneca. He received grants from Bristol Meyer Squibb.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hep.0000000000000684",TRUE,"Conflict of Interest: Rüdiger Adam is employed by the University Medical Centre",TRUE,"Ulrich Baumann consults advises is on the speakers’ bureau and received grants from Albireo and Mirum. He advises and received grants from Alexion and Astellas. Felix Distelmaier received grants from Danone DFG <section> Financial support statement: This study was supported by the BMBF (German Federal Ministry of Education and Research) through the mitoNET German Network for This work was supported in part by the Practical Research Project for Rare/Intractable Diseases from the",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hep.0000000000000735",TRUE,"<section> CONFLICTS OF INTEREST Stephan D.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hjh.0000000000003315",TRUE,"Conflicts of interest <section> T.L.B. G.B. G.P. N.P. and A.P. advise SOMNOmedics on blood pressure and received travel support.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hjh.0000000000003330",TRUE,"Conflicts of interest L.M.R. has received consultancy fees from Bayer. R.A. <section> reports personal fees and nonfinancial support from Bayer Healthcare Pharmaceuticals Inc. during the conduct of the study; he also reports personal fees and nonfinancial support from Akebia Therapeutics Boehringer Ingelheim Janssen Relypsa/Vifor Pharma; he has received personal fees from Diamedica and Reata Pharmaceuticals; he is a member of data safety monitoring committees for Chinook and Vertex; a member of steering committees of randomized trials for Akebia Therapeutics Bayer Janssen and Relypsa Inc.; a member of adjudication committees for Bayer; he has served as associate editor of the American Journal of Nephrology and Nephrology Dialysis and Transplantation and has been an author for UpToDate; and he has received research grants from the U.S. Veterans Administration and the National Institutes of Health. H.H. reports personal fees from Bayer AG during the conduct of the study; personal fees from Alexion Pharma AstraZeneca and Vifor Pharma personal fees from Boehringer AG. G.R. H. does not have any disclosures to declare.",TRUE,"<section> Sources of funding: The ARTS-DN trial was conducted and funded by Bayer AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hjh.0000000000003363",TRUE,"Conflicts of interest <section> There are no conflicts of interest.",TRUE,"<section> Funding sources: Italian Ministry of Health (Ricerca Corrente).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/hjh.0000000000003480",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hs9.0000000000000812",TRUE,"<section> DISCLOSURES <section> The authors have no conflicts of interest to disclose.",TRUE,"<section> SOURCES OF FUNDING <section> Article Publication Charges are funded by the Institute of Cell Therapy University Research Center University of Patras.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hs9.0000000000000893",TRUE,"<section> DISCLOSURES CR: Jazz Pharmaceuticals Servier Clinigen Amgen: honoraria. All the other authors have no conflicts of interest to",TRUE,"<section> SOURCES OF FUNDING Supported by the University Medical Center Schleswig-Holstein Campus Kiel by sponsoring the study at the national and international level; the Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) (Society for Pediatric Oncology and Hematology) by approving and sponsoring this trial; the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) by approving and cosponsoring this trial; the St. The international AIEOP-BFM ALL 2009 study was supported by an unrestricted grant from the company Shire (and previously from medacGmBH Sigma-Tau Baxalta that marketed the drug during the present study period).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hs9.0000000000000907",TRUE,"<section> DISCLOSURES VB: Amgen: Honoraria; Celgene: Research Funding; Pfizer: Honoraria; All the other authors have no conflicts of interest to disclose.",TRUE,"<section> DISCLOSURES VB: Amgen: Honoraria; Celgene: Research Funding; Pfizer: Honoraria; <section> Kite/Gilead: Research Funding Honoraria; Novartis: Honoraria. <section> Gilead: Research Funding and travel support. <section> Novartis: Honoraria Research Funding; Gilead: Consultancy Honoraria Research Funding; Celgene: Research Funding; Janssen: Research Funding. <section> Funding: Jazz Pharmaceuticals Bayer Oncology. MvB: Consultancy Research Funding and MS: Morphosys: Research Funding; <section> Novartis: Consultancy Research Funding; Janssen: Consultancy; Seattle <section> Genetics: Research Funding; AMGEN: Consultancy Honoraria Research <section> Funding; Celgene: Consultancy Honoraria; Kite/Gilead: Consultancy Honoraria Research Funding; Roche AG: Consultancy Research Funding. <section> SOURCES OF FUNDING <section> This work was supported by a Deutsche Forschungsgemeinschaft (DFG German Research Foundation) research grant provided within the Sonderforschungbereich SFB-TRR 388/1 2021 – 452881907 and DFG research grant 451580403 (to MS). The work was further supported by the Bavarian Elite Graduate Training Network (to MS) the Wilhelm-Sander Stiftung (to MS project no. 2018.087.1) the Else-Kröner-Fresenius Stiftung (to MS) the Bavarian Center for Cancer Research (BZKF) and NCI Cancer Center Support Grant P30 CA076292.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hs9.0000000000000926",TRUE,"<section> DISCLOSURES <section> HT was supported within the EKFS clinician scientist program (University Medicine Göttingen). VN was supported within the FORUM female clinician scientist program (Ruhr-University Bochum). All the other authors have have no conflicts of interest to disclose.",TRUE,"<section> HT was supported within the EKFS clinician scientist program (University Medicine Göttingen). VN was supported within the FORUM female clinician scientist program (Ruhr-University Bochum). <section> SOURCES OF FUNDING <section> The authors declare no sources of funding.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/hs9.0000000000000957",TRUE,"<section> DISCLOSURES <section> MH reports fees for advisory or consultancy services from Abbvie Agios BMS Daiichi Sankyo Eurocept Glycostem Janssen Jazz Pharmaceuticals Kura Oncology Novartis Pfizer PinotBio Roche Takeda and Tolremo. FD reports personal fees from Gilead Incyte Roche Novartis AbbVie Astra Zeneca outside the submitted work. JFK reports personal fees from Gilead and Janssen outside the submitted work. GW reports honoraria from Gilead Novartis Clinigen and Janssen outside the submitted work. OP has no conflicts of interest directly related to this work. OP has received honoraria or travel support from Gilead Jazz MSD Novartis Pfizer and Therakos. He has received research support from Incyte and Priothera. He is member of advisory boards to Equillium Bio Jazz Gilead Novartis MSD Omeros Priothera Sanofi Shionogi and SOBI. All the other authors have no conflicts of interest to disclose.",TRUE,"<section> SOURCES OF FUNDING <section> This study was supported by grants from the Deutsche Krebshilfe (70113643) the Alfred und Angelika Gutermuth Stiftung (2022/2) both awarded to FD DJCLS (16 R/2021) and the Deutsche Krebshilfe (70114189) to MH. CMA and AH received support by the Berlin Institute of Health (BIH) junior clinician scientist program. CMS was supported by a stipend from the Berlin School of Integrative Oncology (BSIO). PMS was supported by a Postdoctoral Research Fellowship from Alexander von Humboldt Foundation.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/j.pain.0000000000002956",TRUE,"Conflict of interest statement <section> The authors have no conflicts of interest to declare.",TRUE,"E. Lomax were funded by an operating grant from Crohn’s and Colitis Canada. N. W. Bunnett was funded by grants from the National Institutes of Health (NS102722 DE026806 DK118971 and DE029951) and Department of Defense (W81XWH1810431 W81XWH-22-1-0239 Expansion Award). C. Stein was funded by grants from Deutsche Forschungsgemeinschaft (STE 477/19 EXC 2046 AA1-15 FOR 5177 STE 477/21) and Bundesministerium für Bildung und Forschung (01GQ2109A).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/mat.0000000000001662",TRUE,"Disclosure: The authors have no conflicts of interest to report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/mat.0000000000001916",TRUE,"Disclosure: M.G. received personal fees and research grants from BerlinHeart GmbH and research grants from 4Fontan AG; T.S. received personal fees and grants from Abbott Medtronic CorWave. U.K. <section> received grants from Berlin Heart GmbH; D.Z. received personal fees from Abbott Medtronic Abiomed Edwards Daiichi Sankyo and research grants from Abbott Medtronic Berlin Heart Edwards Corcym. The other authors have no conflicts of interest to report.",TRUE,"<section> Disclosure: M.G. received personal fees and research grants from BerlinHeart GmbH and research grants from 4Fontan AG; T.S. received personal fees and grants from Abbott Medtronic CorWave. <section> received grants from Berlin Heart GmbH; D.Z. received personal fees from Abbott Medtronic Abiomed Edwards Daiichi Sankyo and research grants from Abbott Medtronic Berlin Heart Edwards Corcym. <section> This study was supported by the GIGAX Foundation and the EVER Foundation. <section> This study was supported by the GIGAX Foundation and the",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/mat.0000000000001971",TRUE,"Disclosure: C.H. received consulting fees from Medtronic outside of the submitted work. E.P. is part of the advisory boards and receives grants consulting fees honoraria for lectures and travel grants from Medtronic Abbott and Abiomed. F.S. received institutional grants from Novartis Abbott nonfinancial support from Medtronic and institutional fees (speaker honoraria) from Orion Pharma and AstraZeneca GmbH outside of the submitted work. I.A.J. received speaker honoraria from Astra Zeneca GmbH outside of the submitted work. The other authors have no conflicts of interest to report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/mat.0000000000002009",TRUE,"Disclosure: M.G. received personal fees and grants from BerlinHeart GmbH; D.Z. received personal fees from Abbott Medtronic Abiomed Edwards Daiichi Sankyo and research grants from Abbott Medtronic Berlin Heart Edwards Corcym. The other authors have no conflicts of interest to report.",TRUE,"<section> Disclosure: M.G. received personal fees and grants from BerlinHeart GmbH; D.Z. received personal fees from Abbott Medtronic Abiomed Edwards Daiichi Sankyo and research grants from Abbott Medtronic Berlin Heart Edwards Corcym.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/mat.0000000000002013",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/mat.0000000000002060",TRUE,"Disclosure: C.D. has received personal fees from Abott and Abiomed outside the submitted work. G.L. has received proctor orator and consulting fees from Abbott SA. E.V.P. has received institutional fees from Abott Medtronic and Abiomed outside the submitted work. J.L. has received research funds that were paid to the institution from Shockwave Medical Inc. and from Abiomed and payment or honoraria from AstraZeneca and Boston Scientific outside the submitted work. J.M. has received personal fees from Abiomed outside the submitted work. P.L. has received personal fees from Abiomed outside the submitted work. N.M. has received personal fees from Edwards Lifesciences Medtronic Biotronik Novartis Sanofi Genzyme AstraZeneca Pfizer Bayer Abbott Abiomed and Boston Scientific outside the submitted work. The other authors have no conflicts of interest to report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/mbp.0000000000000640",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/md.0000000000035906",TRUE,"The authors have no conflicts of interest to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/md.0000000000036713",TRUE,"The authors have no funding and conflicts of interest to disclose.",TRUE,"<section> The authors have no funding and conflicts of interest to disclose.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/mej.0000000000001049",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/prs.0000000000009770",TRUE,"Disclosure: The authors have no financial interest from the journal. to declare in relation to the content of this article.",TRUE,"<section> This study was funded by the German Armed Forces as a special research project (SoFo 15K4-S-121517) of the Office of Defence Medical Research and Development.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/psy.0000000000001154",TRUE,"Conflicts of Interest: This research was supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft DFG 403266317). The authors declare that there are no conflicts of interest.",TRUE,"<section> Source of Funding and Conflicts of Interest: This research was supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft DFG 403266317).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: The study was preregistered on OSF (https://osf.io/sna5v/).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1097/psy.0000000000001183",TRUE,"Conflicts of Interest: The authors declare that they have no competing interests.",TRUE,"<section> Source of Funding and Conflicts of Interest: The authors declare that they have no competing interests. This work was supported by grants from the German Center for Diabetes Research <section> (DZD) funded by the German Federal Ministry of Education and Research (grant numbers: HMGU2018Z3 HMGU2020Z4 and HMGU2022Z5) and grants from the German Federal Ministry of Health to develop a diabetes surveillance system in Germany (grant numbers: GE20190305 and 2522DIA700). DEGS1 was primarily funded by the German Federal Ministry of Health as part of the continuous national health monitoring and conducted",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/rli.0000000000000941",TRUE,"Conflicts of interest and sources of funding: none declared.",TRUE,"The NAKO is funded by the Federal Ministry of Education and Research (project funding reference numbers: 01ER1301A/B/C and 01ER1511D) German Federal States and the Helmholtz Association with additional financial support by the participating universities and the institutes of the Leibniz Association. <section> This research was supported by the UK Research and Innovation London Medical Imaging and Artificial Intelligence Centre for Value Based Healthcare and in part by the German Research Foundation (project number 428219130).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/rli.0000000000000971",TRUE,"Conflicts of interest and sources of funding: J.G. L.J.S. and I.S. received funding from the German Research Foundation (DFG) CRC1340.",TRUE,"<section> Conflicts of interest and sources of funding: J.G. L.J.S. and I.S. received funding from the German Research Foundation (DFG) CRC1340. J.G. and I.S. received funding from the DFG GRK2260 BIOQIC.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/scs.0000000000009143",TRUE,"<section> The authors report no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/sla.0000000000005313",TRUE,"<section> The authors report no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/sla.0000000000005530",FALSE,"",TRUE,"<section> There was no funding for this study",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/sla.0000000000005771",TRUE,"<section> The authors report no conﬂicts of interest.",TRUE,"<section> Partially funded by Italian Ministry of Health Ricerca Finalizzata 2019 grant code J99C21000260001. This work was funded by National Cancer Institute award P30-CA008748.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/sla.0000000000005855",FALSE,"",TRUE,"P. Kingham was partially supported by the US National Cancer Institute MSKCC",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/sla.0000000000006054",TRUE,"<section> The authors report no conﬂicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/tp.0000000000004285",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1097/txd.0000000000001398",TRUE,"All other authors have no relevant disclosures.C.H. is the recipient of research grants paid to her institution from Baxter Healthcare Fresenius Medical Care Otsuka Janssen and GlaxoSmithKline for trial steering committee activities.",TRUE,"<section> This project is supported by a National Health and Medical Research Council (NHMRC) program grant (1092597) and project grant (1128564). D.J. is a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant. He is a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant. All other authors have no relevant disclosures.C.H. is the recipient of research grants paid to her institution from Baxter Healthcare Fresenius Medical Care Otsuka Janssen and GlaxoSmithKline for trial steering committee activities. Funding was most commonly from industry sources (49%). Characteristics of all included trials All trials (n = 93) Participants 0–49 50–99 100–499 500–999 1000–4999 Not reported Year 2012–2013 2014–2015 2016–2017 2018–2019 Not published WHO region Australia/New Zealand Europe International Middle East North America South America Duration (mo) 1–3 4–6 7–12 13–24 25–48 >48 Intervention type Behavioral Device Lifestyle Pharmacological Surgical Other Funding source Government Hospital Industry University Not declared/other source 15 (16%) 25 (27%) 38 (41%) 10 (11%) 4 (4%) 1 (1%) 21 (23%) 23 (25%) 25 (27%) 6 (6%) 18 (19%) 2 (5%) 50 (54%) 17 (18%) 2 (2%) 17 (18%) 2 (2%) 7 (8%) 11 (12%) 35 (38%) 19 (20%) 6 (6%) 15 (16%) 9 (10%) 1 (1%) 3 (3%) 72 (78%) 3 (3%) 5 (5%) 11 (12%) 13 (14%) 46 (49%) 17 (18%) 6 (7%)",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1097/wco.0000000000001186",TRUE,"Conflicts of interest <section> F.K. and B.S. report no conflicts of interest relevant to this",TRUE,"<section> Financial support and sponsorship",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1098/rsbl.2023.0152",FALSE,"",TRUE,"<section> Funding. The authors also gratefully acknowledge funding from the Chinese Academy of Sciences (grant no. CAS153E11KYSB20190045) to J.R.S. and the US National Science Foundation (grant no. BCS1824466) awarded to H.P.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1098/rsos.221517",TRUE,"Conflict of interest declaration. We have no competing interests.",TRUE,"<section> Funding. <section> This work is supported by University Grants Commission (UGC) Bangladesh.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1098/rsos.230215",TRUE,"Conflict of interest declaration. We declare we have no competing interests.",TRUE,"<section> Funding. <section> This work was supported by the Max Planck Institute of Animal Behaviour and funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy –",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1098/rsos.230448",TRUE,"Conflict of interest declaration. We declare we have no competing interests.",TRUE,"<section> Institutional Error (Bias): Funding driven by quantifiable outputs <section> Our fictitious researcher Riley was fortunate enough to secure funding to conduct the extension study on y. Funding driven by quantifiable outputs <section> Funding agencies (and other institutions more generally) foster an individualistic mindset when they reward competition among individual researchers over cooperation adding to a conflict between what is good for science and what is good for the individual researcher. Funding agencies could provide more support for largescale collaborations. <section> Funding. <section> D.R. was funded by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (grant no. 016.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1098/rsos.230568",TRUE,"Conflict of interest declaration.",TRUE,"<section> Funding. <section> R.T.T. is supported by a general support grant awarded to METRICS from Arnold Ventures and a postdoctoral fellowship from the Canadian Institutes of Health Research. A.S. was supported by an Amsterdam Brain and Cognition project grant (grant ref.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1099/jgv.0.001840",TRUE,"The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding <section> D.B.S. is supported by a grant from the Microbiology Society. B.E.D. is supported by the European Research Council (ERC) Consolidator grant 865694: DiversiPHI the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany s Excellence Strategy – EXC 2051 – Project-­ID 390713860 the Alexander von Humboldt Foundation in the context of an Alexander von Humboldt-­Professorship founded by German Federal Ministry of Education and Research and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-­Curie Actions Innovative Training Networks grant agreement no. 955 974 (VIROINF). E.J.L. – this publication was supported by the National Institutes of Health (NIH) National Institute of Allergy And Infectious Diseases (NIAID) under Award Number U24AI162625. This work was also supported in part through the Laulima Government Solutions LLC prime contract with the NIH NIAID under Contract No. H.M.O. was supported by the University of Helsinki and Academy of Finland funding for FINStruct part of Biocenter Finland and Instruct-­ERIC.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001926",TRUE,"The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding <section> Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001930",TRUE,"Conflicts of interest The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding information Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001931",TRUE,"Conflicts of interest The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding information Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001932",TRUE,"Conflicts of interest The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding information Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001933",TRUE,"Conflicts of interest The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding information Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/jgv.0.001934",TRUE,"Conflicts of interest The authors declare that there are no conflicts of interest.",TRUE,"Funding information Production of this Profile the ICTV Report and associated resources was supported by the Microbiology Society.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/mgen.0.000937",TRUE,"The authors have no conflicts of interest to declare.",TRUE,"<section> Funding <section> No specific funding has been received for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1099/mgen.0.000963",TRUE,"The authors declare that there are no conflicts of interest.",TRUE,"<section> Funding <section> The study was supported by internal grants of the Robert-­Koch Institute (CK) and by the German Research Foundation (DFG) GRK2046 Research Training Programme (CK TA) and Priority Programme SPP 2332 ‘Physics of Parasitism’ (CK TA).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1101/gr.277334.122",TRUE,"",TRUE,"T.M. and P.E. acknowledge the support and computational infrastructure provided by the Centre for Information and Media Technology at Heinrich Heine University Düsseldorf. This work was supported in part by grants from the National Institutes of Health (NIH; grants 5R01HG002385 and 5U01HG010971 to E.E.E. and 1U01HG010973 to E.E.E. and T.M.) and by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. <section> 956229 to T.M.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1103/physrevresearch.5.013214",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE
"10.1109/jbhi.2023.3267857",FALSE,"",TRUE,"This work was supported in part by European H2020 Programme through euCanSHare Project under Grant 825903 and through HealthyCloud Project under Grant 965345 in part by Spanish Project under Grant PID2019-105093GBI00 and in part by ICREA through ICREA Academia Programme. The work of Sandro Queirós was supported by the National funds through Foundation for Science and Technology (FCT) Portugal Project under Grants PTDC/EMDEMD/1140/2020 and CEECIND/03064/2018. <section> The work of Andrea Guala was supported in part by the Spanish Ministry of Science Innovation and Universities under Grant IJC2018-037349-I and in part by “la Caixa” Foundation under Grant LCF/BQ/PR22/11920008. The work of Karim Lekadir was supported by the Spanish Ministry of Economy and Competitiveness through Ramon y Cajal Program under Grant RYC-2015-17183.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1109/ojies.2023.3339838",FALSE,"",TRUE,"GIUFFRIDA This work was supported by the SPARK program",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/1460-6984.12843",TRUE,"<section> CONFLICTS OF INTEREST M.P. reports outside the submitted work having received partial funding for a self-initiated research project from Novartis Pharma and being awarded a research grant from the Center for Stroke Research Berlin (private donations). <section> The other authors declare no conflict of interest.",TRUE,"<section> Funding information GBHI Alzheimer’s Association and the context of neurodegeneration. Maxime Montembeault is supported by postdoctoral funding from the Canadian Health Institutes of Research and Fonds de Recherche en Santé du Québec. Maria Luisa Gorno Tempini is supported by grants from the National Institutes of Health <section> CONFLICTS OF INTEREST M.P. reports outside the submitted work having received partial funding for a selfinitiated research project from Novartis Pharma and being awarded a research grant from the Center for Stroke Research Berlin (private donations).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/1753-0407.13340",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information COVID-19 pandemic Deutsche Diabetes Gesellschaft; German <section> F U N D I N G IN F O R M A T I O N This study was supported through the German Federal Ministry for Education and Research within the German Centre for Diabetes Research (DZD 82DZD14E03).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aas.14311",TRUE,"Disclosure and management of conflicts of <section> as measured by biomarker of ICM-RPGs use a standardized conflict of interest (COI) disclosure and management process. <section> CONFLIC T OF INTER E ST STATEMENT Neil Adhikari Tomoko Fujii and Francois Lamontagne as primary investigators on studies included in the evidence review were considered to have intellectual conflicts of interest and were non-voting members of the panel. The remainder of the investigators have no conflicts of interest. Alhazzani W Lewis K Jaeschke R et al. Conficts of interest disclosure forms and management in critical care clinical practice guidelines.",TRUE,"Naomi Hammond via The George Institute for Global Health has received research funding from Baxter Health Care CSL Behring Grifols and consultancy fees from Revimmune and the National Health and Medical Research Emerging Leader Investigator Grant not related to vitamin C.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/acel.13894",TRUE,"The authors declare no competing interests.",TRUE,"<section> F U N D I N G I N FO R M AT I O N This work was supported by the DZHK (German Centre for Cardiovascular Research) by the BMBF (German Ministry of Education and Research) and by the Ministry of Science Research and Culture of the State of Brandenburg.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/acel.13935",TRUE,"The authors have no conflict of interest to declare.",TRUE,"<section> Funding information Deutsches Zentrum für Luft-­ und <section> F U N D I N G I N FO R M AT I O N The work in the group of A.R. was funded by the Dr. M.Y. was additionally funded by the Berlin School of Integrative Oncology (BSIO) graduate program of the Charité Medical University Berlin. D.B. and B.S. were supported by a grant from the Federal Department of Economy and Climate protection (BMWK) through Deutsches Zentrum für Luft-­ und Raumfahrt (DLR e.V. Bonn-­Oberkassel Germany #50WB2029 to D.B.).",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/acps.13531",TRUE,"<section> CONFLICT OF INTEREST Mazda Adli received research grants from Servier Lundbeck and Gilead; speaker honoraria from Aristo Pharma Deutsche Bank HRMForum Merz Pharma Gilead ViiV <section> MSD Berlin Chemie BMS myTomorrows Servier and Lundbeck; and reimbursement of fees and of travel expenses from Lundbeck Aristo Pharma and Servier. Pichit Buspavanich received a research grant from Gilead. Roland Ricken received a research grant and speaker honoraria from Aristo Pharma. The other authors declare no conflicts of interest.",TRUE,"<section> Funding information Mood Disorders Research Unit of Charité - We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> FUNDING INFORMATION The study was funded by sources of the Mood Disorders Research Unit of Charité -Universitätsmedizin Berlin Department of Psychiatry and Psychotherapy Campus Charité Mitte (CCM). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/acps.13543",TRUE,"The author declare that they have no conflicts of interest.",TRUE,"<section> FUNDING INFORMATION There was no funding for this research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/acps.13643",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The study was not funded. ODC is currently the President of the European Network of Teratology Information Services (ENTIS). JLR is staff member of the UK Teratology Information Service which is funded by the UK Health Security Agency an executive agency of the UK Government's Department of Health and Social Care; currently it is also funded to participate in the Innovative Medicines Initiative ConcePTION project. KD is the head of the Berlin Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy which is financially supported by the German Federal Institute for Drugs and Medical Devices (BfArM) LL and MO are staff members. No other disclosures were reported.",TRUE,"<section> Funding information German Federal Institute for Drugs and outcomes rate of nonchromosomal Medical Devices (BfArM); UK Health cies and percentiles Security Agency; Ministerie van (HC) were calculated. <section> F U N D I N G IN F O R M A T I O N The Berlin Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy is financially supported by the German Federal Institute for Drugs and Medical Devices (BfArM); included German study cases were obtained from the Embryotox cohort. The UK Teratology Information Service is funded by the UK Health Security Agency. JLR is staff member of the UK Teratology Information Service which is funded by the UK Health Security Agency an executive agency of the UK Government's Department of Health and Social Care; currently it is also funded to participate in the Innovative Medicines Initiative ConcePTION project. KD is the head of the Berlin Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy which is financially supported by the German Federal Institute for Drugs and Medical Devices (BfArM) LL and MO are staff members.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/adb.13263",FALSE,"",TRUE,"<section> Funding information AUDIT-C scores over Deutsche Forschungsgemeinschaft Grant/Award Numbers: 178833530 [SFB 940] ence between Pavlovian 186318919 [FOR 1617] 402170461 [TRR mechanism towards 265] <section> ACKNOWLEDGEMEN TS This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) (Grant Nos.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/adb.13275",TRUE,"Guillery Sven Reiners Marius Fahrner Sören Enge and Golo Kronenberg report no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/adb.13287",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> AC KNOW LEDG EME NT S The study was supported by the Forschungsgemeinschaft (DFG German Research Foundation)—Project-ID 402170461—TRR ; Project-ID 390688087—EXC 2049) and the China Scholarship Council—CSC grant 201806750014 to KC.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/adb.13339",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information ing to a putative neural German Federal Ministry of Education and Research (Bundesministerium für Bildung und evaluate the potential Forschung) Grant/Award Number: and functional connectivity 01ZX1909C [SysMedSUDs to HW AH]; German Research Foundation (Deutsche <section> ACKNOWLEDGMENTS This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG project numbers 186318919 [FOR 16717 to AH EF MNS HW]; 178833530 [SFB 940 to MNS MM HW]; 402170461 [TRR 265 to AH MNS MM HW]; 454245598 [GRK 2773 to MNS]) as well as the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF project ID 01ZX1909C [SysMedSUDs to HW AH]).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/add.16231",TRUE,"<section> DECLARATION OF INTERESTS T.B. served in an advisory or consultancy role for Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH and Shire. He received conference support or speaker’s fee from Lilly Medice Novartis and Shire. He has been involved in clinical trials conducted by Shire and Viforpharma. He has received royalties from Hogrefe Kohlhammer CIP Medien and Oxford University Press. The present work is unrelated to the above grants and relationships. L.P. served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee from Shire. She received royalties from Hogrefe Kohlhammer and <section> Schattauer. The present work is unrelated to the above grants and 14. relationships. The other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding information mate the dynamic associations This work received funding from various sources including the European Unionfunded (drinking motives) risk FP6 Integrated Project IMAGEN early adulthood using (Reinforcementrelated behavior in normal brain function and psychopathology) and it is approach. <section> Tobias Banaschewski: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Arun Bokde: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Sylvane Desrivières: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Herta Flor: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Antoine Grigis: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Hugh Garavan: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Andreas Heinz: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Jean-Luc Martinot: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Marie-Laure Paillère Martinot: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Eric Artiges: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Nees: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Dimitri Papadopoulos: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Luise Poustka: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Hohmann: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). Fröhner: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Michael N Smolka: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Nilakshi Vaidya: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Robert Whelan: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Gunter Schumann: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Henrik Walter: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> Consortium: Funding acquisition (equal); investigation (equal); project administration (equal); resources (equal). <section> ACKNOWLEDGEMEN TS This study is part of the project ‘New Science of Mental Disorders’ (www.nsmd.eu) supported by the Dutch Research Council and the Dutch Ministry of Education Culture and Science (NWO gravitation grant number 024.004.016). This work received support from the following sources: the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated behaviour in normal brain function and psychopathology) (LSHM-CT2007-037286) the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcementrelated disorders) (695313) Human Brain Project (HBP SGA 2 785907 and HBP SGA 3 945539) the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1) the National Institute of Health (NIH) (R01DA049238 A decentralized macro and micro geneby-environment interaction analysis of substance use behavior and its brain biomarkers) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministerium für Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B) the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 SFB 940 TRR 265 NE 1383/14-1) the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1) the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01) NSFC grant 82150710554 and European Union funded project ‘environMEN- (Axon Testosterone and Mental Health during Adolescence; (RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This paper is based on independent research commissioned and funded in England by the National Institute for Health Research (NIHR) Policy Research Programme (project ref. The views expressed in this article are those of the authors and not necessarily those of the national funding agencies or ERANID.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15658",TRUE,"<section> C O N F L I C T O F I N T E R E S T S TAT E M E N T All other authors declare no conflict of interest.",TRUE,"<section> Funding information studies have been conducted Berlin Institute of Health at Charité opment is still widely -­ Universitätsmedizin Berlin; European Union research grant QLK4-­2001-­0 0250; bisulfite sequencing (WGBS) Fondation du Souffle; Helmholtz Centre matic children compared for Environmental Research—­UFZ Leipzig;",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15679",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15689",TRUE,"GK has no conflict of interest to declare. CL and SW are currently employees of MacroArray Diagnostics GmbH Vienna Austria. JB reports personal fees from Cipla Menarini Mylan Novartis Purina Sanofi-­Aventis Teva Uriach. He is shareholder of KYomed Innov and MASK-­air-­SAS. The rest of the authors report no conflict of interest.",TRUE,"<section> Funding information regions of Europe; north European Commission (the Netherlands) BiB Sabadell and Gipuzkoa MeDALL-­allergen chip. <section> F U N D I N G I N FO R M AT I O N The study was supported by the European FP7-­program MeDALL the Danube Allergy Research Cluster by the Country of Lower Austria the Swedish Research Council The Region Stockholm (ALF project) The Swedish Asthma and Allergy Association's Research Foundation The Swedish Cancer and Allergy Foundation The King Gustaf V 80th Birthday Foundation The Swedish Heart-­Lung Foundation The Hesselman Foundation by the European Commission by Mead Johnson Evansville Indiana USA by Nestle Vevey Vaud Switzerland by a Wellcome programme grant [WT223601/Z/21/Z: Age of Wonder a UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) grant: MR/ N02439/1 and by the special program (Programmi speciali-­Art.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15740",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15788",FALSE,"",TRUE,"<section> Funding information <section> F U N D I N G I N FO R M AT I O N The study was funded by Allergy Therapeutics PLC.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15801",FALSE,"",TRUE,"<section> Funding information DBV Technologies SA shellfish) in Europe for provides 10-­year updated col was registered on CRD42021266657). <section> F U N D I N G I N FO R M AT I O N The study was funded through an unrestricted grant from DBV Technologies SA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15807",FALSE,"",TRUE,"<section> Funding information 2019 stratified by geographic Bill and Melinda Gates Foundation; National Research Foundation of DALYs were calculated Korea; Australian National Health and premature mortality. A. Badawi is supported by the Public Health Agency of Canada. Hwang was partially supported by China Medical University Taiwan (CMU111-­MF-­55). M.-­C Li was supported by the National Science and Technology Council Taiwan (NSTC 111-­2410-­H-­0 03-­100-­SSS). L. Monasta received support from the Italian Ministry of Health (Ricerca Corrente 34/2017) payments made to the Institute for Maternal and Child Health IRCCS Burlo Garofolo. <section> F U N D I N G I N FO R M AT I O N This study was funded by the Bill and Melinda Gates Foundation Australian National Health and Medical Research Council and Queensland Department of Health Australia and National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-­2021R1I1A2059735 and RS-­2023-­0 0248157). L. Monasta reports support for the present manuscript from Italian Ministry of Health through a contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy (RC 34/2017).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15817",FALSE,"",TRUE,"The authors would like to thank EAACI for their financial support in the development of this Position Paper.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15836",TRUE,"<section> C O N FL I C T O F I N T E R E S T S TAT E M E N T IPS SD HM IA and AG declare no conflict of interest in relation to the present article.",TRUE,"<section> Funding information AllergyCare®; Bundesministerium human health as the two für Bildung und Forschung; German that contribute to these Federal Joint Committee; Karl Landsteiner Privatuniversität für of consumables which Gesundheitswissenschaften; SNP They are further responsible Foundation; Veterinärmedizinische Universität Wien; National Heart Lung drug products and other and Blood Institute practices and treatments on methods and technologies meetings. SD is supported by the German Federal Ministry of Education and Research (grant number: 16LW0190K) and the German Federal Joint Committee (section healthcare innovation fund grant number: 01NVF21106). KN and AG were supported by the SNP Foundation and National Heart Lung and Blood Institute (NHLBI grant number: P01HL152953).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15843",TRUE,"<section> C O N FL I C T O F I N T E R E S T S TAT E M E N T NC is or recently was a speaker and/or advisor for and/or has received research funding from argenx and Onward Therapeutics and is inventor on patents related to compositions and methods for treating or preventing lupus (W020120710042 & WO2016128565A1); IKK received research funding from Sanofi Regeneron Pfizer and AbbVie; EK has no conflicts of interest regarding any aspects of this study; JS has conducted studies for received research funds/was advisor for Allakos Ascilion AstraZeneca CSL Behring Celldex Genentech Escient Novartis Sanofi Servier ThirdHarmonicBio ThirdRock and ThermoFisher; SA is or recently was a speaker and/or advisor for and/or has received research funding from AstraZeneca Allakos CSL Behring Sanofi Takeda ThermoFisher Moxie and Novartis; CS has no conflicts of interest regarding any aspects of this study; Y-­K X has no conflicts of interest regarding any aspects of this study; JG has no conflicts of interest regarding any aspects of this study; LLR is or recently was a speaker and/or advisor for and/or has received research funding from Argenx Novartis Ceva and Neovacs and is inventor on patents issued or pending relating to IgE detection and anti-­IgE therapies: EP2021/060829 EP20315224-­4 WO2019197607 (A1); MM is or recently was a speaker and/or advisor for and/or has received research funding from Allakos Amgen Aralez ArgenX AstraZeneca Celldex Centogene CSL Behring FAES Genentech GIInnovation GSK Innate Pharma Kyowa Kirin Leo Pharma Lilly Menarini Merckle Recordati Moxie MSD Novartis Pfizer Roche Sanofi/Regeneron Third Harmonic Bio UCB and Uriach.",TRUE,"<section> Funding information contrast in some individuals Agence Nationale de la Recherche; Centre National de la Recherche Scientifique; of signs and symptoms European Research Council; Fondation production isotype profiles pour la Recherche Médicale; Fonds Wetenschappelijk Onderzoek; Institut triggers linked to genetic National de la Santé et de la Recherche dence supports a role Médicale; Université Paris Cité <section> F U N D I N G I N FO R M AT I O N This work was supported by intramural funding and the Fondation pour la Recherche Médicale (FRM) [grant # EQU201903007794] to N.C. the French Agence Nationale de la Recherche (ANR) [grants # ANR-­19-­CE17-­0 029 BALUMET to N.C. and ANRPIA-­10-­L ABX-­0",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15850",FALSE,"",TRUE,"<section> Funding information Allakos Inc.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15854",TRUE,"Adriane Groffik has no conflicts of interest to disclose. Sonja Grundmann has no conflicts of interest to disclose. <section> Thilo Jakob has been a speaker and advisor for and/or has received research funding from ALK-­A bello Allergy Therapeutics/ Bencard Novartis and Thermo-­F isher Scientific. Moisés Labrador-­ Horrillo has been a speaker and/or advisor for Astrazeneca GSK Novartis Sanofi–­Regeneron and Thermo Fisher Scientific. Sabine Müller has received lecture fees and has taken part in advisory boards for Novartis. Petra Staubach-­Renz has no conflicts of interest to disclose. Gerda Wurpts has no conflicts of interest to disclose.",TRUE,"<section> Funding information versus daily maintenance Charité -­ Universitätsmedizin Berlin; rupatadine updosing and <section> F U N D I N G I N FO R M AT I O N This study was funded in part by URIACH and the analysis was funded by Charité—­Universitätsmedizin Berlin as part of the “CU-­ LATER” study. Other features of the study were supported by intramural funding.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15855",FALSE,"",TRUE,"<section> Funding information for the management MASK-­air SAS; MOXIE",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15857",TRUE,"MA AD GE IF CG PG MG KE TJ CM AN SN SF SP AS AK AN MS AV TS IA-­M declare no conflict of interest.",TRUE,"<section> Funding information sufferers are highly susceptible HORIZON EUROPE Health Grant/Award <section> AC K N OW L E D G M E N T S The project is funded by the Horizon Europe project SynAir-­G grant agreement ID: 101057271.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15861",FALSE,"",TRUE,"<section> Funding information <section> AC K N OW L E D G M E N T S This study was financially supported by Takeda Pharma Vertrieb GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15870",TRUE,"The authors have no conflict of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15902",TRUE,"Conflicts of interest management",TRUE,"<section> Funding information proach.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15905",FALSE,"",TRUE,"<section> Funding information DBV Technologies SA mary estimates for tree update of that systematic sensitization to individual published 2012–­2021 identified between 2000 tree nuts meta-­analysis for cashew and Brazil 0.5–­1.1) for hazelnut lence was 4.0% (2.9–­5.2) <section> AC K N OW L E D G E M E N T S The study was funded through an unrestricted grant from DBV Technologies SA. <section> F U N D I N G I N FO R M AT I O N The study was solely funded by the above mentioned DBV unrestricted",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/all.15910",FALSE,"",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15945",FALSE,"",TRUE,"<section> Funding information creased Type 2 responses Ministry of Health Grant/Award Number: SUBZ.A020.22.060 and IgG  decreased mast activation thresholds. <section> AC K N OW L E D G E M E N T S The publication was supported by the Ministry of Health subvention according to the number SUBZ.A020.22.060 from the IT Simple system of Wroclaw Medical University Poland. <section> F U N D I N G I N FO R M AT I O N The publication was supported by the Ministry of Health subvention according to the number SUBZ.A020.22.060 from the IT Simple system of Wroclaw Medical University Poland.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/all.15964",TRUE,"Any potential conflicts of interest indicated by the authors are listed here: Peter Gibson reports being a speaker and/or research grant recipient AstraZeneca Chiesi GSK Novartis Sanofi. Dr. Jutel reports personal fees from ALK-Abello personal fees from Allergopharma personal fees from Stallergenes personal fees from Anergis personal fees from Allergy Therapeutics personal fees from Leti personal fees from HAL personal fees from GSK personal fees from Novartis personal fees from Teva personal fees from Takeda personal fees from Chiesi; outside the submitted work. Nikolaos G. <section> Papadopoulos reports being a speaker and/or advisory board member for Abbott Abbvie ALK Asit Biotech AstraZeneca Biomay Boehringer Ingelheim GSK HAL Faes Farma Medscape Menarini MSD Novartis Nutricia OM Pharma Regeneron Sanofi Takeda Viatris. Oliver Pfaar reports grants and/or personal fees from ALKAbelló Allergopharma Stallergenes Greer HAL Allergy Holding B.V. / HAL Allergie GmbH Bencard Allergie GmbH/Allergy Therapeutics Lofarma ASIT Biotech Tools S.A. Laboratorios LETI/LETI Pharma GlaxoSmithKline ROXALL Medizin Novartis Sanofi-Aventis und Sanofi-Genzyme Med Update Europe GmbH streamedup! GmbH Pohl-Boskamp Inmunotek S.L. John Wiley and Sons AS Paul-Martini-Stiftung (PMS) Regeneron Pharmaceuticals Inc. RG Aerztefortbildung Institut für Disease Management Springer GmbH AstraZeneca IQVIA Commercial Ingress Health Wort&Bild Verlag Verlag ME Procter&Gamble ALTAMIRA Meinhardt Congress GmbH Deutsche Forschungsgemeinschaft Thieme Deutsche AllergieLiga e.V. AeDA Alfried-Krupp Krankenhaus Red Maple Trials Inc. Königlich Dänisches Generalkonsulat Medizinische Hochschule Hannover ECM Expro&Conference Management Technische Universität Dresden Lilly Paul Ehrlich Institut (PEI) all outside the submitted work and within the last 36 months; and he is member of EAACI Excom member of ext. board of directors DGAKI; coordinator main or co-author of different position papers and <section> guidelines in rhinology allergology and allergen-immunotherapy. <section> The remaining authors do not declare any potential and real conflicts of interest to this publication.",TRUE,"<section> Funding information use has become widespread. The authors would like to thank EAACI for financial support in the development of this position paper.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> In allergic patients this could possibly work for registration of daily allergic symptoms in patients' e-diaries. 323941",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/all.15974",TRUE,"Karin Hartmann Dominique Sabouraud-­Leclerc Maria Beatrice Bilò Sabine Dölle-­Bierke and Veronika Höfer have no conflict of interest.",TRUE,"<section> Funding information <section> AC K N OW L E D G M E N T S Funding: NORA e.V. and all members of NORA: The Anaphylaxis Registry is supported by the Network for Online Registration of",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aogs.14688",TRUE,"The authors have stated explicitly that there are no conflicts of interest in connection with this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aor.14515",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The authors do not have any financial disclosure relevant to this manuscript.",TRUE,"<section> FUNDING INFORMATION The European Association for Cardio-­Thoracic Surgery (EACTS) supported this study and made resources available to execute this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aor.14519",TRUE,"<section> CONFLICT OF INTEREST Malcolm P. MacConmara is an employee of Transmedics Inc. The other authors have no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aor.14634",TRUE,"<section> CONFLICT OF INTEREST STATEMENT All Authors have nothing to disclose with regard to commercial support.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aor.14647",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Felix Schoenrath receives institutional grants from Novartis Abbott non-­ financial support from Medtronic and institutional fees (speaker honoraria) from Orion Pharma outside of the submitted work. Volkmar Falk declares relevant financial activities outside the submitted work with Medtronic GmbH Biotronik SE & Co. Abbott GmbH & Co. <section> KG Boston Scientific Edwards Lifesciences LivaNova Berlin Heart Novartis Pharma GmbH JOTEC GmbH and Zurich Heart in relation to educational grants (including travel support) fees for lectures and speeches fees for professional consultation research and study funds. Evgenij Potapov reports institutional grants and professional fees as a proctor and consultant from Abiomed Abbott and Medtronic. The other authors report no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/aor.14702",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The authors have no conflicts to disclose.",TRUE,"<section> Funding information European Regional Development Fund <section> FUNDING INFORMATION The European Regional Development Fund (code: 10168084).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apa.17064",TRUE,"The authors have no conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apha.13913",TRUE,"<section> CONFLICT OF INTEREST All authors declare no conflicts of interest.",TRUE,"<section> Funding information Federal Ministry of Education and <section> FUNDING INFORMATION This study was funded by the German Federal Ministry of Education and Research (BMBF VIP+ AngioAccel project: 03VP01950) as well as the DAZB (Deutsches Angiologie Zentrum Brandenburg-­Berlin) as an investigator-­initiated trial",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The trial was registered in the ISRCTN registry (ISRCTN15405726 URL: https://doi.org/10.1186/ISRCT",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/apha.13915",TRUE,"<section> CONFLICT OF INTEREST All authors declare no competing interests that could have an impact on the study.",TRUE,"<section> Funding information This study was supported by grants of the German Research Foundation (DFG) to HO 353-­ 11/1 GRK-­ 1957 and CRC-­ “LocoTact” (TP13).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apha.13927",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft tory stimulation of Cldn2 Grant/Award Number: Project ID hypercalciuria in Cldn16 394046635 -­ SFB 1365 <section> ACKNOWLEDGMENTS This work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—­ project ID 394046635—­ SFB 1365. <section> FUNDING INFORMATION Funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—­project ID 394046635—­",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apha.13939",TRUE,"<section> CONFLICT OF INTEREST STATEMENT There are no competing interests to declare.",TRUE,"<section> Funding information European Association of Study of <section> FUNDING INFORMATION This work was supported by the European Association of Study of Diabetes (Morgagni Prize 2020 OPR).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apha.13951",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apha.13962",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> FUNDING INFORMATION Authors were supported by grants from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) SFB-­TR84 sub-­projects C06 C09 and Z01b SFB 1449 (431232613) sub-­project B2 and by the German Ministry of Education and Research (BMBF) in the framework of CAPSyS (01ZX1604B 01ZX1304B) SYMPATH (01ZX1906A) PROVID (01KI20160A) Phage4Cure (16GW0141) and MAPVAP (01KI2124).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apha.13966",TRUE,"<section> CONFLICT OF INTEREST STATEMENT WJN has received honoraria and travel support for scientific presentations from Medtronic.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apha.13970",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> ACKNOWLEDGMENTS This work was supported in part by the German Research Foundation (DFG SFB/TRR167 B07).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apha.14028",TRUE,"<section> CONFLICT OF INTEREST STATEMENT None of the authors have a conflict of interest to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/aphw.12450",TRUE,"The authors declared that they had no conflict of interest with respect to their authorship or the publication of this article.",TRUE,"<section> Funding information relationship construct Study 2 and Study 3 were both funded by the Swiss National Science Foundation dyadic score model (grant number Study 2: 100014_124516; spectives on companionship. Gertraud Stadler's cision for detecting effects contribution was supported by the predictor compared with Berliner ChancengleichheitsProgramm. effects of partner differences Janina Lüscher's contribution was supported by grant number outcome while maintaining CR12I1_166348/1 from the Swiss National Science Foundation.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/aphw.12479",TRUE,"<section> CONFLICT OF INTEREST STATEMENT Wolfgang Gaissmaier has received honoraria for lecturing/consulting from Amgen Bayer Biogen Celgene Genzyme Merck Serono MSD Mundipharma Novartis Pharma Roche Sanofi and Teva as well as research support from Biogen.",TRUE,"<section> Funding information acceptance vaccination This work was supported by the Deutsche clicking the affirmative Forschungsgemeinschaft (DFG [German Research Foundation]) under Grant link systematically increased 441541975 and the German Research on the link to make Foundation Centre of Excellence 2117",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/aphw.12482",TRUE,"<section> CONFLICT OF INTEREST STATEMENT We have no known conflicts of interest to disclose.",TRUE,"<section> Funding information higher life satisfaction. <section> The study was funded by budget funds of the University of Tübingen.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/aphw.12505",TRUE,"<section> CONFLICT OF INTEREST STATEMENT R. K. received advisory honoraria from JoyVentures Herzlia Israel. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding information This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. <section> DATA AVAILABILITY STATEMENT The selfreport data used to support the findings of this study are restricted by the Ethics Committee of the Faculty of Arts and Social Sciences of the University of Zurich in order to protect participants' privacy.",TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/apt.17441",TRUE,"The authors disclose no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apt.17456",FALSE,"",TRUE,"<section> Funding information vides a comprehensive Innovative Medicines Initiative 2 Joint <section> Joan Genescà: Funding acquisition (equal); investigation (equal); validation (equal); visualization (equal); writing –­ review and editing (equal). He reports research Grant Funding: Allergan/Tobira AstraZeneca Boehringer-­Ingelheim Glaxo SmithKline Glympse Bio Intercept Novartis Pharma AG Pfizer Ltd. FT lab’ work has been supported by the German Research Foundation (DFG CRC/TR 362) and research grants from Gilead Allergan Bristol-­Myers Squibb and Inventiva. VR consults for and Intercept Novo Nordisk Galmed Poxel NGM Madrigal Enyo Sagimet 89 Bio Prosciento Terns and Theratechnologies and received grants from Intercept and Gilead. <section> Declaration of funding interests: EU-­PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-­2. No writing support was received.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/apt.17755",FALSE,"",TRUE,"<section> Funding information CymaBay Therapeutics J. Jones consults for is on the speakers' bureau Therapeutics Inc. GSK for and received funding from Intercept consults for CymaBay Therand Ipsen Bioscience and has apeutics Inc Kowa and Umecrine and is on the speakers bureau for <section> F U N D I N G I N FO R M AT I O N Funding for this study and manuscript preparation was provided by CymaBay Therapeutics Inc which had a role in study design; in the collection analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Clinical Trial Number: NCT03301506; EudraCT Number: 2017-­0 03910-­16.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/bcp.15711",TRUE,"<section> COM P E TI N G IN TE RE S T S All authors have completed the ICMJE uniform disclosure from www. <section> icmje.org/disclosure-of-interest/ and declare no potential conflicts of interest.",TRUE,"<section> Funding information the Ω shrinkage measure AD is the recipient of the Chercheur-Boursier was met.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/bcp.15802",FALSE,"",TRUE,"Douros is the recipient of Chercheur-Boursier Junior 1 award from the Fonds de recherche du Québec – Santé (FRQS).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/bcp.15911",TRUE,"All other authors declare no conflicts of interest.",TRUE,"<section> Funding information a greater emphasis on Open access funding enabled and organized by the DEAL project. Funding acquisition: Felix Busch and Keno Kyrill Bressem.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/bjhp.12670",TRUE,"<section> C ON F L IC T OF I N T E R E S T S TAT E M E N T All authors declare no conflict of interest.",TRUE,"<section> AC K NOW L ED G EM E N T S The data collection was sponsored by the Leibniz Institute for Psychology (ZPID) Lab Track Preregistration in Psychology programme.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/bpa.13200",FALSE,"",TRUE,"<section> Funding information physiological aspects Association Belge contre les Maladies Neuromusculaire; EU Horizon 2020 program from two Central Grant/Award Number: Solve-RD under grant clinical and neuropathological agreement No 779257; Flanders Fund for compared to 16 controls.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/bph.16051",FALSE,"",TRUE,"<section> Funding information This work was supported by a grant of the ity and reduced endothelial German Research Foundation (Deutsche ited the renal morphological Forschungsgemeinschaft SFB1365) to N.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cdev.13892",FALSE,"",TRUE,"<section> Funding information <section> AC K NOW L E D G M E N T S This research was funded by the German Research Foundation (project MA 6897/2-­1 awarded to CM). We are grateful to the participating families for supporting our research and thank Kristiane Klein and Lisa-­Marie Burmeister for their help in data collection.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cea.14372",TRUE,"The other authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cen.14959",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cge.14290",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information one long and three short Clinician Scientist Programme (Junior Clinician EEF1D had been associated Scientist) of the Medical Faculty of HeinrichHeine-University Düsseldorf Germany; two families. Funding acquisition: Bernd Wollnik Dagmar Wieczorek and Almundher Al-Maawali. <section> FUND ING INFORMATION This study was funded by the DFG EXC 2067/1–390729940 and DZHK 81Z0300112 grants (BW) and Sultan Qaboos University SR/MED/GENT/16/01 (AAM). <section> LA was supported by the Elterninitiative-Kinderkrebsklinik e.V. and by the Clinician Scientist Program of the Medical Faculty of HeinrichHeine-University Düsseldorf.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/clr.14031",TRUE,"The authors deny any conflicts of interest related to this study. Open Access funding enabled and organized by Projekt DEAL. <section> F U N D I N G I N FO R M AT I O N The Study has been supported by a research grant from Ivoclar Vivadent and Oral Reconstruction Foundation. <section> C O N F L I C T O F I N T E R E S T S TAT E M E N T The authors declare no conflicts of interest related to this study.",TRUE,"<section> Funding information Ivoclar Vivadent occurred. <section> AC K N OW L E D G M E N T S The Study has been supported by a research grant from Ivoclar Vivadent and Oral Reconstruction Foundation. <section> F U N D I N G I N FO R M AT I O N The Study has been supported by a research grant from Ivoclar Vivadent and Oral Reconstruction Foundation.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> C L I N I C A L T R I A L R EG I S T R AT I O N This study was registered at the German Clinical Trial Register (Deutsches Register Klinischer Studien) (reg. no. DRKS00005680).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/clr.14065",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/clr.14107",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cod.14332",TRUE,"The other authors have no conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cts.13547",TRUE,"<section> CONFLICT OF INTEREST STATEMENT All authors declared no competing interests for this work.",TRUE,"<section> Funding information Innovative Medicines Initiative PLatforms (EU-­PEARL). <section> FUNDING INFORMATION The conect4children (c4c) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777389. EU-­PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 853966.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/cup.14557",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information <section> ACKNOWLEDGMENTS This study was supported by grants from the Turkish Association of Dermatology.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.14906",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14906_g",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14930",TRUE,"Information on methods conflicts of interest and validity of the guideline This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs provided the original work is properly cited the use is non-commercial and no modifications © 2023 The Authors. <section> CONFLIC T OF INTEREST For information on conflicts of interest the reader is referred to the AWMF guideline report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14932",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14934",TRUE,"<section> CONFLIC T OF INTEREST Lisa Scholl has participated in clinical trials for AbbVie Inc. AbbVie Deutschland GmbH & Co.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.14952",TRUE,"The authors received honoraria for their work as lecturers or as participants of advisory boards or who received travel reimbursements or research support or participated in the conduct of clinical studies carried out by the following <section> companies: <section> D.N.: Abbvie Almirall BMS Eli Lilly GlaxoSmithKline Kyowa Kirin L’Oréal MSD Novartis Pfizer UCB Pharma. <section> S.S.: Biofrontera Lilly. M.T. is Medical Director of OnlineDoctor since 05/2021. <section> The other authors declare that there are no relevant conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14952_g",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.14988",TRUE,"<section> CONFLIC T OF INTEREST AND M E T H O D O LO G Y Please refer to the long version of the present guideline at www.awmf.org for details of conflicts of interest and of methodology.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.15055",TRUE,"<section> CONFLIC T OF INTEREST H.B. has received honoraria for lectures and advisory boards from Abbvie Intercept Pharma Novartis Sanofi-Aventis and Valenza Bio Inc. There is no conflict of interest regarding this article. L.E. has no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.15123",TRUE,"<section> CONFLIC T OF INTEREST None.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.15159",TRUE,"<section> CONFLIC T OF INTEREST S Abraham received lecture and/or consulting fees from Novartis Sanofi Celgene Beiersdorf UCB Amgen LEO Pharma and AbbVie. <section> All other authors declare no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"TREATgermany is registered in the clinicaltrials.gov database (NCT03057860) and the ENCePP Resource Database (EMA).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/ddg.15174",TRUE,"<section> CONFLIC T OF INTEREST None.",TRUE,"<section> Funding information <section> ACKNOWLEDGEMENT This work has been supported by PEGASUS (FOR 2497). The publication was made by a researcher (RM) with a research contract cofunded by the European Union– PON Research and Innovation 2014–2020 in accordance with Article 24 § 3a of Law No. 240 of December 30 2010 as amended and Ministerial Decree No. 1062 of August 10 2021.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.15178",TRUE,"<section> CONFLIC T OF INTEREST MA has served as consultant and/or paid speaker for and/or has received research grants and/or honoraria for consulting and/or scientific lectures for and/or received travel expenses reimbursed and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriatic arthritis including AbbVie Almirall Amgen Bayer Beiersdorf Biogen Boehringer Ingelheim Bristol Myers Squibb Celgene Centocor Dermira Eli Lilly Galderma Genzyme GlaxoSmithKline Hexal Incyte Janssen LEO Medac Menlo MSD Mylan B.V. Novartis Pfizer Regeneron Sandoz Sanofi Stallergenes Trevi and UCB. <section> LL LK AW SJR BS: no conflicts of interest.",TRUE,"<section> FUNDING <section> RABBIT-SpA is supported by a joint unconditional grant from AbbVie Amgen Biogen Celltrion Hexal JanssenCilag Lilly MSD Novartis Pfizer UCB and Viatris.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.15179",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.15187",TRUE,"<section> CONFLIC T OF INTEREST The SHI routine data analysis was funded by Kyowa Kirin GmbH and conducted by LinkCare GmbH (formerly HGC Healthcare Consultants GmbH) and the Institute for Applied Health Research Berlin GmbH (InGef ) in accordance with the study protocol.",TRUE,"<section> CONFLIC T OF INTEREST The SHI routine data analysis was funded by Kyowa Kirin GmbH and conducted by LinkCare GmbH (formerly HGC Healthcare Consultants GmbH) and the Institute for Applied Health Research Berlin GmbH (InGef ) in accordance with the study protocol.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ddg.15229",TRUE,"<section> CONFLIC T OF INTEREST A tabular listing of conflicts of interest of all parties involved can be found in the long version of the guideline.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.15231",TRUE,"A full list of references and the analysis of evidence underlying the recommendations and statements along with the conflicts of interest of the authors involved in the present guideline are available in the long version and in the guideline report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.15256",TRUE,"A full list of references and dence underlying the recommendations along with the conflicts of interest of the in the present guideline are available in and in the guideline report. <section> CONFLIC T OF INTEREST See long version at www.awmf.org.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ddg.15282",TRUE,"The authors R.N.W. A.J.S. P.S.R. and N.H.B. declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/dmcn.15751",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding information <section> This work was supported by the German research council (DFG LI1925/4-­1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/dme.15104",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding information Bundesministerium für Wissenschaft dence and severity in und Forschung Grant/Award Number: <section> FUNDING INFORMATION This article uses data from the Berlin Aging Study II (BASE-­II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under grant numbers #01UW0808; #16SV5536K #16SV5537 #16SV5538 #16SV5837 #01GL1716A and #01GL1716B.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/dme.15259",TRUE,"<section> CONFLICT OF INTEREST STATEMENT This study is part of the Innovative Medicines Initiative (IMI) Health Outcomes Observatory (H2O) project.",TRUE,"<section> Funding information European Federation of Pharmaceutical Type 1 and Type 2 diabetes Industries and Associations; Innovative implementability and Medicines Initiative; Juvenile Diabetes <section> FUNDING INFORMATION This project has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking under grant agreement No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/dom.15000",FALSE,"",TRUE,"<section> NI was supported in part by the Nyman award from the Faculty of Medicine and Health Sciences of McGill University. KBF is supported by a senior salary support award from the Fonds de recherche du Quebec – santé (FRQS; Quebec Foundation for Research – Health) and a William Dawson Scholar award from McGill University. No specific funding was available for this work. <section> No funding was obtained for this study.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/dom.15197",FALSE,"",TRUE,"<section> Funding information <section> FUNDING INF ORMATI ON This work was supported by Bayer AG Berlin Germany who funded the FIDELIO-DKD and FIGARO-DKD studies and pooled analysis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/dom.15305",FALSE,"",TRUE,"<section> Funding information Bayer AG Berlin Germany <section> FUNDING INF ORMATI ON This work was supported by Bayer AG Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/dom.15367",TRUE,"The authors have no conflicts of interest to declare.",TRUE,"<section> FUND ING INFORMATION Dr Filion is supported by a Senior salary support award from the Fonds de recherche du Québec – santé (FRQS; Quebec Foundation for Research – Health) and a William Dawson Scholar award from McGill University. Dr Douros is supported by a Junior 1 salary support award from the FRQS.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study protocol was registered in the Open Science Framework platform (10.17605/OSF.IO/EPV6T).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/echo.15583",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/echo.15695",TRUE,"<section> CONFLICT OF INTEREST STATEMENT All the authors have no conflicts of interest to disclose.",TRUE,"<section> ACKNOWLEDGMENTS This study was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/eci.13961",TRUE,"<section> CONFLICT OF INTEREST STATEMENT V.",TRUE,"<section> FUNDING INFORMATION This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/eip.13423",TRUE,"Rimvall has no conflicts of interest to declare. Dr. Ditte Vassard has no conflicts of interest to declare. Professor Robin Christensen reports that the Parker Institute Bispebjerg and Frederiksberg <section> Hospital is supported by a core grant from the Oak Foundation (OCAY-18-774-OFIL). Dr. Sabrina M. Nielsen has no conflicts of interest to declare.",TRUE,"<section> Funding information Lundbeckfonden; TrygFonden <section> FUNDING INF ORMATI ON The Mind My Mind project was initiated by Psykiatrifonden and sponsored through unrestricted grants from the Danish TrygFonden and the Lundbeckfonden. <section> Hospital is supported by a core grant from the Oak Foundation (OCAY-18-774-OFIL). Professor Anne Katrine Pagsberg received grants from TrygFonden Novo Nordisk fonden Helsefonden and Læge SCE Friis og hustru OD Friis' Legat. He has received grant support from Janssen and Takeda. Professor Pia Jeppesen received grants from the TrygFonden and Lundbeckfonden.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The MMM study was a pragmatic openstudies of adults label analyst-masked parallel 2-arm randomized clinical superiority PEs predicted nontrial of MMM vs MAU for help-seeking children and adolescents with (Perlis et al. 2011) a primary ‘top’ problem within the domains of anxiety depression and findings from a nonbehavioural problems (Clinical Trials identifier NCT03535805).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/ejn.15901",TRUE,"<section> CONFLICT OF INTEREST NS JRM SK AR JH HP and CF have no competing interests.",TRUE,"<section> Funding information litis is characterized <section> ACK NO WLE DGE MEN TS This study was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation grant numbers 327654276 [SFB 1315] FI 2309/1-1 FI 2309/2-1 and PR 1274/6-1) and Deutsches Ministerium für Bildung und Forschung (BMBF German Ministry of Education and Research grant number 01GM1908D CONNECTGENERATE). HP received funding from the Helmholtz Association (HIL-A03).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ejn.15916",TRUE,"The authors have declared that there are no conflicts of interest in relation to the subject of this study.",TRUE,"<section> Funding information This work was supported by the Rubicon directionality is mixed award granted to ZS by the Netherlands MRI (fMRI) in a withinsubjects Organization for Scientific Research",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ejn.16161",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Kudielka: Funding acquisition; resources; writing—review and editing. This study was further supported by German Research Foundation Grants No.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ene.15672",TRUE,"None of the other authors has any conflict of interest to disclose.",TRUE,"N.S. has received funding from the American Academy of Neurology American Brain Foundation Tourette Association of America Medical University of Warsaw and Polish Ministry of Health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.15681",TRUE,"All remaining authors declare no conflicts of interest.",TRUE,"<section> Funding information B.H. received funding from the German Research Foundation under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy; 390857198) and the European Union's Horizon 2020 Research and Innovation Program (grant MultipleMS EU RIA 733161). K.R. has received research support from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283-­2) Stiftung Charité and Arthur Arnstein Foundation and travel grants from Guthy Jackson Charitable Foundation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.15730",FALSE,"",TRUE,"<section> Funding information German Research Foundation Grant/ <section> F U N D I N G I N FO R M AT I O N This research was supported by the German Research Foundation (and Collaborative Research Centre TR-­128 to Catharina C. His research is funded by the German Ministry for Education and Research (BMBF) Deutsche Forschungsgesellschaft (DFG) Deutsche Myasthenie Gesellschaft e.V. Alexion Amicus Therapeutics Inc. Argenx Biogen CSL Behring F.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.15733",TRUE,"The other authors declare no commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding information <section> F U N D I N G I N FO R M AT I O N This study was funded by the Michael J.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study protocol was registered on ClinicalTrials.gov (NCT03043768) and was published prior to commencement elsewhere [17].",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/ene.15760",FALSE,"",TRUE,"<section> Penzkofer: Funding acquisition; resources; software; project administration; writing -­ review and editing; supervision; formal analysis. Tobias Penzkofer was supported by the Berlin Institute of Health (Clinician Scientist Grant Platform Grant) Ministry of Education and Research (BMBF 01KX2021 68GX21001A) and DFG (SFB 1340/2) Horizon 2020 (952172). <section> F U N D I N G I N FO R M AT I O N The authors declare that no funds or other support were received during the preparation of this manuscript.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/ene.15773",TRUE,"The other authors declare no conflicts of interest.",TRUE,"<section> Funding information Boris Canessa ALS Stiftung <section> F U N D I N G I N FO R M AT I O N This work was supported by the Boris Canessa ALS Stiftung. AH has received funding from the European Social Funds the Federal Ministry of Education and Research and the Hermann und Lilly Schilling-­Stiftung für medizinische Forschung im Stifterverband.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.15991",FALSE,"",TRUE,"The authors report no targeted funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.16053",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.16092",TRUE,"Gandini Wheeler-­ Kingshott declare competing interests as share-­h olders in Queen Square Analytics LTD.",TRUE,"<section> Funding information sions developing into SELs European Committee for Treatment Kanber are supported by the National Institute for Health and Research (NIHR) Biomedical Research Centre (BRC) initiative at University College London Hospitals (UCLH). C. Gandini Wheeler-­K ingshott has received funding from the MS Society (#77) Wings for Life (#169111) Horizon2020 (Human Brain Project SGA3 Specific Grant Agreement No.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ene.16160",TRUE,"<section> C O N F L I C T O F I N T E R E S T S TAT E M E N T JID TH LG and MIF declare no conflicts of interest with respect to the research authorship and/or publication of this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/epi.17499",TRUE,"<section> CONFLICT OF INTEREST M.H. reports personal fees as speaker and consultant within the past 3 years from Angelini/Arvelle Bial Desitin Eisai GW Pharma Neuraxpharm UCB and Zogenix outside the submitted work. None of the other authors has any conflict of interest to disclose.",TRUE,"<section> Funding information (odds ratio [OR] = .38 Epilepsy Academy Berlin–­Bethel of the five relevant predictors odds were found for Bien: Funding acquisition; resources; supervision; writing –­ review and editing. <section> Martin Holtkamp: Funding acquisition; resources; supervision; writing –­ review and editing. This study was supported by a grant from the Epilepsy Academy Berlin–­Bethel to L.H.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/epi.17542",TRUE,"<section> CONFLICT OF INTEREST STATEMENT IES has served on scientific advisory boards for BioMarin Chiesi Eisai Encoded Therapeutics GlaxoSmithKline Knopp Biosciences Nutricia Rogcon Takeda Pharmaceuticals UCB and Xenon Pharmaceuticals; has received speaker honoraria from GlaxoSmithKline UCB BioMarin Biocodex Chiesi LivaNova and Eisai; has received funding for travel from UCB Biocodex GlaxoSmithKline BioMarin and Eisai; has served as an investigator for Anavex Life Sciences Cerecin Cerevel Therapeutics Eisai Encoded Therapeutics EpiMinder Epygenyx ES-­Therapeutics GW Pharmaceuticals Marinus Neuren Pharmaceuticals Neurocrine BioSciences Ovid Therapeutics Takeda Pharmaceuticals UCB Ultragenyx Xenon Pharmaceuticals Zogenix and Zynerba; has consulted for Atheneum Partners Care Beyond Diagnosis Epilepsy Consortium Ovid Therapeutics UCB and Zynerba Pharmaceuticals; and is a nonexecutive director of Bellberry and a director of the Australian Academy of Health and Medical Sciences and the Australian Council of Learned Academies Limited. She may accrue future revenue on pending patent WO61/010176 (filed 2008): Therapeutic Compound; has a patent for SCN1A testing held by Bionomics and licensed to various diagnostic companies; and has a patent molecular diagnostic/theranostic target for benign familial infantile epilepsy (PRRT2) 2011904493 & 2 012 900 190 and PCT/AU2012/001321 (TECH ID: 2012–­009). The remaining authors have no conflicts of interest.",TRUE,"<section> Funding <section> FUNDING INFORMATION The authors gratefully acknowledge support provided by the Australian National Health and Medical Research Council (NHMRC) Centre for Research Excellence Grant (GNT2006841) and NHMRC Synergy Grant (GNT2010562). I.E.S. is also supported by an NHMRC Senior Investigator Fellowship (GNT1172897) and M.B. by an Investigator Grant (1195236). K.L.O. is supported by the Australian Commonwealth Government and the University of Melbourne Australian Government Research Training Program Scholarship (APP533086). This work was also supported by the Deutsche Forschungsgemeinschaft (CRC1315 and FOR3004 to A.M.K.) the Günter Endres Fond via the Einstein Stiftung (A.M.K. and I.E.S.) the Victorian Government's Operational Infrastructure Support Program the NHMRC Independent Research Institute Infrastructure Support Scheme and the Australian Epilepsy Research Foundation grant with further funding from Fonds de Recherche du Québec–­Santé (282 228 295 639; K.A.M.).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/epi.17586",FALSE,"",TRUE,"<section> Funding information SWAS associated with Deutsche Forschungsgemeinschaft missense variants. Our research is supported by the German Research Foundation (SFB1315 FOR3004) and the Einstein Foundation. FUNDING INFORMATION Our research is supported by the German Research Foundation (SFB1315 FOR3004) and the Einstein Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/epi.17624",TRUE,"<section> CONFLICT OF INTEREST STATEMENT L.H. J.B. and S.-­U.K. have no conflicts of interest.",TRUE,"This study was supported by a grant from the Epilepsy Academy Berlin–­Bethel to L.H.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/epi.17666",TRUE,"<section> CONFLICT OF INTEREST STATEMENT R.M.R. has served as a consultant for NeuroPace. The remaining authors have no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/epi.17809",TRUE,"<section> CONFLICT OF INTEREST STATEMENT M.H. reports personal fees as speaker and consultant from Angelini/Arvelle Bial Desitin Eisai GW Pharma Neuraxpharm UCB and Zogenix outside the submitted work. C.D.B. has received consulting fees and honoraria from GW Pharmaceuticals UCB Pharma Eisai Angelini Pharma and Bial outside the submitted work. C.P.B. has received honoraria from UCB Eisai and Arvelle outside the submitted work. All other authors did not report possible conflicts of interest relevant to this work.",TRUE,"<section> Funding information with 59 (93.7%) of them German Research Foundation; German tinuation. <section> FUNDING INFORMATION B.J.V. received funding from the German Research Foundation and the German Society of Epileptology not related to this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/exd.14802",TRUE,"The authors have declared no conflicts of interest for the present work.",TRUE,"<section> Funding information Volkswagen Foundation",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/exd.14895",TRUE,"The authors have no conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/exd.14902",TRUE,"The authors state that they have no conflict of interest.",TRUE,"<section> Funding information Bundesministerium für Bildung und <section> AC K N OW L E D G E M E N T S This work was supported by the German Federal Ministry of Education and Research (BMBF) within the projects ‘VIMRE’ (grant number: 03ZZ0146B) and ‘CORSA’ (grant number: 03COV10C).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/fare.12847",FALSE,"",TRUE,"<section> Funding information toparent warmth and This University study was Research supported Profile by “Health the Leiden We thank Marinus van externalizing problems IJzendoorn for his substantial contribution to toward their father and the study and his financial support.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/head.14439",FALSE,"",TRUE,"<section> Funding information (n = 364/543) of participants AbbVie <section> F U N D I N G I N FO R M AT I O N This study was sponsored by Allergan (prior to its acquisition by AbbVie). AMB is a consultant for AbbVie Alder Allergan Amgen Biohaven Lilly Lundbeck Novartis Teva and Theranica and has received grant support from Allergan and Amgen.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/head.14536",FALSE,"",TRUE,"<section> Funding information cation overuse subgroup Amgen <section> F U N D I N G I N FO R M AT I O N The study was funded by Amgen Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/hepr.13952",FALSE,"",TRUE,"<section> Funding information gression of HBV infection Gilead Sciences European population. This study was supported by a research grant of GILEAD Sciences",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/hex.13760",TRUE,"<section> CONFLIC T OF INTEREST STATEM ENT Martin Inderbitzin is the founder of the My Survival Story Foundation. The remaining authors declare no conflict of interest.",TRUE,"<section> Funding information The project was funded by the Participatory Science Academy of the University of Zurich and ETH Zurich (Funding‐ID: PWA 01/2019) and by the Swiss Cancer Foundation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/hiv.13482",TRUE,"The authors declare that they have no competing interests with the specific matter of the manuscript.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/hiv.13583",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ics.12835",TRUE,"<section> CONFLICT OF INTEREST ESJ DWC JRS JPH TLC ALT are employees of The Procter & Gamble Company which paid 100% of the costs of this work.",TRUE,"<section> Funding information efficiency of the scalp Procter and Gamble should result in increased <section> ACKNOWLEDGEMENT This study was funded by The Procter and Gamble Company.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ics.12844",TRUE,"The authors have no conflict of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/idh.12734",TRUE,"The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The review protocol was registered in the PROSPERO international prospective register of systematic reviews hosted by the National Institutefor Health Research (NIHR) University of York Center for Reviews and Dissemination (CRD42021236027).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/iej.13972",TRUE,"The authors have stated unequivocally that there are no conflicts of interests in connection with this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/ijfs.16491",TRUE,"Conflicts of interest The authors declare that they have no conﬂict of interest.",TRUE,"A. Raysyan is grateful for support from BAM’s MI program (BAM/BMWi Grant No. Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE
"10.1111/irv.13147",TRUE,"The authors report there are no competing interests to declare.",TRUE,"<section> Funding information 72 PCR-positive SARS-CoV-2 World Health Organization were classified as Delta",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered in the clinicaltrails.gov registry (NCT050694).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/iwj.13875",TRUE,"The authors declare no potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jcmm.17712",TRUE,"<section> C O N F L I C T O F I N T E R E S T S TAT E M E N T None of the authors have conflicts of interest directly related to this work.",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft tients are steroid-­refractory.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jcpe.13824",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> FUNDING INF ORMATI ON This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft: 468857272 34425848).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jcpe.13838",TRUE,"The authors declare that they have no conflict of interest.",TRUE,"<section> Funding information ARPA Research Foundation; Deutsche <section> FUNDING INF ORMATI ON This study was exclusively supported by a grant from the German",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jcpe.13905",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> FUNDING INF ORMATI ON The study was selffunded by the Department of Oral Surgery University Hospital Düsseldorf (Düsseldorf Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jcpe.13922",FALSE,"",TRUE,"<section> Funding information German Ministry of Education and Research through the POPGEN biobank project Grant/Award Number: 01GR0468; German <section> FUND ING INFORMATION This work was supported by the research grant RI 2827/2-1 of the German Research Foundation DFG. Silvia Diz de Almeida was supported by a Xunta de Galicia predoctoral fellowship.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jcpp.13793",TRUE,"The remaining authors have declared that they have no competing or potential conflicts of interest.",TRUE,"Acknowledgements T.N. received funding from the Cambridge Trust (University of Cambridge). This work received support from the following sources: the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated behavior in normal brain function and psychopathology) (LSHM-CT-2007-037286) the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain networkbased stratification of reinforcementrelated disorders) (695313) Human Brain Project (HBP SGA 2 785907 and HBP SGA 3 945539) the Medical Research Council Grant ‘cVEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1) the National Institute of Health (NIH) (R01DA049238 a decentralized macro and micro geneby-environment interaction analysis of substance use behavior and its brain biomarkers) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministeriumf€ ur Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B) the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 SFB 940 TRR 265 NE 1383/14-1) the Medical Research Foundation and published by John Wiley & Sons Ltd on behalf of Association for <section> WM2NA; and ANR-18-NEUR00002-01 – ADORe) the Fondation de France (00081242) the Fondation pour la Recherche M\u0003 edicale (DPA20140629802) the Mission Interminist\u0003 erielle de Luttecontre-les-Droguesetles-Conduites-Addictives (MILDECA) the AssistancePublique-H^ opitauxde-Paris and INSERM (interface grant) Paris Sud University IDEX 2012 the Fondation de l’Avenir (grant AP-RM-17-013) the F\u0003 ed\u0003 eration pour la Recherche sur le Cerveau the National Institutes of Health Science Foundation Ireland (16/ERCD/3797) USA (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and the NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. <section> Funding <section> T.N. received funding from the Cambridge Trust (University of Cambridge).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jcpp.13853",TRUE,"Conflict of interest statement: No conflicts declared. The authors have declared that they have no competing or potential conflicts of interest.",TRUE,"Acknowledgements Funded by BMBF 01GL1743A and B to C.H. Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE
"10.1111/jdv.18848",FALSE,"",TRUE,"<section> Funding information <section> Funding <section> Funding <section> F U N DI N G I N F OR M AT ION MP's work was partly financed by Deutsche Stiftung Kinderdermatologie.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jdv.18921",TRUE,"The other authors have no conflicts of interest to declare.",TRUE,"<section> Funding information lecular genetic levels. <section> F U N DI N G I N F OR M AT ION This work was supported by the German Federal Ministry of Education and Research through grants 01EW1904 EMBED (to MR) Integrament 01ZX1314A & 01ZX1614A (to MMN) Integrament 01ZX1314G & 01ZX1614G (to MR) Target-­ OXY 031L0190A (to JCF) and Moods 01GS08147 (to MR). Funding from the United States National Institutes of Health include d K01AR075111 (to LP) and P50AR070588 (to AMC).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19134",FALSE,"",TRUE,"<section> Funding information lymphoma (CTCL): Sézary <section> F U N DI N G I N F OR M AT ION This work was supported by Kyowa Kirin Pharma.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19236",FALSE,"",TRUE,"<section> Funding information indicating early treatment <section> F U N DI N G I N F OR M AT ION This study was sponsored by Janssen-­ Cilag GmbH (Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19296",FALSE,"",TRUE,"<section> Funding information <section> AC K N OW L ED G EM E N T S This study was sponsored by Janssen-­ Cilag GmbH (Germany). <section> F U N DI N G I N F OR M AT ION This study was funded by Janssen-­Cilag GmbH (Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19381",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19456",TRUE,"Schnabl declared no conflicts of interest.",TRUE,"<section> AC K N OW L ED G EM E N T S We would like to thank the oncology and dermatosurgery team of the Department of Dermatology University Medical Centre Tuebingen for their collegial support of this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19485",TRUE,"<section> C ON F L IC T OF I N T E R E S T S TAT E M E N T SMR TO KW MMe and JS have no conflicts of interest.",TRUE,"PK and SMR were supported by a GA LEN fellowship.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19637",TRUE,"Other authors have no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jdv.19694",TRUE,"<section> C ON F L IC T OF I N T E R E S T S TAT E M E N T All authors have no conflict of interest to declare in relation to this work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jdv.19745",FALSE,"",TRUE,"<section> Funding information <section> F U N DI N G I N F OR M AT ION This work as well as medical writing support was funded by Galderma SA Lausanne Switzerland.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jerd.13132",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information (237.3 ± 31.6 MPa and Javna Agencija za Raziskovalno Dejavnost RS Grant/Award Numbers: P2-0087 J3-6064 and 73.5 ± 9.9 MPa) 3D group exhibited higher relative strength as possible fracture origins. <section> Elisabeth Prause and Tine Malgaj contributed equally to this work and should be considered cofirst This work was supported by the Slovenian Research Agency funding through the research project manufacturing technologies (J3-6064) and the research program Ceramics and complementary This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs medium provided the original work is properly cited the use is noncommercial and <section> FUNDING INF ORMATI ON The authors do not have any financial interest in the companies whose materials are included in this article.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jhn.13138",TRUE,"<section> CONFLI CT OF I NTE RES T STAT EME NT The authors declare no conﬂict of interest.",TRUE,"<section> Funding information <section> This study was supported by the Comité Nacional para el Desarrollo de la Investigación (CONADI) of Universidad Cooperativa de Colombia.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jhn.13221",TRUE,"<section> CONF LICT OF INTEREST ST ATE MENT The authors declare no conﬂict of interest.",TRUE,"<section> Funding information Nederlandse Organisatie voor protocol.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jir.13080",FALSE,"",TRUE,"<section> We would furthermore like to thank the clinicians and care organisations for supporting the study. <section> Source of funding <section> There was no funding source for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jir.13081",FALSE,"",TRUE,"We would furthermore thank the clinicians and care organisations for supporting the study. <section> Source of funding <section> There was no funding source for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jnc.15842",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information are cleared through the <section> AC K N OW L E D G M E N T S This work was supported by the European Commission funding initiative ERA-­NET NEURON “Novel Methods and Approaches towards the Understanding of Brain Diseases ABETA ID” grant no. <section> 01W1301 funded by the German Federal Ministry for Education and Research (BMBF) and the Collaborative Research Grant in the framework of the Berlin Institute of Health (BIH) “Elucidating the Proteostasis Network to Control Alzheimer's Disease” grant no. <section> 1.1.2.a.3 funded by the German Federal Ministry for Education and Research (BMBF) to E.E.W.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jne.13276",TRUE,"The authors declare that they have no conflict of interest.",TRUE,"<section> Funding information <section> FUND ING INFORMATION The study was supported by the Deutsche Forschungsgemeinschaft",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jne.13311",FALSE,"",TRUE,"She is coordinating investigator of EORTC trial 1203 which is supported by an educational grant from Roche to",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jnp.12305",TRUE,"<section> CONFLICT OF INTEREST All authors declare no conflict of interest.",TRUE,"<section> Peter Vajkoczy: Funding acquisition; writing – review and editing. <section> ACKNOWLEDGEMENTS Effrosyni Ntemou is supported by an IDEALAB PhD scholarship (https://phdidealab.com/). Katharina Faust is supported by the BIH clinical fellowship funded by Stiftung Charité.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jog.15577",TRUE,"The authors have no conflicts of interest to declare.",TRUE,"<section> Funding information Guangdong Basic and Applied Basic Research <section> A CK NO W L E D G M E N T S The work was partly supported by Guangdong Basic and Applied Basic Research Foundation (2019A1515012091).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/joim.13678",TRUE,"Conflict of interest statement",TRUE,"<section> Funding information <section> FPC has received honoraria for lectures in symposia and educational activities supported by unrestricted grants from Deloitte Menarini Omron Academy and Omron Healthcare. <section> AC has received honoraria for lectures in symposia and educational activities sponsored by unrestricted grants from Abbot Berlin-Chemie Biolab Ferrer Gedeon-Richter Menarini Merck Serono and Sanofi-Aventis.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/joim.13709",TRUE,"Conflict of interest statement The remaining coauthors do not declare any conflicts of interest with respect to this work.",TRUE,"This national multidisciplinary collaboration is supported by oncologists molecular biologists bioinformaticians pathologists and clinical geneticists from eight centers across Denmark covering 5.7 million inhabitants. AvD holds patents on DNA-methylation based methods for classifying tumor species (EP16710700 and EP15158660) and is supported by an Illumina research grant. Funding: C.A.P. is supported by the ELBA project and has received funding from the European Union Horizon 2020 Research and Innovation program under the Marie Skłodowska-Curie grant agreement No 765492 by the National Institute of Cancer (INCa http://www.ecancer.fr) SIRIC Montpellier Cancer Grant INCa_Inserm_DGOS_12553 the ERA-NET TRANSCAN 2 JTC 2016 PROLIPSY la Fondation ARC pour la Recherche sur le cancer and les Fonds de dotation AFER pour la recherche médicale.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jon.13081",TRUE,"<section> ACKNOWLEDGEMENTS AND DISCLOSURES Many thanks again to our team of pediatric physiotherapists (Jutta Tolks Martina Müller-Allissat and Patricia Poepperl) for the help and performance of physical examinations. Same to the Division of Pediatric Neurology and the Center for Neuromuscular Diseases at the University Hospital Erlangen and the children and parents who participated in this study. Part of the results were published beforehand by Regensburger et al. <section> APR MJW and FK are listed as co-inventors together with iThera Medical GmbH Germany on an EU patent application (EP 19 304.9) and an U.S. patent application (patent number pending) relating to a device and a method for analyzing optoacoustic data an optoacoustic system and a computer program. Travel support by iThera Medical GmbH was given to APR MJW and FK. Sanofi Genzyme sponsored lectures by APR and travel support by FK APR and ALW. <section> Siemens Healthcare GmbH sponsored lectures by FK. VD JJ SS AB DK AF AR HL MFN JW RT and ALW declare no competing interests.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered at clinicaltrials.gov: national clinireflected-ultrasound cal trial number 04115475.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/jon.13137",TRUE,"<section> CONFLICT OF INTEREST STATEMENT E.C.C. has received reimbursement for developing educational presentations educational and research grants consultation fees and/or travel stipends from Biogen Bayer Genzyme Merck Novartis Roche Raffo Teva LACTRIMS Harvard Medical School (Postgraduate Medical Education) and the Guthy Jackson Charitable Foundation.",TRUE,"<section> Funding information",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/joor.13411",TRUE,"The authors declare they do not have any conflicts of interest.",TRUE,"Open Access Funding provided by Universita degli Studi di Siena within the CRUI-­C ARE Agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/joss.12859",FALSE,"",TRUE,"<section> Funding information This work was supported by the National Natural Science Foundation of China (grant number: 31700963). This work was supported by the National Natural Science Foundation of China (grant number: 31700963).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jpc.16309",TRUE,"<section> Conﬂict of interest: None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jpi.12867",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jsr.13884",TRUE,"The authors declare no competing interests directly related to this work.",TRUE,"<section> Funding information MRI scans in the SHIP and SHIPTrend have been supported by a joint grant from Siemens Healthineers Erlangen Germany and the Federal State of Mecklenburg-West Pomerania. This study was further supported by European Union Joint Programme-Neurodegenerative Disease Research funding for BRID- This work specifically was supported by the Deutsche Forschungsgemeinschaft (DFG grant number: GR 1912/13-1). Thomopoulos are funded partly by the US National Institutes of Health under grants R01MH116147 R01MH129742 P41EB015922 and R01MH121246.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jsr.13981",TRUE,"The authors have no conflict of interest to declare.",TRUE,"<section> Funding information support the hypothesis Deutsche Forschungsgemeinschaft Grant/Award Numbers: 327654276 SFB considered when aiming 1315 B03 to AF and KO <section> AC KNOW LEDG EME NT S This work was supported by the Deutsche Forschungsgemeinschaft",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/jsr.14018",TRUE,"<section> CONFLIC T OF INTER E ST STATEMENT No conflict of interest was identified by the authors.",TRUE,"<section> FUNDING INF ORMATI ON The authors did not receive financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This systematic review and meta-analysis (registered in PROSPERO ID: CRD42022298978) was planned and conducted in accordance with the recommendations of the Cochrane Collaboration (Higgins & Green 2008) and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/jsr.14019",TRUE,"The authors declare that they have no conflict of interest.",TRUE,"<section> Funding information not in men. <section> FUNDING INF ORMATI ON The SHIP is part of the Community Medicine Research Net of the University Medicine Greifswald Germany which is supported by the Federal State of Mecklenburg-West Pomerania.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jsr.14020",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information <section> FUNDING INF ORMATI ON This work was funded by National and Guangzhou Key Clinical Specialty (2021–2024) National Youth Foundation of China (grant number 81900927) National Youth Foundation of China (82301290) and American Heart Association (20CDA35310360).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/jsr.14125",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information French National Research Agency the patient the bed Grant/Award Number: ANR-15-IDEX-02 obtain a Europeanwide tinuous positive airway and intimacy. <section> There was no specific funding for the project; however coauthor SB was supported by the French National Research Agency in the framework of the Investissements d'Avenir program (Grant ANR-15-IDEX02) and the e-Health and Integrated Care and Trajectories Medicine and MIAI Artificial Intelligence chairs of excellence from the Grenoble",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/liv.15517",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information German Federal Ministry of Health E virus genome but the (BMG) Grant/Award Number: ZMVI1-­ <section> F U N D I N G I N FO R M AT I O N This research was funded by grants from the German Federal Ministry of Health (BMG) with regard to a decision of the German Bundestag by the Federal Government (CHED-­project grant No: ZMVI1-­ 2518FSB705). D.T. was supported by a grant from the German Research Association DFG (Project number 448974291) and by the German Federal Ministry of Education and Research (BMBF) [project: VirBio grant number: 01KI2106]. <section> is supported by ProFIT grant of the Investitionsbank Berlin Germany (IBB ProFIT No. 10169028 co-­funded by EFRE no. 10169096).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/liv.15563",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/liv.15644",FALSE,"",TRUE,"<section> Funding information decompensated cirrhosis Berlin Institute of Health; Else Kröner-­ <section> AC K N OW L E D G E M E N T S IWZ is supported by the BIH Clinician Scientist Program.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/liv.15688",FALSE,"",TRUE,"<section> Funding information <section> F U N D I N G I N FO R M AT I O N This study was financially supported by CSL Behring Hattersheim Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/liv.15701",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/liv.15815",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/mcn.13505",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding information Alexander von Humboldt Research regression models with Fellowship Grant/Award Number: precision. <section> The content of this publication is solely the responsibility of the authors and does not necessarily reflect the policies or views of the organizations with which they are affiliated or the funding agencies. <section> Funding organizations did not have a role in the study design hiring or training of staff intervention delivery data collection analysis or data interpretation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/mec.16983",TRUE,"The authors declare no conflict of interests.",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft had a lower body condition. <section> F U N D I N G I N FO R M AT I O N The research was funded by the German Research Foundation (DFG SO 428/17-­1 with samples and metadata obtained by DR 772/3-­1 and 7-­1 KA1241/18-­1 TH 1420/1-­1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nan.12866",FALSE,"",TRUE,"<section> Funding information This study was supported by a DKTK partner site Berlin Young Investigator grant to LS. PS and RS were supported by the German Federal Ministry for Education and Research as Patho234 (ref.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nan.12877",TRUE,"The authors declare that there is no conflict of interest.",TRUE,"<section> Funding information Deutsche Forschungsgemeinschaft; Deutsche proteolysis Gesellschaft für Muskelkranke; European Regional Development Fund; French Muscular Dystrophy Association; Ministerium für Innovation Wissenschaft und Forschung des <section> AC KNOW LEDG EME NT S This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to R. Parts of the study were financed by the European Regional Development Fund (ERDF) (NMD-",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nin.12562",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nup.12447",TRUE,"Ethics need to start from illegibility of human and algorithmic selves and rely on inquiring into the conditions of emergence instead of transparent disclosure: ‘Though the mathematical propositions of algorithms cannot be made fully legible or rendered accountable they can be called to give accounts of the conditions of their emergence. <section> CO NFL I CT OF INTERES T S T ATEME NT The authors declare no conflicts of interest.",TRUE,"Funding for clinical trials is complex (since it entails multiple stakeholders with competing priorities) and pharmaceutical companies themselves are significant contributors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nup.12452",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nyas.15014",TRUE,"The authors declare no competing interests.",TRUE,"<section> Funding information on CLDN16 and CLDN10 Novo Nordisk Foundation; Fondation pour la membrane domains of Recherche Médicale Grant/Award Number: FRM FDT201904007918; Agence Nationale TALs in the outer stripe de la Recherche Grant/Award Number: Furthermore in TALs ANR-17-CE14-0032; Independent Research <section> This work was supported by grants from Agence Nationale de la Recherche (ANR-17-CE14-0032 awarded to P.H.) Filières Maladies Rares OSCAR and ORKID (awarded to C.P.-B.) and the Independent Research Fund Denmark and Novo Nordisk Foundation (awarded to H.D.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/nyas.15072",TRUE,"The authors declare no competing interests.",TRUE,"<section> Funding information Max-Planck-Gesellschaft <section> ACKNOWLEDGMENTS This research was supported by the Max Planck Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/obr.13612",FALSE,"",TRUE,"<section> Funding information Bundesministerium für Bildung und Forschung Grant/Award Number: Deutsches Zentrum für Diabetesforschung (DZD e.V.) <section> ACKNOWLEDG MENTS The current study was funded by transCampus Dresden – King's College London Science to Business Initiative funded from Deutsche Forschungsgemeinschaft (DFG) [C6] and by Bundesministerium für Bildung und Forschung (BMBF) – Deutsches Zentrum für Diabetesforschung (DZD e.V.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/odi.14659",TRUE,"<section> C O N FL I C T O F I N T E R E S T S TAT E M E N T All authors have no conflicts of interest to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study protocol was registered on the international prospective register of systematic reviews (PROSPERO) platform under the registration number CRD42023410147.",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/odi.14816",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/pai.13854",TRUE,"Conflict of Interest –­ MAUG 2.0",TRUE,"<section> A.F.S. is Chair of the EAACI interest group Food Allergy and has received grants from MRC UK NIH USA FARE USA; Asthma UK Rosetrees Trust Wellcome Trust and BBSRC; reports consulting fees from IgGenix Novartis Allergy Therapeutics; and Stallergenes; Speaker's honoraria from Novartis ThermoFisher Nutricia Buhlmann and Nestle and is in the advisory board from <section> N.A. received grant support from the Ministry of Science of the Republic of Colombia (Grants 756-­2017 806-­2018) and reports speaker's honorarium from Sanofi at scientific events; <section> S.B. received grants from Thermo Fisher Sci. Bencard Allergie GmbH Allergy Therapeutics plc and Leti Pharma; consulting fees from Bencard Allergie GmbH and speaker honoraria from DGAKI Bencard; Allergie GmbH and Thermo Fisher Sci. H. is supported by the Johns Hopkins University School of Medicine faculty Scholarship; <section> T.Ho. is advisory board member from Deutscher Allergie-­ und Asthmabund eV DAAB; German Federal Office of Consumer Protection and Food Safety; Senate Commission on Food Safety of the German Research Foundation DFG-­SKLM; International Life Sciences Institute ILSI Europe; received grants from European Dir. for the Quality of Medicines and Health Care; EU-­COST Action ImpARAS; German Federal Ministry of Food and Agriculture; and <section> T.J. is board member of the German Society of Allergy and Clinical Immunology; he has received grants from: ALK Abello Novartis; speaker's honoraria from ALK Abello Novartis Thermo Fisher Sci. and Allergy Therapeutics/Bencard; he is in the advisory board from ALK Abello Novartis and Bencard; <section> A. N-­W. is committee member of IFPIES Annals of Allergy Asthma and Immunology and American Board of Allergy and Immunology; received grant support from DBV Technologies Regeneron Alladapt; and consulting fees from Aquestive; speaker's honoraria from Nestle Danone and ThermoFisher Sci; <section> S.P. received grants from National Institutes of Health NIAID; Food Allergy Science Initiative; and filing of patent: Monoclonal an- <section> R.vR. board member of HESI Protein Allergenicity and Toxins Bioinformatics Committee; holds stock options for Anagany Inc; received grants from Dutch Science Foundation; Health Holland; Angany Inc.; consulting fees from HAL Allergy BV; Citeq Inc. Anagany Inc. Reacta Healthcare Ltd Mission MightyMe and AB Enzymes; speaker's honoraria from ThermoFisher Sci.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/pai.13900",TRUE,"<section> C O N FL I C T O F I N T E R E S T WF MON EPB MB AS CBR PAE TE AE SE CGC AF JJ RJS TK IKK CGM CR JS ZS EU GTS have no specific conflict of interest to report.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pai.13925",TRUE,"Other authors have no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pai.13966",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pai.13982",FALSE,"",TRUE,"<section> Funding information Novartis Pharma AG pediatric drug development. <section> F U N D I N G I N FO R M AT I O N This investigation was sponsored by Novartis Pharma AG Basel Switzerland. Montserrat Alvaro-­Lozano received research funding from the Spanish Pediatric Society of Clinical Immunology Allergy and Asthma (SEICAP) the Catalan Society of Allergy and Clinical Immunology (SCAIC); reports honoraria for consultancy and/or advisory board; and/or lectures from ALK-­Abello FAES Pharma LETI Pharma Merck Aimmune Allergy Therapeutics Stallergenes Diater Novartis Uriach Nestle DBV Technologies and Sanofi Genzyme.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/pai.14060",TRUE,"<section> C O N F L I C T O F I N T E R E S T S TAT E M E N T All authors declare no competing interests.",TRUE,"<section> F U N D I N G I N FO R M AT I O N This work was supported by grants from Mercator Foundation and EFRE grant for COVID.DataNet.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pan.14717",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/pan.14750",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/papt.12484",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Methods were developed according to a protocol available on PROSPERO (registration number CRD42019130678).",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1111/papt.12505",TRUE,"The authors attributed to this manuscript declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pcmr.13114",TRUE,"<section> C O N FL I C T O F I N T E R E S T S TAT E M E N T V.A A.A-­G G.M. and L.R. declares no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/pcmr.13121",TRUE,"The other authors declare they have no relevant conflicts of interest.",TRUE,"<section> Funding information National Institutes of Health K.N. N.G. and S.C.W. were supported by a MSTP grant from the National Institute of General Medical Sciences of the NIH under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-­Institutional MD-­PhD Program. K.N. was also supported by an F30 Award from the NCI/NIH under grant number 5F30CA236302 the Hambrick Medical Student Grant Targeting Melanoma & Skin Cancer Research from the American Skin Association and the Medical Student Research Grant from the Melanoma Research Foundation. J.W.F. and J.G.K. were supported in part by grant # UL1 TR001866 from the National Center for Advancing Translational Sciences National Institutes of Health and the Clinical and Translational Science Award program. This work was also funded by a grant from the Milstein Family.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/petr.14459",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/php.13851",TRUE,"<section> CONFLICT OF INTEREST STATEMENT On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> ACKNOWLEDGMENTS The work was supported by Deutsche Forschungsgemeinschaft grant LA 799/18-­1 to T.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/php.13866",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/psyp.14268",FALSE,"",TRUE,"<section> Funding information monly reported resting-­state H2020 European Research Council Grant/Award Number: 758985; <section> ACKNOWLEDGMENTS This work was supported by the Velux Stiftung Project No. 1126 and by the Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) Grant 100014_175875 awarded to NL. SH received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/sji.13272",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The authors have no relevant financial or non-­financial interests to disclose.",TRUE,"<section> Funding information German Research Foundation (MU <section> FUNDING INFORMATION The German Research Foundation (MU 4006/2-­1) supported this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/spc3.12735",TRUE,"Conflicts of Interest (CoI) statements has sparked a relevant discussion in quantitative research. Therefore as reflexivity continues to gain momentum in research there should be a more comprehensive consideration of what constitutes a positionality statement (vs. for example simply a conflict-of-interest statement). Does psychology have a conflict-of-interest problem?",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/srt.13307",FALSE,"",TRUE,"<section> FUNDING INFORMATION This study was sponsored by Courage + Khazaka.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/tid.14196",TRUE,"<section> CONFLICT OF INTEREST STATEMENT All authors declare no conflicts of interest related to the presented work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/tmi.13934",FALSE,"",TRUE,"<section> Funding information The German Federal Ministry of Education and lowest for soil (1.6%) Research Grant/Award Number: 01KA1774 (93.5%) in addition to sulbactam ciprofloxacin fied increasing age another fetching water current predictors of intestinal <section> FUNDING INFORMATION This study was funded by The German Federal Ministry of Education and Research (BMBF 01KA1774).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/tpj.16601",TRUE,"The authors declare no conflict of interest.",TRUE,"This work was supported by the DFG through STA653/14-1 to DS. MS and KZ acknowledge support by the DFG SPP1935 project number 273941853 and MS is supported by the DFG GRK1721 project number 178567888.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1111/wrr.13111",TRUE,"The authors declare no conflicts of interest.",TRUE,"<section> Funding information Ernst Wendt Family Foundation of the City of <section> AC KNOW LEDG EME NT S The study was financially supported with 35000 euros by the Ernst Wendt Family Foundation of the City of Cologne.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1111/wrr.13127",TRUE,"The authors report no conflict of interest.",TRUE,"<section> Funding information histological molecular Deutsche Forschungsgemeinschaft Research <section> FUNDING INF ORMATI ON The study was funded by the Deutsche Forschungsgemeinschaft",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.abq0651",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding: Chandran laboratory is supported by a Medical Research Council grant (MR/L016400/1) the Euan MacDonald Centre for Motor Neurone Disease Research the UK Dementia Research Institute (DRI) which receives its funding from UK DRI Ltd. funded by the MRC Alzheimer’s Society and Alzheimer’s Research UK and an MS Society Edinburgh Centre of Excellence award. J.P. is supported by a program grant from the UK DRI and by grants from the German Research Foundation (DFG SFB/TRR167 B07). A.R.M. was a Lady Edith Wolfson Clinical Fellow jointly funded by the Medical Research Council (MRC) and the Motor Neurone Disease Association (MR/R001162/1). The creation of an EGFP-C9orf72 tagged human iPSC line and patient blood– derived experiments were supported by a seedcorn grants to A.R.M. and P.B. respectively from The Chief Scientist Office and the RS Macdonald Charitable Trust via the Scottish Neurological Research Fund administered by University of St Andrews.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.abq3851",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by German Ministry of Education and Research (BMBF) grant 13GW0206D (S.K. and C.F.) Funding acquisition: D.D.G. and C.F.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.add0433",TRUE,"Competing interests: N.H. is a stockholder of Siemens Healthineers. F.B. receives unrestricted research grants from Siemens Healthineers and speakers bureau from Siemens Healthineers. The authors declare that they have no other competing interests.",TRUE,"We acknowledge support by the Open Access Publishing Fund of the University of Tübingen. <section> Funding: This study was funded by German Research Foundation grant 428224476/SPP2177 and a grant (01GI10925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The GNC is funded by the Federal Ministry of Education and Research (BMBF) (project funding reference numbers: 01ER1301A/B/C and 01ER1511D) federal states and the Helmholtz Association with additional financial support by the participating universities and the institutes of the Leibniz Association.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.ade2828",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by Swiss National Science Foundation (SNSF) NCCR RNA & Disease grant 141735 (to D.G.)",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.ade7804",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This study was supported by the Deutsche Forschungsgemeinschaft [the Transregio (TRR)–SFB 186 (project ID 278001972)] to S.J.S. and A.M.W. Funding acquisition: A.M.W. and S.J.S.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.ade9238",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by Cancer League Switzerland KLS-5143-08-2020 to B.W.S. Swiss National Science Foundation 3100-175558 to B.W.S. Childhood Research Foundation Switzerland to B.W.S. Children’s Research Center grant from the University Children’s Hospital Zurich 10788_E to S.G.D. California Institute for Regenerative Medicine grant RB5-07469 to H.M.B. Baxter Foundation to H.M.B. BD Biosciences Stem Cell grant to E.P. and Sarcoma Foundation of America grant to B.W.S. Funding acquisition: S.G.D. B.W.S. H.M.B. and E.P.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.adf4240",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by DFG Emmy-Noether grants KR 4062/4-1 and KR 4062/4-2 (J.K.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.adg3919",TRUE,"Competing interests: K.Rej.: Kite/Gilead: Research funding and travel support; The remaining authors declare that they have no competing interests. None of the mentioned conflicts of interest were related to financing of the content of this manuscript.",TRUE,"<section> Funding: K.Rej. received a fellowship from the School of Oncology of the German Cancer Consortium (DKTK) and was funded by the Else Kröner Forschungskolleg (EKFK) within the Munich Clinician Scientist Program (MCSP). This work was supported by a grant within the Gilead Research Scholar Program (to K.Rej. and M.S.) the Bruno & Helene Jöster Foundation (to K.R. M.S.) and by a Deutsche Forschungsgemeinschaft (DFG German Research Foundation) research grant provided within the Sonderforschungbereich SFB-TRR 338/1 2021 – 452881907 and DFG research grant 451580403 (to M.S.). The work was further supported by the Bavarian Elite Graduate Training Network (to M.S.) the Wilhelm-Sander Stiftung (to M.S. project no. 2018.087.1) the ElseKröner-Fresenius Stiftung (to M.S.) and the Bavarian Cancer Research Center (BZKF).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.adg4479",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was funded by the National Key R&D Program of China (2022YFA1302701) the National Natural Science Foundation of China (32030056 31671049 81771188 81901376 and 82271582) Tsinghua-Foshan Innovation Special Fund (TFISF-2022THFS6122) the King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) under Award (OSR-2020-CRG9-4352) the National Key New Drug Creation Program of China (2018ZX09711002-002-012) the Shanghai Municipal Science and Technology Major Project and the Science and Technology Commission of Shanghai Municipality (184319071000 and 19140903102) the Natural Science Foundation of Shanghai (22ZR1449300) the Program of Shanghai Academic/Technology Research Leader (22XD1402400) the Deutsche Forschungsgemeinschaft (DFG) (JE164/14-2 (FOR2625) and under Germany’s Excellence Strategy (EXC-20149-39068087) to TJJ the Italian Ministry of Health (RCR-2021-23671215 and RCR-2022-23682289) to MT and the Belgian Kids’ Fund for Pediatric Research to S.N.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.adg8495",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was funded by NIH NIBIB award number 5R01EB024591 (D.D.V. T.M.S. J.J.C. and R.W.) and MIT Amar G. S. Funding acquisition: J.J.C. R.W. D.D.V. and T.M.S.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.adh2560",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by the Max Planck Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciadv.adi2095",TRUE,"",TRUE,"<section> Funding: This work was supported by the Horizon 2020 ERC Consolidator grant “DeFiNER” (GA 64663); the ERC PoC “Inflacare” (GA 874456); the Horizon 2020 Marie Curie ITN “aDDRess” (GA A.A.-C. was supported by the ELIDEK Fellowship 6204.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciadv.adj2417",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by European Research Area Network Neuron Award (CIHR Award no. NDD 168164) (A.F.) Deutsche Forschungsgemeinschaft (DFG) (German Research Council) (DFG DR 323/10-2) (J.P.D.) BMBF Bundesministerium fuer Bildung und Forschung (Era-Net Neuron EBio2 with funds from BMBF 01EW2004) (J.P.D.) Neurosurgery Research Education Foundation and Academy of Neurological Surgeons Research Fellowship Grant (M.A.M. and A.F.) and Canadian Institute of Health Research Project Grant (grant number 488048) (M.A.M. G.V.H. D.B.C. and A.F.). Funding acquisition: M.A.M. J.H.M. G.V.H. D.B.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/science.abn6366",FALSE,"",TRUE,"<section> Funding: K.A.Z. was supported by the German Cardiac ical trials to further extend the current limited Society (research grant) and by TUM (stipend by PhD program in <section> and robust biomarker can identify cardiac paG.G.S. is supported by grants from the DZHK (German Centre for tients who are at risk for imminent pineal deCardiovascular Research) and the DFG (SFB-1470 – A02). <section> TU files (accession All Funding",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/science.abo3627",TRUE,"The other authors declare no competing interests.",TRUE,"<section> Funding: The Laboratory 74. N. Magusali et al. A genetic link between risk for Alzheimer’s for Mendelian Genomics and the GSP Coordinating Center funded by disease and severe COVID-19 outcomes via the OAS1 gene. the National Human Genome Research Institute (NHGRI) Brain 144 3727–3741 (2021). doi: 10.1093/brain/awab337; (UM1HG006504 and U24HG008956) the Yale High-Performance pmid: 34619763 Computing Center (S10OD018521) the Fisher Center for Alzheimer’s 77. We acknowledge support from the National Institute of Our studies are also funded by the Ministry of Phenotypes (dbGaP) accession number phs002245. This work was supported in part by Attribution 4.0 International (CC BY 4.0) license which permits <section> supported by fellowships from the European Academy of Dermatology Loubna Alavoine Sylvie Behillil Charles Burdet Alessandro Aiuti Ozge Metin Akcan Nihal Akcay Gulsum D.L. is supported by a fellowship from the FRM for medical Félix Djossou Mayka Mergeay-Fabre Aude Lucarelli Bousfiha Oksana Boyarchuk Petter Brodin Yenan residents and fellows. E.H. received funding from the Bank of Montreal Magalie Demar Léa Bruneau Patrick Gérardin Bryceson Giorgia Bucciol Valeria Calcaterra Giorgio Chair of Pediatric Immunology Foundation of CHU Sainte-Justine Adrien Maillot Christine Payet Bruno Laviolle Fabrice Laine Casari Andre Cavalcanti Jale Bengi Celik George P. Q.P.-H. received funding from the European Denis Malvy Duc Nguyen Thierry Pistone Pauline Perreau Francesca Conti Megan Cooper Taner Coskuner Cyril Union’s Horizon 2020 research and innovation program (ATAC Valérie Gissot Carole Le Goas Samatha Montagne Cyrus Enza D’Auria Selket Delafontaine Beth A. Work in the Laboratory of Virology and Maxime Desmarets Alexandre Meunier Benjamin Lefèvre Elnagdy Melike Emiroglu Emine Hafize Erdeniz Infectious Disease was supported by NIH grants P01AI138398-S1 Hélène Jeulin Karine Legrand",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/science.abo7201",TRUE,"Disclosures for each author are listed individually in the consortium spreadsheet (data S7). The authors declare no additional competing interests.",TRUE,"This work is funded by a $10 million award from the Wellcome Trust through the World Health Organization (WHO) Access to COVID-19 Tools Accelerator (ACT-A) program of which results will be reported upon filing Clinical Trials Authorization (CTA) (54). <section> Funding: Funding acknowledgments for each Validating and understanding ring conformations using small author are listed in the consortium spreadsheet (data S7). Chodera: Writing – original draft Conceptualization Investigation Writing – review & editing Methodology Resources Funding acquisition Data curation Validation Supervision Formal analysis Software Project administration and Visualization; A. von Delft: Writing – original draft Conceptualization Investigation Writing – review & editing Funding acquisition Data curation Validation Supervision Project administration and Visualization; F. von Delft: Conceptualization Writing – review & editing Funding acquisition Validation Supervision Project administration and Visualization; D. A. Lee: Writing – original draft Conceptualization Investigation Writing – review & editing Methodology Funding acquisition Validation Supervision Formal analysis Software Project administration and Visualization; N. London: Writing – original draft Conceptualization Investigation Writing – review & editing Methodology Resources Funding acquisition Data curation Validation Supervision Project administration and Visualization; M. <section> This research was funded in whole or in part by the Wellcome Trust (grant no. 209407/Z/17/Z) a cOAlition S organization.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/science.abq5202",TRUE,"Competing interests: The authors declare that they Fellow of the Damon Runyon Cancer Research Foundation have no competing interests.",TRUE,"<section> Funding: M.P. is supported by the German Research Foundation (DFG PE2737/1-1) and is a member of the Berlin Institute of Health (BIH) Clinician Scientist Program; B.A.D. is supported by the Beverly Phillip’s fellowship; J.Z. is supported by the Swiss National Science Foundation (SNSF P1BEP3_181164); J.D. and B.G.J.S. are supported by fellowships from the Canadian Institute of Health Research (CIHR); F.V.S.C. is supported by a fellowship from Canadian Institute of Health Research (MFE-176551); R.S. is a Cancer Research Institute Irvington Fellow supported by the figures.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/science.adg1075",TRUE,"Competing interests: The authors declare no competing financial interests.",TRUE,"<section> Funding acquisition: WC SH VH JSK <section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/science.adi7401",TRUE,"Competing interests: The authors declare that they have 29. L. Vitellaro-Zuccarello S. De Biasi A. Amadeo Cell Tissue Res. no competing interests.",TRUE,"<section> Funding: Natural Sciences and Engineering and Assembly of Biopolymers S. Funding acquisition: L.Y. T.P. 26.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/science.adj0070",TRUE,"Competing interests: V.M.C. is named on make the Author Accepted Manuscript (AAM) version available under patents regarding SARS-CoV-2 serological testing and monoclonal a CC BY public copyright license. antibodies.",TRUE,"<section> Funding: S.H.W. S.T. E.B.L. A.N. R.A.M.F. T.C.J. and D.J.S.: Centers of Excellence for Influenza Research and Response (CEIRR contract no. 75N93021C00014) as part of the SARS-CoV-2 Assessment of Viral Evolution (SAVE) Program. B.M. T.C.J. C.D. and V.M.C.: Funded by the German Federal Ministry of Education and Research through project DZIF (8040701710 and 8064701703) and the German Federal Ministry of Health through project SeroVarCoV. V.M.C. and L.M.J.: Funded by the German Federal Ministry of Education and Research through project VARIpath (01KI2021). E.B.L. is funded by a Gates Cambridge Scholarship. A.N. was supported by the Gates advisory board member of Castlevax a spinoff company formed Cambridge Trust. Also supported by the Office of by the Icahn School of Medicine at Mount Sinai to develop the Assistant Secretary for Preparedness and Response SARS-CoV-2 vaccines.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciimmunol.abp8966",TRUE,"Competing interests: J.-L.C. reports being an inventor on patent application PCT/US2021/042741 filed 22 July 2021 submitted by The Rockefeller University which covers the diagnosis of susceptibility to and treatment of viral disease and viral vaccines including COVID-19 and vaccineassociated diseases. C.S.C. D.J.E. C.M.H. M.F.K. C.R.L. P.G.W. report funding from Genentech. C.S.C. reports funding from The National Heart Lung and Blood Institute (NHLBI) The U.S. Food and Drug Administration (FDA) U.S. <section> Department of Defense (DOD) and Quantum Leap Healthcare Collaborative and serves on consulting and advisory boards for Vasomune Gen1e Life Sciences Janssen and Cellenkos. C.M.H. reports funding from NHLBI and consulting fees for clinical trial design with Spring Discovery. The other authors have no conflicts of interest to report.",TRUE,"Funding: The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute the Rockefeller University the St. EA is supported by the Hellenic Foundation for Research and Innovation (INTERFLU no. 1574) and the European Commission’s Horizon 2020 research and innovation program (CURE grant no. 767015 and IMMUNAID grant no. 779295). LR and LFP were supported by Singapore National Medical Research Council COVID-19 Research Fund (COVID19RF-001; COVID19RF-007; COVID19RF-0008; COVID19RF-060) and A*STAR COVID-19 Research funding (H/20/04/g1/006). The UCSF COMET Consortium is supported by the University of California San Francisco Clinical and Translational Science Institute and the National Institutes of Health (U19AI077439). <section> wish to acknowledge the support of the Chao Family Comprehensive Cancer Center Experimental Tissue Shared Resource supported by the National Cancer Institute of the National Institutes of Health under award number P30CA062203. PB and TLV were supported by the MD-PhD program of the Imagine Institute (with the support of the Fondation Bettencourt-Schueller).",FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/sciimmunol.ade7953",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Acknowledgments: We thank the patients and their families for supporting the study. We acknowledge the extended clinical care team for supporting these patients including the Rare Disease Discovery Hub at BC Children’s Hospital and for the support of this patientcentered research project. <section> Funding: This work was supported by the following grants: National Natural Science Foundation of China (grant #91942302 #31870898 and #82011540008 to J.Y.W.) Ministry of Science and Technology of China (grant #2019YFE0100600 to J.Y.W.) Canadian Institutes for Health Research (grant #PJT-178054 to S.E.T. and grant #FDN-148403 to TRH) BC Children’s Hospital Foundation (to S.E.T.) Canada Research Chairs Program (to S.E.T.) National Institute Of Allergy And Infectious Diseases of the National Institutes of Health (grant #R21AI171466 to R.M.B.) National Institutes of Health intramural research program NIH Clinical Center and NIAID to S.R. Agence Nationale de la Recherche (grant #ANR-19-CE17-0012-01 to S.K. and ANR19-CE17-0012-02 and ANR-19-CE17-0012-04) the French state (via the Agence Nationale de la Recherche’s “Investissments d’avenir” program (ANR-10-IAHU-01 to Institute Imagine) the Ligue Contre le Cancer–Comité de Paris INSERM to S.K. the National Health and Medical Research Council of Australia (GNT2012498) to A.E. and by the Phenomics Translation Initiative an Medical Research Future Funds funded program (#EPCD000035) and the National Collaborative Research Infrastructure Strategy (NCRIS) via Phenomics Australia. C.G. was supported by the German Research Foundation (grant no. 316249678–SFB 1279 subproject B05). O.F. G.N. and W.W.W. were supported by grants from the Canadian Institutes of Health Research (PJT-162120) Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2017-06824) and the BC Children’s Hospital Foundation and Research Institute.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/sciimmunol.adf4968",TRUE,"Competing interests: G.J.H. reports grants from Bristol Myers Squibb during the conduct of the study as well as grants and personal fees from Bicara Exicure Regeneron BMS and Sanofi Genzyme; grants from Gateway for Cancer Research GSK Kite Pharma NantKwest/Altor Bioscience and Secura Bio; and personal fees from Maverick and Merck outside the submitted work. All other authors declare that they have no competing interests.",TRUE,"<section> Funding: R.U. is funded by the National Cancer Institute the National Institute for Dental and Craniofacial Research (NIH/NCI/NIDCR U01DE029188 and NIH/NIDCR R01DE027736) and a V. The Siteman Cancer Center is supported in part by NCI Cancer Center Support grant no. P30 CA91842.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/scisignal.abl8266",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by the fight COVID-19 initiative of the German Cancer Research Center (Heidelberg Germany). Furthermore this work was supported by research grants from the Bundesministerium für Bildung und Forschung (BMBF): project numbers 01KI20239B to M.S. 031L0270 to S.M.K.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/scisignal.adg1913",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/scitranslmed.abm7477",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This study was supported by German Research Foundation (DFG) Research group 2165 (GE2512/2-2 EA4/060/ 16 KO2891/3-2) and Collaborative Research Centre 1444 (M.T. D.J. K.S.-B. J.K.P. and S.G.)",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/scitranslmed.abn5939",TRUE,"Competing interests: S.F. declares consulting fees from Abionyx Pharma Novartis SA Sanofi-Genzyme CSL-Vifor and Alexion and symposium and congress invitations from CSL-Vifor and Alexion. A.D.B. declares participation to speakers bureau and lectures for Hansa Pharma Chiesi Pharma Astellas and Neovii. P.S. has been on scientific advisory boards (unrelated to the study) for FMC Baxter GSK Astra Zeneca CSL Behring Vifor Reata and Invizius. P.S. has also given lectures (unrelated to the study) at events sponsored by FMC Baxter Pfizer Astra Zeneca Astellas Novi Nordisk and Bayer. The other authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Caresyan grant agreement no. 764474 to A.A.-G. J.K. J.P.S. K.K. P.S. and S.H.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1126/scitranslmed.abo3189",TRUE,"Competing interests: Authors declare that they have no competing interests.",TRUE,"<section> The sequencing for Patient #3 was performed under the Care4Rare Canada Consortium funded by Genome Canada and the Ontario Genomics Institute (OGI-147) the Canadian Institutes of Health Research Ontario Research Fund Genome Alberta Genome British Columbia Genome Quebec and Children’s Hospital of Eastern Ontario Foundation. This study makes use of DECIPHER (http://www.deciphergenomics.org) which is funded by the Wellcome Trust. <section> Funding: <section> This work was supported by German Research Foundation Grants SFBTR167 RGT2719-PRO project B4 (to EK) E-Rare project GENOMIT (Austrian Science Fund FWF I4695-B) to JAM US National Institutes of Health (NIH) grants (R01MH101221) and a grant from the Simons Foundation (SFARI #608045) to EEE. This work was also supported in part by “the Fundamental Research Funds for the Central Universities” starting fund (BMU2022RCZX038) to TW.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/scitranslmed.abq6492",TRUE,"",TRUE,"<section> Funding: We acknowledge the support from the NIH: R01 DK093773 and DK087985 to S.S. DK125858 and DK101350 to J.R. and HL153384 and DK128012 to S.S.H.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/scitranslmed.adg1659",TRUE,"Competing interests: P.W.K. is an employee of Rhythm Pharmaceuticals. P.K. received consultation fee once and has been invited to hold talks from Rhythm Pharmaceuticals. All other authors declare that they have no competing interests.",TRUE,"<section> Funding: This work was funded by the Germany Research Foundation (DFG) KU 2673/6-1 KU 2673/7-1 CRC1423/B02 (to P.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1126/scitranslmed.adh2156",TRUE,"Competing interests: The authors declare that they have no competing interests.",TRUE,"<section> Funding: The funders had no role in the design and conduct of the study data collection and statistical analysis interpretation of the data drafting review or approval of the manuscript or decision to submit the manuscript for publication. This work was supported by NIH National Institute of Neurological Disorders and Stroke grants F31NS117124 (to M.E.H.) R01NS118200 (to J.M.S.) and 5R35NS111582 (to P.G.P.); the Ohio State University Center for Muscle Health and Neuromuscular Disorders grant (to M.E.H.)",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1128/jcm.00426-23",FALSE,"",TRUE,"<section> This work was solely funded by QIAGEN.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/jcm.00873-23",TRUE,"The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/jvi.00205-23",TRUE,"The authors declare no conflict of interest.",TRUE,"The work of C.D. was supported by grants received from the BMBF (01KI2006A) and the DFG (DR 772/10–2). M.A.M. received funds from the Volkswagen Foundation (AZ93345). by <section> FUNDING Wallerang Investigation Validation | Christian Drosten Formal analysis Funding acquisition review and editing | Manja Marz Data curation Formal analysis Investigation ogy Writing – review and editing | Benjamin Lamp Conceptualization Methodology Resources Validation Writing – review and editing Conceptualization Data curation Formal analysis Funding acquisition Methodology Project administration Resources Supervision Validation Writing – original draft Writing – review and editing <section> Methodology Funding acquisition",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/jvi.01932-22",TRUE,"<section> The authors declare no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/msphere.00061-23",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> This work was partially supported by Vicerectory of Research University of FEES-CONARE projects of Costa Rica (803-C2-651 the Global Centres for Health and Pandemic exchange services (DAAD) (Grant agreement: The authors have declared that no competing <section> FUNDING <section> Gabriela Hernández-Mora Conceptualization tion Methodology Project administration Visualization Writing – original draft Writing Díaz Data curation Formal analysis Funding Resources Software Supervision Validation | Andres Moreira-Soto Data curation Formal Methodology Resources Validation Visualization Barrantes-Granados Investigation Methodology the National University (FIDA/SIA: 0284-21) Costa Rica CC-D EC-O www.vinv.ucr.ac.cr) <section> Data curation Formal analysis Investiga­ Resources Software Supervision Validation – review and editing | Carlos Chacónacquisition Investigation Methodology Visualization Writing – review and editing analysis Funding acquisition Investigation from Writing – review and editing | Osvaldo <section> Writing – review and editing | Marcela Suárez-Esquivel Data curation Formal analysis Investigation Methodology Software Validation Writing – review and editing | Eunice Viquez-Ruiz Investigation Methodology Writing – review and editing | Elías BarqueroCalvo Formal analysis Funding acquisition Investigation Methodology Resources Visualization Writing – review and editing | Nazareth Ruiz-Villalobos Investigation Methodology Visualization Writing – review and editing | Daniela Hidalgo-Montealegre Investigation Methodology Writing – review and editing | Rocío González-Barrientos Investigation Methodology Resources Writing – review and editing | Elena A. Demeter Investigation Methodology Writing – review and editing | Josimar Estrella-Morales Investigation Methodology Writing – review and editing | Ana-Mariel Zúñiga-Pereira Investigation Methodology Writing – review and editing | Carlos Quesada-Gómez Investigation Methodology Software Writing – review and editing | Esteban ChavesOlarte Funding acquisition Investigation Methodology Resources Writing – review and editing | Bruno Lomonte Formal analysis Methodology Resources Writing – review and editing | Caterina Guzmán-Verri Formal analysis Funding acquisition Methodology Resources Writing – review and editing | Jan Felix Drexler Formal analysis Funding acquisition Investigation Methodology Resources Validation Visualization Writing – original draft Writing – review and editing | Edgardo Moreno Conceptualization Data curation Formal analysis Investigation Methodology Project administration Software Supervision Validation Visualization Writing – original draft Writing – review and",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/msphere.00488-22",TRUE,"<section> The authors declare no conﬂict of interest.",TRUE,"<section> The work was funded by the Deutsche Forschungsgemeinschaft (JU 2857/9-1 and JU 2857/9-2 to S.J.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1128/spectrum.02139-21",TRUE,"<section> The authors declare a conﬂict of interest. All authors declare no conﬂict of interest except Dr. <section> All authors declare no conﬂict of interest except Felix Knauf who reports grants from Oxalosis and Hyperoxaluria Foundation and Deutsche Forschungsgemeinschaft during the conduct of the study; personal fees from Allena Pharmaceuticals Oxthera Pharmaceuticals Sanoﬁ Pharmaceuticals Fresenius Medical Care Alnylam Pharmaceuticals and Advicenne",TRUE,"Trishul Siddharthan is supported by a Mentored Career Development Award through the National Heart Lung and Blood Institute of the <section> This study was funded by the GlaxoSmithKline (GSK) Africa NCD Open Lab grant (project number 8636). <section> A.K. and T.S.: Conceptualization Funding Acquisition Investigation Methodology Project Administration Original Draft Writing and Editing; R.M. and D.M.: Investigation; T.U.P.B. <section> L.M. U.L. and T.B.: Data Curation and Formal Analysis; D.J. and B.S.B.: Conceptualization Investigation Design Funding Acquisition and Drafting the Manuscript for Important",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1128/spectrum.02839-23",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> This work was supported by grants from the National Natural Science Foundation of China (Grant No. <section> FUNDING",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/archdischild-2022-324619",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The study was in part funded by the generous support and grant (PPOC21-­08/L2588 and RES/00264) from Sanquin Blood Supply Foundation Amsterdam the Netherlands and a postdoctoral research grant (RGP2020-­09/ PDRG-­02/04) from The European Society for Pediatric Research Geneva Switzerland.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2022-223429",TRUE,"Competing interests CDe has received consulting/speaker’s fees from Abbvie Eli Lilly Janssen Novartis Pfizer Sparrow Roche Galapagos and Sanofi all unrelated to this manuscript. EH LE AA SA PCG AH TAK and MW declare no competing interests.",TRUE,"<section> Funding Funding was provided by AbbVie (ISM-­51500). SES is supported by the Rheumatology Research Foundation RISE pilot award and Bristol Myers Squibb Foundation Robert A Winn Diversity in Clinical Trials Career Development Award outside of the submitted work.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/ard-2022-223499",TRUE,"Competing interests PMM has received honoraria from Abbvie BMS Celgene Eli Lilly Galapagos Janssen MSD Novartis Orphazyme Pfizer Roche and UCB all unrelated to this manuscript and is supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC).",TRUE,"<section> Funding The study received support from the American College of Rheumatology (ACR) and European Alliance of Associations for Rheumatology (EULAR). JY is supported by NIH/NIAMS K24 AR07534 and AHRQ R01HS028024.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2022-223595",TRUE,"Competing interests DvdH: Consulting fees from AbbVie Bayer BMS Cyxone Eisai Galapagos Gilead GSK Janssen Lilly Novartis Pfizer UCB Pharma and is the director of Imaging Rheumatology BV; AD: Speaker for Janssen Novartis and Pfizer; consultant of AbbVie Amgen Aurinia BMS Celgene Eli Lilly GSK Janssen MoonLake Novartis Pfizer and UCB Pharma; grant/research support from AbbVie Eli Lilly GSK Novartis Pfizer and UCB Pharma; XB: Speaker for AbbVie BMS Chugai Eli Lilly Galapagos Gilead MSD Novartis Pfizer and UCB Pharma; paid instructor for AbbVie BMS Chugai Eli Lilly Galapagos Gilead MSD Novartis Pfizer and UCB Pharma; consultant for AbbVie BMS Chugai Eli Lilly Galapagos Gilead MSD Novartis Pfizer and UCB Pharma; MAB: Grant/research support from UCB; Consultant for Clementia Grey Wolf Therapeutics Incyte Ipsen Pfizer Regeneron and Xinthera; Speaker for Novartis; HD: Speaker for BMS Chugai Eli Lilly GSK MSD Novartis Pfizer UCB Pharma; MD: Consultant for AbbVie Eli Lilly Novartis Merck Pfizer and UCB Pharma; Grant/research support from: AbbVie Eli Lilly Novartis Pfizer and UCB Pharma; DE: Consultancy and speaker fees from AbbVie Eli Lilly Galapagos Novartis and UCB Pharma; KG: Consultant of AbbVie Eli Lilly Novartis and UCB Pharma; grant/research support from AbbVie Gilead Eli Lilly Novartis and UCB Pharma; speakers bureau from AbbVie Eli Lilly Novartis UCB Pharma; LSG: Consulting fees from AbbVie Eli Lilly Gilead Janssen MoonLake Novartis Pfizer and UCB Pharma; grant/research support from Novartis Pfizer and UCB Pharma;",TRUE,"These trials were funded by UCB Pharma. <section> Funding This article was based on the original trials BE MOBILE 1 (NCT03928704) and BE MOBILE 2 (NCT03928743) which were sponsored by UCB Pharma. Support for third party medical writing assistance for this article provided by Evelyn Turner BSc Costello Medical Cambridge UK was funded by UCB Pharma in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3).",TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2022-223628",TRUE,"Competing interests MKC has received consulting fees from AstraZeneca Bristol Meyers Squibb Lilly and Shannon Pharmaceuticals as well as grant/research support from Gilead.",TRUE,"<section> Funding This work was funded by the European Alliance of Associations for Rheumatology (EULAR) (grant number SCI019).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/ard-2023-223850",TRUE,"Competing interests JSS is main editor of the Annals of the Rheumatic Diseases.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-223916",TRUE,"Competing interests RF: research grants and consulting fees from AbbVie Amgen AstraZeneca Biogen BMS Boehringer-­Ingleheim Flexion Galapagos Galvani Genentech Gilead GSK Janssen Lilly Novartis Pfizer Roche Sanofi-­Aventis and UCB.",TRUE,"<section> Funding AbbVie funded the study and had a role in the study design data collection data analysis data interpretation and writing of the report.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-223941",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The project was funded by the European Alliance of Associations for Rheumatology (grant number EDU049).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-223977",TRUE,"Competing interests AAHA: None declared.",TRUE,"<section> Funding Follow-­up study of the GLORIA trial funded by the European Union’s Horizon 2020 research and innovation program under grant agreement number 634886. No additional funding was obtained for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-224148",TRUE,"Competing interests <section> Alen Zabotti Speakers bureau: AbbVie Novartis Paid instructor for: AbbVie Novartis UCB EULAR fellowship; Gabriele De Marco EULAR of: AbbVie Amgen BMS Celltrion Galapagos Sandoz UCB Grant/research support from: Xenofon Baraliakos Speakers bureau: Abbvie Galapagos UCB Lilly Paid instructor for: Pfizer Galapagos UCB Lilly Consultant Pfizer Galapagos UCB Lilly Grant/research Leadership or fiduciary role in other board or unpaid : Editorial Board Member of Annals Daniel Aletaha received grants speaker Gilead Galapagos Eli Lilly Janssen Merck Editorial Board Member of Annals of Rheumatic <section> approved the final version.",TRUE,"<section> Funding Funded by EULAR grant QoC",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-224205",TRUE,"Competing interests None declared.",TRUE,"Funding code: 01NVF16029. <section> Funding Rheuma-­VOR was funded by the Innovation Fund at the Federal Joint Committee (G-­BA) from 2017 to 2021. Funding code: 01NVF16029.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-224356",TRUE,"Competing interests TS was an employee of and shareholder in Bristol Myers Squibb (at the time of the analysis; former employee at present).",TRUE,"<section> Funding This study was sponsored by Bristol Myers Squibb.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-224691",TRUE,"Competing interests T.",TRUE,"<section> Acknowledgements Financial support for medical editorial assistance was provided by Novartis Pharma AG Basel Switzerland. <section> Funding This study was funded by Novartis Pharma AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-224728",TRUE,"Competing interests EP and LM-­A are employees at Thermo Fisher Scientific.",TRUE,"<section> Funding This study was supported by funding (to LK LA RH JA JR) from Vinnova Innovationsfonden and the Research Council of Norway under the frame of NordForsk (grant agreement number 90825 Project NORA) by the Swedish Research Council the Federal Ministry of Education and Research in Germany and the Research Council of Norway under the frame of ERA PerMed (Project ScandRA) the Swedish Foundation for Strategic Research Sweden’s innovation agency the Knut and Alice Wallenberg Foundation the Swedish Research Council for Health Working Life and Welfare the insurance company AFA the Swedish Rheumatism Association King Gustaf V:s 80-­year Foundation and the Stockholm County Council.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/ard-2023-224762",TRUE,"Competing interests AF reports honoraria and/or consulting fees from Lilly Boehringer Novartis Abbvie Astra Zeneca GSK MSD Pfizer UCB Amgen Aenorasis support for attending meetings from UCB.",TRUE,"<section> Funding European League against Rheumatism (project number QoC015).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-225134",TRUE,"Competing interests KKK: Research grants from Independent Research Fund Denmark Danish Rheumatic Association and Central Denmark Region unrelated to this project. All other authors have no competing interests.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors. KKK has received funding for research in PMR from Central Denmark Region and Aarhus University Hospital. EBrouwer: As an employee of the UMCG received a speaker fee for a talk on GCA at a post EULAR symposium in the Netherlands in 2023 which was paid to the UMCG; As an employee of the UMCG received grants from the Dutch Arthritis Society DAS and the EU/EFPIA/Innovative Medicines Initiative 2 Joint Undertaking Immune-­Image grant no 831514 which were paid to the UMCG.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ard-2023-225185",FALSE,"",TRUE,"<section> Helena Marzo-Ortega has received grant support from Janssen Novar5s and UCB.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmj-2022-072348",TRUE,"Competing interests: All authors have completed the ICMJE uniform Veneto Italy disclosure form at www.icmje.org/disclosure-of-interest/ and declare: Medicine MS received honoraria/has been a consultant for AbbVie Angelini Sweden Lundbeck Otsuka.",TRUE,"<section> Funding <section> I) highly Patient and public involvement weak (class This study was author funded and we did not involve of evidence patients and the public in this work but we will apply basis of the for funding to involve them in the knowledge translation of interest of present findings. <section> Mestre Venice Funding: None. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmj-2023-076305",TRUE,"Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/and",TRUE,"Funding requirements for this study did not align with the inclusion of private practices. <section> Funding: Funded by Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee (G-BA) in Germany (grant no. 01VSF18053).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjgh-2023-013073",TRUE,"Competing interests None declared.",TRUE,"<section> Funding Muhammed Afolabi is funded by the UK Research and Innovation Future Leaders Fellowship scheme (MR/S03286X/1) which covers the APC payment for this",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjgh-2023-013551",TRUE,"Competing interests None declared.",TRUE,"13 As of 15 July 2022 a total of 17 995 COVID-­19 research projects had been funded by 345 funders with at least US$6.5bn invested in research. 25 Sources of funding for research involving these countries were identified and the resulting list of funding sources was screened for duplicates which were removed. Funding sources/funders based in the Asia-­Pacific region were further classified by type of funding source or funding organisation. Private entities Funding organisations and funding sources with a profit-­making objective. Public entities Governmental funding organisations and sources of funding; Universities/ hospital-­affiliated entities Funding organisations and sources of funding which are universities or affiliated to universities/hospitals; Philanthropies Charitable funding organisations and funding sources with a non-­profitmotive; Funding source in the ‘other’ category received funding from both private and public sources. National Medical Research Council (Singapore) Grants-­in-­Aid for Scientific Research (KAKENHI Japan) and Japan Agency for Medical Research and Development funded the most research projects (figure 4). 26 27 It is challenging to ascertain whether the institutions identified supported COVID-­19 research directly or received funding from other sources as is typically the case for universities. This could have resulted in variable capturing of research funders to include: sponsors of research (typically sites hosting clinical trials); entities directly providing funding for research and intermediaries disbursing funds received from various sources. Research projects involving these countries were all funded by funders based outside the Asia-­Pacific Region and hence were not identified by the combined analyses of the five databases. Of the funders located outside the Asia-­ Pacific region UK Research and Innovation Canadian Institutes of Health Research and Social Sciences and Humanities Research Council (Canada) funded the most research projects. <section> Funding GloPID-­R is core funded through a CSA award from the EC the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101094188 and the GloPID-­R Research and Policy Team is funded by UK Research and Innovation (grant number 10061268). <section> 19 Antonio E Alobo M Tufet Bayona M et al. Funding and COVID-­19 research priorities are the research needs for Africa being met? <section> Funding and undertaking research during the first year of the Funding COVID-­19 research: insights from an exploratory analysis using open data Infrastructures.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjgh-2023-014225",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This project is part of the EDCTP2 Programme supported by the European and Developing Countries Clinical Trials Partnership (grant number TMA2019CDF-­2734—TIMELY). OW was also supported by an Imperial College London Wellcome Trust Institutional Strategic Support Fund (ISSF) (grant no RSRO_ P67869).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/bmjmed-2023-000554",TRUE,"Competing interests All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the British Heart Foundation University College London (UCL) National Institute for Health and Care Research (NIHR) Biomedical Research Centre UK Research and Innovation (UKRI)/ NIHR funded Multimorbidity Mechanism and Therapeutics Research Collaborative and NIHR for the submitted work; ADH is a member of the advisory group for the Industrial Strategy Challenge Fund Accelerating Detection of Disease Challenge and a co-­opted member of the National Institute for Health and Care Excellence guideline update group for Cardiovascular disease: risk assessment and reduction including lipid modification CG181; ADH is a co-­investigator on a grant from Pfizer to identify potential therapeutic targets for heart failure based on human genomics; NJW is a director of Polypill a company that provides an online cardiovascular disease prevention service accessed on Polypill.com; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.",TRUE,"<section> Funding Supported by the University College London (UCL) British Heart Foundation Accelerator (AA/18/6/34223) UCL Hospitals National Institute for Health and Care Research (NIHR) Biomedical Research Centre (NIHR203328) and UK Research and Innovation (UKRI)/NIHR funded Multimorbidity Mechanism and Therapeutics Research Collaborative (MR/V033867/1).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjment-2022-300626",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjment-2023-300675",TRUE,"Competing interests None declared.",TRUE,"<section> Funding BL was supported by a Fonds de recherche du Québec—Santé (FRQS) Postdoctoral Training Fellowship AB by a FRQS researcher salary award and BT by a Tier 1 Canada Research Chair all outside of the present work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/bmjment-2023-300771",TRUE,"Competing interests None declared.",TRUE,"<section> Funding Michael Berk is supported by a NHMRC Senior Principal Research Fellowship and Leadership 3 Investigator grant (1156072 and 2017131).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-063188",TRUE,"Competing interests All authors were employees of Bayer AG during the project period. None of the authors have a relevant competing interest to declare.",TRUE,"<section> Funding This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777500.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-064170",TRUE,"Competing interests None declared.",TRUE,"Funding organisations are also likely to play an important role in improving the quality and reporting of patient involvement especially as they increasingly require patient involvement in clinical research. <section> Funding This research was funded by intramural funds of the QUEST Center for Responsible Research Berlin Institute of Health Charité–Universitätsmedizin Berlin (award/grant number N/A).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-066445",TRUE,"Competing interests SD is the principal investigator of the study and MFJ has been commissioned by argenx BV and received honoraria to design the study analyse and report the data.",TRUE,"<section> Funding The study is funded by argenx BV Ghent Belgium. HM has served as a paid consultant for argenx BV Alexion Pharmaceuticals Ra Pharmaceuticals and UCB Pharma and has received speaker honoraria from the Japan Blood Products Organisation and research support from the Ministry of Health Labour and Welfare Japan.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-066937",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This study was entirely sponsored by Médecins sans Frontières OCBA (Spain).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-067311",TRUE,"Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-068104",TRUE,"Competing interests The principal investigator ML is CEO and owner of Vitaccess which has been commissioned by argenx BV to carry out the study.",TRUE,"<section> Funding This work was funded by argenx BV Ghent Belgium.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration number NCT04176211.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjopen-2022-068405",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Gunnar Lachmann is participant in the BIH Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the BIH at Charité.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-068865",TRUE,"Competing interests AS has received funding from the FRSQ-­Junior 1 scholars’ program Bayer-­Canadian Cardiovascular Society Alberta Innovates Health Solution Roche Diagnostics Novartis Takeda BoehringerIngelheim and Akcea.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors. <section> Competing interests AS has received funding from the FRSQ-­Junior 1 scholars’ program Bayer-­Canadian Cardiovascular Society Alberta Innovates Health Solution Roche Diagnostics Novartis Takeda BoehringerIngelheim and Akcea. <section> CSPL is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/Executive Committee for Abbott Actelion Allysta Pharma Amgen AnaCardio AB Applied Therapeutics AstraZeneca Bayer Boehringer Ingelheim Boston Scientific Cytokinetics Darma EchoNous Impulse Dynamics Ionis Pharmaceutical Janssen Research & Development LLC Medscape/WebMD Global LLC Merck Novartis Novo Nordisk Prosciento Radcliffe Group Ltd. Roche Diagnostics Sanofi Siemens Healthcare Diagnostics and Us2.ai; and serves as cofounder and non-­executive director of Us2.ai.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-069142",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-069553",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work was partly funded under a grant from the Federal Ministry of Education and Research of Germany (Bundesministerium fuer Bildung und Forschung—BMBF) (01PW18012).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered in ClinicalTrials.gov (NCT02196545) in July 2014 in preparation of a manuscript for publication of the data. In addition the study was registered at www.clinicaltrials. gov (ID no. NCT02168790). (doi: 10.1371/journal.pone.0125035) Miscommunication between investigators The time of first registration was June 17 2013 and final approved trial registration was July 1 2013. When the study principal investigator recognized that it had not been performed we immediately registered the trial at http:// www.ClinicalTrials.gov. When the study coordinator recognized that it has not been performed we immediately registered it at clinicaltrials.gov.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjopen-2022-070054",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This study is funded by the Federal Ministry of Education and Research (BMBF) grant number 01GY1914.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration number DRKS00023480.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjopen-2022-070951",TRUE,"Competing interests The authors MO AKK HC GR MT HH and KL declare that they have no financial or other competing interests.",TRUE,"<section> Funding This research was partly supported by the German Ministry of Health (Bundesgesundheitsministerium). BB was supported by the Kneipp Association in the context of his professorship at the Charité.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> PROSPERO registration number CRD42021237611. healing effect of water through its dissolving draining (of illness) and invigorating (of the body) function.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjopen-2022-070962",TRUE,"Competing interests NP A-­CK ERB and MN have no conflicts of interest to declare.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/bmjopen-2022-071331",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2022-071380",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement number 863664). This work was supported by the Luxembourg National Research Fund (FNR) under grant PRIDE/11823097.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration number NCT04847011.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjopen-2023-073130",TRUE,"Competing interests LO has received speaker honoraria from Pfizer Akcea and Alnylam; and has received honoraria for participation on advisory panels from Alnylam Sobi AstraZeneca Novo Nordisk and Pfizer. FD has no competing interests to declare.",TRUE,"<section> Funding This study and its resultant presentations and publications were funded by Alnylam Pharmaceuticals.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2023-073138",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors disclose receipt of the following financial support for the research authorship and/or publication of this article: Financial support was provided by funding from the National Cancer Institute (U10CA180868 -180822 UG1-­CA189867) and NIH P30CA008748.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjopen-2023-076415",TRUE,"Competing interests FE reports grants from German Research Foundation (DFG) grants from German Ministry of Education and Research grants from the German Herta Foundation; during the conduct of the study; personal fees and non-­financial support from Novartis grants and personal fees from Boehringer Ingelheim personal fees from CVRx Pfizer Medtronic grants and personal fees from Servier personal fees from MSD personal fees from Merck & Co. grants from AstraZeneca personal fees from Bayer personal fees from Resmed personal fees from Berlin Chemie grants from Thermo Fischer personal fees from Vifor Pharma personal fees from PharmaCosmos outside the submitted work; ME reports grants from Bayer and fees paid to the Charité from Abbot Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo Amgen Sanofi Novartis Pfizer all outside the submitted work. KM declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. All remaining authors MA L-­HB K-­UE UG NH JK-­H DL DNM SKP SR GR KS OS BS SS RV JEW do not report potential conflicts of interest.",TRUE,"<section> Funding The Berlin Institute of Health (BIH) funds the basic infrastructure recruitment as well as deep phenotyping after 90 days until December 2024 and long-­term telephone follow-­up for up to 10 years for all participants (Award/grant number: N/A). ME received funding from DFG under Germany’s Excellence Strategy – EXC-­2049 – 390688087 Collaborative Research Center ReTune TRR 295424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. <section> TP received grants from the BMBF the Federal Ministry of Food and Agriculture (BMEL) the Federal Ministry for Economic Affairs and Energy (BMWi) the DFG Deutsche Herzstiftung German Academic Exchange Service (DAAD).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Study registration First study phase: Approved WHO primary register: German Clinical Trials Register: https:// <section> drks.de/search/de/trial/DRKS00016852; WHO International",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/bmjpo-2023-001987",TRUE,"Competing interests No there are no competing interests.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/bmjsem-2023-001626",TRUE,"Competing interests EV is Editor in Chief of BMJ Open Sports & Exercise Medicine.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/gutjnl-2022-328387",TRUE,"Competing interests ANL YW MK AD BB BH LDO JSM HC and MER are employees and stockholders of Genentech/Roche.",TRUE,"This study was funded by Genentech Inc. South San Francisco California USA. <section> Funding This study was funded by Genentech South San Francisco California USA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/gutjnl-2023-329628",TRUE,"Competing interests MFN has served as an advisor for Pentax Giuliani PPM BMS Janssen MSD Takeda and Boehringer.",TRUE,"<section> Funding GS was supported by a DOC fellowship of the Austrian Academy of Sciences.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/gutjnl-2023-330365",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work was supported by grants of the German Research Foundation (DFG) contract grant number 209933838 CRC1052-­03 A1 to VW and MS and by the Berlin School of Mind and Brain (stipend for EM) and the German Foundation for Environment (stipend for EM).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> © Author(s) (or their Trial registration number NCT03829189.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/heartjnl-2022-321730",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or notf or-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/heartjnl-2022-321732",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work was supported by German Research Foundation (DFG SK276/3-­1 to C Skurk and C Scheibenbogen).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/heartjnl-2022-322239",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work (IIT – Investigator-­Initiated-­Trial) was supported by Edwards Lifesciences (Nyon Switzerland) and conducted by IPPMed – Institute for Pharmacology and Preventive Medicine (Cloppenburg Germany).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration number NCT03470155. and rehospitalisation due to heart failure (HF).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/ijgc-2023-004599",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ijgc-2023-004693",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work was funded by the North-­Eastern German Society for Gynecological Oncology (NOGGO eV) Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/ijgc-2023-004804",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jitc-2022-006267",TRUE,"Competing interests SS and CMR are co-­inventors of this approach of CD45RA depletion which has been patented and licensed to Tessa Therapeutics.",TRUE,"<section> Funding This work was supported by: CPRIT RP160283 Baylor College of Medicine Comprehensive Cancer Training Program NIH-­NCI P50 CA126752 NIH-­ NLBI-­HHSN268201600015I American Society of Gene and Cell Therapy (ASGCT) Career Development Award 2019 Alex’s Lemonade Foundation Reach Award A SCOR 7001-­19 from the Leukemia and Lymphoma Society and an SRA from Tessa Therapeutics Singapore.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/jitc-2022-006365",TRUE,"Competing interests MD-­R and EC have been granted by and received honoraria from Jazz Pharmaceuticals. SF and PC have collaborated with Jansen Gilead Kite MSD Alexion and Pfizer outside of the submitted work. MP received speaker’s fee from Jazz Pharmaceuticals. The rest of authors have no competing interests to declare.",TRUE,"<section> Funding This study was supported by Fundació Clínic Barcelona (HCB/2020/0401) Jazz Pharmaceuticals (IST-­16-­10355) the Spanish Institute of",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jitc-2022-006406",TRUE,"Competing interests OP has received honoraria or travel support from Gilead Jazz MSD Novartis Pfizer and Therakos. He has received research support from Incyte and Priothera. He is member of advisory boards to Equillium Bio Jazz Gilead Novartis MSD Omeros Priothera Sanofi Shionogi and Sobi. CC: Bellicum <section> Pharmaceuticals: Membership on an entity’s Board of Directors or advisory committees BMS/Celgene: Membership on an entity’s Board of Directors or advisory committees Speakers Bureau; EBMT: Membership on an entity’s Board of Directors or advisory committees; Fresenius Kabi: Research Funding; Gilead: Membership on an entity’s Board of Directors or advisory committees Speakers <section> Bureau Honoraria; Janssen Pharmaceuticals: Membership on an entity’s Board of Directors or advisory committees; Miltenyi Biotec: Research Funding; Novartis: <section> Speakers Bureau Sanofi SA: Honoraria Research Funding Speakers Bureau Terumo BCT: Speakers Bureau. The remaining authors declare no conflict of interests.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors. <section> Pharmaceuticals: Membership on an entity’s Board of Directors or advisory committees BMS/Celgene: Membership on an entity’s Board of Directors or advisory committees Speakers Bureau; EBMT: Membership on an entity’s Board of Directors or advisory committees; Fresenius Kabi: Research Funding; Gilead: Membership on an entity’s Board of Directors or advisory committees Speakers <section> Bureau Honoraria; Janssen Pharmaceuticals: Membership on an entity’s Board of Directors or advisory committees; Miltenyi Biotec: Research Funding; Novartis: <section> Speakers Bureau Sanofi SA: Honoraria Research Funding Speakers Bureau Terumo BCT: Speakers Bureau.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jitc-2023-006802",TRUE,"Competing interests TA reports institutional grants from SkylineDx institutional grants and personal fees from Novartis institutional grants from NeraCare personal fees from BMS institutional grants from Sanofi personal fees from CeCaVa personal fees from Pierre Fabre outside the submitted work. NW reports an advisory role for Pierre Fabre and Sanofi consultant's honoraria from Novartis and has received travel support from AbbVie and Amgen outside the submitted work. FM reports receiving commercial research grants from Novartis and Roche; and has received travel support and/or speaker’s fees and/or advisor’s honoraria by Novartis Roche Bristol-­Myers Squibb Merck Sharp & Dohme and Pierre Fabre. <section> PT has received travel support and/or speaker’s fees and/or advisor’s honoraria by Almirall Biofrontera Bristol-­Myers Squibb Curevac Kyowa Kirin Merck Merck Sharp & Dohme Novartis Pierre Fabre Roche Sanofi and 4SC. CG reports receiving commercial research grants from Bristol-­Myers Squibb Novartis and Roche; and is a consultant/advisory board member for Amgen Bristol-­Myers Squibb Merck Sharp & Dohme Novartis and Roche. GP has received speaker’s honoraria from Novartis Roche Pfizer GlaxoSmithKline and Astellas. TE has received travel support and/or speaker’s fees and/or advisor’s honoraria by Sanofi Novartis Bristol-­Myers Squibb Merck Sharp & Dohme Almiral Hermal and Pierre Fabre. BW reports receiving commercial research grants from is a consultant/advisory board member for and reports receiving travel reimbursement from Bristol-­Myers Squibb and Merck Sharp & Dohme. KW-­H received commercial research grants from CatalYm GmbH and travel support from Society for Immunotherapy of Cancer. No potential conflicts of interest were disclosed by the other authors.",TRUE,"The funding statement has been updated to include the following ""we acknowledge support from the Open Access Publishing Fund of the University of Tübingen"". <section> Funding acquisition: BW KW-­H. <section> Funding This work was partially funded by the Medical Faculty of the University of Tübingen (2509-­0-­0) Bristol-­Myers Squibb (CA209-­9P4) Merck Sharp & Dohme (52518) and the Klaus Tschira Foundation (00.316.2017). In addition we acknowledge support from the Open Access Publishing Fund of the University of Tübingen. KW-­H received commercial research grants from CatalYm GmbH and travel support from Society for Immunotherapy of Cancer.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/jitc-2023-006889",TRUE,"Competing interests DAS is on a board of or has equity in or income from: Atengen Lantheus Sellas Iovance Pfizer Actinium Pharmaceuticals Inc. OncoPep Repertoire Sapience and Eureka Therapeutics.",TRUE,"We acknowledge the use of the MSK Flow Cytometry Core Facility funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. We thank Dr Joshua Elias (Chan Zuckerberg Biohub Stanford California USA) for providing HLA typing of samples from PXD004746 and <section> Funding ZM and RJO acknowledge support from the Steven A. RJO was supported by NIH NCI P01 CA023766 NCI Cancer Center support grant P30 CA008748 Richard “Rick” J. DAS was supported by NIH NCI P01 CA23766 and R35 CA241894.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/jitc-2023-007336",TRUE,"Competing interests None declared.",TRUE,"Funding acquisition: CC NL and YW. <section> Funding This work was supported by grants from the UK charity Breast Cancer Now (BCN) to RB and YW; and Cancer Research UK (CRUK grant number C15051/ A27224) to CDG LSCD and YW.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/jitc-2023-007353",TRUE,"Competing interests TMB has received support for the present manuscript from Novartis (to institution); consulting fees from AstraZeneca Bayer Blueprint Lilly and Pfizer; and has received honoraria from Bayer Lilly and Pfizer. AP has no conflicts of interests to declare.",TRUE,"<section> Funding This study was funded by Novartis Pharmaceuticals Corporation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Dr Toshikiko Doi; Trial registration number NCT02947165.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/jitc-2023-007369",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work supported by the International Science and Technology Cooperation Program of Guangdong (2022A0505050048) the Natural Science Foundation of Guangdong (2021A1515010838) Science and Technology Program of Guangzhou (201903010028) the Beijing Xisike Clinical Oncology Research Foundation (Y-­HS202102-­0038).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jmedgenet-2021-107820",TRUE,"Competing interests None declared.",TRUE,"Funding acquisition: PO PM RH SJ SM. <section> Funding This work was supported by a joint grant from the Medical Research Council (MRC) and the British Heart Foundation (BHF) (MR/P011543/1).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnis-2022-019859",TRUE,"Competing interests DFV reports consultancy for Medtronic and payed lectures for Cerenovus and a research grant by MicroVention (unrelated to this work). <section> TB reports payment for lectures and presentations from Stryker Penumbra and support for attending meeting and/or travel from Phenox Microvention and Stryker in the last 3 years. ABe reports proctoring for Microvention Stryker and Medtronic; payments for lectures for Stryker Phenox and Penumbra; and board fees for CEC (Phenox) and Bayer. SM reports consultancy for Stryker Medtronic Acandis GmbH Novartis Pharma GmbH (unrelated to study) and a travel grant by Balt (unrelated to study). TL has proctored and consulted for CERUS Stryker Phenox Acandis Medtronic Pfizer and Microvention within the past three years but has no direct conflict of interest in the realm of this study. MB reports the following conflicts of interest outside the present work: board membership: DSMB Vascular <section> Dynamics; consultancy: Roche Guerbet Codman; grants/grants pending: DFG Hopp Foundation Novartis Siemens Guerbet Stryker Covidien; payment for lectures (including service on speakers bureaus): Novartis Roche Guerbet Teva Bayer Codman. MAM has received consulting honoraria speaker honoraria and travel support outside this work from Codman Covidien/Medtronic MicroVention Phenox and Stryker. The other authors declared no specific conflict of interest.",TRUE,"<section> Funding This is an investigator-­initiated study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnis-2023-020531",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnis-2023-020556",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnnp-2022-330048",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/jnnp-2022-330412",TRUE,"Competing interests OA reports grants from the German Ministry of Education and Research (BMBF) and the German Research Foundation (DFG); grants and personal fees from Biogen and Novartis; and travel support and personal fees from Alexion Almirall MedImmune Merck Serono Roche Sanofi Viela Bio/Horizon Therapeutics and Zambon.",TRUE,"<section> Funding This study was funded by Horizon Therapeutics (formerly by Viela Bio/ MedImmune).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Trial registration number NCT02200770. <section> To cite: Aktas O Hartung The study is registered with ClinicalTrials. gov (NCT02200770) and was conducted in accordance with the provisions of the International Council for Harmonisation Guidelines for Good Clinical Practice and the principles of the Declaration of Helsinki in its currently applicable version.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA
"10.1136/jnnp-2022-330533",TRUE,"",TRUE,"<section> Funding This project was funded by the Deutsche Forschungsgemeinschaft (DFG) (RA 3296/1-­1 and GO 1357/8-­2 KFO 296).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnnp-2022-330608",TRUE,"Competing interests The authors have stated explicitly that there are no conflicts of interest in connection with this article.",TRUE,"<section> Funding regarding the CROCTINO project (to FP) the German Neurology Association (DGN) (to FCO) and the German Ministry for Economic Affairs and Climiate Action (to HGZ). FCO received fellowship funding from the American Academy of Neurology (AAN) and the National Multiple Sclerosis Society (NMSS).regarding the CROCTINO project (to FP) the German Neurology Association (DGN) (to FCO) and the German Ministry for Economic Affairs and Climiate Action (to HGZ). FCO received fellowship funding from the American Academy of Neurology (AAN) and the National Multiple Sclerosis Society (NMSS).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnnp-2022-330822",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This research was supported by a VolkswagenStiftung (Freigeist) grant (AZ.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnnp-2023-331183",TRUE,"Competing interests MD has financial and intellectual property interests in and holds employment by Adaptive Sensory Technology.",TRUE,"<section> Funding Initial setup by unrestricted grants from Novartis and MerckSerono. <section> SCR is funded by the Hertie Network of Excellence in Clinical Neuroscience of the Gemeinnützige Hertie Stiftung and by the Bundesministerium für Bildung und Forschung (Funding reference number 01EO2106). His research is funded by the Bundesministerium für Bildung und Forschung (BMBF) Deutsche Forschungsgemeinschaft (DFG) Landesforschungsförderung Hamburg Gemeinnützige Hertie-­Stiftung Else Kröner-­Fresenius-­Stiftung Fritz Thyssen-­Stiftung Werner Otto-­Stiftung and Deutsche Multiple Sklerose-­Gesellschaft.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/jnnp-2023-332069",TRUE,"Competing interests None declared.",TRUE,"Funding Acquisition: CF. <section> Funding Funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant numbers FI 2309/1-­1 (Heisenberg Program) 504745852 (Clinical Research Unit KFO 5023) FI 2309/2-­1 FI 2309/5-­1 PR1274/5-­1 and PR1274/9-­1; and the German Ministry of Education and Research (BMBF) grant number 01GM1908D (CONNECT-­GENERATE).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/medhum-2022-012471",TRUE,"Competing interests None declared.",TRUE,"<section> Acknowledgements The author thanks the editors of this special issue and acknowledges the generous funding of the Deutsche Forschungsgemeinschaft. <section> Funding German Research Foundation (Deutsche Forschungsgemeinschaft).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/medhum-2023-012664",TRUE,"Competing interests None declared.",TRUE,"Funded by the Federal Ministry and the Volkswagen Foundation he appointed a team of six clinicians with different specialisations (mostly gynaecologists and paediatricians) to build a unit for ‘genetic family planning’ (Wendt 1973 352;  27). <section> Funding This research was supported by the German Research Foundation through a UK–German Funding Initiative in the Humanities Grant of the Arts and Humanities Research Council and the German Research Foundation (AH/T013281/1 429045347 and NE 2419/1-­1) the German Federal Ministry of Education and Research and the German Aerospace Centre (01UL1907X).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/neurintsurg-2020-016774",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/rmdopen-2022-002735",TRUE,"Competing interests GRB received consulting fees and honoraria for lectures from AbbVie Eli Lilly Gilead and Pfizer and is editor of RMD Open.",TRUE,"<section> Funding AbbVie funded this study and participated in the study design research analysis data collection interpretation of data reviewing and approval of the publication.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002742",TRUE,"Competing interests None declared.",TRUE,"<section> Funding This work was supported by grants from the Deutsche Forschungsgemeinschaft with grant SCHR 771/8-­1 to AS grant 394046635–SFB 1365 to AS grant 387509280 SFB 1350 to KA and grant Me3644/8-­1 to HM and ECRC grants to AS as well as by funding from the European Union Innovative Medicines Initiative 2 Joint Undertaking under grant agreements no. 777357 (RTCure) and no. 831434 (3TR).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002777",TRUE,"Competing interests JC received speaker fees from Janssen-­Cilag. AS received speaker fees from lectures for AbbVie Celltrion MSD Roche BMS Lilly and Pfizer all unrelated to this manuscript. KA has no conflicts of interest.",TRUE,"<section> Funding The study was supported by the Federal Ministry of Education and Research within the network TARISMA (01EC1902A).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002837",TRUE,"Competing interests None declared.",TRUE,"<section> Funding RABBIT-­SpA is supported by a joint unconditional grant from AbbVie Amgen Biogen Celltrion Hexal Janssen-­Cilag Lilly MSD Novartis Pfizer UCB and Viatris.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/rmdopen-2022-002864",TRUE,"Competing interests MKC has received consulting fees from AstraZeneca Bristol Meyers Squibb Lilly and Shannon Pharmaceuticals as well as grant/ research support from Gilead.",TRUE,"<section> Funding This work was funded by EULAR (grant no SCI019). PGC and EV are supported in part by the UK National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002876",TRUE,"Competing interests MKC has received consulting fees from AstraZeneca Bristol Meyers Squibb Lilly and Shannon Pharmaceuticals as well as grant/ research support from Gilead. LR has received consulting fees from AstraZeneca. <section> EV served in the speakers’ bureau of GSK received consulting fees from AURINIA SANDOZ GSK AstraZeneca Roche and Modus as well as grant/ research support from AstraZeneca. PGC has received consultancies or speaker fees from AbbVie Amgen AstraZeneca BMS Eli Lilly Galapagos GSK Merck Pfizer Novartis and UCB. The rest of the authors have no conflict of interest to declare.",TRUE,"<section> Acknowledgements PGC and EV are supported in part by the UK National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre. <section> Funding This work was funded by the European Alliance of Associations for Rheumatology (EULAR) (grant number SCI019).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1136/rmdopen-2022-002903",TRUE,"Competing interests SMMV is supported by Versus Arthritis (grant number 21755) and the NIHR Manchester Biomedical Research Centre UK (outside this submitted work).",TRUE,"<section> Funding Conduct of this review was financially supported by the European Alliance of Associations for Rheumatology. RC declares that the Section for Biostatistics and Evidence-­Based Research The Parker Institute Bispebjerg and Frederiksberg Hospital is supported by a core grant from the Oak Foundation <section> Competing interests SMMV is supported by Versus Arthritis (grant number 21755) and the NIHR Manchester Biomedical Research Centre UK (outside this submitted work).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002934",TRUE,"Competing interests PR has received fees from AbbVie Amgen Celgene Janssen Eli Lilly MSD Novartis Pfizer and UCB.",TRUE,"<section> Funding Janssen-­Cilag provided financial support for the DISCOVER-­1 and DISCOVER-2 studies.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2022-002960",TRUE,"Competing interests A.R. received speaker fees from lectures for BMS Novartis Pfizer and Roche all unrelated to this manuscript. J.C. received speaker fees from Janssen-­Cilag GmbH. A.S. received speaker fees from lectures for AbbVie Celltrion MSD Roche BMS Lilly and Pfizer all unrelated to this manuscript. K.A. <section> has no conflicts of interest.",TRUE,"<section> Funding The study was supported by the Federal Ministry of Education and Research within the network TARISMA [01EC1902A].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-002998",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The registry is funded in part by the German Society for Rheumatology.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003059",TRUE,"Competing interests ELM reports royalties or licences from UpToDate; consulting fees from Boehringer Ingelheim and Alvotech Inc.; payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Boehringer Ingelheim; participation on a Data Safety Monitoring Board or Advisory Board for Horizon Therapeutics Inc. and National Institutes of Health; and unpaid leadership or fiduciary role for American College of Rheumatology.",TRUE,"<section> Funding This review was supported by Boehringer Ingelheim International GmbH (BI).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003102",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003252",TRUE,"Competing interests STU is participant in the BIH-­Charité Junior Digital Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health.",TRUE,"<section> Acknowledgements This research project was funded by the Assessment of Spondyloarthritis international Society (ASAS) (research grant for KZ). The authors thank the Berlin Institute of Health for personal funding (STU JR LCA and TD) and providing essential infrastructure for data collection. <section> Funding The funding sources were not involved in study design in the collection analysis and interpretation of data in the writing of the report or in the decision to submit the paper for publication. All other authors have no funding to report.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003302",TRUE,"Competing interests EM has been on speaker bureaus for has been a consultant for and or received grant/research support from: AbbVie Amgen Asahi Kasei Pharma AstraZeneca Biogen Bristol Myers Squibb Capella Therapeutics Eli Lilly and Company EMD Serono Galapagos Genentech Gilead GlaxoSmithKline Janssen Novartis Sanofi Servier UCB Pharma and Wolf Bio.",TRUE,"<section> Funding This study was sponsored by Eli Lilly and Company under licence from Incyte Corporation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003357",TRUE,"Competing interests STU is participant in the BIH-­Charité Junior Digital Clinician Scientist Program funded by the Charité-Universitätsmedizin Berlin and the Berlin Institute of Health.",TRUE,"<section> Acknowledgements This research project was supported by the Assessment of Spondyloarthritis international Society (ASAS) (research grant for KZ). The authors thank the Berlin Institute of Health for personal funding (STU JR and TD) and providing essential infrastructure for data collection. <section> Funding This research project was funded by the Assessment of Spondyloarthritis international Society (ASAS) and the Berlin Institute of Health.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003489",TRUE,"Competing interests YM: Lecture honoraria from Lilly Pfizer.",TRUE,"<section> Funding RABBIT is supported by a joint unconditional grant from AbbVie Amgen Bristol Myers Squibb Celltrion Fresenius Kabi Galapagos Hexal Lilly MSD Pfizer Samsung Biosepis Sanofi Aventis UCB and Viatris and previously by Roche.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003538",TRUE,"Competing interests MK received consulting fees or honoraria from Amgen Janssen-­Cilag Lilly Novartis and UCB and received travel support from UCB. UK received grant and research support and consultancy fees from AbbVie Amgen Biocad Biogen BMS Chugai Eli Lilly Fresenius Gilead Grünenthal GSK Hexal Janssen MSD Novartis onkowissen.de Pfizer Roche UCB and Viatris and participated on a data safety monitoring or advisory board for the COPAGO trial conducted by the German Ministry of Health. GRB received fees or honoraria for serving as a speaker and/or consultant from Abbvie Galapagos Janssen Lilly Novartis and UCB meeting or travel support from Abbvie and Lilly and is the editor-­in-­chief of RMD Open. DMK received honoraria for serving as a speaker for Sanofi-­Aventis. SF received scientific grants from Novartis honoraria or fees for serving as a speaker and/or consultant from Abbvie AstraZeneca Chugai Galapagos Novartis NovoNordisc and UCB and travel or meeting support from Abbvie Galapagos Janssen Cilag Novartis SOBI and UCB. RB received honoraria or fees for serving as a speaker and/or consultant from Abbvie BMS Chugai GSK Galapagos Novartis Roche and Vifor and meeting or travel support from Chugai and Galapagos. MS received research support from Charité. FB received research support for this study from Janssen Cilag consulting fees or honoraria from Abbvie Acelyrin Amgen Janssen Cilag Lily Novartis Pfizer and UCB and meeting or travel support from Abbvie and UCB. ACF TR HK and JB have no competing interests to declare.",TRUE,"The manuscript was prepared by MK ACF TR and FB with medical writing support provided by Sharon L. <section> Funding The study was supported by a grant from Janssen Cilag who in addition provided study medication; they had no influence on the design conduct or analysis of the trial. Medical writing services were supported by Fraunhofer Institute for Translational Medicine & Pharmacology ITMP Frankfurt am Main Germany a non-­profit organisation. The clinical research group Frankfurt is supported by the Fraunhofer Cluster of Excellence for Immune-­Mediated Diseases (CIMD) and the LOEWE Zentrum Translational Medicine and Pharmacology.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/rmdopen-2023-003604",TRUE,"Competing interests None declared.",TRUE,"<section> Funding The authors have not declared a specific grant for this research from any funding agency in the public commercial or not-­for-­profit sectors.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/svn-2022-001784",TRUE,"Competing interests PK TI IL MS declare no disclosures or competing interest.",TRUE,"<section> Funding The INSPIRE-­TMS trial was funded by the German Federal Ministry of Education and Research Pfizer and German Stroke Foundation. HJA has received funding from the Deutsche Forschungsgemeinschaft (DFG) the Federal Ministry of Research and Education (BMBF) and the German Innovation Fund for other projects.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/svn-2022-002179",TRUE,"Competing interests RW received grants from Deutsches Zentrum für Herz-/ Kreislaufforschung Deutsche Forschungsgemeinschaft European Union Bundesministerium für Bildung und Forschung Medtronic and Boehringer Ingelheim as well as personal fees from Astra Bayer Boehringer Ingelheim CVRx Daiichi BMS Medtronic Novartis Pfizer Pharmacosmos and Servier all outside the submitted work. ME received funding from DFG under Germany's Excellence Strategy—EXC-­2049—390688087 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. ME reports grants from Bayer and fees paid to the Charité from AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo Amgen GSK Sanofi Covidien Novartis Pfizer all outside the submitted work. CHN received research grants from German Ministry of Research and Education German Center for Neurodegenerative Diseases German Center for cardiovascular Research and speaker and/or consultation fees from Alexion Abbott Bayer Boehringer Ingelheim Bristol-­Myers Squibb Pfizer Pharma and Daiichi Sankyo. KGH reports a study grant by Bayer lecture fees/advisory board fees from Abbott Amarin Alexion AstraZeneca Bayer Biotronik Boehringer Ingelheim Boston Scientific Bristol-­ Myers-­Squibb Daiichi Sankyo Edwards Lifesciences Medtronic Pfizer Portola Sun Pharma and W. L. Gore & Associates. All other authors declare no conflicts of interest.",TRUE,"<section> Funding This study was supported by the German Ministry of Education and Research (grant G.2.17 Center for Stroke Research Berlin) by the DZHK (German Center for Cardiovascular Research) (grant B14-­035_SE) and by the GETEMED AG Teltow Germany by supplying ECG recorders. <section> Competing interests RW received grants from Deutsches Zentrum für Herz-/ Kreislaufforschung Deutsche Forschungsgemeinschaft European Union Bundesministerium für Bildung und Forschung Medtronic and Boehringer Ingelheim as well as personal fees from Astra Bayer Boehringer Ingelheim CVRx Daiichi BMS Medtronic Novartis Pfizer Pharmacosmos and Servier all outside the submitted work. ME received funding from DFG under Germany's Excellence Strategy—EXC-­2049—390688087 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1136/thorax-2022-219653",TRUE,"Competing interests PBM reports grants and personal fees from Philips grants and personal fees from ResMed grants and personal fees from F&P grants and personal fees from B&D Electromedical personal fees from Santhera outside the submitted work.",TRUE,"<section> Funding The original randomised controlled trial was supported by unrestricted educational grants from Philips-­Respironics (Pennsylvania USA) ResMed (California USA) ResMed Foundation and Guy’s & St Thomas’ Charity. The study was supported by Guy’s and St Thomas’ NHS Foundation Trust and King’s College London National Institute of Health Research Comprehensive Biomedical Research Centre London UK and the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The health economic analysis was funded equally by Philips-­Respironics and ResMed.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1145/3569894",FALSE,"",TRUE,"<section> This work received funding from Bosch Research and from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 714797).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1146/annurev-cancerbio-061521-082320",TRUE,"<section> DISCLOSURE STATEMENT <section> G.P. and M.J.R. are joint inventors on a Charité – Universitätsmedizin Berlin–owned patent application covering aspects of CAR NK cell products. G.P. has funding grants for CAR NK cell research from the Berlin Institute of Health at Charité through the SPARK Program Berlin Germany. A.S.F. has no disclosures.",TRUE,"The authors are not aware of any other affiliations memberships funding or financial holdings that might be perceived as affecting the objectivity of this review.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1146/annurev-med-042921-112347",TRUE,"<section> DISCLOSURE STATEMENT <section> S.J. is a paid consultant to Novartis AVROBIO Roche Genentech GSK Foresite Labs and TenSixteen Bio and is on the scientific advisory boards of Bitterroot Bio and TenSixteen Bio.",TRUE,"<section> This work was supported by grants to S.J. from the Burroughs Wellcome Fund Career Award for Medical Scientists Fondation Leducq (TNE-18CVD04) the Ludwig Center for Cancer Stem Cell Research at Stanford University and the National Institutes of Health (DP2-HL157540).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1148/radiol.220229",TRUE,"Disclosures of conflicts of interest: L.M.",TRUE,"Supported by Exxon-Mobil NUS Research Fellowship; Ministry of Health Healthcare Research Scholarship Singapore; editorial board member for the Singapore Medical Journal.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1148/radiol.222276",TRUE,"Disclosures of conflicts of interest: C.A.H.",TRUE,"<section> Study supported by the Berlin Institute of Health (Clinician and Junior Digital Clinician Research project Sondierungsprojekt zu KI in der Pflege (SOKIP) funded by German Federal Ministry of Research and Education; AI Lighthouse Project Green Consumption Assistant with ecosia and TU Berlin funded by German Federal Ministry for the Environment; Research grant on Prozessentwicklung und -begleitung zum KI-Einsatz in der Pflege (ProKIP) funded by the German Federal Ministry of Research; Research grant on KI in der Pflege-Sturz / Delir / Medikation (KIP-SDM) funded by the German Federal Ministry of Research; Research grant on Reduction of the Impact of untreated Waste Water on the Environment in case of torrential Rain (RIWWER) funded by the German Federal Ministry for Economic Affairs and Climate Action; Research grant on Citizenbased Monitoring for Peace & Security in the Era of Synthetic Media and Deepfakes funded by the German Foundation for Peace Research.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1148/radiol.230084",TRUE,"Disclosures of conflicts of interest: J.F.H.",TRUE,"Received January 12 2023; revision requested March 13; revision received May Supported by the German Research Foundation (DFG) (project no. VE1008/1-1 KO Conflicts of interest are listed at the end of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1148/radiol.230806",TRUE,"Disclosures of conflicts of interest: F.K.",TRUE,"J.N.K. is supported by the German Federal Ministry of Health (DEEP LIVER ZMVI1-2520DAT111) S.N. is supported by the Deutsche Forschungsgemeinschaft (DFG) (NE 2136/3-1).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1148/rg.230052",TRUE,"Disclosures of conflicts of interest.—",TRUE,"<section> Funding.— J.Z. supported by the Leeds-Manchester Stella Erdheim Clinical PhD Fellowship grant (95653117/95653118) a Cancer Research United Kingdom (CRUK) award. A.C. and P.H. supported by the National Institute of Health and Care Research (NIHR) and the CRUK Manchester Centre award (CTRQQR-2021\\100010). A.S. and A.H. supported by the CRUK Leeds Radiation Therapy Research Centre of Excellence grant (RadNet C19942/A28832). A.S. supported by the Innovate UK (National Consortium for Intelligent Medical Imaging grant [104688]) and Leeds Hospitals Charity Cancer Imaging grant (9R01-1403).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajpcell.00101.2023",TRUE,"<section> DISCLOSURES <section> J. Trebicka has received speaking and/or consulting fees from Versantis Gore Boehringer-Ingelheim Falk Grifols Genﬁt and CSL Behring. None of the other authors has any conﬂicts of interest ﬁnancial or otherwise to disclose.",TRUE,"<section> This work was supported by the Hessian Ministry of Higher Education Research and the Arts (HMWK) for the ACLF-I cluster projects and by the German Research Council: SFB 1177 (ID 259130777 project E02 to LS) SFB 1382 (ID 403224013 project A09 to JT) by the German Federal Ministry of Education and Research (BMBF) for the DEEP-HCC project to J.T. J.T. has received funding from the European Union’s Horizon 2020 research and innovation program for MICROB-PREDICT (project ID 825694) DECISION (project ID 847949) GALAXY (project ID 668031) LIVERHOPE (project ID 731875) and IHMCSA (project ID 964590) projects.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajpcell.00177.2023",TRUE,"<section> DISCLOSURES <section> No conﬂicts of interest ﬁnancial or otherwise are declared by the",TRUE,"<section> X.C. was supported by China Scholarship Council.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajpcell.00528.2022",TRUE,"<section> DISCLOSURES <section> B.K.K. reports lecture fees and/or advisory board memberships and/or study participation from Astellas Bayer Boehringer Ingelheim Chiesi Riepharm Pﬁzer Sanoﬁ Servier and Vifor Pharma all not related to the submitted work. D.D. and T.K. are research employees of Boehringer Ingelheim. None of the other authors has any conﬂicts of interest ﬁnancial or otherwise to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajpgi.00123.2022",TRUE,"Disclosures: <section> The authors declare no conflict of interest.",TRUE,"<section> Financial support: This work was supported by a grant from the Novartis Foundation for MedicalBiological Research and a grant from Ente Ospedaliero Cantonale to Sheida Moghadamrad. OJ was supported by the Swiss National Science Foundation (IZSEZ0_205275). JZ was supported by the Marie Sklodowska-Curie grant 744257.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajpheart.00612.2022",TRUE,"<section> DISCLOSURES <section> No conﬂicts of interest ﬁnancial or otherwise are declared by the",TRUE,"<section> This work was supported by National Heart Lung and Blood Institute Grant R21HL159501 (to W.L.M.) and University of Florida Health Cancer Center Pilot Grant 00096885 CAFY22-03.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajplung.00040.2023",TRUE,"<section> DISCLOSURES <section> Wolfgang Kuebler is an editor of American Journal of Physiology-Lung Cellular and Molecular Physiology and was not involved and did not have access to information regarding the peer-review process or ﬁnal disposition of this article. An alternate editor oversaw the peer-review and decision-making process for this article. None of the other authors has any conﬂicts of interest ﬁnancial or otherwise to disclose.",TRUE,"<section> This work was supported in part by a Society of Pediatric Anesthesia Young Investigator Award (to M.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajplung.00296.2022",TRUE,"<section> DISCLOSURES <section> No conﬂicts of interest ﬁnancial or otherwise are declared by the",TRUE,"<section> The project was funded by the Deutsche Forschungsgemeinschaft (DFG; BR5347/2-1 and #456214861) the Hochschulinterne Leistungsf € o rderung (HilF) of the Hannover Medical School and by the Bundesministerium f u € r Bildung und Forschung via the German Center for Lung Research.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajplung.00379.2022",TRUE,"<section> DISCLOSURES <section> No conﬂicts of interest ﬁnancial or otherwise are declared by the",TRUE,"P.M.P. was supported by a Max Kade Postdoctoral Research Exchange Grant of the Max Kade Foundation NY and the Austrian Academy of Sciences VIE AUT.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/ajplung.00430.2021",TRUE,"<section> DISCLOSURES <section> O. Dietrich reports nonﬁnancial support from Siemens Healthineers outside the submitted work. M. O. Wielp€ utz reports grants from Vertex grants from Boehringer Ingelheim outside the submitted work. M. A. Mall reports grants from German Federal Ministry of Education and Research grants from Einstein Foundation Berlin during the conduct of the study; personal fees from Bayer personal fees from Boehringer Ingelheim personal fees from Polyphor personal fees from Arrowhead Pharmaceuticals personal fees from ProQR Therapeutics personal fees from Spyryx Biosciences personal fees from Vertex Pharmaceuticals personal fees from Santhera personal fees from Galapagos personal fees from Sterna Biologicals personal fees from Enterprise Therapeutics personal fees from Celtaxys outside the submitted work. None of the other authors has any conﬂicts of interest ﬁnancial or otherwise to",TRUE,"<section> This work was supported by NWG VH-NG-829 (Helmholtz Association) the German Center for Lung Research (DZL) (Federal Ministry of Science) and the Einstein Foundation Berlin",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1152/physiolgenomics.00070.2023",TRUE,"<section> DISCLOSURES <section> No conﬂicts of interest ﬁnancial or otherwise are declared by the",TRUE,"<section> This work was supported in whole or in part by the Al Jalila Foundation National Institutes of Health Grant U01HL131003 internal grant awards from Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) College of Medicine (MBRU-CM-RG2018-04 MBRU-CM-RG2020-02 MBRU-CM-RG2020-12 MBRU-CM-RG202104 and MBRU-CM-RG2022-12) Al-Mahmeed Collaborative Research Awards ALM1801 and ALM20-0074 and Pediatric Cardiac Genomics Consortium Grant U01HL131003. R.T. was supported by MBRU Postdoctoral Fellow award MBRU-2020-04 and PCGC/CDDRC fellowship 5U01HL131003-08 subaward no. OS00000703/313946.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/3901448",TRUE,"Conflicts of Interest <section> Te authors declare that they have no conficts of interest.",TRUE,"<section> Tis work was supported by the European Union Framework Program(grant no. EU 953134-INKplant).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/4659041",TRUE,"Conflicts of Interest <section> The authors declare that there is no conﬂict of interest regarding this publication.",TRUE,"<section> The study was supported by the TSB (Technologie Stiftung Berlin) and the European Union (ERDF European Regional Development Fund) Philips Healthcare (Best Netherlands) Bayer Healthcare Pharmaceuticals (Berlin Germany) and B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/6243771",TRUE,"Conflicts of Interest <section> Te authors declare that there are no conficts of interest.",TRUE,"<section> Tis work was supported by Guangdong Engineering Technology Research Center (507204531040) Guangzhou Medical Key Discipline Construction Project (2021–2023) Guangzhou Development Zone Entrepreneurship Leading Talent Project (no. 2017-L153) Guangdong Province Union Training Postgraduate Demonstration Base (no. 20190630) Guangzhou Entrepreneurship Leading Team (no. <section> 202009030005) and Guangdong Science and Technology projects (no. 2020A1313030112).",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/8092828",TRUE,"Conflicts of Interest <section> The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/8462291",TRUE,"Conflicts of Interest",TRUE,"<section> Tere was no external funding for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1155/2023/8873653",TRUE,"Conflicts of Interest <section> [14] L. Schlaﬀke S. Lissek M. Lenz et al. “Shared and nonshared <section> neural networks of cognitive and aﬀective theory-of-mind: a <section> The authors declare that there is no conﬂict of interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1158/0008-5472.can-22-0275",TRUE,"Disclosures No disclosures were reported by the other",TRUE,"<section> This work was supported by grants from the NCI (P01 CA206978 and R01CA216273 to C.J. L. Penter is supported by a research fellowship from the German Research Foundation (DFG PE 3127/1-1). Lareau is supported by a Stanford Science Fellowship. Ludwig is supported by an Emmy Noether fellowship by the German Research Foundation (DFG LU 2336/2-1). S. Li is supported by the NCI Research Specialist Award (R50CA251956).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1158/0008-5472.can-22-0391",TRUE,"Disclosures <section> conflicts of interest.",TRUE,"Waters was supported by a fellowship from the American Cancer Society (PF-18-061). S. Javaid was supported by a Fellowship from the Royster Society of Fellows. Klomp was supported by NCI T32CA009156 NCI F32CA239328 and American Cancer Society PF-20-069. Bryant was supported by the 2015 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant (15-70-25- K. Drizyte-Miller was supported by NCI T32CA009156 and American Cancer Society (PF-22-066-01). Petricoin were supported by NIH grant CA203657.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1158/1078-0432.ccr-22-1587",TRUE,"Conflict of interest statement All other authors declare no competing interests.",TRUE,"<section> The WSG-ASAPT-HER2+/HRtrial was financially supported by Roche and Bayer.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1158/1078-0432.ccr-22-2032",TRUE,"Disclosures <section> L. Molinero H.",TRUE,"<section> Financial Support: This work was supported by F. The trial was sponsored designed and conducted by F. <section> Medical writing assistance for this manuscript was provided by Jennifer Kelly MA (Medi-Kelsey Ltd Ashbourne UK) funded by F.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This trial is registered with ClinicalTrials.gov NCT03038100.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1158/1078-0432.ccr-22-3790",TRUE,"Competing interests I. <section> All other co-authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This study was supported by Zentrum für Personalisierte Medizin (ZPM-Network BW Project MAX-PRO) the German Cancer Consortium (DKTK) the Helmholtz Cross-Program Initiative Personalized Medicine (iMed) project on “Multi-Scale Integrative Biology of HNSCC” and intramural funds from the National Center for Tumor Diseases (NCT) Heidelberg Radiation Oncology Program. Bouchra Tawk was supported by a stipend of the German Cancer Research Center (DKFZ) Clinician Scientist Program supported by the Dieter Morszeck Foundation. (https://www.dkfz.de/en/clinicianscientist/index.html).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: Retrospective observational study from the German Cancer Consortium (DKTK-ROG) not interventional.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1158/1078-0432.ccr-22-3815",TRUE,"Conflict of Interest.",TRUE,"<section> PH received grants from Astra Zeneca Roche GSK Genmab DFG European Union DKH Immunogen Seagen Clovis Novartis; honoraria from Amgen Astra Zeneca GSK Roche Sotio Stryker Zai Lab MSD Clovis Eisai Mersana Exscientia and is involved through the advisory board of Astra Zeneca Roche GSK Clovis Immunogen MSD Novartis Eisai. <section> SK received grant support from GSK; honoraria from GSK AstraZeneca Eisai MSD and is involved through the advisory board GSK AstraZeneca MSD Roche. <section> We further acknowledge the following financial support: This research was funded in part by the Janet D. SJ Ramus and DW Garsed are supported by National Health and Medical Research Council of Australia (NHMRC) grant APP2009840 (SJR) and grant 1186505 (DWG). This work was supported by the U.S.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1158/1078-0432.ccr-23-0621",TRUE,"Conflict of Interest Statement The other authors do not have potential conflicts of interest to disclose.",TRUE,"<section> Role of the Funding Source: R.N. Aghajanian are funded in part by the National Cancer Institute (NCI) at the National Institutes of Health (NIH; P30 CA008748). The MILO/ENGOT‐ov11 study was supported by Pfizer.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1158/2643-3230.bcd-22-0007",TRUE,"Conflict of Interests H.C.R. received consulting and lecture fees from Roche Novartis BMS Abbvie AstraZeneca Vertex and Merck; H.C.R. received research funding from Gilead Sciences and AstraZeneca. H.C.R. is a co-founder of CDL Therapeutics GmbH. B.v.T reports non-financial support from AbbVie personal fees and non-financial support from BMS; personal fees from Amgen AstraZeneca Pfizer Gilead Sciences Pentixafarm and Roche; grants personal fees and non-financial support from MSD and Takeda; and grants personal fees and non-financial support from Novartis. The remaining authors declare no competing financial interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1158/2643-3230.bcd-22-0082",TRUE,"Competing interests C.J.W. is an equity holder of BioNtech Inc. and receives research funding from Pharmacyclics; K.C. is an employee shareholder and officer of Edilytics Inc. ; J.B. receives honoraria from AstraZeneca Gilead Janssen Novartis consulting fees from AstraZeneca and research funding from Janssen and Novartis; R.G. reports receiving research funds from Roche Astrazeneca Amgen and Abbvie and consulting fees from Roche Astrazeneca Janseen Abbvie and Gilead; M.S.D. reports receiving grant support paid to his institution and consulting fees from Ascentage Pharma AstraZeneca BMS Genentech MEI Pharma Novartis Pharmacyclics TG Therapeutics grant support paid to his institution from Surface Oncology and consulting fees from AbbVie Adaptive Biotechnologies BeiGene Celgene Eli Lilly Janssen Merck and 61 Takeda; St.St. and E.T. were supported by DFG through SFB1074 subprojects B1 B2 and B10; St.St. receives advisory board honoraria research travel support and speaker fees from AbbVie AstraZeneca BeiGene BMS Gilead Hoffmann-La Roche Janssen Novartis Sunesis; P.F. <section> receives advisory board honoraria research travel support and speaker fees from AbbVie AstraZeneca BeiGene Gilead Hoffmann-LaRoche and Janssen; G.G. receives research funds from IBM and Pharmacyclics is an inventor on patent applications related to MuTect and is a founder and consultant of and holds privately held equity in Scorpion Therapeutics. All other authors do not have any relevant conflict of interest.",TRUE,"This study was supported by grants from the NIH/National Cancer Institute (NIH/NCI) (P01 CA206978 R01CA216273). S.Y. was supported by a research fellowship from the Lauri Strauss Leukemia Foundation and is currently supported by NIH/NCI R21CA267527-01. L.P. was supported by a research fellowship from the German Research Foundation (DFG PE 3127/1-1) and is a current Scholar of the American <section> E.P. is supported by a Doris Duke Physician-Scientist Fellowship and an ASCO Conquer Cancer Young Investigator Award. S.L. is supported by the NCI Research Specialist Award (R50CA251956).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1158/2767-9764.crc-23-0101",TRUE,"Conflict of interest: The authors declare no potential conflicts of interest.",TRUE,"<section> Financial support: This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation; SCHI 510/12–1) under Germany's Excellence Strategy—EXC2180–390900677 to B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1158/2767-9764.crc-23-0333",TRUE,"<section> COI/disclosures: Dr. Hanna reports relevant consulting/advisory for Kura Prelude and Remix; research support to institution from AACRF Actuate Elevar Gateway for Cancer Research Genentech Immunitybio and V Foundation.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000518166",TRUE,"Conflict of Interest Statement <section> This work was supported by Ipsen Biopharm Ltd. which was involved in the design and conduct of the study as well as the data collection and management. Additionally the manuscript underwent a professional English proofreading by proof-reading-service.com. The authors have no other conflicts of interest to declare.",TRUE,"<section> A survey of 27 items evaluating diagnostic and therapeutic recommendations (15 cases of strong consensus and 6 cases of consensus) for NMIBC was administered among 14 urologic training courses in Germany and Austria sponsored by Ipsen Biopharm Ltd. the German Society of Residents in Urology e.V the Professional Association of German urologists (BvDU e.V.) and urologic departments of University hospitals in Lübeck and Cologne. <section> This work was supported by Ipsen Biopharm Ltd. which was involved in the design and conduct of the study as well as the data collection and management. <section> Funding Sources",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000523845",TRUE,"Conflict of Interest Statement <section> The authors have no conflicts of interest to declare.",TRUE,"<section> Funding Sources <section> This article uses data from the Berlin Aging Study II (BASE-II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under Grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000524372",TRUE,"Conflict of Interest Statement <section> Beenakker: reports research support from Philips Healthcare. <section> Scholl: editor-in-chief of Ophthalmic Research. All other authors report no conflicts of interest.",TRUE,"<section> This workshop which was supported by the European Vision Institute (EVI) featured numerous new technologies for outcome measures for UM. <section> Funding Sources",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000526836",TRUE,"Conflict of Interest Statement <section> The authors have no conflicts of interest to declare.",TRUE,"<section> The study was also continuously supported by the Medical Director of Charité Ulrich Frei and the Vice Medical Director Joachim Seybold. <section> Funding Sources <section> This study was initially funded by a grant of the Stiftung Charité to L.K.S. and C.D. later personal costs were covered by a grant of the Verein für Frühgeborene Kinder an der Charité to L.K.S. and C.D.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000527652",TRUE,"Conflict of Interest Statement <section> The authors declare that they have no conflicts of interest related to this work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000528315",TRUE,"Conflict of Interest Statement <section> Simone Grimm has served as a consultant to and received research support from Boehringer Ingelheim Pharma. Christian Beckmann and Maarten Mennes are employees of SBGneuro contracted to perform the blinded analysis. Andreas Wunder is an <section> employee of Boehringer Ingelheim International GmbH. Christian Keicher and Rita Hertrampf are employees of Charité Research Organisation. The authors declare no conflict of interest.",TRUE,"<section> Funding Sources <section> This work was funded by Boehringer Ingelheim Pharma GmbH",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"All participants gave written informed consent to participate in the study which was approved by the Local Ethics Committee and registered at ClinicalTrials.gov (NCT04156035). The study is registered at ClinicalTrials.gov (NCT04156035).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000528395",TRUE,"Conflict of Interest Statement <section> Murat Türk has no relevant conflict of interest in relation to this work. Ragıp Ertaş has no relevant conflict of interest in relation to this work. Pavel Kolkhir has no relevant conflict of interest in relation to this work. Ümit Murat Şahiner has no relevant conflict of interest in relation to this work. Bülent Enis Şekerel has no relevant conflict of interest in relation to this work. Özge Soyer has no relevant conflict of interest in relation to this work. Atıl Avcı has no relevant conflict of interest in relation to this work. Mustafa Atasoy has no relevant conflict of interest in relation to this work. Kemal Özyurt has no relevant conflict of interest in relation to this work. Yekta Türk has no relevant conflict of interest in relation to this work. Engin Zeydan has no relevant conflict of interest in relation to this work. Marcus Maurer has no relevant conflicts of interest in relation to this work.",TRUE,"<section> Funding Sources <section> No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000528419",TRUE,"Conflict of Interest Statement <section> Jacopo Saccomanno and Susanne Dittrich have nothing to disclose. Ralf-Harto Hübner has received presentation fees from Olympus Medical Systems and PulmonX International Sarl and has been the head of the Lung Emphysema Registry e.V. and PI of several clinical studies. Martin Witzenrath has attached ICMJE disclosure form.",TRUE,"<section> Funding Sources <section> No funding received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000528805",TRUE,"Conflict of Interest Statement All the remaining authors declare no competing interests.",TRUE,"Claus Ziegler Simonsen is supported by a research grant from Novo Nordisk outside the submitted work. <section> Funding Sources <section> WAKE-UP received funding from the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement No.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000528972",TRUE,"Conflict of Interest Statement",TRUE,"<section> Funding Sources <section> The GC-HBOC was supported by the German Cancer Aid (Grant no. 110837 and Grant no. 70114178 coordinator: Rita K. <section> Schmutzler Cologne) and is currently supported by the Federal Ministry of Education and Research (BMBF) Germany (Grant no. 01GY1901).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The GCHBOC registry was approved by the respective ethics committees (07-048 March 22 2007) and registered in the German Clinical Trials Registry (DRKS-ID: DRKS00017837). <section> The study protocol was reviewed and approved by the Ethics Committee of the University of Cologne approval number 07-048 March 22 2007 and registered in the German Clinical Trials Registry (DRKS-ID: DRKS00017837).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000529040",TRUE,"Conflict of Interest Statement All other authors declare no conflicts of interest.",TRUE,"<section> AMishra is partially supported by the Neurosurgery Research and Education Foundation (2022 Medical Student Summer Research Fellowship). <section> Funding Sources <section> The work on this manuscript was supported by an unconditional grant of the World Society for Stereotactic and Functional Neurosurgery.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000529116",FALSE,"",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000529445",TRUE,"The authors declare that they have no competing interests with regard to the content of the manuscript.",TRUE,"<section> Funding Sources <section> This study was funded by a grant of the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF; Cognitive behavioral therapy for the treatment of LLD – a multicenter randomized observerblinded controlled trial [CBTlate]; Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial is registered at ClinicalTrials.gov (NCT03735576) and DRKS (DRKS00013769).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000529524",TRUE,"None of the authors have any further direct conﬂicts of interest to declare in relation to this study.",TRUE,"<section> SD was supported by the German Cystic Fibrosis Association who made the payment for statistical analysis to STAT-UP Statistical Consulting & Data Science GmbH (MD and FK). <section> The scientiﬁc work of LN FH MM and OS was supported by the German Center for Lung Research funded by the German Federal Ministry of Education and Research. SG and MS were funded by the German Cystic Fibrosis Association and are participants of the BIH-Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the BIH. <section> Funding Sources",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000529550",TRUE,"Conflict of Interest Statement",TRUE,"Nineteen studies were funded by industry studies were funded by public organizations and the authors themselves funded one study. <section> Funding Sources",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000529577",TRUE,"<section> The authors have no conﬂicts of interest to declare.",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000529583",TRUE,"The authors have disclosed their interest fully and no further competing interest exists.",TRUE,"SmartStep Consulting received funding from Argenx Switzerland SA for the conduction of the research and the writing of the publication. <section> Funding Sources <section> This study was funded by argenx Switzerland SA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000529592",TRUE,"Conflict of Interest Statement <section> PvP has received research funding from Germany’s Federal Ministries of Food and Agriculture (BMEL) Education and Research (BMBF) and Environment and Consumer Protection (BMUV) as well as travel cost reimbursements and speaker and manuscript fees from the German and Austrian Nutrition Societies (DGE and ÖGE) among others. ER has received research funding from BMEL and BMBF. ML has received research funding from BMBF. OH is an employee of the German Diabetes Society (DDG) and the German Obesity Society (DAG) and has previously been an employee of foodwatch. The other authors have no conflicts of interest to declare.",TRUE,"<section> Funding Sources <section> The project was supported by funds from members of the German Non-Communicable Disease Alliance including the following: Federal College of Paediatricians German Obesity Association German Heart Foundation Association of Diabetes Advisors and Trainers German Association for Nutritional Medicine and German Association for Social Medicine and Prevention.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Study Registration and Protocol Availability A protocol for this study was developed and prospectively registered with the Open Science Framework (registration DOI 10.17605/OSF.IO/3WJ49) before data were analysed [27].",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000529708",TRUE,"<section> The authors declare that there are no conﬂicts of interest.",TRUE,"<section> Funding Sources <section> The study was funded by the German Society for Allergology and Clinical Immunology.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: The study was registered with the DRKS before study initiation (DRKS00026677).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000529774",TRUE,"<section> The named authors declare no conﬂict of interest.",TRUE,"<section> Funding Sources <section> The authors have no funding sources to report.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000529781",TRUE,"All other authors do not report any conﬂicts of interest.",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000529798",TRUE,"Conﬂict of Interest Statement The authors certify that there is no conﬂict of interest with any ﬁnancial organization regarding the material discussed in the manuscript.",TRUE,"<section> Funding <section> This study was funded by the investigating institute.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000530115",TRUE,"<section> None of the authors has a conﬂict of interest related to this manuscript.",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000530126",TRUE,"<section> The authors have no conﬂicts of interest to declare.",TRUE,"<section> Funding Sources <section> There was no funding for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The review protocol for the meta-analysis was registered on February 26 2019 at the PROSPERO international prospective register of systematic reviews (registration CRD42019124053 available at https://www.crd.york.ac.uk/prospero/display_record. php?",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1159/000530135",FALSE,"",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000530311",TRUE,"<section> The author has no conﬂict of interest to declare.",TRUE,"<section> Funding Sources <section> The author received no funding for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000530312",TRUE,"<section> The authors have no conﬂicts of interest to declare.",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000530418",TRUE,"The authors L.C. and L.H. have no conﬂicts of interest to",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000531128",FALSE,"",TRUE,"<section> Funding Sources <section> The work was funded by institutional research support.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531229",TRUE,"<section> The authors report no conﬂicts of interest regarding this study.",TRUE,"K. Ruprecht has received research support unrelated from this work from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité (BIH Clinical Fellow Program) Arthur Arnstein Foundation and Guthy Jackson Charitable Foundation and travel grants from Guthy Jackson Charitable Foundation. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531268",TRUE,"All remaining authors declared no conﬂicts of interest.",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000531538",TRUE,"All other authors have no conﬂicts of interest to declare.",TRUE,"<section> Funding Sources <section> This research was funded by a grant to J.H. from the German Federal Ministry of Health with regard to a decision of the German Bundestag by the Federal Government CHED-project grant No:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531578",FALSE,"",TRUE,"Trial Funding: Gilead Science. Trial Funding: AstraZeneca. Trial Funding: Amgen AstraZeneca Lilly Novartis Roche. <section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531579",TRUE,"<section> The authors have the following conﬂicts of interest: Prof.",TRUE,"Cornelia Kolberg-Liedtke advisory board: SeaGen Exact Sciences Pﬁzer Novartis AstraZeneca Lilly SeaGen Daiichi Sankyo Agendia Gilead and Onkowissen; and lecture: Novartis Ireland NOGGO CECOG PINK Pﬁzer Roche AstraZeneca Carl Zeiss Meditec Lilly SeaGen and Daiichi Sankyo; other: Gilead Science and POMME; stockholding: Phaon Scientiﬁc and Theraclion SA; and trial Funding: Gilead Science. Hans-Peter Sinn advisory board: Exact Sciences and Daiichi Sankyo; lecture: AstraZeneca; and trial Funding: AstraZeneca. <section> Gilead Science; trial Funding: Amgen AstraZeneca Lilly Novartis and <section> Funding Source",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531712",TRUE,"<section> Authors Marco Del Chiaro Marc Giovannini Alessandro Repici Katrin Salzmann and Uwe Will were not available to conﬁrm co-authorship but the corresponding author Elias Karam afﬁrms that authors Marco Del Chiaro Marc Giovannini Alessandro Repici Katrin Salzmann and Uwe Will contributed to the paper had the opportunity to review the ﬁnal version to be published and guarantees authors Marco Del Chiaro Marc Giovannini Alessandro Repici Katrin Salzmann and Uwe Will coauthorship status and the accuracy of the author contribution and conﬂict of interest statements. <section> Statement of Ethics <section> The ﬁnal study protocol was approved by the Ethics Committee of the Medical Faculty of the University of Leipzig (455/ 18-ek) in accordance with the World Medical Association Declaration of Helsinki the “Medical Association’s Professional Code of Conduct” and the principles of ICH-GCP guidelines (issued in June 1996 ISO14155 from 2012). Furthermore local legal and regulatory authorities as well as the medical secrecy and the Federal Data Protection Act was followed. The need for informed consent was waived by the Ethics Committee of the Medical Faculty of the University of Leipzig (455/18-ek). <section> The authors declare no conﬂict of interest.",TRUE,"<section> This work was performed and written as part of a project of the 9th Pancreas 2000 program funded and organized by the European Pancreatic Club (EPC) and the Karolinska Institute. <section> Funding Sources <section> The authors declare no funding sources.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000531935",FALSE,"",TRUE,"<section> Funding Sources <section> The study was funded by Sanoﬁ-Aventis Deutschland GmbH Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000531936",FALSE,"",TRUE,"<section> Funding Sources <section> The study was funded by Sanoﬁ.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000532102",FALSE,"",TRUE,"<section> Funding Sources <section> This work was supported by Bayer AG who funded for the FIDELIO-DKD study and subanalyses.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000533391",TRUE,"<section> The authors have no conﬂicts of interest to declare.",TRUE,"The registry which is funded by the German Federal Ministry of Education and Research until 2024 aims at structured and qualityassured data collection to further individualize the risk management. <section> Funding Sources <section> No funding was provided for this study.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000533666",FALSE,"",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000533709",TRUE,"<section> The author has no conﬂict of interest to declare.",TRUE,"<section> Funding Sources <section> The author received no funding for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000534620",TRUE,"<section> The authors have no conﬂicts of interest to declare.",TRUE,"<section> Funding Sources <section> This study was supported by Grants from the German Research",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1159/000535027",FALSE,"",TRUE,"<section> Funding Sources <section> No funding was received for conducting this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1159/000535416",FALSE,"",TRUE,"<section> Funding Sources",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.11607/jomi.9698",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.11607/prd.5769",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.11607/prd.6155",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1161/circheartfailure.122.009972",TRUE,"Disclosures see page <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page <section> Source of Funding <section> This work is supported by grants from the National Institutes of Health (NIH) and the Ofﬁce of Dietary Supplements (P01 HL147823 R01HL103866 R01HL126827) and the Foundation Leducq (17CVD01). Dr Romano was supported in part by training grant T32HL134622 from the National Heart Lung and Blood Institute of the NIH. Dr Witkowski was supported by an award from the Deutsche Forschungsgemeinschaft (WI 5229/1-1).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> REGISTRATION: URL: https://clinicaltrials.gov/; Unique identifier: Unique identifier: DRKS00020915. For these analyses we measured that PAGln signaled via adrenergic serum PAGln levels from subjects enrolled in a simialtered sympathetic tone is a key lar registry of sequential cardiology patients undergothe development of HF 1819 we sought to ing coronary angiography at a tertiary referral center PAGln levels show a clinical association in Europe (European Cohort; for details see Methods severity.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1161/circheartfailure.123.010599",TRUE,"Disclosures see page <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page <section> Sources of Funding Funding for this research was provided by Merck Sharp & Dohme Corp. a subsidiary of Merck & Co Inc Kenilworth NJ and Bayer AG Wuppertal Germany.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/circheartfailure.123.010673",TRUE,"Disclosures see page 1050. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 1050. <section> Sources of Funding <section> This study was supported by grant PI15/02229 from the Instituto de Salud Carlos III Spain. Dr Tamargo was partially supported by grants from the Fundación para la Investigación Biomédica Gregorio Marañón Spain and CM20/00054 from the Instituto de Salud Carlos III Spain. In addition the work was supported by the Netherlands Organization for Scientific Research (NWO-ZonMw VIDI grant 016.176.340 to Dr Lumens).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/circresaha.123.321878",TRUE,"Disclosures see page 1314. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 1314. <section> Sources of Funding <section> This work was supported by the National Institutes of Health (NIH) R01 HL164520 R21 AI145356 R21 AI152318 and R21 AI154927 to D.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/circulationaha.122.060757",TRUE,"Disclosures see page 1652. <section> Disclosures Drs Kirwan and Rosano declare no competing interests.",TRUE,"<section> For Sources of Funding and Disclosures see page 1652. <section> Sources of Funding Dr Anker has received grants from Abbott Vascular and Vifor International; and personal fees from Amgen Astra Zeneca Bayer Boehringer Ingelheim Bioventrix Brahms Cardiac Dimensions Cardior Cordio CVRx Edwards Impulse Dynamics Janssen Novartis Occlutech Respicardia Servier Vectorious and V-Wave all outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02937454.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1161/circulationaha.123.065134",TRUE,"Disclosures see page <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page Funding was provided by AstraZeneca with a contract that provided no limitations on data to be considered for publication. <section> Sources of Funding Dr Borlaug is also supported in part by research grants from the National Institutes of Health (R01 HL128526 R01 HL162828 and U01 HL160226) and the US Department of Defense (W81XWH2210245).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/hypertensionaha.122.20392",TRUE,"Disclosures see page <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page <section> Sources of Funding <section> This research was funded by the Deutsche Forschungsgemeinschaft (project number: 394046635—SFB 1365).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/hypertensionaha.122.20767",TRUE,"Disclosures see page 1609. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 1609. <section> Sources of Funding L. Fei received support from China Scholarship Council (202006380140).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1161/jaha.122.027149",TRUE,"Disclosures see page © 2023 The Authors. <section> Disclosures The remaining authors have no disclosures to report.",TRUE,"<section> For Sources of Funding and Disclosures see page © 2023 The Authors. <section> Study Design and Patients The MonDAFIS study was an investigator-­initiated prospective multicenter study sponsored by the Charité -­ Universitätsmedizin Berlin Germany and supported by an unrestricted research grant to the Charité from Bayer Vital GmbH Germany which had no influence on study design study protocol collection analysis interpretation of data and writing and submitting the paper for publication. <section> Sources of Funding <section> The MonDAFIS study is an investigator-­initiated prospective randomized multicentre study sponsored by the Charité -­ Universitätsmedizin Berlin Germany and supported by an unrestricted research grant from Bayer Vital GmbH Germany to the Charité –­ Universitätsmedizin Berlin Germany. Dr Kirchhof receives research support for basic translational and clinical research projects from European Union British Heart Foundation Leducq Foundation Medical Research Council (UK) and German Centre for Cardiovascular Research from several drug and device companies active in atrial fibrillation has received honoraria from several such companies in the past and is listed as inventor on 2 patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571 Markers for Atrial Fibrillation WO 2016012783). <section> Dr Heuschmann reports grants from Charité -­ Universitätsmedizin Berlin during study conduct (within MonDAFIS for biometry; member scientific board); research grants from German Ministry of Research and Education German Research Foundation research grants from Bavarian State (ministry for science and the arts) (within STAAB COVID-­ 19) European Union Charité –­ Universitätsmedizin Berlin Berlin Chamber of Physicians German Parkinson Society University Hospital Würzburg Robert Koch Institute German Heart Foundation Federal Joint Committee (G-­ BA) within the Innovationsfonds University Hospital Heidelberg (within RASUNOA-­ prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer BMS Boehringer-­ Ingelheim Daiichi Sankyo) University Göttingen (within FIND-­ AF randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer-­Ingelheim) outside the submitted work.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02204267.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1161/jaha.122.027284",TRUE,"Disclosures see page © 2023 The Authors. <section> Disclosures <section> Drs Braemswig Kusserow Bellmann Beckhoff Reinthaler von Rennenberg Erdur Scheitz Galinovic and Villringer: no conflicts of interest. Dr Leistner: no relevant conflicts of interest with respect to this study topic. Dr Audebert: no relevant conflicts of interest. Dr Endres: no relevant conflicts of interest. Dr Landmesser: no relevant conflicts of interest. <section> Haeusler: no relevant conflicts of interest. Dr Fiebach: no relevant conflicts of interest. Dr Lauten: no conflicts of interest. <section> Dr Rillig: no relevant conflicts of interest. Dr Nolte: no relevant conflicts of interest.",TRUE,"<section> For Sources of Funding and Disclosures see page © 2023 The Authors. <section> Sources of Funding Dr Endres received funding from DFG under Germany’s Excellence Strategy—­ E XC-­ 2049—­ 390 688 087 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> CLINICAL TRIAL REGISTRATION: German Clinical Trials Register: DRKS00010300 ClinicalTrials.gov : NCT03104556 (https://clinicaltrials.gov/ct2/show/NCT03104556?",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1161/jaha.122.027619",TRUE,"Disclosures see page © 2023 The Authors. <section> Disclosures Dr Heidecker is an inventor on patents that use RNA for diagnosis of myocarditis. The remaining authors have no disclosures to report.",TRUE,"<section> For Sources of Funding and Disclosures see page © 2023 The Authors. <section> Sources of Funding This study was funded by a project grant from the Swiss National Science Foundation issued to Dr Heidecker (money follows researcher program).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/jaha.122.027652",TRUE,"Disclosures see page © 2022 The Authors and Boehringer Ingelheim International GmbH. Disclosures ARTICLE INFORMATION Received September 23 2022; accepted November 14 2022. ; Institut Lorrain Dr Khan reports no relevant disclosures.",TRUE,"<section> For Sources of Funding and Disclosures see page © 2022 The Authors and Boehringer Ingelheim International GmbH. Sources of Funding The EMPEROR-­Reduced trial was funded by the Boehringer Ingelheim & Eli Lilly and Company. Dr Anker has received grants from Vifor Pharma; personal fees from Bayer Brahms GmbH Cardiac Dimensions Cordio Novartis Servier; and has received grants and personal fees from Abbott Vascular outside the submitted work. Dr Januzzi is a Trustee of the American College of Cardiology a Board member of Imbria Pharmaceuticals has received grant support from Applied Therapeutics Innolife Novartis Pharmaceuticals and Abbott Diagnostics; consulting income",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/jaha.122.028516",TRUE,"Disclosures see page xxx. <section> Disclosures The remaining authors have no disclosures to report.",TRUE,"<section> For Sources of Funding and Disclosures see page xxx. <section> The authors received no financial support for the research authorship and/ or publication of this article and agreed on the decision to submit for publication. <section> Sources of Funding C. <section> Arnott is supported by an NHMRC/MRFF Priority Fellowship and a NSW Health EMC Grant. Dr Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health/ National Center for Advancing Translational Sciences Award UL1TR002541); has received research grant support from Amgen and Boehringer Ingelheim; served on advisory boards for Amgen American Regent AstraZeneca Baxter Healthcare Bayer AG Boehringer Ingelheim Cytokinetics and Relypsa; and served on clinical end point committees for studies sponsored by Galmed Novartis and the National Institutes of Health. Jardine is supported by a Medical Research Future Fund Next Generation Clinical Researchers Program Career Development Fellowship; is responsible for research projects that have received unrestricted funding from Baxter Amgen Eli Lilly and Merck Sharpe Dohme; serves on a steering committee sponsored by CSL; has served on advisory boards sponsored by",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT01032629 NCT01989754 NCT02065791.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1161/jaha.123.032441",TRUE,"Disclosures see page © 2023 The Authors. <section> Disclosures Dr Liman received grant support from the German Research Foundation. The remaining authors have no disclosures to report.",TRUE,"<section> For Sources of Funding and Disclosures see page © 2023 The Authors. <section> Sources of Funding The PROSCIS-B study received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801) until May 2018. <section> Disclosures Dr Liman received grant support from the German Research Foundation. Dr Endres received grant support from Bayer the German Research Foundation the German Federal Ministry of Education and Research the German Center for Neurodegenerative Diseases the German Centre for Cardiovascular Research the European Union Corona Foundation and Fondation Leducq.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.122.040247",TRUE,"Disclosures see page 1724. <section> Disclosures R.L. has no personal disclosures but reports consultancy fees paid to the institution from Ischemaview and Boehringer-Ingelheim.",TRUE,"<section> For Sources of Funding and Disclosures see page 1724. <section> Sources of Funding <section> This work was supported by a grant (278276) from the European Union Seventh Framework Program and by a grant from Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—SFB 936—178316478 C1 (CG) and C2 (Drs Cheng and Thomalla). Dr Simonsen is supported by research grants from Novo Nordisk Foundation and Health Research Foundation of Central Denmark Region.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.122.041302",TRUE,"Disclosures see page Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/STROKEAHA.122.041302. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/STROKEAHA.122.041302. <section> Sources of Funding Dr Katsanos is supported from a McMaster University Department of Medicine Career Research Award. Dr Goldstein has received support from the National Institutes of Health Pfizer Takeda Octapharma CSL Behring Astrazeneca Alexion Pharmaceuticals NControl and Cayuga.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.122.041442",TRUE,"Disclosures see page 1514 © 2023 The Authors. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 1514 © 2023 The Authors. <section> Sources of Funding <section> This work has received funding from the German Federal Ministry of Education and Research through a GOBio grant for the research group PREDICTioN2020 (lead: Dr Frey) and funding from the European Commission via the Horizon 2020 program for Precise4Q (No. 777107 lead: Dr Frey).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.122.041505",TRUE,"Disclosures see page 1567. <section> Disclosures Dr Lemmens has no personal disclosures but reports consultancy fees paid to the institution from Ischemaview and Boehringer Ingelheim.",TRUE,"<section> For Sources of Funding and Disclosures see page 1567. <section> Sources of Funding <section> WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-Up Stroke) received funding from the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement no.278276. Dr Scheldeman is supported by Research Foundation Flanders PhD fellowship fundamental research 1193620 N. Dr Endres received funding from Deutsche Forschungsgemeinschaft under Germany’s Excellence Strategy -EXC-2049390688087 BMBF DZNE DZHK EU Corona Foundation and Fondation",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.123.042632",TRUE,"Disclosures see page 2649–2650. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 2649–2650. <section> Sources of Funding Funding was received by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (R01NS102969 to Dr Ayata; R25NS065743 KL2TR002542 and K08NS112601 to Dr Chung; R01AA027097 and R00AG042026 to Dr Yaseen) Fondation Leducq (Drs Ayata and Endres) Ellison Foundation (Dr Ayata) Andrew David Heitman Foundation (Drs Ayata and Chung) German Research Foundation under Germany’s Excellence Strategy-EXC-2049–390688087 (Dr Endres) Federal Ministry of Education and Research Germany (Dr Endres) German Center for Neurodegenerative Diseases (Dr Endres) German Center for Cardiovascular Research (Dr Endres) European Union (Dr Endres) Corona Foundation (Dr Endres) American",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.123.042674",TRUE,"Disclosures see page 1716–1717. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 1716–1717. <section> Sources of Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.123.043302",TRUE,"Disclosures see page 2550. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 2550. <section> Sources of Funding <section> The Swiss-AF study is supported by grants of the Swiss National Science Foundation (grant numbers 33CS30_148474 33CS30_177520 32473B_176178 and 32003B_197524) the Swiss Heart Foundation the Foundation for Cardiovascular Research Basel and the University of Basel.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.123.043669",TRUE,"Disclosures see page 2752. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 2752. <section> Sources of Funding The BASICS trial (Basilar Artery International Cooperation Study) was funded by the Dutch Heart Foundation the Swiss Heart Foundation the São Paulo Research Foundation the National Council for Scientific and Technological Development in Brazil the University Medical Center Utrecht and St.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1161/strokeaha.123.043897",TRUE,"Disclosures see page 2903 & 2904. <section> Disclosures",TRUE,"<section> For Sources of Funding and Disclosures see page 2903 & 2904. <section> Sources of Funding Funding was provided by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) to Drs Hoffmann and Harms (project number Dr Kuffner received funding from the DFG Graduate School 203. This work was supported by Charité3 R Replace–Reduce–Refine and partly by the Fondation Leducq to Drs Endres and Harms. In addition this work was supported by DFG (Project number 73500270 and 413848220) and ERA-NET NEURON EBio2 with funds from BMBF 01EW2004 to Dr Dreier. Dr Endres received funding from DFG under Germany´s Excellence Strategy—EXC-2049—390688087 Collaborative Research Center ReTune TRR 295424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. am received funding from DFG and Fondation Leducq. No funding was received to assist with the preparation of this article.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1162/jocn_a_02043",FALSE,"",TRUE,"Cichy: Conceptualization; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Validation; Writing—Review & editing. <section> Funding Information <section> A. K. is supported by a PhD fellowship of the Einstein Center for Neurosciences.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1164/rccm.202201-0011oc",TRUE,"Furthermore surfactant protein reduction because of the destruction of type 2 pneumocytes by SARS-CoV-2 Author disclosures are available with the text of this article at www.atsjournals.org.",TRUE,"<section> Supported by grants from the Swiss National Science Foundation (PP00P3_157448) Gallen (20/20) (L.F.); the Lungenliga St.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1164/rccm.202301-0084oc",TRUE,"<section> associated with stable nutritional status over Author disclosures are a 24-week treatment period.",TRUE,"<section> Supported by Vertex Pharmaceuticals (VX20-445-111).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Conclusions: In this open-label study in children 2–5 years of age ELX/TEZ/IVA treatment was generally safe and well tolerated with a safety profile consistent with that observed in older age groups and led to clinically meaningful reductions in sweat chloride concentration and LCI 2.5 Clinical trial registered with www.clinicaltrials.gov (NCT04537793).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1164/rccm.202301-0184st",TRUE,"Disclosures: M.P.K. served as Haven Department of Medicine University of guest editor for Clinics in Chest Medicine; Care and California San Diego San Diego California; received research support from NHLBI; shares of Medicine Department of Surgery Medical School of ownership of Serca LLC.",TRUE,"; 0000-0001-6296-6685 Supported by the American Thoracic Society; grants K23 HL138229 (M.P.K.) <section> received research support from NCRR/NIH. B.J.A. received research support from NIH/ NHLBI. M.L.C. received research support from NIH/NINR. T.D.G. served on advisory committee for Haisco Pharmaceutical; served as consultant for Haisco Pharmaceutical and Lungpacer Medical; received research support from Ceribell and NIH. S.P. served as a consultant for Jazz Pharmaceuticals; holds licensing for US patent #20160213879A1; received royalties from UpToDate; received research support from American Academy of Sleep Medicine Foundation Arizona Commerce Authority Department of Defense NIH PCORI Philips Pima County Health Department Regeneron Sergey Brin Family Foundation Sommetrics and US Biotest. I Philips Stiftung Charite; received support from Getinge and Medtronic; received research for symposia sponsored by AbbVie Deutschland support from Canadian Institutes of Health GmbH & Co.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1172/jci.insight.162468",FALSE,"",TRUE,"This work was supported by grants from the Fritz Thyssen Stiftung (10.16.1.027MN) the Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (Rückkehrprogramm and Junges Kolleg) and the Stiftung Charité (BIH Johanna Quandt Professorship) (all to UIS) as well as by the Deutsche Forschungsgemeinschaft (CRC 1453 and CRC 1365 to UIS; STO 1260/1-1 to GS). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG)",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1172/jci.insight.165987",FALSE,"",TRUE,"The work is supported by NIH grants R56DK54983 (WHW and David H. XPD and XY have received grants from National Science Foundation of China grant 81900648 and Education Department of Heilongjiang Grant 2016-KYYWF-0850 respectively.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci.insight.166711",TRUE,"Conflict of interest: The authors have and antibody responses in severe declared that no conflict of interest difference evened out 6 months exists.",TRUE,"<section> FUNDING. <section> The Pa-COVID 19 study is supported by grants from the Berlin Institute of Health (BIH). This study was further supported by the German Federal Ministry of Education and Research grants from NUM-NAPKON (01KX2021) to MW LES and F Kurth; COVIM: NaFoUniMedCovid19 (FKZ: 01KX2021) to LES and F Klein; and by the German Federal Institute for Drugs and Medical Devices grant from COVIM-Boost (V-2021.3/1503_68403/2021-2022) to LES and F Kurth.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci.insight.169135",FALSE,"",TRUE,"<section> This work was supported by the internal research funding program of the Heinrich Heine University to CN CBS and TR (2021-40).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci.insight.172179",FALSE,"",TRUE,"This work was supported in part by the Berlin Institute of Health (BIH) and by grants from the Lymphatic Malformation Institute and European Union (ERC PREVENT 101078827) (to RH). This work was also supported by a joint grant from the Medical Research Council and the British Heart Foundation (MR/P011543/1 and RG/17/7/33217) UK. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci158348",FALSE,"",TRUE,"<section> Acknowledgments MPD is a participant in the BIH-Charité Junior Clinical Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health and is funded by DKTK Berlin (Young Investigator Grant 2022). AMT is supported by the CPRIT Research Training Program (RP170067). Work in GAC’s laboratory is supported by National Cancer Institute (NCI) NIH grants 1R01 CA182905-01 and 1R01CA222007-01A1; National Institute of General Medical Sciences (NIGMS) NIH grant 1R01GM122775-01; US Department of Defense (DOD) Idea Award W81XWH-21-1-0030; a Team DOD grant in Gastric Cancer W81XWH-21-1-0715; a 2023 Chronic Lymphocytic Leukemia (CLL) Moonshot Flagship project grant; a CLL Global Research Foundation 2019 grant; a CLL Global Research Foundation 2020 grant; The G. MWA is supported by the CPRIT Research Training Program (RP210028).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1172/jci161593",TRUE,"Conflict of interest: JR and ES have received payments from Vertex Pharmaceuticals.",TRUE,"<section> FUNDING. This research was supported by the DFG under Germany’s Excellence Strategy – EXC 2167-390884018 “Precision Medicine in Chronic Inflammation” (to PB and AS) and EXC 2051-390713860 “Balance of the Microverse” (to BH and AAB); the Oskar Helene Heim Stiftung (to PB); the Christiane Herzog Stiftung (Stuttgart Germany) (to PB); the Mukoviszidose Institut gGmbH (Bonn Germany) the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V (to PB and CS); and the BMBF InfectControl 2020 Projects AnDiPath BMBF (03ZZ0838A+B) (to AAB and AS).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci161849",TRUE,"Conflict of interest: AP and FK have filed the patent “Composition and method for reducing oxalate levels in patients receiving maintenance dialysis” (EP21156284.8).",TRUE,"The work of FK KILC KUE and TJJ was supported by the German Research Foundation (DFG) grant KN1148/41 to FK and project ID 394046635 SFB 1365. The work of AK was additionally supported by the DFG under Germany’s Excellence Strategy CIBSS – EXC-2189 – project ID 390939984. <section> Plasma metabolomics were partly supported by the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement no. 115974 (Biomarker Enterprise to Attack Diabetic Kidney Disease; BEAT-DKD). The GCKD study was funded by grants from the Federal Ministry of Education and Research (BMBF grant number 01ER0804 to KUE) and the KfH Foundation for Preventive Medicine.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci163548",TRUE,"Conflict of interest: The conflict-of-interest statement is provided in the supplemental",TRUE,"<section> FUNDING. This study was funded in part by the German Research Foundation (DFG 158989968/SFB 900) the Deutsche Kinderkrebsstiftung (DKS 2013.09) Wilhelm-Sander-Stiftung (reference 2015.097.1) Ellen-Schmidt-Program of Hannover Medical School and German Federal Ministry of Education and Research (reference 01EO0802). <section> Acknowledgments This study was funded in part by the German Research Foundation (DFG 158989968/SFB 900) the Deutsche Kinderkrebsstiftung (DKS 2013.09) the Wilhelm-Sander-Stiftung (reference 2015.097.1) the Ellen-Schmidt-Program of Hannover Medical School and the German Federal Ministry of Education and Research (reference 01EO0802).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci164223",TRUE,"",TRUE,"This work was supported by the Swiss National Science Foundation (Eccellenza Professorship to AKP); the Propatient Foundation (to AKP); the Goldschmidt-Jacobson Foundation (to AKP); intramural funding from the University of Basel (to AKP); the Medical Faculty Mannheim of Heidelberg University (to LS and ME); research grants from the Hertie Foundation (medMS MyLab P1180016 to LS; medMS fellowship to HK); the UCSF Program for Breakthrough Biomedical Research (to ACH); the Adelson Medical Research Foundation (to DHR and KAN); the Cambridge Biomedical Research Center (to DHR); the National Institute of Neurological Disorders and Stroke (NINDS) NIH (NS040511 to DHR); the Wellcome Trust (to DHR); the European Research Council (ERC) (ERC AdG “AxoGLIA” and “MyeliNANO” to KAN; ERC AdG “Myel-INCrisis” to DHR; ERC StG “DecOmPress” to LS); the National Multiple Sclerosis Society (FG-20102-A-1 to ACH; FG-1708-28871 to AKP; FG-1902-33617 and RFA-2203-39300 to LS); the Italian Multiple Sclerosis Society (2013/B/4 to CC); Fonds de recherche du Québec – Santé (270746 to MG); the German Multiple Sclerosis Society",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci164637",TRUE,"Conflict of interest: VS has received research funding from Novartis Pharma AG Alexion Pharmaceuticals and Roche Pharma AG.",TRUE,"His research is funded by the Federal Ministry of Education and Research (BMBF) Deutsche Forschungsgemeinschaft Einstein Foundation Guthy-Jackson Charitable Foundation EU FP7 Framework Program Biogen Genzyme Merck Serono Novartis Bayer Alexion Roche Parexel and Almirall.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1172/jci165019",TRUE,"Conflict of interest: The authors have declared that no conflict of interest exists.",TRUE,"<section> This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) NIH (R01NS109858 to VAG); the Paul A. <section> The DEFIDIAG study is funded by grants from the French Ministry of Health in the framewok of the national French initiative for genomic medicine. Funding for the DECIPHER project was provided by Wellcome.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci166333",TRUE,"Conflict of interest: The authors have declared that no conflict of interest exists.",TRUE,"IED KS MR RS RR DS HA and GOC number were supported by a grant of the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) — Project-ID 329628492 – publicly availSFB 1321.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci166954",TRUE,"Conflict of interest: The authors have declared that no conflict of interest exists.",TRUE,"<section> Acknowledgments This work was supported by the intramural program of NIAAA NIH (to BG).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci171797",TRUE,"Conflict of interest: The authors have declared that no conflict of interest exists.",TRUE,"These data were further supported by TCR analysis revealing that identical clonotypes are largely confined to the same cluster indicating related functional programs associated with a given clone even across (paired) tissue samples. <section> KK is supported by grants from the Deutsche Forschungsgemeinschaft (KO-2270/7-1 KO-2270/4-1 KO-2270/8-1) Sander Stiftung (2022.035.1) Zentrales Innovationsprogramm SL is supported by the German Ministry for EducaVMH provided tion and Research through the Medical Informatics Initiative AS CC and (junior research group “Medical Omics” 01ZZ2001). HS received the manufunding from the Ministry for Science Research and Arts of manuscript.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1172/jci171874",TRUE,"Conflict of interest: The authors have declared that no conflict of interest exists.",TRUE,"<section> Acknowledgments This work was supported by National Institutes of Health (NIH) grants R01 HL123658 R01 HL144477 and R01 HL165725 (to PA); American Heart Association (AHA) Pre-Doctoral Grant 906561 and NIH F31 grant HL159907 (to SS); AHA Pre-Doctoral Fellowship 906361 and NIH F30 grant HL162200 (to ALB); NIH F31 grant HL156408 (to MEF); NIH grant R01 HL159964 (to EBT); grants from the DZHK (German Centre for Cardiovascular Research) and the Deutsche Forschungsgemeinschaft (German Research Foundation; SFB-1470 – A02) (to GGS); NIH grants HL128215 HL147933 HL155765 and HL164586 and the AHA (to JAH); NIH grant R01 HL162919 (to RMB); and NIH grants R01 CA282072-01 and R01 CA271619-01A1 and US Department of Defense Investigator Initiated Research Award OC220110 (to JRCR).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1176/appi.ajp.21111176",FALSE,"",TRUE,"<section> Supported by National Institute of Child Health and Human Development grants R01-HD-060628 (to Dr.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00207640231162277",TRUE,"Conflict of interest <section> The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00207640231174372",TRUE,"Conflict of interest <section> The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/00207640231188036",TRUE,"<section> We have no known conflict of interest to potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was conducted in part within the subproject A02 of the CRC 1171 ‘Affective Societies – Dynamics of Coexistence in Mobile Worlds’ granted by the German Research Foundation (DFG – Deutsche Forschungsgemeinschaft).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00207640231196737",TRUE,"Conflict of interest <section> The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00220345231160750",TRUE,"The authors declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00220345231197984",TRUE,"The authors declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was financed with seed funding of the OX/BER research partnership (OX-BER 1 STEM1) a cooperation of the 4 partner institutions of the Berlin University Alliance (Freie Universität Berlin Humboldt–Universität zu Berlin Technische Universität",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00220426231197826",TRUE,"<section> The author(s) declared the following potential conﬂicts of interest with respect to the research authorship and/or publication of this article: Felix Betzler received honoraria (consulting lectures) from Takeda Pharmaceutical. All remaining authors declare that they have no conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00236772231175727",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was supported by the Swiss 3R Competence Centre (Project 3RCC-003-o2018).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00236772231183197",TRUE,"<section> Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was supported by Charite3R Charit\u0002 e-",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/00236772231215077",TRUE,"<section> Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was supported by the Charit\u0002 e 3R Charit\u0002 e – Universit€ atsmedizin Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/00914150231196819",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> People with Multimorbidity: Fortiﬁcation of Effective Health Behavior) was funded by the German Federal Ministry of Education and Research [grant number 01ET1001B].",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/01455613211023009",TRUE,"Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/02676591231172021",TRUE,"<section> Declaration of conﬂicting interests The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/02692163221128938",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors disclose receipt of the following financial support for the research authorship and publication of this article: This work was supported by the Bundesministerium für Bildung und Forschung (Federal Ministry of Education & Research)",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/02698811231209208",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: <section> Christian Otte: Honoraria for lectures and/or scientific advice from Ferring Janssen Lundbeck SAGE Therapeutics Fortbildungskolleg Limes Klinikgruppe and Medical Tribune. Research Funding from the German Research Foundation (OT 209/7-3; 14-1 EXC 2049) the European Commission (IMI2 859366) the German Federal Ministry of Education and Research (KS2017-067) and the Berlin Institute of Health (B3010350). All other authors report no potential conflicts of interest.",TRUE,"Research Funding from the German Research Foundation (OT 209/7-3; 14-1 EXC 2049) the European Commission (IMI2 859366) the German Federal Ministry of Education and Research (KS2017-067) and the Berlin Institute of Health (B3010350). <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This research did not receive any specific grant from public or commercial funding agencies.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/02698811231212151",TRUE,"The authors declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This research was supported by the German Research Foundation (Deutsche",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/0271678x231168499",TRUE,"<section> Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: Funding was provided by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) to C.J.H. and C.H. C.J.H. and L.K. are participants in the Charit\u0002 e Clinical Scientist Program funded by the Charit\u0002 eUniversit€ atsmedizin Berlin and the Berlin Institute of Health. M.K. received funding from the Graduate School 203 of the DFG Excellence Initiative Berlin-Brandenburg School for Regenerative Therapies. M.E. received funding from DFG under Germany’s Excellence Strategy – EXC-2049 – 390688087 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq to ME and CH. Funding to S.M. S.P.K. and P.B.S. was provided by the BMBF under the ERA-NET NEURON scheme (01EW1811) and the DFG (Project-ID 428869206).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/0271678x231170746",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The study was supported by the Deutsche Forschungsgemeinschaft (DFG; grant no. 235802993 to RK and 408355133 to AL and NB as well as by the Sonnenfeld Stiftung to RK.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/0271678x231191600",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: A.U. is the founder and a shareholder of AUTC company commercializing functional ultrasound imaging solutions for preclinical and clinical research.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work is supported by grants from the Fondation Leducq (15CVD02) and KU Leuven (C14/18/ 099-STYMULATE-STROKE). The functional ultrasound imaging platform is supported by grants from FWO (MEDI-RESCU2-AKUL/17/049 G091719N and 1197818 N) VIB Tech-Watch (fUSI-MICE) Neuro-Electronics Research Flanders TechDev fund (3D-fUSI project). The Endres lab received funding from DFG under Germany’s Excellence Strategy – EXC-2049 – 390688087 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/0271678x231222306",TRUE,"<section> Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant no. 408355133 (A.L. N.B.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/02841851231189490",TRUE,"<section> Declaration of conﬂicting interests The authors declared the following potential conﬂicts of interest with respect to the research authorship and/or publication of this article: RD HA RS MS JR and MP have received speaker honoraria from Sirtex Medical.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/03331024221137091",TRUE,"<section> Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: BR reports research grants from Novartis and personal fees from Abbvie/Allergan Hormosan Lilly Novartis and Teva.",TRUE,"<section> Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: BR reports research grants from Novartis and personal fees from Abbvie/Allergan Hormosan Lilly Novartis and Teva. JA received institutional grants from Abbvie Biohaven Eli-Lilly Satsuma and Zosano. <section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/03331024221146315",TRUE,"<section> The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: MJL has received personal or institutional honoraria for participation in clinical trials speaker fees or as consultants from Abbvie Biohaven Eli Lilly Lundbeck Novartis Sanofi-Aventis SK Pharm Teva (Otsuka) Yuhan Company and YuYu Pharma and research support from the National Research Foundation of Korea and Seoul National University. MAA reports no conflicts of interest.",TRUE,"<section> The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: MJL has received personal or institutional honoraria for participation in clinical trials speaker fees or as consultants from Abbvie Biohaven Eli Lilly Lundbeck Novartis Sanofi-Aventis SK Pharm Teva (Otsuka) Yuhan Company and YuYu Pharma and research support from the National Research Foundation of Korea and Seoul National University. UR received personal or institutional honoraria for participation in clinical trials speaker fees or as consultants from Abbvie Allergan Alder Amgen Eli Lilly Lundbeck Medscape Novartis Pfizer StreaMedUp Teva and research support from the German Ministry for Education and Research and Novartis (CHERUB01). <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was supported by the New Faculty Startup Fund from Seoul National University a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465221142320",TRUE,"<section> The authors declared that they have no conflicts of interest in the authorship and publication of this contribution. AOSSM checks author disclosures against the Open Payments Database (OPD).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465231165297",TRUE,"<section> One or more of the authors has declared the following potential conflict of interest Implants B. AOSSM checks author disclosures against the investigation on the OPD and disclaims any liability or responsibility relating",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465231174430",FALSE,"",TRUE,"R-O.D.H. has received grants from AGA. <section> Steadman Philippon Research Institute 181 West Meadow Drive Suite Surgery Charité-University Medicine Berlin Freie Universität Berlin Huminterest or source of funding: This research was supported by the Steadman financially by private donations and corporate support.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/03635465231176557",FALSE,"",TRUE,"<section> One or more of the authors has declared the following potential conflict Philippon Research Institute which is a 501(c)(3) nonprofit institution helped financially pon Research Institute (SPRI) exercises special care to identify any financial interests calendar year SPRI has received grant funding or inkind donations from Arthrex received grants from AGA outside of the submitted work sponsored by Arthrex consulting fees from Arthrex; and research support from Arthrex Ossur Siemens author disclosures against the Open Payments Database (OPD). <section> of interest or source of funding: This work was supported by the Steadman by private donations and corporate support.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465231178292",TRUE,"AOSSM checks author disclosures independent investigation on the OPD and disclaims any liability or respon- <section> The authors declared that they have no conflicts of interest in the authorship against the Open Payments Database (OPD).",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465231188976",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/03635465231193961",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/08982643231152694",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/09567976221140828",TRUE,"Disclosure (OPD) form completed by the 2019 authors makes explicit reference to analysis code or syntax. Moreover a check to the disclosure method of awarding badges. 1 The corresponding Open Practices Disclosure form uses somewhat more permissive language requiring confirmation of “sufficient information for an independent researcher to reproduce all of the reported results.” Psychological Science awards badges based on the disclosure method: Authors complete an Open Practices Disclosure form and the journal may confirm the existence of data materials or a preregistration (Blohowiak et al. 2022; Psychological Science 2022). 2 This means that (a) these articles did not meet the standard for receiving the Open Data badge at Psychological Science according to the explicit requirements stated in the submission guidelines and (b) the authors of these articles may have interpreted the less explicit requirements of the Open Practices Disclosure statement in a rather minimalist way. <section> The disclosure method did not ensure the required higher standard for the Open Data badge at Psychological Science at least in its April 2019 issue. If such journals rely on the disclosure method over the peer-review method they could better describe the specific badge criteria and clarify that code syntax or a detailed analysis description needs to be shared alongside the data— for example as required by the submission guidelines at Psychological Science. One way of doing this is to move to the peer-review method of awarding the Open Data badge (as opposed to the disclosure method; Blohowiak et al. 2022). 5 Regardless whether authors fill in their disclosure items appropriately should continue to be monitored—a recent study found low adherence even to mandatory data availability statements in biomedical research manuscripts (Gabelica et al. 2022). <section> Declaration of Conflicting Interests The author(s) declared that there were no conflicts of interest with respect to the authorship or the publication of 2. According to the arguably ambiguous requirements as phrased in the Open Practices Disclosure (but not according to the explicit requirements in the submission guidelines) Article 111 may be considered eligible for an Open Data badge even without code.",TRUE,"This provides earlier verification and allows authors to upload all materials before publication and award of the badges. <section> Funding <section> This work was supported from Economic and Social Research Council (Data Analytics & Society Centre for Doctoral Train) and Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (no. 1706dgn006).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/09622802231188515",TRUE,"<section> Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/10738584231162810",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: Work in the authors’ laboratories is supported by grants from the German Research Foundation DFG (HA2686/22-1 to V.H. and KU4199/1-1 to M.K. as part of FOR 5228); the Leibniz SAW Program (K284/2019 to V.H.); and the European Research Council (ERC-AdG “SynapseBuild” to V.H. and ERC-StG 101040703 synERgy to M.K.).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/10790632231205784",TRUE,"Interventions offered in educational settings appear to increase children’s knowledge of abuse and putting this knowledge into action in simulated scenarios; however it is less clear whether interventions promote disclosure and an understanding of whether they prevent abuse would require longitudinal research and accurate incidence data (Walsh et al. 2018). <section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> support for the research authorship and/or publication of this article: The research reported in this paper was supported by funding from the National Society for the Prevention of Cruelty to Children UK.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/11206721231178062",TRUE,"<section> Declaration of conﬂicting interests The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/11207000211048425",TRUE,"Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"Funding The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/11795476231158509",TRUE,"<section> Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/11795514231167059",TRUE,"Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/12034754231191472",TRUE,"The authors declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/13524585231151212",TRUE,"",TRUE,"His research is funded by the German Ministry for Education and Research (BMBF) Deutsche Forschungsgemeinschaft (DFG) Einstein Foundation Guthy Jackson Charitable Foundation EU FP7 Framework Program Biogen Genzyme Merck Serono Novartis Bayer Teva Alexion Roche Parexel Viela Bio and Almirall. BW received grants from the German Ministry of Education and Research Deutsche Forschungsgemeinschaft Dietmar Hopp Foundation and Klaus Tschira Foundation grants and personal fees from Merck Novartis and She has received research funding from the Hertha-Nathorff-Program. J.H. is (partially) funded by the German Federal Ministry of Education and Research [Grant Numbers 01ZZ1603[A-D] and 01ZZ1804[A-H] (DIFUTURE)]. <section> Funding The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The NEMOS cohort/Nation NMO is supported by the German Ministry for Education and Research (BMBF) as part of the German Competence Network Multiple Sclerosis (KKNMS; for NEMOS NationNMO-DAB FKZ 01GI1602 C to J.-P.S. NationNMO-PAT FKZ 01GI1602B to O.A. and NationNMO-LAB to B.W.)",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/13524585231161253",TRUE,"Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: C.O. T.S. L.M.J. M.L.S. F.W. F.P. P.S. M.N. A.K. R.R. and C.D. declare no disclosures relevant to the manuscript.",TRUE,"K.R. is site principal investigator in clinical trials sponsored by Roche the manufacturer of ocrelizumab and rituximab and received research support from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (8212832) Stiftung Charité and Arthur Arnstein Foundation and travel grants from Guthy Jackson Charitable Foundation. <section> Funding The author(s) disclosed receipt of the following financial support for the research authorship and/ or publication of this article: Parts of this work were supported by grants from the Berlin Institute of Health (BIH) and Berlin University Alliance to C.D. and V.M.C. This study was further supported by the German Ministry of Education and Research through Forschungsnetzwerk der Universitätsmedizin zu",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/13524585231172145",FALSE,"",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The N-MOmentum trial was funded by MedImmune and Viela Bio (now Horizon Therapeutics plc Gaithersburg MD USA).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered with bers when clinical data were deemed inconclusive or ClinicalTrials.gov (NCT02200770).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/13524585231184738",TRUE,"Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: I.L. has nothing to report. J.J.C. is a consultant to UCB Roche and Horizon. Y.H. receives funding from the MS Society. O.A.-M. receives funding from the Association of British Neurologists MS Society and The Berkeley Foundation. S.M. received speaker honoraria from Novartis and Biogen. S.H. has nothing to report. E.G. has nothing to report. A.W.-F. has nothing to report. M.A.H. has received honoraria from Roche. H.S.-K. reports no disclosures relevant to the manuscript.",TRUE,"<section> Dr E.P.F. has received funding from the NIH (R01NS113828). <section> Funding The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/13524585231187120",TRUE,"Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This research was supported by Roche Argentina.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/13524585231200720",TRUE,"Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: S.S. M.N.O. M.W. S.M. S.T.L. K.S. and N.A. have nothing to disclose.",TRUE,"K.F. has received grants from the Ministry of Education of Japan Ministry of Health Welfare and Labor of Japan and received personal fees from Roche/Chugai Alexion Viela Bio/ Horizon Therapeutics Biogen Eisai Mitsubishi Tanabe Novartis Astellas Tejin Takeda UCB Merck Biopharma Abbvie Japan Tobacco and Asahi Kasei Medical. <section> K.R. has received research support from Novartis Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité (BIH Clinical Fellow Program) and Arthur Arnstein Foundation; and received travel grants from the Guthy-Jackson Charitable Foundation. He has received Program funding from the NIH (R01NS113828) is a member Jackson of the medical advisory board of the MOG project G.L.S. <section> Horizon Chugai Pharma Clene Nanoscience Reistone-Bio Beigene grants and personal fees from Funding Alexion grants from National Institutes of Health The author(s) and has a patent Aquaporumab issued. cial support F.P. has served on the scientific advisory boards of cation Novartis and MedImmune; received travel funding the Danish and/or speaker honoraria from Bayer Novartis A38376 Biogen Teva Sanofi-Aventis/Genzyme Merck Denmark Alexion Chugai MedImmune and Shire; is editor of Neurology: Neuroimmunology is an academic editor of PLoS consulted for Sanofi Genzyme Biogen Shire and Alexion; received research from Bayer Novartis Biogen Teva SanofiAlexion and Merck Serono; and research support from the German Research Werth Stiftung of the City of Cologne Ministry of Education and Research Arthur Stiftung Berlin EU FP7 Framework Arthur Arnstein Foundation Berlin GuthyCharitable Foundation and NMSS. <section> disclosed receipt of the following finanfor the research authorship and/or publiof this article: The research was supported by Multiple Sclerosis Society (A40208 A35152) The University of Southern and the Slagelse Hospital Research Fund.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/13524585231204456",TRUE,"Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: U.D. has received research support travel grants and teaching honorary from Biogen Idec Merck Serono Novartis Bayer Schering and Sanofi Aventis and honoraria from serving on scientific advisory boards of Biogen <section> Idec and Genzyme. S.M.G. reports honoraria from Celgene and Hexal and research funding from Biogen. M.R. T.E. L.A.P. V.D.G. H.B. J.F. A.K. <section> and R.D. declare no conflicts of interest related to this work.",TRUE,"Funding agencies are therefore encouraged to support such highly needed studies. <section> Declaration of Conflicting Interests The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: U.D. has received research support travel grants and teaching honorary from Biogen Idec Merck Serono Novartis Bayer Schering and Sanofi Aventis and honoraria from serving on scientific advisory boards of Biogen <section> Funding The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The initiative has recieved support from Merck.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/1357633x231166226",TRUE,"<section> Declaration of conﬂicting interests The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following ﬁnancial support for the research authorship and/or publication of this article: This work was funded by EIT-Health Campus under Grant No. Further it was partially funded by the German Federal Ministry of Education and Research (BMBF) under Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/15347354231192004",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was kindly supported by the MAHLE-Foundation Brazil.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/15500594231175320",TRUE,"<section> Declaration of Conﬂicting Interests The authors declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/15569845231170000",TRUE,"<section> The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: V.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/15598276231205254",TRUE,"<section> The author(s) declared no potential conﬂicts of interest Despite these limitations we believe with respect to the research authorship and/or our assessment to be valuable and publication of this article.",TRUE,"<section> Future studies in the ﬁeld should Funding include additional variables that The author(s) received no ﬁnancial support for the adequately reﬂect the content of the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/16094069231203953",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/17456916231151584",TRUE,"Declaration of Conflicting Interests The author(s) declared that there were no conflicts of interest with respect to the authorship or the publication of",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/17562864231182519",TRUE,"Competing interests 9.",TRUE,"<section> Funding 1198–1207. <section> The authors disclosed receipt of the following financial support for the research authorship 8.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/17562864231193530",TRUE,"Competing interests ET reports personal fees from EVER Pharma Marinus Arvelle Angelini Argenx Medtronic Bial-Portela & Cª NewBridge GL Pharma GlaxoSmithKline Boehringer Ingelheim LivaNova Eisai UCB Biogen Sanofi Jazz Pharmaceuticals and Actavis.",TRUE,"<section> Joana Moreira: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Vali­ dation; Visualization; Writing – original draft; Writing – review & editing. Fonseca: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Validation; Visualization; Writing – original draft; Writing – review & editing. <section> Guillermo Castilla-Fernández: Conceptuali­ zation; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Valida­ tion; Visualization; Writing – original draft; Writing – review & editing. <section> Fábio Ikedo: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Validation; Visualization; Writing – original draft; Writing – review & editing. <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was funded by Bial – Portela & Cª. His institution received grants from Biogen UCB Pharma Eisai Red Bull Merck Bayer the European Union FWF Osterreichischer Fond zur Wissenscha­ ftsforderung Bundesministerium für Wissens­chaft MJK or his institution received grants from multicenter He received of funding from UCB Pharma and the Swiss National lipids Science Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Registration: ClinicalTrials.gov NCT01162460/NCT02484001; EudraCT 2009-011135-13/2015-",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/17562864231197309",TRUE,"Competing interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: ABa: received personal compensation from Merck Serono Biogen Novartis TEVA Roche Sanofi/Genzyme Celgene/BMS Sandoz/Hexal and Janssen; he received grants for congress travel and participation from Biogen TEVA Novartis Sanofi/Genzyme Merck Serono Celgene and Janssen. Roche None resulted in a conflict of interest. <section> None resulted in a conflict of interest. All other authors report no conflicts of interest relevant to this work.",TRUE,"<section> Salmen: Conceptualization; Data curaFormal analysis; Funding acquisition; Methodology; Project administra- <section> Gisela Antony: Conceptualization; Data curation; Funding acquisition; Methodology; Project administration; Writing – review & editing. <section> Bernhard Hemmer: Conceptualization; Data curation; Funding acquisition; Investigation; Project administration; Writing – review & editing. <section> Heinz Wiendl: Conceptualization; Data curation; Funding acquisition; Investigation; Project administration; Writing – review & editing. <section> Frauke Zipp: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Writing – original draft. <section> Ralf Gold: Conceptualization; Data curation; Funding acquisition; Investigation; Methodology; Resources; Supervision; Writing – review & editing. <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: The competence network Multiple Sclerosis (KKNMS) and the German NationMS cohort were supported by the German Federal Ministry for Education and Research BMBF grant no. 01GI0914 (Bochum) 01GI1601B (Marburg). His research is funded by the Deutsche Care Forschungsgemeinschaft (DFG) and Hertie MedDay Foundation. His department Exchange received grant support from Bayer Schering Biogen Interdisciplinary Idec Genzyme Merck Serono Novartis and Teva. He received research from support within the last 5 years from Roche Merck a participant Sanofi Biogen Chiesi and Bristol-Myers Squibb. funded He also received research grants from the Swiss MS honoraria Society and is a member of the Advisory Board of CSL the Swiss and International MS Society. He is cofounder of Roche Bonescreen GmbH and received grants from the KGaA ERC DFG and BMBF. Amicus received honoraria for lecturing and travel for attending meetings from Almirall Therapeutics Germany Bayer Health Biogen Celgene Diamed Genzyme Pharmaceuticals Merck Serono Novo Nordisk ONO Pharma Roche Chugai Pharma QuintilesIMS and His research is funded by the German for Education and Research (BMBF) Forschungsgemeinschaft (DFG) Else Fresenius Foundation German Academic Service Hertie Foundation Center for Clinical Studies Muenster German Foundation Neurology Almirall Amicus Therapeutics Germany Diamed Fresenius Medical Care Merck Serono Novartis ONO Pharma and Teva. His research is funded by the German Ministry for Education and Research (BMBF) Deutsche Forschungsgesellschaft (DFG) Deutsche Myasthenie Gesellschaft e.V. Alexion Amicus Therapeutics Argenx Biogen CSL Behring F. BW: received grants from the German Ministry of Education and Research Deutsche Forschungsgemeinschaft Dietmar Hopp Foundation and Klaus Tschira Foundation grants and personal fees from Merck and personal fees from Alexion Bayer Biogen Teva; none related to this work. FZ: recently received research grants and/or consultation funds from Biogen Ministry of Education and Research (BMBF) Bristol-Meyers-Squibb Celgene German Research Foundation (DFG) Janssen Max-Planck-Society (MPG) Merck Serono Novartis Progressive MS Alliance (PMSA) Roche Sanofi Genzyme and Sandoz.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/17562864231213240",TRUE,"Competing interests",TRUE,"<section> Funding <section> The authors received no financial support for the 4.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/17562864231214041",TRUE,"Competing interests JK received personal compensation for consulting as well as speaker honoraria from Biogen BristolMyers Squibb Janssen Novartis Roche Bayer Merck Serono Sanofi Genzyme and TEVA Pharmaceuticals.",TRUE,"<section> Juliane Klehmet: Conceptualization; Data curation; Funding acquisition; Investigation; Methodology; Project administration; Super­ vision; Writing – original draft; Writing – review <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study is funded by Biogen GmbH Munich Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: NCT04655222 EUPAS38347.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/17585732211058804",TRUE,"Author’s contribution WRA—is a consultant for Exactech; FU— no disclosures. RB—is a consultant for DePuy Synthes and Zimmer Biomet. He receives research support from DePuy Synthes and Zimmer Biomet; RK— is a consultant for Zimmer Biomet; MS—is a consultant for Wright Medical. He receives research support from Zimmer Biomet; GSA—is a consultant for Wright Medical and Exactech. He receives research support from Zimmer Biomet. Declaration of Conﬂicting Interests The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"Conclusion Funding Stress shielding does occur with a gritblasted four-ﬁnned stemless humeral implant.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/17588359221148023",TRUE,"Competing interests The authors declare that there is no conflict of interest.",TRUE,"<section> Preissner: Conceptualization; Data Funding acquisition; Methodology; Software; Supervision; Writing – <section> Robert Preissner: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Project administration; Resources; Software; Writing – review & editing. <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: Open Access funding enabled and organized by Projekt DEAL. <section> This work was supported by TRR295.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/17588359231200454",TRUE,"Competing interests MR reports honoraria from Pfizer Novartis Lilly Roche Pharma AG AstraZeneca Daiichi Sankyo SOMATEX Seagen Pfizer and Gilead; personal fees for consulting or advisory services from Roche Pharma AG Daiichi Sankyo Lilly Novartis Seagen Pfizer Somatex Gilead AstraZeneca and MSD Oncology outside the submitted work.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/1759720x221149965",TRUE,"Competing interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: L.E.K. has received grant/research support from Biogen Janssen Novartis and UCB and has received speaker’s fees from AbbVie Amgen Biogen BMS Eli Lilly Janssen MSD Novartis",TRUE,"This study was sponsored by Pfizer. <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was sponsored by Pfizer. <section> Competing interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: L.E.K. has received grant/research support from Biogen Janssen Novartis and UCB and has received speaker’s fees from AbbVie Amgen Biogen BMS Eli Lilly Janssen MSD Novartis <section> and has received grants from AbbVie Amgen Celgene Eli Lilly Janssen Novartis Pfizer Inc 7.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/1759720x231187189",TRUE,"Competing interests The Editor-in-Chief of Therapeutic Advances in Musculoskeletal Disease is an author of this paper therefore the peer review process was managed by alternative members of the Board and the submitting Editor was not involved in the decision-making process.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/1759720x231189005",TRUE,"Competing interests AD reports consulting fees from and has participated on advisory boards from AbbVie Bristol Myers Squibb Eli Lilly and Company Janssen Moonlake Novartis Pfizer and UCB and has received research grant from AbbVie Bristol Myers Squibb Celgene Eli Lilly and Company Galvani Janssen Novartis Pfizer and UCB.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: The studies described in this article were sponsored by Eli Lilly and Company which was involved in the study design data collection data analysis and preparation of the manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/19322968231198871",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: The authors declare no financial conflict of interest.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work as part of the OPEN project (www.opendiabetes.eu accessed on April 25 2022) has received funding from the European Commission’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie Action Research and Innovation Staff Exchange (RISE) grant agreement number 823902.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/19433875231179318",TRUE,"<section> The author(s) declared the following potential conﬂicts of interest with respect to the research authorship and/or publication of this article: Max Heiland is Chair of the AOCMF European and Southern African Board.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/19485506231162405",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This research was supported by a Heisenberg Fellowship from the German Research Foundation awarded to David Weiss (396974499).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/20451253231172254",TRUE,"Competing interests The authors declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The article processing charge was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – 491192747 and the Open Access Publication Fund of HumboldtUniversität zu Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20451253231200258",TRUE,"Competing interests The authors declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: UR is an employee of Janssen Global Services LLC and may hold company stocks or stock options.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/ or publication of this article: This work was supported by Janssen Research & Development LLC. He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20451253231211575",TRUE,"Competing interests RP has received grant funding from Janssen consulting fees from Holmusk Akrivia Health Columbia Data Analytics Boehringer Ingelheim and Otsuka.",TRUE,"<section> Patel: Conceptualization; Data curaFormal analysis; Funding acquisition; Supervision; Writing – original Writing – review & editing. <section> McGuire: Funding acquisition; Writing <section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: RP has received funding from an investigatorinitiated study (IIS) grant from Janssen (R092670PSY4003) an NIHR Advanced Fellowship (NIHR301690) and a Medical Research Council (MRC) Health Data Research UK Fellowship (MR/S003118/1). The BRC Case Register and CRIS is supported by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry King’s College London jointly funded by the Guy’s and St Thomas’s Trustees and the South London and Maudsley Trustees. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552076221144506",TRUE,"<section> Declaration of conﬂicting interests: The authors declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"We also appreciate the support of Mr Adeel Ahmad from the University of the Punjab Dr Sobia Javed and Dr Sabeen Fatima Haque. AM provided support for baseline data analysis and SKB provided support for the pre and posttest data analysis. <section> Funding: The authors disclosed receipt of the following ﬁnancial support for the research authorship and/or publication of this article: This project was funded by doctHERS in partnership with University of Health Sciences (UHS) Punjab Population Innovation Fund (PPIF) Women Chamber of Commerce and Industry (WCCI) and Rural Support Programmes Network (RSPN) under their joint agreement to provide maternal child health and family planning services via telemedicine to underprivileged women of Pakistan.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This RCT received ethics clearance from Forman Christian College University Internal Review Board (Reference number: IRB-252/06-2020) and the study was registered at clinicaltrials.gov (Trial registration number NCT04603092). <section> Trial registration: NCT04603092",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/20552076231152989",TRUE,"<section> Declaration of conﬂicting interests: The author(s) declared the following potential conﬂicts of interest with respect to the research authorship and/or publication of this article: LM received personal fees from Biogen and Merck.",TRUE,"<section> research is funded by the German Ministry for Education and Research (BMBF) Bundesinstitut für Risikobewertung (BfR) Deutsche Forschungsgemeinschaft (DFG) Else Kröner Fresenius Foundation Gemeinsamer Bundesausschuss (G-BA) German Academic Exchange Service Hertie Foundation Interdisciplinary Center for Clinical Studies (IZKF) Muenster German Foundation Neurology and by Alexion Almirall Amicus Therapeutics Germany Biogen Diamed Fresenius Medical Care Genzyme HERZ Burgdorf Merck Serono Novartis ONO Pharma Roche and Teva. <section> His research is funded by the German Multiple Sclerosis Society North Rhine-Westphalia (DMSG) and the programme ‘Innovative Medizinische Forschung’ (IMF) of the Medical Faculty of the University of Muenster. <section> Funding: The author(s) received no ﬁnancial support for the research authorship and/or publication of this article.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552076231163788",TRUE,"<section> Declaration of conﬂicting interests: The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: This study was conducted in the context of the NutriAct Competence Cluster – Nutritional Intervention Behaviour and Products (Germany). The authors disclose receipt of the following ﬁnancial support for the research authorship and/or publication of this article: This work was supported by the German Federal Ministry of Education and Research [grant number 01EA1806D].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552076231171475",TRUE,"<section> Declaration of conﬂicting interests: The authors declare that no potential conﬂicts of interest exist with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: The author(s) disclosed receipt of the following ﬁnancial support for the research authorship and/or publication of this article: This work was funded by the German Federal Ministry for Economic Affairs and Climate Action (BMWK) [Grants 01MK20002A 01MK20002B].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552076231180677",TRUE,"<section> Declaration of conﬂicting interests: The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article: T.K. reports having received research grants from the German Federal Ministry of Health and outside the submitted work to have received research grants from the German Joint Committee. He further reports personal compensation from Eli Lilly and Company Teva Pharmaceutical TotalEnergies S.E. the BMJ and Frontiers. N.E. <section> has a collaborative research agreement with Bayer AG. All other authors declare no potential conﬂicts of interest.",TRUE,"<section> Funding: The author(s) received no ﬁnancial support for the research authorship and/or publication of this article: The project was funded by the German Federal Ministry of Health (grant numbers: 2520DAT500 and 2520COR505).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/20552076231194929",TRUE,"<section> Declaration of conﬂicting interests: The authors declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: The authors received no ﬁnancial support for the research and/or authorship of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552076231211169",TRUE,"<section> All other authors declare that they have no competing interests.",TRUE,"SMK and BJ received grants from Löwenstein Medical Innovation (Berlin Germany). SJS received grants from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) personal fees from Springer Verlag GmbH (Vienna Austria) and Advanz Pharma GmbH (Bielefeld Germany). <section> Funding: The authors disclosed receipt of the following ﬁnancial support for the research authorship and/or publication of this article: This study was supported by Cosinuss° GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: EUDAMED No. The study was prospectively registered at the German DIMDI register (application number 00013336) and the EUDAMED register (No.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/20552076231211546",TRUE,"<section> Declaration of conﬂicting interests: The authors declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: This study was funded by the German Pension Insurance Funding covered personnel material and traveling expenses.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study has been registered with the German Clinical Trial Register (DRKS) under the registration number DRKS00019041.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/20552173231195879",TRUE,"Rocca The authors declared no potential conﬂicts of interest with network osis:",TRUE,"<section> Funding Jaeger this article: This study was funded by the German related Research Foundation grant numbers 327654276 (SFB ivity 1315) FI 2309/1-1 and FI 2309/2-1 by the Berlin cortex. Choosing has received research funding from Novartis and unrelated to this study and is a member of the Committee on Science for the Canadian Institutes Research. F.P. received travel and/or speaker honoraria from Bayer Novartis Teva Sanoﬁ-Aventis/Genzyme Merck Serono Chugai MedImmune and Shire and received support from Bayer Novartis Biogen Teva Alexion Merck Serono from Research Council Werth Stiftung of the City German Ministry of Education and Research Arnstein Stiftung Berlin EU FP7 Framework Arthur Arnstein Foundation Berlin GuthyCharitable Foundation and NMSS; OASIS-3 data through the following grants: P50 AG05681 R01 AG021910 P50 MH071616 U24",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552173231203816",FALSE,"",TRUE,"<section> Funding intellectual content; ﬁnal manuscript approval. <section> disclosed receipt of the following ﬁnancial for the research authorship and/or publication of This work was supported by Novartis Pharma Switzerland).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/20552173231205444",TRUE,"<section> Declaration of conﬂicting interests The authors declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/20584601231213740",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/21677026231160709",TRUE,"Declaration of Conflicting Interests The author(s) declared that there were no conflicts of interest with respect to the authorship or the publication.",TRUE,"<section> Ulrike Zetsche: Conceptualization; Formal analysis; Funding acquisition; Project administration; Supervision; Writing – original draft. <section> Funding <section> This study was funded by two grants from the German Research Foundation (DFG) to L.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/21925682211019354",TRUE,"Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/21925682221121300",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> The authors performed an initial search of PubMed Google scholar and Cochrane databases for investigations for possible inclusion in the review. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/21925682221130048",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The present study was registered on the International Prospective Register of Systematic Reviews (PROSPERO) network (CRD42020177426) before starting the review process and performed accordingly to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/21925682221130050",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> The authors performed an initial search of PubMed and Google scholar databases for investigations for possible inclusion in the review. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/21925682231159066",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/21925682231178206",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/22840265231179004",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/23259671221146167",TRUE,"<section> The authors declared that there are no conflicts of interest in the authorship against the Open Payments Database (OPD). AOSSM checks author disclosures investigation on the OPD and disclaims any liability or responsibility",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/23259671221147572",TRUE,"<section> The authors declared that there are no conflicts of interest in the authorship against the Open Payments Database (OPD). AOSSM checks author disclosures investigation on the OPD and disclaims any liability or responsibility",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23259671231190411",TRUE,"<section> The authors have declared that there are no conflicts of interest in the authorship against the Open Payments Database (OPD). AOSSM checks author disclosures investigation on the OPD and disclaims any liability or responsibility",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Registration: ISRCTN registry (study ID: ISRCTN92265154).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/23337214231152700",TRUE,"Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/23969873221143856",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: ME reports grants from Bayer and fees paid to the Charité from Abbot Amgen Bayer Boehringer Ingelheim BristolMyers-Squibb Daiichi Sankyo Novartis Pfizer and Sanofi. <section> Also ME received funding from DFG under Germany’s Excellence Strategy – EXC-2049 – 390688087 Collaborative Research Center ReTune TRR 295-424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. FH reports consulting and/or speaking fees (Alexion Bayer Biogen CSL Behring DIAMED Medizintechnik Grifols Ipsen Janssen Merck Novartis Roche Sanofi and Teva) and grant/research support (Bayer Biogen Merck Novartis). CU reports grants or speaker’s honoraria from Alexion Boehringer Ingelheim BristolMyers-Squibb Daiichi Sankyo and Pfizer. TR received consulting honoraria speakers’ honoraria and travel support from BMS Pfizer Boehringer Ingelheim Bayer HealthCare and Daiichi Sankyo outside the submitted work. AK reports speaker’s honoraria consulting fees and/or lecture honoraria from Bayer Healthcare Sanofi Boehringer Ingelheim Daiichi Sankyo Pfizer Bristol-Myers Squibb and Medtronic. KGH reports speaker’s honoraria consulting fees lecture honoraria and/or study grants from Abbott Amarin Alexion AstraZeneca Bayer Healthcare Sanofi Biotronik Boehringer Ingelheim Bristol-Myers Squibb Daiichi Sankyo Medronic Pfizer Portola SUN Pharma W. L. <section> Gore and Associates and Edwards Lifesciences. All other authors report no conflict of interests in relation to the submitted work.",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: ME reports grants from Bayer and fees paid to the Charité from Abbot Amgen Bayer Boehringer Ingelheim BristolMyers-Squibb Daiichi Sankyo Novartis Pfizer and Sanofi. <section> Also ME received funding from DFG under Germany’s Excellence Strategy – EXC-2049 – 390688087 Collaborative Research Center ReTune TRR 295-424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. <section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23969873221144089",TRUE,"The full details of all MWG members and their disclosures are included in Supplemental Materials-Table 1. <section> The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: Funding for the development of these guidelines was provided by the European Stroke Organisation Basel Switzerland. The author(s) did not receive financial support for the development writing and/or publication of this guideline",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/23969873221149464",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: JLR reports having received a grant from Novartis Pharma for conducting a self-initiated research project outside this work.",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: JLR reports having received a grant from Novartis Pharma for conducting a selfinitiated research project outside this work. MP reports outside the submitted work having received partial funding for a selfinitiated research project from Novartis Pharma and being awarded a research grant from the Center for Stroke Research Berlin (private donations). <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: The B-SPATIAL registry was funded by the German Federal Ministry of Education and Research (BMBF) and the German Research Foundation (DFG) granted to the Center for Stroke Research Berlin.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23969873231177774",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: Dr Nolte reports grants from the German Ministry of Research and Education German Center for Neurodegenerative Diseases and German Center for Cardiovascular Research as well as personal fees from Abbott Boehringer Ingelheim Alexion <section> Bayer Pharma Bristol Myers Squibb Daiichi Sankyo and Pfizer Pharma outside the submitted work. All other authors declare that there is no conflict of interest.",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: Dr Nolte reports grants from the German Ministry of Research and Education German Center for Neurodegenerative Diseases and German Center for Cardiovascular Research as well as personal fees from Abbott Boehringer Ingelheim Alexion <section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/23969873231185895",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: PB: Research funds by the Gottfried and Julia BangerterRhyner Foundation and Swiss Academy of Medical Sciences and funding for travel and conference fees from BMS/Pfizer.",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: PB: Research funds by the Gottfried and Julia BangerterRhyner Foundation and Swiss Academy of Medical Sciences and funding for travel and conference fees from BMS/Pfizer. His institutions have received an educational grant from Pfizer compensation from Stago for educational efforts and research support from Daiichi-Sankyo the Science Funds [Wissenschaftsfonds] of the University Hospital Basel the University Basel from the “Wissenschaftsfonds Rehabilitation” of the University Department for Geriatric Medicine Felix Platter the “Freiwillige Akademische Gesellschaft Basel” the Swiss Heart Foundation and the Swiss National Science Foundation. <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study was funded by the Swiss National Science Foundation (SNSF) PP00P3_202663 the Olga Mayenfish foundation and the UZH Clinical Research Priority Program (CRPP) Stroke.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23969873231190716",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23969873231211166",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: The authors HS RG RR SH JH TK and JFS declare no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> received funding from DFG under Germany’s Excellence Strategy – EXC-2049–390688087 Collaborative Research Center ReTune TRR 295-424778381 BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq. <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: HEBRAS was funded by the BMBF (German Ministry of Education and Research) [grant G.2.17 Center for Stroke Research Berlin] by the DZHK (German Center for Cardiovascular Research) [grant B14-035_SE] and by the GETEMED AG Teltow Germany.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23969873231213156",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: MP reports funding from Novartis Pharma and being awarded a research grant from the Center for Stroke Research Berlin (private donations). ME reports grants from Bayer and fees paid to the Charité from Abbot Amgen AstraZeneca Bayer Boehringer Ingelheim BMS Daiichi Sankyo Sanofi Novartis Pfizer all outside the submitted work. HJA reports personal fees from AstraZeneca Boehringer-Ingelheim Novo -Nordisk and Roche. All other authors do not report conflicts of interest related to the submitted work.",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: MP reports funding from Novartis Pharma and being awarded a research grant from the Center for Stroke Research Berlin (private donations). <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: B_ PROUD was funded by the German Research Foundation (DFG) with grant number EB 525/2-1 and under Germany’s Excellence Strategy – EXC-2049 – 390688087. B-SPATIAL was funded by the Federal Ministry of Education and Research via the Center for Stroke Research Berlin.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The B_PROUD study was registered under ClinicalTrials.gov: NCT02869386.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1177/23971983231163413",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: Aleksandra Djokovic: no conflicts of interest to declare. Alessia Pepe: no conflicts of interest to declare. Alexia Steelandt: no conflicts of interest to declare. Caforio: no conflicts of interest to declare. Anastasia Xintarakou: no conflicts of interest to declare. <section> Anna Baritussio: no conflicts of interest to declare. Arsen Ristic: no conflicts of interest to declare. Elijah R Behr: no conflicts of interest to declare. <section> George Markousis-Mavrogenis: no conflicts of interest to declare. Ghadeer Hasan: no conflicts of interest to declare. <section> Kostantinos Bratis: no conflicts of interest to declare. Buch: no conflicts of interest to declare. <section> Petar Seferovic: no conflicts of interest to declare. Dumitru: no conflicts of interest to declare. <section> Renzo Marcolongo: no conflicts of interest to declare. <section> Mavrogeni: no conflicts of interest to declare. Sven Plein: no conflicts of interest to declare. Yohei Isomura: no conflicts of interest to declare. <section> Atef Suliman: no conflicts of interest to declare.",TRUE,"Cosimo Bruni was supported by an Italian Ministry of University and Research PhD Scholarship and this study is part of his PhD thesis. <section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This study received endorsement from the World Scleroderma Foundation and the Heart Failure Association of the European Society of Cardiology. Cosimo Bruni was supported by an Italian Ministry of University and Research PhD Scholarship.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23971983231164700",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: the editor/editorial board member of Journal of Scleroderma and Related Disorders is an author of this paper; therefore the peer-review process was managed by alternative members of the board and the submitting editor/board member had no involvement in the decision-making process.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: the inception cohort project is supported by an unrestricted grant from the Joachim Herz Stiftung Hamburg Germany.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1177/23971983231168193",TRUE,"The author(s) declared no potential conflicts of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding <section> The author(s) disclosed receipt of the following financial support for the research authorship and/or publication of this article: This work was supported by the Bundesministerium für Wirtschaft und Energie (BMWi Federal Ministry for Economic Affairs and Energy; ZIM project KF2257305AJ1) and the Deutsche Stiftung Sklerodermie (DSS German Scleroderma Foundation).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/24741264221126061",TRUE,"<section> The author(s) declared the following potential conflicts of interest with respect to the research authorship and/or publication of this article: Jeffrey S.",TRUE,"<section> Funding <section> The authors disclosed receipt of the following financial support for the research authorship and/or publication of this article: The ONYX trial was funded by Regeneron Pharmaceuticals Inc. Tarrytown NY USA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1177/25148486231160637",TRUE,"<section> The author(s) declared no potential conﬂicts of interest with respect to the research authorship and/or publication",TRUE,"<section> This article further is the result of an interdisciplinary collaboration between the authors. van Dam who is an anthropologist and environmental humanities scholar conducted the interview study and discourse analysis. van Engelen who is a conservation social scientist contributed to the article with further insights on multispecies studies FMD and the KAZA TFCA based on the literature review. <section> Funding <section> support for the research authorship and/or publication of this article: Agha Bollig Borgemeister Junglen Müller-Mahn and Van Dam received funding from the Bollig and Van Engelen received funding from the European Research Council (grant number 101020976: ‘Rewilding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/blood.2022017230",TRUE,"<section> Conﬂict-of-interest disclosure: The authors declare no competing ﬁnancial interests.",TRUE,"<section> CLL sample acquisition was supported by the Biobank of the Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf funded by the German Cancer Aid. The analysis of GEP data from the CLL8 trial was supported by the German CLL Study Group. This work was also supported by the CMMC (Project C08; Project 23-RP to M. Q.J. was funded by a scholarship of the China Scholarship Council ([2017]3109).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/blood.2022017661",TRUE,"Disclosures The remaining authors declare no competing ﬁnancial interests.",TRUE,"BeLOVE is substantially funded by the Berlin Institute of Health at Charité – Universitätsmedizin Berlin (BIH). <section> This study was supported by grants from the Deutsche Krebshilfe (number 70113643) and the German Cancer Consortium both awarded to C.M.S. and S.D. were supported by a stipend from the Berlin School of Integrative Oncology. P.M.S. was supported by Postdoctoral Research Fellowship from Alexander von Humboldt Foundation. C.H. received funding from Deutsche Forschungsgemeinschaft (DFG) (HA5741/5-1 project numbers 417284923 and 424778381) Sonderforschungsbereich/Transregio 295 M.E. received funding from DFG under Germany’s Excellence Strategy (EXC-2049–390688087) BMBF Deutsches Zentrum für Neurodegenerative Erkrankungen Deutsches Zentrum für Herz-Kreislauf-Forschung European Union Corona Foundation and Fondation Leducq. T.G.L. received funding from DFG.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/blood.2022018246",TRUE,"<section> Conﬂict-of-interest disclosure: S.R. receives research support from BristolMyers-Squibb and KITE/Gilead and is a member of the SAB of Immunitas Therapeutics. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> This work was ﬁnancially supported by National Institutes of Health National Cancer Institute grants P01CA229092 (C.J.W. and R.J.S.) and L.P. is supported by a research fellowship from the German Research Foundation (DFG PE 3127/1-1) and is a scholar of the American Society of Hematology. M.S.D. is supported by the National Institutes of Health National Cancer Institute grant R01CA266298-01A1 and is a clinical scholar of the Leukemia and Lymphoma Society. J.S.G. is supported by the Conquer Cancer Foundation Career Development Award Leukemia and Lymphoma Society Translational Research Program Award and NIH K08CA245209. S.L. is supported by the National Institutes of Health and National Cancer Institute Research Specialist Award (R50CA251956). S.Gnjatic is supported by National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant U01DK124165 and National Cancer Institute grant P30CA196521. N.Cieri is supported by an AACR-Incyte Immunooncology Research Fellowship (20-40-46-CEIR). The Human Immune Monitoring Center at ISMMS received support from the Cancer Center Support Grant CA196521. Scientiﬁc and ﬁnancial support for the CIMACCIDC Network is provided through National Institutes of Health National Cancer Institute Cooperative Agreements U24CA224319 (to the Icahn School of Medicine at Mount Sinai CIMAC) U24CA224331 (to the DanaFarber Cancer Institute CIMAC) U24CA224285 (to the MD Anderson Cancer Center CIMAC) U24CA224309 (to the Stanford University CIMAC) and U24CA224316 (to the CIDC at Dana-Farber Cancer Institute). MDACC received support from NIH Cancer Center Support Grant P30CA016672 and the University of Texas SPORE NCI P50CA70907.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1182/blood.2022019210",TRUE,"<section> Conﬂict-of-interest disclosure: T.B. and J.K. have an exclusive licensing agreement with BioLegend Inc for the commercialization of mC1-multimer. <section> The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> This study was supported by the Deutsche Herzstiftung e.V. Frankfurt a. F.G. received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 747687. This work was also supported by the LMUexcellent program (R.K.) the Friedrich-Baur-Stiftung (R.K.) and the European Research Council (ERC-",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/blood.2023022136",TRUE,"<section> Conﬂict-of-interest disclosure: A.G. reports grants and nonﬁnancial support from Aspen Boehringer Ingelheim Merck Sharp & Dohme (MSD) Bristol Myers Squibb (BMS) Paringenix Bayer HealthCare Gore Inc Rovi Sagent and Biomarin/Prosensa; personal fees from Aspen Boehringer Ingelheim MSD Macopharma BMS Chromatec and Werfen; and nonﬁnancial support from Boehringer Ingelheim Portola Ergomed GTH e.V. outside the submitted work. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> The study has been funded by the Deutsche Forschungsgemeinschaft (DFG): 374031971-TRR240 GR 2232/9-1 SCHO 2052/1-1 TH 2320/3-1. <section> This work was supported by the American Society of Hematology (ASH) with the ASH Global Research Award and within the Gerhard Domagk Research Program by University Medicine Greifswald (L.S.). Some parts of the study have been funded by European Medicines Agency (EMA) service contract number EMA/2021/17/TDA. This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Marie Skłodowska-Curie grant agreement no. <section> 801342 (Tecniospring INDUSTRY) and the Government of Catalonia’s Agency for Business Competitiveness (ACCIÓ).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022007714",TRUE,"<section> Conﬂict-of-interest disclosure: A.V.K. M.H. S.H. L.V. G.J.P.D. E.E.S. N.M.K. S.B. P.H. A.H. A.M. H.K. M.D. Q.Y. J.Z. Z.M. <section> C.M. R.P. F.J.d.S are employees of Genentech or Roche and hold Roche shares. The remaining authors declare no competing ﬁnancial interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022007875",TRUE,"<section> Conﬂict-of-interest disclosure: U.K. received speaker honorary/ advisory fees from Roche Janssen-Cilag Takeda BMS Gilead Hexal Pﬁzer AstraZeneca PentixaPharm Amgen Novartis and MSD; and clinical study support from Celgene Takeda BMS Roche AstraZeneca Novartis MSD Janssen-Cilag and Pﬁzer. F. <section> Bassermann received honoraria and research funding from BMS/ Celgene. J. Krönke received speaker honorary and advisory fees from BMS/Celgene and Takeda. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> This work was supported by Deutsche Forschungsgemeinschaft (grant SFB1335/P3 U.K.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022007988",TRUE,"<section> Conﬂict-of-interest disclosure: H.G. is a current employee of Roche Pharma AG Grenzach-Wyhlen Germany. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> This work is supported by a grant of the Wilhelm-Sander-Stiftung (no. 2013.086.2) funding from the Deutsche José Carreras Leukämie-Stiftung (DJCLS 10 R/2021) the Physician Scientists Grant (G-509200-004) from the Helmholtz Zentrum München (T.H.) the German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung Heidelberg Germany) a grant from Deutsche Forschungsgemeinschaft (DFG SFB 1243 TP A06 and TP A07; K.H.M. K.S. and T.H.) and the BMBF grant 01ZZ1804B",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1182/bloodadvances.2022008042",TRUE,"<section> Conﬂict-of-interest disclosure: U.H. declares having received honoraria from BMS Kite Gilead Miltenyi Biotech and Novartis. B.v.T. is an advisor or consultant for Allogene BMS/Celgene Cerus Incyte Miltenyi Novartis Pentixafarm Roche Amgen Pﬁzer Takeda Merck Sharp & Dohme and Gilead Kite. The remaining authors declare no competing ﬁnancial interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022008497",TRUE,"<section> Conﬂict-of-interest disclosure: C.T. is co-owner and CEO of AgenDix GmbH has received lecture fees from Novartis JAZZ Janssen TEVA Life Technologies Archer; has served on advisory boards for Novartis JAZZ and received research support from Novartis.",TRUE,"This work was also supported by DFG consortia FOR2033 FOR2674 SFB873 German Cancer Consortium (DKTK) joint funding project “RiskYAML” the SyTASC Consortium funded by the Deutsche Krebshilfe the ERC Advanced Grant SHATTER-AML (AdG-101055270) and the Dietmar Hopp Foundation (all to A.T.) and DFG consortia SFB1074 (to L.B.). C.A. is supported by an addon Fellowship of the Joachim Herz Foundation.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022008617",TRUE,"<section> Conﬂict-of-interest disclosure: The authors declare no competing ﬁnancial interests.",TRUE,"<section> The authors thank the following funding agencies for supporting this work: Deutsche Forschungsgemeinschaft (TL820.8-1) Wilhelm Sander-Stiftung (2016.077.1) Deutsche Krebshilfe (70113519) and EU306240 (T.L.) <section> There was no external funding source for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022008981",TRUE,"<section> Conﬂict-of-interest disclosure: P.B. declares research grants from Neovii Riemser Medac and Bristol Myers Squibb (BMS) (to institution); membership in advisory boards for Novartis Celgene Amgen Medac and Servier (personal and to institution); received speaker fees from Miltenyi Jazz Riemser Novartis and Amgen (to institution); and declares a patent and royalties from Medac. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> No thirdparty funding was available for this retrospective study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2022009397",TRUE,"<section> Conﬂict-of-interest disclosure: J.K. D.L.W. M.A.-e.-E. S.M. M.E. and W.D. are listed as inventors on a patent application ﬁled by Charité – Universitätsmedizin Berlin which is based on the data presented in this manuscript. H.-D.V. is founder and the CSO at CheckImmune GmbH. P.R. H.-D.V. and D.L.W. are cofounders of the startup TCBalance Biopharmaceuticals GmbH focused on regulatory T-cell therapy. J.K. W.D. M.S.-H. P.R. H.-D.V. and D.L.W. are listed as inventors on patent applications unrelated to the presented work. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> The study was supported by a grant fromthe Arab-German Young Academy of Sciences and Humanities facilitated by the German Federal Ministry of Research and Education (M.A.-e.-E.) the Einstein Center for Regenerative Therapies research grant (J.K. S.M. H.-D.V. M.S.-H. P.R. and D.L.W.) and an ECRT kickbox grant for young scientists (J.K. W.D. S.M. and M.E.). The work of M.A.-e.-E. is supported in part by the award J.K. and D.L.W. acknowledge the support of the SPARK-BIH program by the Berlin Institute of Health.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2023010887",TRUE,"<section> Conﬂict-of-interest disclosure: L.B. has advisory role in AbbVie Amgen Astellas Bristol Myers Squibb Celgene Daiichi Sankyo Gilead Hexal Janssen Jazz Pharmaceuticals Menarini Novartis Pﬁzer Sanoﬁ and Seattle Genetics; and receives research funding from Bayer and Jazz Pharmaceuticals. The remaining authors declare no competing ﬁnancial interests.",TRUE,"<section> This study was supported in part by the Bundesministerium für Bildung und Forschung (ERA PerMed projects SYNtherapy 01KU1917 and MEET-AML 01KU2014 to L.B.). M.-K.K. was supported by an MD student research scholarship (Berlin Institute of Health) and a Peter-Scriba scholarship of the German Association for Internal Medicine. S.M. was supported by grant MU 880/ 16-1 from the Deutsche Forschungsgemeinschaft.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1182/bloodadvances.2023011041",TRUE,"<section> Conﬂict-of-interest disclosure: G.D. reports being on the advisory boards of Kyowa Kirin and Recordati Rare Diseases. H.M.P. is a member of advisory boards and receives honoraria from Kyowa Kirin Mallinkrodt Therakos Innate Pharma and Takeda. M.B. reports being on the advisory boards for Innate Pharma Kyowa Kirin Takeda and Helsinn/Recordati. M.M. is a (France). J.S. reports receiving consulting and/or honoraria from Takeda Recordati Helsinn Kyowa Kirin Mallinkrodt Therakos Afﬁrmed. The remaining authors declare no competing ﬁnancial interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.00422-2022",TRUE,"Conflict of interest: T. Pataka and A. van Eyck have no conflict of interest to disclose related to the topic discussed in this technical standard.",TRUE,"<section> Support statement: The participants of the project received funding for assistance with the literature search and for editing the manuscript from the European Respiratory Society (TF-2019-16). Funding information for this article has been deposited with the Crossref Funder Registry.",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1183/13993003.00943-2022",TRUE,"Conflict of interest: M.",TRUE,"This work was supported by the French Environment and Energy Management Agency (ADEME) and the Université Paris-Saclay. Savouré reports that this work is a part of a thesis supported by the French Environment and Energy Management Agency (ADEME) and the Université Paris-Saclay. <section> Support statement: This work is a part of Marine Savouré’s thesis supported by the French Environment and Energy Management Agency (ADEME) and the Université Paris-Saclay. The CONSTANCES Cohort Study was supported and funded by the French National Health Insurance Fund (“Caisse Nationale d’Assurance Maladie” (CNAM)). Funding information for this article has been deposited with the Crossref Funder Registry.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.01307-2022",TRUE,"Conflict of interest: M.A.",TRUE,"<section> Acknowledgements: Financial support for medical editorial assistance was provided by Novartis Pharma AG Basel Switzerland. Miravitlles has received consulting fees from AstraZeneca Atriva Therapeutics Boehringer Ingelheim Chiesi GlaxoSmithKline Bial Gebro Pharma CSL Behring Inhibrx Laboratorios Esteve Ferrer Mereo Biopharma Verona Pharma Spin Therapeutics ONO Pharma pH Pharma Palobiofarma SL Takeda Novartis Sanofi and Grifols speaker fees from AstraZeneca GlaxoSmithKline Boehringer Ingelheim Chiesi Cipla Menarini Rovi Bial Sandoz Zambon CSL Behring Grifols and Novartis support for attending meetings/travel from Novartis Boehringer Ingelheim and Menarini research grants from Grifols and has participated on a data safety monitoring board for Mereo. <section> Support statement: Financial support for medical editorial assistance was provided by Novartis Pharma AG Basel Switzerland. Mall has been supported by grants from the German Ministry for Education and Research <section> Funding information for this article has been deposited with the Crossref Funder Registry.",FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.01596-2022",TRUE,"Conflict of interest: H.S. All other authors declare no competing interests.",TRUE,"<section> Support statement: Funding for this systematic review and individual patient data metaanalysis was received from the Indonesia Endowment Fund for Education (LPDP; 201711220412046) through the University of Groningen awarded as a PhD scholarship to F. The findings and conclusions of this systematic review and individual patient data metaanalysis are those of the authors and do not represent the views of these grant providers. Funding information for this article has been deposited with the Crossref Funder Registry.",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.02009-2022",TRUE,"Conflict of interest: E. The remaining authors report no potential conflicts of interest.",TRUE,"<section> Support statement: F. Behrens received funding from the Berlin Institute of Health (BIH). Funding information for this article has been deposited with the Crossref Funder",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.02022-2022",TRUE,"Conflict of interest: W.",TRUE,"<section> MUC-031 is a novel thiolsaccharide mucolytic developed as part of an National Heart Lung and Blood Institutefunded translational programme project grant [18]. Scheffler reports the following support for the present manuscript: statistical consulting coordinated via UCSF Clinical and Translational Science Institute funds provided by NIH P01HL128191. <section> Support statement: This study was supported by P01HL128191 and R01HL080414 from the National Heart Lung and Blood Institute the German Research Foundation (CRC 1449–431232613 A01 C04 and Z02) and the German Federal Ministry of Education and Research (82DZL009B1). Funding information for this article has been deposited with the Crossref Funder Registry.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/13993003.02029-2022",TRUE,"Conflicts of interest: All authors received nonfinancial support (assistance with manuscript preparation) from Nucleus Global which received funding from Vertex Pharmaceuticals Incorporated.",TRUE,"<section> Conflicts of interest: All authors received nonfinancial support (assistance with manuscript preparation) from Nucleus Global which received funding from Vertex Pharmaceuticals Incorporated. <section> Support statement: This study was funded article has been deposited with the Crossref Funding information for this Funder Registry.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This study is registered at ClinicalTrials.gov with identifier number NCT03525574.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1183/13993003.02153-2022",TRUE,"Conflict of interest: J.",TRUE,"D. Lauster has received funding from Deutsche Forschungsgemeinschaft for work related to this manuscript. P. Mertins received funding from Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research related to this work. Mall declares that he has received funding from Deutsche Forschungsgemeinschaft and German Ministry for Education and Research for work related to this manuscript. In the past 36 months he has received grants from Vertex Pharmaceuticals personal fees for consultancy from Boehringer Ingelheim Arrowhead Pharmaceuticals Vertex Pharmaceuticals Santhera Sterna Biologicals Enterprise Therapeutics Antabio and Abbvie lecture fees from Boehringer Ingelheim Arrowhead Pharmaceuticals and Vertex Pharmaceuticals travel reimbursement from Boehringer Ingelheim and Vertex Pharmaceuticals and personal fees for participation in advisory boards from Boehringer Ingelheim Arrowhead Pharmaceuticals Vertex Pharmaceuticals Santhera Enterprise Therapeutics Antabio Kither Biotech Abbvie and Pari. <section> Support statement: This study was supported by grants from the German Research Foundation (CRC 1449 – Funding information for this article has been deposited with the Crossref Funder Registry.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/23120541.00190-2023",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/23120541.00473-2022",TRUE,"Conflict of interest: P.",TRUE,"<section> Support statement: This study was supported by grants from the German Federal Ministry of Education and Research (BMBF) (82DZL004A1 and 82DZL009B1 to M.A. Funding information for this article has been deposited with the Crossref Funder Registry.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/23120541.00653-2022",FALSE,"",TRUE,"MCM is supported by the Swiss National Science Foundation (320030_182628). MG is chair of the Group 07.06 of the ERS and she is supported by the Swiss National Science Foundation (PZ00P3_185923).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1183/23120541.00701-2022",TRUE,"Conflict of interest: P.",TRUE,"<section> Support statement: This study is funded by a Swiss National Science Foundation Ambizione fellowship (PZ00P3_185923). Funding information for this article has been deposited with the Crossref Funder Registry.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01539-8",TRUE,"Competing interests Linda Al-Hassany Hannah S. Lyons Deirdre M. Boucherie Fatemeh Farham Karol Marschollek Dilara Onan Umberto Pensato Angelo Torrente Marta Waliszewska-Prosół declare no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01547-8",TRUE,"Disclosures <section> Competing interests The authors declare no competing interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01552-x",TRUE,"Competing interests R reports research grants from Novartis and personal fees from Abbvie/ Allergan Hormosan Lilly Novartis and Teva.",TRUE,"<section> Funding UR received research funding from the German Federal Ministry of Education and Research and Novartis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01573-6",TRUE,"Competing interests Jakob Paungarttner Tessa de Vries and Dena Zeraatkar report no conflict of interest.",TRUE,"Two of the three trials were industryfunded and performed in the USA [31 33] and the third trial was funded by a public grant from Brazil [34]. <section> Funding <section> Funding <section> This paper was funded by the European Headache Federation (EHF).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01593-2",TRUE,"Competing interests The authors declare that they have had or are having the following economic or personal ties to the pharmaceutical industry consulting firms payers or healthcare providers: A.",TRUE,"<section> Funding This study is funded by TEVA GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01594-1",TRUE,"Competing interests Dena Zeraatkar and Janvir Jassal report no conflict of interest.",TRUE,"<insert> Table 1 Trial characteristics Registered 44 (59%) Funding Industry Government 54 (73%) 4 (5%) Institution 2 (3%) Notfor-profit 0 (0%) None 1 (1%) Not reported 13 (17%) Mean age Male (%) 16% Migraine with aura (%) 18 (45%) Prior prophylaxis (%) 28 (49%) Mean migraine days/month Interventions Amitriptyline 7 (10%) Betablockers 13 (18%) Calcium Channel Blockers 8 (11%) Carismabate 2 (3%) Eptinezumab 5 (7%) Erenumab 9 (13%) Fremanezumab 7 (10%) Gabapentin 2 (3%) Galcanezumab 7 (10%) Gepants 4 (6%) Oxcarbazepine 1 (1%) Pregabalin 1 (1%) Topiramate 13 (18%) Valproate 8 (11%) (atogepant rimegepant telcagepant) 1 (85 patients) on oxcarbazepine 13 (2698 patients) on topiramate and 8 (793 patients) on valproate. Most trials were funded by pharmaceutical companies. <section> Funding",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01624-y",TRUE,"Competing interests MP reports having received partial funding for this project from Novartis Pharma (granted to JLR) and being awarded outside of this work a research grant from the Center for Stroke Research Berlin (private donations) for a selfinitiated <section> project. <section> RB reports no conflicts of interest.",TRUE,"<section> Funding This project was funded by an investigatorinitiated research grant from Novartis Pharma granted to JLR. <section> Competing interests MP reports having received partial funding for this project from Novartis Pharma (granted to JLR) and being awarded outside of this work a research grant from the Center for Stroke Research Berlin (private donations) for a selfinitiated",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s10194-023-01655-5",TRUE,"Competing interests DCB has received grant support and honoraria from AbbVie Amgen Bio‑ haven Collegium Eli Lilly and Company Lundbeck and Teva and for work on the editorial board of Current Pain and Headache Reports.",TRUE,"<section> Funding BLB LL and AJ are employees of Cerner Enviza and received funding from AbbVie to conduct the study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01657-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<insert> PCS d NR PCS d Freitag 1991 [25] PCS Crossover NR NR US Belgium Denmark Funding Country d Sørensen 1986 [24] Louis 1981 [21] Study design Study name (50 in flunarizine (29 e arm) in each arm) Sample size NR (20–47) (19–63) Age median (range) Table 1 Placebo controlled randomized clinical trials of flunarizine. trial characteristics 20.7 25.7 MwA (32.7%) or MwoA c (67.3%) Common Common b ­migraine migraine (31%) or Classical migraine a (69%) % Male Types of migraine 10 mg 10 mg 10 Drug mg dosage (daily) Active Tx period (weeks) Reduction in: • Number of migraine attacks from baseline to the end (50% vs 39.9% p = 0.018) • Duration and sever‑ ity of migraine attacks (reduced in flunarizine arm but p = NS for both) Reduction in: • Monthly migraine attacks (reduction in num‑ ber of attacks at ­4 th mo: 50% vs 15% p = 0.02) • Duration and severity of migraine attacks (p = NS for both) Reduction in: • Monthly migraine attacks (at least one attack rd at ­3 mo: 17.2% vs 55.2% p = 0.006) • Duration and severity of migraine attacks did not differ between two interventions Outcome measures 5 withdrawals among patients on ­flunarizine †† 3 withdrawals among controls Mild daytime seda‑ tion in 3 patients on flunarizine (1 withdrawal) Mild daytime seda‑ tion in 2 patients on flunarizine (without withdrawal) Dry mouth; in controls (without withdrawal) Tolerability <insert> PCS PCS Frenken 1984 [22] Mendenopoulos 1985 [23] NR NR Sample size Greece (9 in flunarizine arm) Netherlands 35 (17 in flunarizine arm) Funding Country 20–65 NR Age median (range) 17.1 10 Drug mg dosage (daily) Classical a migraine 10 mg Common migraine (60%) or Classical migraine a (40%) % Male Types of migraine Active 12–16 Tx period (weeks) Studies included in the metaanalysis One patient withdrew on placebo because of increasing number of migraine attacks Details of the adverse events leading to withrawal were not given in the article d e f defined according to the modified criteria of the Ad Hoc Committee on the Classification of Headache by Olesen et al. [26] defined according to the first edition of the International Headache Classification [27] c defined according to the Ad Hoc Committee on Classification of Headache of the NIH [25] a b AEs Adverse events FU Followup MwA Migraine with aura MwA Migraine without aura NR Not reported NS not significant PCS Prospective cohort study Tx Treatment Study design Study name Table 1 (continued) Reduction in: • Monthly Migraine attacks (50% reduction in attacks after mo; p = 0.033) • Duration and severity of migraine attacks (significant reduc‑ tion in flunarizine arm; p = 0.037 and p = 0.006 respectively after 3rd month) Reduction in: • Monthly migraine attacks (significant reduc‑ tion in flunarizine arm; p = 0.029 st at ­1 mo) • Duration of migraine attacks (p value is not reported) • Severity of migraine attacks (p = NS) Outcome measures No AEs Daytime sedation in 7 weight gain in and other AEs in patients on flunar‑ izine Daytime seda‑ tion in 3 stomach complaints in 4 and other AEs in of Tolerability <section> Funding <section> This paper was funded by the European Headache Federation (EHF).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01663-5",TRUE,"",TRUE,"<section> Funding This study was supported by a Novartis AG (Switzerland) research grant to UR. KR received speaker fees from Bayer travel grants from Guthy Jackson Charitable Foundation and grant support for research or education from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283–2) Stiftung Charité (BIH Clinical Fellow Program) and Arthur Arnstein Foundation. JK received speaker fees research support or travel support from or served on advisory boards for Swiss MS Society Swiss National Research Foundation (320030_189140/1) University of Basel Progressive MS Alliance Bayer Biogen Celgene Merck Novartis Roche and Sanofi. UR received speaker or consulting fees from Amgen Allergan Abbvie Eli Lilly Lundbeck Novartis Medscape Pfizer StreaMedUp and Teva and received grant support for research or education from Novartis (CHERUB01) and German Federal Ministry of Education and Research.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01664-4",TRUE,"Competing interests B.R. reports personal fees from AbbVie Eli Lilly Lundbeck Novartis and Teva and research grants from Novartis all outside of the submitted work.",TRUE,"<section> Funding <section> B.R. was supported by a research grant of the German Research Foundation (GZ: RA 3907/1–1). M.A. was supported by the Lundbeck Foundation Professor Grant (R310-2018-3711).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01666-2",TRUE,"Competing interests MOM CL UR RG-G ERdlT GS YW and TW declare no competing interests.",TRUE,"<section> Acknowledgements AR is supported by the Italian Ministry of Health (RRC); MOO is supported by <section> Funding",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01671-5",TRUE,"Competing interests Deirdre M. Boucherie Sarah Kirsh and Dena Zeraatkar report no conflict of interest.",TRUE,"<section> Funding Bianca Raffaelli has received research funding from Novartis the German Research Foundation and the German Migraine and Headache Society.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s10194-023-01682-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s10194-023-01699-7",TRUE,"Competing interests BR reports personal fees from Abbvie Eli Lilly Lundbeck Novartis and Teva for participating in advisory boards and/or speaker activities as well as research funding from Novartis. <section> ALR has no conflict of interest. <section> DO has no conflict of interest. <section> ERB has no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s11556-023-00323-6",TRUE,"Competing interests The authors declare no potential conflict of interest with respect to the authorship or publication of this article.",TRUE,"<section> Funding <section> DO-HEALTH was funded by the Seventh Framework Program of the European Commission (grant agreement 278588) the University of Zurich (Chair for Geriatric Medicine and Aging Research) DSM Nutritional Products Roche NESTEC Pfizer and Streuli.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s11658-023-00511-3",TRUE,"The authors declare that they do not have any conflicts of interest with the content of this article.",TRUE,"<section> Funding <section> This work was supported by grants from the Deutsche Forschungsgemeinschaft—DFG (KU961/13-1 KU961/14-1 to H.K. HE8295/1-1 to D.H.) and by the Sonnenfeld-Foundation to F.R.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12014-023-09421-0",TRUE,"Competing interests AM is an employee of Pfizer. EW Is now an employee of AstraZeneca. ETD is currently an employee of GSK. The work presented in this manuscript was performed before he joined GSK. All other authors declare they have no competing interests.",TRUE,"<section> Acknowledgements Corinne Carland was supported by a Sarnoff Cardiovascular Fellowship. <section> Funding",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12245-023-00542-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12859-022-05124-9",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported in part by the LOEWE Center Frankfurt Cancer Institute (FCI) funded by the Hessen State Ministry for Higher Education Research and the Arts [III L 5 519/03/03.001 (0015)]. KF has received intramural funding by the Frankfurt Research Funding (FFF) program ‘Nachwuchswissenschaftler’ and the ‘Clinician Scientist Program’ by the Mildred-Scheel Foundation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12864-023-09409-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> This work was supported by the National Key Research and Development Program of China (2022YFD1300200) the National Natural Science Foundation of China grants (32202646 32272848 and 32161143010) the China Postdoctoral Science Foundation (2021M700111) the Key Special Project of Ningxia Science and Technology Department (2021BEF02024) the Shaanxi Livestock and Poultry Breeding Doublechain Fusion Key Project (2022GD-TSLD-46) the China Agriculture Research System (CARS-39-03) Local Grants (NXTS2022-001 and 2020KW-028) Deutsche Forschungsgemeinschaft (DFG CRC 1365) and Stiftung",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12864-023-09830-3",TRUE,"Competing interests The authors declare no conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG) [grant number 400728090 FOR2841 TP02 to J.L. K.S.O. U.H. M.R. Funding for open access charge: Open Access funding enabled and organized by Projekt DEAL.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12866-023-02788-y",TRUE,"Competing interests Krystyna Poplawska received personal payment for participation on the advisory board in December 2021 (Vertex Pharmaceuticals). All other authors have no competing interests.",TRUE,"Forslund: Conceptualization Methodology Validation Resources Writing Review & Editing Supervision Project administration Funding acquisition. Krystyna Poplawska: Conceptualization Methodology Validation Resources Writing Review & Editing Supervision Project administration Funding acquisition. <section> Funding The study was partly funded by Vertex pharmaceuticals—grant fund: CF Circle of Care.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12871-023-02127-8",TRUE,"Competing interests The authors declare that they have no conflict of interest.",TRUE,"<section> Funding <section> This study was supported in part by a research grant from Faculty of Medicine University of Malaya (project no: GPF002-2020).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12871-023-02255-1",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<insert> parents of paediatric ICU patients with at least 12 h ICU stay 78 + 131 (low risk controls) single centre cohort (5 subcohorts) adult postoperative cardiac surgical patients and their caregivers Study Design Target Group 12/2011–10/2012 To describe longterm outcomes To identify parents at risk for PTSD of cardiac intensive care unit (CICU) due to their children’s ICU stay patients and their primary caregivers; and to explore the feasibility of implementing a complex intervention designed to support problems associated with PICS and PICS-F not reported most probably 6 months 52% Centre for heart and lung services InS:PIRE programme McPeak et al. [81] fiveweek multidisciplinary peer support rehabilitation programme To ameliorate the signs and symptoms associated with PICS and PICS-F 12 weeks after discharge (initial visit) and 3 & 12 Months after initial visit Setting Aim of study Intervention Components Aim of intervention Followup HADS EQ-5D Main measurement instruments 13% 4% 100% for patients / unknown for caregivers Loss to followup Completeness of baseline measurement not reported 2/10 components completed (median) Initial uptake rate: 14%; uptake rates 37% improved to between 25 and 30% following some changes in procedures 24% PAS IES-R HADS 100% not reported could be 232/302 readmission rate death rate health care utilisation not reported; patients lost to followup were excluded from baseline analysis not reported most probably 100% Adherence to the intervention not reported 24% not applicable Willingness to participate not reported To increase of use of intervention components / decrease of 30-day readmission inpatient visits brochure medication review phone calls ICU f/up clinic visit assessment neuro evaluation referrals 10 components from discharge to 30 days after To increase the number of ICU recovery program intervention components received by patients due to the followup clinic (feasibility); and to decrease the frequency of 30-day hospital readmission University (efficacy) hospital not reported most probably 6 months adults admitted to the study ICU for at least 48 h with a predicted risk of 30-day samehospital readmission of at least 15% single centre RCT US 05–10/2017 Bloom et al. 2019 Acceptance of randomisation To reduce parents’ levels of posttraumatic stress anxiety and depression review of current health condition of the child reflection on the emotional experience of parents access to further support services followup clinic appointment 2 months after ICU discharge University teaching hospital not reported not reported Sample Size recruiting time single centre RCT plus extra ""low risk"" control UK 2019–2020 UK Year Samuel et al. 2015 Henderson et al. 2021 Country Characteristics Table 5 Characteristics of other ICU followup pilot studies compared to our study SF-12 PHQ PTSS-10 mean 34% 100% 62% 85% 100% planned: 6 months; actual: mean 198 days ~ 7 months To increase HRQOL physical functioning and psychosocial wellbeing assessment medication review social support peer group ICU followup clinic To explore and evaluate feasibility of an ICU followup clinic University hospital; surgical and medical ICU 12 weeks adult ICU (stay > 5 days) patients and their next of kin single centre RCT DE 2021 PINA/our study <section> Funding <section> The study was funded by the Innovation Fund of the Federal Joint Committee (Innovationsfond G-BA) funding code 01VSF16056 which was neither involved in the study design nor in the collection analysis and interpretation of data nor the writing of the article nor the decision to submit the results for publication.",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration ClinicalTrials.gov US NLM NCT04186468 https://clinicaltrials.gov/ct2/show/NCT04186468 We registered the study at a trials registry (clinicaltials.gov NCT04186468) on 04/12/2019 before inclusion of the first participant.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12872-023-03133-x",TRUE,"Competing interests Not",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12872-023-03136-8",TRUE,"Competing interests CHL is receiving royalties from Hogrefe Huber Publishers Berne for the German version of the Hospital Anxiety and Depression Scale. Over the past 3 years he has been receiving lecture honoraria from Servier and Novartis. RW reports personal fees from Bayer grants and personal fees from Boehringer Ingelheim personal fees from Pfizer/BMS other from Daiichi Sankyo personal fees from Novartis personal fees from Sanofi personal fees from Servier grants and personal fees from Medtronic personal fees from Pharmacosmos personal fees from CVRx grants from German Federal Ministry for Education and Research and grants from DFG outside the submitted work. AS is receiv‑ ing grants from the Oskar-Helene-Heim Foundation. MW DB and FE report no competing interest.",TRUE,"<section> Acknowledgements We acknowledge support by the Open Access Publication Funds of the University of Göttingen. Funding was obtained and the work was supervised by FE RW and CHL. <section> Funding Aldo-DHF was funded by the Federal Ministry of Education and Research Grant 01GI0205 (clinical trial program Aldo-DHF [FKZ 01KG0506]).",FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12872-023-03187-x",TRUE,"Competing interests All patient recruiting participants receive remuneration through accounts registered in the name of the vascular centers according to the number of recruited patients. SO is a consultant for the sponsor. PS and MWW are full-time employees of B.Braun Melsungen AG. All other authors have no competing interests.",TRUE,"<section> Funding This study is funded entirely by B.Braun Melsungen AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12872-023-03500-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> (NCT01501981) sponsored by Charité – Universitätsmedizin Berlin and financed by an unrestricted grant by BRAHMS AG (Neuendorfstr. We are also grateful to BRAHMS AG for supporting the study and sharing the study data. <section> Funding <section> This research was funded by BRAHMS AG Molitor 2010. The study is registered under http://clinicaltrials.gov (NCT01501981) sponsored by Charité – Universitätsmedizin Berlin and financed by an unrestricted grant by BRAHMS AG (Neuendorfstr.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12873-023-00838-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12874-023-01855-2",TRUE,"Competing interests The authors declare that no conflicts of interest exist.",TRUE,"<section> Funding The research network EMANET was funded by the German Ministry of Education and Research (Bundesministerium für Bildung und Forschung [BMBF]) grant number 01GY1604.",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration DRKS00011930 (EMACROSS) DRKS00014273",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12874-023-01991-9",TRUE,"Competing interests MS and BM declared that they had received salary from the Volkswagen Foundation to conduct the project. DK declared that he has no conflict of interest.",TRUE,"<section> Funding This study received funding by Volkswagen Foundation (grant no. A118085 (ref.91498) to KL). Researchers collaborated with the CEOsys project which is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF); grant no. 01KX2021). Ramagopalan SV Skingsley AP Handunnetthi L et al. Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12874-023-02003-6",TRUE,"Competing interests TK reports outside the submitted work to have received research grants from the German Joint Committee and the German Ministry of Health. He further reports personal compensation from Eli Lilly and Company Teva TotalEnergies S.E. the BMJ and Frontiers. MP reports having received partial funding for a self-initiated research project from Novartis Pharma. MP further reports being awarded a research grant from the Center for Stroke Research Berlin (private donations) for a self-initiated project. The declared funding sources did not influence the present research study. All other authors do not have any conflicts of interest.",TRUE,"<section> Acknowledgements Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (adni.loni.usc.edu) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica Inc. <section> Funding This research is supported through the German Federal Ministry of Education and Research (BMBF) within the project ‘Syreal’ (Grant No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12874-023-02015-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This research was supported by the Federal Ministry of Education and Research (01GY1611) and German Research Foundation (ME 3538/10-1; BO 5233/1-1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12875-023-02046-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12875-023-02211-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This project was funded by the Federal Ministry of Education and Research (BMBF funding no.: 01GK1902A).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12877-022-03527-0",TRUE,"Competing interests MPo and MPa were employees of Biogen and MT SS and SN (all ICON) were paid consultants/advisors for Biogen during the development of this manuscript.",TRUE,"Data collection and sharing for this project was funded by the Alzheimer’s Disease Cooperative Study (ADCS) (National Institutes of Health Grant U19 AG010483). <section> Funding",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12877-023-04014-w",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12877-023-04238-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12877-023-04245-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The study was supported by the Federal Ministry of Education and Research Germany in the funding program: FPMTI2015-VR/AR: healthy living (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12879-023-08035-z",TRUE,"Competing interests CDS reports grants personal fees from AstraZeneca personal fees and non-financial support from BBraun Melsungen personal fees from BioNtech grants personal fees and non-financial support from Gilead Sciences grants and personal fees from Janssen-Cilag personal fees from Eli Lilly personal fees from Formycon personal fees from Roche other from Apeiron grants and personal fees from MSD grants from Cepheid personal fees from GSK personal fees from Molecular partners other from Eli Lilly personal fees from SOBI during the conduct of the study; personal fees from AbbVie personal fees from MSD personal fees from Synairgen grants and personal fees from ViiV Healthcare outside the submitted work. The other authors report no conflict of interest.",TRUE,"<section> Funding We received no funding for this analysis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12879-023-08064-8",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12879-023-08599-w",TRUE,"The authors declare no competing interests. in",TRUE,"Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by TRR295.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12879-023-08805-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> This work was supported by grants of Mercator Foundation EFRE grant for COVID.DataNet.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12879-023-08824-6",TRUE,"Competing interests TSK reports receiving fees for consultations from infectopharm.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12882-023-03272-5",TRUE,"Competing interests NE is member of an EAB for Bayer AG Leverkusen. ES has received grants from the National Kidney Foundation for editorial board (AJKD) consulting fees from Astra Zeneca and honoraria for lectures from Akademie Niere Berliner Dialyseseminar Siemens Healthineers and Fresenius Kabi. MvdG has grant contracts from the Berlin Institute of Health and Novartis received consulting fees from IEM Pharvaris Medtronic Recor and Nephrolyx honoraria from Bayer Servier Omron Novartis Boehringer Recor Medtrix Streamedup and participated in EAD for Novartis. MKK AS DH AKF NM CL YB GB and VW declare no competing interests.",TRUE,"<section> Funding The Berlin Initiative Study was supported by the KfH Foundation of Preventive Medicine (http://www.kfhstiftung-praventivmedizin.de). The present work was financially supported by Bayer AG Leverkusen. ES has received grants from the National Kidney Foundation for editorial board (AJKD) consulting fees from Astra Zeneca and honoraria for lectures from Akademie Niere Berliner Dialyseseminar Siemens Healthineers and Fresenius Kabi.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12883-023-03223-5",TRUE,"Competing interests JK has received personal compensation for activities associated with Grifols CSL Behring and Octapharma and has received research support from Grifols and Octapharma. BT has received personal compensation for lecturing consulting services and travel expenses from Bayer Healthcare Biogen-idec CSL Behring Grifols Merck Serono Novartis Octapharma Roche Sanofi Genzyme TEVA and UCB Pharma. There have been different research cooperation’s with Biogen-idec Novartis TEVA Bayer Healthcare CSL-Behring Grifols Octapharma Sanofi Genzyme and UCB Pharma. JH declares no conflict of interest.",TRUE,"<section> Funding This study was supported by Grifols Deutschland GmbH Frankfurt Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration Number.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12884-023-05858-1",TRUE,"Conflict of interest The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> Funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12884-023-05942-6",TRUE,"Competing interests The authors have none to declare.",TRUE,"<section> Funding <section> ON was supported by the German Society of Obstetrics and Prenatal Care (DGPGM Deutsche Gesellschaft für Pränatalund Geburtsmedizin) Open Access Publication Fund of Charité and MeFo Graz (PS-Stipendium). AEH KS LB were supported by within the K1 COMET Competence Centre CBmed which is funded by the Federal Ministry of Transport Innovation and Technology (BMVIT); the Federal Ministry of Science Research and Economy (BMWFW) Land Steiermark (Department 12 Business and Innovation) the Styrian Business Promotion Agency (SFG) and the Vienna Business Agency.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12885-023-10763-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> The study was supported by the Basic and clinic collaborate research improvement plan of Anhui Medical University (2020xkjT039) Research Fund of Anhui Institute of translational medicine (2022zhyx-C45) and the National Nature Science Foundation of China (81572507).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12885-023-11013-y",TRUE,"Competing interests DK received travel grants from Accuray and is a member of the advisory board for Novocure he has no competing interest related to the presented work. <section> The other authors declare that they have no competing interest related to the presented",TRUE,"<section> Funding <section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12885-023-11172-y",TRUE,"Competing interests <section> OB: Employee and stockholder at Takeda Pharma (financial interests). MMK: Speaker fee from Roche Gilead Astra Zeneca Sysmex (financial interests). <section> MAB SA CR JUB RR DS declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12885-023-11348-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> The KOKON-KTO study was part of the Competence Network Complementary Medicine in Oncology (KOKON) a collaborative research project in Germany that was funded in a second funding period by German Cancer Aid [14]. <section> Funding <section> The “Complementary Medicine Training for Oncologists” (KOKON-KTO)-project was part of the collaborative research project KOKON which was supported by German Cancer Aid [grant number 109863].",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12885-023-11551-5",TRUE,"Competing interests MJGTV reports grants and personal fees from 3M Arderypharm Astellas Pharma Basilea Bio-Mérieux Biontech DaVolterra Evonik FarmakInterna‑ tional Holding GmbH Ferring Gilead Sciences Glycom Heel Immunic AG MaaT Pharma Merck/MSD Organobalance Pfizer Roche Seres Therapeutics SocraTec R&D GmbH Takeda Pharmaceutical Tillots Pharma GmbH. <section> MS has received consultant or speaker fees or travel grants from BMS MSD Roche Kyowa Kirin Novartis Sanofi Genzyme Pierre Fabre Sun Pharma Immunocore. <section> All remaining authors have declared that they have no competing interests.",TRUE,"<section> Funding This study was funded by a grant from the German Cancer Aid (Stiftung Deutsche Krebshilfe; grant number: 70112696).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12887-022-03814-0",TRUE,"Competing interests CV has received study lecture or consulting fees from AstraZeneca Boehringer Ingelheim Engelhard Arzneimittel GmbH & Co.",TRUE,"<section> Funding This work was supported by Engelhard Arzneimittel GmbH & Co. CPW and LU are employees of Cambridge – a Prime Global Agency which received funding from Engelhard Arzneimittel GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-022-04447-4",TRUE,"Competing interests None of the authors involved in this study report a conflict of interest.",TRUE,"<section> Funding Since 2020 the study is funded by an Individual Research Grant of the German Research Foundation (DFG); for a summary see https://gepris.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-04537-x",TRUE,"Competing interests All authors declare to have no competing interests.",TRUE,"<section> Funding Financial support was granted from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-04620-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The current study was supported by (1) the Foreign Commonwealth & Development Office (FCDO) (2) the project “Empowering Persons with Psychosocial Disabilities to Fight for their Rights: An implementation of the CRPD and QualityRights principles in Ghana Lebanon and Armenia” (EIDHR/2018/155232-4/97) which was funded by the European Commission (PI: University of Cagliari Italy) and (3) the Fondation d’Harcourt.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-04928-0",TRUE,"Competing interests While the authors do not have any competing interests as defined by BMC the following are the author disclosures: Celso Arango has received support by the Spanish Ministry of Science and Innovation Instituto de Salud Carlos III (ISCIII) co-financed by the European Union ERDF Funds from the European Commission “A way of making Europe” financed by the European Union NextGenerationEU (PMP21/00051) PI19/01024.",TRUE,"<section> Funding <section> This Delphi panel was funded by Lundbeck Otsuka Alliance. <section> Competing interests While the authors do not have any competing interests as defined by BMC the following are the author disclosures: Celso Arango has received support by the Spanish Ministry of Science and Innovation Instituto de Salud Carlos III (ISCIII) cofinanced by the European Union ERDF Funds from the European Commission “A way of making Europe” financed by the European Union NextGenerationEU (PMP21/00051) PI19/01024. Kane has received grant support from Otsuka Lundbeck Sunovion and Janssen. He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-05038-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"The study was part of the German research network funded by the German Federal Ministry of Education and Research (BMBF). <section> Funding <section> The study was performed within the framework of the German Research Network on Depression which was funded by the German Federal Ministry for Education and Research BMBF (01GI0219).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12888-023-05168-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Funded by the Brandenburg Medical School publication fund supported by the German Research Foundation and the Ministry of Science Research and Cultural Affairs of the State of Brandenburg.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-05192-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-05230-9",TRUE,"Competing interests CU Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Biogen BoehringerIngelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Denovo Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell <section> F Bermpohl K Rubarth and VB Nöhles have no conflicts of interests to declare.",TRUE,"<section> Funding This trial was funded by Janssen-Cilag GmbH and registered in clinicaltrials.gov (NCT04404309). He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12888-023-05346-y",TRUE,"Competing interests PD Dr. Gutwinski Prof. Beck Mr. Tsamitros and Dr. Lütt cooperate with neomento GmbH without financial interests for the development of the VR software for VirtuCueR a VR treatment for patients with alcohol use disorder currently developed and supported by the BIH Digital Health Accelerator. Prof. <section> Wolbers works as Chief Science Officer for neomento GmbH. All other authors have no competing interest to declare.",TRUE,"<section> Funding The study was supported by a grant from the Berlin Institute of Health (BIH: Digital Health Accelerator (NT SG) and Junior Digital Clinician Scientist (AL)) and was in part supported by the German Research Foundation (DFG: Project-ID 402170461 – TRR 265 (AB AH AR)).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15127-7",TRUE,"Competing interests Sven Mahner reports Research support advisory board honoraria and travel expenses from AbbVie AstraZeneca Clovis Eisai GlaxoSmithKline Medac MSD Novartis Olympus PharmaMar Pfizer Roche Sensor Kinesis Teva and Tesaro. All other authors have no conflict of interest to declare.",TRUE,"<section> Funding <section> The study was funded by sources of the Department of Psychiatry Psychotherapy and Psychosomatics Brandenburg Medical School Theodor Fontane (MHB) as well as the Department of Endocrinology and Reproductive Medicine Ludwig-Maximilians University Munich Germany. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15286-7",TRUE,"Competing interests The authors declare no conflict of interest.",TRUE,"<section> Funding <section> This research received no supporting funds from any funding agency in the public commercial or notfor-profit sector.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15375-7",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The ESEG project was funded by the Innovation Committee of the Federal Joint Committee (grant number 01VSF17034 project period 07/2018–06/2021]).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15550-w",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15598-8",TRUE,"Competing interests FvW and TK are affiliated with the Centre for Digital Health Interventions a joint initiative of the Department of Management Technology and Economics at ETH Zurich and the Institute of Technology Management at the University of St Gallen which is funded in part by CSS a Swiss health insurer. TK is also the cofounder of Pathmate Technologies a university spin-off company that creates and delivers digital clinical pathways. However Pathmate Technologies was not involved in any way in the design interpretation and analysis during the study or in writing the paper. All other authors have no conflict of interest to",TRUE,"<section> Funding This research is supported by the National Research Foundation Prime Minister’s Office Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12889-023-15704-w",TRUE,"Competing interests The Authors declare that there is no conflict of interest.",TRUE,"<section> Funding <section> This study was funded by the Else Kröner-Fresenius-Stiftung (2019_HA178) and the Makerere University Research Innovation Fund (MAKRIF/ DVCFA/026/20).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15730-8",TRUE,"Competing interests The authors declare no conflict of interest.",TRUE,"<section> Funding <section> This research received no supporting funds from any funding agency in the public commercial or notfor-profit sector.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-15799-1",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The TEMPO cohort is supported by the French National Research Agency (ANR) (ANR-Flash COVID) the French Insititue for Public Health Research IReSP (TGIR Cohortes) the French Institute of Cancer (INCa) the French Interdepartmental Mission for the Fight against Drugs and Drug Addiction (MILDeCA) and the Pfizer Foundation. The TEMPO COVID19 study is supported by the European Union’s Horizon 2020 research and innovation program RESPOND (funded under Horizon 2020 – the Framework Programme for Research and Innovation (2014–2020)).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12889-023-16524-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"Further the association between fatigue and SARS-CoV-2 infection in our study was supported by significantly higher mean fatigue scores as assessed by the PROMIS-29 healthrelated quality of life questionnaire among participants with baseline infection compared to those never infected. <section> Acknowledgements We thank the local authorities and colleagues at the Robert Koch Institute for their support in conducting the CORONA-MONITORING lokal study. <section> Funding The CORONA-MONITORING lokal study and its followup were funded by the German Federal Ministry of Health (grant numbers: ZMVI1-2520COR402 ZMI1-2521COR301).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12889-023-16667-8",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-16849-4",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-16924-w",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"We would like to thank the community multipliers and social media channels for supporting recruitment. <section> Funding The authors declare no funding for this project.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-17121-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> R.K. M.H. A.A B.L; Funding acquisition: B.L. G.K. <section> Funding This work was supported by the Helmholtz Association the European Union’s Horizon 2020 research and innovation program (grant number 101003480) and by internal HZI funds.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-17135-z",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-17213-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding FAARM’s GAAP2 work was financially supported by a grant from IFPRI to Heidelberg University and Emory University [IFPRI Project No. The content of this publication is solely the responsibility of the authors and does not necessarily reflect the policies or views of the organizations with which they are affiliated or the funding agencies. Funding organizations did not have a role in the study design hiring or training of staff intervention delivery data collection analysis or data interpretation.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-17258-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> This work was supported by the JSPS KAKENHI Grantin-aid for Young Sci‑ entists (no. 22K15778 recipient Dr Matsui).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12889-023-17362-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG grants HE7464/2–1 to S.H. FY1/5–1 to T.F. and STR504/6–1 to A.St.) the Dalla Vecchia Foundation on Depression Research (Dalla Vecchia Stiftung Depressionsforschung) to A.H. and S.H and by grants from the German Ministry of Education and Research and the State of Brandenburg",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12891-023-06226-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12891-023-06556-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> The GBD study is conducted by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle with financial support from various institutions including the World Bank the National Institutes of Health and the Bill & Melinda Gates Foundation. <section> Funding",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12891-023-06661-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> prevop.charite.de/) and was supported by two subprojectgrants from the German Federal Ministry of Education and Research (Bundesministerium für Authors also gratefully acknowledge the support from the Focus Area DynAge (Freie Universität Berlin; Charité Universitätsmedizin Berlin) during the preparation of the grant application (DynAge 1_4 to W.E. and Petra Knaus) and the support by the Open Access Publication Fund of the Freie Universität Berlin.",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration German Clinical Trials Register; https://drks.de/search/de/trial/DRKS00009677;",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12891-023-06967-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12894-023-01374-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> This original work was supported under indigenous scholarship by Higher Education Commission (HEC) Pakistan.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12902-023-01321-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Education on the Metabolic Control Selfefficacy and Quality of 1 Diabetes Mellitus in Turkey to improve youth questionasking and provider education during encounters: The Promoting Adolescents Communication and Engagement on Glycemic Control in Children and Adolescents with Type 1 Diabetes the Use of Social Media to Support Type 1 Diabetes Management: Focus through a social network in young patients with type 1 diabetes in a adolescents with type 1 diabetes provided by adolescents with type of adolescents’ willingness to share diabetes personal health infor‑ a personal robot playing a selfmanagement education game with children Documentation in Mobile-Phone-Based Self-Management Application for intervention for adolescents with type 1 diabetes. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration The study protocol was registered on the CRD42021282199). <section> The registration number of this review in the PROSPERO register is CRD42021282199.",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12903-023-02951-x",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> The research was funded by a grant from the Research Council of Norway Project number 301517.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12903-023-03362-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Shankeeth Vinayahalingam: Conceptualization Method Investigation Formal Analysis Software Funding acquisition Writing – original draft. David Anssari Moin: Investigation Validation Resources Project administration Funding acquisition Supervision Writing – review &; editing. <section> Funding This research is partially funded by the Radboud AI for Health collaboration between Radboud University and Radboudumc and the Innovation Center for Artificial Intelligence (ICAI).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12903-023-03475-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Materials and methods Study registration and protocol development The protocol of the present review was registered and allocated the identification number CRD42022297500 in the International Prospective Register of Systematic Reviews (PROSPERO).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12903-023-03695-4",TRUE,"Competing interests Patrick Rider Svenja Rogge Draen Tadi and eljka Peri Kaarevi are employees of Botiss biomaterials GmbH.Authors Akiva Elad Luka Pul Eitan Mijiritsky Frank Witte and Larisa Steigmann declare no conflict of interest.",TRUE,"<section> Funding <section> The author(s) received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12904-023-01151-2",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding No funding was received for this research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04025-6",TRUE,"Competing interests The authors report no conflicts of interests.",TRUE,"<section> Funding During data collection and analyses Niklas Keller was supported by a grant from the Berlin Senate Department of Education Youth and Science in the context of the “Berliner Qualitätsoffensive für die Lehre 2012 2016”.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04041-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding National Insti‑ tutes of Health: gender differences in Radiology Funding. National Institutes of Health Funding in Obstetrics and Gynecology: analysis of R01 grants by degree and gender.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04172-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The research project was funded by the German Ministry of Education and Research (Grant",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04213-4",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04568-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04709-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The study was funded by the German Federal Ministry of Health.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04745-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Study design This study was developed based on uncontrolled internal course evaluations conducted by the Institute of Social Medicine at Charité. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04771-7",TRUE,"Conflict of interest The authors declare no competing interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12909-023-04784-2",TRUE,"Competing interests Author HP is the associate editor of BMC Medical Education. All the other authors have no competing interests to declare.",TRUE,"<section> Funding <section> No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12910-022-00873-x",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"DS: Conceptualization Resources Writing— Review & Editing Supervision Project administration Funding acquisition. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Conclusions This mapping study tional process from theory to of evaluative/translational empirical second five categories for types Trial registration: The methodology Science Framework (https://osf.io/r6h4y/).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12910-023-00913-0",TRUE,"Disclosure Status and Relevance on Medical Research from the United States. <section> Elder K Turner KA Cosgrove L Lexchin J Shnier A Moore A et al. Reporting of financial conflicts of interest by canadian clinical practice guideline producers: a descriptive study. Conflict of interest in clinical practice guideline development: a systematic review. <section> Financial conflicts of interest in clinical practice guidelines: a systematic review. Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch.",TRUE,"Rating “Strongly Disagree” “Strongly Agree” if the guideline does not contain any information / explanation pertaining to financial support. requires that the guideline provides information about both the responsible organisation (editors) and any additional financial or other support of the guideline. requires that the guideline provides information about the funding or supporting organisation and details about how the guideline work has been funded. requires that apart from naming the funding and / or supporting bodies the guideline must contain information about the nature and volume of the funding. Funding sources were categorised using examples provided by the AWMF [2]. Funding information of CPGs was considered inconclusive if no direct connection could be made between funding sources and expenses. <section> Funding information provided by CPGs 315/507 (62.1%) of all CPGs provided conclusive information on guideline funding (Table 2a). <insert> Table 2 Funding of Clinical practice guidelines 2a Funding information provided by CPGs Classification n Funding statement (%) No Yes Inconclusive Funding source mentioned (%) Funding type mentioned (%) Statement of independence (%) 2b Funding sources for CPGs with available information Classification n Scientific medical societies (%) Contributions by authors (%) Hospitals/Universities (%) Independent agencies (%) Guideline programs (%) Selfregulatory bodies (%) German Federal Government (%) Pharmaceutical industry (%) Other (%) Insurances (%) 2c Funding types for CPGs with available information Classification n Meeting costs (%) Scientific costs (%) Administrative costs (%) Material costs (%) Independent literature search and appraisal (%) Other (%) S1 Informal consensus S2e Systematic literature search S2k Structured consensus Overall 20 (11.7) 142 (83.0) 9 (5.3) 142 (83.0) 100 (58.5) 51 (29.8) S3 Systematic literature search & Structured consensus 0 (0.0) 125 (93.3) 9 (6.7) 125 (93.3) 98 (73.1) 76 (56.7) 113 (64.6) 24 (13.7) 38 (21.7) 24 (13.7) 3 (1.7) 3 (1.7) 2 (7.4) 24 (88.9) 1 (3.7) 24 (88.9) 14 (51.9) 14 (51.9) S1 5 (20.8) 22 (91.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0) 0 (0.0) S2e 15 (62.5) 14 (58.3) 5 (20.8) 2 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0) S2k 120 (84.5) 68 (47.9) 13 (9.2) 12 (8.5) 1 (0.7) 2 (1.4) 1 (0.7) 0 (0.0) 1 (0.7) 1 (0.7) S3 95 (76.0) 66 (52.8) 22 (17.6) 15 (12.0) 26 (20.8) 10 (8.0) 5 (4.0) 4 (3.2) 3 (2.4) 0 (0.0) Overall 235 (74.6) 170 (54.0) 40 (12.7) 29 (9.2) 27 (8.6) 10 (3.2) 7 (2.2) 5 (1.6) 4 (1.3) 1 (0.3) S1 1 (33.3) 1 (33.3) 2 (66.6) 0 (0.0) 0 (0.0) 0 (0.0) S2e 9 (64.2) 8 (57.1) 5 (35.7) 3 (21.4) 0 (0.0) 1 (7.1) S2k 94 (94.0) 17 (17.0) 8 (8.0) 16 (16.0) 3 (3.0) 0 (0.0) S3 92 (93.9) 69 (70.4) 49 (50.0) 38 (38.8) 10 (10.2) 2 (2.0) Overall 196 (91.2) 95 (44.2) 64 (29.8) 57 (26.5) 13 (6.0) 3 (1.4) 135 (26.6) 315 (62.1) 57 (11.2) 315 (62.1) 215 (42.4) 144 (28.4) 2 b Personal contributions by authors: honorary offices by guideline authors donations by guideline authors; Independent agencies: patient organizations funding associations of charitable foundations; Guideline programs: German Program for National Clinical Practice Guidelines (NVL Program) Guideline Program in Oncology (OL program); Selfregulatory bodies: e.g. <section> Funding sources for CPGs with available information We could assess funding sources of 315/507 (62.1%) CPGs (Table 2b). Funding through corporations in the healthcare sector (e.g. pharmaceutical industry medical device manufacturers) was mentioned by five CPGs once in an S2e and four times in S3 guidelines. <section> Funding types for CPGs with available information Funding types of 215/507 (42.4%) CPGs could be assessed (Table 2c). <section> Boyd et al. [6] recommend (1) public funding for guideline development (2) development without commercial support (3) no COI related to the subject matter and (4) no single source sponsorship. <section> Funding There was no external funding for this study.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12910-023-00959-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding Parts of the NAPKON project suite and study protocols of the Cross-Sectoral Platform are based on projects funded by the German Center for Infection Research (DZIF). <section> We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation 491454339). <section> The authors declare that no funds grants or other support were received dur‑ ing the preparation of this manuscript.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12912-023-01279-9",TRUE,"Competing interests The authors declare no conflict of interest.",TRUE,"<section> Funding <section> This research received no supporting funds from any funding agency in the public commercial or notfor-profit sector.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12912-023-01317-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was part of the Skillslab:XR Project (4/2020 10/2022) supported by the IFAF Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12913-023-09120-4",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"We further acknowledge support by the Open Access Publication Fund of the Freie Universität Berlin. <section> Funding",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12913-023-09226-9",TRUE,"Competing interests The authors report there are no competing interests to declare.",TRUE,"<section> Funding <section> The work of the first author SS was supported by the Berliner Chancengleichheitsprogramm (BCP). No other funding was received to assist with the preparation of this manuscript.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12913-023-09688-x",TRUE,"Disclosure of Interest form is appended. <section> All other authors have no competing interest.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12913-023-09726-8",TRUE,"Competing interests The authors declare no conflict of interest.",TRUE,"<section> Funding This systematic review was conducted as part of the ReCoDID project funded by the EU Horizon 2020 research and innovation programme (grant agreement 825746) and the CIHR Institute of Genetics (grant agreement 01886–000) grant to LM.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12913-023-09886-7",TRUE,"Competing interests All authors declared no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12915-023-01751-7",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12916-023-02743-8",TRUE,"Competing interests P.M.T. receives partial grant support from Biogen Inc. for research unrelated to this manuscript. None of the other authors declares any conflict of interest.",TRUE,"<section> Funding <section> Support for this work was provided by National Institute of Child Health and Human Development [R01 HD060628 K99 HD100593]; National Institute of Mental Health [R01 MH091351]; National Institute of Diabetes and Digestive and Kidney Diseases [R21 DK118578]; National Institutes of Health [UG3OD023349]; Alexander von Humboldt Foundation (SN) Emil Aaltonen Foundation (JJT SN) Hospital District of South-Western Finland State Research Grants for Clinical Research (JJT SN LK HK) Alfred Kordelin Foundation (JJT) Turku University Foundation (JJT) Sigrid Juselius Foundation (JJT) The Finnish Medical Foundation (JJT) Finnish Cultural Foundation Signe and Ane Gyllenberg Foundation (JJT SN LK HK) Yrjö Jahnsson Foundation the Brain and Behavior Research Foundation (YI Grant 19056) NARSAD Brain and Behavior Research Foundation YI Grant #1956 (LK) Academy of Finland Research Council for Health (308176; 253270 264363 and 134950)the Academy of Finland Research Council for Culture and Society (2608063) The Academy of Finland (#325292/Profi5) (LK) and Jane and Aatos Erkko Foundation (HK).",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12916-023-02889-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The authors gratefully acknowledge financial support from the State of Brandenburg (MWFK) the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung) and the Chinese Scholarship Council (CSC).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12916-023-02920-9",TRUE,"Competing interests LP reports personal fees from Janssen Canada; Otsuka Canada; SPMM Course Limited UK; Canadian Psychiatric Association; book royalties from Oxford University Press; and investigator-initiated educational grants from Janssen Canada Sunovion and Otsuka Canada outside the submitted work. All other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding Kai Zhang is sponsored by Shanghai Pujiang Program. BB was supported by the National Natural Science Foundation of China (Grants No. XZ was supported by the National Natural Science Foundation of China (T2225015 61932008) Shanghai Municipal Science and Technology Major Project (2018SHZDZX01) and Greater Bay Area Institute of Precision Medicine (Guangzhou) (Grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12916-023-02977-6",TRUE,"Competing interests TR HE JS JK and WQ are involved in one of the included ongoing economic evaluations [59]. TM declares to have no competing interests.",TRUE,"Funding and competing interest of included economic evaluations. <section> Funding The systematic review is part of a larger project which is supported by the Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee in Germany (Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA)) grant number 01NVF18024.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration PROSPERO CRD42020182813. <section> Registration and protocol The systematic review was prospectively registered in PROSPERO (CRD42020182813) and we published a protocol [21].",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12916-023-03071-7",TRUE,"Competing interests The authors declare no support from any organisation for the submitted work.",TRUE,"<section> Funding <section> Competing interests The authors declare no support from any organisation for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12916-023-03104-1",TRUE,"Competing interests Marc J. Gunter is a member of the editorial board for BMC Medicine. The other authors declare no potential conflicts of interest.",TRUE,"The collection and availability of cancer registry data is also supported by the Cooperative Agreement NU58DP006333 funded by the Centers for Disease Control and Prevention. The authors would like to acknowledge the contribution to this study from central cancer registries supported through the Centers for Disease Control and Prevention’s National Program of Cancer Registries and cancer registries supported by the National Cancer Institute’s Surveillance Epidemiology and End Results Program. <section> NSHDS investigators thank the Västerbotten Intervention Programme the Northern Sweden MONICA study the Biobank Research Unit at Umeå University and Biobanken Norr at Region Västerbotten for providing data and samples and acknowledge the contribution from Biobank Sweden supported by the Swedish Research Council. All are supported in part by funds from the Center for Disease Control and Prevention National Program for Central Registries local states or by the National Cancer Institute Surveillance Epidemiology and End Results program. We are also grateful to the 35533 dedicated men who participated in SELECT. <section> Funding The authors received no specific funding for this work. The coordination of EPIC is financially supported by the International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics School of Public Health Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). <section> The national cohorts are supported by the Danish Cancer Society (Denmark); Ligue Contre le Cancer Institut Gustave Roussy Mutuelle Générale de l’Education Nationale Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid German Cancer Research Center (DKFZ) German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health Welfare and Sports (VWS) Netherlands Cancer Registry (NKR) LK Research Funds Dutch Prevention Funds Dutch ZON (Zorg Onderzoek Nederland) World Cancer Research Fund (WCRF) Statistics Netherlands (The Netherlands); We thank the National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands for their contribution and ongoing support to the EPIC Study. The EPIC-Norfolk study (https://doi.org/10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC-UU_12015/1) and Cancer Research UK (C864/A14136).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12916-023-03161-6",TRUE,"Competing interests The authors report no competing interests related to the submitted work.",TRUE,"Funding acquisition: BG and DS. <section> Funding <section> The DIRECCT project is part of the CEOsys (COVID-19 Evidence Ecosystem) project funded within the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin—NUM) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung—BMBF). Dissemination of the Results of Pediatric Clinical Trials Funded by the US National Institutes of Health.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Since 2020 the number of registered clinical trials addressing COVID-19 grew alongside the pandemic: the WHO International Clinical Trials Registry Platform (ICTRP) database went from 240 COVID-19 trial registrations in February 2020 to 20076 on 5 May 2023 [3]. It leverages clinical trial registry data to examine a comprehensive population of COVID19 research. <section> FAQs: Clinical Trials Registration.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12920-023-01585-w",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The work in the group of A.R. was funded by Dr. M.Y. was funded by the Berlin School of Integrative Oncology (BSIO) graduate program and by the Einstein Foundation. Funding sources had no role in study design interpretation or writing of the report.",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12933-023-01808-5",TRUE,"Competing interests The authors declare that they have no relevant financial interests.",TRUE,"<section> Funding <section> This project has received funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement No 115974. The GCKD Study was supported by grants from the German Federal Ministry of Education and Research (BMBF) the KfH Foundation of Preventive Medicine e.V. and corporate sponsors (https://www.gckd.org/).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12933-023-01899-0",TRUE,"Competing interests UK received research grants/ speaker honoraria from Bayer AG.",TRUE,"The second study SPIRIT-HF (Spironolactone In The Treatment of Heart Failure NCT04727073) is a study funded by the German Centre for Cardiovascular Research (DZHK)/ German Federal Ministry of Education & Research and investigates the effect of spironolactone on the composite endpoint of recurrent hospitalization for heart failure and CV death in 1.300 symptomatic heart failure patients (NYHA II-IV) with midrange (LVEF ≥ 40–49%) or preserved (LVEF ≥ 50%) ejection fraction in Austria France Germany and the Netherlands [27 66]. <section> Funding FE is supported by German Ministry of Education and Research (BMBF Health5G) and the Deutsche Forschungsgemeinschaft (Ex-DHF and SFB-1470-Z02).",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12933-023-01943-z",TRUE,"Competing interests P.P. has received research grants and personal fees from Vifor Pharma (PI of AFFIRM-AHF; participation in clinical trials); and personal fees from Amgen Bayer Novartis Abbott Vascular Boehringer Ingelheim Pfizer Servier AstraZeneca Berlin Chemie Cibiem BMS Impulse Dynamics (participation in clinical trials). <section> C.V. B.A.K. and G.R. declare no competing interests.",TRUE,"<section> Funding <section> The AFFIRM-AHF trial was funded by Vifor Pharma Management Ltd. S.D.A has received grants from Abbott Vascular and Vifor International; and has received personal fees from Amgen AstraZeneca Bayer Boehringer Ingelheim Bioventrix Brahms Cardiac Dimensions Cardior Cordio CVRx Edwards Impulse Dynamics Janssen Novartis Occlutech Respicardia Servier Vectorious and V-Wave all outside the submitted work.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12935-023-03041-2",TRUE,"Competing interests There are no competing interests ber Haj Ali and Michal Walter wrote this review.",TRUE,"<section> Funding The work of Michael Walter was supported by the DGKL (Deutsche Gesellschaft für Klinische Chemie und Laboratoriumsmedizin).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12936-023-04783-0",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding Funding for this project was received by the German Federal Ministry of Health (Grant number: ZMI1-2521GHP914).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12938-023-01111-0",TRUE,"<section> Otherwise the authors have no competing interests.",TRUE,"<section> Funding This work has been funded by the Federal Ministry of Education and Research (BMBF Germany) and is part of the project SOLVe with grant number 13GW0240.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12938-023-01147-2",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding The authors acknowledge the support of the European Union (EU) Horizon 2020 project InterLynk (grant agreement: H2020-NMBP-TR-IND-2020 project ID: 953169) for the present work.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12939-022-01807-0",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The research on which this manuscript is based was funded by the Federal Ministry of Education and Research (grant no. 01GL1710A).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12939-023-01942-2",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Health financing Funding sources for screening programs The financial resources needed to sustain cervical cancer screening programs were either provided by external grants or fees paid for services offered. On the other hand the 5-year long cancer screening program in Dschang was funded primarily by external grants from different institutions in Switzerland [33]. <section> Acknowledgements The authors acknowledge financial support from the German Academic Exchange Service (DAAD). <section> Funding",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12939-023-01958-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12943-023-01787-x",TRUE,"Competing interests The following authors are employees of the following pharmaceutical companies: Eli Lilly (C. Reinhard) and Bayer-Pharma (D.H.). Other authors are <section> founder of Alacris Theranostics (H.L.) founder and CEO of CELLphenomics (C.R.) employee and/or shareholder of EPO (J. Hoffmann M.K.). None of these companies influenced the interpretation of the data or the data reported or financially profit by the publication of the results. The remaining authors declare no competing financial interests.",TRUE,"<section> Funding The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115234 (OncoTrack). <section> This study was funded in part by the Deutsche Forschungsgemeinschaft (DFG #KI702 to A.K.K) and the Wilhelm Sander-Stiftung (#2021.068.1 to S.M.K.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12943-023-01792-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The research reported in this manuscript was supported by DFG funding (RU5433) to S.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12943-023-01900-0",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements This work was supported by the Cluster of Excellence iFIT (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies” University of Tuebingen Germany the Werner Siemens Foundation the Alexander von Humboldt Foundation within the framework of the Sofja Kovalevskaja Award (to AFM) the Wilhelm-Sander-Stiftung (2020.100.1 to MR) and the Open Access Publica‑ tion Fund of the University of Tübingen. <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12944-023-01906-z",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12947-023-00316-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12954-023-00896-6",TRUE,"Competing interests",TRUE,"<section> Supported by preliminary analyses and throughout the data gathering process the adequacy of the initially set number of participants was continuously evaluated. Supported by reflexive memowriting we developed a codebook that contained a comprehensive list of our categories and their definitions. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12955-023-02188-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12955-023-02190-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12955-023-02199-7",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by the EORTC Quality of Life Group [grant EORTC CAT projects 2022].",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12967-023-04439-2",TRUE,"Competing interests <section> Michael Baumann CEO and Scientific Chair of the German Cancer Research Center (DKFZ Heidelberg) is responsible for collaborations with a large number of companies and institutions worldwide. In this capacity he has signed contracts for research funding and/or collaborations including commercial transfers with industry and academia on behalf of his institute(s) and staff. <section> He is a member of several supervisory boards advisory boards and boards of trustees. Michael Baumann confirms that he has no conflict of interest with respect to this paper.",TRUE,"Funding acquisition: AY DZ MB. <section> Funding The study was supported by a Grant of the Deutsche Forschungsgemeinschaft (DFG PAK-124).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12967-023-04502-y",TRUE,"Competing interests LS holds shares of selenOmed GmbH a company involved in selenium status measurement. The remaining authors have no competing interests to declare.",TRUE,"<section> Funding This study has been funded by the Deutsche Forschungsgemeinschaft (DFG) Research Unit FOR-2558 “TraceAge” (Scho 849/6–2) CRC/TR 296 “Local control of TH action” (LocoTact P17) the Mrs.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12967-023-04731-1",TRUE,"Competing interests PB SK ZK and HB have received licensing fees and royalties for MSC-FFM.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12969-023-00798-8",TRUE,"Competing interests GH declares serving on advisory boards and receiving research funds and honoraria from AbbVie Chugai GSK MSD Pfizer Roche and Sobi.",TRUE,"<section> Funding <section> The systematic literature review to support this manuscript was sponsored by Pfizer.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12969-023-00811-0",TRUE,"Competing interests <section> SK: none; JK: none; IL: none; MN: none; DEF: none FD: speaker`s fees from <section> Novartis and Pfizer; IF: none DF: none.",TRUE,"<section> Funding The ICON study was funded by the Federal Ministry of Education and Research (BMBF FKZ",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12969-023-00826-7",TRUE,"Competing interests No potential conflicts of interest relevant to this article were reported by any of",TRUE,"<section> Funding Dr O’Leary’s work was funded by the National Children’s Research Centre Dublin Ireland (grant code G/17/1) and the AbbVie SOBI Nordic Pharma Newman Fellowship in Rheumatology through the UCD Newman Foundation.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12969-023-00875-y",TRUE,"Competing Interests Lisa Ehlers has no conflicts of interest to declare. Elisabeth Rolfes has no conflicts of interest to declare. Dominik Müller has no conflicts of interest to declare. Faekah Gohar has no conflicts of interest to declare. Günter Klaus has no conflicts of interest to declare. Jana Hörstermann has no conflicts of interest to declare. Katharina Palm-Beden has no conflicts of interest to declare. Lusine von Wrangel has no conflicts of interest to declare. <section> Maria Faßhauer has no conflicts of interest to declare. Anne Sae Lim von Stuckrad has no conflicts of interest to declare. Sonja Higgins has no conflicts of interest to declare. Tatjana Welzel has no conflicts of interest to declare.",TRUE,"<section> Funding <section> The AID-NET registry was supported by the Federal Ministry of Education and Research 2009–2018 (01GM08104 01GM1112D 01GM1512D). Helmut Wittkowski received research funding from Takeda honoraria from Novartis and Takeda travel grants from Octapharma and CSL-Behring and is a member of the following medical societies: GKJR API.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12974-023-02711-2",TRUE,"Competing interests Authors declare that they have no competing interests concerning the issues in this manuscript.",TRUE,"Funding acquisition: HR ED FH JK MR. <section> Funding This manuscript is funded by the publication funds of the Charité Universitätsmedizin Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12974-023-02718-9",TRUE,"Competing interests KB BT NR SJ KG and ID have nothing to disclose.",TRUE,"<section> Funding There was no external funding for this study. KR received research support from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité (BIH Clinical Fellow Program) Arthur Arnstein Foundation and Guthy Jackson Charitable Foundation. BW received grants from the German Ministry of Education and Research Deutsche Forschungsgemeinschaft Dietmar Hopp Foundation Klaus Tschira Foundation grants and personal fees from Merck and personal fees from Alexion Bayer Biogen Roche none related to this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12974-023-02763-4",TRUE,"Competing interests Shiv Saidha has received consulting fees from Medical Logix for the development of CME programs in neurology and has served on scientific advisory boards for Biogen Novartis Genentech Corporation TG therapeutics Rewind therapeutics & Bristol Myers Squibb. Galetta Hamid Harandi Teresa C Frohman and Friedemann Paul report no disclosures.",TRUE,"<section> Funding <section> No funding for this research was done.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12974-023-02979-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> This work was financially supported by the Academy of Finland (grant number 335524) Sigrid Juselius foundation and by the University of Eastern Finland. <section> This work was supported by the Ministry of Education Youth and Sports of the Czech Republic (the Research Infrastructure NanoEnviCZ LM2018124) and the European Union—European Structural and Investments Funds in the frame of Operational Programme Research Development and Education—project Pro-NanoEnviCz (Project No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12974-023-02997-2",TRUE,"Competing interests The authors report no competing interests.",TRUE,"<section> Funding <section> The study was supported by International Cooperation and Exchange Pro‑ gram (82320108007) the National Natural Science Foundation of China Grants (82171777 82071389) and the Natural Science Foundation of Tianjin Province",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s12979-023-00376-2",TRUE,"Competing interests The authors declare no competing interests. 2013;368(2):117–127. https://doi.org/10.1056/NEJMO A1211851/SUPPL_FILE/NEJMOA1211851_DISCLOSURES.PDF. 2013;368(2):107– 116. https://doi.org/10.1056/NEJMOA1211103/SUPPL_FILE/NEJMOA1211 103_DISCLOSURES.PDF.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12984-023-01137-4",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This research is supported in part by the European Research Council (ERC) under the project NGBMI (759370) the Federal Ministry of Research and Education (BMBF) under the projects SSMART (01DR21025A) and NEO (01DR21025A) the Korean Minis‑ try of Science and ICT under the framework of the German-Korean AcademiaIndustry International Collaboration Program on Robotics and Lightweight Construction/Carbon (Grant No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12984-023-01185-w",TRUE,"Competing interests S.C. and N.V. have interests in a spin-off company (IUVO S.r.l.) developing and commercializing exoskeleton technolo degy that may benefit in the future from the research presented in this article.",TRUE,"<section> Funding <section> This study was funded by the European Commission under the project AIDE (G.A. no: 645322) Spanish Ministry of Science and Innovation through the projects PID2019-108310RB-I00 and PLEC2022-009424 and by the Ministry of Universities and European Union “financed by European Union-Next Genera‑ tion EU” through Margarita Salas grant for the training of young doctors.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12984-023-01288-4",TRUE,"Competing interests The authors report no competing interests.",TRUE,"AV: Resources Supervision Funding acquisition. <section> Funding This study was supported by the Max Planck Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: the current experiment is not a health care",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s12985-023-02047-6",TRUE,"The authors declare no competing interests.",TRUE,"<section> EF Oliveira-Filho was supported by FACEPE (grant 1380 − 5.05/15) and CNPq (grant DCR0003-5.05/16) until 2018. <section> Funding",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12985-023-02154-4",TRUE,"Conflict of interest The authors declare no competing interests. <section> Competing interests The authors declare no competing interests.",TRUE,"Parts of this work were supported by grants from NIAID-NIH CEIRS contract HHSN272201400008C to TCJ; MAM VMC and CD provided funding. <section> Funding <section> This work was supported by the Bundesministerium für Bildung und Forschung (grant 01KI1723A) as well as the EU via project RECOVER (GA101003589). Parts of this work were supported by grants from NIAID-NIH CEIRS contract HHSN272201400008C.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12986-023-00750-3",TRUE,"Competing interests The authors declare no competing interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12987-023-00441-4",TRUE,"Competing interests The authors declare that they have no competing interests",TRUE,"<section> Funding <section> This work was funded by the Swiss National Science Foundation (ProDoc Cell Migration grant N° PDFMP3_137127 the Sinergia grant CRSII3_154483 and the grant 310030_189080) the Bangerter-Rhyner Foundation to BE and the Microscopy Imaging Center of the University of Bern. IL received educational funds from the SNSF grant ProDoc Cell Migration grant N° PDAMP3_137087 and swissuniversities. HN was supported on the Uehara Memorial Foundation an ECTRIMS Postdoctoral Research Exchange Fellowship JSPS under the Joint Research Program implemented in association with SNSF (JRPs) Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12992-023-00942-9",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"The following data were charted: author publication year study design study methods timeframe financing model type recipient funding target mode of disbursement amount of disbursement and funding source. <section> When looking at aid given to governments Oxman et al. [16] included an evaluation of the first 5 years of GAVI’s Immunization Services Support Funding (ISS) in 2010. The ISS program has since been phased out and is now replaced with a new performancebased funding scheme under the Health Systems Strengthening (HSS) program. <section> Funding The Paris Declaration on Aid Effectiveness.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s12995-023-00370-w",TRUE,"Competing interests Ludger Senker is corporate physician at BP Europa SE Lingen Refinery Lingen (Ems) Germany.",TRUE,"<section> Funding This study has been funded by BP Europa SE Lingen Refinery Lingen (Ems) Germany and the Moving Gesundheitsmanagement GmbH Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13005-023-00368-z",TRUE,"Competing interests F.S. and J.K. are co-founders of the dentalXrai GmbH a startup. dentalXrai GmbH did not have any role in conceiving conducting or reporting this study.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13005-023-00389-8",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13011-023-00576-5",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements The main author (EAS) has a scholarship from The German Academic Exchange Service (DAAD Deutscher Akademischer Austauschdienst) ref.no: 91604276 research grant – Doctoral Programmes in Germany grant number (57440921). We acknowledge financial support from the German Academic Exchange Service (DAAD) the Open Access Publication Fund of Charité Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13014-023-02385-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13017-023-00518-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The authors received no financial support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13018-023-03738-0",TRUE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13018-023-03762-0",TRUE,"Competing interests PM is a consultant for Arthrex. All other authors declare that they have no competing interests.",TRUE,"<section> Funding <section> There was no funding for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13019-023-02267-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13019-023-02285-3",TRUE,"Competing interests Prof. Volkmar Falk reports a financial relationship with Abbott GmbH Medtronic GmbH Boston Scientific Inc. Novartis Pharma Berlin Heart GmbH Biotronik Se & Co. Edwards Lifesciences JOTEC GmbH Zurich Heart and ETH Zurich in relation to research and study funds and fees for lectures and speeches. All other authors have no conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13019-023-02422-y",TRUE,"Competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13019-023-02459-z",TRUE,"Conflict of interest JKRVM None.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02651-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02661-1",TRUE,"Competing interests ALS FT REL BP and KS are employees of Adelphi Values which conducted research on behalf of Blueprint Medicines.",TRUE,"<section> Funding <section> Funding for this study was provided by Blueprint Medicines.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02698-2",TRUE,"Competing interests The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.",TRUE,"<section> Limitations of the study Funding by the German Federal Joint committee is given for projects in the German health care system with the purpose of improving health care provision to specific populations such as patient with RD through new interventions. The other authors received no external funding with relevance to this manuscript. <section> Funding <section> Open Access funding enabled and organized by Projekt DEAL and supported by the Open Access Publication Funds of the Ruhr-Universität Bochum. This study was supported by the German Federal Joint Committee G-BA # 01NVF16024 TRANSLATE-NAMSE.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02706-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by grants from the Niedersächsische Ministerium für Wissenschaft und Kultur to KB (74ZN1284) and to BW (ZN3136) by Germany’s Excel‑ lence Strategy Cluster of Excellence ""Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells"" (MBExC; EXC 2067/1-390729940) to BW. EMV is supported by grants from Telethon Foundation Italy (GGP20070) and Italian Ministry of Health (RC2021-2022 to IRCCS Mondino and to Rete IDEA RF-2019-12369368).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02768-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The study was funded by Alnylam Pharmaceutics Ltd. which participated in development of study design and financed personell expenses. The National Academies Collection: Reports funded by National Institutes of Health.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02821-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"However in order to advocate for allocation of funding for awareness and prevention programs information is first needed on the magnitude of this issue in a given country. <section> Funding ASW was supported by Alexander von Humboldt Research Fellowship for Postdoctoral Researchers grant 3.1–1163387-USA-HFST-P and Thrasher Research Fund Early Career Award TRF13751.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13023-023-02882-4",TRUE,"Competing interests GA has received honoraria for consultancy and for lecturing in educational activities from Kyowa Kirin International. SSBN has received honoraria for providing consultancy from Kyowa Kirin International; and research grants in addition to honoraria for providing consultancy from Inozyme Pharma. <section> AMB has received research grants and honoraria for providing consultancy and lectures from Kyowa Kirin International. MLB has received honoraria from Amgen Bruno Farmaceutici S.p.A. Calcilytix Kyowa Kirin International and UCB Pharma; grants and/or speaker fees from Abiogen Pharma Alexion Amgen Bruno Farmaceutici S.p.A. Echolight Eli Lilly and Company Kyowa Kirin International SPA Theramex and UCB Pharma; and consultancy fees from Alexion Amolyt Pharma Bruno Farmaceutici S.p.A. Calcilytix Kyowa Kirin International and UCB Pharma. KB has received honoraria as a consultant from Amgen Kyowa Kirin International Theramex and UCB Pharma. CLC has received honoraria for consultancy and for lecturing in educational activi‑ ties from Kyowa Kirin International. FE has received honoraria from Chiesi Farmaceutici Kyowa Kirin International and Recordati Rare Diseases; grants and/or speaker fees from Chiesi Farmaceutici Kyowa Kirin International and Recordati Rare Diseases; and consultant fees from Alnylam AVROBIO Kyowa Kirin International and Otsuka. SG has no competing interests to declare.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13031-023-00499-9",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13033-023-00601-x",TRUE,"Competing interests MV has received consultation fees from Camurus. The other authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13033-023-00609-3",TRUE,"Competing interests The authors declare that they do not have any competing interests.",TRUE,"<section> Funding <section> The current study was supported by (1) the Foreign Commonwealth & Devel‑ opment Office (FCDO) (2) the project “Empowering Persons with Psychosocial",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13034-022-00552-0",TRUE,"Competing interests None of the authors had a conflict of interest directly related to the content of the study.",TRUE,"<section> Funding The study was funded by the Senate of Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13034-023-00691-y",TRUE,"Competing interests The authors report no conflict of interest regarding the subject of this study.",TRUE,"<section> Funding <section> This study was realized as part of the COACH project funded by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF) Germany (grant number 01GL1740A) and the DPV initiative is supported by German Center for Diabetes Research (DZD) Munich-Neuherberg Munich Germany (grant number 82DZD14E1G).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13039-023-00637-1",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13045-023-01470-0",TRUE,"Competing interests <section> AS: Travel grants from Hexal and Jazz Pharmaceuticals.",TRUE,"<section> Funding This work was supported by the National Center of Tumor Diseases (NCT) by the German Cancer Research Institute (DKFZ) by the Jochen Siebeneicher Foundation and by a personal donation from Dr. h.c. MLS is supported by the Olympia Morata Program of the Medical Faculty of the University of Heidelberg (grant no. OM 09/2019). Financial support for educational activities and conferences from bluebird bio Kite and Novartis. Financial support congress participation: AbbVie Jazz Pharmaceuti‑ cals. ADH AHK AKei AKul AKun AN BM BN DH DV DW FK JF LJS LW MG MRi NG PP PW SH SLa SY: none.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13046-023-02755-5",TRUE,"Competing interests S.E.D. and A.J. hold equity ownership of the RSK inhibitor PMD-026 (Phoenix Molecular Designs). All other authors declare that they have no competing interests.",TRUE,"<section> Funding This research was supported by the German Cancer Aid via the MSNZ program (Mildred Scheel Early Career Center Wuerzburg) the intramural funding program “fortüne” of the University of Tuebingen (2505–0-0) and the “Hiege-Stiftung gegen Hautkrebs” to C. We acknowledge support from the Open Access Publication Fund of the University of Muenster.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Both preclinical studies and a Phase I clinical trial in metastatic breast cancer (Clinical trial information: NCT04115306) demonstrated a good safety profile of PMD-026 and – in contrast to MAPK pathway inhibitors – no apparent cardiotoxicity ocular toxicity or neutropenia in mice and dogs [31–33].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s13046-023-02799-7",TRUE,"Competing interests The authors declare no competing financial interests.",TRUE,"<section> Funding <section> This research was funded by the “5 × 1000” voluntary contribution and by a grant from the Italian Ministry of Health (Ricerca Corrente 2022–2024) to G.M. V.G. and F.B.. This work was in part supported by the Associazione Italiana Ricerca sul Cancro [IG-22827 to F.B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13046-023-02834-7",TRUE,"Competing interests The authors declare no potential conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by the Fund of National Key R&D Program of China (Grant no. 2022YFC2704303); National Nature Science Foundation of China (Grant no. 82203739); the Fujian Health Young and Middleaged Scientific Research Major Project (grant no. 2021ZQNZD011); the Startup Fund for scientific research Fujian Medical University (Grant no.2020QH2041); the Natural Science Foundation of Fujian Province (Grant no. 2020J02059 and 2021J01404) and Joint Funds for the Innovation of Science and Technology Fujian Province (Grant no. 2020Y9160 and 2021Y9157).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13048-023-01113-5",TRUE,"Competing interests The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.",TRUE,"<section> Funding This work was supported by the German Research Foundation (DFG MI 2098/3–1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13048-023-01239-6",TRUE,"Competing interests PJ reports stock ownership from Myriad Genetics Inc. CAK reports Honoraria from Ipsen. CS reports honoraria consulting or advisory role and travel accomodations exprenses from Amgen. IEB reports honoraria from MSD AstraZeneca GSK CLOVIS RochePharma and consulting or advisory role from SD AstraZeneca GSK CLOVIS NOGGO. CD reports consulting fees or advisory board from AstraZeneca Daiichi Sankyo Lilly Molecular Health MSD Oncology Roche; ownership interests from Sividon Diagnostics and receipt of intellectual property/ patent holder royalty from VMScope. JL SV IH PB MPD MG MJ WDS HK AS JS IEB CW DH SG ETT declare no competing interests.",TRUE,"The study was performed in accordance with the Declaration of Helsinki and with local ethical guidelines (ethic committee approval number EA1/051/18) and is supported by the TRANSCAN-2 project (grant no.: 2014–121). <section> Funding This project is partly funded by Transcan Grant 2014–121. M.P.D.’s work is funded by a DKTK Berlin Young Investigator Grant 2022 and Berliner Krebsgesellschaft (DRFF202204). The study was performed in accordance with the Declaration of Helsinki and with local ethical guidelines (ethic committee approval number EA1/051/18) and is supported by the TRANSCAN-2 project (grant no.: 2014–121).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13049-023-01152-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13052-023-01456-1",TRUE,"Competing interests Authors declare that they have no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-022-04253-0",TRUE,"Competing interests SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work. Dr. Schaller holds stocks in small amounts from Alphabeth Inc. Bayer AG and Siemens AG; these holdings have not affected any decisions regarding his research or this study. All other authors have no conflict of interest",TRUE,"<section> Funding <section> Competing interests SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Reviews [PROSPERO] registration: CRD420222989540. <section> The study protocol was registered and published on January 2022 on the International Prospective Register of Systematic Reviews (PROSPERO) of the National Institute for Health Research (NIHR) under the ID CRD42022298954.",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s13054-022-04291-8",TRUE,"Competing interests MB received research support from MSD (Haar Germany) not related to this manuscript received honoraria for giving lectures from GE Healthcare (Helsinki Finland) and Grünenthal (Aachen Germany). SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work. Dr. Schaller held stocks in small amounts from Rhön-Klinikum AG and holds stocks in small amounts from Alphabeth Inc. Bayer AG and Siemens AG; these holdings have not affected any decisions regarding his research or this study. The other authors declare that they have no competing interests.",TRUE,"<section> Funding SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04485-8",TRUE,"Competing interests Peter Smielewski and Marek Czosnyka receive part of the licensing fees for",TRUE,"<section> Funding For the writing of this manuscript Erta Beqiri was supported by CTBI scholarship (EC Grant n°:602150) and is currently supported by the Medical Research Council (Grant no.: MR N013433-1) and by the Gates Cambridge Scholarship. MJH Aries and J Tas are supported by a grant from the ‘Brain Battle’ Foundation (HersenStrijd fonds) from the University Maastricht The Netherlands. M. M. Placek was supported by the European Union seventh Framework Program (Grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) until March 2021 and by Action Medical Research (Grant GN2609) for Studying Trends of AutoRegulation in Severe Head Injury in Paediatrics (STARSHIP) until December 2021. Marek Czosnyka is supported by National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04620-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This study was supported by the German Federal Ministry of Education and Research (BMBF) Photonics Research Germany funding program (FKZ: 13N15716) and is inte‑ grated into the Leibniz Center for Photonics in Infection Research (LPI). Laboratory experiments were supported by Levi-Montalcini Biomedical Sciences Award from the European Society of Intensive Medicine (ESICM) awarded to JL. MJD is the recipient of a ZonMW AGIKO grant (No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04663-8",TRUE,"Competing interests The authors do not report a competing interests inside or related to the present",TRUE,"<section> Funding This publication was supported by the Open Access Publication Fund of the University of Würzburg.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04681-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04729-7",TRUE,"Competing interests JCP is an editor of Critical Care. All other authors declare that they have no competing interests.",TRUE,"<section> Funding SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovations fund of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organisers) in the field of anaesthesiology and intensive care medicine outside the submitted work. AH’s position is currently supported by a stipend from the Medical Faculty RWTH Aachen “Habilitationsstipendium”.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13054-023-04731-z",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This work was supported by the National Science Centre Poland (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13054-023-04733-x",TRUE,"Competing interests No competing interests.",TRUE,"<section> Funding The study was funded by grant 01VSF19020 from the German Innovations Fund of the Federal Joint Committee.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13058-023-01619-2",TRUE,"Competing interests CD reports personal fees from Novartis Roche MSD Oncology Daiichi Sankyo Molecular Health Astra Zeneca Merck; grants from Myriad Genetic and Roche; Stock and Other Ownership Interests from Sividon Diagnostics (until 2016); and has patent applications WO2015114146A1 and WO2010076322A1therapy response and WO2020109570A1 cancer immunotherapy pending and a patent Software (VMscope digital pathology). HT reports other from Pierre Fabre other from Pfizer Pharma other from Mundipharma other from ClinSol other from Novartis other from Lilly other from AMGEN other from Grünenthal other from Vifor other from AstraZeneca other from Mylan other from BMS during the conduct of the study. JUB reports personal fees from Amgen Astra Zeneca Exact Science MSD Oncology Lilly Novartis Pfizer Sysmex Roche and Sonoscape. KR reports personal fees from AstraZeneca personal fees from Pfizer personal fees from MSD outside the submitted work. <section> PW reports honoraria from AstraZeneca MSD Oncology Eisai Novartis/ Pfizer Roche Pharma AG Amgen Pfizer; Consulting or Advisory Role from Amgen Astra Zeneca MSD Oncology Novartis Roche Pharma AG Tesaro PharmaMar; Travel Accommodations Expenses from RochePharma AG outside the submitted work. SK reports personal fees from Lilly Roche Genomic Health Novartis Amgen Celgene Daiichi Sankyo Astra Zeneca Somatex MSD Pfizer Puma Technology PFM medical non-financial support from Roche Daiichi Sankyo Lilly Sonoscape outside the submitted work and a relationship with the WSG study group as co-director. SL reports grants and other from Abbvie grants and other from Amgen grants and other from AstraZeneca grants and other from Celgene grants personal fees and other from DaiichiSankyo grants and other from Novartis grants and other from Pfizer grants and other from Roche other from BMS other from Eirgenix other from Lilly other from Merck other from MSD other from SeaGen other from Prime/ Medscape other from Puma other from Samsung other from Pierre Fabre grants from Teva grants from Vifor grants from Immunomedics personal fees from Chugai outside the submitted work; In addition Dr. Loibl has a patent EP14153692.0 pending. TL reports scientific talks from MSD Pfizer Novartis Teva Tesaro Roche Amgen Clovis Lilly GSK Gilead; Travel/Kongress-Support from Pharmamar Roche Pfizer MSD Celgene Clovis Daiichi Sankyo; Consult‑ ing or Advisory Role from Amgen Roche Tesaro MSD Pfizer Lilly Myriad Esai GSK Gilead Daiichi Sankyo outside the submitted work. No other potential conflict of interest relevant to this article was reported.",TRUE,"<section> Funding GeparX and the DTC substudy were financially supported by Amgen and BMS.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13059-023-02919-8",TRUE,"The other authors declare no competing interests.",TRUE,"<section> Funding <section> This work was supported in part by the following grants: National Institutes of Health (NIH) U24HG007497 (to E.E.E. J.O.K. T.M.) U01HG010973 (to T.M. E.E.E. and J.O.K.) and R01HG002385 and R01HG010169 (to E.E.E.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13059-023-02928-7",TRUE,"The IVT plasmid backbone contains pro‑ prietary 5′-UTR and 3′-UTR sequences and was procured from TriLink Inc. under a non-disclosure agreement. All other authors declare that they have no competing interests.",TRUE,"<section> Funding This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 825392 (ReSHAPE-h2020.eu) to H-DV MS-H PR and DLW. Further the project was supported by the SPARK-BIH program and the New Crossfield project “Genome Engineering” of the BIH-Center for Regenerative Therapies of the Berlin Institute of Health Berlin Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13059-023-03060-2",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This work was supported by the UKRI Biotechnology and Biological (BB/S017372/1 and BB/R01356X/1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13063-023-07216-0",TRUE,"Competing interests {28} The authors declare the following financial interests/personal relationships which may be considered as a potential competing interest concerning the present work: Fanny Gelas and Philippe Bourgeois are employees of bioMérieux.",TRUE,"<section> Funding {4} <section> The trial is fully funded by a Research and 9 Division of Infectious diseases and Tropical Innovation Action within the Horizon 2020 Medicine Department of Medicine I Medical framework; project name: TTVguideTX; grant University of Vienna Vienna Austria agreement number: 896932; project coordina‑ matthias.vossen@meduniwien.ac.at <section> Funding",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13063-023-07303-2",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The UNITI pro‑ ject has received funding from the European Union’s Horizon 2020 Research and Innovation Program (grant agreement number 848261).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13063-023-07474-y",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> Funding The PragMeta project is supported by the Swiss National Science Foundation project ID 188675.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13063-023-07638-w",TRUE,"Competing interests Author AL declares participation in Advisory Boards of Roche Pharma AG Biogen Alector and Amylyx. Author CJM reports consultancy with Biogen Amylyx and Cytokinetics. Author PV declares participation in Advisory Board meetings for Biogen UCB argenx Cytokinetics Ferrer Muna Therapeutics Augustine Therapeutics Alector Alexion QurAlis VectorY and Amylyx (paid to institution) and grant from CSL Behring (E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; paid to institution). Author OH declares participation in Advisory Boards for Accelsiors Biogen Idec Cytokinetics NeuroSense Therapeutics Neuropath Therapeutics Novartis Orion Denali and Wave Pharmaceuticals; role as principal investigator on the PRECISION ALS Project; Academic/Industry Collaboration funded by Science Foundation Ireland; Research collaboration with Biogen Cytokinetics and Ionis in delivering the IMPACT ALS survey and with Cytokinetics in delivering the REVEALS study of respiratory decline in ALS; editor-in-chief of ALS and the Frontotemporal Degeneration; editorial board member of the Journal of Neurology Neurosurgery and Psychiatry. Author GN declares that Bruschettini S.R.L is the pharmaceutical company providing the investigational medicinal product and industrial partner of the project in which he is an employee as medical director. The remaining authors declare no competing interests.",TRUE,"<section> Supporting analysis Based on suggestions received from the EMA Scientific Advice Working Party on 28 February 2017 we will also consider a definition of responders with a threshold of 25%. <section> Funding <section> This study was funded by the European Union’s Horizon 2020 program SC1PM-08–2017 “New therapies for rare diseases” (grant agreement 755094).",TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13071-023-05800-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by the German Foundation of Scientific Research (DFG) (Grant Number: 285969495/HE 7320/2–1; Grant Number: 440909536 [SCMF]) and the German Academic Exchange Service (DAAD) (VHJD scholarship holder during PhD studies) and the Research Training Group 2046 “Parasite Infections: From Experimental Models to Natural Systems” (VHJD associated PhD student/EH Senior Researcher). VHJD is funded by the Deutsche Forschungsgemeinschaft (DFG) grant Integrative evolutionäre und ökologische Analyse von Antibio‑ tikaresistenzen: Auftreten und Verbreitung vom bakteriellen Genom bis zur geographischen Landschaft FO 1279/6-1|HE 7320/5-1|KR 4266/4-1.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13073-022-01148-1",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www. metabol.ku.dk). The present work was supported in part by Metagenopolis Annette Bang Oturai and Finn Sellebjerg were supported by grants from the Danish Multiple Sclerosis Society.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13073-023-01173-8",TRUE,"Competing interests RN and AKK are employees of Invitae and hold equities in the company. RPL is a member of the board of directors of Roche and its subsidiary Genen‑ tech. I Meyts holds a chair in Primary Immunodeficiencies and receives research grant from CSL Behring paid to KUL. JLC reported a patent to PCT/ US2021/042741 pending. FT is head of the Centre de Pharmacoépidémiologie (Cephepi) of the Assistance Publique – Hôpitaux de Paris and of the Clinical Research Unit of Pitié-Salpêtrière hospital both these structures have received unrestricted research funding and grants for the research projects handled and fees for consultant activities from a large number of pharmaceutical com‑ panies that have contributed indiscriminately to the salaries of its employees. <section> FT is not employed by these structures and did not receive any personal remuneration from these companies. The remaining authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute the Rockefeller University the St. Giles Foundation the National Institutes of Health (NIH) (R01AI088364 and R01AI63029) the National Center for Advancing Translational Sciences (NCATS) NIH Clinical and Translational Science Award (CTSA) program (UL1 TR001866) a Fast Grant from Emergent Ventures Mercatus Center at George Mason University the Yale Center for Mendelian Genomics and the GSP Coor‑ dinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956) the Yale High Performance Computing Center (S10OD018521) the Fisher Center for Alzheimer’s Research Foundation the JPB Foundation the Meyer Foundation the French National Research Agency (ANR) under the “Investments for the Future” program (ANR-10-IAHU-01) the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID) the French Founda‑ tion for Medical Research (FRM) (EQU201903007798) the ANR GenMISC (ANR-21-COVR-039) the ANRS-COV05 ANR GENVIR (ANR-20-CE93-003) ANR AABIFNCOV (ANR-20-CO11-0001) projects the ANR-RHU program COVIF‑ ERON (ANR-21-RHUS-08) the European Union’s Horizon 2020 research and innovation program under grant agreement No. The study was supported by the ORCHESTRA project which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 10101616. P Bastard was supported by the MD-PhD program of the Imagine Institute (with the support of the Fondation Bettencourt-Schueller). The French COVID Cohort study group was sponsored by INSERM and supported by the REACTing consortium and by a grant from the French Ministry of Health (Grant PHRC 20–0424). The Cov-Contact Cohort was supported by the REACTing consortium the French Ministry of Health and the European Commission (Grant RECOVER WP 6). The COVIDeF study was supported by the French Ministry of Health Fondation AP-HP et Programme Hospitalier de Recherche Clinique (PHRC COVID-19–200048) and was sponsored by APHP. Y.Z. O.M.D. L.D.N. H.C.S. are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases NIH. I Meyts is a Senior Clinical Investigator at the Research Foundation – Flanders and is supported by the CSL Behring Chair of Primary Immunodeficiencies by the KU Leuven C1 Grant C16/18/007 by a VIB GC PID Grant by the FWO Grants G0C8517N G0B5120N and G0E8420N and by the Jeffrey Modell Foundation. <section> This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 948959). This work is supported by the Swiss National Science Foundation (grant # 310030L_197721 to JF). This work is supported by ERN-RITA. This work was funded at least in part by grant AJF202059 from Al Jalila Foundation Dubai United Arab Emirates.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13073-023-01206-2",TRUE,"Competing interests LMB reports personal fees from Hoffman La Roche Ltd Remix Therapeu‑ tics Annexon Biosciences and Genentech. EJW reports personal fees from Hoffman La Roche Ltd Triplet Therapeutics PTC Therapeutics Takeda Teitur Trophics and Vico Therapeutics. All honoraria for these consultancies were paid through the offices of UCL Consultants Ltd. a wholly-owned subsidiary of University College London. The mentioned commercial entities have not participated in the design performance evaluation or writing of the study. <section> The remaining authors declare that they have no competing interests.",TRUE,"Human brain samples for this study were provided by the Newcastle Brain Tissue Resource which is funded in part by a grant from the UK Medical Research Council (G0400074) by NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University and as part of the Brains for Dementia Research Program jointly funded by Alzheimer’s Research UK and Alzheimer’s Society. The manuscript was written by EEW with support from AB CH and SS. <section> Funding This study received funding from the Berlin Institute of Health (BIH) Collaborative Research grant “Elucidating the Proteostasis Network to Control Alzheimer’s Disease” funded by the German Federal Ministry for Education and Research (BMBF) to EEW and OP the ERA-NET NEURON initiative funded by the BMBF grant no. <section> 01W1301 ABETA ID the Helmholtz Validation Fund grant no. HVF-0013 funded by the Helmholtz Association Germany (to EEW) and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association for applicationoriented research (to EEW). The Newcastle Brain Tissue Resource is funded in part by a grant from the UK Medical Research Council (G0400074) by NIHR Newcastle Biomedical Research Centre and Unit awarded to the Newcastle upon Tyne NHS Foundation Trust and New‑ castle University and as part of the Brains for Dementia Research Programme jointly funded by Alzheimer’s Research UK and Alzheimer’s Society.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13073-023-01215-1",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) Clinical research unit [KFO 329 AL901/2-1 and AL901/3-1] to JA and Clinical research unit [KFO 329 BE6072/2-1 and BE6072/3-1] to BB. <section> This work was supported by the DFG Research Infrastructure as part of the Next Generation Sequencing Competence Network [project 423957469].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13073-023-01242-y",TRUE,"Competing interests G. Steven Bova certifies that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g. employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: Naser Ansari-Pour Kerstin Haase Gunilla Högnäs Serafiina Jaatinen Juho Jasu Antti Kaipia Matti Kankainen Antti Koskenalho Jenni Kesäniemi Tiia Nikupaavola Paula Kujala Tom Lesluyes Anssi Nurminen Hanna Rauhala Jarno Riikonen Irina Rinta-Kiikka Sinja Taavitsainen Teemu Tolonen Peter Van Loo Tapio Visakorpi and David Wedge have no conflict of interest disclosures.",TRUE,"<section> Funding Financial support to G. Financial support to Naser Ansari-Pour for computational aspects of this research was partly supported by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z and the NIHR Oxford BRC. Antti Kaipia was partly supported by the Cancer Society of Finland. This work was supported in part by the Francis Crick Institute which receives its core funding from Cancer Research UK (CC2008) the UK Medical Research Council (CC2008) and the Wellcome Trust (CC2008). This work was supported in part by the Academy of Finland Center of Excellence program (project no. 312043 for MN). Teuvo Tammela has received research funding from Finnish Cancer Society and Sigrid Juselius Foundation and has been an investigator in studies sponsored by Bayer Astellas Orion Pharma and Pfizer.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13075-022-02969-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The German Research Foundation (DFG) supported this study through funding from RG2165 (GE2512/2-2) and CRC1444. This project was partially funded by the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03051-5",TRUE,"Competing interests <section> JB: Grant/research support from: Abbvie (Abbott) Amgen BMS Boehringer Celgene Celltrion Centocor Chugai Medac MSD (Schering-Plough) Mun‑ dipharma Novartis Pfizer (Wyeth) Roche Sanofi-Aventis and UCB Eli Lilly consultant for: Abbvie (Abbott) Amgen BMS Boehringer Celgene Celltrion Centocor Chugai Medac MSD (Schering-Plough) Mundipharma Novartis Pfizer (Wyeth) Roche Sanofi-Aventis and UCB Eli Lilly and received speak‑ ers bureau fees from: Abbvie (Abbott) Amgen BMS Boehringer Celgene Celltrion Centocor Chugai Medac MSD (Schering-Plough) Novartis Pfizer (Wyeth) Roche Sanofi-Aventis and UCB pharma Eli Lilly.",TRUE,"<section> Funding The study was sponsored by Novartis Pharma AG Basel Switzerland. Supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03068-w",TRUE,"Competing interests NS received research grant support from BMS Amgen Eli Lilly Mallinckrodt SanofiRegeneron and Crescendo Biosciences; OH AP and SF are employees of Sanofi and may hold stock/stock options in the company; MW received consultation fees from AbbVie Aclaris Amgen Arena Bayer Bristol Myers Squibb Corvitas Eqrx Genosco GSK Gilead Horizon Johnson & Johnson Kiniksa Eli Lilly Novartis Pfizer Rami Therapeutics R Pharma Roche Sanofi Scipher Sci Rhom Set Point and Tremeau; may hold stock/stock options of CanFite Inmedix Vorso and Scipher.",TRUE,"<section> Funding <section> This analysis was funded by Sanofi and Regeneron. Received grant support from Amgen Bristol Myers Squibb Eli Lilly and Sanofi; GB received grants/contracts from AbbVie Eli Lilly Merck Sharp & Dohme Pfizer Roche Sanofi and UCB and honoraria from AbbVie Eli Lilly Merck Sharp & Dohme Pfizer Roche Sanofi and UCB.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03083-x",TRUE,"Competing interests AP RC SMN SH and ZB have no relevant conflicts of interest.",TRUE,"<section> Funding This study has received funding from the Elsbeth Bonhoff Stiftung under grant agreement number 228. The Rh-GIOP cohort study is or was supported by a joint funding from Abbvie Amgen Almirall Biogen BMS Chugai Galapagos Generic Assays GSK Hexal Horizon Therapeutics Lilly Medac Mundipharma Novartis Pfizer Roche and Sanofi. The Parker Institute is funded by a core grant from the Oak Foundation (OCAY-18–774-OFIL).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03112-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was supported by a grant from the German Research Foundation (DFG) (BU 1015/9–1) in association with the Priority Program SPP 1468 “Osteoimmunology IMMUNOBONE – A Program to Unravel the Mutual Interactions between the Immune System and Bone” and by the National Health & Medical Research Council Australia Project Grant 632818 to FB MJS and HZ.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03127-2",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding RABBIT-SpA is supported by a joint unconditional grant from AbbVie Amgen Biogen Celltrion Hexal Janssen-Cilag Lilly MSD Novartis Pfizer UCB and Viatris.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13075-023-03128-1",TRUE,"Competing interests XB has received grant/research support from AbbVie and Novartis; consult‑ ing fees from AbbVie BMS Chugai MSD Novartis Pfizer and UCB; speakers’ bureau fees from AbbVie BMS Celgene Chugai Merck Novartis Pfizer and UCB; and is an editorial board member of the Annals of Rheumatic Diseases.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03177-6",TRUE,"Competing interests <section> WAS: Received consulting fees and grants from AbbVie GSK Novartis Roche and Sanofi; speakers bureau for AbbVie Chugai GSK Novartis Roche and Sanofi; has been an investigator on clinical trials for AbbVie GSK Novartis and Sanofi.",TRUE,"<section> Acknowledgements Medical writing support for this manuscript was provided by Vasudha Chachra MPharm of Sanofi. <section> Funding <section> This study was funded by Sanofi and Regeneron Pharmaceuticals Inc. <section> and personal fees from Horizon Therapeutics AbbVie and Sanofi; received grants from Mundipharma; received grants personal fees and nonfinancial support from Roche; received personal fees from Galapagos outside the sub‑ mitted work.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03195-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> We acknowledge support from the Open Access Publication Fund of the University of Tübingen.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13075-023-03215-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"Funding: TW ST JK and TM. <section> Funding This work was supported by the Stiftung Oskar-Helene-Heim (OHH) to TM; the Else Kröner-FreseniusStiftung (EKFS 2017_A22) to JK; the Deutsche Forschungsgemeinschaft (DFG KE 2179/2–1 TS 303/2–1) to JK and ST. This study was partly funded by the DFG Collaborative Research Center 1444 and the European Union under Grant Agreement Nr.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13099-023-00577-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding This work was supported by the Research Committee of the Freie Universität Berlin.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13104-023-06497-7",TRUE,"Competing interests Prof. Heinz Zeichhardt declares that he is majority owner and managing director of GBD Gesellschaft fuer Biotechnologische Diagnostik mbH Berlin and owner and managing director of IQVD GmbH Institut fuer Qualitaetssicherung Berlin. All other authors declared no competing interests.",TRUE,"<section> Funding <section> This work was supported by the European Metrology Programme for Innovation and Research (EMPIR) joint research project (20SIP03 Bio-Stand 2) which has received funding from the EMPIR programme cofinanced by the Participating States and the European Union´s Horizon 2020 research and innovation programme and by the UK National Measurement System.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13148-023-01434-8",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The LipidCardio Study was partially funded by the Sanofi-Aventis Deutschland GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13148-023-01437-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> Research reported in this manuscript was supported by grants from the National Institutes of Health National Institute of Child Health and Human Development P50HD089922 (J.G.N) R01HD072468 (J.G.N) National Institutes of Aging through R01AG04879 (J.G.N) National Institutes of Aging through R21AG055621 (I.S.) and by the National Center for Advancing Translational Sciences through UL1 TR002014 grant. A.T.A and L.E. were supported by National Institute on Aging Grant T32 AG049676 to The Pennsylvania State University.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13148-023-01580-z",TRUE,"Competing interests. <section> The authors declare no competing interests.",TRUE,"The open access publication of this article was supported by the DFG sponsored Open Access Fund of the University of Augsburg. The open access publication of this article was supported by the University of Augsburg. <section> Funding This study was supported in part by the Deutsche Krebshilfe (DKH 110530).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Lead Ethics Committee and registered at clinicaltrialsregister.eu (EudraCT Number: 2009-016142-44) and clinicaltrials.gov (ClinicalTrials.gov",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s13195-022-01118-0",TRUE,"Competing interests MTH and FJ have associate editor positions at the Alzheimer’s Research & Therapy editorial board. The authors declare no further competing interests.",TRUE,"<section> Funding <section> This work was funded by the German Center for Neurodegenerative Diseases (DZNE e.V.) within the Helmholtz Association.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13195-023-01185-x",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The study was funded by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)) reference number BN012. <section> Data collection and sharing for the ADNI dataset in this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is further funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengi‑ neering and by contributions from the following: AbbVie Alzheimer’s Associa‑ tion; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica Inc.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13195-023-01187-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding The study was funded by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen [DZNE]) and funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) – Project-ID 42589994. ZY and FD have received research support from the Turkish Neurological Society.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13195-023-01225-6",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Acknowledgements Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica Inc. <section> Funding We acknowledge the support from the German Research Foundation (DFG 389563835; 402170461-TRR 265; 414984028-CRC 1404; 442075332-RU 5187; 459422098RU 5363) the Brain & Behavior Research Foundation (NARSAD grant) and the Manfred and Ursula-Müller Stiftung. This study was supported in part by the National Institute of Health (NIH) grant numbers 1R01AG080821 P30AG066546 1U24AG074855 and the San Antonio Medical Foundation grant SAMF-1000003860.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13195-023-01243-4",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This research was supported by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen DZNE; reference number BN012) and funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; Project IDs 425899996 and 362321501/RTG 2413 SynAGE).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration German Clinical Trials Register (DRKS00007966 DELCODE is retrospectively registered at the German Clinical Trials Register (DRKS00007966 04/05/2015) and was approved by local ethical committees and review boards.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s13195-023-01349-9",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Acknowledgements Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica Inc. <section> Funding <section> This research was funded by Grant PID2021-122136OB-C22 funded by MCIN/ AEI/ 10.13039/501100011033 and by ERDF A way of making Europe of GP. This work was supported by an addon fellowship of the Joachim Herz Foundation of XK. This work was supported by the Virtual Research Environment at the Charité Berlin and EBRAINS Health Data Cloud operated by the Charité Universitätsmedizin Berlin for PR.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13223-023-00757-8",TRUE,"Competing interests KBl reports personal fees and/or grants and/or nonfinancial support from Aimmune Therapeutics a Nestlé Health Science company DBV Technologies HiPP GmbH Novartis Allergy Therapeutics HAL Allergy ALK Allergopharma Nestlé and Bausch + Lomb outside the submitted work and other financial and nonfinancial interests from the German Society for Pediatric Allergology & Environmental Medicine (GPA) German Society for Allergology & Clinical Immunology (DGKJ) the German Society for Pediatric Pneumology (GPP) and the German Society of Pneumology (DGP). AK reports study funding medical writing honoraria expert testimony support for attending meetings/ travel and participation on a data safety monitoring board or advisory board from Aimmune Therapeutics a Nestlé Health Science company. <section> Other disclosures include AbbVie Aimmune Therapeutics a Nestlé Health Science company Almirall Galderma Janssen/JNJ Leo Pharma Lilly Medac Novartis and Regeneron/Sanofi.",TRUE,"<section> Funding <section> This study was sponsored by Aimmune Therapeutics a Nestlé Health Science company.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13223-023-00795-2",TRUE,"Competing interests J.",TRUE,"Takeda Development Center Americas Inc. provided funding to Excel Medical Affairs for support in writing and editing this manuscript. <section> Funding <section> This study was funded by Takeda Development Center Americas Inc.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13223-023-00819-x",TRUE,"Competing interests The authors have no conflicts of interest to declare that are relevant to the content of this article. Outside this topic: Sabine Altrichter has conducted studies for/was advisor for/was speaker for AstraZeneca Allakos ALK CSLBehring LeoPharma Moxie Novartis Sanofi Takeda Thermofisher. <section> Wolfram Hoetzenecker has conducted studies for/was advisor for/was speaker for Novartis Eli Lilly Bencard ALK Leo Pharma Kyowa Kirin Takeda SanofiAventis and AbbVie. The other authors state no conflict of interests.",TRUE,"<section> Funding <section> No funding was received for the study and the preparation of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-022-01353-x",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-022-01362-w",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-023-01382-0",TRUE,"Competing interests The authors declare that they have no competing interests in the subject matter of this paper.",TRUE,"Supported by the European Society of Radiology the “Handson Radiology” summer school first took place in 2018 and again in 2019 and then paused due to the COVID-19 pandemic. <section> Funding No funding was provided for the scientific analysis of the event presented here. The “Handson Radiology” Summer School was financially supported by the European Society of",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-023-01427-4",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This study was supported by the Shanghai Science and Technology Foundation (21TS1400600) and the Deutsche Forschungsgemeinschaft (BIOQIC GRK 2260 and SFB1340 Matrix-In-Vision).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-023-01432-7",TRUE,"Competing interests MD has received grant support from the FP7 Program of the European Com‑ mission for the randomized multicenter DISCHARGE trial (EC-GA 603266 in HEALTH.2013.2.4.2-2).",TRUE,"<section> Registration number and name of registry 9 (n = 6) 3 (n = 1) 19 (n = 5) Where the full study protocol can be accessed 62 (n = 41) 59 (n = 23) 67 (n = 18) Sources of funding and other support; role of funders 100 (n = 66) 100 (n = 39) 100 (n = 27) Diagnostic Accuracy; Item-No. item number; AUC area under the curve <section> Funding <section> Competing interests MD has received grant support from the FP7 Program of the European Com‑ mission for the randomized multicenter DISCHARGE trial (EC-GA 603266 in HEALTH.2013.2.4.2-2). He also received grant support from German Research Foundation (DFG) in the Heisenberg Program (DE 1361/14-1 DFG project number: 213705389) graduate program on quantitative biomedical imaging (BIOQIC GRK 2260/1 DFG project number: 289347353) for fractal analysis of myocardial perfusion (DE 1361/18-1 DFG project number: 392304398) the DFG Priority Programme Radiomics (DFG project number: 402688427) for the investigation of coronary plaque and coronary flow (DE 1361/19-1 [DFG project number: 428222922] and DE 1361/20-1 [DFG project number: 428223139] in SPP 2177/1). He also received funding from the Berlin University Alliance (GC_SC_PC 27) and from the Digital Health Accelerator of the Berlin Institute of Health.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-023-01537-z",TRUE,"Competing interests One of the authors (Jürgen Mews) is an employee of Canon.",TRUE,"<section> Funding The Department of Radiology received grant under a Master research agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13244-023-01538-y",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13244-023-01548-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> No funding was received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13256-023-03806-3",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13256-023-03809-0",TRUE,"Competing interests See ICMJE form for disclosure of potential competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13256-023-04021-w",TRUE,"Competing interests None",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13256-023-04024-7",TRUE,"Competing interests The authors have no competing interests to declare.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13287-023-03287-7",TRUE,"Competing interests No potential competing interest was disclosed.",TRUE,"<section> Funding <section> This study was supported by NIDDK grants 1R01DK105183 DK120394 DK118529 DK125464 and the Department of Veterans Affairs grant I01BX004536.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13287-023-03519-w",FALSE,"",TRUE,"Funding acquisition: MG CS. <section> Funding This study was supported by the German Federal Ministry of Education and Research (grant numbers 1315848A 1315848B 13GW0098 and 13GW0099) the Helmholtz Association through programmeoriented funding the German Research Foundation through the Berlin‐Brandenburg School for Regenerative Thera‑ pies GSC 203 and the Charité – Universitätsmedizin Berlin (doctoral research stipends to DBS and KK).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13326-023-00292-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This work was funded by the German Federal Institute for Risk Assessment Berlin....",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13550-023-00973-8",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13550-023-00993-4",TRUE,"Competing interests PentixaPharm GmbH is the exclusive IP license holder for PentixaFor and PentixaTher (WO/2020/053256A1 EP/2019/074196W; WO/2015/185162A1 EP2014/061875; WO/2011/131735 EP2011/056358).",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13578-023-01114-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding <section> Martin Gauster was supported by funds of the Oesterreichische Nationalbank (Oesterreichische Nationalbank Anniversary Fund project number: 18175) the Austrian Science Fund (FWF): (I 3304 P 33554 and P 35118) and the Medical University Graz through the PhD programs Inflammatory Disorders in Pregnancy (DP-iDP Doc 31-B26) and MolMed.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13613-022-01093-7",TRUE,"Competing interests T. Michael Bauer Frank Bloos Holger Bogatsch Josef Briegel Gunnar Elke Didier Keh and Markus Löffler declare that they have no competing interest.",TRUE,"It was supported by the German Federal Ministry of Education and Research and conducted between January 2009 and February 2014 at intermediate care (IMCs) or intensive care units (ICUs) of university and community hospitals in Germany. <section> Funding <section> The HYPRESS trial was supported by Charité–Universitätsmedizin Berlin and by grant 01KG0701 from the German Federal Ministry of Education and Research [14]. Parts of the study infrastructure of the SISPCT trial were funded by Grant 01 KI 0106 from the German Federal Ministry of Education and Research.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13613-023-01116-x",TRUE,"Competing interests CS received support by the Deutsche Forschungsgemeinschaft (DFG) grants STO 1099/10‐11 and STO 1099/8‐1.",TRUE,"<section> Funding <section> Competing interests CS received support by the Deutsche Forschungsgemeinschaft (DFG) grants STO 1099/10‐11 and STO 1099/8‐1.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> PROSPERO Registration ID: CRD42022323880. The study protocol was registered in PROSPERO (CRD42022323880).",TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s13613-023-01162-5",TRUE,"Competing interests Uli Fehrenbach reports research agreements with Bayer Healthcare and fees for lectures (Bayer Healthcare Guerbet GE Siemens Ipsen) as well as for attending meetings (Bayer Healthcare Asahi Intecc Ipsen). <section> Tobias Penzkofer was supported by Berlin Institute of Health (Clinician Scientist Grant Platform Grant) Ministry of Education and Research (BMBF 01KX2021 68GX21001A) German Research Foundation (DFG SFB 1340/2) Horizon 2020 (952172) and reports research agreements (no personal payments outside of submitted work) with AGO Aprea AB ARCAGY-GINECO Astellas Pharma Global Inc. (APGD) Astra Zeneca Clovis Oncology Inc. Dohme Corp Holaira Incyte Corporation Karyopharm Lion Biotechnologies Inc. MedImmune Merck Sharp Millennium Pharmaceuticals Inc. Morphotec Inc. NovoCure Ltd. PharmaMar S.A. and PharmaMar USA Inc. Roche Siemens Healthineers and TESARO Inc. and fees for a book translation (Elsevier). <section> All other authors declare that they have no competing interests.",TRUE,"<section> Funding <section> Tobias Penzkofer was supported by Berlin Institute of Health (Clinician Scientist Grant Platform Grant) Ministry of Education and Research (BMBF 01KX2021 68GX21001A) German Research Foundation (DFG SFB 1340/2) Horizon 2020 (952172) and reports research agreements (no personal payments outside of submitted work) with AGO Aprea AB ARCAGY-GINECO Astellas Pharma Global Inc.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13613-023-01183-0",TRUE,"Competing interests JHN received a travel allowance from Eisai; FS received speaker’s honoraria from Ameos AstraZeneca Bristol-Myers Squibb and MD Horizonte; MW received speaker’s honoraria and consultancy fees from Portola/Alexion; AG received speaker’s honoraria from Boehringer Ingelheim Daiichi Sankyo Ipsen Occlutech and Pfizer as well as research grants from Merz and Ipsen; MH received speaker’s honoraria and/or consultancy fees from Angelini Bial Desitin Eisai Jazz Neuraxpharm UCB and Zogenix. All other authors declare that they have no competing interests.",TRUE,"<section> Funding Not related to this study HF received funding from the DGNI (Young Researcher Promotion Award 2020) and the Medical Faculty University of Freiburg (Clinical Studies Program 3091332005); FK was supported by the Köln Fortune Program Faculty of Medicine University of Cologne (472/2020); MH holds the ‘Friedrich von Bodelschwingh Endowed Professorship for Clinical and Experimental Epileptology’ at the Department of Neurology Charité – Universitätsmedizin Berlin funded by v. Bodelschwingh Foundation; BJV received funding from the German Research Foundation (DFG 422589384) and the German Society for Epileptology (Otfrid Foerster scholarship 2021).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13613-023-01201-1",TRUE,"Competing interests SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzer‑ land) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial sup‑ port from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine outside the submit‑ ted work. Dr. Schaller holds stocks in small amounts from Alphabeth Inc. Bayer AG and Siemens AG; these holdings have not affected any decisions regarding his research or this study. GC reports research grants and personal fees as a Speakers’ Bureau Member and Advisory Board Member from Integra Neurop‑ tics Biogen Idorsia and Invex Therapeutics all not related with this study. MO has received lecture fees and research funding from Baxter Fresenius Medical and Biomerieux. JDW is supported by a Senior Clinical Investigator Grant from the Flanders Research Foundation (ref. 1881020N). JDW has consulted for Pfizer MSD ThermoFisher (honoraria paid to institution). All other authors declare no competing interests.",TRUE,"<section> Funding This study was supported by the European Society of Intensive Care Medicine. JDW is supported by a Senior Clinical Investigator Grant from the Flanders Research Foundation (ref.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13643-023-02347-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s13722-023-00414-w",TRUE,"Competing interests Not",TRUE,"<section> Financial support by parents <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13756-023-01251-x",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding The RAI students project is funded by the Federal Ministry of Education and Research as part of the InfectControl national network (funding sign 03ZZ0837).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13756-023-01253-9",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13756-023-01260-w",TRUE,"Competing interests All authors have no conflicts of interest to declare. On behalf of all authors the corresponding author states that there is no conflict of interest.",TRUE,"<section> Author contributions Funding acquisition conceptualization and supervision were provided by P.G. <section> Funding The CLIP-ID trial was funded by the German Federal Ministry of Education and Research within the scope of the InfectControl consortium (03ZZ0807A).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s13756-023-01351-8",TRUE,"Conflict of interest The authors declare no conflict of interest.",TRUE,"<section> Funding Financial support for this study was from the Armed Forces Health Surveillance Division (AFHSD) Global Emerging Infections Surveillance (GEIS) Branch (funding year 2018 ProMIS ID P0028_18_N3_2.1).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40001-023-01072-z",TRUE,"Competing interests The authors have disclosed that they do not have any competing interests.",TRUE,"<section> The research was part of a project supported by the German Federal Ministry of Education and Research (NaFoUniMedCovid19 funding number: 01KX2021; part of the project CEOsys). <section> Funding The research was part of a project supported by the German Federal Ministry of Education and Research (NaFoUniMedCovid19 funding number: 01KX2021; part of the project",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40001-023-01114-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding There was no specific funding for this study. In general work in group of TL was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl (Grant Agreement 771083).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40001-023-01284-3",TRUE,"Competing interests FV reports personal fees non-financial support from Gilead Sciences and grants from MSD outside the submitted work.",TRUE,"<section> Funding This project received funding from B. The institution of E.D.W. R.S. and W.B. received Funding from Inflammatix Gentian and B. The UP laboratory received grants from Hoenle AG and SCG Cell Therapy.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40001-023-01375-1",TRUE,"Competing interests No author reports a competing interests regarding this manuscript.",TRUE,"<section> Funding The publication of the manuscript is supported by the funds for publication of the Charité Universitätsmedizin Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40249-023-01080-5",TRUE,"Competing interests All authors declare no competing interests.",TRUE,"; Supervision UF JK; Project Administration UF JK; Funding Acquisition UF JK. <section> Funding <section> Research funding for this work was provided by the German Research Foundation (DFG) through the project “Tungiasis in East-Africa—an interdisciplinary approach to understand the interactions between parasite and host” (Project number 405027164; KR 2245/7-1) granted to Jürgen Krücken Amina Abubakar Ulrike Fillinger and Charles Waiswa. Additional support was provided through icipe core funding by the Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); the Federal Democratic Republic of Ethiopia; and the Government of the Republic of Kenya. LE was supported by a Wellcome Trust Career Re-Entry Fellowship (Grant number 213724/Z/18/Z).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40249-023-01110-2",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Search strategy and selection process This review was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols (PRISMA-P) 2020 statement [15] and registered in PROSPERO in March 2022 (Registration ID: CRD42022312359).",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s40249-023-01154-4",TRUE,"Competing interests All authors declare no competing interest.",TRUE,"; Supervision AA LE UF JK; Project Administration UF JK; Funding Acquisition <section> Funding <section> This research was funded by the German Research Foundation (DFG) through the project ""Tungiasis in East-Africa—an interdisciplinary approach to understanding the interactions between parasite and host""(project number 405027164; KR 2245/7-1) to Jürgen Krücken Amina Abubakar Ulrike Fillinger and Charles Waiswa.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40337-023-00862-4",TRUE,"Competing interests The authors BF SA and CJ declare that they have no competing interests.",TRUE,"<section> Funding <section> Thereby the study was financed by the clinic Charité-Universitaetsmedizin Berlin. The authors received no financial support for this project the authorship or this article’s publication. He has received grant support from Janssen and Takeda.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40345-023-00313-8",TRUE,"Competing interests G. Hasler has received honoraria from Lundbeck Servier Takeda Otsuka Schwabe Janssen Sunovion Vifor Desitin Pharma Sanofi Recordati. K. Cattapan has received honoraria from Zeller Medical Lundbeck OmPharma Janssen Mepha. A. Erfurth has received lectures and/or Advisory Boards for Angelini Boehringer Ingelheim Germania Idorsia Janssen Lundbeck Mylan Neuraxp‑ harm Recordati and Sandoz. S. Bleich and S. Toto are project managers of the AMSP program. S. Toto is a member of the advisory board for Otsuka and Janssen-Cilag and has received speaker’s honoraria from Janssen-Cilag Lundbeck/Otsuka Recor‑ dati Pharma GmbH and Servier. J. Seifert has taken part in educational events sponsored by Otsuka/Lundbeck. G. Schoretsanitis has served as a consultant for Dexcel Pharma HLS Thera‑ peutics Saladax and Thermo Fisher and has received speaker’s fees from HLS Therapeutics. <section> All other authors state they have no conflicts of interest to declare.",TRUE,"<section> Funding The authors did not receive any specific grants or funding for the present study. The AMSP program has been supported with unrestricted educational and research grants since 1993 by the following companies—Austrian companies: Astra Zeneca Österreich GmbH Boehringer Ingelheim Austria Bristol-Myers Squibb GmbH CSC Pharmaceuticals GmbH Eli Lilly GmbH Germania Pharma GmbH GlaxoSmithKline Pharma GmbH Janssen-Cilag Pharma GmbH Lundbeck GmbH Novartis Pharma GmbH Pfizer Med Inform and Wyeth Lederle Pharma GmbH; German companies: Abbott GmbH & Co.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40348-023-00170-6",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40348-023-00173-3",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"<section> Funding This study was supported in part funded by European Union’s Horizon 2020 research innovation program “ImmunAID” (H2020-EU.3.1.1.) and ERA network PerSAIDs (Personalised medicine for SAIDs 01KU2213).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40478-023-01525-w",TRUE,"Competing interests The authors declare no relevant conflicts of interest.",TRUE,"The work was supported by the NeuroCure Cluster of Excellence grant to H.K. a National Cancer Institute grant (1-R01-CA214146-01 to D.H.G.) a National Institute of Health grant (5R01CA214146-05 to D.H.G) and a Berlin Institute of Health/Einstein fellowship grant to D.H.G. and H.K. <section> Funding",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40478-023-01662-2",TRUE,"Competing interests NFD accepted speaker honoraria of Integra LifeSciences and serves as advisor for Alexion Pharmaceuticals. All other authors declare that they have no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40479-023-00215-2",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40479-023-00216-1",TRUE,"Competing interests The authors SA and CJ declare that they have no competing interests.",TRUE,"<section> Funding Thereby the study was financed by the clinic Charité – Universitaetsmedizin Berlin. The authors received no financial support for this project the authorship or this article’s publication. He has received grant support from Janssen and Takeda.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40479-023-00220-5",TRUE,"Competing interests Dr Meyer-Lindenberg has received lecture fees from the Lundbeck International Foundation Paul-Martini-Stiftung Lilly Deutschland Atheneum Fama Public Relations IDIBAPS Janssen-Cilag Hertie-Stiftung BodelschwinghKlinik Pfizer Universität Freiburg Schizophrenia Academy Hong Kong Society of Biological Psychiatry Spanish Society of Psychiatry Italian Society of Biological Psychiatry Reunions I Ciencia S.L. Brain Center Rudolf Magnus UMC Utrecht Friedrich-Merz-Stiftung and consultant fees from Boehringer Ingelheim Elsevier Brainsway Lundbeck Int. Neuroscience Foundation Lundbeck A/S Sumitomo Dainippon Pharma Co. Academic Medical Center of the University of Amsterdam Synapsis Foundation-Alzheimer Research Switzerland IBS Center for Synaptic Brain Dysfunction Blueprint Partnership University of Cambridge Dt. Zentrum für Neurodegenerative Erkrankungen Zürich University Brain Mind Institute L.E.K. Consulting ICARE Schizophrenia Science Advances Fondation FondaMental von Behring Röntgen Stiftung The Wolfson Foundation Sage Therapeutics. Dr. Ebner-Priemer reports consultancy for Boehringer-Ingelheim. The other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40479-023-00229-w",TRUE,"Competing interests The authors declare no competing interests.",TRUE,"Stefan Roepke: Conceptualization Supervision Resources Writing Review & Editing Project administration Funding acquisition. <section> Funding This project has been supported with funds from the Transfer BONUS program.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40560-023-00664-5",TRUE,"Conflicts of interest is available from the Editorial Office.",TRUE,"<section> Funding This research was supported by institutional sources.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40560-023-00697-w",TRUE,"Competing interests All committee members and working group members submitted disclosure forms of financial and academic conflict of interest (COI) prior to being requested to participate in individual activities. Declarations regarding conflicts of interest (COI) were made in accordance with the COI Management Guidelines of the Japanese Association of Medical Sciences and COIs were confirmed by a group independent of the committee.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40560-023-00703-1",TRUE,"Competing interests SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial support from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine outside the submitted work.",TRUE,"<section> Funding <section> Competing interests SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40635-023-00503-9",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40635-023-00506-6",FALSE,"",TRUE,"<section> Funding This work was supported by a project Grant and equip‑ ment by STIMIT AG Biel Switzerland.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40635-023-00543-1",TRUE,"Competing interests AF declares the below mentioned research grant as a related conflict of inter‑ est. The other authors declare that they have no competing interests.",TRUE,"<section> Funding This work was partially supported by funding from the Investitionsbank Berlin (IBB) Technology-Transfer Bonus program (Registry No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40635-023-00574-8",TRUE,"Competing interests Outside of this work the authors disclose the following relationships: SF: pay‑ ments to the institution (Canadian Institutes of Health Research National Insti‑ tute of Health Medtronic Boston Scientific Amgen) participation on advisory board (PolyPid).",TRUE,"<section> Funding The original study (SUSTAIN CSX) has been funded by the HECHT foundation. <section> The analytical work in the lab of LS is funded by the Deutsche Forschungsge‑ meinschaft (DFG) Research Unit FOR-2558 (Scho 849/6-2) and CRC/TR (LocoTact",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40635-023-00577-5",TRUE,"Competing interests SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial support from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine outside the submitted work.",TRUE,"<section> Funding <section> Competing interests SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine outside the submitted work. This official conference report was cosponsored by the American Thoracic Society The European Society of Intensive Care Medicine and The Societe de Reanimation de Langue Francaise and was approved by the ATS Board of Directors.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40644-023-00527-0",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> This study received funding by the National Natural Science Foundation of China (Nos.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration ChiCTR NO.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s40644-023-00580-9",TRUE,"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. <section> Ethics approval and consent to participate This study was approved by the LMU Munich Institutional Review Board (Ethikkommission der Medizinischen Fakultät der Ludwig-MaximiliansUniversität München) with a waiver for informed consent. <section> Consent for publication Not <section> applicable. <section> Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> No funding was received for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40658-023-00544-9",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40729-023-00493-z",TRUE,"Competing interests The authors have no conflict of interest to declare.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40729-023-00494-y",TRUE,"The authors declare that they have no competing interest.",TRUE,"Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Also its protocol was recorded on the PROSPERO registration platform with the registration number CRD42022360353.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s40729-023-00498-8",TRUE,"Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s40878-023-00353-0",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> The research was conducted as a part of the project Forced Displacement and Refugee-Host community solidarity funded by the European Commission through the HORIZON 2020 Research and Innovation programme (822491) (https://www.focusrefugees.eu/).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s40878-023-00355-y",TRUE,"They may try to extend existing rules to apply to new situations or conflicts of interest by regulating very specific details (Kühl 2020).",TRUE,"<section> Funding This research was funded by the German Ministry for Research and Education (BMBF).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41181-023-00196-1",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41181-023-00218-y",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41181-023-00222-2",TRUE,"Competing interests SS is an Associate Editor of EJNMMI Radiopharmacy and Chemistry. interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41181-023-00225-z",TRUE,"All other declare that they have no competing interests.",TRUE,"<section> We thank the Berlin University Alliance for the Career Development Award for Sarah Spreckelmeyer and the financial support for the research stay in Prof. We also gratefully acknowledge CNPq for providing a scholarship and financial support to P. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41182-023-00545-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41687-023-00576-w",TRUE,"Competing interests MV was a full-time employee of ICON plc at the time of this analysis and is currently an employee of Takeda Development Center Americas.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41747-023-00348-7",TRUE,"Competing interests JM is an employee of Canon Medical Systems Europe BV. However the corresponding nonemployee author (MK) had full control of the data and information submitted for publication. The company did not influence or authorize the results or the publication of our research. The other authors declare that they have no competing interests.",TRUE,"<section> Funding We acknowledge financial support from the Open Access Publication Fund of Charité — Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s41747-023-00362-9",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42358-023-00292-5",TRUE,"Competing interests The authors declare that they have no competing interests.",TRUE,"This study was supported by the Research Incentive Fund (FIPE) of the Hospital de Clínicas de Porto Alegre and the National Council for Scientific and Technological Development (CNPq). <section> Funding <section> This study was funded by the Research Incentive Fund of the Hospital de Clínicas de Porto Alegre (FIPE-HCPA) [No. 12-0044 and No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42466-023-00246-8",TRUE,"Competing interests ST UG CK MJUQ and MO report no conflict of interests outside the submit‑ ted work.",TRUE,"<section> investigatorinitiated prospective multicentre study sponsored by the Charité Universitätsmedizin Berlin Germany and supported by an unrestricted research grant from Bayer Vital GmbH Germany to the Charité. <section> Funding <section> The MonDAFIS study is an investigatorinitiated prospective randomised multicentre study sponsored by the Charité Universitätsmedizin Berlin Ger‑ many and supported by an unrestricted research grant from Bayer Vital GmbH Germany to the Charité Universitätsmedizin Berlin Germany. PUH reports grants from Charité Univer‑ sitätsmedizin Berlin during study conduct (within MonDAFIS for biometry; member scientific board); research grants from German Ministry of Research and Education German Research Foundation Bavarian State European Union German Cancer Aid German Parkinson Society University Hospital Würzburg German Heart Foundation Federal Joint Committee (G-BA) within the Innova‑ tionsfonds University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer BMS Boehringer-Ingelheim Daiichi Sankyo) University Göttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim) outside the submitted work.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42466-023-00251-x",TRUE,"Competing interests No competing interests regarding the contents. All participants in the guideline have submitted their declarations of interest (AWMF form for the declaration of interests in the context of guideline projects) to the Editorial Office for Guidelines of the DGN. The evaluation of the declarations of interest with regard to thematic relevance to the guideline was carried out by a member of the DGN guideline commission.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42466-023-00279-z",TRUE,"Competing interests fibrillation MO ES CM BC ST and TI report no conflict of interests outside the submitted of variance work.",TRUE,"Briefly the MonDAFIS study was an investigatorinitiated randomised multicentre study sponsored by the Charité – Universitätsmedizin Berlin and funded by Bayer Vital GmbH Germany [8]. <section> Funding",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42466-023-00282-4",TRUE,"Competing interests MP is founder of Tcelltech GmbH and inventor of associated intellectual property related to glioma-reactive T cell receptors (patent number: WO2022200456A1). MP KS LB TB and WW are inventors of associated intellectual property related to H3K27M vaccines (patent numbers: EP3118217A1 US20180155403A1). TB EWG MP and KS are listed as inventors on a patent application describing K27M specific antibodies. GhT has served on advisory boards (Bayer Boehringer Ingelheim CureVac Novocure) as a consultant (Bayer Boehringer Ingelheim CureVac) as steering committee member in non-interventional trials (Bayer Novocure) and financial compensation for all these activities was provided as institutional funding to the University Hospital Tübingen. UH received speakers and/or advisory board honoraria from Medac Janssen and Bayer. GhT WW and MP are Editorial Board Members of Neurological Research and Practice. The remaining authors declare no competing interests.",TRUE,"<section> Acknowledgements This study is supported by the German Cancer Aid the Hertie Foundation the German Research Foundation the Baden-Württemberg Stiftung the Rolf Schwiete Foundation and the German Research Center. <section> Funding <section> This study was supported by the Hertie Foundation (P1200013 to K.S.) the Helmholtz Institute for Translational Oncology HI-TRON (to E.G. M.P. and K.S.) the German Research Foundation (EB 187/8 − 1 to N.G. project 445549683 SFB1366-TPC01 to K.S. and M.P. project 39404578 GRK2727-TPB1.1 to M.P. and K.S. project 404521405 SFB1389-TPB06 to M.O.B. and K.S. and SFB1389-TPB01 to M.P.) the Baden-Württemberg-Stiftung (BWST_ISF2018-046) to M.P. and the Rolf Schwiete Foundation (2021-009) to L.B and M.P and the German Cancer Aid project 70113456 to K.S and M.P.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration NCT04808245.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1186/s42466-023-00285-1",TRUE,"Competing interests No competing interests with regard to the contents (see attached CoI-sate‑ ment.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42466-023-00292-2",TRUE,"Competing interests All participants in the guideline have submitted their declarations of inter‑ est (AWMF form for the declaration of interests in the context of guideline projects) to the coordinator or the Editorial Office for Guidelines of the DGN in time and completely filled out. The evaluation of the declarations of interest with regard to thematic relevance to the guideline was carried out by Carsten Saft. The external evaluation of the interests in the overall view was also carried out by NN AWMF. No conflicts of interest were found so no consequences e.g. abstentions were taken. For reasons of transparency the interests of the participants and the consequences drawn from them are listed on the respective AWMF guideline website and are also shown in the appendix of the short version. No competing interests with regard to the contents (see attached CoI-satement A detailed listing is available at https:// dgn.org/leitlinien/.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s42522-023-00090-5",TRUE,"Competing interests Jan Felix Drexler is an editorial board member.",TRUE,"<section> Funding This work was supported by DFG project COALITION (project number DR 810/6–1) the Euro‑ pean Union´s Horizon 2020 research and innovation programme through the ZIKAlliance project 734548 and partially supported by CONACYT – FONCICYT project “Una Alianza Global para Controlar y Prevenir el Virus del Zika” number 274386.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1186/s42523-023-00237-9",TRUE,"Competing interests The authors declare that there are no competing interests.",TRUE,"<section> Funding This project is part of and funded by the DFG (German Science Foundation) Priority Program SPP 1596/2 Ecology and Species Barriers in Emerging Infectious Diseases (SO 428/9-1 9-2 and DR 772/8-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1186/s43088-023-00380-x",TRUE,"Competing interests The authors have no relevant financial or non-financial interests to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bji.2022.16",TRUE,"<section> Declaration of interest None.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjo.2023.34",TRUE,"<section> Declaration of interest None.",TRUE,"<section> Funding <section> This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft) (formerly grant DA 1222/4-1 now grant WA 1539/8-2 to J.K.D.) and the EU Rosalind-Franklin Fellowship Program awarded to J.K.D.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjo.2023.41",TRUE,"<section> Declaration of interest <section> N.S. is a member of the BJPsych Open editorial board but did not take part in the review or decision-making process for this paper. All other authors have no conflicts of interest to report.",TRUE,"<section> Funding <section> This work was supported by seed funding from the Association for the Improvement of Mental Health Programs. P.C.G. is supported by the UK Medical Research Council via the Indigo Partnership award (number MR/R023697/1). G.T. is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration South London at King’s College London NHS Foundation Trust and by the NIHR Asset Global Health Unit award.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjo.2023.501",TRUE,"<section> Declaration of interest None.",TRUE,"<section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjo.2023.504",TRUE,"<section> Declaration of interest None.",TRUE,"<section> Funding <section> This work was supported by the Innovation fund of the Joint National Committee Ministry of",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjo.2023.601",TRUE,"<section> Declaration of interest <section> T.B. has served in an advisory or consultancy role for Eye Level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda.",TRUE,"<section> Funding <section> This work received support from the following sources: the Medical Research Council and Medical Research Foundation (‘ESTRA’ – Neurobiological underpinning of eating disorders: integrative biopsychosocial longitudinal analyses in adolescents: grant MR/R00465X/; This work was cofunded by UK Research and Innovation under the UK Government’s Horizon Europe funding guarantee (10041392 and 10038599) as part of Horizon Europe HORIZON-HLTH-2021-STAYHLTH-01 under European Union grant agreement number 101057429 (environMENTAL). Z.Z. is supported by a fellowship from the Medical Research Foundation (MRF-058-0014-F-ZHAN-C0866).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjp.2022.203",TRUE,"<section> Declaration of interest <section> G.S.P. has received personal fees from Janssen Cilag and Menarini.",TRUE,"<section> Funding A.C. has received personal fees from Janssen and is supported by the Instituto de Salud Carlos III Spanish Ministry of Economy and Competitiveness. J.D. is supported by NIHR Clinician Science Fellowship award and has received support from a Medical Research Council Clinical Research Training Fellowship and Psychiatry Research Trust Peggy Pollak Research Fellowship in Developmental Psychiatry. C.U.C. has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris; he provided expert testimony for Janssen and Otsuka; he served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva; he has received grant support from Janssen and Takeda and royalties from UpToDate and is a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/bjp.2023.107",TRUE,"<section> Declaration of interest <section> B.J.S. consults for Cambridge Cognition Greenfield BioVentures and Cassava Sciences. T.W.R. <section> consults for Cambridge Cognition Shionogi Heptares Takeda Arcadia and Greenfield BioVentures; and receives royalties from Cambridge Cognition and research grants from Shionogi and GlaxoSmithKline. All other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding W.C. was supported by grants from the National Natural Sciences Foundation of China (No. 82071997) and the Shanghai Rising Star Program (No. B.B. was supported by the National Key Research and Development Program of China (2018YFA0701400) and National Natural Science Foundation of China (No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/j.eurpsy.2023.2421",TRUE,"Competing interest. The authors declare that they have no conflicts of interest.",TRUE,"<section> Financial support. This work was supported by the German Federal Ministry of Education and Research (M.S. S.A.E. J.G. Mi.F. Ma.F. L.M. S.P. A.W.; grant number 01GP1792) and the Wellcome Trust (T.G. G.O. L.A.S.; grant number 203376/Z/16/Z).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/j.eurpsy.2023.2431",TRUE,"Competing interest. The other authors declare no competing interests.",TRUE,"; Funding acquisition: M.B. I.K-B. T.B. M.R. P.F. A.J-H. U.H. T.S. A.H. A.U. F.P. <section> Financial support. This project is funded by the Innovationsfond and the German Ministry of Health [grant number 01VSF16061].",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The MEHIRA project was registered in ClinicalTrials.gov (registration number: NCT03109028; registration date November 4 2017).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1192/j.eurpsy.2023.2443",TRUE,"Competing interest. The authors declare none.",TRUE,"<section> Financial support. The research presented in this article was funded by the innovation fund of the Federal Joint Committee (Gemeinsamer Bundesausschuss/GBA) in the course of funding for research projects according to § 92a (2) sentence 1 Social Code V: Research projects for the further development of health care within the statutory health insurance from October 19 2018 within the research project AKtiV (“Outreach crisis intervention at home including teambased and integrated care”): “Evaluation of inpatient equivalent home treatment (IEHT according to § 115d Social Code V) – a proofofconcept-study.” The trial is funded by the German Innovation Fund with the funding number: 01VSF19048.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/j.eurpsy.2023.2466",TRUE,"Competing interest. The authors declare none.",TRUE,"<section> Financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1192/j.eurpsy.2023.2470",TRUE,"All other authors declare that they have no conflicts of interest with respect to the subject addressed in this study.",TRUE,"<section> Financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/go.22.00401",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> INTEREST <section> The following represents disclosure information provided by authors this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conﬂict of interest policy please refer to www.asco.org/rwc or ascopubs. org/go/authors/author-center. <section> Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments). <section> No other potential conﬂicts of interest were reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.00533",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.00533. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this manuscript. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Supported by Bristol Myers Squibb. <section> Research Funding: Bristol Myers Squibb (Inst) Merck (Inst) GlaxoSmithKline (Inst) Genentech (Inst) Astellas Pharma (Inst) Incyte (Inst) Roche (Inst) Novartis (Inst) NextCure (Inst) Moderna Therapeutics (Inst) <section> Research Funding: Pﬁzer (Inst) Novartis (Inst) MSD Recipient (Inst) Bristol Myers Squibb (Inst) Achilles Therapeutics (Inst) Roche (Inst) Nektar (Inst) Covance (Inst) Immunocore (Inst) AVEO (Inst) Pharmacyclics (Inst) <section> Research Funding: Bristol Myers Squibb Roche NISD Amgen Pﬁzer/EMD Serono Lilly Astellas Pharma AstraZeneca GlaxoSmith Kline Regeneron Novartis AbbVie Gilead Sciences Sanoﬁ/Regeneron Dylan BIOVEN Clovis Oncology Tesaro Five Prime Therapeutics <section> Research Funding: Bristol Myers Squibb (Inst) Roche (Inst) USD Oncology (Inst) Amgen (Inst) Novartis (Inst) lovance Biotherapeutics (Inst) <section> Research Funding: BristolMyers Squibb (Inst) Merck Sharp & Dohme (Inst) <section> Research Funding: Bristol Myers Squibb (Inst) USD Oncology (Inst) <section> Research Funding: Bristol Myers Squibb (Inst) Roche/Genentech (Inst) Array BioPharma (Inst) Sanoﬁ (Inst) Pﬁzer (Inst) <section> Research Funding: Amgen (Inst) Astra Zeneca (Inst) Merck (Inst) Endocyte/ Advanced Accelerator Applications (Inst) Genentech/Roche (Inst) Novartis (Inst) Pﬁzer (Inst) Senhwa Biosciences (Inst) Roche/Genentech (Inst) <section> Research Funding: Pﬁzer (Inst) Novartis (Inst) Johnson & Johnson (Inst) Amgen (Inst) Merck Serono (Inst) Sun Pharma (Inst) Sanoﬁ (Inst) <section> Research Funding: Bristol Myers Squibb (Inst) Novartis (Inst) Immunocore (Inst) BioNTech (Inst) 4SC (Inst) Philogen (Inst) Idera (Inst) Genentech/ Roche (Inst) lovance Biotherapeutics (Inst) Pierre Fabre (Inst) Regeneron (Inst) Sanoﬁ (Inst) Nektar (Inst) Sun Pharma (Inst) <section> Research Funding: Novartis (Inst) Phio Pharmaeutical (Inst) <section> Research Funding: Merck Takara Bio <section> Research Funding: Bristol Myers Squibb (Inst) Merck Sharp & Dohme (Inst) Pharmaust (Inst) Zucero Therapeutics (Inst) CStone Pharmaceuticals (Inst) <section> Research Funding: Novartis (Inst) Roche (Inst) Bristol Myers Squibb (Inst) <section> Research Funding: Roche (Inst) Celgene (Inst) <section> Research Funding: Merck Serono",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.01010",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Disclosures provided by the authors are available with this article at https://doi.org/10.1200/JCO.22.01010. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this manuscript. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Financial support and drug supply was provided by F. <section> Research Funding: Roche Pharma AG (Inst) Tesaro (Inst) <section> Research Funding: Roche AstraZeneca Boehringer Ingelheim GlaxoSmithKline Janssen-Cilag Medac PharmaMar Tesaro Bayer <section> Research Funding: PharmaMar (Inst) Onxeo (Inst) <section> Research Funding: AstraZeneca (Inst) Clovis Oncology (Inst) Merck (Inst) Bayer (Inst) PharmaMar (Inst) Pﬁzer (Inst) Tesaro (Inst) MSD Oncology (Inst) <section> Research Funding: Exact Sciences (Inst) <section> Research Funding: AstraZeneca Roche Pharma GlaxoSmithKline MSD Clovis <section> Research Funding: Genomic Health (Inst) <section> Research Funding: AstraZeneca (Inst) Roche (Inst) Genmab (Inst) GlaxoSmithKline (Inst) Immunogen (Inst) Clovis Oncology (Inst)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.01420",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.01420. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> The following represents disclosure information provided by authors of otherwise noted. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Research Funding: Pierre Fabre (Inst) Roche Molecular Diagnostics (Inst) Merck Serono (Inst) Amgen (Inst) <section> Research Funding: AstraZeneca (Inst) Servier (Inst) Roche (Inst) MSD <section> Research Funding: Amgen (Inst) Servier (Inst) <section> Research Funding: Roche (Inst) Celgene (Inst) Ipsen (Inst) Amgen (Inst) Alexion Pharmaceuticals (Inst) AstraZeneca (Inst) Lilly (Inst) Servier (Inst) AIO-Studien (Inst) Rafael Pharmaceuticals (Inst) ERYTECH Pharma (Inst) BioNTech (Inst) <section> Research Funding: Merck Serono Bristol Myers Squibb Celgene Lilly <section> Research Funding: Merck (Inst) Amgen (Inst) Roche (Inst)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.01630",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.01630. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this Relationships are self-held unless noted. I 5 Immediate Family Member Inst For more information about ASCO’s conﬂict of interest policy please refer Open Payments is a public database containing information reported by <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Supported by grants from Aktion Nils to R.H. and the Gesellschaft fuer Kinderkrebsforschung (GKKF) Geltendorf to R.H. from BILD hilft e.V. <section> Research Funding: Apeiron Biologics (Inst) EUSA Pharma (Inst) <section> Research Funding: Roche Pharma AG (Inst) EUSA Pharma (Inst) <section> Research Funding: Crispr therapeutics (Inst) Vertex (Inst) Novartis (Inst) Miltenyi Biotec (Inst) Celgene/Bristol Myers Squibb (Inst) Kite/Gilead (Inst) <section> Research Funding: Miltenyi Biotec (Inst) <section> Research Funding: Miltenyi Biotec Biosceptre International <section> Research Funding: Biontech (Inst) <section> Research Funding: EUSA Pharma",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.01816",TRUE,"<section> DISCLOSURES OF POTENTIAL CONFLICTS <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> De-Escalated Neoadjuvant T-DM1 With or Without Endocrine Therapy Versus Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial The following represents disclosure information provided by authors of otherwise noted. <section> Travel Accommodations Expenses: Roche Daiichi Sankyo No other potential conﬂicts of interest were reported.",TRUE,"<section> Research Funding: Roche/Genentech (Inst) Lilly (Inst) MSD (Inst) <section> Research Funding: Roche (Inst) Amgen (Inst) NanoString Technologies (Inst) Celgene (Inst) Exact Sciences (Inst) Pﬁzer (Inst) <section> Research Funding: Gilead Sciences <section> Research Funding: F.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.02166",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS <section> Disclosures provided by the authors are available with this article at DOI <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this manuscript. For more information about ASCO’s conﬂict of interest policy please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center. <section> No other potential conﬂicts of interest were reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.02355",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.02355. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this Relationships are self-held unless noted. I 5 Immediate Family Member Inst For more information about ASCO’s conﬂict of interest policy please refer Open Payments is a public database containing information reported by <section> Speakers’ Bureau: No disclosure <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Financial support: Paul J. <section> Research Funding: Bristol Myers Squibb (Inst) Takeda (Inst) Merck Sharp Dohme (Inst) BeiGene (Inst) <section> Research Funding: Amgen Novartis Sobi Grifols <section> Research Funding: MSD Oncology (Inst) Takeda (Inst) <section> Research Funding: Bristol Myers Squibb (Inst) <section> Research Funding: Novartis (Inst) MSD (Inst) Takeda (Inst)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.02582",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.02582. Information that will be considered for disclosure includes individual participant data that underlie the results reported in this article (text tables ﬁgures and appendices). <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST <section> The following represents disclosure information provided by authors of this manuscript. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Financial support: Dominik Paul Modest <section> Research Funding: Bristol Myers Squibb Shire/Takeda Novartis Octapharma <section> Research Funding: Ipsen (Inst) MacroGenics (Inst) <section> Research Funding: Merck Serono Bristol Myers Squibb Celgene Lilly Servier <section> Research Funding: Roche (Inst) Celgene (Inst) Ipsen (Inst) Amgen (Inst) Alexion Pharmaceuticals (Inst) AstraZeneca (Inst) Lilly (Inst) Servier (Inst) AIO-Studien (Inst) Rafael Pharmaceuticals (Inst) Erytech Pharma (Inst) <section> Research Funding: Merck (Inst) Amgen (Inst) Roche (Inst) <section> Research Funding: Pierre Fabre (Inst) Roche Molecular Diagnostics (Inst) <section> Research Funding: Amgen (Inst) Servier (Inst)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1200/jco.22.02673",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.22.02673. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> The following represents disclosure information provided by authors of otherwise noted. <section> Consulting or Advisory Role: Jazz Pharmaceuticals No other potential conﬂicts of interest were reported.",TRUE,"<section> The CWS-96 and CWS-2002P trials were supported by grants from the German Cancer Aid Foundation (CWS-96: T9/96/TrI CWS-2002P: 50-2721-Tr2) the CWS Registry SoTiSaR from the German Children’s Cancer Foundation (DKS 2009.08 2012.04 and 2015.12) and the Förderkreis Krebskranke Kinder Stuttgart Germany. <section> Financial support: Ewa Koscielniak Thomas Klingebiel <section> Research Funding: Apeiron Biologics (Inst) EUSA Pharma (Inst) <section> Research Funding: Biontech (Inst)",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.22.02906",TRUE,"<section> DISCLOSURES OF POTENTIAL CONFLICTS <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for The following represents disclosure information provided by authors of otherwise noted. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> Research Funding: Roche (Inst) Amgen (Inst) Oncoinvent (Inst) <section> Research Funding: GlaxoSmithKline (Inst) Pharmamar (Inst) <section> Research Funding: AstraZeneca (Inst) Hutchison MediPharma (Inst) OncoMed (Inst) MedImmune (Inst) Stem CentRx (Inst) Genentech/ Roche (Inst) Curis (Inst) Verastem (Inst) Zymeworks (Inst) Syndax (Inst) Lycera (Inst) Rgenix (Inst) Novartis (Inst) Mersana (Inst) Millennium (Inst) TapImmune Inc (Inst) Lilly (Inst) Pﬁzer (Inst) Tesaro (Inst) Boehringer Ingelheim (Inst) H3 Biomedicine (Inst) Radius Health (Inst) Acerta Pharma (Inst) Macrogenics (Inst) AbbVie (Inst) Immunomedics (Inst) Fujiﬁlm (Inst) eFFECTOR Therapeutics (Inst) Merus (Inst) Nucana (Inst) Regeneron (Inst) Leap Therapeutics (Inst) Taiho Pharmaceutical (Inst) EMD Serono (Inst) Daiichi Sankyo (Inst) ArQule (Inst) Syros Pharmaceuticals (Inst) Clovis Oncology (Inst) CytomX Therapeutics (Inst) InventisBio (Inst) Deciphera (Inst) Sermonix Pharmaceuticals (Inst) Sutro Biopharma (Inst) Zenith Epigenetics (Inst) Arvinas (Inst) Harpoon (Inst) Black Diamond Therapeutics (Inst) Orinove (Inst) Molecular Templates (Inst) Seagen (Inst) Compugen (Inst) G1 Therapeutics (Inst) Karyopharm Therapeutics (Inst) Dana Farber Cancer Hospital (Inst) Onconova Therapeutics (Inst) Shattuck Labs (Inst) PharmaMar (Inst) Olema Pharmaceuticals (Inst) Immunogen (Inst) Plexxikon (Inst) Amgen (Inst) Akeso Biopharma (Inst) ADC Therapeutics (Inst) AtlasMedx <section> Research Funding: Amgen (Inst) Roche (Inst) AstraZeneca (Inst) <section> Research Funding: AstraZeneca (Inst) Clovis Oncology (Inst) Merck (Inst) Bayer (Inst) PharmaMar (Inst) Pﬁzer (Inst) Tesaro (Inst) MSD <section> Research Funding: Genentech (Inst) AstraZeneca (Inst) Syros Pharmaceuticals (Inst) Innovent Biologics (Inst) Deciphera (Inst) ArQule (Inst) Roche (Inst) Tesaro (Inst) Merck (Inst) Karyopharm Therapeutics (Inst) Aravive (Inst) Mersana (Inst) Harpoon therapeutics (Inst) Hookipa Biotech (Inst) Five Prime Therapeutics (Inst) Fujiﬁlm (Inst) Clovis Oncology (Inst) Arch Oncology (Inst) Plexxikon (Inst) GlaxoSmithKline (Inst) Lilly (Inst) Celsion (Inst) Shattuck Labs (Inst) <section> Research Funding: US Biotest (Inst) Advenchen Laboratories (Inst) Tesaro (Inst) Xenetic Biosciences (Inst) Advaxis (Inst) Janssen (Inst) Aeterna Zentaris (Inst) TRACON Pharma (Inst) Pﬁzer (Inst) Immunogen (Inst) Mateon Therapeutics (Inst) Merck Sharp & Dohme (Inst) AstraZeneca (Inst) Millenium Pharmaceuticals (Inst) Aprea AB (Inst) Regeneron (Inst) NVision (Inst) Novartis (Inst) Syros Pharmaceuticals (Inst) Karyopharm Therapeutics (Inst) Agenus (Inst) Akeso Biopharma (Inst) EMD Serono Incyte (Inst) Leap Therapeutics <section> Research Funding: AstraZeneca (Inst) <section> Research Funding: Tesaro (Inst) Clovis Oncology (Inst) Genentech (Inst) Takeda (Inst) Celsion (Inst) Celgene (Inst) AstraZeneca (Inst) Immunogen (Inst) Merck (Inst) GlaxoSmithKline (Inst) NRG Oncology (Inst) Eisai (Inst) Karyopharm Therapeutics (Inst) Incyte (Inst) Agenus (Inst) Mersana (Inst) VBL Therapeutics (Inst) Novocure (Inst) Seagen (Inst) InxMed (Inst) Sutro Biopharma (Inst) Toray Industries (Inst) Acrivon Therapeutics (Inst) Xencor (Inst) Onconova Therapeutics (Inst) <section> Research Funding: Roche (Inst) GlaxoSmithKline (Inst) <section> Research Funding: Novartis (Inst) Amgen (Inst) Genentech (Inst) Lilly (Inst) Janssen (Inst) Array BioPharma (Inst) Tesaro (Inst) Morphotek (Inst) Pﬁzer (Inst) Advaxis (Inst) AstraZeneca (Inst) Immunogen (Inst) Regeneron (Inst) Nucana (Inst) <section> Research Funding: AstraZeneca (Inst) Boehringer Ingelheim (Inst) Pﬁzer (Inst) Tesaro (Inst) Clovis Oncology (Inst) Ultimovacs (Inst) Apexigen (Inst) GlaxoSmithKline (Inst) <section> Research Funding: Lilly (Inst) AstraZeneca (Inst) Eisai (Inst) Merck (Inst) Bristol Myers Squibb (Inst) Karyopharm Therapeutics (Inst) Takeda (Inst) Clovis Oncology (Inst) Bayer (Inst) Zymeworks (Inst) DualityBio (Inst) Faeth Therapeutics (Inst)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.23.00233",TRUE,"<section> DISCLOSURES OF POTENTIAL CONFLICTS <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected The Randomized Open-Label Phase III KEYLYNK-010 Trial The following represents disclosure information provided by authors of otherwise noted. <section> Research Funding: Dendreon (Inst) Merck (Inst) Seagen (Inst) Daiichi Sankyo (Inst) Taiho Pharmaceutical (Inst) Blue Earth Diagnostics (Inst) Bayer (Inst) Lantheus Medical Imaging (Inst) Surface Oncology (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc (Inst) No other potential conﬂicts of interest were reported.",TRUE,"<section> Research Funding: Janssen Biotech (Inst) Johnson & Johnson (Inst) Sanoﬁ (Inst) Dendreon (Inst) Aragon Pharmaceuticals (Inst) Exelixis (Inst) Millennium (Inst) Genentech (Inst) Novartis (Inst) Astellas Pharma (Inst) Tokai Pharmaceuticals (Inst) Merck (Inst) AstraZeneca (Inst) Clovis Oncology (Inst) Constellation Pharmaceuticals (Inst) <section> Research Funding: Merck Sharp & Dohme LLC (Inst) <section> Research Funding: BeiGene (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc (Inst) <section> Research Funding: Pﬁzer (Inst) Janssen (Inst) Novartis (Inst) Bristol Myers Squibb (Inst) Roche/Genentech (Inst) AstraZeneca/ MedImmune (Inst) MSD (Inst) Bayer Schering Pharma (Inst) Seagen (Inst) GI Innovation (Inst) Amgen (Inst) Oscotec (Inst) <section> Research Funding: Pﬁzer (Inst) Janssen-Cilag (Inst) Astellas Pharma (Inst) Sanoﬁ (Inst) Roche/Genentech (Inst) AstraZeneca/Merck (Inst) <section> Research Funding: Sanoﬁ (Inst) Janssen (Inst) Bayer (Inst) Astellas Pharma (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Celgene (Inst) Merck (Inst) Takeda (Inst) AstraZeneca (Inst) Novartis (Inst) Amgen (Inst) Bristol Myers Squibb (Inst) MSD (Inst) Sandoz (Inst) Gilead Sciences (Inst) Roche (Inst) Daiichi Sankyo Europe GmbH (Inst) AbbVie <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Astellas Medivation (Inst) Merck Serono (Inst) Janssen Oncology (Inst) Roche (Inst) Pﬁzer/EMD Serono (Inst) Bristol Myers Squibb (Inst) MSD (Inst) Exelixis (Inst) <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: MSD Oncology (Inst) <section> Research Funding: Janssen (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc (Inst) <section> Research Funding: AstraZeneca/MedImmune MSD Oncology <section> Research Funding: Bayer (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc Rahway NJ for this study (Inst) <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Takeda (Inst) Bayer Yakuhin (Inst) Kissei Pharmaceutical (Inst) Nihonkayaku (Inst) Chugai Pharma (Inst) Janssen (Inst) Astellas Pharma (Inst) AstraZeneca (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc (Inst) <section> Research Funding: Merck Sharp & Dohme LLC a subsidiary of Merck & <section> Research Funding: Dendreon (Inst) Merck (Inst) Seagen (Inst) Daiichi Sankyo (Inst) Taiho Pharmaceutical (Inst) Blue Earth Diagnostics (Inst) Bayer (Inst) Lantheus Medical Imaging (Inst) Surface Oncology (Inst) Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc (Inst) No other potential conﬂicts of interest were reported.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/jco.23.00529",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS <section> Disclosures provided by the authors are available with this article at DOI https://doi.org/10.1200/JCO.23.00529. <section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF <section> The following represents disclosure information provided by authors of otherwise noted. <section> Research Funding: AstraZeneca (Inst) Amedes (Inst) No other potential conﬂicts of interest were reported.",TRUE,"<section> Supported by F. <section> Research Funding: AstraZeneca (Inst) <section> Research Funding: AbbVie (Inst) Advaxis (Inst) Aeterna Zentaris (Inst) Aprea Therapeutics (Inst) Clovis Oncology Inc (Inst) Eisai (Inst) Roche (Inst) Regeneron (Inst) Bristol Myers Squibb International Corporation (BMS) (Inst) Immunogen (Inst) Medimmune (Inst) Merck Sharp & Dohme (Inst) Tesaro (Inst) Amgen (Inst) Millennium Pharmaceuticals <section> Research Funding: Gilead Sciences (Inst) <section> Research Funding: Daiichi Sankyo/AstraZeneca <section> Research Funding: Roche (Inst) Amgen (Inst) Oncoinvent (Inst) <section> Research Funding: PharmaMar (Inst) Onxeo (Inst) <section> Research Funding: MSD Oncology GlaxoSmithKline AstraZeneca <section> Research Funding: Roche (Inst) <section> Research Funding: AstraZeneca (Inst) Clovis Oncology (Inst) Merck (Inst) Bayer (Inst) PharmaMar (Inst) Pﬁzer (Inst) Tesaro (Inst) MSD <section> Research Funding: Fresenius (Inst) <section> Research Funding: AstraZeneca (Inst) Amedes (Inst) No other potential conﬂicts of interest were reported.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1200/po.22.00555",TRUE,"<section> AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS <section> The following represents disclosure information provided by authors of this manuscript. <section> No other potential conﬂicts of interest were reported.",TRUE,"<section> study was partially funded by AstraZeneca Cambridge UK Merck Sharp & Dohme LLC a subsidiary of Merck & Co Inc NJ. <section> Research Funding: AstraZeneca Cambridge UK and Merck Sharp & Dohme <section> Research Funding: AstraZeneca (Inst) Clovis Oncology (Inst) Merck (Inst) Bayer (Inst) PharmaMar (Inst) Pﬁzer (Inst) Tesaro (Inst) MSD Oncology <section> Research Funding: Roche (Inst) Tesaro/GSK (Inst) <section> Research Funding: AstraZeneca (Inst) MSD (Inst) Regeneron (Inst) <section> Research Funding: Roche (Inst) Amgen (Inst) Oncoinvent (Inst) <section> Research Funding: MSD Oncology BMS Roche/Genentech (Inst) <section> Research Funding: AstraZeneca (Inst) <section> Research Funding: AstraZeneca",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1210/clinem/dgad031",TRUE,"Disclosures <section> R.M. has received speaker fees from Illumina Ltd and is a sci­ entific advisor to the Epigenetic Clock Development Foundation.",TRUE,"<section> Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006) and is currently supported by the Wellcome Trust (216767/Z/19/Z). Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Edinburgh Clinical Research Facility University of Edinburgh Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award “STratifying Resilience And Depression Longitudinally” (STRADL) Reference 104036/ Z/14/Z). This research was funded in part by the European Research Council (ERC) under grant agreement ERC-SyG-2020 951475 (to M.R.) the Wellcome Trust (FC001134 and IA 200829/Z/16/Z to M.R.) and by the German Ministry of Education and Research (BMBF) as part of the National Research Node “Mass spectrometry in Systems Medicine (MSCoreSys)” under grant agreements 031L0220 to M.R. and 161L0221 to V.D. T.H.C.’s research is supported by grants from the Swiss National Science Foundation the Leenaards Foundation the Vontobel Foundation the Medical Board of the Geneva University Hospitals the Nutrition 2000plus Foundation and the Swiss Society of Endocrinology and Diabetes. I.S.F. was supported by the Wellcome Trust (207462/Z/17/Z) the NIHR (National Institute for Health Research) Cambridge Biomedical Research Centre Fondation Botnar the Bernard Wolfe Health Neuroscience Endowment and a NIHR Senior Investigator Award. Computing resources at the Chalmers Center for Computational Science and Engineering (C3SE) were partially funded by the Swedish Research Council through grant agreement no. 2018-05973 (A.Z.). NJW and CL were supported by the Medical Research Council (MC_UU_00006/1).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1210/clinem/dgad125",TRUE,"Disclosures <section> W.B.M. and L.S. are listed as inventors on a related patent ap­ plication.",TRUE,"<section> Funding <section> This work was supported by the German Federal Ministry of Economic Affairs and Climate Action (BMWi) project KF2257304AJ0 within the ZIM program and by the intra­ mural research program of the National Institute of Diabetes and Digestive and Kidney Diseases.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinicaltrials.gov registration number NCT00001987 (regis­ tered January 31 2000).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1210/clinem/dgad223",TRUE,"Disclosures <section> All authors declare no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1210/clinem/dgad365",TRUE,"Disclosures <section> M.F. has been a scientific consultant for Amryt Ipsen Ionis NovoNordisk Recordati and Pfizer and has been receiving grants to her University from Amryt Crinetics Ionis and Recordati.",TRUE,"<section> Funding M.M. is a consultant for Corcept Janssen Merck NovoNordisk Pfizer and Novartis received grant support from Amryt Crinetics and Ionis and is a research in­ vestigator at Bayer.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1210/clinem/dgad597",TRUE,"Disclosures <section> D.H. and D.S. received speaker fees consultation fees and research grants from Kyowa Kirin.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1210/endocr/bqad076",TRUE,"Disclosures <section> The authors have nothing to disclose.",TRUE,"<section> Funding <section> This work was supported by the National Institutes of Health (R01HD034283 and R01HD097096 to S.A.C.)",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1210/jendso/bvad140",TRUE,"Disclosures The authors have nothing to disclose.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"10.1212/wnl.0000000000201426",TRUE,"Disclosure The other authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.",TRUE,"Funding information and disclosures deemed relevant by the authors if any are provided at the The study was funded by the Society of Vascular and Interventional Neurology research pilot grant. <section> Study Funding <section> The study was funded by the Society of Vascular and Inter- Kan received grant support from NIH U18EB029353-01 and Medtronic. CA18118 IRENE COST Action funded by COST Association by the IRIS-TEPUS Project No. R. Herzig was supported by the Ministry of Health of the Czech Republic (grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1212/wnl.0000000000201537",TRUE,"Disclosures: Michel: Research grants from the Swiss National Science Foundation and Swiss Heart Foundation; All the other authors report no relevant disclosures. <section> All the other authors do report no conflict of interest.",TRUE,"Study Funding: Czech national stroke registry is supported by STROCZECH within CZECRIN Large Research Infrastructure (No.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1212/wnl.0000000000207219",TRUE,"Disclosures: Liew reports no disclosures relevant to the manuscript; N. Schweighofer reports no disclosures relevant to the manuscript; J.H. Zavaliangos-Petropulu reports no disclosures relevant to the manuscript; B.P. Lo reports no disclosures relevant to the manuscript; L.K.M. Han reports no disclosures relevant to the manuscript; T. Hahn reports no disclosures relevant to the manuscript; L. Schmaal reports no disclosures relevant to the manuscript; M.R. Donnelly reports no disclosures relevant to the manuscript; J.N. Jeong reports no disclosures relevant to the manuscript; Z. Wang reports no disclosures relevant to the manuscript; A. Abdullah reports no disclosures relevant to the manuscript; J.H. Kim reports no disclosures relevant to the manuscript; A. Hutton reports no disclosures relevant to the manuscript; G. Barisano reports no disclosures relevant to the manuscript; M. R. Borich reports no disclosures relevant to the manuscript; L.A. Boyd reports no disclosures relevant to the Buetefisch reports no disclosures relevant to the manuscript; W.D. Byblow reports no disclosures relevant to the manuscript; J.M. Cassidy reports no disclosures relevant to the manuscript; C.C. Charalambous reports no disclosures relevant to the manuscript; V. Ciullo reports no disclosures relevant to the manuscript; A.B. Conforto reports no disclosures relevant to the manuscript; R. Dacosta-Aguayo reports no disclosures relevant to the manuscript; J.A. DiCarlo reports no disclosures relevant to the manuscript; M. Domin reports no disclosures relevant to the manuscript; A.N. Dula reports no disclosures relevant to the manuscript; N. <section> Egorova-Brumley reports no disclosures relevant to the manuscript; W. Feng reports no disclosures relevant to the manuscript; F. Geranmayeh reports no disclosures relevant to the manuscript; C.M. <section> Gregory reports no disclosures relevant to the manuscript; C.A. Hanlon reports no disclosures relevant to the manuscript; K.S. Hayward reports no disclosures relevant to the manuscript; J.A. Holguin reports no disclosures relevant to the manuscript; B. Jahanshad reports no disclosures relevant to the manuscript; S.A. Kautz reports no disclosures relevant to the manuscript; M.S. Khlif reports no disclosures relevant to the manuscript; H. Kim reports no disclosures relevant to the manuscript; A. Kuceyeski reports no disclosures relevant to the manuscript; D.J. Lin reports no disclosures relevant to the manuscript; J. Liu reports no disclosures relevant to the manuscript; M. <section> Lotze reports no disclosures relevant to the manuscript; B.J. MacIntosh reports no disclosures relevant to the manuscript; J.L. Margetis reports no disclosures relevant to the manuscript; M. Mataro reports no disclosures relevant to the manuscript; F.B. Mohamed reports no disclosures relevant to the manuscript; E.R. Olafson reports no disclosures relevant to the manuscript; G. Park reports no disclosures relevant to the manuscript; F. Piras reports no disclosures relevant to the manuscript; K.P. <section> Revill reports no disclosures relevant to the manuscript; P. Roberts reports no disclosures relevant to the manuscript; A.D. Robertson reports no disclosures relevant to the manuscript; N. Sanossian reports no disclosures relevant to the manuscript; H.M. Schambra reports no disclosures relevant to the manuscript; N.J. Seo reports no disclosures relevant to the manuscript; S.R. Soekadar reports no disclosures relevant to the manuscript; G. Spalletta reports no disclosures relevant to the manuscript; Tang reports no disclosures relevant to the manuscript; G.T. <section> Thielman reports no disclosures relevant to the manuscript; D. Vecchio reports no disclosures relevant to the manuscript; N.S. Ward reports no disclosures relevant to the manuscript; L.T. Westlye reports no disclosures relevant to the manuscript; C.J. Winstein reports no disclosures relevant to the manuscript; G.F.W. is on the Medical Advisory Board Myomo Inc. Wong reports no disclosures relevant to the manuscript; C. Yu reports no disclosures relevant to the manuscript; S.C.",TRUE,"<section> Study Funding: A.G. Brodtmann is supported by Australian National Health and Medical Research Council (NHMRC) GNT1020526 GNT1045617(AB) GNT1094974; Brain Foundation; Wicking Trust; Collie Trust; Sidney and Fiona Myer Family Foundation; and Heart Foundation Future Leader Fellowship 100784. Buetefisch is supported by NIH R01NS090677. Byblow is supported by the Health Research Council of New Zealand. Cassidy is supported by NIH R00 HD091375. Conforto is supported by NIH R01 NS076348; IIEP-2250-14. N. Egorova-Brumley is supported by Melbourne Research Fellowship. F. Geranmayeh is supported by Wellcome Trust (093957). Han is supported by a Rubicon fellowship provided by The Dutch Research Council (NWO). T. Hahn is supported by the German Research Foundation (DFG grants HA7070/2-2 HA7070/3 HA7070/4 to TH). B. Hordacre is supported by National Health and Medical Research Council (NHMRC) fellowship (GNT1125054). Kautz is supported by NIH P20 GM109040 1IK6RX003075. Khlif is supported by National Health and Medical Research Council (NHMRC) grant (APP1020526). Liew is supported by NIH R01 NS115845. M. Mataro is supported by ICREA Academia program. F. Piras is supported by Italian Ministry of Health Ricerca Corrente RC 21 22. Revill is supported by NIH R01NS090677. L. Schmaal is supported by National Institute of Mental Health of the NIH (R01MH117601) and by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (1140764). N. Schweighofer is supported by NIH R56 NS100528. Seo is supported by NIH/NICHD 1R01HD094731-01A1 G. Spalletta is supported by Italian Ministry of Health RC 18-19-20-21-22/A. Stinear is supported by Health Research Council of New Zealand. M. Taga is supported by NIH R01 NS110696. G. Thielman is supported by Temple University subaward of NIH R24 –NHLBI Thompson is supported by NIH U54 EB020403. Westlye is supported by European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG Grant 802998) the Research Council of Norway (298646 300767) the South-Eastern Norway Regional Health Authority (2019101). Winstein is supported by Grants HD065438 NS100528.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1212/wnl.0000000000207550",TRUE,"<section> Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors if any are provided at the <section> no disclosures relevant <section> disclosures relevant to the manuscript. <section> for full disclosures.",TRUE,"Funding information and disclosures deemed relevant by the authors if any are provided at the <section> Study Funding This work was supported by the National Institute for Neurological Disorders and Stroke (K02 NS112600) the Eunice Kennedy Shriver National Institute of Child Health and Human Development through the Intellectual and Developmental Disabilities Research Center (IDDRC) at Children’s Hospital of Philadelphia and the University of Pennsylvania (U54 HD086984) and by intramural funds of the Children’s Hospital of Philadelphia through the Epilepsy NeuroGenetics Initiative (ENGIN). Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the NIH under Award Number UL1TR001878. This project was also supported in part by the Institute for Translational Medicine and Therapeutics’ (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics at the Perelman School of Medicine of the University of Pennsylvania. S. Syrbe received funding from Stiftung (grant 1DH1813319).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1212/wnl.0000000000207624",TRUE,"Disclosure: Curtze report no disclosures relevant to the manuscript.",TRUE,"Study Funding: This work was supported by a personal grant (“Filling the gap”) of the University of Zurich Switzerland and “Walter and Gertrud Siegenthaler Foundation” to KS (no grant number is applicable). A. Zini received payments for lectures from CSL Behring and Alexion-Astra Zeneca honoraria for participation as National Coordinator and steering committee of the OCEANIC STROKE TRIAL in addition he is Principal Investigator for the funded project RF-2019-12370834 “FibER: Fibrinogen replacement to prevent intracranial haemorrhage in ischemic stroke patients after thrombolysis: a pilot RCT (sponsored by Grant of the Italian Health Ministry) EudraCT 2020-005242-41 and is member in the steering committee of the Italian registry of endovascular treatmentin acute stroke (IRETAS) and of the Italian Stroke Association (ISA_AII) each without payment. C. H. Nolte received funding for the PRAISE Study from the German Center for cardiovascular research and the German Center for neurodegenerative Diseases. S. T. <section> Engelter has received funding for travel or speaker honoraria from Bayer Boehringer Ingelheim and DaiichiSankyo has served on scientific advisory boards for Bayer Boehringer Ingelheim BMS/Pfizer and MindMaze and on the editorial board of Stroke his institutions have received an educational grant from Pfizer compensation from Stago for educational efforts and research support from Daiichi-Sankyo the Science Funds [Wissenschaftsfonds] of the University Hospital Basel the University Basel from the “Wissenschaftsfonds Rehabilitation” of the University Department for Geriatric Medicine Felix Platter the “Freiwillige Akademische Gesellschaft Basel” the Swiss Heart Foundation and the Swiss National Science Foundation. S. Wegener was supported by grants from the Swiss National Science Foundation (PP00P3_202663) and the Clinical Research Priority Program Stroke from the University of Zurich. P. Michel received grants from the Swiss National Science Foundation the Swiss Heart Foundation and the University of Lausanne all outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1212/wnl.0000000000207858",TRUE,"Disclosure The remaining authors report no disclosures. Go to Neurology.org/N for full disclosures.",TRUE,"Funding information and disclosures deemed relevant by the authors if any are provided at the <section> This study was supported by inhouse funding of the Department of Neurology Klinikum rechts der Isar der TU München.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1213/ane.0000000000006295",TRUE,"<section> DISCLOSURES <section> Name: Shahla Siddiqui MD MSc FCCM.",TRUE,"<section> Funding: S.S. was funded by the John Hedley-Whyte grant from Harvard Medical School (Beth Israel Deaconess Medical Center). <section> Contribution: This author helped conceive the study plan and acquire funding conduct the study analyze the data and write and edit the manuscript. <section> Contribution: This author helped conduct the study acquire funding and edit the manuscript.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1242/dev.201023",TRUE,"Declaration of Interests The authors declare that they have no conflicts of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the Belgian National Fund for Scientific Research (FNRS) (FRSM 3-4598-12 CDR-J.0034.20; CDR-J.0026.19 CDR-J.0145.16 GEQ U.G030.19) the Fonds d’Encouragement à la Recherche de l’Université Libre de Bruxelles (FER-ULB).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1242/dev.201228",TRUE,"Competing interests The authors declare no competing or financial interests.",TRUE,"<section> We acknowledge the computational support from the OMICS compute cluster at the University of Lu beck. ; Funding acquisition: J. <section> Funding <section> This work was funded by the German Research Council (DFG; Deutsche Forschungsgemeinschaft) within the framework of the TR/CRC 296 ‘Local Control of Thyroid Hormone Action’ [LocoTact P12 (project ID 424957847) to J. M.S. is a Deutsches Zentrum fu r Herz-Kreislaufforschung principal investigator and is supported by grants from the DFG (SP1532/3-2 SP1532/4-1 and SP1532/5-1) the Max-Planck-Gesellschaft and the Deutsches Zentrum fu r Luftund Raumfahrt (DLR 01GM1925).",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1242/dev.201562",TRUE,"Competing interests <section> The authors declare no conflict of interest.",TRUE,"<section> Funding <section> F.M.R. was supported by grants from the Deutsche Forschungsgemeinschaft (MU 880/16-1). M.O. was supported by Swiss National Science Foundation (SNSF) grant PCEFP3_186993. <section> was supported by National Institutes of Health (NIH) grants R01HG003988 UM1HG009421 R01HL162304 and R01DE028599.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1242/dmm.049861",TRUE,"<section> No competing interests declared.",TRUE,"<section> Funding <section> The work was supported by the NeuroCure Cluster of Excellence grant to H.K. a National Institute of Health grant (R35NS097211 to D.H.G) and a Berlin Institute of Health/Einstein fellowship grant to D.H.G. and H.K.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1242/jcs.261413",TRUE,"Competing interests The authors declare no competing or financial interests.",TRUE,"<section> Funding <section> D.M. is supported by startup funds from Deutsches Zentrum fu r Neurodegenerative Erkrankungen (DZNE) grants from Deutsche Forschungsgemeinschaft (SFB 1286/ B10 and MI 2104) and the European Research Council (ERC) grant MemLessInterface (101078172). C.H. is supported by a fellowship of the Innovative Minds Program of the German Dementia Association.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1245/s10434-022-13054-2",TRUE,"<section> DISCLOSURES Prof. Marc Besselink and Prof.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1245/s10434-023-13353-2",TRUE,"<section> DISCLOSURES Sarah Hoffe: Galera Pharmaceuticals Institutional Principal Investigator for the GRECO-2 randomized international study for which my cancer center receives funding to support the trial it is a pancreas trial that includes SBRT.",TRUE,"<section> Role of the Funding Source <section> There was no funding for this systematic review with metaanalysis. <section> FUNDING Open access funding provided by University of Zurich. <section> DISCLOSURES Sarah Hoffe: Galera Pharmaceuticals Institutional Principal Investigator for the GRECO-2 randomized international study for which my cancer center receives funding to support the trial it is a pancreas trial that includes SBRT.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1245/s10434-023-13525-0",TRUE,"<section> AUTHOR CONTRIBUTIONS All authors confirm they are accountable for all aspects of this work and report the following disclosures: BKPG has received travel grants and honorarium from Johnson and Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot outside the submitted work.",TRUE,"<section> AUTHOR CONTRIBUTIONS All authors confirm they are accountable for all aspects of this work and report the following disclosures: BKPG has received travel grants and honorarium from Johnson and Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot outside the submitted work. <section> FUNDING For this study T. Peter Kingham was partially supported by the US National Cancer Institute MSKCC Core Grant number P30 CA008747.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1245/s10434-023-13863-z",TRUE,"<section> DISCLOSURE Dr Goh BK has received travel grants and honoraria from Johnson & Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot.",TRUE,"<section> FUNDING Dr T. P. Kingham was partially supported by the US National Cancer Institute MSKCC Core Grant number P30 CA008747 for this study. <section> DISCLOSURE Dr Goh BK has received travel grants and honoraria from Johnson & Johnson Olympus and Transmedic the local distributor for the Da Vinci Robot.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1245/s10434-023-14551-8",TRUE,"<section> DISCLOSURE Sherko Kuemmel has received personal fees for consulting or advisory services from Roche/Genentech Genomic Health Novartis AstraZeneca Amgen Celgene SOMATEX Daiichi Sankyo PFM Medical Pfizer MSD Oncology Lilly Sonoscape Gilead Sciences Seagen and Agendia; funding for travel and accommodation expenses from Roche Daiichi Sankyo and Sonoscape; and is Co-Director of the WSG Study group. Marc Thill has been a member of the Advisory Boards of Agendia Amgen AstraZeneca Aurikamed Becton/Dickinson Biom‘Up ClearCut Clovis Daiichi Sankyo Eisai Exact Sciences Gilead Science Grünenthal GSK Lilly MSD Norgine Neodynamics Novartis Onkowissen Organon Pfizer PFM Medical Pierre-Fabre Roche RTI Surgical Seagen Sirius Pintuition and Sysmex; has received manuscript support from <section> Amgen ClearCut Clovis PFM Medical Roche and Servier; received funding for travel expenses from Amgen Art Tempi AstraZeneca Clearcut Clovis Connect Medica Daiichi Sankyo Eisai Exact Sciences Gilead Hexal I-Med-Institute Lilly MCI Medtronic MSD Neodynamics Norgine Novartis Pfizer pfm Medical Roche RTI Surgical and Seagen; received congress support from Amgen AstraZeneca Celgene Daiichi Sanyko Hexal Neodynamics Novartis Pfizer Roche and Sirius Medical; received lecture honoraria from Amgen Art Tempi AstraZeneca Clovis Connect Medica Eisai Exact Sciences Gedeon Richter Gilead Science GSK Hexal I-Med-Institute Jörg Eickeler Laborarztpraxis Walther et al. Lilly MCI Medscape MSD Medtronic Novartis Onkowissen Pfizer PFM Medical Roche Seagen StreamedUp Sysmex Vifor and Viatris; received trial funding from Endomag and Exact Sciences; and received trial honoraria from AstraZeneca Biom’Up Celgene Clearcut Neodynamics Novartis PFM Medical Roche and RTI Surgical. Marion van Mackelenbergh has received personal fees honoraria or travel grants from Amgen AstraZeneca Daiichi Sankyo GenomicHealth Gilead GSK Lilly Molecular Health MSD Mylan Novartis Pfizer PierreFabre Roche and Seagen. Maggie Banys-Paluchowski has received honoraria for lectures and advisory boards from Roche Novartis Pfizer PFM Medical Eli Lilly Onkowissen Seagen AstraZeneca Eisai Amgen Samsung Canon MSD GSK Daiichi Sankyo Gilead Sirius Pintuition Pierre Fabre and ExactSciences; and has received study support from EndoMag Mammotome MeritMedical Gilead Hologic and ExactSciences. Mattea Reinisch has received honoraria and/or consultancy fees and/or travel support from AstraZeneca Daiichi Sankyo Gilead Lilly MSD Novartis Pfizer Roche Seagen and Somatex. <section> André Pfob Lie Cai Andreas Schneeweiss Geraldine Rauch Bettina Thomas Benedikt Schaefgen Toralf Reimer Markus Hahn Jens-Uwe Blohmer John Hackmann Wolfram Malter Inga Bekes Kay Friedrichs Sebastian Wojcinski Sylvie Joos Stefan Paepke Tom Degenhardt Joachim Rom Achim Rody Regina Große Maria Margarete Karsten Chris Sidey-Gibbons Markus Wallwiener Michael Golatta and Joerg Heil have no conflicts of interest to declare in relation to this",TRUE,"<section> FUNDING Open Access funding enabled and organized by Projekt DEAL. This trial was funded by Deutsche Forschungsgemeinschaft (German Research Group GZ:HE 6824/5-1). <section> Amgen ClearCut Clovis PFM Medical Roche and Servier; received funding for travel expenses from Amgen Art Tempi AstraZeneca Clearcut Clovis Connect Medica Daiichi Sankyo Eisai Exact Sciences Gilead Hexal I-Med-Institute Lilly MCI Medtronic MSD Neodynamics Norgine Novartis Pfizer pfm Medical Roche RTI Surgical and Seagen; received congress support from Amgen AstraZeneca Celgene Daiichi Sanyko Hexal Neodynamics Novartis Pfizer Roche and Sirius Medical; received lecture honoraria from Amgen Art Tempi AstraZeneca Clovis Connect Medica Eisai Exact Sciences Gedeon Richter Gilead Science GSK Hexal I-Med-Institute Jörg Eickeler Laborarztpraxis Walther et al. Lilly MCI Medscape MSD Medtronic Novartis Onkowissen Pfizer PFM Medical Roche Seagen StreamedUp Sysmex Vifor and Viatris; received trial funding from Endomag and Exact Sciences; and received trial honoraria from AstraZeneca Biom’Up Celgene Clearcut Neodynamics Novartis PFM Medical Roche and RTI Surgical.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1245/s10434-023-14774-9",FALSE,"",TRUE,"<section> FUNDING This work was funded by National Cancer Institute award P30-CA008748.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1249/mss.0000000000003160",TRUE,"The authors declare that they have no conflicts of interest.",TRUE,"<section> This work was supported by the German Research Foundation (DFG—Deutsche Forschungsgemeinschaft BR 6698/1-1 KR 4783/21 RE 1123/22-1 DU 298/25-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1259/dmfr.20220333",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1259/dmfr.20220335",FALSE,"",TRUE,"<section> The authors received no financial support. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1287/isre.2023.1209",FALSE,"",TRUE,"Integrative View of Generativity and Growth on Digital Platforms as Supported by the PVAR Model Dynamic Boundary Ecosystem boundaries stabilizes Platform Core expands Product boundaries User base",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1302/0301-620x.105b2.bjj-2022-1035.r1",FALSE,"",TRUE,"Karczewski: Conceptualization Methodology Funding acquisition Resources Software Project administration Investigation Data curation Formal analysis Validation Visualization Writing – original draft Writing – review <section> S. Hardt: Conceptualization Methodology Funding acquisition Resources Software Project administration Supervision Investigation Formal analysis Validation Visualization Writing – original draft Writing – review <section> Funding statement: The authors received no financial or material support for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.13109/tode.2023.20.1.53",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pbio.3001922",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The workshop and D.B.S. were funded by a Wellcome Biomedical Resource grant to P.S. and S.S. This work was supported in part through Laulima Government Solutions LLC prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. E.M.A. is supported by the Biotechnology and Biological Sciences Research Council (BBSRC); under the BBSRC Institute Strategic Program Gut Microbes and Health BB/R012490/1 and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356. J.M. is supported by Science Foundation Ireland under Grant Numbers 20/FFPP/8664 and 15/SIRG/3430. H.M.O. was supported by University of Helsinki funding for FINStruct and Instruct-ERIC research infrastructure. The work conducted by the US Department of Energy (DOE) Joint Genome Institute (S.R.) a DOE Office of Science User Facility is supported by the Office of Science of the U.S. B.E.D. was supported by the European Research Council (ERC) Consolidator grant 865694- A.K. was supported by the ERC Consolidator grant 101001623-PALVIREVOL. E.J.L. was supported by the NIH NIAID under Award Number U24AI162625. C.L. was supported by a Postdoctoral Mandate (PDMt2/21/038) from the KU Leuven Research Council and a fellowship (12D8623N) from the Research Foundation – Flanders (FWO). M.B.S. was supported by the US National Science Foundation awards OCE#1829831 and ABI#1759874. Y.B. was supported by the Professional Association of the Alliance of <section> Funding acquisition: Peter Simmonds.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pbio.3001949",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: CLA is the editor-inchief of JOSPT (Journal of Orthopaedic & Sports Physical Therapy). Participants agreed that “registering clinical trials on a registry prior to recruitment” and “reporting author conflicts of interest in published articles” were essential to include. An item describing “reporting that registered clinical trials were reported in the registry within 2 years of study completion” reached consensus in round 2; however several participants commented that the timeframe was inconsistent with requirements of funders that have signed the World Health Organization joint statement on public disclosure of results from clinical trials which specified 12 months. <section> Reporting whether author conflicts of interests Practice Score Traditional open science practices Reporting whether clinical trials were registered before they started recruitment 9.71 Reporting whether study data were shared openly at the time of publication (with limited exceptions) 9.18 Reporting what proportion of articles are published open access with a breakdown of time delay 8.12 Reporting whether study code was shared openly at the time of publication (with limited exceptions) 7.94 Reporting whether systematic reviews have been registered before data collection began 6.76 Reporting whether clinical trials results appeared in the registry from 1 year after study completion 6.76 Reporting whether there was a statement about study materials sharing with publications Reporting whether a reporting guideline checklist was used 5.88 Reporting citations to data 5.53 Reporting trial results in a manuscript-style publication (peer reviewed or preprint) 4.82 Reporting the number of preprints 4.35 Reporting systematic review results in a manuscript-style publication (peer reviewed or preprint) 2.94 Broader transparency practices Reporting whether author contributions were described Reporting whether author conflicts of interest were described 5.12 4.71 Reporting the use of persistent identifiers when sharing data/code/materials 4.65 Reporting whether ORCID identifiers were used 4.47 Reporting whether data/code/materials are shared with a clear license 3.47 Reporting whether research articles include funding statements Reporting whether the data/code/materials license is open or not 2.59 https://doi.org/10.1371/journal.pbio.3001949.t003 The top two broader transparency practices by priority were reporting whether author contributions were described and reporting whether author conflicts of interest were described. 2. <section> Reporting whether author conflicts of interest were reported. Reporting of conflicts of interest is a standard practice at many journals but this practice is not uniform with some publications lacking statements altogether. Monitoring conflicts of interest reporting helps to ensure transparency. In the absence of a statement of conflicts of interest the reader cannot assume none exist. <section> Joint statement on public disclosure of results from clinical trials [Internet].",TRUE,"<section> Funding: This work was supported by a Wellcome Trust Open Research Fund (223828/Z/21/Z to KDC SH JB UD LGH JP DSJPA RC ESS TvL.) <section> Funding acquisition: Kelly D.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Practice Score Traditional open science practices Reporting whether clinical trials were registered before they started recruitment 9.71 Reporting whether study data were shared openly at the time of publication (with limited exceptions) 9.18 Reporting what proportion of articles are published open access with a breakdown of time delay 8.12 Reporting whether study code was shared openly at the time of publication (with limited exceptions) 7.94 Reporting whether systematic reviews have been registered before data collection began 6.76 Reporting whether clinical trials results appeared in the registry from 1 year after study completion 6.76 Reporting whether there was a statement about study materials sharing with publications Reporting whether a reporting guideline checklist was used 5.88 Reporting citations to data 5.53 Reporting trial results in a manuscript-style publication (peer reviewed or preprint) 4.82 Reporting the number of preprints 4.35 Reporting systematic review results in a manuscript-style publication (peer reviewed or preprint) 2.94 Broader transparency practices Reporting whether author contributions were described Reporting whether author conflicts of interest were described 5.12 4.71 Reporting the use of persistent identifiers when sharing data/code/materials 4.65 Reporting whether ORCID identifiers were used 4.47 Reporting whether data/code/materials are shared with a clear license 3.47 Reporting whether research articles include funding statements Reporting whether the data/code/materials license is open or not 2.59 https://doi.org/10.1371/journal.pbio.3001949.t003",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.pbio.3002164",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: CS acknowledges support by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) through grant number SCHM3362/2-1 (Project-ID 414704559). <section> Funding acquisition: Christoph Schmal Maria S.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pbio.3002362",TRUE,"Competing interests: AB is an Academic Editor for PLOS Biology. AB is a founder of SciCrunch Inc a company that works with publishers to improve the representation of research resources in scientific literature. She is also a member of the board and serves as the CEO. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. <section> OBA is a member of the eLife Global South Advisory Committee and co-founder of the Brazilian Reproducibility Network. N.D. is an external consultant and animal welfare officer at Medizinisches Kompetenzzentrum c/o HCx Consulting Brandenburg Germany. All other authors declare no conflict of interest.",TRUE,"<section> Funding: The author(s) received no specific funding for this work. <section> Abbreviations: ARRIVE AU Animal : Anabbreviationlisthasbeencompiledforthoseusedthroughoutthetext:Pleaseverifythatallentriesarecorrectlyabbreviated: Research Reporting of In Vivo Experiments; BIDS Brain Imaging Data Structure; CONSORT Consolidated Standards of Reporting Trials; COS Center for Open Science; EQUATOR Enhancing the QUAlity and Transparency Of health Research; FAIR findable accessible interoperable and reusable; FDA Food and Drug Administration; ISRCTN International Standard Randomised Controlled Trial Number; MDAR Materials Design Analysis and Reporting; NIH National Institutes of Health; OSF Open Science Framework; OSTP Office of Science and Technology Policy; PRISMA Preferred Reporting Items for Systematic Reviews and MetaAnalyses; REF Research Excellence Framework; RRFP Registered Report Funding Partnership; RRID Research Resource Identifier; SciELO Scientific Electronic Library Online; TACS Transparency in Author Contributions in Science; TOPS Transform to Open Science; UKRN UK Reproducibility Network; WHO World Health Organization. Funding calls for metaresearch (researchon-research) remain rare. These authors then suggested performing a reproducibility check during peer review before awarding an open data badge which could serve as the basis for another interventional study. Initiatives such as Registered Report Funding Partnerships (RRFPs) [108] aim to align these stakeholders and have been encouraged by Reproducibility Networks. 2022; 378:1263. https:// <section> doi.org/10.1126/science.adg3932 PMID: 36548413 Funding Agencies And Quality Control. Evaluating Registered Reports Funding Partnerships: a feasibility study [version 1; peer review: 2 approved with reservations].",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pbio.3002393",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: For this project EA received funding from the Max Planck School of Cognition Walter Benjamin Program of the German Research Foundation (DFG) and the experiment was funded by the Max Planck Society. <section> Funding acquisition: Esra Al Arno Villringer Vadim V.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pbio.3002410",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: VW was funded by the Leopoldina <section> VW and HS were funded by the Berlin Institute of Health Clinician Scientist Program (https://www. <section> bihealth.org/en/translation/innovationenabler/ academy/bihcharite-clinicianscientist-program). <section> Funding acquisition: Veith Weilnhammer Philipp Sterzer.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pcbi.1010750",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: CH and TLW were funded via the SPOKES Subproject of the Wellcome Trust Translational Partnership at Charité and Berlin Institutes of Health (218358/Z/19/Z). DW was supported by the Economic and Social Research Council Studentship (ES/P000592/1). APK was funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pcbi.1010919",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: PM and CM are funded by Charité — Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pcbi.1011379",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: CS acknowledges grant support from AstraZeneca BoehringerIngelheim BMS Pfizer Roche-Ventana Invitae (previously Archer Dx collaboration in minimal residual disease sequencing technologies) Ono Pharmaceutical and Personalis; is an AstraZeneca advisory board member and chief investigator for the AZ MeRmaiD 1 and 2 clinical trials and is also co-chief investigator of the NHS Galleri trial funded by GRAIL and a paid member of GRAIL’s scientific advisory board; receives consultant fees from Achilles Therapeutics (also a scientific advisory board member) Bicycle Therapeutics (also a scientific advisory board member) Genentech Medicxi China Innovation Centre of Roche (CICoR) formerly Roche Innovation Centre – Shanghai Metabomed (until July 2022) and the Sarah Cannon Research Institute; has received honoraria from Amgen AstraZeneca Pfizer Novartis GlaxoSmithKline MSD Bristol Myers Squibb Illumina and Roche-Ventana; had stock options in Apogen Biotechnologies and GRAIL until June 2021 and currently has stock options in Epic Bioscience Bicycle Therapeutics and has stock options and is co-founder of Achilles Therapeutics; is listed as an inventor on a European patent application relating to assay technology to detect tumour recurrence (PCT/GB2017/053289) the patent has been licensed to commercial entities and under his terms of employment CS is due a revenue share of any revenue generated from such license(s); holds patents relating to targeting neoantigens (PCT/EP2016/059401) identifying patient response to immune checkpoint blockade (PCT/EP2016/071471) determining HLA LOH (PCT/GB2018/052004) predicting survival rates of patients with cancer (PCT/GB2020/050221) identifying patients who respond to cancer treatment (PCT/GB2018/051912) a US patent relating to detecting tumour mutations (PCT/ US2017/28013) methods for lung cancer detection (US20190106751A1) and both a All other authors declare no competing interests.",TRUE,"<section> Funding: This work was supported by the Francis Crick Institute that receives its core funding from Cancer Research UK (CC2008 CC2041) the UK Medical Research Council (CC2008 CC2041) and the Wellcome Trust (CC2008 CC2041). This work was supported by a Stand Up To Cancer? <section> NM is a Sir Henry Dale Fellow jointly funded by the Wellcome Trust and the Royal Society (211179/Z/ 18/Z) and also receives funding from Cancer Research UK Rosetrees and the NIHR BRC at University College London Hospitals and the CRUK University College London Experimental Cancer Medicine Centre. NM is a Sir Henry Dale Fellow jointly funded by the Wellcome Trust and the Royal Society (Grant Number 211179/Z/18/Z) and also receives funding from Cancer Research UK Lung Cancer Centre of Excellence Rosetrees and the NIHR BRC at University College London Hospitals. RFS and TLK received funds from the German Ministry for Education and Research as BIFOLD Berlin Institute for the Foundations of Learning and Data (ref. <section> Funding acquisition: Charles Swanton Nicholas McGranahan Roland F.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pcbi.1011647",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This study was funded by the German Research Foundation (DFG) through the Collaborative Research Centre (CRC) 1444 project We would like to acknowledge the High-Performance Computing Center North (HLRN) for providing the computational resources that enabled us to conduct the simulations presented in this work. <section> Funding acquisition: Holger Gerhardt Petra Knaus Georg N.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pgen.1011004",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was supported by grants from the Agence Nationale de la Recherche to J.Z. D.M. was supported by PhD fellowships from Le ministère de la Recherche et de l’Enseignement Supérieur A.P. was supported by ANR-17-CE13-0002 grant and Association pour la Recherche contre le Cancer foundation. <section> Funding acquisition: Jennifer Zanet.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pmed.1004175",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: The authors are affiliated to the Charité – Universitätsmedizin Berlin one of the institutions included in this evaluation and in the dashboard. <section> For clinical trials to generate useful and generalizable medical knowledge gain trial results should also be reported in a timely manner after trial completion per the World Health Organization (WHO) Joint Statement on Public Disclosure of Results from Clinical Trials [2]. Disclosure is a necessary but not sufficient component of transparency: Trial results should also be openly accessible and findable in line with established guidelines [2–6]. Joint statement on public disclosure of results from clinical trials.",TRUE,"<section> Funding: This work was funded by the Federal Ministry of Education and Research of Germany (BMBF 01PW18012 https://www.bmbf.de). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding acquisition: Daniel Strech.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Raw data obtained from trial registries are openly available on Zenodo at: https:// doi.org/10.5281/zenodo.7590083. Section Practice Sample (denominator) What was measured Trial registration Prospective registration DRKS (IntoValue): trials in the IntoValue cohort and registered in DRKS (interventional led by a German UMC completion date between 2009–2017 and considered as complete based on study status in the registration) with a start date in the registry Was the trial registered in the same month or in a previous month to the trial start date? DOI Digital Object Identifier; DRKS German Clinical Trials Register; EUCTR EU Clinical Trials Register; OA Open Access; TRN Trial Registration Number; UMC University Medical Center. https://doi.org/10.1371/journal.pmed.1004175.t001 responsible research who provided feedback on a prototype version [39].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.pmed.1004202",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: LB has received honoraria/has been a consultant for Lundbeck.",TRUE,"<section> Funding: The authors received no specific funding for He has received grant support from Janssen and Takeda. <section> Funding acquisition: Laurent Boyer Guillaume Fond.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pmed.1004306",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was funded under a grant from the Federal Ministry of Education and Research of Germany (Bundesministerium fuer Bildung und Forschung – BMBF) [01PW18012] awarded to DS. <section> Funding acquisition: Daniel Strech.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Overview of timepoints of outcome subsequent key trial timepoints were assessed the latest registry entry and results publication corresponding categorizations of changes https://doi.org/10.1371/journal.pmed.1004306.g001 Characteristic Population (N = 1746) Median (IQR) Median (IQR) Registration Year 2011 (2009 2013) 2011 (2009 2013) Publication Year 2015 (2013 2017) 2015 (2013 2017) Sample Size 100 (50 264) 100 (48 269) Number of trials (%) Number of trials (%) General Medicine 598 (34%) 93 (32%) Internal Medicine 333 (19%) 65 (22%) Neuroscience 121 (7%) 19 (7%) Pharmacology Toxicology and Pharmaceutics 115 (7%) 20 (7%) Surgery 103 (6%) 23 (8%) Oncology 97 (6%) 16 (5%) Psychology and Psychiatry 83 (5%) 13 (4%) Family & Reproductive Medicine 50 (3%) 12 (4%) Dentistry 25 (1%) 3 (1%) Nursing 19 (1%) 1 (0%) Health Professions 16 (1%) 4 (1%) Immunology and Microbiology 15 (1%) 1 (0%) Epidemiology and Public Health 13 (1%) 4 (1%) Basic 10 (1%) 2 (1%) Other Clinical Field 41 (2%) 3 (1%) Other Medical Field 33 (2%) 4 (1%) Other 74 (4%) 9 (3%) None/not applicable 862 (49%) 154 (53%) Medical Field Study Phase Sample (n = 292) Phase: 56 (3%) 6 (2%) Phase: 268 (15%) 38 (13%) Phase: 382 (22%) 62 (21%) Phase: 178 (10%) 32 (11%) Sponsor Industry 455 (26%) 69 (24%) Other 1291 (74%) 223 (76%) Registry ClinicalTrials.gov 1402 (80%) 240 (82%) DRKS 344 (20%) 52 (18%) Multicenter Trial Intervention No 930 (53%) 155 (53%) Yes 815 (47%) 137 (47%) Device 281 (16%) 47 (16%) Drug or Biological 631 (36%) 96 (33%) Other or not provided 834 (48%) 149 (51%) https://doi.org/10.1371/journal.pmed.1004306.t002 We revealed potential indicators for these practices with trials that were registered later trials not registered on ClinicalTrials.gov and non-industry-sponsored trials having lower odds of within-registry outcome changes.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.pntd.0010439",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was supported the German Federal Foreign office (https://www. <section> bundesregierung.de/bregen/federalgovernment/ ministries/federalforeign-office) by the GLACIER Global Centre for Health and Pandemic Prevention from the German academic exchange services (DAAD) (Grant agreement: 57592642) (https:// <section> www.daad.de/en/informationservices-forhigher- The work in Mexico was partially supported by CONACYT – FONCICYT (https://conahcyt.mx) <section> The work in Costa Rica was also supported by the FEES-CONARE (Fondo Especial para la Educación SuperiorConsejo Nacional de Rectores) B7362 project (https://www.conare.ac.cr/) (AMS). <section> Funding acquisition: Alvaro Aguilar-Setién Jan Felix Drexler.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pntd.0011270",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This study was funded by European Union’s Horizon 2020 Research and Innovation Programme under the ZIKAlliance Consortium (grant number H2020 734548 to T.J. and E.T.A. <section> and INCT-FCx to R.D.L.); the State of Pernambuco Funding Agency (Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco FACEPE; grant number BFP-0010-2.11/22 to I.F.T.V. and APQ-0346-2.09/19 to R.D.L.); the Oswaldo Cruz Foundation through the Innovation Program (INOVA grant numbers VPPCB-007-FIO-18-2-134 to R.D.L. and I.F.T.V. The content of the present study is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. <section> Funding acquisition: Cynthia Braga Roberto D.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0278325",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The German Research Foundation (grant number TR 43 to SAW and HK) funded this study. <section> In addition SAW has received funding from a <section> Funding acquisition: Helmut Kettenmann Susanne A.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0279088",TRUE,"Competing interests: The authors declare no competing interests. <section> Others considered disclosure unnecessary or simply challenging concluding that too much information might in fact be harmful confuse and overwhelm patients or even erode their trust especially in the acute setting.",TRUE,"<section> Funding: This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. Supporting quotes presented in this paper have been translated to English and are accompanied by anonymized participant identifiers. <section> Funding acquisition: Effy Vayena Dietmar Frey Alessandro Blasimme.",TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0279532",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant number FOR 1617 (subproject 3 Modelling learning SCHA 1971/1-2 to DJS) and grant number (Projektnummer) 491466077. <section> Funding acquisition: Daniel J.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0279697",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: SMM and KO are shareholder of Motognosis GmbH and named as inventors on patent applications describing perceptive visual computing for tracking of motor dysfunction. HMR and TK are employed at Motognosis GmbH. All others report no conflict of interest.",TRUE,"<section> Funding: The work was supported by the German Federal Ministry for Education and Science (BMBF IFB 01EO1401) the Else Kröner-Fresenius Foundation (2018EKES09 80766157) and the Federal Joint Committee (G-BA 01NVF19030). <section> Funding acquisition: Roman Schniepp Max Wuehr.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0279763",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The author(s) received no specific funding for this work. <section> Funding acquisition: Adrian Rosada.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0279880",TRUE,"Competing interests: The authors declare that no competing interests exist.",TRUE,"<section> Funding: The study was funded by Theracur Stiftung and Doctors for Madagascar a nongovernmental organization registered in the United Kingdom Germany and the Grand Duchy of Luxembourg. <section> The authors thank the Madagascan Ministry of Health all health officials and health care professionals who provided their support for this study. <section> Funding acquisition: Etienne Lacroze Till Bärnighausen Samuel Knauss Julius Valentin Emmrich.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0280062",TRUE,"Competing interests: ‘TB’s commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The remaining authors have declared that no competing interests",TRUE,"<section> Funding: JS is funded by the ESRC-BBSRC Soc-B Centre for Doctoral Training (ES/P000347/1). <section> LM is partially funded by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration Greater Manchester (ARC- The IMAGEN study was funded by the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated A. (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0280206",TRUE,"Competing interests: Bruno Scheller is a shareholder of InnoRa GmbH.",TRUE,"<section> Funding: the author(s) received no specific funding for <section> Funding acquisition: Bruno Scheller.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0280364",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The authors received no specific funding for",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0281387",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was funded by Freie Universität Berlin and the German Research Foundation (Deutsche Forschungsgemeinschaft): (BR grant RE 1419/8-1) (SH grant HE 7464/6-1). <section> Funding acquisition: Babette Renneberg Stephan Heinzel.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0282619",TRUE,"Competing interests: The authors declare that there are no competing interests.",TRUE,"<section> Funding: The project and all authors received funding by the German Federal Ministry of Education and Research (BMBF) through the projects PRIMA-AI (01GP2202C) and vALID (01GP1903C) https://www.gesundheitsforschung- <section> Funding acquisition: Roland Roller Aljoscha Burchardt Sebastian Möller Peter Dabrock Klemens",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0282919",TRUE,"Competing interests: No authors have competing",TRUE,"<section> Funding: This work was supported by core funding by the Max Planck Institute of Infection Biology provided by the Max Planck Gesellschaft and the Leibniz Science Campus Chronic Inflammation (www.chronischeentzuendung.org). <section> Funding acquisition: Falko Apel.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0283889",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The study was funded by German Ministry of Health (Grant number 2517MIG013). This approach is supported by resilience studies which frequently report that a focus on the Here and Now rather than a deeplyrooted pathology or past traumatic experiences is a source of resilience for migrants and refugees which helps them to cope with ongoing difficulties [3 4 12 26 49]. <section> Funding acquisition: Inge Missmahl.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered in the German Clinical Trials Register (DRKS00016867).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.pone.0284271",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: TTS: This research was supported by an unrestricted donation from Lumenate Growth ltd to Freie Universität Berlin allocated to TTS.",TRUE,"<section> Funding: The investigatorinitiated study was financially supported by a donation from Lumenate Growth Ltd to Freie Universität Berlin allocated to TTS. There was no additional external funding received for this study. <section> Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: TTS: This research was supported by an unrestricted donation from Lumenate Growth ltd to Freie Universität Berlin allocated to TTS. <section> Funding acquisition: Timo Torsten Schmidt.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0284839",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The author(s) received no specific funding for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0286304",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: No. This work was supported by the German Research Foundation [DFG] under Grant 441541975 and FOR2374. <section> Funding acquisition: Helge Giese.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0286522",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This study is funded by a donation from TrygFonden Denmark (Funding ID 129372 https:// www.tryghed.dk/). <section> Funding acquisition: Christiane Stock.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0287547",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: Georg Richtig received funding from the Austrian Science Fund FWF (W1241) and the Medical University Graz through the PhD Program Molecular Fundamentals of Inflammation (DKMOLIN).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0288366",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The author(s) received no specific funding for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0288741",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: Funding This project is part of the EDCTP2 Programme supported by the European and Developing Countries Clinical Trials Partnership (grant number TMA2019CDF-2734 – TIMELY). OW was also supported by an Imperial College London Wellcome Trust Institutional Strategic Support Fund (ISSF) (grant no RSRO_P67869). This commitment is supported by development partners such as Gavi the Vaccine Alliance which continues to make huge investments towards ensuring that all children receive all their basic vaccinations within the recommended timeframes [36]. <section> Funding acquisition: Oghenebrume Wariri Beate Kampmann.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0289203",TRUE,"Competing interests: The authors have declared that no competing interests exist. <section> Boutron I Page MJ Higgins JPT Altman DG Lundh A Hróbjartsson A et al.",TRUE,"<section> Funding: The author(s) received no specific funding for this work. <section> The subgroup analysis results compiled in Table 2 under the subheadings “Country” “Geographic zone” “Cultural value zone” and “Religious affiliation” suggest: If the religious/spiritual worldviews values and practices of the subgroup under study are supported by the cultural environment i.e. if social plausibility structures are broadly intact the R/S-SOC relationship turns out stronger.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration. PROSPERO registration number: CRD42021240380. https://www.crd.york.ac.uk/prospero/display_record.php? This meta-analysis was registered with PROSPERO on 2 April 2021 (registration number: CRD42021240380).",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.pone.0290043",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This work was supported financially by the Deutsche Forschungsgemeinschaft (DFG <section> Funding acquisition: Rachel N.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0290103",TRUE,"Competing interests: The authors have declared that no competing interests exist. isolates.",TRUE,"<section> Funding: The authors received no specific funding for",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0290318",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: TH has nothing to disclose.",TRUE,"<section> Funding: The author(s) received no specific funding for this work. His research is supported by Grants from the Innovationsfonds/ Gemeinsamer Bundesausschuss and the European Union (EFRE). UR received research funding from the German Federal Ministry of Education and Research and Novartis. BR received honoraria for consulting and lectures from Abbvie/Allergan Lilly Novartis and Teva as well as research funding from the German Research Foundation the German Migraine and Headache Society and Novartis. Funding of Research on Headache Disorders by the National Institutes of Health.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0291725",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This research was funded by the grant within the programme ""Facilitation of the ScientificResearch Activities"" of Petre Shotadze Tbilisi Medical Academy to EK which supported the provision of resources and infrastructure and the grant ""Die Role von HPV being Krebs in Georgien"" [KFZ: 01DK20029] funded by Bundesministerium",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0292180",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Roy N.",TRUE,"<section> Funding: CK received a grant for this project by the Michael J Fox Foundation (ID 15015.03 https:// www.michaeljfox.org/). Melinda Barkhuizen received a PhD scholarship from the National Research Foundation of South Africa (grant numbers 89230 and 98217) and internal funding from the research center where the study was conducted (DST/NWU Preclinical Drug Development Platform NorthWest University South Africa); Ampath Pathology laboratories in South Africa donated services in the form of drawing participant blood for DNA extractions Several neurologists in South Africa assisted the authors with identifying patients with Parkinson‘s disease and referring them to the genotyping study; the North-West University South Africa provided Ethical oversight and approval of the genotyping project. Vincenzo Bonifati received grants from Stichting Parkinson Fonds (Netherlands) and Alzheimer Nederland he received honoraria from the International Parkinson and Movement Disorder Society (MDS) for lectures and as Chair of the International Congress Scientific Program Committee (20202021) and from Elsevier Ltd. as co-Editor in Chief of the journal Parkinsonism & Related Disorders (2018-current); he is unpaid member of the Stichting Parkinson Fonds (Netherlands). Kathrin Brockmann received grants from the German Federal Ministry of Education and Research (BMBF; PDStrat; FKZ 031L0137B) and from the German Center for Neurodegenerative Diseases (DZNE) consulting fees from Abbvie Lundbeck UCB Zambon Roche and honoraria from Abbvie and UCB. Jean-Christophe Corvol received grants from Sanofi and the Michael J. Anna De Rosa received grants for ROPAD – the Rostock International Parkinson’s Disease Study sponsored by Centogene and grants from Zambon and AIFA (Italian Agency of Drug) and she is member of the advisory board at BIAL. Joaquim Ferreira received grants from Fundação MSD (Portugal) Novartis Medtronic and Abbvie and lecture fees from Lundbeck Abbvie BIAL Biogen Sunovion Pharmaceuticals ONO Affiris and Zambon payment for expert testimony from Novartis and he participates in advisory boards of Lundbeck Abbvie BIAL Affiris Sunovion Pharmaceuticals and Zambon; he is employed by CNS (Campus Néurologico Sénior) and the Medical Faculty of Lisbon. Nir Giladi received grants from the Michael J Fox Foundation The National Parkinson Foundation The European Union The Israel Science Foundation Teva NNE program Biogen Ionis Sieratzki Family Foundation and The Aufzien Academic Center in Tel-Aviv University; he holds royalties or licenses at Lysosomal Therapeutics (LTI); he received consulting fees from Sionara NeuroDerm Pharma2B Denali Neuron23 Sanofi-Genzyme Biogen and Abbvie; he received honoraria from Abbvie SanofiGenzyme and the Movement Disorder Society. <section> Nobutaka Hattori received grants from the Japan Society for the Promotion of Science (JSPS; 18H04043 21H04820 19K22603) the Japan Agency for Medical Research and Development (AMED; JP20dm0307101 JP20dm0207070 <section> Funding acquisition: Christine Klein.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0292214",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The project on which the article is based was supported by the Berlin Institute of Health (BIH) QUEST Center for Responsible Research. <section> Funding acquisition: Wolfram J.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0292222",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: (1) Thailand Science Research and Innovation (TSRI) for the Senior Research Scholar on Health Policy and System Research (Contract No. <section> Funding acquisition: Thitikorn Topothai.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0293630",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This study was funded by grant (1400.285) from Shahid Sadoughi University of Medical Sciences Yazd Iran to H.A.. <section> Funding acquisition: Hossein Azizian.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0293736",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: This research was funded by the Society for Interdisciplinary Language Acquisition Research and Child Language Disorders in the German-Speaking Countries (GISKID) to the whole D-A-CH Konsortium SES (DACH 2020/1-1; www. giskid.eu). We acknowledge support from the Open Access Publication Fund of the University of Muenster and the University Hospital Münster. <section> Funding acquisition: Carina Lüke Christina Kauschke Katrin Neumann.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0293905",TRUE,"Competing interests: BR is the principal investigator for Volatile Anaesthesia and <section> Perioperative Outcomes Related to Cancer: The VAPOR-C Study. The other authors declare no competing interests.",TRUE,"<section> Funding: This work was supported by the <section> Funding acquisition: Julia Dubowitz Bernhard Riedel Erica K.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.pone.0294693",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: The author(s) received no specific funding for this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1371/journal.pone.0295179",TRUE,"Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Breidenbach Dieng Kowalski Sibert Wesselmann are employees of the two institutions in charge of the certification system (Deutsche Krebsgesellschaft e.V. and OnkoZert GmbH).",TRUE,"<section> Funding: Funding was received from the Movember Foundation through Help for Prostate <section> Funding acquisition: Simone Wesselmann Günther Feick Ernst-Günter Carl Sebastian Dieng Christoph Kowalski.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered in the German Clinical Trials Register (ID: DRKS00010774).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1371/journal.ppat.1011167",TRUE,"Competing interests: MDdC received postdoctoral funding (2017–2019) from Pfizer and consulting fees from GSK. LO reports research grants from Pfizer and Sanofi-Pasteur through her institution. <section> All other authors declare no competing interests.",TRUE,"<section> Funding: We did not receive specific funding for this <section> Funding acquisition: Matthieu Domenech de Cellès.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1371/journal.ppat.1011657",TRUE,"Competing interests: The authors have declared that no competing interests exist.",TRUE,"<section> Funding: Parts of this work were supported by grants from NIAID-NIH CEIRS contract This work was supported by funding of Berlin Institute of Health (BIH Award Number IA56104004) Berliner Sparkassen Stiftung Medizin (Award Number 2022-055) Stiftung Charité (Award Number WIS_PRO_652) and the DFG (SPP1923 Award Number GO2153/4) to C.G. Organo-Strat to C.G. <section> Funding acquisition: Ruth Olmer Terry C.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.14218/jcth.2022.00019",TRUE,"Conflict of interest The authors have no conflict of interests related to this publication.",TRUE,"<section> Funding <section> Wrote the paper and are guarantors of this work (MR SK) conceptualized the publication (SK) provided supervision reviewed the manuscript and acquired financial support by public funding (AFHP JS).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.14309/ctg.0000000000000610",TRUE,"<section> Potential competing interests: None to report.",TRUE,"<section> Financial support: C.V.S. is supported NRW Rueckkehr Program. M.S. is supported by the DFG Emmy Noether Program (Si1983 41) ERC (Starting Grant REVERT Einstein Foundation Berlin (EC3R Consortium). K.M.S. is supported by the Federal Ministry of Education and Research (BMBF) and the Ministry of Culture and Science of the German State of North Rhine-Westphalia (MKW) under the Excellence strategy of the federal government and the Laender.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.14336/ad.2023.0920",TRUE,"Conflict of Interest <section> The authors declare no competing interests.",TRUE,"<section> Q. L. is supported by the Guangdong Basic and Applied Basic Research Foundation (2021A1515110799 and 2023A1515010144) and Shenzhen Science and Technology Program (JCYJ20220530142000001) and Shenzhen Nanshan District Science and Technology Plan Funding Program (NS2021077). G. F. is supported by the Guangdong Basic and Applied Basic Research Foundation (2020A1515110158) Guangdong Medical Research Foundation (A2021375) Shenzhen Natural Science Foundation (JCYJ20220530141613031) Shenzhen Nanshan District Science and Technology Plan Project (NS2021044) and Huazhong University of Science and Technology Union Shenzhen Hospital Foundation.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.14336/ad.2023.1022",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.14336/ad.2023.1109",TRUE,"Conflict of interest <section> The Authors declare no Competing Financial or NonFinancial Interests.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.14814/phy2.15847",TRUE,"<section> CONFLICT OF INTEREST STATEMENT The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding information <section> FUNDING INFORMATION This work was supported in part by the Dutch National Kidney Foundation (IP 11.57).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1503/jpn.220202",TRUE,"Competing interests: B.J. No other competing interests were declared.",TRUE,"Zhang is Sponsored by Shanghai Pujiang Program. J. Zhang is supported by Science and Technology Innovation 2030 Major Projects (Grant No.2021ZD0200204) Science and Technology Innovation 2030 Brain Science and Brain-Inspired ­Intelligence Project (Grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1513/annalsats.202203-195oc",TRUE,"䊏 Third although we used a 12-month time frame presepsis to detect relevant Author disclosures are available with the comorbidities our adjustment is limited to text of this article at www.atsjournals.org.",TRUE,"<section> (Received in original form March 6 2022; accepted in final form October Supported by the German Innovations Fund of the Federal Joint Committee Ann Am Thorac Soc Vol 20 No 2 pp 279–288 Feb 2023 Copyright © 2023 by the American Thoracic Society",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1513/annalsats.202207-577oc",TRUE,"<section> ancestry-deﬁned evidence that Author disclosures are available with the",TRUE,"<section> Supported by the Basic Science Research Program (NRF-2020R1I1A1A01071011) and by the Korea funded by Ministry of Health & Welfare grant HI20C0469 Author Contributions: K.S. S.K. O.J.V. B.T.K. G.M. design of the study. <section> through the National Research Foundation of Korea funded by the Ministry of Education Health Technology R&D Project through the Korea Health Industry Development Institute (S.K.).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1513/annalsats.202208-684oc",TRUE,"<section> Declaration of interests : All authors received nonfinancial support (assistance with manuscript preparation) from ArticulateScience LLC which received funding from Vertex Pharmaceuticals Incorporated.",TRUE,"<section> Declaration of interests : All authors received nonfinancial support (assistance with manuscript preparation) from ArticulateScience LLC which received funding from Vertex Pharmaceuticals Incorporated. LN received support (institutional fees for study participation) from the German Center for Lung Research Vertex and Boehringer Ingelheim; participated in the trial steering committee for CF STORM; was medical lead of the German CF registry; and was pharmacovigilance study manager of the ECFS patient registry in the past 36 months. MVK received support (institutional fees for study participation) from the German Center for Lung Research Vertex and Allergopharma; payment or honoraria from Allergopharma GmbH Sanofi Aventis GmbH Infectopharm GmbH Novartis Pharma GmbH and <section> Sources of Support: This study was supported by Vertex Pharmaceuticals Incorporated. <section> received funding from Vertex Pharmaceuticals Incorporated.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,"<section> Clinical trial registered with ClinicalTrials.gov (NCT03625466).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.1513/annalsats.202211-915st",TRUE,"Disclosures: C.C.W.H. served as a consultant for Ono Pharmaceutical; served as QI continues to evolve with advances in a consultant (spouse/partner) for Allena Pharmaceuticals Alnylam Applied hardware and software capabilities.",TRUE,"E.A.H. served on a photon counting advisory committee for Siemens Healthineers; founder and shareholder of VIDA Diagnostics; received research support from NIH. B.M.S. received research support from research support from NIH-NHLBI.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/cclm-2022-1001",TRUE,"Competing interests: All authors have no conﬂict of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1515/crpm-2023-0006",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1515/iss-2023-0012",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/jpm-2021-0604",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/jpm-2022-0547",TRUE,"Competing interests: The author(s) state(s) no conﬂict of interest.",TRUE,"Katja Schneider’s work is supported in part by a grant from the German Research Council [DFG Project No.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/jpm-2022-0550",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/jpm-2023-0099",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1515/jpm-2023-0170",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1515/jpm-2023-0221",TRUE,"Competing interests: The authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1515/jpm-2023-0403",TRUE,"Competing interests: Authors state no conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1523/eneuro.0215-22.2023",TRUE,"The authors declare no competing financial interests.",TRUE,"P.R. was supported by H2020 Research and Innovation Action Grants Human Brain Project SGA2 785907 SGA3 945539 and VirtualBrainCloud 826421; the European Innovation Council Grant PHRASE 101058240; Horizon Grants AISN 101057655 and EBRAINS-Prep 101079717; ERC 683049 and JPND ERA PerMed PatternCog 2522FSB904; Berlin Institute of Health & Foundation Charité Johanna Quandt Excellence Initiative German Research Foundation SFB 1436 (Project ID 425899996); SFB 1315 (Project ID 327654276); SFB (Project ID 178316478); SFB-TRR 295 (Project ID 424778381); and SPP Computational Connectomics RI 2073/6-1 RI 2073/10-2 and RI 2073/9-1. <section> was supported by the German Federal Ministry of Education and Research Grant BMBF 01GQ1905 the Human Brain Project SGA3 945539 the German Research Foundation SFB 1451 (Project ID 431549029); and GRK 2150 (Project 269953372).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1523/eneuro.0408-22.2023",TRUE,"The authors declare no competing financial interests.",TRUE,"<section> This investigatorinitiated study was partly supported by donations from private citizens. We acknowledge support by the Open Access Publication Fund of the Freie Universität Berlin.",FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1523/jneurosci.1416-22.2023",TRUE,"<section> All other authors declare no competing financial interests.",TRUE,"J.M. was supported by the German Research Foundation Fellowship MI 2158/1-1 and is participant in the Berlin Institute of Health (BIH) Charité (Junior; Digital) Clinician Scientist Program funded by the Charité–Universitätsmedizin Berlin and the BIH at Charité. The Max Planck UCL Centre for Computational Psychiatry and Ageing Research is a joint initiative supported by the Max Planck Society and University College London. The Wellcome Centre for Human Neuroimaging is supported by core funding from the Wellcome Trust (203147/Z/16/Z). T.U.H. is supported by a Sir Henry Dale Fellowship (211155/Z/18/Z; 211155/Z/18/B; 224051/Z/21) from Wellcome & Royal Society; the Jacobs Foundation Grant 2017-1261-04; the Medical Research Foundation; the 2018 NARSAD Young Investigator Grant 27023 from the Brain & Behavior Research Foundation; and a Philip Leverhulme Prize from the Leverhulme Trust (PLP-2021-040). This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (Grant Agreement No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1523/jneurosci.2330-22.2023",FALSE,"",TRUE,"<section> The Lifebrain project is funded by the EU Horizon 2020 Grant Agreement Number 732592 (Lifebrain). In addition the different substudies are supported by different sources. The Center for Lifespan Changes in Brain and Cognition (LCBC) is supported by European Research Council Grant Agreements 283634 and 725025 (to A.M.F.) and 313440 (to K.B.W.) as well as the Norwegian Research Council (to A.M.F. K.B.W.) and The National Association for Public Health’s Dementia Research Program Norway (A.M.F.). Betula is supported by a scholar grant from the Knut and Alice Wallenberg (KAW) Foundation (L.N.). Barcelona is partially supported by a Spanish Ministry of Economy and Competitiveness (MINECO) grant and ICREA Academia 2019 grants to D.B.-F. [grant number PSI2015-64227-R (AEI/ FEDER UE)] and by the Walnuts and Healthy Aging Study (http://www.clinicaltrials.gov; Grant NCT01634841) funded Work on the Whitehall II Imaging Substudy was mainly funded by the Lifelong Health and Wellbeing Program Grant G1001354 from the United Kingdom Medical Research Council (“Predicting MRI Abnormalities with Longitudinal Data of the Whitehall II Substudy”; to K.P.E.). The Wellcome Center for Integrative Neuroimaging is supported by core funding from the Wellcome Trust Award 203139/Z/16/Z.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.15252/embj.2022112202",TRUE,"Disclosure and competing interests statement BDH is founder of EicOsis Human Health developing sEH inhibitors as human pharmaceuticals.",TRUE,"This work was supported by grants from the Wellcome Trust (Investigator award 103830/Z/14/Z and 220784/ Z/20/Z to AKS Investigator award 212240/Z/18/Z to FP PhD studentship award",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.15252/embj.2022112351",TRUE,"Disclosure and competing interests statement The authors declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements This research was supported by the German Research Foundation (DFG) Emmy Noether Programme SCHW1851/1-1 (D.S.) by an EMBO Advanced grant aALTF-1650 (D.S.) and by an iNEXT grant 5419 (D.S.).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.15252/embr.202255363",TRUE,"Disclosure and competing interests statement The authors declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements This work was supported by French-German Collaboration for Joint Projects of the French Agence Nationale de Recherche (ANR) and the Deutsche Forschungsgemeinschaft (DFG) to BC RM (15-CE15-0024-01) and JT (Tu220/ BC and RM were supported by CNRS (Centre National de la Recherche Scientifique) Inserm and Soci \u0002 et \u0002 e Française de Myologie GJ by AFM-Telethon. JPT was supported by FDG Collaborative Research Centers CRC1149 Trauma Project-ID <section> 251293561 and GC was supported by Baustein Grant from the Medical Faculty of Ulm University and ProtrainU grant from Ulm University.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.15252/embr.202256702",TRUE,"<section> 11) The journal requires a statement specifying whether or not authors have competing interests (defined as all potential or actual interests that could be perceived to influence the presentation or interpretation of an article). In case of competing interests this must be specified in your disclosure statement. <section> Please correct the conflict of interest subheading to ""DISCLOSURE AND COMPETING INTERESTS STATEMENT"" <section> Please correct the conflict of interest subheading to ""DISCLOSURE AND COMPETING INTERESTS",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.15252/emmm.202216225",TRUE,"Disclosure statement and competing interests The authors declare that they have no conflict of interest.",TRUE,"<section> Acknowledgements This work was supported by the Duchenne Parent Project NL (2018) to F.A.I and the Joint International Research Unit for Chemical and Biomolecular Studies on the Microbiome and its Impact on Metabolic Health and Nutrition (JIRU-MicroMeNu) which is supported by the Sentinelle Nord project of Universit \u0001 e Laval in turn supported by the Canada First programme of the Federal Tri-Agency of Canada (to F.A.I. C.S. and V.D.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.15252/emmm.202318144",TRUE,"Disclosure and competing interests statement SDV is patent co-holder of GB1519841.9 (filed as international application N° PCT/EP2016/078547) initiated by KU Leuven (LRD) and ULB (TTO) in mutual agreement: “Treatment of central nervous tumors” (Patent N° WO2017089392A1 CA3005992-A1 AU2016358718-A1). The patent relates to intranasal delivery of nanoparticles encapsulating siRNA for gene silencing of galectin-1 as treatment of nervous brain tumors such as GBM. The other authors declare that they have no competing interests or disclosures.",TRUE,"<section> Acknowledgements This work was supported by FWO (Fonds voor Wetenschappelijk Onderzoek Vlaanderen/Flemish Fund for Scientific Research) grants (G0B3722N G0I1118N and S001221N; FDS BC MD GS) a KOTK (Kom op tegen Kanker/Stand against Cancer) grant (KOTK/2019/11892/1; FDS) KU Leuven grants (IDN/20/021 and CELSA/20/022; FDS) Fondation Leducq Transatlantic Network of Excellence Grant LF was supported by an FWO PhD fellowship strategic basic research (1S49718N & 1S49720N). MV is supported by an FWO PhD fellowship fundamental research (11L0822N). BD and SDV are supported by a KOTK grant (KOTK/2018/11509/2). The computational resources and services used in this work were provided by the VSC (Vlaams Supercomputer Centrum/ Flemish Supercomputer Center) funded by FWO and the Flemish Government (BB DL).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.15252/msb.202211147",TRUE,"Disclosure and competing interests statement The authors declare that they have no conflict of interest.",TRUE,"Work in JPJ’s laboratory was funded by a Multiscale Omics grant from the Berlin Institute of Health (BIH) by Helmholtz AI grant SC-SLAM-ATAC (ZT-I-PF-5-54) and by the DZHK (Berlin partner site project 81Z0100112). AN was supported by a PhD fellowship from Studienstiftung des deutschen Volkes.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1530/eor-23-0072",TRUE,"The authors declare no conflict of interest relevant to this work.",TRUE,"SO TGR SR and KPG all received logistic help and staff support for organisation of the consensus conference from EFORT and support from the Medical Faculty at the University of Dresden for infrastructure (room and audiovisual cost staff support) for the organisation of the consensus conference (unrestricted educational grants). <section> Funding statement The work reported in the manuscript did not receive any specific grant from any funding agency in the public commercial or notfor-profit sector.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.15326/jc.2022.0383",TRUE,"Declaration of Interests <section> Authors EP TS AP BS CG FS and SEg have nothing disclose.",TRUE,"<section> Funding Support: <section> This study was supported in part by grants from CapNetz Stiftung EP TS AP and R-HH provided a formal analysis of the Funding acquisition was provided by R-HH and MW.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.15698/mic2023.02.791",TRUE,"The authors have declared no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1590/1678-4685-gmb-2023-0117",TRUE,"Conflict of Interest The authors report no conflicts of interest.",TRUE,"<section> Acknowledgements The study was financed by the National Coordination for Improvement of Higher Education Personnel (CAPES-Brazil) FIPE-HCPA and the National Council of Technological and Scientific Development (CNPq-Brazil).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1590/1807-3107bor-2023.vol37.0046",TRUE,"Declaration of Interests: The authors health conditions certify that they have no commercial or <section> or dropping out. <section> associative interest that represents a conflict of interest in connection with the manuscript.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1681/asn.0000000000000248",TRUE,"<section> DISCLOSURES <section> C. Arnott is supported by an NHMRC/MRFF Priority Fellowship and a NSW Health EMC Grant.",TRUE,"<section> C. Arnott is supported by an NHMRC/MRFF Priority Fellowship and a NSW Health EMC Grant. R. Correa-Rotter also reports Consultancy: Dimerix; Research Funding: Astra Zeneca Baxter GSK and Novo Nordisk; Honoraria: Amgen Astra Zeneca Bayer Boehringer Ingelheim Janssen and Sanoﬁ; Advisory or Leadership Role: Astra Zeneca Bayer GSK Membership Steering Committee of DAPA-CKD Membership Steering Committee FINEREAL National Leader ASCEND study National Leader FLOW study Novo Nordisk Editorial Board Nefrologia Latinoamericana Revista de Investigación Clinica American Journal of Kidney Diseases Frontiers in <section> Fletcher is supported by a PhD studentship from the Health Data Research UKThe Alan Turing Institute Wellcome Trust Program in Health Data Science. Jardine is supported by a Medical Research Future Fund Next Generation Clinical Researchers Program Career Development Fellowship; is responsible for research projects that have received unrestricted funding from Amgen Baxter Eli Lilly and Merck Sharpe Dohme; serves on a Steering Committee sponsored by CSL; has served on advisory boards sponsored by Akebia Baxter Boehringer Ingelheim and Vifor; and has spoken at scientiﬁc meetings sponsored by Janssen; with any consultancy honoraria or travel support paid to her institution. Jardine also reports the following: Research Funding: CSL and Dimerix with all payments to institution; Honoraria: AstraZeneca Bayer Boehringer Ingelheim Janssen MSD Occuryx and Vifor and directs honoraria to clinical research programs; <section> Funding: Bayer; Honoraria: AstraZeneca Bayer Boehringer and Ingelheim Cornerstone Medical Education Janssen the Limbic and Medscape; Advisory or Leadership Role: AstraZeneca Bayer and Boehringer and Ingelheim; and V. Perkovic also reports Consultancy: AstraZeneca Bayer Boehringer Ingelheim Chinook Eli Lilly Gilead GlaxoSmithKline Janssen Mitsubishi Tanabe Mundipharma Novartis Novo Nordisk Otsuka Travere Tricida and UptoDate; Ownership Interest: George Clinical; Research Funding: AstraZeneca Bayer Chinook Gilead GlaxoSmithKline Janssen Novartis Novo Nordisk Otsuka Travere and Tricida; Honoraria: AstraZeneca Bayer Boehringer Ingelheim Chinook Eli Lilly Gilead GlaxoSmithKline Janssen Mitsubishi Tanabe Mundipharma Novartis Novo Nordisk Otsuka Travere Tricida and UptoDate. M. <section> Vaduganathan also reports Consultancy: American Regent Amgen AstraZeneca Baxter Healthcare Bayer AG Boehringer Ingelheim Chiesi Cytokinetics Lexicon Pharmaceuticals Novartis Novo Nordisk Pharmacosmos Relypsa Roche Diagnostics Sanoﬁ and Tricog Health; Research Funding: Galmed Impulse Dynamics and Occlutech; and Speakers Bureau: AstraZeneca Cytokinetics Lexicon Pharmaceuticals Novartis and Roche Diagnostics. <section> Research Funding: AHA Apple Inc Bayer California Institute Regenerative Medicine Eidos Ferring Gilead Google (Verily) Idorsia Johnson & Johnson Luitpold Novartis PAC-12 Precordior Saniﬁt; and Honoraria: Inova Intermountain Health Medscape Mount Sinai CSL. C. Arnott reports Research Funding: Abbott Vascular; Honoraria: Amgen; Astra Zeneca Novo Nordisk; and Advisory or Leadership Role: Novo Nordisk. <section> Consultancy: Amgen Bayer Astra-Zeneca Boehringer-Ingelheim Novartis Novo Nordisk CinCor Calliditas Otsuka Medscape; Research Funding: NIH; Honoraria: Amgen Bayer Astra-Zeneca Boehringer-Ingelheim Novartis Novo Nordisk CinCor Calliditas Otsuka Medscape; and Advisory or Leadership Role: Amgen Bayer Astra-Zeneca Boehringer-Ingelheim Novartis Novo Nordisk CinCor Calliditas Otsuka Medscape. <section> FUNDING",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1681/asn.2022010050",TRUE,"Disclosures: F.H. is a co-founder and S.A.B. member of Goldfinch Biopharma Inc.",TRUE,"F. Hildebrandt also reports Research Funding: NIH; Honoraria: E. Banne reports Consultancy: Pronto Diagnostics Israel; and Research Funding: Rhythm Pharmaceuticals. <section> Funding: We also thank the National Institutes of Health (5R01DK076683-13 (FH) F32 DK122766 (ACO) 5K12HD052896-13 and 1K08DK125768-01A1 (AJM) the Deutsche Forschungsgemeinschaft (403877094 (VK) 404527522 (FB) 442070894 (SSe) 394046635 (TS KK) the Else-Kröner Fresenius Stiftung (Else-Kröner Memorial Grant (VK) the American Society of Nephrology (Carl W. <section> Georg Rosenberger: Data curation Funding acquisition Supervision Writing – review & editing <section> Klaus-Dieter Fischer: Funding acquisition Resources Supervision Writing – review & editing <section> Soeren Lienkamp: Data curation Formal analysis Funding acquisition Investigation Supervision <section> Mirjam Zegers: Data curation Formal analysis Funding acquisition Visualization Writing – review <section> Friedhelm Hildebrandt: Conceptualization Funding acquisition Investigation Project administration Resources Supervision Writing – review & editing F. Hildebrandt also reports Research Funding: NIH; Honoraria: Sanofi; Patents or Royalties: NPHP1; and Advisory or Leadership Role: Goldfinch-Bio. <section> Consultancy: Pronto Diagnostics Israel; and Research Funding: Rhythm Pharmaceuticals.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.1681/asn.2022010076",TRUE,"<section> DISCLOSURES <section> K. Grand reports other interests or relationships: the Swiss National Center of Competence in Research (NCCR) Kidney Control of Homeostasis (Kidney.CH).",TRUE,"<section> FUNDING <section> This work was supported by the Swiss National Science Foundation (SNF) by the NCCR Kidney.CH and project (310030_189102/1) to S.S. Lienkamp received funding from the European Union’s Horizon 2020 research and innovation program under Marie SkłodowskaCurie grant No. Kaminski was supported by the Emmy Noether Programme (grant no. KA5060/1-1) of the German Research Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.1684/ejd.2023.4578",TRUE,"Conflict of interest: Sergio Vañó-Galván has received consulting fees from Eli Lilly and Company and Pfizer.",TRUE,"<section> Funding: the study analysis and all costs relating to the publication of this manuscript were funded by Eli Lilly and Company.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.17879/freeneuropathology-2023-5156",TRUE,"Disclosure <section> M. Snuderl D.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.18413/rrpharmacology.9.10047",TRUE,"Conflict of interest <section> improvement reduction of free-radical generation and stimulation of cell proliferation. The authors have no conflict of interests to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.21037/acs-2022-urats-27",TRUE,"Conflicts of Interest: The authors have no conflicts of interest to",TRUE,"<section> Funding: None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.21037/jgo-23-842",TRUE,"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups. com/article/view/10.21037/jgo-23-842/coif). The authors have no conflicts of interest to declare.",TRUE,"<section> Funding: This research was funded by President Foundation of Baiyun Branch of Nanfang Hospital (No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.21037/qims-22-955",TRUE,"Conflicts of Interest: All authors have completed the ICMJE Imaging 2019;20:31-9.",TRUE,"HR reports that this work was supported by the National Natural Science Foundation of China-Youth Foundation (No. 82102058) and the Natural Science Research of <section> Funding: This work was supported by the National Natural by Contrast-Enhanced Steady State Free Precession Science Foundation of China-Youth Foundation (No. and T2-Weighted Short Tau Inversion Recovery 82102058 to Hong Ran) and the Natural Science Research Magnetic Resonance Imaging.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.21053/ceo.2023.00808",FALSE,"",TRUE,"<section> This study has been funded 2020 Research and Innovation Number 848261-H2020-SC1-BHC-2018-2020 has received funds from (Grant RH-0150-2020).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2106/jbjs.23.00092",TRUE,"Disclosure: The Disclosure of Potential Conﬂicts of Interest forms are provided with the online version of the article (http://links.lww.com/JBJS/H587).",TRUE,"<section> Source of Funding No external funding was received for this study. <insert> Appendix Supporting material provided by the authors is posted with the online version of this article as a data supplement at jbjs.org (http://links.lww.com//JBJS/H588). n Vincent J.",FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2106/jbjs.oa.22.00101",TRUE,"Disclosure: The Disclosure of Potential Conﬂicts of Interest forms are provided A462).",TRUE,"<section> Source of Funding Dr. <section> This study was supported by grant number P482 from the nonproﬁt Deutsche Arthrose-Hilfe e.V.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/cmar.s400430",TRUE,"Disclosure <section> Prof. Dr Lars Bullinger reports personal fees from AbbVie Bristol-Myers Squibb Celgene Daiichi Sankyo Gilead Hexal Janssen Jazz Pharmaceuticals Menarini Novartis Pfizer; grants from Bayer Jazz Pharmaceuticals outside the submitted work. Prof. Dr Kai-Uwe Eckardt reports personal fees from Akebia Astra Zeneka Evotec Fresenius Otsuka Sanofi; grants from Vifor Amgen Bayer outside the submitted work. The authors report no other conflicts of interest in this",TRUE,"<section> Acknowledgments The project was enabled by generous funding by the Clinical Fellow Program Stiftung Charité (AF).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/copd.s408845",TRUE,"Disclosure <section> The authors have no conflicts of interest to declare for this work.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/copd.s420137",TRUE,"Disclosure <section> The authors report no conflicts of interest for this work.",TRUE,"<section> Funding <section> This study was funded by the Else Kröner-Fresenius-Stiftung (2019_HA178).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/hmer.s326468",TRUE,"Disclosure <section> FT’s lab has received research funding from Allergan Bristol-Myers Squibb Gilead and Inventiva. FT has received honoraria for consulting or lectures from Astra Zeneca Gilead AbbVie BMS Boehringer Madrigal Intercept Falk Ionis Inventiva Merz Pfizer Alnylam NGM CSL Behring Novo Nordisk Novartis. The other authors report no <section> conflicts of interest in this work.",TRUE,"F.T. is supported by the German Research Foundation (DFG Ta434/8-1 SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium BMBF Immun Avatar consortium).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/idr.s402313",TRUE,"Disclosure <section> We declare no conflicts of interest associated with this publication.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/jaa.s418658",TRUE,"Disclosure <section> C.N. received honoraria and advisory board fees from GSK Sanofi AstraZeneca and Novartis. D.K. reports speaker and/or advisory fees from AstraZeneca Boehringer Chiesi Berlin-Chemie GSK Novartis and Sanofi. K.C.B. and O.S. have no relevant competing interests to disclose. S.H. is a GSK employee and shareholder. K.M. reports speaker and/or advisory fees from Astrazeneca GSK Novartis Sanofi. D.S. received honoraria for lectures and/or consultancy from AstraZeneca Bayer Berlin-Chemie BMBF Boehringer Chiesi DFG GSK Janssen MSD Novartis Sanofi Pfizer. F.S. is affiliated with IQVIA Commercial GmbH & Co and reports grants from GSK. J.C.V. has lectured for and received honoraria from AstraZeneca Avontec Bayer Bencard Bionorica Boehringer-Ingelheim Chiesi Essex/Schering-Plough GSK JanssenCilag Leti MEDA Merck MSD Mundipharma Novartis Nycomed/Altana Pfizer Revotar Sandoz-Hexal Stallergens TEVA UCB/Schwarz-Pharma and Zydus/Cadila and has participated in advisory boards for Avontec BoehringerIngelheim Chiesi Essex/Schering-Plough GSK Janssen-Cilag MEDA MSD Mundipharma Novartis Regeneron Revotar Roche Sanofi-Aventis Sandoz-Hexal TEVA and UCB/Schwarz-Pharma and has received research grants from Deutsche Forschungsgesellschaft Land Mecklenburg-Vorpommern GSK and MSD and is a full-time employee of the Universitätsmedizin Rostock. The authors report no other conflicts of interest in this work.",TRUE,"<section> 45 The study was supported by an expert committee of pulmonologists from private practices and hospitals. The study was funded by",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/jhc.s347944",TRUE,"Disclosure <section> AL is supported by the Digital Clinician Scientist Program of the Berlin Institute of Health. FT reports grants from Gilead BMS and Inventiva outside the submitted work. The authors report no other conflicts of interest in this work.",TRUE,"<section> AL is supported by the Digital Clinician Scientist Program of the Berlin Institute of Health.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/jhc.s391537",TRUE,"Disclosure <section> CAH and LJS are fellows of the BIH Charité (Junior Digital) Clinician Scientist Program funded by the Charité– Universitätsmedizin Berlin and the Berlin Institute of Health. Outside the submitted work LJS receives research grants from the Berliner Krebsgesellschaft e.V. the Collaborative Research Center (CRC) 1340 “Matrix in Vision” funded by the Deutsche Forschungsgemeinschaft (DFG) and Guerbet. BG reports honoraria and travel support in the last 10 years from Parexel/CALYX C.R. BARD/BD SIRTex Medical St. Jude Medical COOK AngioDynamics Pharmcept Guerbet Ewimed Terumo Roche Merck 3M Beacon Bioscience/ICON IPSEN Bayer Pfizer Eisai MSD and INARI. The author reports no other conflicts of interest in this work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/jmdh.s425406",TRUE,"Disclosure <section> The authors report no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2147/ndt.s379703",TRUE,"Disclosure <section> Professor Catherine Sarret reports personal fees from EGETIS during the conduct of the study; personal fees from NOVARTIS ARGENX ORCHARD and LUPIN outside the submitted work. The authors report no other conflicts of interest",TRUE,"Baseline characteristics: SLC16A2 mutation sex: male age: 16 years Interventions Oral PTU (8 mg/kg per day) for 5 months Oral PTU (8 mg/kg/d) + LT4 (2 µg/kg/d) for 1 month Oral PTU (8 mg/kg/d) + LT4 (3 µg/kg/d) for 1 month Oral PTU (8 mg/kg/d) + LT4 (4 µg/kg/d) for 2 months Outcomes Laboratory tests: TSH fT4 fT3 TG SHBG Somatic data: BMI Metabolism: resting energy expenditure Cardiac diagnostics: heart rate Neurological diagnostics: Imaging: thyroid volume Notes Funding/sponsor: n.r. <section> Notes Three children had received PTU + LT4 before being Funding/sponsor: n.r. Outcomes Neurological diagnostics: ● clinical evaluation of extrapyramidal movement Notes Funding/sponsor: n.r. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/ndt.s392351",TRUE,"Disclosure The authors report no other conflicts of interest",TRUE,"<section> Funding <section> This study was funded by Laboratorios Farmacéuticos Rovi S.A. He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2147/opth.s395989",TRUE,"Disclosure <section> LMB and DC are founders of the self-monitoring tests described in this paper. LMB’s company Medignition is shareholder of Oculocare Medical the company that developed the Alleye platform. DC reports App4eyes co-owner <section> and has a patent US 10588506 B2 DE102015215557A1 issued to German Patent and Trademark Office a patent DE10 <section> 2015 215557 issued to European Patent Office a patent PCT/EP2016/069156) issued to United States Patent and Trademark Office. KH reports Bayer provided the AllEyeApp Licences for this study; contract research advisory board fees from Novartis and Roche; advisory board fees from Bayer and Allergan/AbbVie outside the submitted <section> work. The authors report no other conflicts of interest in this work.",TRUE,"<section> Funding No further funding was provided to this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered at ClinicalTrial.gov (NCT 04112524).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.2186/jpr.jpr_d_22_00126",TRUE,"Conflict of interest statement <section> The authors have no commercial or financial relationships with tested product manufacturers that may pose a conflict of interest or potential conflicts of interest.",TRUE,"<section> This research was funded by the Guangdong Basic and Applied Basic Research Foundation in China (2021A1515111140 and 2021B1515120059) and the Science Research Cultivation Program of the Hospital of Stomatology at Southern Medical University (PY2021003).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.21873/anticanres.16317",TRUE,"Conflicts of Interest <section> Elena Ioana Braicu MD PhD receives research funding from: Bayer Roche Diagnostics Tesaro GSK AstraZeneca and personal fees from: AstraZeneca Clovis GSK Tesaro EISAI RochePharma Roche Diagnostics.",TRUE,"Sehouli receives Research Funding from: Roche Pharma AstraZeneca Bayer Clovis GlaxoSmith Lilly Tesaro honorary from: Tesaro GlaxoSmith PharmaMar AstraZeneca Clovis Bayer Roche PharmaMar Vifor Pharma",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.21873/anticanres.16573",TRUE,"Conflicts of Interest <section> All the Authors declare that there are no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.21873/invivo.13109",TRUE,"Conflicts of Interest <section> The Authors declare no conflicts of interest in relation to this study.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.21873/invivo.13345",TRUE,"Conflicts of Interest <section> All the Authors declare that there are no conflicts of interest in relation to this study.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2196/38959",TRUE,"Conflicts of Interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/39155",TRUE,"Conflicts of Interest <section> FP has grants or contracts with Novartis Lilly and Union Chimique Belge (UCB); consulting fees from AbbVie Celgene Janssen Novartis and UCB; payment or honoraria from Applied Molecular Genetics Inc AbbVie Bristol Myers Squibb Celgene Janssen Merck Sharp & Dohme (MSD) Novartis Pfizer Roche and UCB; support for attending meetings and travel from Celgene Janssen Pfizer and Novartis; participation in the Data Safety Monitoring Board or Advisory Board at AbbVie Celgene Janssen Novartis and UCB; receipt of study materials from Aidian Oy.",TRUE,"This study was funded by Assessment of Spondyloarthritis International Society the",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/39929",TRUE,"Conflicts of Interest None to declare.",TRUE,"Funding for this scoping review was supported by funding from the Federal Ministry for Economic Affairs and Climate Action “Zentrales Innovationsprogramm Mittelstand” Program for smalland mediumsized enterprises under the grant number 16KN0732.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/40958",TRUE,"Conflicts of Interest None declared.",TRUE,"<section> The impact of COVID-19 on COVID-19 symptoms in genderdiverse individuals has not been well captured; however the more than 5-fold increase in the likelihood of genderdiverse users reporting prior contact with an individual who tested positive for COVID-19 as well as the higher odds of reporting symptoms observed in this study is supported by the notion that genderdiverse individuals are more vulnerable to COVID-19 which extends to the areas of increased barriers to COVID-19 transmission prevention strategies decreased physical and mental health and barriers to health services [37].",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/41089",TRUE,"Conflicts of Interest <section> ST is vice chair of HL7 Deutschland e.V. AD is the chairwoman of the Supervisory Board of Dr. Jäschke AG a member of the Interop Council and has received lecture/consulting fees from ValueBasedManagedCare GmbH Janssen-Cilag GmbH Getinge Deutschland GmbH EIT Health Germany GmbH Face-to-face GmbH Siemens Aktiengesellschaft gematik GmbH Medical Congresses & Events e.K. and Pfizer GmbH. The remaining authors declare no conflicts of interest.",TRUE,"This work was supported by the BIH Gender Equality Fund.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/41177",TRUE,"Conflicts of Interest <section> CS received a public grant from the Federal Ministry of Education and Research (BMBF grant titled NUM-Ceosys).",TRUE,"<section> The COVID-19 Evidence Ecosystem project was funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung; grant number 01KX2021). The CODEX+ project was funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung; grant number 01KX2121).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/41179",TRUE,"Conflicts of Interest None declared.",TRUE,"The project described in this publication was funded by the Innovation Committee of the Federal Joint Committee (“Innovationsausschuss beim Gemeinsamen Bundesausschuss”) under the funding code VSF1_2017-053.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2196/42258",FALSE,"",TRUE,"<section> This study was conducted in the context of the MOBILE study (Mobility in Old Age by Integrating Health Care and Personal Network Resources in Older Adults Living in Rural Areas) funded by the German Federal Ministry of Education and Research (grant number 01GY1803) an interventional study focusing on promoting outof-home mobility including GPS-based mobility outcomes. <section> This study is funded by the German Federal Ministry of Education and Research (grant agreement number 1GY1803). We thank the Joint Transnational Call 2017 project launched by the Joint Programming Initiative “More Years Better Lives” (JPI MYBL) which is supported by Horizon2020 the EU Framework for Research and Innovation (grant agreement number 643850). We acknowledge support by the German Research Foundation and the Open Access Publication Fund of Technische Universität Berlin.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/42289",TRUE,"Conflicts of Interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/42905",TRUE,"ZP GB and CK have no conflicts of interest directly related to this manuscript.",TRUE,"This study was funded by Novartis Pharmaceuticals GA in accordance with the Good Publication Practice (GPP3) guidelines.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: Not applicable",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.2196/43036",TRUE,"Conflicts of Interest None declared.",TRUE,"This study is supported by internal research funds from Charité–Universitätsmedizin Berlin (SL).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: German Clinical Trials Register DRKS00027116;",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.2196/43110",TRUE,"Conflicts of Interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2196/43847",FALSE,"",TRUE,"<section> This work was partially funded by the German Federal Ministry of Education and Research under Grant 16SV8559.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/44002",FALSE,"",TRUE,"This manuscript was supported by the “Outcomes of Patients’ Evidence with Novel Doit-Yourself Artificial Pancreas” (OPEN) team and we are thankful for our colleagues’ combined efforts. <section> This project has received funding from the European Commission’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie Action Research and Innovation Staff Exchange (RISE) grant agreement number 823902 the SPOKES Wellcome Trust Funded Translational Partnership program and the Berlin Institute of Health (BIH) Digital Clinician Scientist program. J Schipp is funded by a joint PhD scholarship from Deakin University and the University of Copenhagen. J Speight and CH are supported by the core funding from the Australian Centre for Behavioral Research in Diabetes derived from the collaboration between Diabetes Victoria and Deakin University.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/45496",TRUE,"Conflicts of Interest ST is the vice chair of Health Level Seven International (HL7) Germany. The other authors declare that they have no competing interests.",TRUE,"<section> Acknowledgments The NAPKON (“Nationales Pandemie Kohorten Netz”; German National Pandemic Cohort Network) project is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin [NUM]) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung [BMBF]; grant number 01KX2021).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/45665",TRUE,"Conflicts of Interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2196/45764",TRUE,"<section> SME CMJLG XHC RMvD CST and FM-R declare no competing interests. AL JC DK and KC declare no competing financial interests but they are current employees at the Singapore Government Health Promotion Board.",TRUE,"<section> This study was funded by the Health Promotion Board of the Singapore Government.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: ClinicalTrials.gov NCT05154227; https://clinicaltrials.gov/ct2/show/NCT05154227",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.2196/46231",FALSE,"",TRUE,"<section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation. <section> MK HN DF FB and MLS previously received funding from the German Federal Ministry of Health. DF received funding from the German Ministry of Education and Research the European Commission Horizon Europe Program and the Einstein Foundation.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/46336",TRUE,"Conflicts of Interest <section> The authors are employees of the independent nonprofit foundation Stiftung Gesundheitswissen and were involved in the development and evaluation of the web-based intervention.",TRUE,"<section> This research was funded by the independent nonprofit foundation Stiftung Gesundheitswissen.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/46518",TRUE,"Conflicts of Interest <section> RK has received advisory honoraria from JoyVentures Herzlia and Israel.",TRUE,"<section> This project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement Numbers 777084 (DynaMORE project) and 101016127 (RESPOND) Deutsche Forschungsgemeinschaft (DFG Grant CRC 1193 subprojects B01 C01 C04 Z03) BMBF NUM EViPan 01KX2021 and the State of Rhineland-Palatinate Germany (MARP program DRZ program Leibniz Institute for Resilience Research).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2196/46980",TRUE,"Conflicts of Interest None declared.",TRUE,"The authors acknowledge financial support from the Else Kröner-Fresenius-Stiftung within the Heidelberg Graduate School of Global Health; the German Research Foundation (Deutsche Forschungsgemeinschaft) within the Open Access Publishing funding program by the Baden-Württemberg Ministry of Science Research and the Arts and by Ruprecht-Karls-Universität Heidelberg.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2214/ajr.22.28077",TRUE,"Chapiro contributed equally ing features were to this work. el combined through 6 years The authors declare that there are no endpoint was disclosures relevant to the subject matter of <section> Version of record: Nov 23 2022 The author declares that there are no disclosures relevant to the subject matter of this",TRUE,"<section> models predicted model) 0.71–0.85 Supported by the NIH/National Cancer higher for the Institute (grant R01CA206180) and the Rolf but the mean W.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2215/cjn.0000000000000223",TRUE,"Disclosures <section> S.D.",TRUE,"<section> Funding <section> This work was supported by Vifor Pharma.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The trial was registered with ClinicalTrials.gov (NCT02937454; October 18 2016) and approved by the institutional review boards of all 121 study sites.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.2217/fmb-2022-0280",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2217/fnl-2022-0014",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2319/011722-55.1",FALSE,"",TRUE,"This work was supported with materials by",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2319/013022-90.1",FALSE,"",TRUE,"This study was supported by the Spanish Association of Orthodontics without any involvement in the study’s design analysis or interpretation.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2319/062523-440.1",TRUE,"<section> None of the authors has any other potential conﬂicts of interest related to this work.",TRUE,"<section> This project was funded by Magellan Medical Technology Consultants (Minneapolis Minn) and 3M (St Paul Minn).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2337/dc22-1584",TRUE,"Pharmacoepidemiol Drug Duality of Interest.",TRUE,"<section> com/sites/default/ﬁles/2022-02/2021-01%20 Funding. This research was funded by a Project CPRD%20Aurum%20Release%20Notes.pdf Grant from the Canadian Institutes of Health Re12. <section> supported by a Chercheur-Boursier Senior Award",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2337/dc22-2257",TRUE,"Chambers MA Mecham C Arreola EV Sinha Duality of Interest.",TRUE,"Funding. The DPV Initiative is supported through the German Federal Ministry for Education and Research within the German Centre for Diabetes Research (82DZD14E03 and 82DZD14E1G). This manuscript is also part of a project (www.imisophia.eu) that has received funding from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement 875534.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2337/dc23-0710",TRUE,"<section> Duality of Interest. T.B. received grants from the Romanian Ministry of European Funds the Romanian Government and the European Union.",TRUE,"<section> Funding. This study was funded by the European Union FP7 Health Framework Program 2007–2013 grant EC-GA 603266 to M.D. T.B. received grants from the Romanian Ministry of European Funds the Romanian Government and the European Union. K.F.K. received grants from AP Møller og hustru; Chastine McKinney Møllers Fond; Danish Heart Foundation; the Danish Agency for Science Technology and Innovation by The Danish Council for Strategic Research; and the Health Insurance Company Denmark and an unrestricted research grant from Canon Medical Corporation and GE Healthcare. E.Z. received grants from Deutsche Forschungsgemeinschaft. M.D. received grant support from the G.D. E.Z. C.Ke R R.V. M.Fr. M.I.-S. F.P. J.K. R.F. German Research Foundation; received funding S.S. C.B. L.S. B.R. N.R. C.Ku. K.S.H. J.M.-N. from the Berlin University Alliance and the Digital B.M. P.E.S. I.B. C.O. F.X.V. L.Z. M.H. A.J. F.A. Health Accelerator of the Berlin Institute of M.W. N.M. I.L. E.T. M.L. M.Kr. M.S. M.Ma. Health; is an editor for Springer Nature; receives D.K. G.F. M.P. V.G.R. T.D. C.D. M.Me. M.Fi. other from Handson Cardiac CT Course (https:// M.Bou. C.Kr. R.A. S.K. B.G.d.B. A.R. M.K\u0001 a. www.ctkurs.de); receives funding through instituJ.D.H. I.R. S.R. H.C.C. L.G. L.L. R.Ho. A.E.N. tional research agreements with Siemens General R.Ha. S.F. M.Mo. L.M.S.-H. K.N. H.D. M.R. Electric Philips and Canon; holds a patent on J.D. M.E. M.Bos. P.M. J.D.D. and M.D. contribfractal analysis of perfusion imaging (jointly with uted to the data collection and review and inFlorian Michallek PCT/EP2016/071551 and USPTO terpretation of the ﬁndings provided critical 2021 10991109 approved); was a European Socirevisions of the manuscript for important intelety of Radiology research chair (2019–2022); and lectual content and gave ﬁnal approval of the is publications chair (2022–2025) for the European ﬁnal version of the manuscript to be published.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2340/actadv.v102.2939",TRUE,"Conflicts of interest: The authors declare that IC is a full–time physician practicing at the Internal Medicine and Clinical Immunology Department at Hôtel-Dieu de France hospital Beirut. Otherwise the authors have no other conflicts of interest or financial support from pharmaceutical companies to declare in relation to this work.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2340/actadv.v103.11592",TRUE,"Conflicts of interest: MMe is or recently was a speaker and/or advisor for and/or has received research funding from AbbVie Amgen ArgenX AstraZeneca Bayer Celldex Celgene Escient Galderma Grünenthal GSK Menlo Novartis Pfizer Pharvaris Regeneron Roche Sanofi-Aventis Teva Third Harmonic Bio and Viforpharma.",TRUE,"<section> This study was funded by Kamedi.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2340/actadv.v103.11947",TRUE,"The authors have no conflicts of interest to declare.",TRUE,"<section> This study received infrastructural and financial support from the Deutsche Forschungsgemeinschaft (DFG) by the Collaborative Research Center (CRC) 1526 Pathomechanisms of Antibodymediated Autoimmunity (PANTAU) grant no. 454193335.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2340/actadv.v103.4426",TRUE,"Conflict of interest. JS is Co-PI of TREATgermany and reports institutional grants for investigator-initiated research from the German GBA the BMG BMBF EU Federal State of Saxony Novartis Sanofi ALK and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi Lilly and ALK. <section> KS received honoraria as investigator and/or received speakers’ honoraria and/or received grants and/or has been an advisor for the following companies: AbbVie Almirall-Hermal Amgen Biogen Idec Boehringer-Ingelheim Bristol-Myers Squibb Celgene Eli-Lilly Galderma Janssen LEO-Pharma Merck Serono Morphosys Novartis Pfizer Regeneron Sanofi a und UCB Pharma. LH is research associate of TREATgermany which is an academic investigator-initiated clinical registry that is financially supported AbbVie GmbH & Co. KG Galderma S.A. LEO Pharma GmbH Lilly Deutschland GmbH Pfizer Inc. and Sanofi-Aventis Deutschland GmbH. SA received lecture and/or consultancy fees from Novartis LEO Pharma Amgen Lilly Sanofi Beiersdorf Janssen UCB and AbbVie. EW received consultancy fees from Sanofi/Genzyme and participated in clinical trials of Galderma Ltd and TREVI Ltd. The other authors have no conflicts of interests",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2340/actadv.v103.4859",TRUE,"Conflicts of interest: SF: received personal fees from Recordati Kyowa Kirin and Takeda Pharamceuticals (speakers honoraria) as well as institutional grants from NeraCare SkylineDX and BioNTech outside the submitted work. SG: Mavig provided a Vivascope microscope for the duration of a separate study. MM: Mavig provided a Vivascope microscope for the duration of this study. In the past MM had performed studies with previous models of Vivascopes (Mavig) and Histolog TM Scanner (SamanTree Medical SA). TE: declares speakers and advisory board honoraria from Almirall Hermal Merck Sharp & Dome Immunocore Novartis Sanofi Genzyme Roche Pierre Fabre and BMS. GM AKM and HO have no conflicts of interest to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.23736/s1973-9087.22.07529-3",TRUE,"Conflicts of interest.—The authors certify that there is no conflict of interest with Funding.—This study received financial support from the Open Access Publication Foundation (DFG).",TRUE,"<section> Conflicts of interest.—The authors certify that there is no conflict of interest with Funding.—This study received financial support from the Open Access Publication Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.23736/s1973-9087.23.08031-0",FALSE,"",TRUE,"<section> Funding <section> This work was supported by a project grant and equipment by STIMIT AG Biel Switzerland.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.23868/gc568125",TRUE,"Competing interests. The authors declare that they have no competing interests.",TRUE,"<section> Funding source. This work was supported by Russian Science Foundation (project 22-14-00232).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2478/raon-2023-0020",TRUE,"Disclosure: The authors` institution operates a Linac Unity (Elekta Sweden). The Department of Radiation Oncology Tübingen receives financial and technical support by Elekta Philips Siemens Dr. Sennewald Medizintechnik Kaiku Health TheraPanacea PTW and ITV in the context of research cooperation’s. The aforementioned entities had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results. The authors declare no further conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.26508/lsa.202201411",TRUE,"<section> The authors declare that they have no conﬂict of interest.",TRUE,"This work was supported by the German Federal Ministry of Education and Research (grant numbers 031A427A 031A427B 031A427C 031A427D and 01ZZ1802H) the ERA-CVD (SICVALVES) the CRC1470 and the European Commission under the H2020 Program (Grant No. I Baczko was supported by the Ministry of Human Capacities Hungary (20391-3/2018/ FEKUSTRAT). This work was also supported by the DFG (German Research Foundation) Grant SFB-1470 project Z03 (to T Kuehne) and B05 (to",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.26508/lsa.202301969",FALSE,"",TRUE,"<section> Grant support to D Batlle from NIH (1R21 AI166940-01) and a gift from the Joseph and Bessie Feinberg Foundation. L Hassler and C Cianfarini were supported by the Biomedical Education Program during a part of their stay in Chicago. D Batlle has received consulting fees from Advicenne unrelated to this work and received unrelated research support from a grant from AstraZeneca; G Randall reports consultancy agreements with Optikira.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.26641/2307-0404.2023.2.283427",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2807/1560-7917.es.2023.28.32.2200718",TRUE,"Conflict of interest None declared.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2807/1560-7917.es.2023.28.48.2300258",TRUE,"Conflict of interest None declared.",TRUE,"<section> Funding statement <section> The project was funded by the BMBF-ZooSeq (grant no. <section> 01KI1905C) and the BMBF VekInhibit (grant no. 01KI2026C).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2807/1560-7917.es.2023.28.9.2200535",TRUE,"Conflict of interest None declared.",TRUE,"<section> The validity of our analysis is supported by confirming various wellknown risk factors for SSI occurrence such as increased ASA scores [30] prolonged duration of surgery [31] high wound contamination class [30] male sex [32] and season (i.e. procedures not being conducted during winter) [33].",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2807/1560-7917.es.2023.28.9.2200618",TRUE,"Conflict of interest",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.29228/jrp.331",TRUE,"Conflict of interest statement: The author declares there <section> are no competing interests",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2967/jnumed.122.264112",TRUE,"DISCLOSURE “Mitteldeutsche grants Sick Research “Artiﬁcial Zurich. was ACKNOWLEDGMENTS C2 providing Martin H€ ullner received from GE Healthcare from the Alfred and Annemarie von Legacy for Translational and Clinical Cardiac and Oncologic and from the Clinical Research Priority Program (CRRP) Intelligence in Oncologic Imaging” of the University of No other potential conﬂict of interest relevant to this article reported.",TRUE,"<section> Our study was supported by grants from the foundation Kinderkrebsforschung.”",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.2967/jnumed.122.264850",TRUE,"<section> DISCLOSURE <section> No other potential conﬂict of interest relevant to this article was reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2967/jnumed.123.265642",TRUE,"<section> DISCLOSURE <section> This research project was funded by the “Deutsche Forschungsgemeinschaft” (DFG German Research Foundation) (SFB1340/1 2018 SFB1315 and SFB295RETUNE). The PET/MRI scanner was cofunded by the “Deutsche Forschungsgemeinschaft” (INST 335/543-1 FUGG 2015). No other potential conﬂict of interest relevant to this article was reported.",TRUE,"<section> This research project was funded by the “Deutsche Forschungsgemeinschaft” (DFG German Research Foundation) (SFB1340/1 2018 SFB1315 and SFB295RETUNE).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.2967/jnumed.123.266114",TRUE,"<section> No potential conﬂict of interest relevant to this article was reported.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.31083/j.rcm2404098",TRUE,"Conflict of Interest <section> The authors declare no conflict of interest.",TRUE,"<section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.31083/j.rcm2406169",TRUE,"Conflict of Interest The authors declare no conflict of interest.",TRUE,"<section> Funding <section> This research is funded through a Blue Skies research grant from the National Research Foundation to Sebastian Skatulla (Grant Numbers 104839 and 105858).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3171/2022.10.jns221523",TRUE,"Disclosures <section> The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.",TRUE,"This work was supported by the National Science Centre Poland (grant no. UMO-2019/35/B/ST7/00500). Czosnyka is supported by the National Institute for Health Research and MIC (Biomedical Research Centre Cambridge United Kingdom).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3174/ajnr.a7840",TRUE,"Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3201/eid2903.221328",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3201/eid2905.221646",FALSE,"",TRUE,"<section> E.L-G. B.M. D.J.S. and S.T. are supported by the NIH NIAID Centers of Excellence for Influenza Research and Response (CEIRR) contract 75N93021C00014 as part of the SAVE program; B.M. is funded in part by the German Ministry of research under project codes DZIF MolTrax and PREPARED; M.J. is funded in part with federal funds from the NIH National Institute of Drug Abuse under contract 1U01DA053893-01; D.O’C. is funded by Centers for Disease Control and Prevention (CDC) contract 75D30121C11060 CDC contract 75D30122C15355 and State of Wisconsin Department of Health Services project 435100-A22-ELCProjE-01; W.M.F. B.K. J.T. and H.Y. are funded by the Laboratory Directed Research and Development program of LANL under project 20220660ER and through the SAVE program NIH AAI22018-001; A.M.N. R.H.S. M.S. Z.S.W. and Y.Z. are supported with federal funds from the NIH NIAID Bacterial and Viral Bioinformatics Resource Center contract HHS75N93019C00076; E.G. was supported in part by the Division of Intramural Research of the NIH NIAID; B.L.D. and M.R. are supported by a cooperative agreement between The Henry M Jackson Foundation for the Advancement of Military Medicine and the US Department of the Army (W81XWH-18-2-0040); J.E.L. is supported by CDC BAA 75D30120C09605 and U19AI110818; A.A A.G. L.J. and M.S. are funded by HHSN272201700060C; H.v.B. A.S.G.-R. and Z.K. are supported by the NIH NIAID CEIRR contract 75N93021C00014 and NIAID contract HHSN272201400008C; L.C.-L. and T.H. are funded in part by the NIH NIAID CEIRR under contract 75N9302100016 St Jude Children’s Research Hospital; M.S. is supported by NIH NIAID Contract 75N93019C00076.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3201/eid2912.231123",FALSE,"",TRUE,"<section> This study was funded by grants from the German Ministry of Research (BMBF ZooSeq 01KI1905C) by DZIF (German Center for Infection research) infrastructural funds and by the DURABLE project. The DURABLE project has been cofunded by the European Union under the EU4Health Programme (EU4H) project no. 101102733. Parts of this work were supported by grants from the Centers of Excellence for Influenza Research and Surveillance National Institute for Allergies and Infectious Diseases National Institutef of Health (NIAID-NIH CEIRS) (contract HHSN272201400008C to T.C.J.). V.M.C. is supported by the BMBF through the project VARIPath (01KI2021) and by the Berlin Institute of Health (BIH) Charité Clinician Scientist program.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3205/dgkh000440",TRUE,"Competing interests <section> The authors declare that they have no competing interests.",TRUE,"<section> Funding source <section> This study was partly funded by the EU Aspire Award 2013 given to Simone Scheithauer (a 47500– € grant) by Pfizer.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3233/adr-230027",TRUE,"<section> CONFLICTS OF INTEREST <section> SJT participated in scientific advisory boards of [7] <section> Roche Pharma AG Biogen Grifols and Eisai and is member of the independent data safety and monitoring board of the Study ENVISION (Biogen). [8]",TRUE,"<section> The DELCODE study (Study-ID: BN012) was disseminated supported and conducted by the Deutsches Zenat trum für Neurodegenerative Erkrankungen (DZNE). <section> FUNDING studies/delcode. The DELCODE study was supported in respect to the MR imaging by Max Delbrück Center for Molecular Medicine in the Helmholtz the Association (MDC) Berlin; Center for Cognitive Research <section> Part of the data collection and sharing for this was funded by the Alzheimer’s Disease NeuInitiative (ADNI) (National Institutes of Grant U01 AG024904) and DOD ADNI of Defense award number W81XWHADNI is funded by the National Institute Aging the National Institute of Biomedical and Bioengineering and through genercontributions from the following: Alzheimer’s Alzheimer’s Drug Discovery FoundaAraclon Biotech; BioClinica Inc. <section> The work was supported by a grant to SJT within CureDem funding of the Federal Ministry of (BMBF) grant number 01KX2130.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3233/jad-220464",TRUE,"<section> DISCLOSURES <section> Ersin Ersoezlue Boris-Stephan Rauchmann Maia Tatò Julia Utecht Carolin Kurz Jan Häckert Selim Guersel Lena Burow Gabriele Koller Sophia Stöcklein Daniel Keeser Boris Papazov Marie Totzke Tommaso Ballarini Frederic Brosseron Katharina Buerger Peter Dechent Laura Dobisch Michael Ewers Klaus Fliessbach Wenzel Glanz John Dylan Haynes Michael T Heneka Daniel Janowitz Ingo Kilimann Luca Kleineidam Christoph Laske Franziska Maier Matthias H Munk Oliver Peters osef PrillerAlfredo Ramirez Sandra Röske Nina Roy Klaus Scheffler Anja Schneider Björn H Schott Annika Spottke Eike Jakob Spruth Stefan Teipel Chantal Unterfeld Michael Wagner Xiao Wang Jens Wiltfang Steffen Wolfsgruber Renat Yakupov and Emrah Düzel report no disclosures.",TRUE,"<section> The DZNE-Longitudinal Cognitive Impairment and Dementia Study (DELCODE) study was funded by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen DZNE) reference number BN012.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3233/jad-230708",TRUE,"The authors have no conflict of interest to report. [13]",TRUE,"<section> FUNDING <section> This project has received funding from the European Union’s Horizon 2020 Research and Innovation program under grant agreement No 779237. [11]",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3233/jnd-221525",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/jnd-221577",TRUE,"<section> CONFLICTS OF INTEREST <section> ities <section> Becker M.: owner of a commercial entitiy (Labor",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/jnd-221600",TRUE,"<section> CONFLICTS OF INTEREST AND C. <section> DISCLOSURES",TRUE,"<section> SOURCES OF SUPPORT",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: DRKS00012699",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3233/shti230058",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/shti230071",FALSE,"",TRUE,"The aim of this paper is to describe the measures taken and lessons learned to reconcile these conflicts during the first funding phase and how these aspects are addressed in the NUM clinical epidemiology and study platform (NUKLEUS) established within the second funding period as a permanent collaborative research infrastructure. <section> Acknowledgement: The work presented is funded by the German Ministry of Research and Education (NUM – 01KX2121).",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/shti230082",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/shti230241",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/shti230757",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/thc-220138",TRUE,"The authors declare that they have no conflict of interests.",TRUE,"<section> Funding <section> The authors report no funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3233/wor-220145",TRUE,"The authors declare that they have no conflict of interest.",TRUE,"<section> Funding <section> The authors report no funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.32604/chd.2023.031075",TRUE,"<section> The authors declare that they have no conﬂicts of interest to report regarding the present",TRUE,"<section> Funding Statement: This work was supported by Deutsche Herzstiftung e.V.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.32614/rj-2023-029",FALSE,"",TRUE,"This work was supported by the German Research Foundation project DFG KO 4680/4-1.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3324/haematol.2021.280005",TRUE,"Disclosures No conflicts of interest to disclose.",TRUE,"The support of the technical staff of the Institutes of Human Genetics in Kiel and Ulm as well as the former masters student Ivan Potreba are gratefully acknowledged. <section> Funding <section> This study was supported by the German Ministry of Science and Education (BMBF) in the framework of the ICGC MMML-Seq (01KU1002A-J) and ICGC DE-Mining (01KU1505G and 01KU1505E) projects. This work was also supported by the BMBF-funded Heidelberg Center for Human Bioinformatics (HD-HuB) within the German Network for Bioinformatics Infrastructure (de.NBI) (#031A537A #031A537C). Former grant support for MMML by the Deutsche Krebshilfe (2003-2011) is gratefully acknowledged. CL was supported by an Alexander von Humboldt Foundation postdoctoral fellowship. RSi and MG received funding from the European Union's Horizon 2020 research and innovation program under grant agreement n.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3324/haematol.2021.280027",TRUE,"Disclosures <section> CT is chief executive officer and co-owner of AgenDix GmbH a company that performs molecular diagnostics. <section> The other authors declare that they have no competing financial interests.",TRUE,"<section> Funding <section> This work was supported by a MeDDrive grant number 60499 ‘Machine learning for advanced integrated diagnostics in hematological malignancies’ to JMM from the Technical University Dresden.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3324/haematol.2022.280995",TRUE,"Disclosures UK received reimbursement for advisory board function speaker honorary and travel support from Takeda for content unrelated to this manuscript. All other authors report no conflicts of interest.",TRUE,"<section> Disclosures UK received reimbursement for advisory board function speaker honorary and travel support from Takeda for content unrelated to this manuscript. <section> Funding <section> This work was supported by Deutsche Forschungsgemeinschaft (DFG SFB824/C3 and SFB1335/P3 to UK; grant KE 222/10-1 to UK and SM DFG grants MU 1764/7-1 (#494535244) and MU 1764/7-1 to to SM) Deutsche Krebshilfe (grants 70114425 and 70114724 to UK grant 70114823 to SM) Stiftung Charité (to UK) and Wilhelm-Sander Foundation (2017.048.2 to UK).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3324/haematol.2022.281820",TRUE,"Disclosures No conflicts of interest to disclose.",TRUE,"Academic clinical trials are usually funded by public agencies and no funds are available for the longterm followup. <section> Funding <section> This retrospective analysis was funded by the Jose Carreras <section> The clinical trials were funded by Deutsche Krebshilfe and BMBF.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3324/haematol.2022.281996",TRUE,"Disclosures No conflicts of interest to disclose.",TRUE,"<section> Funding <section> This work was supported by grants from the excellence cluster iFIT (EXC 2180) [Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) im Rahmen der Exzellenzstrategie des Bundes und der Länder – WXC 2180 – 390900677] from the Dieter Schwarz Stiftung Neckarsulm and from the Reinhold-Beitlich Stiftung Tuebingen to PL; from the Foerderverein and from the Stiftung fuer krebskranke Kinder Tuebingen e.V. to PL and to ATH.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3324/haematol.2022.282127",TRUE,"Disclosures No conflicts of interest to disclose.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3324/haematol.2022.282524",TRUE,"Disclosures <section> AS reports Novartis honoraria and research funding; Sobi and Takeka honoraria; Platelet Disorder Support Association (PDSA) grant recipient.",TRUE,"<section> Funding <section> Funding was receieved from the Platelet Disease Support Association (PDSA) Ohio USA; Stiftung hämatologische Forschung Basel CH; Stiftung zur Förderung medizinischer und biologischer Forschung Arlesheim CH. The PARC registry received financial support from the Intercontinental Cooperative ITP Study Group (ICIS). The CARMEN registry received support from the French National Society of Internal Medicine Toulouse Referral Center for Autoimmune Cytopenias Toulouse University Hospital Amgen CSL Behring Grifols and Novartis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3346/jkms.2023.38.e333",TRUE,"Disclosure <section> All authors have completed the ICMJE uniform The frequency of retractions disclosure form at www.icmje.org/disclosuredebates about whether this of-interest/ and declare Marco Solmi received Other reasons conflict of interest’ ‘image duplication’ ‘no permission for policy’ ‘property or legal concerns’ ‘citation manipulation’ and Moylan and Kowalczuk 44 and Campos-Varela and Ruanoa certain reason for retraction as misconduct honest error concerns honest error and unreliable or not reproducible et al. 49 used the expression ‘inability to reproduce’ for cases data fabrication/falsification by the US ORI and distinguished error.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/falgy.2023.1152927",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/falgy.2023.1186353",FALSE,"",TRUE,"<section> Funding <section> SA was supported by the EAACI Fellowship Award of the European Academy of Allergy and Clinical Immunology. The study was supported by an unrestricted grant from EUROIMMUN (grant no 118583).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/falgy.2023.1228495",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/falgy.2023.1236977",FALSE,"",TRUE,"<section> Funding <section> HPW: Is recipient of consultancy/lecture fees or unrestricted research grants from Sanoﬁ/Regeneron Novartis GSK Medtronic and Viatris. BV: Is recipient of consultancy/lecture fees or unrestricted research grants from Sanoﬁ/Regeneron Novartis GSK AZ ALK Abello and BORK-npc. HLG: Has received grant funding participated in advisory boards and given lectures at meetings supported by Amgen AstraZeneca Boehringer Ingelheim Chiesi Circassia Hoffmann la Roche GlaxoSmithKline Novartis Theravance Evelo Biosciences Sanoﬁ and Teva; he has received grants from MedImmune Novartis UK Roche/ Genentech Inc and Glaxo Smith Kline Amgen Genentech/Hoffman la Roche Astra Zeneca MedImmune Glaxo Smith Kline Aerocrine and Vitalograph; he has received sponsorship for attending international scientiﬁc meetings from AstraZeneca Boehringer Ingelheim Chiesi GSK and Napp Pharmaceuticals; he has also taken part in asthma clinical trials sponsored by AstraZeneca Boehringer Ingelheim Hoffmann la Roche and GlaxoSmithKline for which his institution received remuneration; he is the Academic Lead for the Medical Research Council Stratiﬁed Medicine UK Consortium in Severe Asthma which involves industrial partnerships with a number of pharmaceutical companies including Amgen AstraZeneca Boehringer Ingelheim GlaxoSmithKline Hoffmann la Roche and Janssen.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/falgy.2023.1244012",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationship that could be construed as a potential conﬂict of interest.",TRUE,"<section> This study and medical writing support was funded by Viatris.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical Trial Registration: ClinicalTrials.gov identiﬁer: NCT00712920.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/falgy.2023.1267663",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/falgy.2023.1272851",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Financial support for the roundtable and for publication was provided by Novartis Pharma AG (Basel Switzerland).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fbioe.2022.1042711",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fbioe.2023.1075357",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was supported by the German Research Foundation (DFG) (TR 1657/1-1 DA 1786/5-1 SFB 1444 (427826188)) the Federal Ministry of Education and Research (workHEALTH (01EC 1905D) and the OrthoLoadClub.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fbioe.2023.1091899",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was funded by the Max Planck Society and by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. This work was funded by the Max Planck Society and by the European Union’s Horizon 2020 research and innovation programme under grant agreement No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fbioe.2023.1140734",TRUE,"<section> The authors declare that the research was conducted in the absence of any other commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The authors declare that this study received funding from Pﬁzer. <section> The authors declare that this study received funding from Pﬁzer.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fbioe.2023.1169385",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fbioe.2023.1221314",FALSE,"",TRUE,"<section> Funding <section> The authors gratefully acknowledge funding by the German Research Foundation (DFG Grant KN 377/8-1) and support by the Charité Foundation in form of the Berlin Institute of Health visiting professorship (Contract No.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fbioe.2023.1236949",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fbioe.2023.1284091",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding This study was supported by funding from the Deutsche Forschungsgemeinschaft DFG SFB1444/CRC1444 (Directed Cellular Self-Organisation to Advance Bone Regeneration https:// <section> boneregeneration.charite.de/en/ Project-ID 427826188) DFG project TR 1657/1-1 DA 1786/5-1 and the OrthoLoad Club.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcdhc.2023.1270028",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"BH: Funding acquisition Writing – review & editing. WG: Funding acquisition Writing – review & editing. YD: Funding acquisition Supervision Writing – review & editing. LY: Funding acquisition Supervision Writing – review <section> Funding This research was funded by Guangdong Engineering Technology Research Center 507204531040; Guangzhou Development Zone Entrepreneurship Leading Talent Project 2017-L153; Guangzhou Entrepreneurship Leading Team 202009030005; Introduction Plan for Hingh End Foreign Experts by the Ministry of Science and Technology G2022199014L; Science and Technology Projects in Projects in Guangzhou 202201010196.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcell.2022.1081644",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was funded by the ReSHAPE project from the European Union’s Horizion 2020 research and innovation programme under grant agreement No 825392.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcell.2023.1091047",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the German Ministry for Education and Research through the Medical Informatics Initiative (01ZZ2001 to SL and RE). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcell.2023.1104709",FALSE,"",TRUE,"<section> Funding <section> This work was supported by grants from the German Research Foundation (DFG; project no. 249509554/ FOR 2165 to CHB GND This work was supported by a grant from the Leibniz Association (ID K398/2021 to TJS).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcell.2023.1122998",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> CO is funded by the DZHK (German Center for Cardiovascular Research; 81Z2100502). The human study is funded by the German Science Foundation (DFG RA 3340/31 OP-R).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcell.2023.1183793",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> MG was supported by the Austrian Science Fund (FWF): P 33554 and P 35118 and by the Medical University Graz through the PhD program MolMed.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcell.2023.1229584",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Studies were funded in part by grants from the Novo Nordisk Foundation (NNF18OC0033928) to TW.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcimb.2022.1047281",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Supported by the data from this and other European studies this practice should be reconsidered and blood donors of LA origin should actively be offered screening for infection with T. cruzi. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcimb.2023.1201394",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the German Research foundation DFG to AS (SCHA 1582/7-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcimb.2023.1224356",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcimb.2023.1324668",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2022.1073814",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by National Institutes of Health Moreover this study was funded by the grant no. NU22-02-00418 by the Ministry of Health of <section> The authors would like to acknowledge the Mayo Clinic Biobank supported by the Mayo Clinic Center for",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2022.1089968",TRUE,"Conflict of interest <section> E-LB was employed by revFLect GmbH. GF and ML are the CEOs of revFLect GmbH. OJ is CEO of Hypertension Care UG which offers the Hypertonie.App. OJ and MM are the founder of the Hypertonie.App. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This project was supported by a grant of the Federal Joint Committee (Gemeinsamer Bundesausschuss G-BA) in Germany from May 2022 to April 2025 (Innovation fund grant number 01VSF21042).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: identifier DRKS00029761.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fcvm.2022.1091768",TRUE,"Conflict of interest <section> SK reports grants and other support by the DZHK (German Center for Cardiovascular Research) Partner Site Berlin Philips Healthcare BioVentrix Berlin Chemie Merck/Bayer Novartis AstraZeneca Siemens and Myocardial Solutions outside of the submitted work. SK was also on the advisory board for Merck/Bayer BioVentrix and Myocardial <section> Solutions. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential <section> conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the German Centre Our research was also supported by an unrestricted research grant from Philips Healthcare.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2022.981333",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the Faculty of Health Sciences Brandenburg (Fakultät für Gesundheitswissenschaften Brandenburg FGW).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2022.984326",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1025957",TRUE,"<section> The remaining author declares that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This paper was supported by ﬁnancial assistance from Vifor Pharma.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1038337",TRUE,"Conflict of interest <section> SK reported grants and other support by the Philips Healthcare BioVentrix Berlin-Chemie Merck/Bayer Novartis Astra Zeneca Siemens and Myocardial Solutions outside of the submitted work. <section> SK was also on the advisory board for Merck/Bayer BioVentrix and Myocardial Solutions. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the German Centre for Cardiovascular Research (DZHK) funded by the German Federal Ministry of Education and Research the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)— CRC-1470—B06 and the Charité – Universitätsmedizin Berlin Germany as well as the German Heart Institute Berlin Germany and Myocardial Solutions. This research was also supported by an unrestricted research grant from Philips Healthcare.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1070450",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the DZHK (German Center for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1071643",TRUE,"Conflict of interest <section> The authors received research support from Siemens Healthineers (JS-M SW and MM) and Circle Cardiovascular Imaging (JS-M and SW) research grants from Circle Cardiovascular Imaging (MM) and Cryolife Inc (MM) and performed activities in consulting Circle Cardiovascular Imaging (MM). <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> The authors received research support from Siemens Healthineers (JS-M SW and MM) and Circle Cardiovascular Imaging (JS-M and SW) research grants from Circle Cardiovascular Imaging (MM) and Cryolife Inc (MM) and performed activities in consulting Circle Cardiovascular Imaging (MM).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered at ISRCTN (ISRCTN17935517).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fcvm.2023.1102502",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was partially funded by the BMBF project “Berlin Institute for the Foundations of Learning and Data” (grant number 01IS18037E) and by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) SFB-1470 B06. AH received funding from Berta-OttensteinProgramme for Advanced Clinician Scientists Medical Faculty University of Freiburg Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1117419",TRUE,"The other authors have no conﬂicts of interests to <section> declare. <section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)— SFB-1470 to C.T. S.S. was further supported by the German Ministry of Research and Education (DZHK FKZ 81Z0600205).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1118499",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1129348",TRUE,"Conflict of interest <section> DF is on the advisory board of Cytokinetics. BH is inventor on patents that use RNA for diagnosis of myocarditis. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential <section> conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the National Institutes of Health (NIH) R01 HL164520 R21 AI145356 R21 AI152318 and R21 AI154927 to DF; American Heart Association 20TPA35490415 to DF; NIH grants TL1 TR002380 to DB and DF; R21 AI163302 to KB; R01 HL135165 to LC; the For Elyse Foundation to DF; and the Mayo Clinic Center for Regenerative Medicine to DF. Consideration of Sex as a Biological Variable in NIH-funded Research.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1132680",FALSE,"",TRUE,"<section> Funding <section> This research was partially supported by the Scientiﬁc Grant Agency of the Ministry of Education Science Research and Sport of the Slovak Republic grant (VEGA 1/0563/21).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1133373",FALSE,"",TRUE,"<section> Funding <section> This publication was supported by the National Center for Research and Development CRACoV-HHS project (Model of multispecialist hospital and nonhospital care for patients with SARSCoV-2 infection) through the initiative “Support for specialist hospitals in ﬁghting the spread of SARSCoV-2 infection and in treating COVID-19” (contract number SZPITALE-JEDNOIMIENNE/18/2020).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1136935",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The work presented here is largely built on the “ArtiCardio” project which was funded by the German Federal Ministry of Education and Research (BMBF) grant number 13GW0208B.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered at ClinicalTrials.gov (NCT04600739) and was approved by the internal review board (EA2/174/19). <section> The study was registered at ClinicalTrials.gov (NCT04600739) and was approved by the internal review board (EA2/174/19).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fcvm.2023.1138356",TRUE,"Conflict of interest <section> NP AP and TB advised SOMNOmedics on blood pressure and received travel support.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1147166",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1157571",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the Faculty of Health Sciences Brandenburg (Fakultät für Gesundheitswissenschaften Brandenburg FGW).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1163525",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1177998",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany’s Excellence Strategy within the framework of Munich Cluster for Systems Neurology (EXC 2145 SyNergy ID 390857198). <section> Andreas Harloff was funded by the Berta-OttensteinProgramme for Advanced Clinician Scientists Medical Faculty University of Freiburg and DFG grant HA5399/5-1. Christoph Strecker was funded by DFG grant HA5399/5-1. The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science Research and Art and the Albert Ludwigs University Freiburg under the Open Access Publishing funding programme.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1189920",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Funding acquisition: FB KS and UL. IM received grants from Pﬁzer Pharmaceuticals Abbott Laboratories and Edwards Lifesciences as well as lecture fees from Sanoﬁ.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1193156",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1193209",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work has been funded under the European Union’s Horizon 2020 research and innovation program under grant agreement N \u0004 101017578 (SIMCor: In-Silico testing and validation",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1213696",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1224578",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The study in the context of which this case was also investigated was funded by a project grant from the Swiss National Science Foundation to BH (money follows researcher program).",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1225057",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The study in which the presented case was examined was funded by a project grant from the Swiss National Science Foundation issued to BH.",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1231000",FALSE,"",TRUE,"<section> Funding <section> This work was supported by Sanoﬁ. FK has received research funding grants from the German Federal Ministry of Education and Research and grants from the Federal Ministry of Economic Affairs and Energy for conducting research and clinical trials in remote patient management. SSM is supported by the American Heart Association (20SFRN35380046 and COVID19811000) PCORI (ME-2019C1-15328) NIH (P01 HL108800) the Aetna Foundation the David and June Trone Family Foundation the Pollin Digital Innovation Fund the PJ Schafer Cardiovascular Research Fund Sandra and Larry Small CASCADE FH Apple Google and Amgen.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1232327",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1242215",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1242805",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1256112",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"FB: Conceptualization Data curation Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – original draft Writing – review & editing. <section> Funding <section> This study was supported by the Tiroler Wissenschaftsförderung (Innsbruck Austria) (TWF-2017-1-5 GZ: UNI-0404-2104).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was approved by the local ethics committees and registered on https://clinicaltrials.gov/ (NCT02448485).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fcvm.2023.1256752",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1258890",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1272945",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1276321",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1280899",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by Ottovon-Guericke University Chair of Medical System Technology Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1294505",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1299192",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fcvm.2023.1323760",FALSE,"",TRUE,"SF: Conceptualization Funding acquisition Writing – review & editing. JF: Conceptualization Data curation Funding acquisition Methodology Supervision Writing – original draft Writing – review & editing. <section> Funding <section> This study was supported by the Deutsche Forschungsgemeinschaft [FI 965/9-1 FI 965/10-1 (to JF)] and the German Center for Cardiovascular Research partner site Greifswald [DZHK 81Z5400153 (to JF)].",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fcvm.2023.1352592",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"FK: Conceptualization Data curation Funding acquisition Investigation Methodology Project administration Resources Supervision Writing – review & editing. HD: Conceptualization Data curation Funding acquisition Investigation Methodology Project administration Resources Supervision Visualization Writing – review & editing. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fdgth.2023.1039171",TRUE,"The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding acquisition: FvW EF; Project administration: JM AS OC TK FMR LTC; Supervision: TK FMR LTC; Writing—original draft: OC JM AA AS TK; Writing—review & editing: all authors. <section> Funding The research is supported by the National Research Foundation Prime Minister’s Ofﬁce Singapore under its Campus for Research Excellence and Technological Enterprise program.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The review was conducted in accordance with the registered protocol (Open Science Framework Registry; 10.17605/OSF.IO/GE2RS) and the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) 2020 statement (86).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fdgth.2023.1157654",FALSE,"",TRUE,"<section> Funding <section> The work in the group of AR was funded by the Dr. MY was additionally funded by the Berlin School of Integrative Oncology (BSIO) graduate program of the Charité Medical University Berlin and by the Einstein Foundation. <section> The TimeTeller project was additionally funded by the I4H (Inventors for Health) Program of the Stiftung Charité and by the Digital Health Accelerator (DHA) Program from the Berlin Institute of Health (BIH) at the Charité Medical University of Berlin (grants to AR).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2022.1034580",FALSE,"",TRUE,"<section> Funding <section> This manuscript was based on a series of meetings organized and sponsored by Kyowa Kirin International. <section> The authors declare that this study received funding from Kyowa Kirin International.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fendo.2023.1068418",FALSE,"",TRUE,"Funding acquisition DF MR. <section> Funding <section> The research was funded by National Science Centre in Poland (grant number 2019/33/N/NZ5/02303) a PRELUDIUM-17 grant.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2023.1112892",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fendo.2023.1163046",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2023.1176199",TRUE,"Conﬂict of interest The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Funding Funded by the Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) grant SYSE PI/E Medical Hackathon of Scientists and Entrepreneurs (Festival of Innovative Projects) Creation of Experimental Laboratories in the Natural Sciences Program and Basic Research Program at HSE University.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fendo.2023.1178166",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2023.1181044",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the German Heart research Foundation (DSHF) and the German Research Foundation (DFG). We would like to thank Bayer AG (Wuppertal) for handing over the highly selective ERb agonist (BAY-1214257) for testing our hypothesis in the animal experiments.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fendo.2023.1195247",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This project was supported by funds from the Ministry of Science Research and Culture of the State of Brandenburg and by the Brandenburg Medical School (Medizinische Hochschule Brandenburg MHB) publication fund supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) and Open Access Publication Fund of Charité Universitätsmedizin Berlin.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2023.1195677",FALSE,"",TRUE,"However the observations of our study are supported by data from cell and animal models (1 8). <section> Funding This work was funded in part by the German Center for Diabetes Research (DZD",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fendo.2023.1240104",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding The work was funded by DZD (Deutsches Zentrum für Diabetesforschung grant no 82DZD14E03) DDG (Deutsche Diabetes Gesellschaft) and INNODIA.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fgene.2022.1056114",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Work discussed in this review was supported by a grant from ERC AIG 844952. The views expressed in this publication are those of the authors and not necessarily those of the funding bodies.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fgwh.2023.1009473",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2022.1023206",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> AE JS and AK were supported by the TransOnc priority program of the German Cancer Aid within grant #70112951 (ENABLE). This work has been funded by the Stiftung Charité",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2022.1045523",FALSE,"",TRUE,"<section> Funding <section> This study was supported by the Edith Busch Foundation Germany in the form of a research grant to ES.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2022.1066456",FALSE,"",TRUE,"<section> Funding <section> This work was supported by Deutsche Forschungsgemeinschaft MB received a scholarship from the Sonnenfeld-Stiftung while LH was supported by a scholarship from the German Academic Scholarship Foundation",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2022.1079921",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by Deutsche Krebshilfe (70113055) DKMS Stiftung Leben Spenden (88133122) Kommission für Nachwuchsförderung of the Charite Jose Carreras Leukämie-Stiftung (3R/2019 23R/2021) Deutsche Krebshilfe (70113519) Deutsche Forschungsgemeinschaft (PE 1450/7-1 PE 1450/9-1) and Stiftung Charite BIH (BIH_PRO_549 Focus Group Vascular Biomedicine).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2022.1083119",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the DFG (CH 1968/1-1 to V.T.C and K.R.) and by the Helmholtz-Gemeinschaft Zukunftsthema “Immunology and Inﬂammation” (ZT-0027 to K.R.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2022.1085551",FALSE,"",TRUE,"<section> Funding <section> This review article was funded by grants awarded to AK from the European Union Developing Countries Clinical Trials Partnership",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2022.959141",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1042650",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1056525",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Formal Analysis: LH; Funding acquisition: AT; Investigation: LH JB <section> Funding <section> This work was funded by the Federal Ministry of Health through a resolution of the German Bundestag (Charité Corona Cross (CCC) 2.0 and 2.1 and Charité Corona Protect (CCP)).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1058267",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"SJA was supported by the German Research Foundation (DFG) through the Heisenberg Program (AR 732/3-1) project A08 of SFB 992 (project ID 192904750) project P7 of SFB 1453 (project ID 431984000) and Germany’s Excellence Strategy MB was also supported from the German Federal Ministry of Education and Research (BMBF) within the Medical Informatics Funding Scheme MIRACUM-FKZ 01ZZ1801B (MB) BT PK and LK were supported by the Doctoral College Programm MOTI-VATE of the Faculty of Medicine University of Freiburg. <section> Flourescence activated cell sorting was performed at the Lighthouse Core Facility which is funded in part by the Medical Faculty University of Freiburg (Project Numbers 2021/A2-Fol; 2021/B3-Fol) and the DFG (Project Number 450392965).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1086433",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding Within the Institute of Translational ImmunoOncology at the University Hospital Cologne RS is funded by the Cancer Research Center Cologne Essen (CCCE) through the state of North Rhine-Westphalia. DW has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 825392 (ReSHAPE-h2020.eu) and is generously supported by the German Federal Ministry of Education and Research (BIH Center for Regenerative Therapies) a Berlin Institute of Health (BIH) Crossﬁeld project fund of the BIH Research Focus Regenerative Medicine and the SPARK-BIH program. PHN is funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grants NG182/1-1 and SFB1530-455784452 (subproject B01); the research network CANcer TARgeting (CANTAR) of the Ministry of Culture and Science of the State of North Rhine-Westphalia (MKW NRW); and the Fritz Thyssen Foundation grants 10.20.1.008MN and 10.20.1.014MN.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1094862",FALSE,"",TRUE,"<section> Funding <section> Funding by the Open Access Publishing Fund of Leipzig University supported by the German Research Foundation within the program Open Access Publication Funding.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1101087",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the German Research Foundation (DFG) (grants FOR3004 PR1274/4-1 PR1274/5-1 PR1274/9-1) by the Helmholtz Association (HIL-A03) the German Federal Ministry of Education and Research (Connect-Generate 01GM1908D) the Einstein Stiftung Fellowship through the Günter Endres Fond and the Sonnenfeld-Stiftung.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1108116",FALSE,"",TRUE,"<section> Funding <section> The project was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany´s Excellence Strategy (EXC-2049 – 390688087 to ME) as well as the Berlin Institute of Health SPARK program (to WB). PH is the recipient of a Rahel-Hirsch stipend by Charité Universitätsmedizin Berlin. ME received funding from DFG (Collaborative Research Center ReTune TRR 295-424778381) BMBF DZNE DZHK EU Corona Foundation and Fondation Leducq all outside the scope of this work. The authors declare that this study received funding from EUROIMMUN AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This cohort study was registered (DRKS00012668) and approved by the Ethics Committee of Charité Universitätsmedizin Berlin (EA1/ 099/17 and EA4/219/21).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fimmu.2023.1114368",FALSE,"",TRUE,"<section> Funding <section> The work was supported by grants from BIH and research funding from the Stiftung Charité (BIH Johanna Quandt funding).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1114509",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1115272",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1119498",FALSE,"",TRUE,"<section> Funding <section> Funding was provided by grants from the German Research Foundation (SFB-TR36) the Berlin Institute of Health (CRG-1) Deutsche Krebshilfe (111546) DKTK joint funding (NEO-ATT) European Union (ERC Advanced Grant 882963) and the Helmholtz-Gemeinschaft Zukunftsthema ‘Immunology and Inﬂammation’ (ZT-0027).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1120328",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The research and analyses are supported by the Deutsche Forschungsgemeinschaft (DFG) Research Unit FOR-2558 “TraceAge” (Scho 849/6-2) and CRC/TR 296 “Local control of TH action” (LocoTact P17) and by the German Federal Ministry for Economic Affairs and Energy (BMWi ZIM program project #KK5051601BM0 to LS).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1125017",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Jose Carreras Leukämie-Stiftung (grants DJCLS R 15/11 and DJCLS 06R/2019) to MS and MB as well as by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) project number 444949889",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1130933",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the European Research Council Starting Grant (ERCEA; 803087 to CSNK) the German Research Foundation (DFG; Project-ID 259373024 – CRC/TRR 167 FOR2599 project 5 KL 2963/5-2 SPP1937 KL 2963/2-1 and KL 2963/3-1 to CSNK SPP1937 DU1295/4-1 to CDU); the Swiss Branco and the Benjamin Franklin Flow Cytometry Facility for cell sorting (supported by DFG Instrument Grants INST 335/597-1 FUGG and INST 335/777-1) and L.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1133207",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1139683",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1163198",FALSE,"",TRUE,"<section> Funding <section> This study was funded by Deutsche Forschungsgemeinschaft (DFG German Research Foundation): SFB-TRR241-375876048 to CN (A08) to KK (B04) to ML (B04) to ZT AK and RA (Z03); FOR2438 to CN and MN (P09); NE1927/2-2 to CN; CRC1181261193037 to CN and RA (C02); SFB1340 to AK (B06). MN was supported by a research grant of Boehringer Ingelheim and Boehringer Ingelheim was not involved in the study design collection analysis interpretation of data the writing of this article or the decision to submit it for publication. GS was supported by a DOC fellowship of the Austrian Academy of",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1165758",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be constructed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1166765",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the SPARK-Validation Track II program of the Berlin Institute of Health. NE was funded by a full scholarship from the Ministry of Higher Education from the Arab Republic of Egypt.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1174289",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1179355",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1187880",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1188760",FALSE,"",TRUE,"<section> Funding <section> This study was supported by grants from the Luzhou Science and Technology Department Applied Basic Research program (No: 2022-JYJ-145) the Sichuan Province Science and Technology",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1190235",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding HB is supported by King Saud bin Abdulaziz University for Health Sciences Jeddah Saudi Arabia. This research was funded in whole or in part by the Wellcome Trust [209553/Z/17/Z]. JJ was supported by Wellcome Trust Clinical Research Career Development Fellowship 209553/Z/17/Z and the <section> NIHR Biomedical Research Centre at University College London.JD reports fees for advisory board meetings teaching and educational activities and congress participation from Boehringer Ingelheim outside the submitted work.PM has received grant support from the National Institutes of Health AAAAI Foundation Immune Deﬁciency Foundation Takeda Horizon Pharma and Boston University and has received consulting fees from Medscape and Pharming.KW reports honoraria for advisory board meetings teaching and educational activities from TAKEDA",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol was registered on PROSPERO (registration: CRD42022276337).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fimmu.2023.1192840",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study is funded by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium) Young talent project of Changzhou (China) Health Commission (CZQM2022007) Youth fund of Changzhou (China) Health Commission (QN202121) Basic application project of Changzhou (China) Science and Technology Bureau (CJ20220142) and General project of Changzhou Medical Center Nanjing Medical University (CZKYCMCB202221). XC and HL are funded by China Scholarship Council Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1197821",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was funded by intramural funding.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1200180",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1200725",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This is supported by the Deutsche Forschungsgemeinschaft (DFG) grant STR480/26-1 and the Jackstaedt Foundation. <section> Furthermore this work was supported by a grant from the Friedrich-Baur-Foundation.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1204543",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"Funding acquisition: MB. <section> Funding <section> This study was funded by the Saxon State Ministry for Science Culture and Tourism (“Diese Maßnahme wird mitﬁnanziert mit Steuermitteln auf Grundlage des vom Sächsischen Landtag beschlossenen Haushaltes” application-ID: 100526737) the Else This work was further supported by the Higher Education Institutional Excellence Program of the Ministry of Innovation and Technology (TKP2021-EGA Therapeutic Development of Semmelweis University TKP-Bioimaging-20204.1.1-TKP2020 and the Investment to the Future grant 2020.1.16jövő -2021-00013) the European Union’s Horizon 2020-EU.4.a. This work was supported by the European Union’s Horizon 2020 OPEN FET RIA (NEURAM No 712821) the Higher Education Institutional Excellence Program of the Ministry for Innovation and Technology in Hungary within the framework of the “Innovation for the sustainable life and environment” thematic program of the University of Pé cs. In addition the work was supported by a grant from the Saxony-Anhalt State Ministry for Science (BS) and from the DAAD “GLACIER” (BS JD AM-S).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1205080",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1208567",FALSE,"",TRUE,"<section> Funding <section> Funding for the writing of this article and the submission processing fee comes from Pharming Group N.V. Catharina Schütz’ research is in part funded by the Rosemarie-Germscheid Stiftung (funding goes to Klinisches Studienzentrum Pädiatrie – <section> The authors declare that this study received funding from Pharming Group N.V..",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1209464",FALSE,"",TRUE,"<section> Funding The “lab research” was funded by academic grants through BMBF DFG BCRT/BSRT and EU-Project Grants and CGS/CSC-Scholarships as outlined in detail below. HZ DW and PW were supported by Chinese Scholarship Council (CSC) Stipends (HZ: 202008080251 DW: 202108080082 and PW 202108440113 respectively): https:// www.chinesescholarshipcouncil.com/.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1214098",FALSE,"",TRUE,"<section> Funding This study was partly supported by the WES Leukemia Research Foundation (RC). This research was also supported by Mercer University School of Medicine’s Research funds (RC). HZ and RP were supported by the cancer research scholarship from the Landings Women’s Golf <section> Association (Savannah GA) CU and TF were supported by the graduate program of Biomedical Sciences at Mercer University.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1231329",FALSE,"",TRUE,"<section> Funding <section> The authors gratefully acknowledge funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (FP/2014-2020)/ERC (Grant Agreement n. 772418) from the Foundation of Scientiﬁc Research Flanders FWO-Vlaanderen (Grant n.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1233101",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1236374",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft with grant (DFG Di 714/20-1) to UD.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1239151",FALSE,"",TRUE,"<section> Funding Preparation of this manuscript was funded by Insmed Incorporated. Ralph Kettritz was supported by grant KE 576/10-1 from the Deutsche Forschungsgemeinschaft. <section> Editorial assistance for preparation of this manuscript was provided by Richard Boehme Ph.D. of Meditech Media and funded by Insmed Incorporated.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1239519",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"KK Conceptualization Funding acquisition Supervision Writing Review. <section> Funding <section> KK is supported by grants from the Deutsche Forschungsgemeinschaft (KO-2270/7-1 KO-2270/4-1 KO-2270/8-1) Zentrales Innovationsprogramm Mittelstand (KK5463201BA2) and unconditional project funding from Chiesi GmbH. HS received funding from the Ministry for Science Research and Arts of Baden-Württemberg Germany and the European Commission (HORIZON2020 Project SUPPORT-E no. 101015756). This study received funding from Chiesi GmbH.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1243516",FALSE,"",TRUE,"<section> Funding We acknowledge the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES/PROEX) (grant 88887.848413/202300 to AA) and the National Council for Scientiﬁc and Technological",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1251593",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding This work was supported by grants from the BayImmunet network of the Government of Bavaria and the German Research Foundation (SFB643). Many thanks go to the excellent study monitors provided by the Center for Clinical Studies CCS and the support from the IT department of the University Hospital of Erlangen.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fimmu.2023.1252811",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Bureau; EBMT: Membership on an entity’s Board of Directors or advisory committees; FRESENIUS KABI: Research Funding; <section> Research Funding; NOVARTIS: Speakers Bureau SANOFI SA: Honoraria Research Funding Speakers Bureau TERUMO BCT:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1254176",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> GR: Funding acquisition Supervision Validation Writing – original draft Writing – review & editing. JH: Conceptualization Data curation Formal Analysis Funding acquisition Supervision Validation Writing – original draft Writing – review & editing. <section> Funding This study was supported by funds from the German Research Foundation (DFG) within the Collaborative Research Centre 650 (SFB650; project number 10) and research grants from the Charité – University Medicine Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1257526",FALSE,"",TRUE,"CF: Conceptualization Data curation Formal Analysis Funding acquisition Project administration Supervision Validation <section> Funding This project was supported by the German Research Foundation DFG SFB738 project B3 and FA-483/1-1 the German Center for Infection Research DZIF TTU-IICH and the MHH Transplant Center <section> KL JI and NL were enrolled in the StrucMed-Program at Hannover Biomedical Research School (HBRS) and KL and JI received stipends from HBRS.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1261666",FALSE,"",TRUE,"PB: Writing – review & editing Writing – original draft Data curation Resources Visualization Conceptualization Funding acquisition Investigation Methodology Project administration Supervision Validation. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1268207",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1279652",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be constructed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Inﬁll received funding from Pharming Group N.V. <section> The authors declare that this study received funding from Pharming Group N.V.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1281646",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"CC: Funding acquisition Methodology Project administration Resources Supervision Writing – review & editing. <section> Funding DK was supported by DG grant Ka 502/19-3. The work was supported by the Department of Molecular Biology at MPIIB. The authors acknowledge support from the Max Planck Society for covering the Article Publishing Fees via the Central Invoicing agreement with Frontiers.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1281685",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1283034",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study received funding from Mallinckrodt Pharmaceuticals.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1289744",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> GM: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Resources Software Supervision Visualization Writing – original draft Writing – review & editing. MA: Conceptualization Formal Analysis Funding acquisition Investigation Methodology Resources Data curation Writing – review & editing. HH: Data curation Formal Analysis Funding acquisition Investigation Methodology Resources Conceptualization Wr iting – review & edit ing. A H: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Resources Writing – review & editing. DD: Conceptualization Funding acquisition Investigation Resources Supervision Data curation Formal Analysis Methodology Writing – review & editing. KB: Conceptualization Funding acquisition Investigation Resources Supervision Data curation Formal Analysis Methodology Writing OP: Conceptualization Funding acquisition Investigation Methodology Resources Supervision Writing – review & editing Data curation Formal Analysis. GR: Conceptualization Funding acquisition Investigation Methodology Resources Supervision Data curation Formal Analysis Writing – review & editing. OC-M: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Resources Supervision Visualization Writing – original draft Writing – review & editing Software Validation Project administration. JW: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing – original draft Writing review & editing. RC: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing – original draft Writing – review & editing. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1291972",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"JV-A: Conceptualization Data curation Funding acquisition Investigation Methodology Supervision Writing – review & editing. JB: Conceptualization Data curation Funding acquisition Writing – review & editing. BC: Conceptualization Funding acquisition Writing – review & editing. JC: Conceptualization Data curation Funding acquisition <section> Funding This work was supported by Grifols pharmaceutical the CERCA Program (2021 SGR 00452; Generalitat de Catalunya) Direcció General de Recerca i Innovació en Salut (Generalitat de Catalunya) (projects SLD0015 and SLD0016) the Carlos III Health Institute (PI17/01518 and PI18/ 01332) and the crowdfunding projects “YomeCorono” BonPreu/ Esclat and Correos. JB is supported by the Health Department of the Catalan Government (Generalitat de Catalunya). CA -N AP-G and PA-R were supported by predoctoral grants from Generalitat de Catalunya and Fons Social Europeu (2020 FI_B_0742; 2022 FI_B_00698 and 2020FI_B2_00138 respectively). EP was supported by a doctoral grant from National Agency for Research and Development of Chile (ANID: 72180406). NI-U is supported by the Spanish Ministry of Science and Innovation (grant PID2020117145RB-I00) EU HORIZON-HLTH-2021-CORONA-01 (grant 101046118). This study was also supported by CIBER Consorcio Centro de Investigació n Biomé dica en Red (CB 2021) Carlos III Health Institute Ministerio de Ciencia e Innovació n and Unió n Europea – NextGenerationEU.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1320414",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> QB: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing – original draft Writing – review & editing. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fimmu.2023.1326078",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> LK: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing – original draft Writing – review & editing. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fimmu.2023.1331730",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"KR: Conceptualization Funding acquisition Supervision Writing – review & editing Visualization. <section> Funding This work was supported by the European Research Council Advanced Grant",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2022.1033181",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fmed.2022.1034290",FALSE,"",TRUE,"<section> Localization / Funding <section> Funding <section> This study was supported in part by grants from the German Federal Ministry of Education and Research (82DZL002A1 to AMD 82DZL00401 82DZL004A1 and 82DZL009B1 to MM) the German Cystic Fibrosis Association Mukoviszidose e.V. GN and IRi were supported by the Clinician Scientist Program of the University of Luebeck.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2022.1069042",TRUE,"Conflict of interest <section> CF-S was funded by grants from the German Federal Ministry of Education and Research outside the submitted work and the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) inside and outside the submitted work. DS leads the coordinating bureau of the German Quality Network sepsis–a quality initiative to improve hospital care for sepsis–and was partly funded via this project from 2015 to 2022. KR was shareholder with less of 0.5% of InflaRx NV a Jena/Germany based Biotech Company that evaluates an immunmodulatory approach for the adjunctive treatment of COVID-19. PS was funded by grants from the German Federal Ministry of Education and Research outside the submitted work and the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) outside the submitted work. AS was funded by grants from the German Federal Ministry of Education and Research outside the submitted work. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was funded by the grant 01VSF17010 from the German Innovations Fund of the Federal Joint Committee. <section> We acknowledge support by the German Research Foundation Project-Nr. 512648189 and the Open Access Publication Fund of the Thüringer Universitätsund Landesbibliothek Jena. <section> CF-S was funded by grants from the German Federal Ministry of Education and Research outside the submitted work and the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) inside and outside the submitted work. PS was funded by grants from the German Federal Ministry of Education and Research outside the submitted work and the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) outside the submitted work. AS was funded by grants from the German Federal Ministry of Education and Research outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2022.1080052",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported in part by CENAUG Foundation Liechtenstein (grant to KH Vista Augenklinik).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2022.1083760",TRUE,"Conflict of interest <section> AH was supported through a stipend “Habilitationsstipendium” of the Medical Faculty RWTH Aachen University. AH received a grant for an investigator initiated trial from B. Braun and through START Project of the Medical Faculty RWTH Aachen University as well as from WOERWAG Pharma. AH and CSo received lecture fees as well as a grant for an investigator-initiated trial from Fresenius Kabi which are all unrelated to this manuscript. KA receives speaker fees and unrestricted research von Fresenius Kabi. CSo was employed by the company Abiomed Europe GmbH at the time this mansucript was conceived. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1088764",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1098547",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2023.1128154",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the “Progetto Ricerca Corrente” and “Ricerca Finalizzata” (N.12367807) of the Italian Ministry of Health Rome Italy. The publication was made by a researcher (RM) with a research contract cofunded by the European Union– PON Research and Innovation 2014–2020 in accordance with Article 24 paragraph 3a of Law No. 240 of December 30 2010 as amended and Ministerial Decree No. 1062 of August 10 2021.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1137027",TRUE,"Conflict of interest 0.001 0.028 0.963 −0.054 0.056 −0.012 0.03 0.685 −0.07 0.046 The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The study was funded by the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) (grant number: We acknowledge support by the German Research Foundation Projekt-Nr. 512648189 and the Open Access Publication Fund of the Thueringer Universitaetsund Landesbibliothek Jena. The MSC was funded by the German Ministry of Education and Research (BMBF No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2023.1145651",TRUE,"Conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2023.1164466",TRUE,"<section> The authors declare that the research absence of any commercial or financial construed as a potential conflict of interest.",TRUE,"We acknowledge financial support Publication Fund of Charité – Universitätsmedizin German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1173528",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The EMANet project is supported by the Federal Ministry of Education and Research (Bundesministerium für Bildung und We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1179145",TRUE,"Conflict of interest <section> ME is a scientific advisor to Stethoglove GmbH. Outside the submitted work: VF has relevant (institutional) financial activities with following commercial entities: Medtronic GmbH Biotronik SE & Co. Abbott GmbH & Co. KG Boston Scientific Edwards Lifesciences Berlin Heart Novartis Pharma GmbH JOTEC GmbH and Zurich Heart in relation to educational Grants (including travel <section> support) fees for lectures and speeches fees for professional <section> consultation and research and study funds. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by Stethoglove GmbH Hamburg Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Study Registration: EUDAMED no. CIV-21-09-037762.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fmed.2023.1180746",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work has been funded in part by the Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research: PermedCOPD – FKZ 01EK2203A; ERACoSysMed2 – SysMed-COPD – FKZ 031L0140; e:Med CAPSYS – FKZ 01ZX1604E) the Deutsche Forschungsgemeinschaft (SFB/TR-84 TP C01) and the von-BehringRöntgen-Stiftung (66-LV07) to BS the Deutsche Forschungsgemeinschaft (SFB/TR-84 TP A04/B06) to SH as well as the Hessisches Ministerium für Wissenschaft und Kunst (LOEWE Diffusible Signals LOEWESchwerpunkt Diffusible Signals) to DH AJ and BS.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1187809",FALSE,"",TRUE,"<section> Funding <section> The study was funded by the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) (grant number: 01VSF17010). <section> Funding <section> The study was funded by the German Innovations Fund of the Federal Joint Committee in Germany (G-BA) (grant number: 01VSF17010). <section> We acknowledge support by the German Research Foundation Projekt-Nr. 512648189 and the Open Access Publication Fund of the Thueringer Universitaetsund Landesbibliothek Jena.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1194754",TRUE,"Conflict of interest <section> The Charité Universitaetsmedizin Berlin holds a patent for the use of vericiguat in Post-COVID Syndrome. CS JB-S CH KW ES CaF HPru HPre M-LM HA ChF HZ BS CM MT AK MR MM LS FKo FP LB and SB are employed at Charité Universitaetsmedizin Berlin. <section> CM was employed by Labor Berlin Charité Vivantes GmbH. <section> The remaining authors declare that the research was conducted in the absence of any comercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The clinical trial platform is funded by the Bundesministerium für Bildung und Forschung (German Ministry of Education and Research) Grant 01EP2201.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1196160",TRUE,"Conflict of interest <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The study was funded by Vayamed GmbH Jägerstr.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1201517",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1202969",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1228833",TRUE,"The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"Funding The authors acknowledge the funding by the Federal Ministry of Education and Research of the Federal Republic of Germany grant 13GW0341.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1231667",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was funded by grants from the German Society of Musculoskeletal Radiology (Deutsche Gesellschaft für muskuloskelettale Radiologie; DGMSR). We acknowledge financial support from the Open Access Publication Fund of Charité Universitätsmedizin Berlin <section> The authors thank the DGMSR for the grants and the Berlin Institute of Health for personal funding (SU and TD) and providing",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1254747",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2023.1274397",TRUE,"Conflict of interest <section> SP is employed by BioCryst Pharma Deutschland GmbH. KB is employed by Primus Consulting Group GmbH. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmed.2023.1278641",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"PB: Conceptualization Resources Writing – review & editing Funding acquisition Project administration. FK: Supervision Writing – review & editing Conceptualization Funding acquisition Investigation Project administration Resources Writing – original draft. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work was funded by a grant from the Else Kroener-Fresenius-Stiftung (EKFS) (Grant Number: 2020_EKTP29).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmed.2023.1289948",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmedt.2022.1055189",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> We were granted ethical committee approval and Thai clinical trials registry number TCTR20221103003.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fmicb.2023.1128500",TRUE,"Conflict of interest <section> AB and SS were employed by Hofmann & Sommer GmbH & Co. KG Büro Berlin. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> SB MH and SK received funding from the German Federal Ministries of Education (zoonoses research consortium Furthermore SB and MH received grant support from the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag (ZIM ZF4117908 AJ8). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmicb.2023.1154407",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the German Federal Ministries of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter to MH and SB (IP7/01KI1725D and 01KI2007D) and from the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag to MH and SB (ZIM ZF4117908 AJ8). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmicb.2023.1172574",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> MRP is supported by a postdoctoral grant from the FWO (1521716N). This study was supported by Gilead Sciences (grant number BE-2019-000016).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmicb.2023.1196721",TRUE,"Conflict of interest <section> Author HH was employed by company CellTrend GmbH. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by grants of Mercator Foundation EFRE grant for COVID.DataNet.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmicb.2023.1256210",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> CZ: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Supervision Writing – review & editing. MaS: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Visualization Writing – original draft. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study protocol was published in the German Clinical Trials Registry prior to inclusion of the first patient (ID: DRKS00021591).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fmicb.2023.1325473",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"RS: Conceptualization Funding acquisition Resources Supervision Writing – review & editing. BT: Conceptualization Funding acquisition Resources Supervision Writing – review & editing. <section> SJ: Conceptualization Formal analysis Funding acquisition Methodology Resources Supervision Validation Writing – review & editing. DT: Conceptualization Formal analysis Funding acquisition Methodology Resources Supervision Validation Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. The work was funded by the Deutsche Forschungsgemeinschaft (JU 2857/9-1 / and -2 to SJ). Edwin Ogola was supported by a German Academic Exchange Service (DAAD) through the icipe ARPPIS-DAAD scholarship and a UP postgraduate bursary. We also gratefully acknowledge the financial support and technical support of ICIPE core donors: Swiss Agency for Development and Cooperation (SDC) Switzerland; Swedish International Development Cooperation Agency (Sida) Sweden; Australian Centre for International Agricultural Research (ACIAR) Federal Democratic Republic of Ethiopia and the Government of the Republic of Kenya.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmicb.2023.1331114",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"SB: Writing – review & editing Conceptualization Funding acquisition Supervision Validation. MH: Conceptualization Funding acquisition Supervision Validation Writing – review & editing Investigation. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This project received funding from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin the German Research Foundation (DFG) and the European Union’s Horizon 2020 research and innovation programme (under the Marie Sklodowska-Curie grant agreement No.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmolb.2022.1081661",TRUE,"<section> The remaining author declares that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fmolb.2023.1129831",FALSE,"",TRUE,"<section> Funding <section> This work was funded by the German Research Foundation (DFG SFB/TRR 296 and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium). <section> HL is funded by the China Scholarship Council (CSC) Foundation.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fmolb.2023.1302016",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study is supported by China Postdoctoral Science Foundation (2022M720385) and Beijing JST Research Funding (YGQ-202313).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnagi.2022.1076393",TRUE,"Conflict of interest <section> SK is an inventor on patents sold to Medtronic and received speaker’s honoraria from Medtronic. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding SL was financially supported by the Berlin Institute of Health (BIH) with a research stipend.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnagi.2023.1067268",TRUE,"Conflict of interest <section> be construed as a potential conflict of interest.",TRUE,"Both studies were funded by Baxter. <section> Funding <section> The research leading to these results was supported by Charité – Universitätsmedizin Berlin. The initial study has received funding from Aspect Medical Systems now Medtronic.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Data privacy and security regulations were followed and the study was registered under ISRCTN 36437985.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fnagi.2023.1170879",TRUE,"Conflict of interest <section> OP received fees for consultation from Abbvie Biogen Eisai Griffols MSD Roche and Schwabe. JP received fees for consultation lectures and patents from Neurimmune Axon Desitin and Epomedics. JW is an advisory board member of Abbott Biogen Boehringer Ingelheim Immunogenetics Lilly MSD Sharp & Dohme and Roche Pharma and received honoraria for lectures from Actelion Amgen Beijing Yibai Science and Technology Ltd. Janssen Cilag Med Update GmbH Pfizer Roche <section> Pharma and holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945 and also supported by an Ilidio Pinho professorship iBiMED (UIDB/04501/2020) at the University of Aveiro Portugal. ED received fees for consultation from Roche Biogen RoxHealth and holds shares in neotiv. FJ received fees for consultation from Eli Lilly Novartis Roche BioGene MSD Piramal Janssen and Lundbeck. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The DELCODE study was funded by the German Center for Neurodegenerative Diseases [Deutsches Zentrum für <section> Pharma and holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945 and also supported by an Ilidio Pinho professorship iBiMED (UIDB/04501/2020) at the University of Aveiro Portugal.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnagi.2023.1204134",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be <section> construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The work performed at the IRCCS Mondino Foundation was supported by the Italian Ministry of Health (RC2022RC2024). The work performed at the University of Pavia was supported by H2020 Research and Innovation Action Grants Human Brain Project 785907 and 945539 (SGA2 and SGA3) to ED’A FP and PR. Moreover the project was supported by the MNL Project “Local Neuronal Microcircuits” of the Centro Fermi (Rome Italy) #NEXTGENERATIONEU (NGEU) and funded by the Ministry of University and Research (MUR) the National Recovery and Resilience Plan (NRRP) project IR00011-EBRAINS-Italy to ED’A; Horizon2020 [Research and Innovation Action Grants Human Brain Project 945539 (SGA3)] BRC (#BRC704/CAP/CGW) MRC (#MR/S026088/1) Ataxia UK to CW-K; PR acknowledges Digital Europe Grant TEF-Health #101100700; H2020 Research and Innovation Action Grant Human Brain Project (ICEI 800858 EOSC VirtualBrainCloud 82642 AISN 101057655); H2020 Research Infrastructures Grant (EBRAINSPREP 101079717 EBRAIN-Health 101058516); H2020 European Innovation Council (PHRASE 101058240); H2020 European Research Council Grant (ERC BrainModes 683049); JPND ERA PerMed PatternCog 2522FSB904; Berlin Institute of Health and Foundation Charité; Johanna Quandt Excellence Initiative; and German Research Foundation (SFB 1436 project ID 425899996;",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnagi.2023.1327388",TRUE,"Conflict of interest <section> GW is coordinator of the BioCog consortium and is chief executive of the company Pharmaimage Biomarker Solutions GmbH (https://www.pi-pharmaimage.com) and employed by PI Health Solutions GmbH. Among other academic and private partners the company is a partner of the BioCog study. CS and TP are project leaders in BioCog. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"CS: Funding acquisition Resources Supervision Writing – review & editing. GW: Funding acquisition Project administration Resources Supervision Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work was funded by the European Union Seventh Framework Programme [FP7/2007–2013] under Grant agreement no. HEALTHF2–2014602461 BioCog [Biomarker Development for Postoperative Cognitive We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnana.2023.1276325",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work was supported by the Ministry of Science and Higher Education of the Russian Federation (project no. FSWR-2023-0029).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fncel.2023.1077204",TRUE,"Conflict of interest <section> MS was employed by the company EUROIMMUN AG Lübeck Germany. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the German Research Foundation (DFG; grants FOR3004 PR1274/3-1 PR1274/5-1 and PR1274/9-1) by the Helmholtz Association (HIL-A03 BaoBab) and by the German Federal Ministry of Education and Research (Connect-Generate 01GM1908D) to HP. We acknowledge financial support from the Open Access Publication Fund of Charitè—Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fncel.2023.1129417",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> MJ was funded by a PhD-fellowship from the Einstein Center for Neurosciences Berlin. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG German Research This work was also supported by the Novo Nordisk Foundation: Grant number: NNF19OC0056047 Young Investigator Award to AMW.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fncel.2023.1156802",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by NIH grants (AI46374 and AI043496 to SK) NMSS RG 3945 grant to SK and PP1236 from the National Multiple Sclerosis Society and UConn-Biogen Award to JI.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fncir.2023.1172464",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnetp.2023.1271042",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"RK: Conceptualization Funding acquisition Project administration Resources Supervision Writing–review and editing. <section> Funding This research was funded by the Deutsche Forschungsgemeinschaft (DFG)— Project number 394046635—SFB 1365.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2022.1045678",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> BT was supported by NIH NIDA 5K23DA049216. CC was supported by CIBM and the Swiss National Science Foundation under Grant Agreement No. CRKC and PT were supported by NIH R01AG058854 R01MH116147 P41EB015922 and R01NS107513. ED and EW were supported by NIH R61 NS120249. SE was supported by the German Research Foundation (Grant No. <section> GO was supported by NIH NIA R00AG062230.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2022.1046564",TRUE,"<section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The ANNOTeM intervention program was funded by the Innovation Fund of the German Government (01NVF16028) (2017–2021).",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2022.1051397",FALSE,"",TRUE,"<section> Funding <section> This work has received funding from the European Commission through a Horizon2020 grant (PRECISE4Q Grant No. 777 107 coordinator: DF) and the German Federal Ministry of Education and Research through a Go-Bio grant (PREDICTioN2020 Grant No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2022.1056322",FALSE,"",TRUE,"<section> Funding <section> This study was supported by the NeuroCure Clinical PM is Einstein Junior Fellow funded by the Einstein Foundation Berlin and has been supported by grants from the Bundesministerium für Bildung und Forschung (Grant No. PM receives funding from the Einstein Foundation Berlin and is supported by grants from the Bundesministerium für Bildung und Forschung the Volkswagen Foundation and the Else Kröner Fresenius Stiftung and is on the board of HealthNextGen Inc. and has equity interest in the company.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2022.1066724",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the START-Program of the Faculty of Medicine RWTH Aachen Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: This cohort observational study has been registered at ClinicalTrials.gov (NCT02142166) as part of a larger scale prospective data collection.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fneur.2022.1089610",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2022.1091987",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2022.1113811",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding Our research work was supported by the grants from the German Research Foundation (DFG) (grant FOR3004) the Helmholtz Association (HIL-A03) and the Einstein Stiftung Fellowship through the Günter Endres",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1069434",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This research was funded by the AMS Stiftung. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Moreover the study was registered (ClinicalTrials: NCT02747758) and applied the CONSORT checklist (45).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fneur.2023.1114360",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> We acknowledge support from the German Research Foundation (DFG 389563835; 402170461-TRR 265; 414984028CRC 1404; 42075332-RU 5187) and the Manfred and Ursula-Müller Stiftung. ME received funding from DFG under Germany’s Excellence Strategy–EXC-2049–390688087 Collaborative Research Center ReTune TRR 295-424778381 Bundesministerium für Bildung und Forschung (BMBF) Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Deutsches Zentrum für Herz-Kreislauferkrankungen (DZHK) EU Corona Foundation and Fondation Leducq.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1124886",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the Einstein Stiftung Fellowship through the Günter Endres Fond (AK) the German Research Foundation (DFG SFB1315 FOR3004 AK) and the Charité (AK ER). This work was supported by the Institut national de la santé et de la recherche médicale (Inserm) sponsor of the DEFIDIAG study (NCT04154891). The DEFIDIAG study was funded by The French Ministry of Health in the framework of the French initiative for genomic medicine (Plan France Médecine Génomique 2025; PFMG 2025; https://pfmg2025.aviesan.fr/). The DEIFIDIAG study was supported by government funding from the Agence Nationale de la Recherche under the “Investissements d’avenir” program (ANR10-IAHU-01).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1142253",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> Our research was supported by the German Research Foundation (DFG; SFB1315 and FOR3004) and the Günter Endres Fond through the Einstein Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1149604",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The development of the GDQ was supported by the University of Excellence of Technical University (TU) Dresden funded by the excellence strategy of the federal and state governments (Str1911_038) without any influence on the scientific content. <section> The Article Processing Charge (APC) were funded by the joint publication funds of the TU Dresden including Carl Gustav Carus Faculty of Medicine and the SLUB Dresden as well as the Open Access Publication Funding of the DFG. AR has received salary support from the National Institute of Health Research (NIHR) Clinical Research Network (CRN) South London Guy’s Hospital Great Maze Pond London SE1 9RT UK and the International Parkinson and Movement Disorder Society (MDS) 555 East Wells Street Suite 1100 Milwaukee WI 53202-3823 USA outside the present study. AS has received funding from the Deutsche Forschungsgemeinschaft (German Research Association) and the Helmholtz-Association outside the present study. Further the development of the GDQ was supported by the university of excellence of TU Dresden funded by the excellence strategy of the federal and state governments (Str1911_038) without any influence on the scientific content.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1154420",FALSE,"",TRUE,"UR received speaker or consulting fees from Amgen Allergan Abbvie Eli Lilly Lundbeck Novartis Medscape Pfizer StreaMedUp and Teva and received grant support for research or education from Novartis (CHERUB01) and German Federal Ministry of Education and Research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1175370",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> Our research is supported by the German Research Foundation (DFG; SFB1315 FOR3004) and the Günter Endres Fond through the Einstein Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1203241",TRUE,"Conflict of interest <section> JF reports a relationship with Abbvie AC Immune Alzheon Artemida BioClinica/Clario Biogen BMS Brainomix Cerevast Daiichi-Sankyo EISAI Eli Lilly F. Hoffmann-LaRoche AG Guerbet Ionis Pharmaceuticals Janssen Julius Clinical jung diagnostics Merck Novo Nordisk Premier Research Roche and Tau RxInc that includes: consulting or advisory. AK reports a relationship with Bayer <section> AG that includes: consulting or advisory. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This project received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). We acknowledge financial support from the Open Access Publication Fund of Charité Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1208638",TRUE,"Conflict of interest <section> FK received honoraria for lecturing and advisory activities unrelated to the presented research from Abbvie Stadapharm Esteve and CSL Behring. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> This analysis is supported by the Bayesian statistics finding the likelihood of absent differences in the MED-ON versus MED-OFF conditions three to four times higher than the likelihood of their presence. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This research was funded by the transverse research project (S2020649). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1209487",TRUE,"Conflict of interest <section> A-LF has received funding for speaking engagements from Angelini Pharma. BG has received funding for speaking engagements from Angelini Pharma. KM served as a speaker and received travel expenses from Angelini Pharma and Jazz Pharmaceuticals. <section> The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This research was undertaken in part thanks to scientific writing funding from Angelini Pharma GmbH Munich Germany.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1211812",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by grants from the German Research Foundation (DFG; grants FOR3004 PR1274/3-1 PR1274/5-1 and PR1274/9-1) by the Helmholtz Association (HIL-A03 BaoBab) and by the German Federal Ministry of Education and Research (ConnectGenerate 01GM1908D) to HP.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fneur.2023.1216477",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> We thank the Sumaira Foundation for supporting this article collection.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1230402",TRUE,"Conflict of interest <section> VM TK and AH reported receiving personal fees from ai4medicine outside the submitted work. Whilst not related to this work JS reports receipt of speakers’ honoraria from Pfizer Boehringer Ingelheim Daiichi Sankyo Gore Maquet Paion Sanofi Takeda pharma UCB and Berlin Chemie. DF reported receiving grants from the European Commission reported receiving personal fees from and holding an equity interest in ai4medicine outside the submitted work. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study has received funding from the European Commission through a Horizon2020 grant (PRECISE4Q grant no. 777 107 coordinator: DF) and the German Federal Ministry of Education and Research through a Go-Bio grant (PREDICTioN2020 grant no. <section> 031B0154 lead: DF).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1269030",TRUE,"Disclosure Policy which is administered by the Praxis Spinal Cord Institute. <section> Conflict of interest <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"VN: Conceptualization Funding acquisition Writing – review & editing. JS: Conceptualization Funding acquisition Writing – original draft. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. JS received funding support from the National Institutes of Neurological Disorders-NIH (Grant R01NS118200); the Craig H. MK received funding support from the Wingsfor-Life Spinal Cord Research Foundation (Grants WfL-DE16/16 and WfL-DE-11/20). The Rick Hansen Spinal Cord Injury Registry and this study are supported by the Praxis Spinal Cord Institute with funding from the Government of Canada and the Government of British Columbia.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1269406",FALSE,"",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. We acknowledge the support of Saarland University.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1284444",TRUE,"Conflict of interest <section> SS CT’j and BH are employees of argenx Ghent Belgium.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. The phase ADAPT+ study (NCT03669588) was funded by argenx the manufacturer of efgartigimod an approved agent for gMG in multiple countries. Funding for the writing and editing of this work was provided by argenx. JH has received research support (paid to his institution) from Alexion Pharmaceuticals argenx Cartesian Therapeutics the Centers for Disease Control and Prevention (Atlanta GA USA) the Myasthenia Gravis Foundation of America the Muscular Dystrophy Association the National Institutes of Health (including the National Institute of Neurological Disorders and Stroke and the National Institute of Arthritis and Musculoskeletal and Skin Diseases) PCORI Ra Pharmaceuticals (now UCB Biosciences) and Millennium Pharmaceuticals/Takeda Pharmaceuticals; honoraria from AcademicCME Alexion Pharmaceuticals argenx Biologix Pharma F. HM has served as a paid consultant for Alexion AstraZeneca Rare Disease argenx UCB Pharma and Roche and has received speaker honoraria from the Japan Blood Products Organization and Chugai Pharmaceutical and research support from the Ministry of Health Labour and Welfare Japan.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1307627",TRUE,"Conflict of interest <section> AM received speaker’s honoraria from Alexion Grifols and Hormosan and honoria from Argenx Alexion MorphoSys and UCB for consulting services and financial research support from Alexion and Octapharma. He is chairperson of the medical advisory board of the DMG. FS has received speaker’s honoria and honoria for attendance of advisory boards from Argenx Alexion and UCB. MS has received speaker’s honoraria and honoraria for attendance at advisory boards from Argenx and Alexion. SH has received speaker’s honoria and honoraria for attendance at advisory boards from Argenx Alexion Roche and UCB. SL has received speaker’s honoraria for the attendance at patient events and advisory boards from Argenx Alexion Biogen Hormosan Huma Roche and UCB. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> registration: https://clinicaltrials.gov/study/NCT03979521 The study was conducted in accordance with the declaration of Helsinki and registered on clinicaltrials.gov (NCT03979521).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fneur.2023.1308683",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> JS: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Supervision Validation Visualization Writing – original draft Writing – review & editing. AM: Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Software Validation Visualization Writing – original draft Writing – review & editing. JO: Conceptualization Funding acquisition Project administration Resources Supervision Validation Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work has been supported by financial award of voluntary association “Friends of Saarland University Medical Center” for JS.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fneur.2023.1330484",TRUE,"Conflict of interest <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. <section> TSe was funded by the Ellen-Schmidt-Scholarship of the Hannover Medical School. FK is supported by the Cologne Clinician Scientist Program (CCSP) / Faculty of Medicine / University of Cologne funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation; Project no. 413543196). His research is supported by the German Ministry for Education and Research (BMBF) Bristol-Myers Squibb Foundation for Immuno-Oncology Claudia von Schilling Foundation for Breast Cancer Research Else Kröner Fresenius Foundation Hannover Biomedical Research School (HBRS) Alnylam Pharmaceuticals CSL Behring Novartis Sanofi Genzyme VHV Foundation.",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnhum.2023.1080177",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This research discussed here is supported by the International Psychoanalytic University (IPU) Berlin the American Psychoanalytic Association (APsaA grant nos.",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnhum.2023.1147352",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This research was funded by the Scientific and Technological Research Council of Türkiye (TÜBİTAK) project number 214S069.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnhum.2023.1151531",TRUE,"Conflict of interest <section> CC has received honoraria for speaking from Bayer and research funding from Novartis and Alexion unrelated to this study. CC is a member of the Standing Committee on Science for the Canadian Institutes of Health Research (CIHR). <section> The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnhum.2023.1152204",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding This publication has been financially supported by Regione Sicilia through the Rehastart project (Grant identifier: PO FESR 2014-2020 Azione 1.1.5. n.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnhum.2023.1277539",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships <section> that could be construed as a potential conflict of",TRUE,"J-DH: Conceptualization Funding acquisition Methodology Project administration Resources Supervision Validation Writing – review and editing Writing – original draft. <section> Funding <section> The authors declare financial support was received for the research authorship and/or publication of this article. We acknowledge financial support from the Open Access Publication Fund of",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnhum.2023.1325154",TRUE,"Conflict of interest <section> AK declares that she was on the advisory board of Medtronic and Boston Scientific and had received honoraria from Medtronic and Boston Scientific LF received honoraria for talks for Medtronic; no other relationships or activities that could appear to <section> have influenced the submitted work. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> LF: Conceptualization Data curation Funding acquisition Investigation Methodology Project administration Visualization Writing – original draft Writing – review & editing. <section> JH: Conceptualization Data curation Funding acquisition Investigation Methodology Project administration Writing – original draft Writing – review & editing. <section> Funding <section> The authors declare financial support was received for the research authorship and/or publication of this article. <section> This study was funded by the NeuroCure Patient and the BIH QUEST Stakeholder Engagement Fund Deutsche Forschungsgemeinschaft (DFG German Research Foundation)— Project ID 4247788381–TRR 295 Grant the Lundbeck Foundation Grant Nr.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2022.1105376",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships <section> that could be construed as a potential conflict of",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1025428",TRUE,"<section> construed as a potential conflict of interest.",TRUE,"<section> This study was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)SPP2041 WA 1539/9-1/SPP2031 WA 1539/11-1 ERK 724/4-1 and 337619223/RTG2386.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1081295",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1105233",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be <section> construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1159914",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by H2020 Research and Innovation Action Grant Human Brain Project SGA2 785907 (PR) H2020 Research and Innovation Action Grant Human Brain Project SGA3 945539 (PR) H2020 Research and Innovation Action Grant Interactive Computing E-Infrastructure for the Human Brain Project ICEI 800858 (PR) H2020 Research and Innovation Action Grant EOSC VirtualBrainCloud 826421 (PR) H2020 Research and Innovation Action Grant AISN 101057655 (PR) H2020 Research Infrastructures Grant EBRAINS-PREP 101079717 (PR) H2020 European Innovation Council PHRASE 101058240 (PR) H2020 Research Infrastructures Grant EBRAIN-Health 101058516 (PR) H2020 European Research Council Grant ERC BrainModes 683049 (PR) JPND ERA PerMed",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnins.2023.1183312",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was partly supported by funding to YW from NIH (EB023507 NS121706-01) AHA (18CDA34140024) and DoD (W81XWH1810070 W81XWH-22-1-0221). Funding to SM SK and PB-S was provided by the German Federal Ministry of Education and Research (BMBF) under the ERA-NET NEURON scheme (01EW1811) and the German Research Foundation (DFG Project BO 4484/2-1 and EXC-2049-390688087 NeuroCure). MRI data analysis was supported by Charité R |Replace Reduce Refine.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1185483",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnins.2023.1210949",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> CW was supported by Human Frontier Science Program (HFSP",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1227858",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"Funding sources <section> Of the 76 included studies 27 research groups did not provide funding information. Four trials were partly sponsored by companies (Johnson et al. 1991; Allison et al. 1995; Hasan et al. 2015; Wagenseil et al. 2018). The majority of the studies were funded either by public funds (Napadow et al. 2012; Yeo et al. 2014; Sellaro et al. 2015; Stavrakis et al. 2015 2020; Steenbergen et al. 2015; Luo et al. 2016; Abdi et al. 2017; Burger et al. 2017 2019; SabinoCarvalho et al. 2017; Badran et al. 2018; Colzato et al. 2018; VenturaBort et al. 2018; Keute et al. 2019; Nakahara et al. 2019; Sclocco et al. 2019; Tobaldini et al. 2019; Villani et al. 2019; Giraudier et al. 2020; Wu et al. 2020; Zhu et al. 2021) or were investigator initiated (Karst et al. 2007; Usichenko et al. 2007 2020; la Marca et al. 2010; Black et al. 2011; Taylor et al. 2013; Clancy et al. 2014; Laqua et al. 2014; Klausenitz et al. 2016; Kuo et al. 2016; Antonino et al. 2017; Chen et al. 2017; de Couck et al. 2017; Borges et al. 2019; Bretherton et al. 2019; Gan et al. 2020; Gauthey et al. 2020; Hendawy and Abuelnaga 2020; Ricci et al. 2020; Staley et al. 2020; Koenig et al. 2021).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnins.2023.1255209",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnmol.2022.1084633",TRUE,"Conflict of interest <section> JV PM SG and CG have significant financial interests in Draupnir Bio a company involved in the development of small molecule inhibitors of PCSK9.",TRUE,"<section> Funding <section> This study was funded by the Lundbeck Foundation (SG) Novo Nordisk Foundation (SG) Carlsberg Foundation (SG) Kristjan Jaak Scholarship program “Degree Studies Abroad” of Foundation Archimedes” (AP) Danish Council for Independent Research Sapere Aude starting grant (SG grant number DFF 4183–00604). TT and JT were supported by Estonian Research Council (grant PRG805) European Union through the European Regional Development Fund (Project No. IUE experiments were funded by Russian Science Foundation grant number 21–65-00017 (VT and EB).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnmol.2023.1171855",TRUE,"Conflict of interest <section> SS was the founder and scientific advisor of 7TM Antibodies GmbH Jena Germany. The Charité – Universitätsmedizin Berlin has filed a patent on pH-dependent opioid receptor agonists (US <section> 9133120 <section> B2). <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> CS was supported by grants from Deutsche Forschungsgemeinschaft (FOR 5177; EXC 2046 AA1-15; STE 477/19-1; STE 477/21-1; and STE 477/22-1) US National Science Foundation (NSF; 2113030) and Bundesministerium für Bildung und Forschung (BMBF; 01GQ2109A). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnmol.2023.1260345",FALSE,"",TRUE,"SS: Conceptualization Funding acquisition Project administration Resources Supervision Validation Writing—original draft Writing—review and editing. KA: Conceptualization Formal analysis Funding acquisition Methodology Project administration Supervision Validation Visualization Writing—original draft Writing—review and <section> Funding <section> The authors declare financial support was received for the research authorship and/or publication of this article. This study was supported by the German Research Foundation (DFG– Deutsche Forschungsgemeinschaft; grant FOR 2690).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnmol.2023.1280556",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"RH: Conceptualization Formal analysis Funding acquisition Supervision Writing—review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This study was funded by a GO-Bio award of the German Bundesministerium für Bildung und Forschung (BMBF) to RH. We acknowledge financial support from the Open Access Publication Fund of",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fnrgo.2023.1233722",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> SRS and DH were supported by the ERA-NET NEURON project HYBRIDMIND (BMBF 01GP2121) the European Research Council (ERC) under the project NGBMI (759370) and",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnut.2022.1061299",FALSE,"",TRUE,"<section> Funding <section> The project was funded by China Postdoctoral Science Foundation (Grant numbers 2022TQ0016 and 2022M720298) Beijing Postdoctoral Research Foundation (Grant number 2022-",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration:",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fnut.2023.1032430",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships <section> that could be construed as a potential conflict of",TRUE,"<section> Funding <section> This research was funded by the German Ministry of Education and Research (BMBF) the State of Brandenburg and the German Center for Diabetes Research (DZD 82DZD03D03).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fnut.2023.1213661",FALSE,"",TRUE,"<section> Funding <section> The study was funded by the German Diabetic Association/Abbott (DDG Adam Heller Prize 2021 OP-R) and by the German Research Foundation (DFG 491394008).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Conclusion: The dietary fat which may be associated the daily mean glucose Clinical trial registration: identiﬁer: DRKS00026699.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fonc.2022.1056786",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The study was supported by the East German Study Group Hematology and Oncology (OSHO) ﬁle number OSHO #97.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2022.1080492",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This work was supported by German Research Foundation (TRR295).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2022.1095633",FALSE,"",TRUE,"<section> Funding CG DZ SG and DT received funding by the German Research Council (DFG ZI 736/2-1; PAK 997/1: GA 2996/1-1 ZI 736/4-1). We acknowledge support by Open Access Publishing Fund of University of Tübingen.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fonc.2022.946850",FALSE,"",TRUE,"<section> Funding <section> This work was supported by Merck Healthcare KGaA Darmstadt Germany (CrossRef Funder ID: 10.13039/100009945).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fonc.2023.1056330",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1073793",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> Supported by the FONCYT Argentina (PICT 2016-#1093) CONICET (PIP2014-2016 #300) and donations from Doctors Choi H (Kit ELISA of Gal-3 CCL-2 and CCL-5) and Chudzinski-Tavassi AM (Kit ELISA of pro and active MMP-9).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"However in this study we have not registered higher CCL-2 levels in PB plasma from BCPs contrary to observations made by Lubowicka et al. which related CCL-2 to breast cancer progression (76).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fonc.2023.1107134",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1128176",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be constructed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This trial is funded by MSD Sharp & Dohme GmbH. This publication was funded by the Open Access Publishing Fund of Leipzig University supported by the German Research Foundation within the program Open Access Publication Funding.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial is registered on the clinicaltrials.gov database (NCT03480672).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fonc.2023.1129627",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1171003",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was funded by the German research foundation: DFG Si-1983 4/1.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fonc.2023.1171794",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fonc.2023.1224347",FALSE,"",TRUE,"<section> Funding <section> Funding received from the Joint Federal Committee Innovation Fund Grant Number 01VSF21047.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1227036",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the following grants awarded to",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1248926",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1272175",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"AS: Conceptualization Data curation Funding acquisition Investigation Visualization Writing – review & editing Formal Analysis Resources. MB: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Methodology Writing – review & editing. EG: Conceptualization Data curation Formal Analysis Funding acquisition Investigation Project administration Resources Writing – review & editing. <section> Funding The trial is funded by MS and was sponsored by the IKF.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fonc.2023.1273478",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fonc.2023.1280977",FALSE,"",TRUE,"HS: Conceptualization Data curation Formal analysis Investigation Methodology Project administration Writing – original draft Writing – review & editing Funding acquisition. MJ: Data curation Funding acquisition Investigation Writing – original draft Writing – review & editing. FR: Conceptualization Funding acquisition Investigation Writing – review & editing. PS: Conceptualization Funding acquisition Investigation Writing – review & editing. US: Project administration Supervision Writing – original draft Investigation Writing – review & editing Conceptualization Funding acquisition. <section> Funding This work was supported by grants from the Max-Delbrück-Center for Molecular Medicine and the Charité Universitätsmedizin Berlin",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fonc.2023.1342367",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fped.2023.1068103",FALSE,"",TRUE,"<section> Funding <section> This study was supported in part by grants from the German Federal Ministry of Education and Research (82DZL004A1) and Novartis Institutes for Biomedical Research Cambridge MA United",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fped.2023.1144914",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fped.2023.1235877",FALSE,"",TRUE,"<section> Funding <section> This study was funded by the Open Access Publishing Fund of Leipzig University which is supported by the German Research Foundation within the program Open Access Publication Funding. <section> The authors acknowledge receipt of a travel grant for collecting the data from the Medical Faculty of the University of Leipzig.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fped.2023.1266738",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"UB: Conceptualization Formal Analysis Funding acquisition Project administration Resources Supervision Writing – original draft Writing – review & editing. <section> Funding <section> This work has been supported by the Lost Voices and Weidenhammer-Zoebele foundations. <section> We thank all patients who participated in this study and their parents for supporting their participation. CS was consulting Roche Celltrend and Bayer; she received support for clinical trials by Bayer Fresenius and Miltenyi honoraria for lectures by Fresenius AstraZeneca BMS Roche Bayer and Novartis and research grants from the German Research Association (DFG) the BMBF the BMG the Weidenhammer-Zoebele Foundation the Lost-Voices Foundation and the ME/CFS Research Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2022.1090554",TRUE,"<section> The remaining author declares that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> We acknowledge support by the Open Access Publication Initiative of Freie Universität Berlin.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1040584",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 754995.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1076800",FALSE,"",TRUE,"<section> Funding <section> This work was funded by the Deutsche Forschungsgemeinschaft (STE1765/3-2).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphar.2023.1124214",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding Publication funded by the Brandenburg Medical School (Medizinische Hochschule Brandenburg MHB) publication fund supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) and by the Ministry of Science Research and Culture of the State of Brandenburg. This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1136174",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1161891",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was supported by grants from the German Federal Ministry of Education and Research (BMBF) (82DZL004A1 and 82DZL009B1). MM received grants from Vertex Pharmaceuticals and personal fees for participation in advisory boards or consulting from Abbvie Antabio Arrowhead Pharmaceuticals Boehringer Ingelheim Enterprise Therapeutics Kither Biotech Pieris Pharmaceuticals Santhera Sterna Biologicals Vertex Pharmaceuticals outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphar.2023.1179208",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was supported by the German Federal Ministry of Education and Research (82DZL009B1) and the German Research Foundation (DFG; STA 1685-1/1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1180826",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1188051",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was supported by grants from the German Federal Ministry of Education and Research (BMBF) (82DZL004A182DZL009B1). MM received grants from Vertex Pharmaceuticals and personal fees for participation in advisory boards or consulting from Abbvie Antabio Arrowhead Pharmaceuticals Boehringer Ingelheim Enterprise Therapeutics Kither Biotech Pieris Pharmaceuticals Santhera Sterna Biologicals Vertex Pharmaceuticals outside the submitted work.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphar.2023.1211824",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (DFG Grant No. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphar.2023.1214351",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study received funding from Dr.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphar.2023.1254706",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphar.2023.1257345",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"FW: Funding acquisition Supervision. <section> Funding This study was supported by the National Key R&D Program of China",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This study was registered in the PROSPERO database (CRD42021231297) and conducted following the standards of the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) (Page et al. 2021).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fphar.2023.1301800",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"J-DS: Funding acquisition Methodology Supervision Writing–review and editing. RB: Formal Analysis Funding acquisition Project administration Supervision Writing–review and editing. <section> Funding The study was supported by the German Research Foundation Deutsche Forschungsgemeinschaft DFG Schu 559/11-5—175142815 and GRK 2318—318905415 (project C01).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphys.2023.1057592",FALSE,"",TRUE,"<section> Funding The present study was sponsored by Roche Pharmaceuticals Basel Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphys.2023.1086730",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> FH was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research) as well as the DFG (German Research Foundation; HO 5647/4-1 SFB1470).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphys.2023.1152301",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> The authors acknowledge the support of the European Union (EU) Horizon 2020 project InterLynk (grant agreement: H2020-",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fphys.2023.1173171",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was supported by the DLR (German Aerospace Center Bonn Germany) grant number 50WB1832. PC is funded by the Italian Ministry of Health (Ricerca Corrente).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphys.2023.1188802",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fphys.2023.1306178",FALSE,"",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2022.1000572",TRUE,"Conflict of interest <section> The authors declare that the submitted work was conducted in the absence of any personal professional or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was funded by the Mind-Institute SE. and the",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2022.1072719",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"Supported by the interview data and other studies (Dawson et al. 2019; Tribe et al. 2019) this leads to the hypothesis that in addition to the lack of adequate structural conditions barriers for implementation can also be found in the attitudes of individual staff members or an institutional culture as a whole caused by personal doubts or resistances when an OD principle challenges previous treatment routines or approaches. <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyg.2022.964658",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> The research is funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—CRC 1412 416591334. <section> Funding <section> This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—SFB 1412 416591334.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyg.2023.1113654",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was funded by the Excellence Initiative of the German Federal Ministry of Education and Research (Excellence Cluster science of Intelligence) and the Max Planck School of Cognition.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyg.2023.1121986",TRUE,"Transparency beyond information disclosure: strategies of the Scandinavian public health authorities during the COVID-19 pandemic.",TRUE,"<section> The results of the genderspecific moderation analyses are also supported by the zeroorder correlational patterns of the subsamples of women and men (Supplementary Table S1). <section> Funding <section> This study was funded by Innlandet Hospital Trust.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2023.1123907",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This research was supported by a grant from the Milton Erickson Gesellschaft für klinische Hypnose e.V. to AZ and WS and also partly funded by the Federal Ministry of Education and Research of Germany (BMBF) under Grant No. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Humboldt-Universität zu Berlin.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2023.1125545",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> The study is funded by the German Cancer Aid Foundation (Stiftung Deutsche Krebshilfe) (funding numbers: 70113544 70113611 and 70113613) and additionally financially supported by the Department of Medical Psychology and Medical Sociology at the University Medical Center of Leipzig by the Charité Comprehensive Cancer Center Berlin and the Department of Psychosomatic Medicine and Psychotherapy Hannover Medical School Hannover. <section> Funding <section> This study was funded by grants from the German Cancer Aid Foundation (Stiftung Deutsche Krebshilfe) and financially supported by the Department of Medical Psychology and Medical Sociology at the University Medical Center of Leipzig by the Charité Comprehensive Cancer Center Berlin and the Department of Psychosomatic Medicine and Psychotherapy Hannover Medical School Hannover.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial registration: NCT04620564 Registrier-No.: ST-U134",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyg.2023.1139128",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the Berlin School of Mind and Brain.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyg.2023.1195607",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by a grant from the University of Cologne Center of Excellence for Social and Economic Behavior This work was supported by the Open Access",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyg.2023.1200798",FALSE,"",TRUE,"<section> Funding <section> This study was funded by the Federal Ministry of Education and Research Germany (BMBF; grant number 02L16D010). We acknowledge support by Open Access Publishing Fund of University of Tübingen.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2023.1239425",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2023.1271180",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"J-DH: Conceptualization Funding acquisition Project <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work was funded by the Excellence Initiative of the German Federal Ministry of Education (Excellence Cluster Science of intelligence) the BMBF and Max Planck Society (through Max Planck School of Cognition) the",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyg.2023.1287706",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> There was no funding for the current study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2022.1010273",TRUE,"Conflict of interest <section> MDu received fees for consultation and lectures from Roche Bayer Hovid Berhad and Sanofi. OP received fees for consultation and lectures from Biogen Eisai Griffols <section> MSD Roche and Schwabe. JP received fees for consultation lectures patents from Neurimmune Axon Desitin and Epomedics. JW was an honorary speaker for Actelion Amgen Beeijing Yibai Science and Technology Ltd. Janssen Cilag Med Update GmbH Pfizer Roche Pharma and was a member of the advisory boards of Abbott Biogen Boehringer Ingelheim Lilly MSD Sharp & Dohme and Roche Pharma and received fees as a consultant for Immungenetics and Roboscreen. FJ received fees for consultation from Eli Lilly Novartis Roche BioGene MSD Piramal Janssen <section> and Lundbeck. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential <section> conflict of interest.",TRUE,"<section> Funding <section> The DELCODE study was funded by the German Center for Neurodegenerative Diseases (reference no. BN012). The DELCODE study was supported by the Max-Delbrückcentrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) Freie Universität Berlin Center for Cognitive Neuroscience Berlin (CCNB) Nuklearmedizin und Klinische Molekulare Bildgebung—Univeristätsklinikum Tübingen Bernstein Center für Computional Neuroscience Berlin Universitätsmedizin Göttingen Core Facility MR-Research Göttingen Institut für Klinische Radiologie Klinikum der Universität München and Universitätsklinikum Tübingen MR-Forschungszentrum.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"DELCODE was registered at the German Clinical Trials Register DRKS00007966 (2015/05/04) and approved by the local ethics committees of all participating institutions in accordance with the Declaration of Helsinki. The DELCODE study was approved under a harmonized vote in which the approval process is coordinated by the ethical committee of the medical faculty of the University of Bonn (Ethik-Kommission der Medizinische Fakultät Rheinische Friedrich-Wilhelms-Universität Bonn Germany; Registration number: 117/13) in charge.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2022.1033020",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships <section> that could be construed as a potential conflict",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2022.1037451",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2022.1052874",TRUE,"Conflict of interest <section> RR was employed as a Vivantes staff member for <section> the evaluation during data collection and analysis. <section> Previously RR was employed as a psychologist at the day hospital during the implementation of the therapy program. CR was the chief physician and behavior <section> therapist. <section> The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential <section> conflict of interest.",TRUE,"<section> Funding <section> We acknowledge financial support for publication fees from Vivantes GmbH.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: DRKS00029992.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2022.1100030",TRUE,"<section> The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1001085",TRUE,"Conflict of interest <section> NK owns issued patent US20160192889A1 (“Adaptive pattern recognition for psychosis risk modeling”). As a member of Spring Health’s Scientific Advisory Board. NK has advised that company on the development of tools to predict treatment outcomes for depression and psychosis. He has no equity and has received no financial compensation from this company. PF received research support/honoraria for lectures or advisory activities from: Boehringer-Ingelheim Janssen Lundbeck Otsuka Recordati and Richter. These affiliations did not influence the writing of this <section> manuscript. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding This work was also supported by the Bavarian State Ministry of Justice through the “Kein Täter werden” project as well as by the PRONIA project as funded by the European Union 7th Framework Program (grant 602152). NK was supported through grants from NIH (U01MH124639-01; ProNET) the Wellcome Trust the German Innovation Fund (CARE project) the German Federal Ministry of Education and Research (COMMITMENT and BEST projects) as well as ERA PerMed (IMPLEMENT project).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1086468",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be <section> construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1089484",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as <section> a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> This study is registered at the German Clinical Trials Register (DRKS-ID: DRKS00015494).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2023.1130727",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The study is funded by the Innovationsausschuss beim Gemeinsamen Bundesausschuss (Project no. 01VSF19037).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> scope of mental health Clinical trial registration:",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2023.1130809",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The Zurich Program for Sustainable Development of Mental Health Services (ZInEP) was supported by a private donation.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1134458",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (DFG Project-ID 402170461 – TRR 265; 390688087 – EXC 2049).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1155582",TRUE,"None of the other authors has any financial conflicts of interest to declare. Regarding nonfinancial aspects it is pointed out that all authors except for <section> SD are working at one of the German University Departments of <section> Psychosomatic Medicine and Psychotherapy. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"His research is funded by the German Ministry of Education and Research the German Research Foundation and the EU Commission.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: identiﬁer: DRKS00016412.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2023.1155725",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1161097",TRUE,"Conflict of interest <section> FP is a member of the European Scientific Advisory Board of Brainsway Inc. Jerusalem Israel and the International Scientific Advisory Board of Sooma Helsinki Finland. He has received speaker’s honoraria from Mag&More GmbH the neuroCare Group Munich Germany and Brainsway Inc. His lab has received support with equipment from neuroConn GmbH Ilmenau Germany Mag&More GmbH and Brainsway Inc. TB served in an advisory or consultancy role for eye level Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. He received conference support or speaker’s fee by Janssen Medice and Takeda. <section> He received royalities from Hogrefe Kohlhammer CIP Medien Oxford University Press; the present work is unrelated to these relationships. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This work was supported by the Phenotypic Diagnostic and Clinical Domain Assessment Network Germany (PD-CAN) research consortium (FKZ 01EE1406I) and the following research consortia AERIAL (01EE1406) APIC (01EE1405) ASD-Net (01EE1409) ESPRIT (01EE1407) GCBS (01EE1403) ESCAlife (01EE1408) BipoLife (01EE1404) OptiMD (01EE1401) and PROTECT-AD (01EE1402) funded by the German Federal Ministry of Education and Research (BMBF; http://www.Bmbf.de).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1166197",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> Funded by the Brandenburg Medical School publication fund supported by the German Research Foundation and the Ministry of Science Research and Cultural Affairs of the State of Brandenburg.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1170168",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the Deutsche Forschungsgemeinschaft (DO1915-3/1). SF and LW received financial support from the Einstein Center of Neuroscience. FS received financial support from the German Research Foundation (SCHL1969/1-2 SCHL1969/3-1 and SCHL 1969/5-1). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1173466",TRUE,"<section> 9. Gray MJ Schorr Y Nash W Amidon A Lansing A Maglione M et al. Adaptive disclosure: an open trial of a novel exposure-based intervention for service members with combat-related psychological stress injuries. Adaptive disclosure a combat-specific PTSD treatment versus cognitive-processing therapy in deployed marines and sailors: a randomized controlled non-inferiority trial.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1176721",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1189970",TRUE,"Conflict of interest <section> Dr.",TRUE,"<section> Funding <section> This work was supported by the Else Kröner-Fresenius-Stiftung (SK grant number 2018_A142).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1194222",TRUE,"Conflict of interest <section> CC has been a consultant and/or advisor to or has received honoraria from: AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. <section> The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"He has received grant support from Janssen and Takeda.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1194228",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1198146",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The study was funded by the Deutsche Rentenversicherung Bund (Federal German Pension Agency) grant number 0421/40-64-50-01. Supported by the European Commission.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1208856",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding The MPP-S study is supported by Deutsche Gesellschaft für Psychoanalyse Psychotherapie Psychosomatik und Tiefenpsychologie (DGPT e.V.) and by Köhler Stiftung (Grant number: S112/10211/16). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1223147",FALSE,"",TRUE,"<section> Funding <section> We acknowledge the generous support provided by the German Research Foundation (Projekt-Nr. 512648189) and the Open Access Publication Fund of the Thüringer Universitätsund",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1227153",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1229113",TRUE,"Conflict of interest <section> The authors DvH GL and CM published a book on the presented therapeutic approach (MPP-s). <section> The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1232148",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1240703",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> We acknowledge financial support for the publication fee from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1252268",TRUE,"Conflict of interest <section> MG-S was employed by Helios Klinik Rottweil and received payments for scientific lectures from Dr.",TRUE,"<section> Funding <section> This research and its publication were funded by Dr.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1258303",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1267038",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"FB: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. KB: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. SH: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. RB: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. SW: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. MK: Conceptualization Funding acquisition Investigation Methodology Project administration Resources Supervision Validation Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This work was partially supported by the German Federal Ministry of Education and Research (BMBF; Grant No. We also acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1294314",TRUE,"Conflict of interest <section> MS has received speaker’s fees from MEDICE Arzneimittel Pütter GmbH & Co. KG and Takeda and was an advisory board member for Takeda in the past 3 years. AR has received honoraria for advisory boards or talks from MEDICE Arzneimittel Pütter GmbH & Co. KG Takeda Janssen Boehringer Ingelheim SAGE/Biogen cyclerion COMPASS and LivaNova. JG has received research funding from the German Federal Ministry of Education and Research German Science Foundation and speaker fees from Lundbeck Janssen-Cilag Lilly and Boehringer. SK-S. has received author’s and speaker’s honoraria from Takeda and Medice Arzneimittel Pütter GmbH &Co. KG in the past 3 years. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. The author(s) acknowledge support from the German Research Foundation (DFG) and Universität Leipzig within the program of Open Access Publishing. JG has received research funding from the German Federal Ministry of Education and Research German Science Foundation and speaker fees from Lundbeck Janssen-Cilag Lilly and Boehringer.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This study was reviewed and approved by the local ethics committee (registration: EudraCT 2015–000488–15; German Clinical Trial Register DRKS00009971 University of Leipzig Ethics Committee 337/15-ff). <section> The studies involving humans were reviewed and approved by the local ethics committee (registration: EudraCT 2015–000488–15; German Clinical Trial Register DRKS00009971 University of Leipzig Ethics Committee 337/15-ff).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpsyt.2023.1303009",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"This multicenter study was conducted in 2016 and 2017 in six German federal states and was funded by the State Commissioner for Migration Refugees and Integration of the German government. <section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpsyt.2023.1321345",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. This study was funded by POR CAMPANIA FESR 2014–2020 ASSE PRIORITARIO 3 (Grant No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpsyt.2023.1325021",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1001132",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The present work was supported by a scholarship by the Deutscher Akademischer Austauschdienst (DAAD) Grant 57460842 to SK. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Humboldt-Universität zu Berlin.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1054015",TRUE,"<section> construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The research project was funded by Stiftung Charité (file number WIS_PRO_619). <section> We would like to thank Iasmina Iepan for supporting the organization of the data collection and for transcribing the focus group interviews.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1065938",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The “MHS–Establishment of a National Mental Health Surveillance at Robert Koch-Institute” project is funded by the",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1076065",TRUE,"The authors have declared competing interests as listed at the end of this manuscript. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study was supported by the Physical Activity and Nutrition Determinants in Asia (PANDA) Research Programme Saw Swee Hock School of Public Health National University of",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1118522",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1126503",TRUE,"Conflict of interest <section> SJS received grants and non-financial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) non-financial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work. Dr. Schaller holds stocks in small amounts from Alphabeth Inc. Bayer AG and Siemens AG; these holdings have not affected any decisions regarding his research or this study. <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study received institutional funding by Technical University Munich. <section> SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovationsfond of The Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1134546",TRUE,"Conflict of interest <section> VC was employed by Labor Berlin – Charité Vivantes GmbH. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> Funding for B-FAST was provided by the German Ministry for Education and Research (BMBF).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical trial registration: [https://doi.org/10.1186/ISRCTN17401860] identifier The trial was registered prospectively at ISRCTN registry (Trial number: 17401860).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fpubh.2023.1140665",TRUE,"<section> construed as a potential conflict of interest.",TRUE,"Supported by the World Health Organization 18 game industry companies joined the #PlayApartTogether social media campaign in March 2020 to encourage players around the globe to practice physical distancing.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1147558",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1148029",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> This study received financial support from the Open Access Publication Fund of Charite Universitatsmedizin Berlin and the German Research Foundation (DFG). We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1186929",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> The egePan Unimed and PREPARED projects are funded by the German Federal Ministry of Education and Research as part of the were provided but not used while 1.7–11.6% indicated for them such services were not available. <section> Funding <section> egePan Unimed and PREPARED are funded by the German Federal Ministry of Education and Research as part of the Netzwerk",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1196596",TRUE,"Conflict of interest <section> Outside the submitted work SB reports ownerships in Intomics <section> A/S Hoba Therapeutics Aps Novo Nordisk A/S Lundbeck A/S <section> ALK abello A/S and managing board memberships in Proscion A/S <section> and Intomics A/S. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1204101",TRUE,"Conflict of interest <section> AK: advisory board and presentations for GlaxoSmithKline and MS. <section> The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The study was funded by the Federal Ministry of Health of Germany (Bundesministerium für Gesundheit).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1231266",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1256829",TRUE,"Conflict of interest <section> be construed as a potential conflict of interest.",TRUE,"<section> OW: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing – original draft Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. The publication of this article was partially funded by the Charité publication funds.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fpubh.2023.1271486",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"VK: Conceptualization Funding acquisition Supervision Writing – review & editing. <section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1284460",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare financial support was received for the research authorship and/or publication of this article. We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG) for the publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1286056",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could <section> be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fpubh.2023.1293575",TRUE,"Conflict of interest <section> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding <section> The author(s) declare that no financial support was received for the research authorship and/or publication of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/fresc.2022.1093871",TRUE,"<section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/frtra.2023.1273890",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding <section> This study was funded by Novartis Pharma GmbH Nuremberg Germany. BN was in the advisory board and received funding from Novartis.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Clinical Trial Registration: number: 2011-005238-21).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3389/fspor.2023.1197640",FALSE,"",TRUE,"<section> Funding <section> This work was supported by the German Heart Foundation (September 2013 to June 2021). The pilot phase and scientiﬁc planning of the MYKKE registry was supported by two project grants from Deutsche Herzstiftung (Frankfurt am Main Germany). Logistic support and management of the research database are provided by the Competence Network for Congenital Heart Defects (Berlin Germany) which received funding from the Federal Ministry of Education and Research grant number 01GI0601 (until 2014) and the DZHK (German Centre for Cardiovascular Research) as of 2015.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fsurg.2023.1141017",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/fsurg.2023.1186971",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/ftox.2023.1304885",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/ijph.2023.1606096",TRUE,"<section> CONFLICT OF INTEREST <section> Author SaL was employed by the company Cardinal Health RealWorld Evidence and Insights. <section> The remaining authors declare that they do not have any conﬂicts of interest.",TRUE,"<section> FUNDING <section> The BEAR study is funded by the German Research Council (HO 3314/13-1 WI 5556/2-1 CY 68/5-1) and air pollution modeling is part of the ULTRAFLEB project (“Ultrafeinstaubbelastung durch Flughäfen in Berlin”) funded by the German Federal Environment Agency (Umweltbundesamt; FKZ 3720522010; AZ. MG is supported by a Miguel Servet fellowship (CPII18/00018) from the Spanish Institute of Health Carlos III. We also acknowledge support from the Spanish Ministry of Science and Innovation the State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S) and the Generalitat de Catalunya through the CERCA Program.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/ijph.2023.1606097",TRUE,"<section> CONFLICT OF INTEREST <section> The authors declare that they do not have any conﬂicts of interest.",TRUE,"<section> FUNDING The NAKO is funded by the Federal Ministry of Education and Research (BMBF) (project funding reference numbers: 01ER1301A/B/C and 01ER1511D) federal states and the Helmholtz Association with additional ﬁnancial support by the participating universities and the institutes of the Leibniz Association.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/pore.2023.1610707",TRUE,"<section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> The authors declare that this study received funding from AstraZeneca Cambridge UK and Biocartis Mechelen Belgium.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3389/ti.2023.11321",TRUE,"<section> CONFLICT OF INTEREST <section> KB declares honoraria and or travel support from: Aicuris Astellas Astra CareDx Carealytics Digital Health Chiesi MSD Neovii Natera Paladin Stada Takeda Veloxis Vifor. <section> AVR received lecture and consultancy fees from Sandoz Chiesi Astellas Hansa CSL Behring and Novartis in the past three years all of which went to his employer and none to personal bank accounts. <section> The remaining authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> FUNDING",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3389/ti.2023.11370",TRUE,"<section> CONFLICT OF INTEREST <section> The authors declare that the research was conducted in the absence of any commercial or ﬁnancial relationships that could be construed as a potential conﬂict of interest.",TRUE,"<section> FUNDING <section> The authors declare that the ITP-NODAT study received funding from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases in the form of grant R01DK092475 issued to University of Michigan for which the Medical University of Vienna held a subcontract (#3002300292). <section> The ITP-NODAT study received additional support from Astellas Pharma and Eli Lilly in the form of contracts with the Medical University of Vienna.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antibiotics12030441",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Slovak Research and Development Agency under contracts of SK-PT-18-0006 as part of the Bilateral Cooperation Program (2019–2022) APVV-21-0302 and APVV-18-0075. This work was also supported by the EU Grant number 952398—CEMBO Call: H2020-WIDESPREAD-05-2020—Twinning.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antibiotics12040734",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antibiotics12040752",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: No funding was required for this study. <section> Acknowledgments: Steadman wishes to acknowledge support from the Queensland University of Technology Postgraduate Research Award Scholarship.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antibiotics12050848",TRUE,"Conflicts of Interest: J.S. A.T. and K.-D.K. declare no conflicts of interest.",TRUE,"<section> Funding: This research and was funded by Heraeus Medical GmbH.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antibiotics12091387",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was developed within the scope of the CICS-UBI projects UIDB/00709/2020 and UIDP/00709/2020 funded by national funds through the Portuguese Foundation for Science and <section> Acknowledgments: Cristiana Mateus is recipient of a doctoral fellowship (UI/BD/151023/2021) under the scope of the CICS-UBI Programmatic Funding (UIDP/00709/2020). The microscopy facility used in the development of this work is part of the PPBI-Portuguese Platform of BioImaging and is partially supported by the Project POCI-01-0145-FEDER-022122.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antibiotics12111560",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antibiotics12121657",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"(Anja Menzel) G.S. and J.B. Data visualisation A.S. Supervision: J.B. I.G. and C.H. Project Administration J.B. and A.G. Funding acquisition; I.G. C.H. T.E. A.M. <section> Funding: This research was funded by the Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee (G-BA) in Germany (Grant Number: 01VSF18053) which had no influence in developing the protocol.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"In January 2020 the RedAres study was registered at the Trial registration site DRKS under the trial registration number DRKS00020389.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/antiox12020295",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by our employer the Department of Neonatology Charité—Universitätsmedizin Berlin Germany and by one grant by the Förderverein für Frühgeborene an der Charité e.V. and Sonnenfeld Stiftung Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12020388",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: A.G. received the Alexander von Humboldt Polish Honorary Research Scholarship from the Foundation for Polish Science.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12040980",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was supported by our employer the Department of Neonatology Charité— Universitätsmedizin Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12051011",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> The work is funded by the European Regional Development Fund within the program “Pro FIT—Programm zur Förderung von Forschung Innovationen und Technologien” grant ID: 10168708.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antiox12051068",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was funded by the German Research Foundation (DFG WI2140/4-1 and DFG WI2140 5/1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12061206",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by our employer the Department of Neonatology CharitéUniversitätsmedizin Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12081589",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: The authors are supported by research grants of Deutsche Forschungsgemeinschaft (DFG) (Grants MO 1695/4-1 and 5-1; to H.M. IRTG 2251; to S.R.B. and H.M. Grant 470814312 to H.B.) German Centre for Cardiovascular Research (DZHK) (Grant 81X2800207 to H.M.) and by funding of the Excellence Initiative by the German Federal and State Governments (Institutional Strategy measure ‘support the best’ 3-25 2 Grant F-03661-553-41B-1250000; to H.M.).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/antiox12081646",TRUE,"Conflicts of Interest: J.H. received royalties from Cook Myocyte.",TRUE,"; Funding Acquisition J.H. <section> Funding: <section> This project was funded by a Philanthropic gift from Borgen Family and the Linda and Mitch <section> Acknowledgments: This project was funded by a Philanthropic gift from the Borgen Family and from the Linda and Mitch Hart Family foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/antiox12111927",TRUE,"Conflicts of Interest: L.S. holds shares of selenOmed GmbH a company involved in selenium status assessment.",TRUE,"<section> Funding: This research was supported by the Deutsche Forschungsgemeinschaft (DFG) Research Unit FOR-2558 “TraceAge” (Scho 849/6–2) and CRC/TR 296 “Local control of TH action” (LocoTact P17).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/app13116713",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was partially funded by PRECISE4Q Personalized Medicine by Predictive Modelling in Stroke for Better Quality of Life—European Union’s Horizon 2020 research and innovation program under grant agreement No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/app132111952",TRUE,"Conflicts of Interest: M.M. has a contract with Yen co. for giving lectures and teaching doctors how to use resin TERA HARZ TC 85-DAC.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/audiolres13030039",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bioengineering10020212",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was sponsored by Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) Project-ID 424778381-TRR 295 and Fondazione Grigioni per il Morbo di Parkinson. <section> received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. C.P. was supported by a grant from German Excellence Initiative to the Graduate School of Life Sciences University of Würzburg. I.U.I. received funding from New York University School of Medicine and The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders which was made possible with support from Marlene and Paolo Fresco.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/bioengineering10030387",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by DFG priority program SPP 2084 “µBONE: Colonization and interaction of tumor cells within the bone microenvironment” (grant Raum 1380/10-1) and the position of RP was funded by DFG PU 701/1-1 grant.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bioengineering10040476",TRUE,"Conflicts of Interest: J.D.V.D.V. I.H. N.G.P. P.C. I.U.I. S.H. and C.P. declare no conflicts of interest related to this study.",TRUE,"<section> Funding: The study was sponsored by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project-ID 424778381-TRR 295 and the Fondazione Grigioni per il Morbo di Parkinson. IUI was supported by a grant from the New York University School of Medicine and The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders which was made possible with support from Marlene and Paolo Fresco. This publication was supported by the Open Access Publication Fund of the University of Würzburg. J.D.V.D.V. and I.H. received financial support from the Graduate School of Life Sciences University of Würzburg. I.H. was supported by a scholarship from the German Academic Exchange Service (DAAD; Deutscher Akademischer Austauschdienst). S.H. received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (Grant agreement No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bioengineering10090992",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bioengineering10111247",TRUE,"Conflicts of Interest: The first author as well as some secondary authors are employed by GrOwnValve",TRUE,"<section> Funding: This research was funded by EXIST—Forschungstransfer (03EFIBE103) and the Federal Ministry of Education and Research—Kleine Patienten großer Bedarf—Medizintechnische Lösungen für eine kindgerechte Gesundheitsversorgung (13GW0498).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/bioengineering10121408",TRUE,"Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Research Foundation (DFG Grant KN 377/8-1) and by the Charité Foundation in the form of the Berlin Institute of Health visiting professorship (contract no. BIH_PRO_605).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biology12020171",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Part of this work was funded by the European Research Council (ERC grant agreement no. 201975) under the European Union’s Seventh Framework Program (FP/2007–2013) and Fondation Santé (2018).",FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biology12050706",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: G.R. S.R. M.K. and D.R. received funding from the Austrian Science Fund FWF (doctoral programs: DK-MOLIN (W1241)) and were trained within the frame of the Ph.D. This research was funded in whole or in part by the Austrian Science Fund (FWF) [W1241].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biology12060783",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biology12091207",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was carried out with the support of the Russian Science Foundation grant No Mouse husbandry was supported by the Ministry of Science and Higher Education of the Russian Federation (project No.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13010071",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the German Federal Ministries of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter to MMH and SB (IP7/01KI1725D and 01KI2007D) and by the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag to MMH and SB (ZIM ZF4117908 AJ8).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13010095",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Research Foundation DFG (SFB1002 to G.H. K.T.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13020320",TRUE,"Conflicts of Interest: All authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by grants from the German Federal Ministries of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter to MMH and SB (IP7/01KI1725D and 01KI2007D) and from the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag to MMH and SB (ZIM ZF4117908 AJ8). We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biom13030409",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; or in the writing of the manuscript.",TRUE,"<section> Funding: This work is supported by grants from the zoonoses research consortium PAC-Campylobacter of the German Federal Ministry of Education and Research (BMBF) to TA (project IP2/01KI1725A) SBa (project IP9/01KI2007E) MMH SBe (project IP7/01KI1725) and from the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag to MMH and SBe (ZIM ZF4117908 AJ8). We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13030422",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition C.P.R.H. and R.H. <section> Funding: Funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project ID 431232613-SFB 1449 (C.P.R.H.)",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biom13030449",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (Schu 559/11-5– 175142815 and GRK 2318–318905415 (C01)) and the Sonnenfeld-Stiftung Berlin. This research was partly supported by the German Federal Ministry of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter (project IP2/01KI2007A and project IP8/01KI2007D).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13061009",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the Berlin Institute of Health (BIH). Funding was also provided by German Research Foundation (DFG) [491780329; GE2223/2-1] to A.R. and A.G.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13071114",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biom13121799",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The research was supported by grants from the German Research Foundation (DFG) within FOR2625 to T.J.J. J.K. and T.S. and by a fellowship from the China Scholarship Council to F.W. The EM equipment used in this work is part of the research program National Roadmap for Large-Scale Research Infrastructure which is financed by the Dutch Research Council (project number 184.034.014).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11010001",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11010103",TRUE,"Conflicts of Interest: C.S.P. H.J. and S.M. received speaker’s honoraria of Novartis. C.F. received speaker’s honoraria from Bayer Novartis Allergan MedUpdate Roche and Omnivision received research funds from Novartis and acts as an advisor to Bayer Novartis and Appelis. M.J.G. received speaker’s honoraria from Novartis and Bayer. S.G.P. received speaker’s honoraria from Allergan Alcon BVI B&L Bayer Novartis Örtli Roche and Zeiss and is on the advisory board of Allergan Alcon Bayer B&L Roche and Zeiss. G.R. D.J.S. and K.H. declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11010176",TRUE,"Conflicts of Interest: All authors confirm that they have no conflicts of interest.",TRUE,"; Funding acquisition U.L. U.R. and J.F. <section> Funding: The scientists were funded by the German Cardiac Society (J.F. S.L. L.B.) M.W. is supported by an award from the Deutsche Forschungsgemeinschaft (WI 5229/1-1). We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11010211",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Bundesministerium für Bildung und Forschung (grant number: FK031L0231 to M.T. and M.S.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11020313",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the German Research Foundation (DFG; CRC1382 Project-ID 403224013).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11020452",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Federal Ministry for Education and Research as (Patho234 ref.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11020526",TRUE,"Conflicts of Interest: The authors declare no competing interests.",TRUE,"<section> Funding: This work was supported by the German Research Foundation (DFG) [AL 1795/3-1 to T.F.A.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11020575",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition N.H. <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11030764",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the Federal Ministry of Education and Research Germany (noChro FKZ: 13GW0338E).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11030773",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11051371",TRUE,"Conflicts of Interest: All authors declare that there have no conflicts of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11051378",TRUE,"Conflicts of Interest: The author declares no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11072088",TRUE,"Conflicts of Interest: In the last two years MP has received lectures or advisory board honoraria or engaged in clinical trial activities with Angelini Pharma Lundbeck Janssen Pfizer MSD Rovi and Recordati which are unrelated to this study; ADC has received advisory board honoraria from Fidia which are unrelated to this study. All the other authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11082276",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Conceptualization Data Curation Writing—Review and Editing Validation Funding Acquisition Project Administration G.M. <section> Funding: This research was funded by grants BMBF 02NUK064A 02NUK064B BMWi ZF4320102CS7 Bayerische Forschungsstiftung BAYCELLator Dr. med.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11082279",TRUE,"Conflicts of Interest: A.S. B.V. and R.K. are/were cofounders and shareholders of Pentracor GmbH.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11092482",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/biomedicines11102593",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11112984",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by grants to Weiwei Kong from the Natural Foundation of Zhejiang LQ21H050004 and National Natural Foundation of China 82000635 to En Yin Lai and Pontus B.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/biomedicines11123153",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by grants from the Barrow Neurological Foundation (BNF) the Leducq Foundation (ATTRACT) and the US Department of Defense (PR161205) awarded to S.P.O. and BNF Postdoctoral Fellowship Grants awarded to C.H. and L.S.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13020353",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/brainsci13030480",TRUE,"Conflicts of Interest: J.B. N.H. and L.R. declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13030516",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was funded by intramural performancebased research funds to A.J.S. from the Charité Universitätsmedizin Berlin.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13040680",TRUE,"Conflicts of Interest: All authors declare that they have no conflict of interest related to this publication.",TRUE,"<section> Funding: <section> Academies Collection: Reports funded by National Institutes of Health.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13060870",TRUE,"Conflicts of Interest: K. All other authors declared no conflicts of interest. <section> Implied expressed negative declaration of intent to participate in the study by a minor",TRUE,"<section> Funding: Early-BipoLife is funded by the Federal Ministry of Education and Research (BMBF grant numbers: 01EE1404A (A1: Improvement of early recognition and early intervention for people with high risk for the development of bipolar disorder) 01EE1404E (TPP1: Internet based platform for secure multicentric recruiting phenotypical characterization collecting of biomaterial and molecular analysis) and 01EE1404F (TPP2: Imaging and neurophysiology platform). MM was supported by the Deutsche Forschungsgemeinschaft (DFG grant Nos. She has received grant support from Janssen/J&J and Otsuka.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/brainsci13070980",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Research Foundation (STE 1765/3-2) Charité University Funding (UFF 89/441-176 to A.S.) and the Open Access Publication Fund of the University of",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13071025",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the European Union’s Horizon 2020 research and innovation programme under grant number No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/brainsci13071101",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/brainsci13121616",TRUE,"Conflicts of Interest: The authors declare that they have no financial or non-financial conflict of interest to disclose.",TRUE,"<section> Funding: <section> We acknowledge financial support from the Open Access Publication Fund of Charité– Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/brainsci13121673",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bs13050432",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work is supported by the Open Access Publishing Funds of the German Research Foundation (DFG) and the University of Tübingen.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/bs13100788",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding Acquisition D.B. E.Z. T.P. and S.L. <section> Funding: This research was funded by the Australian Research Council Linkage grant scheme grant numbers LP0989708 and LP100200842.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15010301",TRUE,"The other authors declare no potential conflict of interest.",TRUE,"<section> Funding: This work was funded by the German Research Foundation (CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15020456",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition I.P. <section> Funding: This study was funded by Oskar-Helene-Heim Foundation grant number 48 Pozios PI.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15020494",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15030686",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Ministry for Education and Research in MSTAR (#031L0220A).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15030742",TRUE,"Conflicts of Interest: F.W. received speaker fees from Astra Zeneca GmbH and Merck Sharp & Dohme. J.D. reports grants from CRI The Clinical Research Institute grants from View Ray Incl. grants from Accuray International grants from Accuray Incorporated grants from RaySearch Laboratories AB grants from Vision RT limited grants from Merck Serono GmbH grants from Astellas Pharma GmbH grants from Astra Zeneca GmbH grants from Siemens Healthcare GmbH grants from Solution Akademie GmbH grants from Eromed PLC Surrey Research Park grants from Quintiles GmbH grants from Pharmaceutical Research Associates GmbH grants from Boehringer Ingelheim Pharma GmbH Co grants from PTW-Frieburg Dr. Pychlau GmbH and grants from Nanobiotix A.a. outside the submitted work. The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. The other authors declare no conflict of interest.",TRUE,"Author Year Entity Group Type of Study N Treatment Type of HT COI Funding Petrovich et al. [34] 1989 HN Single institution prospective phase I/II single arm Interstitial BT + iHT Interstitial MW n.r. n.r. Author Year Entity Group Type of Study N Treatment Type of HT COI Funding Maier-Hauff et al. [47] 2007 CNS Single institution prospective single arm EBRT + HT Internal Fe3O4 (magnetite nanoparticles) Employee/cofounder of MagForce AG patents n.r. Funding statements were missing in 14 of 23 studies (61%). <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15030746",FALSE,"",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15030774",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15030818",TRUE,"<section> The authors disclosed the following conflicts of interest: FH received personal fees/ad boards from NovoCure and PharmaMar; received personal fees/ad boards and nonfinancial support from AstraZeneca Roche Tesaro GSK Clovis and amedes; received nonfinancial support from New Oncology; and had a fiduciary role in other boards (unpaid) such as the AGO study group. B.A. had a membership on the advisory boards of Roche GSK Amgen MSD and Sanofi–Aventis; lectures at Roche GSK Celgene Clovis AstraZeneca Novartis MSD and Eisai; and other conflicts of interest (congress travel support) with Roche GSK AstraZeneca and PharmaMar.",TRUE,"<section> Funding: This research received no external funding. P.H. received grant support from AstraZeneca Roche GSK Genmab DFG the European Union DKH Immunogen and Clovis; received consultancy from AstraZeneca; was on the advisory boards of AstraZeneca Roche GSK Clovis Immunogen MSD and Eisai; received honoraria from AstraZeneca GSK Clovis Immunogen MSD Eisai Amgen Roche Sotio Stryker and Zai Lab; and had a fiduciary role in other boards such as the AGO study group.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15030936",TRUE,"Conflicts of Interest: G.R. is a member of the Bracco consultation agency and the AAA speaker’s bureau. The other authors declare no potential conflicts of interest.",TRUE,"<section> Funding: This work was supported by the German Federal Ministry of Education and Research (BMBF) e:Med Demonstrator (MAPTor-NET grant 031A426 to U.L. K.M.D. and C.S.) and by the Deutsche Krebshilfe (grant 70113482 to C.S.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15041031",TRUE,"Conflicts of Interest: Y.N. is a stockholder and a scientific advisor at OncoTherapy Science Inc.",TRUE,"<section> Funding: <section> This work was partly supported by the Japan Agency for Medical Research and Development (grant nos. 17ck0106364h0003 and 20ck0106543h0001) and Japan Society for the Promotion of Science (grant nos.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15041088",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Results of this study were supported by Al-Mamgani et al. who also advocate contralateral RT only according to T stages and midline involvement in oropharyngeal carcinomas [39]. <section> Funding: This research received no external funding.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15041311",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15051394",TRUE,"Conflicts of Interest: The authors declare no conflicts of interest.",TRUE,"Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15051475",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was funded by a grant of the German Research Foundation to KB (DFG BE 5515/6-1).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15051598",TRUE,"Conflicts of Interest: The authors declare that they have no competing interest.",TRUE,"<section> Funding: The research program was funded by the Homburg Research Funding Program (HOMFOR Funding Number: T201000872). We acknowledge support by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) and Saarland University within the ‘Open Access Publication Funding’ program.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15061773",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was funded by a grant from the German Research Foundation to KB (DFG BE 5515/6-1).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15061833",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The clinical trial was funded by the “Deutsche Krebshilfe” grant number 70108399.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> In this prospective multicentric study (trial registration: ClinicalTrials.gov: NCT00964977; study approval of the Ethics Committee of the State Medical Council of Rhineland-Palatinate Germany 837.148.03 (3810)) patients with completely resected (R0) histologically proven squamous cell carcinoma of the oral cavity up to a histologically determined tumor size of a maximum of 4 cm (T1/T2) and the oropharynx up to a histologically determined tumor size of a maximum of 2 cm (T1) were included regardless of the histological degree of",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cancers15061842",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15072038",TRUE,"Conflicts of Interest: The authors declare no competing interest that are relevant to the content of this manuscript.",TRUE,"<section> Funding: Parts of this work were funded by the NOGGO (Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15072048",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15072050",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding Acquisition E.K. and T.K. <section> Funding: The CWS-IV 2002 trial was financially supported by Foerderkreis Krebskranke Kinder Suttgart",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15082222",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15082303",TRUE,"Conflicts of Interest: Thoralf Niendorf is founder and CEO of MRI.TOOLS GmbH Berlin Germany.",TRUE,"<section> Funding: This project is funded by the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program grant agreement No.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15082342",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Deutsche Forschungsgemeinschaft (grant number TRR295).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Trial Registration: Due to the retrospective nature of the study",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cancers15082359",TRUE,"Conflicts of Interest: K.J.R. Accuray research funding travel expenses; icotec travel expenses; Brainlab travel expenses; Elekta A.B. research funding travel expenses; Canon research funding; BioMimetix data safety monitoring board; icotec consulting; Y.Y. Varian Medical Systems consultant. <section> BrainLab consultant. Vision RT consultant. University of Wollongong consultant. Chordoma Foundation Medical Advisory Board. M.K. Consultant: Stryker medical Medwaves Avecure Caerus medical Icometrix and Cohere Medical. S.L.L. consultant for Depuy-Synthes Icotec SpineAlign Stryker Bioventus. S.S.L. Elekta AB member of ICON Gamma Knife Expert Group and research support; Kuni Foundation research funding Hutchinson Center as Lead Academic Participating Site; UG1 CA 233328; Japanese Society for Radiation Oncology travel expenses; American College of Radiology Alternate councilor on behalf of American Radium Society and Chair of CARROS Nominating Committee; Radiosurgery Society Board of Directors and National Medical Director of the Distinction in Practice in Stereotatic Radiotherapy Program. S.K.S. D.L. M.B. M.F. E.G. P.V. F.R. B.M. A.A. S.E.C. have no conflict of interest to report.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15082367",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Berliner Krebsgesellschaft grant number #PEFF202104.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15092420",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15092534",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15092655",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge APC funding from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité-Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15112920",TRUE,"Conflicts of Interest: FS reports grants from Helixor Heilmittel GmbH (travel costs and honoraria for speaking) grants from AstraZeneca (travel costs and honoraria for speaking) grants from Abnoba GmbH and grants from Iscador AG outside the submitted work. JG reports grants from Roche Siemens mte and Celgene (travel costs and honoraria for speaking) outside the submitted work. HM is a member of the board of directors of Weleda AG a member of the Network Arbeitsgemeinschaft der Wissenschaftlichen Fachgesellschaften (AWMF e.V.) guideline committee for integrative oncology (Guideline for Complementary Medicine in the Treatment of Oncological Patients) and has an endowed professorship at the Charité Universitätsmedizin Berlin which is financed by the Software AG Foundation outside the submitted work. The other authors have declared that no competing interests exist. No payment was received for any other aspects of the submitted work. There are no patents products in development or marketed products to declare. There are no other relationships/conditions/circumstances that present a potential conflict of interest.",TRUE,"<section> Funding: This study was supported via the institutional budget of the Research Institute Havelhöhe gGmbH at the Hospital Gemeinschaftskrankenhaus Havelhöhe which is the primary sponsor of the study and received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Trial registration: trial registration number DRKS00021601.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,NA,NA,NA,NA
"10.3390/cancers15123093",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15123155",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15133364",TRUE,"Conflicts of Interest: H.N.L. R.L. and A.W. act as consultants for EUSA Pharma and W.B. received travel grants from EUSA Pharma. The other authors declared no conflict of interest.",TRUE,"<section> Funding: This work was supported by funding from the following institutions: University Medicine Greifswald grant number 97237000; Deutsche Forschungsgemeinschaft (DFG) grant number SI 2147; Hector Stiftungen Germany grant number M2116. The project was in part carried out within TEMICARE (German-Polish pediatric oncology center integrated by telemedicine in the Euroregion Pomerania [INT113]) funded by the European Union.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15133445",TRUE,"Conflicts of Interest: Elena Ioana Braicu MD PhD receives research funding from: Bayer Roche Diagnostics Tesaro GSK AstraZeneca and personal fees from: AstraZeneca Clovis GSK Tesaro EISAI RochePharma Roche Diagnostics; Michael Hummel Honorarium: Amgen AstraZeneca BMS Lilly Novartis Pfizer Pierre Fabre ThermoFisher; Regina Berger receipt of grants/research supports to Institution: Merck Pharma Mar AstraZeneca Kartos Therapeutics Mersana Therapeutics Novocure Clovis Oncology Seagen Inc.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: We thank Agilent Technologies for supporting this project with reagents.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15133448",TRUE,"Conflicts of Interest: J.C.H. reports grants or contracts from Bristol Myers Squibb Sanofi and Sun Pharma; consulting fees from Onkowissen and Glaxo Smith Kline; payment or honoraria for lectures presentations speakers bureaus manuscript writing or educational events from Amgen Bristol Myers Squibb Glaxo Smith Kline Immunocore Merck Sharp & Dohme Novartis Pierre Fabre Sanofi and Sun Pharma; support for attending meetings and/or travel from Bristol Myers Squibb Iovance Biotherapeutics and Sun Pharma; participation in a data safety monitoring board or advisory board for Merck Sharp & Dohme Pierre Fabre Sun Pharma Bristol Myers Squibb Immunocore Novartis Philogen Sanofi and Nekvax. All other authors declare no conflicts of interest.",TRUE,"<section> Funding: This work was funded by Bristol Myers Squibb.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15143650",TRUE,"Conflicts of Interest: O.H.K. has patents on HDACi (WO/2004/027418; WO 2013/062344 A1) but none of them contains the KH-compounds shown herein.",TRUE,"<section> Funding: Work done by R.A. in the group of O.H.K. is funded by the DAAD Egypt/Germany. We gratefully acknowledge funding to M.W. from Deutsche Krebshilfe (Grant 70115444) and Wilhelm Sander Foundation (Grant 2023.027.1).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15143670",TRUE,"Conflicts of Interest: C.D.D.: Consulting fees and travel expenses from Carl Zeiss Meditec AG. J.B. O.G. M.H. M.M. A.R. S.R. K.S. M.S. P.V. H.V. and A.W. report no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15153909",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by Portuguese funds through FCT in the framework of a Ph.D. The project was funded by FCT through RESEARCH4COVID19 Special Programme Project nº625. This research was partly supported by the project “Cancer",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15164089",TRUE,"Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: This project was partially funded by the Interdisciplinary Center of Clinical Research (IZKF) at the University of Würzburg (Z-2/72_P) and the German Cancer Consortium (DKTK). The publication was supported by the University of Würzburg in the funding program Open Access Publishing.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15184436",TRUE,"Conflicts of Interest: For the past 36 months C.B. reports honoraria (for lectures) from AlmirallHermal Bristol-Myers Squibb Immunocore Leo Pharma MSD Novartis Regeneron and Sanofi; and fees for advisory board participation from Almirall-Hermal BMS Immunocore InflaRx MSD Pierre Fabre Regeneron and Sanofi. F.K. has for the past 36 months no disclosures to report.",TRUE,"<section> Funding: This research was funded by Novartis Pharma GmbH (Nürnberg Germany).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15184524",TRUE,"Conflicts of Interest: M.D. reports nothing to disclose.",TRUE,"<section> Funding: This study was a collaborative research project between Baxalta Innovations GmbH a Takeda company and GWT-TUD GmbH Dresden Germany.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15184540",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15184573",TRUE,"Conflicts of Interest: F.D. reports honoraria from AbbVie AstraZeneca Gilead Incyte Novartis and Roche outside the submitted work.",TRUE,"<section> Funding: This study was supported in part by the Bundesministerium für Bildung und Forschung (ERA PerMed project MEET-AML 01KU2014 to L.B.) the Else Kröner-Fresenius Stiftung (2022_EKES.50 to M.F.) the Deutsche Krebshilfe (grant no. 70114156 to M.F. and grant no. 70113643 to F.D.) and a research grant from DKTK Berlin to F.D. and L.B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15184587",TRUE,"Conflicts of Interest: Silvia Mezi (S.M.) speaker fee for Novartis Pierre-Fabre BMS MSD; Andrea Botticelli (A.B.) speaker and advisory board for BMS Novartis Pfizer Lilly MSD Daiichi-Sankyo Gilead; Simone Scagnoli (S.S.) has/had consulting fees with Pfizer Novartis Lily; Federica De Galitiis has/had consulting fees with Novartis BMS MSD Pierre-Fabre; Simona Pisegna (S.P.) speaker fee for Novartis Roche Pfizer Astrazeneca Lilly; Maurizio Simmaco (M.S.) is a member of the Advisory Board of Drug-PIN AG.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15184595",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition C.S.K. A.M. and M.J. <section> Funding: This research was funded by Berg foundation. <section> Acknowledgments: We acknowledge financial support from Berg Foundation and the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"After registration at ClinicalTrials.gov (NCT04411251) reporting was performed according to the CONSORT (Consolidated Standards of Reporting Trials) extension for pilot and feasibility trials",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cancers15184667",TRUE,"Conflicts of Interest: L.B.L. received honoraria from Celgene/BMS Janssen-Cilag Sanofi GSK; research funding from GSK Abbvie. C. K. declares no conflicts of interest. V. R. declares no conflicts of interest. A. J. declares no conflicts of interest. M. Z. declares no conflicts of interest. P. M. declares no conflicts of interest.",TRUE,"; Funding acquisition C.B. and K.C.W. <section> Funding: This trial was sponsored by University Medical Center Hamburg-Eppendorf. Funding and drug supply by Janssen-CILAG. The trial was sponsored by the University Medical Center Hamburg-Eppendorf. Funding and utilized drugs supplied by Janssen-Cilag.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial is registered at clinicaltrials.gov (NCT02977494).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cancers15194897",TRUE,"Conflicts of Interest: Michael Baumann CEO and Scientific Chair of the German Cancer Research Center (DKFZ Heidelberg) is responsible for collaborations with a large number of companies and institutions worldwide. In this capacity he has signed contracts for research funding and/or collaborations including commercial transfers with industry and academia on behalf of his institute(s) and staff. He is a member of several supervisory boards advisory boards and boards of trustees. <section> Michael Baumann confirms that he has no conflicts of interest with respect to this paper. The other authors declare no conflicts of interest.",TRUE,"<section> Funding: This research received no external funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15204907",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15205035",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge financial support from the Open Access Publication Fund of Charité– Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15225428",TRUE,"Conflicts of Interest: M.-P.B.-G. reports personal fees from an advisory role and consultancy speakers’ bureau travel grants and accommodation from AstraZeneca Clovis GSK MSD and Pharmamar outside the submitted work. J.B. reports honoraria from AstraZeneca outside the submitted work. E.I.B. <section> receives research funding from Bayer Roche Diagnostics Tesaro GSK and AstraZeneca and received personal fees from AstraZeneca Clovis GSK Tesaro EISAI RochePharma and RocheDiagnostics. J.L. reports a conflict of interest regarding GSK PharmaMar and AstraZeneca. T.L. reports honoraria travel expenses and advisory board fees from GSK Gilead Pfizer Novartis Daiichi Sankyo AstraZeneca Roche MSD and Lilly. J.S. reports receiving research funding consultancy/advisory board fees honoraria travel and accommodation fees and expenses from AstraZeneca Clovis Oncology Merck Bayer PharmaMar Pfizer Tesaro MSD Oncology Roche Lilly Novocure J&J Ingress Health Riemser Sobi GSK Novartis Eisai Olympus Medical Systems Teva and Pharma AG. I.V. reports consulting fees and accommodation and travel expenses from Agenus Akesobio AstraZeneca Bristol Myers Squibb Deciphera Pharmaceuticals Eisai Elevar Therapeutics Exelixis F. Hoffmann-La Roche Genmab GSK Immunogen Jazzpharma Karyopharm Mersana MSD Novocure Novartis Oncoinvent OncXerna Regeneron Sanofi Seagen Sotio Verastem Oncology and Zentalis and contracted research with Oncoinvent AS as well as corporate sponsored research from Amgen and Roche. All other authors declare no conflict of interest.",TRUE,"<section> Funding: The survey ‘Expression VI—Carolin meets HANNA—Holistic Analysis of loNgterm survivors with ovariaN cAncer’ was funded by the German Ovarian Cancer Foundation AstraZeneca GmbH Janssen-Cilag GmbH PfizerPharma GmbH Roche and Tesaro.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15235521",TRUE,"Conflicts of Interest: H.N. and T.S. were supported by a research grant from Pierre Fabre.",TRUE,"<section> Funding: H.N. and T.S. were supported by a research grant from Pierre Fabre. <section> Conflicts of Interest: H.N. and T.S. were supported by a research grant from Pierre Fabre.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15235547",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cancers15235678",TRUE,"The other authors have declared that no competing interests exist. No payment was received for any other aspects of the submitted work. <section> There are no patents products in development or marketed products to declare. There are no other relationships/conditions/circumstances that present a potential conflict of interest.",TRUE,"; Funding acquisition F.S. <section> Funding: This study was supported via the institutional budget of the Research Institute Havelhöhe which is the primary sponsor of the study and received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Attribution (CC BY) license (https:// registration: Trial registration numbers DRKS00013335 on 27 November 2017 and DRKS00021601 on This trial was registered at the German Clinical Trials Register (Trial registration number DRKS00013335 on 27 November 2017 retrospectively registered and DRKS00021601 on 21 August 2020 retrospectively",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cancers15245717",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cancers15245753",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was partially supported by the European Union under the seventh framework programme: Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer (CAM-PaC) under grant agreement no. 602783.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12010125",TRUE,"The authors declare no conflict of interest; portions of the doctoral thesis of Vinita Sharma are incorporated into this report.",TRUE,"; Funding acquisition: F.G. W.S. N.S. N.W. <section> Funding: This work was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)–Projektnummer 268555672–SFB 1213 A07 to N.W. and CP02 to B.K.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12010132",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study is funded by the Young Talent Project of Changzhou Health Commission (grant no. CZQM2022007) the Youth Fund of Changzhou Health Commission (grant no. QN202121) and the Basic Application Project of Changzhou Science and Technology Bureau (grant no. CJ20220142). Xiurong Cai and Hanyang Liu are funded by the Chinese Scholarship Council Foundation (202008320386; 201806380041). <section> Acknowledgments: This research was supported by Charité Universitätsmedizin Berlin Nanjing Medical University and Chinese Scholarship Council Foundation. We acknowledge financial support from the Open Access Publication Fund of Charité–Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12010141",TRUE,"Conflicts of Interest: All authors confirm that they have no conflict of interest.",TRUE,"; Funding acquisition J.F. U.L. and U.R. <section> Funding: The scientists were funded by the German Cardiac Society (J.F. S.L. L.B.) M.W. was supported by an award from the Deutsche Forschungsgemeinschaft (WI 5229/1-1).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12020236",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG) grant GRK 23182 C1 and DFG Schu 559/11-5.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12020254",TRUE,"Conflicts of Interest: The authors declare that they have no competing interests.",TRUE,"<section> Funding: <section> M.B. H.N. C.B. T.S. and S.V. were supported by grants from Pascoe pharmazeutische Praeparate GmbH (grant no. D.31.15100 and D.32.22506). M.B. and S.V. were supported by the Else-Uebelmesser-Stiftung (grant no. D.30.21947; reference: GzV 1.14). The authors acknowledge support by the Open Access Publishing Fund of the University of Tuebingen.",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12020282",TRUE,"Conflicts of Interest: Author Frank Leypoldt has received speaker honoraria and travel accommodation and meeting expenses from Biogen Grifols Teva Roche Fresenius and Merck and is working in an institute in which studies on antineuronal antibodies are performed.",TRUE,"; Funding Acquisition M.K. B.S. F.L. and P.K. <section> Funding: This study was in part supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony (to M.K.) and the SFB854 (to M.K. B.S.). This study was not sponsored by industry. Furthermore the publication is supported by the publication fonds of the Charité Universitätsmedizin.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12040606",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition M.S. <section> Funding: M.N. and J.K. are participants in the BIH-Charité Clinician Scientist Program funded by Charité-Universitätsmedizin Berlin and the Berlin Institute of Health. This research was also funded by grants of the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany’s Excellence Strategy—EXC-2049—390688087 to M.S.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12040647",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12060959",TRUE,"Conflicts of Interest: M.W. reports research grants received from the Deutsche Forschungsgemeinschaft (DFG) Bundesministerium für Bildung and Forschung (BMBF) Deutsche Gesellschaft für Pneumologie European Respiratory Society Marie Curie Foundation Else Kröner Fresenius Stiftung CAPNETZ Stiftung International Max Planck Research School Vaxxilon Actelion Bayer Health Care Biotest Boehringer Ingelheim; personal fees for advisory work from Noxxon Pantherna Vaxxilon Aptarion Glaxo Smith Kline Sinoxa Biotest Thieme; lecture honoraria from Astra Zeneca Berlin Chemie Chiesi Novartis Actelion Boehringer Ingelheim Glaxo Smith Klein Biotest Bayer Health Care; a patent issued in 2012 titled “EPO 12181535.1: IL-27 for modulation of immune response in acute lung injury”; a patent issued in 2010 titled “WO/2010/094491: Means for inhibiting the expression of Ang-2”.",TRUE,"<section> Funding: This research was funded by a German Federal Ministry of Education and Research (BMBF) grant to M.W. grant number e:Med CAPSyS (01ZX1304B 01ZX1604B) and an academic stipend awarded to C.G. by the Interdisciplinary Center of Infection Biology and Immunity (ZIBI). A.D.G. received funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation); project ID 114933180–SFB-TR84 subproject Z01b. N.S. received funding from the DFG (project ID 114933180–SFB-TR84 subprojects B01 C09 and Z02) and BMBF (e:Med CAPSyS grants 01ZX1304B and 01ZX1604B). M.W. received funding from the DFG (project ID 114933180–SFB-TR84 subprojects C06 and C09; and project ID 431232613– SFB-1449 subproject B02) the BMBF in the framework of e:Med CAPSyS (01ZX1304B 01ZX1604B) PROVID (01KI20160A) e:Med SYMPATH (01ZX1906A) NUM-NAPKON (01KX2021 01KX2121) and the BIH (CM-COVID). H.K. and M.S. received funding from the BMBF in the framework of e:Med CAPSyS (01ZX1304A) PROVID (01KI20160C) and e:Med SYMPATH (01ZX1906B).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12071062",TRUE,"Conflicts of Interest: S.v.H. has been a paid consultant for and/or received honoraria payments from AstraZeneca Bayer Boehringer Ingelheim BRAHMS Chugai Grünenthal Helsinn Hexal Novartis Pharmacosmos Respicardia Roche Servier Sorin and Vifor.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered at ClinicalTrials.gov (NCT02116153).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cells12091227",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12091306",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was funded by the Deutsche Forschungsgemeinschaft DFG grant number BA-3769/3 to M.B. G.B. is funded by grant BA-3769/4 (to M.B.). Z.L. was funded by a scholarship from CSC. The study also received funding from ECARF (European Center for Allergy Research Foundation)",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12091321",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Heimer Foundation Bielefeld Germany (to M.V.) and the German Research Foundation (to D.F.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12091333",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> The German Federal Ministry of Education and Research funded this trial (01KG1104). <section> Funding: The German Federal Ministry of Education and Research funded the trial (01KG1104 to O.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered at www.ClinicalTrials.gov (NCT01485978); the EudraCT number is 2010-024300-10. The trial was registered at www.ClinicalTrials.gov (NCT01485978); the EudraCT number was 2010-024300-10.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/cells12101395",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was sponsored by Grünenthal GmbH.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12131785",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the AMS Stiftung and the Prof. <section> Acknowledgments: We acknowledge financial support from the Open Access Publication Fund of Charité – Universitätsmedizin Berlin and the German Research Foundation (DFG). We furthermore thank the German Pain Association (Deutsche Schmerzgesellschaft e.V.) for their support of the study with the young researcher award (Nachwuchsförderpreis Schmerz 2021) awarded to Jan D.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12141887",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG GRK 2318/1-318905415 and DFG TRR 241-375876048 (B06)) and the Open Access Publication Fund of the Charité—Universitätsmedizin Berlin.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12152001",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Deutsche Forschungsgemeinschaft (DFG) grant number MU 880/16-1 received by SM.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12162115",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by grants from the German Research Foundation (DFG) (HA 6880/2-3) the Government of Canada’s New Frontiers in Research Fund (NFRF) NFRFT-2020-00787 and the European Union’s Horizon 2020 Research and Innovation Program (825392; RESHAPE consortium). This publication was funded by the DFG within the framework of the Open Access Publication",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12192375",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Swiss National Science Foundation grant number 175953 to J.C.S. grant number 159500 to C.B.-A. by Schweizerische Gesellschaft für Cystische Fibrose (CFCH) to P.A. by Swiss Lung Liga and the OPO Fundation to C.B.-A and the German Research Foundation (CRC 1449—project 431232613; subprojects A01 and Z02) to M.A.M. and the German Federal Ministry of Education and Research (82DZL009B1) to M.A.M.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12222660",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work in the Krichevsky Lab is supported by R01 CA215072 and R01 NS113929 NIH grants and the Rainwater Foundation/Tau Consortium award.",TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cells12222667",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Russian Science Foundation project #23-75-30001 (Initiation and Supervision Introduction Conceptualization Section 2); project #22-15-00143 (Sections 3–5) and by the Governmental project #075-15-2022-1094 (Section 6).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12232700",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the Deutsche Forschungsgemeinschaft DFG to M.B. grant number BA-3769/3. G.B. is funded by the grant BA-3769/4 to M.B. Z.L. was funded by a scholarship from CSC. The study also received funding from ECARF (the European Center for Allergy Research Foundation)",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12232756",TRUE,"Conflicts of Interest: Author Rachel Steeg was employed by Fraunhofer Research UK Ltd. a not-forprofit research and technology organisation.",TRUE,"The first phase of EBiSC was supported by the Innovative Medicines Initiative (IMI) programme as a joint initiative between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) with the aim of establishing a quality iPSC resource that could be used by academia and pharma alike to develop new iPSC-based applications. The access to sensitive datasets is managed by the EBiSC Data Access Committee (DAC) which reviews data access requests from interested researchers and grants access contingent primarily upon (i) the planned research activity and experience of named personnel and (ii) clashes with any defined use restrictions. Currently to the best of our knowledge hPSCreg ® is the only active independent global stem cell data resource accepting registrations from around the world regardless of the cell line distributor. hPSCreg ® has been funded since 2007 by the European Commission (EC) as a registry to keep track of pluripotent stem cell research and enforce the ethical provenance and biological quality of hPSC lines used in EC-funded research projects. <section> Funding: EBiSC (the European Bank for induced pluripotent Stem Cells project) has received funding from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement n ◦ 115582 and from the Innovative Medicines Initiative 2 JU under grant agreement n ◦ 821362.",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12242846",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was funded by the Deutsche Forschungsgemeinschaft (DFG) grant GRK 2318—318905415 (project C1) and DFG Schu 559/11-5—175142815.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells12242850",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cells13010017",TRUE,"The authors declare no conflicts of interest.",TRUE,"; Funding acquisition F.K.-S. <section> Funding: This research was funded by the German Research Foundation (grant number: KL 2983/3-1).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10010010",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study is implemented as part of the joint project “A prospective analysis of the longterm impact of the COVID-19 pandemic on wellbeing and healthcare among children with a highrisk chronic condition and their families” funded by the German Research Foundation (Grant No: HO 3228/2-1; MI 2760/1-1; WA 1143/18-1). NPRD: supported by an unconditional grant of Novartis and gsk in 2021 and 2022.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10010015",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/children10010038",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10020324",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Stiftung Kinderförderung von Playmobil.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10050783",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study is registered in ClinicalTrial.gov under trial number NCT05390437.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/children10071095",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The APC was funded by the MSB Medical School Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10091431",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10091455",TRUE,"",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: This work was supported by the German Federal Ministry of Education and Research (BMBG; grant 01KR1803C; https://www.ubica.site (accessed on 1 february 2019)). He has received grant support from Janssen and Takeda.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/children10121885",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition T.R. A.B. J.F. S.R. T.K. C.L.-K. L.K. K.v.K. and F.S.-S. <section> Funding: The studies as part of the SKKIPPI project are supported by a grant from the Innovationsfonds/GBA Germany (No 01 VSF17027).",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cimb45010051",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: G.G. and C.B. were funded by the German Research Foundation (DFG)—Project-ID 259373024—CRC/TRR 167 (B05). G.G. was additionally funded by the State of Berlin Germany with the Elsa Neumann Ph.D. scholarship (Antrags Nr.: 069032). K.R. received research support from Novartis Pharma Merck Serono German Ministry of Education and Research European Union (821283-2) Stiftung Charité (BIH Clinical Fellow Program) and Arthur Arnstein Foundation and received speaker honoraria from Bayer and travel grants from Guthy Jackson Charitable Foundation. We acknowledge support by the OpenAccess Publication Fund of Freie Universität",FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/cosmetics10010001",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: The investigation has been supported by Shanghai Pechoin Daily Chemical Corporation Shanghai China and by the Foundation of Skin Physiology which is incorporated in the Donor Association for the Promotion of Sciences and Humanities in Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/cosmetics10040104",TRUE,"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: This research was funded by The Procter & Gamble Company (Grant Number 131159).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/covid3040033",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/curroncol30020113",TRUE,"Conflicts of Interest: J.W. invented and founded the network OnkoAktiv and is currently a member of the association board. The other authors declare no conflict of interests.",TRUE,"The YOUEX study is based on a comprehensive evaluation design and is supported by the German Foundation for Young Adults with Cancer. <section> Funding: This research was funded by the German Foundation of Young Adults with Cancer grant number",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered at clinicaltrials.gov (NCT05613699).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/curroncol30020115",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: This study was made possible with the support from the Outpatient Clinic Neuroendocrine Tumor Diseases (NETs)—Center of Excellence for Neuroendocrine Tumors (CoE) of Charité—Universitaetsmedizin Berlin.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/d15090950",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work by O.E.K. was partly supported by the scientific program FWNR-2022-0019 by the Ministry of Science and High Education.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13010012",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition T.F. and P.A. <section> Funding: We acknowledge financial support from the Open Access Publication Fund of Charité– Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13010157",TRUE,"Conflicts of Interest: The authors declare that there is no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13040586",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Research Foundation/DFG RE 4803/1-1.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13040638",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Author Contributions: L.B.: Conceptualization Data curation Formal analysis Investigation Methodology Visualization Writing—original draft Writing—review & editing; F.S.: Visualization Writing—review & editing; L.M.-S.C.: Investigation Writing—review & editing; G.N.D.: Funding acquisition Resources Writing—review & editing; M.P.: Funding acquisition Resources Writing—review & editing; H.S.: Conceptualization Funding acquisition Project administration Resources Software Supervision Writing—review & editing. <section> Funding: This work was supported by Deutsche Forschungsgemeinschaft [Grant number: SCHM 2572/11-1; SCHM 2572/13-1; DU 298/29-1; PU 762/1-1].",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13040642",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13040776",TRUE,"Conflicts of Interest: T.D. lectures for Canon MS MSD UCB Eli Lilly and Novartis.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13050996",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13061135",TRUE,"Conflicts of Interest: A.M.K. is the named inventor on a patent owned by Charité-Universitätsmedizin Berlin of a later version of this assay system. All other authors declare no conflict of interest.",TRUE,"; Funding acquisition A.M.K. <section> Funding: This research was funded in part by the EU 7th framework program FP7-HEALTH (grant",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13101701",TRUE,"Conflicts of Interest: None were reported see also section on funding.",TRUE,"<section> Funding: None of the authors report funding by organizations that may gain or lose financially through the publication of this manuscript.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13122076",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: Torsten Diekhoff has received speaker honoraria from Canon Medical System. The department of radiology received grant under a Master research agreement.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13132176",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13152541",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13172812",TRUE,"Conflicts of Interest: F.C. S.R. S.Z. G.W. U.G. V.S. M.A. A.M.M. C.B. T.B. G.B. A.P.S. C.C. J.H. P.B. and A.R. are (or were during conduction of the study) employees of CENTOGENE GmbH Rostock Germany.",TRUE,"<section> Funding: The LYSO-PROOF study was funded by Takeda Pharmaceuticals International AG (formerly Shire HGT; Master Services Agreement 2011).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The LYSO-PROOF study is an international multicenter observational study (ClinicalTrials.gov registry number: NCT02416661) that has been conducted in Israel Russia Pakistan Egypt Iran Morocco Algeria India Spain Albania Greece Sweden Columbia and Tunisia.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/diagnostics13182870",TRUE,"Disclosure Agreement (NDA) and is therefore not available to the public. <section> Conflicts <section> of <section> Interest: <section> The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13182957",TRUE,"Conflicts of Interest: The authors declare no conflict of interest regarding this publication.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13203210",TRUE,"Conflicts of Interest: The authors declare that they have no competing interests.",TRUE,"; Funding acquisition F.P. S.G. T.K.E. T.A. J.H.M. and A.E.O. <section> Funding: This study was funded by the SPP2177 program of the German Research Foundation (Deutsche Forschungsgemeinschaft ‘DFG’) project number #428216905. We acknowledge support from the Open Access Publication Fund of the University of Tübingen.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13203278",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diagnostics13233493",TRUE,"Conflicts of Interest: Philipp Arens Heidi Olze and Steffen Dommerich received financial support from ImThera Inc. and Apnex Medical Inc. within the framework of research projects related to hypoglossal nerve stimulation therapy.",TRUE,"<section> Funding: <section> Conflicts of Interest: Philipp Arens Heidi Olze and Steffen Dommerich received financial support from ImThera Inc. and Apnex Medical Inc. within the framework of research projects related to hypoglossal nerve stimulation therapy.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/diagnostics13233498",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge support from Leipzig University for openaccess",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diseases11040124",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/diseases11040161",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This manuscript received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/dj11120275",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by VITA Zahnfabrik Bad Säckingen Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/e25050813",TRUE,"Conflicts of Interest: The authors have no conflict of interest to declare.",TRUE,"<section> Funding: This project (18HLT09 NeuroMET2) has received funding from the EMPIR programme cofinanced by the Participating States and from the European Union’s Horizon 2020 research and innovation programme.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/environments10120221",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/foods12051014",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: This research was funded by the Thailand Science Research and Innovation Fund Chulalongkorn University (grant number: CU_FRB65_hea (60)_069_33_13) and the Ratchadaphiseksomphot Endowment Fund Chulalongkorn University (grant number: RCU_H_64_028_33).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/gels9100797",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was partially funded by Sapienza University of Rome (grant number",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/genes14010030",TRUE,"Conflicts of Interest: T.H. is employed by Limbus Medical Technologies GmbH Rostock Germany. <section> The other authors declare no conflict of interest.",TRUE,"<section> Funding: B.P. is supported by the Deutsche Forschungsgemeinschaft (DFG) through grant PO2366/2–1.",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/genes14071408",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: M.S. received funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project-ID 431984000–SFB 1453) and Germany’s Excellence Strategy CIBSS—EXC2189—project ID 390939984 under Germany’s Excellence Strategy. ST received funding from the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Project-ID TU 492/3-1).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/genes14101910",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was financed by statutory funding of the Faculty of Veterinary Medicine and Animal Science Poznan University of Life Sciences (506.558.09.00).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/healthcare11050716",TRUE,"Conflicts of Interest: J.G.E. received honoraria for lectures presentations and/or participation in scientific boards from Idorsia Pharmaceuticals Emma Sleep Cogni Unmind Sleep Consulting Ltd. and Perrigo.",TRUE,"<section> Funding: The medical writing support and the APC were funded by Idorsia Pharmaceuticals Ltd. T.P. received honoraria for lectures and/or participation in the scientific boards from Idorsia Löwenstein Medical Bioprojet Idorsia Pharmaceuticals Jazz Pharma Neuwirth Philips Cerebra Sleepimage and National Sleep Foundation and received grants from Cidelec Löwenstein Medical and Novartis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/healthcare11060906",TRUE,"Conflicts of Interest: Monica Pinto reports personal fees from Meeting & Words and Hinovia S.r.l. <section> The other authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the European Organization for the Research and Treatment of Cancer’s Quality of Life Group grant number 010-2016 (EORTC 1629).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/healthcare11152186",TRUE,"Conflicts of Interest: Daniel Hattesohl is a board member of the German Association for ME/CFS which contributed to funding costs for conducting the webinars with an external webinar provider.",TRUE,"<section> Funding: Costs for conducting the webinar with an external provider were funded by the German Association for ME/CFS and the Austrian Association for ME/CFS.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/healthcare11172377",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was partially funded by RACOON (NUM) under BMBF grant numbers 01KX2021 and",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/healthcare11172382",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Cultural Organizational and Funding Differences in Disaster Response Disaster reactions and mitigation strategies vary based on sociopolitical dimensions healthcare system structure and the extent of the disaster. <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20010270",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was financially supported by a grant from the Polish National Science Centre (grant number 2018/02/X/HS6/02645).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20010792",TRUE,"Conflicts of Interest: The authors declare no conflict of interest regarding this publication.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20021265",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20032167",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijerph20032721",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Funded by Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—490988677—and Bielefeld University of Applied Sciences and Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (MKW NRW).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20042784",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"The following decisions about data analysis were made: Themes were understood to represent meaningful patterns that are supported by an organising concept across the dataset [45] that consisted of codes that were strongly related to one another and that were defined by their importance rather than by the quantity of the quotes. <section> Funding: The present research received funding by Stiftung Charité grant number WIS_PRO_619. <section> The development of the Danish Version VR FestLab was funded by TrygFonden Denmark grant number",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20043182",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Randomized clinical trials are rare in this context since participation in CR programs is supported by different facilities such as government policy health insurance and pension funds in most countries. <section> Funding: This work was supported through the joint German-Austrian DFG and FWF project [DFG:",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijerph20043746",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: The authors acknowledge receipt of the following financial support for the research authorship and/or publication of this article: this work was supported by the German Federal Institute for Research on Building Urban Affairs and Spatial Development (BBSR) in the German Federal Office for Building and Regional Planning (BBR) [SWD-10.08.18.7-20.02] as part of the project “Effektive Strategien zur Kontrolle und zum Umgang mit Ausbreitungswegen von Erregern zum Schutz kritischer Infrastrukturen (SAVE)”.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijerph20054016",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20054159",TRUE,"Conflicts of Interest: The authors declare no potential conflict of interest with respect to the research authorship and/or publication of this article.",TRUE,"<section> Funding: This research was funded by the Kuratorium für Dialyse und Nierentransplantation (KfH) Foundation of Preventive Medicine (http://www.kfhstiftung-praeventivmedizin.de; accessed on February 2023) and the DDnÄ—Institut für Disease Management e.V. (all granted to E.S.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20054641",TRUE,"Conflicts of Interest: The authors declare no conflict of interest regarding this publication.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijerph20064927",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Aerospace Center (Deutsches Zentrum für Luftund Raumfahrt e.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial was registered on the German Clinical Trials Register (DRKS-ID: DRKS00026684; UTN: U1111-1271-0066).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/ijerph20075240",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition S.W.-G. R.K. and S.M.W. <section> Funding: The study is funded by a grant from the Federal Ministry of Education and Research (BMBF) of Germany (O1GY1337).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijerph20075286",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20095658",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> The work is part of a multiphase empirical research project on the “Maintenance of home care infrastructures in crisis and disasters” (AUPIK) which runs from February 2020 to June 2023 and is funded by the German Federal Ministry of Research (BMBF) in the context of the civil security research programme (SOFI). <section> Funding: This research was part of the project AUPIK which was funded by the German Federal Ministry of Research (BMBF) in the context of the civil security research programme (SOFI) grant number",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20105867",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was funded by the German Research Foundation (grant number FL 1061/1-1).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijerph20136286",TRUE,"Conflicts of Interest: T. Banaschewski served in an advisory or consulting role for ADHS Digital Infectopharm Lundbeck Medice Neurim Pharmaceuticals Oberberg GmbH Roche and Takeda. <section> He received conference support or speaker’s fee from Medice and Takeda. He received royalties from Hogrefe Kohlhammer CIP Medien and Oxford University Press; the present work is unrelated to these relationships. L. Poustka served in an advisory or consulting role for Roche and Viforpharm and received a speaker’s fee from Shire. She received royalties from Hogrefe Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.",TRUE,"<section> Funding: This work received support from the following sources: the European Unionfunded FP6 Integrated Project IMAGEN (Reinforcementrelated behaviour in normal brain function and psychopathology) (LSHM-CT-2007-037286) the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcementrelated disorders) (695313) Human Brain Project (HBP SGA 2 785907 and HBP SGA 3 945539) the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1) the National Institute of Health (NIH) (R01DA049238 a decentralized macro and micro geneby-environment interaction analysis of substance use behavior and its brain biomarkers) the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A 01EE1406B; Forschungsnetz IMACMind 01GL1745B) the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2 SFB 940 TRR 265 NE 1383/14-1 FL 156/44-1) the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1) the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01) NSFC grant 82150710554 and European Union funded project ‘environMENTAL’ grant No: 101057429. (Axon Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by the NIH Consortium grant U54 EB020403 supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. This paper is based on independent research commissioned and funded in England by the National Institute for Health Research (NIHR) Policy Research Programme (project ref. The views expressed in this article are those of the authors and not necessarily those of the national funding agencies or ERANID.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24010040",TRUE,"Conflicts of Interest: The authors declare that there are no competing interest associated with the",TRUE,"R.K.: Conceptualization Resources Data curation Formal analysis Supervision Funding acquisition Validation Investigation Visualization Methodology Writing—original draft Project administration Writing—review and editing. M.S.F.-A.: Conceptualization Resources Data curation Formal analysis Supervision Funding acquisition Validation Investigation Visualization <section> Funding: This work was supported by Ministerio de Economía y Competitividad [grant number BFU2017-82565-C2-2-R] MINDSHIFT (Mechanistic Integration of vascular aND endocrine pathways for Subtyping Hypertension: an Innovative network approach for Future generation research Training—MARIE Skłodowska-CURIE ACTIONS Innovative Training Networks.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24010093",TRUE,"Conflicts of Interest: The authors declare no <iend> conflict of interest.",TRUE,"Funding: This project has received funding from the Special Account for Research Grants University of Crete (Grant No.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24010711",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Sonderforschungsbereich (SFB) Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—SFB 1340/1 2018 B01. <section> Acknowledgments: We are grateful for financial support from the DFG-German Research Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24010854",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: P.D. is grateful for grants from the Department of Defense (CA201135) the American Gastroenterological Association Research Scholar Award (2021RSA-12522) and the startup funds from the University of Kansas Cancer Center.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24020928",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was funded by the German Society for Nutritional Medicine (DGEM) “DGEM research",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24021179",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the MDC BOOST program (to U.S. and P.C.S.) by the German Research Association (DFG STE 671/8-1 to US) the Alexander von Humboldt Foundation (to U.S.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24021189",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was funded by the Berlin Institute of Health at Charité–Universitätsmedizin Berlin Metabolomics Platform Berlin Germany. This work was supported by the DZHK (German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24021236",TRUE,"Conflicts of Interest: The authors declare that they have no conflict of interest.",TRUE,"<section> Funding: A.B. was supported by the Ministère de l’Enseignement Supérieur de la Recherche et de l’Innovation and by the Fondation pour la Recherche Médicale (FRM). T.A.-S. was supported by grants from the Fondation pour la Recherche Médicale (FRM-EQU-2020-03010517) the association Mucoviscidose-ABCF2 and FILFOIE (Filière de santé des maladies rares du foie Paris France).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24021276",TRUE,"Conflicts of Interest: K. Wolk has received research grants travel grants consulting honoraria or lecturer's honoraria from AbbVie Celgene/BMS Charité Research Organisation Dr. Willmar Schwabe GmbH & Co. KG Flexopharm JanssenCilag Novartis Pfizer Sanofi -Aventis TFS and UCB. D. Wils-mann-Theis has been an advisor speaker or investigator for Abbvie Almirall Amgen Biogen Boehringer Ingelheim Bristol Myers Squibb Celgene Forward Pharma GlaxoSmithKline Janssen-Cilag Leo Pharma Eli Lilly Medac Merck Sharp & Dohme Corp. Novartis Pfizer UCB Pharma and VBL. C. Kromer has been an advisor speaker or investigator for Janssen-Cilag and Novartis Pharma. K. Witte and T.-C. Brembach declare no conflict of interest.",TRUE,"<section> Funding: Different parts of this work were supported by research grants from Novartis and Celgene.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24021484",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by German Research Foundation (DFG) through funding of the Collaborative Research Centre 1444 EUROPEAN HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA grant number 101095635—PROTO) the Federal Ministry of Education and Research (BMBF 031L0234B-BOAC) and by Land Salzburg IWB/EFRE 2014-2020 P1812596 STEBS and Land Salzburg 20102-F2100572-FPR “EV-Quant”.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24021633",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge support from the German Research Foundation (DFG) and the OpenAccess Publication Fund of Charité—Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032160",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work of M.P.D. is supported by Berlin Institute of Health Junior Clinician Scientist Program DKTK Berlin Young Investigator Grant 2022 Berliner Krebsgesellschaft (DRFF202204).",TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032292",TRUE,"Conflicts of Interest: S.O. holds a patent for Cyclin A1 as a T cell antigen for treatment of malignant",TRUE,"<section> Funding: This research received funding from the German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by NCI NHGRI NHLBI NIDA NIMH and NINDS.",FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032399",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032493",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the Erben Felder Foundation Heinrich-Heine University Düsseldorf and the German Research Society (DFG STE2042/2-1).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24032555",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24032685",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032772",TRUE,"Conflicts of Interest: The authors have stated that they have no interests which might be perceived as",TRUE,"<section> Funding: Our research was supported by the German Research Foundation (DFG KFO192/2) the Berlin Institute of Health (BIH) and the Charité.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24032860",TRUE,"Conflicts of Interest: The RapifleX MALDI Tissuetyper TOF mass spectrometer was provided by Bruker Daltonics GmbH as part of a collaboration agreement between Bruker Daltonics GmbH and the Technical University of Munich. All other authors declare that no conflicts of interests",TRUE,"<section> Funding: The authors gratefully acknowledge the financial support of the Deustche Krebshilfe (German Cancer Aid) for the INTEGRATE-TN project (grant number: 70113450). <section> has received funding from Abbvie Amgen Astra Zeneca Celgene Novartis Pfizer Roche Seattle Genetics PriME/Medscape Teva Daiichi-Sankyo Vifor Samsung Lilly Eirgenix BMS Puma MSD and Immunomedics and personal fees from Chugai; in addition S.L. has a patent EP14153692.0 pending.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24043221",TRUE,"Conflicts of Interest: The authors declare that they have no competing interest.",TRUE,"<section> Funding: <section> O.S.-G. A.T. A.K. I.B. V.T. J.K. T.P. E.S. and E.K. were supported by RF Governmental grant No. 075-15-2022-1094 grant Nos. 20-15-00090 and 21-75-10088 from RSF and grant Nos. 20015-00308-a and Chinaa 19-515-55016 from RFBR. D.Z. was supported by National Natural Science Foundation of China (NSFC) (grant Nos. 61860206009 and 81870934) Innovation Fund of WNLO and Innovation Project of Optics Valley Laboratory (grant No. T.Y. was supported by National Natural Science Foundation of China (NSFC) (grant No. D.L. was supported by National Natural Science Foundation of China (NSFC) (grant No.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24043393",TRUE,"Conflicts of Interest: The author declares no conflict of interest.",TRUE,"<section> Funding: This research is funded by the EU Horizon 2020 programme ATHENA project: “Assays for the identification of Thyroid Hormone axisdisrupting chemicals: Elaborating Novel Assessment Strategies” grant number 825161 which is gratefully acknowledged.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24043521",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research has received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24043569",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was partially supported by the German Research Foundation through the funding of the FOR 2165 and the SFB 1444 (G.N.D. and K.S.-B) and the Autibone LOEWE-Exploration Project of the State of Hesse Germany (T.E.K).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24043891",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work was supported by the IMPRS-IDI to A.B.K. by the Deutsche Forschungsgemeinschaft (LE 2498/11-1 to B.L. OP 86/12-1 to B.O. and SFB/TR84 to B.O. M.W. and A.H.) and the German Federal Ministry of Education and Research (MAPVAP FKZ 16GW0247 to B.O.).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24044083",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24044095",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: German Federal Department of Economy and Energy (BMWi) German Aerospace Board Deutsches Zentrum für Luft und Raumfahrt e.V.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24044135",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This work was funded by the Deutsche Forschungsgemeinschaft DFG grant number BA-3769/3. G.B. is funded by the grant BA-3769/4. Z.L. was funded by a scholarship from CSC. The study also received funding from ECARF (European Center for Allergy Research Foundation) to T.Z.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24054620",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Performance-Based Funds LOM awarded by the CharitéUniversitätsmedizin Berlin to A.J.S.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24054815",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24054861",TRUE,"Conflicts of Interest: J.S. (Joshua Seifert) Y.C. W.S. K.M. J.S. (Joachim Spranger) J.K. and E.K.W. <section> declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the German Research Foundation (DFG SFB/TRR296 TP15 and",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24054961",TRUE,"Conflicts of Interest: Authors declare no conflict of interest.",TRUE,"<section> Funding: This project did not receive external funding but was supported by the internal research fund of the Charité (LOM 51419191); Z.P. received a stipendium from the China Scholarship Council (202008430180).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24065188",TRUE,"Conflicts of Interest: S.P.H. is a shareholder at Xeltis BV and LifeMatrix AG. M.Y.E. is a shareholder at LifeMatrix AG. The funders had no role in the design of the study; in the collection analyses or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results. <section> All other authors declare no conflict of interest.",TRUE,"Funding: M.Y.E. is funded by the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program grant number: 852814 (TAVI4Life).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24065295",TRUE,"Conflicts of Interest: The authors declare no conflict of interest that pertain to this work.",TRUE,"<section> Funding: A.L. and T.P. are supported by the (Digital) Clinician Scientist Program by the Berlin Institute of Heath (BIH). F.T. is supported by the German Research Foundation (DFG SFB/TRR and CRC1382 Project-ID 403224013) and the German Ministry of Education and Research (BMBF DEEP-HCC consortium BMBF Immun Avatar consortium).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24065509",TRUE,"Conflicts of Interest: S.H.E.K and L.G. are co-holders of a patent on the tuberculosis vaccine candidate VPM1002 licensed to Vakzine Projekt Management GmbH Hannover Germany and Serum Institute India Pvt. Ltd. Pune India. L.G. and G.P. are employed by Vakzine Projekt Management GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: The project “Innovative Vaccines Against Mycobacterium tuberculosis—Complex (MTC) and Staphylococcus aureus for Application in Veterinary and Human Medicine” (funding code 03ZZ0806C) was funded by the German Ministry for Education and Research (BMBF) as part of the consortium InfectControl 2020—Novel antiinfective strategies.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24065517",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work has been funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—TRR 241-375876048 (A06 to M.S. and N.B.-L. Lutz Stiftung and by the Forschungsstiftung Medizin am Universitätsklinikum Erlangen to M.S. by the Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universität Erlangen-Nürnberg within the funding programme ""Open Access Publication Funding”.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24076052",TRUE,"Conflicts of Interest: M.T. and T.R. report personal fees and others from Edwards and Novartis Bristol Myers Squibb Bayer Daiichi Sankyo and AstraZeneca which are outside the submitted work.",TRUE,"<section> Funding: This work was supported by Universitätsmedizin Essen Clinician Scientist Academy (UMEA)/German Research Foundation (DFG Deutsche Forschungsgemeinschaft) under Grant",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24076096",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition T.W. <section> Funding: This study was funded by the National Science Center of Poland (grant number 2016/21/B/ NZ9/00943 to T.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24076197",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: J.F.is a participant in the BIH–Charité Clinician Scientist Program funded by the Charité– Universitätsmedizin Berlin and the Berlin Institute of Health. <section> The German Konsiliarlabor is appointed and supported by the Robert Koch-Institute (to A.M.).",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms24076232",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24076684",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Italian Ministry of University and Research (MUR) under the competitive grant PRIN 2017-2017BTHJ4R to S.O. and M.M. and partly by the intramural competitive grant of the Department of Biotechnological and Applied Clinical Sciences-University of L’Aquila (DISCAB GRANT 07_DG_2022_12).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24087121",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Volkswagen Foundation (Materials Science going Life Science—New Tactile Materials for the Future of Haptic Communication). <section> Acknowledgments: We acknowledge the financial support provided by the Volkswagen Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24087306",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This project was supported by the German Research Foundation to J.B.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24087402",TRUE,"Conflicts of Interest: Authors declare no conflict of interest.",TRUE,"All authors have read and Funding: Support came from Foundation)—TRR 241–375876048 (B08) KFO5024–50553912 (A01 A03 by the Interdisciplinary Center (Jochen-Kalden funding program Institutional Review Board Statement: ethics committee of the University of Charité—Universitätsmedizin the Institutional Animal Care and Informed Consent Statement: Informed Data Availability Statement: The Array Express service of the Molecular the accession IDs E-MTAB-9850 course) [35].",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24097683",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. Philipp-Alexander Schencke is supported by a research grant of the German Cardiac Society",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24097804",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by our employer the Department of Neonatology Charité—Universitätsmedizin Berlin Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24098153",TRUE,"Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: This work was funded by the Deutsche Forschungsgemeinschaft SPP1656 (BS and US) GL 899/1-1 (RG) and TRR241 (BS and MS) as well as the Deutsche Zöliakie-Gesellschaft e.V.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24098198",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24108854",TRUE,"Conflicts of Interest: K. Witte G. Salinas and K. Ghoreschi declare no conflict of interest.",TRUE,"<section> Funding: The study received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24109038",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Berlin Institute of Health at Charité SPARK-Validation Track",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24119341",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Swiss National Science Foundation (SNF) grant number 320030_120269 to Oliver Baum.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms24119701",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the intramural funding from MPIIB and FLI.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241210046",TRUE,"Conflicts of Interest: The authors declare that they do not have any conflict of interest with the content",TRUE,"<section> Funding: The experimental part of the study was supported by research grants of Deutsche Forschungsgemeinschaft to H.K. and D.H. The in silico part of this study was supported by a grant (PID2020-113764GB-I00) from the Spanish Ministerio de Ciencia e Innovación.",FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241210327",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> The study has been supported by an unrestricted research grant by Novartis Pharma GmbH Nürnberg Germany.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms241210332",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms241310480",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: We acknowledge financial support from the Open Access Publication Fund of Charité–Universitätsmedizin Berlin and the German Research Foundation (DFG). This work is part of a project funded by the DFG (project number 510857108).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms241310946",TRUE,"Conflicts of Interest: The authors declare that they have no competing interests.",TRUE,"<section> Funding: O.S.-G. T.P. M.P. I.F. I.B. A.T. and J.K. were supported by an RSF grant (23-75-30001) and RF Governmental grant no. 075-15-2022-1094; J.K. was supported by the Academic leadership program Priority 2030 proposed by the First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241311034",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Financial support for this work was kindly provided by Deutsche Forschungsgemeinschaft to D.H.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms241411285",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by FEEI-Fundos Europeus Estruturais e de Investimento FEDER— Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI) Portugal 2020 and by Portuguese funds through FCT—Fundação para a Ciência e a Tecnologia/Ministério da Ciência Tecnologia e Ensino Superior in the framework of the projects: PTDC/MEC-ONC/31520/2017 and POCI-01-0145FEDER-028779 (PTDC/BIA-MIC/28779/2017) and of the project “Institute for Research and Innovation in Health Sciences” (UID/BIM/04293/2019). This work was also financed by the Portuguese Mass Spectrometry Network integrated in the National Roadmap of Research Infrastructures of Strategic Relevance",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241411815",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: S.M. and M.V. were supported by DFG (ME 1706/18-1; VA 179/4-1) for a TRP channelrelated research project.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241512127",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This research was funded by National Institutes of Health grant R01 GM119398 Russian Science Foundation grant 19-74-30003 (electron microscopy and spFRET experiments).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241512365",TRUE,"Conflicts of Interest: S.Y.G. reports grants from Vertex Pharmaceuticals; and lecture honoraria from Chiesi and Vertex Pharmaceuticals; and advisory board participation for Chiesi and Vertex Pharmaceuticals outside the submitted work.",TRUE,"<section> Funding: This research was supported by a financial grant from the Christiane Herzog Stiftung Stuttgart Germany and the Mukoviszidose Institut gGmbH Bonn the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ijms241713567",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—444748124.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241713604",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: This publication has been supported by RUDN University project №",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241814154",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition D.H. and H.K. <section> Funding: <section> Financial support for this work was kindly provided by Deutsche Forschungsgemeinschaft to D.H.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241814253",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—Grant No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms241914636",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The study was partly funded by the Foundation for Skin Physiology of the Donor Association for German Science and Humanities for financial support.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms242015117",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Bundesministerium für Bildung und Forschung grant number 03IPT614A to C.G. and G.K. and P.S. were supported by the Deutsche Forschungsgemeinschaft (DFG) (German Research Foundation) through SFB1423 Project-ID 421152132 subproject A01 (to P.S.) through Germany’s Excellence Strategy—EXC 2008—390540038—UniSysCat (Research Unit E) and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314 [ALLODD].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms242317008",TRUE,"Conflicts of Interest: The authors declare that there are no competing interest associated with the",TRUE,"<section> Funding: This work was supported by Ministerio de Ciencia e Innovación [grant number PID2022137116OB-I00] by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement MINDSHIFT [ID 954798] and Grupos Santander Universidad Complutense de Madrid [grant number GR-921641]. [CT58/21-CT59/21] is a recipient of a fellowship from Universidad Complutense",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ijms242317104",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition E.V.K. and V.S.T. <section> Funding: This research was funded by the Ministry of Science and Higher Education of the Russian",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcdd10010028",TRUE,"Conflicts of Interest: All authors declare that there are no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcdd10070294",TRUE,"Conflicts of Interest: Ahmed Sheriff is the Founder and Shareholder of Pentracor GmbH.",TRUE,"<section> Funding: This research received no external funding. Sebastian Kelle is supported by a grant from Philips Healthcare. Sebastian Kelle received funding from the DZHK (German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was registered under the number WHO ICTRP: DRKS00008988.",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcdd10070310",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the grant of the Ministry of Health of Russian Federation (registration number AAAA-A18-118022290061-2).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Funding: This research was funded by the grant of the Ministry of Health of Russian Federation (registration number AAAA-A18-118022290061-2). <section> Institutional Review Board Statement: The study protocol was approved by the ethics committee of Institute of Clinical Cardiology Moscow Russia and registered under Russian National Information System of Research Development and Technology Data of Civilian Usage (registration number AAAA-A18-118022290061-2).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcdd10080316",TRUE,"Conflicts of Interest: P.D. owns stock of Siemens and Bayer. D.H. S.K. and B.P. received support from the DZHK (German Centre for Cardiovascular Research). S.K. was supported by an unrestricted research grant from Philips Health Care. All other authors declare that they have no financial and non-financial competing interests to disclose.",TRUE,"<section> Funding: The NAPKON-HAP trial was funded by the BMBF (Grant FKZ 01KX2021). S.K. was supported by an unrestricted research grant from Philips Health Care.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcdd10080351",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The European Association for Cardio-Thoracic Surgery (EACTS) supported this study and made resources available to execute this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12010032",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12010035",TRUE,"Conflicts of Interest: G.K. has received travel grants or honoraria or has been a consultant member of advisory boards and speakers bureaus for one or more of the following: AbbVie Actelion Pharmaceuticals Almirall Amgen Basilea Pharmaceutica Bayer Schering Pharma Biogen Idec Boehringer-Ingelheim Celgene Bristol-Myers Squibb Hexal-Sandoz Janssen-Cilag Leo Pharma",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12010192",TRUE,"Conflicts of Interest: The authors declare no competing interest.",TRUE,"<section> Funding: Cornelia Lachmann is participant in the Berlin Institute of Health (BIH) Charité Digital Clinician Scientist Program funded by the Charité–Universitätsmedizin Berlin and the BIH at Charité.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study was registered with www.ClinicalTrials.gov (NCT02854943) on 1 August 2016.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcm12010335",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12020630",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12020727",TRUE,"Conflicts of Interest: The authors declare the following financial interest/personal relationships.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol was registered with PROSPERO (CRD42018080895) and PRISMA guidelines have been followed. <section> 2. Materials and Methods This review is based on a protocol registered in the PROSPERO database (CRD42018080895) and the recommendations of the PRISMA statement for the reporting of systematic reviews have been followed [24].",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcm12030856",FALSE,"",TRUE,"<section> Funding: This research received no external funding. He has received educational and research support from Gilead Pfizer Astellas Accelerate Novartis Abbvie ViiV and MSD and funds from European Commission/EFPIA IMI2 853966-2 IMI2 777377 H2020 847989 and ISCIII PI19/01898 (all outside the submitted work).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12030937",TRUE,"Conflicts of Interest: F.S. and J.K. are co-founders of the startup dentalXrai GmbH. dentalXrai GmbH had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: We acknowledge financial support from the Open Access Publication Fund of Charité— Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study protocol was registered after the initial screening stage (PROSPERO registration no. CRD42021288159).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcm12031060",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12031142",TRUE,"Conflicts of Interest: F D’Amico has served as a speaker for Sandoz Janssen Galapagos and Omega Pharma. S Al Awadhi declares no conflict of interest.",TRUE,"<section> Funding: This work was supported by Ferring Pharmaceuticals.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12031216",TRUE,"Conflicts of Interest: All authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12031240",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12041434",TRUE,"Conflicts of Interest: M.P.F. reports personal fees from Teva.",TRUE,"<section> Funding: U.R. received research funding from the German Federal Ministry of Education and Research and Novartis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12041444",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12041456",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Open access funding was enabled and organized by the Open Access Publication Funds of the",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12041545",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12041603",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12062098",TRUE,"Conflicts of Interest: CHL is receiving royalties from Hogrefe Huber Publishers for the German version of the Hospital Anxiety and Depression Scale.",TRUE,"<section> Funding: The SPIRR-CAD trial was funded by the German Research Foundation (DFG) #HE3115/101; PI Christoph Herrmann-Lingen Göttingen Christian Albus Köln (SPIRR-CAD NCT00705965). He received lecture honoraria from Pfizer and Novartis and research support from the German Ministry of Education and Research (BMBF) the German Research Foundation (DFG) and the European Commission.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12062101",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG) grant DA 1810/2-1 to Amro Daboul; the Bundesministerium für Bildung und Forschung grants 01ZZ9603 01ZZ0103 and 01ZZ0701; the Deutsche Stiftung für Herzforschung grant F/34/10; and the Research Network of Community Medicine University Medicine Greifswald. <section> The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research Network of the University Medicine Greifswald which is supported by the German Federal State of Mecklenburg-West Pomerania the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg—West Pomerania.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12062102",TRUE,"Conflicts of Interest: C.A.B. received consultancy fees (AMGEN ASTELLAS ASTRA-ZENECA) unrelated to this project.",TRUE,"<section> Funding: This research was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation: Project-ID 387509280—SFB1350 and Project-ID 509149993—TRR 374 (Subproject C6 to I.M.H.). The AugUR study was supported by the German Federal Ministry of Education and Research (grant number BMBF 01ER1206 BMBF 01ER1507 to I.M.H.) and by the German Research Foundation (grant number HE 3690/7-1 to I.M.H. BR 6028/2-1 to C.B.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12062103",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The trial was an investigatorinitiated trial and was partially funded by JD’s research grant from the Veronica and Karl Carstens Foundation Am Deimelsberg Essen Germany.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The trial is registered on ClinicalTrials.gov NCT03755960.",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcm12062271",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12062302",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Deutsche Forschungsgemeinschaft (DFG) EXPAND-PD CA2816/1-1; Deutsche Forschungsgemeinschaft (DFG) CRC-1365 Number #394046635 subproject A03; European Commission Horizon 2020—PACE (Grant Agreement Number 733006); European Commission Horizon 2020—HIPGEN (Grant Agreement Number 779293).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12062405",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12062437",TRUE,"Conflicts of Interest: M.O. acts as a consultant to Oncocyte.",TRUE,"<section> Funding: Laboratory testing was sponsored by Oncocyte.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12072633",FALSE,"",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12082912",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12082925",TRUE,"Conflicts of Interest: The authors declare they have no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12082945",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the Professor Manfred von Ardenne Forschungsförderungsgesellschaft e.V. [grant number P22.2021].",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12082963",TRUE,"Conflicts of Interest: The authors declare no conflict of interest regarding this publication.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12093058",TRUE,"Conflicts of Interest: F.S. and J.K. are co-founders of a Charité startup on dental image analysis.",TRUE,"<section> Funding: We acknowledge financial support from the Open Access Publication Fund of Charité— Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12093159",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: We acknowledge financial support from the Open Access Publication Fund of Charité–Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12093168",TRUE,"Conflicts of Interest: P.M. has received consulting fees from Arthrex Inc. Medacta and Alyve Medical. The other authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12093317",TRUE,"Conflicts of Interest: J.N. received a speaker honorarium from Dahlhausen Medizintechnik GmbH. <section> The other authors do not have any conflict of interest related to the content of the manuscript.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12103373",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12103546",TRUE,"Conflicts of Interest: A.-S.E. reports no conflict.",TRUE,"<section> Funding: This study was supported by an unconditional research grant provided by the Deutsche Atemwegsliga e.V.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12103561",TRUE,"Conflicts of Interest: J.A.B. has received grants from Novartis Astra Zeneca Sanofi-Regeneron Amgen Roche Allakos Celldex CSL Behring Takeda/Shire Biocryst Pharming Ionis Biomarin and Genentech outside of the submitted work as well as personal fees from Novartis Astra Zeneca Sanofi-Regeneron Amgen Roche Allakos Celldex CSL Behring Takeda/Shire Biocryst Pharming Ionis Biomarin and Genentech outside of the submitted work.",TRUE,"<section> Funding: This research was funded by Novartis Pharma AG Switzerland. This investigation was sponsored by Novartis Pharma AG Basel Switzerland. <section> Conflicts of Interest: J.A.B. has received grants from Novartis Astra Zeneca Sanofi-Regeneron Amgen Roche Allakos Celldex CSL Behring Takeda/Shire Biocryst Pharming Ionis Biomarin and Genentech outside of the submitted work as well as personal fees from Novartis Astra Zeneca Sanofi-Regeneron Amgen Roche Allakos Celldex CSL Behring Takeda/Shire Biocryst Pharming Ionis Biomarin and Genentech outside of the submitted work.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12113640",TRUE,"Conflicts of Interest: David Ellenberger Firas Fneish Sarah Schilling and Melanie Peters had no personal financial interests to disclose other than being employees of the German MS Registry. None resulted in a conflict of interest.",TRUE,"<section> Funding: The conduct of this study was supported by multistakeholder sponsors organized by the DMSG. Friedemann Paul has received speaking fees travel support honoraria from advisory boards and/or financial support for research activities from Bayer Novartis Biogen Teva Sanofi-Aventis/Genzyme Merck Serono Alexion Chugai MedImmune Shire German Research Council Werth Stiftung of the City of Cologne German Ministry of Education and Research EU FP7 Framework Program Arthur Arnstein Foundation Berlin Guthy Jackson Charitable Foundation and National Multiple Sclerosis of the USA.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12113656",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Berliner Krebsgesellschaft grant number #PEFF202104.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12113709",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12113778",TRUE,"Conflicts of Interest: The authors declare that there are no conflict of interest.",TRUE,"<section> Funding: This project was funded by the Karl and Veronica Carstens Foundation (grant number KVC 0/098/2018).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12113814",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work of J.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12113843",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no funding. <section> Acknowledgments: The UNITI project was financed by the European Union’s Horizon 2020 Research and Innovation Programme Grant Agreement Number 848261.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12124005",FALSE,"",TRUE,"<section> Funding: <section> Acknowledgments: J.N. is grateful for being supported by the Berlin Institute of Health (Digital Clinician Scientist Grant funded by Charité—Universitaetsmedizin Berlin the Berlin Institute of Health and the German Research Foundation DFG). F.S. was supported by the Berlin Institute of Health (Clinician Scientist Grant). T.P. was supported by the Berlin Institute of Health (Clinician Scientist Grant and Platform Grant) Ministry of Education and Research (BMBF 01KX2021 and 68GX21001A) German Research Foundation (DFG SFB 1340/2) and Horizon 2020 (952172).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12124147",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12124159",TRUE,"Conflicts of Interest: S.T. has recieved the following grants: Bundesministerium für Wirtschaft und Klima Research project “5G-OR” (Institute).",TRUE,"<section> Funding: The APC was funded by the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG). We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12134219",FALSE,"",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12134328",TRUE,"Conflicts of Interest: The authors declare that they have no competing interests.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12134359",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Corona foundation (Corona Stiftung Deutsches Stiftungszentrum Essen; project number S199/10063/2016) and the German Federal Ministry of Education and Research (BMBF) with the network project ArthroMark (01EC1009A).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12134510",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Abbott Austria in form of an unrestricted educational grant.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12134527",TRUE,"Conflicts of Interest: Eli Lilly and Company was involved in the choice of research project; in the collection analyses and interpretation of data; in the writing of the manuscript; and in the decision to publish the results.",TRUE,"<section> Funding: This review article was funded by Eli Lilly and Company.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12144573",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition T.T. <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12144750",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by the Youth Science Fund of the National Natural Science Foundation of China (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12144861",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12154937",TRUE,"Conflicts of Interest: H.K. is affiliated with Orchid Pharmed Company which is a partner of NanoAlvand Company in conducting clinical trials. However H.K.’s contribution to this study was independent and not influenced by any potential conflicts of interest.",TRUE,"<section> Funding: <section> The financial support for covering the publication fee associated with this paper was provided by Orchid Pharmed Company.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12154938",TRUE,"Conflicts of Interest: MB JS EL BL AK RW AD FE and KL have no conflict of interest to disclose regarding this manuscript.",TRUE,"<section> Funding: The German Foundation of Heart Research supported this work [F/19/18].",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12154947",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by grants from the Italian Ministry of University and Research (PNRR-National Center for Gene Therapy and Drugs based on RNA Technology” CN00000041) and from the Italian Ministry of Health (PSC SALUTE 2014-2020 -POS4 “Cal-Hub-Ria”-T4-AN-09 and PNRR-MAD-2022-12376814) to D.T. and S.D.R.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12154994",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> The Rh-GIOP cohort study is or was supported by a joint funding from Abbvie Amgen Almirall Biogen BMS Chugai Galapagos Generic Assays GSK Hexal Horizon Therapeutics Lilly Medac Mundipharma Novartis Pfizer Roche and Sanofi.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12155050",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was funded by a ProFIT grant of the Investitionsbank Berlin/cofunded by EFRE (Nos. 10169096 10169098 10169028) and a grant from the Central SMEs Innovation Programme of the Federal Ministry of Economic Affairs and Climate Action Germany (KK5175802AP2 KK5463501AP2 KK5463901AP2).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12165269",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the German Research Foundation (rotational position of KFO 342-ZA428/18-1 to C.C.D. and A.R. We would like to acknowledge the support of the Open Access Publication Fund of the University of Münster.",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12165419",TRUE,"Conflicts of Interest: The authors declare that there is no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12175464",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> We acknowledge financial support from the Open Access Publication Fund of Charité— Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12175619",TRUE,"Conflicts of Interest: We declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: H.H. S.S. S.N. and V.K. have received a salary from HRTBT Medical Solutions GmbH.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12175763",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: SHIP is part of the Community Medicine Research net of the University of Greifswald Germany which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603 01ZZ0103 and 01ZZ0403) the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The BASE-II research project is supported by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung BMBF) under grant numbers #16SV5536K #16SV5537 #16SV5538 #16SV5837 #01UW0808 01GL1716A and 01GL1716B.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12186103",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12196196",TRUE,"Conflicts of Interest: T.F. received travel accommodations and expenses from EUSA Pharma and has served as a consultant/advisor for EUSA Pharma. <section> M.S. B.H. M.U.S. J.S. F.P. and B.T. declare no conflicts of interest.",TRUE,"<section> Funding: Editorial assistance for the preparation of the manuscript was funded by EUSA Pharma. <section> Acknowledgments: Writing assistance for the preparation of this manuscript was provided by mXm Medical Communications funded by EUSA Pharma.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12196204",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12196371",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12196428",TRUE,"Conflicts of Interest: Charité holds together with CellTrend a patent for the diagnostic use of AABs against ADRB2.",TRUE,"This study is conducted within the Nationale Klinische Studiengruppe (NKSG) a clinical trial and translational research platform for the development of treatment in PCS and ME/CFS funded by the German Ministry of Education and Research (BMBF) [22]. <section> Funding: The study is funded by Bundesministerium für Bildung und Forschung (BMBF) and the Weidenhammer Research Foundation (Weidenhammer Zöbele Stiftung). Funding Number 01EP2201.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12206432",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12206482",TRUE,"Conflicts of Interest: F.B. reports royalties from Smith & Nephew consultant fees and royalties from Ortho Development Corporation and stock options in AccuPREDICT.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12206542",TRUE,"Conflicts of Interest: The authors report there are no competing interests to declare.",TRUE,"<section> Funding: This study was supported by Helios Kliniken GmbH Grant-ID: 2022-0330.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12206546",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding related to the work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12216828",TRUE,"Conflicts of Interest: The authors declare no conflict of interest. The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12216881",TRUE,"Conflicts of Interest: P.Z. U.S. M.G. and F.S. received study support (third-party funding) from Arthex. T.H. S.M. and C.I. declare that no conflicts of interest exist.",TRUE,"<section> Funding: This study was financially supported by Arthrex. We acknowledge support from the Open Access Publication Fund of the University of Tübingen.",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> 2. Materials and Methods The study was registered at the German Register of Clinical Trials in Freiburg (DRKS00011376) and the protocol was approved by the local ethics committee (347/2016MP1).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/jcm12227089",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12227169",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12227176",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge support from the German Research Foundation (DFG) and the OpenAccess Publication Fund of Charité—Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12237441",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jcm12247516",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jcm12247547",FALSE,"",TRUE,"<section> Funding: The authors gratefully acknowledge the financial support from the German Federal Ministry of Education and Research (LiSyM 031L0057 to I.S.) and the German Research Foundation (467843609 to S.R.M.G. FOR5628 to I.S. and S.R.M.G. SFB 1340 to B.H. and I.S. <section> Acknowledgments: We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jfb14060305",TRUE,"Conflicts of Interest: The authors A.H. V.E. N.A. and J.B. are employees of the German Institute for Cell and Tissue Replacement (DIZG gemeinnützige GmbH) a nonprofit provider of sterile allografts. <section> The other authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Institute for Cell and Tissue Replacement (DIZG gemeinnützige GmbH) 12555 Berlin Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jfb14110534",TRUE,"Conflicts of Interest: F.S. is a consultant for DMG Dental-Material Gesellschaft mbH but did not receive any payment or personal benefits for this study.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: The work was supported by DMG Dental-Material Gesellschaft mbH and the Fraunhofer Institute for Microstructure of Materials and Systems. The Fraunhofer Institute for Microstructure of Materials and Systems received financial support from DMG Dental-Material Gesellschaft mbH to conduct parts of the experimental investigations but did not receive any other benefits for this study.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jof9020158",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Basque Government grant numbers IT1362-19 and IT165722.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13010130",TRUE,"Conflicts of Interest: The funders had no role in study design data collection and analysis interpretation of the data decision to publish or preparation of the manuscript. There are no financial or non-financial competing interests. This includes: employment consultancy patents products in development marketed products etc. The authors declare no further conflict of interests.",TRUE,"; Funding acquisition T.K. and A.M. <section> Funding: The study was financed by a grant from OPED GmbH Medizinpark 1 D-83626 Valley Germany.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jpm13010160",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13030472",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13040690",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13050835",TRUE,"Conflicts of Interest: J. Bousquet reports personal fees and other support from Chiesi Cipla Hikma Menarini Mundipharma Mylan Novartis Sanofi-Aventis Takeda Teva and Uriach and other support from KYomed INNOV outside the submitted work. C. Bachert reports fees from ALK-Abello Mylan Stallergenes Novartis Sanofi GlaxoSmithKline and Astra Zeneca outside the submitted work. All other authors declare no conflict of interest.",TRUE,"<section> Funding: The APC was funded by the Malaysian Society of Allergy and Immunology (MSAI). <section> Acknowledgments: This research was funded by the Malaysian Society of Allergy and Immunology (MSAI) via an educational grant provided by GlaxoSmithKline Pharmaceutical (M) Sdn Bhd.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13050852",TRUE,"Conflicts of Interest: There was no formal funding by private government or commercial funders. <section> The participating clinical centers (Center For Advanced Spine Care of Southern Arizona—Tucson Arizona Department of Orthopaedic Surgery—The University of Arizona Desert Institute of Spine Care—Phoenix Arizona Department of Orthopaedics Fundación Universitaria Sanitas—Bogotá D.C. Colombia Department of Neurosurgery and Orthopaedics at Hospital Universitário Gaffre e Guinle Universidade Federal do Estado do Rio de Janeiro—Rio de Janeiro Brazil Department <section> of Orthopaedic Surgery The First Affiliated Hospital of Soochow University The American-British Cowdray Medical Center Good Doctor Teun Teun Spine Hospital Endoscopic Spine Clinic Santiago Chile Department of Neurosurgery Nanoori Hospital Gangnam Hospital West China Hospital Sichuan University The First Affiliated Hospital of Soochow University supported with their internal resources the design and conduction of this study. They aided in the collection analyses or interpretation of data; in the writing of the manuscript; and in the decision to publish the results. The authors declare no conflict of interest and there was no personal circumstance or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/jpm13071044",TRUE,"Conflicts of Interest: There was no formal funding by private governmental or commercial funders. <section> The participating spine centers (Center For Advanced Spine Care of Southern Arizona—Tucson Arizona; Desert Institute of Spine Care—Phoenix Arizona; Department of Orthopaedics Fundación Universitaria Sanitas—Bogotá D.C. Colombia; Department of Neurosurgery and Orthopaedics at Hospital Universitário Gaffre e Guinle Universidade Federal do Estado do Rio de Janeiro—Rio de Janeiro Brazil; Department of Orthopaedic Surgery The First Affiliated Hospital of Soochow University; The American–British Cowdray Medical Center; Good Doctor Teun Teun Spine Hospital; Endoscopic Spine Clinic Santiago Chile; Department of Neurosurgery Nanoori Hospital Gangnam Hospital; West China Hospital of Sichuan University supported with their internal resources the design and conduction of this study. They aided in the collection analysis or interpretation of data; in the writing of the manuscript and in the decision to publish the results. The authors declare no conflict of interest to the work presented herein including no personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of the research data or professional information.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/jpm13071046",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13010065",TRUE,"Conflicts of Interest: Lan Huong Timm declares gainful employment by the DZK Zahnklinik GmbH and is the Chief Medical Officer of the DrSmile Group.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13010071",TRUE,"Conflicts of Interest: H.L. K.-G.H. and W.S. are currently working at UPPThera Inc. but conducted the current research without any conflicts of financial interest.",TRUE,"<section> Funding: This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A4A1019423).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13010152",TRUE,"Conflicts of Interest: All the authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13010223",TRUE,"Conflicts of Interest: Stefan Niehues has received research grants from Bracco Group Bayer Vital GmbH Canon Medical Systems and Guerbet. Bernd Hamm has received research grants for the Department of Radiology Charité—Universitätsmedizin Berlin from the following companies: (1) Abbott (2) Actelion Pharmaceuticals (3) Bayer Schering Pharma (4) Bayer Vital (5) BRACCO Group (6) Bristol-Myers Squibb (7) Charite Research Organisation GmbH (8) Deutsche Krebshilfe (9) Dt. Stiftung für Herzforschung (10) Essex Pharma (11) EU Programmes (12) FibrexMedical Inc (13) Focused Ultrasound Surgery Foundation (14) Fraunhofer Gesellschaft (15) Guerbet (16) INC Research (17) lnSightec Ud (18) IPSEN Pharma (19) Kendlel MorphoSys AG (20) Lilly GmbH (21) Lundbeck GmbH (22) MeVis Medical Solutions AG (23) Nexus Oncology (24) Novartis (25) Parexel Clinical Research Organisation Service (26) Perceptive (27) Pfizer GmbH (28) Philipps (29) Sanofis-Aventis S.A. (30) Siemens (31) Spectranetics GmbH (32) Terumo Medical Corporation (33) TNS Healthcare GMbH (34) Toshiba (35) UCB Pharma (36) Wyeth Pharma (37) Zukunftsfond Berlin (TSB) (38) Amgen (39) AO Foundation (40) BARD (41) BBraun (42) Boehring Ingelheimer (43) Brainsgate (44) PPD (Clinical Research Organisation) (45) CELLACT Pharma (46) Celgene (47) CeloNova Bio-Sciences (48) Covance (49) DC Deviees Ine. USA (50) Ganymed (51) Gilead Sciences (52) GlaxoSmithKline (53) ICON (Clinical Research Organisation) (54) Jansen (55) LUX Bioseienees (56) MedPass (57) Merek (58) Mologen (59) Nuvisan (60) Pluristem (61) Quintiles (62) Roehe (63) SehumaeherGmbH (Sponsoring eines Workshops) (64) Seattle Geneties (65) Symphogen (66) TauRx Therapeuties Ud (67) Accovion (68) AIO: Arbeitsgemeinschaft Internistische Onkologie (69) ASR Advanced sleep research (70) Astellas (71) Theradex (72) Galena Biopharma (73) Chiltern (74) PRAint (75) lnspiremd (76) Medronic (77) Respicardia (78) Silena Therapeutics (79) Spectrum Pharmaceuticals (80) St Jude (81) TEVA (82) Theorem (83) Abbvie (84) Aesculap (85) Biotronik (86) Inventivhealth (87) ISATherapeutics (88) LYSARC (89) MSD (90) Novocure (91) Ockham Oncology (92) Premier-Research (93) Psi-cro (94) Tetec-ag (95) Winicker-Norimed (96) Achaogen Inc (97) ADIR (98) AstraZenaca AB (99) Demira Inc (100) Euroscreen S.A. (101) Galmed Research and Development Ltd. (102) GETNE (103) Guidant Europe NV (104) Holaira Inc (105) Immunomedics Inc (106) Innate Pharma (107) Isis Pharmaceuticals Inc (108) Kantar Health GmbH (109) MedImmune Inc (110) Medpace Germany GmbH (CRO) (111) Merrimack Pharmaceuticals Inc (112) Millenium Pharmaceuticals Inc (113) Orion Corporation Orion Pharma (114) Pharmacyclics Inc (115) PIQUR Therapeutics Ltd. (116) Pulmonx International Sárl (117) Servier (CRO) (118) SGS Life Science Services (CRO) and (119) Treshold Pharmaceuticals Inc. These grants had no role in the study design data collection and analysis decision to publish or preparation of the manuscript. The remaining authors declare that they have no conflicts of interest and did not receive any funds.",TRUE,"<section> Funding: This research received no external funding. The remaining authors declare that they have no conflicts of interest and did not receive any funds.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13020585",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/life13040979",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13061290",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/life13061341",TRUE,"Conflicts of Interest: The authors S.B. M.B. L.S. T.C. and P.D. declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Stavros Niarchos Complex Joint Reconstruction Center at Hospital for Special Surgery NY USA and the Stiftung Friedrichsheim at Goethe University Frankfurt Germany.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13102045",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/life13102073",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: There was no funding for this study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ma16010102",TRUE,"Conflicts of Interest: Max Heiland and Carsten Rendenbach received research funding and speaker remuneration by Karl Leibinger Medizintechnik GmbH & Co.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ma16010276",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Funding: The research was supported by Kuraray Noritake Japan.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ma16237310",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Croatian Science Foundation project ‘Research and Development of New Micro and Nanostructural Bioactive Materials in Dental Medicine’ BIODENTMED No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/machines11010034",TRUE,"The authors declare no conflict of interest.",TRUE,"; Funding acquisition R.D. and L.O. <section> Funding: This research was funded by the German Federal Ministry of Education and Research (BMBF) within the project RoMi “Roboterunterstützung bei Routineaufgaben zur Stärkung des Miteinanders in Pflegeheimen” under grant number 16SV8436.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/magnetochemistry9010006",TRUE,"Conflicts of Interest: Thoralf Niendorf is the founder and CEO of MRI.TOOLS GmbH Berlin Germany.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/medicina59010183",TRUE,"Conflicts of Interest: B.C. reports lecture and/or consulting fees from Abbvie Amgen Celltrion Ferring Galapagos Janssen Takeda. V.J. reports consulting/advisory board fees from AbbVie Alimentiv Inc (formerly Robarts Clinical Trials) Arena pharmaceuticals Asahi Kasei Pharma Asieris Bristol Myers Squibb Celltrion Eli Lilly Ferring Flagship Pioneering Fresenius Kabi Galapagos GlaxoSmithKline Genentech Gilead Janssen Merck Mylan Pandion Pendopharm Pfizer Protagonist Reistone Biopharma Roche Sandoz Second Genome Takeda Teva Topivert Vividion; speaker’s fees from Abbvie Ferring Galapagos Janssen Pfizer Shire Takeda Fresenius Kabi. F D’Amico has served as a speaker for Janssen Galapagos Sandoz and Omega Pharma. S Al Awadhi reports no conflict of interest.",TRUE,"Funding: This research was funded by Ferring Pharmaceuticals.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/medicina59050925",TRUE,"Conflicts of Interest: The authors declare that there are no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: We acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publication Fond (DFG-OA-Fonds).",FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/medicina59101791",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/medicina59111981",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/medicina59112001",TRUE,"Conflicts of Interest: The authors declare that there are no conflict of interest.",TRUE,"<section> 2.3. National Register for Congenital Heart Defects The National Register for Congenital Heart Defects was founded in 2003 by the three German cardiac medical societies (DGPK DGTHG DGK) as a nonprofit scientific association and is currently funded by the German Federal Ministry of Education and Research (BMBF). <section> Funding: This study received funding from Deutsche Herzstiftung e.V.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/medicina59112045",TRUE,"Conflicts of Interest: The authors declare that they have no conflict of interest.",TRUE,"<section> Funding: This study was supported by grants from “Piano di incentivi per la Ricerca Linea Intervento 2 PIACERI 2020–2022” University of Catania Italy. <section> The authors extend their appreciation to the Deanship of Scientific Research and the Research Center College of Pharmacy King Saud University for their financial support. Traditional Applications of Tannin Rich Extracts Supported by Scientific Data: Chemical Composition Bioavailability and Bioaccessibility.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/medicina60010083",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/metabo13010011",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study is funded by the Natural Science Foundation of Jiangsu province (grant no. <section> BK20181155) Young talent project of Changzhou Health Commission (grant no. CZQM2022007) Youth fund of Changzhou Health Commission (grant no. QN202121) and Basic application project of Changzhou science and Technology Bureau (grant no. CJ20220142). Hanyang Liu is funded by Chinese Scholarship Council (CSC) Foundation. <section> Acknowledgments: This research was supported by Nanjing Medical University and Charité Universitätsmedizin",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/metabo13050665",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/metabo13060757",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/metabo13080910",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Austrian Science Fund (FWF) grant number P 31228-B33 by the Paracelsus Medical University (PMU-RIF) grant number 2022-PRE-006-Catalano and the Children Cancer Foundation Salzburg Austria. Also thanks for “Open Access Funding by the Austrian Science Fund (FWF)”.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/microorganisms11020283",TRUE,"Conflicts of Interest: S.K. and H.S. received funding for convalescent plasma trials in COVID-19 from the German Federal Ministry of Health (“Bundesministerium für Gesundheit” CAPSID Trial) and the Federal Ministry of Education and Research (“Bundesministerium für Bildung und Forschung”) and H.S. H.K. and S.K. are affiliated with a blood transfusion service providing plasma products. <section> The other authors declare no conflicts of interest.",TRUE,"<section> Funding: Virus diagnostics were performed at the National Consultation Laboratory for Hantaviruses at the Institute of Virology in Berlin with financial support from the Robert Koch Institute/Federal Ministry for Health. <section> Conflicts of Interest: S.K. and H.S. received funding for convalescent plasma trials in COVID-19 from the German Federal Ministry of Health (“Bundesministerium für Gesundheit” CAPSID Trial) and the Federal Ministry of Education and Research (“Bundesministerium für Bildung und Forschung”) and H.S. H.K. and S.K. are affiliated with a blood transfusion service providing plasma products.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/microorganisms11040833",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by the Sister Institution Network Fund (SINF) 2019-20 (AHK) and was partially supported by the generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Moon Shots Program (AHK). Funding was also obtained from Else Kroener-Fresenius-Stiftung grant 2017-HA03. Furthermore this study was supported by Addis",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/molecules28145418",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition I.I. À.G.-L. <section> Funding: Russian Ministry of Science and High Education (FSFZ-2023-0004) supported the experimental part of this work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/molecules28145421",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the CNPq: (grants: 203044/2019-3 309145/2020-1 and 408926/2021-0: scholarship and financial support to P.I.d.S.M.) and PhD scholarship for S.F.S. and the DAAD. The publication of this article was funded by Freie Universität Berlin.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/molecules28207096",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Bulgarian Ministry of Education and Science (MES) of Bulgaria in the frames of Bulgarian National Recovery and Resilience Plan Component “Innovative Bulgaria” the Project No BG-RRP-2.004-0006-C02 “Development of research and innovation at Trakia University in service of health and sustainable wellbeing” as well as in the frame of Bilateral Cooperation Programs—Bulgaria—China 2019 grant number KP-06-China/6-20.11.2020.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15010063",TRUE,"Conflicts of Interest: The authors declare that they have no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15040828",TRUE,"Conflicts of Interest: E.W. reports honoraria for consulting and lectures from Amedes AMGEN AstraZeneca Berlin Chemie Daiichi-Sankyo Fresenius Hexal MSD Sharp & Dohme Novartis",TRUE,"<section> Funding: This work received no external funding. J.P. received research funding from the Dutch Research Council (NWO) The Netherlands Organization for Health Research and Development (ZonMW) Applied and Engineering Sciences (STW) The Dutch Topsector for Life Sciences and Health (TKI-LSH) The Californian Almond Foundation EzCol Newtricious BASF RAISIO Upfield and Unilever and has received honoraria from Unilever Raisio BASF and Upfield and is secretary of the board from the foundation Nutrition in Transition (NIT) is chair of the supervisory board of the FIVES foundation and is chair of the Department Nutrition and Movement Sciences of the Maastricht University. O.W. received honoraria and/or travel support from AMGEN Daiichi-Sankyo Amarin Novo Nordisk Novartis Hexal Sanofi Fresenius Medical Care Akcea TAD Pharma Pfizer and from the German Society of Cardiology.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15040851",TRUE,"Conflicts of Interest: A.M. and D.K. have co-founded the Academy of Integrative Fasting (AIF). The other authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Corona Foundation (Corona Stiftung Deutsches Stiftungszentrum Essen) grant number S199/10063/2016. We acknowledge financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Acknowledgments: We thank all participating patients as well as all cooperating rheumatologists for supporting the patient recruitment.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15041015",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by NIH grant DA0256234 (MFR); ANR grants ANR-17-EURE0017 and ANR-10-IDEX-0001-02 (BSG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15071565",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition M.K. <section> Funding: A.C. was supported by the Research Foundation Flanders (FWO) Belgium (Project ID 11L8322N). J.V. was supported by UHasselt Methusalem project 08M03VGRJ and by a BOF grant (ADMIRE Project ID 21GP17BOF) from Hasselt University. M.K. was supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (Project ID 640116) by a SALK-grant from the government of Flanders by an Odysseusgrant (Project ID G0G1216FWO) and senior research project (Project ID G080121N) of the FWO and by a BOF grant (ADMIRE Project ID 21GP17BOF) from Hasselt University.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15081949",TRUE,"Conflicts of Interest: E.B. and U-F.P. received consultation/lecture/advisory board honoraria and grant/research support from Takeda/Shire Pharmaceuticals/NPS*.",TRUE,"<section> Funding: This study was supported by an Investigator Initiated Research grant from Shire International GmbH a member of the Takeda group of companies (IIR-DE-002746).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15092048",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15092081",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: F.P. was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) grant PE 3135/1-1. J.H. received funding from the DFG: HA 6908/3-1 HA 6908/4-1 HA 6908/7-1 HA 6908/8-1. R.S. received funding from Else Kroner-Fresenius Stiftung (EKFS 2019_A96).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15092150",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15102325",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: Funding for this work was provided by DSM Nutritional Products Ltd.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"Ethical approval was obtained from the National Healthcare Group Domain Specific Review Board (NHG DSRB reference 2021/00455) and the study is registered at ClinicalTrials.gov (NCT05046457).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/nu15102338",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by a grant from the German Federal Ministry of Education and Research (#0315424 to A.F.H.P.).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This study was registered at ClinicalTrials.gov (NCT01631123).",TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/nu15112466",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: <section> This study was conducted in the context of the NutriAct Competence Cluster—Nutritional Intervention Behaviour and Products Berlin-Potsdam (Germany) which was funded by the German Federal Ministry of Education and Research (grant number 01EA1806D).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15122695",TRUE,"Conflicts of Interest: A.M. and D.A.K. co-founded the Academy of Integrative Fasting (AIF). A.M. is also co-founder of the SALUFAST company and D.A.K. serves as a consultant for a mobile application on intermittent fasting (FASTIC) as well as a company producing plant-based supplements (EVERYYIN). All other authors declare no conflicts of interest related to this manuscript.",TRUE,"; Funding acquisition A.M. <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15122763",TRUE,"Conflicts of Interest: Elizabeth Wall has advised for Baxter Healthcare Corporation Takeda Pharmaceuticals and Zealand Pharma.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: This research study was supported by Zealand Pharma (ZP).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15132872",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The animal funding was provided by the Kerscher’sche Diabetes Research Foundation to MK and GST. Some aspects of this study were supported by Stiftung Endoprothetik to GST (S04/21).",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15153366",TRUE,"Conflicts of Interest: K.S. was employed by the company AnalytiCon Discovery GmbH Potsdam Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",TRUE,"<section> Funding: <section> Funding for this research were provided by Horizon 2020 Framework Programme; H2020 AwE “Ageing with Elegans” [grant agreement N. The Ristow lab was supported by the Swiss National Science Foundation (Schweizerischer Nationalfonds SNF 31003A_156031 31003A_176127 and",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15153414",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15163519",TRUE,"Conflicts of Interest: C.K. is a member of the scientific advisory board of Bruno Zimmer Mittel zum Leben. E.H. is a board member of the Medical Association for Therapeutic Fasting and Nutrition (Ärztegesellschaft Heilfasten & Ernährung e. V. (ÄGHE)). All the other authors declare no conflict of interest regarding this study.",TRUE,"<section> Funding: The study BrainFit-Nutrition was funded by Karl and Veronica Carstens Stiftung (funding number KVC 0/117/2021E).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15163619",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The research was supported by grants from the Biomedical Research Council (grant 03/1/27/18/216) National Medical Research Council (grants 0838/2004 and 1111/2007) and National Research Foundation (through the Biomedical Research Council grants 05/1/21/19/425 and 11/1/21/19/678) and by the Ministry of Health NUS and the National University Health System all Republic of Singapore.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15163657",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"; Funding acquisition A.S. and T.H. <section> Funding: This study was supported by the Charité University Funding UFF 89/441-176 (A.S. and T.H.). We acknowledge financial support from the Open Access Publication Fund of Charité— Universitätsmedizin Berlin and the German Research Foundation (DFG).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15173797",TRUE,"Conflicts of Interest: K. Wolk received research grants travel grants consulting honoraria and lecturer’s honoraria from AbbVie Celgene/BMS Charité Research Organisation Willmar Schwabe GmbH & Co. KG Flexopharm JanssenCilag Novartis Pfizer Sanofi-Aventis TFS and UCB. R. <section> Sabat received research grants or honoraria for participation in advisory boards clinical trials or as a speaker for one or more of the following: AbbVie Almirall Hermal Amgen Bayer Schering Pharma Boehringer Ingelheim Celgene Charité Research Organisation CSL Behring Willmar Schwabe Flex- <section> opharm ICON PLC Incyte Corporation JanssenCilag La Roche-Posay Laboratoire Dermatologique MoonLake Immunotherapeutics Novartis Parexel Rheinischen Friedrich-Wilhelms-Universität Bonn Sanofi–Aventis TFS and UCB. The other authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. <section> Acknowledgments: We acknowledge the financial support from the Open Access Publication Fund of Charité–Universitätsmedizin Berlin and the German Research Foundation (DFG).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15183913",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received funding from the Zhejiang Administration of Traditional Chinese Medicine (2022ZB112) which was obtained by Y.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15183915",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: We acknowledge support from the Open Access Publication Fund of the University of Tübingen Germany. K.S. is supported by the Ministry of Science Research and the Arts Baden– Württemberg Germany.",FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15184047",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the National Science Centre in Poland (2019/33/N/NZ5/02303) through a PRELUDIUM-17 grant to D.F. and M.R. and by Deutsche Forschungsgemeinschaft (DFG) research unit FOR-2558 “TraceAge” (Scho 849/6-2) awarded to L.S.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15194220",TRUE,"Conflicts of Interest: J.B. receives research support from Takeda/Shire Pharmaceuticals/NPS",TRUE,"<section> Funding: The study was supported by the Takeda",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/nu15214629",TRUE,"The authors declare no conflict of interest.",TRUE,"(Tilman Grune); Funding acquisition: K.-H.W. and T.G. <section> Funding: This research was funded by the German Research Foundation (DFG) under the grant (WE2908/13-1) awarded to K.-H.W. and T.G. This study was also funded by the Ministry of Science Research and Culture of the State of Brandenburg and the Brandenburg Medical School Theodor Fontane (Medizinische Hochschule Brandenburg Theodor Fontane MHB) publication fund supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/nu15234884",TRUE,"Conflicts of Interest: Markus Schauer is CEO of Biogena Diagnostics apart from the submitted work. <section> The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be considered as a potential conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12010054",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was supported by a research grant from GILEAD Sciences GmbH.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12040551",TRUE,"",TRUE,"<section> Funding: The work was supported by funding from the Federal German Ministry of Health.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12040612",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The publication of this article was funded by Freie Universität Berlin.",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/pathogens12050685",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The research was funded by the Deutsche Forschungsgemeinschaft grant number JU 2857/9-1 and JU 2857/9-2 to S.J. We gratefully acknowledge the financial support for this research given by the following organizations and agencies: the Swedish International Development Cooperation Agency (Sida) the Swiss Agency for Development and Cooperation (SDC) the Australian Centre for International Agricultural Research (ACIAR) the Federal Democratic Republic of Ethiopia and the Government of the Republic of Kenya. <section> Acknowledgments: The authors gratefully acknowledge the technical support of the National Museums of Kenya (NMK) and assistance from Samson Omondi Onyuok of NMK Josephine Osalla and Caroline Getugi of the Martin Lüscher Emerging Infectious Diseases (ML-EID) Laboratory icipe.",TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12060761",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12060850",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was supported by a grant from the German Federal Ministry of Health (BMG) regarding a decision of the German Bundestag by the Federal Government (CHEDProject grant No: ZMVI12518FSB705).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12070967",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work was funded by the Deutsche Forschungsgemeinschaft (JU 2857/9-1 and JU 2857/9-2 to S.J.) and the German Center for Infection Research (DZIF) Germany (TTU 01.801). Ogola was supported by a German Academic Exchange Service (DAAD) through the icipe ARPPISDAAD scholarship and a UP postgraduate bursary. Tchouassi was supported by a Wellcome Trust International Intermediate Fellowship (222005/Z/20/Z) and from the Nooradfunded project We also gratefully acknowledge the financial support and technical support of ICIPE core donors: Swiss Agency for Development and Cooperation (SDC) Switzerland; Swedish International Development Cooperation Agency (Sida) Sweden; Australian Centre for International Agricultural Research (ACIAR); Government of the Republic of Kenya and the Federal Democratic Republic of Ethiopia.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12081053",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research study has received support from the Innovative Medicines 320 Initiative Joint Undertaking under grant agreement no 115721 resources of which are 321 compared of financial contribution from the European Unions’ Seventh Framework 322 Programme (FP&/2007-20130 and EFPIA companies’ inkind contribution and from the European Union’s Seventh Framework Programme (FP7/2007-2013) under CFMATTERS grant agreement no. 603038 the German Research Foundation (SFB-TR84 subproject B08 and SFB-1449 project 431232613 subproject Z02) and the German Federal Ministry of Education and Research (82DZL009B1).",TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pathogens12091100",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Poliomyelitis Research Foundation: 20/29; the German",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pediatric15010020",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/ph16030464",TRUE,"",TRUE,"<section> Funding: The work was carried out under a Cooperation Agreement between Freie Universitaet and Diurnal funded by Diurnal Ltd Cardiff CF14 4UJ United Kingdom. We acknowledge support from the Open Access Publication Initiative of Freie Universität Berlin for funding the publication of this article.",TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/ph16070934",TRUE,"Conflicts of Interest: B.R. reports research grants from Novartis and personal fees from Abbvie/Allergan Eli Lilly Hormosan Novartis and Teva.",TRUE,"<section> Funding: This research received no external funding. U.R. received research funding from the German Federal Ministry of Education and Research and Novartis.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15010293",TRUE,"Conflicts of Interest: B.R. reports research grants from Novartis and personal fees from Abbvie/Allergan Eli Lilly Hormosan Novartis and Teva.",TRUE,"<section> Funding: This research received no external funding. U.R. received research funding from the German Federal Ministry of Education and Research and",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15020609",TRUE,"Conflicts of Interest: Peter Rotsch is the managing director of OSA Opto Light GmbH. The authors declare no other conflict of interest.",TRUE,"<section> Funding: This research was funded by the German Federal Ministry of Education and Research (BMBF) within the “Advanced UV for Life” project “NanUVsept” grant number 03ZZ0142A and B.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15020619",TRUE,"Conflicts of Interest: C.C.Z. reports consultancy/advisory boards disease-relevant honoraria from AbbVie Bayer Boehringer-Ingelheim Incyte InflaRx Janssen-Cilag Novartis Regeneron UCB and Viatris. He has received speaker fees from AbbVie Almirall Biogen and UCB and is President of the EHSF e.V. coordinator of the ALLOCATE Skin group of the ERN Skin and chair of the ARHS Task Force group of the EADV. He is Editor of the EADV News and is co-copyright holder of IHS4 on behalf of the EHSF e.V. His employer has received disease-relevant grants from AbbVie BoehringerIngelheim InflaRx Novartis and UCB for his participation as a clinical investigator. X.H. H.v.W. K.C.Z. and A.M.H. declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15041228",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Financial support should be provided to perform such studies with high quality in the target population. <section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15051350",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15071876",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: This research was funded by the German Federal Ministry of Economics (BMWi) grants:",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/pharmaceutics15071980",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) grant number DFG GRK 2318/1+2 (A02)—318905415 and DFG PI 837/ 4-2—289412825 to JP and Stiftung Oskar-Helene-Heim to LE and CK.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/pharmaceutics15092202",TRUE,"Conflicts of Interest: K.E. R.T. M.R. M.G. and P.P. received grant research support from BfArM. (Michael Kaess) T.R. C.R. G.S.-K. and S.F.) declare no conflict of interest.",TRUE,"The project was funded by the German Federal Institute of Drugs and Medical Devices (BfArM) and received approval from the ethics committee at the primary study center University Hospital Wuerzburg (301/13) as well as from the local ethics committees of participating centers. <section> Funding: This research was funded by a research grant from the German Federal Institute for Drugs and Medical Devices (BfArM reference number V-15322/68605/2013-2018). He has received grant support from Janssen and Takeda. J.M.F. received research funding in the last five years from European Union BMG (Federal Ministry of Health) BMBF (Federal Ministry of Education and Research) BMFSFJ (Federal Ministry of Family Senior Citizens Women and Youth) DFG (German Research Foundation) G-BA Innovation Fund State Ministries of Baden-Württemberg and Saarland State Foundation BadenWürttemberg Porticus Foundation and Evangelical-Lutheran Church in Württemberg. Her work was supported in the last 5 years by the Swiss National Science Foundation different EU FP7s programs Hochspezialisierte Medizin of the Kanton Zurich Switzerland BfArM ZInEP Hartmann Müller Stiftung Olga Mayenfisch Gertrud Thalmann Vontobel Unicentia Erika Schwarz Fonds and Gesundheitsforderung Schweiz.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"This study was conducted in accordance with the Declaration of Helsinki and registered in the European Clinical Trials Database (EudraCT 2013-004881-33). This study was conducted in accordance with the Declaration of Helsinki and registered in the European Clinical Trials Database (EudraCT 2013-004881-33).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/pharmaceutics15102410",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: This work was supported by grants from the German Federal Ministries of Education and Research (BMBF) in the frame of the zoonoses research consortium PAC-Campylobacter to MMH and SB (IP7/01KI2007D) and from the Federal Ministry for Economic Affairs and Energy following a resolution of the German National Parliament Deutscher Bundestag to MMH and SB (ZIM ZF4117908 AJ8).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/publications11010004",TRUE,"Conflicts of Interest: The author declares no conflict of interest. <section> World Health Organization Joint Statement on Public Disclosure of Results from Clinical Trials.",TRUE,"<section> Funding: This research was funded by the Bundesministerium für Bildung und Forschung (BMBF https://www.bmbf.de/ accessed on 17 January 2023) grant number 01PW18012.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/s23031209",TRUE,"Conflicts of Interest: Thoralf Niendorf is the founder and CEO of MRI.TOOLS GmbH Berlin Germany.",TRUE,"<section> Funding: This project was funded in part (T.N. and N.S.) by the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program grant agreement No 743077 (ThermalMR) and funded in part (T.N. and F.R.) by the European Horizon 2020 MSCAInnovative Training Network grant agreement number 955625 (Hyperboost).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/s23042168",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was supported by the German Federal Ministry of Education and Research (grant number 13GW0228) and the German Research Foundation (grant number ER 817/1-1). We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/s23063304",TRUE,"MN MP JK CB PB and NW report no conflict of interest.",TRUE,"<section> Funding: This project was partially funded by the German Government sponsored ZIM (Zentrales Innovationsprogramm Mittelstand) program (grant number 4279701AW6). <section> RFT has received funding from Deutsche Herzstiftung (German Heart Foundation) and DZHK (German Centre for Cardiovascular Research).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The study was approved by the local ethics committee (EA1/155/17) and registered at ClinicalTrials.gov (NCT 03263988).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/s23115238",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The work was supported by Deutsche Forschungsgemeinschaft under Project-ID 424778381– This work was supported by the Lundbeck Foundation as part of the collaborative project grant “Adaptive and precise targeting of cortexbasal ganglia circuits in Parkinson’s Disease” (Grant Nr.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/s23146597",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research project bearing the grant number ZF4776601HB9 received full funding from the German Federal Ministry for Economic Affairs and Energy to facilitate the execution of this study. We are also immensely grateful to the German Federal Ministry for Economic Affairs and Energy for their generous support of this project through grant number ZF4776601HB9. Lastly we would like to thank the University of Potsdam for funding the publication costs associated with this research.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/s23187931",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the National Medical Research Council Singapore (STAR19may0001) The Lee Foundation and support funds for the Centre for Sleep and Cognition Yong Loo Lin School of Medicine. B.T.T.Y. is supported by the NUS Yong Loo Lin School of Medicine (NUHSRO/2020/124/TMR/LOA) the Singapore National Medical Research Council (NMRC) LCG (OFLCG19May-0035) NMRC CTG-IIT (CTGIIT23jan-0001) NMRC STaR (STaR20nov-0003) Singapore Ministry of Health (MOH) Centre Grant (CG21APR1009) the Temasek Foundation (TF2223IMH-01) and the United States National Institutes of Health (R01MH120080 and R01MH133334).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/su151612217",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The article processing charge was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—491192747 and the Open Access Publication Fund of HumboldtUniversität",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/tomography9010008",TRUE,"Conflicts of Interest: All other authors have nothing to disclose.",TRUE,"<section> Funding: No funding available.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/tomography9010024",TRUE,"Conflicts of Interest: Thoralf Niendorf is founder and CEO of MRI.TOOLS Berlin Germany.",TRUE,"; Funding Acquisition T.N. <section> Funding: This research was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program grant number 743077 (ThermalMR).",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/tomography9020049",TRUE,"Conflicts of Interest: Mostafa Berangi and Helmar Waiczies are employees of MRI.TOOLS GmbH Berlin Germany.",TRUE,"<section> Funding: This work received funding (M.B. A.K. T.N.) from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. <section> This project received funding (T.N.) from the European Research Council (ERC) under the European Union Horizon 2020 research and innovation program under grant agreement No.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/tomography9050131",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/toxins15010030",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/toxins15010054",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Deutsche Forschungsgemeinschaft grant number Schu 559/11-5 and GRK 2318-2 project C1.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/toxins15070431",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This work has been supported by a restricted grant from the private Inge Diesbach-Stiftung to H.H.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/toxins15070454",TRUE,"Conflicts of Interest: All authors declare that they do not have any financial disclosures or conflicts of interest related directly to the work carried out in this study.",TRUE,"<section> Funding: This work was supported by a restricted grant of the private institution Inge DiesbachStiftung to HH.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/toxins15100592",TRUE,"Conflicts of Interest: All authors declare that they do not have any financial disclosure or conflicts of interest related directly to the work carried out in this study.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/toxins15100615",TRUE,"The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by Region of Friuli Venezia Giulia POR FESR 2014–2020 Activity 1.3.a.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/toxins15100618",TRUE,"Conflicts of Interest: All authors declare that they do not have any financial disclosures or conflicts of interest related directly to the work carried out in this study.",TRUE,"<section> Funding:",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/toxins15110643",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)—GRK 2318—318905415 (project C01) DFG TRR241—375876048 (project B06) and DFG Schu 559/11-5—175142815.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/tropicalmed8020111",TRUE,"Conflicts of Interest: The authors have no conflicts of interest to declare.",TRUE,"The VTHWs were supported by stateestablished village health teams (VHTs) (we had initially planned to work with VHTs to collect data but this was not feasible as many of them could not operate the mobile data collection devices and were not fluent in English which was necessary for data documentation) and the Local Council One (LC1) leaders who participated as mobilisers and field guides. ; Funding acquisition: H.F. <section> Funding: The study was conducted within the framework of a humanitarian project aimed at eliminating tungiasis from highly endemic communities in the Napak district. The project was supported by the Else Kröner Fresenius Foundation a philanthropic institution in Bad Homburg Germany (Award number: 2019_HA.116) and German Doctors a medical NGO.",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/tropicalmed8040206",TRUE,"Conflicts of Interest: The funders had no role in the design of the study; in the collection analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.",TRUE,"<section> Funding: This research was carried out as part of a humanitarian project aimed at eliminating tungiasis in highly endemic communities in the Napak district. Thielecke have previously received financial support from G.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/tropicalmed8080386",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico e Ministério da Saúde MS-SCTIE-Decit No.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/tropicalmed8090425",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"Their work was supervised by two social workers and a project nurse and supported by existing stateestablished village health teams (VHTs) and Local Council One (LC1) leaders [26]. <section> Our study highlights that implementation of control practices requires not only a good level of knowledge but also resources and the availability of alternatives which is supported by KAP studies on tungiasis from Brazil and Kenya [2136]. ; Funding acquisition: H.F. <section> Funding: The study was conducted within the framework of a humanitarian project aimed at eliminating tungiasis from a highly endemic community in Napak district Karamoja. The project was supported by Else Kröner Fresenius Stiftung (EFKS) 61348 Bad Homburg v.d.H. Germany (Award number: 2019_HA.116) and German Doctors e.V.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/v15010064",TRUE,"Conflicts of Interest: S.W. is an inventor on European and International patent applications addressing the rAdV-mediated rAAV vector packaging technology described in this study.",TRUE,"<section> Funding: This research received funding from the SPARK/BIH program of the Berlin Institute of Health",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/v15010235",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by BMBF Zoonosenplattform grant number 01Kl1911.",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15020387",TRUE,"Conflicts of Interest: S.-M.W. reports non-financial support from Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. non-financial support from Mukoviszidose e.V. non-financial support from the Universität des Saarlands and personal fees from the German University in Cairo as well as personal fees and non-financial support from the Schlütersche Verlagsgesellschaft for a",TRUE,"<section> Funding: <section> This research was funded by a German Federal Ministry of Education and Research (BMBF) grant to G.N. and M.W. in the framework of project MAPVAP (01KI2124) and to L.D. and J.-D.R. by the Agence Nationale de la Recherche (ANR) in the framework of the project MAPVAP (ANR-19AMRB-0002). G.N. and M.W. were supported by the BMBF grant number e:Med CAPSyS (01ZX1304B 01ZX1604B). M.W. received funding from the DFG (project ID 114933180—SFB-TR84 subprojects C06 and C09; and project ID 431232613—SFB-1449 subproject B02) e:Med SYMPATH (01ZX1906A) and Phage4Cure (16GW0141). A.D.G. received funding from the DFG (project ID 114933180—SFB-TR84 subproject Z01b). Unrelated to this project G.N. received funding for research from Biotest AG and M.W. received funding for research from Bayer Health Care Biotest AG Pantherna and for lectures and advisory from Actelion Aptarion Astra Zeneca Bayer Health Care Biotest AG Boehringer Ingelheim Chiesi Glaxo Smith Kline Inflarx Insmed Novartis Pantherna Pherecydes Sinoxa and Teva.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15020467",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was partially supported by DZIF (TTU 01.808_00; “Emerging Infections”; awarded to R.G.U.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15020588",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> //phage4cure.de accessed on 12 January 2023 funded by the German Federal Ministry of Education and Research (BMBF)) is a firstin-human (FIH) study to investigate safety tolerability and preliminary efficacy of a phage cocktail in healthy volunteers and patients with chronic P. aeruginosa lung infection. The MAPVAP project is a collaborative research program financed by France and Germany through the 2019 dedicated call on antimicrobial resistance (BMBF & Agence Nationale de la Recherche (ANR France)) [27]. The validation study required for this is funded by the Federal Agency for Disruptive Innovation SPRIN-D (www.sprind.org). Conducting multiple projects funded by the European Research Council Innovative Training Networks (ITN; ‘VIROINF’ duration 2020–2024) DFG priority program ‘Novel Concepts in Phage Biology’ (duration 2021–2024) and sequencing program ‘Asthma-Phage’(2023–2025) that aim to explore the crosstalk between virome microbiome and the human host in dysbiosisassociated digestive and respiratory diseases (e.g. asthma) and to eradicate causative bacteria using synthesizedphage communities (phageome therapy). <section> In addition “PHARMS” (duration 2019–2024 funded by an ERC Starting Grant) aims to discover novel antibacterials against A. baumannii Helicobacter pylori and Haemophilus influenza by studying phage–host interactions using cultureindependent and multiomics approaches. <section> Funding: This research was funded by the German Federal Agency for Disruptive Innovation (Bundesagentur für Sprunginnovationen GmbH) 04103 Leipzig Germany with a grant awarded to C.W.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/v15030697",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15040953",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This study was supported by the Ministry of Science Technology and Innovation (Minciencias) Colombia (Grant number: 210477757671 to JAU-C and DP-C).",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15051076",TRUE,"Conflicts of Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work.",TRUE,"<section> The study was supported by the Helios research grant HCRI ID 2021-0339. <section> Funding: The study was supported by the Helios research grant by Helios Center for Research and Innovation (HCRI) with the following funding number: HCRI ID 2021-0339.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> The study was approved by the Ethics Committee of the Medical Faculty University Leipzig (490/20-EK) and registered in the German Clinical Trials Register (DRKS 00027266).",TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3390/v15051087",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)-398066876/GRK 2485/1-VIPER-GRK. This open access publication was funded by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation)-491094227 “Open Access Publication Funding” and the University of Veterinary Medicine Hannover Foundation.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15071553",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research received no external funding. We acknowledge financial support regarding the article processing costs from the Open Access Publication Fund of UKE–University Medical Center Hamburg-Eppendorf and DFG–German Research Foundation Individual grants from the German Centre for Infection Research (DZIF; financed by the German Ministry of Education and Research BMBF; partnersite Hamburg-Lübeck-Borstel-Riems) and from the iSTAR program (financed by the BMBF 01EO2106) have supported the work of J.P. R.B. and N.T. received funding by the German Federal Ministry of Education and Research as part of the coverCHILD project of the Network University Medicine (NUM) (FKZ 01KX2121).",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15071585",TRUE,"Conflicts of Interest: The authors declare no conflict of interest regarding this article.",TRUE,"<section> Funding: This research received no external funding.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/v15091891",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: This research was funded by the Deutsche Forschungsgemeinschaft grant number JU 2857/9-1 and JU 2857/9-2 to S.J. and the German Center for Infection Research (DZIF) Germany (TTU 01.801). Tchouassi is supported by a Wellcome Trust International Intermediate Fellowship (222005/Z/20/Z) and by the Noradfunded project Combatting Arthropod Pests for Better Health Food and Climate Resilience (CAP-Africa; project number RAF-3058 KEN-18/0005). <section> We gratefully acknowledge the financial support for this research by the following organisations and agencies: Swedish International Development Cooperation Agency (Sida) the Swiss Agency for Development and Cooperation (SDC) the Federal Democratic Republic of Ethiopia and the Government of the Republic of Kenya.",TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/vaccines11010144",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"<section> Funding: The publication fees were funded through the Open Access Publication Fund of Charité— Universitätsmedizin Berlin and the German Research Foundation (DFG). <section> Acknowledgments: We acknowledge the financial support from the Open Access Publication Fund of Charité—Universitätsmedizin Berlin and the German Research Foundation (DFG) to support the publication of our research paper.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/vaccines11020451",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/vaccines11081361",TRUE,"Conflicts of Interest: The authors declare no conflict of interest.",TRUE,"It was funded under the EU research and innovation funding program Horizon 2020 and launched in December 2020. <section> Funding: <section> The ORCHESTRA project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No.",TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/vaccines11091469",TRUE,"Conflicts of Interest: The authors F.G. G.B.A. H.B. M.V. B.S. C.H. L.A. and A.P. declare no conflict of interest.",TRUE,"<section> Funding: The project partners Charité (S.H. A.P.) University of Potsdam (K.H.) CellTrend GmbH (K.S.F.) Sifin GmbH (M.V.) and Wimedko GmbH (O.K.E. J.K.M.) received funding from the German Federal Ministry of Education and Research (BMBF project code: 03COV01C). This project was supported by European regional development funds (EFRE—Europe Funds Brandenburg; BIG FuE 80259678) to preclinics GmbH (J.F.) and Charité (S.H.).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3390/vaccines11101552",TRUE,"The authors declare no conflict of interest.",TRUE,"The Federal MoH received support with logistics from the Federal armed forces especially in the beginning of the campaign [3435] and support with the digital capture of vaccination data from the Federal Institute of Public Health Robert Koch Institute [36]. <section> Funding: The publication fees were funded through Charité—Universitätsmedizin Berlin.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/vaccines11121859",TRUE,"Conflicts of Interest: David Ellenberger Firas Fneish Sarah Schilling and Melanie Peters had no personal financial interests to disclose other than being employees of the German MS Registry. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in a conflict of interest. None resulted in conflicts of interest.",TRUE,"<section> Funding: The conduct of this study was supported by multistakeholder sponsors organized by the DMSG. Friedemann Paul has received speaking fees travel support honoraria from advisory boards and/or financial support for research activities from Bayer Novartis Biogen Bristol Myers Squibb Teva Sanofi-Aventis/Genzyme Merck Serono Alexion Chugai MedImmune Shire the German Research Council the Werth Stiftung of the City of Cologne the German Ministry of Education and Research the EU FP7 Framework Program the Arthur Arnstein Foundation Berlin the Guthy Jackson Charitable Foundation and the National Multiple Sclerosis Foundation of the USA.",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3390/vetsci10050314",TRUE,"Conflicts of Interest: J.K. and A.M. hold shares in MoKi Analytics GmbH. A.M. holds shares in Moter diagnostics Private Practice. L.K. is a part-time employee at MoKi Analytics GmbH. None of these disclosures affects the content of this work. The remaining authors declare no conflict of interest.",TRUE,"<section> Funding: This work was supported by the German Research Foundation (DFG) (grant FU 1027/3-1 to MF and FU 1027/5-1 to MF and MK) as well as by the Petplan Charitable Trust foundation (grant no. S20-851-890 to MF and EA). The publication of this article was funded by Freie Universität Berlin.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.36129/jog.2022.36",TRUE,"Disclosure of interests <section> The authors declare that they have no conflict of interests.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.36141/svdld.v40i2.13243",TRUE,"Conflict of Interest: Each author declares that he or she has no commercial associations (e.g. consultancies stock ownership equity interest patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.",TRUE,"<section> Statements and Declarations: No financial support was received from any institution in our study.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.36185/2532-1900-339",TRUE,"Conflict of interest statement <section> The views expressed in this article are those of the authors who declare that they have no conflict of interest.",TRUE,"<section> Funding <section> This work was funded by the Barts Charity HeartOME1000 Grant (MGU0427/G-001411). G.C. is supported by British Heart Foundation (MyoFit46 Special Programme Grant SP/20/2/34841) the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC) and by the NIHR UCL Hospitals Biomedical Research Centre.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.36660/ijcs.20220115",TRUE,"Conflict of Interest No potential conflict of interest relevant to this article was reported.",TRUE,"<section> Sources of Funding This study was partially funded by a research project for SUS PPSUS Public Notice FAPERGS/MS/CNPq/SESRS n.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"These differences could affect patients' fibrillation (AF) using DOACs have better treatment Embase LILACS SciELO CINAHL and Cochrane and compared treatment adherence and QoL The methodological quality of the studies was assessed was registered in the PROSPERO (CRD 42020165238).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.3758/s13428-023-02134-0",TRUE,"The authors declare no conflict of interest.",TRUE,"Sophia Rekers: Conceptualization Investigation Project administration Data Curation Software Formal Analysis Methodology Visualization Writing Original Draft Preparation Writing Review & Editing; Carsten Finke: Conceptualization Funding Acquisition Methodology Supervision Writing Review & Editing. <section> Funding Open Access funding enabled and organized by Projekt DEAL.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3762/bjnano.14.85",TRUE,"Conflicts of Interest <section> The authors declare no conflict of interest.",TRUE,"<section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3762/bjnano.14.93",TRUE,"Conflict of Interest <section> The authors declare no conflicts of interest.",TRUE,"<section> Funding <section> This research project was supported by the Thailand science research and innovation fund and the University of Phayao (Grant No.",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3892/mco.2023.2615",TRUE,"Competing interests <section> The authors declare that they have no competing interests.",TRUE,"<section> Funding <section> No funding was received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3892/ol.2023.13840",TRUE,"Competing interests <section> All authors declare that they had no competing interests.",TRUE,"<section> Funding <section> No funding was received.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.2022-1320",TRUE,"The remaining authors declare no conflicts of interest relevant to this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3899/jrheum.2023-0424",TRUE,"The remaining authors Toronto Western Hospital and University Health declare no conflicts of interest relevant to this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.2023-0520",TRUE,"<section> conflicts of interest relevant to this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.2023-0523",FALSE,"",TRUE,"Poddubnyy OF received grants from and UCB.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.2023-0531",TRUE,"The remaining authors declare no conflict of interests relevant to this article.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.2023-0537",TRUE,"The remaining authors declare no conflicts of interest relevant to this article.",TRUE,"<section> DJ was supported by Cambridge Arthritis Research Endeavour (CARE) and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC-1215-20014); and has received research grants education grants and/or honoraria from the following pharmaceutical companies: AbbVie Amgen Biogen Celgene Eli Lilly Fresenius Kabi Galapagos/Gilead GSK Healthcare Celltrion Janssen Merck Novartis Pfizer Roche Sandoz and UCB. <section> VC is supported by a Pfizer Chair Research Award Rheumatology University of Toronto; has received research grants from AbbVie Amgen and Eli Lilly; has received honoraria for advisory board member roles from AbbVie Amgen BMS Eli Lilly Janssen Novartis Pfizer and UCB; and his spouse is an employee of AstraZeneca. ERS participated in advisory boards gave conferences or received grants from AbbVie Amgen BMS Eli Lilly GSK Janssen Novartis Pfizer Sandoz Roche and UCB.",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.3899/jrheum.220212",TRUE,"9 The ASAS HI consists and Department of Rheumatology and Clinical Universitätsmedizin Berlin Berlin Germany. of 17 patient-reported items addressing the categories of pain emotional function sleep sexual function mobility self-care conflicts of interest relevant to this manuscript.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3899/jrheum.220309",TRUE,"Nash MBBS School of Medicine Griffith University authors declare no conflicts of interest relevant Queensland Australia; D.D.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3899/jrheum.220317",TRUE,"The remaining authors declare no conflicts of interest relevant to this article.",TRUE,"<section> ERS has participated in advisory boards given conferences or received grants from AbbVie Amgen BMS Lilly GSK Janssen Novartis Pfizer Sandoz Roche and UCB.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.3899/jrheum.221022",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.4081/aiua.2023.11509",TRUE,"Conflict of interest: The authors declare no potential conﬂict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"The protocol for this review was registered on the PROSPERO platform (registration number: CRD42022375951).",TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.4088/jcp.22m14674",FALSE,"",TRUE,"<section> Rovi Supernus and Teva; received grant support from Janssen and Takeda; received royalties from UpToDate; and is a stock option holder of Cardio <section> received grant support from Otsuka Lundbeck 3. <section> Funding/support: This study was sponsored by Evaluation of Medication (EMBLEM) Advisory Alkermes Inc.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Trial Registration: ClinicalTrials.gov identifier: NCT03187769",TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.4088/jcp.22r14626",FALSE,"",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.4103/1673-5374.343896",TRUE,"Conflicts of interest: The authors declare no conflicts of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.4239/wjd.v14.i12.1813",TRUE,"Conflict-of-interest statement: The authors declare no conflict of interest.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.4244/eij-d-21-00214",TRUE,"",TRUE,"Department of Cardiovascular Medicine Gifu Heart Center Gifu Japan Funding Medis Medical Imaging BV has provided an institutional research grant to fund the trial. <section> Funding The study is funded by the manufacturer and distributor of the QFR software (Medis Medical Imaging bv. Leiden The Netherlands).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.4244/eij-d-22-00960",TRUE,"Conflict of interest statement M. The other authors have no conflicts of interest to declare in relation to this manuscript.",TRUE,"B. Trejo-Velasco received funding from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) via the 2021 EAPCI Andersen & Cribier Fellowship Program.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.4244/eij-d-22-01037",TRUE,"Conflict of interest statement",TRUE,"<section> Funding <section> This study was supported by a grant from the German Heart Foundation (DHS). <section> S. Ludwig has received travel compensation from Edwards Lifesciences; honoraria from Bayer and Abbott; and was supported by a research grant from the German Heart Foundation (DHS).",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.46497/archrheumatol.2023.10580",TRUE,"Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.",TRUE,"<section> Funding: The authors received no financial support for the research and/or authorship of this article.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.47626/1516-4446-2023-3044",TRUE,"Disclosure <section> The authors report no conflicts of interest.",TRUE,"This work was supported by Fundac¸ão de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Brazil (grant 2016/09069-1).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.47626/1516-4446-2023-3126",TRUE,"Disclosure <section> RB has received research grants from Janssen Cilag Novartis and Roche; has been a forum consultant for Janssen Novartis and Roche; and has participated in speaker bureaus for Ache Janssen Lundbeck and Novartis. CUC has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris; has provided expert testimony for Janssen and Otsuka; has served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva; has received grant support from Janssen and Takeda; has received royalties from UpToDate; and is a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic. AG has been a consultant and/or advisor to or has received honoraria from Aché Daiichi-Sankyo Torrent Bayer Cristalia and Janssen. ARB has received in-kind support from Flow Neuroscience and MagVenture unrelated to the present study. The other authors report no conflicts of interest.",TRUE,"<section> ARB has received grants from Fundac¸ão de Amparo à Pesquisa do Estado de São Paulo (FAPESP; 2018/ 10861-7 2019/06009-6) Conselho Nacional de Desenvolvimento Cientı́fico e Tecnológico (CNPq; CNPq-1B) Universidade de São Paulo productivity support (Programa de Incentivo à Produtividade Acadêmica [PIPAA]) and Newton Advanced Fellowship (NAFR 2012\\ 1010). CUC has been a consultant and/or advisor to or has received honoraria from AbbVie Acadia Alkermes Allergan Angelini Aristo Boehringer-Ingelheim Cardio Diagnostics Cerevel CNX Therapeutics Compass Pathways Darnitsa Gedeon Richter Hikma Holmusk IntraCellular Therapies Janssen/J&J Karuna LB Pharma Lundbeck MedAvante-ProPhase MedInCell Merck Mindpax Mitsubishi Tanabe Pharma Mylan Neurocrine Newron Noven Otsuka Pharmabrain PPD Biotech Recordati Relmada Reviva Rovi Seqirus SK Life Science Sunovion Sun Pharma Supernus Takeda Teva and Viatris; has provided expert testimony for Janssen and Otsuka; has served on a Data Safety Monitoring Board for Lundbeck Relmada Reviva Rovi Supernus and Teva; has received grant support from Janssen and Takeda; has received royalties from UpToDate; and is a stock option holder of Cardio Diagnostics Mindpax LB Pharma and Quantic.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,"<section> Registration number: PROSPERO CRD42018092033. <section> The protocol for this review was preregistered in PROSPERO (CRD42018092033 at http://www.crd.york.",TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA
"10.47717/turkjsurg.2023.6285",TRUE,"Conflict of Interest: The authors have no conflicts of interest to declare.",TRUE,"<section> Financial Disclosure: The authors declared that this study has received no financial support.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.5152/iao.2023.22671",TRUE,"Declaration of Interests: The authors declare that they have no competing interest.",TRUE,"Funding – D.B. A.E. <section> Acknowledgments: The authors would like to thank Sonova AG for the grant they <section> Funding: This study was supported by Sonova AG Steafa Switzerland.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.52628/89.2.11497",TRUE,"Conflict of interest: The authors have no conflict of interest directly related to this work.",TRUE,"No funds were received in support of this",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.5334/ijic.7636",TRUE,"The authors have no competing interests to declare.",FALSE,"",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.55563/clinexprheumatol/hlmsao",TRUE,"Competing interests: see page 1471. <section> Competing interests F.",TRUE,"<section> Funding: this work was supported by Chugai Pharma Germany GmbH and Roche Pharma AG. S. Wassenberg received research funding from Fraunhofer Society speakers’ honoraria from Abbvie Celgene Lilly Hexal MSD Pfizer and Sanofi",FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.5588/ijtld.23.0085",TRUE,"The remaining authors have no conflicts of interest.",TRUE,"<section> Authors SSC DJ and MMvdZ are supported by the US National Institutes of Health (Bethesda MD USA; K01TW010829 to SSC K23HL153581 to DJ and K43TW011028 to MMvdZ). JF has received funding from the Stop TB Partnership’s Global Drug Facility to support the rollout of paediatric formulations of secondline drugs for the treatment of drugresistant TB in children. <section> EL-V has received funding from the European Respiratory Society and the European Union’s H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. MMvdZ is also supported by a career development grant from the EDCTP2 programme supported by the European Union (TMA2019SFP-2836 TB lung-FACT2).",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.5826/dpc.1301a16",TRUE,"Competing Interests: None.",TRUE,"<section> Funding: None.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.5853/jos.2022.03370",TRUE,"Disclosures of conflicts of interest <section> Christian Hametner reports no disclosures. <section> Philipp Baumgartner reports no disclosures. <section> Mauro Magoni reports no disclosures. <section> Nicolas Martinez-Majander reports no disclosures. <section> Katharina Feil reports no disclosures. <section> Rosario Pascarella reports no disclosures. <section> Pnagioatis Papanagiotou reports no disclosures. <section> Annika Nordanstig reports no disclosures. <section> Marios Psychogios reports no disclosures. <section> Andreas Kastrup reports no disclosures. <section> Sami Curtze reports no disclosures. <section> All other authors report no relevant disclosures.",TRUE,"<section> Funding statement Discuss both direction and magnitude of any potential bias Give a cautious overall interpretation of results considering objectives limitations multiplicity of analyses results from similar studies and other relevant evidence Discuss the generalisability (external validity) of the study results Participants Variables Data sources/ measurement Bias Study size Quantitative variables Statistical methods Results Participants Descriptive data 7 NA 3 4 ff Discussion Other information Funding Give the source of funding and the role of the funders for the present study and if applicable for the original study on which the present article is based An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. <section> Susanne Wegener received research funds by the Swiss National Science Foundation the UZH Clinical research priority program (CRPP) stroke the Swiss Heart foundation the Zurich Neuroscience Center (ZNZ) BoehringerIngelheim (2016) speaker honoraria from Amgen (2018) Springer (2021) Teva. Nederkoorn has received funding from the Dutch Heart Foundation for acute stroke intervention trials in the Collaboration for New Trials in Stroke (CONTRAST) consortium. <section> Henrik Gensicke has received research support from the Swiss National Science Foundation advisory board honoraria from Daiichi Sankyo and funding for travel from BMS/Pfizer.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7150/jca.85691",TRUE,"Competing Interests <section> The authors have declared that no competing <section> interest exists.",TRUE,"<section> This work was funded by the German Research Foundation (DFG grant no. WO 2178/2-1 to PW) and supported by the Open Access Publication Fund of",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7150/thno.77041",TRUE,"Competing Interests <section> The authors have declared that no competing <section> interest exists.",TRUE,"<section> This study was supported by Novartis the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement No",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7150/thno.79976",TRUE,"Competing Interests <section> R.K. and I.W. are employees of ImaginAB. ClF is an advisor of ImaginAB. The other authors report no <section> conflicts of interest.",TRUE,"<section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation Germany´s Excellence Strategy-EXC2180 <section> Funding <section> This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation Germany´s Excellence Strategy-EXC2180",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7326/m23-0192",TRUE,"Disclosures: Disclosures can be viewed at www.acponline.org/ authors/icmje/ConﬂictOfInterestForms.do?",TRUE,"<section> Primary Funding Source: None. <section> Role of the Funding Source No speciﬁc funding was acquired for this study. <section> Grant Support: No speciﬁc funding was acquired for this study. <section> Section for Biostatistics and Evidence-Based Research the Parker Institute Bispebjerg and Frederiksberg Hospital Copenhagen is supported by a core grant from the Oak Foundation (OCAY-18774-OFIL).",FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7326/m23-1023",TRUE,"Disclosures: Disclosures can be viewed at www.acponline.org/ authors/icmje/ConﬂictOfInterestForms.do?",TRUE,"<section> Primary Funding Source: Bayer AG. <section> Role of the Funding Source This work was supported by Bayer AG who provided funding for the FIDELIO-DKD and FIGARO-DKD trials as well as the FIDELITY prespeciﬁed pooled analysis. <section> The ﬁndings of the present mediation analysis are supported by previous associational analyses in other classes of drugs that also reduce albuminuria. <section> Financial Support: By Bayer AG.",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,TRUE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7554/elife.66550",FALSE,"",TRUE,"<section> Funding: The work was funded the Federal Ministry of Education and Research (grant agreement number 01KI1716) as part of the Research Network Zoonotic Infectious Diseases and by the Deutsche Forschungsgemeinschaft (under grant agreement numbers JU2857/3-­2 and DR772/10-­2). <section> Funding <section> Author contributions Kyra Hermanns Conceptualization Data curation Formal analysis Investigation Visualization Writing original draft Writing – review and editing; Marco Marklewitz Florian Zirkel Anne Kopp Investigation Writing – review and editing; Stephanie Kramer-­Schadt Formal analysis Visualization Writing – review and editing; Sandra Junglen Conceptualization Resources Supervision Funding acquisition Investigation Writing original draft Writing – review and editing",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.79642",TRUE,"Competing interests <section> Andrea A Kühn: has received from honoraria from Boston Scientific Medtronic and Teva. The other authors declare that no competing interests exist.",TRUE,"<section> Funding: <section> TPG was funded by a NRS Fellowship from the Chief Scientist Office (Scotland). <section> Funding <section> Author contributions Ana Luisa de A Marcelino Conceptualization Formal analysis Investigation Writing – original draft Writing – review and editing; Owen Gray Formal analysis Methodology Writing – review and editing; Bassam Al-­Fatly Formal analysis Visualization Methodology Writing – review and editing; William Gilmour Data curation Investigation Writing – review and editing; J Douglas Steele Supervision Investigation Methodology Writing – review and editing; Andrea A Kühn Conceptualization Resources Supervision Writing – review and editing; Tom Gilbertson Conceptualization Formal analysis Supervision Funding acquisition Investigation Visualization Methodology Writing – original",FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.81032",TRUE,"Competing interest: The",TRUE,"<section> Funding: See The study was supported by the Einstein Stiftung Fellowship through the Günter Endres Fond. <section> Funding <section> Author contributions Lydie Burglen Conceptualization Resources Writing – original draft; Evelien Van Hoeymissen Data curation Formal analysis Methodology Visualization Writing – review and editing; Leila Qebibo Magalie Barth Newell Belnap Felix Boschann Christel Depienne Andrew GL Douglas Mark Fitzgerald Nicola Foulds Catherine Garel Ingo Helbig Denise Horn Vinodh Narayanan Mailys Rupin-­Mas Alexandra Afenjar Vincent Th Ramaekers Sarah M Ruggiero Simon Thomas Stéphanie Valence Lionel Van Maldergem Diana Rodriguez Data curation; Katrien De Clercq Siyuan Zhao Data curation Visualization; Katharina Held Conceptualization; Annelies Janssen Methodology; Angela Kaindl Writing – original draft; Christina Prager Conceptualization Supervision; Tibor Rohacs Supervision; David Dyment Thomas Voets Conceptualization Supervision Writing – original draft; Joris Vriens Supervision Funding acquisition Investigation Visualization Methodology Writing – original",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.83484",FALSE,"",TRUE,"<section> Funding: <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.84029",FALSE,"",TRUE,"<section> Funding: This work was supported by the ERC grant 647895 'GluActive' (to AJRP) the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) under Germany's Excellence Strategy—EXC-­2049-­390688087 (to both CR and AJRP) and Heisenberg Professorship to AJRP (project numbers: 323514590 and 446182550). <section> Funding <section> Author contributions Yuchen Hao Data curation Formal analysis Investigation Methodology Writing – original draft Writing – review and editing; Estelle Toulmé Conceptualization Data curation Formal analysis Supervision Investigation Visualization Methodology Writing – original draft Writing – review and editing; Benjamin König Software Formal analysis; Christian Rosenmund Conceptualization Resources Supervision Funding acquisition Project administration; Andrew JR Plested Conceptualization Resources Data curation Software Formal analysis Supervision Funding acquisition Validation Investigation Visualization Methodology Writing – original draft Project administration Writing",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.85488",TRUE,"The authors declare that they have no competing interests.",TRUE,"<section> Funding: <section> This study was supported by the German Research Foundation Deutsche Forschungsgemeinschaft (DFG) project 184695641 – SFB 958 project 327654276 – SFB 1315 Germany’s Excellence Strategy – Exc-­2049-­390688087 and by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 810580). <section> Funding <section> Author contributions Roberto De Filippo Conceptualization Data curation Software Formal analysis Supervision Investigation Visualization Methodology Writing – original draft Project administration Writing – review and editing; Dietmar Schmitz Resources Funding acquisition Writing – review and editing",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.86090",FALSE,"",TRUE,"<section> Funding: IL was recipient of a Marie Curie Incoming International Fellowship (798696) and “Wiedereinstiegsstipendium” from the Leibniz FMP. <section> This work was funded by the DFG TRR 186 (Project A07 Projektnummer 272140445 to AJRP) and a DFG Heisenberg Professorship (to AJRP Projektnummern 323514590 & 446182550). <section> Funding <section> Author contributions Iva Lučić Conceptualization Data curation Formal analysis Supervision Funding acquisition Investigation Visualization Writing – original draft Writing – review and editing; Léonie Héluin Data curation Formal analysis Visualization Writing – review and editing; Pin-­Lian Jiang Data curation Formal analysis Methodology Writing – review and editing; Alejandro G Castro Scalise Data curation Formal analysis; Cong Wang Data curation Software Formal analysis; Andreas Franz Data curation Visualization Methodology Writing – review and editing; Florian Heyd Markus C Wahl Funding acquisition Writing – review and editing; Fan Liu Resources Software Formal analysis Funding acquisition Methodology Writing – review and editing; Andrew JR Plested Conceptualization Resources Formal analysis Supervision Funding acquisition Writing – original draft Writing – review and editing",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.86266",TRUE,"Competing interests: Rebecca Luckett: received a Hospital Harvard Medical School Boston United grant from NIH NCI 1K08CA271949-­01. <section> has no other competing interests to declare. The author Universitätsmedizin Berlin Berlin Freie Universität has no other competing interests to declare. The author has no other competing interests to <section> grants and consulting fees from Merck & Co Inc Neerja Bhatla is at the All India Institute of Medical No other competing interests to declare. <section> http://orcid.org/0000-0002-5097-3818 other competing interests to declare. No other competing interests to <section> competing interests to declare. <section> competing interests to declare. <section> No other competing interests to declare.",TRUE,"<section> Funding: <section> Feldman: received grants from NCI/NIH and the The Center Montreal Canada author participated on a Data Safety Monitoring Francisco Garcia Deputy County Administrator for Board/Advisory Board for CVIA 087 DSMB funded by Community and Health Services and Chief Medical PATH and is an International Papillomavirus Society Officer Pima County Tuscon United States Board member. Andreas M Kaufmann: has Kingdom received grants from the EU EUROSTARS Program; <section> received grants from Merck & Co. Roche Diagnostics <section> Funding",FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.86655",FALSE,"",TRUE,"<section> Funding: This work was supported from the European Union’s Horizon 2020 research and innovation program under grant agreement No 857560. <section> Funding <section> Author contributions Eva Budinská Conceptualization Data curation Formal analysis Validation Visualization Methodology Writing – original draft Project administration Writing – review and editing; Martina Hrivňáková Data curation Methodology Writing – review and editing; Tina Catela Ivkovic Lenka Zdražilová Dubská Data curation Validation Writing – original draft Writing – review and editing; Marie Madrzyk Data curation Software Writing – original draft; Rudolf Nenutil Resources Methodology Writing – original draft; Beatrix Bencsiková Data curation Formal analysis Writing – original draft Writing – review and editing; Dagmar Al Tukmachi Data curation Methodology Writing original draft Writing – review and editing; Michaela Ručková Software Validation Writing – original draft; Ondřej Slabý Supervision Investigation Methodology Writing – original draft; Josef Feit Supervision Validation Investigation Writing – original draft; Mihnea-­Paul Dragomir Formal analysis Investigation Writing – original draft Writing – review and editing; Petra Borilova Linhartova Investigation Writing – original draft Writing – review and editing; Sabine Tejpar Supervision Investigation Writing – original draft; Vlad Popovici Conceptualization Supervision Funding acquisition Investigation Methodology Writing – original draft Project administration Writing – review and editing",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7554/elife.86740",FALSE,"",TRUE,"<section> Funding: Funding: This work has been supported by the Deutsche Forschungsgemeinschaft (DFG) projects DO1240-­4-­1 DO1240_2–2 and SFB 936 – 178316478 – Z3 and by the Federal Ministry of Education and Research (BMBF) project 01EW2007B (all to THD). <section> Funding <section> Author contributions Anke Braun Conceptualization Data curation Software Formal analysis Investigation Visualization Methodology Writing – original draft Writing – review and editing; Tobias H Donner Conceptualization Supervision Funding acquisition Writing – original draft Project administration Writing – review",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.87860",FALSE,"",TRUE,"<section> Funding: This research was funded in whole or in part by the Wellcome Trust (FC001203). This work was supported by the Francis Crick Institute (FC001203) which receives its core funding from Cancer Research UK (FC001203) the UK Medical Research Council (FC001203) and the Wellcome Trust (FC001203). SS received funding by the Israel Science Foundation (913/21) and by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant nos. 714023 and 101000970). <section> Funding <section> Author contributions Imke Ensinck Conceptualization Data curation Formal analysis Validation Investigation Visualization Methodology Writing – original draft Project administration Writing – review and editing; Alexander Maman Conceptualization Resources Data curation Formal analysis Validation Investigation Visualization Methodology Writing – original draft Writing – review and editing; Waleed S Albihlal Data curation Formal analysis Validation Methodology; Michelangelo Lassandro Data curation Formal analysis Investigation Methodology; Giulia Salzano Theodora Sideri Steven Howell Enrica Calvani Harshil Patel Data curation Formal analysis Methodology; Guy Bushkin Investigation; Markus Ralser Supervision Funding acquisition; Ambrosius P Snijders Mark Skehel Formal analysis Supervision Methodology; Ana Casañal Data curation Formal analysis Supervision Methodology Project administration; Schraga Schwartz Conceptualization Resources Data curation Formal analysis Supervision Funding acquisition Investigation Visualization Methodology Writing – original draft Project administration Writing – review and editing; Folkert J van Werven Conceptualization Data curation Formal analysis Supervision Funding acquisition Investigation Visualization Methodology Writing – original draft Project administration Writing – review",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.88289",FALSE,"",TRUE,"<section> Funding: This work was supported by the DFG Emmy-­Noether grants KR 4062/4-­1 and KR 4062/4-­2 (JK). <section> Funding <section> Author contributions Carolin Gehr Conceptualization Data curation Formal analysis Investigation Visualization Methodology Writing original draft Writing review and editing; Jeremie Sibille Conceptualization Supervision Methodology Project administration; Jens Kremkow Conceptualization Resources Supervision Funding acquisition Validation Writing original draft Project administration Writing review",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7554/elife.88367",TRUE,"Competing interests <section> Denis Alexander Engemann: D.E. is a full-­time employee of F. Hoffmann-­La Roche Ltd. The other authors declare that no competing interests exist.",TRUE,"<section> Funding: See <section> Funding",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7554/elife.89736",FALSE,"",TRUE,"<section> Funding: Collaborative Research Centers funded by the Deutsche Forschungsgemeinschaft (German Research Foundation DFG) may require PhD students to attend workshops on good scientific practice research transparency and research data management. <section> Funding <section> Author contributions Friederike E Kohrs Investigation Visualization Writing – original draft Project administration Writing – review and editing; Susann Auer Alexandra Bannach-­Brown Susann Fiedler Tamarinde Laura Haven Verena Heise Constance Holman Conceptualization Investigation Methodology Writing – original draft Writing – review and editing; Flavio Azevedo René Bernard Arnim Bleier Nicole Bössel Brian Patrick Cahill Leyla Jael Castro Adrian Ehrenhofer Kristina Eichel Maximillian Frank Claudia Frick Malte Friese Anne Gärtner Kerstin Gierend David Joachim Grüning Lena Hahn Maren Hülsemann Malika Ihle Sabrina Illius Laura König Matthias König Louisa Kulke Anton Kutlin Fritjof Lammers David MA Mehler Christoph Miehl Anett Müller-­Alcazar Claudia Neuendorf Helen Niemeyer Florian Pargent Aaron Peikert Christina U Pfeuffer Robert Reinecke Jan Philipp Röer Jessica L Rohmann Alfredo Sánchez-­Tójar Stefan Scherbaum Elena Sixtus Lisa Spitzer Vera Maren Straßburger Marcel Weber Clarissa J Whitmire Josephine Zerna Dilara Zorbek Philipp Zumstein Investigation Writing – review and editing; Tracey L Weissgerber Conceptualization Funding acquisition Investigation",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7717/peerj.14607",TRUE,"Competing Interests Guido Hesselmann is an Academic Editor for PeerJ.",TRUE,"<section> Funding <section> This work was supported by the German Research Foundation (DFG grant HE 6244/1-2). <section> Grant Disclosures The following grant information was disclosed by the authors:",TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7717/peerj.14671",TRUE,"Disclosures The following grant information The Federal Ministry of Open Access Publication The German Research Foundation <section> Competing Interests The authors declare there <section> are no competing interests.",TRUE,"<section> The study is part of the research network EMANET—Emergency and Acute Medicine Network for Health Care Research which is funded by the Federal Ministry of Education and Research (BMBF). <section> Funding This study was funded by number 01GY1604. <section> Grant Disclosures The following grant information The Federal Ministry of Open Access Publication The German Research Foundation",TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7717/peerj.15499",TRUE,"Disclosures The following grant information was disclosed by the authors: Netherlands Organisation for Scientiﬁc Research (NWO).",TRUE,"<section> Funding <section> This research was supported by the Netherlands Organisation for Scientiﬁc Research (NWO) and the Graduate School of Behavioural and Cognitive Neuroscience (BCN) (No. <section> Grant Disclosures The following grant information was disclosed by the authors: Netherlands Organisation for Scientiﬁc Research (NWO).",TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,TRUE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA
"10.7759/cureus.43440",TRUE,"Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following: There are no prescribed conflicts of interest for any of the authors of this paper.",TRUE,"<section> Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. SJS received grants and nonfinancial support from Reactive Robotics GmbH (Munich Germany) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovations fond of the Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work.ny) ASP GmbH (Attendorn Germany) STIMIT AG (Biel Switzerland) ESICM (Geneva Switzerland) grants personal fees and nonfinancial support from Fresenius Kabi Deutschland GmbH (Bad Homburg Germany) grants from the Innovations fond of the Federal Joint Committee (G-BA) personal fees from Springer Verlag GmbH (Vienna Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld Germany) nonfinancial support from national and international societies (and their congress organizers) in the field of anesthesiology and intensive care medicine outside the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7759/cureus.45360",TRUE,"Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following:",TRUE,"<section> info: All authors have declared that no financial support was received from any organization for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7759/cureus.46751",TRUE,"Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.",TRUE,"<insert> TABLE 7: ClinicalTrials.gov search strategy advanced search Additional Information Disclosures Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7759/cureus.49612",TRUE,"Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following:",TRUE,"<section> Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",TRUE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"10.7759/cureus.50140",TRUE,"Conflicts of interest: In compliance with the ICMJE uniform disclosure form all authors declare the following:",TRUE,"<section> info: All authors have declared that no financial support was received from any organization for the submitted work.",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,"",FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
